PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Izar, P; Fernandez-Bolanos, M; Seex, L; Gort, G; Suscke, P; Tokuda, M; Mendonca-Furtado, O; Verderane, MP; Hemelrijk, CK				Izar, Patricia; Fernandez-Bolanos, Marcelo; Seex, Lauren; Gort, Gerrit; Suscke, Priscila; Tokuda, Marcos; Mendonca-Furtado, Olivia; Verderane, Michele P.; Hemelrijk, Charlotte K.			Female emancipation in a male dominant, sexually dimorphic primate under natural conditions	PLOS ONE			English	Article							FACED CAPUCHIN MONKEYS; SAPAJUS-LIBIDINOSUS; SOCIAL RELATIONSHIPS; CEBUS-CAPUCINUS; COMPETITION; MECHANISMS; HIERARCHY; BEHAVIOR; SOCIOECOLOGY; ORGANIZATION	In most group-living animals, a dominance hierarchy reduces the costs of competition for limited resources. Dominance ranks may reflect prior attributes, such as body size, related to fighting ability or reflect the history of self-reinforcing effects of winning and losing a conflict (the winner-loser effect), or both. As to prior attributes, in sexually dimorphic species, where males are larger than females, males are assumed to be dominant over females. As to the winner-loser effect, the computational model DomWorld has shown that despite the female's lower initial fighting ability, females achieve some degree of dominance of females over males. In the model, this degree of female dominance increases with the proportion of males in a group. This increase was supposed to emerge from the higher fraction of fights of males among themselves. These correlations were confirmed in despotic macaques, vervet monkeys, and in humans. Here, we first investigate this hypothesis in DomWorld and next in long-term data of 9,300 observation hours on six wild groups of robust capuchin monkeys (Sapajus libidinosus; S. nigritus, and S. xanthosternos) in three Brazilian sites. We test whether both the proportion of males and degree of female dominance over males are indeed associated with a higher relative frequency of aggression among males and a higher relative frequency of aggression of females to males. We confirm these correlations in DomWorld. Next, we confirm in empirical data of capuchin monkeys that with the proportion of males in the group there is indeed an increase in female dominance over males, and in the relative frequency of both male-male aggression and aggression of females to males and that the female dominance index is significantly positively associated with male male aggression. Our results reveal that adult sex ratio influences the power relation between the sexes beyond predictions from socioecological models.	[Izar, Patricia; Fernandez-Bolanos, Marcelo; Suscke, Priscila; Mendonca-Furtado, Olivia; Verderane, Michele P.] Univ Sao Paulo, Dept Expt Psychol, Sao Paulo, Brazil; [Seex, Lauren; Hemelrijk, Charlotte K.] Univ Groningen, Groningen Inst Evolutionary Life Sci, TRES, Theoret Res Evolutionary Life Sci, Groningen, Netherlands; [Gort, Gerrit] Wageningen Univ & Res, Biometris, Wageningen, Netherlands; [Tokuda, Marcos] Parque Zool Municipal Quinzinho Barros, Sorocaba, Brazil; [Mendonca-Furtado, Olivia] Natl Inst Atlantic Forest, Santa Teresa, Brazil	Universidade de Sao Paulo; University of Groningen; Wageningen University & Research	Izar, P (corresponding author), Univ Sao Paulo, Dept Expt Psychol, Sao Paulo, Brazil.	patrizar@usp.br	Izar, Patricia/C-3445-2012	Izar, Patricia/0000-0001-6741-0731	Dutch Research Council/NWO visitor grant [040.11.605]; Sao Paulo Research Foundation/FAPESP [00/01052-4, 00/14590-4, 06/51577-2, 08/55684-3, 09/51589-9, 10/51455-0, 14/13237-1, 06/51578-9, 08/52293-3, 09/50182-2, 10/51252-1]; National Council for Scientific and Technological Development/CNPq [420038/2005-1, 146183/2014-2]	Dutch Research Council/NWO visitor grant; Sao Paulo Research Foundation/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Dutch Research Council/NWO visitor grant 040.11.605 to CKH; by Sao Paulo Research Foundation/FAPESP grants to PI: 00/01052-4; 00/14590-4; 06/51577-2; 08/55684-3; 09/51589-9; 10/51455-0; 14/13237-1; to MPV: 06/51578-9; to OMF: 08/52293-3, to MT: 09/50182-2, and to PS: 10/51252-1; and by National Council for Scientific and Technological Development/CNPq grants to PI: 420038/2005-1 and to MFB: 146183/2014-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; Barton K., 2020, **DATA OBJECT**; Beacham JL, 2003, BEHAVIOUR, V140, P1275, DOI 10.1163/156853903771980594; Bergstrom ML, 2010, BEHAVIOUR, V147, P899, DOI 10.1163/000579510X497283; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; Bode NWF, 2012, BEHAV ECOL SOCIOBIOL, V66, P835, DOI 10.1007/s00265-012-1331-6; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Broom M, 2009, BEHAV ECOL, V20, P844, DOI 10.1093/beheco/arp069; Bush JM, 2016, ANIM BEHAV, V118, P65, DOI 10.1016/j.anbehav.2016.04.026; Cha^line N, 2015, FORMIGAS PONEROMORFA, V1st, P203; Chapais Bernard, 1992, P29; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941, DOI 10.1073/pnas.91.21.9941; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Engh AL, 2000, ANIM BEHAV, V60, P323, DOI 10.1006/anbe.2000.1502; Ferrari SF, 2009, DEV PRIMATOL-PROG PR, P155, DOI 10.1007/978-1-4419-0293-1_8; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Fragaszy DM, 2016, AM J PRIMATOL, V78, P473, DOI 10.1002/ajp.22509; Franz M, 2015, P ROY SOC B-BIOL SCI, V282, P113, DOI 10.1098/rspb.2015.1512; Hartig F., DHARMA RESIDUAL DIAG; Hemelrijk CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002678; Hemelrijk CK, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00839; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Hemelrijk CK, 2003, BEHAVIOUR, V140, P1247, DOI 10.1163/156853903771980585; Holekamp KE, 2016, CURR OPIN BEHAV SCI, V12, P44, DOI 10.1016/j.cobeha.2016.08.005; Honorio R, 2019, ANIM BEHAV, V157, P129, DOI 10.1016/j.anbehav.2019.09.007; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Izar P, 2006, AM J PRIMATOL, V68, P189, DOI 10.1002/ajp.20216; Izar P, 2004, BEHAVIOUR, V141, P71, DOI 10.1163/156853904772746619; Izar P, 2012, AM J PRIMATOL, V74, P315, DOI 10.1002/ajp.20968; IZAWA K, 1980, Primates, V21, P443, DOI 10.1007/BF02373834; Jack KM, 2006, DEV PRIMATOL-PROG PR, P367, DOI 10.1007/0-387-25872-8_18; Jandt JM, 2014, INSECT SOC, V61, P11, DOI 10.1007/s00040-013-0328-0; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Kappeler PM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0321; KAPPELER PM, 1990, FOLIA PRIMATOL, V55, P92, DOI 10.1159/000156504; Kappeler PM, 1993, FEMALE DOMINANCE PRI, P143; Lewis RJ, 2018, ANNU REV ANTHROPOL, V47, P533, DOI 10.1146/annurev-anthro-102317-045958; Lloyd EA, 1999, BIOL PHILOS, V14, P211, DOI 10.1023/A:1006638501739; Lukaszewski AW, 2016, J PERS SOC PSYCHOL, V110, P385, DOI 10.1037/pspi0000042; Mendonca-Furtado O, 2014, BEHAV PROCESS, V109, P79, DOI 10.1016/j.beproc.2014.09.010; MENDOZA SP, 1983, J HUM EVOL, V12, P185, DOI 10.1016/S0047-2484(83)80023-2; Newton-Fisher NE, 2017, INT J PRIMATOL, V38, P427, DOI 10.1007/s10764-017-9952-2; Ossi K, 2006, BEHAV ECOL SOCIOBIOL, V61, P53, DOI 10.1007/s00265-006-0236-7; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Palombit RA, 2014, ADV STUD BEHAV, V46, P191, DOI 10.1016/B978-0-12-800286-5.00005-5; Plavcan J. Michael, 2004, P230, DOI 10.1017/CBO9780511542459.015; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; R Core Team, 2021, R LANGUAGE ENV STAT; Rendall D, 2007, J HUM EVOL, V52, P504, DOI 10.1016/j.jhevol.2006.11.014; ROWELL TE, 1974, BEHAV BIOL, V11, P131, DOI 10.1016/S0091-6773(74)90289-2; Schjelderup-Ebbe T., 1922, Zeitschrift fuer Psychologie Leipzig, V88, P225; Schoof VAM, 2014, BEHAVIOUR, V151, P963, DOI 10.1163/1568539X-00003179; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Snow SS, 2019, J EVOLUTION BIOL, V32, P545, DOI 10.1111/jeb.13436; Strier KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114099; Strier KB, 2009, CURR ANTHROPOL, V50, P213, DOI 10.1086/592026; Stulp G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117860; Surbeck M, 2013, BEHAV ECOL SOCIOBIOL, V67, P1767, DOI 10.1007/s00265-013-1584-8; Suscke P, 2017, PRIMATES, V58, P141, DOI 10.1007/s10329-016-0557-8; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Tokuda M, 2018, ACTA ETHOL, V21, P1, DOI 10.1007/s10211-017-0277-0; Verderane MP, 2013, BEHAVIOUR, V150, P659, DOI 10.1163/1568539X-00003076; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4; Wong MYL, 2008, CURR BIOL, V18, pR372, DOI 10.1016/j.cub.2008.02.063; Young C, 2017, ANIM BEHAV, V125, P61, DOI 10.1016/j.anbehav.2017.01.006; Zhou TT, 2017, SCIENCE, V357, P162, DOI 10.1126/science.aak9726	71	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0249039	10.1371/journal.pone.0249039	http://dx.doi.org/10.1371/journal.pone.0249039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP4TZ	33872318	Green Published, gold			2022-12-26	WOS:000641723300005
J	Guillou, L; Sheybani, R; Jensen, AE; Di Carlo, D; Caffery, TS; Thomas, CB; Shah, AM; Tse, HTK; O'Neal, HR				Guillou, Lionel; Sheybani, Roya; Jensen, Anne E.; Di Carlo, Dino; Caffery, Terrell S.; Thomas, Christopher B.; Shah, Ajay M.; Tse, Henry T. K.; O'Neal, Hollis R., Jr.			Development and validation of a cellular host response test as an early diagnostic for sepsis	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; MORTALITY; CRITERIA	Sepsis must be diagnosed quickly to avoid morbidity and mortality. However, the clinical manifestations of sepsis are highly variable and emergency department (ED) clinicians often must make rapid, impactful decisions before laboratory results are known. We previously developed a technique that allows the measurement of the biophysical properties of white blood cells as they are stretched through a microfluidic channel. In this study we describe and validate the resultant output as a model and score-the IntelliSep Index (ISI)-that aids in the diagnosis of sepsis in patients with suspected or confirmed infection from a single blood draw performed at the time of ED presentation. By applying this technique to a high acuity cohort with a 23.5% sepsis incidence (n = 307), we defined specific metrics-the aspect ratio and visco-elastic inertial response-that are more sensitive than cell size or cell count in predicting disease severity. The final model was trained and cross-validated on the high acuity cohort, and the performance and generalizability of the model was evaluated on a separate low acuity cohort with a 6.4% sepsis incidence (n = 94) and healthy donors (n = 72). For easier clinical interpretation, the ISI is divided into three interpretation bands of Green, Yellow, and Red that correspond to increasing disease severity. The ISI agreed with the diagnosis established by retrospective physician adjudication, and accurately identified subjects with severe illness as measured by SOFA, APACHE-II, hospital-free days, and intensive care unit admission. Measured using routinely collected blood samples, with a short run-time and no requirement for patient or laboratory information, the ISI is well suited to aid ED clinicians in rapidly diagnosing sepsis.	[Guillou, Lionel; Sheybani, Roya; Jensen, Anne E.; Di Carlo, Dino; Shah, Ajay M.; Tse, Henry T. K.] Cytovale Inc, San Francisco, CA 94134 USA; [Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Caffery, Terrell S.; Thomas, Christopher B.; O'Neal, Hollis R., Jr.] Louisiana State Univ, Hlth Sci Ctr, Baton Rouge, LA USA	University of California System; University of California Los Angeles; Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport	Tse, HTK (corresponding author), Cytovale Inc, San Francisco, CA 94134 USA.	henry.tse@cytovale.com	Caffery, Terrell/AAR-3579-2021		Cytovale, Inc.; Breakout Labs (San Francisco, California); National Science Foundation [IIP-1315895, IIP-1431033]	Cytovale, Inc.; Breakout Labs (San Francisco, California); National Science Foundation(National Science Foundation (NSF))	Cytovale, Inc. funded this research, in part through grant support from Breakout Labs (San Francisco, California) and the National Science Foundation (IIP-1315895 and IIP-1431033). Patient consent and medical direction for the study was conducted independently at the study facilities under the direction of Drs. Caffery, Thomas, and O'Neal, who have no financial interest in Cytovale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crawford K, 2018, AM J RESP CRIT CARE, V198, P280, DOI 10.1164/rccm.201710-2077LE; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kochanek Kenneth D, 2019, Natl Vital Stat Rep, V68, P1; Liu VX, 2017, AM J RESP CRIT CARE, V196, P856, DOI 10.1164/rccm.201609-1848OC; Masaeli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37863; McHugh L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001916; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Rhee C, 2021, CLIN INFECT DIS, V72, P541, DOI 10.1093/cid/ciaa059; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Schuetz P, 2017, CRIT CARE MED, V45, P781, DOI [10.1097/CCM.0000000000002321, 10.1097/ccm.0000000000002321]; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Tsalik EL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6873; Tse HTK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006559; Wang HE, 2017, CRIT CARE MED, V45, P1443, DOI 10.1097/CCM.0000000000002538	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0246980	10.1371/journal.pone.0246980	http://dx.doi.org/10.1371/journal.pone.0246980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857126	Green Submitted, Green Published, gold			2022-12-26	WOS:000641474900089
J	Ingman, K; Hines, E; Mazzini, PLF; Rockwood, RC; Nur, N; Jahncke, J				Ingman, Kaytlin; Hines, Ellen; Mazzini, Piero L. F.; Rockwood, R. Cotton; Nur, Nadav; Jahncke, Jaime			Modeling changes in baleen whale seasonal abundance, timing of migration, and environmental variables to explain the sudden rise in entanglements in California	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; TROPHIC TRANSFER; EL-NINO; ECOSYSTEM; VARIABILITY; RECOVERY; NORTH; KRILL; INDICATOR; SELECTION	We document changes in the number of sightings and timing of humpback (Megaptera novaeangliae), blue (Balaenoptera musculus), and gray (Eschrichtius robustus) whale migratory phases in the vicinity of the Farallon Islands, California. We hypothesized that changes in the timing of migration off central California were driven by local oceanography, regional upwelling, and basin-scale climate conditions. Using 24 years of daily whale counts collected from Southeast Farallon Island, we developed negative binomial regression models to evaluate trends in local whale sightings over time. We then used linear models to assess trends in the timing of migration, and to identify potential environmental drivers. These drivers included local, regional and basin-scale patterns; the latter included the El Nino Southern Oscillation, the Pacific Decadal Oscillation, and the North Pacific Gyre Oscillation, which influence, wind-driven upwelling, and overall productivity in the California Current System. We then created a forecast model to predict the timing of migration. Humpback whale sightings significantly increased over the study period, but blue and gray whale counts did not, though there was variability across the time series. Date of breeding migration (departure) for all species showed little to no change, whereas date of migration towards feeding areas (arrival) occurred earlier for humpback and blue whales. Timing was significantly influenced by a mix of local oceanography, regional, and basin-scale climate variables. Earlier arrival time without concomitant earlier departure time results in longer periods when blue and humpback whales are at risk of entanglement in the Gulf of the Farallones. We maintain that these changes have increased whale exposure to pot and trap fishery gear off the central California coast during the spring, elevating the risk of entanglements. Humpback entanglement rates were significantly associated with increased counts and early arrival in central California. Actions to decrease the temporal overlap between whales and pot/trap fishing gear, particularly when whales arrive earlier in warm water years, would likely decrease the risk of entanglements.	[Ingman, Kaytlin; Rockwood, R. Cotton; Nur, Nadav; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA 94954 USA; [Ingman, Kaytlin; Hines, Ellen] SFSU, Estuary & Ocean Sci Ctr, Tiburon, CA 94920 USA; [Hines, Ellen] SFSU, Dept Geog & Environm, San Francisco, CA USA; [Mazzini, Piero L. F.] William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA USA	California State University System; San Francisco State University; California State University System; San Francisco State University; William & Mary; Virginia Institute of Marine Science	Ingman, K (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.; Ingman, K (corresponding author), SFSU, Estuary & Ocean Sci Ctr, Tiburon, CA 94920 USA.	kaytliningman@yahoo.com		Fernandes Mazzini, Piero Luigi/0000-0001-5048-5550; Rockwood, R. Cotton/0000-0002-1231-4221; Ingman, Kaytlin/0000-0003-0682-8194	Paul Angell Family Foundation; Bently Foundation; Boring Family Foundation; California Sea Grant; Campini Foundation; David and Lucile Packard Foundation; Elinor Paterson Baker Trust; Firedoll Foundation; Faucett Catalyst Fund; Giles W. and Elise G. Mead Foundation; Hellman Family Foundation; Kimball Foundation; Marisla Foundation; Moore Family Foundation; National Fish and Wildlife Foundation; Pacific Life Foundation; Resources Legacy Fund; RHE Charitable Fund; Thelma Doelger Trust; The Volganeau Foundation; Council on Ocean Affairs, Science, and Technology (COAST); American Cetacean Society -San Francisco Chapter (ACS); Estuary and Ocean Science Center	Paul Angell Family Foundation; Bently Foundation; Boring Family Foundation; California Sea Grant; Campini Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Elinor Paterson Baker Trust; Firedoll Foundation; Faucett Catalyst Fund; Giles W. and Elise G. Mead Foundation; Hellman Family Foundation; Kimball Foundation; Marisla Foundation; Moore Family Foundation; National Fish and Wildlife Foundation; Pacific Life Foundation; Resources Legacy Fund; RHE Charitable Fund; Thelma Doelger Trust; The Volganeau Foundation; Council on Ocean Affairs, Science, and Technology (COAST); American Cetacean Society -San Francisco Chapter (ACS); Estuary and Ocean Science Center	JJ, NN, KBI, and the biologist collecting data on the Farallon Islands received support from the Paul Angell Family Foundation, Bently Foundation, Boring Family Foundation, California Sea Grant, Campini Foundation, David and Lucile Packard Foundation, Elinor Paterson Baker Trust, Firedoll Foundation, Faucett Catalyst Fund, Giles W. and Elise G. Mead Foundation, Hellman Family Foundation, Kimball Foundation, Marisla Foundation, Moore Family Foundation, National Fish and Wildlife Foundation, Pacific Life Foundation, Resources Legacy Fund, RHE Charitable Fund, Thelma Doelger Trust, The Volganeau Foundation, and the many Point Blue donors who have helped fund wildlife monitoring on the Southeast Farallon Island. KBI also received support from the Council on Ocean Affairs, Science, and Technology (COAST), the American Cetacean Society -San Francisco Chapter (ACS), and the Estuary and Ocean Science Center Scholarship and Student Association.	Abrahms B, 2019, P NATL ACAD SCI USA, V116, P5582, DOI 10.1073/pnas.1819031116; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Becker E. A., 2012, Endangered Species Research, V16, P97, DOI 10.3354/esr00390; Benson SR, 2002, PROG OCEANOGR, V54, P279, DOI 10.1016/S0079-6611(02)00054-X; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Busquets-Vass G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177880; Calambokidis J, 2000, MAR ECOL PROG SER, V192, P295, DOI 10.3354/meps192295; Calambokidis John, 2002, Journal of Cetacean Research and Management, V4, P267; Carretta JV., 2016, US PACIFIC DRAFT MAR; [CDFW] California Department of Fish and Wildlife, 2014, CURR CAL OC RECR FIS; Chenillat F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049966; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; Dorman JG, 2015, MAR ECOL PROG SER, V528, P87, DOI 10.3354/meps11253; Dransfield A, 2014, ENDANGER SPECIES RES, V26, P39, DOI 10.3354/esr00627; Fleming AH, 2016, GLOBAL CHANGE BIOL, V22, P1214, DOI 10.1111/gcb.13171; Fontana RE, 2016, PROG OCEANOGR, V142, P1, DOI 10.1016/j.pocean.2016.01.004; Garcia-Reyes M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005576; Hazen EL, 2017, J APPL ECOL, V54, P1415, DOI 10.1111/1365-2664.12820; Hilty J, 2000, BIOL CONSERV, V92, P185, DOI 10.1016/S0006-3207(99)00052-X; IvensDuran M, 2019, DUNGENESS CRAB METAC; Jacox M., 2016, NINO, V57; Kerosky SM, 2012, DEEP-SEA RES PT I, V65, P125, DOI 10.1016/j.dsr.2012.03.013; Kutner M., 2004, APPL LINEAR STAT MOD; LAWLESS JF, 1987, CAN J STAT, V15, P209, DOI 10.2307/3314912; Lawson D., 2016, UPDATES WHALE ENTANG; Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032; Leising AW., 2015, CALCOFI REPORT, V56; Lewison RL, 2015, BIOSCIENCE, V65, P486, DOI 10.1093/biosci/biv018; LYNN RJ, 1987, J GEOPHYS RES-OCEANS, V92, P12947, DOI 10.1029/JC092iC12p12947; MacLeod Colin D., 2009, Endangered Species Research, V7, P125, DOI 10.3354/esr00197; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinez-Rincon RO, 2019, DEEP-SEA RES PT II, V159, P103, DOI 10.1016/j.dsr2.2018.12.001; Miller AJ, 2004, J OCEANOGR, V60, P163, DOI 10.1023/B:JOCE.0000038325.36306.95; Monnahan CC, 2015, MAR MAMMAL SCI, V31, P279, DOI 10.1111/mms.12157; Mood A., 1973, INTRO THEORY STAT; National Marine Fisheries Service, 2020, 2019 W COAST WHAL EN; National Marine Fisheries Service, 2017, 2016 W COAST ENT SUM; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Pyle Peter, 1996, Northwestern Naturalist, V77, P1, DOI 10.2307/3536517; Racault MF, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00133; Ramp C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121374; Rockwood RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183052; Rugh David J., 2001, Journal of Cetacean Research and Management, V3, P31; Salvadeo CJ, 2011, CIENC MAR, V37, P215, DOI 10.7773/cm.v37i2.1840; Salvadeo CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134655; Salvadeo Christian J., 2010, Endangered Species Research, V11, P13, DOI 10.3354/esr00252; Santora JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14215-w; Santora JA, 2012, PROG OCEANOGR, V106, P154, DOI 10.1016/j.pocean.2012.08.005; Santora JA, 2012, ICES J MAR SCI, V69, P1317, DOI 10.1093/icesjms/fss048; Santora JA, 2011, PROG OCEANOGR, V91, P397, DOI 10.1016/j.pocean.2011.04.002; Shelden KEW, 2004, ECOL APPL, V14, P1789, DOI 10.1890/03-5349; Silber GK, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00413; Studwell AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169517; Surma S, 2015, FISH OCEANOGR, V24, P291, DOI 10.1111/fog.12109; Szesciorka AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64855-y; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Tulloch VJD, 2019, GLOBAL CHANGE BIOL, V25, P1263, DOI 10.1111/gcb.14573; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015	61	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248557	10.1371/journal.pone.0248557	http://dx.doi.org/10.1371/journal.pone.0248557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857163	Green Published, gold			2022-12-26	WOS:000641474900009
J	Nieman, CM; Rudman, AN; Chory, ML; Murray, GD; Fairbanks, L; Campbell, LM				Nieman, Cassandra M.; Rudman, Alexie N.; Chory, Margaret L.; Murray, Grant D.; Fairbanks, Luke; Campbell, Lisa M.			Fishing for food: Values and benefits associated with coastal infrastructure	PLOS ONE			English	Article							HEALTH; FUN	While there is substantial literature about the socio-cultural characteristics and values associated with recreational and commercial fisheries in the U.S., studies directed at those who 'fish for food'-those who depend on consuming their catch to various degrees-are relatively sparse. Using qualitative data collected through 80 semi-structured interviews with fishers in the summer and fall of 2018 in Carteret County, North Carolina, this study aims to better understand the group of recreational fishers who consume their catch by describing social and cultural dimensions and values associated with fishing for food, examining the role of infrastructure in facilitating access to benefits associated with this activity, and considering how knowledge of existing licensing regulations surrounding subsistence license waivers affect this fishing community. Interviews conducted at free public fishing structures in the region revealed that fishers derive a variety of values and benefits from fishing at these sites, including access to recreation, nutrition, a social community, and mental health benefits, which were found to be negatively impacted by Hurricane Florence in September 2018. We also found an informal economy of sharing catch on- and off-site that extends the reach and benefits facilitated by public infrastructure to people beyond those using it directly. Overall, we call for conceptualizations of 'fishing for food' that include aspects that go beyond traditional definitions of 'subsistence' or 'recreational' fishing such as food security, access, and less obvious social and cultural motivations behind the activity. These findings are a compelling rationalization for the creation and maintenance of formal and informal fishing places locally and, by extension, in other coastal areas, given the array of benefits provided by access to these types of locations.	[Nieman, Cassandra M.; Rudman, Alexie N.; Chory, Margaret L.; Murray, Grant D.; Campbell, Lisa M.] Duke Univ, Nicholas Sch Environm, Marine Lab, Beaufort, NC 28516 USA; [Nieman, Cassandra M.] US EPA, Oak Ridge Inst Sci & Educ, Washington, DC 20460 USA; [Fairbanks, Luke] Univ Southern Mississippi, Sch Ocean Sci & Engn, Div Coastal Sci, Ocean Springs, MS USA	Duke University; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; University of Southern Mississippi	Rudman, AN (corresponding author), Duke Univ, Nicholas Sch Environm, Marine Lab, Beaufort, NC 28516 USA.	alexienrudman@gmail.com		Fairbanks, Luke/0000-0003-3477-7806; Chory, Margaret/0000-0002-2067-2459; Nieman, Cassandra/0000-0003-4509-914X; Campbell, Lisa/0000-0001-8731-3699; , Alexie/0000-0003-3487-6396	NC Sea Grant project "The Value of Fishing, Farming, and Eating: new approaches to understanding coastal community well-being in a changing world" [R/18-RCE-1]; Joseph S. Ramus Endowment Fund [2018-001]	NC Sea Grant project "The Value of Fishing, Farming, and Eating: new approaches to understanding coastal community well-being in a changing world"; Joseph S. Ramus Endowment Fund	G.M. and L.C. received funding from the NC Sea Grant project "The Value of Fishing, Farming, and Eating: new approaches to understanding coastal community well-being in a changing world", Project Number R/18-RCE-1. https://ncseagrant.ncsu.edu/news/2018/05/nc-sea-grant-announces-2018-2020-core-research-projects/Additional funding was provided to G.M. and L.C. from the Joseph S. Ramus Endowment Fund (2018-001). Neither funding source was involved in the study design, collection and interpretation of the data, the writing of the report, or the decision to submit for publication.	Aas Oystein, 2008, GLOBAL CHALLENGES RE; Association of Fish & Wildlife Agencies, 2019, AM SYSTEM CONSERVATI; Boucquey N, 2017, J RURAL STUD, V54, P138, DOI 10.1016/j.jrurstud.2017.06.018; Brown RB, 1998, RURAL SOCIOL, V63, P599, DOI 10.1111/j.1549-0831.1998.tb00694.x; Brown-Pickren L, 2016, ISKY BUSINESS CONSUM; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Cooke SJ, 2018, FISH FISH, V19, P201, DOI 10.1111/faf.12246; Dray A., 2009, POLITICS PRIVATIZATI; Ebbin S. A., 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-016-0087-z; Erlambang T., 2008, ESTIMATING EC IMPACT; Food and Agriculture Organization, 2012, FAO TECHN GUID RESP; Hunt W, 2016, AUST NZ J PUBL HEAL, V40, P292, DOI 10.1111/1753-6405.12490; Kalina M, 2019, J POLIT ECOL, V26, P363, DOI 10.2458/v26i1.23008; Lambden J, 2006, INT J CIRCUMPOL HEAL, V65, P331, DOI 10.3402/ijch.v65i4.18117; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Mason M., 2010, FORUM QUAL SOC RES, V11; McClenachan L, 2013, ENVIRON HIST-US, V18, P76, DOI 10.1093/envhis/ems110; North Carolina Wildlife Resources Commission, 2018, PUBLIC RECORDS REQUE; Perkinson MT, 2016, ENVIRON HEALTH INSIG, V10, P201, DOI [10.4137/EHI.S40668, 10.4137/ehi.s40668]; Pitchon Ana, 2012, Bulletin Southern California Academy of Sciences, V111, P141; Pulford E, 2017, J ENVIRON MANAGE, V199, P242, DOI 10.1016/j.jenvman.2017.05.046; Siwar C., 2006, P PERS ANT PEMB AC U, P41; Steinback S, 2009, MAR POLICY, V33, P49, DOI 10.1016/j.marpol.2008.04.001; STRUTZEL E, 1968, NURS RES, V17, P364; Toth JF., 2001, J RURAL SOC SCI, V17, P5; U.S. Department of the Interior U.S. Fish and Wildlife Service and U.S. Department of Commerce U.S. Census Bureau, 2018, 2016 NATL SURVEY FIS; United States Access Board, 2003, ACCESSIBLE FISHING P	28	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249725	10.1371/journal.pone.0249725	http://dx.doi.org/10.1371/journal.pone.0249725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857188	Green Published, gold			2022-12-26	WOS:000641474900078
J	Morgan, K; Lowthian, E; Hawkins, J; Hallingberg, B; Alhumud, M; Roberts, C; Murphy, S; Moore, G				Morgan, Kelly; Lowthian, Emily; Hawkins, Jemma; Hallingberg, Britt; Alhumud, Manal; Roberts, Chris; Murphy, Simon; Moore, Graham			Sugar-sweetened beverage consumption from 1998-2017: Findings from the health behaviour in school-aged children/school health research network in Wales	PLOS ONE			English	Article							ENERGY DRINK CONSUMPTION; SOFT DRINKS; ADOLESCENTS; RISK; ASSOCIATIONS; PREVALENCE; CHILDHOOD; YOUNG	To date no study has examined time trends in adolescent consumption of sugar-sweetened beverages and energy drinks, or modelled change in inequalities over time. The present study aimed to fill this gap by identifying historical trends among secondary school students in Wales, United Kingdom. The present study includes 11-16 year olds who completed the Health Behaviour in School-aged Children (HBSC) survey and the Welsh School Health Research Network (SHRN) survey between 1998 to 2017. Multinomial regression models were employed alongside tests for interaction effects. A total of 176,094 student responses were assessed. From 1998 to 2017, the prevalence of daily sugar-sweetened beverage consumption decreased (57% to 18%) while weekly consumption has remained constant since 2006 (49% to 52%). From 2013 to 2017, daily consumption of energy drinks remained stable (6%) while weekly consumption reports steadily decreased (23% to 15%). Boys, older children and those from a low socioeconomic group reported higher consumption rates of sugar-sweetened beverages and energy drinks. Consumption according to socioeconomic group was the only characteristic to show a statistically significant change over time, revealing a widening disparity between sugar-sweetened beverage consumption rates of those from low and high socioeconomic groups. Findings indicate a positive shift in overall consumption rates of both sugar-sweetened beverages and energy drinks. Adolescents from a low socioeconomic group however were consistently shown to report unfavourable sugar-sweetened beverages consumption when compared to peers from high socioeconomic group. Given the established longer term impacts of sugar-sweetened beverage and energy drink consumption on adolescent health outcomes, urgent policy action is required to reduce overall consumption rates, with close attention to equity of impact throughout policy design and evaluation plans.	[Morgan, Kelly; Lowthian, Emily; Hawkins, Jemma; Murphy, Simon; Moore, Graham] Cardiff Univ, Ctr Dev Evaluat Complex & Implementat Publ Hlth I, Sch Social Sci, Cardiff, Wales; [Hallingberg, Britt] Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cardiff, Wales; [Alhumud, Manal] King Saudi Univ, Community Hlth Sci, Appl Med Sci, Riyadh, Saudi Arabia; [Roberts, Chris] Welsh Govt, Knowledge & Analyt Serv, Cardiff, Wales	Cardiff University; Cardiff Metropolitan University	Morgan, K (corresponding author), Cardiff Univ, Ctr Dev Evaluat Complex & Implementat Publ Hlth I, Sch Social Sci, Cardiff, Wales.	Morgank22@cardiff.ac.uk		Lowthian, Emily/0000-0001-9362-0046	Health and Care Research Wales Health Fellowship Award [HF-16-1164]; Welsh Government through Health and Care Research Wales; Public Health Division, Welsh Government; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation [MR/KO232331/1]; Cancer Research UK, Economic and Social Research Council; Medical Research Council; Wellcome Trust; UK Clinical Research Collaboration; Welsh Government; MRC [MR/L002787/1, G0701875, MR/K023233/1] Funding Source: UKRI	Health and Care Research Wales Health Fellowship Award; Welsh Government through Health and Care Research Wales; Public Health Division, Welsh Government; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); British Heart Foundation(British Heart Foundation); Cancer Research UK, Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; Welsh Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Health and Care Research Wales Health Fellowship Award [grant number HF-16-1164 to K.M.]. The Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer) is funded by Welsh Government through Health and Care Research Wales. This work was supported also by the Public Health Division, Welsh Government with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence. Joint funding [grant number MR/KO232331/1] from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BBC NEWS; Arthur R, UK BANS SALE ENERGY; Benton D, 2015, CRIT REV FOOD SCI, V55, P988, DOI 10.1080/10408398.2012.679980; Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00134; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; British Dietetics Association, ENERGY DRINKS YOUNG; British Soft Drinks Association, 2020, POSITION STATEMENTS; British Soft Drinks Association, 2017, POISITON STATEMENT E; Cheng R, 2009, J ZHEJIANG UNIV-SC B, V10, P395, DOI 10.1631/jzus.B0820245; Church S. Report to the Food Standards Agency, 2008, TRENDS PORTION SIZES; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; GOV.UK, POLICY PAPER SOFT DR; Hallingberg B, 2019, TOB CONTROL; Harris JL, 2011, EVALUATING SUGARY DR; Hartley JEK, 2016, CHILD INDIC RES, V9, P233, DOI 10.1007/s12187-015-9325-3; Hashem KM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018136; Holstein Bjorn E., 2020, Nutrition and Health (Bicester), V26, p0260106019900742, DOI 10.1177/0260106019900742; Isgor Z, 2016, HEALTH PLACE, V39, P43, DOI 10.1016/j.healthplace.2016.02.008; Larson N, 2016, J ACAD NUTR DIET, V116, P240, DOI 10.1016/j.jand.2015.09.013; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Miller Caroline, 2019, BMC Obes, V6, P1, DOI 10.1186/s40608-018-0224-2; Mordor Intelligence, GLOBAL ENERGY DRINKS; Oh J., 2019, KOREAN J HLTH PROMOT, V19, P145; Public Health England, SUG RED RESP CHALL; Public Health Wales NHS Trust, CHILD MEASUREMENT PR; Reid JL, 2015, CAN J PUBLIC HEALTH, V106, pE101, DOI 10.17269/cjph.106.4684; Rethink sugary drink, ENERGY DRINKS HIDE 2; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Scarborough P, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003025; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Scottish Goverment, ENDING SALE ENERGY D; Tahmassebi JF, 2020, EUR ARCH PAEDIATR DE, V21, P109, DOI 10.1007/s40368-019-00458-0; Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53; Terry-McElrath YM, 2013, AM J PREV MED, V44, P573, DOI 10.1016/j.amepre.2013.01.026; Torsheim T, 2016, CHILD INDIC RES, V9, P771, DOI 10.1007/s12187-015-9339-x; Utter J, 2018, J PAEDIATR CHILD H, V54, P279, DOI 10.1111/jpc.13708; Vercammen KA, 2019, AM J PREV MED, V56, P827, DOI 10.1016/j.amepre.2018.12.007; Visram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010380; Welsh Assembly Government, 2008, APPETITE LIFE ACTION; Welsh Government, HLTH WEIGHT HLTH WAL; World Health Organisation, 2017, ADOLESCENT OBESITY R; Zucconi S., 2013, EFSA SUPPORT PUBL, V10, p394E, DOI DOI 10.2903/SP.EFSA.2013.EN-394	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0248847	10.1371/journal.pone.0248847	http://dx.doi.org/10.1371/journal.pone.0248847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852585	Green Accepted, Green Published, gold			2022-12-26	WOS:000640604500021
J	Broberg, L				Broberg, Len			Relative snowpack response to elevation, temperature and precipitation in the Crown of the Continent region of North America 1980-2013	PLOS ONE			English	Article							WESTERN UNITED-STATES; ROCKY-MOUNTAIN RIVERS; INTERANNUAL VARIABILITY; WATER EQUIVALENT; EXTREME SNOWFALL; SNOWMELT RUNOFF; CLIMATE-CHANGE; IMPACTS; TRENDS; ACCUMULATION	Water availability in western Canada and the United States is dependent on the accumulation of snowpack in the montane regions and threatened by increased winter temperature and more precipitation as rain linked to climate change. In order to make reasoned decisions to adapt to climate change managers require knowledge of the role of temperature and precipitation in SWE development and data to distinguish the relative retention response of snowpack regions to expected temperature and precipitation regime shifts at the watershed scale. Using the Daymet interpolated 1 km(2) dataset, effects of elevation, temperature (T-max, T-min and T-avg) and precipitation on April 1 SWE in the Crown of the Continent were tested by linear regression and Kendall correlation. Changes in Daymet estimated snow water equivalent (SWE) in response to increased temperatures and changes in precipitation were estimated in two ways: 1) comparing April 1SWE in the 11 warmest (mean T-max February) and driest (mean precipitation January to March) years with the 22 cooler/wetter years 1981-2013 and 2) SWE retention from April 1 to June 1 over the period 1980 to 2013 across 120 watersheds in a major continental headwater region, the Crown of the Continent of North America. Historical analysis of period warm year April 1 SWE was assumed to indicate the recent impact of warmer winter temperatures. Changes in snowpack April 1 to June 1 reflected likely effects on peak runoff and were, therefore, also relevant for future climate change adaptation considerations. Winter (JFM) precipitation proved more influential than temperature in shaping April 1 SWE response at the regional scale. Of the three factors, elevation was most positively associated with April 1 SWE at the watershed scale. Temperature and precipitation influenced SWE accumulation and persistence at the watershed scale, but higher precipitation was more closely associated with higher April 1 SWE retention. Ranking of watershed snowpack retention in warm and dry years, combined with spring snowpack retention offers data to assist identification of watersheds with greatest snowpack persistence in the face of anticipated climate change effects.	[Broberg, Len] Univ Montana, Environm Studies Program, Missoula, MT 59812 USA	University of Montana System; University of Montana	Broberg, L (corresponding author), Univ Montana, Environm Studies Program, Missoula, MT 59812 USA.	len.broberg@umontana.edu			LB, Crown Managers Partnership	LB, Crown Managers Partnership	LB, Crown Managers Partnership, https://www.crownmanagers.org/.The funders assisted in GIS data collection.	Adam JC, 2009, HYDROL PROCESS, V23, P962, DOI 10.1002/hyp.7201; Alberta Environment, ALBERTA RIVER BASINS; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Broxton PD, 2016, EARTH SPACE SCI, V3, P246, DOI 10.1002/2016EA000174; Buttle JM, 2016, HYDROL PROCESS, V30, P4644, DOI 10.1002/hyp.10931; Carey SK, 2010, HYDROL PROCESS, V24, P3591, DOI 10.1002/hyp.7880; Cayan DR, 1996, J CLIMATE, V9, P928, DOI 10.1175/1520-0442(1996)009<0928:ICVASI>2.0.CO;2; Clow DW, 2012, HYDROL PROCESS, V26, P2583, DOI 10.1002/hyp.9385; Crown Managers Partnership Sexton E, STREAMS CROWN CONTIN; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DeBeer CM, 2017, J HYDROL, V553, P199, DOI 10.1016/j.jhydrol.2017.07.051; DeBeer CM, 2016, HYDROL EARTH SYST SC, V20, P1573, DOI 10.5194/hess-20-1573-2016; Driscoll JM, 2017, J AM WATER RESOUR AS, V53, P655, DOI 10.1111/1752-1688.12520; ELDER K, 1991, WATER RESOUR RES, V27, P1541, DOI 10.1029/91WR00506; Essou GRC, 2016, J HYDROL, V537, P334, DOI 10.1016/j.jhydrol.2016.03.063; Farjad B, 2016, WATER RESOUR MANAG, V30, P2851, DOI 10.1007/s11269-016-1329-3; Fassnacht SR, 2017, FRONT EARTH SCI-PRC, V11, P505, DOI 10.1007/s11707-017-0641-4; Fyfe JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14996; Geddes CIA, 2005, ARCT ANTARCT ALP RES, V37, P197, DOI 10.1657/1523-0430(2005)037[0197:TAVAPO]2.0.CO;2; Great Northern Landscape Conservation Cooperative and Sexton E, CROWN CONTINENT; Grunewald T, 2010, CRYOSPHERE, V4, P215, DOI 10.5194/tc-4-215-2010; Hall DK, 2007, HYDROL PROCESS, V21, P1534, DOI 10.1002/hyp.6715; Hamlet AF, 2007, J CLIMATE, V20, P1468, DOI 10.1175/JCLI4051.1; Hauer FR, 2007, J AM WATER RESOUR AS, V43, P104, DOI 10.1111/j.1752-1688.2007.00009.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hu JM, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab763f; Hunter T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026600; IPCC, 2014, 2014 IEEE STUD C EL, DOI 10.1017/CBO9781107415324; Jones LA, 2017, CLIMATIC CHANGE, V144, P641, DOI 10.1007/s10584-017-2060-7; Joyce LA, 2018, ADV GLOB CHANGE RES, V63, P17, DOI 10.1007/978-3-319-56928-4_2; Kang DH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19299; Kapnick S, 2012, CLIM DYNAM, V38, P1885, DOI 10.1007/s00382-011-1089-y; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Kovach RP, 2016, REV FISH BIOL FISHER, V26, P135, DOI 10.1007/s11160-015-9414-x; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Lisi PJ, 2015, GEOPHYS RES LETT, V42, P3380, DOI 10.1002/2015GL064083; Luce CH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039407; Lukas J., 2014, CLIMATE CHANGE COLOR; Lute AC, 2015, WATER RESOUR RES, V51, P960, DOI 10.1002/2014WR016267; Lute AC, 2014, WATER RESOUR RES, V50, P2874, DOI 10.1002/2013WR014465; McCabe GJ, 2005, J HYDROMETEOROL, V6, P476, DOI 10.1175/JHM428.1; Mendoza PA, 2015, J HYDROMETEOROL, V16, P762, DOI 10.1175/JHM-D-14-0104.1; Ministry of Environment and Climate, 2019, PREL STRAT CLIM RISK; Moran-Tejeda E, 2013, GEOPHYS RES LETT, V40, P2131, DOI 10.1002/grl.50463; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Mott R, 2011, CRYOSPHERE, V5, P1083, DOI 10.5194/tc-5-1083-2011; Musselman KN, 2017, NAT CLIM CHANGE, V7, P214, DOI [10.1038/nclimate3225, 10.1038/NCLIMATE3225]; National Hydro Network, RELEASE NOTES; Natural Resources Canada, TOPOGRAPHIC INFORM; O'Gorman PA, 2014, NATURE, V512, P416, DOI 10.1038/nature13625; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Patton T, 2017, WATER CLIMATE CHANGE; PEDERSON G, 2007, SUSTAINING ROCKY MOU, P151; Pederson GT, 2013, GEOPHYS RES LETT, V40, P1811, DOI 10.1002/grl.50424; Pierce DW, 2013, J CLIMATE, V26, P4148, DOI 10.1175/JCLI-D-12-00534.1; Romolo L, 2006, HYDROL PROCESS, V20, P4097, DOI 10.1002/hyp.6421; Rood SB, 2008, J HYDROL, V349, P397, DOI 10.1016/j.jhydrol.2007.11.012; Roth TR, 2017, HYDROL EARTH SYST SC, V21, P5427, DOI 10.5194/hess-21-5427-2017; Selkowitz DJ, 2002, HYDROL PROCESS, V16, P3651, DOI 10.1002/hyp.1234; Sensing NOHR, 2004, **DATA OBJECT**; Serreze MC, 2001, WATER RESOUR RES, V37, P675, DOI 10.1029/2000WR900307; Serreze MC, 1999, WATER RESOUR RES, V35, P2145, DOI 10.1029/1999WR900090; Sexstone GA, 2014, CRYOSPHERE, V8, P329, DOI 10.5194/tc-8-329-2014; Shepherd A, 2010, HYDROL PROCESS, V24, P3864, DOI 10.1002/hyp.7818; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Sospedra-Alfonso R, 2015, GEOPHYS RES LETT, V42, P4429, DOI 10.1002/2015GL063898; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Thornton P.E., 2019, DAYMET DAILY SURFACE; Thornton PE, 2000, AGR FOREST METEOROL, V104, P255, DOI 10.1016/S0168-1923(00)00170-2; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Troch PA, 2015, WATER RESOUR RES, P1; Vincent LA, 2015, J CLIMATE, V28, P4545, DOI 10.1175/JCLI-D-14-00697.1; Viviroli D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005653; Vose RS, 2012, B AM METEOROL SOC, V93, P1677, DOI 10.1175/BAMS-D-11-00241.1; Wessa P., PAIRED UNPAIRED 2 SA; Wessa P., MULTIVARIATE CORRELA; Whitlock C., 2017, 2017 MONTANA CLIMATE; Zeng XB, 2018, GEOPHYS RES LETT, V45, P12940, DOI 10.1029/2018GL079621; Zhao HX, 2013, INT J CLIMATOL, V33, P388, DOI 10.1002/joc.3431	80	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0248736	10.1371/journal.pone.0248736	http://dx.doi.org/10.1371/journal.pone.0248736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848296	gold, Green Published			2022-12-26	WOS:000640373500001
J	Ibrahim, AA; Akindele, MO; Ganiyu, SO; Kaka, B; Bello, B				Ibrahim, Aminu Alhassan; Akindele, Mukadas Oyeniran; Ganiyu, Sokunbi Oluwaleke; Kaka, Bashir; Bello, Bashir			The Hausa Back Beliefs Questionnaire: Translation, cross-cultural adaptation and psychometric assessment in mixed urban and rural Nigerian populations with chronic low back pain	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; HEALTH-CARE; NEGATIVE BELIEFS; DISABILITY; INTENSITY; VERSION; IMPACT; WORK; ASSOCIATION; VALIDATION	Introduction Negative attitudes and beliefs about low back pain (LBP) can lead to reduced function and activity and consequently disability. One self-report measure that can be used to assess these negative attitudes and beliefs and to determine their predictive nature is the Back Beliefs Questionnaire (BBQ). This study aimed to translate and cross-culturally adapt the BBQ into Hausa and assess its psychometric properties in mixed urban and rural Nigerian populations with chronic LBP. Methods The BBQ was translated and cross-culturally adapted into Hausa (Hausa-BBQ) according to established guidelines. To assess psychometric properties, a consecutive sample of 200 patients with chronic LBP recruited from urban and rural clinics of Nigeria completed the questionnaire along with measures of fear-avoidance beliefs, pain catastrophizing, functional disability, physical and mental health, and pain. One hundred of the 200 patients completed the questionnaire twice at an interval of 7-14 days to assess test-retest reliability. Internal construct validity was assessed using exploratory factor analysis, and external construct validity was assessed by examining convergent, divergent, and known-groups validity. Reliability was assessed by calculating internal consistency (Cronbach's alpha), intraclass correlation coefficients (ICC), standard error of measurement (SEM), minimal detectable change at 95% confidence interval (MDC95), and limits of agreement using Bland-Altman plots. Reliability (ICC, SEM and MDC95) was also assessed separately for rural and urban subgroups. Results The factor analysis revealed a four-factor solution explaining 58.9% of the total variance with the first factor explaining 27.1%. The nine scoring items loaded on the first factor hence supporting a unidimensional scale. The convergent and divergent validity were supported as 85% (6:7) of the predefined hypotheses were confirmed. Known-groups comparison showed that the questionnaire discriminated well for those who differed in education (p < 0.05), but not in age (p > 0.05). The internal consistency and ICC (alpha = 0.79; ICC = 0.91) were adequate, with minimal SEM and MDC95 (1.9 and 5.2, respectively). The limits of agreements were -5.11 to 5.71. The ICC, SEM and MDC95 for the urban and rural subgroups were comparable to those obtained for the overall population. Conclusions The Hausa-BBQ was successfully adapted and psychometrically sound in terms of internal and external construct validity, internal consistency, and test-retest reliability in mixed urban and rural Hausa-speaking populations with chronic LBP. The questionnaire can be used to detect and categorize specific attitudes and beliefs about back pain in Hausa culture to prevent or reduce potential disability due to LBP.	[Ibrahim, Aminu Alhassan; Akindele, Mukadas Oyeniran; Ganiyu, Sokunbi Oluwaleke; Kaka, Bashir; Bello, Bashir] Bayero Univ Kano, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Physiotherapy, Kano, Kano State, Nigeria; [Ibrahim, Aminu Alhassan] Hosp Management Board, Dept Physiotherapy, Muhammad Abdullahi Wase Teaching Hosp, Kano, Kano State, Nigeria	Bayero University	Ibrahim, AA (corresponding author), Bayero Univ Kano, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Physiotherapy, Kano, Kano State, Nigeria.; Ibrahim, AA (corresponding author), Hosp Management Board, Dept Physiotherapy, Muhammad Abdullahi Wase Teaching Hosp, Kano, Kano State, Nigeria.	amenconafs@gmail.com	Bello, Bashir/GOJ-9866-2022; Kaka, Bashir/D-3342-2018; Ibrahim, Aminu A./AAJ-9996-2020	Kaka, Bashir/0000-0001-9138-0675; A. Ibrahim, Aminu/0000-0002-5711-1639				Adamu AS, 2019, SPINE, V44, pE1092, DOI 10.1097/BRS.0000000000003068; Alamrani S, 2016, SPINE, V41, pE681, DOI 10.1097/BRS.0000000000001341; Alyousef B, 2018, MENOPAUSE, V25, P977, DOI 10.1097/GME.0000000000001145; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Beales D, 2015, PHYS THER, V95, P180, DOI 10.2522/ptj.20140064; Beaton DE, 2000, SPINE, V25, P3192, DOI 10.1097/00007632-200012150-00015; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bostick GP, 2013, EUR J PAIN, V17, P1074, DOI 10.1002/j.1532-2149.2012.00275.x; Bowey-Morris J, 2011, CLIN J PAIN, V27, P214, DOI 10.1097/AJP.0b013e3181ffc00b; Buchbinder R, 2005, SPINE, V30, P1323, DOI 10.1097/01.brs.0000164121.77862.4b; Burnett A, 2009, CLIN J PAIN, V25, P20, DOI 10.1097/AJP.0b013e3181805a1e; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Chen G, 2011, SPINE, V36, P1505, DOI 10.1097/BRS.0b013e3181f49eec; Cheung PWH, 2018, EUR SPINE J, V27, P1724, DOI 10.1007/s00586-018-5576-2; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; de Vet HW, 2011, MEASUREMENT MED PRAC; Dupeyron A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186753; Elfering A, 2015, PSYCHOL HEALTH MED, V20, P767, DOI 10.1080/13548506.2015.1017824; Elfering A, 2009, SCAND J WORK ENV HEA, V35, P437, DOI 10.5271/sjweh.1360; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; FERKETICH S, 1991, RES NURS HEALTH, V14, P165, DOI 10.1002/nur.4770140211; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; George SZ, 2009, EUR SPINE J, V18, P1050, DOI 10.1007/s00586-009-1016-7; Gross DP, 2006, SPINE, V31, P2142, DOI 10.1097/01.brs.0000231771.14965.e4; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hill JC, 2011, PHYS THER, V91, P712, DOI 10.2522/ptj.20100280; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Ibrahim AA, 2021, HEALTH QUAL LIFE OUT, V19, DOI 10.1186/s12955-020-01644-1; Ibrahim AA, 2019, SCAND J PAIN, V19, P83, DOI 10.1515/sjpain-2018-0303; Ibrahim AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232223; Karaman CA, 2021, DISABIL REHABIL, V43, P1917, DOI 10.1080/09638288.2019.1677788; Lim BW, 2002, IJAHSP, V2, P34; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Maki D, 2017, DISABIL REHABIL, V39, P272, DOI 10.3109/09638288.2016.1140832; Mannion AF, 2013, SPINE, V38, P1016, DOI 10.1097/BRS.0b013e31828473b5; Mannion AF, 2009, J OCCUP ENVIRON MED, V51, P1256, DOI 10.1097/JOM.0b013e3181beac69; Mbada CE, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01322-2; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Ng SK, 2017, PSYCHOL HEALTH MED, V22, P790, DOI 10.1080/13548506.2016.1220602; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; Pett MA, 2003, MAKING SENSE FACTOR, DOI DOI 10.4135/9781412984898; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pincus T, 2013, SPINE, V38, P2118, DOI 10.1097/BRS.0b013e3182a8c5d6; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Rajan P, 2022, DISABIL REHABIL, V44, P646, DOI 10.1080/09638288.2020.1773942; Ramond-Roquin A, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00073; Simons G.F., 2018, ETHNOLOGUE LANGUAGES; Smith AJ, 2012, PHYS THER, V92, P1258, DOI 10.2522/ptj.20110396; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Suzuki T., 2012, RIGAKURYOHO KAGAKU, V27, P475; Symonds TL, 1996, OCCUP MED-OXFORD, V46, P25, DOI 10.1093/occmed/46.1.25; Tan BK, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-255; Teixeira LF, 2020, SAO PAULO MED J, V138, P287, DOI [10.1590/1516-3180.2019.0542.R2.16042020, 10.1590/1516-3180.2019.0542.r2.16042020]; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tingulstad A, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2910-8; Urquhart DM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-148; Vassilaki Maria, 2014, Hawaii J Med Public Health, V73, P122; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vos T., 2016, LANCET, V388, P1545, DOI [10.1016/s0140-6736(16)31678-6, DOI 10.1016/S0140-6736(16)31678-6]; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	66	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249370	10.1371/journal.pone.0249370	http://dx.doi.org/10.1371/journal.pone.0249370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN5ED	33848295	Green Published, gold			2022-12-26	WOS:000640373500026
J	Tonen-Wolyec, S; Djang'eing'a, RM; Batina-Agasa, S; Tshilumba, CK; Masidi, JM; Hayette, MP; Belec, L				Tonen-Wolyec, Serge; Djang'eing'a, Roland Marini; Batina-Agasa, Salomon; Tshilumba, Charles Kayembe; Masidi, Jeremie Muwonga; Hayette, Marie-Pierre; Belec, Laurent			Self-testing for HIV, HBV, and HCV using finger-stick whole-blood multiplex immunochromatographic rapid test: A pilot feasibility study in sub-Saharan Africa	PLOS ONE			English	Article							HEPATITIS-B; CARE; ADOLESCENTS; RECOMMENDATIONS; ACCEPTABILITY; COINFECTIONS; ELIMINATION; STRATEGIES	Background The burden of HIV, HBV, and HCV infections remains disproportionately high in sub-Saharan Africa, with high rates of co-infections. Multiplex rapid diagnostic tests for HIV, HBV and HCV serological testing with high analytical performances may improve the "cascade of screening" and quite possibly the linkage-to-care with reduced cost. Based on our previous field experience of HIV self-testing, we herein aimed at evaluating the practicability and acceptability of a prototype finger-stick whole-blood Triplex HIV/HCV/HBsAg self-test as a simultaneous serological screening tool for HIV, HBV, and HCV in the Democratic Republic of the Congo (DRC). Methods A cross-sectional multicentric study consisting of face-to-face, paper-based, and semi-structured questionnaires with a home-based and facility-based recruitment of untrained adult volunteers at risk of HIV, HBV, and HCV infections recruited from the general public was conducted in 2020 in urban and rural areas in the DRC. The practicability of the Triplex self-test was assessed by 3 substudies on the observation of self-test manipulation including the understanding of the instructions for use (IFU), on the interpretation of Triplex self-test results and on its acceptability. Results A total of 251 volunteers (mean age, 28 years; range, 18-49; 154 males) were included, from urban [160 (63.7%)] and rural [91 (36.3%)] areas. Overall, 242 (96.4%) participants performed the Triplex self-test and succeeded in obtaining a valid test result with an overall usability index of 89.2%. The correct use of the Triplex self-test was higher in urban areas than rural areas (51.2% versus 16.5%; aOR: 6.9). The use of video IFU in addition to paper-based IFU increased the correct manipulation and interpretation of the Triplex self-test. A total of 197 (78.5%) participants correctly interpreted the Triplex self-test results, whereas 54 (21.5%) misinterpreted their results, mainly the positive test results harboring low-intensity band (30/251; 12.0%), and preferentially the HBsAg band (12/44; 27.3%). The rates of acceptability of reuse, distribution of the Triplex self-test to third parties (partner, friend, or family member), linkage to the health care facility for confirmation of results and treatment, and confidence in the self-test results were very high, especially among participants from urban areas. Conclusions This pilot study shows evidence for the first time in sub-Saharan Africa on good practicability and high acceptability of a prototype Triplex HIV/HCV/HBsAg self-test for simultaneous diagnosis of three highly prevalent chronic viral infections, providing the rational basis of using self-test harboring four bands of interest, i.e. the control, HIV, HCV, and HBsAg bands. The relatively frequent misinterpretation of the Triplex self-test points however the necessity to improve the delivery of this prototype Triplex self-test probably in a supervised setting. Finally, these observations lay the foundations for the potential large-scale use of the Triplex self-test in populations living in sub-Saharan Africa at high risk for HIV, HBV, and HCV infections.	[Tonen-Wolyec, Serge] Ecole Doctorale Reg Afr Cent Infectiol Trop, Franceville, Gabon; [Tonen-Wolyec, Serge; Djang'eing'a, Roland Marini; Batina-Agasa, Salomon; Tshilumba, Charles Kayembe] Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO; [Djang'eing'a, Roland Marini] Univ Liege, Fac Med, Lab Analyt Chem, Liege, Belgium; [Masidi, Jeremie Muwonga] Natl AIDS & STIs Reference Lab, Kinshasa, DEM REP CONGO; [Masidi, Jeremie Muwonga] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Hayette, Marie-Pierre] Univ Liege, Univ Hosp Liege, Fac Med, Lab Microbiol, Liege, Belgium; [Belec, Laurent] Hop Europeen Georges Pompidou, AP HP, Lab Virol Med & Oncol, Paris, France; [Belec, Laurent] Univ Paris, Fac Med Paris Descartes, Paris Sorbonne Cite, Paris, France	University of Liege; Universite de Kinshasa; University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tonen-Wolyec, S (corresponding author), Ecole Doctorale Reg Afr Cent Infectiol Trop, Franceville, Gabon.; Tonen-Wolyec, S (corresponding author), Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO.	wolyec@gmail.com	Tonen-Wolyec, Serge/ADM-2951-2022	Tonen-Wolyec, Serge/0000-0002-7734-7729				Aman W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-57; Belete W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210866; Bottero Julie, 2015, Open Forum Infect Dis, V2, pofv162, DOI 10.1093/ofid/ofv162; Chevaliez S, 2018, J HEPATOL, V69, P916, DOI 10.1016/j.jhep.2018.05.017; Choko AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208191; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Easterbrook PJ, 2017, CURR OPIN HIV AIDS, V12, P302, DOI 10.1097/COH.0000000000000370; Ekouevi DK, 2020, INT J INFECT DIS, V95, P162, DOI 10.1016/j.ijid.2020.02.016; Figueroa C, 2018, LANCET HIV, V5, pE277, DOI 10.1016/S2352-3018(18)30044-4; Fisher DG, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv101; Gresenguet Gerard, 2017, Open AIDS J, V11, P101, DOI 10.2174/1874613601711010101; Guise A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3185-7; Hatzold K, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25244; Hurt CB, 2014, SEX TRANSM DIS, V41, P10, DOI 10.1097/OLQ.0000000000000076; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Kalla GCM, 2018, LANCET INFECT DIS, V18, P716, DOI 10.1016/S1473-3099(18)30343-8; Kimble MM, 2019, DIAGN MICR INFEC DIS, V95, P149, DOI 10.1016/j.diagmicrobio.2019.05.010; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kuecuekbalaban P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188653; Kuecuekbalaban P, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2394-x; Lacombe K, 2010, ANTIVIR THER, V15, P493, DOI 10.3851/IMP1495; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lippman SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206849; Liu LL, 2020, VIROL J, V17, DOI 10.1186/s12985-020-1293-7; Majam M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227198; Migge Bettina., 2007, HDB APPL LINGUISTICS, P297; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Okoboi S, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25269; Olsen MF, 2009, EUR SPINE J, V18, P1121, DOI 10.1007/s00586-009-0948-2; Ortblad KF, 2018, JAIDS-J ACQ IMM DEF, V79, pE42, DOI 10.1097/QAI.0000000000001765; Pai NP, 2015, FUTURE MICROBIOL, V10, P1393, DOI [10.2217/fmb.15.77, 10.2217/FMB.15.77]; Pai NP, 2015, EXPERT REV MOL DIAGN, V15, P463, DOI 10.1586/14737159.2015.1021335; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pintye J, 2019, AIDS, V33, P1369, DOI 10.1097/QAD.0000000000002211; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Prazuck T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146755; Rajput MK, 2016, J CLIN DIAGN RES, V10, pKE1, DOI 10.7860/JCDR/2016/16981.7319; Ritchwood TD, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6402-4; Robin L, 2018, J VIROL METHODS, V253, P1, DOI 10.1016/j.jviromet.2017.12.001; Shimakawa Y, 2018, LANCET GASTROENTEROL, V3, P222, DOI 10.1016/S2468-1253(18)30033-5; Simwinga M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25253; Sonderup MW, 2017, LANCET GASTROENTEROL, V2, P910, DOI 10.1016/S2468-1253(17)30249-2; Spearman CW, 2017, LANCET GASTROENTEROL, V2, P900, DOI 10.1016/S2468-1253(17)30295-9; Tahlil KM, 2020, AIDS PATIENT CARE ST, V34, P147, DOI 10.1089/apc.2019.0283; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; Tonen-Wolyec S, 2020, MED MALADIES INFECT, V50, P648, DOI 10.1016/j.medmal.2020.07.007; Tonen-Wolyec S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05554-x; Tonen-Wolyec S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240779; Tonen-Wolyec S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239607; Tonen-Wolyec S, 2020, INT J STD AIDS, V31, P481, DOI 10.1177/0956462419898616; Tonen-Wolyec Serge, 2019, Niger Med J, V60, P165, DOI 10.4103/nmj.NMJ_75_19; Tonen-Wolyec S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218795; Tonen-Wolyec S, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014218; Tonen-Wolyec S, 2018, LANCET HIV, V5, pE341, DOI 10.1016/S2352-3018(18)30141-3; Tonen-Wolyec S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189475; Unitaid, 2018, MULT DIAGN LANDSC IN; WHO, 2016, GUID HIV SELF TEST P; WHO, 2018, HIV SELF TEST STRAT; Witzel TC, 2017, CURR OPIN INFECT DIS, V30, P50, DOI 10.1097/QCO.0000000000000336; World Health Organization, HUM IMM VIR HIV RAP; World Health Organization, WHO GUID HEP B C TES; World Health Organization & UNITAID, 2016, TECHN LANDSC HIV RAP, V2016; World Health Organization & UNITAID, 2018, HIV RAP DIAGN TEST S, V4th; World Health Organization (WHO), 2015, WHO PREQ SAMPL PROD; Xiao YZ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102233; Zanolini A, 2018, AIDS RES HUM RETROV, V34, P254, DOI [10.1089/aid.2017.0156, 10.1089/AID.2017.0156]; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	67	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249701	10.1371/journal.pone.0249701	http://dx.doi.org/10.1371/journal.pone.0249701			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836036	Green Published, gold			2022-12-26	WOS:000639361000010
J	Eggers, KM; Lindhagen, L; Baron, T; Erlinge, D; Hjort, M; Jernberg, T; Johnston, N; Marko-Varga, G; Rezeli, M; Spaak, J; Lindahl, B				Eggers, Kai M.; Lindhagen, Lars; Baron, Tomasz; Erlinge, David; Hjort, Marcus; Jernberg, Tomas; Johnston, Nina; Marko-Varga, Gyorgy; Rezeli, Melinda; Spaak, Jonas; Lindahl, Bertil			Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry	PLOS ONE			English	Article							GROWTH-FACTOR 23; FOLLOW-UP; RISK; MORTALITY; DISEASE	Background Sex-differences in the pathobiology of myocardial infarction are well established but incompletely understood. Improved knowledge on this topic may help clinicians to improve management of men and women with myocardial infarction. Methods In this registry-based cohort study (SWEDEHEART), we analyzed 175 circulating biomarkers reflecting various pathobiological axes in 856 men and 243 women admitted to Swedish coronary care units because of myocardial infarction. Two multimarker panels were applied (Proximity Extension Assay [Olink Bioscience], Multiple Reaction Monitoring mass spectrometry). Lasso analysis (penalized logistic regression), multiple testing-corrected Mann-Whitney tests and Cox regressions were used to assess sex-differences in the concentrations of these biomarkers and their implications on all-cause mortality and major adverse events (median follow-up up to 6.6 years). Results Biomarkers provided a very high discrimination between both sexes, when considered simultaneously (c-statistics 0.972). Compared to women, men had higher concentrations of six biomarkers with the most pronounced differences seen for those reflecting atherogenesis, myocardial necrosis and metabolism. Women had higher concentrations of 14 biomarkers with the most pronounced differences seen for those reflecting activation of the renin-angiotensin-aldosterone axis, inflammation and for adipokines. There were no major variations between sexes in the associations of these biomarkers with outcome. Conclusions Severable sex-differences exist in the expression of biomarkers in patients with myocardial infarction. While these differences had no impact on outcome, our data suggest the presence of various sex-related pathways involved in the development of coronary atherosclerosis, the progression to plaque rupture and acute myocardial damage, with a greater heterogeneity in women.	[Eggers, Kai M.; Lindhagen, Lars; Baron, Tomasz; Hjort, Marcus; Johnston, Nina; Lindahl, Bertil] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lindhagen, Lars; Lindahl, Bertil] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Erlinge, David] Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, Lund, Sweden; [Jernberg, Tomas; Spaak, Jonas] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Marko-Varga, Gyorgy; Rezeli, Melinda] Lund Univ, Dept Biomed Clin Prot Sci & Imaging, Engn, Lund, Sweden	Uppsala University; Uppsala University; Lund University; Skane University Hospital; Danderyds Hospital; Karolinska Institutet; Lund University	Eggers, KM (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	kai.eggers@ucr.uu.se		Spaak, Jonas/0000-0002-2135-1294; Hjort, Marcus/0000-0002-7887-5929; Eggers, Kai/0000-0002-8806-5778				Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bickel C, 2017, BIOMARKERS, V22, P210, DOI 10.3109/1354750X.2015.1130745; Eggers KM, 2014, AM HEART J, V168, P317, DOI 10.1016/j.ahj.2014.06.006; Fairweather D, 2014, CLIN MED INSIGHTS-CA, V8, P49, DOI 10.4137/CMC.S17068; Fuernau G, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0713-8; Gijsberts CM, 2015, ATHEROSCLEROSIS, V241, P234, DOI 10.1016/j.atherosclerosis.2015.02.002; Grammer TB, 2014, FREE RADICAL RES, V48, P706, DOI 10.3109/10715762.2014.901510; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Ku IA, 2011, ATHEROSCLEROSIS, V217, P503, DOI 10.1016/j.atherosclerosis.2010.10.047; Lau ES, 2019, J AM COLL CARDIOL, V74, P1543, DOI 10.1016/j.jacc.2019.06.077; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Lew J, 2017, CIRCULATION, V135, P544, DOI 10.1161/CIRCULATIONAHA.116.023005; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Mingels AMA, 2018, ADV EXP MED BIOL, V1065, P545, DOI 10.1007/978-3-319-77932-4_33; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Redfors B, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001995; Reindl M, 2017, HEART, V103, P856, DOI 10.1136/heartjnl-2016-310520; Rezeli M, 2017, J PROTEOME RES, V16, P3242, DOI 10.1021/acs.jproteome.7b00235; Ritsinger V, 2017, DIABETES VASC DIS RE, V14, P77, DOI 10.1177/1479164116678156; Samnegard A, 2006, J INTERN MED, V259, P530, DOI 10.1111/j.1365-2796.2006.01632.x; Savarese G, 2018, ADV EXP MED BIOL, V1065, P529, DOI 10.1007/978-3-319-77932-4_32; Taqueti VR, 2018, ADV EXP MED BIOL, V1065, P257, DOI [10.1007/978/-3-319-77932-4_17, 10.1007/978-3-319-77932-4_17]; Thorand B, 2006, ATHEROSCLEROSIS, V184, P216, DOI 10.1016/j.atherosclerosis.2005.04.011; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Wiviott SD, 2004, CIRCULATION, V109, P580, DOI 10.1161/01.CIR.0000109491.66226.26	27	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249830	10.1371/journal.pone.0249830	http://dx.doi.org/10.1371/journal.pone.0249830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831096	Green Published, gold			2022-12-26	WOS:000639359600128
J	Premarathna, GI; Ellingson, L				Premarathna, Galkande Iresha; Ellingson, Leif			A mathematical representation of protein binding sites using structural dispersion of atoms from principal axes for classification of binding ligands	PLOS ONE			English	Article							DATABASE	Many researchers have studied the relationship between the biological functions of proteins and the structures of both their overall backbones of amino acids and their binding sites. A large amount of the work has focused on summarizing structural features of binding sites as scalar quantities, which can result in a great deal of information loss since the structures are three-dimensional. Additionally, a common way of comparing binding sites is via aligning their atoms, which is a computationally intensive procedure that substantially limits the types of analysis and modeling that can be done. In this work, we develop a novel encoding of binding sites as covariance matrices of the distances of atoms to the principal axes of the structures. This representation is invariant to the chosen coordinate system for the atoms in the binding sites, which removes the need to align the sites to a common coordinate system, is computationally efficient, and permits the development of probability models. These can then be used to both better understand groups of binding sites that bind to the same ligand and perform classification for these ligand groups. We demonstrate the utility of our method for discrimination of binding ligand through classification studies with two benchmark datasets using nearest mean and polytomous logistic regression classifiers.	[Premarathna, Galkande Iresha] Minnesota State Univ, Dept Math & Stat, Mankato, MN 56001 USA; [Ellingson, Leif] Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA	Minnesota State Colleges & Universities; Minnesota State University Mankato; Texas Tech University System; Texas Tech University	Premarathna, GI (corresponding author), Minnesota State Univ, Dept Math & Stat, Mankato, MN 56001 USA.	iresha.premarathna@mnsu.edu		Premarathna, Galkande/0000-0002-4425-5369				Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bertolazzi P, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14132-1; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chruszcz M, 2010, CURR OPIN STRUC BIOL, V20, P587, DOI 10.1016/j.sbi.2010.08.001; Ellingson L., 2015, COMMUNICATIONS STAT; Ellingson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040540; FISCHER D, 1994, PROTEIN SCI, V3, P769; Gold ND, 2006, NUCLEIC ACIDS RES, V34, pD231, DOI 10.1093/nar/gkj062; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hertz T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S3; Hoffmann B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-99; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Kinoshita Kengo, 2002, Journal of Structural and Functional Genomics, V2, P9, DOI 10.1023/A:1011318527094; Marron JS, 2014, BIOMETRICAL J, V56, P732, DOI 10.1002/bimj.201300072; Nadzirin N, 2012, INT J MOL SCI, V13, P12761, DOI 10.3390/ijms131012761; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; Schwartzman A, 2016, INT STAT REV, V84, P456, DOI 10.1111/insr.12113; Shulman-Peleg A, 2005, NUCLEIC ACIDS RES, V33, pW337, DOI 10.1093/nar/gki482; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Zhang L, 2006, MOL CELL PROTEOMICS, V5, P1224, DOI 10.1074/mcp.M500346-MCP200	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0244905	10.1371/journal.pone.0244905	http://dx.doi.org/10.1371/journal.pone.0244905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831020	gold, Green Published			2022-12-26	WOS:000639359600016
J	Al-Sadi, R; Engers, J; Haque, M; King, S; Al-Omari, D; Ma, TY				Al-Sadi, Rana; Engers, Jessica; Haque, Mohammad; King, Steven; Al-Omari, Deemah; Ma, Thomas Y.			Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-kappa B activation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TNF-ALPHA MODULATION; MATRIX METALLOPROTEINASES; INDUCED-INCREASE; PERMEABILITY; EXPRESSION; MECHANISM; APOPTOSIS; COLITIS; CACO-2	Background Matrix Metalloproteinase-9 (MMP-9) has been shown to play a key role in mediating inflammation and tissue damage in inflammatory bowel disease (IBD). In patients with IBD, the intestinal tight junction (TJ) barrier is compromised as characterized by an increase in intestinal permeability. MMP-9 is elevated in intestinal tissue, serum and stool of patients with IBD. Previous studies from our laboratory showed that MMP-9 causes an increase in intestinal epithelial TJ permeability and that the MMP-9 induced increase in intestinal permeability is an important pathogenic factor contributing to the development of intestinal inflammation in IBD. However, the intracellular mechanisms that mediate the MMP-9 modulation of intestinal barrier function remain unclear. Aims The main aim of this study was to further elucidate the molecular mechanisms involved in MMP-9 induced increase in intestinal epithelial TJ permeability using Caco-2 monolayers as an in-vitro model system. Results MMP-9 induced increase in Caco-2 TJ permeability was associated with activation and cytoplasmic-to-nuclear translocation of NF-kappa B p65. Knocking-down NF-kappa B p65 by siRNA transfection prevented the MMP-9 induced expression of the NF-kappa B target gene IL-8, myosin light chain kinase (MLCK) protein expression, and subsequently prevented the increase in Caco-2 TJ permeability. In addition, the effect of MMP-9 on Caco-2 intestinal epithelial TJ barrier function was not mediated by apoptosis or necrosis. Conclusion Our data show that the MMP-9 induced disruption of Caco-2 intestinal epithelial TJ barrier function is regulated by NF-kappa B pathway activation of MLCK.	[Al-Sadi, Rana; Engers, Jessica; Haque, Mohammad; King, Steven; Ma, Thomas Y.] Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Coll Med, Hershey, PA 17033 USA; [Al-Omari, Deemah] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of New Mexico	Al-Sadi, R (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Coll Med, Hershey, PA 17033 USA.	ralsadi@pennstatehealth.psu.edu		Al-Sadi, Rana/0000-0002-9826-5132; King, Scott/0000-0001-6821-9234	Crohn's and Colitis Foundation of America (CCFA) [326502]; DOM Innovation Pilot Award at the Penn State College of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases Grant [R0-1-DK-106072-01, R01-DK-121073-01]	Crohn's and Colitis Foundation of America (CCFA); DOM Innovation Pilot Award at the Penn State College of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases Grant	This research project was supported by Crohn's and Colitis Foundation of America (CCFA) 326502 (RAS) and, DOM Innovation Pilot Award at the Penn State College of Medicine (RAS), and National Institute of Diabetes and Digestive and Kidney Diseases Grant R0-1-DK-106072-01 and R01-DK-121073-01 (TYM).	Abdel-Hamid NI, 2017, N-S ARCH PHARMACOL, V390, P379, DOI 10.1007/s00210-016-1337-0; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Al-Sadi R, 2019, AM J PHYSIOL-GASTR L, V316, pG278, DOI 10.1152/ajpgi.00126.2018; Al-Sadi R, 2016, AM J PATHOL, V186, P1151, DOI 10.1016/j.ajpath.2015.12.016; Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; Al-Sadi R, 2012, J INTERF CYTOK RES, V32, P474, DOI 10.1089/jir.2012.0031; Al-Sadi R, 2011, J CELL MOL MED, V15, P970, DOI 10.1111/j.1582-4934.2010.01065.x; Al-Sadi R, 2010, AM J PATHOL, V177, P2310, DOI 10.2353/ajpath.2010.100371; Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Amano S, 2001, EXP CELL RES, V271, P249, DOI 10.1006/excr.2001.5387; Ammarguellat FZ, 2002, HYPERTENSION, V39, P679, DOI 10.1161/hy0202.103481; Fernadez-Blanco JA, 2015, J CROHNS COLITIS, V9, P463, DOI 10.1093/ecco-jcc/jjv056; Aram G, 2008, HEPATOLOGY, V47, P2051, DOI 10.1002/hep.22278; Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Banan A, 2007, ALCOHOL, V41, P447, DOI 10.1016/j.alcohol.2007.07.003; Banan A, 2003, J PHARMACOL EXP THER, V306, P13, DOI 10.1124/jpet.103.047415; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bast BT, 2003, J ORAL MAXIL SURG, V61, P1463, DOI 10.1016/j.joms.2003.06.002; Baugh MD, 1999, GASTROENTEROLOGY, V117, P814, DOI 10.1016/S0016-5085(99)70339-2; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Blam ME, 2001, AM J GASTROENTEROL, V96, P1977, DOI 10.1016/S0002-9270(01)02494-7; Camilleri M, 2019, GUT, V68, P1516, DOI 10.1136/gutjnl-2019-318427; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Capaldo CT, 2017, J MOL MED, V95, P927, DOI 10.1007/s00109-017-1557-x; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chang CL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-244; Chen YT, 2019, J TISSUE ENG REGEN M, V13, P2155, DOI 10.1002/term.2960; Cui N, 2017, PROG MOL BIOL TRANSL, V147, P1, DOI 10.1016/bs.pmbts.2017.02.005; Dou W, 2014, INT IMMUNOPHARMACOL, V23, P170, DOI 10.1016/j.intimp.2014.08.025; Eickelberg O, 1997, AM J RESP CRIT CARE, V156, P1987, DOI 10.1164/ajrccm.156.6.9704112; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Garg P, 2011, GASTROENTEROLOGY, V141, P1381, DOI 10.1053/j.gastro.2011.06.056; Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008; Gitter AH, 2000, ANN NY ACAD SCI, V915, P193; Goretsky T, 2012, AM J PATHOL, V181, P1306, DOI 10.1016/j.ajpath.2012.06.016; Goto K, 2009, CYTOKINE, V46, P96, DOI 10.1016/j.cyto.2008.12.021; Graham WV, 2019, NAT MED, V25, P690, DOI 10.1038/s41591-019-0393-7; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guo SH, 2015, J IMMUNOL, V195, P4999, DOI 10.4049/jimmunol.1402598; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Hasebe T, 2007, DEV DYNAM, V236, P2338, DOI 10.1002/dvdy.21252; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Hayden DM, 2011, J SURG RES, V168, P315, DOI 10.1016/j.jss.2010.03.002; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; He WQ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030993; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; Hering NA, 2009, DIGEST DIS, V27, P450, DOI 10.1159/000233283; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hozumi A, 2001, AM J PHYSIOL-LUNG C, V281, pL1444, DOI 10.1152/ajplung.2001.281.6.L1444; Hu CAA, 2015, ANIM NUTR, V1, P123, DOI 10.1016/j.aninu.2015.08.014; Jeong CH, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP5701; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Khandoga A, 2006, J LEUKOCYTE BIOL, V79, P1295, DOI 10.1189/jlb.0805468; Kirkegaard T, 2004, GUT, V53, P701, DOI 10.1136/gut.2003.017442; Lakatos G, 2012, DIGEST DIS, V30, P289, DOI 10.1159/000336995; Lee B, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2645465; Lin JC, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12547; Liu HC, 2013, AM J PHYSIOL-GASTR L, V304, pG793, DOI 10.1152/ajpgi.00249.2012; Lu Y, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1549-3; Ma TY, 2000, AM J PHYSIOL-GASTR L, V279, pG875, DOI 10.1152/ajpgi.2000.279.5.G875; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma TY., 2012, PHYSL GASTROINTESTIN, V5; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Meijer MJW, 2007, DIGEST LIVER DIS, V39, P733, DOI 10.1016/j.dld.2007.05.010; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Moore BA, 2011, GASTROENTEROLOGY, V141, P1283, DOI 10.1053/j.gastro.2011.06.035; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Nighot P, 2015, AM J PHYSIOL-GASTR L, V309, pG988, DOI 10.1152/ajpgi.00256.2015; O'Sullivan S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/964131; Olle EW, 2006, HEPATOLOGY, V44, P540, DOI 10.1002/hep.21314; Pasparakis M, 2008, MUCOSAL IMMUNOL, V1, pS54, DOI 10.1038/mi.2008.53; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Patrick David M, 2006, BMC Physiol, V6, P2, DOI 10.1186/1472-6793-6-2; Qi L, 2014, INT J MOL MED, V34, P1629, DOI 10.3892/ijmm.2014.1965; Rodrigues DM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-105; Rosenthal R, 2017, INT J COLORECTAL DIS, V32, P623, DOI 10.1007/s00384-016-2736-x; Sinnamon MJ, 2008, INT J EXP PATHOL, V89, P466, DOI 10.1111/j.1365-2613.2008.00621.x; Strober W, 2001, ACTA ODONTOL SCAND, V59, P244, DOI 10.1080/00016350152509274; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Turner JR, 2000, SEMIN CELL DEV BIOL, V11, P301, DOI 10.1006/scdb.2000.0180; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Vu TH, 2001, NAT GENET, V28, P202, DOI 10.1038/90023; Wallberg Fredrik, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087387; Walter L, 2017, ONCOTARGET, V8, P364, DOI 10.18632/oncotarget.13406; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yang RD, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.573475	92	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249544	10.1371/journal.pone.0249544	http://dx.doi.org/10.1371/journal.pone.0249544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826658	gold, Green Published			2022-12-26	WOS:000638119900031
J	Buckner, BA; Lato, AM; Campagna, SR; Downs, DM				Buckner, Brandi A.; Lato, Ashley M.; Campagna, Shawn R.; Downs, Diana M.			The Rid family member RutC of Escherichia coli is a 3-aminoacrylate deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLONING; VECTORS; PATHWAY; AMIDE	The Rid protein family (PF14588, IPR006175) is divided into nine subfamilies, of which only the RidA subfamily has been characterized biochemically. RutC, the founding member of one subfamily, is encoded in the pyrimidine utilization (rut) operon that encodes a pathway that allows Escherichia coli to use uracil as a sole nitrogen source. Results reported herein demonstrate that RutC has 3-aminoacrylate deaminase activity and facilitates one of the reactions previously presumed to occur spontaneously in vivo. RutC was active with several enamine-imine substrates, showing similarities and differences in substrate specificity with the canonical member of the Rid superfamily, Salmonella enterica RidA. Under standard laboratory conditions, a Rut pathway lacking RutC generates sufficient nitrogen from uracil for growth of E. coli. These results support a revised model of the Rut pathway and provide evidence that Rid proteins may modulate metabolic fitness, rather than catalyzing essential functions.	[Buckner, Brandi A.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Lato, Ashley M.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dmdowns@uga.edu		Buckner, Brandi/0000-0002-7173-7312; Lato, Ashley/0000-0003-4076-9714	National Institutes of Health [GM095837]; National Science Foundation [MCB1615373]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by an award from the competitive grants program at the National Institutes of Health (GM095837 to D. M. D.) and the National Science Foundation (MCB1615373 to S. R. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 2017, BIOCHEMISTRY-US, V56, P3708, DOI 10.1021/acs.biochem.7b00493; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Borchert AJ, 2019, TRENDS BIOCHEM SCI, V44, P849, DOI 10.1016/j.tibs.2019.04.011; Degani G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040945; Ernst DC, 2018, MBIO, V9, DOI 10.1128/mBio.00084-18; Ernst DC, 2014, J BACTERIOL, V196, P3335, DOI 10.1128/JB.01960-14; Galloway NR, 2013, CRYST GROWTH DES, V13, P2833, DOI 10.1021/cg400171z; HAFNER EW, 1979, BIOCHEMISTRY-US, V18, P411, DOI 10.1021/bi00570a004; Hodge-Hanson KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185544; Irons J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02058; Irons J, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00434-18; Irons JL, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00024-20; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Knapik AA, 2012, ACTA CRYSTALLOGR F, V68, P1294, DOI 10.1107/S1744309112041796; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mukherjee T, 2010, J AM CHEM SOC, V132, P5550, DOI 10.1021/ja9107676; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Niehaus TD, 2014, PLANT CELL, V26, P3010, DOI 10.1105/tpc.114.126854; Rehberg GM, 1995, ORG PREP PROCED INT, V27, P651, DOI 10.1080/00304949509458523; VanDrisse CM, 2016, PLASMID, V86, P1, DOI 10.1016/j.plasmid.2016.05.001; VOGEL HJ, 1956, J BIOL CHEM, V218, P97	24	2	2	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100651	10.1016/j.jbc.2021.100651	http://dx.doi.org/10.1016/j.jbc.2021.100651			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839153	Green Published, gold			2022-12-26	WOS:000672866400622
J	Delerue, T; Ramamurthi, KS				Delerue, Thomas; Ramamurthi, Kumaran S.			How bacteria block their own biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Bacterial biofilms are surface-associated multicellular communities that are highly resistant to removal. Scheffler et al. discovered that Pseudomonas aeruginosa secretes a small molecule that inhibits other P. aeruginosa cells from adsorbing to surfaces by interfering with type IV pili dynamics. The inhibition of cell adsorption could present a method to prevent biofilm formation on sensitive surfaces in hospitals and industry.	[Delerue, Thomas; Ramamurthi, Kumaran S.] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ramamurthi, KS (corresponding author), NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	ramamurthiks@mail.nih.gov		delerue, thomas/0000-0002-8900-247X	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research (K. S. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berne C, 2018, NAT REV MICROBIOL, V16, P616, DOI 10.1038/s41579-018-0057-5; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Marathe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4759; Mccallum M, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0006-2018; Persat A, 2015, P NATL ACAD SCI USA, V112, P7563, DOI 10.1073/pnas.1502025112; Scheffler R. J., 2021, J BIOL CHEM, V296	7	1	1	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100392	10.1016/j.jbc.2021.100392	http://dx.doi.org/10.1016/j.jbc.2021.100392			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839681	gold, Green Published			2022-12-26	WOS:000672866400366
J	Yang, J; Gong, WB; Wu, S; Zhang, H; Perrett, S				Yang, Jie; Gong, Weibin; Wu, Si; Zhang, Hong; Perrett, Sarah			PES inhibits human-inducible Hsp70 by covalent targeting of cysteine residues in the substrate-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; 2-PHENYLETHYNESULFONAMIDE; CANCER; DNAK; IDENTIFICATION; CONFORMATION; CHAPERONES; REVEALS	Hsp70 proteins are a family of ancient and conserved chaperones. They play important roles in vital cellular processes, such as protein quality control and the stress response. Hsp70 proteins are a potential drug target for treatment of disease, particularly cancer. PES (2-phenylethynesulfonamide or pifithrin-mu) has been reported to be an inhibitor of Hsp70. However, the mechanism of PES inhibition is still unclear. In this study we found that PES can undergo a Michael addition reaction with Cys-574 and Cys-603 in the SBD alpha of human HspA1A (hHsp70), resulting in covalent attachment of a PES molecule to each Cys residue. We previously showed that glutathionylation of Cys-574 and Cys-603 affects the structure and function of hHsp70. In this study, PES modification showed similar structural and functional effects on hHsp70 to glutathionylation. Further, we found that susceptibility to PES modification is influenced by changes in the conformational dynamics of the SBD alpha, such as are induced by interaction with adjacent domains, allosteric changes, and mutations. This study provides new avenues for development of covalent inhibitors of hHsp70.	[Yang, Jie; Gong, Weibin; Wu, Si; Zhang, Hong; Perrett, Sarah] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Yang, Jie; Wu, Si; Zhang, Hong; Perrett, Sarah] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, H; Perrett, S (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Zhang, H; Perrett, S (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhangh@moon.ibp.ac.cn; sarah.perrett@cantab.net		Zhang, Hong/0000-0001-9204-2547; Gong, Weibin/0000-0001-7130-4093	Chinese Ministry of Science and Technology [2017YFA0504000]; National Natural Science Foundation of China [31770829, 31570780, 31920103011, 21673278]; Beijing Natural Science Foundation [5172026]; National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	This work was supported by Chinese Ministry of Science and Technology (2017YFA0504000), National Natural Science Foundation of China (31770829, 31570780, 31920103011, 21673278), Beijing Natural Science Foundation (5172026), the National Laboratory of Biomacromolecules, and the CAS Center of Excellence in Biomacromolecules.	Bailey CK, 2015, CANCER BIOL THER, V16, P1422, DOI 10.1080/15384047.2015.1071743; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Colvin TA, 2014, CANCER RES, V74, P4731, DOI 10.1158/0008-5472.CAN-14-0747; Das D, 2020, MINI-REV MED CHEM, V20, P1732, DOI 10.2174/1389557520666200513121524; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fung E, 2015, BIOORG MED CHEM LETT, V25, P763, DOI 10.1016/j.bmcl.2014.12.094; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Gray VJ, 2014, J ORG CHEM, V79, P5869, DOI 10.1021/jo500814y; Hassan AQ, 2015, CHEM BIOL, V22, P87, DOI 10.1016/j.chembiol.2014.11.007; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jamil S, 2017, BIOCHEM BIOPH RES CO, V482, P154, DOI 10.1016/j.bbrc.2016.11.015; Johnston AN, 2020, P NATL ACAD SCI USA, V117, P6521, DOI 10.1073/pnas.1916503117; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kumar S, 2016, CANCER LETT, V374, P156, DOI 10.1016/j.canlet.2016.01.056; Leak RK, 2014, J CELL COMMUN SIGNAL, V8, P293, DOI 10.1007/s12079-014-0243-9; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Mattiolo P, 2014, BIOCHEM PHARMACOL, V91, P301, DOI 10.1016/j.bcp.2014.08.005; McAulay K, 2020, J AM CHEM SOC, V142, P10358, DOI 10.1021/jacs.9b13391; McKeon AM, 2016, MOLECULES, V21, DOI 10.3390/molecules21070949; Meng WL, 2018, P NATL ACAD SCI USA, V115, P11970, DOI 10.1073/pnas.1811105115; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Mons E, 2019, J AM CHEM SOC, V141, P3507, DOI 10.1021/jacs.8b11027; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Ribas J, 2015, CURR DRUG TARGETS, V16, P31, DOI 10.2174/1389450115666141114153536; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Sekihara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078772; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Vahid S, 2017, RECENT PAT ANTI-CANC, V12, P35, DOI 10.2174/1574892811666161102125252; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wu S, 2020, P NATL ACAD SCI USA, V117, P7814, DOI 10.1073/pnas.1914376117; Yang J, 2020, J BIOL CHEM, V295, P8302, DOI 10.1074/jbc.RA119.012372; Yeramian A, 2016, PIGM CELL MELANOMA R, V29, P352, DOI 10.1111/pcmr.12472; Zeng FX, 2014, AQUAT TOXICOL, V146, P45, DOI 10.1016/j.aquatox.2013.10.026; Zhang H, 2016, J BIOL CHEM, V291, P6967, DOI 10.1074/jbc.M115.673608; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zylicz M, 2001, IUBMB LIFE, V51, P283	57	4	5	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100210	10.1074/jbc.RA120.015440	http://dx.doi.org/10.1074/jbc.RA120.015440			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33835030	gold, Green Published			2022-12-26	WOS:000672866400188
J	Cole, JW; Adigun, T; Akinyemi, R; Akpa, OM; Bell, S; Chen, BW; Conde, JJ; Dobao, UL; Fernandez, I; Fornage, M; Gallego-Fabrega, C; Jern, C; Krawczak, M; Lindgren, A; Markus, HS; Melander, O; Owolabi, M; Schlicht, K; Soderholm, M; Srinivasasainagendra, V; Tarraga, CS; Stenman, M; Tiwari, H; Corasaniti, M; Fecteau, N; Guizzardi, B; Lopez, H; Nguyen, K; Gaynor, B; O'Connor, T; Stine, OC; Kittner, SJ; McArdle, P; Mitchell, BD; Xu, HC; Grond-Ginsbach, C				Cole, John W.; Adigun, Taiwo; Akinyemi, Rufus; Akpa, Onoja Matthew; Bell, Steven; Chen, Bowang; Conde, Jordi Jimenez; Dobao, Uxue Lazcano; Fernandez, Israel; Fornage, Myriam; Gallego-Fabrega, Cristina; Jern, Christina; Krawczak, Michael; Lindgren, Arne; Markus, Hugh S.; Melander, Olle; Owolabi, Mayowa; Schlicht, Kristina; Soderholm, Martin; Srinivasasainagendra, Vinodh; Tarraga, Carolina Soriano; Stenman, Martin; Tiwari, Hemant; Corasaniti, Margaret; Fecteau, Natalie; Guizzardi, Beth; Lopez, Haley; Nguyen, Kevin; Gaynor, Brady; O'Connor, Timothy; Stine, O. Colin; Kittner, Steven J.; McArdle, Patrick; Mitchell, Braxton D.; Xu, Huichun; Grond-Ginsbach, Caspar			The copy number variation and stroke (CaNVAS) risk and outcome study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; ISCHEMIC-STROKE; PHENOTYPIC HETEROGENEITY; GENETICS; CLASSIFICATION; DUPLICATION; DISEASE; ONSET; DELETION	Background and purpose The role of copy number variation (CNV) variation in stroke susceptibility and outcome has yet to be explored. The Copy Number Variation and Stroke (CaNVAS) Risk and Outcome study addresses this knowledge gap. Methods Over 24,500 well-phenotyped IS cases, including IS subtypes, and over 43,500 controls have been identified, all with readily available genotyping on GWAS and exome arrays, with case measures of stroke outcome. To evaluate CNV-associated stroke risk and stroke outcome it is planned to: 1) perform Risk Discovery using several analytic approaches to identify CNVs that are associated with the risk of IS and its subtypes, across the age-, sex- and ethnicity-spectrums; 2) perform Risk Replication and Extension to determine whether the identified stroke-associated CNVs replicate in other ethnically diverse datasets and use biomarker data (e.g. methylation, proteomic, RNA, miRNA, etc.) to evaluate how the identified CNVs exert their effects on stroke risk, and lastly; 3) perform outcome-based Replication and Extension analyses of recent findings demonstrating an inverse relationship between CNV burden and stroke outcome at 3 months (mRS), and then determine the key CNV drivers responsible for these associations using existing biomarker data. Results The results of an initial CNV evaluation of 50 samples from each participating dataset are presented demonstrating that the existing GWAS and exome chip data are excellent for the planned CNV analyses. Further, some samples will require additional considerations for analysis, however such samples can readily be identified, as demonstrated by a sample demonstrating clonal mosaicism. Conclusion The CaNVAS study will cost-effectively leverage the numerous advantages of using existing case-control data sets, exploring the relationships between CNV and IS and its subtypes, and outcome at 3 months, in both men and women, in those of African and European-Caucasian descent, this, across the entire adult-age spectrum.	[Cole, John W.; Fecteau, Natalie; Lopez, Haley; Kittner, Steven J.] Univ Maryland, Sch Med, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; [Adigun, Taiwo; Akinyemi, Rufus; Akpa, Onoja Matthew; Owolabi, Mayowa] Univ Ibadan, Ibadan, Nigeria; [Bell, Steven; Markus, Hugh S.] Univ Cambridge, Cambridge, England; [Chen, Bowang] Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Conde, Jordi Jimenez; Dobao, Uxue Lazcano; Tarraga, Carolina Soriano] Univ Autonoma Barcelona, IMIM, Hosp del Mar, Barcelona, Spain; [Fernandez, Israel; Gallego-Fabrega, Cristina] Inst Res Hosp Santa Creu & St Pau, Barcelona, Spain; [Fornage, Myriam] Univ Texas Hlth Sci Houston, Inst Mol Med, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Houston, Sch Publ Hlth, Houston, TX USA; [Jern, Christina] Univ Gothenburg, Gothenburg, Sweden; [Krawczak, Michael; Schlicht, Kristina] Univ Kiel, Inst Med Stat & Informat, Kiel, Germany; [Lindgren, Arne; Melander, Olle] Lund Univ, Neurol, Lund, Sweden; [Soderholm, Martin] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Soderholm, Martin] Skane Univ Hosp Malmo & Lund, Dept Neurol, Lund, Sweden; [Srinivasasainagendra, Vinodh; Tiwari, Hemant] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Stenman, Martin] Lund Univ, Lund, Sweden; [Corasaniti, Margaret; Guizzardi, Beth; Nguyen, Kevin; Gaynor, Brady; O'Connor, Timothy; Stine, O. Colin; McArdle, Patrick; Mitchell, Braxton D.; Xu, Huichun] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Grond-Ginsbach, Caspar] Heidelberg Univ, Heidelberg, Germany	University System of Maryland; University of Maryland Baltimore; University of Ibadan; University of Cambridge; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Gothenburg; University of Kiel; Lund University; Lund University; Lund University; Skane University Hospital; University of Alabama System; University of Alabama Birmingham; Lund University; University System of Maryland; University of Maryland Baltimore; Ruprecht Karls University Heidelberg	Cole, JW (corresponding author), Univ Maryland, Sch Med, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA.	jcole@som.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Gallego Fabrega, Cristina/AGY-1529-2022; Krawczak, Michael/A-8964-2010	Gallego Fabrega, Cristina/0000-0003-3229-5512; Krawczak, Michael/0000-0003-2603-1502; Lazcano, Uxue/0000-0003-3948-3372; Schlicht, Kristina/0000-0003-0281-5142; Melander, Olle/0000-0002-2581-484X; Akpa, Onoja/0000-0002-5201-512X; Cole, John/0000-0001-9263-8930	NIH/NINDS [R01-NS114045]; NIHR Senior Investigator award	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIHR Senior Investigator award	The CaNVAS Study is supported by NIH/NINDS R01-NS114045. Hugh Markus is supported by an NIHR Senior Investigator award.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Akinyemi RO, 2015, CARDIOVASC J AFR, V26, pS39, DOI 10.5830/CVJA-2015-039; [Anonymous], PROSEEK MULTIPLEX CV; Arsava EM, 2010, NEUROLOGY, V75, P1277, DOI 10.1212/WNL.0b013e3181f612ce; Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bluher A, 2015, EUR J NEUROL, V22, P1488, DOI 10.1111/ene.12827; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cheng YC, 2016, STROKE, V47, P307, DOI 10.1161/STROKEAHA.115.011328; Cheng YC, 2014, CIRC-CARDIOVASC GENE, V7, P383, DOI 10.1161/CIRCGENETICS.113.000390; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Cole JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206554; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Debette S, 2009, INT J STROKE, V4, P224, DOI 10.1111/j.1747-4949.2009.00281.x; DEFAIRE U, 1975, PREV MED, V4, P509, DOI 10.1016/0091-7435(75)90036-5; Erhart P, 2018, MOL GENET GENOM MED, V6, P441, DOI 10.1002/mgg3.371; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Fan WM, 2013, J CLIN NEUROSCI, V20, P316, DOI 10.1016/j.jocn.2012.02.026; Felbor U, 2007, NEUROGENETICS, V8, P149, DOI 10.1007/s10048-006-0076-7; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Ginsbach Philip, 2013, Microarrays (Basel), V2, P284, DOI 10.3390/microarrays2040284; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Grond-Ginsbach C, 2018, STROKE, V49, P2549, DOI 10.1161/STROKEAHA.118.020371; Grond-Ginsbach C, 2017, CURR GENOMICS, V18, P206, DOI 10.2174/1389202917666160805152627; Grond-Ginsbach C, 2012, EUR J HUM GENET, V20, P1295, DOI 10.1038/ejhg.2012.82; Hayani E, 2017, NEUROL-GENET, V3, pS12; Holliday EG, 2015, STROKE, V46, P615, DOI 10.1161/STROKEAHA.114.007930; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacocca MA, 2018, CURR OPIN LIPIDOL, V29, P125, DOI 10.1097/MOL.0000000000000483; Kibe T, 2011, AM J MED GENET A, V155A, P215, DOI 10.1002/ajmg.a.33786; Kuang SQ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002118; Lindgren A, 2016, STROKE, V47, P2427, DOI 10.1161/STROKEAHA.116.010648; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacClellan LR, 2006, GENET EPIDEMIOL, V30, P602, DOI 10.1002/gepi.20171; Mace A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00556-x; Maguire JM, 2017, EUR STROKE J, V2, P229, DOI 10.1177/2396987317704547; Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3; Matarin M, 2008, NEUROGENETICS, V9, P101, DOI 10.1007/s10048-008-0119-3; McArdle PF, 2014, NEUROLOGY, V83, P1653, DOI 10.1212/WNL.0000000000000942; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McLysaght A, 2014, P NATL ACAD SCI USA, V111, P361, DOI 10.1073/pnas.1309324111; Meschia JF, 2013, STROKE, V44, P2694, DOI 10.1161/STROKEAHA.113.001857; Mola-Caminal M, 2019, CIRC RES, V124, P114, DOI 10.1161/CIRCRESAHA.118.313533; NHLBI, TOPMED T OM PREC MED; Olsson M, 2018, J THROMB HAEMOST, V16, P2024, DOI 10.1111/jth.14258; Pfeiffer D, 2019, STROKE, V50, P298, DOI 10.1161/STROKEAHA.118.021856; Renard D, 2014, NEUROLOGY, V83, P1029, DOI 10.1212/WNL.0000000000000769; Rosand J, 2016, LANCET NEUROL, V15, P174, DOI 10.1016/S1474-4422(15)00338-5; Rosenberg RE, 2013, PEDIATRICS, V131, pE1996, DOI 10.1542/peds.2012-0749; Saskin A, 2018, NEUROLOGY, V90, P1026, DOI 10.1212/WNL.0000000000005601; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; Seshan VE, 2018, DNACOPY DNA COPY NUM; Singh PP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004394; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Tiszlavicz Z, 2012, ACTA NEUROL SCAND, V126, P109, DOI 10.1111/j.1600-0404.2011.01613.x; Toldo I, 2016, EUR J PAEDIATR NEURO, V20, P766, DOI 10.1016/j.ejpn.2016.02.008; Torres-Aguila NP, 2019, STROKE, V50, P3618, DOI 10.1161/STROKEAHA.119.026593; Traylor M, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000142; Traylor M, 2015, STROKE, V46, P2407, DOI 10.1161/STROKEAHA.115.009485; Traylor M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004469; Traylor M, 2013, GENET EPIDEMIOL, V37, P495, DOI 10.1002/gepi.21729; Tsai CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10190; Voll SL, 2017, GENET MED, V19, P204, DOI 10.1038/gim.2016.98; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xu HC, 2017, GLOB HEART, V12, P163, DOI 10.1016/j.gheart.2017.01.004; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	68	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0248791	10.1371/journal.pone.0248791	http://dx.doi.org/10.1371/journal.pone.0248791			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP4TZ	33872305	Green Published, Green Submitted, gold			2022-12-26	WOS:000641723300013
J	Afulani, PA; Gyamerah, AO; Nutor, JJ; Laar, A; Aborigo, RA; Malechi, H; Sterling, M; Awoonor-Williams, JK				Afulani, Patience A.; Gyamerah, Akua O.; Nutor, Jerry J.; Laar, Amos; Aborigo, Raymond A.; Malechi, Hawa; Sterling, Mona; Awoonor-Williams, John K.			Inadequate preparedness for response to COVID-19 is associated with stress and burnout among healthcare workers in Ghana	PLOS ONE			English	Article							PHYSICIAN BURNOUT; INTERVENTIONS; LESSONS	Introduction The COVID-19 pandemic has compounded the global crisis of stress and burnout among healthcare workers. But few studies have empirically examined the factors driving these outcomes in Africa. Our study examined associations between perceived preparedness to respond to the COVID-19 pandemic and healthcare worker stress and burnout and identified potential mediating factors among healthcare workers in Ghana. Methods Healthcare workers in Ghana completed a cross-sectional self-administered online survey from April to May 2020; 414 and 409 completed stress and burnout questions, respectively. Perceived preparedness, stress, and burnout were measured using validated psychosocial scales. We assessed associations using linear regressions with robust standard errors. Results The average score for preparedness was 24 (SD = 8.8), 16.3 (SD = 5.9) for stress, and 37.4 (SD = 15.5) for burnout. In multivariate analysis, healthcare workers who felt somewhat prepared and prepared had lower stress (beta = -1.89, 95% CI: -3.49 to -0.30 and beta = -2.66, 95% CI: -4.48 to -0.84) and burnout (beta = -7.74, 95% CI: -11.8 to -3.64 and beta = -9.25, 95% CI: -14.1 to -4.41) scores than those who did not feel prepared. Appreciation from management and family support were associated with lower stress and burnout, while fear of infection was associated with higher stress and burnout. Fear of infection partially mediated the relationship between perceived preparedness and stress/burnout, accounting for about 16 to 17% of the effect. Conclusions Low perceived preparedness to respond to COVID-19 increases stress and burnout, and this is partly through fear of infection. Interventions, incentives, and health systemic changes to increase healthcare workers' morale and capacity to respond to the pandemic are needed.	[Afulani, Patience A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Afulani, Patience A.; Sterling, Mona] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Gyamerah, Akua O.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Nutor, Jerry J.] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA USA; [Laar, Amos] Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana; [Aborigo, Raymond A.] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Malechi, Hawa] Tamale Teaching Hosp, Tamale, Ghana; [Awoonor-Williams, John K.] Ghana Hlth Serv, Policy Planning Monitoring & Evaluat Div, Accra, Ghana; [Gyamerah, Akua O.] Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Ghana; Navrongo Health Research Center; Ghana Health Service; University of California System; University of California San Francisco	Gyamerah, AO (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.; Gyamerah, AO (corresponding author), Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA 94143 USA.	akua.gyamerah@ucsf.edu		Gyamerah, Akua/0000-0003-3394-6532; Awoonor-Williams, Koku/0000-0002-1094-8212	University of California, San Francisco COVID-19 Related Rapid Research Pilot Initiative	University of California, San Francisco COVID-19 Related Rapid Research Pilot Initiative(University of California System)	This research is financially supported by the University of California, San Francisco COVID-19 Related Rapid Research Pilot Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu Z, 2020, THE CNN; Adokiya MN, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.29763; Adongo PB, 2017, BMC HEALTH SERV RES, DOI 10.1186/s12913-017-2225-0; Afulani PA., 2020, J GLOB HLTH SCI; Alessandra Prentice, 2020, GHAN HLTH WORK WARN; Amnesty International , 2020, EXP SIL ATT FAIL PRO; Aneshensel CS, 2012, THEORY BASED DATA AN, DOI [10.1136/jech-2012-201537, DOI 10.1136/JECH-2012-201537]; Annan AA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4474-6; [Anonymous], 2019, LANCET, V394, P93, DOI 10.1016/S0140-6736(19)31573-9; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Belfroid E, 2018, J HOSP INFECT, V98, P212, DOI 10.1016/j.jhin.2017.07.001; Chersich MF, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00574-3; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Craig J., 2020, NATL ESTIMATES CRITI, V727; Du J, 2020, GEN HOSP PSYCHIAT, V67, P144, DOI 10.1016/j.genhosppsych.2020.03.011; Dubale BW, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7566-7; GhanaWeb, 2020, KORL BU NURS STAG SI; GhanaWeb, 2020, KORL BU DOCT THREAT; Grossi G, 2015, SCAND J PSYCHOL, V56, P626, DOI 10.1111/sjop.12251; Guest JL, 2020, JMIR PUBLIC HLTH SUR, V6, P4, DOI 10.2196/19043; Johns Hopkins Coronavirus Resource Center, 2020, COVID 19 MAP; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Klein J, 2010, INT J QUAL HEALTH C, V22, P525, DOI 10.1093/intqhc/mzq056; Kopacz MS, 2019, LANCET PSYCHIAT, V6, pE28, DOI 10.1016/S2215-0366(19)30385-2; Labrague LJ, 2021, J NURS MANAGE, V29, P395, DOI 10.1111/jonm.13168; Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; MELAMED S, 1992, BEHAV MED, V18, P53, DOI 10.1080/08964289.1992.9935172; Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441; Nyarko Y, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0094-z; Odonkor ST, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1614968; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Raina S, 2020, J FAM MED PRIM CARE, V9, P2161, DOI 10.4103/jfmpc.jfmpc_384_20; Ross J, 2020, J PERIANESTH NURS, V35, P439, DOI 10.1016/j.jopan.2020.04.001; Sasangohar F, 2020, ANESTH ANALG, V131, P106, DOI 10.1213/ANE.0000000000004866; Selamu M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2370-5; Shirom A., 2006, INT J STRESS MANAGE, V13, P176, DOI [10.1037/1072-5245.13.2.176, DOI 10.1037/1072-5245.13.2.176]; Suleiman A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093181; Sultana Abida, 2020, Indian J Med Ethics, VV, P1, DOI 10.20529/IJME.2020.73; Toh SG, 2012, INT J EVID-BASED HEA, V10, P126, DOI 10.1111/j.1744-1609.2012.00271.x; United Nations Economic Commission for Africa, 2020, COVID 19 AFR PROT LI; VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; WHO, 2020, LOUISIANA WEEKL 0526; WHO, 2020, JANETAKES HIST 0910; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; World Health Organization, 2020, NURS MIDW PERS PER 1; World Health Organization, 2019, DENS PHYS TOT NUMB P	52	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250294	10.1371/journal.pone.0250294	http://dx.doi.org/10.1371/journal.pone.0250294			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861808	Green Published, gold, Green Submitted			2022-12-26	WOS:000641475400053
J	Kur-Zalewska, J; Kisiel, B; Kania-Pudlo, M; Tlustochowicz, M; Chcialowski, A; Tlustochowicz, W				Kur-Zalewska, Joanna; Kisiel, Bartlomiej; Kania-Pudlo, Marta; Tlustochowicz, Malgorzata; Chcialowski, Andrzej; Tlustochowicz, Witold			A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients	PLOS ONE			English	Article							EXTRAARTICULAR MANIFESTATIONS; PULMONARY INVOLVEMENT; PNEUMONIA; COMPLICATIONS; MORTALITY	Objectives The aim of the study was to assess the influence of different factors, including treatment, on the risk of ILD in the course of RA. Methods A total of 109 RA patients were included in the analysis. High-resolution computed tomography (HRCT) of chest was obtained in each patient. Patients were classified as having ILD (ILD group) or not (N-ILD group). The ILD was graded using the semi-quantitative Warrick scale of fibrosis. Warrick extent score (WES) and Warrick severity score (WSS) were calculated separately for each patient, then combined to obtain a global score (WGS). Results In univariate analysis the presence of ILD was associated positively with age (P = 5x10(-6)) and negatively with MTX treatment (P = 0.0013), mean MTX dose per year of treatment (P = 0.003) and number of DMARDs used (P = 0.046). On multivariate analysis only age and treatment with MTX were independently associated with the presence of ILD. WGS was significantly lower in patients treated with MTX in a dose of >= 15 mg/week (MTX >= 15 group) as compared to patients treated with lower doses of MTX (0<MTX<15 group) or not treated with MTX (N-MTX group) (P = 0.04 and P = 0.037, respectively). The ILD prevalence was higher in N-MTX group than in 0<MTX<15 group (P = 0.0036) and MTX >= 15 group (0.0007). The difference in ILD prevalence between MTX >= 15 and 0<MTX<15 groups was not significant, but the latter group had higher WES (P = 0.044) and trended to have higher WSS and WGS. Consclusions We found a beneficial effect of MTX on RA-ILD. Importantly, this effect seems to be dose dependent.	[Kur-Zalewska, Joanna; Kisiel, Bartlomiej; Tlustochowicz, Malgorzata; Tlustochowicz, Witold] Mil Inst Med, Dept Internal Dis & Rheumatol, Warsaw, Poland; [Kur-Zalewska, Joanna; Kisiel, Bartlomiej] Mil Inst Med, Clin Res Support Ctr, Warsaw, Poland; [Kania-Pudlo, Marta] Mil Inst Med, Dept Radiol, Warsaw, Poland; [Chcialowski, Andrzej] Mil Inst Med, Dept Infect Dis & Allergol, Warsaw, Poland	Military Institute of Aviation Medicine; Military Institute of Aviation Medicine; Military Institute of Aviation Medicine; Military Institute of Aviation Medicine	Kur-Zalewska, J (corresponding author), Mil Inst Med, Dept Internal Dis & Rheumatol, Warsaw, Poland.; Kur-Zalewska, J (corresponding author), Mil Inst Med, Clin Res Support Ctr, Warsaw, Poland.	jkur-zalewska@wim.mil.pl		Kur-Zalewska, Joanna/0000-0001-8954-9144				Alarcon GS, 1997, ANN INTERN MED, V127, P356, DOI 10.7326/0003-4819-127-5-199709010-00003; Balbir-Gurman A, 2006, SEMIN ARTHRITIS RHEU, V35, P368, DOI 10.1016/j.semarthrit.2006.03.002; BARRERA P, 1994, ANN RHEUM DIS, V53, P434, DOI 10.1136/ard.53.7.434; Biederer J, 2004, EUR RADIOL, V14, P272, DOI 10.1007/s00330-003-2026-1; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Chikura B, 2009, RHEUMATOLOGY, V48, P1065, DOI 10.1093/rheumatology/kep050; Cho SK, 2012, RHEUMATOL INT, V32, P1055, DOI 10.1007/s00296-009-1350-4; Conway R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1269; Conway R, 2014, ARTHRITIS RHEUMATOL, V66, P2642, DOI [10.1002/art.38732, 10.1002/art.38322]; Daien CI, 2009, RHEUMATOLOGY, V48, P883, DOI 10.1093/rheumatology/kep046; Dascalu C, 2010, JCR-J CLIN RHEUMATOL, V16, P172, DOI 10.1097/RHU.0b013e3181df8361; Fessi R, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.congress-2018.PA2926; Fragoulis GE, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00238; Furukawa H, 2013, ANN RHEUM DIS, V72, P153, DOI 10.1136/annrheumdis-2012-201944; Gabbay E, 1997, AM J RESP CRIT CARE, V156, P528, DOI 10.1164/ajrccm.156.2.9609016; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Giles JT, 2014, ANN RHEUM DIS, V73, P1487, DOI 10.1136/annrheumdis-2012-203160; Gochuico BR, 2008, ARCH INTERN MED, V168, P159, DOI 10.1001/archinternmed.2007.59; Gutsche M, 2012, CURR PULMONOL REP, V1, P224, DOI 10.1007/s13665-012-0028-7; Habib HM, 2011, CLIN RHEUMATOL, V30, P217, DOI 10.1007/s10067-010-1492-5; Horai Y, 2012, J CLIN PHARM THER, V37, P117, DOI 10.1111/j.1365-2710.2010.01234.x; Hozumi H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003132; Inokuma S, 2011, EXPERT OPIN DRUG SAF, V10, P603, DOI 10.1517/14740338.2011.560835; Ishida T, 2012, J RHEUMATOL, V39, P1104, DOI 10.3899/jrheum.111415; Ito S, 2004, INTERNAL MED, V43, P1103, DOI 10.2169/internalmedicine.43.1103; Kiely P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028466; Kim EJ, 2010, EUR RESPIR J, V35, P1322, DOI 10.1183/09031936.00092309; Kinder AJ, 2005, RHEUMATOLOGY, V44, P61, DOI 10.1093/rheumatology/keh512; Pearce F, 2012, RHEUMATOLOGY, V51, P578, DOI 10.1093/rheumatology/ker309; Perez-Alvarez R, 2011, SEMIN ARTHRITIS RHEU, V41, P256, DOI 10.1016/j.semarthrit.2010.11.002; Restrepo JF, 2015, CLIN RHEUMATOL, V34, P1529, DOI 10.1007/s10067-015-3025-8; Rockall AG, 2001, POSTGRAD MED J, V77, P621, DOI 10.1136/pmj.77.912.621; Rojas-Serrano J, 2017, CLIN RHEUMATOL, V36, P1493, DOI 10.1007/s10067-017-3707-5; Roubille C, 2014, SEMIN ARTHRITIS RHEU, V43, P613, DOI 10.1016/j.semarthrit.2013.09.005; Salaffi F, 2000, CLIN RHEUMATOL, V19, P35; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Shidara K, 2010, MOD RHEUMATOL, V20, P280, DOI 10.1007/s10165-010-0280-z; Sidhu HS, 2011, J CLIN IMAG SCI, V1, DOI 10.4103/2156-7514.82244; Taki H, 2009, RHEUMATOL INT, V30, P275, DOI 10.1007/s00296-009-0931-6; Tsuchiya Y, 2011, EUR RESPIR J, V37, P1411, DOI 10.1183/09031936.00019210; Turesson C, 2004, SCAND J RHEUMATOL, V33, P65, DOI 10.1080/03009740310004621; Wasko MCM, 2013, ARTHRITIS RHEUM-US, V65, P334, DOI 10.1002/art.37723; Wolfe F, 2007, SCAND J RHEUMATOL, V36, P172, DOI 10.1080/03009740601153774; Yamazaki H, 2010, MOD RHEUMATOL, V20, P518, DOI 10.1007/s10165-010-0308-4; Young A, 2007, BEST PRACT RES CL RH, V21, P907, DOI 10.1016/j.berh.2007.05.007; Zou YQ, 2012, RHEUMATOL INT, V32, P669, DOI 10.1007/s00296-010-1665-1	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250339	10.1371/journal.pone.0250339	http://dx.doi.org/10.1371/journal.pone.0250339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861812	Green Published, gold			2022-12-26	WOS:000641475400032
J	Saijo, Y; Yoshioka, E; Sato, Y; Miyamoto, T; Azuma, H; Tanahashi, Y; Ito, Y; Kobayashi, S; Minatoya, M; Bamai, YA; Yamazaki, K; Itoh, S; Miyashita, C; Araki, A; Kishi, R				Saijo, Yasuaki; Yoshioka, Eiji; Sato, Yukihiro; Miyamoto, Toshinobu; Azuma, Hiroshi; Tanahashi, Yusuke; Ito, Yoshiya; Kobayashi, Sumitaka; Minatoya, Machiko; Bamai, Yu Ait; Yamazaki, Keiko; Itoh, Sachiko; Miyashita, Chihiro; Araki, Atsuko; Kishi, Reiko		Japan Environm Childrens Study JEC	Parental educational level and childhood wheezing and asthma: A prospective cohort study from the Japan Environment and Children's Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MATERNAL EDUCATION; HEALTH; RATIONALE; RISK; INEQUALITIES; ALLERGIES; ISAAC; EMPLOYMENT	Background The influence of mothers' and fathers' educational levels in separate evaluations of asthma has not been fully investigated. This study aims to examine the associations of the mother's and fathers' educational levels with childhood wheeze and asthma adjusting for crude and pre-and post-natal modifiable risk factors. Methods We conducted a prospective cohort study using data from the Japan Environment and Children's Study, which recruited pregnant women from 2011 to 2014. The mother's and father's educational levels were surveyed by a questionnaire during the pregnancy, and childhood wheezing and doctor-diagnosed asthma were estimated using a 3-year questionnaire. Multilevel logistic regression analysis was performed to evaluate the association between the mother's and father's educational levels and childhood wheezing and asthma, adjusted for pre-and post-natal factors. Results A total of 69,607 pairs of parents and their single infants were analyzed. We found 17.3% of children had wheezing and 7.7% had asthma. In crude analyses, lower educational level of parents was associated with an increased risk of childhood wheezing and asthma. After full adjustment, a lower educational level of mothers was associated with an increased risk of childhood asthma (junior high school (reference: high school); odds ratio (OR): 1.17, 95% CI, 1.01-1.36), and higher educational level, especially the mother's, was associated with an increased risk of childhood wheezing (technical junior college, technical/vocational college, or associate degree (ECD3); OR: 1.12, 95% CI, 1.06-1.18, bachelor's degree, or postgraduate degree; OR: 1.10, 95% CI, 1.03-1.18), and asthma (ECD3; OR: 1.13, 95% CI, 1.04-1.21). Conclusions Parents' lower educational level was a crude risk factor for childhood wheezing and asthma. However, an increased risk of wheezing due to mothers' higher educational level was found after adjusting for pre-and post-natal factors.	[Saijo, Yasuaki; Yoshioka, Eiji; Sato, Yukihiro] Asahikawa Med Univ, Dept Social Med, Div Publ Hlth & Epidemiol, Asahikawa, Hokkaido, Japan; [Miyamoto, Toshinobu] Asahikawa Med Univ, Dept Obstet & Gynecol, Asahikawa, Hokkaido, Japan; [Azuma, Hiroshi; Tanahashi, Yusuke] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan; [Ito, Yoshiya] Japanese Red Cross Hokkaido Coll Nursing, Fac Nursing, Kitami, Hokkaido, Japan; [Kobayashi, Sumitaka; Minatoya, Machiko; Bamai, Yu Ait; Yamazaki, Keiko; Itoh, Sachiko; Miyashita, Chihiro; Araki, Atsuko; Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan	Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Hokkaido University	Saijo, Y (corresponding author), Asahikawa Med Univ, Dept Social Med, Div Publ Hlth & Epidemiol, Asahikawa, Hokkaido, Japan.	y-saijo@asahikawa-med.ac.jp	Saijo, Yasuaki/J-3796-2019; Ait Bamai, Yu/AAA-3639-2022	Saijo, Yasuaki/0000-0002-6211-8202; Yoshioka, Eiji/0000-0003-3316-1057; Sato, Yukihiro/0000-0001-5657-8379; Ait Bamai, Yu/0000-0003-2510-4757	Ministry of the Environment, Japan	Ministry of the Environment, Japan(Ministry of the Environment, Japan)	The JECS was funded by the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received a salary from the funder.	Arakawa H, 2017, ALLERGOL INT, V66, P190, DOI 10.1016/j.alit.2016.11.003; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bonato M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081180; Campos-Serna J, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-57; Cesaroni G, 2003, EUR RESPIR J, V22, P619, DOI 10.1183/09031936.03.00091202; Currie J, 2009, J ECON LIT, V47, P87, DOI 10.1257/jel.47.1.87; Doyle O, 2015, ECON HUM BIOL, V19, P224, DOI 10.1016/j.ehb.2015.09.004; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Ferrante G, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00186; Fuchs O, 2017, LANCET RESP MED, V5, P224, DOI 10.1016/S2213-2600(16)30187-4; Furuhata M, 2020, MATERN CHILD HLTH J, V24, P911, DOI 10.1007/s10995-020-02944-0; Gong T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106579; Gopal Srirupa Hari, 2016, J Environ Health Sci, V2; Hafkamp-de Groen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078266; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Lewis KM, 2017, EUR J EPIDEMIOL, V32, P797, DOI 10.1007/s10654-017-0309-0; Magnus MC, 2018, AM J EPIDEMIOL, V187, P1199, DOI 10.1093/aje/kwx366; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Miyake Y, 2012, INT J TUBERC LUNG D, V16, P756, DOI 10.5588/ijtld.11.0484; Pierron A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5915-6; Ruijsbroek A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-225; Sekine M, 2006, SOC SCI MED, V63, P430, DOI 10.1016/j.socscimed.2006.01.020; Spencer N, 2005, J EPIDEMIOL COMMUN H, V59, P842, DOI 10.1136/jech.2005.036301; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Suizzo MA, 2007, EDUC PSYCHOL-UK, V27, P533, DOI 10.1080/01443410601159936; Umeda M, 2015, SSM-POPUL HLTH, V1, P8, DOI 10.1016/j.ssmph.2015.09.002; von Mutius E, 2020, LANCET, V396, P854, DOI 10.1016/S0140-6736(20)31861-4; Vukojevic M, 2017, ACTA CLIN CROAT, V56, P742, DOI 10.20471/acc.2017.56.04.23; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303	30	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250255	10.1371/journal.pone.0250255	http://dx.doi.org/10.1371/journal.pone.0250255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861791	Green Published, gold			2022-12-26	WOS:000641475400063
J	Libwea, JN; Fletcher, MA; Ndombo, PK; Boula, A; Ashukem, NT; Baleba, MN; Bebey, RSK; Mviena, EGN; Tageube, J; Mbollo, MK; Koulla-Shiro, S; Madhi, S; Njanpop-Lafourcade, BM; Mohammad, A; Begier, E; Southern, J; Beavon, R; Gessner, B				Libwea, John Njuma; Fletcher, Mark A.; Ndombo, Paul Koki; Boula, Angeline; Ashukem, Nadesh Taku; Baleba, Madeleine Ngo; Bebey, Rachel Sandrine Kingue; Mviena, Eric Gaston Nkolo; Tageube, Jean; Mbollo, Marie Kobela; Koulla-Shiro, Sinata; Madhi, Shabir; Njanpop-Lafourcade, Berthe-Marie; Mohammad, Ali; Begier, Elizabeth; Southern, Joanna; Beavon, Rohini; Gessner, Bradford			Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children < 5 years in Cameroon, 2011-2018	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TEMPORAL-CHANGES; BURKINA-FASO; DISEASE; BURDEN; COLONIZATION; PREVALENCE	Background The 13-valent pneumococcal conjugate vaccine (PCV13) entered Cameroon's childhood national immunization programme (NIP) in July 2011 under a 3-dose schedule (6, 10, 14 weeks of age) without any catch-up. We described the impact of PCV13 onserotype distribution among pneumococcal meningitis cases over time. Methods We used laboratory-based sentinel surveillance data to identify meningitis cases among 2- to 59-month-old children with clinically-suspected bacterial meningitis (CSBM) admitted to hospitals in Yaounde (August 2011-December 2018). Purulent meningitis cases had a cerebrospinal fluid (CSF) white blood cell (WBC) count >= 20 per mm(3). Pneumococcal meningitis cases had S. pneumoniae identified from CSF, with serotyping by polymerase chain reaction. Years 2011-2014 were described as early PCV13 era (EPE) and years 2015-2018 as late PCV13 era (LPE) impact periods. Results Among children hospitalized with CSBM who had a lumbar puncture obtained, there was no significant change from the EPE versus the LPE in the percentage identified with purulent meningitis: 7.5% (112/1486) versus 9.4% (154/1645), p = 0.0846. The percentage of pneumococcal meningitis cases due to PCV13 vaccine-serotype (VST) decreased from 62.0% (31/50) during the EPE to 35.8% (19/53) in the LPE, p = 0.0081. The most frequent pneumococcal meningitis VSTs during the EPE were 6A/6B (30%) and 5 (6%), and during the LPE were 14 (13.2%), 3 (7.6%), 4 (5.6%) and 18C (5.6%). Conclusion Four to seven years after PCV13 introduction, the proportion of pneumococcal meningitis due to vaccine serotypes has declined, mainly due to reductions of serotypes 6A/6B, 1, 19A, and 23F; nevertheless, PCV13 VSTs remain common. Because the analyzed surveillance system was not consistent or population based, we could not estimate incidence or overall impact; this emphasizes the need for improved surveillance to document further the utility of PCV13 immunization in Cameroon.	[Libwea, John Njuma] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Libwea, John Njuma] Tampere Univ, Fac Social Sci, Hlth Sci Unit, Tampere, Finland; [Libwea, John Njuma; Ndombo, Paul Koki; Mbollo, Marie Kobela] Expanded Programme Immunizat, Yaounde, Cameroon; [Fletcher, Mark A.] Pfizer Inc, Vaccines, Emerging Markets Med Affairs, Paris, France; [Ndombo, Paul Koki; Boula, Angeline; Ashukem, Nadesh Taku; Baleba, Madeleine Ngo; Bebey, Rachel Sandrine Kingue; Mviena, Eric Gaston Nkolo; Tageube, Jean] Mother & Child Hosp MCH, Chantal Biya Fdn, Yaounde, Cameroon; [Ashukem, Nadesh Taku; Koulla-Shiro, Sinata] Minist Publ Hlth, Yaounde, Cameroon; [Mbollo, Marie Kobela; Koulla-Shiro, Sinata] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Madhi, Shabir] Univ Witwatersrand, South African Med Res Council, Vaccines & Infect Dis Analyt Res Unit, Fac HealthSci, Johannesburg, South Africa; [Njanpop-Lafourcade, Berthe-Marie] Agence Med Prevent AMP, Paris, France; [Mohammad, Ali; Begier, Elizabeth; Southern, Joanna; Beavon, Rohini; Gessner, Bradford] Pfizer Vaccines Med Dev & Med Sci Affairs, New York, NY USA	Finland National Institute for Health & Welfare; Tampere University; Pfizer; University of Yaounde I; South African Medical Research Council; University of Witwatersrand; Pfizer	Libwea, JN (corresponding author), Natl Inst Hlth & Welf THL, Helsinki, Finland.; Libwea, JN (corresponding author), Tampere Univ, Fac Social Sci, Hlth Sci Unit, Tampere, Finland.; Libwea, JN (corresponding author), Expanded Programme Immunizat, Yaounde, Cameroon.	libwea_j@yahoo.com		Madhi, Shabir/0000-0002-7629-0636; Nadesh, Taku/0000-0002-6514-6743	Cameroon Academy of Sciences from Pfizer Inc. [WI232068]	Cameroon Academy of Sciences from Pfizer Inc.	This study was sponsored by the Cameroon Academy of Sciences, which received a collaborative research grants from Pfizer Inc. [WI232068]. However, the sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boula A., 2019, HOSP BASED SURVEILLA, V69, P148, DOI [10.1093/cid/ciz506, DOI 10.1093/CID/CIZ506]; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Esposito S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-12; Faye PM, 2019, CLIN INFECT DIS, V69, pS66, DOI 10.1093/cid/ciz457; Gervaix A, 2012, PEDIATR INFECT DIS J, V31, P1084, DOI 10.1097/INF.0b013e318260552d; Hammitt LL, 2019, LANCET, V393, P2146, DOI 10.1016/S0140-6736(18)33005-8; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Kambire D, 2018, J INFECTION, V76, P270, DOI 10.1016/j.jinf.2017.12.002; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kwambana-Adams BA., 2016, BMC INFECT DIS BMC I; Libwea JN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212939; Libwea JN, 2020, INT J INFECT DIS, V98, P113, DOI 10.1016/j.ijid.2020.06.048; Libwea JN, 2018, INT J PEDIATR OTORHI, V115, P181, DOI 10.1016/j.ijporl.2018.10.007; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS161, DOI 10.1097/INF.0000000000000084; Mackenzie GA, 2017, LANCET INFECT DIS, V17, P965, DOI 10.1016/S1473-3099(17)30321-3; Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2; Madhi SA, 2016, HUM VACC IMMUNOTHER, V12, P314, DOI 10.1080/21645515.2015.1084450; Neves FPG, 2017, VACCINE, V35, P2794, DOI 10.1016/j.vaccine.2017.04.019; Nhantumbo AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177746; Nzenze SA, 2015, J INFECT DIS, V212, P1082, DOI 10.1093/infdis/jiv167; Nzenze SA, 2013, PEDIATR INFECT DIS J, V32, P1270, DOI 10.1097/01.inf.0000435805.25366.64; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oligbu G, 2019, EMERG INFECT DIS, V25, P1708, DOI 10.3201/eid2509.180747; Olivia Cohen M, 2017, PNEUMOCOCCAL CONJUGA; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Roca A, 2015, VACCINE, V33, P7144, DOI 10.1016/j.vaccine.2015.11.012; Rodrigo C, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0403-3; Sanneh B, 2019, CLIN INFECT DIS, V69, pS126, DOI 10.1093/cid/ciz505; Soeters HM, 2019, J INFECT DIS, V220, pS253, DOI 10.1093/infdis/jiz301; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2018, CAMEROON WHO UNICEF; Yun KW, 2011, J KOREAN MED SCI, V26, P971, DOI 10.3346/jkms.2011.26.8.971	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250010	10.1371/journal.pone.0250010	http://dx.doi.org/10.1371/journal.pone.0250010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857235	Green Published, gold			2022-12-26	WOS:000641474900121
J	Paudel, DB; Sanfacon, H				Paudel, Dinesh Babu; Sanfacon, Helene			Mapping of sequences in the 5' region and 3' UTR of tomato ringspot virus RNA2 that facilitate cap-independent translation of reporter transcripts in vitro	PLOS ONE			English	Article							INTERNAL RIBOSOMAL ENTRY; GENOME-LINKED PROTEIN; TRACT BINDING-PROTEIN; T-SHAPED STRUCTURE; N-TERMINAL REGION; MOSAIC-VIRUS; NUCLEOTIDE-SEQUENCE; SECONDARY STRUCTURE; INITIATION CODON; CLEAVAGE SITE	Tomato ringspot virus (ToRSV, genus Nepovirus, family Secoviridae, order Picornavirales) is a bipartite positive-strand RNA virus, with each RNA encoding one large polyprotein. ToRSV RNAs are linked to a 5'-viral genome-linked protein (VPg) and have a 3' polyA tail, suggesting a non-canonical cap-independent translation initiation mechanism. The 3' untranslated regions (UTRs) of RNA1 and RNA2 are unusually long (similar to 1.5 kb) and share several large stretches of sequence identities. Several putative in-frame start codons are present in the 5' regions of the viral RNAs, which are also highly conserved between the two RNAs. Using reporter transcripts containing the 5' region and 3' UTR of the RNA2 of ToRSV Rasp1 isolate (ToRSV-Rasp1) and in vitro wheat germ extract translation assays, we provide evidence that translation initiates exclusively at the first AUG, in spite of a poor codon context. We also show that both the 5' region and 3' UTR of RNA2 are required for efficient cap-independent translation of these transcripts. We identify translation-enhancing elements in the 5' proximal coding region of the RNA2 polyprotein and in the RNA2 3' UTR. Cap-dependent translation of control reporter transcripts was inhibited when RNAs consisting of the RNA2 3' UTR were supplied in trans. Taken together, our results suggest the presence of a CITE in the ToRSV-Rasp1 RNA2 3' UTR that recruits one or several translation factors and facilitates efficient cap-independent translation together with the 5' region of the RNA. Non-overlapping deletion mutagenesis delineated the putative CITE to a 200 nts segment (nts 773-972) of the 1547 nt long 3' UTR. We conclude that the general mechanism of ToRSV RNA2 translation initiation is similar to that previously reported for the RNAs of blackcurrant reversion virus, another nepovirus. However, the position, sequence and predicted structures of the translation-enhancing elements differed between the two viruses.	[Paudel, Dinesh Babu] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Sanfacon, Helene] Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada; [Paudel, Dinesh Babu] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada	University of British Columbia; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Sanfacon, H (corresponding author), Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada.	helene.sanfacon@canada.ca	Paudel, Dinesh/GRR-3044-2022	Sanfacon, Helene/0000-0003-3807-3590	Agriculture and Agri-Food Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 122249-10]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by Agriculture and Agri-Food Canada (https://www.agr.gc.ca/eng/agriculture and agrifood canada id= 1395690825741) A-base core funding awarded to HS. The work was also supported in part by the Natural Sciences and Engineering Research Council of Canada (NSERC, https://www.nserccrsng.gc.ca/index_eng.asp) Discovery Grant RGPIN 122249-10 awarded to HS (and used for a graduate stipend for DBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Sanz MA, 2019, RNA, V25, P431, DOI 10.1261/rna.068858.118; Browning Karen S, 2015, Arabidopsis Book, V13, pe0176, DOI 10.1199/tab.0176; Carrier K, 1999, VIROLOGY, V258, P161, DOI 10.1006/viro.1999.9729; Carrier K, 2001, J GEN VIROL, V82, P1785, DOI 10.1099/0022-1317-82-7-1785; CHU PWG, 1981, VIROLOGY, V109, P428, DOI 10.1016/0042-6822(81)90513-4; Ciullo M, 2000, DNA CELL BIOL, V19, P39, DOI 10.1089/104454900314690; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; de Oliveira LC, 2019, P NATL ACAD SCI USA, V116, P24056, DOI 10.1073/pnas.1904752116; Du ZY, 2017, NUCLEIC ACIDS RES, V45, P9558, DOI 10.1093/nar/gkx643; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Eskelin K, 2011, J VIROL, V85, P9210, DOI 10.1128/JVI.00052-11; Fuchs M, 2017, ADV VIRUS RES, V97, P61, DOI 10.1016/bs.aivir.2016.08.009; Gao F, 2013, J VIROL, V87, P11987, DOI 10.1128/JVI.02005-13; Gao F, 2012, J VIROL, V86, P9828, DOI 10.1128/JVI.00677-12; Gupta P, 2016, J THEOR BIOL, V404, P303, DOI 10.1016/j.jtbi.2016.06.015; HELLEN CUT, 1987, J GEN VIROL, V68, P2913, DOI 10.1099/0022-1317-68-11-2913; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hunt SL, 1999, RNA, V5, P344, DOI 10.1017/S1355838299981414; Hwang WL, 1999, J GEN VIROL, V80, P1769, DOI 10.1099/0022-1317-80-7-1769; Jaafar ZA, 2019, NAT REV MICROBIOL, V17, P110, DOI 10.1038/s41579-018-0117-x; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jan E, 2016, ANNU REV VIROL, V3, P283, DOI 10.1146/annurev-virology-100114-055014; Jiang J, 2011, CURR OPIN VIROL, V1, P347, DOI 10.1016/j.coviro.2011.09.010; Johnson PZ, 2019, RNA BIOL, V16, P1667, DOI 10.1080/15476286.2019.1659081; Joshi CP, 1997, PLANT MOL BIOL, V35, P993, DOI 10.1023/A:1005816823636; Karetnikov A, 2008, VIROLOGY, V371, P292, DOI 10.1016/j.virol.2007.10.003; Karetnikov A, 2007, J GEN VIROL, V88, P286, DOI 10.1099/vir.0.82307-0; Karetnikov A, 2006, VIROLOGY, V354, P178, DOI 10.1016/j.virol.2006.06.028; Kearse MG, 2017, GENE DEV, V31, P1717, DOI 10.1101/gad.305250.117; Kerr CH, 2016, J VIROL, V90, P5538, DOI 10.1128/JVI.00737-15; KOENIG I, 1982, J GEN VIROL, V60, P343, DOI 10.1099/0022-1317-60-2-343; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kraft JJ, 2013, NUCLEIC ACIDS RES, V41, P3398, DOI 10.1093/nar/gkt026; Langereis MA, 2014, NUCLEIC ACIDS RES, V42, P2473, DOI 10.1093/nar/gkt1162; Lehto K, 2004, ARCH VIROL, V149, P1867, DOI 10.1007/s00705-004-0295-x; Leonard S, 2002, J GEN VIROL, V83, P2085, DOI 10.1099/0022-1317-83-8-2085; Lozano G, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180155; Lu WT, 2014, BIOCHEM SOC T, V42, P166, DOI 10.1042/BST20130161; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; Martinez-Salas E, 2015, VIRUS RES, V206, P62, DOI 10.1016/j.virusres.2015.01.012; Merrick WC, 2015, J BIOL CHEM, V290, P24091, DOI 10.1074/jbc.R115.675280; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Miller WA, 2006, ANNU REV PHYTOPATHOL, V44, P447, DOI 10.1146/annurev.phyto.44.070505.143353; Miras M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00494; Miras M, 2014, NEW PHYTOL, V202, P233, DOI 10.1111/nph.12650; Nicholson BL, 2011, CURR OPIN VIROL, V1, P373, DOI 10.1016/j.coviro.2011.10.002; NOMOTO A, 1977, P NATL ACAD SCI USA, V74, P5345, DOI 10.1073/pnas.74.12.5345; Patrick RM, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/287814; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Rangan L, 2008, MOL BIOTECHNOL, V39, P207, DOI 10.1007/s12033-008-9036-9; RIECHMANN JL, 1991, VIROLOGY, V185, P544, DOI 10.1016/0042-6822(91)90524-F; ROTT ME, 1995, J GEN VIROL, V76, P465, DOI 10.1099/0022-1317-76-2-465; ROTT ME, 1991, J GEN VIROL, V72, P1505, DOI 10.1099/0022-1317-72-7-1505; ROTT ME, 1991, VIROLOGY, V185, P468, DOI 10.1016/0042-6822(91)90801-H; Sanfacon H., ENCY VIROLOGY, V4th, P486; Sanfacon H, 2015, VIRUSES-BASEL, V7, P3392, DOI 10.3390/v7072778; Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609; Stupina VA, 2008, RNA, V14, P2379, DOI 10.1261/rna.1227808; Stupina VA, 2011, J VIROL, V85, P4638, DOI 10.1128/JVI.00005-11; THOMAS AAM, 1991, J VIROL, V65, P2953, DOI 10.1128/JVI.65.6.2953-2959.1991; Thompson JR, 2017, J GEN VIROL, V98, P529, DOI 10.1099/jgv.0.000779; Truniger V, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02047; VERVER J, 1991, J GEN VIROL, V72, P2339, DOI 10.1099/0022-1317-72-10-2339; Vicens Q, 2018, MOL CELL, V72, P805, DOI 10.1016/j.molcel.2018.10.047; Walker M, 2015, ARCH VIROL, V160, P543, DOI 10.1007/s00705-014-2240-y; Wang AM, 1999, J GEN VIROL, V80, P799, DOI 10.1099/0022-1317-80-3-799; Wang AM, 2000, J GEN VIROL, V81, P2771, DOI 10.1099/0022-1317-81-11-2771; WELLINK J, 1993, BIOCHIMIE, V75, P741, DOI 10.1016/0300-9084(93)90105-2; WITHERELL GW, 1993, BIOCHEMISTRY-US, V32, P8268, DOI 10.1021/bi00083a030; Zhang J., 2015, VIRUS RES; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	77	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249928	10.1371/journal.pone.0249928	http://dx.doi.org/10.1371/journal.pone.0249928			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836032	gold, Green Published			2022-12-26	WOS:000639361000006
J	Baecklund, TM; Morrison, J; Donaldson, ME; Hueffer, K; Kyle, CJ				Baecklund, Tristan M.; Morrison, Jaycee; Donaldson, Michael E.; Hueffer, Karsten; Kyle, Christopher J.			The role of a mechanistic host in maintaining arctic rabies variant distributions: Assessment of functional genetic diversity in Alaskan red fox (Vulpes vulpes)	PLOS ONE			English	Article							LOCAL ADAPTATION; R-PACKAGE; POPULATION-STRUCTURE; UNITED-STATES; MHC; SELECTION; VIRUS; FRAMEWORK; EVOLUTION; SEQUENCE	Populations are exposed to different types and strains of pathogens across heterogeneous landscapes, where local interactions between host and pathogen may present reciprocal selective forces leading to correlated patterns of spatial genetic structure. Understanding these coevolutionary patterns provides insight into mechanisms of disease spread and maintenance. Arctic rabies (AR) is a lethal disease with viral variants that occupy distinct geographic distributions across North America and Europe. Red fox (Vulpes vulpes) are a highly susceptible AR host, whose range overlaps both geographically distinct AR strains and regions where AR is absent. It is unclear if genetic structure exists among red fox populations relative to the presence/absence of AR or the spatial distribution of AR variants. Acquiring these data may enhance our understanding of the role of red fox in AR maintenance/spread and inform disease control strategies. Using a genotyping-by-sequencing assay targeting 116 genomic regions of immunogenetic relevance, we screened for sequence variation among red fox populations from Alaska and an outgroup from Ontario, including areas with different AR variants, and regions where the disease was absent. Presumed neutral SNP data from the assay found negligible levels of neutral genetic structure among Alaskan populations. The immunogenetically-associated data identified 30 outlier SNPs supporting weak to moderate genetic structure between regions with and without AR in Alaska. The outliers included SNPs with the potential to cause missense mutations within several toll-like receptor genes that have been associated with AR outcome. In contrast, there was a lack of genetic structure between regions with different AR variants. Combined, we interpret these data to suggest red fox populations respond differently to the presence of AR, but not AR variants. This research increases our understanding of AR dynamics in the Arctic, where host/disease patterns are undergoing flux in a rapidly changing Arctic landscape, including the continued northward expansion of red fox into regions previously predominated by the arctic fox (Vulpes lagopus).	[Baecklund, Tristan M.; Donaldson, Michael E.; Kyle, Christopher J.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada; [Morrison, Jaycee] Trent Univ, Forens Sci Undergrad Program, Peterborough, ON, Canada; [Hueffer, Karsten] Univ Alaska Fairbanks, Dept Vet Med, Fairbanks, AK USA; [Kyle, Christopher J.] Trent Univ, Forens Sci Dept, Peterborough, ON, Canada; [Kyle, Christopher J.] Trent Univ, Nat Resources DNA Profiling & Forens Ctr, Peterborough, ON, Canada	Trent University; Trent University; University of Alaska System; University of Alaska Fairbanks; Trent University; Trent University	Baecklund, TM (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada.	tristanbaecklund@trentu.ca			Natural Sciences and Engineering Research Council [PGPIN2016-05373]; Compute Canada [RRG gme-665-ab]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Compute Canada	This research was funded by a Natural Sciences and Engineering Research Council Discovery Grant to CJK (PGPIN2016-05373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was enabled in part by support provided by Compute Canada (www.computecanada.ca; RRG gme-665-ab).	Ahrens CW, 2018, MOL ECOL, V27, P1342, DOI 10.1111/mec.14549; [Anonymous], 2013, PREPRINTS; Attard CRM, 2018, MOL ECOL RESOUR, V18, P381, DOI 10.1111/1755-0998.12739; Attard CRM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170925; Aubry KB, 2009, MOL ECOL, V18, P2668, DOI 10.1111/j.1365-294X.2009.04222.x; Berteaux D, 2015, POLAR BIOL, V38, P913, DOI 10.1007/s00300-015-1647-6; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Bradley Michael, 2005, Int J Circumpolar Health, V64, P468; Chhatre VE, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1593-0; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Crispin JC, 2013, NAT REV RHEUMATOL, V9, P476, DOI 10.1038/nrrheum.2013.78; Cullingham CI, 2009, MOL ECOL, V18, P43, DOI 10.1111/j.1365-294X.2008.03989.x; Dell'Arte GL, 2007, ACTA OECOL, V31, P276, DOI 10.1016/j.actao.2006.12.007; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; Donaldson ME, 2018, ECOL EVOL, V8, P572, DOI 10.1002/ece3.3583; Donaldson ME, 2017, EVOL APPL, V10, P1076, DOI 10.1111/eva.12514; Doxiadis GGM, 2000, J IMMUNOL, V164, P3193, DOI 10.4049/jimmunol.164.6.3193; Dyer JL, 2014, JAVMA-J AM VET MED A, V245, P1111, DOI 10.2460/javma.245.10.1111; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards CJ, 2012, QUATERNARY SCI REV, V57, P95, DOI 10.1016/j.quascirev.2012.10.010; Eizaguirre C, 2011, EVOL ECOL, V25, P605, DOI 10.1007/s10682-010-9424-z; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Elmhagen B, 2002, CAN J ZOOL, V80, P1274, DOI 10.1139/Z02-108; Elmhagen B, 2015, AMBIO, V44, P39, DOI 10.1007/s13280-014-0606-8; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frick WF., BATS ANTHROPOCENE CO, P245; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Fuller ZL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1712-0; Gautier M, 2017, MOL ECOL RESOUR, V17, P78, DOI 10.1111/1755-0998.12634; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Goldsmith EW, 2016, MOL ECOL, V25, P675, DOI 10.1111/mec.13509; Guerra MA, 2003, EMERG INFECT DIS, V9, P1143; Guo Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-194; Gutierrez-Espeleta GA, 2001, HEREDITY, V86, P439, DOI 10.1046/j.1365-2540.2001.00853.x; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hueffer K, 2018, INT J CIRCUMPOL HEAL, V77, DOI 10.1080/22423982.2018.1475185; Hueffer K, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-17; Huettmann F, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0285-0; Huguet G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088600; Ito N, 2016, J VET MED SCI, V78, P1089, DOI 10.1292/jvms.16-0092; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamler JF, 2002, WILDLIFE SOC B, V30, P370; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Komatsu T, 1998, CYTOKINE GROWTH F R, V9, P277, DOI 10.1016/S1359-6101(98)00017-3; Kukurba Kimberly R, 2015, Cold Spring Harb Protoc, V2015, P951, DOI 10.1101/pdb.top084970; Kumar V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1724-9; Kuzmin IV, 2008, EPIDEMIOL INFECT, V136, P509, DOI 10.1017/S095026880700903X; Kyle CJ, 2014, MOL ECOL, V23, P2287, DOI 10.1111/mec.12726; Lariviere Serge, 1996, Mammalian Species, V537, P1; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JW, 2011, ADV VIRUS RES, V79, P115, DOI 10.1016/B978-0-12-387040-7.00007-X; Li S., 2019, BIORXIV, V1; Luu K, 2017, MOL ECOL RESOUR, V17, P67, DOI 10.1111/1755-0998.12592; MacInnes CD, 2001, J WILDLIFE DIS, V37, P119, DOI 10.7589/0090-3558-37.1.119; Madhu BP, 2016, VIRUS GENES, V52, P61, DOI 10.1007/s11262-015-1265-y; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Medvedev AE, 2013, J INTERF CYTOK RES, V33, P467, DOI 10.1089/jir.2012.0140; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Mork T, 2004, ACTA VET SCAND, V45, P1, DOI 10.1186/1751-0147-45-1; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Nadin-Davis SA, 2006, CAN J VET RES, V70, P11; Nadin-Davis SA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007699; Nadin-Davis SA, 2012, VIRUS RES, V163, P352, DOI 10.1016/j.virusres.2011.10.026; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nishiura H, 2009, EPIDEMICS-NETH, V1, P118, DOI 10.1016/j.epidem.2009.04.002; Noren K, 2017, CONSERV GENET, V18, P359, DOI 10.1007/s10592-016-0910-x; Nuismer SL, 1999, P ROY SOC B-BIOL SCI, V266, P605, DOI 10.1098/rspb.1999.0679; Pantel JH, 2015, ECOL LETT, V18, P992, DOI 10.1111/ele.12480; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parkinson Alan J, 2005, Int J Circumpolar Health, V64, P478; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; R Core Team, 2021, R LANGUAGE ENV STAT; RAUSCH RL, 1972, ARCH ENVIRON HEALTH, V25, P246, DOI 10.1080/00039896.1972.10666170; Rico Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140170; Rosatte RC, 2007, EMERG INFECT DIS, V13, P25, DOI 10.3201/eid1301.060622; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schaefer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S4; Schweizer RM, 2016, MOL ECOL, V25, P357, DOI 10.1111/mec.13467; Schweizer RM, 2016, MOL ECOL, V25, P380, DOI 10.1111/mec.13364; Semnani RT, 2008, BLOOD, V112, P1290, DOI 10.1182/blood-2008-04-149856; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Sokolov AA, 2016, ARCTIC, V69, P121, DOI 10.14430/arctic4559; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Srithayakumar V, 2014, J GEN VIROL, V95, P16, DOI 10.1099/vir.0.053942-0; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; Sunyer JO, 2003, IMMUNOL RES, V27, P549, DOI 10.1385/IR:27:2-3:549; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Turner AJ, 2015, P NATL ACAD SCI USA, V112, P15414, DOI 10.1073/pnas.1515978112; vanTienderen PH, 1997, EVOLUTION, V51, P1372, DOI [10.1111/j.1558-5646.1997.tb01460.x, 10.2307/2411189]; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Voight B.F., 2006, PLOS BIOL, V4, P72, DOI [10.1371/journal.pbio.0040072, DOI 10.1371/JOURNAL.PBIO.0040072]; WASER NM, 1985, AM J BOT, V72, P1726, DOI 10.2307/2443730; Whitlock MC, 2003, GENETICS, V164, P767; Whitlock MC, 2015, AM NAT, V186, pS24, DOI 10.1086/682949; Yaremych SA, 2004, EMERG INFECT DIS, V10, P709, DOI 10.3201/eid1004.030499; Zecchin B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213515; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhao SC, 2013, NAT GENET, V45, P67, DOI 10.1038/ng.2494	121	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249176	10.1371/journal.pone.0249176	http://dx.doi.org/10.1371/journal.pone.0249176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831031	Green Published, gold			2022-12-26	WOS:000639359600095
J	Crowe, SA; Simister, RL; Spence, JS; Kenward, PA; Van Slyke, AC; Lennox, P; Carr, N				Crowe, Sean A.; Simister, Rachel L.; Spence, Jenifer S.; Kenward, Paul A.; Van Slyke, Aaron C.; Lennox, Peter; Carr, Nick			Microbial community compositions in breast implant biofilms associated with contracted capsules	PLOS ONE			English	Article							BACTERIAL BIOFILMS; ANTIBIOTIC-RESISTANCE; GUT MICROBIOME; SEQUENCE DATA; INFECTION; DIVERSITY; AUGMENTATION; RISK; ALIGNMENT; TISSUE	Subclinical bacterial infections (biofilms) are strongly implicated in breast augmentation failure due to capsular contracture, and while these infections are generally ascribed to common skin commensals, this remains largely unsubstantiated through robust cultivation independent analyses. To determine capsule biofilm microbial community compositions, we employed amplicon sequencing of the 16S rRNA gene using DNA extracted from breast implant capsule samples. These cultivation independent analyses revealed that capsule associated biofilms are more diverse than canonical single-species infections, but have relatively low diversity (similar to <100 species) compared to many host-associated microbial communities. In addition to taxa commonly associated with capsular contracture, the biofilms analyzed comprised a number of taxa that escaped detection in cultivation-dependent work. We have also isolated several key taxa identified through the culture-independent analyses. Together our analyses reveal that capsule biofilms are more diverse than cultivation studies suggest and can be heterogeneous within an individual capsule, between breasts of the same patient, across similar implant types, and over a range in severity of contracture. The complex nature of these communities requires further study across a broader suite of patients in addition to higher resolution analyses including metagenomics to better assess the fundamental role of microorganisms in capsular contracture.	[Crowe, Sean A.; Simister, Rachel L.; Spence, Jenifer S.; Kenward, Paul A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Van Slyke, Aaron C.; Lennox, Peter] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Lennox, Peter] Vancouver Plast Surg, Vancouver, BC, Canada; [Carr, Nick] Skinworks, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Crowe, SA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.; Carr, N (corresponding author), Skinworks, Vancouver, BC, Canada.	sean.crowe@ubc.ca; drcarr@skinworks.ca	Carr, Nicholas/ABD-2360-2021	Spence, Jenifer/0000-0003-0368-1019	Natural Sciences and Engineering Research Council of Canada (NSERC) [0487]; NSERC [488438]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported through a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant 0487 to S,A.C, and a NSERC engage grant 488438 to S. A.C, N.C and P.L. https://www.nserc-crsng.gc.ca/index_eng.asp.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NC and PL are also employed at Skin Works and Vancouver Plastic Surgery, respectively. Skin Works and Vancouver Plastic Surgery provided income for NC and PL as well as matching funds for NSERC engage grant 488438. NC and PL helped design sampling methodology and provided sample materials along with patient metadata. They also had roles in data interpretation, manuscript preparation and decision to publish.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Ajdic D, 2016, AESTHET SURG J, V36, P297, DOI 10.1093/asj/sjv177; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachour Y, 2019, AESTHET PLAST SURG, V43, P918, DOI 10.1007/s00266-019-01383-9; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Blount AL, 2013, AESTHET SURG J, V33, P516, DOI 10.1177/1090820X13484465; Boisrenoult P, 2018, ORTHOP TRAUMATOL-SUR, V104, pS19, DOI 10.1016/j.otsr.2017.05.030; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; Chaves F, 2005, J CLIN MICROBIOL, V43, P4877, DOI 10.1128/JCM.43.9.4877-4879.2005; Collett DJ, 2019, PLAST RECONSTR SURG, V143, DOI 10.1097/PRS.0000000000005567; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cook J, 2021, AESTHET SURG J, V41, P440, DOI 10.1093/asj/sjaa097; Costantini L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35329-z; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de la Fuente-Nunez C, 2013, CURR OPIN MICROBIOL, V16, P580, DOI 10.1016/j.mib.2013.06.013; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Del Pozo JL, 2009, J CLIN MICROBIOL, V47, P1333, DOI 10.1128/JCM.00096-09; Deva AK, 2013, PLAST RECONSTR SURG, V132, P1319, DOI 10.1097/PRS.0b013e3182a3c105; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fitzal F., 2019, OPEN BIOL, V9, P190006, DOI [10.1098/rsob.190006, DOI 10.1098/rsob.190006]; Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877, DOI 10.1128/JCM.38.2.877-880.2000; Giordano S, 2013, AESTHET SURG J, V33, P675, DOI 10.1177/1090820X13491490; Greenblum S, 2013, CURR OPIN BIOTECH, V24, P810, DOI 10.1016/j.copbio.2013.04.001; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hu H, 2016, PLAST RECONSTR SURG, V137, P1659, DOI 10.1097/PRS.0000000000002010; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; KOTILAINEN P, 1990, J CLIN MICROBIOL, V28, P2779, DOI 10.1128/JCM.28.12.2779-2785.1990; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Meng S, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00318; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rieger UM, 2013, BRIT J SURG, V100, P768, DOI 10.1002/bjs.9084; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; RStudio Team, 2019, RSTUDIO INT DEV R; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Seng P, 2015, INT J INFECT DIS, V35, P62, DOI 10.1016/j.ijid.2015.04.010; SHAH Z, 1981, PLAST RECONSTR SURG, V68, P34, DOI 10.1097/00006534-198107000-00007; Silverman BG, 1996, ANN INTERN MED, V124, P744, DOI 10.7326/0003-4819-124-8-199604150-00008; SPEAR SL, 1995, PLAST RECONSTR SURG, V96, P1119, DOI 10.1097/00006534-199510000-00018; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Svec P, 2015, INT J SYST EVOL MICR, V65, P2071, DOI 10.1099/ijs.0.000220; Tamboto H, 2010, PLAST RECONSTR SURG, V126, P835, DOI 10.1097/PRS.0b013e3181e3b456; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Walk JC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38129-7; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	64	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249261	10.1371/journal.pone.0249261	http://dx.doi.org/10.1371/journal.pone.0249261			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831065	gold, Green Published			2022-12-26	WOS:000639359600119
J	Han, J; Qin, ZT; Zhang, J; Wang, WQ; Wu, JY; Lu, YZ; Sun, LW				Han, Jing; Qin, Ze-Tian; Zhang, Jing; Wang, Wen-Qiang; Wu, Jing-Ya; Lu, Yong-Ze; Sun, Li-Wei			Acute toxicity and ecological risk assessment of 4,4'-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone and 4-MBC in ultraviolet (UV)-filters	PLOS ONE			English	Article							PERSONAL CARE PRODUCTS; UV-FILTERS; SURFACE WATERS; BENZOPHENONE; STABILIZERS; AGENTS	Ultraviolet (UV) filters are used in cosmetics, personal care products and packaging materials to provide sun protection for human skin and other substances. Little is known about these substances, but they continue to be released into the environment. The acute toxicity of 4,4'-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone and 4-MBC to Chlorella vulgaris and Daphnia magna were analyzed in this study. The 96 h-EC50 values of 4,4'-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone and 4-MBC on C. vulgaris were 183.60, 3.50 and 0.16874 mg/L, respectively. The 48 h-LC50 of 4,4'-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone and 4-MBC on D. magna were 12.50, 3.74 and 0.54445 mg/L, respectively. The toxicity of a mixture of 4,4'-dihydroxybenzophenone and 4-MBC showed addictive effect on C. vulgaris, while the toxicity of mixtures of 4,4'-dihydroxybenzophenone and 2,4,4'-trihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone and 4-MBC as well as 4,4'-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone and 4-MBC all showed antagonistic effect on C. vulgaris. The induced no-effect concentrations of 4,4'-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone and 4-MBC by the assessment factor (AF) method were 0.0125, 0.00350 and 0.000169 mg/L, respectively.	[Han, Jing; Qin, Ze-Tian; Zhang, Jing; Wang, Wen-Qiang; Wu, Jing-Ya; Lu, Yong-Ze; Sun, Li-Wei] Southeast Univ, Sch Energy & Environm, Nanjing, Peoples R China; [Qin, Ze-Tian; Zhang, Jing; Wang, Wen-Qiang; Wu, Jing-Ya; Sun, Li-Wei] Southeast Univ, Taihu Lake Water Environm Engn Res Ctr Wuxi, Wuxi, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Sun, LW (corresponding author), Southeast Univ, Sch Energy & Environm, Nanjing, Peoples R China.; Sun, LW (corresponding author), Southeast Univ, Taihu Lake Water Environm Engn Res Ctr Wuxi, Wuxi, Jiangsu, Peoples R China.	liwei-sun@seu.edu.cn	Lu, Yong-Ze/AAT-5425-2021	Lu, Yong-Ze/0000-0002-0927-5727	National Key Research and Development Program-China [2018YFC1803100]; Natural Science Foundation of Jiangsu Province [BK20180409]	National Key Research and Development Program-China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	Liwei-Sun received the National Key Research and Development Program-China (2018YFC1803100)(URL: https://service.most.gov.cn/).Yong-Ze Lu received Natural Science Foundation of Jiangsu Province (BK20180409) (URL: https://service.most.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer ME, 2005, ENVIRON SCI TECHNOL, V39, P953, DOI 10.1021/es040055r; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Du Y, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111414; Fent K, 2010, MAR ENVIRON RES, V69, pS4, DOI 10.1016/j.marenvres.2009.10.010; Fent K, 2010, ENVIRON POLLUT, V158, P1817, DOI 10.1016/j.envpol.2009.11.005; Fong HCH, 2016, CHEMOSPHERE, V164, P413, DOI 10.1016/j.chemosphere.2016.08.073; Health Mo, 2012, METH AC TOX TEST DAP; Health Mo, 2008, CHEM ALGA GROWTH INH; Kameda Y, 2011, ENVIRON POLLUT, V159, P1570, DOI 10.1016/j.envpol.2011.02.055; Kawamura Y, 2005, J HEALTH SCI, V51, P48, DOI 10.1248/jhs.51.48; Kawamura Y, 2003, J HEALTH SCI, V49, P205, DOI 10.1248/jhs.49.205; Kim S, 2014, ENVIRON INT, V70, P143, DOI 10.1016/j.envint.2014.05.015; Liu Q, 2014, J ENVIRON SCI-CHINA, V26, P440, DOI 10.1016/S1001-0742(13)60411-8; Nguyen KTN, 2011, TALANTA, V85, P2375, DOI 10.1016/j.talanta.2011.07.085; Peck AM, 2006, ANAL BIOANAL CHEM, V386, P907, DOI 10.1007/s00216-006-0728-3; Poiger T, 2004, CHEMOSPHERE, V55, P951, DOI 10.1016/j.chemosphere.2004.01.012; Sang ZY, 2016, SCI TOTAL ENVIRON, V566, P489, DOI 10.1016/j.scitotenv.2016.05.120; Sun HQ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090925; Suzuki T, 2005, TOXICOL APPL PHARM, V203, P9, DOI 10.1016/j.taap.2004.07.005; Wei XW F., 2013, MONITORING ANAL METH, V4th; Wu JW, 2013, J CHROMATOGR A, V1302, P20, DOI 10.1016/j.chroma.2013.06.017; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P3909, DOI 10.1021/es2004057	22	1	1	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249915	10.1371/journal.pone.0249915	http://dx.doi.org/10.1371/journal.pone.0249915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831101	gold, Green Published			2022-12-26	WOS:000639359600061
J	He, LS; Zhou, W; He, M; Nie, XH; He, J				He, Leshui; Zhou, Wen; He, Ming; Nie, Xuanhua; He, Jun			Openness and COVID-19 induced xenophobia: The roles of trade and migration in sustainable development	PLOS ONE			English	Article							PUBLIC-ATTITUDES; IMMIGRATION; CONTEXT; THREAT	Along with the plight of the COVID-19 outbreak in 2020 come the xenophobic behaviors and hate crimes against people with Asian descent around the globe. The threat of a public health emergency catalyzed underlying xenophobic sentiments, manifesting them into racial discrimination of various degrees. With most discriminatory acts reported in liberal societies, this article investigates whether an economy more open to trade and migration can be more susceptible to xenophobia. Using our first-hand survey data of 1767 Chinese respondents residing overseas from 65 different countries during February of 2020, we adopt an instrumental variable strategy to identify the causal effect of openness to trade and migration of their residence country on the likelihood of them receiving discriminatory behaviors during the early stage of the COVID-19 outbreak. Our results show that greater openness to trade increases the likelihood of reported xenophobic behaviors, while openness to migration decreases it. On the other hand, stronger trade or immigration relationships with China are associated with less reported discrimination. And these effects primarily influence discriminatory behavior in interpersonal spaces, rather than through media outlets. Our findings highlight nuances of the effect of trade relations on the culture of a society.	[He, Leshui] Bates Coll, Dept Econ, Lewiston, ME USA; [Zhou, Wen; He, Ming; Nie, Xuanhua; He, Jun] Yunnan Univ, Sch Ethnol & Sociol, Kunming, Yunnan, Peoples R China	Yunnan University	He, J (corresponding author), Yunnan Univ, Sch Ethnol & Sociol, Kunming, Yunnan, Peoples R China.	Jun.he@ynu.edu.cn		He, Jun/0000-0002-1994-8075	National Social Sciences Foundation of China [16ZDA151]; Ministry of Education of People's Republic of China [16JJD850015]	National Social Sciences Foundation of China; Ministry of Education of People's Republic of China(Ministry of Education, China)	The research received financial support from the National Social Sciences Foundation of China (No. 16ZDA151) and the Ministry of Education of People's Republic of China (No. project no. 16JJD850015). We also acknowledge all 1767 participants who volunteered to response to this survey.	Abel GJ, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0089-3; Ahlerup P, 2011, J COMP ECON, V39, P431, DOI 10.1016/j.jce.2011.05.001; Autor DH, 2013, AM ECON REV, V103, P2121, DOI 10.1257/aer.103.6.2121; Barbieri K., 2016, CORRELATES WAR PROJE; Barbieri K, 2009, CONFLICT MANAG PEACE, V26, P471, DOI 10.1177/0738894209343887; Bertrand M, 2001, AM ECON REV, V91, P67, DOI 10.1257/aer.91.2.67; Bove V, 2017, WORLD DEV, V89, P227, DOI 10.1016/j.worlddev.2016.08.012; Brader T, 2008, AM J POLIT SCI, V52, P959, DOI 10.1111/j.1540-5907.2008.00353.x; Bradford A, 2019, J LAW ECON, V62, P29, DOI 10.1086/701438; Burns P, 2000, POLIT SCI QUART, V115, P201, DOI 10.2307/2657900; Campbell AL, 2006, POLIT BEHAV, V28, P129, DOI 10.1007/s11109-006-9005-6; Ceobanu AM, 2010, ANNU REV SOCIOL, V36, P309, DOI 10.1146/annurev.soc.012809.102651; Chander CR, 2001, SOC SCI J, V38, P177, DOI 10.1016/S0362-3319(01)00106-9; de Figueiredo RJP, 2003, AM J POLIT SCI, V47, P171, DOI 10.2307/3186100; Dharmapala D., 2004, AM LAW ECON REV, V6, P185, DOI [10.1093/aler/ahh001, DOI 10.1093/ALER/AHH001]; Dustmann C, 2001, ECON J, V111, P353, DOI 10.1111/1468-0297.00611; Dustmann C, 2007, BE J ECON ANAL POLI, V7, DOI 10.2202/1935-1682.1655; Dustmann C, 2011, SCAND J ECON, V113, P689, DOI 10.1111/j.1467-9442.2011.01660.x; Ellison CG, 2011, SOC SCI QUART, V92, P938, DOI 10.1111/j.1540-6237.2011.00798.x; Foged M, 2016, AM ECON J-APPL ECON, V8, P1, DOI 10.1257/app.20150114; Frankel JA, 1999, AM ECON REV, V89, P379, DOI 10.1257/aer.89.3.379; Friebel G, 2014, J PUBLIC ECON, V120, P97, DOI 10.1016/j.jpubeco.2014.09.001; Hainmueller J, 2014, ANNU REV POLIT SCI, V17, P225, DOI 10.1146/annurev-polisci-102512-194818; Hollifield JF., 2006, MIGRATION TRADEAND D, V249; Lapinski JS, 1997, PUBLIC OPIN QUART, V61, P356, DOI 10.1086/297799; Levine DI, 2006, J HEALTH ECON, V25, P538, DOI 10.1016/j.jhealeco.2005.10.001; Mayda AM, 2006, REV ECON STAT, V88, P510, DOI 10.1162/rest.88.3.510; McLaren LM, 2003, SOC FORCES, V81, P909, DOI 10.1353/sof.2003.0038; Middleton A, 2007, WORLD DEV, V35, P1904, DOI 10.1016/j.worlddev.2007.02.001; OROURKE KH, 2006, EUR J POLIT EC, V0022; Ortega F, 2014, J INT ECON, V92, P231, DOI 10.1016/j.jinteco.2013.11.008; Ozden C, 2011, WORLD BANK ECON REV, V25, P12, DOI 10.1093/wber/lhr024; Peri G, 2016, J ECON PERSPECT, V30, P3, DOI 10.1257/jep.30.4.3; Timmer AS, 1998, POPUL DEV REV, V24, P739, DOI 10.2307/2808023; United Nations, 2016, CEB20166ADD1 UN; Weiner M., 1995, GLOBAL MIGRATION CRI; Wilkes R, 2008, INT MIGR REV, V42, P302, DOI 10.1111/j.1747-7379.2008.00126.x	37	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249579	10.1371/journal.pone.0249579	http://dx.doi.org/10.1371/journal.pone.0249579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831012	Green Published, gold			2022-12-26	WOS:000639359600088
J	Higashi, E; Matsumoto, S; Nakahara, I; Hatano, T; Ishii, A; Sadamasa, N; Ohta, T; Ishihara, T; Tokunaga, K; Ando, M; Chihara, H; Furuta, K; Hashimoto, T; Tanaka, K; Sonoda, K; Koge, J; Takita, W; Hashikawa, T; Funakoshi, Y; Kondo, D; Kamata, T; Tsujimoto, A; Matsushita, T; Murai, H; Matsuo, K; Kitazono, T; Kira, J				Higashi, Eiji; Matsumoto, Shoji; Nakahara, Ichiro; Hatano, Taketo; Ishii, Akira; Sadamasa, Nobutake; Ohta, Tsuyoshi; Ishihara, Takuma; Tokunaga, Keisuke; Ando, Mitsushige; Chihara, Hideo; Furuta, Konosuke; Hashimoto, Tetsuya; Tanaka, Koji; Sonoda, Kazutaka; Koge, Junpei; Takita, Wataru; Hashikawa, Takuro; Funakoshi, Yusuke; Kondo, Daisuke; Kamata, Takahiko; Tsujimoto, Atsushi; Matsushita, Takuya; Murai, Hiroyuki; Matsuo, Keitaro; Kitazono, Takanari; Kira, Junichi			Clopidogrel response predicts thromboembolic events associated with coil embolization of unruptured intracranial aneurysms: A prospective cohort study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MODIFIED ANTIPLATELET PREPARATION; VERIFYNOW P2Y12 ASSAY; PLATELET REACTIVITY; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; CLINICAL-OUTCOMES; COMPLICATIONS; VARIABILITY; EXPERIENCE	Objective Periprocedural thromboembolic events are a serious complication associated with coil embolization of unruptured intracranial aneurysms. However, no established clinical rule for predicting thromboembolic events exists. This study aimed to clarify the significance of adding preoperative clopidogrel response value to clinical factors when predicting the occurrence of thromboembolic events during/after coil embolization and to develop a nomogram for thromboembolic event prediction. Methods In this prospective, single-center, cohort study, we included 345 patients undergoing elective coil embolization for unruptured intracranial aneurysm. Thromboembolic event was defined as the occurrence of intra-procedural thrombus formation and postprocedural symptomatic cerebral infarction within 7 days. We evaluated preoperative clopidogrel response and patients' clinical information. We developed a patient-clinical-information model for thromboembolic event using multivariate analysis and compared its efficiency with that of patient-clinical-information plus preoperative clopidogrel response model. The predictive performances of the two models were assessed using area under the receiver-operating characteristic curve (AUC-ROC) with bootstrap method and compared using net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results Twenty-eight patients experienced thromboembolic events. The clinical model included age, aneurysm location, aneurysm dome and neck size, and treatment technique. AUC-ROC for the clinical model improved from 0.707 to 0.779 after adding the clopidogrel response value. Significant intergroup differences were noted in NRI (0.617, 95% CI: 0.247-0.987, p < .001) and IDI (0.068, 95% CI: 0.021-0.116, p = .005). Conclusions Evaluation of preoperative clopidogrel response in addition to clinical variables improves the prediction accuracy of thromboembolic event occurrence during/after coil embolization of unruptured intracranial aneurysm.	[Higashi, Eiji; Nakahara, Ichiro; Hatano, Taketo; Chihara, Hideo; Kamata, Takahiko] Kokura Mem Hosp, Stroke Ctr, Dept Neurosurg, Kitakyushu, Fukuoka, Japan; [Matsumoto, Shoji; Furuta, Konosuke; Kondo, Daisuke] Kokura Mem Hosp, Stroke Ctr, Dept Neurol, Kitakyushu, Fukuoka, Japan; [Ishii, Akira] Kyoto Univ, Dept Neurosurg, Grad Sch Med, Kyoto, Japan; [Sadamasa, Nobutake] Koseikai Takeda Hosp, Stroke Ctr, Dept Neurosurg, Kyoto, Japan; [Ohta, Tsuyoshi] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Osaka, Japan; [Ishihara, Takuma] Gifu Univ Hosp, Innovat & Clin Res Promot Ctr, Gifu, Japan; [Tokunaga, Keisuke] Natl Hosp Org Kyushu Med Ctr, Dept Cerebrovasc Med & Neurol, Fukuoka, Japan; [Ando, Mitsushige] Shiga Gen Hosp, Dept Neurosurg, Moriyama, Japan; [Hashimoto, Tetsuya] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Tanaka, Koji; Matsushita, Takuya; Kira, Junichi] Kyushu Univ, Grad Sch Med Sci, Dept Neurol, Fukuoka, Japan; [Sonoda, Kazutaka] Fukuoka Saiseikai Gen Hosp, Dept Neurol, Fukuoka, Japan; [Koge, Junpei] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Osaka, Japan; [Takita, Wataru] Natl Hosp Org Nagoya Med Ctr, Dept Neurol, Nagoya, Aichi, Japan; [Hashikawa, Takuro] St Marys Hosp, Dept Neurosurg, Kurume, Fukuoka, Japan; [Funakoshi, Yusuke] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Japan; [Tsujimoto, Atsushi] Japan Community Hlth Care Org Kyushu Hosp, Dept Neurol, Kitakyushu, Fukuoka, Japan; [Murai, Hiroyuki] Int Univ Hlth & Welf, Dept Neurol, Narita, Japan; [Matsuo, Keitaro] Aichi Canc Ctr Res Inst, Div Canc Epidemiol & Prevent, Nagoya, Aichi, Japan; [Matsuo, Keitaro] Nagoya Univ, Dept Canc Epidemiol, Grad Sch Med, Nagoya, Aichi, Japan; [Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan; [Matsumoto, Shoji; Nakahara, Ichiro] Fujita Hlth Univ, Dept Comprehens Strokol, Toyoake, Aichi, Japan	Kokura Memorial Hospital; Kokura Memorial Hospital; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Gifu University; University of California System; University of California Los Angeles; Kyushu University; National Cerebral & Cardiovascular Center - Japan; Nagoya Medical Center; Kyushu University; International University of Health & Welfare; Aichi Cancer Center; Nagoya University; Kyushu University; Fujita Health University	Matsumoto, S (corresponding author), Kokura Mem Hosp, Stroke Ctr, Dept Neurol, Kitakyushu, Fukuoka, Japan.; Matsumoto, S (corresponding author), Fujita Hlth Univ, Dept Comprehens Strokol, Toyoake, Aichi, Japan.	shoji.neuro@gmail.com	Nakahara, Ichiro/G-3259-2010; Matsuo, Keitaro/H-6758-2019; Funakoshi, Yusuke/ABB-5796-2021	Nakahara, Ichiro/0000-0001-8909-2949; Matsuo, Keitaro/0000-0003-1761-6314; Higashi, Eiji/0000-0002-3461-9149; Matsumoto, Shoji/0000-0003-0640-3364; Hashimoto, Tetsuya/0000-0002-8121-0215	Health and Labor Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labor, and Welfare, Japan [H22-Nanchi-Ippan-030]; JSPS KAKENHI [GAG2591591, FAG5462221, FAG6K10727]; Japan Society for the Promotion of Science [FAG5870502]; Department of Neurology, Kyushu University Hospital, Fukuoka, Japan [GAXU0121]; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan [FA81052724, FAG3591247]	Health and Labor Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labor, and Welfare, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Department of Neurology, Kyushu University Hospital, Fukuoka, Japan; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan	This study was supported in part by a Health and Labor Sciences Research Grant on Intractable Diseases (H22-Nanchi-Ippan-030) from the Ministry of Health, Labor, and Welfare, Japan; Grants-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Numbers GAG2591591, FAG5462221, and FAG6K10727); a Grant-in-Aid for Young Scientists (B) (JSPS KAKENHI Grant Number FAG5870502) from the Japan Society for the Promotion of Science; a Research Grant (GAXU0121) from the Department of Neurology, Kyushu University Hospital, Fukuoka, Japan; and Research Grants (FA81052724, and FAG3591247) from the Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2016, J NEUROINTERV SURG, V8, DOI 10.1136/neurintsurg-2015-011727; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Fifi JT, 2013, AM J NEURORADIOL, V34, P716, DOI 10.3174/ajnr.A3405; Gonzalez N, 2004, AM J NEURORADIOL, V25, P577; Hahnemann ML, 2014, J NEUROINTERV SURG, V6, P461, DOI 10.1136/neurintsurg-2013-010820; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hwang G, 2015, JAMA NEUROL, V72, P764, DOI 10.1001/jamaneurol.2015.0654; Hwang G, 2014, RADIOLOGY, V273, P194, DOI 10.1148/radiol.14140070; Hwang G, 2010, NEUROSURGERY, V67, P743, DOI 10.1227/01.NEU.0000374770.09140.FB; Jakubowski JA, 2008, THROMB HAEMOSTASIS, V99, P409, DOI 10.1160/TH07-09-0575; Jeong YH, 2012, AM HEART J, V164, P35, DOI 10.1016/j.ahj.2012.03.022; Kang DH, 2013, STROKE, V44, P789, DOI 10.1161/STROKEAHA.112.669853; Kang HS, 2010, AM J NEURORADIOL, V31, P1206, DOI 10.3174/ajnr.A2051; Kim CH, 2017, RADIOLOGY, V282, P542, DOI 10.1148/radiol.2016160542; Kim MS, 2016, AM J NEURORADIOL, V37, P1099, DOI 10.3174/ajnr.A4777; Kim MJ, 2013, J KOREAN NEUROSURG S, V54, P19, DOI 10.3340/jkns.2013.54.1.19; Lee DH, 2008, AM J NEURORADIOL, V29, P1389, DOI 10.3174/ajnr.A1070; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pierot L, 2008, STROKE, V39, P2497, DOI 10.1161/STROKEAHA.107.512756; Pierot L, 2013, STROKE, V44, P2046, DOI 10.1161/STROKEAHA.113.000733; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Shimizu K, 2016, AM J NEURORADIOL, V37, P679, DOI 10.3174/ajnr.A4577; Soeda A, 2003, AM J NEURORADIOL, V24, P127; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; von Beckerath N, 2006, THROMB HAEMOSTASIS, V95, P910, DOI 10.1160/TH06-01-0046; Yi HJ, 2019, J KOREAN NEUROSURG S, V62, P3, DOI 10.3340/jkns.2018.0151	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249766	10.1371/journal.pone.0249766	http://dx.doi.org/10.1371/journal.pone.0249766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831086	Green Published, gold			2022-12-26	WOS:000639359600009
J	Sansupa, C; Purahong, W; Wubet, T; Tiansawat, P; Pathom-Aree, W; Teaumroong, N; Chantawannakul, P; Buscot, F; Elliott, S; Disayathanoowat, T				Sansupa, Chakriya; Purahong, Witoon; Wubet, Tesfaye; Tiansawat, Pimonrat; Pathom-Aree, Wasu; Teaumroong, Neung; Chantawannakul, Panuwan; Buscot, Francois; Elliott, Stephen; Disayathanoowat, Terd			Soil bacterial communities and their associated functions for forest restoration on a limestone mine in northern Thailand	PLOS ONE			English	Article							ENVIRONMENTAL-IMPACT; RIBOSOMAL-RNA; REHABILITATION; TERRESTRIAL; DIVERSITY; QUALITY	Opencast mining removes topsoil and associated bacterial communities that play crucial roles in soil ecosystem functioning. Understanding the community composition and functioning of these organisms may lead to improve mine-rehabilitation practices. We used a culture-dependent method, combined with Illumina sequencing, to compare the taxonomic richness and composition of living bacterial communities in opencast mine substrates and young mine-rehabilitation plots, with those of soil in adjacent remnant forest at a limestone mine in northern Thailand. We further investigated the effects of soil physico-chemical factors and ground-flora cover on the same. Although, loosened subsoil, brought in to initiate rehabilitation, improved water retention and facilitated plant re-establishment, it did not increase the population density of living microbes substantially within 9 months. Planted trees and sparse ground flora in young rehabilitation plots had not ameliorated the micro-habitat enough to change the taxonomic composition of the soil bacteria compared with non-rehabilitated mine sites. Viable microbes were significantly more abundant in forest soil than in mine substrates. The living bacterial community composition differed significantly, between the forest plots and both the mine and rehabilitation plots. Proteobacteria dominated in forest soil, whereas Firmicutes dominated in samples from both mine and rehabilitation plots. Although, several bacterial taxa could survive in the mine substrate, soil ecosystem functions were greatly reduced. Bacteria, capable of chitinolysis, aromatic compound degradation, ammonification and nitrate reduction were all absent or rare in the mine substrate. Functional redundancy of the bacterial communities in both mine substrate and young mine-rehabilitation soil was substantially reduced, compared with that of forest soil. Promoting the recovery of microbial biomass and functional diversity, early during mine rehabilitation, is recommended, to accelerate soil ecosystem restoration and support vegetation recovery. Moreover, if inoculation is included in mine rehabilitation programs, the genera: Bacillus, Streptomyces and Arthrobacter are likely to be of particular interest, since these genera can be cultivated easily and this study showed that they can survive under the extreme conditions that prevail on opencast mines.	[Sansupa, Chakriya; Tiansawat, Pimonrat; Pathom-Aree, Wasu; Chantawannakul, Panuwan; Elliott, Stephen; Disayathanoowat, Terd] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand; [Sansupa, Chakriya] Chiang Mai Univ, Grad Sch, Chiang Mai, Thailand; [Sansupa, Chakriya; Purahong, Witoon; Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Wubet, Tesfaye] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saale, Germany; [Wubet, Tesfaye; Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Tiansawat, Pimonrat; Elliott, Stephen] Chiang Mai Univ, Sci Fac, Environm Sci Res Ctr, Chiang Mai, Thailand; [Tiansawat, Pimonrat; Elliott, Stephen] Chiang Mai Univ, Sci Fac, Forest Restorat Res Unit, Biol Dept, Chiang Mai, Thailand; [Teaumroong, Neung] Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Nakhon Ratchasima, Thailand; [Disayathanoowat, Terd] Chiang Mai Univ, Res Ctr Bioresources Agr Ind & Med, Chiang Mai, Thailand; [Disayathanoowat, Terd] Chiang Mai Univ, Res Ctr Microbial Divers & Sustainable Utilizat, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Chiang Mai University; Chiang Mai University; Suranaree University of Technology; Chiang Mai University; Chiang Mai University	Disayathanoowat, T (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand.; Purahong, W (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.; Disayathanoowat, T (corresponding author), Chiang Mai Univ, Res Ctr Bioresources Agr Ind & Med, Chiang Mai, Thailand.; Disayathanoowat, T (corresponding author), Chiang Mai Univ, Res Ctr Microbial Divers & Sustainable Utilizat, Chiang Mai, Thailand.	witoon.purahong@ufz.de; terd.dis@gmail.com	Purahong, Witoon/AAX-8455-2021; Pathom-aree, Wasu/AAF-4080-2020; Elliott, Stephen/AAS-4584-2021; Wubet, Tesfaye/C-6241-2012	Purahong, Witoon/0000-0002-4113-6428; Elliott, Stephen/0000-0002-5846-3353; Wubet, Tesfaye/0000-0001-8572-4486; Disayathanoowat, Terd/0000-0002-6416-2266; Pathom-aree, Wasu/0000-0003-0299-3731	Siam Cement (Lampang) Co., Ltd. - Chiang Mai University	Siam Cement (Lampang) Co., Ltd. - Chiang Mai University	Fieldwork and lab analyses of this research were funded by the Siam Cement (Lampang) Co., Ltd. Terd Disayathanoowat and Stephen Elliott's contributions to this work were funded by Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie J, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P143; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Navarro-Cano JA, 2018, J APPL ECOL, V55, P1195, DOI 10.1111/1365-2664.13094; Aoshima H, 2006, APPL MICROBIOL BIOT, V71, P875, DOI 10.1007/s00253-005-0245-x; ATLAS RM, 1991, MICROBIAL ECOL, V22, P249, DOI 10.1007/BF02540227; Bell R.W., 2002, CHIANG MAI U J, V1, P1; Blagodatskaya E, 2013, SOIL BIOL BIOCHEM, V67, P192, DOI 10.1016/j.soilbio.2013.08.024; Castillejo JM, 2010, ARID LAND RES MANAG, V24, P344, DOI 10.1080/15324982.2010.502920; Cheng YP, 2011, INT J GREENH GAS CON, V5, P157, DOI 10.1016/j.ijggc.2010.07.007; Direito SOL, 2012, FEMS MICROBIOL ECOL, V81, P111, DOI 10.1111/j.1574-6941.2012.01325.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elhottova D, 2006, ANTON LEEUW INT J G, V89, P459, DOI 10.1007/s10482-005-9044-8; Elliott S., 2014, RESTORING TROPICAL F; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hou HP, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072286; Johnston-Monje D, 2016, PLANT SOIL, V405, P337, DOI 10.1007/s11104-016-2826-0; KIEFT TL, 1987, SOIL BIOL BIOCHEM, V19, P119, DOI 10.1016/0038-0717(87)90070-8; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lamb D., 2003, Rehabilitation and restoration of degraded forests; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Legrand F, 2018, APPL SOIL ECOL, V132, P135, DOI 10.1016/j.apsoil.2018.08.016; Lewis DE, 2010, MICROB ECOL, V59, P710, DOI 10.1007/s00248-009-9621-x; Li H, 2019, AGR ECOSYST ENVIRON, V283, DOI 10.1016/j.agee.2019.106578; Li J, 2018, EUR J SOIL SCI, V69, P1056, DOI 10.1111/ejss.12714; Li L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203812; Li YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115024; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Martins SV., 2017, NEW PERSPECTIVES FOR, DOI [10.5772/intechopen.72908, DOI 10.5772/INTECHOPEN.72908]; Maxwell JF., 2001, BIODIVERSITY RES TRA; Miransari M, 2011, ARCH MICROBIOL, V193, P77, DOI 10.1007/s00203-010-0657-6; Monjezi M, 2009, ENVIRON GEOL, V58, P205, DOI 10.1007/s00254-008-1509-4; Moreira-Grez B, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01617; Mungkorndin Sompetch, 1994, Journal of Tropical Forest Science, V7, P136; Ngugi MR, 2018, RESTOR ECOL, V26, P839, DOI 10.1111/rec.12631; Oksanen J., 2011, MULTIVARIATE ANAL EC; Padda KP, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz172; Pang J, 2003, CHEMOSPHERE, V52, P1559, DOI 10.1016/S0045-6535(03)00496-X; Peltz CD, 2016, SSSA SPEC PUBL, V63, P325, DOI 10.2136/sssaspecpub63.2014.0047.5; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purahong W, 2012, ANN FOREST SCI, V69, P659, DOI 10.1007/s13595-012-0210-7; Qin S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01415; Ramani RV, 2012, PROCEDIA ENGINEER, V46, P9, DOI 10.1016/j.proeng.2012.09.440; Rangseekaew P, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00387; Rayment G.E., 1992, AUSTR SOIL LAND SURV; Rosenfeld CE, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.01394-18, 10.1128/aem.01394-18]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schops R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02711; Shen CC, 2019, J SOIL SEDIMENT, V19, P3442, DOI 10.1007/s11368-019-02307-5; Shin CS, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124793; Shrestha RK, 2011, GEODERMA, V161, P168, DOI 10.1016/j.geoderma.2010.12.015; Stefani FOP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128272; Sun SY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101757; Tiwary RK, 2001, WATER AIR SOIL POLL, V132, P185, DOI 10.1023/A:1012083519667; Tripathi BM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00376; Van Horn DJ, 2014, APPL ENVIRON MICROB, V80, P3034, DOI 10.1128/AEM.03414-13; Van Horn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066103; Walpola B. C., 2010, Tropical Agricultural Research and Extension, V13, P19; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066829; Wubs ERJ, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.107, 10.1038/nplants.2016.107]; Yadav AN, 2015, ANN MICROBIOL, V65, P611, DOI 10.1007/s13213-014-0897-9; Yin B, 2000, APPL ENVIRON MICROB, V66, P4361, DOI 10.1128/AEM.66.10.4361-4365.2000; Zanuzzi A, 2009, GEODERMA, V154, P69, DOI 10.1016/j.geoderma.2009.09.014; Zhang HC, 2017, SCI REP-UK, V7, DOI [10.1038/srep39911, 10.1038/srep43163]	66	7	7	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0248806	10.1371/journal.pone.0248806	http://dx.doi.org/10.1371/journal.pone.0248806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831034	Green Published, gold			2022-12-26	WOS:000639359600082
J	Wallace, AD; Sasani, TA; Swanier, J; Gates, BL; Greenland, J; Pedersen, BS; Varley, KE; Quinlan, AR				Wallace, Amelia D.; Sasani, Thomas A.; Swanier, Jordan; Gates, Brooke L.; Greenland, Jeff; Pedersen, Brent S.; Varley, Katherine E.; Quinlan, Aaron R.			CaBagE: A Cas9-based Background Elimination strategy for targeted, long-read DNA sequencing	PLOS ONE			English	Article							C9ORF72 GGGGCC REPEAT; DISCOVERY; GENOME; EXPANSION; INSERTIONS; LENGTH; GENES; CAS9	A substantial fraction of the human genome is difficult to interrogate with short-read DNA sequencing technologies due to paralogy, complex haplotype structures, or tandem repeats. Long-read sequencing technologies, such as Oxford Nanopore's MinION, enable direct measurement of complex loci without introducing many of the biases inherent to short-read methods, though they suffer from relatively lower throughput. This limitation has motivated recent efforts to develop amplification-free strategies to target and enrich loci of interest for subsequent sequencing with long reads. Here, we present CaBagE, a method for target enrichment that is efficient and useful for sequencing large, structurally complex targets. The CaBagE method leverages the stable binding of Cas9 to its DNA target to protect desired fragments from digestion with exonuclease. Enriched DNA fragments are then sequenced with Oxford Nanopore's MinION long-read sequencing technology. Enrichment with CaBagE resulted in a median of 116X coverage (range 39-416) of target loci when tested on five genomic targets ranging from 4-20kb in length using healthy donor DNA. Four cancer gene targets were enriched in a single reaction and multiplexed on a single MinION flow cell. We further demonstrate the utility of CaBagE in two ALS patients with C9orf72 short tandem repeat expansions to produce genotype estimates commensurate with genotypes derived from repeat-primed PCR for each individual. With CaBagE there is a physical enrichment of on-target DNA in a given sample prior to sequencing. This feature allows adaptability across sequencing platforms and potential use as an enrichment strategy for applications beyond sequencing. CaBagE is a rapid enrichment method that can illuminate regions of the 'hidden genome' underlying human disease.	[Wallace, Amelia D.; Swanier, Jordan; Pedersen, Brent S.; Quinlan, Aaron R.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Wallace, Amelia D.; Pedersen, Brent S.; Quinlan, Aaron R.] Univ Utah, Sch Med, Utah Ctr Genet Discovery, Salt Lake City, UT 84112 USA; [Sasani, Thomas A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Gates, Brooke L.; Greenland, Jeff; Varley, Katherine E.] Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Quinlan, Aaron R.] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Quinlan, AR (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA.; Quinlan, AR (corresponding author), Univ Utah, Sch Med, Utah Ctr Genet Discovery, Salt Lake City, UT 84112 USA.; Quinlan, AR (corresponding author), Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84112 USA.	aquinlan@genetics.utah.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022	Gates, Brooke/0000-0001-9864-4012	NIH Ruth L. Kirschstein National Research Service Award (NRSA)Institutional Training Grant (T32): National Human Genome Research Institute Training in Genomic Medicine [5T32HG008962-05]; University of Utah Equipment Grant; National Institutes of Health from the National Human Genome Research Institute [R01HG006693]; National Institutes of Health from the National Institute of General Medical Sciences [R01GM124355]	NIH Ruth L. Kirschstein National Research Service Award (NRSA)Institutional Training Grant (T32): National Human Genome Research Institute Training in Genomic Medicine; University of Utah Equipment Grant; National Institutes of Health from the National Human Genome Research Institute; National Institutes of Health from the National Institute of General Medical Sciences	A.D.W. was awarded the NIH Ruth L. Kirschstein National Research Service Award (NRSA)Institutional Training Grant (T32): National Human Genome Research Institute Training in Genomic Medicine to support this work (5T32HG008962-05, PI: Lynn Jorde, https://www.genome.gov). A.R.Q. received the University of Utah Equipment Grant A.R.Q. received the National Institutes of Health R01HG006693 award from the National Human Genome Research Institute (https://www.genome.gov) A.R.Q. received the National Institutes of Health R01GM124355 award from the National Institute of General Medical Sciences (https://www.nigms.nih.gov) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], POVERLAP SIMPLE FLEX; [Anonymous], 2019, BIORXIV, DOI [10.1101/507244, DOI 10.1101/507244]; [Anonymous], SCIK BIO BIOINF LIB; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Audano PA, 2019, CELL, V176, P663, DOI 10.1016/j.cell.2018.12.019; Bennett-Baker PE, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx749; Bidichandani SI, 1999, HUM MOL GENET, V8, P2425, DOI 10.1093/hmg/8.13.2425; Bolognini Davide, 2020, GigaDB, DOI 10.5524/100790; Bram E, 2019, AMYOTROPH LAT SCL FR, V20, P107, DOI 10.1080/21678421.2018.1522353; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Clarke R, 2018, MOL CELL, V71, P42, DOI 10.1016/j.molcel.2018.06.005; De Roeck A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1856-3; Ebbert MTW, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1707-2; Ebbert MTW, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0274-4; Flynn JM, 2020, MOL BIOL EVOL, V37, P1362, DOI 10.1093/molbev/msaa010; Gabrieli T, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky411; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Giesselmann P, 2019, NAT BIOTECHNOL, V37, P1478, DOI 10.1038/s41587-019-0293-x; Gilpatrick T, 2019, TARGETED NANOPORE SE, P604173, DOI [10.1101/604173, DOI 10.1101/604173]; Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5; Haiminen N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-336; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0; Jiang WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9101; Kovanda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17944; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Lee NCO, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv112; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lopez-Girona E, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00661-x; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mandelker D, 2016, GENET MED, V18, P1282, DOI 10.1038/gim.2016.58; Mitsuhashi S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1667-6; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Paulson Henry, 2018, Handb Clin Neurol, V147, P105, DOI 10.1016/B978-0-444-63233-3.00009-9; Payne A, 2020, NAT BIOTECHNOL, DOI [10.1101/2020.02.03.926956, DOI 10.1038/S41587-020-00746-X]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossi MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05265-7; Slesarev A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39667-4; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stevens RC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215441; Suh E, 2018, J MOL DIAGN, V20, P871, DOI 10.1016/j.jmoldx.2018.07.001; van Blitterswijk M, 2013, LANCET NEUROL, V12, P978, DOI 10.1016/S1474-4422(13)70210-2; Varley KE, 2008, GENOME RES, V18, P1844, DOI 10.1101/gr.078204.108; Vollger MR, 2019, NAT METHODS, V16, P88, DOI 10.1038/s41592-018-0236-3; Wallace AD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00298; Watson CM, 2020, LAB INVEST, V100, P135, DOI 10.1038/s41374-019-0283-0; Wildschutte JH, 2016, P NATL ACAD SCI USA, V113, pE2326, DOI 10.1073/pnas.1602336113; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0241253	10.1371/journal.pone.0241253	http://dx.doi.org/10.1371/journal.pone.0241253			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33830997	Green Submitted, Green Published, gold			2022-12-26	WOS:000639359600017
J	Orozco-Nunnelly, DA; Pruet, J; Rios-Ibarra, CP; Gamarra, ELB; Lefeber, T; Najdeska, T				Annette Orozco-Nunnelly, Danielle; Pruet, Jeffery; Patricia Rios-Ibarra, Clara; Bocangel Gamarra, Estefany Lucia; Lefeber, Theodore; Najdeska, Teodora			Characterizing the cytotoxic effects and several antimicrobial phytocompounds of Argemone mexicana	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; MULTIDRUG-RESISTANCE; BERBERINE; CHELERYTHRINE; EXTRACTS; SANGUINARINE; ALKALOIDS; MECHANISM; PRODUCTS; L.	Commonly called the Mexican prickly poppy, Argemone mexicana is a stress-resistant member of the Papaveraceae family of plants that has been used in traditional medicine for centuries by indigenous communities in Mexico and Western parts of the United States. This plant has been exploited to treat a wide variety of ailments, with reported antimicrobial and antioxidant properties, as well as cytotoxic effects against some human cancer cell lines. Due to its various therapeutic uses and its abundance of secondary metabolites, A. mexicana has great potential as a drug discovery candidate. Herein, the germination conditions of A. mexicana are described and the cytotoxic activities of different parts (seeds, leaves, inner vs. outer roots) of the plant from methanol or hexane extracts are preliminarily characterized against cells of seven unique organisms. When comparing 1 mg of each sample normalized to background solvent alone, A. mexicana methanol outer root and leaf extracts possessed the strongest antimicrobial activity, with greatest effects against the Gram-positive bacteria tested, and less activity against the Gram-negative bacteria and fungi tested. Additionally, using the MTT colorimetric assay, the outer root methanol and seed hexane extracts displayed pronounced inhibitory effects against human colon cancer cells. Quantification of c-MYC (oncogene) and APC (tumor suppressor) mRNA levels help elucidate how the A. mexicana root methanol extract may be affecting colon cancer cells. After ultra-performance liquid chromatography coupled with mass spectrometry and subsequent nuclear magnetic resonance analysis of the root and leaf methanol fractions, two main antibacterial compounds, chelerythrine and berberine, have been identified. The roots were found to possess both phytocompounds, while the leaf lacked chelerythrine. These data highlight the importance of plants as an invaluable pharmaceutical resource at a time when antimicrobial and anticancer drug discovery has plateaued.	[Annette Orozco-Nunnelly, Danielle; Bocangel Gamarra, Estefany Lucia; Lefeber, Theodore; Najdeska, Teodora] Valparaiso Univ, Dept Biol, Valparaiso, IN 46383 USA; [Pruet, Jeffery] Valparaiso Univ, Dept Chem, Valparaiso, IN 46383 USA; [Patricia Rios-Ibarra, Clara] Tecnol Monterrey, Dept Biotechnol, Campus Guadalajara, Guadalajara, Jalisco, Mexico; [Patricia Rios-Ibarra, Clara] Univ Guadalajara, Univ Ctr Hlth Sci, Inst Res Biomed Sci, Guadalajara, Jalisco, Mexico	Valparaiso University; Valparaiso University; Tecnologico de Monterrey; Universidad de Guadalajara	Orozco-Nunnelly, DA (corresponding author), Valparaiso Univ, Dept Biol, Valparaiso, IN 46383 USA.	Danielle.OrozcoNunnelly@valpo.edu		Rios Ibarra, PhD, Clara Patricia/0000-0002-6601-8030; Orozco-Nunnelly, Danielle/0000-0003-3381-0504	internal Valparaiso University Wheat Ridge Ministry O.P. Kretzmann Memorial Grant	internal Valparaiso University Wheat Ridge Ministry O.P. Kretzmann Memorial Grant	This work was funded by institutional start-up grants (to DON and JP) and by an internal Valparaiso University Wheat Ridge Ministry O.P. Kretzmann Memorial Grant (to DON and JP).	Andleeb S, 2020, J KING SAUD UNIV SCI, V32, P2053; [Anonymous], 2018, GLOB HLTH EST 2016 D; Bhattacharjee I, 2006, MEM I OSWALDO CRUZ, V101, P645, DOI 10.1590/S0074-02762006000600011; Bouyer PG, 2013, AM J PHYSIOL-GASTR L, V304, pG142, DOI 10.1152/ajpgi.00483.2011; Brahmachari G, 2013, REV BRAS FARMACOGN, V23, P559, DOI 10.1590/S0102-695X2013005000021; Chang YC, 2003, Z NATURFORSCH C, V58, P521; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Correa A., 2004, ANAM CORREDOR BIOL M; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Cragg GM, 2016, MED PRIN PRACT, V25, P41, DOI 10.1159/000443404; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Duhan JS, 2011, AFR J BIOTECHNOL, V10, P8654; Elizondo-Luevano JH, 2021, EXP PARASITOL, V220, DOI 10.1016/j.exppara.2020.108043; FENNER M, 1987, NEW PHYTOL, V106, P35, DOI 10.1111/j.1469-8137.1987.tb04681.x; Gupta R, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25504; He N, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2317-3; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Ishizuka K., 2020, J BIOL MACROMOL, V20, P17, DOI [10.14533/jbm.20.17, DOI 10.14533/JBM.20.17]; Jain R. A., 2012, International Journal of Pharmaceutical Innovations (IJPI), V2, punpaginated; Jaiswal J., 2020, ACTA SCI MICROBIOL, V3, P01, DOI 10.31080/ASMI.2020.03.0524; Johnson JR, 2016, CLIN INFECT DIS, V62, P1529, DOI 10.1093/cid/ciw193; Jorissen RN, 2015, BRIT J CANCER, V113, P979, DOI 10.1038/bjc.2015.296; Khan AM, 2019, J KING SAUD UNIV SCI, V31, P1020, DOI 10.1016/j.jksus.2018.05.009; Kugimiya N, 2015, J CELL MOL MED, V19, P1569, DOI 10.1111/jcmm.12531; Kushtwar RS., 2017, WORLD J PHARM RES, P1025, DOI 10.20959/wjpr20176-8558; Marek R, 2003, J NAT PROD, V66, P481, DOI 10.1021/np0204996; Miao F, 2011, NAT PROD RES, V25, P863, DOI 10.1080/14786419.2010.482055; Min YD, 2006, ARCH PHARM RES, V29, P757, DOI 10.1007/BF02974076; Moore M., 1990, REMEDIOS TRADITIONAL; More Nilesh V, 2016, Medicines (Basel), V3, DOI 10.3390/medicines3040028; Nayak P. S., 2012, International Journal of Green Pharmacy, V6, P321, DOI 10.4103/0973-8258.108244; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Neill J., 2014, TACKLING CRISIS HLTH; Palanikumar P, 2018, FISH SHELLFISH IMMUN, V75, P243, DOI 10.1016/j.fsi.2018.02.011; Pandeya KB, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109905; Peng LC, 2015, INT J CLIN EXP PATHO, V8, P5217; Prabhakaran M., 2020, INT J RES PHARM SCI, V11, P323, DOI [10.26452/ijrps.v11i1.1824, DOI 10.26452/IJRPS.V11I1.1824]; Rahman M., 2009, CHIANG MAI U J NAT, V8, P77; Rahman M. S., 2011, Research Journal of Medicinal Plant, V5, P621, DOI 10.3923/rjmp.2011.621.626; Sahu Mahesh C., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS800; SALEH MA, 1987, J CHEM ECOL, V13, P1361, DOI 10.1007/BF01012283; Saranya M., 2012, INT J CURR PHARM RES, V4, P85; Shaukat SS, 2002, PLANT SOIL, V245, P239; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh Amitabh, 2009, Journal of Plant Protection Research, V49, P287, DOI 10.2478/v10045-009-0046-9; Singh N, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00021; Singh SK, 2009, AFR J BIOTECHNOL, V8, P7077; Tariq K, 2016, CANCER BIOL MED, V13, P120, DOI 10.28092/j.issn.2095-3941.2015.0103; Tousek J, 2002, J MOL STRUCT, V613, P103, DOI 10.1016/S0022-2860(02)00138-2; Uddin SJ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep111; Zhang L, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw332	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249704	10.1371/journal.pone.0249704	http://dx.doi.org/10.1371/journal.pone.0249704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826680	gold, Green Published, Green Submitted			2022-12-26	WOS:000638119900027
J	Madsen, SMK; Dau, T; Oxenham, AJ				Madsen, Sara M. K.; Dau, Torsten; Oxenham, Andrew J.			No interaction between fundamental-frequency differences and spectral region when perceiving speech in a speech background	PLOS ONE			English	Article								Differences in fundamental frequency (F0) or pitch between competing voices facilitate our ability to segregate a target voice from interferers, thereby enhancing speech intelligibility. Although lower-numbered harmonics elicit a stronger and more accurate pitch sensation than higher-numbered harmonics, it is unclear whether the stronger pitch leads to an increased benefit of pitch differences when segregating competing talkers. To answer this question, sentence recognition was tested in young normal-hearing listeners in the presence of a single competing talker. The stimuli were presented in a broadband condition or were highpass or lowpass filtered to manipulate the pitch accuracy of the voicing, while maintaining roughly equal speech intelligibility in the highpass and lowpass regions. Performance was measured with average F0 differences (Delta F0) between the target and single-talker masker of 0, 2, and 4 semitones. Pitch discrimination abilities were also measured to confirm that the lowpass-filtered stimuli elicited greater pitch accuracy than the highpass-filtered stimuli. No interaction was found between filter type and Delta F0 in the sentence recognition task, suggesting little or no effect of harmonic rank or pitch accuracy on the ability to use F0 to segregate natural voices, even when the average Delta F0 is relatively small. The results suggest that listeners are able to obtain some benefit of pitch differences between competing voices, even when pitch salience and accuracy is low. The accuracy with which we are able to discriminate the pitch of a harmonic complex tone depends on the F0 and the harmonic numbers present. For F0s in the average range of speech (100-200 Hz), pitch discrimination is best (implying accurate F0 coding) when harmonics below about the 10(th) are present [6-10]. When these lower-numbered harmonics are present, pitch discrimination is also independent of the phase relationships between the harmonics, suggesting that these harmonics are spectrally resolved to some extent. In contrast, when only harmonics above the 10(th) are present in this range of F0s, pitch discrimination is poorer and is affected by the phase relationships between harmonics, suggesting that interactions occur between these spectrally unresolved harmonics [6-10]. Psychoacoustic studies of sound segregation have often been carried out with interleaved sequences of tones. Some of these studies have investigated segregation based on differences in pitch accuracy and have varied the accuracy by systematically varying whether resolved or only unresolved harmonics are present. Previous studies have found that stream segregation can occur with alternating sequences of tones, even if the tones consist only of unresolved harmonics [11-14]. However, the question of whether streaming is greater with resolved than unresolved harmonics has received mixed answers. In cases where the listeners' task was to segregate the streams, some studies have shown little difference in streaming between conditions containing resolved or only unresolved harmonics [11, 15], whereas another study using a similar approach found significantly greater stream segregation when resolved harmonics were present than when only unresolved harmonics were present [12]. However, in situations where the task was either neutral or encouraged listeners to integrate the sequences into a single stream, the results have been consistent across studies in showing greater segregation for complex tones containing resolved harmonics than for tones containing only unresolved harmonics [13, 14]. These findings support the idea that pitch accuracy can affect our ability to segregate sounds. Less is known about the role of low-numbered harmonics in the context of segregating competing speech. Bird and Darwin [2] showed that lower harmonics dominate performance in a speech-segregation task based on F0 differences, but they did not test any conditions containing only high-numbered harmonics. Oxenham and Simonson [16] explored the effect of harmonic rank on speech intelligibility by comparing conditions where the target and single-talker masker had been lowpass (LP) or highpass (HP) filtered to either retain (LP-filtered) or remove (HP-filtered) the spectrally resolved components from the target and masker [16]. The LP and HP cutoff frequencies were selected to produce roughly equal performance in noise for both conditions. Surprisingly, performance in the LP and HP conditions improved by similar amounts when the noise masker was replaced by a single-talker masker with a different average F0, suggesting no clear benefit of having resolved harmonic components in the speech. However, that study only used relatively large values of average Delta F0 that according to recent F0 estimates were approximately 4 and 8 semitones (ST). Moreover, this study did not parametrically vary the Delta F0 between the target and masker. It may be that pitch accuracy is only relevant for more challenging conditions, i.e. for conditions with smaller average values of Delta F0. Thus, it remains unclear whether the effect of Delta F0 on performance is affected by the presence or absence of low-numbered, spectrally resolved harmonics. The aim of the present study was to determine whether there is an effect of spectral region, and hence pitch coding accuracy, on the ability of listeners to use average F0 differences between a target and an interfering talker to understand natural speech.	[Madsen, Sara M. K.; Oxenham, Andrew J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Madsen, Sara M. K.; Dau, Torsten] Tech Univ Denmark, Dept Hlth Technol, Hearing Syst Sect, Lyngby, Denmark	University of Minnesota System; University of Minnesota Twin Cities; Technical University of Denmark	Madsen, SMK (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.; Madsen, SMK (corresponding author), Tech Univ Denmark, Dept Hlth Technol, Hearing Syst Sect, Lyngby, Denmark.	saramiay@gmail.com	Dau, Torsten/AAJ-3709-2020	Dau, Torsten/0000-0001-8110-4343; Oxenham, Andrew/0000-0002-9365-1157	William Demant Foundation - NIH [R01 DC005216]	William Demant Foundation - NIH	SM is funded by the William Demant Foundation (http://williamdemantfoundation.com/).AJO is funded by NIH grant R01 DC005216 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apoux F, 2008, J ACOUST SOC AM, V123, P1665, DOI 10.1121/1.2828067; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bernstein JG., 2006, PITCH PERCEPTION HAR; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; Bird J., 1998, PSYCHOPHYSICAL PHYSL, P263; Boersma P, 2021, PRAAT DOING PHONETIC; BROKX JPL, 1982, J PHONETICS, V10, P23, DOI 10.1016/S0095-4470(19)30909-X; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Calandruccio L, 2007, J ACOUST SOC AM, V121, P3827, DOI 10.1121/1.2722211; Croghan NBH, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518787276; David M, 2018, HEARING RES, V364, P118, DOI 10.1016/j.heares.2018.03.017; Doherty KA, 1996, J ACOUST SOC AM, V100, P3769, DOI 10.1121/1.417336; Ellis D., 2020, MATLAB CENTRAL FILE; Fereczkowski M., 2018, TASK DIALOG NATIVE D; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P19, DOI 10.1007/s10162-004-5024-3; Gilbert G, 2005, ACTA ACUST UNITED AC, V91, P145; Grimault N, 2000, J ACOUST SOC AM, V108, P263, DOI 10.1121/1.429462; Hoekstra A., 1977, PSYCHOPHYSICS PHYSL, P263; Lutfi RA, 1996, J ACOUST SOC AM, V100, P2258, DOI 10.1121/1.417935; Madsen SMK, 2018, HEARING RES, V367, P161, DOI 10.1016/j.heares.2018.06.002; Madsen SMK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12937-9; Madsen SMK., 2019, SCI REP-UK, P9, DOI [10.1038/s41598-018-36956-2, DOI 10.1038/S41598-018-36956-2]; Mehta AH, 2020, J ACOUST SOC AM, V147, P2314, DOI 10.1121/10.0001092; Mesiano P., 2020, P INT S AUDIT AUDIOL, P7; Nelson PB, 2003, J ACOUST SOC AM, V113, P961, DOI 10.1121/1.1531983; Nielsen JB, 2009, INT J AUDIOL, V48, P729, DOI 10.1080/14992020903019312; Oxenham AJ, 2009, J ACOUST SOC AM, V125, P2189, DOI 10.1121/1.3089220; Oxenham AJ, 2009, J ACOUST SOC AM, V125, P457, DOI 10.1121/1.3021299; Popham S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04551-8; Ruggles DR, 2018, J ACOUST SOC AM, V144, P2424, DOI 10.1121/1.5065392; SHACKLETON TM, 1994, J ACOUST SOC AM, V95, P3529, DOI 10.1121/1.409970; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; Turner CW, 1998, J ACOUST SOC AM, V104, P1580, DOI 10.1121/1.424370; Vliegen J, 1999, J ACOUST SOC AM, V105, P339, DOI 10.1121/1.424503; Vliegen J, 1999, J ACOUST SOC AM, V106, P938, DOI 10.1121/1.427140	35	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249654	10.1371/journal.pone.0249654	http://dx.doi.org/10.1371/journal.pone.0249654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826663	Green Published, gold			2022-12-26	WOS:000638119900019
J	Cardle, II; Jensen, MC; Pun, SH; Sellers, DL				Cardle, Ian I.; Jensen, Michael C.; Pun, Suzie H.; Sellers, Drew L.			Optimized serum stability and specificity of an alpha v beta 6 integrin-binding peptide for tumor targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUTH-DISEASE-VIRUS; IN-VIVO; BETA-6 INTEGRIN; UP-REGULATION; CANCER; EXPRESSION; INTEGRIN-ALPHA(V)BETA(6); ALPHA(V)BETA(6); ACTIVATION; CARCINOMA	The integrin alpha v beta 6 is an antigen expressed at low levels in healthy tissue but upregulated during tumorigenesis, which makes it a promising target for cancer imaging and therapy. A20FMDV2 is a 20-mer peptide derived from the foot-and-mouth disease virus that exhibits nanomolar and selective affinity for alpha v beta 6 versus other integrins. Despite this selectivity, A20FMDV2 has had limited success in imaging and treating alpha v beta 6(+) tumors in vivo because of its poor serum stability. Here, we explore the cyclization and modification of the A20FMDV2 peptide to improve its serum stability without sacrificing its affinity and specificity for alpha v beta 6. Using cysteine amino acid substitutions and cyclization by perfluoroarylation with decafluorobiphenyl, we synthesized six cyclized A20FMDV2 variants and discovered that two retained binding to alpha v beta 6 with modestly improved serum stability. Further D-amino acid substitutions and C-terminal sequence optimization outside the cyclized region greatly prolonged peptide serum stability without reducing binding affinity. While the cyclized A20FMDV2 variants exhibited increased nonspecific integrin binding compared with the original peptide, additional modifications with the non-natural amino acids citrulline, hydroxyproline, and D-alanine were found to restore binding specificity, with some modifications leading to greater alpha v beta 6 integrin selectivity than the original A20FMDV2 peptide. The peptide modifications detailed herein greatly improve the potential of utilizing A20FMDV2 to target alpha v beta 6 in vivo, expanding opportunities for cancer targeting and therapy.	[Cardle, Ian I.; Jensen, Michael C.; Pun, Suzie H.; Sellers, Drew L.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Cardle, Ian I.; Jensen, Michael C.] Seattle Childrens Therapeut, Seattle, WA USA; [Jensen, Michael C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Jensen, Michael C.] Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Sellers, DL (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	drewfus@uw.edu		Sellers, Drew/0000-0003-1799-5908; Cardle, Ian/0000-0001-9000-2293	National Institutes of Health [R01NS118247, R21NS099654, R01CA177272]; National Science Foundation Graduate Research Fellowship [DGE-1762114]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This research was supported by the National Institutes of Health under grant nos. R01NS118247 (to D. L. S.), R21NS099654 (to D. L. S.), and R01CA177272 (to S. H. P.), and by a National Science Foundation Graduate Research Fellowship under grant no. DGE-1762114 (to I. I. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and National Science Foundation.	Ahmed N, 2002, J HISTOCHEM CYTOCHEM, V50, P1371, DOI 10.1177/002215540205001010; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645, DOI 10.2174/138945009788680374; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BREUSS JM, 1995, J CELL SCI, V108, P2241; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; BUSK M, 1992, J BIOL CHEM, V267, P5790; Desnoyers A GonzAlez, 2020, MOL DIAGN THER, V24, P143; DiCara D, 2008, J VIROL, V82, P1537, DOI 10.1128/JVI.01480-07; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; Elayadi AN, 2007, CANCER RES, V67, P5889, DOI 10.1158/0008-5472.CAN-07-0245; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; Foster CC, 2020, J NUCL MED, V61, DOI 10.2967/jnumed.120.255364; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gu X, 2002, BRIT J CANCER, V87, P348, DOI 10.1038/sj.bjc.6600480; Hamidi Hellyeh, 2018, Nat Rev Cancer, V18, P533, DOI 10.1038/s41568-018-0038-z; Hausner SH, 2007, CANCER RES, V67, P7833, DOI 10.1158/0008-5472.CAN-07-1026; Hausner SH, 2019, CLIN CANCER RES, V25, P1206, DOI 10.1158/1078-0432.CCR-18-2665; Hausner SH, 2015, J NUCL MED, V56, P784, DOI 10.2967/jnumed.114.150680; Hausner SH, 2009, CANCER RES, V69, P5843, DOI 10.1158/0008-5472.CAN-08-4410; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Hsiao JR, 2010, HEAD NECK-J SCI SPEC, V32, P160, DOI 10.1002/hed.21166; Hung KY, 2017, EUR J MED CHEM, V136, P154, DOI 10.1016/j.ejmech.2017.05.008; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Keat N, 2018, J NUCL MED TECHNOL, V46, P136, DOI 10.2967/jnmt.117.203547; Khan Z, 2016, CELL TISSUE RES, V365, P657, DOI 10.1007/s00441-016-2474-y; Kimura RH, 2012, CLIN CANCER RES, V18, P839, DOI 10.1158/1078-0432.CCR-11-1116; Kogelberg H, 2008, J MOL BIOL, V382, P385, DOI 10.1016/j.jmb.2008.07.013; Kolodziej A F., 2014, PEPTIDE OPTIMIZATION, P185; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Liu H, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0705-y; Liu H, 2014, AM J NUCL MED MOLEC, V4, P333; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Lukey PT, 2020, EUR J NUCL MED MOL I, V47, P967, DOI 10.1007/s00259-019-04586-z; Moore KM, 2020, THERANOSTICS, V10, P2930, DOI 10.7150/thno.38702; Moore KM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju169; Morgan MR, 2004, J BIOL CHEM, V279, P26533, DOI 10.1074/jbc.M401736200; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Ngambenjawong C, 2016, BIOCONJUGATE CHEM, V27, P2854, DOI 10.1021/acs.bioconjchem.6b00502; Nieberler M, 2017, CANCERS, V9, DOI 10.3390/cancers9090116; Patsenker E, 2010, J HEPATOL, V52, P362, DOI 10.1016/j.jhep.2009.12.006; Peng ZW, 2016, HEPATOLOGY, V63, P217, DOI 10.1002/hep.28274; Raab-Westphal S, 2017, CANCERS, V9, DOI 10.3390/cancers9090110; Reader CS, 2019, J PATHOL, V249, P332, DOI 10.1002/path.5320; Regezi JA, 2002, ORAL ONCOL, V38, P332, DOI 10.1016/S1368-8375(01)00062-8; Saleem A, 2020, INT J RADIAT ONCOL, V107, P370, DOI 10.1016/j.ijrobp.2020.02.014; Sellers DL, 2019, ACS NANO, V13, P10961, DOI 10.1021/acsnano.9b01515; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Slack RJ, 2016, PHARMACOLOGY, V97, P114, DOI 10.1159/000443180; Spokoyny AM, 2013, J AM CHEM SOC, V135, P5946, DOI 10.1021/ja400119t; Sun CC, 2016, AM J THER, V23, pE198, DOI 10.1097/MJT.0000000000000053; Sylvestre M, 2021, J CONTROL RELEASE, V331, P142, DOI 10.1016/j.jconrel.2021.01.015; Thomas GJ, 2002, BRIT J CANCER, V87, P859, DOI 10.1038/sj.bjc.6600545; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V116, P898, DOI 10.1046/j.1523-1747.2001.01352.x; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wagstaff JL, 2012, RSC ADV, V2, P11019, DOI 10.1039/c2ra21655h; Wang Y, 2016, MOL CANCER THER, V15, P232, DOI 10.1158/1535-7163.MCT-15-0544; Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612; Whilding LM, 2017, MOL THER, V25, P259, DOI 10.1016/j.ymthe.2016.10.012; Yan PW, 2018, TRANSL ONCOL, V11, P619, DOI 10.1016/j.tranon.2018.02.013; Yang GY, 2015, WORLD J GASTROENTERO, V21, P7457, DOI 10.3748/wjg.v21.i24.7457; Zhuang ZN, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0580-1	68	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100657	10.1016/j.jbc.2021.100657	http://dx.doi.org/10.1016/j.jbc.2021.100657			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857478	Green Published, gold			2022-12-26	WOS:000672866400628
J	Collins, JF				Collins, James F.			Iron chelates hitch a ride on PAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NICOTIANAMINE; DMT1; ACID	The nicotianamine-iron chelate [NA-Fe2+], which is found in many plant-based foods, has been recently described as a new form of bioavailable iron in mice and chickens. How NA-Fe2+ is assimilated from the diet, however, remains unclear. The current investigation by Murata et al. has identified the proton-coupled amino acid transporter 1 (PAT1) as the main mechanism by which NA-Fe2+ is absorbed in the mammalian intestine. Discovery of this new form of dietary iron and elucidation of its pathway of intestinal absorption may lead to the development of improved iron supplementation approaches.	[Collins, James F.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA.	jfcollins@ufl.edu		Collins, James Forrest/0000-0002-8765-0297	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK074867]; NIDDK [DK109717]; Office of Dietary Supplements	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grant DK074867 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and grant DK109717 from NIDDK and the Office of Dietary Supplements.	Allen LH, 2002, NUTR REV, V60, pS18, DOI 10.1301/002966402320285047; Beasley JT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57598-3; Eagling T, 2014, J AGR FOOD CHEM, V62, P10320, DOI 10.1021/jf5026295; Gulec S, 2014, AM J PHYSIOL-GASTR L, V307, pG397, DOI 10.1152/ajpgi.00348.2013; Lee S, 2012, MOL CELLS, V33, P269, DOI 10.1007/s10059-012-2231-3; Mims MP, 2005, BLOOD, V105, P1337, DOI 10.1182/blood-2004-07-2966; Murata Y, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015861; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107	10	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100418	10.1016/j.jbc.2021.100418	http://dx.doi.org/10.1016/j.jbc.2021.100418			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837730	gold, Green Published			2022-12-26	WOS:000672866400392
J	Taudte, N; Linnert, M; Rahfeld, JU; Piechotta, A; Ramsbeck, D; Buchholz, M; Kolenko, P; Parthier, C; Houston, JA; Veillard, F; Eick, S; Potempa, J; Schilling, S; Demuth, HU; Stubbs, MT				Taudte, Nadine; Linnert, Miriam; Rahfeld, Jens-Ulrich; Piechotta, Anke; Ramsbeck, Daniel; Buchholz, Mirko; Kolenko, Petr; Parthier, Christoph; Houston, John A.; Veillard, Florian; Eick, Sigrun; Potempa, Jan; Schilling, Stephan; Demuth, Hans-Ulrich; Stubbs, Milton T.			Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURES; EXPRESSION; VIRULENCE; PH; INHIBITION; CATALYSIS; PLANTS; HEALTH; BRAIN	The development of a targeted therapy would significantly improve the treatment of periodontitis and its associated diseases including Alzheimer's disease, rheumatoid arthritis, and cardiovascular diseases. Glutaminyl cyclases (QCs) from the oral pathogens Porphyromonas gingivalis, Tannerella forsythia, and Prevotella intermedia represent attractive target enzymes for small-molecule inhibitor development, as their action is likely to stabilize essential periplasmic and outer membrane proteins by N-terminal pyroglutamination. In contrast to other microbial QCs that utilize the so-called type I enzymes, these oral pathogens possess sequences corresponding to type II QCs, observed hitherto only in animals. However, whether differences between these bacteroidal QCs and animal QCs are sufficient to enable development of selective inhibitors is not clear. To learn more, we recombinantly expressed all three QCs. They exhibit comparable catalytic efficiencies and are inhibited by metal chelators. Crystal structures of the enzymes from P. gingivalis (PgQC) and T. forsythia (TfQC) reveal a tertiary structure composed of an eight-stranded beta-sheet surrounded by seven a-helices, typical of animal type II QCs. In each case, an active site Zn ion is tetrahedrally coordinated by conserved residues. Nevertheless, significant differences to mammalian enzymes are found around the active site of the bacteroidal enzymes. Application of a PgQC-selective inhibitor described here for the first time results in growth inhibition of two P. gingivalis clinical isolates in a dose-dependent manner. The insights gained by these studies will assist in the development of highly specific small-molecule bacteroidal QC inhibitors, paving the way for alternative therapies against periodontitis and associated diseases.	[Taudte, Nadine; Buchholz, Mirko] Periotrap Pharmaceut GmbH, Halle, Saale, Germany; [Linnert, Miriam; Rahfeld, Jens-Ulrich; Piechotta, Anke; Ramsbeck, Daniel; Buchholz, Mirko; Schilling, Stephan; Demuth, Hans-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Mol Drug Design & Target Validat, Halle, Saale, Germany; [Kolenko, Petr; Parthier, Christoph; Stubbs, Milton T.] Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, Inst Biochem & Biotechnol, Halle, Saale, Germany; [Houston, John A.; Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Veillard, Florian; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Eick, Sigrun] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Schilling, Stephan] Hsch Anhalt, Angew Biowissensch & Prozesstech, Kothen, Germany; [Stubbs, Milton T.] Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, ZIK HALOmem, Halle, Saale, Germany; [Kolenko, Petr] Czech Acad Sci, Inst Biotechnol, Vvi, Biocev, Vestec, Czech Republic; [Kolenko, Petr] Czech Tech Univ, Dept Solid State Engn, Vvi, Fac Nucl Sci & Phys Engn, Prague, Czech Republic	Fraunhofer Gesellschaft; Martin Luther University Halle Wittenberg; University of Louisville; Jagiellonian University; University of Bern; Martin Luther University Halle Wittenberg; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Technical University Prague	Rahfeld, JU (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Mol Drug Design & Target Validat, Halle, Saale, Germany.; Stubbs, MT (corresponding author), Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, Inst Biochem & Biotechnol, Halle, Saale, Germany.; Stubbs, MT (corresponding author), Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, ZIK HALOmem, Halle, Saale, Germany.	jens-ulrich.rahfeld@izi.fraunhofer.de; stubbs@biochemtech.uni-halle.de	Ramsbeck, Daniel/AAG-2174-2021; Kolenko, Petr/G-5732-2014	Ramsbeck, Daniel/0000-0002-4966-142X; Veillard, Florian/0000-0003-1248-2396; Kolenko, Petr/0000-0002-4619-9276; Linnert, Miriam/0000-0002-5337-4765; Stubbs, Milton/0000-0003-1278-9013	National Institutes of Health/NIDCR [DE 022597]; EU [306029]	National Institutes of Health/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EU(European Commission)	This work was supported in part by National Institutes of Health/NIDCR DE 022597 to J. P. and the EU project "TRIGGER -King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies", Grant agreement number 306029 to H.-U. D., J. P., and S. E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahrendt K. A., 2019, World patent, Patent No. [WO/2009/111277, 2009111277]; Baliga Sharmila, 2013, J Indian Soc Periodontol, V17, P461, DOI 10.4103/0972-124X.118317; Bender P, 2019, ARCH ORAL BIOL, V97, P223, DOI 10.1016/j.archoralbio.2018.10.022; Benedyk M, 2019, MOL ORAL MICROBIOL, V34, P237, DOI 10.1111/omi.12268; BICKEL M, 1985, J DENT RES, V64, P1218, DOI 10.1177/00220345850640100801; BICKEL M, 1985, J PERIODONTAL RES, V20, P35, DOI 10.1111/j.1600-0765.1985.tb00408.x; Bochtler M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00230; Booth RE, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Carrillo DR, 2010, BIOL CHEM, V391, P1419, DOI 10.1515/BC.2010.130; Chen YW, 2019, ONCOTARGETS THER, V12, P11131, DOI 10.2147/OTT.S230262; Chevrier B, 1996, EUR J BIOCHEM, V237, P393, DOI 10.1111/j.1432-1033.1996.0393k.x; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Duran-Pinedo AE, 2014, INFECT IMMUN, V82, P3374, DOI 10.1128/IAI.01976-14; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gorasia DG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005152; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hayashi J, 2002, FEMS MICROBIOL LETT, V216, P217, DOI 10.1111/j.1574-6968.2002.tb11438.x; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang KF, 2014, ACTA CRYSTALLOGR D, V70, P789, DOI 10.1107/S1399004713033488; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; Hutcherson JA, 2016, MOL ORAL MICROBIOL, V31, P354, DOI 10.1111/omi.12135; Ide M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151081; Ishida N, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0015-x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamer AR, 2008, J ALZHEIMERS DIS, V13, P437; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Kobayashi Tetsuo, 2015, Curr Oral Health Rep, V2, P1; Koch B, 2012, BIOCHEMISTRY-US, V51, P7383, DOI 10.1021/bi300687g; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kupski O, 2020, BIOCHEMISTRY-US, V59, P2585, DOI 10.1021/acs.biochem.0c00337; Laugisch O, 2016, CLIN ORAL INVEST, V20, P675, DOI 10.1007/s00784-015-1556-7; MARSH PD, 1994, MICROBIOL-UK, V140, P861, DOI 10.1099/00221287-140-4-861; Matthews Debora, 2013, Evid Based Dent, V14, P87, DOI 10.1038/sj.ebd.6400955; MESSER M, 1964, BIOCHIM BIOPHYS ACTA, V92, P409, DOI 10.1016/0926-6569(64)90204-4; Nie R, 2019, J ALZHEIMERS DIS, V72, P479, DOI 10.3233/JAD-190298; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Patel RM, 2016, J CLIN DIAGN RES, V10, pZC58, DOI 10.7860/JCDR/2016/20973.8182; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Rajesh K S, 2015, Contemp Clin Dent, V6, P461, DOI 10.4103/0976-237X.169846; Reichert S, 2013, J CLIN PERIODONTOL, V40, P591, DOI 10.1111/jcpe.12102; Ruiz-Carrillo D, 2011, BIOCHEMISTRY-US, V50, P6280, DOI 10.1021/bi200249h; Scheltens P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0431-6; Schilling S, 2003, BIOL CHEM, V384, P1583, DOI 10.1515/BC.2003.175; Schilling S, 2003, J BIOL CHEM, V278, P49773, DOI 10.1074/jbc.M309077200; Schilling S, 2002, ANAL BIOCHEM, V303, P49, DOI 10.1006/abio.2001.5560; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Smiley CJ, 2015, J AM DENT ASSOC, V146, P508, DOI 10.1016/j.adaj.2015.01.028; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tonetti MS, 2017, J CLIN PERIODONTOL, V44, P456, DOI 10.1111/jcpe.12732; Totaro MC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4243; Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wilson I, 2011, GENOME BIOL, V12, P4; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029; Wu V. W., 2017, MBIO, V8; Wu Z, 2017, BRAIN BEHAV IMMUN, V65, P350, DOI 10.1016/j.bbi.2017.06.002	70	3	3	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100263	10.1016/j.jbc.2021.100263	http://dx.doi.org/10.1016/j.jbc.2021.100263			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837744	gold, Green Published			2022-12-26	WOS:000672866400239
J	Yasuda, K; Nishikawa, M; Okamoto, K; Horibe, K; Mano, H; Yamaguchi, M; Okon, R; Nakagawa, K; Tsugawa, N; Okano, T; Kawagoe, F; Kittaka, A; Ikushiro, S; Sakaki, T				Yasuda, Kaori; Nishikawa, Miyu; Okamoto, Kairi; Horibe, Kyohei; Mano, Hiroki; Yamaguchi, Mana; Okon, Risa; Nakagawa, Kimie; Tsugawa, Naoko; Okano, Toshio; Kawagoe, Fumihiro; Kittaka, Atsushi; Ikushiro, Shinichi; Sakaki, Toshiyuki			Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D; BIOLOGICAL-ACTIVITY; D-3; SERUM; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; D3-26,23-LACTONE; DERIVATIZATION; MUTATIONS; MICE	CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately twofold higher than in wild-type rats. Wild-type rats showed five metabolites of 25(OH)D3 in plasma following oral administration of 25(OH)D3, and these metabolites were not detected in Cyp24a1 KO rats. Among these metabolites, 25(OH)D3-26,23-lactone was identified as the second major metabolite with a significantly higher T-max value than others. When 23S,25(OH)2D3 was administered to Cyp24a1 KO rats, neither 23,25,26(OH)(3)D3 nor 25(OH)D3-26,23-lactone was observed. However, when 23S,25R,26(OH)(3)D3 was administered to Cyp24a1 KO rats, plasma 25(OH)D3-26,23-lactone was detected. These results suggested that CYP24A1 is responsible for the conversion of 25(OH)D3 to 23,25,26(OH)3D3 via 23,25(OH)2D3, but enzyme(s) other than CYP24A1 may be involved in the conversion of 23,25,26(OH)3D3 to 25(OH)D3-26,23-lactone. Enzymatic studies using recombinant human CYP species and the inhibitory effects of ketoconazole suggested that CYP3A plays an essential role in the conversion of 23,25,26(OH)3D3 into 25(OH)D3-26,23-lactone in both rats and humans. Taken together, our data indicate that Cyp24a1 KO rats are valuable for metabolic studies of vitamin D and its analogs. In addition, long-term administration of 25(OH)D3 to Cyp24a1 KO rats at 110 mu g/kg body weight/day resulted in significant weight loss and ectopic calcification. Thus, Cyp24a1 KO rats could represent an important model for studying renal diseases originating from CYP24A1 dysfunction.	[Yasuda, Kaori; Okamoto, Kairi; Horibe, Kyohei; Mano, Hiroki; Yamaguchi, Mana; Okon, Risa; Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Pharmaceut Engn, Imizu, Toyama, Japan; [Nishikawa, Miyu; Ikushiro, Shinichi] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama, Japan; [Nakagawa, Kimie] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Hyg Sci, Chuo Ku, Kobe, Hyogo, Japan; [Tsugawa, Naoko] Osaka Shoin Womens Univ, Fac Hlth & Nutr, Dept Hlth & Nutr, Higashiosaka, Osaka, Japan; [Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo, Japan; [Kawagoe, Fumihiro; Kittaka, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Tokyo, Japan	Toyama Prefectural University; Toyama Prefectural University; Kobe Gakuin University; Kobe Pharmaceutical University; Teikyo University	Sakaki, T (corresponding author), Toyama Prefectural Univ, Fac Engn, Dept Pharmaceut Engn, Imizu, Toyama, Japan.	tsakaki@pu-toyama.ac.jp		Yasuda, Kaori/0000-0003-3495-3216	JSPS KAKENHI [16H04912, 17K15261, 19H02889, 19K05829]; Kato Memorial Bioscience Foundation; Kanamori Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kato Memorial Bioscience Foundation; Kanamori Foundation	This work was supported by JSPS KAKENHI (16H04912, 17K15261, 19H02889, and 19K05829), Kato Memorial Bioscience Foundation, and Kanamori Foundation.	BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Chatterjee B, 2005, METHOD ENZYMOL, V400, P165, DOI 10.1016/S0076-6879(05)00010-8; Higashi T, 2001, BIOL PHARM BULL, V24, P738, DOI 10.1248/bpb.24.738; ISHIZUKA S, 1987, J BIOL CHEM, V262, P7165; ISHIZUKA S, 1986, J STEROID BIOCHEM, V25, P505; ISHIZUKA S, 1981, FEBS LETT, V134, P207, DOI 10.1016/0014-5793(81)80603-5; ISHIZUKA S, 1982, FEBS LETT, V139, P267, DOI 10.1016/0014-5793(82)80867-3; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kaufmann M, 2019, J STEROID BIOCHEM, V188, P23, DOI 10.1016/j.jsbmb.2018.12.001; Kaufmann M, 2017, J BONE MINER RES, V32, P1589, DOI 10.1002/jbmr.3135; Kaufmann M, 2015, ENDOCRINOLOGY, V156, P4388, DOI 10.1210/en.2015-1664; Kaufmann M, 2014, J CLIN ENDOCR METAB, V99, P2567, DOI 10.1210/jc.2013-4388; Kawagoe F, 2019, J STEROID BIOCHEM, V186, P161, DOI 10.1016/j.jsbmb.2018.10.010; Kusudo T, 2004, BIOCHEM BIOPH RES CO, V321, P774, DOI 10.1016/j.bbrc.2004.07.040; Masuda S, 2005, ENDOCRINOLOGY, V146, P825, DOI 10.1210/en.2004-1116; Matsunaga T, 2005, BIOL PHARM BULL, V28, P646, DOI 10.1248/bpb.28.646; NAPOLI JL, 1982, J BIOL CHEM, V257, P9634; Nesterova G, 2013, CLIN J AM SOC NEPHRO, V8, P649, DOI 10.2215/CJN.05360512; Nishikawa M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62048-1; Nishikawa M, 2019, J STEROID BIOCHEM, V185, P71, DOI 10.1016/j.jsbmb.2018.07.012; PEDERSEN JI, 1988, BIOCHEM J, V250, P527, DOI 10.1042/bj2500527; Pronicka E, 2017, J APPL GENET, V58, P349, DOI 10.1007/s13353-017-0397-2; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Qin X, 2019, ACTA PHARM SIN B, V9, P1087, DOI 10.1016/j.apsb.2019.03.005; Roizen JD, 2018, J CLIN INVEST, V128, P1913, DOI 10.1172/JCI98680; Sakaki T, 2000, EUR J BIOCHEM, V267, P6158, DOI 10.1046/j.1432-1327.2000.01680.x; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; St-Arnaud R, 1999, BONE, V25, P127, DOI 10.1016/S8756-3282(99)00118-0; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; TANAKA Y, 1980, P NATL ACAD SCI-BIOL, V77, P6411, DOI 10.1073/pnas.77.11.6411; Tieu EW, 2014, FEBS J, V281, P3280, DOI 10.1111/febs.12862; Wang ZC, 2014, ENDOCRINOLOGY, V155, P2052, DOI 10.1210/en.2013-2013; Wong T, 2018, DRUG METAB DISPOS, V46, P367, DOI 10.1124/dmd.117.078428; Yasuda K, 2018, J STEROID BIOCHEM, V178, P333, DOI 10.1016/j.jsbmb.2018.02.001	35	8	10	5	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100668	10.1016/j.jbc.2021.100668	http://dx.doi.org/10.1016/j.jbc.2021.100668			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865853	Green Published, gold			2022-12-26	WOS:000672866400639
J	Uda, Y; Spatz, JM; Hussein, A; Garcia, JH; Lai, F; Dedic, C; Fulzele, K; Dougherty, S; Eberle, M; Adamson, C; Misener, L; Gerstenfeld, L; Pajevic, PD				Uda, Yuhei; Spatz, Jordan M.; Hussein, Amira; Garcia, Joseph H.; Lai, Forest; Dedic, Chris; Fulzele, Keertik; Dougherty, Sean; Eberle, Margaret; Adamson, Chris; Misener, Lowell; Gerstenfeld, Louis; Pajevic, Paola Divieti			Global transcriptomic analysis of a murine osteocytic cell line subjected to spaceflight	FASEB JOURNAL			English	Article						bone cells; bone loss; gene expression; International Space Station; microgravity	PPAR-GAMMA; INHIBITOR SCLEROSTIN; NITRIC-OXIDE; BONE; GENE; INVOLVEMENT; EXPRESSION; OSTEOCLASTOGENESIS; DIFFERENTIATION; IDENTIFICATION	Bone loss is a major health concern for astronauts during long-term spaceflight and for patients during prolonged bed rest or paralysis. Growing evidence suggests that osteocytes, the most abundant cells in the mineralized bone matrix, play a key role in sensing mechanical forces applied to the skeleton and integrating the orchestrated response into subcellular biochemical signals to modulate bone homeostasis. However, the precise molecular mechanisms underlying both mechanosensation and mechanotransduction in late-osteoblast-to-osteocyte cells under microgravity (mu G) have yet to be elucidated. To unravel the mechanisms by which late osteoblasts and osteocytes sense and respond to mechanical unloading, we exposed the osteocytic cell line, Ocy454, to 2, 4, or 6 days of mu G on the SpaceX Dragon-6 resupply mission to the International Space Station. Our results showed that mu G impairs the differentiation of osteocytes, consistent with prior osteoblast spaceflight experiments, which resulted in the downregulation of key osteocytic genes. Importantly, we demonstrate the modulation of critical glycolysis pathways in osteocytes subjected to microgravity and discovered a set of mechanical sensitive genes that are consistently regulated in multiple cell types exposed to microgravity suggesting a common, yet to be fully elucidated, genome-wide response to microgravity. Ground-based simulated microgravity experiments utilizing the NASA rotating-wall-vessel were unable to adequately replicate the changes in microgravity exposure highlighting the importance of spaceflight missions to understand the unique environmental stress that microgravity presents to diverse cell types. In summary, our findings demonstrate that osteocytes respond to mu G with an increase in glucose metabolism and oxygen consumption.	[Uda, Yuhei; Lai, Forest; Dedic, Chris; Fulzele, Keertik; Pajevic, Paola Divieti] Boston Univ, Henry M Goldman Sch Dent Med, Dept Translat Dent Med, 700 Albany St,W201E, Boston, MA 02118 USA; [Spatz, Jordan M.; Pajevic, Paola Divieti] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Spatz, Jordan M.; Pajevic, Paola Divieti] Harvard Med Sch, Boston, MA 02115 USA; [Spatz, Jordan M.; Garcia, Joseph H.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Hussein, Amira; Gerstenfeld, Louis] Boston Univ, Sch Med, Dept Orthopaed Surg, Boston, MA 02118 USA; [Dougherty, Sean; Eberle, Margaret; Adamson, Chris; Misener, Lowell] CALM Technol Inc, Kingston, ON, Canada	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Boston University	Pajevic, PD (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Translat Dent Med, 700 Albany St,W201E, Boston, MA 02118 USA.	pdivieti@bu.edu	Uda, Yuhei/AAZ-4978-2021	Uda, Yuhei/0000-0003-4705-6215	Canadian Space Agency; NIH [NIAMS AR059655]; CASIS [GA2015-209]; Boston University Microarray Core Facility (CTSA grant) [U54-TR001012]	Canadian Space Agency(Canadian Space Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CASIS; Boston University Microarray Core Facility (CTSA grant)	The authors wish to thank Dr Lisa E. Freed for her invaluable advice and contribution in the developing this project, all staff and members of the Kennedy Space Center ISS processing facility and NASA mission support team for their help and support for the ISS mission, with a particular thanks to Derek Duflo (Jacobs--TOSC), Gerard Newsham (Jacobs--TOSC), Larry Cotton (NASA/JSC PIM), Henry Orosco (NASA/JSC RIM), and Brienne Shkedi (NASA/JSC ISS liaison). The authors also would like to thank Jenna Aronson and Dr Chao Shi for their contribution to this work and Dr Faye Chen (NIH--NIAMS) for her advice and continuous support. The authors also thank Luc Lefebvre and the Canadian Space Agency for the support and loaning of the eOSTEO payload hardware. This work was supported by grants from NIH (NIAMS AR059655 to PDP), CASIS (grant GA2015-209 to PDP), and the Boston University Microarray Core Facility (CTSA grant U54-TR001012).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Camirand A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160034; Cardinaux JR, 1996, J NEUROSCI, V16, P919; Chakraborty N, 2020, J BONE MINER RES, V35, P2049, DOI 10.1002/jbmr.4102; Cho YE, 2007, NEUROSCI LETT, V416, P144, DOI 10.1016/j.neulet.2007.01.073; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Cuzzocrea S, 2003, ENDOCRINOLOGY, V144, P1098, DOI 10.1210/en.2002-220597; Delgado-Calle J, 2015, CURR MOL BIOL REP, V1, P157; Dobrosak Cale, 2017, Bone Rep, V7, P114, DOI 10.1016/j.bonr.2017.10.002; Frings-Meuthen P, 2013, J MUSCULOSKEL NEURON, V13, P45; Fritton SP, 2009, ANNU REV FLUID MECH, V41, P347, DOI 10.1146/annurev.fluid.010908.165136; Fulzele K, 2017, J BONE MINER RES, V32, P373, DOI 10.1002/jbmr.3001; Gabel LA-O, 2021, BRIT J SPORT MED, DOI [10.1136/bjsports-2020-103602, DOI 10.1136/BJSP0RTS-2020-103602]; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalaitzoglou E, 2016, CURR OSTEOPOROS REP, V14, P310, DOI 10.1007/s11914-016-0329-9; Kanai Y, 2017, J CLIN INVEST, V127, P4136, DOI 10.1172/JCI94912; Khoury-Haddad H, 2014, P NATL ACAD SCI USA, V111, pE728, DOI 10.1073/pnas.1317585111; Kuang HB, 2009, ENDOCRINOLOGY, V150, P5596, DOI 10.1210/en.2009-0570; KUKITA A, 1990, P NATL ACAD SCI USA, V87, P3023, DOI 10.1073/pnas.87.8.3023; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; Lee MJ, 2004, MOL CELL BIOL, V24, P3918, DOI 10.1128/MCB.24.9.3918-3927.2004; Lee NJ, 2018, MOL METAB, V13, P30, DOI 10.1016/j.molmet.2018.05.004; Meakin LB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00154; Michaletti A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15612-1; Moeller LC, 2005, J CLIN ENDOCR METAB, V90, P936, DOI 10.1210/jc.2004-1768; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Ortega MT, 2012, ADV SPACE RES, V49, P1441, DOI 10.1016/j.asr.2012.02.021; Pajevic PD, 2020, CURR OSTEOPOROS REP, V18, P551, DOI 10.1007/s11914-020-00613-3; Pajevic Paola Divieti, 2013, Curr Biotechnol, V2, P179; Pajevic PD, 2009, IBMS BONEKEY, V6, P63, DOI DOI 10.1138/20090363; Patel MJ, 2007, J CELL BIOCHEM, V101, P587, DOI 10.1002/jcb.21218; Pino E, 2012, J BIOL CHEM, V287, P18351, DOI 10.1074/jbc.M112.350918; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Qusous A, 2011, J MEMBRANE BIOL, V243, P25, DOI 10.1007/s00232-011-9389-z; RAMBAUT PC, 1979, ACTA ASTRONAUT, V6, P1113, DOI 10.1016/0094-5765(79)90059-6; Robling AG, 2020, ANNU REV PHYSIOL, V82, P485, DOI 10.1146/annurev-physiol-021119-034332; Rodionova NV, 2002, ADV SPACE RES, V30, P765, DOI 10.1016/S0273-1177(02)00393-9; SHOWS TB, 1969, BIOCHEM GENET, V3, P525, DOI 10.1007/BF00485474; Smith SM, 2015, BONE, V81, P712, DOI 10.1016/j.bone.2015.10.002; Smith SM, 2012, NUTRIENTS, V4, P2047, DOI 10.3390/nu4122047; Smith SM, 2012, J BONE MINER RES, V27, P1896, DOI 10.1002/jbmr.1647; Spatz JM, 2012, J CLIN ENDOCR METAB, V97, pE1736, DOI 10.1210/jc.2012-1579; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takiguchi S, 2014, INT J ONCOL, V44, P1316, DOI 10.3892/ijo.2014.2293; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Uda Y, 2017, CURR OSTEOPOROS REP, V15, P318, DOI 10.1007/s11914-017-0373-0; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Wu C, 2015, GENE DEV, V29, P817, DOI 10.1101/gad.255000.114; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Xu LCH, 2019, J ORTHOP RES, V37, P1681, DOI 10.1002/jor.24302; Yamada T, 2004, J BONE MINER RES, V19, P1452, DOI 10.1359/JBMR.040515	72	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21578	10.1096/fj.202100059R	http://dx.doi.org/10.1096/fj.202100059R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835498				2022-12-26	WOS:000645260100042
J	Jon, K; Liu, J; Lv, XG; Zhu, WS				Jon, Kyongson; Liu, Jun; Lv, Xiaoguang; Zhu, Wensheng			Poisson noisy image restoration via overlapping group sparse and nonconvex second-order total variation priors	PLOS ONE			English	Article							ALTERNATING DIRECTION METHOD; LIKELIHOOD ESTIMATION; DECONVOLUTION; ALGORITHMS; RECONSTRUCTION; MULTIPLIERS; REMOVAL	The restoration of the Poisson noisy images is an essential task in many imaging applications due to the uncertainty of the number of discrete particles incident on the image sensor. In this paper, we consider utilizing a hybrid regularizer for Poisson noisy image restoration. The proposed regularizer, which combines the overlapping group sparse (OGS) total variation with the high-order nonconvex total variation, can alleviate the staircase artifacts while preserving the original sharp edges. We use the framework of the alternating direction method of multipliers to design an efficient minimization algorithm for the proposed model. Since the objective function is the sum of the non-quadratic log-likelihood and nonconvex nondifferentiable regularizer, we propose to solve the intractable subproblems by the majorization-minimization (MM) method and the iteratively reweighted least squares (IRLS) algorithm, respectively. Numerical experiments show the efficiency of the proposed method for Poissonian image restoration including denoising and deblurring.	[Jon, Kyongson; Liu, Jun; Zhu, Wensheng] Northeast Normal Univ, Sch Math & Stat, Key Lab Appl Stat MOE, Changchun, Peoples R China; [Jon, Kyongson] Kim Il Sung Univ, Fac Math, Pyongyang, North Korea; [Lv, Xiaoguang] Jiangsu Ocean Univ, Sch Sci, Lianyungang, Jiangsu, Peoples R China	Northeast Normal University - China; Jiangsu Ocean University	Zhu, WS (corresponding author), Northeast Normal Univ, Sch Math & Stat, Key Lab Appl Stat MOE, Changchun, Peoples R China.	wszhu@nenu.edu.cn	Jon, Kyongson/AAQ-4459-2021	Jon, Kyongson/0000-0002-1209-9808	National Natural Science Foundation of China [11771072, 61806024]; Science and Technology Development Plan of Jilin Province [20191008004TC, 20180520026JH]; Fundamental Research Funds for the Central Universities [2412020FZ023]; Nature Science Foundation of Jiangsu Province [BK20181483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Plan of Jilin Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work is supported in part by the National Natural Science Foundation of China (11771072, 61806024); the Science and Technology Development Plan of Jilin Province (20191008004TC, 20180520026JH); Fundamental Research Funds for the Central Universities (2412020FZ023); the Nature Science Foundation of Jiangsu Province (BK20181483).	Adam T, 2020, SIGNAL IMAGE VIDEO P, V14, P115, DOI 10.1007/s11760-019-01531-3; Adam T, 2019, MULTIDIM SYST SIGN P, V30, P503, DOI 10.1007/s11045-018-0567-3; Bardsley JM, 2003, SIAM J SCI COMPUT, V25, P1326, DOI 10.1137/S1064827502410451; Bardsley JM, 2008, INVERSE PROBL SCI EN, V16, P199, DOI 10.1080/17415970701404235; Bardsley JM, 2009, ADV COMPUT MATH, V31, P35, DOI 10.1007/s10444-008-9081-8; Benvenuto F, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/3/035016; Bertero M, 2008, CRM SER, V7, P37; Bonettini S, 2013, INT J COMPUT MATH, V90, P9, DOI 10.1080/00207160.2012.716513; Bonettini S, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/9/095001; Bonettini S, 2012, J MATH IMAGING VIS, V44, P236, DOI 10.1007/s10851-011-0324-9; CHAN T. F. C., 1978, TECHNICAL REPORT STA; Chang HB, 2018, SIAM J IMAGING SCI, V11, P24, DOI 10.1137/16M1103270; Chartrand R, 2008, INT CONF ACOUST SPEE, P3869, DOI 10.1109/ICASSP.2008.4518498; Chen K, 2013, INT J COMPUT MATH, V90, P1, DOI 10.1080/00207160.2012.757073; Chen PY, 2014, IEEE T SIGNAL PROCES, V62, P3464, DOI 10.1109/TSP.2014.2329274; Deng W, 2016, J SCI COMPUT, V66, P889, DOI 10.1007/s10915-015-0048-x; Ding M, 2019, APPL MATH COMPUT, V341, P128, DOI 10.1016/j.amc.2018.08.014; Fang HZ, 2013, J ELECTRON IMAGING, V22, DOI 10.1117/1.JEI.22.2.023033; Fang HZ, 2013, OPT LETT, V38, P389, DOI 10.1364/OL.38.000389; Figueiredo MAT, 2007, IEEE T IMAGE PROCESS, V16, P2980, DOI 10.1109/TIP.2007.909318; Figueiredo MAT, 2010, IEEE T IMAGE PROCESS, V19, P3133, DOI 10.1109/TIP.2010.2053941; Gong Pinghua, 2013, JMLR Workshop Conf Proc, V28, P37; HEBERT TJ, 1992, IEEE T SIGNAL PROCES, V40, P2290, DOI 10.1109/78.157228; James AP, 2014, INFORM FUSION, V19, P4, DOI 10.1016/j.inffus.2013.12.002; Jiang L, 2013, J MATH-UK, V2013, DOI 10.1155/2013/274573; Jiang L, 2015, NUMER ALGORITHMS, V69, P495, DOI 10.1007/s11075-014-9908-y; Kumar A, 2019, IEEE ACCESS, V7, P26200, DOI 10.1109/ACCESS.2019.2901691; Lai MJ, 2013, SIAM J NUMER ANAL, V51, P927, DOI 10.1137/110840364; Landi G, 2008, NUMER ALGORITHMS, V48, P279, DOI [10.1007/s11075-008-9198-3, 10.1007/S11075-008-9198-3]; Landi G, 2012, COMPUT MED IMAG GRAP, V36, P38, DOI 10.1016/j.compmedimag.2011.07.002; Landi G, 2012, NUMER ALGORITHMS, V60, P169, DOI 10.1007/s11075-011-9517-y; Lanteri H, 2002, INVERSE PROBL, V18, P1397, DOI 10.1088/0266-5611/18/5/313; Le T, 2007, J MATH IMAGING VIS, V27, P257, DOI 10.1007/s10851-007-0652-y; Levin A, 2009, PROC CVPR IEEE, P1964, DOI 10.1109/CVPRW.2009.5206815; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122562; Liu J, 2017, APPL MATH MODEL, V45, P516, DOI 10.1016/j.apm.2017.01.009; Liu J, 2016, NEUROCOMPUTING, V216, P502, DOI 10.1016/j.neucom.2016.07.049; Liu J, 2015, INFORM SCIENCES, V295, P232, DOI 10.1016/j.ins.2014.10.041; Liu XW, 2012, MATH METHOD APPL SCI, V35, P520, DOI 10.1002/mma.1588; Lu CY, 2018, IEEE T PATTERN ANAL, V40, P527, DOI 10.1109/TPAMI.2017.2689021; Lv XG, 2020, INT J COMPUT MATH, V97, P602, DOI 10.1080/00207160.2019.1581178; Lv XG, 2016, APPL MATH COMPUT, V289, P132, DOI 10.1016/j.amc.2016.03.029; Lyu Q, 2013, NEUROCOMPUTING, V119, P413, DOI 10.1016/j.neucom.2013.03.017; Ma LY, 2013, IEEE T MED IMAGING, V32, P1277, DOI 10.1109/TMI.2013.2255883; Sebastiani G, 1997, SIGNAL PROCESS, V56, P111, DOI 10.1016/S0165-1684(97)00002-9; Setzer S, 2010, J VIS COMMUN IMAGE R, V21, P193, DOI 10.1016/j.jvcir.2009.10.006; Shi Y, 2017, COMPUT ELECTR ENG, V62, P319, DOI 10.1016/j.compeleceng.2016.09.032; Tao SY, 2016, J VIS COMMUN IMAGE R, V38, P582, DOI 10.1016/j.jvcir.2016.04.005; VARDI Y, 1985, J AM STAT ASSOC, V80, P8, DOI 10.2307/2288030; Wang XD, 2013, APPL MATH COMPUT, V223, P264, DOI 10.1016/j.amc.2013.07.090; Wang Y, 2019, J SCI COMPUT, V78, P29, DOI 10.1007/s10915-018-0757-z; Wen YW, 2016, SCI CHINA MATH, V59, P141, DOI 10.1007/s11425-015-5079-0; Woo H, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19090482; Xiu XC, 2019, COMPUT STAT DATA AN, V136, P59, DOI 10.1016/j.csda.2019.01.002; Zhang HM, 2017, SIGNAL PROCESS, V137, P363, DOI 10.1016/j.sigpro.2017.01.025; Zhang JH, 2020, MULTIVAR BEHAV RES, V55, P161, DOI 10.1080/00273171.2019.1700773; Zhang ZR, 2015, SIGNAL PROCESS, V116, P127, DOI 10.1016/j.sigpro.2015.04.020; Zhou W, 2012, ABSTR APPL ANAL, P1, DOI 10.1155/2012/965281	59	0	0	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2021	16	4							e0250260	10.1371/journal.pone.0250260	http://dx.doi.org/10.1371/journal.pone.0250260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RQ1EM	33878121	gold, Green Published			2022-12-26	WOS:000642162200008
J	Burggraaff, O; Panchagnula, S; Snik, F				Burggraaff, Olivier; Panchagnula, Sanjana; Snik, Frans			Citizen science with colour blindness: A case study on the Forel-Ule scale	PLOS ONE			English	Article							PARTICIPATION; SCIENTISTS; PREVALENCE; APPEARANCE; DEFICIENCY; WATERS; URBAN	Many citizen science projects depend on colour vision. Examples include classification of soil or water types and biological monitoring. However, up to 1 in 11 participants are colour blind. We simulate the impact of various forms of colour blindness on measurements with the Forel-Ule scale, which is used to measure water colour by eye with a 21-colour scale. Colour blindness decreases the median discriminability between Forel-Ule colours by up to 33% and makes several colour pairs essentially indistinguishable. This reduces the precision and accuracy of citizen science data and the motivation of participants. These issues can be addressed by including uncertainty estimates in data entry forms and discussing colour blindness in training materials. These conclusions and recommendations apply to colour-based citizen science in general, including other classification and monitoring activities. Being inclusive of the colour blind increases both the social and scientific impact of citizen science.	[Burggraaff, Olivier; Panchagnula, Sanjana; Snik, Frans] Leiden Univ, Leiden Observ, Leiden, Netherlands; [Burggraaff, Olivier] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands; [Panchagnula, Sanjana] Leiden Univ, Leiden Observ, Lab Astrophys, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Burggraaff, O (corresponding author), Leiden Univ, Leiden Observ, Leiden, Netherlands.; Burggraaff, O (corresponding author), Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.	burggraaff@strw.leidenuniv.nl		Panchagnula, Sanjana/0000-0002-7583-1672; Burggraaff, Olivier/0000-0002-2487-4533	European Union [776480]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 776480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alender B, 2016, JCOM-J SCI COMMUN, V15; ALPERN M, 1983, J PHYSIOL-LONDON, V335, P655, DOI 10.1113/jphysiol.1983.sp014557; Asingizwe D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237396; Birch J, 2012, J OPT SOC AM A, V29, P313, DOI 10.1364/JOSAA.29.000313; Bone J, 2012, ENVIRON SCI TECHNOL, V46, P3687, DOI 10.1021/es203880p; Bremer S, 2019, ENVIRON SCI POLICY, V94, P245, DOI 10.1016/j.envsci.2018.12.029; Brettel H, 1997, J OPT SOC AM A, V14, P2647, DOI 10.1364/JOSAA.14.002647; Brewin RJW, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19040936; Brouwer S, 2019, PUBLIC UNDERST SCI, V28, P606, DOI 10.1177/0963662519840934; Budde Matthias, 2017, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V1, DOI 10.1145/3131900; Burggraaff O, 2019, OPT EXPRESS, V27, P19075, DOI 10.1364/OE.27.019075; Castilla EP, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4912-9; CHICKERING KD, 1969, J OPT SOC AM, V59, P986, DOI 10.1364/JOSA.59.000986; Crameri F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19160-7; Forel FA, 1890, ARCH SCI PHYS NATURE, V6; Gustafson A, 2020, PUBLIC UNDERST SCI, V29, P614, DOI 10.1177/0963662520942122; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Hashemi H, 2019, J CURR OPHTHALMOL, V31, P80, DOI 10.1016/j.joco.2017.05.005; HUNT RWG, 1991, COLOR RES APPL, V16, P146, DOI 10.1002/col.5080160306; Jimenez M, 2019, INFORM SCIENCES, V479, P301, DOI 10.1016/j.ins.2018.12.011; Jordan G, 2010, J VISION, V10, DOI 10.1167/10.8.12; Land-Zandstra AM, 2016, PUBLIC UNDERST SCI, V25, P45, DOI 10.1177/0963662515602406; Leeuw T, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010256; Lindbloom B., 2017, CHROMATIC ADAPTATION; MAHNY M, 1994, COLOR RES APPL, V19, P105; Marshall NJ, 2012, FRONT ECOL ENVIRON, V10, P332, DOI 10.1890/110266; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Nie YF, 2020, ESTUAR COAST SHELF S, V246, DOI 10.1016/j.ecss.2020.107032; Novoa S, 2014, J EUR OPT SOC-RAPID, V9, DOI 10.2971/jeos.2014.14025; Novoa S, 2013, J EUR OPT SOC-RAPID, V8, DOI 10.2971/jeos.2013.13057; Novoa S, 2015, LIMNOL OCEANOGR-METH, V13, P697, DOI 10.1002/lom3.10059; PENTAO L, 1992, AM J HUM GENET, V50, P690; Pitarch J, 2019, REMOTE SENS ENVIRON, V231, DOI 10.1016/j.rse.2019.111249; Rambonnet L, 2019, MAR POLLUT BULL, V145, P271, DOI 10.1016/j.marpolbul.2019.05.056; Schmitz J., 2020, COLOR BLINDNESS SIMU; Scott AB, 2017, SCI TOTAL ENVIRON, V592, P738, DOI 10.1016/j.scitotenv.2017.01.201; Sharma G, 2005, COLOR RES APPL, V30, P21, DOI 10.1002/col.20070; Sharma G, 2003, EL EN AP SI, P1; Ule W., 1892, KLEINERE MITTHEILUNG, V38, P70; VERRIEST G, 1963, J OPT SOC AM, V53, P185, DOI 10.1364/JOSA.53.000185; Vienot F, 1999, COLOR RES APPL, V24, P243, DOI 10.1002/(SICI)1520-6378(199908)24:4<243::AID-COL5>3.0.CO;2-3; Vohland K., 2017, SCI CITIZEN SCI, V1st; Wang SL, 2018, REMOTE SENS ENVIRON, V217, P444, DOI 10.1016/j.rse.2018.08.026; Wernand MR, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10014s; Wernand MR, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10015s; Wernand MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063766; Worthington JP, 2012, METHODS ECOL EVOL, V3, P303, DOI 10.1111/j.2041-210X.2011.00164.x	47	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0249755	10.1371/journal.pone.0249755	http://dx.doi.org/10.1371/journal.pone.0249755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP4TZ	33872327	Green Published, gold			2022-12-26	WOS:000641723300004
J	Ramatillah, DL; Isnaini, S				Ramatillah, Diana Laila; Isnaini, Suri			Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta	PLOS ONE			English	Article							CORONAVIRUS; INSIGHTS; SARS	Background Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a virus that causes COVID-19, which has become a worldwide pandemic. However, until now, there is no vaccine or specific drug to prevent or treat COVID-19. Objectives To find out the effective treatment as an antiviral agent for COVID-19, to determine the correlation between sociodemography with clinical outcomes and duration of treatment, and to determine the relationship between comorbidities with clinical outcomes and duration of treatment for COVID-19 patients. Methods A prospective cohort study was conducted in this study. This study included only confirmed COVID-19 patients who were admitted to the hospital during April-May 2020. Convenience sampling was used to select 103 patients, but only 72 patients were suitable for inclusion. Results The survival analysis for COVID-19 patients using the Kaplan Meier method showed that patients receiving Oseltamivir + Hydroxychloroquine had an average survival rate of about 83% after undergoing treatment of about ten days. Gender (p = 0.450) and age (p = 0.226) did not have a significant correlation with the duration of treatment for COVID-19 patients. Gender (p = 0.174) and age (p = 0.065) also did not have a significant correlation with clinical outcome of COVID-19 patients. Comorbidities showed a significant correlation with duration of treatment (p = 0.002) and clinical outcome (p = 0.014) of COVID-19 patients. Conclusion The most effective antiviral agent in this study based on treatment duration was the combination of Oseltamivir + Hydroxychloroquine. The higher the patient's average treatment duration is, the lower the average survival rate for COVID-19 patients.	[Ramatillah, Diana Laila; Isnaini, Suri] Univ 17 Agustus 1945, Fac Pharm, Jakarta, Indonesia		Ramatillah, DL (corresponding author), Univ 17 Agustus 1945, Fac Pharm, Jakarta, Indonesia.	diana.ramatillah@uta45jakarta.ac.id	Ramatillah, Diana Laila/J-4240-2019	Ramatillah, Diana Laila/0000-0002-3921-3455				Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896; Chen C, 2020, MEDRXIV, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]; ClinicalTrials.gov Bethesda (MD): National Library of Medicine (US)., 2020, ID NCT04303299 VARIO; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Deng GT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02902-w; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Drozdzal S, 2020, DRUG RESIST UPDATE, V53, DOI 10.1016/j.drup.2020.100719; Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027; Global Health 5050, 2020, MEN SEX GEND COVID 1; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Indonesian COVID-19 Handling Task Force, 2020, DISTRIBUTION MAP; Jaillon S, 2019, CLIN REV ALLERG IMMU, V56, P308, DOI 10.1007/s12016-017-8648-x; Kim Y, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005531, 10.1371/journal.ppat.1005650]; Lelapi N, 2020, BIOMARK MED; Lippi G, 2020, J MED VIROL, V92, P1759, DOI 10.1002/jmv.25860; Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020; Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286; Thai PQ, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001259; Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015; Salinas-Escudero G, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09721-2; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9; Smee DF., 2020, ANTIMICROB AGENTS CH; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Rosa SGV, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.40; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang z., 2020, MEDRXIV, DOI [10.1101/2020.04.07.20057299, DOI 10.1101/2020.04.07.20057299]; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wu Renyi, 2020, Curr Pharmacol Rep, V6, P56, DOI 10.1007/s40495-020-00216-7; Zhang, 2020, EFFICACY HYDROXYCHLO, P7, DOI [10.1101/.20040758, 10.1101/2020.03.22.20040758, DOI 10.1101/2020.03.22.20040758]; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	38	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250147	10.1371/journal.pone.0250147	http://dx.doi.org/10.1371/journal.pone.0250147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861777	Green Published, Green Submitted, gold			2022-12-26	WOS:000641475400035
J	Nishitsuka, K; Sugano, A; Matsushita, T; Nishi, K; Yamashita, H				Nishitsuka, Koichi; Sugano, Akira; Matsushita, Takayuki; Nishi, Katsuhiro; Yamashita, Hidetoshi			Surgical outcomes after primary Baerveldt glaucoma implant surgery with vitrectomy for neovascular glaucoma	PLOS ONE			English	Article							AHMED GLAUCOMA; INTRAVITREAL BEVACIZUMAB; PRACTICE PREFERENCES; VALVE IMPLANTATION; ENDOTHELIAL-CELLS; TUBE; SOCIETY	This study aimed to evaluate the 3-year long-term outcomes of primary Baerveldt glaucoma implant (BGI) surgery for neovascular glaucoma (NVG). We retrospectively evaluated 27 consecutive patients with NVG between November 2013 and November 2017. All the patients were treated with panretinal photocoagulation and pars plana vitrectomy before BGI surgery without anti-vascular endothelial growth factor treatment. The surgical success of the BGI was defined as an IOP of <22 mmHg and <5 mmHg with or without antiglaucoma medication. The outcomes were assessed on the basis of intraocular pressure (IOP), visual acuity, postoperative complications, and cumulative success rate. Except for 2 mortality cases, 25 eyes (92.6%) were followed up for 3 years. The mean IOPs (mmHg)/numbers of glaucoma medications +/- standard error of the mean before and 12 and 36 months after BGI surgery were 41.6/4.6 +/- 1.9/0.2, 14.8/2.2 +/- 0.8/0.4 and 16.9/2.6 +/- 1.1/0.3, respectively. In all of the follow-up time points, the postoperative mean IOP and number of glaucoma medications were statistically significantly lower than the preoperative values (analysis of variance, P < 0.001). At 3 years after surgery, the rates of visual acuity improvement (logMAR <= -0.3), invariance (-0.3 < logMAR < 0.3), and worsening (logMAR >= 0.3) were 56.0% (14/25 eyes), 24.0% (6/25 eyes), and 20.0% (5/25 eyes), respectively. The most common postoperative complications were hyphema (4 eyes, 14.8%) and vitreous hemorrhage (5 eyes, 18.5%), and serious complications such as expulsive hemorrhage, endophthalmitis, and tube/plate exposure did not occur. The cumulative probabilities of surgical success after the operation were 100% at 1 year, 85.2% at 2 years, and 77.4% at 3 years. In conclusion, combined non-valved pars plana tube placement in conjunction with vitrectomy was successful at lowering IOP with relatively low complication rates.	[Nishitsuka, Koichi; Sugano, Akira; Matsushita, Takayuki; Nishi, Katsuhiro; Yamashita, Hidetoshi] Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata, Japan	Yamagata University	Sugano, A (corresponding author), Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata, Japan.	mlc12186@nifty.com	Nishi, Katsuhiro/HHC-9480-2022	Nishi, Katsuhiro/0000-0002-5596-8962; Nishitsuka, Koichi/0000-0003-2394-9561	JSPS KAKENHI [JP25462704, JP20K18373]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP25462704, JP20K18373.	Arora KS, 2015, OPHTHALMOLOGY, V122, P1615, DOI 10.1016/j.ophtha.2015.04.015; Chen PP, 1997, J GLAUCOMA, V6, P192; Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI [10.3928/15428877-20110224-94, 10.3928/15428877-20110224-04]; Dong ZX, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009897; Gedde SJ, 2020, OPHTHALMOLOGY, V127, P333, DOI 10.1016/j.ophtha.2019.10.002; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Gedde SJ, 2009, AM J OPHTHALMOL, V148, P670, DOI 10.1016/j.ajo.2009.06.018; Higashide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135766; Iwasaki K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201342; Joshi AB, 2005, J GLAUCOMA, V14, P172, DOI 10.1097/01.ijg.0000151684.12033.4d; Kobayashi S, 2016, J GLAUCOMA, V25, P281, DOI 10.1097/IJG.0000000000000211; Kolomeyer AM, 2015, RETINA-J RET VIT DIS, V35, P17, DOI 10.1097/IAE.0000000000000235; Koo EB, 2015, CORNEA, V34, P37, DOI 10.1097/ICO.0000000000000301; Netland PA, 2010, J GLAUCOMA, V19, P581, DOI 10.1097/IJG.0b013e3181ca7f7f; Noor NA, 2017, CLIN OPHTHALMOL, V11, P1417, DOI 10.2147/OPTH.S137470; Park UC, 2011, J GLAUCOMA, V20, P433, DOI 10.1097/IJG.0b013e3181f3eb06; Saheb H, 2014, AM J OPHTHALMOL, V157, P1179, DOI 10.1016/j.ajo.2014.02.027; Tojo Naoki, 2017, Nippon Ganka Gakkai Zasshi, V121, P138; Vinod K, 2017, J GLAUCOMA, V26, P687, DOI 10.1097/IJG.0000000000000720; Yang HF, 2018, TAIWAN J OPHTHALMOL, V8, P60, DOI 10.4103/tjo.tjo_39_18; Zhang Q, 2021, OPHTHALMOLOGY, V128, P218, DOI 10.1016/j.ophtha.2020.06.050; Zhou MW, 2016, J GLAUCOMA, V25, P551, DOI 10.1097/IJG.0000000000000241	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249898	10.1371/journal.pone.0249898	http://dx.doi.org/10.1371/journal.pone.0249898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857167	gold, Green Published			2022-12-26	WOS:000641474900028
J	Park, D; Han, JC; Lee, EJ; Kee, C				Park, Do Young; Han, Jong Chul; Lee, Eun Jung; Kee, Changwon			Relationship between peripheral vasospasm and visual field progression rates in patients with normal-tension glaucoma with low-teen intraocular pressure	PLOS ONE			English	Article							OCULAR PERFUSION-PRESSURE; BLOOD-FLOW; RISK-FACTORS; PATHOGENESIS; VARIABILITY; VELOCITY	Purpose To investigate the association between peripheral vasospasm and the visual field (VF) progression rate in patients with normal-tension glaucoma (NTG) with low-teen intraocular pressure (IOP). Methods The finger temperature of 113 NTG patients was measured before and after exposure to ice water using a Temperature gun (cold pressor test). These patients had confirmed VF progression, despite a low-teen IOP during a follow-up period of >5 years. VF progression rates were calculated as the slope of the visual field index (VFI) and mean deviation (MD) over time. Demographic, systemic, and ocular factors and VF progression rates were compared, based on the cold pressor test results. A regression analysis was used to investigate the factors affecting VF progression rates. Results Mean age, initial IOP, mean IOP during the follow-up period, and initial VF MD were 57.1 years, 15.8 mmHg, 12.0 mmHg, and -5.2 dB, respectively. When patients were divided into two groups (less vasospasm and more vasospasm) according to changes in temperature after exposure to ice water, the VF progression rate was significantly faster in the group with more vasospasm. In a multiple regression analysis, older age, worse initial VF MD, and greater decrease in finger temperature after ice water exposure were significantly associated with faster VF progression rates. Conclusion An excessive drop in finger temperature after exposure to ice water was significantly associated with faster VF progression in patients with low-teen NTG. This suggests that the blood flow in the optic nerve head may also be disturbed by peripheral vasospasm, accelerating glaucomatous damage regardless of IOP.	[Park, Do Young] Yeungnam Univ, Yeungnam Univ Hosp, Dept Ophthalmol, Coll Med, Daegu, South Korea; [Han, Jong Chul; Lee, Eun Jung; Kee, Changwon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea	Yeungnam University; Yeungnam University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Kee, C (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea.	ckee@skku.edu		Park, Do Young/0000-0001-6089-6898; Kee, Changwon/0000-0002-7419-0316	Basic Science Research Program [2019R1F1A1062796, 2019M3E5D1A02068088]; National Research Foundation of Korea - Ministry of Science, ICT and Future Planning	Basic Science Research Program; National Research Foundation of Korea - Ministry of Science, ICT and Future Planning	This work was supported by the Basic Science Research Program (2019R1F1A1062796 and 2019M3E5D1A02068088) through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Baek SU, 2020, BRIT J OPHTHALMOL, V104, P81, DOI 10.1136/bjophthalmol-2018-313375; Binggeli T, 2018, EPMA J, V9, P387, DOI 10.1007/s13167-018-0155-5; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Charlson ME, 2014, OPHTHALMOLOGY, V121, P2004, DOI 10.1016/j.ophtha.2014.04.016; Chauhan BC, 2008, ARCH OPHTHALMOL-CHIC, V126, P1030, DOI 10.1001/archopht.126.8.1030; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Fan N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/308505; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Flammer J, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-14; GASSER P, 1991, AM J OPHTHALMOL, V111, P585, DOI 10.1016/S0002-9394(14)73703-1; Grieshaber Matthias C, 2005, Curr Opin Ophthalmol, V16, P79, DOI 10.1097/01.icu.0000156134.38495.0b; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2013, ACTA OPHTHALMOL, V91, P406, DOI 10.1111/j.1755-3768.2012.02492.x; Ishii T, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1653-y; Killer HE, 2018, EYE, V32, P924, DOI 10.1038/s41433-018-0042-2; Lee EJ, 2017, PROG RETIN EYE RES, V60, P20, DOI 10.1016/j.preteyeres.2017.08.002; Lee J, 2015, AM J OPHTHALMOL, V160, P522, DOI 10.1016/j.ajo.2015.05.034; Lee NY, 2013, CURR EYE RES, V38, P516, DOI 10.3109/02713683.2012.745881; Lindemann F, 2018, CURR EYE RES, V43, P1507, DOI 10.1080/02713683.2018.1506036; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Melsens K, 2020, SEMIN ARTHRITIS RHEU, V50, P321, DOI 10.1016/j.semarthrit.2019.08.007; Mizeva I, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.7.070501; Mozaffarieh M, 2008, MOL VIS, V14, P224; Nakazawa T, 2016, ASIA-PAC J OPHTHALMO, V5, P38, DOI 10.1097/APO.0000000000000183; Nicolela MT, 2003, INVEST OPHTH VIS SCI, V44, P2565, DOI 10.1167/iovs.02-0913; O'Brien C, 1999, OPHTHALMOLOGICA, V213, P150, DOI 10.1159/000027410; Park DY, 2018, J GLAUCOMA, V27, P610, DOI 10.1097/IJG.0000000000000970; Park HYL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014658; Philip S, 2019, JAMA OPHTHALMOL, V137, P618, DOI 10.1001/jamaophthalmol.2019.0434; Prata TS, 2010, OPHTHALMOLOGY, V117, P24, DOI 10.1016/j.ophtha.2009.06.028; Raman P, 2018, EYE, V32, P1183, DOI 10.1038/s41433-018-0057-8; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Stefanczyk Ludomir, 2007, Med Sci Monit, V13 Suppl 1, P121; Vosborg F, 2020, EUR J OPHTHALMOL, V30, P235, DOI 10.1177/1120672119858891	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250085	10.1371/journal.pone.0250085	http://dx.doi.org/10.1371/journal.pone.0250085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857246	Green Published, gold			2022-12-26	WOS:000641474900011
J	Castro, KJS; Salomao, RC; Feitosa, NQ; Henriques, LD; Kleiner, AFR; Belgamo, A; Cabral, AS; Silva, AACE; Callegari, B; Souza, GS				Santana Castro, Ketlin Jaquelline; Salomao, Railson Cruz; Feitosa Jr, Newton Quintino; Henriques, Leonardo Dutra; Rozin Kleiner, Ana Francisca; Belgamo, Anderson; Cabral, Andre Santos; Costa e Silva, Anselmo Athayde; Callegari, Bianca; Souza, Givago Silva			Changes in plantar load distribution in legally blind subjects	PLOS ONE			English	Article							POSTURAL CONTROL; PERIPHERAL-VISION; BALANCE; INDIVIDUALS; ORIENTATION; STABILITY; MUSCLE; CUES	We investigated the impact of visual impairment on balance control. We measured the center of pressure (COP) between the two feet and plantar surface pressures on each foot in 18 normal-sighted participants and compared their data with measures from 18 legally blind participants, either acquired or congenital. Pressures were measured in open- and closed-eye conditions using a baropodometric resistive plate. In the eyes-open condition, there were no differences between the sighted and legally blind groups in COP displacement. However, participants with visual loss had significantly increased pressures in two metatarsal regions (M1 and M2 zones) of the plantar surface in both viewing conditions (p < 0.05). The differences in pressure measures between the normally sighted and legally blind groups could be attributed mainly to the subgroup of subjects with acquired impairment. Our findings suggest that subjects with visual impairment present increased metatarsal pressures (i.e. forefoot), not yet associated to anterior displacement of COP or impaired balance control.	[Santana Castro, Ketlin Jaquelline; Souza, Givago Silva] Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil; [Salomao, Railson Cruz; Feitosa Jr, Newton Quintino; Souza, Givago Silva] Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil; [Henriques, Leonardo Dutra] Univ Sao Paulo, Inst Psicol, Sao Paulo, Brazil; [Rozin Kleiner, Ana Francisca] Univ Fed Sao Carlos, Dept Fisioterapia, Sao Carlos, Brazil; [Belgamo, Anderson] Inst Fed Sao Paulo, Piracicaba, Brazil; [Cabral, Andre Santos] Univ Estado Para, Ctr Ciencias Biol & Saude, Belem, Para, Brazil; [Costa e Silva, Anselmo Athayde; Callegari, Bianca] Fed Univ Para, Masters Program Human Movement Sci, Belem, Para, Brazil; [Callegari, Bianca] Fed Univ Para, Lab Human Motric Sci, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Instituto Federal de Sao Paulo (IFSP); Universidade do Estado do Para (UEPA); Universidade Federal do Para; Universidade Federal do Para	Souza, GS (corresponding author), Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil.; Souza, GS (corresponding author), Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil.	givagosouza@ufpa.br	Henriques, Leonardo D/D-6469-2014; Souza, Givago/H-9977-2017; Kleiner, Ana/C-3748-2015	Henriques, Leonardo D/0000-0003-4095-2025; Souza, Givago/0000-0002-4525-3971; Kleiner, Ana/0000-0003-1843-2787	APESPA [2019/589349]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [431748/2016-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [310845/2018-1]	APESPA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by: APESPA, 2019/589349, Mr Anselmo Athayde Costa e Silva Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR), 431748/2016-0, Mr Givago Silva Souza Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, 310845/2018-1, Mr Givago Silva Souza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Faraj ZO, 2013, I IEEE EMBS C NEUR E, P1549, DOI 10.1109/NER.2013.6696242; Ajina S, 2017, NEUROSCIENTIST, V23, P529, DOI 10.1177/1073858416673817; Alghadir AH, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1436; Anand V, 2003, INVEST OPHTH VIS SCI, V44, P2885, DOI 10.1167/iovs.02-1031; Aydog E, 2006, INT J SPORTS MED, V27, P415, DOI 10.1055/s-2005-865777; Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; Bellizzi M, 2011, STRABISMUS, V19, P21, DOI 10.3109/09273972.2010.545469; Caldani S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00830; Sanchez-Gonzalez MC, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6834591; D'Antonio E, 2020, HUM MOVEMENT SCI, V70, DOI 10.1016/j.humov.2020.102569; Easton RD, 1998, EXP BRAIN RES, V118, P541, DOI 10.1007/s002210050310; Giagazoglou P, 2009, EUR J APPL PHYSIOL, V107, P571, DOI 10.1007/s00421-009-1163-x; Habak C, 2002, VISION RES, V42, P2843, DOI 10.1016/S0042-6989(02)00355-3; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Jeka JJ, 1996, PERCEPT PSYCHOPHYS, V58, P409, DOI 10.3758/BF03206817; Jung J.-Y., 2017, INT J BIOL BIOMED EN, V11, P187; Juodzbaliene Vilma, 2006, Medicina (Kaunas), V42, P49; Kinoshita M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08058-0; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Maurer C, 2000, NEUROSCI LETT, V281, P99, DOI 10.1016/S0304-3940(00)00814-4; McCollum G, 1996, J THEOR BIOL, V180, P257, DOI 10.1006/jtbi.1996.0101; Melzer L, 2011, CLIN BIOMECH, V26, P358, DOI 10.1016/j.clinbiomech.2010.11.008; Nakata H, 2001, GAIT POSTURE, V14, P36, DOI 10.1016/S0966-6362(00)00100-4; Nougier V, 1997, GAIT POSTURE, V5, P34, DOI 10.1016/S0966-6362(96)01071-5; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Ozdemir RA, 2013, GAIT POSTURE, V38, P603, DOI 10.1016/j.gaitpost.2013.02.003; Parreira RB, 2017, GAIT POSTURE, V57, P161, DOI 10.1016/j.gaitpost.2017.06.008; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; Razak AHA, 2012, SENSORS-BASEL, V12, P9884, DOI 10.3390/s120709884; Rougier P, 2000, BRAIN RES, V871, P165, DOI 10.1016/S0006-8993(00)02357-X; Schieppati M, 1999, J NEUROL NEUROSUR PS, V66, P313, DOI 10.1136/jnnp.66.3.313; Schwesig R, 2011, EUR J OPHTHALMOL, V21, P303, DOI 10.5301/EJO.2010.5504; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; STRAUBE A, 1994, EXP BRAIN RES, V99, P501; Tinetti ME, 2000, ANN INTERN MED, V132, P337, DOI 10.7326/0003-4819-132-5-200003070-00002; Varela DG, 2012, BRAZ J OTORHINOLAR, V78, P7, DOI 10.1590/S1808-86942012000300002; Wiszomirska I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/136969; YANG JF, 1991, EXP BRAIN RES, V87, P679	42	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249467	10.1371/journal.pone.0249467	http://dx.doi.org/10.1371/journal.pone.0249467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857169	gold, Green Published			2022-12-26	WOS:000641474900048
J	Fischer, CB; Adrien, N; Silguero, JJ; Hopper, JJ; Chowdhury, AI; Werler, MM				Fischer, Charlie B.; Adrien, Nedghie; Silguero, Jeremiah J.; Hopper, Julianne J.; Chowdhury, Abir, I; Werler, Martha M.			Mask adherence and rate of COVID-19 across the United States	PLOS ONE			English	Article								Mask wearing has been advocated by public health officials as a way to reduce the spread of COVID-19. In the United States, policies on mask wearing have varied from state to state over the course of the pandemic. Even as more and more states encourage or even mandate mask wearing, many citizens still resist the notion. Our research examines mask wearing policy and adherence in association with COVID-19 case rates. We used state-level data on mask wearing policy for the general public and on proportion of residents who stated they always wear masks in public. For all 50 states and the District of Columbia (DC), these data were abstracted by month for April September 2020 to measure their impact on COVID-19 rates in the subsequent month (May October 2020). Monthly COVID-19 case rates (number of cases per capita over two weeks) >200 per 100,000 residents were considered high. Fourteen of the 15 states with no mask wearing policy for the general public through September reported a high COVID-19 rate. Of the 8 states with at least 75% mask adherence, none reported a high COVID-19 rate. States with the lowest levels of mask adherence were most likely to have high COVID-19 rates in the subsequent month, independent of mask policy or demographic factors. Mean COVID-19 rates for states with at least 75% mask adherence in the preceding month was 109.26 per 100,000 compared to 249.99 per 100,000 for those with less adherence. Our analysis suggests high adherence to mask wearing could be a key factor in reducing the spread of COVID-19. This association between high mask adherence and reduced COVID-19 rates should influence policy makers and public health officials to focus on ways to improve mask adherence across the population in order to mitigate the spread of COVID-19.	[Fischer, Charlie B.; Adrien, Nedghie; Silguero, Jeremiah J.; Hopper, Julianne J.; Chowdhury, Abir, I; Werler, Martha M.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	Boston University	Werler, MM (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA.	werler@bu.edu		Adrien, Nedghie/0000-0003-1565-5352				Al-Hasan A, 2020, J MED INTERNET RES, V22, DOI 10.2196/20634; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Centers for Disease Control and Prevention, COVID 19 PEOPL INCR; Centers for Disease Control and Prevention, SCI BRIEF COMM US CL; Centers for Disease Control and Prevention, US COVID 19 CAS DEAT; Chia T, 2020, Ethics Med Public Health, V14, P100511, DOI 10.1016/j.jemep.2020.100511; Havey NF, 2020, J COMPUT SOC SCI, V3, P319, DOI 10.1007/s42001-020-00089-2; Hubbard K., 2020, US NEWS WORLD REP; Insler M., 2020, COVID EC, V43, P42; Jefferson T, MASKING LACK EVIDENC; Kasting ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241662; Kreuter F, 2020, SURV RES METHODS-GER, V14, P159, DOI 10.18148/srm/2020.v14i2.7761; Lerner AM, 2020, JAMA-J AM MED ASSOC, V324, P1935, DOI 10.1001/jama.2020.21946; Leung CC, 2020, INT J TUBERC LUNG D, V24, P556, DOI 10.5588/ijtld.20.0244; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Rader B, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa076; Raifman J., 2021, COVID 19 US STATE PO, DOI DOI 10.3886/E119446V143; USDA Economic Research Service, 2020, POPULATION ESTIMATES	18	34	34	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249891	10.1371/journal.pone.0249891	http://dx.doi.org/10.1371/journal.pone.0249891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852626	gold, Green Submitted, Green Published			2022-12-26	WOS:000640604500039
J	Kapila, R; Kashyap, M; Poddar, S; Gangwal, S; Prasad, NGG				Kapila, Rohit; Kashyap, Mayank; Poddar, Soumyadip; Gangwal, Shreya; Prasad, N. G. G.			Evolution of pathogen-specific improved survivorship post-infection in populations of Drosophila melanogaster adapted to larval crowding	PLOS ONE			English	Article							DEPENDENT NATURAL-SELECTION; LIFE-HISTORY; COMPETITIVE ABILITY; IMMUNE-RESPONSES; GROWTH-RATE; STRESS; UREA; ADAPTATION; SENESCENCE; RESISTANCE	The environment experienced by individuals during their juvenile stages has an impact on their adult stages. In holometabolous insects like Drosophila melanogaster, most of the resource acquisition for adult stages happens during the larval stages. Larval-crowding is a stressful environment, which exposes the larvae to scarcity of food and accumulation of toxic waste. Since adult traits are contingent upon larval stages, in larval-crowding like conditions, adult traits are prone to get affected. While the effect of resource limited, poor-developmental environment on adult immune response has been widely studied, the effect of adaptation to resource-limited developmental environment has not been studied, therefore in this study we assayed the evolution of ability to survive infection in adult stages as a correlated response to adaptation to larval crowding environments. Using four populations of Drosophila melanogaster adapted to larval crowding for 240 generations and their respective control populations, we show that populations adapted to larval crowding show an improved and evolved post-infection survivorship against a gram-negative bacteria Pseudomonas entomophila. Whereas, against a gram-positive bacteria Enterococcus faecalis, no difference in post-infection survivorship was observed across control and selected populations. In this study, we report the co-related evolution of pathogen-specific increased survivorship post-infection in populations of Drosophila melanogaster as a result of adaptation to larval crowding environment.	[Kapila, Rohit; Kashyap, Mayank; Poddar, Soumyadip; Gangwal, Shreya; Prasad, N. G. G.] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Mohali, India	Indian Institute of Science Education & Research (IISER) - Mohali	Prasad, NGG (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Mohali, India.	prasad@iisermohali.ac.in	Kapila, Rohit/ABG-7911-2021	Kapila, Rohit/0000-0003-0263-5598				ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; BIERBAUM TJ, 1989, EVOLUTION, V43, P382, DOI 10.1111/j.1558-5646.1989.tb04234.x; Borash DJ, 2000, J EVOLUTION BIOL, V13, P181, DOI 10.1046/j.1420-9101.2000.00167.x; Borash DJ, 2001, J INSECT PHYSIOL, V47, P1349, DOI 10.1016/S0022-1910(01)00108-1; Borash DJ, 1998, AM NAT, V151, P148, DOI 10.1086/286108; BOTELLA LM, 1985, J INSECT PHYSIOL, V31, P179, DOI 10.1016/0022-1910(85)90118-0; Brzek P, 2007, J EXP BIOL, V210, P2361, DOI 10.1242/jeb.003517; Campero M, 2008, J ANIM ECOL, V77, P66, DOI 10.1111/j.1365-2656.2007.01308.x; Chapman JR, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020234; Chin EH, 2005, J AVIAN BIOL, V36, P549, DOI 10.1111/j.0908-8857.2005.03496.x; De Block M, 2008, ECOL ENTOMOL, V33, P796, DOI 10.1111/j.1365-2311.2008.01024.x; Dios S, 2010, FISH SHELLFISH IMMUN, V29, P1019, DOI 10.1016/j.fsi.2010.08.006; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Joshi A, 1996, HEREDITY, V77, P33, DOI 10.1038/hdy.1996.105; Joshi A, 1998, J BIOSCIENCE, V23, P279, DOI 10.1007/BF02720030; Khan I, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0125; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Moore SE, 2004, AM J CLIN NUTR, V80, P453, DOI 10.1093/ajcn/80.2.453; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107; Moret Y, 2009, OIKOS, V118, P371, DOI 10.1111/j.1600-0706.2008.17187.x; Mueller LD, 1997, ANNU REV ECOL SYST, V28, P269, DOI 10.1146/annurev.ecolsys.28.1.269; Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x; Nagarajan A, 2016, J GENET, V95, P411, DOI 10.1007/s12041-016-0655-9; Okech BA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-50; Owens IPF, 1999, TRENDS ECOL EVOL, V14, P170, DOI 10.1016/S0169-5347(98)01580-8; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Prasad NG, 2003, J GENET, V82, P45, DOI 10.1007/BF02715881; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Rolff J, 2004, AM NAT, V164, P559, DOI 10.1086/423715; Roper C, 1996, J EVOLUTION BIOL, V9, P609, DOI 10.1046/j.1420-9101.1996.9050609.x; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Santos M, 1997, EVOLUTION, V51, P420, DOI 10.2307/2411114; Sarangi M, 2016, J GENET, V95, P491, DOI 10.1007/s12041-016-0656-8; Schwenke RA, 2016, ANNU REV ENTOMOL, V61, P239, DOI 10.1146/annurev-ento-010715-023924; Shenoi VN, 2016, J EVOLUTION BIOL, V29, P407, DOI 10.1111/jeb.12795; Shenoi VN, 2016, ANIM BEHAV, V120, P183, DOI 10.1016/j.anbehav.2016.08.004; Silverman N, 2009, ISJ-INVERT SURVIV J, V6, P163; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250055	10.1371/journal.pone.0250055	http://dx.doi.org/10.1371/journal.pone.0250055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852596	gold, Green Published			2022-12-26	WOS:000640604500077
J	Wan, KS; Tok, PSK; Ratnam, KKY; Aziz, N; Isahak, M; Zaki, RA; Farid, NDN; Hairi, NN; Rampal, S; Ng, CW; Samsudin, MF; Venugopal, V; Asyraf, M; Damanhuri, NH; Doraimuthu, S; Arumugam, CT; Marthammuthu, T; Nawawi, FA; Baharudin, F; Chong, DWQ; Jayaraj, VJ; Magarita, V; Ponnampalavanar, S; Hasnan, N; Kamarulzaman, A; Said, MA				Wan, Kim Sui; Tok, Peter Seah Keng; Ratnam, Kishwen Kanna Yoga; Aziz, Nuraini; Isahak, Marzuki; Zaki, Rafdzah Ahmad; Farid, Nik Daliana Nik; Hairi, Noran Naqiah; Rampal, Sanjay; Ng, Chiu-Wan; Samsudin, Mohd Fauzy; Venugopal, Vinura; Asyraf, Mohammad; Damanhuri, Narisa Hatun; Doraimuthu, Sanpagavalli; Arumugam, Catherine Thamarai; Marthammuthu, Thaneswaran; Nawawi, Fathhullah Azmie; Baharudin, Faiz; Chong, Diane Woei Quan; Jayaraj, Vivek Jason; Magarita, Venna; Ponnampalavanar, Sasheela; Hasnan, Nazirah; Kamarulzaman, Adeeba; Said, Mas Ayu			Implementation of a COVID-19 surveillance programme for healthcare workers in a teaching hospital in an upper-middle-income country	PLOS ONE			English	Article							SARS	Introduction The reporting of Coronavirus Disease 19 (COVID-19) mortality among healthcare workers highlights their vulnerability in managing the COVID-19 pandemic. Some low- and middle-income countries have highlighted the challenges with COVID-19 testing, such as inadequate capacity, untrained laboratory personnel, and inadequate funding. This article describes the components and implementation of a healthcare worker surveillance programme in a designated COVID-19 teaching hospital in Malaysia. In addition, the distribution and characteristics of healthcare workers placed under surveillance are described. Material and methods A COVID-19 healthcare worker surveillance programme was implemented in University Malaya Medical Centre. The programme involved four teams: contact tracing, risk assessment, surveillance and outbreak investigation. Daily symptom surveillance was conducted over fourteen days for healthcare workers who were assessed to have low-, moderate- and high-risk of contracting COVID-19. A cross-sectional analysis was conducted for data collected over 24 weeks, from the 6(th) of March 2020 to the 20(th) of August 2020. Results A total of 1,174 healthcare workers were placed under surveillance. The majority were females (71.6%), aged between 25 and 34 years old (64.7%), were nursing staff (46.9%) and had no comorbidities (88.8%). A total of 70.9% were categorised as low-risk, 25.7% were moderate-risk, and 3.4% were at high risk of contracting COVID-19. One-third (35.2%) were symptomatic, with the sore throat (23.6%), cough (19.8%) and fever (5.0%) being the most commonly reported symptoms. A total of 17 healthcare workers tested positive for COVID-19, with a prevalence of 0.3% among all the healthcare workers. Risk category and presence of symptoms were associated with a positive COVID-19 test (p<0.001). Fever (p<0.001), cough (p = 0.003), shortness of breath (p = 0.015) and sore throat (p = 0.002) were associated with case positivity. Conclusion COVID-19 symptom surveillance and risk-based assessment have merits to be included in a healthcare worker surveillance programme to safeguard the health of the workforce.	[Wan, Kim Sui; Tok, Peter Seah Keng; Ratnam, Kishwen Kanna Yoga; Aziz, Nuraini; Isahak, Marzuki; Zaki, Rafdzah Ahmad; Farid, Nik Daliana Nik; Hairi, Noran Naqiah; Rampal, Sanjay; Ng, Chiu-Wan; Samsudin, Mohd Fauzy; Venugopal, Vinura; Asyraf, Mohammad; Damanhuri, Narisa Hatun; Doraimuthu, Sanpagavalli; Arumugam, Catherine Thamarai; Marthammuthu, Thaneswaran; Nawawi, Fathhullah Azmie; Baharudin, Faiz; Chong, Diane Woei Quan; Jayaraj, Vivek Jason; Said, Mas Ayu] Univ Malaya, Fac Med, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Wan, Kim Sui; Tok, Peter Seah Keng; Ratnam, Kishwen Kanna Yoga; Aziz, Nuraini; Samsudin, Mohd Fauzy; Venugopal, Vinura; Asyraf, Mohammad; Damanhuri, Narisa Hatun; Doraimuthu, Sanpagavalli; Arumugam, Catherine Thamarai; Marthammuthu, Thaneswaran; Nawawi, Fathhullah Azmie; Chong, Diane Woei Quan; Jayaraj, Vivek Jason] Minist Hlth Malaysia, Putrajaya, Malaysia; [Baharudin, Faiz; Magarita, Venna; Ponnampalavanar, Sasheela; Hasnan, Nazirah; Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Ponnampalavanar, Sasheela; Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Hasnan, Nazirah] Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Universiti Malaya; Universiti Malaya; Universiti Malaya	Said, MA (corresponding author), Univ Malaya, Fac Med, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	mas@ummc.edu.my	Daliana, Nik/I-6196-2015; Hoe, VICTOR CW/B-5190-2010; vanar, sasheela/AGU-5973-2022; Ayu, Mas/AAK-6870-2020; Rampal, Sanjay/B-9691-2010; Wan, Kim Sui/ABC-1576-2021; HAIRI, NORAN/B-9339-2010; ISAHAK, MARZUKI/B-8955-2010; Tok, Peter Seah Keng/ABE-6489-2021; ZAKI, RAFDZAH AHMAD/B-9520-2010; NG, CHIU WAN/B-5218-2010	Daliana, Nik/0000-0001-5303-558X; Hoe, VICTOR CW/0000-0002-8073-157X; Ayu, Mas/0000-0002-1341-4582; Rampal, Sanjay/0000-0002-0105-6407; HAIRI, NORAN/0000-0002-2692-9016; Tok, Peter Seah Keng/0000-0003-3663-450X; ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; NG, CHIU WAN/0000-0002-7687-2310; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304; Wan, Kim Sui/0000-0002-0859-1648; Chong, Diane Woei Quan/0000-0002-0699-0418				Aghaizu A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-541; [Anonymous], COVID 19 CORONAVIRUS; Bandyopadhyay S, 2020, BMJ GLOB HEALTH, V5, DOI [DOI 10.1136/BMJGH-2020-003097, 10.1101/2020.06.04.20119594]; Carter C., 2020, CLIN INTEGR CARE, V1, DOI [10.1016/j.intcar.2020.100005, DOI 10.1016/J.INTCAR.2020.100005]; Centers for Disease Control and Prevention, MANAGING EXPOSED HEA; Centers for Disease Control and Prevention (CDC, 2020, INTERIM CLIN GUIDANC; Chirico F, 2020, INFECT CONT HOSP EP, V41, P1117, DOI 10.1017/ice.2020.148; Cook T., EXCLUSIVE DEATHS NHS; Gan WH, 2020, SAF HEALTH WORK-KR, V11, P241, DOI 10.1016/j.shaw.2020.03.001; Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2013; International Council of Nurses, 2020, MORE 600 NURSES COVI; Kawana A, 2006, JPN J INFECT DIS, V59, P377; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673; Kursumovic E, 2020, ANAESTHESIA, V75, P989, DOI 10.1111/anae.15116; Lahner E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124417; Lai XQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9666; Leclerc Quentin J, 2020, Wellcome Open Res, V5, P83, DOI [10.12688/wellcomeopenres.15889.1, 10.12688/wellcomeopenres.15889.2]; Ministry of Health Malaysia, 2020, GUIDELINES COVID 19; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Said MA., 2020, COVID 19 SURVEILLANC; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Samsudin MF., 2020, GUIDELINES SURVEILLA; Sim BLH, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100055; Wee LE, 2020, INFECT CONT HOSP EP, V41, P765, DOI 10.1017/ice.2020.219; WHO, 2010, WORLD MALARIA REPORT 2010, P1; who, WHO CORONAVIRUS DIS; Willan J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1117; Xiao J, 2020, J INFECT PUBLIC HEAL, V13, P843, DOI 10.1016/j.jiph.2020.05.019; Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696	31	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249394	10.1371/journal.pone.0249394	http://dx.doi.org/10.1371/journal.pone.0249394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852588	Green Published, gold			2022-12-26	WOS:000640604500075
J	Venugopalan, A; Lynberg, M; Cultraro, CM; Nguyen, KDP; Zhang, X; Waris, M; Dayal, N; Abebe, A; Maity, TK; Guha, U				Venugopalan, Abhilash; Lynberg, Matthew; Cultraro, Constance M.; Nguyen, Khoa Dang P.; Zhang, Xu; Waris, Maryam; Dayal, Noelle; Abebe, Asebot; Maity, Tapan K.; Guha, Udayan			SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma	ONCOGENE			English	Article								Mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain constitutively activate EGFR resulting in lung tumorigenesis. Activated EGFR modulates downstream signaling by altering phosphorylation-driven interactions that promote growth and survival. Secretory carrier membrane proteins (SCAMPs) are a family of transmembrane proteins that regulate recycling of receptor proteins, including EGFR. The potential role of SCAMPs in mutant EGFR function and tumorigenesis has not been elucidated. Using quantitative mass-spectrometry-based phosphoproteomics, we identified SCAMP3 as a target of mutant EGFRs in lung adenocarcinoma and sought to further investigate the role of SCAMP3 in the regulation of lung tumorigenesis. Here we show that activated EGFR, either directly or indirectly phosphorylates SCAMP3 at Y86 and this phosphorylation increases the interaction of SCAMP3 with both wild-type and mutant EGFRs. SCAMP3 knockdown increases lung adenocarcinoma cell survival and increases xenograft tumor growth in vivo, demonstrating a tumor suppressor role of SCAMP3 in lung tumorigenesis. The tumor suppressor function is a result of SCAMP3 promoting EGFR degradation and attenuating MAP kinase signaling pathways. SCAMP3 knockdown also increases multinucleated cells in culture, suggesting that SCAMP3 is required for efficient cytokinesis. The enhanced growth, increased colony formation, reduced EGFR degradation and multinucleation phenotype of SCAMP3-depleted cells were reversed by re-expression of wild-type SCAMP3, but not SCAMP3 Y86F, suggesting that Y86 phosphorylation is critical for SCAMP3 function. Taken together, the results of this study demonstrate that SCAMP3 functions as a novel tumor suppressor in lung cancer by modulating EGFR signaling and cytokinesis that is partly Y86 phosphorylation-dependent.	[Venugopalan, Abhilash; Lynberg, Matthew; Cultraro, Constance M.; Nguyen, Khoa Dang P.; Zhang, Xu; Waris, Maryam; Dayal, Noelle; Abebe, Asebot; Maity, Tapan K.; Guha, Udayan] NCI, Thorac & GI Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Guha, Udayan] Bristol Myers Squibb, Lawrenceville, NJ 08648 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Bristol-Myers Squibb	Venugopalan, A; Guha, U (corresponding author), NCI, Thorac & GI Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Guha, U (corresponding author), Bristol Myers Squibb, Lawrenceville, NJ 08648 USA.	abhilash.venugopalan@nih.gov; udayan.guha@nih.gov		Guha, Udayan/0000-0003-1087-9218; Nguyen, Khoa Dang/0000-0003-0888-304X	NIH Intramural Research Program, Center of Cancer Research, National Cancer Institute	NIH Intramural Research Program, Center of Cancer Research, National Cancer Institute	We thank Gaga Geneti for the assistance with the mice handling and treatments. This research was supported by the NIH Intramural Research Program, Center of Cancer Research, National Cancer Institute.	Aoh QL, 2009, MOL BIOL CELL, V20, P1816, DOI 10.1091/mbc.E08-09-0894; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Awasthi S, 2018, DATA BRIEF, V19, P424, DOI 10.1016/j.dib.2018.04.086; Awasthi S, 2018, J PROTEOMICS, V189, P48, DOI 10.1016/j.jprot.2018.04.005; Beaumatin F, 2019, MOL CELL, V76, P163, DOI 10.1016/j.molcel.2019.07.021; Brose MS, 2002, CANCER RES, V62, P6997; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Diaz-Carballo D, 2018, CANCER RES, V78, P2318, DOI 10.1158/0008-5472.CAN-17-1861; Falguieres T, 2012, TRAFFIC, V13, P131, DOI 10.1111/j.1600-0854.2011.01291.x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao S, 2020, BIORXIV, DOI [10.1101/2020.07.04.187617, DOI 10.1101/2020.07.04.187617]; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Ghosh D, 2016, STEM CELLS, V34, P2276, DOI 10.1002/stem.2411; Glubb DM, 2017, ONCOTARGET, V8, P64670, DOI 10.18632/oncotarget.18501; Kulyte A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50210-3; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maity TK, 2015, CANCER DISCOV, V5, P534, DOI 10.1158/2159-8290.CD-14-0750; Mittal K, 2017, BRIT J CANCER, V116, P1186, DOI 10.1038/bjc.2017.78; Murray D., 2018, CANCERS, V10, p118.; Padron D, 2007, CANCER RES, V67, P7695, DOI 10.1158/0008-5472.CAN-07-0484; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Parekh A, 2018, ONCOGENE, V37, P4546, DOI 10.1038/s41388-018-0272-6; Pinilla-Macua I, 2017, ELIFE, V6, DOI 10.7554/eLife.31993; Pinilla-Macua I, 2016, P NATL ACAD SCI USA, V113, P2122, DOI 10.1073/pnas.1520301113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Singleton DR, 1997, J CELL SCI, V110, P2099; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Stewart EL, 2015, TRANSL LUNG CANCER R, V4, P67, DOI 10.3978/j.issn.2218-6751.2014.11.06; Suarez-Arroyo IJ, 2016, AM J CANCER RES, V6, P1720; Tabara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041017; Thomas P, 2016, BIOCHEM BIOPH RES CO, V478, P1028, DOI 10.1016/j.bbrc.2016.08.012; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Venugopalan A, 2016, ONCOTARGET, V7, P54137, DOI 10.18632/oncotarget.11021; Walsh AM, 2014, INTEGR BIOL-UK, V6, P312, DOI 10.1039/c3ib40176f; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wu TT, 1998, MOL BIOL CELL, V9, P1661, DOI 10.1091/mbc.9.7.1661; Zhang XY, 2017, ONCOTARGET, V8, P109247, DOI 10.18632/oncotarget.22665; Zhang X, 2017, MOL CELL PROTEOMICS, V16, P891, DOI 10.1074/mcp.M117.067439; Zhang X, 2015, PROTEOMICS, V15, P340, DOI 10.1002/pmic.201400315	45	4	4	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3331	3346		10.1038/s41388-021-01764-y	http://dx.doi.org/10.1038/s41388-021-01764-y		APR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33850265	Green Accepted			2022-12-26	WOS:000639730800001
J	Rasmussen, S; Petersen, MS; Hoiby, N				Rasmussen, Steen; Petersen, Michael Skytte; Hoiby, Niels			SARS-CoV-2 infection dynamics in Denmark, February through October 2020: Nature of the past epidemic and how it may develop in the future	PLOS ONE			English	Article								Background Initially, the relative sizes of the asymptomatic and the symptomatic infected populations were not known for the COVID-19 pandemic and neither was the actual fatality rate. Therefore it was not clear either how the pandemic would impact the healthcare system. As a result it was initially predicted that the COVID-19 epidemic in Denmark would overwhelm the healthcare system and thus both the diagnosis and treatment of other hospital patients were compromised for an extended period. Aim To develop a mathematical model, which includes both asymptomatic and symptomatic infected persons, for early estimation of the epidemic's course, its Infection Fatality Rate and the healthcare system load in Denmark, both retrospectively and prospectively. Methods The SEIRS (Susceptible-Exposed-Infected-Recovered-Susceptible) model including deaths outside hospitals and separate assessments of symptomatic and asymptomatic cases (based on seroprevalence) with different immunological memories. Optimal model parameters are in part identified by Monte Carlo based Least Square Error methods while micro-outbreaks are modeled by noise and explored in Monte Carlo simulations. Estimates for infected population sizes are obtained by using a quasi steady state method. Results The calculations and simulations made by the model were shown to fit with the observed development of the COVID-19 epidemic in Denmark. The antibody prevalence in the general population in May 2020 was 1.37%, which yields a relative frequency of symptomatic and asymptomatic cases of 1 to 5.2. Due to the large asymptomatic population, the Infection Mortality Rate was only 0.4%. However, with no non-pharmacological restrictions the COVID-19 death toll was calculated to have more than doubled the national average yearly deaths within a year. The transmission rate R-0 was 5.4 in the initial free epidemic period, 0.4 in the lock-down period and 0.8-1.0 in the successive re-opening periods through August 2020. The large asymptomatic population made the termination of the epidemic difficult and micro-outbreaks occurred when the country re-opened. The estimated infected population size July 15 to August 15 was 2,100 and 12,200 for October 1-20, 2020. Conclusions The results of the model show, that COVID-19 has a low Infection Fatality Rate because the majority of infected persons are either asymptomatic or with few symptoms. A minority of the infected persons, therefore, requires hospitalization. That means that for a given infection pressure of both symptomatic and asymptomatic infected there will be a lower pressure on the capacity of the health care system than previously predicted. Further the epidemic will be difficult to terminate since about 84% of the infected individuals are asymptomatic but still contagious. The model may be useful if a major infection wave occurs in the autumn-winter season as it could make robust estimates both for the scale of an ongoing expanding epidemic and for the expected load on the healthcare system. The simulation may also be useful to evaluate different testing strategies based on estimated infected population sizes. The model can be adjusted and scaled to other regions and countries, which is illustrated with Spain and USA.	[Rasmussen, Steen] Univ Southern Denmark, Ctr Fundamental Living Technol FLinT, Dept Phys Chem & Pharm, Odense, Denmark; [Rasmussen, Steen] Santa Fe Inst, Santa Fe, NM 87501 USA; [Petersen, Michael Skytte] Statens Serum Inst, Ctr Biosecur & Biopreparedness CBB, Copenhagen, Denmark; [Hoiby, Niels] Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Hoiby, Niels] Univ Copenhagen, Inst Immunol & Microbiol, Panum Inst, Copenhagen, Denmark	University of Southern Denmark; The Santa Fe Institute; Statens Serum Institut; Rigshospitalet; University of Copenhagen; University of Copenhagen	Rasmussen, S (corresponding author), Univ Southern Denmark, Ctr Fundamental Living Technol FLinT, Dept Phys Chem & Pharm, Odense, Denmark.; Rasmussen, S (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	steen@sdu.dk		Rasmussen, Steen/0000-0002-3336-843X; Hoiby, Niels/0000-0002-1347-725X				Amendola A, 2020, INFECT CONT HOSP EP, V41, P1468, DOI 10.1017/ice.2020.401; [Anonymous], 2020, CORONAOPSPORING STYR; [Anonymous], 2020, EPIDEMIOLOGISK TREND; [Anonymous], 2020, CORONAVIRUS DENMARK; [Anonymous], 2020, **DROPPED REF**; Baggio S, 2021, CLIN INFECT DIS, V73, P148, DOI 10.1093/cid/ciaa1157; Benson P, 2020, BERLINGSKE TIDENDE, DOI DOI 10.1016/S0140-6736(17)32366-8; Boglione L., 2020, J INFECT; Davido B., 2020, INTERNAT J ANTIMICRO; Dora AV, 2020, MMWR-MORBID MORTAL W, V69, P651, DOI 10.15585/mmwr.mm6921e1; Ferguson NM LD, 2020, IMPACT NONPH INT NPI; Government D, 2020, DAN GOV PRESS C MARC; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Haider N, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000424; Li G., 2020, CLIN INFECT DIS; Lui G-Y., 2020, CLIN INFECT DIS; Moghadasa S., 2020, PNAS; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Sakurai A, 2020, NEW ENGL J MED, V383, P885, DOI 10.1056/NEJMc2013020; Wang K, 2020, CLIN INFECT DIS; Wang YB, 2020, CLIN INFECT DIS, V71, P2132, DOI 10.1093/cid/ciaa629; Yang HK, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001703; Yin SX, 2020, J INFECTION, V81, pE31, DOI 10.1016/j.jinf.2020.06.076	23	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249733	10.1371/journal.pone.0249733	http://dx.doi.org/10.1371/journal.pone.0249733			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836034	gold, Green Published, Green Submitted			2022-12-26	WOS:000639361000026
J	Palander, O; Lam, A; Collins, RF; Moraes, TJ; Trimble, WS				Palander, Oliva; Lam, Adam; Collins, Richard F.; Moraes, Theo J.; Trimble, William S.			Nonredundant roles of DIAPHs in primary ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION	Primary cilia are hubs for several signaling pathways, and disruption in cilia function and formation leads to a range of diseases collectively known as ciliopathies. Both ciliogenesis and cilia maintenance depend on vesicle trafficking along a network of microtubules and actin filaments toward the basal body. The DIAPH (Diaphanous-related) family of formins promote both actin polymerization and microtubule (MT) stability. Recently, we showed that the formin DIAPH1 is involved in ciliogenesis. However, the role of other DIAPH family members in ciliogenesis had not been investigated. Here we show that depletion of either DIAPH2 or DIAPH3 also disrupted ciliogenesis and cilia length. DIAPH3 depletion also reduced trafficking within cilia. To specifically examine the role of DIAPH3 at the base, we used fused full-length DIAPH3 to centrin, which targeted DIAPH3 to the basal body, causing increased trafficking to the ciliary base, an increase in cilia length, and formation of bulbs at the tips of cilia. Additionally, we confirmed that the microtubule-stabilizing properties of DIAPH3 are important for its cilia length functions and trafficking. These results indicate the importance of DIAPH proteins in regulating cilia maintenance. Moreover, defects in ciliogenesis caused by DIAPH depletion could only be rescued by expression of the specific family member depleted, indicating nonredundant roles for these proteins.	[Palander, Oliva; Lam, Adam; Collins, Richard F.; Trimble, William S.] Hosp Sick Children, Programs Cell Biol, Toronto, ON, Canada; [Palander, Oliva; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Moraes, Theo J.] Hosp Sick Children, Programs Translat Med, Toronto, ON, Canada; [Moraes, Theo J.] Univ Toronto, Dept Paediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Trimble, WS (corresponding author), Hosp Sick Children, Programs Cell Biol, Toronto, ON, Canada.; Trimble, WS (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	wtrimble@sickkids.ca	Moraes, Theo/CAJ-3254-2022	Moraes, Theo/0000-0001-9968-6601; Lam, Adam/0000-0002-5518-6901; Trimble, William/0000-0001-9776-5111	CIHR grant [PJT-162194]	CIHR grant(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from CIHR grant PJT-162194 to W. S. T.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yan YM, 2020, NAT PROTOC, V15, P1829, DOI 10.1038/s41596-020-0312-x; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100680	10.1016/j.jbc.2021.100680	http://dx.doi.org/10.1016/j.jbc.2021.100680			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33872598	gold, Green Published			2022-12-26	WOS:000672866400651
J	Essa, HL; Abdelfattah, MS; Marzouk, AS; Shedeed, Z; Guirguis, HA; El-Sayed, MMH				Essa, Hanaa L.; Abdelfattah, Mohamed S.; Marzouk, Alaa S.; Shedeed, Zeinab; Guirguis, Hania A.; El-Sayed, Mayyada M. H.			Biogenic copper nanoparticles from Avicennia marina leaves: Impact on seed germination, detoxification enzymes, chlorophyll content and uptake by wheat seedlings	PLOS ONE			English	Article							OXIDE NANOPARTICLES; SILVER NANOPARTICLES; MANGROVE PLANTS; GROWTH; PHYTOTOXICITY; EXTRACTS; OXIDASES; DEFENSE; FOLIAR; SILICA	Biogenic copper nanoparticles (Cu NPs) were synthesized using the aqueous crude extract of mangrove leaves, Avicennia marina (CE). GC-MS metabolite profiling of CE showed that their carbohydrates are mainly composed of D-mannose (29.21%), D-fructose, (18.51%), L-sorbose (12.91%), D-galactose (5.47%) and D-Talose (5.21%). Ultra-fine nanoparticles of 11.60 +/- 4.65 nm comprising Cu2O and Cu(OH)(2) species were obtained with a carbohydrate and phenolic content of 35.6 +/- 3.2% and 3.13 +/- 0.05 mgGA/g, respectively. The impact of the biogenic Cu NPs on wheat seedling growth was dose-dependent. Upon treatment with 0.06 mg/mL of Cu NPs, the growth was promoted by 172.78 +/- 23.11 and 215.94 +/- 37.76% for wheat root and shoot, respectively. However, the lowest relative growth % of 81.94 +/- 11.70 and 72.46 +/- 18.78% were recorded for wheat root and shoot, respectively when applying 0.43 mg/mL of Cu NPs. At this concentration, peroxidase activity (POX) of the germinated wheat seeds also decreased, while ascorbic acid oxidase (AAO) and polyphenol oxidase (PPO) activities increased. Higher uptake of copper was observed in the root relative to the shoot implying the accumulation of the nanoparticles in the former. The uptake was also higher than that of the commercial Cu NPs, which showed an insignificant effect on the seedling growth. By treating the wheat leaves in foliar application with 0.06 mg/mL of Cu NPs, their contents of Chlorophyll a, Chlorophyll b, and total chlorophyll were enhanced after 21 days of application. Meanwhile, the high concentration (0.43 mg/mL) of Cu NPs was the most effective in reducing the leaf content of chlorophyll (a, b, and total) after the same time of application. The findings of this study manifest the potential of utilizing controlled doses of the prepared biogenic Cu NPs for inhibition or stimulation of seedling growth.	[Essa, Hanaa L.; Guirguis, Hania A.; El-Sayed, Mayyada M. H.] Amer Univ Cairo, Chem Dept, New Cairo, Egypt; [Essa, Hanaa L.; Marzouk, Alaa S.] Agr Res Ctr, Pesticides Phytotoxic Dept, CAPL, Giza, Egypt; [Abdelfattah, Mohamed S.] Helwan Univ, Fac Sci, Chem Dept, Nat Prod Res Unit NPRU, Cairo, Egypt; [Shedeed, Zeinab] Helwan Univ, Fac Sci, Bot & Microbiol Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Helwan University; Egyptian Knowledge Bank (EKB); Helwan University	Essa, HL; El-Sayed, MMH (corresponding author), Amer Univ Cairo, Chem Dept, New Cairo, Egypt.; Essa, HL (corresponding author), Agr Res Ctr, Pesticides Phytotoxic Dept, CAPL, Giza, Egypt.	Hanaa@aucegypt.edu; Mayyada@aucegypt.edu	Abdelfattah, Mohamed/S-7033-2016	Abdelfattah, Mohamed/0000-0002-6416-9011; El-Sayed, Mayyada/0000-0001-6257-5748	American University in Cairo [1709695]	American University in Cairo(American University Cairo)	H.G., UG#1709695, the American University in Cairo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz HMM, 2019, CATRINA, V18, P81; Ali SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep36359; Ananda S., 2019, Journal of Drug Delivery and Therapeutics, V9, P296, DOI 10.22270/jddt.v9i2.2554; Ananthi S, 2010, FOOD CHEM TOXICOL, V48, P187, DOI 10.1016/j.fct.2009.09.036; ANGELINI R, 1990, PLANTA, V182, P89, DOI 10.1007/BF00239989; Asmathunisha N., 2016, INT J ADV RES, V4, P522; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Behbahani BA., 2012, SCIENTIFIC J, V7, P147, DOI [10.1016/j.micpath.2017.12.004, DOI 10.1016/J.MICPATH.2017.12.004]; Behravan M, 2019, INT J BIOL MACROMOL, V124, P148, DOI 10.1016/j.ijbiomac.2018.11.101; Bharali B, 2019, COMP ANAL C, V87, P133, DOI 10.1016/bs.coac.2019.09.009; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Caroling G., 2015, INT J NANO CHEM, V1, P53; Choudhury FK, 2017, PLANT J, V90, P856, DOI 10.1111/tpj.13299; Da Costa MVJ, 2016, PHOTOSYNTHETICA, V54, P110, DOI 10.1007/s11099-015-0167-5; Das SK, 2016, FRONT LIFE SCI, V9, P75, DOI 10.1080/21553769.2015.1091386; De Tullio MC, 2004, BIOL PLANTARUM, V48, P161, DOI 10.1023/B:BIOP.0000033439.34635.a6; Duran NM, 2017, J AGR FOOD CHEM, V65, P7874, DOI 10.1021/acs.jafc.7b03014; Eichert T, 2008, PHYSIOL PLANTARUM, V134, P151, DOI 10.1111/j.1399-3054.2008.01135.x; El-Rafie HM, 2013, CARBOHYD POLYM, V96, P403, DOI 10.1016/j.carbpol.2013.03.071; Esmaeili N, 2017, PHARMACOGN MAG, V13, pS519, DOI 10.4103/0973-1296.216333; Essa H, 2018, IOP CONF SER-MAT SCI, V464, DOI 10.1088/1757-899X/464/1/012007; Essa HL, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10186302; Fang XB, 2010, CHEM J CHINESE U, V31, P492; Fleita D, 2015, LWT-FOOD SCI TECHNOL, V63, P1236, DOI 10.1016/j.lwt.2015.04.024; Gohari G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57794-1; Gopalakrishnan K, 2012, DIG J NANOMATER BIOS, V7, P833; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Govorov AO, 2007, NANO LETT, V7, P620, DOI 10.1021/nl062528t; Hafeez A., 2015, J NANOSCI ADV TECHNO, V1, P6, DOI [10.24218/jnat.2015.02, DOI 10.24218/JNAT.2015.02]; Hillis DG, 2011, ARCH ENVIRON CON TOX, V60, P220, DOI 10.1007/s00244-010-9624-0; Hu WL, 2010, MATER SCI ENG B-ADV, V170, P88, DOI 10.1016/j.mseb.2010.02.034; Jaleel CA, 2009, ACTA PHYSIOL PLANT, V31, P427, DOI 10.1007/s11738-009-0275-6; KOCACALISKAN I, 1995, PHYTON-ANN REI BOT A, V35, P37; Laware S. L., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P749; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Lu ChangMei, 2002, Soybean Science, V21, P168; MAXWELL DP, 1967, PHYTOPATHOLOGY, V57, P132; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; Mishra V, 2014, EMERGING TECHNOLOGIES AND MANAGEMENT OF CROP STRESS TOLERANCE, VOL 1: BIOLOGICAL TECHNIQUES, P159, DOI 10.1016/B978-0-12-800876-8.00008-4; Mouafi F. E., 2014, World Applied Sciences Journal, V29, P547; Nair PMG, 2014, ENVIRON SCI POLLUT R, V21, P12709, DOI 10.1007/s11356-014-3210-3; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Nworie OE, 2019, TOXICS, V7, DOI 10.3390/toxics7010003; Peng C., TRANSLOCATION BIOTRA, DOI [10.1016/j.envpol.2014.12.008, DOI 10.1016/J.ENVPOL.2014.12.008]; Plaksenkova I, 2019, J NANOMATER, V2019, DOI 10.1155/2019/2678247; Racuciu M, 2007, ROM J PHYS, V52, P395; Radulescu C, 2013, ROM J PHYS, V58, P1337; Rastogi A, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00078; Ravikumar S., 2010, INT J MED SCI, V2, P94; Roy K, 2016, NANOTECHNOL REV, V5, P529, DOI 10.1515/ntrev-2016-0040; Ruttkay-Nedecky B, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0268-3; Saifuddin N., 2011, Asian Journal of Biochemistry, V6, P142, DOI 10.3923/ajb.2011.142.159; Salama A., 2016, EFFECT FOLIAR SPRAY, P90; Sanghdeep Gautam, 2016, Vegetos, V29, P157; Santos SM, 2015, CARBOHYD POLYM, V116, P173, DOI 10.1016/j.carbpol.2014.03.064; Shaikh RR, 2016, PHARM LETT, V8, P265; Sharaf M, 2000, FITOTERAPIA, V71, P274, DOI 10.1016/S0367-326X(99)00169-0; Shaw AK, 2013, CHEMOSPHERE, V93, P906, DOI 10.1016/j.chemosphere.2013.05.044; Shelar P. S., 2012, Continental Journal of Fisheries and Aquatic Sciences, V6, P26; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Spielman-Sun E, 2018, ENVIRON SCI TECHNOL, V52, P9777, DOI 10.1021/acs.est.8b02111; Suriyaprabha R, 2012, CURR NANOSCI, V8, P902, DOI 10.2174/157341312803989033; Tapan Adhikari, 2012, Journal of Agricultural Science and Technology A, V2, P815; Tariq Marium, 2007, Turkish Journal of Biology, V31, P225; Thatoi HN, 2014, ACTA PHYSIOL PLANT, V36, P561, DOI 10.1007/s11738-013-1438-z; Verma Jay Prakash, 2011, International Journal of Botany, V7, P200, DOI 10.3923/ijb.2011.200.204; Vijayavel K, 2006, CHEM-BIOL INTERACT, V163, P170, DOI 10.1016/j.cbi.2006.06.003; Walker Kira., 2013, EGYPT INDEPENDENT; Wang SL, 2015, ENVIRON TOXICOL CHEM, V34, P554, DOI 10.1002/etc.2826; Yang F, 2006, BIOL TRACE ELEM RES, V110, P179, DOI 10.1385/BTER:110:2:179; Yasmeen F., 2015, INT J BIOSCI, V6, P112, DOI DOI 10.12692/ijb/6.4.112-117; Yin LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047674; Zhang TJ, 2010, ADV FUNCT MATER, V20, P1152, DOI 10.1002/adfm.200902104; Zhao LJ, 2016, ENVIRON SCI TECHNOL, V50, P2000, DOI 10.1021/acs.est.5b05011; Zhu Feng, 2009, Open Natural Products Journal, V2, P24, DOI 10.2174/1874848100902010024	75	7	7	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249764	10.1371/journal.pone.0249764	http://dx.doi.org/10.1371/journal.pone.0249764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857218	gold, Green Published			2022-12-26	WOS:000641474900010
J	Emmerson, KM; Silver, JD; Thatcher, M; Wain, A; Jones, PJ; Dowdy, A; Newbigin, EJ; Picking, BW; Choi, J; Ebert, E; Bannister, T				Emmerson, Kathryn M.; Silver, Jeremy D.; Thatcher, Marcus; Wain, Alan; Jones, Penelope J.; Dowdy, Andrew; Newbigin, Edward J.; Picking, Beau W.; Choi, Jason; Ebert, Elizabeth; Bannister, Tony			Atmospheric modelling of grass pollen rupturing mechanisms for thunderstorm asthma prediction	PLOS ONE			English	Article								The world's most severe thunderstorm asthma event occurred in Melbourne, Australia on 21 November 2016, coinciding with the peak of the grass pollen season. The aetiological role of thunderstorms in these events is thought to cause pollen to rupture in high humidity conditions, releasing large numbers of sub-pollen particles (SPPs) with sizes very easily inhaled deep into the lungs. The humidity hypothesis was implemented into a three-dimensional atmospheric model and driven by inputs from three meteorological models. However, the mechanism could not explain how the Melbourne event occurred as relative humidity was very low throughout the atmosphere, and most available grass pollen remained within 40 m of the surface. Our tests showed humidity induced rupturing occurred frequently at other times and would likely lead to recurrent false alarms if used in a predictive capacity. We used the model to investigate a range of other possible pollen rupturing mechanisms which could have produced high concentrations of SPPs in the atmosphere during the storm. The mechanisms studied involve mechanical friction from wind gusts, electrical build up and discharge incurred during conditions of low relative humidity, and lightning strikes. Our results suggest that these mechanisms likely operated in tandem with one another, but the lightning method was the only mechanism to generate a pattern in SPPs following the path of the storm. If humidity induced rupturing cannot explain the 2016 Melbourne event, then new targeted laboratory studies of alternative pollen rupture mechanisms would be of considerable value to help constrain the parameterisation of the pollen rupturing process.	[Emmerson, Kathryn M.; Thatcher, Marcus] CSIRO Oceans & Atmosphere, Aspendale, Vic, Australia; [Silver, Jeremy D.] Univ Melbourne, Sch Math & Stat, Parkville, Vic, Australia; [Wain, Alan; Dowdy, Andrew; Ebert, Elizabeth; Bannister, Tony] Bur Meteorol, Docklands, Vic, Australia; [Jones, Penelope J.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Newbigin, Edward J.; Picking, Beau W.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Choi, Jason] Environm Protect Author Victoria, Macleod, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; Bureau of Meteorology - Australia; University of Tasmania; Menzies Institute for Medical Research; University of Melbourne	Emmerson, KM (corresponding author), CSIRO Oceans & Atmosphere, Aspendale, Vic, Australia.	kathryn.emmerson@csiro.au	Thatcher, Marcus J/G-4010-2011; Emmerson, Kathryn M/A-1678-2012	Thatcher, Marcus J/0000-0003-4139-5515; Emmerson, Kathryn M/0000-0002-0727-0340; Choi, Jason/0000-0002-5204-8837; Ebert, Elizabeth/0000-0001-5284-1651	Victorian Department of Health and Human Services [C5949]	Victorian Department of Health and Human Services	This research has been supported by the Victorian Department of Health and Human Services (contract no. C5949). https://www.dhhs.vic.gov.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister T, 2021, B AM METEOROL SOC, V102, pE399, DOI 10.1175/BAMS-D-19-0140.1; Bannister T, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140263; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; Celenza A, 1996, BMJ-BRIT MED J, V312, P604; Cope M., 2009, CHEM TRANSPORT MODEL, P114; Dabrera G, 2013, QJM-INT J MED, V106, P207, DOI 10.1093/qjmed/hcs234; Damialis A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44535; Davies JM, 2017, LIT REV THUNDERSTORM; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Emmerson KM, 2019, GEOSCI MODEL DEV, V12, P2195, DOI 10.5194/gmd-12-2195-2019; Erbas B, 2018, ALLERGY, V73, P1632, DOI 10.1111/all.13407; Grote M, 2003, J ALLERGY CLIN IMMUN, V111, P1017, DOI 10.1067/mai.2003.1452; Grote M, 2001, J ALLERGY CLIN IMMUN, V108, P109, DOI 10.1067/mai.2001.116431; Grundstein A, 2017, J APPL METEOROL CLIM, V56, P1337, DOI 10.1175/JAMC-D-17-0027.1; Guest C, 2017, CHIEF HLTH OFFICERS; Hughes DD, 2020, ENVIRON SCI TECH LET, V7, P409, DOI 10.1021/acs.estlett.0c00213; Hutchins ML, 2013, GEOPHYS RES LETT, V40, P2390, DOI 10.1002/grl.50406; Idrose NS, 2020, ENVIRON RES, V181, DOI 10.1016/j.envres.2019.108911; Jung S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193958; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kitinoja MA, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-029069; Lu H, 2001, ENVIRON MODELL SOFTW, V16, P233, DOI 10.1016/S1364-8152(00)00083-9; Marks GB, 2001, THORAX, V56, P468, DOI 10.1136/thorax.56.6.468; McGregor JL, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P51, DOI 10.1007/978-0-387-49791-4_4; Melbourne Pollen Count and Forecast,, 2016, FORECASTING GRASS PO; Mesa JAS, 2005, J INVEST ALLERG CLIN, V15, P112; Monk K, 2019, ATMOSPHERE-BASEL, V10, DOI 10.3390/atmos10070374; ONG EK, 1995, GRANA, V34, P58, DOI 10.1080/00173139509429034; Plaza MP, 2016, INT J BIOMETEOROL, V60, P1841, DOI 10.1007/s00484-016-1171-6; POLLART SM, 1988, J ALLERGY CLIN IMMUN, V82, P224, DOI 10.1016/0091-6749(88)91003-2; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; PURI AK, 2013, AUST METEOROL OCEAN, P265; S. G. of V, INSPECTOR GEN EMERGE; Silver JD, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135147; Silver JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194929; Skamarock C., 2005, DESCRIPTION ADV RES; SMART IJ, 1979, AUST J BOT, V27, P333, DOI 10.1071/BT9790333; Sofiev M, 2013, INT J BIOMETEOROL, V57, P45, DOI 10.1007/s00484-012-0532-z; SPORIK RB, 1993, CLIN EXP ALLERGY, V23, P326, DOI 10.1111/j.1365-2222.1993.tb00330.x; SUPHIOGLU C, 1992, LANCET, V339, P569, DOI 10.1016/0140-6736(92)90864-Y; Taylor PE, 2004, CURR ALLERGY ASTHM R, V4, P409, DOI 10.1007/s11882-004-0092-3; Taylor PE, 2004, CLIN EXP ALLERGY, V34, P1591, DOI 10.1111/j.1365-2222.2004.02078.x; Taylor PE, 2002, J ALLERGY CLIN IMMUN, V109, P51, DOI 10.1067/mai.2002.120759; Taylor PE, 2007, INT ARCH ALLERGY IMM, V144, P162, DOI 10.1159/000103230; Thien F, 2018, LANCET PLANET HEALTH, V2, pE255, DOI 10.1016/s2542-5196(18)30120-7; Vaidyanathan V, 2006, J ALLERGY CLIN IMMUN, V117, pS157, DOI 10.1016/j.jaci.2005.12.625; Virts KS, 2013, B AM METEOROL SOC, V94, P1381, DOI 10.1175/BAMS-D-12-00082.1; Visez N, 2015, J AEROSOL SCI, V89, P77, DOI 10.1016/j.jaerosci.2015.07.005; Wozniak MC, 2018, GEOPHYS RES LETT, V45, P7156, DOI 10.1029/2018GL077692	49	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249488	10.1371/journal.pone.0249488	http://dx.doi.org/10.1371/journal.pone.0249488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852572	Green Published, Green Accepted, gold			2022-12-26	WOS:000640604500004
J	Levers, LR; Pradhananga, AK				Levers, Lucia R.; Pradhananga, Amit K.			Recreationist willingness to pay for aquatic invasive species management	PLOS ONE			English	Article							PRO-ENVIRONMENTAL BEHAVIOR; CHANGE RISK PERCEPTION; MOTIVATION; PREFERENCES; EXPERIENCE; ATTITUDES; BARRIERS; BELIEFS; VALUES	We estimated willingness to pay for local aquatic invasive species lake management in the form of a daily lake access fee by conducting summer lake surveys in Minnesota, USA. Similar pairs of lakes with differing infestations of zebra mussels, Dreissena polymorpha, and starry stonewort, Nitellopsis obtuse, were used as study sites to infer how being at an infested lake vs. being at an uninfested lake and different local species would impact responses. We also examined recreationists' visit motivation, and aquatic invasive species perceived risk, knowledge, and awareness of problem. We estimated mean willingness to pay about nine to ten dollars per day, which did not differ significantly by lake. Additionally, perceived risk, awareness of problem, and visit motivation were significant in predicting willingness to pay, which could have important ramifications for aquatic invasive species management.	[Levers, Lucia R.] Univ Minnesota, Water Resources Ctr, Minneapolis, MN 55455 USA; [Pradhananga, Amit K.] Univ Minnesota, Ctr Changing Landscapes, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Levers, LR (corresponding author), Univ Minnesota, Water Resources Ctr, Minneapolis, MN 55455 USA.	llevers@umn.edu		Levers, Lucia/0000-0001-5657-1038	Minnesota Environmental and Natural Resources Trust Fund; Legislative-Citizen Commission on Minnesota Resources (LCCMR)	Minnesota Environmental and Natural Resources Trust Fund; Legislative-Citizen Commission on Minnesota Resources (LCCMR)	Research funding was provided by the Minnesota Environmental and Natural Resources Trust Fund as recommended by the Minnesota Aquatic Invasive Species Research Center (MAISRC) and the Legislative-Citizen Commission on Minnesota Resources (LCCMR).	Adaman F, 2011, ENERG POLICY, V39, P689, DOI 10.1016/j.enpol.2010.10.042; Adams DC, 2011, FOREST POLICY ECON, V13, P465, DOI 10.1016/j.forpol.2011.04.003; Ajzen I., 1991, HDB THEORIES SOCIAL, V211 1, P438; Baptiste AK, 2014, COMMUNITY DEV, V45, P337, DOI 10.1080/15575330.2014.934255; Bradley GL, 2020, J ENVIRON PSYCHOL, V68, DOI 10.1016/j.jenvp.2020.101410; Bruskotter J. T., 2008, Human Dimensions of Wildlife, V13, P207, DOI 10.1080/10871200802023227; Census U, 2019, QUICKFACTS MINNESOTA; Chakir R, 2016, J AGR ECON, V67, P619, DOI 10.1111/1477-9552.12160; Champ P., 2017, PRIMER NONMARKET VAL, V2nd, P111; Devesa M, 2010, TOURISM MANAGE, V31, P547, DOI 10.1016/j.tourman.2009.06.006; Elias W, 2012, TRANSPORT RES A-POL, V46, P1241, DOI 10.1016/j.tra.2012.05.013; Estevez RA, 2015, CONSERV BIOL, V29, P19, DOI 10.1111/cobi.12359; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Garcia-Llorente M, 2011, ENVIRON MANAGE, V48, P418, DOI 10.1007/s00267-011-9646-z; Hansla A, 2008, J ENVIRON PSYCHOL, V28, P1, DOI 10.1016/j.jenvp.2007.08.004; Huang S, 2009, J TRAVEL RES, V48, P29, DOI 10.1177/0047287508328793; Jensen B., 2002, ENVIRON EDUC RES, V8, P213, DOI [DOI 10.1080/13504620220145474, 10.1080/13504620220145474]; Johnston RJ, 2017, J ASSOC ENVIRON RESO, V4, P319, DOI 10.1086/691697; Jones N, 2010, RESOUR CONSERV RECY, V54, P533, DOI 10.1016/j.resconrec.2009.10.010; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Kyle GT, 2004, J ENVIRON PSYCHOL, V24, P439, DOI 10.1016/j.jenvp.2004.11.001; Lacroix K, 2018, ENVIRON BEHAV, V50, P749, DOI 10.1177/0013916517715296; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Liebe U, 2011, ENVIRON BEHAV, V43, P106, DOI 10.1177/0013916509346229; Lopez-Feldman A., 2012, MPRA PAP, V41018, P16; Manfredo MJ, 1996, J LEISURE RES, V28, P188, DOI 10.1080/00222216.1996.11949770; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; McFarlane BL, 2003, J ENVIRON PSYCHOL, V23, P79, DOI 10.1016/S0272-4944(02)00080-4; MNDNR, 2007, BOATING NO MINNESOTA; MNDNR, 2002, BOAT CENTR MINN STAT; MNDNR, 2006, BOATING N CENTRAL MI; Niemiec RM, 2017, BIOL CONSERV, V209, P415, DOI 10.1016/j.biocon.2017.02.036; Nunes PALD, 2004, ENVIRON RESOUR ECON, V28, P517, DOI 10.1023/B:EARE.0000036777.83060.b6; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Pradhananga AK, 2015, J AM WATER RESOUR AS, V51, P1600, DOI 10.1111/1752-1688.12346; Schwartz S. H., 1977, ADV EXP SOC PSYCHOL, V10, P221, DOI [10.1016/s0065-2601(08)60358-5, 10.1016/S0065-2601(08) 60358-5, DOI 10.1016/S0065-2601(08)60358-5]; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Slimak MW, 2006, RISK ANAL, V26, P1689, DOI 10.1111/j.1539-6924.2006.00832.x; Spash CL, 2009, ECOL ECON, V68, P955, DOI 10.1016/j.ecolecon.2006.09.013; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Toma L, 2007, J ENVIRON MANAGE, V83, P145, DOI 10.1016/j.jenvman.2006.02.004; Vaske JJ, 1999, SOC NATUR RESOUR, V12, P523, DOI 10.1080/089419299279425; Wang YT, 2017, RESOUR CONSERV RECY, V122, P11, DOI 10.1016/j.resconrec.2017.02.002	43	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0246860	10.1371/journal.pone.0246860	http://dx.doi.org/10.1371/journal.pone.0246860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852584	Green Published, gold			2022-12-26	WOS:000640604500033
J	Eder, M; Omic, H; Gorges, J; Badt, F; Kikic, Z; Saemann, MD; Tong, A; Bauer, D; Semmler, G; Reiberger, T; Lagler, H; Scheiner, B				Eder, Michael; Omic, Haris; Gorges, Jana; Badt, Florian; Kikic, Zeljko; Saemann, Marcus D.; Tong, Allison; Bauer, David; Semmler, Georg; Reiberger, Thomas; Lagler, Heimo; Scheiner, Bernhard			Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease	PLOS ONE			English	Article							SEASONAL INFLUENZA; PERCEPTION; PREVENTION; AUSTRIA	Introduction Seasonal influenza is a major global health problem causing substantial morbidity and health care costs. Yet, in many countries, the rates of influenza vaccination remain low. Chronic kidney or liver diseases (CKLD) predispose patients to severe influenza infections, but data on vaccination acceptance and status is limited in this risk population. We investigated the influenza vaccination awareness considering sociodemographic factors in CKLD patients. Patients and methods This cross-sectional, questionnaire-based study recruited CKLD patients managed at three Viennese tertiary care centers between July and October 2020. CKLD was defined as chronic kidney- (all stages) or compensated/decompensated liver disease, including kidney/liver transplant recipients. Questionnaires assessed sociodemographic and transplant- associated parameters, patients vaccination status and the individuals self-perceived risks of infection and associated complications. Results In total 516 patients (38.1% female, mean age 56.4 years) were included. 43.9% of patients declared their willingness to be vaccinated in the winter season 2020/2021, compared to 25.4% in 2019/2020 and 27.3% in 2016-2018. Vaccination uptake was associated with the self-perceived risks of infection (OR: 2.8 (95%CI: 1.8-4.5), p<0.001) and associated complications (OR: 3.8 (95%CI: 2.3-6.3), p<0.001) as well as with previously received influenza vaccination (2019/2020: OR 17.1 (95%CI: 9.5-30.7), p<0.001; season 2016-2018: OR 8.9 (95%CI: 5.5-14.5), p<0.001). Most frequent reasons for not planning vaccination were fear of a) graft injury (33.3%), b) complications after vaccination (32.4%) and c) vaccine inefficiency (15.0%). Conclusion While influenza vaccination willingness in patients with CKLD is increasing in the 2020/2021 season, vaccination rates may still remain <50%. Novel co-operations with primary health care, active vaccination surveillance and financial reimbursement may substantially improve vaccination rates in high-risk CKLD patients.	[Eder, Michael; Omic, Haris; Gorges, Jana; Badt, Florian; Kikic, Zeljko] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria; [Kikic, Zeljko] Med Univ Vienna, Dept Urol, Vienna, Austria; [Saemann, Marcus D.] Clin Ottakring, Dept Nephrol, Vienna, Austria; [Tong, Allison] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Tong, Allison] Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia; [Bauer, David; Semmler, Georg; Reiberger, Thomas; Scheiner, Bernhard] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Bauer, David; Semmler, Georg; Reiberger, Thomas; Scheiner, Bernhard] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria; [Lagler, Heimo] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Sydney; University of Sydney; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Scheiner, B (corresponding author), Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.; Scheiner, B (corresponding author), Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria.	bernhard.scheiner@meduniwien.ac.at	Reiberger, Thomas/H-7613-2019; Semmler, Georg/O-3323-2019	Reiberger, Thomas/0000-0002-4590-3583; Semmler, Georg/0000-0002-0411-166X; Eder, Michael/0000-0002-6341-1275; Lagler, Heimo/0000-0003-3240-7385; Scheiner, Bernhard/0000-0002-4904-5133; , Jana/0000-0002-3538-3844				Barry MA, 2020, CAN J INFECT DIS MED, V2020, DOI 10.1155/2020/7653745; Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100169; Bundesministerium f??r Soziales G, 2021, IMPFPLAN OSTERREICH, V2021; Cavaille-Coll M, 2013, AM J TRANSPLANT, V13, P1134, DOI 10.1111/ajt.12210; Cordero E, 2012, CLIN MICROBIOL INFEC, V18, P67, DOI 10.1111/j.1469-0691.2011.03537.x; Danziger-Isakov L, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13563; Duchini A, 2003, CLIN MICROBIOL REV, V16, P357, DOI 10.1128/CMR.16.3.357-364.2003; Harmala S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031070; Harrison N, 2018, VACCINE, V36, P4875, DOI 10.1016/j.vaccine.2018.06.065; Hirzel C, 2018, CURR OPIN INFECT DIS, V31, P309, DOI [10.1097/QCO.0000000000000461, 10.1097/qco.0000000000000461]; Krueger KM, 2020, AM J KIDNEY DIS, V75, P417, DOI 10.1053/j.ajkd.2019.06.014; Kumar D, 2018, CLIN INFECT DIS, V67, P1322, DOI 10.1093/cid/ciy294; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Kunze U, 2019, CENT EUR J PUBL HEAL, V27, P127, DOI 10.21101/cejph.a5010; Kunze U, 2013, VACCINE, V31, P5099, DOI 10.1016/j.vaccine.2013.08.050; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mulley WR, 2018, J HEART LUNG TRANSPL, V37, P844, DOI 10.1016/j.healun.2018.03.001; Ortega-Sanchez IR, 2012, VACCINE, V30, P4175, DOI 10.1016/j.vaccine.2012.04.057; Pavlic DR, 2020, PRIM HEALTH CARE RES, V21, DOI 10.1017/S1463423620000419; Phen SS, 2020, SEMIN DIALYSIS, V33, P330, DOI 10.1111/sdi.12889; Poeppl W, 2015, VACCINE, V33, P1682, DOI 10.1016/j.vaccine.2015.02.029; Premkumar M, 2019, J CLIN EXP HEPATOL, V9, P162, DOI 10.1016/j.jceh.2018.04.006; Reiberger T, 2017, WIEN KLIN WOCHENSCHR, V129, pS135, DOI 10.1007/s00508-017-1262-3; Schutte A, 2019, J HEPATOL, V70, P797, DOI 10.1016/j.jhep.2018.11.015; Schulte K, 2019, DTSCH ARZTEBL INT, V116, P413, DOI 10.3238/arztebl.2019.0413; Tsujimura K, 2018, TRANSPL P, V50, P2443, DOI 10.1016/j.transproceed.2018.02.186; Van Wormer JJ, 2017, J OCCUP ENVIRON MED, V59, P1135, DOI [10.1097/JOM.0000000000001120, 10.1097/jom.0000000000001120]; Vilchez R A, 2002, Transpl Infect Dis, V4, P177, DOI 10.1034/j.1399-3062.2002.t01-4-02001.x; Wiedermann U, 2016, WIEN KLIN WOCHENSCHR, V128, pS337, DOI 10.1007/s00508-016-1033-6; Wu SS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017459; Zhang J, 2012, EPIDEMIOL INFECT, V140, P1569, DOI 10.1017/S0950268811002214	32	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249785	10.1371/journal.pone.0249785	http://dx.doi.org/10.1371/journal.pone.0249785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848305	gold, Green Published			2022-12-26	WOS:000640373500006
J	Kumar, K; Misra, S				Kumar, Krishna; Misra, Sheuli			Sex differences in prevalence and risk factors of hypertension in India: Evidence from the National Family Health Survey-4	PLOS ONE			English	Article							BLOOD-PRESSURE; GLOBAL BURDEN; AWARENESS	To estimate sex-specific prevalence and associated socio-economic, demographic, and lifestyle risk factors of hypertension in India. We used data from the National Family Health Survey (NFHS-4) of 2015-16. The analysis based on 6,99,686 women (15-49 years) and 1,12,122 men (15-54 years) whose blood pressure (BP) were measured during the survey. Bivariate distribution was used to show the prevalence of hypertension and, maps were used to present its spatial patterns. Logistic regression model was used to identify sex-specific association between risk factors and hypertension. Results show that the overall prevalence of hypertension was 16.32% among men and 11.56% among women. We also found that the prevalence of hypertension across selected socio-economic, demographic and lifestyle background characteristics and in a majority of the states was higher among men compared to women. Odds ratios from logistic regression analysis direct sex-related differences in risk factors. Hypertension increases with an increase in age and the risk is higher among older women (AOR, 5.58; 95% CI, 5.16-6.03 for women aged 40-49 and AOR, 4.24; 95% CI, 3.94-4.57 for men aged 50-54) compared to men. Education, types of jobs (specially technical, administrative and managerial), marital status and non-vegetarian diet were significantly associated with hypertension in men. While other than age; non-working, consumption of alcohol, and being a diabetic was found to be major risk factors for this disease among women. There are sex-related differences in prevalence as well as risk factors of hypertension in India. In order to prevent early developments of hypertension, awareness related to changing lifestyles such as a diet rich in fruits, vegetables as well as screening to control BP should be promoted among youths and adults in India. The study also recommends sex-specific approaches in health infrastructure and policies besides increasing public awareness.	[Kumar, Krishna; Misra, Sheuli] Jawaharlal Nehru Univ, Ctr Study Reg Dev, Sch Social Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi	Misra, S (corresponding author), Jawaharlal Nehru Univ, Ctr Study Reg Dev, Sch Social Sci, New Delhi, India.	sheulimisra93@gmail.com	Misra, Sheuli/AAQ-7011-2021	Misra, Sheuli/0000-0001-5643-3161				Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Afghahi H, 2015, DIABETOLOGIA, V58, P1203, DOI 10.1007/s00125-015-3548-1; Agho KE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203278; Anand Krishnan, 2013, Regional Health Forum, V17, P7; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; [Anonymous], 2015, AUST J EMERG MANAG, V30, P9; Bansal Sushil K, 2012, J Cardiovasc Dis Res, V3, P117, DOI 10.4103/0975-3583.95365; Bhise MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191948; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Choi HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178334; Dey J., 2020, INT J COMMUNITY SOCI, V2, P327; Dorans KS, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.008888, 10.1161/jaha.118.008888]; Duell Eric J, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P622, DOI 10.1007/s00103-006-1293-9; El Bcheraoui C, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/564679; Esteghamati A, 2008, AM J HYPERTENS, V21, P620, DOI 10.1038/ajh.2008.154; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Ghosh S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010085; Ghosh S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029714; GILBERTS ECAM, 1994, J EPIDEMIOL COMMUN H, V48, P258, DOI 10.1136/jech.48.3.258; Giles Thomas D, 2005, J Clin Hypertens (Greenwich), V7, P505, DOI 10.1111/j.1524-6175.2005.04769.x; Halperin RO, 2008, AM J HYPERTENS, V21, P148, DOI 10.1038/ajh.2007.36; Hasan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198028; Hazarika N C, 2003, J Assoc Physicians India, V51, P567; International Institute for Population Sciences,, 2017, NATL FAMILY HLTH SUR; Jesus TS, 2020, PHYSIOTHER CAN, V72, P122, DOI 10.3138/ptc-2018-0065; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kishore J, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/7962595; Kringeland E, 2020, BLOOD PRESSURE, V29, P267, DOI 10.1080/08037051.2020.1762070; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Pankevich DE, 2011, SEX DIFFERENCES IMPL; Patel S, 2020, J BIOSOC SCI, V52, P629, DOI 10.1017/S0021932019000671; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Reddy PMC, 2020, J FAM MED PRIM CARE, V9, P4778, DOI 10.4103/jfmpc.jfmpc_489_20; Registrar General of India, 2017, REP MED CERT CAUS DE; Simsolo RB, 1999, AM J HYPERTENS, V12, P260, DOI 10.1016/S0895-7061(98)00253-2; Singh S, 2017, INT J HYPERTENS, V2017, DOI 10.1155/2017/5491838; Tabrizi JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165264; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; World Health Organization, 2013, GUIDELINES MANAGEMEN; Yu GQ, 2018, AM J HYPERTENS, V31, P679, DOI 10.1093/ajh/hpy005	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0247956	10.1371/journal.pone.0247956	http://dx.doi.org/10.1371/journal.pone.0247956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848291	Green Published, gold			2022-12-26	WOS:000640373500017
J	Postic, E; Outreman, Y; Derocles, S; Granado, C; Le Ralec, A				Postic, Estelle; Outreman, Yannick; Derocles, Stephane; Granado, Caroline; Le Ralec, Anne			Genetics of wild and mass-reared populations of a generalist aphid parasitoid and improvement of biological control	PLOS ONE			English	Article							HYMENOPTERA; BRACONIDAE; VIRULENCE; GENUS	Due to their ability to parasitize various insect species, generalist parasitoids are widely used as biological control agents. They can be mass-reared and released in agroecosystems to control several pest species in various crops. However, the existence of genetic differentiation among populations of generalist parasitoid species is increasingly recognized and this can be associated with an adaptation to local conditions or to a reduced range of host species. Moreover, constraints of mass-rearing conditions can alter genetic variation within parasitoid populations released. These features could be associated with a reduced efficiency of the control of targeted pest species. Here, we focused on strawberry greenhouses where the control of aphids with the generalist parasitoid Aphidius ervi appears to be inefficient. We investigated whether this inefficiency may have both genetic and ecological bases comparing wild and commercial populations of A. ervi. We used two complementary genetic approaches: one based on the mitochondrial marker COI and one based on microsatellite markers. COI analysis showed a genetic differentiation within the A. ervi species, but the structure was neither associated with the commercial/wild status nor with host species factors. On the other hand, using microsatellite markers, we showed a genetic differentiation between commercial and wild A. ervi populations associated with a loss of genetic diversity within the mass-reared populations. Our ecological genetics study may potentially explain the weak efficiency of biological control of aphids in protected strawberry crops and enable to provide some insights to improve biological control.	[Postic, Estelle; Outreman, Yannick; Le Ralec, Anne] Univ Rennes, Inst Agro, INRAE, IGEPP, Rennes, France; [Postic, Estelle; Granado, Caroline] AOPn Fraises France, Estillac, France; [Derocles, Stephane] Univ Rennes, Inst Agro, INRAE, IGEPP, Le Rheu, France	INRAE; Institut Agro; Universite de Rennes; INRAE; Institut Agro	Le Ralec, A (corresponding author), Univ Rennes, Inst Agro, INRAE, IGEPP, Rennes, France.	anne.leralec@agrocampus-ouest.fr	Le Ralec, Anne/HCI-7822-2022; Yannick, OUTREMAN/B-9309-2012	Yannick, OUTREMAN/0000-0002-7337-3049; Postic, Estelle/0000-0002-2634-5440	AOPn Fraises de France; ANRT (Association nationale de la recherche et de la technologie); French Office for Biodiversity; Ecophyto II+ plan [30001445]	AOPn Fraises de France; ANRT (Association nationale de la recherche et de la technologie)(French National Research Agency (ANR)); French Office for Biodiversity; Ecophyto II+ plan	EP received funding from AOPn Fraises de France (http://fraisesdefrance.fr/), ANRT (Association nationale de la recherche et de la technologie; http://www.anrt.asso.fr/fr), GIS Picle ' g (https://www.picleg.fr/) ALR received funding from the French Office for Biodiversity (Project AphidInnov; call for research projects "Sustainable crop protection without neonicotinoids"; Ecophyto II+ plan; grant number: 30001445; https://ofb.gouv.fr/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, INNOVATIONS AGRONOMI, DOI DOI 10.15454/ELO9ME; Antolin MF, 2006, ECOL ENTOMOL, V31, P242, DOI 10.1111/j.1365-2311.2006.00769.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bilodeau E, 2013, EVOL ECOL, V27, P165, DOI 10.1007/s10682-012-9577-z; Blackman RL, 2010, HDB IDENTIFICATION B, V2; Derocles SAP, 2020, INSECTS, V11, DOI 10.3390/insects11010006; Derocles SAP, 2016, SYST ENTOMOL, V41, P379, DOI 10.1111/syen.12160; Derocles SAP, 2012, MOL ECOL RESOUR, V12, P197, DOI 10.1111/j.1755-0998.2011.03083.x; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Dion E, 2011, J EVOLUTION BIOL, V24, P741, DOI 10.1111/j.1420-9101.2010.02207.x; Dupas S, 2003, HEREDITY, V90, P84, DOI 10.1038/sj.hdy.6800182; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estoup A, 2016, ANNU REV ECOL EVOL S, V47, P51, DOI 10.1146/annurev-ecolsys-121415-032116; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fauvergue X, 2012, EVOL APPL, V5, P424, DOI 10.1111/j.1752-4571.2012.00272.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gebiola M, 2019, PEST MANAG SCI, V75, P3102, DOI 10.1002/ps.5427; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haran J, 2015, J ZOOL SYST EVOL RES, V53, P109, DOI 10.1111/jzs.12095; Henry LM, 2008, EVOLUTION, V62, P689, DOI 10.1111/j.1558-5646.2007.00316.x; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Hopper KR, 2019, EVOL APPL, V12, P815, DOI 10.1111/eva.12759; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufbauer RA, 2004, MOL ECOL, V13, P337, DOI 10.1046/j.1365-294X.2003.02084.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kambhampati S, 2000, SYST ENTOMOL, V25, P437, DOI 10.1046/j.1365-3113.2000.00129.x; Kavallieratos NG, 2004, APPL ENTOMOL ZOOL, V39, P527, DOI 10.1303/aez.2004.527; Kavallieratos NG, 2001, PHYTOPARASITICA, V29, P306, DOI 10.1007/BF02981847; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lozier JD, 2008, BIOL CONTROL, V46, P532, DOI 10.1016/j.biocontrol.2008.05.002; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Nyabuga FN, 2012, J INSECT BEHAV, V25, P80, DOI 10.1007/s10905-011-9279-3; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Parreno MA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S14; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Postic E, 2020, BIOL CONTROL, V148, DOI 10.1016/j.biocontrol.2020.104302; Postic E, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3126; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Quicke DLJ, 2012, MOL ECOL RESOUR, V12, P676, DOI 10.1111/j.1755-0998.2012.03143.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond L, 2016, J PEST SCI, V89, P7, DOI 10.1007/s10340-015-0687-6; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Sorensen JG, 2012, CROP PROT, V38, P87, DOI 10.1016/j.cropro.2012.03.023; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Szucs M, 2019, ENTOMOL EXP APPL, V167, P598, DOI 10.1111/eea.12807; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomanovic Z, 2014, B ENTOMOL RES, V104, P552, DOI 10.1017/S0007485314000327; UNRUH TR, 1989, ANN ENTOMOL SOC AM, V82, P754, DOI 10.1093/aesa/82.6.754; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1; Zepeda-Paulo F, 2015, ECOL EVOL, V5, P2149, DOI 10.1002/ece3.1504; Zepeda-Paulo FA, 2013, EVOL APPL, V6, P983, DOI 10.1111/eva.12081	63	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249893	10.1371/journal.pone.0249893	http://dx.doi.org/10.1371/journal.pone.0249893			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848317	gold, Green Published			2022-12-26	WOS:000640373500023
J	Bolte, LA; Klaassen, MAY; Collij, V; Vila, AV; Fu, JY; van der Meulen, TA; de Haan, JJ; Versteegen, GJ; Dotinga, A; Zhernakova, A; Wijmenga, C; Weersma, RK; Imhann, F				Bolte, Laura A.; Klaassen, Marjolein A. Y.; Collij, Valerie; Vila, Arnau Vich; Fu, Jingyuan; van der Meulen, Taco A.; de Haan, Jacco J.; Versteegen, Gerbrig J.; Dotinga, Aafje; Zhernakova, Alexandra; Wijmenga, Cisca; Weersma, Rinse K.; Imhann, Floris			Patient attitudes towards faecal sampling for gut microbiome studies and clinical care reveal positive engagement and room for improvement	PLOS ONE			English	Article							ULCERATIVE-COLITIS; TRANSPLANTATION; PARTICIPATION; REMISSION; THERAPY	Faecal sample collection is crucial for gut microbiome research and its clinical applications. However, while patients and healthy volunteers are routinely asked to provide stool samples, their attitudes towards sampling remain largely unknown. Here, we investigate the attitudes of 780 Dutch patients, including participants in a large Inflammatory Bowel Disease (IBD) gut microbiome cohort and population controls, in order to identify barriers to sample collection and provide recommendations for gut microbiome researchers and clinicians. We sent questionnaires to 660 IBD patients and 112 patients with other disorders who had previously been approached to participate in gut microbiome studies. We also conducted 478 brief interviews with participants in our general population cohort who had collected stool samples. Statistical analysis of the data was performed using R. 97.4% of respondents reported that they had willingly participated in stool sample collection for gut microbiome research, and most respondents (82.9%) and interviewees (95.6%) indicated willingness to participate again, with their motivations for participating being mainly altruistic (57.0%). Responses indicated that storing stool samples in the home freezer for a prolonged time was the main barrier to participation (52.6%), but clear explanations of the sampling procedures and their purpose increased participant willingness to collect and freeze samples (P = 0.046, P = 0.003). To account for participant concerns, gut microbiome researchers establishing cohorts and clinicians trying new faecal tests should provide clear instructions, explain the rationale behind their protocol, consider providing a small freezer and inform patients about study outcomes. By assessing the attitudes, motives and barriers surrounding participation in faecal sample collection, we provide important information that will contribute to the success of gut microbiome research and its near-future clinical applications.	[Bolte, Laura A.; Klaassen, Marjolein A. Y.; Collij, Valerie; Vila, Arnau Vich; Fu, Jingyuan; Weersma, Rinse K.; Imhann, Floris] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Bolte, Laura A.; Klaassen, Marjolein A. Y.; Collij, Valerie; Vila, Arnau Vich; Zhernakova, Alexandra; Wijmenga, Cisca; Imhann, Floris] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [van der Meulen, Taco A.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [de Haan, Jacco J.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Versteegen, Gerbrig J.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Psychol, Groningen, Netherlands; [Dotinga, Aafje] Lifelines Cohort Study, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Imhann, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.; Imhann, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	f.imhann@rug.nl	Zhernakova, Alexandra/ABA-9372-2020; Fu, Jingyuan/ABE-6868-2020; Weersma, Rinse/ABE-3807-2021	Fu, Jingyuan/0000-0001-5578-1236; Bolte, Laura/0000-0001-6036-0831	Seerave Foundation; collaborative TIMID project - PPP allowance by Top Sector Life Sciences Health [LSHM18057-SGF]; Gravitation grant ExposomeNL from the from the Dutch Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) [024.004.017]; European Research Council (ERC) Starting Grant [715772]; NWO-VIDI grant [016.178.056]; NWO Gravitation Netherlands Organ-on-Chip Initiative [024.003.001]; ERC Consolidator grant [101001678]; Dutch Heart Foundation (CardioVasculair Onderzoek Nederland, CVON) [2018-27]; NWO Gravitation grant [024.003.001]; Spinoza award [NWO SPI 92-266]; Netherlands' Top Institute Food and Nutrition [GH001]	Seerave Foundation; collaborative TIMID project - PPP allowance by Top Sector Life Sciences Health; Gravitation grant ExposomeNL from the from the Dutch Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO); European Research Council (ERC) Starting Grant(European Research Council (ERC)); NWO-VIDI grant(Netherlands Organization for Scientific Research (NWO)); NWO Gravitation Netherlands Organ-on-Chip Initiative; ERC Consolidator grant(European Research Council (ERC)); Dutch Heart Foundation (CardioVasculair Onderzoek Nederland, CVON); NWO Gravitation grant; Spinoza award; Netherlands' Top Institute Food and Nutrition	LAB and RKW are supported by a research grant from the Seerave Foundation. RKW is supported by the collaborative TIMID project (LSHM18057-SGF) financed by the PPP allowance made available by Top Sector Life Sciences & Health to Samenwerkende Gezondheidsfondsen (SGF) to stimulate public-private partnerships and co-financing by health foundations that are part of the SGF. JF and AZ are supported by the Gravitation grant ExposomeNL from the from the Dutch Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) (024.004.017). AZ is further supported by a European Research Council (ERC) Starting Grant (715772) and a NWO-VIDI grant (016.178.056). JF is supported by the NWO Gravitation Netherlands Organ-on-Chip Initiative (024.003.001) and the ERC Consolidator grant (101001678). JF and AZ are further supported by a grant from the Dutch Heart Foundation (CardioVasculair Onderzoek Nederland, CVON) (2018-27). CW is supported by the NWO Gravitation grant (024.003.001), a Spinoza award (NWO SPI 92-266) and a grant from the Netherlands' Top Institute Food and Nutrition (GH001).	Ananthakrishnan AN, 2017, CELL HOST MICROBE, V21, P603, DOI 10.1016/j.chom.2017.04.010; [Anonymous], 2012, LANG ENV STAT COMP; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; Chu ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170922; De Filippis F, 2018, INFLAMM BOWEL DIS, V24, P2142, DOI 10.1093/ibd/izy080; Del Savio L, 2017, GENET MED, V19, P959, DOI 10.1038/gim.2016.208; Dunn KA, 2016, INFLAMM BOWEL DIS, V22, P2853, DOI 10.1097/MIB.0000000000000956; Dunn KA, 2016, INFLAMM BOWEL DIS, V22, P2607, DOI 10.1097/MIB.0000000000000949; Fischer M, 2016, INFLAMM BOWEL DIS, V22, P2402, DOI 10.1097/MIB.0000000000000908; Forbes JD, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0603-4; Gharaibeh RZ, 2019, GUT, V68, P385, DOI 10.1136/gutjnl-2018-317220; Glymenaki M, 2017, INFLAMM BOWEL DIS, V23, P912, DOI 10.1097/MIB.0000000000001118; Goncalves P, 2018, INFLAMM BOWEL DIS, V24, P558, DOI 10.1093/ibd/izx029; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Imhann F, 2018, GUT, V67, P108, DOI 10.1136/gutjnl-2016-312135; Kahn SA, 2012, INFLAMM BOWEL DIS, V18, P676, DOI 10.1002/ibd.21775; Lecky DM, 2014, BRIT J GEN PRACT, V64, pE684, DOI 10.3399/bjgp14X682261; Magnusson MK, 2016, J CROHNS COLITIS, V10, P943, DOI 10.1093/ecco-jcc/jjw051; McNulty CAM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-77; McSweeney B, 2020, GUT MICROBES, V11, P51, DOI 10.1080/19490976.2019.1611153; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Narula N, 2017, INFLAMM BOWEL DIS, V23, P1702, DOI 10.1097/MIB.0000000000001228; O'Carroll RE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-849; Park L, 2017, ANN GASTROENTEROL, V30, P83, DOI 10.20524/aog.2016.0098; Prainsack B, 2013, MED LAW REV, V21, P71, DOI 10.1093/medlaw/fws040; Price CL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-103; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Sood A, 2009, MAYO CLIN PROC, V84, P243, DOI 10.1016/S0025-6196(11)61141-5; von Euler-Chelpin M, 2010, J PUBLIC HEALTH-UK, V32, P395, DOI 10.1093/pubmed/fdp115; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wu X, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819869144; Zeitz J, 2017, EUR J GASTROEN HEPAT, V29, P322, DOI 10.1097/MEG.0000000000000783	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249405	10.1371/journal.pone.0249405	http://dx.doi.org/10.1371/journal.pone.0249405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831035	Green Submitted, Green Published, gold			2022-12-26	WOS:000639359600004
J	Cho, SW; Kim, DY; Choi, S; Won, S; Kang, HR; Yi, H				Cho, Sung-Woo; Kim, Dong-Young; Choi, Sungmi; Won, Sungho; Kang, Hye-Ryun; Yi, Hana			Microbiome profiling of uncinate tissue and nasal polyps in patients with chronic rhinosinusitis using swab and tissue biopsy	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ALLERGIC RHINITIS; CYTOKINES; CELLS	Chronic rhinosinusitis (CRS) is characterized according to the presence or absence of nasal polyps (NPs) and displays nasal microbiota dysbiosis. However, optimal sampling methods of the nasal microbiome in CRS have not been identified. We aimed to assess the microbial composition in patients with CRS, comparing different sampling methods (swab and tissue biopsy), tissue types (uncinate tissue and NP), and disease subtypes. Samples were obtained by swabbing the middle meatus and taking a biopsy of uncinate tissue (UT) in patients with CRS with (CRSwNP, N = 8) or without NP (CRSsNP, N = 6) and controls (N = 8). NPs were also harvested in CRSwNP. DNAs were extracted from fifty-two samples and analyzed by 16S rRNA gene amplicon sequencing. As a result, a great interpersonal variance was observed in nasal swabs, while UT samples presented distinct microbiome with low inter-personal differences. Moreover, the UT microbiomes were further differentiated into three clusters which are associated with disease status (control, CRSsNP, and CRSwNP). Compared to UT, NP revealed a unique microbiome profile with significantly less bacterial diversity. Prevotella was the genus whose abundance was negatively correlated with disease severity in NP. In conclusion, tissue samples are better specimens than nasal swabs for assessing the microbiomes of CRS patients. Several bacteria in UT and NP tissues revealed an association with clinical severity of CRSwNP.	[Cho, Sung-Woo] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea; [Kim, Dong-Young] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea; [Choi, Sungmi] Korea Univ, Inst Biomat, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Dept Publ Hlth Sci, Seoul, South Korea; [Kang, Hye-Ryun] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Inst Allergy & Clin Immunol, Med Res Ctr, Seoul, South Korea; [Yi, Hana] Korea Univ, Interdisciplinary Program Precis Publ Hlth, Seoul, South Korea; [Yi, Hana] Korea Univ, Sch Biosyst & Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Korea University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea University; Korea University	Kang, HR (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.; Kang, HR (corresponding author), Seoul Natl Univ, Coll Med, Inst Allergy & Clin Immunol, Med Res Ctr, Seoul, South Korea.; Yi, H (corresponding author), Korea Univ, Interdisciplinary Program Precis Publ Hlth, Seoul, South Korea.; Yi, H (corresponding author), Korea Univ, Sch Biosyst & Biomed Sci, Seoul, South Korea.	helenmed@snu.ac.kr; hanayi@korea.ac.kr		Kang, Hye-Ryun/0000-0002-2317-4201	Seoul National University Hospital [03-2018-0030, 30-2016-0300]; Seoul National University Bundang Hospital [14-2018-031]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2019R1C1C1009886]	Seoul National University Hospital; Seoul National University Bundang Hospital; National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	1. D.-Y.K -Grant No. : 03-2018-0030 -Funder : Seoul National University Hospital (http://www.snuh.org/) -Role : Study design, data collection and analysis 2. H.-R.K -Grant No. : 30-2016-0300 -Funder : Seoul National University Hospital (http://www.snuh.org/) -Role : Study design, data collection and analysis 3. S.-W.C Grant No. : 14-2018-031 -Funder : Seoul National University Bundang Hospital (http://www.snubh.org/) -Role : Study design, data collection and analysis Grant No. : NRF-2019R1C1C1009886 -Funder : National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (http://www.nrf.re.kr/eng/index) -Role : preparation of the manuscript.	Ahn JC, 2016, JAMA OTOLARYNGOL, V142, P162, DOI 10.1001/jamaoto.2015.3142; Banerji A, 2007, AM J RHINOL, V21, P19, DOI 10.2500/ajr.2007.21.2979; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Biswas K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00134; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chalermwatanachai T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26327-2; Cheng C, 2020, TRANSL LUNG CANCER R, V9, P693, DOI 10.21037/tlcr-19-590; Choi EB, 2014, ALLERGY, V69, P517, DOI 10.1111/all.12374; Cleland EJ, 2013, INT FORUM ALLERGY RH, V3, P642, DOI 10.1002/alr.21159; Copeland E, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00057; Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI [10.4193/Rhino50E2, 10.4193/Rhino12.000]; Gordon A, 2010, FASTX TOOLKIT FASTQA; Hopkins C, 2007, OTOLARYNG HEAD NECK, V137, P555, DOI 10.1016/j.otohns.2007.02.004; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jain R, 2018, INT FORUM ALLERGY RH, V8, P890, DOI 10.1002/alr.22110; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Kim DK, 2019, ALLERGY ASTHMA IMMUN, V11, P201, DOI 10.4168/aair.2019.11.2.201; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Lal D, 2017, INT FORUM ALLERGY RH, V7, P561, DOI 10.1002/alr.21934; Mackenzie BW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53975-9; Mangalam A, 2017, CELL REP, V20, P1269, DOI 10.1016/j.celrep.2017.07.031; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Min JY, 2017, J ALLERGY CLIN IMMUN, V139, P130, DOI 10.1016/j.jaci.2016.07.020; Ramakrishnan VR, 2017, INT FORUM ALLERGY RH, V7, P16, DOI 10.1002/alr.21854; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sistek D, 2001, EUR RESPIR J, V17, P214, DOI 10.1183/09031936.01.17202140; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Sverrild A, 2017, J ALLERGY CLIN IMMUN, V140, P407, DOI 10.1016/j.jaci.2016.10.046; Taylor SL, 2018, J ALLERGY CLIN IMMUN, V141, P94, DOI 10.1016/j.jaci.2017.03.044; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Toros SZ, 2007, EUR ARCH OTO-RHINO-L, V264, P1003, DOI 10.1007/s00405-007-0301-5; Udayappan SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181693; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Weibman AR, 2017, INT FORUM ALLERGY RH, V7, P1058, DOI 10.1002/alr.22005; Witten IH, 2011, MOR KAUF D, P1; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	42	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249688	10.1371/journal.pone.0249688	http://dx.doi.org/10.1371/journal.pone.0249688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831071	gold, Green Published			2022-12-26	WOS:000639359600076
J	Hewage, S; Somasundaram, N; Ratnasamy, V; Ranathunga, I; Fernando, A; Perera, I; Perera, U; Vidanagama, D; Cader, M; Fernando, P; Pallewatte, N; Rathnayaka, L; Jayawardhana, D; Danansuriya, M; Gunawardena, N				Hewage, Sumudu; Somasundaram, Noel; Ratnasamy, Vithiya; Ranathunga, Ishara; Fernando, Amitha; Perera, Indika; Perera, Udara; Vidanagama, Dhammika; Cader, Mizaya; Fernando, Poorna; Pallewatte, Nirupa; Rathnayaka, Lakmal; Jayawardhana, Dushani; Danansuriya, Manjula; Gunawardena, Nalika			Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka	PLOS ONE			English	Article							RISK-FACTORS	End TB strategy by the WHO suggest active screening of high-risk populations for tuberculosis (TB) to improve case detection. Present study generates evidence for the effectiveness of screening patients with diabetes mellitus (DM) for Pulmonary TB (PTB). A study was conducted among 4548 systematically recruited patients over 45 years attending DM clinic at the National Hospital of Sri Lanka. The study units followed an algorithm specifying TB symptom and risk factor screening for all, followed by investigations and clinical assessments for those indicated. Bacteriologically confirmed or clinically diagnosed PTB were presented as proportions with 95% CI. Mean (SD) age was 62 center dot 5 (29 center dot 1) years. Among patients who completed all indicated steps of algorithm, 3500 (76 center dot 9%) were investigated and 127 (2 center dot 8%) underwent clinical assessment. Proportion of bacteriologically confirmed PTB patients was 0 center dot 1% (n = 6,95%CI = 0 center dot 0-0 center dot 3%). None were detected clinically. Analysis revealed PTB detection rates among males aged >= 60 years with HbA1c >= 8 to be 0 center dot 4% (n = 2, 95%CI = 0 center dot 0-1 center dot 4%). The study concludes that active screening for PTB among all DM patients at clinic settings in Sri Lanka, to be non-effective measure to enhance TB case finding. However, the sub-category of diabetic males with uncontrolled diabetics who are over 60 years of age is recommended as an option to consider for active screening for PTB.	[Hewage, Sumudu; Fernando, Amitha; Cader, Mizaya; Pallewatte, Nirupa; Rathnayaka, Lakmal; Jayawardhana, Dushani] Minist Hlth, Natl Program TB Control & Chest Dis, Colombo, Sri Lanka; [Somasundaram, Noel; Ratnasamy, Vithiya; Ranathunga, Ishara] Natl Hosp Sri Lanka, Diabet & Endocrinol Unit, Colombo, Sri Lanka; [Perera, Indika] Cent Chest Clin, Colombo, Sri Lanka; [Perera, Udara; Fernando, Poorna] Minist Hlth, Hlth Informat Unit, Colombo, Sri Lanka; [Vidanagama, Dhammika] Natl Hosp Sri Lanka, Microbiol Dept, Colombo, Sri Lanka; [Danansuriya, Manjula; Gunawardena, Nalika] WHO Country Off Sri Lanka, Colombo, Sri Lanka		Hewage, S (corresponding author), Minist Hlth, Natl Program TB Control & Chest Dis, Colombo, Sri Lanka.	sumuduavanthi@gmail.com	Hewage, Sumudu Avanthi/H-9218-2017	Hewage, Sumudu Avanthi/0000-0001-8079-4338; Fernando, Poorna/0000-0003-3848-7371	World Health Organization	World Health Organization(World Health Organization)	This study was funded by the World Health Organization. The technical staff of the World Health Organization also contributed to the design of the study, analysis and interpretation of data.	Arambewela MH, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/4504287; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Chen CH, 2006, TRANSPL INFECT DIS, V8, P148, DOI 10.1111/j.1399-3062.2006.00147.x; De Silva AP, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0759-3; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Ekeke N, 2020, ADV RESPIR MED, V88, P6, DOI 10.5603/ARM.2020.0072; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kamper-Jorgensen Z, 2015, INT J TUBERC LUNG D, V19, P1169, DOI 10.5588/ijtld.14.0932; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Kumar A, 2013, TROP MED INT HEALTH, V18, P646, DOI 10.1111/tmi.12083; Kumpatla S, 2013, PUBLIC HEALTH ACTION, V3, pS23, DOI 10.5588/pha.13.0035; Lin Y, 2015, TROP MED INT HEALTH, V20, P1073, DOI 10.1111/tmi.12519; Liu QQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01213-5; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mave V, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2483-9; Ministry of Health and World Health Organization, 2015, NONC DIS RISK FACT S; Ministry of Health Nutrition and Indigenous Medicine World Health Organization, 2015, NONC DIS RISK FACT S; Morsy A M, 2003, East Mediterr Health J, V9, P689; MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187; Mullins J, 2012, LANCET, V380, P635, DOI 10.1016/S0140-6736(12)61355-5; National Programme for Tuberculosis Control and Chest Diseases, ANN REP 2019; National Programme for Tuberculosis Control and Chest Diseases, 2018, END TUB AIDS SRI LAN; National Programme for Tuberculosis Control and Chest Diseases, 2017, NAT HLTH RES S; National Sexually Acquired Disease Control Programme, ANN REP 2018; Nunn P, 2017, MIDTERM REV NATL TB; Pizzol D, 2016, TROP MED INT HEALTH, V21, P694, DOI 10.1111/tmi.12704; Rawat J, 2011, LUNG INDIA, V28, P187, DOI 10.4103/0970-2113.83975; Senanayake MGB, 2018, MULTIDISCIP RESP MED, V13, DOI 10.1186/s40248-018-0121-z; Somasundaram NP, 2019, SRI LANKA J DIABETES, DOI [10.4038/sjdem.v9i2.7393, DOI 10.4038/SJDEM.V9I2.7393]; Trinidad R M, 2016, J Clin Tuberc Other Mycobact Dis, V5, P4, DOI 10.1016/j.jctube.2016.10.001; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2014, END TB STRAT; WHO, 2020, GLOB TB REP; World Health Organization, 2018, TUB PROF SRI LANK; World Health Organization, TUB FACT SHEET; World Health Organization, CHEST RAD TUB DIAGN; World Health Organization, SRI LANK TUB COUNTR; World Health Organization and International Union against Tuberculosis and Lung Disease, 2011, COLLABORATIVE FRAMEW; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x; Young F, 2012, J EPIDEMIOL COMMUN H, V66, P519, DOI 10.1136/jech.2010.114595; Zhao WJ, 2013, DIABETES CARE, V36, pE159, DOI 10.2337/dc13-1007; Zheng CL, 2017, GLOBAL HEALTH ACTION, V10, P1, DOI 10.1080/16549716.2016.1264702	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249787	10.1371/journal.pone.0249787	http://dx.doi.org/10.1371/journal.pone.0249787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831095	Green Published, gold			2022-12-26	WOS:000639359600112
J	Janz, L; Rosen, AM; Bukhchuluun, D; Odsuren, D				Janz, Lisa; Rosen, Arlene M.; Bukhchuluun, Dashzeveg; Odsuren, Davaakhuu			Zaraa Uul: An archaeological record of Pleistocene-Holocene palaeoecology in the Gobi Desert	PLOS ONE			English	Article							RECONSTRUCTION; LANDSCAPES; WETLANDS; CONTEXT	Environmentally-based archaeological research at Zaraa Uul, including zooarchaeology, phytolith analysis, and radiocarbon dating, is the first of its kind in Mongolia and presents critical new insight on the relationship between periods of occupational intensity and climatic amelioration from the earliest anatomically modern humans to the adoption of pastoralism. The palaeoenvironmental and faunal record of Zaraa Uul show that Early-Middle Holocene hydrology and species distributions were distinct from all other periods of human occupation. Holocene hunter-gatherers inhabited an ecosystem characterized by extensive marshes, riparian shrub and arboreal vegetation along the hill slopes and drainages. The exploitation of species associated with riparian and wetland settings supports the hypothesis of, but suggests an earlier timing for, oasis-based logistical foraging during the Early-Middle Holocene of arid Northeast Asia. The onset of wetter conditions at 8500 cal BP agrees with other regional studies, but multiple lines of evidence present the first integrated field- and laboratory-based record of human-environment relationships in arid East Asia during the Holocene Climatic Optimum. We compare it to Late Pleistocene climatic amelioration, and highlight specific responses of the hydrological, vegetative and faunal communities to climate change in arid Northeast Asia.	[Janz, Lisa] Trent Univ, Dept Anthropol, Peterborough, ON, Canada; [Janz, Lisa] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Rosen, Arlene M.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Bukhchuluun, Dashzeveg; Odsuren, Davaakhuu] Mongolian Acad Sci, Inst Archaeol, Ulaanbaatar, Mongolia; [Bukhchuluun, Dashzeveg] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	Trent University; University of Arizona; University of Texas System; University of Texas Austin; Mongolian Academy of Sciences; Yale University	Janz, L (corresponding author), Trent Univ, Dept Anthropol, Peterborough, ON, Canada.; Janz, L (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	lisajanz@trentu.ca		Dashzeveg, Bukhchuluun/0000-0002-5858-0269	American Philosophical Society Franklin Grant; Wenner-Gren Foundation [9050]; Social Sciences and Humanities Research Council of Canada [756-2015-0019, 430-2016-00173]; Roberta Bondar Postdoctoral Fellowship in Northern and Polar Studies, Trent University	American Philosophical Society Franklin Grant; Wenner-Gren Foundation; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Roberta Bondar Postdoctoral Fellowship in Northern and Polar Studies, Trent University	Funding for this research was provided to LJ by the American Philosophical Society Franklin Grant (https://www.amphilsoc.org/), the WennerGren Foundation (Grant No. 9050)(http://www.wennergren.org/), and the Social Sciences and Humanities Research Council of Canada's Post Doctoral Fellowship (Grant No. 756-2015-0019) and Insight Development Grant (Grant No. 430-2016-00173)(https://www.sshrc-crsh.gc.ca).LJ was partially supported by the Roberta Bondar Postdoctoral Fellowship in Northern and Polar Studies, Trent University (https://www.trentu.ca/frostcentre/bfellowship).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LJ: Association for Asian Studies, China and Inner Asia Council Small Grants for Short Research Travel Professors/Independent Scholars (https://www.asianstudies.org).	Batbaatar J, 2018, QUATERNARY SCI REV, V182, P1, DOI 10.1016/j.quascirev.2017.12.001; Batsaikhan N., 2010, FIELD GUIDE MAMMALS; Bazarova VB, 2019, QUATERN INT, V503, P105, DOI 10.1016/j.quaint.2018.10.017; Beaumont W, 2010, NUCL INSTRUM METH B, V268, P906, DOI 10.1016/j.nimb.2009.10.061; Berkey CP., 1926, AM MUS NOVIT, V222, P9; Boessneck J., 1963, SEEBURG BURG SCHISEE, V3; Boldbaatar Sh., 2013, PHOTOGUIDE BIRDS MON, V2; Capriles JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5449; Crann CA, 2017, RADIOCARBON, V59, P695, DOI 10.1017/RDC.2016.55; Dunne J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.194; Elston RG, 2014, QUATERN INT, V352, P200, DOI 10.1016/j.quaint.2014.09.064; Evoy A., 2019, THESIS TRENDS U; Fairservis WA., 1993, ARCHAEOLOGY SO GOBI; Felauer T, 2012, J ASIAN EARTH SCI, V48, P125, DOI 10.1016/j.jseaes.2011.12.002; Feng ZD, 2007, PALAEOGEOGR PALAEOCL, V245, P505, DOI 10.1016/j.palaeo.2006.09.009; Fuller DQ, 2010, ENVIRON ARCHAEOL, V15, P139, DOI 10.1179/146141010X12640787648531; Gabori M, 1962, ACTA ARCHAEOL BUD, VXIV, P59; Gamble C., 1986, HUNTERS TRANSITION M, P33; Gladyshev SA, 2010, ARCHAEOL ETHNOL ANTH, V38, P33, DOI 10.1016/j.aeae.2010.10.003; Grunert J., 2004, PALEOECOLOGY QUATERN, P195, DOI DOI 10.1007/978-3-540-44930-0_11; Guthrie R.D., 1984, P259; Habu J., 2014, CAMBRIDGE WORLD PREH, P724; Hedin S., 1943, HIST EXPEDITION ASIA; Herzschuh U, 2006, QUATERNARY SCI REV, V25, P163, DOI 10.1016/j.quascirev.2005.02.006; Hillman GC, 1989, FORAGING FARMING EVO, P207; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Holguin LR, 2018, ARCHAEOL RES ASIA, V15, P137, DOI 10.1016/j.ara.2016.12.001; Honeychurch W., 2015, INNER ASIA SPATIAL P; Janz L., 2012, THESIS U ARIZONA; Janz L, 2017, J WORLD PREHIST, V30, P1, DOI 10.1007/s10963-016-9100-5; Janz L, 2016, CURR ANTHROPOL, V57, P537, DOI 10.1086/688436; Janz L, 2015, J ARCHAEOL SCI, V57, P119, DOI 10.1016/j.jas.2015.02.006; Janz L, 2009, J ARCHAEOL SCI, V36, P1982, DOI 10.1016/j.jas.2009.05.012; Jigjidsuren S., 2003, FORAGE PLANTS MONGOL; Kozlowski JK., 1972, ARCHAEOL POL, V13, P231; Lee MK, 2013, J QUATERNARY SCI, V28, P370, DOI 10.1002/jqs.2626; Lu P, 2017, ASIAN PERSPECT, V56, P92, DOI 10.1353/asi.2017.0003; Maringer J., 1950, CONTRIBUTION PREHIST; Mccuaig Balkwill D., 1992, GUIDE IDENTIFICATION; Nelson NC, 1926, AM ANTHROPOL, V28, P305, DOI 10.1525/aa.1926.28.1.02a00180; Nelson NC., 1925, DIARY CENTRAL ASIATI; Nelson NC., 1926, NAT HIST, V26, P246; Nicholas GP, 1998, CURR ANTHROPOL, V39, P720, DOI 10.1086/204795; Odsuren D., 2017, MONG ARCHAEOL, V2016, P22; Odsuren D., 2015, STUD ARCHAEOL, V35, P72; Okladnikov AP., 1962, SOV ETNOGRAFIYA, V1, P83; Okladnikov AP., 1951, VESTN DREVNEJ ISTOR, V4, P162; Perlee Kh., 1957, SCI TECHNOL MONG, P5; Popov AN, 2014, J WORLD PREHIST, V27, P247, DOI 10.1007/s10963-014-9073-1; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Ramsey MN, 2016, QUATERN INT, V396, P5, DOI 10.1016/j.quaint.2015.10.109; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Rosen A.M., PLOS ONE; Rosen AM, 2019, VEG HIST ARCHAEOBOT, V28, P295, DOI 10.1007/s00334-018-0710-y; Shelach-Lavi G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218751; Shi YF, 2001, PALAEOGEOGR PALAEOCL, V169, P69, DOI 10.1016/S0031-0182(01)00216-4; Smith BD, 2011, CURR ANTHROPOL, V52, pS471, DOI 10.1086/659645; Stephens L, 2019, SCIENCE, V365, P897, DOI 10.1126/science.aax1192; Stuart AJ, 2004, NATURE, V431, P684, DOI 10.1038/nature02890; Tumen D., 2014, ASIAN ARCHAEOLOGY, V2, P40; Wen RL, 2017, QUATERNARY SCI REV, V176, P29, DOI 10.1016/j.quascirev.2017.10.008; Winkler Marjorie G., 1993, P221; Wright J, 2019, ANTIQUITY, V93, P393, DOI 10.15184/aqy.2018.174; Zhao C, 2021, ANTIQUITY, V95, P45, DOI 10.15184/aqy.2020.236; Zwyns N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47972-1	65	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249848	10.1371/journal.pone.0249848	http://dx.doi.org/10.1371/journal.pone.0249848			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831092	Green Published, gold			2022-12-26	WOS:000639359600067
J	Tawa, M; Nagata, R; Sumi, Y; Nakagawa, K; Sawano, T; Ohkita, M; Matsumura, Y				Tawa, Masashi; Nagata, Rikako; Sumi, Yuiko; Nakagawa, Keisuke; Sawano, Tatsuya; Ohkita, Mamoru; Matsumura, Yasuo			Preventive effects of nitrate-rich beetroot juice supplementation on monocrotaline-induced pulmonary hypertension in rats	PLOS ONE			English	Article							DIETARY NITRATE; NITRIC-OXIDE; BLOOD-PRESSURE; DOUBLE-BLIND; HEART-FAILURE; EXERCISE; SYNTHASE; CGMP; NO	Beetroot (Beta vulgaris L.) has a high level of nitrate; therefore, its dietary intake could increase nitric oxide (NO) level in the body, possibly preventing the development of pulmonary hypertension (PH). In this study, we examined the effects of beetroot juice (BJ) supplementation on PH and the contribution of nitrate to such effects using a rat model of monocrotaline (MCT, 60 mg/kg s.c.)-induced PH. Rats were injected subcutaneously with saline or 60 mg/kg MCT and were sacrificed 28 days after the injection. In some rats injected with MCT, BJ was supplemented from the day of MCT injection to the day of sacrifice. First, MCT-induced right ventricular systolic pressure elevation, pulmonary arterial medial thickening and muscularization, and right ventricular hypertrophy were suppressed by supplementation with low-dose BJ (nitrate: 1.3 mmol/L) but not high-dose BJ (nitrate: 4.3 mmol/L). Of the plasma nitrite, nitrate, and their sum (NOx) levels, only the nitrate levels were found to be increased by the high-dose BJ supplementation. Second, in order to clarify the possible involvement of nitrate in the preventive effects of BJ on PH symptoms, the effects of nitrate-rich BJ (nitrate: 0.9 mmol/L) supplementation were compared with those of the nitrate-depleted BJ. While the former exerted preventive effects on PH symptoms, such effects were not observed in rats supplemented with nitrate-depleted BJ. Neither supplementation with nitrate-rich nor nitrate-depleted BJ affected plasma nitrite, nitrate, and NOx levels. These findings suggest that a suitable amount of BJ ingestion, which does not affect systemic NO levels, can prevent the development of PH in a nitrate-dependent manner. Therefore, BJ could be highly useful as a therapy in patients with PH.	[Tawa, Masashi; Nagata, Rikako; Sumi, Yuiko; Nakagawa, Keisuke; Sawano, Tatsuya; Ohkita, Mamoru; Matsumura, Yasuo] Osaka Univ Pharmaceut Sci, Lab Pathol & Mol Pharmacol, Osaka, Japan; [Tawa, Masashi] Kanazawa Med Univ, Dept Pharmacol, Kahoku, Ishikawa, Japan; [Sawano, Tatsuya] Tottori Univ, Fac Med, Div Mol Pharmacol, Yonago, Tottori, Japan	Osaka University of Pharmaceutical Sciences; Kanazawa Medical University; Tottori University	Tawa, M (corresponding author), Osaka Univ Pharmaceut Sci, Lab Pathol & Mol Pharmacol, Osaka, Japan.; Tawa, M (corresponding author), Kanazawa Med Univ, Dept Pharmacol, Kahoku, Ishikawa, Japan.	masashi.tawa@ompu.ac.jp		Tawa, Masashi/0000-0002-9282-0828; Sawano, Tatsuya/0000-0003-1713-2045				Abdul-Salam VB, 2019, CIRC RES, V124, P52, DOI 10.1161/CIRCRESAHA.118.313705; Abman SH, 2013, HANDB EXP PHARMACOL, V218, P257, DOI 10.1007/978-3-642-38664-0_11; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Bahadoran Z, 2017, ADV NUTR, V8, P830, DOI 10.3945/an.117.016717; Bakker JR, 2016, FREE RADICAL BIO MED, V99, P189, DOI 10.1016/j.freeradbiomed.2016.08.009; Baliga RS, 2012, CIRCULATION, V125, P2922, DOI 10.1161/CIRCULATIONAHA.112.100586; Baybutt RC, 1999, TOXICOLOGY, V137, P69, DOI 10.1016/S0300-483X(99)00060-8; Bhaswant M, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700478; Bubb KJ, 2014, CIRCULATION, V130, P496, DOI 10.1161/CIRCULATIONAHA.114.009751; Carlstrom M, 2015, ANTIOXID REDOX SIGN, V23, P295, DOI 10.1089/ars.2013.5481; Chhikara N, 2019, FOOD CHEM, V272, P192, DOI 10.1016/j.foodchem.2018.08.022; de Jong JW, 2000, J MOL CELL CARDIOL, V32, P2083, DOI 10.1006/jmcc.2000.1240; DeMartino AW, 2019, BRIT J PHARMACOL, V176, P228, DOI 10.1111/bph.14484; Gall H, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-015-0164-2; Henrohn D, 2018, J CARD FAIL, V24, P640, DOI 10.1016/j.cardfail.2018.09.010; Hobbs DA, 2012, BRIT J NUTR, V108, P2066, DOI 10.1017/S0007114512000190; Hoeper MM, 2018, INT J CARDIOL, V272, P37, DOI 10.1016/j.ijcard.2018.08.082; Kapil V, 2020, PHARMACOL REV, V72, P692, DOI 10.1124/pr.120.019240; Kapil V, 2015, HYPERTENSION, V65, P320, DOI 10.1161/HYPERTENSIONAHA.114.04675; Kerley CP, 2018, BRIT J NUTR, V119, P658, DOI 10.1017/S0007114518000144; Kirtania L, 2019, CLIN DRUG INVEST, V39, P1031, DOI 10.1007/s40261-019-00841-1; Klewicka E, 2015, NUTRIENTS, V7, P5905, DOI 10.3390/nu7075260; Lionetti V, 2019, EUR HEART J, V40, P575, DOI 10.1093/eurheartj/ehy597; Malikova E, 2020, BASIC CLIN PHARMACOL, V126, P99, DOI 10.1111/bcpt.13309; Montenegro MF, 2016, REDOX BIOL, V10, P206, DOI 10.1016/j.redox.2016.10.011; Morales-Cano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114492; Morris RC, 2019, HYPERTENSION, V73, P1042, DOI 10.1161/HYPERTENSIONAHA.118.12234; Ogoshi T, 2018, AM J RESP CRIT CARE, V198, P232, DOI 10.1164/rccm.201709-1783OC; Omar SA, 2014, J MOL CELL CARDIOL, V73, P57, DOI 10.1016/j.yjmcc.2014.01.012; Pankey EA, 2012, NITRIC OXIDE-BIOL CH, V27, P1, DOI 10.1016/j.niox.2012.02.004; Rathod KS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012728; Rocha BS, 2019, NITRIC OXIDE-BIOL CH, V88, P27, DOI 10.1016/j.niox.2019.04.001; Sandner P, 2018, NITRIC OXIDE-BIOL CH, V77, P88, DOI 10.1016/j.niox.2018.05.001; Shaltout HA, 2017, NITRIC OXIDE-BIOL CH, V69, P78, DOI 10.1016/j.niox.2017.05.005; Sharma RK, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00253-2019; Sharma RK, 2020, HYPERTENSION, V76, P206, DOI 10.1161/HYPERTENSIONAHA.120.14931; Socco S, 2017, PHARMACOL RES, V121, P52, DOI 10.1016/j.phrs.2017.04.011; Steven S, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4353462; Tawa M, 2019, AM J HYPERTENS, V32, P216, DOI 10.1093/ajh/hpy144; Tawa M, 2018, LIFE SCI, V203, P203, DOI 10.1016/j.lfs.2018.04.045; Thenappan T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5492; Tropea T, 2020, J PHYSIOL-LONDON, V598, P4079, DOI [10.1113/JP279655, 10.1113/JP280091]; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Velmurugan S, 2016, AM J CLIN NUTR, V103, P25, DOI 10.3945/ajcn.115.116244; Velmurugan S, 2013, FREE RADICAL BIO MED, V65, P1521, DOI 10.1016/j.freeradbiomed.2013.06.031; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Woessner M, 2018, CIRC RES, V123, P654, DOI 10.1161/CIRCRESAHA.118.313131; Woessner MN, 2020, J APPL PHYSIOL, V128, P1355, DOI 10.1152/japplphysiol.00850.2019; Zamani P, 2015, CIRCULATION, V131, P371, DOI 10.1161/CIRCULATIONAHA.114.012957; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249816	10.1371/journal.pone.0249816	http://dx.doi.org/10.1371/journal.pone.0249816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831045	gold, Green Published			2022-12-26	WOS:000639359600021
J	Kvaslerud, AB; Santic, K; Hussain, AI; Auensen, A; Fiane, A; Skulstad, H; Aaberge, L; Gullestad, L; Broch, K				Kvaslerud, Anette Borger; Santic, Kenan; Hussain, Amjad Iqbal; Auensen, Andreas; Fiane, Arnt; Skulstad, Helge; Aaberge, Lars; Gullestad, Lars; Broch, Kaspar			Outcomes in asymptomatic, severe aortic stenosis	PLOS ONE			English	Article							VALVULAR HEART-DISEASE; NATURAL-HISTORY; MANAGEMENT; GUIDELINES; SURGERY; ADULTS	Background and aim of the study Patients with asymptomatic, severe aortic stenosis are presumed to have a benign prognosis. In this retrospective cohort study, we examined the natural history of contemporary patients advised against aortic valve replacement due to a perceived lack of symptoms. Materials and methods We reviewed the medical records of every patient given the ICD-10-code for aortic stenosis (I35.0) at Oslo University Hospital, Rikshospitalet, between Dec 1(st), 2002 and Dec 31(st), 2016. Patients who were evaluated by the heart team due to severe aortic stenosis were categorized by treatment strategy. We recorded baseline data, adverse events and survival for the patients characterized as asymptomatic and for 100 age and gender matched patients scheduled for aortic valve replacement. Results Of 2341 patients who were evaluated for aortic valve replacement due to severe aortic stenosis, 114 patients received conservative treatment due to a lack of symptoms. Asymptomatic patients had higher mortality than patients who had aortic valve replacement, log-rank p<0.001 (mean follow-up time: 4.0 (SD: 2.5) years). Survival at 1, 2 and 3 years for the asymptomatic patients was 88%, 75% and 63%, compared with 92%, 83% and 78% in the matched patients scheduled for aortic valve replacement. 28 (25%) of the asymptomatic patients had aortic valve replacement during follow-up. Age, previous history of coronary artery disease and N-terminal pro B-type natriuretic peptide (NT-proBNP) were predictors of mortality and coronary artery disease and NT-proBNP were predictors of 3-year morbidity in asymptomatic patients. Conclusions In this retrospective study, asymptomatic patients with severe aortic stenosis who were advised against surgery had significantly higher mortality than patients who had aortic valve replacement.	[Kvaslerud, Anette Borger; Santic, Kenan; Auensen, Andreas; Fiane, Arnt; Skulstad, Helge; Gullestad, Lars] Univ Oslo, Fac Med, Oslo, Norway; [Kvaslerud, Anette Borger; Hussain, Amjad Iqbal; Auensen, Andreas; Skulstad, Helge; Aaberge, Lars; Gullestad, Lars; Broch, Kaspar] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Kvaslerud, Anette Borger; Hussain, Amjad Iqbal; Auensen, Andreas; Gullestad, Lars; Broch, Kaspar] Oslo Univ Hosp, KG Jebsen Cardiac Res Ctr, Ulleval, Norway; [Kvaslerud, Anette Borger; Hussain, Amjad Iqbal; Auensen, Andreas; Gullestad, Lars; Broch, Kaspar] Oslo Univ Hosp, Ctr Heart Failure Res, Ulleval, Norway; [Fiane, Arnt] Oslo Univ Hosp, Rikshosp, Dept Cardiothorac Surg, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Kvaslerud, AB (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.; Kvaslerud, AB (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway.; Kvaslerud, AB (corresponding author), Oslo Univ Hosp, KG Jebsen Cardiac Res Ctr, Ulleval, Norway.; Kvaslerud, AB (corresponding author), Oslo Univ Hosp, Ctr Heart Failure Res, Ulleval, Norway.	a.b.kvaslerud@medisin.uio.no		Kvaslerud, Anette Borger/0000-0001-9923-2685				Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Bohbot Y, 2018, J AM COLL CARDIOL, V72, P2938, DOI 10.1016/j.jacc.2018.09.049; Bouhout I, 2019, ANN THORAC SURG, V108, P79, DOI 10.1016/j.athoracsur.2019.01.043; Campo J, 2019, ANN THORAC SURG, V108, P74, DOI 10.1016/j.athoracsur.2019.01.031; Cattaneo M, 2017, STATA J, V17, P1015, DOI 10.1177/1536867X1701700415; Genereux P, 2016, J AM COLL CARDIOL, V67, P2263, DOI 10.1016/j.jacc.2016.02.057; George SA, 2019, J INVASIVE CARDIOL, V31, P166; Henchoz Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014485; Kang DH, 2020, NEW ENGL J MED, V382, P111, DOI 10.1056/NEJMoa1912846; Kim HJ, 2019, AM J CARDIOL, V123, P1321, DOI 10.1016/j.amjcard.2019.01.035; Lancellotti P, 2018, JAMA CARDIOL, V3, P1060, DOI 10.1001/jamacardio.2018.3152; Lim WY, 2017, HEART, V103, P268, DOI 10.1136/heartjnl-2016-309830; Morgan R, 1997, BRIT J GEN PRACT, V47, P427; Nakatsuma K, 2019, HEART, V105, P384, DOI 10.1136/heartjnl-2018-313746; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Pai RG, 2006, ANN THORAC SURG, V82, P2116, DOI 10.1016/j.athoracsur.2006.07.043; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012, DOI 10.1016/0735-1097(90)90234-G; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61; *STROBE STAT, 2007, STROBE CHECKL VERS 4; Taniguchi T, 2015, J AM COLL CARDIOL, V66, P2827, DOI 10.1016/j.jacc.2015.10.001; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455	23	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249610	10.1371/journal.pone.0249610	http://dx.doi.org/10.1371/journal.pone.0249610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826652	gold, Green Published			2022-12-26	WOS:000638119900018
J	Eickelschulte, S; Hartwig, S; Leiser, B; Lehr, S; Joschko, V; Chokkalingam, M; Chadt, A; Al-Hasani, H				Eickelschulte, Samaneh; Hartwig, Sonja; Leiser, Ben; Lehr, Stefan; Joschko, Viola; Chokkalingam, Manopriya; Chadt, Alexandra; Al-Hasani, Hadi			AKT/AMPK-mediated phosphorylation of TBC1D4 disrupts the interaction with insulin-regulated aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-UPTAKE; SKELETAL-MUSCLE; AS160 PHOSPHORYLATION; GLUT4 TRANSLOCATION; DOMAIN FAMILY; EXERCISE; SENSITIVITY; ACTIVATION; INCREASES; TRANSPORT	TBC1D4 is a 160 kDa multidomain Rab GTPase-activating protein (RabGAP) and a downstream target of the insulin- and contraction-activated kinases AKT and AMPK. Phosphorylation of TBC1D4 has been linked to translocation of GLUT4 from storage vesicles (GSVs) to the cell surface. However, its impact on enzymatic activity is not well understood, as previous studies mostly investigated the truncated GAP domain lacking the known phosphorylation sites. In the present study, we expressed and purified recombinant full-length TBC1D4 using a baculovirus system. Size-exclusion chromatography and coimmunoprecipitation experiments revealed that full-length TBC1D4 forms oligomers of similar to 600 kDa. Compared with the truncated GAP domain, full-length TBC1D4 displayed similar substrate specificity, but had a markedly higher specific GAP activity toward Rab10. Using high-resolution mass spectrometry, we mapped 19 Ser/Thr phosphorylation sites in TBC1D4. We determined Michaelis-Menten kinetics using in vitro phosphorylation assays with purified kinases and stable isotopelabeled gamma-[O-18(4)]-ATP. These data revealed that Ser(324) (K-M similar to 6 mu M) and Thr(649) (K-M similar to 25 mu M) were preferential sites for phosphorylation by AKT, whereas Ser(348), Ser(577), Ser(595) (K-M similar to 10 mu M), Ser(711) (K-M similar to 79 mu M), and Ser(764) were found to be preferred targets for AMPK. Phosphorylation of TBC1D4 by AKT or AMPK did not alter the intrinsic RabGAP activity, but did disrupt interaction with insulin-regulated aminopeptidase (IRAP), a resident protein of GSVs implicated in GLUT4 trafficking. These findings provide evidence that insulin and contraction may regulate TBC1D4 function primarily by disrupting the recruitment of the RabGAP to GLUT4 vesicles.	[Eickelschulte, Samaneh; Hartwig, Sonja; Leiser, Ben; Lehr, Stefan; Joschko, Viola; Chokkalingam, Manopriya; Chadt, Alexandra; Al-Hasani, Hadi] Heinrich Heine Univ, Med Fac, Inst Clin Biochem & Pathobiochem, German Diabet Ctr,Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Eickelschulte, Samaneh; Hartwig, Sonja; Lehr, Stefan; Chokkalingam, Manopriya; Chadt, Alexandra; Al-Hasani, Hadi] German Ctr Diabet Res DZD, Partner Dusseldorf, Munich, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Al-Hasani, H (corresponding author), Heinrich Heine Univ, Med Fac, Inst Clin Biochem & Pathobiochem, German Diabet Ctr,Leibniz Ctr Diabet Res, Dusseldorf, Germany.; Al-Hasani, H (corresponding author), German Ctr Diabet Res DZD, Partner Dusseldorf, Munich, Germany.	hadi.al-hasani@ddz.de		Eickelschulte, Samaneh/0000-0002-8040-8393; Leiser, Ben/0000-0001-6470-4750	Deutsche Forschungsgemeinschaft [SFB1116]; EFSD/Novo Nordisk European Diabetes Research Program; DDG Allgemeine Projektforderung 2020	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EFSD/Novo Nordisk European Diabetes Research Program; DDG Allgemeine Projektforderung 2020	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB1116), the EFSD/Novo Nordisk European Diabetes Research Program (to H. A.), and DDG Allgemeine Projektforderung 2020 (to S. E.).	An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Consitt LA, 2013, DIABETES, V62, P3437, DOI 10.2337/db13-0229; Ducommun S, 2012, AM J PHYSIOL-ENDOC M, V302, pE1036, DOI 10.1152/ajpendo.00379.2011; Funai K, 2010, AM J PHYSIOL-ENDOC M, V298, pE999, DOI 10.1152/ajpendo.00758.2009; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Guerra B, 2010, EUR J APPL PHYSIOL, V109, P731, DOI 10.1007/s00421-010-1413-y; Hamada T, 2006, J APPL PHYSIOL, V101, P1368, DOI 10.1152/japplphysiol.00416.2006; Hansen PA, 1998, J APPL PHYSIOL, V85, P1218, DOI 10.1152/jappl.1998.85.4.1218; Hartwig S, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2018.11.009; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Kido K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65397-z; Kjobsted R, 2019, DIABETES, V68, P1756, DOI 10.2337/db18-0769; Kjobsted R, 2017, DIABETES, V66, P598, DOI 10.2337/db16-0530; Kjobsted R, 2015, DIABETES, V64, P2042, DOI 10.2337/db14-1402; Klip A, 2019, J BIOL CHEM, V294, P11369, DOI 10.1074/jbc.REV119.008351; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Mafakheri S, 2018, J BIOL CHEM, V293, P17853, DOI 10.1074/jbc.RA118.005040; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Oki K, 2018, APPL PHYSIOL NUTR ME, V43, P795, DOI 10.1139/apnm-2017-0858; Park S, 2012, BMB REP, V45, P360, DOI 10.5483/BMBRep.2012.45.6.030; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Pehmoller C, 2012, DIABETES, V61, P2743, DOI 10.2337/db11-1572; Pencek RR, 2003, DIABETES, V52, P1897, DOI 10.2337/diabetes.52.8.1897; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rajamohan F, 2016, BIOCHEM J, V473, P581, DOI 10.1042/BJ20151051; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schweitzer GG, 2012, J APPL PHYSIOL, V113, P1852, DOI 10.1152/japplphysiol.00619.2012; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Treebak JT, 2010, AM J PHYSIOL-CELL PH, V298, pC377, DOI 10.1152/ajpcell.00297.2009; Vendelbo MH, 2014, J APPL PHYSIOL, V117, P289, DOI 10.1152/japplphysiol.00044.2014; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Woo JR, 2017, INT J BIOL MACROMOL, V103, P965, DOI 10.1016/j.ijbiomac.2017.05.119; Zhou Z, 2017, FEBS LETT, V591, P88, DOI 10.1002/1873-3468.12509	49	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100637	10.1016/j.jbc.2021.100637	http://dx.doi.org/10.1016/j.jbc.2021.100637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33872597	Green Published, gold			2022-12-26	WOS:000672866400608
J	Zhao, J; Kim, HJ; Ueda, K; Zhang, K; Montenegro, D; Dunaief, JL; Sparrow, JR				Zhao, Jin; Kim, Hye Jin; Ueda, Keiko; Zhang, Kevin; Montenegro, Diego; Dunaief, Joshua L.; Sparrow, Janet R.			A vicious cycle of bisretinoid formation and oxidation relevant to recessive Stargardt disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTITATIVE FUNDUS AUTOFLUORESCENCE; RETINAL-PIGMENT EPITHELIUM; CHELATOR DEFERIPRONE PROTECTS; MOUSE MODEL; SHORT-WAVELENGTH; RPE LIPOFUSCIN; IRON; DEGENERATION; HEPCIDIN; A2E	The ability of iron to transfer electrons enables the contribution of this metal to a variety of cellular activities even as the redox properties of iron are also responsible for the generation of hydroxyl radicals ((OH)-O-center dot), the most destructive of the reactive oxygen species. We previously showed that iron can promote the oxidation of bisretinoid by generating highly reactive hydroxyl radical ((OH)-O-center dot). Now we report that preservation of iron regulation in the retina is not sufficient to prevent ironinduced bisretinoid oxidative degradation when blood iron levels are elevated in liver-specific hepcidin knockout mice. We obtained evidence for the perpetuation of Fenton reactions in the presence of the bisretinoid A2E and visible light. On the other hand, iron chelation by deferiprone was not associated with changes in postbleaching recovery of 11-cis-retinal or dark-adapted ERG b-wave amplitudes indicating that the activity of Rpe65, a rate-determining visual cycle protein that carries an iron-binding domain, is not affected. Notably, iron levels were elevated in the neural retina and retinal pigment epithelial (RPE) cells of Abca4(-/-) mice. Consistent with higher iron content, ferritin-L immunostaining was elevated in RPE of a patient diagnosed with ABCA4-associated disease and in RPE and photoreceptor cells of Abca4(-/-) mice. In neural retina of the mutant mice, reduced Tfrc mRNA was also an indicator of retinal iron overload. Thus iron chelation may defend retina when bisretinoid toxicity is implicated in disease processes.	[Zhao, Jin; Kim, Hye Jin; Ueda, Keiko; Montenegro, Diego; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA; [Zhang, Kevin; Dunaief, Joshua L.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University; University of Pennsylvania; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA.; Sparrow, JR (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	jrs88@columbia.edu	Montenegro, Diego/AAZ-4321-2021	Montenegro, Diego/0000-0001-6892-7492	National Institutes of Health [EY028131, P30EY019007]; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported in whole or in part by the National Institutes of Health Grant EY028131 and P30EY019007 and by unrestricted funds from Research to Prevent Blindness to the Department of Ophthalmology, Columbia University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumann BH, 2019, AM J PATHOL, V189, P1814, DOI [10.1016/j.ajpath.2019.05.022, 10.1016/j.ajpath.2019.0.5.022]; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Chowers I, 2006, INVEST OPHTH VIS SCI, V47, P2135, DOI 10.1167/iovs.05-1135; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Crooks DR, 2018, J BIOL CHEM, V293, P8297, DOI 10.1074/jbc.RA118.001885; Delori F. C., 2007, ATLAS FUNDUS AUTOFLU, P17; Duncker T, 2014, INVEST OPHTH VIS SCI, V55, P8134, DOI 10.1167/iovs.14-14848; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Ganz T, 2004, CURR OPIN HEMATOL, V11, P251, DOI 10.1097/00062752-200407000-00004; Gatica E, 2019, PHOTOCHEM PHOTOBIOL, V95, P901, DOI 10.1111/php.13047; Gliem M, 2016, JAMA OPHTHALMOL, V134, P817, DOI 10.1001/jamaophthalmol.2016.1475; Gnana-Prakasam JP, 2008, BIOCHEM J, V411, P79, DOI 10.1042/BJ20071377; Gonzalez AS, 2006, EUR J CLIN NUTR, V60, P802, DOI 10.1038/sj.ejcn.1602384; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Hayyan M, 2016, CHEM REV, V116, P3029, DOI 10.1021/acs.chemrev.5b00407; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Hirayama T, 2017, J CLIN BIOCHEM NUTR, V60, P39, DOI 10.3164/jcbn.16-70; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kim HJ, 2018, J LIPID RES, V59, P1620, DOI 10.1194/jlr.M084459; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2008, EXP EYE RES, V86, P975, DOI 10.1016/j.exer.2008.03.016; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Lakhal-Littleton S, 2016, ELIFE, V5, DOI 10.7554/eLife.19804; de Carvalho JRL, 2020, J BIOL CHEM, V295, P6767, DOI 10.1074/jbc.RA120.012695; Miyazawa M, 2018, RNA, V24, P468, DOI 10.1261/rna.063941.117; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Musallam KM, 2018, CURR MED RES OPIN, V34, P81, DOI 10.1080/03007995.2017.1394833; Namaste SML, 2017, AM J CLIN NUTR, V106, p359S, DOI 10.3945/ajcn.116.141762; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Obolensky A, 2011, FREE RADICAL BIO MED, V51, P1482, DOI 10.1016/j.freeradbiomed.2011.07.014; Paavo M, 2018, INVEST OPHTH VIS SCI, V59, P2459, DOI 10.1167/iovs.18-24213; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Picard E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030705; Puig S, 2017, METALLOMICS, V9, P1483, DOI 10.1039/c7mt00116a; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Song DL, 2014, INVEST OPHTH VIS SCI, V55, P4525, DOI 10.1167/iovs.14-14568; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Timoshnikov VA, 2015, FREE RADICAL BIO MED, V78, P118, DOI 10.1016/j.freeradbiomed.2014.10.513; Trawinski J, 2017, ENVIRON SCI POLLUT R, V24, P1152, DOI 10.1007/s11356-016-7727-5; Ueda K, 2018, P NATL ACAD SCI USA, V115, P4963, DOI 10.1073/pnas.1722601115; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; Winter WE, 2014, LABMEDICINE, V45, P92, DOI 10.1309/LMF28S2GIMXNWHMM; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xian T, 2019, NANOSCALE RES LETT, V14, DOI 10.1186/s11671-019-3206-5; Yamamoto K, 2011, INVEST OPHTH VIS SCI, V52, P9084, DOI 10.1167/iovs.11-8632; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Yoon KD, 2011, MOL VIS, V17, P1839; Zhao XR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00770-7; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2015, J BIOL CHEM, V290, P27215, DOI 10.1074/jbc.M115.680363	65	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100259	10.1016/j.jbc.2021.100259	http://dx.doi.org/10.1016/j.jbc.2021.100259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837742	gold, Green Published			2022-12-26	WOS:000672866400235
J	Barayan, D; Abdullahi, A; Vinaik, R; Knuth, CM; Auger, C; Jeschke, MG				Barayan, Dalia; Abdullahi, Abdikarim; Vinaik, Roohi; Knuth, Carly M.; Auger, Christopher; Jeschke, Marc G.			Interleukin-6 blockade, a potential adjunct therapy for post-burn hypermetabolism	FASEB JOURNAL			English	Article						anti-IL-6 mAb; burn; effectiveness; hypermetabolism; interleukin-6; safety	WHITE ADIPOSE-TISSUE; RECEPTOR ANTIBODY; INJURY; SKIN; TOCILIZUMAB; CYTOKINES; MARKER; IL-6	Severe burns remain a leading cause of death and disability worldwide. Despite advances in patient care, the excessive and uncontrolled hypermetabolic stress response induced by this trauma inevitably affects every organ system causing substantial morbidity and mortality. Recent evidence suggests interleukin-6 (IL-6) is a major culprit underlying post-burn hypermetabolism. Indeed, genetic deletion of IL-6 alleviates various complications associated with poor clinical outcomes including the adverse remodeling of adipose tissue, cachexia and hepatic steatosis. Thus, pharmacological blockade of IL-6 may be a more favorable treatment option to fully restore metabolic function after injury. To test this, we investigated the safety and effectiveness of blocking IL-6 for post-burn hypermetabolism using a validated anti-IL-6 monoclonal antibody (mAb) in our experimental murine model. Here, we show daily anti-IL-6 mAb administration protects against burn-induced weight loss (P < .0001) without any adverse effect on mortality. At the organ level, post-burn treatment with the IL-6 blocker suppressed the thermogenic activation of adipose tissue (P < .01) and its associated wasting (P < .05). The reduction of browning-induced lipolysis (P < .0001) indirectly decreased hepatic lipotoxicity (P < .01) which improved liver dysfunction (P < .05). Importantly, the beneficial effects of this anti-IL-6 agent extended to the skin, reflected by the decrease in excessive collagen deposition (P < .001) and genes involved in pathologic fibrosis and scarring (P < .05). Together, our results indicate that post-burn IL-6 blockade leads to significant improvements in systemic hypermetabolism by inhibiting pathological alterations in key immunometabolic organs. These findings support the therapeutic potential of anti-IL-6 interventions to improve care, quality of life, and survival in burned patients.	[Barayan, Dalia; Abdullahi, Abdikarim; Vinaik, Roohi; Knuth, Carly M.; Auger, Christopher; Jeschke, Marc G.] Sunnybrook Res Inst, Toronto, ON, Canada; [Jeschke, Marc G.] Univ Toronto, Dept Surg, Div Plast Surg, Toronto, ON, Canada; [Jeschke, Marc G.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Jeschke, Marc G.] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Jeschke, MG (corresponding author), Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada.	marc.jeschke@sunnybrook.ca	Jeschke, Marc/D-3501-2019	Jeschke, Marc/0000-0003-0870-1664	Canadian Institutes of Health Research [123336]; CFI Leaders Opportunity Fund [25407]; NIH [R01GM087285, 5R01GM133961-02]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CFI Leaders Opportunity Fund(Canada Foundation for Innovation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Canadian Institutes of Health Research: #123336; CFI Leaders Opportunity Fund: Project #25407; NIH: R01GM087285, 5R01GM133961-02	Abdullahi A, 2014, CELL MOL LIFE SCI, V71, P3241, DOI 10.1007/s00018-014-1612-5; Abdullahi A, 2020, J CELL MOL MED, V24, P9764, DOI 10.1111/jcmm.15548; Abdullahi A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2103-2; Abdullahi A, 2019, ANN SURG, V269, P554, DOI 10.1097/SLA.0000000000002465; Abdullahi A, 2017, SHOCK, V47, P33, DOI 10.1097/SHK.0000000000000749; Abdullahi A, 2016, TRENDS ENDOCRIN MET, V27, P542, DOI 10.1016/j.tem.2016.06.006; Ando K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102436; Barayan D, 2020, SHOCK, V53, P137, DOI 10.1097/SHK.0000000000001439; Biffl WL, 1996, ANN SURG, V224, P647, DOI 10.1097/00000658-199611000-00009; Brigham Peter A., 1996, Journal of Burn Care and Rehabilitation, V17, P95, DOI 10.1097/00004630-199603000-00003; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971; Finnerty CC, 2016, LANCET, V388, P1427, DOI 10.1016/S0140-6736(16)31406-4; Gallucci RM, 2001, J INTERF CYTOK RES, V21, P603, DOI 10.1089/10799900152547867; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Guzik TJ, 2017, CARDIOVASC RES, V113, P1009, DOI 10.1093/cvr/cvx108; Hager S, 2018, J BURN CARE RES, V39, P379, DOI 10.1097/BCR.0000000000000604; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Jeschke MG, 2009, MOL MED, V15, P337, DOI 10.2119/molmed.2009.00005; KOCH AE, 1993, PATHOBIOLOGY, V61, P239, DOI 10.1159/000163802; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Mihara M, 2011, OPEN ACCESS RHEUMATO, V3, P19, DOI 10.2147/OARRR.S17118; Narsale AA, 2014, CURR OPIN SUPPORT PA, V8, P321, DOI 10.1097/SPC.0000000000000091; Ohsugi Y, 2007, BIOL PHARM BULL, V30, P2001, DOI 10.1248/bpb.30.2001; Peters HPF, 2000, MED SCI SPORT EXER, V32, P134; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Price LA., 2007, J BURNS WOUNDS, V12; Rose-John S, 2017, NAT REV RHEUMATOL, V13, P399, DOI 10.1038/nrrheum.2017.83; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Villarroya F, 2018, J INTERN MED, V284, P492, DOI 10.1111/joim.12803; Yeh FL, 1999, BURNS, V25, P131, DOI 10.1016/S0305-4179(98)00150-8	34	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21596	10.1096/fj.202100388R	http://dx.doi.org/10.1096/fj.202100388R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871073	Green Accepted			2022-12-26	WOS:000645260100023
J	Mizera, J; Kazek, G; Niedzielska-Andres, E; Pomierny-Chamiolo, L				Mizera, Jozef; Kazek, Grzegorz; Niedzielska-Andres, Ewa; Pomierny-Chamiolo, Lucyna			Maternal high-sugar diet results in NMDA receptors abnormalities and cognitive impairment in rat offspring	FASEB JOURNAL			English	Article						maternal high-sugar diet; memory impairment; miRNA; NMDA receptor; proximity ligation assay	NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; ECTO-ATPASE NTPDASE2; PURINERGIC RECEPTORS; OLFACTORY-BULB; PROGENITOR CELLS; NUCLEOTIDE RECEPTORS; SIGNALING PATHWAY; EXPRESSION LEVELS; P2Y(2) RECEPTORS	Cognitive impairment affects patients suffering from various neuropsychiatric diseases, which are often accompanied by changes in the glutamatergic system. Epidemiological studies indicate that predispositions to the development of neuropsychiatric diseases may be programmed prenatally. Mother's improper diet during pregnancy and lactation may cause fetal abnormalities and, consequently, predispose to diseases in childhood and even adulthood. Considering the prevalence of obesity in developed countries, it seems important to examine the effects of diet on the behavior and physiology of future generations. We hypothesized that exposure to sugar excess in a maternal diet during pregnancy and lactation would affect memory as the NMDA receptor-related processes. Through the manipulation of the sugar amount in the maternal diet in rats, we assessed its effect on offspring's memory. Then, we evaluated if memory alterations were paralleled by molecular changes in NMDA receptors and related modulatory pathways in the prefrontal cortex and the hippocampus of adolescent and young adult female and male offspring. Behavioral studies have shown sex-related changes like impaired recognition memory in adolescent males and spatial memory in females. Molecular results confirmed an NMDA receptor hypofunction along with subunit composition abnormalities in the medial prefrontal cortex of adolescent offspring. In young adults, GluN2A-containing receptors were dominant in the medial prefrontal cortex, while in the hippocampus the GluN2B subunit contribution was elevated. In conclusion, we demonstrated that a maternal high-sugar diet can affect the memory processes in the offspring by disrupting the NMDA receptor composition and regulation in the medial prefrontal cortex and the hippocampus.	[Mizera, Jozef; Niedzielska-Andres, Ewa; Pomierny-Chamiolo, Lucyna] Jagiellonian Univ Med Coll, Dept Toxicol, Med 9, PL-30688 Krakow, Poland; [Kazek, Grzegorz] Jagiellonian Univ Med Coll, Dept Pharmacodynam, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Niedzielska-Andres, E; Pomierny-Chamiolo, L (corresponding author), Jagiellonian Univ Med Coll, Dept Toxicol, Med 9, PL-30688 Krakow, Poland.	ewa.niedzielska@uj.edu.pl; lucyna.pomierny-chamiolo@uj.edu.pl		Pomierny-Chamiolo, Lucyna/0000-0002-8308-8030	National Science Center, Poland [2015/19/D/NZ7/00082]; Statutory Funds of the Department of Toxicology, Jagiellonian University Medical College, Poland [N42/DBS/000145, N42/DBS/000146]	National Science Center, Poland(National Science Centre, Poland); Statutory Funds of the Department of Toxicology, Jagiellonian University Medical College, Poland	National Science Center, Poland, Grant/Award Number: 2015/19/D/NZ7/00082; Statutory Funds of the Department of Toxicology, Jagiellonian University Medical College, Poland, Grant/Award Number: N42/DBS/000145 and N42/DBS/000146	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Adeosun SO, 2014, J BIOL CHEM, V289, P2946, DOI 10.1074/jbc.M113.497909; Agresti C, 2005, GLIA, V50, P132, DOI 10.1002/glia.20160; Ali AAH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103423; Ali AAH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041394; Ali AAH, 2019, BRAIN STRUCT FUNCT, V224, P373, DOI 10.1007/s00429-018-1775-1; Ali AAH, 2015, AGING-US, V7, P435, DOI 10.18632/aging.100764; Anders JJ, 2008, IEEE J SEL TOP QUANT, V14, P118, DOI 10.1109/JSTQE.2008.916181; Arthur DB, 2006, J NEUROSCI, V26, P3798, DOI 10.1523/JNEUROSCI.5338-05.2006; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Bassani TB, 2018, MOL NEUROBIOL, V55, P4280, DOI 10.1007/s12035-017-0645-9; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Braun N, 2003, EUR J NEUROSCI, V17, P1355, DOI 10.1046/j.1460-9568.2003.02567.x; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2018, BIOCHEM PHARMACOL, V151, P157, DOI 10.1016/j.bcp.2017.07.016; Burnstock G, 2016, NEUROPHARMACOLOGY, V104, P4, DOI 10.1016/j.neuropharm.2015.05.031; Burnstock G, 2013, ADV EXP MED BIOL, V986, P1, DOI 10.1007/978-94-007-4719-7_1; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Cao L, 2013, EMBO REP, V14, P184, DOI 10.1038/embor.2012.215; Cao X, 2013, STEM CELLS, V31, P1633, DOI 10.1002/stem.1408; Chen JZ, 2014, CELLS TISSUES ORGANS, V199, P131, DOI 10.1159/000365654; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cronin C, 2011, BEHAV BRAIN RES, V223, P417, DOI 10.1016/j.bbr.2011.05.002; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Fischer T, 2012, PURINERG SIGNAL, V8, P191, DOI 10.1007/s11302-011-9286-z; Fischer W, 2009, NEUROSCIENCE, V160, P767, DOI 10.1016/j.neuroscience.2009.02.026; Fujita T, 2009, GLIA, V57, P244, DOI 10.1002/glia.20749; Gampe K, 2015, STEM CELLS, V33, P253, DOI 10.1002/stem.1846; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; Grimm I, 2009, J CELL SCI, V122, P2524, DOI 10.1242/jcs.044891; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754; Jacobson KA, 2020, BRIT J PHARMACOL, V177, P2413, DOI [10.1111/bph.1500510.1111/bph.15005, 10.1111/bph.15005]; Jacobson KA, 2009, PURINERG SIGNAL, V5, P75, DOI 10.1007/s11302-008-9106-2; Jia CH, 2010, NEUROBIOL DIS, V38, P405, DOI 10.1016/j.nbd.2010.02.013; Katz S, 2011, ARCH BIOCHEM BIOPHYS, V513, P144, DOI 10.1016/j.abb.2011.06.013; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Kim HJ, 2012, J NEUROCHEM, V121, P228, DOI 10.1111/j.1471-4159.2012.07700.x; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; Lipp HP, 2016, BRAIN BEHAV EVOLUT, V87, P205, DOI 10.1159/000446905; Lommen J, 2017, CELL TISSUE RES, V369, P579, DOI 10.1007/s00441-017-2634-8; Malin SA, 2008, PAIN, V138, P484, DOI 10.1016/j.pain.2008.01.026; Messemer N, 2013, NEUROPHARMACOLOGY, V73, P122, DOI 10.1016/j.neuropharm.2013.05.017; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Neary Joseph T, 2005, Purinergic Signal, V1, P329, DOI 10.1007/s11302-005-8075-y; Neary JT, 2009, TRENDS NEUROSCI, V32, P189, DOI 10.1016/j.tins.2009.01.002; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Pannangrong W, 2019, J ZHEJIANG UNIV-SC B, V20, P253, DOI 10.1631/jzus.B1800340; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Potthoff SA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00234; Prieur EAK, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3162; Rakai BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099527; Ralevic V, 1998, PHARMACOL REV, V50, P413; Recinto P, 2012, NEUROPSYCHOPHARMACOL, V37, P1275, DOI 10.1038/npp.2011.315; Rotermund N, 2018, J PHYSIOL-LONDON, V596, P717, DOI 10.1113/JP275503; Sakamoto M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00121; Schnell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099883; Schulz K, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00435; SCOTT JW, 1993, MICROSC RES TECHNIQ, V24, P142, DOI 10.1002/jemt.1070240206; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shukla V, 2005, J NEUROSCI RES, V80, P600, DOI 10.1002/jnr.20508; Stefani J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00134; Suadicani SO, 2003, GLIA, V42, P160, DOI 10.1002/glia.10197; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Suyama S, 2012, J NEUROSCI, V32, P9238, DOI 10.1523/JNEUROSCI.4001-11.2012; Takahashi H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00229; Tang Y, 2017, GLIA, V65, P213, DOI 10.1002/glia.23056; Toda T, 2019, MOL PSYCHIATR, V24, P67, DOI 10.1038/s41380-018-0036-2; von Kugelgen I, 2016, NEUROPHARMACOLOGY, V104, P50, DOI 10.1016/j.neuropharm.2015.10.030; von Kugelgen I, 2019, BRAIN RES BULL, V151, P12, DOI 10.1016/j.brainresbull.2019.03.010; Walter J, 2011, NEUROBIOL AGING, V32, P1906, DOI 10.1016/j.neurobiolaging.2009.11.011; Weisman GA, 2005, MOL NEUROBIOL, V31, P169, DOI 10.1385/MN:31:1-3:169; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Weisman GA, 2012, PURINERG SIGNAL, V8, P559, DOI 10.1007/s11302-012-9307-6; Whitman MC, 2007, J NEUROSCI, V27, P9951, DOI 10.1523/JNEUROSCI.1633-07.2007; Xu PF, 2018, BIOORGAN MED CHEM, V26, P366, DOI 10.1016/j.bmc.2017.11.043; Zarrinmayeh H, 2020, MOL IMAGING, V19, DOI 10.1177/1536012120927609; Zheng F, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12458; Zlomuzica A, 2008, EUR J NEUROSCI, V27, P1461, DOI 10.1111/j.1460-9568.2008.06115.x	96	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21547	10.1096/fj.202002691R	http://dx.doi.org/10.1096/fj.202002691R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855764				2022-12-26	WOS:000645260100080
J	Zhang, RM; Zeyer, KA; Odenthal, N; Zhang, YY; Reinhardt, DP				Zhang, Rong-Mo; Zeyer, Karina A.; Odenthal, Nadine; Zhang, Yiyun; Reinhardt, Dieter P.			The fibrillin-1 RGD motif posttranscriptionally regulates ERK1/2 signaling and fibroblast proliferation via miR-1208	FASEB JOURNAL			English	Article						ERK1/2 signaling; fibrillin-1; fibroblasts; miR-1208; proliferation; RGD	CELL-ADHESION; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; AORTIC-ANEURYSM; MICRORNAS; MICROFIBRILS; ACTIVATION; BINDING; INTEGRINS; RECEPTOR	Fibrillin-1 is an extracellular matrix protein which contains one conserved RGD integrin-binding motif. It constitutes the backbone of microfibrils in many tissues, and mutations in fibrillin-1 cause various connective tissue disorders. Although it is well established that fibrillin-1 interacts with several RGD-dependent integrins, very little is known about the associated intracellular signaling pathways. Recent published evidence identified a subset of miRNAs regulated by fibrillin-1 RGD-cell adhesion, with miR-1208 among the most downregulated. The present study shows that the downregulated miR-1208 controls fibroblast proliferation. Inhibitor experiments revealed that fibrillin-1 RGD suppressed miR-1208 expression via c-Src kinase and the downstream JNK signaling. Bioinformatic prediction and experimental target sequence validation demonstrated four miR-1208 binding sites on the ERK2 mRNA and one on the MEK1 mRNA. ERK2 and MEK1 are critical proliferation-promoting kinases. Decreased miR-1208 levels elevated the total and phosphorylated ERK1/2 and MEK1/2 protein levels and the phosphorylated to total ERK1/2 ratio. Together, the data demonstrate a novel outside-in signaling mechanism explaining how fibrillin-1 RGD-cell binding regulates fibroblast proliferation.	[Zhang, Rong-Mo; Zeyer, Karina A.; Zhang, Yiyun; Reinhardt, Dieter P.] McGill Univ, Fac Med & Hlth Sci, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 0C7, Canada; [Odenthal, Nadine] Univ Lubeck, Dept Nat Sci, Lubeck, Germany; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada	McGill University; University of Lubeck; McGill University	Reinhardt, DP (corresponding author), McGill Univ, Fac Med & Hlth Sci, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 0C7, Canada.	dieter.reinhardt@mcgill.ca	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872	Canadian Institutes of Health Research [PJT-162099]; Marfan Foundation; Genetic Aortic Disorders Association Canada; China Scholarship Council; Hector and Ada Ma Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Marfan Foundation; Genetic Aortic Disorders Association Canada; China Scholarship Council(China Scholarship Council); Hector and Ada Ma Fellowship	Canadian Institutes of Health Research, Grant/Award Number: PJT-162099; Marfan Foundation; Genetic Aortic Disorders Association Canada; China Scholarship Council; Hector and Ada Ma Fellowship	AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arihiro K, 2000, Breast Cancer, V7, P19, DOI 10.1007/BF02967183; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; BITTERMAN PB, 1983, J CELL BIOL, V97, P1925, DOI 10.1083/jcb.97.6.1925; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brandt R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10954-y; Breuksch I, 2017, ONCOTARGET, V8; Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Gerber EE, 2013, NATURE, V503, P126, DOI 10.1038/nature12614; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hubmacher D, 2014, BIOMACROMOLECULES, V15, P1456, DOI 10.1021/bm5000696; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin Yi, 2013, Methods Mol Biol, V936, P117; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Juliano RL, 1993, CURR OPIN CELL BIOL, V5, P812, DOI 10.1016/0955-0674(93)90030-T; Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4; Kim EA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143540; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Lefloch R, 2009, CELL CYCLE, V8, P705, DOI 10.4161/cc.8.5.7734; Li B, 2006, J BIOMED MATER RES A, V79A, P989, DOI 10.1002/jbm.a.30847; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Loeys B. L., 2010, SCI TRANSL MED, V2, P20, DOI 10.1126/scitranslmed.3000488; Mariko B, 2010, AM J PHYSIOL-CELL PH, V299, pC977, DOI 10.1152/ajpcell.00377.2009; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Merk DR, 2012, CIRC RES, V110, P312, DOI 10.1161/CIRCRESAHA.111.253740; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; MORGAN TL, 1991, EXP CELL RES, V197, P125, DOI 10.1016/0014-4827(91)90489-H; Nissan MH, 2013, CANCER DISCOV, V3, P719, DOI 10.1158/2159-8290.CD-13-0245; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Piha-Gossack A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033560; Polioudakis D, 2013, NUCLEIC ACIDS RES, V41, P2239, DOI 10.1093/nar/gks1452; Porst M, 2006, KIDNEY INT, V69, P450, DOI 10.1038/sj.ki.5000030; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; Skarpen E, 2008, FASEB J, V22, P466, DOI 10.1096/fj.07-8650com; Suh EJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r121; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zeyer KA, 2019, J MOL BIOL, V431, P401, DOI 10.1016/j.jmb.2018.11.021; Zhang RM, 2020, METHODS MOL BIOL, V2043, P237, DOI 10.1007/978-1-4939-9698-8_19	78	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21598	10.1096/fj.202100282R	http://dx.doi.org/10.1096/fj.202100282R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871068				2022-12-26	WOS:000645260100021
J	Liu, JY; Huang, Z; Chen, HN; Qin, SY; Chen, Y; Jiang, JW; Zhang, Z; Luo, MC; Ye, Q; Xie, N; Zhou, ZG; Wei, YQ; Xie, K; Huang, CH				Liu, Jiayang; Huang, Zhao; Chen, Hai-Ning; Qin, Siyuan; Chen, Yan; Jiang, Jingwen; Zhang, Zhe; Luo, Maochao; Ye, Qin; Xie, Na; Zhou, Zong-Guang; Wei, Yuquan; Xie, Ke; Huang, Canhua			ZNF37A promotes tumor metastasis through transcriptional control of THSD4/TGF-beta axis in colorectal cancer	ONCOGENE			English	Article							DIFFERENTIATION	Poorly differentiated colorectal cancer (CRC) is characterized by aggressive invasion and stromal fibroblast activation, which results in rapid progression and poor therapeutic consequences. However, the regulatory mechanism involved remains unclear. Here, we showed that ZNF37A, a member of KRAB-ZFP family, was upregulated in poorly differentiated CRCs and associated with tumor metastasis. ZNF37A enhanced the metastatic potential of multiple CRC cell lines and promoted distant metastasis in an orthotopic CRC model. Further investigation attributed the ZNF37A-exacerbated metastasis to increased extracellular TGF-beta and the consequent activation of cancer-associated fibroblasts (CAFs) in tumor microenvironment (TME). Mechanistically, ZNF37A formed a complex with KAP1 and bound to the promoter of THSD4, a TME modulator, to suppress its transcription, which is required for ZNF37A-mediated TGF-beta activation and CRC metastasis. Collectively, our study indicates that ZNF37A promotes TGF-beta signaling in CRC cells and activates CAFs by transcriptionally repressing THSD4 to drive CRC metastasis, implicating ZNF37A as a potential biomarker for CRC differentiation and progression.	[Liu, Jiayang; Huang, Zhao; Qin, Siyuan; Chen, Yan; Jiang, Jingwen; Zhang, Zhe; Luo, Maochao; Wei, Yuquan; Huang, Canhua] West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Liu, Jiayang; Huang, Zhao; Qin, Siyuan; Chen, Yan; Jiang, Jingwen; Zhang, Zhe; Luo, Maochao; Wei, Yuquan; Huang, Canhua] West China Hosp, Ctr Canc, Chengdu, Peoples R China; [Liu, Jiayang; Huang, Zhao; Qin, Siyuan; Chen, Yan; Jiang, Jingwen; Zhang, Zhe; Luo, Maochao; Wei, Yuquan; Huang, Canhua] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu, Peoples R China; [Liu, Jiayang; Huang, Zhao; Qin, Siyuan; Chen, Yan; Jiang, Jingwen; Zhang, Zhe; Luo, Maochao; Wei, Yuquan; Huang, Canhua] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Chen, Hai-Ning; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Gastrointestinal Surg, Chengdu, Peoples R China; [Chen, Hai-Ning; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China; [Ye, Qin; Xie, Ke] Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Ye, Qin; Xie, Ke] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Sichuan, Peoples R China; [Xie, Na] Sichuan Univ, West China Hosp, West China Sch Basic Med Sci & Forens Med, Chengdu, Peoples R China; [Xie, Na] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Xie, Na] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China; [Xie, Na] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Huang, Canhua] Chengdu Univ Tradit Chinese Med, Sch Basic Med Sci, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan University; Sichuan University; Sichuan University; Chengdu University of Traditional Chinese Medicine	Huang, CH (corresponding author), West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China.; Huang, CH (corresponding author), West China Hosp, Ctr Canc, Chengdu, Peoples R China.; Huang, CH (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu, Peoples R China.; Huang, CH (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China.; Xie, K (corresponding author), Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Dept Oncol, Chengdu, Sichuan, Peoples R China.; Xie, K (corresponding author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Sichuan, Peoples R China.; Huang, CH (corresponding author), Chengdu Univ Tradit Chinese Med, Sch Basic Med Sci, Chengdu, Sichuan, Peoples R China.	mei97@sina.com; hcanhua@hotmail.com	Jiang, Jing wen/AAP-5996-2021; Chen, Hai-Ning/AAR-8059-2021	Chen, Hai-Ning/0000-0003-0104-8498; Huang, Zhao/0000-0001-9994-2070; , Zongguang/0000-0002-7616-1199	Guangdong Basic and Applied Basic Research Foundation [2019B030302012]; National Key RAMP;D Program of China [2020YFA0509400, 2020YFC2002700]; Chinese NSFC [81821002, 81672867, 81790251, 81702378]; China Postdoctoral Science Foundation [2019T120845, 2018M643496]	Guangdong Basic and Applied Basic Research Foundation; National Key RAMP;D Program of China; Chinese NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from Guangdong Basic and Applied Basic Research Foundation (2019B030302012), National Key R&D Program of China (2020YFA0509400, 2020YFC2002700), the Chinese NSFC (nos 81821002, 81672867, 81790251, 81702378) and China Postdoctoral Science Foundation (2019T120845, 2018M643496).	Adamski V, 2020, ONCOGENE, V39, P4421, DOI 10.1038/s41388-020-1302-8; Aiello NM, 2019, J EXP MED, V216, P1016, DOI 10.1084/jem.20181827; Alexandre C., 2015, NAT GENET, V47; Alonso-Alconada L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-223; Andre T, 2015, J CLIN ONCOL, V33, P4176, DOI 10.1200/JCO.2015.63.4238; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y; Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06654-8; Cohen H, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0464-0; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Derwinger K, 2010, ACTA ONCOL, V49, P57, DOI 10.3109/02841860903334411; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; Fleming M, 2012, J GASTROINTEST ONCOL, V3, P153, DOI 10.3978/j.issn.2078-6891.2012.030; Gauthier M, 2013, HUM MOL GENET, V22, P5188, DOI 10.1093/hmg/ddt373; Gremel G, 2015, J GASTROENTEROL, V50, P46, DOI 10.1007/s00535-014-0958-7; Guo Z, 2017, NUCLEIC ACIDS RES, V46, P1266; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jung B, 2017, GASTROENTEROLOGY, V152, P36, DOI 10.1053/j.gastro.2016.10.015; Kobayashi H, 2019, NAT REV GASTRO HEPAT, V16, P282, DOI 10.1038/s41575-019-0115-0; Koliaraki V, 2017, GASTROENTEROLOGY, V152, P964, DOI 10.1053/j.gastro.2016.11.049; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Liu R, 2013, CANCER RES, V73, P5926, DOI 10.1158/0008-5472.CAN-12-4718; McCarthy N, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3272; Nathan RW., 2015, NAT REV IMMUNOL, V15; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Punt CJA, 2017, NAT REV CLIN ONCOL, V14, P235, DOI 10.1038/nrclinonc.2016.171; Robertson IB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021907; Saito M, 2011, J BIOL CHEM, V286, P38602, DOI 10.1074/jbc.M111.243451; Schmitges FW, 2016, GENOME RES, V26, P1742, DOI 10.1101/gr.209643.116; Tada Y, 2015, ONCOGENE, V34, P752, DOI 10.1038/onc.2013.599; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Tauriello DVF, 2016, TRENDS CANCER, V2, P495, DOI 10.1016/j.trecan.2016.08.001; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Valkenburg KC, 2018, NAT REV CLIN ONCOL, V15, P366, DOI 10.1038/s41571-018-0007-1; Wu D, 2016, HEPATOLOGY, V64, P1148, DOI 10.1002/hep.28708; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	45	6	6	1	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2021	40	19					3394	3407		10.1038/s41388-021-01713-9	http://dx.doi.org/10.1038/s41388-021-01713-9		APR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SB1JB	33875786				2022-12-26	WOS:000641218600005
J	Bougneres, P; Porcher, R; Esterle, L; Baker, D; de la Vaissiere, A; Meurisse, S; Valtat, S; Castell, AL; Mouriquand, P; Valleron, AJ				Bougneres, Pierre; Porcher, Raphael; Esterle, Laure; Baker, David; de la Vaissiere, Adrien; Meurisse, Sofia; Valtat, Sophie; Castell, Anne-Laure; Mouriquand, Pierre; Valleron, Alain-Jacques			Exploring the risk of hypospadias in children born from mothers living close to a vineyard	PLOS ONE			English	Article							BIRTH-DEFECTS; CRYPTORCHIDISM; EXPOSURE; NITRATE; SONS	Hypospadias (H) is a common birth defect affecting the male urinary tract. It has been suggested that exposure to endocrine disrupting chemicals might increase the risk of H by altering urethral development. However, whether H risk is increased in places heavily exposed to agricultural pesticides, such as vineyards, remains debated and difficult to ascertain. The objective of the work is to test the possible association of H with residential proximity to vineyards. Residential address at birth of 8,766 H cases born 1980-2011 was taken from 17 specialized surgery centers. The geographical distribution of vineyards was obtained from the European Land Parcel Identification System (LPIS) and the distance of address to the nearest vineyard was computed. A first estimate of the variation of H relative risk with distance to vineyards was obtained using as controls 13,105 cryptorchidism (C) cases operated during the same period in the same centers. A separate estimate was obtained from a case-control study using "virtual controls" (VC) defined as points of the map sampled to match the demographic distribution of births within the recruitment territories of the study centers. Non-exposed patients were defined as those with a residence between 5,000 and 10,000 m from the closest vineyard. The residential distance to vineyard was smaller for H than for C cases (p<10(-4)). We found 42/8766 H cases (0.48%) and 50/13,105 C cases (0.38%) born to mothers living within 20 m of a vineyard. The odds ratios for H were 2.48 (CI: 1.0 to 5.1) and 2.4 (CI: 1.3 to 4.4), vs C or vs VC, respectively, when pregnant mothers lived 10-20 m from a vineyard. In conclusion, our study supports that children born to mothers living close to a vineyard have a two-fold increased risk of H. For environmental research, the use of VC provides an alternative to classical case control technique.	[Bougneres, Pierre; Esterle, Laure; Baker, David; de la Vaissiere, Adrien; Meurisse, Sofia; Valtat, Sophie; Castell, Anne-Laure; Valleron, Alain-Jacques] Univ Paris Saclay, Inserm U1195, Le Kremlin Bicetre, France; [Porcher, Raphael] Univ Paris V, Ctr Res Epidemiol & Stat CRESS, INSERM U1153, Paris, France; [Mouriquand, Pierre] Hosp Civils Lyon, Hop Mere Enfant, Dept Pediat Urol, Lyon, France; [Mouriquand, Pierre] Univ Lyon 1, Lyon, France	UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bougneres, P; Valleron, AJ (corresponding author), Univ Paris Saclay, Inserm U1195, Le Kremlin Bicetre, France.	pierre.bougneres@inserm.fr; alain-jacques.valleron@inserm.fr		valleron, alain-jacques/0000-0002-5678-9923; Esterle, Laure/0000-0002-1017-1327	INSERM [U986/U1169]; Programme Hospitalier de Recherche Clinique [AOM11139]; Agence Nationale de la Recherche (ANR HYPOCRYPT 2010); Groupe d'Etude et de Therapeutique pour le Diabete, l'Obesite et la Croissance	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Programme Hospitalier de Recherche Clinique; Agence Nationale de la Recherche (ANR HYPOCRYPT 2010)(French National Research Agency (ANR)); Groupe d'Etude et de Therapeutique pour le Diabete, l'Obesite et la Croissance	This study was funded by an institutional support of INSERM (PB: www.inserm.fr, U986/U1169), the Programme Hospitalier de Recherche Clinique (PB: http://solidarites-sante.gouv.fr/systeme-de-sante-et-medico-social/recherche-etinnovation/l-innovation-et-la-recherche-clinique/appels-a-projets/programmes-recherche, PB: PHRC GEO-HYPOCRYPT 2011, AOM11139), the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/, ANR HYPOCRYPT 2010), and the Groupe d'Etude et de The ' rapeutique pour le Diabete, l'Obe ' site ' et la Croissance (PB: GET-DOC: https://www.getdoc.fr/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman JEH, 2015, WORLD J UROL, V33, P2159, DOI 10.1007/s00345-015-1507-6; Blandin M, 2008, RISQUES DANGERS SANT; Carbone P, 2006, REPROD TOXICOL, V22, P8, DOI 10.1016/j.reprotox.2006.01.006; Edwards TM, 2006, AQUAT TOXICOL, V78, P50, DOI 10.1016/j.aquatox.2006.02.003; Fernandez N, 2017, INT BRAZ J UROL, V43, P325, DOI [10.1590/S1677-5538.IBJU.2016.0002, 10.1590/s1677-5538.ibju.2016.0002]; Geller F, 2014, NAT GENET, V46, P957, DOI 10.1038/ng.3063; Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x; Gray LE, 1998, TOXICOL LETT, V103, P331, DOI 10.1016/S0378-4274(98)00327-0; Guillette LJ, 2005, INTEGR COMP BIOL, V45, P19, DOI 10.1093/icb/45.1.19; Jorgensen KT, 2014, SCAND J WORK ENV HEA, V40, P323, DOI 10.5271/sjweh.3399; Lasalle J, 2004, MALFORMATIONS CONGEN; MACKENBACH JP, 1988, HEALTH POLICY, V10, P207, DOI 10.1016/0168-8510(88)90006-1; Manson JM, 2003, BIRTH DEFECTS RES A, V67, P825, DOI 10.1002/bdra.10084; Meyer KJ, 2006, ENVIRON HEALTH PERSP, V114, P1589, DOI 10.1289/ehp.9146; MIETTINEN OS, 1985, J CHRON DIS, V38, P543, DOI 10.1016/0021-9681(85)90039-6; Nordenvall AS, 2014, J UROLOGY, V191, P783, DOI 10.1016/j.juro.2013.09.058; Nuckols JR, 2004, ENVIRON HEALTH PERSP, V112, P1007, DOI 10.1289/ehp.6738; Ostby J, 1999, TOXICOL IND HEALTH, V15, P80; Plank CM, 2018, AM J ENOL VITICULT, V69, P307, DOI 10.5344/ajev.2018.17041; Rappazzo KM, 2016, BIRTH DEFECTS RES A, V106, P240, DOI 10.1002/bdra.23479; Richard MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69725-1; Rocheleau CM, 2011, BIRTH DEFECTS RES A, V91, P927, DOI 10.1002/bdra.22860; Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317; Schneuer FJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2768; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Springer A, 2017, EUR UROL SUPPL, V16, P8, DOI 10.1016/j.eursup.2016.09.006; Steven L, 2013, J PEDIATR UROL, V9, P1126, DOI 10.1016/j.jpurol.2013.04.008; Vottero A, 2011, J CLIN ENDOCR METAB, V96, pE1953, DOI 10.1210/jc.2011-0511; Vrijheid M, 2014, ENVIRON HEALTH PERSP, V122, P535, DOI 10.1289/ehp.1307204; Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122; Yu X, 2019, EUR UROL, V76, P482, DOI 10.1016/j.eururo.2019.06.027	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249800	10.1371/journal.pone.0249800	http://dx.doi.org/10.1371/journal.pone.0249800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857192	gold, Green Published			2022-12-26	WOS:000641474900007
J	Mendez-Rebolledo, G; Guzman-Venegas, R; Valencia, O; Watanabe, K				Mendez-Rebolledo, Guillermo; Guzman-Venegas, Rodrigo; Valencia, Oscar; Watanabe, Kohei			Contribution of the peroneus longus neuromuscular compartments to eversion and plantarflexion of the ankle	PLOS ONE			English	Article							FIBULARIS LONGUS; LEG MUSCLES; INSTABILITY; EMG; ACTIVATION; KINEMATICS; VOLUNTARY; STATEMENT; LOCATION; WALKING	Compartmentalization of animal and human skeletal muscle by multiple motor nerve branches known as the neuromuscular compartment (NMC) has been observed primarily in muscles that participate in a plane of motion. In this context, the peroneus longus muscle contributes to eversion and plantarflexion of the ankle and the presence of NMCs has been reported. However, no research has reported the selective activation of the compartments of the peroneus longus during the performance of different ankle movements. The purpose of this research was to determine the contribution of peroneus longus NMCs, through multi-channel surface electromyography (sEMG), to eversion and plantarflexion movements. Multi-channel sEMG was recorded from the peroneus longus muscle by using an electrode grid during eversion and plantarflexion of the ankle at 10%, 30%, 50%, and 70% of maximal voluntary isometric contraction (MVIC). The root mean square and displacement of the center of mass position in the X (COMx) and Y (COMy) components were calculated. The primary finding was that eversion showed significantly higher sEMG amplitude than plantarflexion in the posterior compartment in low, moderate, and high percentages of MVIC. However, no significant difference in sEMG amplitude was observed in the anterior compartment between eversion and plantarflexion. In addition, a posterior displacement of the COMx in eversion compared to plantarflexion in all MVIC percentages, with greater topographic distancing of the COMx at higher levels of activation. In conclusion, the peroneus longus muscle presented NMCs; the anterior compartment contributed to both eversion and plantarflexion movements, whereas the posterior compartment mainly contributed to the eversion movement of the ankle in low, moderate, and high percentages of MVIC.	[Mendez-Rebolledo, Guillermo] Univ Santo Tomas, Fac Salud, Escuela Kinesiol, Santiago, Chile; [Guzman-Venegas, Rodrigo; Valencia, Oscar] Univ Los Andes, Fac Med, Lab Integrat Biomecan & Fisiol Esfuerzo LIBFE, Escuela Kinesiol, Santiago, Chile; [Watanabe, Kohei] Chukyo Univ, Fac Liberal Arts & Sci, Lab Neuromuscular Biomech, Nagoya, Aichi, Japan; [Watanabe, Kohei] Chukyo Univ, Sch Int Liberal Studies, Nagoya, Aichi, Japan	Universidad Santo Tomas; Universidad de los Andes - Chile; Chukyo University; Chukyo University	Mendez-Rebolledo, G (corresponding author), Univ Santo Tomas, Fac Salud, Escuela Kinesiol, Santiago, Chile.	guillermomendezre@santotomas.cl		Mendez-Rebolledo, Guillermo/0000-0001-7948-3807; Valencia, Oscar/0000-0001-7568-4169				Bakkum B W, 1996, Clin Anat, V9, P381, DOI 10.1002/(SICI)1098-2353(1996)9:6<381::AID-CA4>3.0.CO;2-E; Barbero M., 2012, ATLAS MUSCLE INNERVA, DOI [10.1007/978-88-470-2463-2, DOI 10.1007/978-88-470-2463-2]; Bavdek R, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-018-0291-0; Bogacka U, 2017, FOLIA MORPHOL, V76, P284, DOI 10.5603/FM.a2016.0054; Campanini I, 2007, J ELECTROMYOGR KINES, V17, P515, DOI 10.1016/j.jelekin.2006.06.001; De Luca CJ, 2012, J BIOMECH, V45, P555, DOI 10.1016/j.jbiomech.2011.11.010; Delahunt E, 2018, BRIT J SPORT MED, V52, P1304, DOI 10.1136/bjsports-2017-098885; Delahunt E, 2006, AM J SPORT MED, V34, P1970, DOI 10.1177/0363546506290989; Dellon AL, 2002, ANN PLAS SURG, V48, P30, DOI 10.1097/00000637-200201000-00004; Donnelly L, 2017, FOOT ANKLE INT, V38, P769, DOI 10.1177/1071100717701231; ENGLISH AW, 1993, PHYS THER, V73, P857, DOI 10.1093/ptj/73.12.857; Gallina A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00367; Gao ZX, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19030555; Gribble PA, 2016, BRIT J SPORT MED, V50, P1493, DOI 10.1136/bjsports-2016-096188; Guzman-Venegas RA, 2016, J ELECTROMYOGR KINES, V27, P18, DOI 10.1016/j.jelekin.2016.01.002; Guzman-Venegas RA, 2018, ARCH ORAL BIOL, V90, P130, DOI 10.1016/j.archoralbio.2018.03.010; Guzman-Venegas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116923; Hagen M, 2016, HUM MOVEMENT SCI, V50, P30, DOI 10.1016/j.humov.2016.10.002; Hegyi A, 2019, MED SCI SPORT EXER, V51, P2274, DOI 10.1249/MSS.0000000000002060; Hegyi A, 2019, SCAND J MED SCI SPOR, V29, P34, DOI 10.1111/sms.13303; Hertel J, 2019, J ATHL TRAINING, V54, P572, DOI 10.4085/1062-6050-344-18; Holtermann A, 2009, J ELECTROMYOGR KINES, V19, P896, DOI 10.1016/j.jelekin.2008.04.016; Lee JH, 2011, CLIN ANAT, V24, P232, DOI 10.1002/ca.21076; Mendez GA, 2013, BRAZ J PHYS THER, V17, P427, DOI 10.1590/S1413-35552012005000110; Rebolledo GM, 2009, INT J MORPHOL, V27, P699, DOI 10.4067/S0717-95022009000300012; Mendez-Rebolledo G, 2015, PHYS THER SPORT, V16, P242, DOI 10.1016/j.ptsp.2014.10.008; Merletti R, 2019, J ELECTROMYOGR KINES, V49, DOI 10.1016/j.jelekin.2019.102363; Merletti R, 2008, J ELECTROMYOGR KINES, V18, P879, DOI 10.1016/j.jelekin.2008.09.002; SEGAL RL, 1991, ACTA ANAT, V142, P261; Stachaczyk M, 2020, IEEE T NEUR SYS REH, V28, P1511, DOI 10.1109/TNSRE.2020.2986099; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; von Tscharner V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00223; Watanabe K, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01274; Watanabe K, 2017, MUSCLE NERVE, V56, P982, DOI 10.1002/mus.25556; Watanabe K, 2013, MUSCLE NERVE, V48, P226, DOI 10.1002/mus.23739; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; Watanabe Kohei, 2009, J Electromyogr Kinesiol, V19, pe280, DOI 10.1016/j.jelekin.2008.06.002; Wikstrom EA, 2010, GAIT POSTURE, V32, P82, DOI 10.1016/j.gaitpost.2010.03.015; WOODS JJ, 1983, AM J PHYS MED REHAB, V62, P287; Yen SC, 2015, EUR J APPL PHYSIOL, V115, P1683, DOI 10.1007/s00421-015-3154-4	40	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250159	10.1371/journal.pone.0250159	http://dx.doi.org/10.1371/journal.pone.0250159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857199	Green Published, gold			2022-12-26	WOS:000641474900095
J	Park, MB; Ranabhat, CL				Park, Myung-Bae; Ranabhat, Chhabi Lal			Effect of parental smoking on their children's urine cotinine level in Korea: A population-based study	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; GENDER-DIFFERENCES; 2ND-HAND SMOKE; YOUNG-CHILDREN; EXPOSURE; HEALTH; INFANTS; HOMES	Background Children may be exposed to tobacco products in multiple ways if their parents smoke. The risks of exposure to secondhand smoke (SHS) are well known. This study aimed to investigate the association between parental smoking and the children's cotinine level in relation to restricting home smoking, in Korea. Methods Using the Korea National Health and Nutrition Health Examination Survey data from 2014 to 2017, we analyzed urine cotinine data of parents and their non-smoking children (n = 1,403), in whose homes parents prohibited smoking. We performed linear regression analysis by adjusting age, sex, house type, and household income to determine if parent smoking was related to the urine cotinine concentration of their children. In addition, analysis of covariance and Tukey's post-hoc tests were performed according to parent smoking pattern. Finding Children's urine cotinine concentrations were positively associated with those of their parents. Children of smoking parents had a significantly higher urine cotinine concentration than that in the group where both parents are non-smokers (diff = 0.933, P < .0001); mothers-only smoker group (diff = 0.511, P = 0.042); and fathers-only smoker group (diff = 0.712, P < .0001). In the fathers-only smoker group, the urine cotinine concentration was significantly higher than that in the group where both parents were non-smoker (diff = 0.221, P < .0001), but not significantly different compared to the mothers-only smoker group (diff = - -0.201, P = 0.388). Children living in apartments were more likely to be exposed to smoking substances. Conclusion This study showed a correlation between parents' and children's urine cotinine concentrations, supporting the occurrence of home smoking exposure due to the parents' smoking habit in Korea. Although avoiding indoor home smoking can decrease the children's exposure to tobacco, there is a need to identify other ways of smoking exposure and ensure appropriate monitoring and enforcement of banning smoking in the home.	[Park, Myung-Bae; Ranabhat, Chhabi Lal] Pai Chai Univ, Dept Gerontol Hlth & Welf, Daejeon, South Korea; [Ranabhat, Chhabi Lal] Global Ctr Res & Dev GCRD, Kathmandu, Nepal; [Ranabhat, Chhabi Lal] Manmohan Mem Inst Hlth Sci, Kathmandu, Nepal	Pai Chai University	Ranabhat, CL (corresponding author), Pai Chai Univ, Dept Gerontol Hlth & Welf, Daejeon, South Korea.; Ranabhat, CL (corresponding author), Global Ctr Res & Dev GCRD, Kathmandu, Nepal.; Ranabhat, CL (corresponding author), Manmohan Mem Inst Hlth Sci, Kathmandu, Nepal.	chhabir@gmail.com		Ranabhat, Chhabi/0000-0002-4460-2121				Allem JP, 2012, YONSEI MED J, V53, P433, DOI 10.3349/ymj.2012.53.2.433; Allen AM, 2016, NICOTINE TOB RES, V18, P1408, DOI 10.1093/ntr/ntv138; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Bauer T, 2007, HEALTH ECON, V16, P895, DOI 10.1002/hec.1259; Becquemin MH, 2010, TOB CONTROL, V19, P347, DOI 10.1136/tc.2009.034694; Benowitz NL., 2002, NICOTINE TOBACCO RES, V4; Blackburn C, 2003, BRIT MED J, V327, P257, DOI 10.1136/bmj.327.7409.257; Chen CY, 2013, J ADOLESCENT HEALTH, V52, P724, DOI 10.1016/j.jadohealth.2012.12.009; Choi E, 2019, HLTH WELOFARE ISSUE, V366, P1; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; Gunter R, 2020, KOREAN J FAM MED, V41, P3, DOI 10.4082/kjfm.18.0015; Health UDo, 2006, HLTH CONSEQUENCES IN; Hoh E, 2012, ENVIRON SCI TECHNOL, V46, P4174, DOI 10.1021/es300267g; Jacob P, 2017, CHEM RES TOXICOL, V30, P270, DOI 10.1021/acs.chemrestox.6b00343; Jarvis MJ, 2015, ADDICTION, V110, P1484, DOI 10.1111/add.12962; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; Kang Y.H., 2003, ANN LAB MED, V23, P92; KCDC, 2018, 2018 KOREA NATL HLTH; Kim J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4774-x; Kim SS, 2005, WESTERN J NURS RES, V27, P604, DOI 10.1177/0193945905276258; Kim SM, 2016, PSYCHIAT INVEST, V13, P239, DOI 10.4306/pi.2016.13.2.239; King BA, 2016, PREV MED, V82, P51, DOI 10.1016/j.ypmed.2015.11.010; King BA, 2010, NICOTINE TOB RES, V12, P1133, DOI 10.1093/ntr/ntq162; Lee P, 2004, IARC MONOGRAPHS EVAL, V83, P9; Mahabee-Gittens EM, 2019, TOB USE INSIGHTS, V12, DOI 10.1177/1179173X18823493; Matt GE, 1999, TOB CONTROL, V8, P282, DOI 10.1136/tc.8.3.282; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; Matt GE, 2020, PREV MED REP, V18, DOI 10.1016/j.pmedr.2020.101088; Mott JA, 1999, J BEHAV MED, V22, P35, DOI 10.1023/A:1018747602026; Oshio T, 2013, J FAM ECON ISS, V34, P211, DOI 10.1007/s10834-012-9321-4; Paasche-Orlow MK, GLOBAL PROGR REPORT, V2016, P11; Park MB, 2015, ASIA-PAC J PUBLIC HE, V27, P542, DOI 10.1177/1010539514565447; Park MB, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0156-z; Ranabhat C, 2016, CHILDREN-BASEL, V3, DOI 10.3390/children3010003; Ranabhat CL, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00981; Ranabhat CL, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0283-z; Rosen LJ, 2012, PEDIATRICS, V129, P141, DOI 10.1542/peds.2010-3209; Rumchev K, 2008, INDOOR AIR, V18, P202, DOI 10.1111/j.1600-0668.2008.00517.x; Sheu R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay4109; Sleiman M, 2014, ENVIRON SCI TECHNOL, V48, P13093, DOI 10.1021/es5036333; Tong EK, 2007, CIRCULATION, V116, P1845, DOI 10.1161/CIRCULATIONAHA.107.715888; Wakefield M, 2000, AM J PREV MED, V19, P188, DOI 10.1016/S0749-3797(00)00197-5; Winickoff JP, 2009, PEDIATRICS, V123, pE74, DOI 10.1542/peds.2008-2184; 조성호, 2015, [The Journal of Women and Economics, 여성경제연구], V12, P163	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248013	10.1371/journal.pone.0248013	http://dx.doi.org/10.1371/journal.pone.0248013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857161	gold, Green Published			2022-12-26	WOS:000641474900043
J	Nantha, YS; Chelliah, AAP; Haque, S; Zain, AZM				Nantha, Yogarabindranath Swarna; Chelliah, Azriel Abisheg Paul; Haque, Shamsul; Zain, Anuar Zaini Md			The internal realities of individuals with type 2 diabetes-Psychological disposition in self-management behaviour via grounded theory approach	PLOS ONE			English	Article							CARE; PEOPLE; ATTITUDES; WISHES; MODELS	Background A paradigm shift in the disease management of type 2 diabetes is urgently needed to stem the escalating trends seen worldwide. A "glucocentric" approach to diabetes management is no longer considered a viable option. Qualitative strategies have the potential to unearth the internal psychological attributes seen in people living with diabetes that are crucial to the sustenance of self-management behaviour. This study aims to identify and categorize the innate psychological dispositions seen in people with type 2 diabetes in relation to self-management behaviour. Methods We adopted a grounded theory approach to guide in-depth interviews of individuals with type 2 diabetes and healthcare professionals (HCP) at a regional primary care clinic in Malaysia. Twenty-four people with type 2 diabetes and 10 HCPs were recruited into the study to examine the inner narratives about disease management. Two focus group discussions (FGD) were also conducted for data triangulation. Results Participants' internal dialogue about the management of their disease is characterized by 2 major processes- 1) positive disposition and 2) negative disposition. Optimism, insight, and awareness are important positive values that influence T2D self-care practices. On the other hand, constructs such as stigma, worries, reservations, and pessimism connote negative dispositions that undermine the motivation to follow through disease management in individuals with type 2 diabetes. Conclusions We identified a contrasting spectrum of both constructive and undesirable behavioural factors that influence the 'internal environment' of people with type 2 diabetes. These results coincide with the constructs presented in other well-established health belief theories that could lead to novel behavioural change interventions. Furthermore, these findings allow the implementation of psychosocial changes that are in line with cultural sensitivities and societal norms seen in a specific community.	[Nantha, Yogarabindranath Swarna; Zain, Anuar Zaini Md] Monash Univ Malaysia, Clin Sch Johor Bahru, Jeffrey Cheah Sch Med & Hlth Sci, Subang Jaya, Malaysia; [Nantha, Yogarabindranath Swarna; Haque, Shamsul] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Dept Psychol, Subang Jaya, Malaysia; [Chelliah, Azriel Abisheg Paul] Hosp Sibu, Sarawak, Malaysia	Monash University; Monash University Sunway; Monash University; Monash University Sunway	Nantha, YS (corresponding author), Monash Univ Malaysia, Clin Sch Johor Bahru, Jeffrey Cheah Sch Med & Hlth Sci, Subang Jaya, Malaysia.; Nantha, YS (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Dept Psychol, Subang Jaya, Malaysia.	Yoga.rabindranath@monash.edu		Haque, Shamsul/0000-0002-1561-6989	MOH-NIH grant [:91000440]; Ministry of Health Malaysia	MOH-NIH grant; Ministry of Health Malaysia	This study was funded by the MOH-NIH grant (Grant No.:91000440) received from the Ministry of Health Malaysia. YSN was the recipient of this grant. URL to grant website (http://www.nih.gov.my/web/grant-application/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beverly EA, 2012, J GEN INTERN MED, V27, P1180, DOI 10.1007/s11606-012-2070-0; Bootle S, 2015, DIABETES RES CLIN PR, V109, P6, DOI 10.1016/j.diabres.2015.04.004; Burns KK, 2016, DIABETIC MED, V33, P1184, DOI 10.1111/dme.13136; Charmaz K., 2006, CONSTRUCTING GROUNDE; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Harvey JN, 2009, DIABETIC MED, V26, P5, DOI 10.1111/j.1464-5491.2008.02628.x; Holt RIG, 2016, DIABETIC MED, V33, P1174, DOI 10.1111/dme.13109; Hussein Z, 2015, ANN GLOB HEALTH, V81, P851, DOI 10.1016/j.aogh.2015.12.016; International Diabetes Federation, 2017, IDF DIABETES ATLAS 8, V8th, P1; Low LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147127; Low Lee Lan, 2014, Coll Antropol, V38, P11; Lu Y, 2016, EVAL HEALTH PROF, V39, P131, DOI 10.1177/0163278715588927; Monnier L, 2008, DIABETES METAB, V34, P207, DOI 10.1016/j.diabet.2008.01.011; Murray M., 2014, HLTH PSYCHOL THEORY, V4th; Nantha YS, 2019, FAM PRACT, V36, P581, DOI 10.1093/fampra/cmy119; Newton P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/638205; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Ockleford E, 2008, CHRONIC ILLN, V4, P28, DOI 10.1177/1742395307086673; Ogden J., 2012, HLTH PSYCHOL TXB; Rubin RR., 2002, PRACTICAL PSYCHOL DI, V2nd, P1; Rushforth B, 2016, BRIT J GEN PRACT, V66, pE114, DOI 10.3399/bjgp16X683509; Serrano-Gil M, 2010, ADV THER, V27, P321, DOI 10.1007/s12325-010-0034-5; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Strauss, 2015, BASICS QUALITATIVE R; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zimmet Paul Z, 2017, Clin Diabetes Endocrinol, V3, P1, DOI 10.1186/s40842-016-0039-3	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249620	10.1371/journal.pone.0249620	http://dx.doi.org/10.1371/journal.pone.0249620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN5ED	33848301	Green Published, gold			2022-12-26	WOS:000640373500007
J	Yuan, LF; Forshay, KJ				Yuan, Lifeng; Forshay, Kenneth J.			Enhanced streamflow prediction with SWAT using support vector regression for spatial calibration: A case study in the Illinois River watershed, US	PLOS ONE			English	Article							QUALITY; BASIN; FLOW; SIMULATION; MACHINES; RAINFALL; RUNOFF; SOIL	Accurate streamflow prediction plays a pivotal role in hydraulic project design, nonpoint source pollution estimation, and water resources planning and management. However, the highly non-linear relationship between rainfall and runoff makes prediction difficult with desirable accuracy. To improve the accuracy of monthly streamflow prediction, a seasonal Support Vector Regression (SVR) model coupled to the Soil and Water Assessment Tool (SWAT) model was developed for 13 subwatersheds in the Illinois River watershed (IRW), U.S. Terrain, precipitation, soil, land use and land cover, and monthly streamflow data were used to build the SWAT model. SWAT Streamflow output and the upstream drainage area were used as two input variables into SVR to build the hybrid SWAT-SVR model. The Calibration Uncertainty Procedure (SWAT-CUP) and Sequential Uncertainty Fitting-2 (SUFI-2) algorithms were applied to compare the model performance against SWAT-SVR. The spatial calibration and leave-one-out sampling methods were used to calibrate and validate the hybrid SWAT-SVR model. The results showed that the SWAT-SVR model had less deviation and better performance than SWAT-CUP simulations. SWAT-SVR predicted streamflow more accurately during the wet season than the dry season. The model worked well when it was applied to simulate medium flows with discharge between 5 m(3) s(-1) and 30 m(3) s(-1), and its applicable spatial scale fell between 500 to 3000 km(2). The overall performance of the model on yearly time series is "Satisfactory". This new SWAT-SVR model has not only the ability to capture intrinsic non-linear behaviors between rainfall and runoff while considering the mechanism of runoff generation but also can serve as a reliable regional tool for an ungauged or limited data watershed that has similar hydrologic characteristics with the IRW.	[Yuan, Lifeng] US EPA, Natl Res Council, Resident Res Associate, Robert S Kerr Environm Res Ctr, Ada, OK USA; [Forshay, Kenneth J.] US EPA, Ctr Environm Solut & Emergency Response, Robert S Kerr Environm Res Ctr, Ada, OK 74820 USA	National Academies of Sciences, Engineering & Medicine; United States Environmental Protection Agency; United States Environmental Protection Agency	Forshay, KJ (corresponding author), US EPA, Ctr Environm Solut & Emergency Response, Robert S Kerr Environm Res Ctr, Ada, OK 74820 USA.	Forshay.Ken@epa.gov	Forshay, Kenneth/N-4068-2014	Forshay, Kenneth/0000-0002-2867-8492	United States Environmental Protection Agency as part of the Office of Research and Development, Safe and Sustainable Water Research Program; NRC Research Associateship award at Robert S. Kerr Environmental Research Center, Ada [OK 74820]	United States Environmental Protection Agency as part of the Office of Research and Development, Safe and Sustainable Water Research Program; NRC Research Associateship award at Robert S. Kerr Environmental Research Center, Ada	This research was funded by the United States Environmental Protection Agency as part of the Office of Research and Development, Safe and Sustainable Water Research Program. Ken Forshay is a Research Ecologist of the Environmental Protection Agency. Lifeng Yuan was a National Research Council, Senior Research Associate, resident at the U.S. EPA working with Dr. Kenneth Forshay.; This research was performed while Dr. Lifeng Yuan held an NRC Research Associateship award at Robert S. Kerr Environmental Research Center, Ada, OK 74820. This work does not reflect the views of the US EPA, and no official endorsement should be inferred. We appreciate Dr. Yongping Yuan, Dr. Mohamed Hantush, Katherine Buckler, and Pat Bush for support of this paper. We are also thankful for Dr. Tibebe B. Tigabu and other two anonymous reviewers for their constructive comments.	Abbaspour K.C., 2015, SWAT CUP SWAT CALIBR; Alizadeh MJ, 2017, J HYDROL, V548, P588, DOI 10.1016/j.jhydrol.2017.03.032; Arnold JG, 2012, T ASABE, V55, P1491; ASABE, 2017, T ASABE, V621, P1; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; Chiogna G, 2018, SCI TOTAL ENVIRON, V633, P220, DOI 10.1016/j.scitotenv.2018.03.162; Daggupati P, 2015, T ASABE, V58, P1705; David MM, 2011, WATER AIR SOIL POLL, V215, P525, DOI 10.1007/s11270-010-0497-7; Devi GK, 2015, AQUAT PR, V4, P1001, DOI 10.1016/j.aqpro.2015.02.126; EPA, EPA600R19232; Gao X, 2018, WATER-SUI, V10, DOI 10.3390/w10030274; Nieto PJG, 2014, ECOL ENG, V73, P192, DOI 10.1016/j.ecoleng.2014.09.042; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Hrachowitz M, 2013, HYDROLOG SCI J, V58, P1198, DOI 10.1080/02626667.2013.803183; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Huo ZL, 2012, J HYDROL, V420, P159, DOI 10.1016/j.jhydrol.2011.11.054; Jajarmizadeh M, 2015, KSCE J CIV ENG, V19, P345, DOI 10.1007/s12205-014-0060-y; Johnson HL., 1995, ATLAS OKLAHOMA CLIMA, P104; Kalteh AM, 2013, COMPUT GEOSCI-UK, V54, P1, DOI 10.1016/j.cageo.2012.11.015; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Kisi O, 2011, J HYDROL, V399, P132, DOI 10.1016/j.jhydrol.2010.12.041; KLEMES V, 1986, HYDROLOG SCI J, V31, P13, DOI 10.1080/02626668609491024; Kundu S, 2017, GEOSCI FRONT, V8, P583, DOI 10.1016/j.gsf.2016.06.002; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Londhe SN., 2018, J SOFT COMPUTING CIV, V2, P56, DOI DOI 10.22115/SCCE.2017.96717.1024; McDonnell JJ, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005467; Misra D, 2009, BIOSYST ENG, V103, P527, DOI 10.1016/j.biosystemseng.2009.04.017; Mittelstet A.R., 2016, SUSTAINABILITY WATER, V7, P5, DOI [10.1016/j.swaqe.2016.01.002, DOI 10.1016/J.SWAQE.2016.01.002]; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Muleta MK, 2012, J HYDROL ENG, V17, P191, DOI 10.1061/(ASCE)HE.1943-5584.0000421; Narr CF, 2019, ECOL ENG, V129, P123, DOI 10.1016/j.ecoleng.2018.12.030; Neitsch S.L., 2011, SOIL WATER ASSESSMEN; Noori N, 2016, J HYDROL, V533, P141, DOI 10.1016/j.jhydrol.2015.11.050; Nourani V, 2016, WATER RESOUR MANAG, V30, P393, DOI 10.1007/s11269-015-1168-7; Olsen RL, 2012, WATER RES, V46, P3110, DOI 10.1016/j.watres.2012.03.028; Patil SD, 2015, J HYDROL, V525, P409, DOI 10.1016/j.jhydrol.2015.04.003; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pushpalatha R, 2012, J HYDROL, V420, P171, DOI 10.1016/j.jhydrol.2011.11.055; Scott JT, 2011, J ENVIRON QUAL, V40, P1249, DOI 10.2134/jeq2010.0476; Shabri A, 2012, HYDROLOG SCI J, V57, P1275, DOI 10.1080/02626667.2012.714468; Shepherd SL, 2011, RIVER RES APPL, V27, P857, DOI 10.1002/rra.1401; Shyu, 1992, STAT MODELS; Singh HV, 2018, ECOL ENG, V116, P110, DOI 10.1016/j.ecoleng.2018.02.001; Singh KP, 2011, ANAL CHIM ACTA, V703, P152, DOI 10.1016/j.aca.2011.07.027; Smakhtin VU, 2001, J HYDROL, V240, P147, DOI 10.1016/S0022-1694(00)00340-1; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Soil Conservation Service, 1972, NAT ENG HDB; Srinivasan R, 2014, SWAT 2014 C PERN BRA; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tripathi S, 2006, J HYDROL, V330, P621, DOI 10.1016/j.jhydrol.2006.04.030; Vapnik V., 2013, NATURE STAT LAERNING; Weingessel A., 2019, E1071 MISC FUNCTIONS; Yan B, 2013, J HYDROL, V484, P26, DOI 10.1016/j.jhydrol.2013.01.008; Yang J, 2008, J HYDROL, V358, P1, DOI 10.1016/j.jhydrol.2008.05.012; Yuan L., 2013, J ANHUI AGR SCI, V41, P732; Yuan L., 2008, J CHONGQ I TECHNOL N, V22, P112; Yuan LF, 2020, WATER-SUI, V12, DOI 10.3390/w12010039; Yuan LF, 2020, GEOSCIENCES, V10, DOI 10.3390/geosciences10010025; Yuan LF, 2006, INT GEOSCI REMOTE SE, P4221, DOI 10.1109/IGARSS.2006.1083; Zambrano-Bigiarini M., 2017, PACKAGE HYDROGOF GOO, DOI [10.5281/zenodo.839854Rpackageversion0.4-0, DOI 10.5281/ZENODO.839854]; Zhang DJ, 2015, ECOL MODEL, V301, P54, DOI 10.1016/j.ecolmodel.2015.01.018; Zhang XS, 2009, J AM WATER RESOUR AS, V45, P460, DOI 10.1111/j.1752-1688.2009.00302.x; Zhu S, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5337-7	64	4	4	13	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2021	16	4							e0248489	10.1371/journal.pone.0248489	http://dx.doi.org/10.1371/journal.pone.0248489			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM7RW	33844687	gold, Green Published			2022-12-26	WOS:000639857200011
J	Lee, Y; Do, V; Kim, S; Kweon, H; McGhie, TK				Lee, Youngsuk; Do, Van Giap; Kim, Seonae; Kweon, Hunjoong; McGhie, Tony K.			Cold stress triggers premature fruit abscission through ABA-dependent signal transduction in early developing apple	PLOS ONE			English	Article							CBF GENE; BIOSYNTHESIS; ACID; TRANSCRIPTION; TEMPERATURE; HOMEOSTASIS; EXPRESSION; TOLERANCE; MECHANISM; ETHYLENE	Fruit abscission is a complex physiological process that is regulated by internal and environmental factors. During early development, apple fruit are exposed to extreme temperature fluctuations that are associated with premature fruit drop; however, their effect on fruit abscission is largely unknown. We hypothesized that fruit abscission is triggered by cold stress and investigated the molecular basis of premature fruit drop using RNA-Seq and metabolomics data from apple fruit undergoing abscission following cold stress in the field. Genes responsive to abscisic acid signaling and cell wall degradation were upregulated during abscission, consistent with the increased abscisic acid concentrations detected by liquid chromatography-mass spectrometry. We performed ex vivo cold shock experiments with excised tree subunits consisting of a branch, pedicel, and fruit. Abscission induction occurred in the cold-stressed subunits with concurrent upregulation of abscisic acid biosynthesis (MdNCED1) and metabolism (MdCYP707A) genes, and ethylene biosynthesis (MdACS1) and receptor (MdETR2) genes in the pedicel. Another key finding was the activation of cytoplasmic streaming in abscission-zone cells detected by electron microscopy. Our results provide a novel insight into the molecular basis of fruit abscission physiology in response to cold stress in apple.	[Lee, Youngsuk; Do, Van Giap; Kim, Seonae; Kweon, Hunjoong] Rural Dev Adm, Apple Res Inst, Natl Inst Hort & Herbal Sci, Gunwi, South Korea; [Lee, Youngsuk] Seoul Natl Univ, Coll Natl Sci, Sch Biol Sci, Seoul, South Korea; [McGhie, Tony K.] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand	National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU); New Zealand Institute for Plant & Food Research Ltd	Lee, Y (corresponding author), Rural Dev Adm, Apple Res Inst, Natl Inst Hort & Herbal Sci, Gunwi, South Korea.; Lee, Y (corresponding author), Seoul Natl Univ, Coll Natl Sci, Sch Biol Sci, Seoul, South Korea.	terra1936@gmail.com		Lee, Youngsuk/0000-0002-2248-2528	Rural Development Administration research program [PJ01371001]; Apple Research Institute, National Institute of Horticultural and Herbal Sciences, Rural Development Administration, Republic of Korea	Rural Development Administration research program; Apple Research Institute, National Institute of Horticultural and Herbal Sciences, Rural Development Administration, Republic of Korea	This study was funded by the Rural Development Administration research program (PJ01371001), Apple Research Institute, National Institute of Horticultural and Herbal Sciences, Rural Development Administration, Republic of Korea.	Bassett CL, 2009, PLANTA, V230, P107, DOI 10.1007/s00425-009-0927-1; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Bowen J, 2014, TREE GENET GENOMES, V10, P751, DOI 10.1007/s11295-014-0720-6; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Dal Cin V, 2005, J EXP BOT, V56, P2995, DOI 10.1093/jxb/eri296; Dal Cin V, 2008, PLANT GROWTH REGUL, V56, P317, DOI 10.1007/s10725-008-9312-5; Eccher G, 2013, PLANT PHYSIOL, V161, P1952, DOI 10.1104/pp.112.208470; Estornell LH, 2013, PLANT SCI, V199, P48, DOI 10.1016/j.plantsci.2012.10.008; Fu JJ, 2018, BIOL PLANTARUM, V62, P671, DOI 10.1007/s10535-018-0812-5; Gao JH, 2013, INT J AGRIC BIOL, V15, P871; Gao YR, 2019, PLANT J, V99, P1159, DOI 10.1111/tpj.14412; Huang D, 2019, PEERJ, V7, DOI 10.7717/peerj.7935; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Kim Dae-jun, 2018, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V20, P313; Kim J, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8060154; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Lee HY, 2015, PLANT BIOTECHNOL REP, V9, P319, DOI 10.1007/s11816-015-0366-3; Lee Kyoungmi, 2012, [Journal of the Korean Geographical Society, 대한지리학회지], V47, P208; Lee Y, 2018, CELL, V173, P1468, DOI 10.1016/j.cell.2018.03.060; Lenka SK, 2018, MOL BIOTECHNOL, V60, P350, DOI 10.1007/s12033-018-0076-5; Li CQ, 2019, J EXP BOT, V70, P5189, DOI 10.1093/jxb/erz276; Liu S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37943; Ma YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113643; Ma YY, 2014, SCI HORTIC-AMSTERDAM, V174, P65, DOI 10.1016/j.scienta.2014.05.009; Meir S, 2019, J EXP BOT, V70, P1461, DOI 10.1093/jxb/erz038; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Nakano T, 2012, PLANT PHYSIOL, V158, P439, DOI 10.1104/pp.111.183731; Nonogaki M, 2014, PLANT J, V78, P527, DOI 10.1111/tpj.12472; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Ouyang KX, 2013, GENET MOL RES, V12, P1061, DOI 10.4238/2013.April.10.2; Park Y, 2016, PLANT CELL, V28, P2528, DOI 10.1105/tpc.16.00359; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Roongsattham P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00540; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Seiler C, 2011, J EXP BOT, V62, P2615, DOI 10.1093/jxb/erq446; Shani E, 2017, CURR BIOL, V27, P437, DOI 10.1016/j.cub.2016.12.016; Shaya F, 2019, SCI HORTIC-AMSTERDAM, V243, P575, DOI 10.1016/j.scienta.2018.08.044; Skubacz A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01884; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tellmann G., 2006, GENE EXPRESSION, V4, P16; Matus JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110372; Wisniewski ME, 2006, TREE PHYSIOL, V26, P575, DOI 10.1093/treephys/26.5.575; Wisniewski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00085; Wisniewski M, 2011, PLANTA, V233, P971, DOI 10.1007/s00425-011-1358-3; Yan F, 2012, PLANT GROWTH REGUL, V68, P383, DOI 10.1007/s10725-012-9727-x; Yang W, 2011, PLANTA, V233, P219, DOI 10.1007/s00425-010-1279-6; Yuan RC, 2004, J AM SOC HORTIC SCI, V129, P287, DOI 10.21273/JASHS.129.3.0287; Yuan RC, 2003, J AM SOC HORTIC SCI, V128, P302, DOI 10.21273/JASHS.128.3.0302; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang ZJ, 2010, PLANTA, V232, P765, DOI 10.1007/s00425-010-1208-8	53	5	6	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249975	10.1371/journal.pone.0249975	http://dx.doi.org/10.1371/journal.pone.0249975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836019	Green Published, gold			2022-12-26	WOS:000639361000025
J	Jaikaew, R; Satiansukpong, N				Jaikaew, Rujira; Satiansukpong, Nuntanee			Movement performance and movement difficulties in typical school-aged children	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; ASSESSMENT BATTERY; BALANCE; PREVALENCE	Introduction Developmental Coordination Disorder (DCD) is an impairment of executive motor skills. Children aged 7-10 years gradually develop effective movement that enables smooth performance in various daily self-care, academic and sport activities. The purpose of this study was to examine whether the Movement Assessment Battery for Children-Second Edition-Age Band 2, (MABC2-AB2), which is a western standardized test, could be used in Thai children for differentiating between movement performance and movement difficulties. Method Three hundred and sixty typical Thai children aged 7-10 years old were recruited from three primary schools in Chiang Mai district, Thailand. The participants were divided into four age groups and tested using the Movement Assessment Battery for Children-Second Edition-Age Band 2-Thai version (MABC2-AB2-T). Results Manual Dexterity, Aiming and Catching, and Balance rose with age increment. Older participants had better movement performance than younger ones. The results showed that 91.11 percent of the participants had typical movement, while 3.61 and 5.28 percent of them had movement difficulty and movement at risk, respectively. In addition, three test items: Drawing Trail, Walking Heel to Toe Forward, and Hopping on Mats had a ceiling effect when used for Thai children. Conclusion The MABC2-AB2-T could be used to assess movement performance and movement difficulties in Thai children. About 9 percent of typical Thai children aged 7-10 years old needed early intervention. Administration of the three test items may need to be revised.	[Jaikaew, Rujira; Satiansukpong, Nuntanee] Chiang Mai Univ, Fac Associated Med Sci, Dept Occupat Therapy, Chiang Mai, Thailand	Chiang Mai University	Satiansukpong, N (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Dept Occupat Therapy, Chiang Mai, Thailand.	nuntanee.s@cmu.ac.th		Satiansukpong, Nuntanee/0000-0001-8373-2095				Amador-Ruiz S, 2018, J SCHOOL HEALTH, V88, P538, DOI 10.1111/josh.12639; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Bruininks BD., 2010, BRUININKS OSERETSKY, VSecond; Caplan B., 2011, ENCY CLIN NEUROPSYCH; Cech D., 1995, FUNCTIONAL MOVEMENT; Condon C, 2014, PHYSIOTHER RES INT, V19, P1, DOI 10.1002/pri.1549; French B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198426; Gallahue D L., 1998, UNDERSTANDING MOTOR; Hazard CM., 2016, NEURODEVELOPMENTAL T, P308; Henderson ES., 2007, MOVEMENT ASSESSMENT; Holm I, 2013, RES DEV DISABIL, V34, P795, DOI 10.1016/j.ridd.2012.11.002; Jaikaew R, 2019, OCCUP THER INT, V2019, DOI 10.1155/2019/4086594; Jelsma LD, 2016, HUM MOVEMENT SCI, V49, P148, DOI 10.1016/j.humov.2016.07.003; Kita Y, 2016, BRAIN DEV-JPN, V38, P706, DOI 10.1016/j.braindev.2016.02.012; Kwan MYW, 2013, RES DEV DISABIL, V34, P3691, DOI 10.1016/j.ridd.2013.08.020; Lee K, 2019, RES DEV DISABIL, V94, DOI 10.1016/j.ridd.2019.103459; Libardoni TD, 2018, GAIT POSTURE, V60, P122, DOI 10.1016/j.gaitpost.2017.11.004; Licari MK, 2018, RES DEV DISABIL, V83, P280, DOI 10.1016/j.ridd.2018.07.005; Lingam R, 2009, PEDIATRICS, V123, pE693, DOI 10.1542/peds.2008-1770; MANCINI V, 2016, FRONT PSYCHOL, V7, P1, DOI DOI 10.3389/FPSYG.2016.00543; Ministry of Education Thailand, 2008, BASIC ED CORE CURRIC; Missiuna Cheryl, 2007, Phys Occup Ther Pediatr, V27, P81, DOI 10.1300/J006v27n01_06; Mitsiou M., 2016, EUR J PHYS ED SPORT, V11, P17, DOI DOI 10.13187/EJPE.2016.11.17; Pineda DA, 2003, INT J NEUROSCI, V113, P49, DOI 10.1080/00207450390161921; Satiansukpong N., 2019, ACAD PSYCHIAT PSYCHO, V35, P34; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Tseng MH, 2010, RES DEV DISABIL, V31, P33, DOI 10.1016/j.ridd.2009.07.018; Valentini NC, 2015, CHILD CARE HLTH DEV, V41, P970, DOI 10.1111/cch.12219; Van der Linde BW, 2015, PHYS THER, V95, P1496, DOI 10.2522/ptj.20140211; Wilson BN, 2009, PHYS OCCUP THER PEDI, V29, P182, DOI 10.1080/01942630902784761	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249401	10.1371/journal.pone.0249401	http://dx.doi.org/10.1371/journal.pone.0249401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831074	gold, Green Published			2022-12-26	WOS:000639359600014
J	Brooks, ER; Benson, AC; Fox, AS; Bruce, LM				Brooks, Edward R.; Benson, Amanda C.; Fox, Aaron S.; Bruce, Lyndell M.			Movement intensity demands between training activities and competition for elite female netballers	PLOS ONE			English	Article								The aim of this study was to assess the differences in movement intensity demands between training activities and competition match-play in elite netball. Twelve elite female netballers (mean +/- SD, age = 25.9 +/- 5.1 years; height = 178.6 +/- 8.9 cm, body mass = 71.1 +/- 7.1 kg) competing in Australia's premier domestic netball competition participated. Data were collected across the season from all pre-season training sessions (n = 29), pre-season practice matches (n = 8), in-season training sessions (n = 21), in-season practice matches (n = 5), and competition matches (n = 15). Linear mixed-effects models assessed differences in PlayerLoad (TM) per minute and metreage per minute between activity types (Specialist, Skill Drills, Set-piece, Match Scenarios, Practice Match-play, and Competition Match-play) for positional groupings (Defenders, Midcourters, and Goalers). Competition Match-play resulted in higher (p < 0.05) PlayerLoad<(TM)> than all training activity types, with the largest magnitudes of difference between Specialist-Competition (d = 0.44-0.59; small to medium) and Skill Drills-Competition (d = 0.35-0.63; small to medium) for all positional groups. The smallest difference was found between Match Scenarios-Competition (d = 0.12-0.20; trivial to small) and Practice Match-play-Competition (d = 0.12-0.14; trivial). Competition Match-play also resulted in higher (p < 0.05) metreage per minute than Specialist (d = 0.23-0.53; small to medium), Skill Drills (d = 0.19-0.61; trivial to medium) and Set-piece (d = 0.05-0.31; trivial to small). Training activity demands in order of least to most similar to competition were specialist, skill drills, set-piece, match scenarios, and practice match-play. We provide data that enables coaches and physical preparation staff to incorporate progressions into their training session designs that can replicate the movement intensity demands of competition in training.	[Brooks, Edward R.; Fox, Aaron S.; Bruce, Lyndell M.] Deakin Univ, Ctr Sport Res, Sch Exercise & Nutr Sci, Burwood, Vic, Australia; [Benson, Amanda C.] Swinburne Univ Technol, Dept Hlth & Med Sci, Sport Innovat Res Grp, Hawthorn, Vic, Australia	Deakin University; Swinburne University of Technology	Brooks, ER (corresponding author), Deakin Univ, Ctr Sport Res, Sch Exercise & Nutr Sci, Burwood, Vic, Australia.	edwardbrooksau@gmail.com	Benson, Amanda/AAW-3670-2021; Brooks, Edward/AAY-4380-2020	Brooks, Edward/0000-0003-2649-9535; Benson, Amanda Clare/0000-0003-2959-8969; Bruce, Lyndell/0000-0003-4652-5171	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	EB is supported by an Australian Government Research Training Program Scholarship.	Brooks ER, 2020, J SPORT SCI, V38, P1488, DOI 10.1080/02640414.2020.1745504; Chandler PT, 2014, J STRENGTH COND RES, V28, P2732, DOI 10.1519/JSC.0000000000000486; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cormack SJ, 2014, INT J SPORT PHYSIOL, V9, P283, DOI [10.1123/ijspp.2012-0216, 10.1123/IJSPP.2012-0216]; Dawson B, 2004, J SCI MED SPORT, V7, P292, DOI 10.1016/S1440-2440(04)80024-0; Farrow D, 2017, SPORTS MED, V47, P1043, DOI 10.1007/s40279-016-0646-2; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; Gamble P, 2004, J STRENGTH COND RES, V18, P491; Gamble P, 2007, STRENGTH COND J, V29, P60, DOI 10.1519/1533-4295(2007)29[60:CAGSTM]2.0.CO;2; Kinnerk P, 2018, QUEST, V70, P401, DOI 10.1080/00336297.2018.1439390; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth RV., 2021, EMMEANS ESTIMATED MA; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Luteberget LS, 2018, FRONT PHYSIOL, V9, DOI [10.3389/fphys.2078.00775, 10.3389/fphys.2018.00115]; Luteberget LS, 2018, INT J SPORT PHYSIOL, V13, P467, DOI 10.1123/ijspp.2017-0036; Makowski D., 2020, EFFECTSIZE COMPUTE I; Mujika I, 2018, INT J SPORT PHYSIOL, V13, P538, DOI 10.1123/ijspp.2018-0093; Plisk SS, 1997, STRENGTH COND, V19, P44, DOI 10.1519/1073-6840(1997)019<0044:TMTP>2.3.CO;2; RCore Team, 2020, R LANG ENV STAT COMP; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Young CM, 2016, INT J SPORT PHYSIOL, V11, P1074, DOI 10.1123/ijspp.2015-0156	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249679	10.1371/journal.pone.0249679	http://dx.doi.org/10.1371/journal.pone.0249679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826642	Green Published, gold			2022-12-26	WOS:000638119900047
J	Munoz, SM; Castro-Fernandez, V; Guixe, V				Munoz, Sebastian M.; Castro-Fernandez, Victor; Guixe, Victoria			Structure of an ancestral ADP-dependent kinase with fructose-6P reveals key residues for binding, catalysis, and ligand-induced conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PYROCOCCUS-HORIKOSHII; GLUCOKINASE; SPECIFICITY; EVOLUTION; FAMILY; ENZYME	ADP-dependent kinases were first described in archaea, although their presence has also been reported in bacteria and eukaryotes (human and mouse). This enzyme family comprises three substrate specificities; specific phosphofructokinases (ADP-PFKs), specific glucokinases (ADP-GKs), and bifunctional enzymes (ADP-PFK/GK). Although many structures are available for members of this family, none exhibits fructose-6-phosphate (F6P) at the active site. Using an ancestral enzyme, we obtain the first structure of an ADP-dependent kinase (AncMsPFK) with F6P at its active site. Key residues for sugar binding and catalysis were identified by alanine scanning, D36 being a critical residue for F6P binding and catalysis. However, this residue hinders glucose binding because its mutation to alanine converts the AncMsPFK enzyme into a specific ADPGK. Residue K179 is critical for F6P binding, while residues N181 and R212 are also important for this sugar binding, but to a lesser extent. This structure also provides evidence for the requirement of both substrates (sugar and nucleotide) to accomplish the conformational change leading to a closed conformation. This suggests that AncMsPFK mainly populates two states (open and closed) during the catalytic cycle, as reported for specific ADP-PFK. This situation differs from that described for specific ADP-GK enzymes, where each substrate independently causes a sequential domain closure, resulting in three conformational states (open, semiclosed, and closed).	[Munoz, Sebastian M.; Castro-Fernandez, Victor; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Lab Bioquim & Biol Mol, Santiago, Chile	Universidad de Chile	Castro-Fernandez, V; Guixe, V (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Lab Bioquim & Biol Mol, Santiago, Chile.	vcasfe@uchile.cl; vguixe@uchile.cl	Castro-Fernandez, Victor/K-9621-2018; Guixe, Victoria/I-1126-2013	Castro-Fernandez, Victor/0000-0002-4309-6415; Guixe, Victoria/0000-0001-9643-1339; Munoz, Sebastian M./0000-0002-3077-9794	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1191321]; Vicerrectoria de Investigacion y Desarrollo (VID-Universidad de Chile) [UI2018-23]; Fondequip [EQM 120208];  [REDI170497]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Vicerrectoria de Investigacion y Desarrollo (VID-Universidad de Chile); Fondequip; 	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT Grant 1191321), REDI170497, and Vicerrectoria de Investigacion y Desarrollo (VID-Universidad de Chile Grant UI2018-23). The high-throughput ARI crystallization robot was funded by Fondequip EQM 120208.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/NCHEMBIO.1453, 10.1038/nchembio.1453]; Castro-Fernandez V, 2017, J BIOL CHEM, V292, P21218, DOI 10.1074/jbc.AAC117.001147; Castro-Fernandez V, 2014, FEBS J, V281, P2017, DOI 10.1111/febs.12757; Currie MA, 2009, J BIOL CHEM, V284, P22664, DOI 10.1074/jbc.M109.012401; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Girdlestone C, 2016, J COMPUT BIOL, V23, P21, DOI 10.1089/cmb.2015.0143; Gonzalez-Ordenes F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01305; Grudnik P, 2018, J BIOL CHEM, V293, P11088, DOI 10.1074/jbc.RA117.001562; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Gumulya Y, 2017, BIOCHEM J, V474, P1, DOI 10.1042/BCJ20160507; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Abarca-Lagunas MJ, 2015, FEBS LETT, V589, P3271, DOI 10.1016/j.febslet.2015.09.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Richter JP, 2016, J BIOL CHEM, V291, P3694, DOI 10.1074/jbc.M115.679902; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tokarz P, 2018, PROTEIN SCI, V27, P790, DOI 10.1002/pro.3377; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu MY, 2020, CURR OPIN STRUC BIOL, V64, P9, DOI 10.1016/j.sbi.2020.05.007; Zamora RA, 2017, ARCH BIOCHEM BIOPHYS, V633, P85, DOI 10.1016/j.abb.2017.09.008	32	1	1	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100219	10.1074/jbc.RA120.015376	http://dx.doi.org/10.1074/jbc.RA120.015376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839685	Green Published, gold			2022-12-26	WOS:000672866400197
J	Schapansky, J; Grinberg, YY; Osiecki, DM; Freeman, EA; Walker, SG; Karran, E; Gopalakrishnan, SM; Talanian, RV				Schapansky, Jason; Grinberg, Yelena Y.; Osiecki, David M.; Freeman, Emily A.; Walker, Stephen G.; Karran, Eric; Gopalakrishnan, Sujatha M.; Talanian, Robert, V			MEK1/2 activity modulates TREM2 cell surface recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASU-HAKOLA-DISEASE; MOUSE MODEL; MICROGLIA; RECEPTOR; DEFICIENCY; IMPAIRS; ACTIVATION; RESPONSES; VARIANTS; BINDS	Rare sequence variants in the microglial cell surface receptor TREM2 have been shown to increase the risk for Alzheimer's disease (AD). Disease-linked TREM2 mutations seem to confer a partial loss of function, and increasing TREM2 cell surface expression and thereby its function(s) might have therapeutic benefit in AD. However, druggable targets that could modulate microglial TREM2 surface expression are not known. To identify such targets, we conducted a screen of small molecule compounds with known pharmacology using human myeloid cells, searching for those that enhance TREM2 protein at the cell surface. Inhibitors of the kinases MEK1/2 displayed the strongest and most consistent increases in cell surface TREM2 protein, identifying a previously unreported pathway for TREM2 regulation. Unexpectedly, inhibitors of the downstream effector ERK kinases did not have the same effect, suggesting that noncanonical MEK signaling regulates TREM2 trafficking. In addition, siRNA knockdown experiments confirmed that decreased MEK1 and MEK2 were required for this recruitment. In iPSC-derived microglia, MEK inhibition increased cell surface TREM2 only modestly, so various cytokines were used to alter iPSC microglia phenotype, making cells more sensitive to MEK inhibitor-induced TREM2 recruitment. Of those tested, only IFN-gamma priming prior to MEK inhibitor treatment resulted in greater TREM2 recruitment. These data identify the first known mechanisms for increasing surface TREM2 protein and TREM2-regulated function in human myeloid cells and are the first to show a role for MEK1/MEK2 signaling in TREM2 activity.	[Schapansky, Jason; Grinberg, Yelena Y.; Freeman, Emily A.; Karran, Eric; Talanian, Robert, V] AbbVie Inc, Cambridge Res Ctr, Cambridge, MA 02139 USA; [Osiecki, David M.; Walker, Stephen G.; Gopalakrishnan, Sujatha M.] AbbVie Inc, Drug Discovery Sci & Technol, N Chicago, IL USA	AbbVie; AbbVie	Schapansky, J (corresponding author), AbbVie Inc, Cambridge Res Ctr, Cambridge, MA 02139 USA.	jason.schapansky@abbvie.com		Schapansky, Jason/0000-0001-6389-891X; Talanian, Robert/0000-0002-6221-4923; Grinberg, Yelena/0000-0003-4255-5293				Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Biber K, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00840; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; Cheng QW, 2018, J BIOL CHEM, V293, P12620, DOI 10.1074/jbc.RA118.001848; Del-Aguila JL, 2015, CURR OPIN GENET DEV, V33, P49, DOI 10.1016/j.gde.2015.07.008; Eblen ST, 2018, ADV CANCER RES, V138, P99, DOI 10.1016/bs.acr.2018.02.004; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P107; Garcia-Reitboeck P, 2018, CELL REP, V24, P2300, DOI 10.1016/j.celrep.2018.07.094; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Griciuc A, 2019, NEURON, V103, P820, DOI 10.1016/j.neuron.2019.06.010; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017; Haney MS, 2018, NAT GENET, V50, P1716, DOI 10.1038/s41588-018-0254-1; Hasselmann J, 2020, GLIA, V68, P721, DOI 10.1002/glia.23781; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Korvatska O, 2015, JAMA NEUROL, V72, P920, DOI 10.1001/jamaneurol.2015.0979; Lee CYD, 2018, NEURON, V97, P1032, DOI 10.1016/j.neuron.2018.02.002; Leyns CEG, 2019, NAT NEUROSCI, V22, P1217, DOI 10.1038/s41593-019-0433-0; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Nugent AA, 2020, NEURON, V105, P837, DOI 10.1016/j.neuron.2019.12.007; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Park-Min KH, 2009, J IMMUNOL, V183, P2444, DOI 10.4049/jimmunol.0804165; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Prokop S, 2019, ACTA NEUROPATHOL, V138, P613, DOI 10.1007/s00401-019-02048-2; Ren MR, 2018, EXP NEUROL, V302, P205, DOI 10.1016/j.expneurol.2018.01.016; Rosenthal SL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.04.012; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Sayed FA, 2018, P NATL ACAD SCI USA, V115, P10172, DOI 10.1073/pnas.1811411115; Schlepckow K, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911227; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Varnum MM, 2017, J BIOL CHEM, V292, P10651, DOI 10.1074/jbc.M116.759159; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xing JJ, 2015, RES REP BIOCHEM, V5, P89, DOI 10.2147/RRBC.S58057; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9	61	1	1	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100218	10.1074/jbc.RA120.014352	http://dx.doi.org/10.1074/jbc.RA120.014352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839686	Green Published, gold			2022-12-26	WOS:000672866400196
J	Gu, TY; Shen, B; Li, BH; Guo, YC; Li, F; Ma, ZZ; Chen, LY; Zhang, QD; Qu, Y; Dong, H; Cai, XB; Lu, LG				Gu, Tianyi; Shen, Bo; Li, Binghang; Guo, Yuecheng; Li, Fei; Ma, Zhenzeng; Chen, Liuying; Zhang, Qidi; Qu, Ying; Dong, Hui; Cai, Xiaobo; Lu, Lungen			miR-30c inhibits angiogenesis by targeting delta-like ligand 4 in liver sinusoidal endothelial cell to attenuate liver fibrosis	FASEB JOURNAL			English	Article						delta-like ligand 4; liver fibrosis; liver sinusoidal endothelial cell; miR-30c	HEPATIC STELLATE CELLS; INTERFERING RNA; UP-REGULATION; FIBROGENESIS; MICRORNAS; DELIVERY	Liver fibrosis is a common feature of liver dysfunction during chronic liver diseases and is frequently associated with angiogenesis, a dynamic process that forms new blood vessels from preexisting vasculature. MicroRNAs (miRNAs), which act as posttranscriptional regulators of gene expression, have been shown to regulate liver fibrosis; however, how miRNAs regulate angiogenesis and its mechanism in fibrosis are not well understood. We aimed to elucidate the role and mechanism of miR-30c in attenuating liver fibrosis. Using miRNA profiling of fibrotic murine livers, we identified differentially regulated miRNAs and discovered that miR-30c is aberrantly expressed and targets endothelial delta-like ligand 4 (DLL4) in either carbon tetrachloride-treated or bile duct ligated fibrotic mice, as well as in patients with liver fibrosis. Using CCK-8, wound healing and Matrigel tube formation assays, we found that miR-30c inhibited liver sinusoidal endothelial cell (LSEC) proliferation, migration, and angiogenesis capacity by targeting DLL4 in vitro. Importantly, nanoparticle-based delivery of miR-30c to LSECs inhibited the DLL4/Notch pathway and angiogenesis, thereby ameliorating liver fibrosis in vivo. Collectively, our findings demonstrate a protective role of miR-30c in liver fibrosis by regulating DLL4/Notch signaling and angiogenesis. Thus, miR-30c may serve as a potential treatment for chronic liver diseases.	[Gu, Tianyi; Shen, Bo; Li, Binghang; Guo, Yuecheng; Li, Fei; Zhang, Qidi; Qu, Ying; Dong, Hui; Cai, Xiaobo; Lu, Lungen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai 201620, Peoples R China; [Gu, Tianyi; Shen, Bo; Li, Binghang; Guo, Yuecheng; Li, Fei; Zhang, Qidi; Qu, Ying; Dong, Hui; Cai, Xiaobo; Lu, Lungen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China; [Ma, Zhenzeng] Bengbu Med Coll, Affiliated Hosp 1, Dept Gastroenterol, Bengbu, Peoples R China; [Chen, Liuying] Huazhong Univ Sci & Technol, Union Hosp, Div Gastroenterol, Tongji Med Coll, Wuhan, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Bengbu Medical College; Huazhong University of Science & Technology	Cai, XB; Lu, LG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gastroenterol, Shanghai 201620, Peoples R China.	caixiaobo19790719@126.com; lungenlu1965@163.com	Guo, Yuecheng/GNP-6792-2022		National Natural Science Foundation of China (NSFC) [81670548, 81470858, 81970528]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670548, 81470858 and 81970528	Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bocca C, 2015, CELL MOL GASTROENTER, V1, P477, DOI 10.1016/j.jcmgh.2015.06.011; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen LY, 2019, BBA-MOL CELL RES, V1866, P1663, DOI 10.1016/j.bbamcr.2019.06.011; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; DeLeve LD, 2017, SEMIN LIVER DIS, V37, P377, DOI 10.1055/s-0037-1617455; Elpek GO, 2015, WORLD J HEPATOL, V7, P377, DOI 10.4254/wjh.v7.i3.377; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Farra R, 2015, WORLD J GASTROENTERO, V21, P8994, DOI 10.3748/wjg.v21.i30.8994; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; FRASER JRE, 1985, CELL TISSUE RES, V242, P505; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; GARCIAMONZON C, 1995, GASTROENTEROLOGY, V108, P231, DOI 10.1016/0016-5085(95)90029-2; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Greuter T, 2016, J GASTROENTEROL, V51, P511, DOI 10.1007/s00535-016-1190-4; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Huang JW, 2013, CANCER SCI, V104, P1609, DOI 10.1111/cas.12291; Huang QB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067294; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Lin LT, 2017, NANOMED-NANOTECHNOL, V13, P2329, DOI 10.1016/j.nano.2017.06.019; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Ma RQ, 2016, INTERDISCIP SCI, V8, P209, DOI 10.1007/s12539-015-0117-8; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; Menakuru SR, 2008, BRIT J CANCER, V99, P1961, DOI 10.1038/sj.bjc.6604733; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Park HJ, 2016, ADV HEALTHC MATER, V5, P2931, DOI 10.1002/adhm.201600416; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shen Z, 2016, AM J PATHOL, V186, P1874, DOI 10.1016/j.ajpath.2016.03.010; Shi ZG, 2012, J ONCOL, V2012, DOI 10.1155/2012/903581; SHIMIZU H, 1994, HEPATOLOGY, V20, P1323, DOI 10.1002/hep.1840200533; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Thomas H., 2017, NAT REV GASTRO HEPAT, V15, P6; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	44	4	4	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21571	10.1096/fj.202002694R	http://dx.doi.org/10.1096/fj.202002694R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33861889				2022-12-26	WOS:000645260100045
J	Luo, ZT; Luo, ST; Ju, YC; Ding, P; Xu, J; Gu, Q; Zhou, HH				Luo, Zhiteng; Luo, Siting; Ju, Yingchen; Ding, Peng; Xu, Jun; Gu, Qiong; Zhou, Huihao			Structural insights into the ligand recognition and catalysis of the key aminobutanoyltransferase CntL in staphylopine biosynthesis	FASEB JOURNAL			English	Article						biosynthesis; metallophore; Staphylococcus aureus; substrate selectivity; X-ray crystallography	STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; SIDEROPHORE BIOSYNTHESIS; TRANSITION-METALS; ABC-TRANSPORTER; NICKEL IMPORT; METALLOPHORE; GROWTH; IDENTIFICATION; CONTRIBUTES	Staphylopine (StP) and other nicotianamine-like metallophores are crucial for many pathogens to acquire the transition metals from hosts during invasion. CntL from Staphylococcus aureus (SaCntL) catalyzes the condensation of the 2-aminobutyrate (Ab) moiety of S-adenosylmethionine (SAM) with D-histidine in the biosynthesis of StP. Here, we report the crystal structures of SaCntL in complex with either SAM or two products. The structure of SaCntL consists of an N-terminal four-helix bundle (holding catalytic residue E84) and a C-terminal Rossmann fold (binding the substrates). The sequence connecting the N-and C-terminal domains (N-C linker) in SaCntL was found to undergo conformational alternation between open and closed states. Our structural and biochemical analyses suggested that this intrinsically dynamic interdomain linker forms an additional structural module that plays essential roles in ligand diffusion, recognition, and catalysis. We confirmed that SaCntL stereoselectively carries out the catalysis of D-His but not its enantiomer, L-His, and we found that the N-C linker and active site of SaCntL could accommodate both enantiomers. SaCntL is likely able to bind L-His without catalysis, and as a result, L-His could show inhibitory effects toward SaCntL. These findings provide critical structural and mechanistic insights into CntL, which facilitates a better understanding of the biosynthesis of nicotianamine-like metallophores and the discovery of inhibitors of this process.	[Luo, Zhiteng; Luo, Siting; Ju, Yingchen; Ding, Peng; Xu, Jun; Gu, Qiong; Zhou, Huihao] Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, Guangzhou 510006, Peoples R China; [Luo, Zhiteng; Luo, Siting; Ju, Yingchen; Ding, Peng; Xu, Jun; Gu, Qiong; Zhou, Huihao] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Chiral Mol & Drug Discover, Guangzhou 510006, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, Guangzhou 510006, Peoples R China.; Zhou, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Chiral Mol & Drug Discover, Guangzhou 510006, Peoples R China.	zhuihao@mail.sysu.edu.cn	ZHOU, HUIHAO/L-6133-2016	ZHOU, HUIHAO/0000-0002-9675-5007	National Key Research and Development Program [2017YFE0109900]; National Natural Science Foundation of China [81773636]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2016ZT06Y337]; Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery [2019B030301005]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery	This research was supported by National Key Research and Development Program (No. 2017YFE0109900), National Natural Science Foundation of China (No. 81773636), Program for Guangdong Introducing Innovative and Entrepreneurial Teams (No. 2016ZT06Y337), and Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery (No. 2019B030301005)	Andreini C, 2004, BIOINFORMATICS, V20, P1373, DOI 10.1093/bioinformatics/bth095; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Begg SL, 2019, BIOCHEM SOC T, V47, P77, DOI 10.1042/BST20180275; Bielecki P, 2013, ENVIRON MICROBIOL, V15, P570, DOI 10.1111/1462-2920.12024; Chen CH, 2019, FEBS LETT, V593, P1213, DOI 10.1002/1873-3468.13396; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Dawadi S, 2018, ACS MED CHEM LETT, V9, P386, DOI 10.1021/acsmedchemlett.8b00090; del Campo JSM, 2016, ACS CHEM BIOL, V11, P3035, DOI 10.1021/acschembio.6b00666; Ding YP, 2012, J BACTERIOL, V194, P6586, DOI 10.1128/JB.01414-12; Dreyfus C, 2009, P NATL ACAD SCI USA, V106, P16180, DOI 10.1073/pnas.0904439106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14644; Grim KP, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00014-20; Grim KP, 2017, MBIO, V8, DOI [10.1128/mbio.01281-17, 10.1128/mBio.01281-17]; Hajjar C, 2019, J AM CHEM SOC, V141, P5555, DOI 10.1021/jacs.9b01676; Hiron A, 2010, MOL MICROBIOL, V77, P1246, DOI 10.1111/j.1365-2958.2010.07287.x; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Laffont C, 2020, METALLOMICS, V12, P1480, DOI 10.1039/d0mt00150c; Laffont C, 2019, BIOCHEM J, V476, P2221, DOI 10.1042/BCJ20190384; Lebrette H, 2015, METALLOMICS, V7, P613, DOI 10.1039/c4mt00295d; Lebrette H, 2014, STRUCTURE, V22, P1421, DOI 10.1016/j.str.2014.07.012; Lebrette H, 2013, J INORG BIOCHEM, V121, P16, DOI 10.1016/j.jinorgbio.2012.12.010; Lhospice S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16765-9; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Luo ST, 2019, INT J BIOL MACROMOL, V135, P725, DOI 10.1016/j.ijbiomac.2019.05.169; Mastropasqua MC, 2017, MOL MICROBIOL, V106, P543, DOI 10.1111/mmi.13834; McFarlane JS, 2019, J BIOL CHEM, V294, P17988, DOI 10.1074/jbc.RA119.011059; McFarlane JS, 2018, J BIOL CHEM, V293, P8009, DOI 10.1074/jbc.RA118.002007; McFarlane JS, 2017, BIOCHEMISTRY-US, V56, P5967, DOI 10.1021/acs.biochem.7b00804; McFarlane JS, 2020, CHEM BIOL, V5, P395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neres J, 2013, J MED CHEM, V56, P2385, DOI 10.1021/jm301709s; Palmer LD, 2016, ANNU REV GENET, V50, P67, DOI 10.1146/annurev-genet-120215-035146; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sassone-Corsi M, 2016, P NATL ACAD SCI USA, V113, P13462, DOI 10.1073/pnas.1606290113; Song LQ, 2018, P NATL ACAD SCI USA, V115, P3942, DOI 10.1073/pnas.1718382115; Tang JY, 2019, J MOL BIOL, V431, P4868, DOI 10.1016/j.jmb.2019.10.009; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tripathi A, 2014, J AM CHEM SOC, V136, P1579, DOI 10.1021/ja4115924; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zhang J, 2019, CHEM SCI, V10, P6635, DOI 10.1039/c9sc01405e; Zhang J, 2017, J ORG CHEM, V82, P13643, DOI 10.1021/acs.joc.7b02342	48	1	1	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21575	10.1096/fj.202002287RR	http://dx.doi.org/10.1096/fj.202002287RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826776				2022-12-26	WOS:000645260100048
J	Radadiya, PS; Thornton, MM; Daniel, EA; Idowu, JY; Wang, W; Magenheimer, B; Subramaniam, D; Tran, PV; Calvet, JP; Wallace, DP; Sharma, M				Radadiya, Priyanka S.; Thornton, Mackenzie M.; Daniel, Emily A.; Idowu, Jessica Y.; Wang, Wei; Magenheimer, Brenda; Subramaniam, Dharmalingam; Tran, Pamela, V; Calvet, James P.; Wallace, Darren P.; Sharma, Madhulika			Quinomycin A reduces cyst progression in polycystic kidney disease	FASEB JOURNAL			English	Article						Quinomycin A; proliferation; Notch; polycystic kidney	MONOCYTE CHEMOATTRACTANT PROTEIN-1; ELEVATED AROMATASE EXPRESSION; ADIPOSE STROMAL CELLS; BREAST-CANCER; CORTISOL METABOLISM; SIGNALING PATHWAYS; MMP-9 EXPRESSION; OBESE WOMEN; WEIGHT-GAIN; CYP19 GENE	Polycystic kidney disease (PKD) is a genetic disorder characterized by aberrant renal epithelial cell proliferation and formation and progressive growth of numerous fluid-filled cysts within the kidneys. Previously, we showed that there is elevated Notch signaling compared to normal renal epithelial cells and that Notch signaling contributes to the proliferation of cystic cells. Quinomycin A, a bis-intercalator peptide, has previously been shown to target the Notch signaling pathway and inhibit tumor growth in cancer. Here, we show that Quinomycin A decreased cell proliferation and cyst growth of human ADPKD cyst epithelial cells cultured within a 3D collagen gel. Treatment with Quinomycin A reduced kidney weight to body weight ratio and decreased renal cystic area and fibrosis in Pkd1(RC/RC); Pkd2(+/-) mice, an orthologous PKD mouse model. This was accompanied by reduced expression of Notch pathway proteins, RBPjk and HeyL and cell proliferation in kidneys of PKD mice. Quinomycin A treatments also normalized cilia length of cyst epithelial cells derived from the collecting ducts. This is the first study to demonstrate that Quinomycin A effectively inhibits PKD progression and suggests that Quinomycin A has potential therapeutic value for PKD patients.	[Radadiya, Priyanka S.; Thornton, Mackenzie M.; Daniel, Emily A.; Idowu, Jessica Y.; Wallace, Darren P.; Sharma, Madhulika] Univ Kansas, Dept Internal Med, Med Ctr, Kansas City, KS 66160 USA; [Magenheimer, Brenda; Calvet, James P.] Univ Kansas, Biochem & Mol Biol, Med Ctr, Kansas City, KS 66160 USA; [Wang, Wei; Tran, Pamela, V] Univ Kansas, Med Ctr, Anat & Cell Biol, Kansas City, KS 66160 USA; [Radadiya, Priyanka S.; Thornton, Mackenzie M.; Daniel, Emily A.; Idowu, Jessica Y.; Wang, Wei; Magenheimer, Brenda; Tran, Pamela, V; Calvet, James P.; Wallace, Darren P.] Univ Kansas, Med Ctr, Jared Grantham Kidney Inst, Kansas City, KS 66160 USA; [Subramaniam, Dharmalingam] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Sharma, M (corresponding author), Univ Kansas, Dept Internal Med, Med Ctr, Kansas City, KS 66160 USA.	msharma3@kumc.edu		Subramaniam, Dharmalingam/0000-0002-2710-485X; Calvet, James/0000-0001-5928-9820; Tran, Pamela/0000-0003-4619-4376	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103418]; PKD Biomarkers, Biomaterials, and Cellular Models Core in the Kansas PKD Research and Translational Core Center part of the national PKD Research Resource Consortium [U54 DK126126];  [R01DK103033];  [R01DK108433]	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); PKD Biomarkers, Biomaterials, and Cellular Models Core in the Kansas PKD Research and Translational Core Center part of the national PKD Research Resource Consortium; ; 	This project was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103418--summer scholarship award to PR, PKD Biomarkers, Biomaterials, and Cellular Models Core in the Kansas PKD Research and Translational Core Center (U54 DK126126), which is part of the national PKD Research Resource Consortium; R01DK103033 to PVT, Lied pilot award and R01DK108433 to MS	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; An J, 2017, ONCOTARGET, V8, P39230, DOI 10.18632/oncotarget.16837; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Basurto L, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.05.013; Bezemer ID, 2005, CANCER CAUSE CONTROL, V16, P561, DOI 10.1007/s10552-004-7472-9; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Brown KA, 2017, J CLIN ENDOCR METAB, V102, P1692, DOI 10.1210/jc.2016-3606; Brown KA, 2014, J MAMMARY GLAND BIOL, V19, P183, DOI 10.1007/s10911-014-9321-0; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P428, DOI 10.1210/jc.78.2.428; Bulun SE, 2007, J STEROID BIOCHEM, V106, P81, DOI 10.1016/j.jsbmb.2007.05.027; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Burkhard K, 2010, METHODS MOL BIOL, V661, P107, DOI 10.1007/978-1-60761-795-2_6; Chen D, 2012, MOL CELL ENDOCRINOL, V355, P114, DOI 10.1016/j.mce.2012.01.027; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dutta P, 2018, BREAST CANCER RES TR, V170, P477, DOI 10.1007/s10549-018-4760-8; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; Han R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27810-6; Hao QY, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00589-8; Hetemaki N, 2017, J CLIN ENDOCR METAB, V102, P4588, DOI 10.1210/jc.2017-01474; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Ignacio RMC, 2016, IMMUNE NETW, V16, P189, DOI 10.4110/in.2016.16.3.189; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; Iyengar NM, 2015, CANCER PREV RES, V8, P349, DOI 10.1158/1940-6207.CAPR-14-0243; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kulendran M, 2009, ANTICANCER RES, V29, P1095; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; Lim SY, 2016, ONCOTARGET, V7, P28697, DOI 10.18632/oncotarget.7376; Lubowicka E, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2124390; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Martinez-Chacon G, 2018, FASEB J, V32, P3361, DOI 10.1096/fj.201700938RRR; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P1327, DOI 10.1210/jc.87.3.1327; McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Nascimento-Sales M, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13271; NEWTON CJ, 1986, J STEROID BIOCHEM, V24, P1033, DOI 10.1016/0022-4731(86)90356-0; Park KS, 2009, CLIN CHIM ACTA, V403, P92, DOI 10.1016/j.cca.2009.01.025; Peuhu E, 2017, EMBO J, V36, P165, DOI 10.15252/embj.201694387; Polari L, 2015, MOL CELL ENDOCRINOL, V412, P123, DOI 10.1016/j.mce.2015.06.002; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rice S, 2012, FERTIL STERIL, V97, P1460, DOI 10.1016/j.fertnstert.2012.03.008; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 1997, RECENT PROG HORM RES, V52, P185; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Stingl John, 2005, Methods Mol Biol, V290, P249; Strauss L, 2013, FASEB J, V27, P1342, DOI 10.1096/fj.12-219048; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Svensson S, 2015, CLIN CANCER RES, V21, P3794, DOI 10.1158/1078-0432.CCR-15-0204; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Thijssen JHH., 1976, CONSENSUS MENOPAUSE, P25; To SQ, 2015, J STEROID BIOCHEM, V145, P179, DOI 10.1016/j.jsbmb.2014.05.004; To SQ, 2013, BIOCHEM BIOPH RES CO, V433, P96, DOI 10.1016/j.bbrc.2013.02.058; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; VANLANDEGHEM AAJ, 1985, CANCER RES, V45, P2900; Vrieling A, 2010, BREAST CANCER RES TR, V123, P641, DOI 10.1007/s10549-010-1116-4; Westerbacka J, 2008, AM J PHYSIOL-ENDOC M, V294, pE841, DOI 10.1152/ajpendo.00653.2006; Zhao Y, 1997, J STEROID BIOCHEM, V61, P203, DOI 10.1016/S0960-0760(97)80013-1; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350	73	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21533	10.1096/fj.202002490R	http://dx.doi.org/10.1096/fj.202002490R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826787	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000645260100088
J	Nayan, SI; Chowdhury, FI; Akter, N; Rahman, MM; Selim, S; Saffoon, N; Khan, F; Subhan, N; Hossain, M; Ahmed, KS; Hossain, H; Haque, MA; Alam, MA				Nayan, Shariful Islam; Chowdhury, Faizul Islam; Akter, Noushin; Rahman, Md Mizanur; Selim, Saima; Saffoon, Nadia; Khan, Ferdous; Subhan, Nusrat; Hossain, Maqsud; Ahmed, K. Shahin; Hossain, Hemayet; Haque, Md Areeful; Alam, Md Ashraful			Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats	PLOS ONE			English	Article							ACID	Obesity is an enduring medical issue that has raised concerns around the world. Natural plant extracts have shown therapeutic potential in preventing oxidative stress and inflammation related to obesity complications. In this study, Senna alexandrina Mill. leaves were utilized to treat high-fat diet-related metabolic disorders and non-alcoholic fatty liver diseases. Plasma biochemical assays were conducted to determine the lipid profiles and oxidative stress parameters, and the gene expression of antioxidant enzymes and inflammatory mediators was measured. Histological stained livers of high-fat diet-fed rats were observed. S. alexandrina leaf powder supplementation prevented the increase in cholesterol and triglyceride levels in high-fat diet-fed rats. Moreover, S. alexandrina leaves also reduced lipid peroxidation and nitric oxide production in these rats. Prevention of oxidative stress by S. alexandrina leaf supplementation in high-fat diet-fed rats is regulated by enhancing the antioxidant enzyme activity, followed by the restoration of corresponding gene expressions, such as NRF-2, HO-1, SOD, and CAT. Histological staining provides further evidence that S. alexandrina leaf supplementation prevents inflammatory cell infiltration, lipid droplet deposition, and fibrosis in the liver of high-fat diet-fed rats. Furthermore, this investigation revealed that S. alexandrina leaf supplementation controlled non-alcoholic fatty liver disease by modulating the expression of fat metabolizing enzymes in high-fat diet-fed rats. Therefore, S. alexandrina leaf supplementation inhibits fatty liver inflammation and fibrosis, suggesting its usefulness in treating non-alcoholic steatohepatitis. Thus, this natural leaf extract has potential in treatment of obesity related liver dysfunction.	[Nayan, Shariful Islam; Chowdhury, Faizul Islam; Akter, Noushin; Rahman, Md Mizanur; Selim, Saima; Saffoon, Nadia; Khan, Ferdous; Subhan, Nusrat; Alam, Md Ashraful] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Rahman, Md Mizanur; Haque, Md Areeful] Int Islamic Univ Chittagong, Dept Pharm, Chittagong, Bangladesh; [Hossain, Maqsud] North South Univ, NSU Genome Res Inst NGRI, Dhaka, Bangladesh; [Ahmed, K. Shahin; Hossain, Hemayet] Bangladesh Council Sci & Ind Res, BCSIR Labs, Dhaka, Bangladesh	North South University (NSU); International Islamic University Chittagong (IIUC); North South University (NSU); Bangladesh Council of Scientific & Industrial Research (BCSIR); BCSIR Laboratories Dhaka	Alam, MA (corresponding author), North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh.; Haque, MA (corresponding author), Int Islamic Univ Chittagong, Dept Pharm, Chittagong, Bangladesh.	areeful@gmail.com; ashraful.alam@northsouth.edu	Haque, Md Areeful/C-6963-2018; Rahman, MD Mizanur/AAC-7666-2019; shahin, Khondoker/O-6195-2018; hossain, hemayet/O-5996-2018	Haque, Md Areeful/0000-0003-2935-6345; Rahman, MD Mizanur/0000-0002-7178-7977; shahin, Khondoker/0000-0003-3051-8348; Hossain, Hemayet/0000-0001-8759-9279; Nayan, Shariful Islam/0000-0003-3066-4820	Ministry of Science and Technology, Bangladesh	Ministry of Science and Technology, Bangladesh	This research is supported by a Special Allocation Grant from the Ministry of Science and Technology, Bangladesh to Dr. Md Ashraful Alam in 2019.	Akiyama T, 1996, DIABETES RES CLIN PR, V31, P27, DOI 10.1016/0168-8227(96)01205-3; Anstee QM, 2011, BBA-MOL BASIS DIS, V1812, P1557, DOI 10.1016/j.bbadis.2011.07.017; Boaduo NKK, 2014, PHARM BIOL, V52, P756, DOI 10.3109/13880209.2013.869828; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; da Cunha NV, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00520.2013; Delfan B., 2016, TRADITIONAL INTEGRAT, P28; Echeverria F, 2019, J NUTR BIOCHEM, V63, P35, DOI 10.1016/j.jnutbio.2018.09.012; Farag MA, 2015, ANAL BIOANAL CHEM, V407, P1937, DOI 10.1007/s00216-014-8432-1; Feng XJ, 2017, BIOCHEM PHARMACOL, V136, P136, DOI 10.1016/j.bcp.2017.04.014; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Gaikwad SB., 2014, PHARM CROPS, V5; Ghorbani A, 2017, BIOMED PHARMACOTHER, V96, P305, DOI 10.1016/j.biopha.2017.10.001; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; HEIDEMANN A, 1993, PHARMACOLOGY, V47, P178, DOI 10.1159/000139857; Hernandez-Rodas MC, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700479; IACUC, 2018, ANESTH GUID; Illesca P, 2020, FOOD FUNCT, V11, P9086, DOI [10.1039/d0fo01790f, 10.1039/D0FO01790F]; Illesca P, 2019, BIOMED PHARMACOTHER, V109, P2472, DOI 10.1016/j.biopha.2018.11.120; Jani DK, 2020, J TRADIT COMPL MED, V10, P124, DOI 10.1016/j.jtcme.2019.03.002; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Laghari AQ, 2011, AM J ANAL CHEM, V2, P871, DOI DOI 10.4236/AJAC.2011.28100; Lasker S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56538-0; Low S, 2009, ANN ACAD MED SINGAP, V38, P57; Ma L, 2020, DIABET METAB SYND OB, V13, P1407, DOI 10.2147/DMSO.S247251; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Milic S, 2014, WORLD J GASTROENTERO, V20, P9330, DOI 10.3748/wjg.v20.i28.9330; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Morales MA, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/287247; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Ortiz M, 2020, DIGEST LIVER DIS, V52, P895, DOI 10.1016/j.dld.2020.04.019; Osman N, 2017, INT J PHARM RES ALLI, V6; Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Rahman MM, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0539-x; Reddy SH, 2018, INT J PHARM SCI RES, V9, P490, DOI 10.13040/IJPSR.0975-8232.9(2).490-97; Saheed SA, 2010, NOT BOT HORTI AGROBO, V38, P21; Savulescu E., 2018, SCIENDO, P305; Singh R, 2013, J ETHNOPHARMACOL, V150, P51, DOI 10.1016/j.jep.2013.08.051; Snezhkina AV, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6175804; Soto-Alarcon SA, 2019, BIOFACTORS, V45, P930, DOI 10.1002/biof.1556; Sumida Y, 2018, J GASTROENTEROL, V53, P362, DOI 10.1007/s00535-017-1415-1; Surh I, 2013, TOXICOL PATHOL, V41, P770, DOI 10.1177/0192623312464304; Timmers S, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.7; Tiwari Brahm Kumar, 2014, ISRN Pharmacol, V2014, P608590, DOI 10.1155/2014/608590; TRACEY WR, 1995, J PHARMACOL EXP THER, V272, P1011; Ugbogu A. E, 2016, AM J BIOMEDICAL RES, V4, P80, DOI 10.12691/ajbr-4-4-1; Villalpando-Arteaga EV, 2013, FOOD FUNCT, V4, P618, DOI 10.1039/c3fo30270a; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Yi HW, 2020, CHIN J NAT MEDICINES, V18, P169, DOI 10.1016/S1875-5364(20)30018-2; Yuan Y, 2019, INT J BIOL MACROMOL, V141, P822, DOI 10.1016/j.ijbiomac.2019.09.002; Yuniarto A, 2018, INT J PHARM PHYTOPHA, V8, P18	54	0	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2021	16	4							e0250261	10.1371/journal.pone.0250261	http://dx.doi.org/10.1371/journal.pone.0250261			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RQ1EM	33878116	Green Published, gold			2022-12-26	WOS:000642162200010
J	Paszta, W; Kleckowska-Nawrot, JE; Gozdziewska-Harlajczuk, K				Paszta, Wojciech; Kleckowska-Nawrot, Joanna E.; Gozdziewska-Harlajczuk, Karolina			Anatomical and morphometric evaluation of the orbit, eye tunics, eyelids and orbital glands of the captive females of the South African painted dog (Lycaon pictus pictus Temminck, 1820) (Caniformia: Canidae)	PLOS ONE			English	Article							TEAR FILM; COMPARATIVE MORPHOLOGY; CORNEAL EPITHELIUM; TAPETUM-LUCIDUM; LYMPHOID-TISSUE; WILD DOGS; CANINE; CARNIVORA; SKULL; DIVERGENCE	In this study, we present the first data concerning the anatomical, morphometrical, histological and histochemical study of the orbit, eye tunics, eyelids and orbital glands in South African Painted Dogs (Lycaon pictus pictus). The study was performed using eyeball morphometry, analysis of the bony orbit including its morphometry, macroscopic study, morphometry, histological examination of the eye tunics and chosen accessory organs of the eye and histochemical analysis. The orbit was funnel shaped and was open-type. There was a single ethmoid opening for the ethmoid nerve on the orbital lamina. The pupil was round, while the ciliary body occupied a relatively wide zone. The iris was brown and retina had a pigmented area. The cellular tapetum lucidum was semi-circular and milky and was composed of 14-17 layers of tapetal cells arranged in a bricklike structure. In the lower eyelid, there was a single conjunctival lymph nodule aggregate. One or two additional large conjunctval folds were observed within the posterior surface of the upper eyelids. The superficial gland of the third eyelid had a serous nature. The third eyelid was T-shaped and was composed of hyaline tissue. Two to three conjunctival lymph nodul aggregates were present within the bulbar conjunctiva of the third eyelid. The lacrimal gland produced a sero-mucous secretion. A detailed anatomic analysis of the eye area in the captive South African Painted Dogs females showed the similarities (especially in the histological examination of the eyetunics and orbital glands) as well as the differences between the Painted dog and the other representatives of Canidae. The differences included the shape and size od the orbita with comparison to the domestic dog. Such differences in the orbit measurements are most likely associated with the skull type, which are defined in relation to domestic dogs. The presented results significantly expand the existing knowledge on comparative anatomy in the orbit, eye and chosen accessory organs in wild Canidae.	[Paszta, Wojciech] Wroclaw Zool Garden, Wroclaw, Poland; [Kleckowska-Nawrot, Joanna E.; Gozdziewska-Harlajczuk, Karolina] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biostruct & Anim Physiol, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences	Paszta, W (corresponding author), Wroclaw Zool Garden, Wroclaw, Poland.; Gozdziewska-Harlajczuk, K (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biostruct & Anim Physiol, Wroclaw, Poland.	wojciech.paszta@gmail.com; k.gozdziewska.wroc@gmail.com	Goździewska-Harłajczuk, Karolina/A-4469-2017	Goździewska-Harłajczuk, Karolina/0000-0003-4412-1966	Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences	Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences	The translation and publication costs were supported by statutory research and development activity funds assigned to the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft JD., 2008, THEORY PRACTICE HIST, V6th ed, P173; Banks MS, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500391; BERTA A, 1982, Mammalian Species, P1, DOI 10.2307/3503974; Bubadue JD, 2016, EVOL BIOL, V43, P145, DOI 10.1007/s11692-015-9362-3; Burck NC., 1975, TECHNIKA HISTOLOGICZ; Cabral Vânia Pais, 2005, Cienc. Rural, V35, P391, DOI 10.1590/S0103-84782005000200023; Carson F., 1990, HISTOTECHNOLOGY SELF, V1 st ed, P126; Carvalho CM, 2020, VET OPHTHALMOL, V23, P460, DOI 10.1111/vop.12741; Castello JR., 2018, COMPREHENSIVE SURVEY; Cazacu P, 2010, RESEARCHES MORPHOLOG; CHIJIWA T, 1990, GRAEF ARCH CLIN EXP, V228, P161, DOI 10.1007/BF00935727; CONSTANTINESCU GM, 1990, AM J VET RES, V51, P260; Constantinescu GM, 1998, WIEN TIERARZTL MONAT, V85, P229; Corfield AP, 2005, GLYCOCONJUGATE J, V22, P409, DOI 10.1007/s10719-005-3698-3; Cossios E. Daniel, 2010, Mammalian Species, P1, DOI 10.1644/848.1; Creel S, 1998, ANIM CONSERV, V1, P1, DOI 10.1111/j.1469-1795.1998.tb00220.x; Cummings JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036097; Dalponte Julio C., 2009, Mammalian Species, DOI 10.1644/847.1; Davidson HJ, 2004, VET OPHTHALMOL, V7, P71, DOI 10.1111/j.1463-5224.2004.00325.x; El-Fadaly AB, 2014, ANN ANAT, V196, P336, DOI 10.1016/j.aanat.2014.06.005; El-naseery NI., 2016, BENHA VET MED J, V31, P106; Estes R., 2012, BEHAV GUIDE AFRICAN; Evans HE., 1994, PHILADELPHIA LONDON, VThird edition; FANSHAWE J H, 1991, Oryx, V25, P137; Fanshawe John H., 1997, P11; German AJ, 1998, VET IMMUNOL IMMUNOP, V64, P107, DOI 10.1016/S0165-2427(98)00132-9; GOLLER T, 1993, ANN ANAT, V175, P127, DOI 10.1016/S0940-9602(11)80165-2; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Honsho CS, 2016, PESQUI VET BRASIL, V36, P919, DOI [10.1590/S0100-736X2016000900020, 10.1590/s0100-736x2016000900020]; Igado Olumayowa O, 2017, Niger J Physiol Sci, V32, P153; IUCN, 2020, IUCN RED LIST THREAT; Janeczek M, 2005, MED WETER, V61, P789; JOHNSINGH AJT, 1982, J ZOOL, V198, P443, DOI 10.1111/jzo.1982.198.4.443; Kirk EC, 2006, J HUM EVOL, V51, P159, DOI 10.1016/j.jhevol.2006.02.004; Kirk EC, 2004, ANAT REC PART A, V281A, P1095, DOI 10.1002/ar.a.20115; Kleckowska-Nawrot JE, 2018, ACTA ZOOL-STOCKHOLM, V99, P367, DOI 10.1111/azo.12223; Knoest JJT., 2015, OSTEOMETRIC STUDY; Knop E, 2008, INVEST OPHTH VIS SCI, V49, P2322, DOI 10.1167/iovs.07-0691; Lamberts D.W., 1994, CORNEA, P439; Lantyer-Araujo NL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224245; Lee LG., 1992, HISTOPATHOLOGIC METH, P151; Lluch S, 2008, ANAT HISTOL EMBRYOL, V37, P41, DOI 10.1111/j.1439-0264.2007.00796.x; Lucherini Mauro, 2008, Mammalian Species, P1, DOI 10.1644/820.1; Machado FD, 2009, BIOL J LINN SOC, V98, P77; Malcolm JR., 1999, ENCY MAMMALS, V2 nd ed, P56; Mallory FB., 1938, PATHOLOGICAL TECHNIQ, P72; Malmstrom T, 2006, J EXP BIOL, V209, P18, DOI 10.1242/jeb.01959; MARTIN CL, 1988, AM J VET RES, V49, P1566; Martinez PA, 2013, J ANIM ECOL, V82, P997, DOI 10.1111/1365-2656.12076; Neto AM, 2020, INT J MORPHOL, V38, P640; Meloro C, 2017, MAMMAL REV, V47, P159, DOI 10.1111/mam.12085; Merindano MD, 1998, ANAT HISTOL EMBRYOL, V27, P105, DOI 10.1111/j.1439-0264.1998.tb00164.x; Montiani-Ferreira F, 2008, VET OPHTHALMOL, V11, P386, DOI 10.1111/j.1463-5224.2008.00663.x; MOORE CP, 1987, INVEST OPHTH VIS SCI, V28, P1925; MOORE JC, 1979, EXP EYE RES, V29, P291, DOI 10.1016/0014-4835(79)90008-3; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; MUNAKATA H, 1985, TOHOKU J EXP MED, V145, P251, DOI 10.1620/tjem.145.251; Nautscher N, 2016, VET OPHTHALMOL, V19, P297, DOI 10.1111/vop.12298; NICHOLS BA, 1985, INVEST OPHTH VIS SCI, V26, P464; Nickel R., 2004, LEHRBUCH ANATOMIE HA, VVol. I; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Ofri R, 2009, VET J, V179, P70, DOI 10.1016/j.tvjl.2007.08.034; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; Onar V, 2001, ANAT HISTOL EMBRYOL, V30, P41, DOI 10.1046/j.1439-0264.2001.00292.x; Park SA, 2016, VET OPHTHALMOL, V19, P230, DOI 10.1111/vop.12288; Pole A, 2004, J ZOOL, V262, P207, DOI 10.1017/S0952836903004576; Pollock RVH., 2012, MILLERS ANATOMY DOG, V4 th, P746; Presutti L., 2016, ENDOSCOPIC SURG LACR, P3; Prevosti FJ, 2015, BIOL J LINN SOC, V116, P704, DOI 10.1111/bij.12625; Prevosti Francisco J, 2013, Mastozool. neotrop., V20, P289; RADINSKY L, 1973, BRAIN BEHAV EVOLUT, V7, P169, DOI 10.1159/000124409; Renzo R, 2020, J ZOO WILDLIFE MED, V51, P280, DOI 10.1638/2018-0129; Saito A, 2004, VET OPHTHALMOL, V7, P113, DOI 10.1111/j.1463-5224.2004.04007.x; Santos ALQ., 2017, CIEN ANIM BRAS, V18e, P37693; Sarma Kamal, 2006, Int. J. Morphol., V24, P449, DOI 10.4067/S0717-95022006000400025; Savage R.J.G., 1978, P249; Schmitt E, 2014, INT J OSTEOARCHAEOL, V24, P42, DOI 10.1002/oa.1306; Segura V, 2013, MAMMALIA, V77, P205, DOI 10.1515/mammalia-2012-0028; Segura V, 2012, ZOOMORPHOLOGY, V131, P79, DOI 10.1007/s00435-012-0145-4; Shaker MM., 2016, GLOB J BIOSCI BIOTEC, V5, P520; Sheehan DC., 1980, THEORY PRACTICE HIST, V52, P164; Siebelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082355; Slatter DH., 2005, FUNDAMENTO OPHTHALMO, V3 rd edtion, P686; Smithers RHN, 1983, MAMMALS SO AFRICAN S; Spicer SS, 1967, METHODS ACHIEVEMENTS, V1, P78; Venkataraman AB, 1995, CURR SCI INDIA, V69, P934; von den Driesch A, 1976, PEABODY MUSEUM B; WAYNE RK, 1993, TRENDS GENET, V9, P218, DOI 10.1016/0168-9525(93)90122-X; WEN GY, 1985, LAB ANIM SCI, V35, P200; WENZELHORA BI, 1982, LYMPHOLOGY, V15, P32; Wilson DE, 2005, TAXONOMIC GEOGRAPHIC; Woodroffe R, 2012, IUCN RED LIST THREAT; Zlamal A., 2000, KOSMOS PROBLEMY NAUK, P69; Zurano JP, 2017, J BIOGEOGR, V44, P821, DOI 10.1111/jbi.12984; Zwingenberger AL, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-116	97	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0249368	10.1371/journal.pone.0249368	http://dx.doi.org/10.1371/journal.pone.0249368			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP4TZ	33872321	gold, Green Published			2022-12-26	WOS:000641723300007
J	Ismail, II; Abdelkarim, A; Al-Hashel, JY				Ismail, Ismail Ibrahim; Abdelkarim, Ahmed; Al-Hashel, Jasem Y.			Physicians' attitude towards webinars and online education amid COVID-19 pandemic: When less is more	PLOS ONE			English	Article							MEDICAL-EDUCATION; TECHNOLOGY; GUIDELINES	Background Since the declaration of COVID-19 as a pandemic, all scientific medical activities were shifted to an online format, in the form of webinars, to maintain continuing medical education (CME). We aimed to assess physicians' attitude among different medical specialties towards this sudden and unexpected shift of traditional face-to-face meetings into webinars, and to suggest future recommendations. Methods We conducted a cross-sectional, internet-based survey study using a 25-item questionnaire, from November 1 and November 15, 2020. The survey was created and distributed to physicians from different medical and surgical specialties and from different countries via several social media platforms, using a snowball technique. Results A total of 326 physicians responded; 165 (50.6%) were females, mean age of responders was 38.7 +/- 7.5 years. The majority of responses (93.2%) came from Arab countries. Of them, 195 (59.8%) reported attending more webinars compared to the same period last year, with average of 3 per month. As regard to the general impression; 244 (74.8%) were "strongly satisfied" or "satisfied", with the most satisfaction for "training courses: by 268 (82.2%), and "International conferences" by 218 (66.9%). However, 246 respondents (75.5%) felt overwhelmed with the number and frequency of webinars during the pandemic, 171 (52.5%) reported attending less than 25% of webinars they are invited to, 205 (62.8%) disagreed that webinars can replace in-person meetings after the pandemic, and 239 (73.3%) agreed that online meetings need proper regulations. Conclusions Webinars comprised a major avenue for education during COVID-19 pandemic, with initial general satisfaction among physicians. However, this paradigm shift was sudden and lacked proper regulations. Despite initial satisfaction, the majority of physicians felt overwhelmed with the number and frequency of webinars. Physicians' satisfaction is crucial in planning future educational activities, and considering that this current crisis will most likely have long lasting effects, webinars should be viewed as complementing traditional in-person methods, rather than replacement. In this study, we are suggesting recommendations to help future regulation of this change.	[Ismail, Ismail Ibrahim; Al-Hashel, Jasem Y.] Ibn Sina Hosp, Dept Neurol, Kuwait, Kuwait; [Abdelkarim, Ahmed] Alexandria Univ, Fac Med, Dept Neuropsychiat, Alexandria, Egypt; [Al-Hashel, Jasem Y.] Kuwait Univ, Fac Med, Hlth Sci Ctr, Dept Med, Kuwait, Kuwait	Egyptian Knowledge Bank (EKB); Alexandria University; Kuwait University	Ismail, II (corresponding author), Ibn Sina Hosp, Dept Neurol, Kuwait, Kuwait.	dr.ismail.ibrahim2012@gmail.com	Abdelkarim, Ahmed/GXZ-8573-2022	Ibrahim Ismail, Ismail/0000-0002-9788-7044; Abdelkarim, Ahmed/0000-0002-1429-1051				Adedoyin OB, 2020, INTERACT LEARN ENVIR, DOI 10.1080/10494820.2020.1813180; Ahmed H, 2020, LANCET INFECT DIS, V20, P777, DOI 10.1016/S1473-3099(20)30226-7; Al-Ahmari AN, 2021, WORLD NEUROSURG, V146, pE811, DOI 10.1016/j.wneu.2020.11.015; Alsoufi A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242905; Bassett RL, 2007, J PSYCHOL CHRISTIANI, V26, P87; Bedford N., 2016, WEBINAR BEST PRACTIC; Bliss Michael, 2007, WILLIAM OSLER LIFE M; Cauchemez S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-207; Chen TG, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030200; Dedeilia A, 2020, IN VIVO, V34, P1603, DOI 10.21873/invivo.11950; Ferrel MN, 2020, CUREUS, V12, DOI 10.7759/cureus.7492; Figueroa F, 2020, ACTA ORTHOP, V91, P543, DOI 10.1080/17453674.2020.1776461; Foster MJ, 2014, J MED LIBR ASSOC, V102, P31, DOI 10.3163/1536-5050.102.1.007; Goh P.S., 2020, MEDEDPUBLISH, V9, P19, DOI 10.15694/mep.2020.000049.1; Guanci G, 2010, CREAT NURS, V16, P119, DOI 10.1891/1078-4535.16.3.119; Helou S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134866; Hilliard JD., 2020, NEUROSURGERY, V67; Kummer TF, 2017, INFORM MANAGE-AMSTER, V54, P73, DOI 10.1016/j.im.2016.04.002; Li L, 2020, LANCET RESP MED, V8, pE23, DOI 10.1016/S2213-2600(20)30125-9; Mbati L, 2015, INT REV RES OPEN DIS, V16, P272; Mitchell LD, 2015, J MANAG EDUC, V39, P350, DOI 10.1177/1052562914547964; Molay K, 2009, BEST PRACTICES WEBIN, V29, P2011; Navia A, 2020, AESTHET SURG J, V40, pNP569, DOI 10.1093/asj/sjaa163; Nepal PR, 2020, E GREEN NEUROSURG, V2, P1, DOI [DOI 10.3126/EGN.V2I2.29235, 10.3126/egn.v2i2.29235]; Paudel P., 2021, INT J STUDIES ED, V3, P70, DOI [10.46328/ijonse.32, DOI 10.46328/IJONSE.32]; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Radovic-Markovic M., 2010, ANN U PETROSANI EC, V10, P289; Rajab MH, 2020, CUREUS, V12, DOI 10.7759/cureus.8966; Reyna J., 2020, EDMEDIA INNOVATE LEA, P265; Reyna J., 2020, MEDEDPUBLISH, V9, P103, DOI [10.15694/mep.2020.000103.1, DOI 10.15694/MEP.2020.000103.1]; Rosen L, 2016, SLEEP HEALTH, V2, P49, DOI 10.1016/j.sleh.2015.11.003; Schifferdecker KE, 2009, MED EDUC, V43, P637, DOI 10.1111/j.1365-2923.2009.03386.x; Wroclawski M, 2021, J ENDOUROL, V35, P885, DOI 10.1089/end.2020.0631; Zoumenou V, 2015, J FAM CONSUM SCI, V107, P62	34	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250241	10.1371/journal.pone.0250241	http://dx.doi.org/10.1371/journal.pone.0250241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861799	Green Published, gold			2022-12-26	WOS:000641475400011
J	Li, YH; Wei, JZ; Wu, B; Wang, CL; Wang, CF; Zhang, YL; Yang, XD				Li, Yahong; Wei, Jianzhou; Wu, Bin; Wang, Chunli; Wang, Caifen; Zhang, Yulei; Yang, Xiaodong			Obfuscating encrypted threshold signature algorithm and its applications in cloud computing	PLOS ONE			English	Article							SECURITY; EFFICIENT	Current cloud computing causes serious restrictions to safeguarding users' data privacy. Since users' sensitive data is submitted in unencrypted forms to remote machines possessed and operated by untrusted service providers, users' sensitive data may be leaked by service providers. Program obfuscation shows the unique advantages that it can provide for cloud computing. In this paper, we construct an encrypted threshold signature functionality, which can outsource the threshold signing rights of users to cloud server securely by applying obfuscation, while revealing no more sensitive information. The obfuscator is proven to satisfy the average case virtual black box property and existentially unforgeable under the decisional linear (DLIN) assumption and computational Diffie-Hellman (CDH) assumption in the standard model. Moreover, we implement our scheme using the Java pairing-based cryptography library on a laptop.	[Li, Yahong; Wang, Chunli] Lanzhou Jiaotong Univ, Sch Elect & Informat Engn, Lanzhou, Gansu, Peoples R China; [Li, Yahong] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Sichuan, Peoples R China; [Wei, Jianzhou] Gansu Agr Univ, Coll Sci, Lanzhou, Gansu, Peoples R China; [Wu, Bin; Zhang, Yulei; Yang, Xiaodong] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China; [Wang, Caifen] Shenzhen Technol Univ, Coll Big Data & Internet, Shenzhen, Peoples R China	Lanzhou Jiaotong University; University of Electronic Science & Technology of China; Gansu Agricultural University; Northwest Normal University - China; Shenzhen Technology University	Li, YH (corresponding author), Lanzhou Jiaotong Univ, Sch Elect & Informat Engn, Lanzhou, Gansu, Peoples R China.; Li, YH (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Sichuan, Peoples R China.	liyahong@mail.lzjtu.cn			National Natural Science Foundation of China [61063041, 61901201, 61762058, 62002050, 61872060]; National Key R&D Program of China [2017YFB080200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	This work was supported by the National Natural Science Foundation of China (61063041, 61901201, 61762058, 62002050, 61872060) and National Key R&D Program of China (2017YFB080200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arul O., 2016, INT J ADV RES COMPUT, V9, P1, DOI [10.17148/IJARCCE.2016.5294, DOI 10.17148/IJARCCE.2016.5294]; Barak B, 2012, J ACM, V59, DOI 10.1145/2160158.2160159; Bellare M, 2016, LECT NOTES COMPUT SC, V9563, P565, DOI 10.1007/978-3-662-49099-0_21; Boneh D, 2004, LECT NOTES COMPUT SC, V3152, P41, DOI 10.1007/978-3-540-28628-8_3; BONEH D, 2001, LNCS, V2139; Canetti R, 2010, LECT NOTES COMPUT SC, V5978, P72, DOI 10.1007/978-3-642-11799-2_5; Canetti R, 2010, LECT NOTES COMPUT SC, V5978, P52, DOI 10.1007/978-3-642-11799-2_4; Cheng R, 2015, CONCURR COMP-PRACT E, V27, P2170, DOI 10.1002/cpe.3399; Desmedt Y., 2011, ENCY CRYPTOGRAPHY SE, P1288, DOI [10.1007/978-1-4419-5906-5_330, DOI 10.1007/978-1-4419-5906-5_330]; Gautam P, 2019, INT J INF SECUR PRIV, V13, P59, DOI 10.4018/IJISP.2019010105; Gennaro R, 1999, LECT NOTES COMPUT SC, V1592, P295; Hada S., 2010, LNCS, V6110, P92, DOI [10.1007/978-3-642-13190-55, DOI 10.1007/978-3-642-13190-55]; Hofheinz D, 2010, J CRYPTOL, V23, P121, DOI 10.1007/s00145-009-9046-1; Hohenberger S, 2011, J CRYPTOL, V24, P694, DOI 10.1007/s00145-010-9077-7; Islam S, 2018, IEEE T CLOUD COMPUT, V6, P387, DOI 10.1109/TCC.2015.2511719; Joycee, 2017, INT J ADV STUDIES CO, V12, P16; Kim K., 2007, INT C PROV SEC, DOI [10.1007/978-3-540-75670-5_14, DOI 10.1007/978-3-540-75670-5_14]; Li J, 2018, COMPUT SECUR, V72, P1, DOI 10.1016/j.cose.2017.08.007; Luo X., 2020, IEEE T DEPEND SECURE, P1, DOI [DOI 10.1109/TDSC.2021.3074146, 10.1109/TNSE.2020.3040407]; Lynn B, 2013, PAIRING BASED CRYTOG; MARY B, 2017, IEEE COMPUTER SOC, P181, DOI DOI 10.1109/WCCCT.2016.52; Nishimaki R, 2015, DESIGN CODE CRYPTOGR, V77, P61, DOI 10.1007/s10623-014-9986-9; OLI SA, 2017, 2017 WORLD C COMP CO, DOI DOI 10.1109/WCCCT.2016.51; Pedersen T. P., 1991, Advances in Cryptology - EUROCRYPT '91. Workshop on the Theory and Application of Cryptographic Techniques Proceedings, P522; Rehman Au., 2011, INT J ADV SCI TECHNO, V35, P1; Saroj SK, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND COMMUNICATION TECHNOLOGY CICT 2015, P202, DOI 10.1109/CICT.2015.149; SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; SHI Y, 2015, PLOS ONE, V10, P1, DOI [DOI 10.1371/JOURNAL.PONE.0115625, 10.1371/JOURNAL.PONE.0262162, DOI 10.1371/JOURNAL.PONE.0262162]; Shi Y, 2019, IEEE SYST J, V13, P2918, DOI 10.1109/JSYST.2018.2881711; Singh A, 2017, J NETW COMPUT APPL, V79, P88, DOI 10.1016/j.jnca.2016.11.027; Sun PJ, 2020, J NETW COMPUT APPL, V160, DOI 10.1016/j.jnca.2020.102642; Ye Q, 2018, IEEE VEH TECHNOL MAG, V13, P65, DOI 10.1109/MVT.2018.2809473; Zhang H, 2019, SOFT COMPUT, V23, P2061, DOI 10.1007/s00500-017-2921-z; Zhang MW, 2019, IEEE SYST J, V13, P1478, DOI 10.1109/JSYST.2019.2900723; Zhang W, IEEE T WIREL COMMUN, DOI [10.1109/GLOCOM.2018.8647178, DOI 10.1109/GLOCOM.2018.8647178]; Zhang Y, 2021, IEEE T CLOUD COMPUT, V9, P1335, DOI 10.1109/TCC.2019.2923222; Zhang Y, 2020, IEEE T SERV COMPUT, V13, P216, DOI 10.1109/TSC.2019.2947476; Zhang Y, 2021, IEEE T CLOUD COMPUT, V9, P923, DOI 10.1109/TCC.2019.2908400; Zhang Y, 2018, IEEE T IND INFORM, V14, P4101, DOI 10.1109/TII.2018.2832251; Zhuang WH, 2020, P IEEE, V108, P274, DOI 10.1109/JPROC.2019.2951169	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250259	10.1371/journal.pone.0250259	http://dx.doi.org/10.1371/journal.pone.0250259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861767	gold, Green Published			2022-12-26	WOS:000641475400058
J	Caballero, C; Barbado, D; Hernandez-Davo, H; Hernandez-Davo, JL; Moreno, FJ				Caballero, Carla; Barbado, David; Hernandez-Davo, Hector; Hernandez-Davo, Jose Luis; Moreno, Francisco J.			Balance dynamics are related to age and levels of expertise. Application in young and adult tennis players	PLOS ONE			English	Article							POSTURAL CONTROL; SWAY MEASURES; RELIABILITY; COMPLEXITY; STABILITY; VELOCITY; SPORTS; TIME; COP	In tennis, coaches consider balance fundamental for the acquisition of skilled motor performance. However, the potential relationship between balance and tennis expertise and performance has not been explored yet. Therefore, this study assessed the relationship between balance and tennis performance using linear and non-linear parameters through 1) the comparison of tennis players of different ages and levels of expertise, and 2) analyzing the relationship between balance and tennis serving speed and accuracy. One hundred and six recreational and expert male tennis players took part in the study (age range 10-35 years old). Temporal dynamics of postural control during a balance task on an unstable surface were analyzed through the mean velocity and the detrended fluctuation analysis (DFA(V)) of center of pressure (COP). Tennis serve performance was quantified by measuring accuracy and speed. Traditional variables measuring balance performance only showed differences according to age but not to sport performance. COP showed a reduction of auto-correlated variability (reflected by DFA(V)) with age but mainly in expert players. COP dynamics was the only balance parameter discriminating sport expertise and it was related to age. Balance dynamics exhibited by expert tennis players DFA(V) results support the idea that, along the years, sport experience induces balance adaptations characterized by a higher ability to perform postural adjustments. These results also reinforce the use of non-linear analysis to reveal subtle balance adaptations produced by sport practice. Finally, the lack of correlations suggests that balance, measured with scattering variables, in a non-specific task is not a main determinant of sport performance in tennis serve.	[Caballero, Carla; Barbado, David; Hernandez-Davo, Hector; Hernandez-Davo, Jose Luis; Moreno, Francisco J.] Miguel Hernandez Univ Elche, Dept Sport Sci, Sports Res Ctr, Alicante, Spain	Universidad Miguel Hernandez de Elche	Moreno, FJ (corresponding author), Miguel Hernandez Univ Elche, Dept Sport Sci, Sports Res Ctr, Alicante, Spain.	fmoreno@umh.es	Caballero, Carla/Q-2654-2019; Moreno, Francisco J/P-6683-2015; Hernandez, Jose/AAS-6643-2021	Caballero, Carla/0000-0001-7624-232X; Moreno, Francisco J/0000-0002-2520-892X; Hernandez-Davo, Jose Luis/0000-0001-5785-4697	Economy, Industry and Competitiveness Ministry of Spain, Spanish Government [DEP2013-44160-P, DEP2016-79395-P]	Economy, Industry and Competitiveness Ministry of Spain, Spanish Government	This study was made possible by financial support from the Economy, Industry and Competitiveness Ministry of Spain, projects cod DEP2013-44160-P and DEP2016-79395-P, Spanish Government. Author who received the award: Francisco J. Moreno The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Murillo DB, 2017, J EXP PSYCHOL HUMAN, V43, P596, DOI 10.1037/xhp0000303; Bashan A, 2008, PHYSICA A, V387, P5080, DOI 10.1016/j.physa.2008.04.023; Caballero C, 2015, J MOTOR BEHAV, V47, P550, DOI 10.1080/00222895.2015.1014545; Sanchez CC, 2016, EXP BRAIN RES, V234, P1611, DOI 10.1007/s00221-016-4563-2; Carrick FR, 2007, DISABIL REHABIL, V29, P1881, DOI 10.1080/09638280601141335; Chapman DW, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2006.033688; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Correll J, 2008, J PERS SOC PSYCHOL, V94, P48, DOI 10.1037/0022-3514.94.1.48; Cumberworth VL, 2007, J LARYNGOL OTOL, V121, P449, DOI 10.1017/S0022215106004051; Dusing SC, 2013, DEV PSYCHOBIOL, V55, P404, DOI 10.1002/dev.21045; Elliott B, 2006, BRIT J SPORT MED, V40, P392, DOI 10.1136/bjsm.2005.023150; Elliott B., 2003, ITF BIOMECHANICS ADV; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fong SSM, 2014, MOTOR CONTROL, V18, P103, DOI 10.1123/mc.2012-0117; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Harbourne RT, 2009, NONLIN DYNAM PSYCHOL, V13, P123; Hernandez-Davo H, 2014, J SPORT SCI, V32, P1383, DOI 10.1080/02640414.2014.891290; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Kiers H, 2013, SPORTS MED, V43, P1171, DOI 10.1007/s40279-013-0082-5; Kilby MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108905; Kioumourtzoglou E, 1997, PERCEPT MOTOR SKILL, V84, P1363, DOI 10.2466/pms.1997.84.3c.1363; Lamoth CJC, 2012, GAIT POSTURE, V35, P489, DOI 10.1016/j.gaitpost.2011.11.014; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Leanderson J, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P203; Lee H, 2008, CLIN BIOMECH, V23, P735, DOI 10.1016/j.clinbiomech.2008.01.008; Lin CH, 2006, AM J PHYS MED REHAB, V85, P216, DOI 10.1097/01.phm.0000200376.12974.41; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Malliou VJ, 2010, J STRENGTH COND RES, V24, P389, DOI 10.1519/JSC.0b013e3181c068f0; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Nashner LM, 1997, HDB BALANCE FUNCTION, P261; NEWELL KM, 1979, J MOTOR BEHAV, V11, P49; Ni M, 2016, ARCH PHYS MED REHAB, V97, P345, DOI 10.1016/j.apmr.2015.10.095; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Paillard T, 2002, BRIT J SPORT MED, V36, P304, DOI 10.1136/bjsm.36.4.304; Paillard T, 2011, EUR J APPL PHYSIOL, V111, P1619, DOI 10.1007/s00421-010-1782-2; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pluim BM, 2006, BRIT J SPORT MED, V40, P415, DOI 10.1136/bjsm.2005.023184; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Sannicandro I, 2014, J SPORT SCI MED, V13, P397; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; van Dieen JH, 2010, GAIT POSTURE, V31, P42, DOI 10.1016/j.gaitpost.2009.08.242; Wang CC, 2012, ARCH GERONTOL GERIAT, V55, P673, DOI 10.1016/j.archger.2011.11.008; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062585	46	3	3	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249941	10.1371/journal.pone.0249941	http://dx.doi.org/10.1371/journal.pone.0249941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857225	Green Published, gold			2022-12-26	WOS:000641474900104
J	Guo, JW; Wu, Y; Deng, XL; Liu, ZF; Chen, LJ; Huang, YX				Guo, Jianwei; Wu, Yun; Deng, Xinlei; Liu, Zifeng; Chen, Lijin; Huang, Yixiang			Association between social determinants of health and direct economic burden on middle-aged and elderly individuals living with diabetes in China	PLOS ONE			English	Article							CARE; COMPLICATIONS; MELLITUS; IMPACT; OUTCOMES; TRENDS; COSTS	Aims The aim of this study was to determine the association between social determinants of health and direct economic burden on Chinese middle-aged and elderly individuals living with diabetes in China. Methods This study used data from the baseline wave of The China Health and Retirement Longitudinal Study (CHARLS) database, covering 17,708 middle-aged and elderly residents in China. The population with diabetes was grouped into those diagnosed with diabetes mellitus (DDM) and those undiagnosed with diabetes mellitus (UDM). Direct economic cost data, including total direct medical costs (TC) and out-of-pocket (OOP) payments, were extracted as outcome variables. A two-part model was applied to analyze the association between social determinants of health and direct economic burden. Results In our analysis, we included 958 patients with DDM and 1,285 patients with UDM. The mean TC and OOP payments were 11,193 CNY (US $1,733; 6.46 CNY = 1 USD) and 7,266 CNY (US $1,125) in DDM patients, and 3,700 CNY (US $573) and 3,060 CNY (US $474) in UDM patients. Rural-urban status (p<0.05), regional status (p<0.05), household personal consumption expenditures (p<0.05), and comorbidities(p<0.05) were crucial factors associated with medical costs in people with diabetes. Conclusion Although progress has been made in the development of current health policies intended to contain the direct economic burden of diabetes, the gaps in that burden in populations with different social characteristics remains a burning issue. More policy breakthroughs are needed to achieve health equity.	[Guo, Jianwei; Wu, Yun; Chen, Lijin; Huang, Yixiang] Sun Yat Sen Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Guangzhou, Guangdong, Peoples R China; [Deng, Xinlei] SUNY Albany, Dept Environm Hlth Sci, Rensselaer, NY USA; [Liu, Zifeng] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Clin Data Ctr, Guangzhou, Peoples R China	Sun Yat Sen University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Sun Yat Sen University	Huang, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Guangzhou, Guangdong, Peoples R China.	huangyx@mail.sysu.edu.cn		Huang, Yixiang/0000-0003-3370-148X; Deng, Xinlei/0000-0001-8129-6007	National Social Science Fund of China [18BGL218]	National Social Science Fund of China	This work was supported by National Social Science Fund of China (grant number 18BGL218).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; An JJ, 2019, J DIABETES, V11, P65, DOI 10.1111/1753-0407.12818; Cai L, 2013, INT J CARDIOL, V165, P273, DOI 10.1016/j.ijcard.2011.08.039; Centers for Disease Control and Prevention (CDC), 2020, SOCIAL DETERMINANTS; Chen S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002975; Domeikiene A, 2014, MEDICINA-LITHUANIA, V50, P54, DOI 10.1016/j.medici.2014.05.007; Dupre ME, 2015, DIABETES RES CLIN PR, V107, P392, DOI 10.1016/j.diabres.2014.12.013; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Hu HM, 2015, DIABETES THER, V6, P7, DOI 10.1007/s13300-015-0096-0; Hu SL, 2008, CHINESE HLTH EC, V27, P5; Huang YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159297; Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y; Li CY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018703; Li HF, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/9626413; Liu Ming, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P782; Liu P, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3611-y; Liu W, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0357-1; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6; Meng QY, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001694; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Rodbard HW, 2010, DIABETES RES CLIN PR, V87, P360, DOI 10.1016/j.diabres.2009.11.021; Rumball-Smith J, 2014, HEALTH AFFAIR, V33, P110, DOI 10.1377/hlthaff.2013.0518; Schofield D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-220; Segel J, 2006, COST OF ILLNESS STUD; Sun HM., 2001, CHINESE HLTH SERVICE, P143; Sun YX, 2018, J DIABETES, V10, P724, DOI 10.1111/1753-0407.12653; Walker RJ, 2016, AM J MED SCI, V351, P366, DOI 10.1016/j.amjms.2016.01.008; Walker RJ, 2014, GEN HOSP PSYCHIAT, V36, P662, DOI 10.1016/j.genhosppsych.2014.06.011; Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0; Wang HaiPeng, 2013, Chinese Preventive Medicine, V14, P132; Wang L, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0486-6; Wang ZH, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6134-x; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; World Health Organization, GLOBAL REPORT DIABET; World Health Organization (WHO), 2016, WHO DIAB COUNTR PROF; Wu HB, 2019, J DIABETES INVEST, V10, P531, DOI 10.1111/jdi.12897; Wu Yang-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P564; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang C, 2018, MED SCI MONITOR, V24, P3098, DOI 10.12659/MSM.907909; Yip WN, 2019, LANCET, V394, P1192, DOI 10.1016/S0140-6736(19)32136-1; Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203; Zheng YM, 2012, CHINA PHARM C, P1789; Zhu K, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0690-z; Zhuo XH, 2014, DIABETES CARE, V37, P2557, DOI 10.2337/dc13-2484	46	3	3	12	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250200	10.1371/journal.pone.0250200	http://dx.doi.org/10.1371/journal.pone.0250200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857252	gold, Green Published			2022-12-26	WOS:000641474900085
J	Kim, J; Jung, J; Nam, K				Kim, Jeahong; Jung, JeYoung; Nam, Kichun			Neural correlates of confusability in recognition of morphologically complex Korean words	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LETTER TRANSPOSITIONS; TIME-COURSE; DORSAL; PERCEPTION; ATTENTION; PHONOLOGY	When people confuse and reject a non-word that is created by switching two adjacent letters from an actual word, is called the transposition confusability effect (TCE). The TCE is known to occur at the very early stages of visual word recognition with such unit exchange as letters or syllables, but little is known about the brain mechanisms of TCE. In this study, we examined the neural correlates of TCE and the effect of a morpheme boundary placement on TCE. We manipulated the placement of a morpheme boundary by exchanging places of two syllables embedded in Korean morphologically complex words made up of lexical morpheme and grammatical morpheme. In the two experimental conditions, the transposition syllable within-boundary condition (TSW) involved exchanging two syllables within the same morpheme, whereas the across-boundary condition (TSA) involved the exchange of syllables across the stem and grammatical morpheme boundary. During fMRI, participants performed the lexical decision task. Behavioral results revealed that the TCE was found in TSW condition, and the morpheme boundary, which is manipulated in TSA, modulated the TCE. In the fMRI results, TCE induced activation in the left inferior parietal lobe (IPL) and intraparietal sulcus (IPS). The IPS activation was specific to a TCE and its strength of activation was associated with task performance. Furthermore, two functional networks were involved in the TCE: the central executive network and the dorsal attention network. Morpheme boundary modulation suppressed the TCE by recruiting the prefrontal and temporal regions, which are the key regions involved in semantic processing. Our findings propose the role of the dorsal visual pathway in syllable position processing and that its interaction with other higher cognitive systems is modulated by the morphological boundary in the early phases of visual word recognition.	[Kim, Jeahong; Nam, Kichun] Korea Univ, Dept Psychol, Seoul, South Korea; [Jung, JeYoung] Univ Nottingham, Sch Psychol, Nottingham, England	Korea University; University of Nottingham	Nam, K (corresponding author), Korea Univ, Dept Psychol, Seoul, South Korea.; Jung, J (corresponding author), Univ Nottingham, Sch Psychol, Nottingham, England.	jeyoung.jung@nottingham.ac.uk; kichun@korea.ac.kr		Jung, JeYoung/0000-0003-3739-7331	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program [IITP-2019-2017-0-01630]	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program	This work was supported by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2019-2017-0-01630) supervised by the IITP (Institute for Information & Communications Technology Promotion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunabeitia JA, 2012, J COGNITIVE NEUROSCI, V24, P1610, DOI 10.1162/jocn_a_00180; Dunabeitia JA, 2009, NEUROREPORT, V20, P381, DOI 10.1097/WNR.0b013e3283249b1c; Andrews S, 1996, J MEM LANG, V35, P775, DOI 10.1006/jmla.1996.0040; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Beyersmann E, 2012, Q J EXP PSYCHOL, V65, P1798, DOI 10.1080/17470218.2012.672437; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Borowsky R, 2006, BRAIN TOPOGR, V18, P233, DOI 10.1007/s10548-006-0001-2; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Carreiras M, 2015, CEREB CORTEX, V25, P4748, DOI 10.1093/cercor/bhu163; Carreiras M, 2014, TRENDS COGN SCI, V18, P90, DOI 10.1016/j.tics.2013.11.005; Cavalli E, 2016, J COGNITIVE NEUROSCI, V28, P1228, DOI 10.1162/jocn_a_00959; CHAMBERS SM, 1979, J VERB LEARN VERB BE, V18, P225, DOI 10.1016/S0022-5371(79)90136-1; Chen Y, 2016, CORTEX, V79, P1, DOI 10.1016/j.cortex.2016.02.015; Christianson K, 2005, J EXP PSYCHOL LEARN, V31, P1327, DOI 10.1037/0278-7393.31.6.1327; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cornelissen PL, 1998, VISION RES, V38, P2181, DOI 10.1016/S0042-6989(98)00016-9; Crepaldi D, 2013, J EXP PSYCHOL HUMAN, V39, P510, DOI 10.1037/a0029713; Crittenden BM, 2014, CEREB CORTEX, V24, P532, DOI 10.1093/cercor/bhs333; Davis CJ, 2004, J EXP PSYCHOL HUMAN, V30, P923, DOI 10.1037/0096-1523.30.5.923; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Davis CJ, 2006, J EXP PSYCHOL HUMAN, V32, P535, DOI 10.1037/0096-1523.32.3.535; Diependaele K, 2009, MEM COGNITION, V37, P895, DOI 10.3758/MC.37.6.895; Dunabeitia JA, 2007, COGNITION, V105, P691, DOI 10.1016/j.cognition.2006.12.001; Dunabeitia JA, 2014, PSYCHON B REV, V21, P1557, DOI 10.3758/s13423-014-0609-2; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fernandez-Lopez M, 2021, BRIT J PSYCHOL, V112, P52, DOI 10.1111/bjop.12469; Forster KI, 1998, J PSYCHOLINGUIST RES, V27, P203, DOI 10.1023/A:1023202116609; Frankish C, 2007, J MEM LANG, V56, P189, DOI 10.1016/j.jml.2006.11.002; Garcia AM, 2019, NEUROIMAGE, V197, P439, DOI 10.1016/j.neuroimage.2019.05.002; Gold BT, 2007, J COGNITIVE NEUROSCI, V19, P1983, DOI 10.1162/jocn.2007.19.12.1983; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; Grainger J, 2006, PSYCHOL SCI, V17, P1021, DOI 10.1111/j.1467-9280.2006.01821.x; Grainger J, 2009, LANG LINGUIST COMPAS, V3, P128, DOI 10.1111/j.1749-818x.2008.00121.x; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hyatt CJ, 2015, HUM BRAIN MAPP, V36, P3047, DOI 10.1002/hbm.22827; Jernigan TL, 1998, NEUROIMAGE, V8, P93, DOI 10.1006/nimg.1998.0350; Jung J., 2019, BIORXIV 2019 716266; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kim Jeahong, 2018, [Korean Journal of Cognitive and Biological Psychology, 한국심리학회지: 인지 및 생물], V30, P373, DOI 10.22172/cogbio.2018.30.4.004; Kim Jeahong, 2018, [Korean Journal of Cognitive and Biological Psychology, 한국심리학회지: 인지 및 생물], V30, P261, DOI 10.22172/cogbio.2018.30.3.004; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Korean Word Database, 2001, 21 CENTURY SEJONG PR; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lee CH, 2015, J PSYCHOLINGUIST RES, V44, P309, DOI 10.1007/s10936-015-9353-7; Lee CH, 2011, PSYCHON B REV, V18, P129, DOI 10.3758/s13423-010-0028-y; Lee CH, 2009, J MEM LANG, V60, P530, DOI 10.1016/j.jml.2009.01.002; Lin N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149583; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Marcet A, 2019, Q J EXP PSYCHOL, V72, P1344, DOI 10.1177/1747021818789876; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Massol S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068460; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Mollo G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169269; Nam K.S., 1985, STANDARD KOREAN GRAM; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Noonan KA, 2013, J COGNITIVE NEUROSCI, V25, P1824, DOI 10.1162/jocn_a_00442; OCONNOR RE, 1981, MEM COGNITION, V9, P78, DOI 10.3758/BF03196953; Pammer K, 2006, NEUROPSYCHOLOGIA, V44, P2926, DOI 10.1016/j.neuropsychologia.2006.06.028; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Perea M, 2004, J MEM LANG, V51, P231, DOI 10.1016/j.jml.2004.05.005; Perea M, 2003, MEM COGNITION, V31, P829, DOI 10.3758/BF03196438; Perea M, 2008, LANG COGNITIVE PROC, V23, P69, DOI 10.1080/01690960701578146; Perea M, 2006, EXP PSYCHOL, V53, P308, DOI 10.1027/1618-3169.53.4.308; Perea M, 2009, LANG COGNITIVE PROC, V24, P67, DOI 10.1080/01690960802053924; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Pulvermuller F, 2001, EUR J NEUROSCI, V13, P201, DOI 10.1046/j.0953-816X.2000.01380.x; Rabovsky M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00011; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Ralph MAL, 2017, NAT REV NEUROSCI, V18, P42, DOI 10.1038/nrn.2016.150; Rastle K, 2004, PSYCHON B REV, V11, P1090, DOI 10.3758/BF03196742; Rastle K, 2019, J EXP PSYCHOL HUMAN, V45, P458, DOI 10.1037/xhp0000617; Rastle K, 2008, LANG COGNITIVE PROC, V23, P942, DOI 10.1080/01690960802069730; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rueckl JG, 2011, LANG COGNITIVE PROC, V26, P482, DOI 10.1080/01690965.2010.500020; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Sanchez-Gutierrez C, 2013, PSYCHON B REV, V20, P988, DOI 10.3758/s13423-013-0425-0; Schoonbaert S, 2004, LANG COGNITIVE PROC, V19, P333, DOI 10.1080/01690960344000198; Skrandies W, 1998, COGNITIVE BRAIN RES, V6, P173, DOI 10.1016/S0926-6410(97)00033-5; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Taft M, 1999, J MEM LANG, V40, P498, DOI 10.1006/jmla.1998.2625; Taft M, 2013, LANG COGNITIVE PROC, V28, P917, DOI 10.1080/01690965.2012.679662; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vergara-Martinez M, 2013, BRAIN LANG, V125, P11, DOI 10.1016/j.bandl.2012.12.009; Vidyasagar TR, 2001, PROG BRAIN RES, V134, P297; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Witzel N, 2011, J EXP PSYCHOL HUMAN, V37, P914, DOI 10.1037/a0022194	97	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249111	10.1371/journal.pone.0249111	http://dx.doi.org/10.1371/journal.pone.0249111			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857191	gold, Green Published			2022-12-26	WOS:000641474900067
J	Zoorob, D; Shah, S; La Saevig, D; Murphy, C; Aouthmany, S; Brickman, K				Zoorob, Dani; Shah, Shivam; La Saevig, Danielle; Murphy, Courtney; Aouthmany, Shaza; Brickman, Kris			Insight into resident burnout, mental wellness, and coping mechanisms early in the COVID-19 pandemic	PLOS ONE			English	Article							MEDICAL-STUDENTS; MINDFULNESS; HEALTH; SATISFACTION; STRESS	Background Acute augmentation of stress and disruption of training, such as during the COVID-19 pandemic, may impact resident wellbeing. Objectives We investigated how residents in various specialties in the United States were impacted by COVID-19 on mental wellbeing and resilience levels, and the methodology for coping with the stress incurred. Methods In April 2020, the authors electronically surveyed 200 residency programs of all specialties nationally. The survey utilized two validated questionnaires to assess wellbeing and resilience, while investigating demographics and coping mechanisms. The authors used student t-test and ANOVA to quantitatively analyze the data. Results The sample consisted of 1115 respondents (with an 18% response rate). Male gender & Age >39 years were associated with more favorable average well-being indices (both p<0.01). Regarding resources, institutional support (IS) appeared favorable for resident well-being (IS 2.74, SD1.96 vs NoIS 3.71, SD2.29, p<0.01) & resilience (IS 3.72, SD0.70 vs NoIS 3.53, SD0.73, p = 0.05). The effects of mindfulness practices (MP) were not statistically significant for improvement of wellness (MP 2.87, SD 1.99 vs No MP 2.76, SD 2.15, p = 0.85) or resilience (MP 3.71, SD 0.70 vs No MP 3.72, SD 0.68, p = 0.87). Conclusions Findings highlight the critical importance of resident mental status in cases of augmented stress situations. Institutional support may contribute to promotion of resident wellbeing.	[Zoorob, Dani; Murphy, Courtney] Univ Toledo, Dept Obstet & Gynecol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Shah, Shivam; La Saevig, Danielle] Univ Toledo, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Aouthmany, Shaza; Brickman, Kris] Univ Toledo, Coll Med & Life Sci, Dept Emergency Med, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Zoorob, D (corresponding author), Univ Toledo, Dept Obstet & Gynecol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	dzurogyn@gmail.com						COVID C, 2020, DASHB CTR SYST SCI E; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; de Vibe M, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-107; Dewa CS, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1040-y; Dyrbye Liselotte N, 2014, J Grad Med Educ, V6, P78, DOI 10.4300/JGME-D-13-00117.1; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Goldhagen BE, 2015, ADV MED EDUC PRACT, V6, P525, DOI 10.2147/AMEP.S88580; Gomez-Baya D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071474; Hassed C, 2009, ADV HEALTH SCI EDUC, V14, P387, DOI 10.1007/s10459-008-9125-3; Jennings ML, 2015, ACAD MED, V90, P1246, DOI 10.1097/ACM.0000000000000842; Lee N, 2017, J SURG RES, V215, P6, DOI 10.1016/j.jss.2017.02.054; Levin KH, 2017, NEUROLOGY, V89, P492, DOI 10.1212/WNL.0000000000004135; Lin DT, 2016, J AM COLL SURGEONS, V223, P352, DOI 10.1016/j.jamcollsurg.2016.04.044; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350; Olson K, 2014, J EVID-BASED INTEGR, V19, P292, DOI 10.1177/2156587214539977; Sabir F., 2018, INDIAN J POSITIVE PS, V9, P55, DOI [10.15614/ijpp.v9i01.11743, DOI 10.15614/IJPP.V9I01.11743]; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Shipley N.L., 2010, EFFECTS EMOTIONAL IN; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880	21	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250104	10.1371/journal.pone.0250104	http://dx.doi.org/10.1371/journal.pone.0250104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857247	gold, Green Published			2022-12-26	WOS:000641474900053
J	Di Francesco, J; Mastromonaco, GF; Rowell, JE; Blake, J; Checkley, SL; Kutz, S				Di Francesco, Juliette; Mastromonaco, Gabriela F.; Rowell, Janice E.; Blake, John; Checkley, Sylvia L.; Kutz, Susan			Fecal glucocorticoid metabolites reflect hypothalamic-pituitary-adrenal axis activity in muskoxen (Ovibos moschatus)	PLOS ONE			English	Article							CORTISOL METABOLITES; ADRENOCORTICAL ACTIVITY; NONINVASIVE MEASUREMENT; RANGE EXPANSION; STRESS; FECES; HORMONES; BIRDS; REPRODUCTION; EXCRETION	Muskoxen (Ovibos moschatus), a taxonomically unique Arctic species, are increasingly exposed to climate and other anthropogenic changes. It is critical to develop and validate reliable tools to monitor their physiological stress response in order to assess the impacts of these changes. Here, we measured fecal glucocorticoid metabolite (FGM) levels in response to the administration of adrenocorticotropic hormone (ACTH) in the winter (1 IU/kg) and summer (2 IU/kg) using two enzyme immunoassays, one targeting primarily cortisol and the other targeting primarily corticosterone. Fecal cortisol levels varied substantially within and among individuals, and none of the animals in either challenge showed an increase in fecal cortisol following the injection of ACTH. By contrast, two of six (winter) and two of five (summer) muskoxen showed a clear response in fecal corticosterone levels (i.e., maximal percentage increase as compared to time 0 levels > 100%). Increases in fecal corticosterone post-ACTH injection occurred earlier and were of shorter duration in the summer than in the winter and fecal corticosterone levels were, in general, lower during the summer. These seasonal differences in FGM responses may be related to the use of different individuals (i.e., influence of sex, age, social status, etc.) and to seasonal variations in the metabolism and excretion of glucocorticoids, intestinal transit time, voluntary food intake, and fecal output and moisture content. Results from this study support using FGMs as a biomarker of hypothalamic-pituitary-adrenal axis activity in muskoxen, advance our understanding of the physiological adaptations of mammals living in highly seasonal and extreme environments such as the Arctic, and emphasize the importance of considering seasonality in other species when interpreting FGM levels.	[Di Francesco, Juliette; Checkley, Sylvia L.; Kutz, Susan] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Di Francesco, Juliette] French Armed Forces Ctr Epidemiol & Publ Hlth CES, Marseille, France; [Mastromonaco, Gabriela F.] Toronto Zoo, Reprod Sci Unit, Scarborough, ON, Canada; [Rowell, Janice E.] Univ Alaska Fairbanks, Agr & Forestry Expt Stn, Fairbanks, AK USA; [Blake, John] Univ Alaska Fairbanks, Anim Resources Ctr, Fairbanks, AK USA	University of Calgary; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Di Francesco, J (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada.; Di Francesco, J (corresponding author), French Armed Forces Ctr Epidemiol & Publ Hlth CES, Marseille, France.	juliette.difrancesco@ucalgary.ca		kutz, susan/0000-0003-2352-8687	Morris Animal Foundation Fellowship [D18ZO-407]; Polar Knowledge Canada [NST-1718-0015]; Natural Sciences and Engineering Research Council [RGPIN/04171-2014]; Natural Sciences and Engineering Research Council Northern Supplement Grant [RGPNS/316244-2014]; ArcticNet	Morris Animal Foundation Fellowship; Polar Knowledge Canada; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council Northern Supplement Grant; ArcticNet	JDF was funded by the Morris Animal Foundation Fellowship Training Grant D18ZO-407. This work was supported by the following grants awarded to Susan Kutz: Polar Knowledge Canada Grant NST-1718-0015, the Natural Sciences and Engineering Research Council Discovery Grant RGPIN/04171-2014, the Natural Sciences and Engineering Research Council Northern Supplement Grant RGPNS/316244-2014, and ArcticNet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMCZEWSKI JZ, 1994, CAN J ANIM SCI, V74, P305, DOI 10.4141/cjas94-042; Adamczewski JZ, 1997, J ZOOL, V241, P245, DOI 10.1111/j.1469-7998.1997.tb01956.x; AMAP (Arctic Monitoring and Assessment Programme), 2017, UPD KEY FIND SNOW WA; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Atwood MP, 2020, MAMMAL RES, V65, P349, DOI 10.1007/s13364-019-00474-x; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P497, DOI 10.1086/501058; Bashaw MJ, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0864-8; Baxter-Gilbert JH, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou036; Carlsson AM, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow058; Coburn S, 2010, J WILDLIFE MANAGE, V74, P532, DOI 10.2193/2008-152; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Cuyler C, 2020, AMBIO, V49, P805, DOI 10.1007/s13280-019-01205-x; Dantzer B, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou023; Dehnhard M, 2001, GEN COMP ENDOCR, V123, P111, DOI 10.1006/gcen.2001.7656; Di Francesco J, 2021, GEN COMP ENDOCR, V306, DOI 10.1016/j.ygcen.2021.113737; Di Francesco J, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox052; Dulude-de Broin F, 2019, GEN COMP ENDOCR, V280, P147, DOI 10.1016/j.ygcen.2019.04.022; Ganswindt A, 2012, AFR ZOOL, V47, P261, DOI 10.3377/004.047.0211; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Gulzari SO, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9110987; Gunn A., 2003, WILD MAMMALS N AM BI, V2nd, P1076; Holleman D.F., 1984, Biological Papers of the University of Alaska, P188; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; Kafle P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74358-5; Khonmee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091633; Koren L, 2012, GEN COMP ENDOCR, V177, P113, DOI 10.1016/j.ygcen.2012.02.020; Kutz S, 2017, ARCTIC, V70, P225; Kutz Susan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P198, DOI 10.1016/j.ijppaw.2014.01.002; Kutz SJ, 2013, GLOBAL CHANGE BIOL, V19, P3254, DOI 10.1111/gcb.12315; Lawler James P., 1997, Rangifer, V17, P135; Lay DC, 1996, J ANIM SCI, V74, P1806; Majchrzak YN, 2015, GEN COMP ENDOCR, V211, P123, DOI 10.1016/j.ygcen.2014.11.007; Mastromonaco GF, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou055; Millspaugh JJ, 2002, WILDLIFE SOC B, V30, P899; Morrow CJ, 2002, GEN COMP ENDOCR, V126, P229, DOI 10.1006/gcen.2002.7797; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Palme R, 1999, WIEN TIERARZTL MONAT, V86, P237; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Palme R, 2019, PHYSIOL BEHAV, V199, P229, DOI 10.1016/j.physbeh.2018.11.021; Prewer E, 2020, BIOL J LINN SOC, V129, P459, DOI 10.1093/biolinnean/blz175; R Core Team, 2021, R LANGUAGE ENV STAT; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Schmidt NM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58298-8; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sid-Ahmed OE, 2013, TROP ANIM HEALTH PRO, V45, P1453, DOI 10.1007/s11250-013-0374-7; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; White R.G., 1984, Biological Papers of the University of Alaska, P193; Zbyryt A, 2018, BEHAV ECOL, V29, P19, DOI 10.1093/beheco/arx142; Zwijacz-Kozica T, 2013, ACTA THERIOL, V58, P215, DOI 10.1007/s13364-012-0108-7	54	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249281	10.1371/journal.pone.0249281	http://dx.doi.org/10.1371/journal.pone.0249281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852609	Green Published, gold			2022-12-26	WOS:000640604500013
J	Machado, AF; Ritter, CD; Miranda, CL; Bredin, YK; Pereira, MJR; Duarte, L				Machado, Arielli Fabricio; Ritter, Camila Duarte; Miranda, Cleuton Lima; Bredin, Yennie Katarina; Pereira, Maria Joao Ramos; Duarte, Leandro			Potential mammalian species for investigating the past connections between Amazonia and the Atlantic Forest	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; NORTHEASTERN BRAZIL; SIGMODONTINE RODENTS; PHYLOGEOGRAPHY; BIOGEOGRAPHY; DIVERSITY; HISTORY; BIODIVERSITY; POPULATIONS; VEGETATION	Much evidence suggests that Amazonia and the Atlantic Forest were connected through at least three dispersion routes in the past: the Eastern route, the central route, and the Western route. However, few studies have assessed the use of these routes based on multiple species. Here we present a compilation of mammal species that potentially have dispersed between the two forest regions and which may serve to investigate these connections. We evaluate the present-day geographic distributions of mammals occurring in both Amazonia and the Atlantic Forest and the likely connective routes between these forests. We classified the species per habitat occupancy (strict forest specialists, species that prefer forest habitat, or generalists) and compiled the genetic data available for each species. We found 127 mammalian species presently occurring in both Amazonia and the Atlantic Forest for which, substantial genetic data was available. Hence, highlighting their potential for phylogeographic studies investigating the past connections between the two forests. Differently from what was previously proposed, the present-day geographic distribution of mammal species found in both Amazonia and the Atlantic Forest points to more species in the eastern portion of the dry diagonal (and adjoining forested habitats). The Central route was associated with the second most species. Although it remains to be seen how this present-day geography reflects the paleo dispersal routes, our results show the potential of using mammal species to investigate and bring new insights about the past connections between Amazonia and the Atlantic Forest.	[Machado, Arielli Fabricio; Duarte, Leandro] Univ Fed Rio Grande do Sul UFRGS, Phylogenet & Funct Ecol Lab LEFF, Postgrad Programme Ecol, Porto Alegre, RS, Brazil; [Ritter, Camila Duarte] Univ Duisburg Essen, Eukaryot Microbiol, Essen, Germany; [Ritter, Camila Duarte] Univ Fed Parana, Dept Zootecnia, Grp Integrad Aquicultura & Estudos Ambientais, Curitiba, Parana, Brazil; [Miranda, Cleuton Lima] Univ Fed Para UFPA, Museu Paraense Emilio Goeldi, Postgrad Program Zool, Belem, Para, Brazil; [Bredin, Yennie Katarina] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Pereira, Maria Joao Ramos] Univ Fed Rio Grande do Sul UFRGS, Postgrad Programme Anim Biol, Bird & Mammal Evolut Systemat & Ecol Lab BiMa Lab, Porto Alegre, RS, Brazil; [Pereira, Maria Joao Ramos] Univ Fed Rio Grande do Sul UFRGS, Postgrad Programme Ecol, Porto Alegre, RS, Brazil; [Machado, Arielli Fabricio; Miranda, Cleuton Lima] Univ Fed Amazonas UFAM, Lab Evolucao & Genet Anim Legal, Manaus, Amazonas, Brazil	Universidade Federal do Rio Grande do Sul; University of Duisburg Essen; Universidade Federal do Parana; Museu Paraense Emilio Goeldi; Universidade Federal do Para; Norwegian University of Life Sciences; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Amazonas	Machado, AF (corresponding author), Univ Fed Rio Grande do Sul UFRGS, Phylogenet & Funct Ecol Lab LEFF, Postgrad Programme Ecol, Porto Alegre, RS, Brazil.; Ritter, CD (corresponding author), Univ Duisburg Essen, Eukaryot Microbiol, Essen, Germany.; Ritter, CD (corresponding author), Univ Fed Parana, Dept Zootecnia, Grp Integrad Aquicultura & Estudos Ambientais, Curitiba, Parana, Brazil.; Machado, AF (corresponding author), Univ Fed Amazonas UFAM, Lab Evolucao & Genet Anim Legal, Manaus, Amazonas, Brazil.	ariellifm@gmail.com; kmicaduarte@gmail.com	da Silva Duarte, Leandro/B-6552-2012	da Silva Duarte, Leandro/0000-0003-1771-0407; Fabricio Machado, Arielli/0000-0001-9282-1807; Duarte Ritter, Camila/0000-0002-3371-7425	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [141008/2016-4]; MCTIC/CNPq [465610/2014-5]; FAPEG [201810267000023]; CNPq [307527/2018-2, 311297/2018-8]; Alexander von Humboldt Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTIC/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	AFM was supported by a doctoral fellowship (grant 141008/2016-4) provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). LD is a member of the National Institute for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation, supported by MCTIC/CNPq (proc. 465610/2014-5) and FAPEG (proc. 201810267000023)., LD and MJRP were supported by CNPq Productivity Fellowships (grants 307527/2018-2 and 311297/2018-8). CDR thanks the financial support from Alexander von Humboldt Foundation.	Abessa D, 2019, NAT ECOL EVOL, V3, P510, DOI 10.1038/s41559-019-0855-9; ANDRADE-LIMA D., 1982, BIOL DIVERSIFICATION, P245; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Auler AS, 2001, QUATERNARY RES, V55, P159, DOI 10.1006/qres.2000.2213; Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; BATES HW, 1981, BIOL J LINN SOC, V16, P41, DOI 10.1111/j.1095-8312.1981.tb01842.x; Behling H, 2000, QUATERNARY SCI REV, V19, P981, DOI 10.1016/S0277-3791(99)00046-3; Belmaker J, 2015, ECOL LETT, V18, P563, DOI 10.1111/ele.12438; Benson DA., 2012, GENBANK NUCL ACIDS R, V41, pD36; Bigarella J.J., 1982, P27; Bivand R., 2020, **DATA OBJECT**; Brooks TM, 2019, TRENDS ECOL EVOL, V34, P977, DOI 10.1016/j.tree.2019.06.009; Carmignotto A. P., 2017, CAATINGA LARGEST TRO, P211, DOI DOI 10.1007/978-3-319-68339-3_8; Costa GC, 2018, GLOBAL ECOL BIOGEOGR, V27, P285, DOI 10.1111/geb.12694; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; da Fonseca G.A.B., 1982, CIENCIA CULTURA, V34, P1359; da Silva JMC., 1996, ORNITOL NEOTROP, V7, P1; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; de Sa RO, 2019, MOL PHYLOGENET EVOL, V130, P198, DOI 10.1016/j.ympev.2018.10.021; de Vivo Mario, 2015, P1; Ledo RMD, 2017, J BIOGEOGR, V44, P2551, DOI 10.1111/jbi.13049; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Eisenberg JF., 1999, MAMMALS NEOTROPICS C; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Faria Michel Barros, 2013, Revista Nordestina De Biologia, V21, P27; Feer F, 1997, NEOTROPICAL RAINFORE; Ferraz EMN, 2003, PHYTOCOENOLOGIA, V33, P71, DOI 10.1127/0340-269X/2003/0033-0071; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Coimbra RTF, 2017, GENET MOL BIOL, V40, P40, DOI [10.1590/1678-4685-GMB-2016-0040, 10.1590/1678-4685-gmb-2016-0040]; Gardner AL., 2008, MAMMALS S AM; Goncalves-Souza D, 2020, BIOL CONSERV, V246, DOI 10.1016/j.biocon.2020.108579; Gregorin R, 2006, REV BRAS ZOOL, V23, P64, DOI 10.1590/S0101-81752006000100005; Gurgel-Filho Newton M., 2015, Revista Nordestina De Biologia, V23, P3; Gutierrez EE, 2010, AM MUS NOVIT, P1, DOI 10.1206/708.1; Hijmans RJ., 2017, **DATA OBJECT**; Hintze F, 2020, J MAMMAL, V101, P417, DOI 10.1093/jmammal/gyz167; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; IUCN Red List Technical Working Group, 2019, MAPP STAND DAT QUAL; IUCN Standards and Petitions Committee, 2019, IUCN CMP UN CLASS DI; Jaramillo C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P317; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jung M, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00599-8; Ledru Marie-Pierre., 2002, CERRADOS BRAZIL ECOL, P33; Loughry WJ, 2015, J MAMMAL, V96, P635, DOI 10.1093/jmammal/gyv005; Luza AL, 2019, DATA BRIEF, V23, DOI 10.1016/j.dib.2019.103842; Machado AF, 2019, EVOL ECOL, V33, P111, DOI 10.1007/s10682-019-09968-1; Machado LF, 2018, J MAMMAL, V99, P377, DOI 10.1093/jmammal/gyy015; Maestri R, 2016, J BIOGEOGR, V43, P1192, DOI 10.1111/jbi.12718; Malcher SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181434; Miranda CL, 2005, PUBL AVULSAS CONSERV, V2, P1; Mirando Cleuton Lima, 2009, Check List, V5, P360; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Moraes-Barros N, 2015, J MAMMAL, V96, P690, DOI 10.1093/jmammal/gyv077; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Mouchet M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131924; Nascimento FF, 2017, J MAMM EVOL, V24, P439, DOI 10.1007/s10914-016-9354-9; Nowak R.M, 1999, WALKERS MAMMALS WORL, V6th; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Paglia A.P., 2012, ANNOTATED CHECKLIST; Patton James L., 2015, P733; Pavan SE, 2014, MOL PHYLOGENET EVOL, V79, P199, DOI 10.1016/j.ympev.2014.05.029; Pellegrino KCM, 2011, MOL PHYLOGENET EVOL, V61, P446, DOI 10.1016/j.ympev.2011.07.010; Peres EA, 2017, BIOL J LINN SOC, V121, P771, DOI 10.1093/biolinnean/blx036; Por F. D., 1992, Sooretama: the Atlantic rain forest of Brazil.; Prates I, 2017, MOL PHYLOGENET EVOL, V113, P49, DOI 10.1016/j.ympev.2017.05.009; Prates I, 2016, MOL ECOL, V25, P5174, DOI 10.1111/mec.13821; Queiroz L.P., 2017, CAATINGA LARGEST TRO, P23, DOI [10.1099/ijsem, DOI 10.1007/978-3-319-68339-3_2, 10.1007/978-3-319, DOI 10.1007/978-3-319]; R Core Team, 2020, R LANG ENV STAT COMP; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Sandom C, 2013, ECOLOGY, V94, P1112, DOI 10.1890/12-1342.1; Scott C., 2020, **DATA OBJECT**; Sobral-Souza T, 2015, EVOL ECOL, V29, P643, DOI 10.1007/s10682-015-9780-9; Viana Maria C., 2015, Oecologia Australis, V19, P173; Vieira OQ, 2020, BIOTA NEOTROP, V20, DOI [10.1590/1676-0611-BN-2019-0912, 10.1590/1676-0611-bn-2019-0912]; Vilela B, 2015, METHODS ECOL EVOL, V6, P1229, DOI 10.1111/2041-210X.12401; Voss RS, 2019, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090.432.1.1; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Wilson DE, 2009, HDB MAMMALS WORLD, V1; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106	82	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0250016	10.1371/journal.pone.0250016	http://dx.doi.org/10.1371/journal.pone.0250016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836018	Green Published, Green Submitted, gold			2022-12-26	WOS:000639361000037
J	McElvaney, TJ; Osman, M; Mareschal, I				McElvaney, Terence J.; Osman, Magda; Mareschal, Isabelle			Perceiving threat in others: The role of body morphology	PLOS ONE			English	Article							MALE ATTRACTIVENESS; SOCIAL-PERCEPTION; FACIAL-WIDTH; FACE; HEIGHT; TRUSTWORTHINESS; EXPRESSIONS; DOMINANCE; ATTITUDES; EMOTIONS	People make judgments of others based on appearance, and these inferences can affect social interactions. Although the importance of facial appearance in these judgments is well established, the impact of the body morphology remains unclear. Specifically, it is unknown whether experimentally varied body morphology has an impact on perception of threat in others. In two preregistered experiments (N = 250), participants made judgments of perceived threat of body stimuli of varying morphology, both in the absence (Experiment 1) and presence (Experiment 2) of facial information. Bodies were perceived as more threatening as they increased in mass with added musculature and portliness, and less threatening as they increased in emaciation. The impact of musculature endured even in the presence of faces, although faces contributed more to the overall threat judgment. The relative contributions of the faces and bodies seemed to be driven by discordance, such that threatening faces exerted the most influence when paired with non-threatening bodies, and vice versa. This suggests that the faces and bodies were not perceived as entirely independent and separate components. Overall, these findings suggest that body morphology plays an important role in perceived threat and may bias real-world judgments.	[McElvaney, Terence J.; Osman, Magda; Mareschal, Isabelle] Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, London, England	University of London; Queen Mary University London	McElvaney, TJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, London, England.	t.mcelvaney@qmul.ac.uk		McElvaney, Terence J./0000-0003-3846-1833				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrade EB, 2009, ORGAN BEHAV HUM DEC, V109, P1, DOI 10.1016/j.obhdp.2009.02.003; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Aviezer H, 2012, J PERS SOC PSYCHOL, V103, P20, DOI 10.1037/a0027411; Aviezer H, 2011, EMOTION, V11, P1406, DOI 10.1037/a0023578; CANN A, 1991, J SOC PSYCHOL, V131, P225, DOI 10.1080/00224545.1991.9713845; Connor CE, 2004, CURR BIOL, V14, pR850, DOI 10.1016/j.cub.2004.09.041; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Enea V, 2016, SOC NEUROSCI-UK, V11, P495, DOI 10.1080/17470919.2015.1114020; FESSLER DMT, 2014, J EVOLUTIONARY PSYCH, V12, P67, DOI DOI 10.1556/JEP-D-14-00009; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Gustavsson JP, 1997, PERS INDIV DIFFER, V22, P783, DOI 10.1016/S0191-8869(96)00268-1; Harvey T, 2002, INT J EAT DISORDER, V32, P213, DOI 10.1002/eat.10069; HENSLEY WE, 1993, PSYCHOLOGY, V30, P40; Hester N, 2018, P NATL ACAD SCI USA, V115, P2711, DOI 10.1073/pnas.1714454115; Hu Y, 2018, PSYCHOL SCI, V29, P1969, DOI 10.1177/0956797618799300; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Keating C. F., 1985, POWER DOMINANCE NONV, P89, DOI [10.1007/978-1-4612-5106-4_5, DOI 10.1007/978-1-4612-5106-4_5]; KEATING CF, 1981, J PERS SOC PSYCHOL, V40, P615, DOI 10.1037/0022-3514.40.4.615; Knutson B, 1996, J NONVERBAL BEHAV, V20, P165, DOI 10.1007/BF02281954; Kraus MW, 2011, PERS SOC PSYCHOL B, V37, P1376, DOI 10.1177/0146167211410987; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; Lin CJ, 2018, PSYCHOL SCI, V29, P1807, DOI 10.1177/0956797618788882; Maisey DS, 1999, LANCET, V353, P1500, DOI 10.1016/S0140-6736(99)00438-9; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; MELAMED T, 1992, PERS INDIV DIFFER, V13, P1349, DOI 10.1016/0191-8869(92)90179-S; MELAMED T, 1994, PERS INDIV DIFFER, V17, P689, DOI 10.1016/0191-8869(94)90143-0; Mileva VR, 2014, PERS INDIV DIFFER, V69, P115, DOI 10.1016/j.paid.2014.05.019; Montepare JM, 2003, J NONVERBAL BEHAV, V27, P237, DOI 10.1023/A:1027332800296; Olivola CY, 2014, TRENDS COGN SCI, V18, P566, DOI 10.1016/j.tics.2014.09.007; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Palmer-Hague JL, 2018, AGGRESSIVE BEHAV, V44, P553, DOI 10.1002/ab.21774; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Schvey NA, 2013, INT J OBESITY, V37, P1275, DOI 10.1038/ijo.2012.211; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SINGH D, 1995, J PERS SOC PSYCHOL, V69, P1089, DOI 10.1037/0022-3514.69.6.1089; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Stogdill RM, 1948, J PSYCHOL, V25, P35, DOI 10.1080/00223980.1948.9917362; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Todorov A, 2013, EMOTION, V13, P724, DOI 10.1037/a0032335; Todorov A, 2011, IEEE SIGNAL PROC MAG, V28, P117, DOI 10.1109/MSP.2010.940006; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Tulloch M, 2000, BRIT J CRIMINOL, V40, P451, DOI 10.1093/bjc/40.3.451; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Vrancken L, 2017, J VISION, V17, DOI 10.1167/17.1.24; Welsch R, 2020, EUR EAT DISORD REV, V28, P282, DOI 10.1002/erv.2715; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wilson JP, 2017, J PERS SOC PSYCHOL, V113, P59, DOI 10.1037/pspi0000092; Wilson JP, 2015, PSYCHOL SCI, V26, P1325, DOI 10.1177/0956797615590992; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	53	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249782	10.1371/journal.pone.0249782	http://dx.doi.org/10.1371/journal.pone.0249782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831099	Green Published, gold			2022-12-26	WOS:000639359600107
J	Sabater-Cruz, N; Figueras-Roca, M; Padro-Pitarch, L; Tort, J; Casaroli-Marano, RP				Sabater-Cruz, Noelia; Figueras-Roca, Marc; Padro-Pitarch, Lydia; Tort, Jaume; Casaroli-Marano, Ricardo P.			Corneal transplantation activity in Catalonia, Spain, from 2011 to 2018: Evolution of indications and surgical techniques	PLOS ONE			English	Article							ENDOTHELIAL KERATOPLASTY; TRENDS; TISSUE	Purpose To report corneal transplant activity carried out in Catalonia (Spain) and the evolving indications for keratoplasty over an 8-year period. Methods Annual reports from the Catalan Transplant Organization, Spain, on corneal graft indications and techniques from 2011 to 2018 were reviewed. Results A total of 9457 keratoplasties were performed in Catalonia, from January 2011 to December 2018. The most frequent indications were bullous keratopathy (BK; 20.5%), Fuchs endothelial dystrophy (FED; 17.9%), re-graft (13.7%), and keratoconus (11.3%). Penetrating keratoplasty (PKP) accounted for 63.4% of all performed keratoplasties. Since the introduction of eye bank precut tissue for Descemet stripping automated endothelial keratoplasty (DSAEK) in 2013 and for Descemet membrane endothelial keratoplasty (DMEK) in 2017 the number of endothelial keratoplasties has drastically increased. An increasing trend of posterior lamellar techniques over the total of keratoplasties was found (p<0.001). Endothelial keratoplasties for different endothelial diseases indications (BK, FED, and re-graft), also showed and increasing trend (p<0.001). DMEK is the technique with the highest increase (statistically significantly different from linearity) over other endothelial keratoplasties in FED (p<0.001) but not in BK (p = 0.67) or re-grafts (p = 0.067). Conclusion Endothelial diseases represented the top indication for keratoplasty over the 8-year period. PKP is still the most used technique in Catalonia, but endothelial keratoplasties and especially DMEK showed a significant increasing trend over the last years. This is congruent with the main rationale nowadays for keratoplasties: to customize and transplant as less tissue as possible. Therefore, the availability of precut tissue could have definitely enforced such approach.	[Sabater-Cruz, Noelia; Figueras-Roca, Marc; Casaroli-Marano, Ricardo P.] Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain; [Padro-Pitarch, Lydia; Tort, Jaume] Org Catalana Trasplantaments OCATT, Catalan Transplant Org, Barcelona, Spain; [Casaroli-Marano, Ricardo P.] Banc Sang & Teixits BST, Barcelona Tissue Bank BTB, Barcelona, Spain; [Casaroli-Marano, Ricardo P.] Univ Barcelona, Sch Med & Hlth Sci, Dept Surg, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Sabater-Cruz, N (corresponding author), Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain.	Noelia.sabater@gmail.com		Tort, Jaume/0000-0001-6246-7317; Sabater-Cruz, Noelia/0000-0003-3700-602X				Ang M, 2016, BRIT J OPHTHALMOL, V100, P15, DOI 10.1136/bjophthalmol-2015-306837; Ang M, 2014, BRIT J OPHTHALMOL, V98, P1028, DOI 10.1136/bjophthalmol-2013-304622; Ang M, 2012, OPHTHALMOLOGY, V119, P2239, DOI 10.1016/j.ophtha.2012.06.012; Banc de Sang i Teixits, PROF AR; Chen WL, 2001, CORNEA, V20, P141, DOI 10.1097/00003226-200103000-00004; Fasolo A, 2006, CORNEA, V25, P507, DOI 10.1097/01.ico.0000214211.60317.1f; Frigo AC, 2015, TRANSPL P, V47, P528, DOI 10.1016/j.transproceed.2014.10.040; Gadhvi KA, 2020, CORNEA, V39, P1599, DOI 10.1097/ICO.0000000000002476; Gencat, GEN CAT INF TRAM SER; Gomez-Benlloch A, 2021, ACTA OPHTHALMOL, V99, pE922, DOI 10.1111/aos.14708; Guerra FP, 2011, CORNEA, V30, P1382, DOI 10.1097/ICO.0b013e31821ddd25; Gupta N, 2015, BRIT J OPHTHALMOL, V99, P147, DOI 10.1136/bjophthalmol-2014-305945; Kitzmann AS, 2008, CORNEA, V27, P634, DOI 10.1097/QAI.0b013e31815e4011; Kymionis GD, 2014, ADV THER, V31, P494, DOI 10.1007/s12325-014-0121-0; Le R, 2017, CAN J OPHTHALMOL, V52, P74, DOI 10.1016/j.jcjo.2016.07.005; Maier P, 2013, DTSCH ARZTEBL INT, V110, P365, DOI 10.3238/arztebl.2013.0365; Mathes KJ, 2019, CORNEA, V38, P263, DOI 10.1097/ICO.0000000000001839; Melles GRJ, 2000, OPHTHALMOLOGY, V107, P1850, DOI 10.1016/S0161-6420(00)00253-0; Montesel A, 2021, EUR J OPHTHALMOL, V31, P1700, DOI 10.1177/1120672120947592; Organitzacio Catalana de Trasplantaments, HIST TRANSPL CAT; Organizacion Nacional de Trasplantes, SPEC INF REP DON TRA; Palma-Carvajal F, 2020, J FR OPHTALMOL, V43, P1, DOI 10.1016/j.jfo.2019.06.026; Park CY, 2015, OPHTHALMOLOGY, V122, P2432, DOI 10.1016/j.ophtha.2015.08.017; Patel SV, 2012, EXP EYE RES, V95, P40, DOI 10.1016/j.exer.2011.05.013; Ple-Plakon PA, 2014, CURR OPIN OPHTHALMOL, V25, P300, DOI 10.1097/ICU.0000000000000080; Ragunathan S, 2014, CELL TISSUE BANK, V15, P573, DOI 10.1007/s10561-014-9429-x; Rauen MP, 2012, CORNEA, V31, P376, DOI 10.1097/ICO.0b013e31823cbee3; Regnier M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006885; Rock T, 2017, ANN TRANSPL, V22, P749, DOI 10.12659/AOT.905498; Sabater-Cruz N, 2021, EYE, V35, P3087, DOI 10.1038/s41433-020-01342-8; Singh NP, 2018, INDIAN J OPHTHALMOL, V66, P1239, DOI 10.4103/ijo.IJO_95_18; Singh R, 2019, INDIAN J MED RES, V150, P7, DOI 10.4103/ijmr.IJMR_141_19; Tan JCH, 2014, CORNEA, V33, P252, DOI 10.1097/ICO.0000000000000066; Terry MA, 2012, CORNEA, V31, P469, DOI 10.1097/ICO.0b013e31823f8ee2; Terry Mark A, 2009, Trans Am Ophthalmol Soc, V107, P184; Tourtas T, 2012, AM J OPHTHALMOL, V153, P1082, DOI 10.1016/j.ajo.2011.12.012; Wang TW, 2020, EYE CONTACT LENS, V46, P301, DOI 10.1097/ICL.0000000000000638; Woodward MA, 2012, JOVE-J VIS EXP, DOI 10.3791/3847; Zare M, 2012, MIDDLE EAST AFR J OP, V19, P323, DOI 10.4103/0974-9233.97941; Zhang AQ, 2013, CAN J OPHTHALMOL, V48, P153, DOI 10.1016/j.jcjo.2012.12.008	40	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249946	10.1371/journal.pone.0249946	http://dx.doi.org/10.1371/journal.pone.0249946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831081	gold, Green Published			2022-12-26	WOS:000639359600100
J	Luo, JL; Hu, SQ; Fu, ML; Luo, LM; Li, YY; Li, WH; Cai, YT; Dong, RL; Yang, Y; Tu, L; Xu, XZ				Luo, Jinlan; Hu, Shuiqing; Fu, Menglu; Luo, Liman; Li, Yuanyuan; Li, Wenhua; Cai, Yueting; Dong, Ruolan; Yang, Yan; Tu, Ling; Xu, Xizhen			Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTOLIC BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; DIABETES-MELLITUS; KAPPA-B; INFLAMMATION; MECHANISMS; CHANNEL; MODELS; INJURY; CELLS	The epoxyeicosatrienoic acid (EET) exerts beneficial effects on insulin resistance and/or hypertension. EETs could be readily converted to less biological active diols by soluble epoxide hydrolase (sEH). However, whether sEH inhibition can ameliorate the comorbidities of insulin resistance and hypertension and the underlying mechanisms of this relationship are unclear. In this study, C57BL/6 mice were rendered hypertensive and insulin resistant through a high-fat and high-salt (HF-HS) diet. The sEH inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), was used to treat mice (1 mg/kg/day) for 8 weeks, followed by analysis of metabolic parameters. The expression of sEH and the sodium-glucose cotransporter 2 (SGLT2) was markedly upregulated in the kidneys of mice fed an HF-HS diet. We found that TPPU administration increased kidney EET levels, improved insulin resistance, and reduced hypertension. Furthermore, TPPU treatment prevented upregulation of SGLT2 and the associated increased urine volume and the excretion of urine glucose and urine sodium. Importantly, TPPU alleviated renal inflammation. In vitro, human renal proximal tubule epithelial cells (HK-2 cells) were used to further investigate the underlying mechanism. We observed that 14,15-EET or sEH knockdown or inhibition prevented the upregulation of SGLT2 upon treatment with palmitic acid or NaCl by inhibiting the inhibitory kappa B kinase alpha/beta/NF-kappa B signaling pathway. In conclusion, sEH inhibition by TPPU alleviated insulin resistance and hypertension induced by an HF-HS diet in mice. The increased urine excretion of glucose and sodium was mediated by decreased renal SGLT2 expression because of inactivation of the inhibitory kappa B kinase alpha beta/NF-kappa B-induced inflammatory response.	[Luo, Jinlan; Fu, Menglu; Luo, Liman; Li, Yuanyuan; Li, Wenhua; Tu, Ling] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr Med, Wuhan, Peoples R China; [Luo, Jinlan; Hu, Shuiqing; Cai, Yueting; Xu, Xizhen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan, Peoples R China; [Luo, Jinlan; Hu, Shuiqing; Cai, Yueting; Yang, Yan; Xu, Xizhen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan, Peoples R China; [Dong, Ruolan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Integrated Tradit Chinese & Western Med, Wuhan, Peoples R China; [Yang, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Endocrinol, Wuhan, Peoples R China; [Tu, Ling; Xu, Xizhen] Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tu, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr Med, Wuhan, Peoples R China.; Xu, XZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan, Peoples R China.; Xu, XZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan, Peoples R China.; Tu, L; Xu, XZ (corresponding author), Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Peoples R China.	lingtu@tjh.tjmu.cn; xzxu@tjh.tjmu.edu.cn	fu, meng/GZG-3120-2022; li, yuanyuan/GZA-4435-2022		National Natural Science Foundation of China [81873512, 81471021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81873512 and no. 81471021).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; [Anonymous], 2015, Nat Rev Dis Primers, V1, P15039, DOI 10.1038/nrdp.2015.39; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; Eaddy MT, 2008, CURR MED RES OPIN, V24, P2501, DOI 10.1185/03007990802297529 ; El-Sherbeni AA, 2014, ARCH TOXICOL, V88, P2013, DOI 10.1007/s00204-014-1371-y; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Fu ML, 2021, MOL CELL ENDOCRINOL, V523, DOI 10.1016/j.mce.2020.111149; Guzik TJ, 2018, ANTIOXID REDOX SIGN, V29, P257, DOI 10.1089/ars.2017.7299; Han HJ, 2005, J CELL PHYSIOL, V202, P246, DOI 10.1002/jcp.20108; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2020, HYPERTENSION, V76, P3, DOI 10.1161/HYPERTENSIONAHA.120.13898; Kabakov Emma, 2006, J Cardiometab Syndr, V1, P95, DOI 10.1111/j.1559-4564.2006.05513.x; Khan MAH, 2013, HYPERTENSION, V62, P905, DOI 10.1161/HYPERTENSIONAHA.113.01949; Koepsell H, 2017, PHARMACOL THERAPEUT, V170, P148, DOI 10.1016/j.pharmthera.2016.10.017; Laethem M, 1993, J BIOL CHEM, V268; Lastra G, 2014, ENDOCRIN METAB CLIN, V43, P103, DOI 10.1016/j.ecl.2013.09.005; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Li R., 2015, AM J PHYSIOL-ENDOC M, V308, pE270; Lu XH, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0903-x; Makita K., 1994, J BIOL CHEM, V94, p2414 2420; Merkel MJ, 2010, AM J PHYSIOL-HEART C, V298, pH679, DOI 10.1152/ajpheart.00533.2009; Muntner P, 2018, DIABETES CARE, V41, P2322, DOI 10.2337/dc18-1307; Olearczyk JJ, 2009, CLIN SCI, V116, P61, DOI 10.1042/CS20080039; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pidkovka N, 2013, J BIOL CHEM, V288, P5223; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Rang H., 2011, PROSTAG OTH LIPID M, V98, P93; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Shen HC, 2010, EXPERT OPIN THER PAT, V20, P941, DOI 10.1517/13543776.2010.484804; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Wan EYF, 2018, DIABETES CARE, V41, P1134, DOI 10.2337/dc17-2443; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yang HH, 2020, THERANOSTICS, V10, P4749, DOI 10.7150/thno.43108; Yang Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12718; Zelniker TA, 2018, J AM COLL CARDIOL, V72, P1845, DOI 10.1016/j.jacc.2018.06.040; Zhang DH, 2012, CIRC RES, V110, P808, DOI 10.1161/CIRCRESAHA.111.259325; Zhang LN, 2011, EUR J PHARMACOL, V654, P68, DOI 10.1016/j.ejphar.2010.12.016; Zuloaga KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097529	48	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100667	10.1016/j.jbc.2021.100667	http://dx.doi.org/10.1016/j.jbc.2021.100667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864813	gold, Green Published			2022-12-26	WOS:000672866400638
J	Fiorelli, S; Anesi, A; Porro, B; Cosentino, N; Werba, JP; Di Minno, A; Manega, CM; Barbieri, S; Colombo, GI; Marenzi, G; Cavalca, V; Tremoli, E; Eligini, S				Fiorelli, Susanna; Anesi, Andrea; Porro, Benedetta; Cosentino, Nicola; Werba, Jose P.; Di Minno, Alessandro; Manega, Chiara Maria; Barbieri, Simone; Colombo, Gualtiero, I; Marenzi, Giancarlo; Cavalca, Viviana; Tremoli, Elena; Eligini, Sonia			Lipidomics analysis of monocytes from patients with acute myocardial infarction reveals lactosylceramide as a new player in monocyte migration	FASEB JOURNAL			English	Article						cell migration; lipidomics; monocytes; myocardial infarction	AMYLOID-BETA PEPTIDE; ACID AMIDE HYDROLASE; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; RECEPTOR TRAFFICKING; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; INDUCED TOXICITY; NEURONAL LOSS	Monocyte recruitment after vascular injury and their migration through the vessel wall represent crucial events in the initiation, progression, and destabilization of atherosclerotic plaque. Circulating monocytes are exposed to stimuli that alter their physiological state, and among them, lipids play a key role. Several studies investigated the mechanisms by which lipids affect monocyte functions promoting coronary atherosclerotic plaque initiation, but information on the relationship between lipid composition and function of monocyte is scant. We aimed at studying the migration of circulating monocytes isolated from patients with acute myocardial infarction (AMI) at hospital presentation and investigating its correlation with cellular lipid profile. The migration of monocytes was tested using both fetal bovine serum (FBS) and autologous serum as chemoattractant stimuli. Monocyte lipid profile was evaluated through an untargeted lipidomics approach, using a liquid chromatography/time-of-flight mass spectrometry platform. We observed that AMI patients' monocytes showed a significant increase in FBS and autologous serum-mediated migration compared to controls. Moreover, a different monocyte lipidomic profile between the two study groups was detected. In particular, AMI patients' monocytes showed an altered composition in ceramides, with an increase in lactosylceramide and in phospholipids (ie, phosphatidylethanolamine and lisophosphatidylethanolamine). Of note, a positive correlation between lactosylceramide levels and monocyte migration was observed. Furthermore, the lactosylceramide synthase inhibition significantly reduced FBS-induced monocyte migration. Our results highlight the influence of lactosylceramide on the monocyte migration capacity, pointing out a new possible mechanism of lipids in the onset of atherothrombosis and, hence, in AMI.	[Fiorelli, Susanna; Anesi, Andrea; Porro, Benedetta; Cosentino, Nicola; Werba, Jose P.; Manega, Chiara Maria; Barbieri, Simone; Colombo, Gualtiero, I; Marenzi, Giancarlo; Cavalca, Viviana; Tremoli, Elena; Eligini, Sonia] IRCCS, Ctr Cardiol Monzino, Via C Parea 4, I-20138 Milan, Italy; [Di Minno, Alessandro] Univ Naples Federico II, Dept Pharm, Naples, Italy	IRCCS Centro Cardiologico Monzino; University of Naples Federico II	Cavalca, V (corresponding author), IRCCS, Ctr Cardiol Monzino, Via C Parea 4, I-20138 Milan, Italy.	viviana.cavalca@ccfm.it	Anesi, Andrea/ACJ-6729-2022; Colombo, Gualtiero I./B-4737-2010; Porro, Benedetta/K-1390-2016; Eligini, Sonia/F-3846-2018	Anesi, Andrea/0000-0002-9334-2610; Colombo, Gualtiero I./0000-0002-7348-1939; Porro, Benedetta/0000-0002-4019-4618; Eligini, Sonia/0000-0002-5507-6737	Ministero della Salute (Ministry of Health, Italy)	Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy)	Ministero della Salute (Ministry of Health, Italy)	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alexander AG, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00279; Androuin A, 2018, ACTA NEUROPATHOL, V135, P839, DOI 10.1007/s00401-018-1847-6; Aso E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00037; Attems J, 2007, ACTA NEUROPATHOL, V113, P53, DOI 10.1007/s00401-006-0146-9; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Beltramo M, 2000, J NEUROSCI, V20, P3401, DOI 10.1523/JNEUROSCI.20-09-03401.2000; Benito C, 2003, J NEUROSCI, V23, P11136; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Borlikova GG, 2013, NEUROBIOL AGING, V34, P1315, DOI 10.1016/j.neurobiolaging.2012.10.028; Branca JJV, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224420; BRENNER S, 1974, GENETICS, V77, P71; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Burns JM, 2005, NEUROLOGY, V64, P1397, DOI 10.1212/01.WNL.0000158423.05224.7F; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Campos AC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00269; Campos AC, 2016, PHARMACOL RES, V112, P119, DOI 10.1016/j.phrs.2016.01.033; Chege PM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00089; Cheng D, 2014, PSYCHOPHARMACOLOGY, V231, P3009, DOI 10.1007/s00213-014-3478-5; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Currais A, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.12; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Deutsch DG, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.7016.00370; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Elmes MW, 2015, J BIOL CHEM, V290, P8711, DOI 10.1074/jbc.M114.618447; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; GIBB WRG, 1989, J NEUROL NEUROSUR PS, V52, P193, DOI 10.1136/jnnp.52.2.193; Glass M, 2001, PROG NEURO-PSYCHOPH, V25, P743, DOI 10.1016/S0278-5846(01)00162-2; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Santos NAG, 2015, TOXICOL IN VITRO, V30, P231, DOI 10.1016/j.tiv.2015.11.004; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Harvey BS, 2012, NEUROTOXICOLOGY, V33, P138, DOI 10.1016/j.neuro.2011.12.015; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Land MH, 2020, CANNABIS CANNABINOID, DOI 10.1089/can.2020.0103; Lee JH, 2010, NEUROCHEM INT, V57, P985, DOI 10.1016/j.neuint.2010.10.010; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Margie O, 2013, JOVE-J VIS EXP, DOI 10.3791/50069; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Maulik Malabika, 2017, Front Genet, V8, P77, DOI 10.3389/fgene.2017.00077; McCollum L, 2007, J PHARMACOL EXP THER, V321, P930, DOI 10.1124/jpet.106.117549; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Murakami H, 2008, NEUROBIOL AGING, V29, P1093, DOI 10.1016/j.neurobiolaging.2007.01.013; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Ng LF, 2014, FREE RADICAL BIO MED, V71, P390, DOI 10.1016/j.freeradbiomed.2014.03.003; Nobili A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14727; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Oakes MD, 2017, J NEUROSCI, V37, P2859, DOI 10.1523/JNEUROSCI.3151-16.2017; Ofengeim D, 2012, J BIOL CHEM, V287, P8714, DOI 10.1074/jbc.M111.290957; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pandelides Z, 2020, GEROSCIENCE, V42, P785, DOI 10.1007/s11357-020-00182-4; Popugaeva E, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0034-7; Prenderville JA, 2015, BRIT J PHARMACOL, V172, P3950, DOI 10.1111/bph.13186; Price TJ, 2005, NEUROPHARMACOLOGY, V49, P25, DOI 10.1016/j.neuropharm.2005.01.031; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; Bassi MS, 2017, CANNABIS CANNABINOID, V2, P21, DOI 10.1089/can.2017.0002; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Takuma H, 2004, J NEUROPATH EXP NEUR, V63, P255, DOI 10.1093/jnen/63.3.255; Tejeda-Benitez L, 2016, REV ENVIRON CONTAM T, V237, P1, DOI 10.1007/978-3-319-23573-8_1; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Thomas A, 2004, EUR J PHARMACOL, V487, P213, DOI 10.1016/j.ejphar.2004.01.023; Wang CY, 2018, NEUROBIOL DIS, V109, P88, DOI 10.1016/j.nbd.2017.10.003; Watt G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00020; Williams EJ, 2003, J CELL BIOL, V160, P481, DOI 10.1083/jcb.200210164; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yang ZZ, 2018, FREE RADICAL BIO MED, V129, P310, DOI 10.1016/j.freeradbiomed.2018.09.035; Zheng MG, 2013, AMYLOID, V20, P13, DOI 10.3109/13506129.2012.755122	83	1	1	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21494	10.1096/fj.202001872RRR	http://dx.doi.org/10.1096/fj.202001872RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33856696				2022-12-26	WOS:000645260100092
J	Guo, W; Tang, ZY; Cai, ZY; Zhao, WE; Yang, J; Wang, XP; Ji, J; Huang, XX; Sun, XL				Guo, Wei; Tang, Zi-Yang; Cai, Zhen-Yu; Zhao, Wen-E; Yang, Jin; Wang, Xi-Peng; Ji, Juan; Huang, Xin-Xin; Sun, Xiu-Lan			Iptakalim alleviates synaptic damages via targeting mitochondrial ATP-sensitive potassium channel in depression	FASEB JOURNAL			English	Article						depression; Iptakalim; mitochondrial fission and fusion; mitochondrial KATP-channels; synaptic plasticity	RAT SUPRACHIASMATIC NUCLEUS; STRESS; FISSION; OPENER; DYSFUNCTION; PLASTICITY; VOLUME; INFLAMMATION; APOPTOSIS; PROTECTS	Synaptic plasticity damages play a crucial role in the onset and development of depression, especially in the hippocampus, which is more susceptible to stress and the most frequently studied brain region in depression. And, mitochondria have a major function in executing the complex processes of neurotransmission and plasticity. We have previously demonstrated that Iptakalim (Ipt), a new ATP-sensitive potassium (K-ATP) channel opener, could improve the depressive-like behavior in mice. But the underlying mechanisms are not well understood. The present study demonstrated that Ipt reversed depressive-like phenotype in vivo (chronic mild stress-induced mice model of depression) and in vitro (corticosterone-induced cellular model). Further study showed that Ipt could upregulate the synaptic-related proteins postsynaptic density 95 (PSD 95) and synaptophysin (SYN), and alleviated the synaptic structure damage. Moreover, Ipt could reverse the abnormal mitochondrial fission and fusion, as well as the reduced mitochondrial ATP production and collapse of mitochondrial membrane potential in depressive models. Knocking down the mitochondrial ATP-sensitive potassium (Mito-KATP) channel subunit MitoK partly blocked the above effects of Ipt. Therefore, our results reveal that Ipt can alleviate the abnormal mitochondrial dynamics and function depending on MitoK, contributing to improve synaptic plasticity and exert antidepressive effects. These findings provide a candidate compound and a novel target for antidepressive therapy.	[Guo, Wei; Tang, Zi-Yang; Cai, Zhen-Yu; Yang, Jin; Wang, Xi-Peng; Ji, Juan; Huang, Xin-Xin; Sun, Xiu-Lan] Nanjing Med Univ, Ctr Global Hlth, Neuroprotect Drug Discovery Key Lab, Jiangsu Key Lab Neurodegenerat, Nanjing, Peoples R China; [Zhao, Wen-E] Nanjing Med Univ, Anal Ctr, Nanjing, Peoples R China; [Sun, Xiu-Lan] Nanjing Univ Chinese Med, Affiliated Hosp, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine	Sun, XL (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Neurodegenerat, Dept Pharmacol, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China.	xiulans@njmu.edu.cn	Sun, Xiu-Lan/AAW-5376-2021	Sun, Xiu-Lan/0000-0001-8741-3833	National Natural Science Foundation of China [81973301, 81773701]; Medical Research Project of Jiangsu Commission of Health [ZDA2020006]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [18KJA310004]; Major Project of Nanjing Medical University [NMUD2018008]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX19_1121, KYCX20_1417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Research Project of Jiangsu Commission of Health; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Major Project of Nanjing Medical University; Postgraduate Research and Practice Innovation Program of Jiangsu Province	National Natural Science Foundation of China, Grant/Award Number: 81973301 and 81773701; Medical Research Project of Jiangsu Commission of Health, Grant/Award Number: ZDA2020006; Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Grant/Award Number: 18KJA310004; Major Project of Nanjing Medical University, Grant/Award Number: NMUD2018008; Postgraduate Research and Practice Innovation Program of Jiangsu Province, Grant/Award Number: KYCX19_1121 and KYCX20_1417	Anastacio MM, 2013, CIRCULATION, V128, pS130, DOI 10.1161/CIRCULATIONAHA.112.000128; Ballmaier M, 2008, AM J PSYCHIAT, V165, P229, DOI 10.1176/appi.ajp.2007.07030506; Balog J, 2016, J CEREBR BLOOD F MET, V36, P2022, DOI 10.1177/0271678X16671528; Bansal Y, 2016, CURR NEUROPHARMACOL, V14, P610, DOI 10.2174/1570159X14666160229114755; Berthet A, 2014, J NEUROSCI, V34, P14304, DOI 10.1523/JNEUROSCI.0930-14.2014; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen H, 2006, ACTA PHARMACOL SIN, V27, P665, DOI 10.1111/j.1745-7254.2006.00356.x; Cohen JW, 2011, SYNAPSE, V65, P763, DOI 10.1002/syn.20900; David DJ, 2016, ENCEPHALE, V42, P255, DOI 10.1016/j.encep.2016.03.012; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Fan Y, 2016, BRAIN STRUCT FUNCT, V221, P3111, DOI 10.1007/s00429-015-1090-z; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gong Y, 2011, NEUROSCI LETT, V488, P76, DOI 10.1016/j.neulet.2010.11.006; GULDNER FH, 1980, NEUROSCI LETT, V17, P27, DOI 10.1016/0304-3940(80)90056-7; Guldner FH, 1997, CELL TISSUE RES, V287, P43; Hei MF, 2019, BEHAV BRAIN RES, V365, P26, DOI 10.1016/j.bbr.2019.02.044; Holmes SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09562-7; Hu LF, 2005, J NEUROCHEM, V94, P1570, DOI 10.1111/j.1471-4159.2005.03306.x; Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758; JONES DG, 1978, BRAIN RES, V147, P47, DOI 10.1016/0006-8993(78)90771-0; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P99, DOI 10.1007/978-1-4939-8994-2_9; Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8; Lim GY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21243-x; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Lu M, 2014, INT J NEUROPSYCHOPH, V17, P1501, DOI 10.1017/S1461145714000285; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Manczak M, 2016, HUM MOL GENET, V25, P5148, DOI 10.1093/hmg/ddw330; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; Onukwufor JO, 2016, J EXP BIOL, V219, P2743, DOI 10.1242/jeb.140186; Paggio A, 2019, NATURE, V572, P609, DOI 10.1038/s41586-019-1498-3; Peng KG, 2018, BBA-MOL BASIS DIS, V1864, P1086, DOI 10.1016/j.bbadis.2018.01.013; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Price JB, 2018, NEUROSCI BIOBEHAV R, V90, P212, DOI 10.1016/j.neubiorev.2018.04.002; Ran YH, 2011, J ZHEJIANG UNIV-SC B, V12, P835, DOI 10.1631/jzus.B1100067; Shan H, 2016, NEUROPHARMACOLOGY, V107, P68, DOI 10.1016/j.neuropharm.2016.03.019; Streck EL, 2014, REV BRAS PSIQUIATR, V36, P156, DOI 10.1590/1516-4446-2013-1224; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Thomzig A, 2005, J COMP NEUROL, V484, P313, DOI 10.1002/cne.20469; Todorova V, 2017, CURR NEUROPHARMACOL, V15, P166, DOI 10.2174/1570159X14666160414111821; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wu J, 2006, J PHARMACOL EXP THER, V319, P155, DOI 10.1124/jpet.106.106286; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang FF, 2018, CNS NEUROSCI THER, V24, P994, DOI 10.1111/cns.12835; Zhang S, 2007, J NEUROCHEM, V103, P569, DOI 10.1111/j.1471-4159.2007.04775.x; Zhao XJ, 2017, BRAIN RES BULL, V130, P146, DOI 10.1016/j.brainresbull.2017.01.026; Zhao Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00293	53	2	3	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21581	10.1096/fj.202100124RR	http://dx.doi.org/10.1096/fj.202100124RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871072				2022-12-26	WOS:000645260100036
J	Dejene, H; Abera, M; Tadele, A				Dejene, Hiwot; Abera, Muluemebet; Tadele, Afework			Unmet need for family planning and associated factors among married women attending anti-retroviral treatment clinics in Dire Dawa City, Eastern Ethiopia	PLOS ONE			English	Article							HEALTH	Background Unmet need for family planning is a measure of the gap between women's contraceptive behavior and their fertility desires. It should be measured among different population groups to effectively implement public health interventions. Thus, this study aimed to determine the magnitude of unmet need for family planning and associated factors among HIV- positive women in Dire Dawa city Anti-retroviral treatment (ART) clinics, Eastern Ethiopia. Methods We carried out a facility-based cross-sectional study (March-June 2020) among 409 married women aged 15-49 on ART, using systematic random sampling. A face-to-face interview was done using a structured questionnaire. Bivariable and multivariable logistic regression was done to identify factors associated with unmet need for family planning. Results Overall, 33% [95% confidence interval (CI): 28.9-37.9] of the respondents had unmet need for family planning. Woman's residing in a rural area (adjusted odds ratio (AOR): 2.41 [95% CI: 1.24-4.67]), woman's not attained formal education (AOR: 4.14 [95% CI: 1.73-9.93]) and attaining primary education (AOR: 2.97 [95% CI: 1.54-5.74]), poor knowledge (AOR: 2.87 [95% CI: 1.52-5.40]), and unfavorable attitude towards family planning (AOR: 2.21 [95% CI: 1.12-4.34]), clients not satisfied with family planning service (AOR: 6.34 [95% CI: 3.31-12.15]), the woman not having decision making power on family planning (AOR:3.97 [95% CI: 2.14-7.38]) and not getting family planning counseling in ART clinics (AOR: 2.87 [95% CI: 1.54-5.35]) were positively associated with having unmet need for family planning. Conclusion This study indicates there a high unmet need for family planning among married HIV-positive women. Factors like a place of residence, educational status of women, knowledge and attitude towards family planning, client satisfaction with FP service, women decision-making power, and FP counseling service in ART. Therefore, we recommend that the concerned bodies should collaborate with ART clinics to design interventions that enhance access to family planning programs to combat the high unmet need for family planning among HIV-positive women.	[Dejene, Hiwot] Mettu Univ, Dept Publ Hlth, Mettu, Ethiopia; [Abera, Muluemebet; Tadele, Afework] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia	Jimma University	Dejene, H (corresponding author), Mettu Univ, Dept Publ Hlth, Mettu, Ethiopia.	hiwotdejene74@gmail.com	Tadele, Afework/AAK-3071-2020	Tadele, Afework/0000-0001-5682-6117; Dejene, Hiwot/0000-0002-5110-4075	Jimma University	Jimma University	This research work is funded by Jimma University.	Abeje Gedefaw, 2016, BMC Res Notes, V9, P43, DOI 10.1186/s13104-016-1850-8; Abubeker Ferid A, 2019, Int J Reprod Med, V2019, P3276780, DOI 10.1155/2019/3276780; Asrat Woineshet, 2018, Contracept Reprod Med, V3, P25, DOI 10.1186/s40834-018-0079-4; Baschieri A, 2017, MATERN CHILD HLTH J, V21, P467, DOI 10.1007/s10995-016-2124-8; Berhane Yemane, 2013, ISRN AIDS, V2013, P319724, DOI 10.1155/2013/319724; Bogale B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-342; Bradley SEK., 2012, REVISING UNMET NEED, V63 25; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2016, ETHIOPIA DEMOGRAPHIC; Chakraborty NM, 2016, GLOB HEALTH-SCI PRAC, V4, P141, DOI 10.9745/GHSP-D-15-00384; Claridge AM, 2013, WOMEN HEALTH, V53, P777, DOI 10.1080/03630242.2013.831018; Endriyas M, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-016-0036-z; Fagbamigbe AF, 2018, SAGE OPEN, V8, DOI 10.1177/2158244017754023; Federal Democratic Republic of Ethiopia(FDRE), ETHIOPIA RH STRATEGI; Federal Democratic Republic of Ethiopia Ministry of Health, 2016, NATL REPROD HLTH STR, P102; Feyssa MD., 2015, J AIDS CLIN RES, V6; Fisheljoy D., 2012, DHS ANAL STUDIES, V25; Haile A, 2009, ETHIOP J HEALTH DEV, V20, DOI [10.4314/ejhd.v20i3.46824, DOI 10.4314/EJHD.V20I3.46824]; Kalolo A., 2018, INT J POPUL RES, V2018, P1; Koshewara P., 2019, J EVID BASED MED HEA, V6, P893; Laryea DO, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-126; MacQuarrie, 2015, DHS WORKING PAPERS, V122; Melaku YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094682; Njuguna E., 2017, INT J REPROD CONTRAC, V6, P1746, DOI DOI 10.18203/2320-1770.IJRCOG20171935; Okigbo CC, 2014, AFR J REPROD HEALTH, V18, P134; Okunola TO, 2019, TROP DOCT, V49, P26, DOI 10.1177/0049475518809605; Rucinski KB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209114; Shafei MN., 2012, J COMMUNITY MED HLTH, V2, P180, DOI [10.4172/2161-0711.1000180, DOI 10.4172/2161-0711.1000180]; Sisay SelamwiytMKS., 2015, ADDIS ABABA U ELECT; Thindwa D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217330; Wanyenze RK, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-014-0158-x; World Health Organization (WHO) , 2019, UNMET NEED FAMILY PL; Yotebieng M, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.235.5859; Zewdu G, 2011, UNMET REPROD HLTH CA	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250297	10.1371/journal.pone.0250297	http://dx.doi.org/10.1371/journal.pone.0250297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861787	Green Published, gold			2022-12-26	WOS:000641475400062
J	Lee, SY; Song, R; Yang, HI; Chung, SW; Lee, YA; Hong, SJ; Yun, SJ; Lee, SH				Lee, So Yun; Song, Ran; Yang, Hyung In; Chung, Sang Wan; Lee, Yeon-Ah; Hong, Seung-Jae; Yun, Seong Jong; Lee, Sang-Hoon			The bone bridge significantly affects the decrease in bone mineral density measured with quantitative computed tomography in ankylosing spondylitis	PLOS ONE			English	Article							INFLAMMATORY BACK-PAIN; PROTON PUMP INHIBITORS; VERTEBRAL FRACTURES; FOLLOW-UP; SPINAL MOBILITY; RISK-FACTORS; OSTEOPOROSIS; PREVALENCE; MANAGEMENT; SPONDYLOARTHROPATHY	Introduction and objective Ankylosing spondylitis (AS) has characteristics of spinal bone bridge and fusion. Although BMD reduction in AS may be presumed to be due to spinal inflammation, this study was designed to confirm whether immobilization of the spine due to syndesmophytes is related to BMD reduction, as immobilization itself is a risk factor for BMD reduction. Methods Among male patients diagnosed with AS according to the modified New York criteria, those who underwent bone density tests with quantitative computed tomography (QCT) were retrospectively analyzed through a chart review. The correlation between the presence or absence of bone bridges for each vertebral body level of the L spine confirmed with radiography and BMD confirmed with QCT was analyzed. Results A total of 47 male patients with AS were enrolled. The mean patient age was 46.8 +/- 8.2 years, and the mean disease duration was 7.9 +/- 6.4 years. The trabecular BMD of the lumbar spine (L1-L4) ranged from 23.1 to 158.45 mg/cm(3) (mean 102.2 +/- 37 mg/cm(3)), as measured with QCT. The lumbar BMD measurements showed that 30 patients (63.8%) had osteopenia or osteoporosis. Bone bridge formation showed a negative correlation with BMD. Low BMD was significantly correlated with bone bridge in the vertebral body (p < 0.05). Positive correlations were observed between bone bridge score and BASMI flexion score, whereas significant negative correlations were found between BMD and BASMI flexion score (p < 0.05). Conclusion Decreased mobility of the vertebrae due to bone bridge formation affects the decrease in BMD in patients with AS.	[Lee, So Yun; Song, Ran; Yang, Hyung In; Chung, Sang Wan; Lee, Yeon-Ah; Hong, Seung-Jae; Lee, Sang-Hoon] Kyung Hee Univ, Coll Med, Dept Rheumatol, Seoul, South Korea; [Yun, Seong Jong] Kyung Hee Univ, Coll Med, Dept Radiol, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Lee, SH (corresponding author), Kyung Hee Univ, Coll Med, Dept Rheumatol, Seoul, South Korea.	boltaguni@gmail.com	Chung, Sang Wan/ABB-6921-2021	Lee, Sang-Hoon/0000-0003-3655-9546				Allali F, 2003, ANN RHEUM DIS, V62, P347, DOI 10.1136/ard.62.4.347; American College of Radiology, 2018, ACR SPR SSR PRACT PA; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Briot K, 2013, ANN RHEUM DIS, V72, P1914, DOI 10.1136/annrheumdis-2012-201845; Carbone LD, 2003, J BONE MINER RES, V18, P1795, DOI 10.1359/jbmr.2003.18.10.1795; Dagfinrud H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002822.pub3; Davey-Ranasinghe N, 2013, CURR OPIN RHEUMATOL, V25, P509, DOI 10.1097/BOR.0b013e3283620777; Deminger A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1480-0; DONNELLY S, 1994, ANN RHEUM DIS, V53, P117, DOI 10.1136/ard.53.2.117; Eimori K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156991; Engelke K, 2008, J CLIN DENSITOM, V11, P123, DOI 10.1016/j.jocd.2007.12.010; Frost M, 2012, AGE AGEING, V41, P171, DOI 10.1093/ageing/afr170; Ghozani I, 2009, BONE, V44, P772, DOI 10.1016/j.bone.2008.12.028; Gratacos J, 1999, ARTHRITIS RHEUM, V42, P2319, DOI 10.1002/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G; Haugeberg G, 2010, ANN RHEUM DIS, V69, P1364, DOI 10.1136/ard.2009.124982; Henneicke H, 2014, TRENDS ENDOCRIN MET, V25, P197, DOI 10.1016/j.tem.2013.12.006; Iwasaki T, 2008, PEDIATR INT, V50, P269, DOI 10.1111/j.1442-200X.2008.02571.x; JENKINSON TR, 1994, J RHEUMATOL, V21, P1694; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kim HR, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1731-8; Klingberg E, 2012, J RHEUMATOL, V39, P1987, DOI 10.3899/jrheum.120316; Klingberg E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3833; Lange U, 2005, RHEUMATOL INT, V26, P115, DOI 10.1007/s00296-004-0515-4; Li N, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/895474; Lories RJU, 2012, RHEUM DIS CLIN N AM, V38, P555, DOI 10.1016/j.rdc.2012.08.003; Machado P, 2010, ANN RHEUM DIS, V69, P1465, DOI 10.1136/ard.2009.124206; Maillefert JF, 2001, OSTEOPOROSIS INT, V12, P605, DOI 10.1007/s001980170084; MARHOFFER W, 1995, ANN RHEUM DIS, V54, P556, DOI 10.1136/ard.54.7.556; Mitra D, 2000, RHEUMATOLOGY, V39, P85, DOI 10.1093/rheumatology/39.1.85; O'Dwyer T, 2014, RHEUMATOL INT, V34, P887, DOI 10.1007/s00296-014-2965-7; Panday K, 2014, THER ADV MUSCULOSKEL, V6, P185, DOI 10.1177/1759720X14546350; Rosenbaum J, 2012, AM J MED SCI, V343, P364, DOI 10.1097/MAJ.0b013e3182514059; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; RUBINSTEIN HM, 1991, BRIT J RHEUMATOL, V30, P160; Schett G, 2011, AM J MED SCI, V341, P269, DOI 10.1097/MAJ.0b013e31820f8b29; SPENCER DG, 1979, J RHEUMATOL, V6, P305; Szentpetery A, 2017, AUTOIMMUN REV, V16, P313, DOI 10.1016/j.autrev.2017.01.014; Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vestergaard P, 2006, CALCIFIED TISSUE INT, V79, P76, DOI 10.1007/s00223-006-0021-7; Viitanen JV, 1998, BRIT J RHEUMATOL, V37, P377; Vosse D, 2008, RHEUMATOLOGY, V47, P1219, DOI 10.1093/rheumatology/ken148; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446; WILL R, 1989, LANCET, V2, P1483; Willson T, 2015, CLIN EPIDEMIOL, V7, P65, DOI 10.2147/CLEP.S40966; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Yu EW, 2008, CALCIFIED TISSUE INT, V83, P251, DOI 10.1007/s00223-008-9170-1	50	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249578	10.1371/journal.pone.0249578	http://dx.doi.org/10.1371/journal.pone.0249578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861786	Green Published, gold			2022-12-26	WOS:000641475400024
J	Mendes, RJ; Luz, JP; Santos, C; Tavares, F				Mendes, Rafael J.; Luz, Joao Pedro; Santos, Conceicao; Tavares, Fernando			CRISPR genotyping as complementary tool for epidemiological surveillance of Erwinia amylovora outbreaks	PLOS ONE			English	Article							FIRE BLIGHT; GENETIC-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; 1ST REPORT; STRAINS; DNA; IDENTIFICATION; TRANSLOCATION; DIVERSITY; BACTERIA	Fire blight is a destructive plant disease caused by Erwinia amylovora affecting pome fruit trees, and responsible for large yield declines, long phytosanitary confinements, and high economic losses. In Portugal, the first major fire blight outbreaks occurred in 2010 and 2011, and although later considered eradicated, the emergence of other outbreaks in recent years stressed the need to characterize the E. amylovora populations associated with these outbreaks. In this regard, CRISPR genotyping, assessment of three virulence markers, and semi-quantitative virulence bioassays, were carried out to determine the genotype, and assess the virulence of thirty-six E. amylovora isolates associated with outbreaks occurring between 2010 and 2017 and affecting apple and pear orchards located in the country central-west, known as the main producing region of pome fruits in Portugal. The data gathered reveal that 35 E. amylovora isolates belong to one of the widely-distributed CRISPR genotypes (5-24-38 / D-a-alpha) regardless the host species, year and region. Ea 680 was the single isolate revealing a new CRISPR genotype due to a novel CR2 spacer located closer to the leader sequence and therefore thought to be recently acquired. Regarding pathogenicity, although dot-blot hybridization assays showed the presence of key virulence factors, namely hrpL (T3SS), hrpN (T3E) and amsG from the amylovoran biosynthesis operon in all E. amylovora isolates studied, pathogenicity bioassays on immature pear slices allowed to distinguish four virulence levels, with most of the isolates revealing an intermediate to severe virulence phenotype. Regardless the clonal population structure of the E. amylovora associated to the outbreaks occurring in Portugal between 2010 and 2017, the different virulence phenotypes, suggests that E. amylovora may have been introduced at different instances into the country. This is the first study regarding E. amylovora in Portugal, and it discloses a novel CRISPR genotype for this bacterium.	[Mendes, Rafael J.; Santos, Conceicao; Tavares, Fernando] Univ Porto, Fac Sci, Porto, Portugal; [Mendes, Rafael J.; Santos, Conceicao] Univ Porto, LAQV REQUIMTE, Fac Sci, Porto, Portugal; [Mendes, Rafael J.] Univ Tras Os Montes & Alto Douro, CITAB Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal; [Mendes, Rafael J.; Tavares, Fernando] Univ Porto, CIBIO Res Ctr Biodivers & Genet Resources, Associated Lab, InBIO, Campus Agrario Vairao, Vairao, Portugal; [Luz, Joao Pedro] Polytech Inst Castelo Branco, Sch Agr, QRural, Castelo Branco, Portugal	Universidade do Porto; Universidade do Porto; University of Tras-os-Montes & Alto Douro; Universidade do Porto; Polytechnic Institute of Castelo Branco	Mendes, RJ (corresponding author), Univ Porto, Fac Sci, Porto, Portugal.; Mendes, RJ (corresponding author), Univ Porto, LAQV REQUIMTE, Fac Sci, Porto, Portugal.; Mendes, RJ (corresponding author), Univ Tras Os Montes & Alto Douro, CITAB Ctr Res & Technol Agroenvironm & Biol Sci, Vila Real, Portugal.; Mendes, RJ (corresponding author), Univ Porto, CIBIO Res Ctr Biodivers & Genet Resources, Associated Lab, InBIO, Campus Agrario Vairao, Vairao, Portugal.	rafael.mendes@fc.up.pt	Luz, João Pedro/M-7245-2013; santos, conceição/GQQ-7378-2022; Santos, Conceição/ABE-6172-2020; Mendes, Rafael/AAT-9093-2020; Tavares, Fernando/C-3375-2013	Luz, João Pedro/0000-0002-3494-737X; Santos, Conceição/0000-0003-4129-6381; Mendes, Rafael/0000-0001-5212-6172; Tavares, Fernando/0000-0001-9913-1155	Fundacao para a Ciencia e Tecnologia [SFRH/BD/133519/2017]; European Union [857251]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union(European Commission)	RM received support for this study from the Fundacao para a Ciencia e Tecnologia, grant number SFRH/BD/133519/2017, [https://www.fct.pt/index.phtml.en].FT received support from the European Union's Horizon 2020 Research and Innovation Programme, grant number 857251, [https://ec.europa.eu/programmes/horizon2020/en].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeolu M, 2016, INT J SYST EVOL MICR, V66, P5575, DOI 10.1099/ijsem.0.001485; Albuquerque P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037836; Albuquerque P, 2011, APPL ENVIRON MICROB, V77, P5619, DOI 10.1128/AEM.05189-11; Almeida A, 2013, VET MICROBIOL, V164, P370, DOI 10.1016/j.vetmic.2013.03.011; Almendros C, 2014, MBIO, V5, DOI 10.1128/mBio.00767-13; Ammouneh H, 2011, J PLANT PATHOL, V93, P105; [Anonymous], 2015, PHYTOPATHOLOGY, DOI DOI 10.1094/PHYT0-03-15-0078-R; [Anonymous], 1999, ACTA HORTIC, DOI DOI 10.17660/ACTAH0RTIC.1999.489.28; [Anonymous], 2006, PHYTOPATHOLOGY; [Anonymous], 2019, ECOSAL PLUS, DOI DOI 10.1128/EC0SALPLUS.ESP-0008-2018; [Anonymous], 2014, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0108353; [Anonymous], 2020, EPPO REP SERV NO 05; [Anonymous], 2011, PHYTOPATHOLOGY, DOI DOI 10.1094/PHYT0-04-10-0127; [Anonymous], 2021, CROPS PROD QUANT; [Anonymous], 2012, EUR J PLANT PATHOL, DOI DOI 10.1007/S10658-012-0024-3; [Anonymous], 2014, ACTA HORTIC, DOI DOI 10.17660/ACTAH0RTIC.2014.1056.9; [Anonymous], 2011, J BIOTECHNOL, DOI DOI 10.1016/J.JBI0TEC.2010.10.075; [Anonymous], 2014, ACTA HORTIC, DOI DOI 10.17660/ACTAH0RTIC.2014.1056.22; [Anonymous], 2009, ROUM ARCH MICROBIOL; [Anonymous], 2017, FRONT MICROBIOL; [Anonymous], 2020, GENOMICS, DOI DOI 10.1016/J.YGEN0.2020.04.001; Authie E, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3877; Bocsanczy AM, 2008, MOL PLANT PATHOL, V9, P425, DOI 10.1111/J.1364-3703.2008.00471.X; Boureau T, 2011, MOL PLANT MICROBE IN, V24, P577, DOI 10.1094/MPMI-09-10-0212; Buhlmann A, 2014, ENVIRON MICROBIOL, V16, P2112, DOI 10.1111/1462-2920.12289; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; BUGERT P, 1995, MOL MICROBIOL, V15, P917, DOI 10.1111/j.1365-2958.1995.tb02361.x; Dardouri S, 2017, J PLANT PATHOL, V99, P331; Donat V, 2007, J APPL MICROBIOL, V103, P1639, DOI 10.1111/j.1365-2672.2007.03399.x; Doolotkeldieva T, 2019, EUR J PLANT PATHOL, V155, P677, DOI 10.1007/s10658-019-01790-3; EPPO, 2019, EPPO A1 A2 LISTS PES, P1; Fernandes C, 2017, PLANT DIS, V101, P858, DOI 10.1094/PDIS-10-16-1481-RE; Gottsberger RA, 2010, LETT APPL MICROBIOL, V51, P285, DOI 10.1111/j.1472-765X.2010.02892.x; Halupecki E, 2006, EUR J PLANT PATHOL, V114, P435, DOI 10.1007/s10658-006-0003-7; Jock S, 2002, ENVIRON MICROBIOL, V4, P106, DOI 10.1046/j.1462-2920.2002.00277.x; Jock S, 2013, MICROBIOL RES, V168, P447, DOI 10.1016/j.micres.2013.01.008; Kharadi RR, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02233-18; KING EO, 1954, J LAB CLIN MED, V44, P301; Koczan JM, 2011, APPL ENVIRON MICROB, V77, P7031, DOI 10.1128/AEM.05138-11; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Llop P, 2000, APPL ENVIRON MICROB, V66, P2071, DOI 10.1128/AEM.66.5.2071-2078.2000; Llop P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00874; Llop P, 2012, TREES-STRUCT FUNCT, V26, P31, DOI 10.1007/s00468-011-0630-2; Llop P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028651; Lopez M. M., 2013, Bulletin OEPP, V43, P21, DOI 10.1111/epp.12019; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Mann RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055644; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Marco-Noales E, 2017, PLANT DIS, V101, P502, DOI 10.1094/PDIS-09-16-1251-PDN; McGhee GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041706; Medina-Aparicio L, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty002; Momol EA, 1999, ACTA HORTIC, V489, P55, DOI 10.17660/ActaHortic.1999.489.5; Momol MT, 1997, J APPL MICROBIOL, V82, P389, DOI 10.1046/j.1365-2672.1997.00377.x; Obradovic D, 2007, MICROBIOLOGY+, V76, P748, DOI 10.1134/S002626170706015X; Pester D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032583; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.340; Pique N, 2015, INT J MOL SCI, V16, P12836, DOI 10.3390/ijms160612836; Popovic T, 2020, EUR J PLANT PATHOL, V157, P857, DOI 10.1007/s10658-020-02046-1; Powney R, 2011, AUSTRALAS PLANT PATH, V40, P87, DOI 10.1007/s13313-010-0017-7; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Rhouma A, 2014, PLANT DIS, V98, P158, DOI 10.1094/PDIS-05-13-0542-PDN; Rico A, 2004, J APPL MICROBIOL, V96, P302, DOI 10.1046/j.1365-2672.2003.02156.x; Schwarczinger I, 2017, EUR J PLANT PATHOL, V149, P639, DOI 10.1007/s10658-017-1214-9; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shtienberg D, 2015, PLANT DIS, V99, P1048, DOI 10.1094/PDIS-01-15-0101-FE; Stockwell VO, 2012, REV SCI TECH OIE, V31, P199; Sundin G.W., 2014, COMPENDIUM APPLE PEA, V2nd ed.; Tafifet L, 2020, EUR J PLANT PATHOL, V156, P867, DOI 10.1007/s10658-020-01938-6; Tancos KA, 2016, PLANT DIS, V100, P1307, DOI 10.1094/PDIS-01-16-0088-RE; Taylor RK, 2001, NEW ZEAL J CROP HORT, V29, P35, DOI 10.1080/01140671.2001.9514158; Turland NJ, 2018, REGNUM VEG, V159, P1; Vanneste JL, 2000, FIRE BLIGHT, P1, DOI 10.1079/9780851992945.0001; Vegh A, 2012, PLANT DIS, V96, P759, DOI 10.1094/PDIS-12-11-1013-PDN; Vegh A, 2017, EUR J PLANT PATHOL, V147, P455, DOI 10.1007/s10658-016-1001-z; Wang DP, 2010, PHYTOPATHOLOGY, V100, P192, DOI 10.1094/PHYTO-100-2-0192; WEI ZM, 1995, J BACTERIOL, V177, P6201, DOI 10.1128/jb.177.21.6201-6210.1995; Yuan XC, 2021, J PLANT PATHOL, V103, P25, DOI 10.1007/s42161-020-00623-1; Zeng Q, 2018, MOL PLANT PATHOL, V19, P1652, DOI 10.1111/mpp.12647; Zeng Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-414	79	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250280	10.1371/journal.pone.0250280	http://dx.doi.org/10.1371/journal.pone.0250280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861806	Green Published, gold			2022-12-26	WOS:000641475400006
J	Zambrano, MLA; Kilroy, D; Kumar, A; Gilchrist, MD; Annaidh, AN				Zambrano, Lilibeth A. M.; Kilroy, David; Kumar, Arun; Gilchrist, Michael D.; Annaidh, Aisling Ni			The presence of Wormian bones increases the fracture resistance of equine cranial bone	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; OSTEOGENESIS IMPERFECTA; INFANT SKULL; SUTURE; BIOMECHANICS; DEFORMATION; PARAMETERS	Wormian (intrasutural) bones are small, irregular bones, that are found in the cranial sutures of the skull. The occurrence of Wormian bones in human skulls has been well documented but few studies have detected the presence of such bones in domestic animals. Although some research has linked the presence of Wormian bones to bone pathology, its anatomical significance in healthy individuals is not known. To the best of our knowledge, no previous study has examined the biomechanical features of Wormian bone. This study uses microCT imaging of the parietal bone region to determine the frequency of occurrence of Wormian bones in horse skulls and, through 3-point bending tests, to calculate the mechanical differences that result from the presence of such bones. In addition, bone properties such as bone mineral density (BMD) and stiffness were measured and analysed to determine the influence of Wormian bone. Our findings on 54 specimens taken from 10 horses (ages ranging from 4 to 29 years) showed that Wormian bone was present in 70% of subjects and that its occurrence was unrelated to age or sex. 3-point bend tests revealed that the stiffness normalised by cross section area (P = 0.038) was lower in samples where Wormian bone was present. An idealised Finite Element simulation confirmed that the presence of Wormian bone reduced the maximum stress and strain, as well as their distribution throughout the sample. We consequently conclude that the presence of Wormian bones, which are confined to the calvaria, increase the compliance of the bone and reduce the likelihood of skull fracture. As all skull samples were collected from a local abattoir, ethical approval was not required for this work.	[Zambrano, Lilibeth A. M.; Gilchrist, Michael D.; Annaidh, Aisling Ni] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Kilroy, David; Kumar, Arun] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland	University College Dublin; University College Dublin	Annaidh, AN (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	aisling.niannaidh@ucd.ie	Ní Annaidh, Aisling/ABF-8938-2021	Ní Annaidh, Aisling/0000-0002-9929-4541	European Union [642662]	European Union(European Commission)	LZ was funded by the European Union's Horizon 2020 research programme under the Marie Sklodowska - Curie grant agreement No. 642662. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2000, MECH TESTING BONE BO, V1st, DOI [10.1201/9781420073560, DOI 10.1201/9781420073560]; Auperrin A, 2009, CARACACTERISATION TI; Auperrin A, 2014, J BIOMECH, V47, P1180, DOI 10.1016/j.jbiomech.2013.10.060; Barberini F, 2008, SURG RADIOL ANAT, V30, P683, DOI 10.1007/s00276-008-0371-0; Bellary SS, 2013, CLIN ANAT, V26, P922, DOI 10.1002/ca.22262; BENNETT KA, 1965, AM J PHYS ANTHROPOL, V23, P255, DOI 10.1002/ajpa.1330230313; Brothwell D., 1959, DTSCH GES ANTHR, V6, P103; Burrows AM, 1997, AM J PHYS ANTHROPOL, V102, P555, DOI 10.1002/(SICI)1096-8644(199704)102:4<555::AID-AJPA9>3.0.CO;2-Q; Butaud P, 2016, COMPOS STRUCT, V153, P401, DOI 10.1016/j.compstruct.2016.06.040; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; CREMIN B, 1982, SKELETAL RADIOL, V8, P35, DOI 10.1007/BF00361366; Curtis N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0442; ELNAJJAR MY, 1977, AM J PHYS ANTHROPOL, V46, P155, DOI 10.1002/ajpa.1330460119; Gere J, 2004, MECH MATER, V6th; Goto Tomohide, 2004, Congenital Anomalies, V44, P225, DOI 10.1111/j.1741-4520.2004.00043.x; Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024; Hibbeler RC., 2011, MECH MATER, V8th; Huang ZC, 2016, J VIB CONTROL, V22, P1876, DOI 10.1177/1077546314545527; Hylander WL, 1997, AM J PHYS ANTHROPOL, V102, P203, DOI 10.1002/(SICI)1096-8644(199702)102:2<203::AID-AJPA5>3.0.CO;2-Z; HYLANDER WL, 1991, AM J PHYS ANTHROPOL, V86, P1, DOI 10.1002/ajpa.1330860102; International ASTM, 2009, ANN B ASTM STAND, Vi, P1; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Khan AA, 2011, FOLIA MORPHOL, V70, P291; Kozerska Magdalena, 2013, Folia Med Cracov, V53, P21; KRIEWALL TJ, 1981, J BIOMECH, V14, P73, DOI 10.1016/0021-9290(81)90166-4; Maloul A, 2013, J BIOMECH, V46, P912, DOI 10.1016/j.jbiomech.2012.12.016; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Marti B, 2013, Diagn Interv Imaging, V94, P428, DOI 10.1016/j.diii.2013.01.001; McGeady T.A., 2017, VET EMBRYOLOGY, P251; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Morgan EF, 2004, STAND HDB BIOMED ENG, DOI [DOI 10.1385/1-59259-366-6%3A369, 10.1385/1-59259-366-6%3A369]; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; O'Loughlin VD, 2004, AM J PHYS ANTHROPOL, V123, P146, DOI 10.1002/ajpa.10304; Ojanen X, 2015, J BIOMECH, V48, P269, DOI 10.1016/j.jbiomech.2014.11.034; PRITCHARD JJ, 1956, J ANAT, V90, P73; PUCEK ZDZISLAW, 1962, ACTA THERIOLOGICA, V6, P33; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; Rahmoun J, 2014, MECH RES COMMUN, V60, P7, DOI 10.1016/j.mechrescom.2014.04.001; Ravosa MJ, 2010, ANAT REC, V293, P557, DOI 10.1002/ar.21133; Rikards R, ANAL LAMINATED STRUC; Semler O, 2010, AM J MED GENET A, V152A, P1681, DOI 10.1002/ajmg.a.33448; Sisson S, 1953, ANATOMY DOMESTIC ANI, V3; Stefan U, 2010, BONE, V47, P1048, DOI 10.1016/j.bone.2010.08.012; Torimitsu S, 2015, FORENSIC SCI INT, V249, P101, DOI 10.1016/j.forsciint.2015.01.030; Wang JW, 2014, MED SCI MONITOR, V20, P1808, DOI 10.12659/MSM.892278; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249451	10.1371/journal.pone.0249451	http://dx.doi.org/10.1371/journal.pone.0249451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861736	gold, Green Published			2022-12-26	WOS:000641475400027
J	Bates, BR; Tami, A; Carvajal, A; Grijalva, MJ				Bates, Benjamin R.; Tami, Adriana; Carvajal, Ana; Grijalva, Mario J.			Knowledge, attitudes, and practices towards COVID-19 among Venezuelans during the 2020 epidemic: An online cross-sectional survey	PLOS ONE			English	Article							HEALTH; OUTBREAK; RISE	Background COVID-19 threatens health systems worldwide, but Venezuela's system is particularly vulnerable. To prevent the spread of COVID-19, individuals must adopt preventive behaviors. However, to encourage behavior change, we must first understand current knowledge, attitudes, and practices (KAPs) that inform response to this health threat. Methods We explored KAPs among Venezuelans using a cross-sectional, internet-based questionnaire. The questionnaire explored individuals' knowledge about COVID-19; their attitudes toward the world's and the Venezuelan authorities' abilities to control it; and their self-reported practices. We also collected demographic data. Binomial logistic regression analyses were used to predict the adoption of preventive behaviors based on demographic variables, individual knowledge level, and individual attitudes. Results 3122 individuals completed the questionnaire. Participants had a high level of knowledge about COVID-19. They expressed high levels of optimism that the world would eventually control COVID-19, but they were very pessimistic about the public authorities in Venezuela. Most participants adopted preventive practices. Binomial regression suggests younger people, less educated people, and manual laborers hold lower levels of knowledge, and these groups, as well as men, were less likely to adopt preventive practices. Knowledge, by itself, had no association with optimism and little association with self-reported practices. Conclusions As other KAP studies in Latin America found, knowledge is not sufficient to prompt behavior change. Venezuelans' pessimism about their own country's ability should be explored in greater depth. Health promotion in Venezuela may wish to target the most at risk groups: men, younger people, less educated people, and manual laborers.	[Bates, Benjamin R.] Ohio Univ, Sch Commun Studies, Athens, OH 45701 USA; [Bates, Benjamin R.; Grijalva, Mario J.] Ohio Univ, Heritage Coll Osteopath Med, Infect & Trop Dis Inst, Dept Biomed Sci, Athens, OH 45701 USA; [Tami, Adriana] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands; [Tami, Adriana] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela; [Carvajal, Ana] Hosp Univ Caracas, Postgrad Infectol, Caracas, Venezuela; [Carvajal, Ana] Univ Cent Venezuela, Fac Med, Caracas, Venezuela; [Grijalva, Mario J.] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Ctr Invest Salud Amer Latina, Quito, Ecuador	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University of Groningen; University of Central Venezuela; Pontificia Universidad Catolica del Ecuador	Grijalva, MJ (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Infect & Trop Dis Inst, Dept Biomed Sci, Athens, OH 45701 USA.; Grijalva, MJ (corresponding author), Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Ctr Invest Salud Amer Latina, Quito, Ecuador.	grijalva@ohio.edu	Grijalva, Mario J/U-8356-2018	Grijalva, Mario J/0000-0003-1964-1425; Tami, Adriana/0000-0002-1918-9144	UK Research and Innovation, Global Challenges Research Fund [EP/T003782/1]; University of Glasgow Small Grants Fund; Scottish Funding Council; Ohio University Infectious and Tropical Disease Institute; EPSRC [EP/T003782/1] Funding Source: UKRI	UK Research and Innovation, Global Challenges Research Fund; University of Glasgow Small Grants Fund; Scottish Funding Council; Ohio University Infectious and Tropical Disease Institute; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the UK Research and Innovation, Global Challenges Research Fund to MG (EP/T003782/1), the University of Glasgow Small Grants Fund and Scottish Funding Council to MG, and the Ohio University Infectious and Tropical Disease Institute to MG.	Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Akinyinka Modupe R, 2019, J Infect Prev, V20, P179, DOI 10.1177/1757177419830779; [Anonymous], 2018, LANCET, V391, P1331, DOI 10.1016/S0140-6736(16)00277-4; [Anonymous], 2020, ASS PRESS; [Anonymous], 2020, REUTERS; [Anonymous], 2020, HUMAN RIGHTS WATCH; [Anonymous], NEWS; Bates B. R., 2020, Journal of Communication in Healthcare, V13, P262, DOI 10.1080/17538068.2020.1842843; Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7; Berwick A, 2020, RUN DOWN CARACAS I V; Berwick A, 2020, CORONAVIRUS HITS VEN; Burki T, 2020, LANCET INFECT DIS, V20, P547, DOI 10.1016/S1473-3099(20)30303-0; Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094; Cincurova S., VENEZUELA ARBITRARIL; Daniels JP, 2020, LANCET, V395, P1023, DOI 10.1016/S0140-6736(20)30718-2; Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575; Ebrahim SH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1066; ECLAC, 2020, ADDR GROW IMP COVID; Garrett L, 2020, LANCET, V395, P942, DOI 10.1016/S0140-6736(20)30600-0; Grillet ME, 2019, LANCET INFECT DIS, V19, pE149, DOI 10.1016/S1473-3099(18)30757-6; Henriquez G., 2020, PRUEBAS R PIDAS COVI; Hernandez E., 2020, EL NACIONAL; Herrero AV, 2020, WASH POST; Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005423; Joshi A, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/984626; Lana RM, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00019620, 10.1590/0102-311x00019620]; Lee CCM, 2020, ANAESTHESIA, V75, P861, DOI 10.1111/anae.15074; Litewka SG, 2020, DEV WORLD BIOETH, V20, P69, DOI 10.1111/dewb.12262; Ma QX, 2020, J MED VIROL, V92, P1567, DOI 10.1002/jmv.25805; Mareiniss DP, 2020, AM J EMERG MED, V38, P1293, DOI 10.1016/j.ajem.2020.03.033; McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4; Mlenga DH, 2016, JAMBA-J DISASTER RIS, V8, DOI 10.4102/jamba.v8i2.183; Nagata JM, 2020, J ADOLESCENT HEALTH, V67, P297, DOI 10.1016/j.jadohealth.2020.04.020; Ncube A, 2016, JAMBA-J DISASTER RIS, V8, DOI 10.4102/jamba.v8i2.164; Oliveiros A., 2020, VENEZUELA SHOULD THI; Page KR, 2019, LANCET, V393, P1254, DOI 10.1016/S0140-6736(19)30344-7; PAHO, VEN NEIGHB COUNTR I; Paniz-Mondolfi AE, 2019, EMERG INFECT DIS, V25, P625, DOI 10.3201/eid2504.181305; Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033; Rendon M., 2020, COVID 19 VEN PAND DE; Reuters Staff, 2020, REUTERS STAFF; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101613; Sequera V., 2020, REUTERS; Sheeran P, 2016, HEALTH PSYCHOL, V35, P1178, DOI 10.1037/hea0000387; Smith S., 2020, VENEZUELAS APPARENT; Sommer P, 2020, ANESTH ANALG, V131, P55, DOI 10.1213/ANE.0000000000004830; Stam HJ, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2677; Stratton SJ, 2020, PREHOSP DISASTER MED, V35, P119, DOI 10.1017/S1049023X2000031X; Suarez JA, 2019, INF DIS SOC EC POL; Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077; Van Praag O, CRISIS CRISIS VENEZU; Vasquez A, 2020, HARD KNOCK LIFE GETS; Wahed T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-242; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249022	10.1371/journal.pone.0249022	http://dx.doi.org/10.1371/journal.pone.0249022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857159	Green Published, gold			2022-12-26	WOS:000641474900105
J	Buys, B; Derycke, S; De Meester, N; Moens, T				Buys, Bartelijntje; Derycke, Sofie; De Meester, Nele; Moens, Tom			Colonization of macroalgal deposits by estuarine nematodes through air and potential for rafting inside algal structures	PLOS ONE			English	Article							FREE-LIVING MARINE; DISPERSAL DYNAMICS; MOLECULAR ANALYSIS; GENETIC-STRUCTURE; SPECIES COMPLEX; WIND DISPERSAL; MEIOFAUNA; PATTERNS; INVERTEBRATES; TRANSPORT	Dispersal is an important life-history trait. In marine meiofauna, and particularly in nematodes, dispersal is generally considered to be mainly passive, i.e. through transport with water currents and bedload transport. Because nematodes have no larval dispersal stage and have a poor swimming ability, their per capita dispersal capacity is expected to be limited. Nevertheless, many marine nematode genera and even species have near-cosmopolitan distributions, and at much smaller spatial scales, can rapidly colonise new habitat patches. Here we demonstrate that certain marine nematodes, like the morphospecies Litoditis marina, can live inside macroalgal structures such as receptacula and-to a lesser extent-floating bladders, which may allow them to raft over large distances with drifting macroalgae. We also demonstrate for the first time that these nematodes can colonize new habitat patches, such as newly deposited macroalgal wrack in the intertidal, not only through seawater but also through air. Our experimental set-up demonstrates that this aerial transport is probably the result of hitchhiking on vectors such as insects, which visit, and move between, the patches of deposited algae. Transport by wind, which has been observed for terrestrial nematodes and freshwater zooplankton, could not be demonstrated. These results can be important for our understanding of both large-scale geographic distribution patterns and of the small-scale colonization dynamics of habitat patches by marine nematodes.	[Buys, Bartelijntje; Derycke, Sofie; De Meester, Nele; Moens, Tom] Univ Ghent, Dept Biol, Marine Biol Lab, Ghent, Belgium; [Derycke, Sofie; De Meester, Nele] Univ Ghent, Ctr Mol Phylogeny & Evolut, Ghent, Belgium; [Derycke, Sofie] Res Inst Agr Fisheries & Food, Aquat Environm & Qual, Oostende, Belgium	Ghent University; Ghent University; Institute For Agricultural & Fisheries Research	Moens, T (corresponding author), Univ Ghent, Dept Biol, Marine Biol Lab, Ghent, Belgium.	tom.moens@ugent.be		Buys, Bartelijntje/0000-0002-6970-9793	Flemish Science Fund FWO [G038715N]	Flemish Science Fund FWO(FWO)	Financial support for this work was obtained from the Flemish Science Fund FWO through project nr. G038715N, awarded to T.M. and S.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.fwo.be/	ALKEMADE R, 1994, MAR ECOL PROG SER, V105, P277, DOI 10.3354/meps105277; Arroyo NL, 2006, HYDROBIOLOGIA, V554, P83, DOI 10.1007/s10750-005-1008-5; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BAUJARD P, 1994, FUND APPL NEMATOL, V17, P543; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Boeye J, 2013, EVOL APPL, V6, P353, DOI 10.1111/eva.12004; Buys B, 2014, DISPERSAL MARINE NEM; CARROLL JJ, 1981, J NEMATOL, V13, P476; Chitwood B, 1970, ZESZYTY PROBLEMOWE P, V92; Chizhov Vladimir N., 1996, Russian Journal of Nematology, V4, P185; COMMITO JA, 1995, ECOL MONOGR, V65, P1, DOI 10.2307/2937157; Commito JA, 1995, LIMNOL OCEANOGR, V40, P1513, DOI 10.4319/lo.1995.40.8.1513; Commito JA, 2002, J EXP MAR BIOL ECOL, V268, P237, DOI 10.1016/S0022-0981(01)00386-0; Commito JA, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11010011; De Grisse A.T., 1969, MEDEDELINGEN RIJKSFA, V34, P351, DOI DOI 10.1163/156854199508559; De Meester N, 2018, MAR ECOL PROG SER, V600, P71, DOI 10.3354/meps12658; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Derycke S, 2007, LIMNOL OCEANOGR, V52, P992, DOI 10.4319/lo.2007.52.3.0992; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2012, MOL ECOL RESOUR, V12, P607, DOI 10.1111/j.1755-0998.2012.03128.x; Derycke S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-1; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; dos Santos GAP, 2009, MAR BIOL, V156, P629, DOI 10.1007/s00227-008-1114-9; Eng MS, 2005, J INVERTEBR PATHOL, V88, P173, DOI 10.1016/j.jip.2004.11.005; ESKIN RA, 1985, BIOL BULL, V169, P615, DOI 10.2307/1541303; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Giere O., 2008, MEIOBENTHOLOGY MICRO; Goecke F, 2013, PHYCOLOGIA, V52, P14, DOI 10.2216/12-24.1; Goecke F, 2012, GAYANA BOT, V69, P376, DOI 10.4067/S0717-66432012000200016; Green AJ, 2008, FRESHWATER BIOL, V53, P380, DOI 10.1111/j.1365-2427.2007.01901.x; Ingels J, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12050203; INGLIS WILLIAM G., 1961, BULL BRIT MUS [NAT HIST] ZOOL, V7, P320; JENSEN P, 1981, MAR ECOL PROG SER, V4, P203, DOI 10.3354/meps004203; Jorger KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-245; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Guden RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204750; Micoletsky H., 1922, Mitteil Zool Staatsinst Zool Mus (Jahrb Hamburg wiss Anst) Hamburg, V39, P1; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P137, DOI 10.1016/S0022-0981(99)00114-8; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Moens T., 2018, MUDFLAT ECOLOGY, P91, DOI DOI 10.1007/978-3-319-99194-8_5; Moens T, 2014, HBK ZOOL, P109; Nkem JN, 2006, POLAR BIOL, V29, P346, DOI 10.1007/s00300-005-0061-x; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; PALMER MA, 1988, ECOLOGY, V69, P1251, DOI 10.2307/1941280; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Ptatscheck C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24747-8; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Sarkar D, 2020, **DATA OBJECT**; Steel H, 2013, INVERTEBR BIOL, V132, P108, DOI 10.1111/ivb.12020; SUDHAUS W, 1974, Faunistisch-Oekologische Mitteilungen, V4, P365; Sudhaus W., 2008, ADV ARACHNOL DEV BIO, V12, P143; Sudhaus W, 2011, NEMATOLOGY, V13, P61, DOI 10.1163/138855410X500334; Temmerman S, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2005JF000301; Thomas MC, 2011, ZOOLOGIA-CURITIBA, V28, P449, DOI 10.1590/S1984-46702011000400006; Todaro MA, 1996, MAR BIOL, V125, P735, DOI 10.1007/BF00349256; Ullberg J, 2003, MAR ECOL PROG SER, V260, P141, DOI 10.3354/meps260141; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Viglierchio D.R., 1981, Nematologia Mediterranea, V9, P111; VRANKEN G, 1983, NEMATOLOGICA, V29, P468, DOI 10.1163/187529283X00348; Walters K, 1996, J EXP MAR BIOL ECOL, V195, P251, DOI 10.1016/0022-0981(95)00103-4; Winston JE, 2012, INTEGR COMP BIOL, V52, P447, DOI 10.1093/icb/ics040; Yamasaki H, 2014, ZOOL SCI, V31, P421, DOI 10.2108/zs140011; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448	68	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0246723	10.1371/journal.pone.0246723	http://dx.doi.org/10.1371/journal.pone.0246723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857148	Green Published			2022-12-26	WOS:000641474900107
J	Goncalves, P; Saez-Lopez, E; Carneiro, S; Simoes, MJ				Goncalves, Paulo; Saez-Lopez, Emma; Carneiro, Sofia; Simoes, Maria Joao			Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme	PLOS ONE			English	Article							CARRIAGE; AGE	Background The incidence of invasive meningococcal disease due to serogroup C (MenC) decreased in Portugal since the introduction of the conjugate vaccine (MCC) in the free market in 2001 and in the National Immunisation Plan in 2006. Considering the potential waning of the antibody response reported in the literature, the different vaccination schemes that were used in our country over the past decade, and that Neisseria meningitidis serogroup C continues to circulate, the Portuguese population may currently be at increased risk of infection. In the absence of national data, we evaluated the seroprotection level of the Portuguese population against MenC, in order to identify the protected fraction of the population and ponder on the necessity of a booster dose of the MCC vaccine. Methods We measured serum bactericidal antibody levels against MenC in a representative sample of the population (n = 1500) aged 2-64 years who participated in the 2015/2016 National Serological Survey. Results A total of 31.1% (466/1500, 95%CI: 29-33%) of the individuals studied were protected against MenC. The geometric mean titre was 6.5. The proportion of seroprotected was particularly low in children aged 2-4 years (<16%) who received a single dose of the vaccine at 12 months of age (vaccination strategy since 2012). The proportion of seroprotected was higher (44.7% to 53.5%) in adolescent and young adults (15-24 years of age), resulting from vaccination during the catch-up campaign at 5-15 years of age. The highest protection rates were observed when the vaccine was administered during adolescence. Conclusion The small fraction of population seroprotected, combined with the already known waning effect of the antibody response over time, may indicate that the Portuguese population will become progressively more exposed to the risk of infection. Taking in consideration our results, we recommend to change the current vaccination strategy and introduce a booster dose of the MCC vaccine during adolescence.	[Goncalves, Paulo; Carneiro, Sofia; Simoes, Maria Joao] Natl Inst Hlth Doutor Ricardo Jorge, Lisbon, Portugal; [Goncalves, Paulo; Saez-Lopez, Emma] European Ctr Dis Prevent & Control, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden	Instituto Nacional de Saude Dr. Ricardo Jorge; European Centre for Disease Prevention & Control	Goncalves, P (corresponding author), Natl Inst Hlth Doutor Ricardo Jorge, Lisbon, Portugal.; Goncalves, P (corresponding author), European Ctr Dis Prevent & Control, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden.	paulo.goncalves@insa.min-saude.pt		GONCALVES, PAULO/0000-0002-4633-6306	National Institute of Health Doutor Ricardo Jorge, Lisboa, Portugal; GlaxoSmithKline	National Institute of Health Doutor Ricardo Jorge, Lisboa, Portugal; GlaxoSmithKline(GlaxoSmithKline)	National Institute of Health Doutor Ricardo Jorge, Lisboa, Portugal, and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; Centers for Disease Control and Prevention, CHAPTER 8 MENINGOCOC; Chandra M., 2006, INVASIVE NEISSERIA M; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Christodoulides Myron, 2002, P1; Coureuil M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012393; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; DGS and INSA, 2007, DGS DOCUMENTOS PUBLI; Direcao-Geral da Saude, 2005, DGS DOCUMENTOS PUBLI; Direcao-Geral da Saude, 2012, PROGRAMA NACL VACINA; Direcao-Geral da Saude, 2012, NORMA 0402011 PROGRA; ECDC, SURV ATL INF DIS; ECDC, 2019, INV MEN DIS ANN EP R; ECDC, INVASIVE MENINGICOCC; Findlow H, 2019, EUROSURVEILLANCE, V24, P17, DOI 10.2807/1560-7917.ES.2019.24.1.1700818; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Granoff DM, 2007, PEDIATR INFECT DIS J, V26, P716, DOI 10.1097/INF.0b013e3180cc2c25; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Heymann DL, 2008, CONTROL COMMUNICABLE; Instituto Nacional de Saude Doutor Ricardo Jorge, 2017, INQU RITO SEROL GICO; Ishola DA, 2012, CLIN VACCINE IMMUNOL, V19, P1126, DOI 10.1128/CVI.05655-11; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Martins M. M., 2020, TECNOLOGIAS UTILIZAD; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; NASSIF X, 1995, CLIN MICROBIOL REV, V8, P376, DOI 10.1128/CMR.8.3.376; Pelton SI, 2016, J ADOLESCENT HEALTH, V59, pS3, DOI 10.1016/j.jadohealth.2016.04.012; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Safadi MA, 2015, EXPERT REV VACCINES, V14, P505, DOI 10.1586/14760584.2015.979799; Taha Muhamed-Kheir, 2002, P39; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250103	10.1371/journal.pone.0250103	http://dx.doi.org/10.1371/journal.pone.0250103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857245	Green Published, gold			2022-12-26	WOS:000641474900052
J	Murakami, M; Murakami, AM; Matsuzaki, Y; Sawamura, D; Ohba, T; Miyoshi, I; Itagaki, S; Sakagami, H				Murakami, Manabu; Murakami, Agnieszka M.; Matsuzaki, Yasushi; Sawamura, Daisuke; Ohba, Takayoshi; Miyoshi, Ichirou; Itagaki, Shirou; Sakagami, Hiroyuki			Attenuated beta-adrenergic response in calcium/calmodulin-dependent protein kinase IV-knockout mice	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; BINDING PROTEIN; EXPRESSION; IDENTIFICATION; CALCINEURIN; CHANNELS; MEMORY; GR	In the present study, we examined the importance of Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) in the regulation of cardiac function using genetically modified CaMKIV-null mice. RT-PCR analysis revealed decreased expression of voltage-dependent calcium channels in the cardiac myocytes of CaMKIV-null mice compared with wild-type mice. CaMKIV-null mice showed shortened QT time on electrocardiograms. Pharmacological analysis revealed decreased responsiveness to the beta-adrenergic blocker propranolol in CaMKIV-null mice, whereas the plasma norepinephrine level was not affected. CaMKIV-null mice showed decreased baroreflex on electrocardiograms. Heart rate variability analysis showed unstable R-R intervals, a decreased low frequency power/high frequency power (LF/HF) ratio, and increased standard deviation of the normal to normal R-R intervals (SDNN) in CaMKIV-null mice, suggesting decreased responsiveness to beta-adrenergic stimulation in CaMKIV-null mice. Atrial contraction analysis and cardiac action potential recording showed a decreased response to the beta-adrenoceptor agonist isoproterenol in CaMKIV-null mice. Furthermore, fluorescence imaging in a CRE-hrGFP assay revealed a decreased response to isoproterenol in CaMKIV-null cardiac myocytes. Taken together, our data strongly suggest a significant effect of CaMKIV gene ablation on cardiac beta-adrenergic signal transduction.	[Murakami, Manabu; Murakami, Agnieszka M.] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori, Japan; [Matsuzaki, Yasushi; Sawamura, Daisuke] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan; [Ohba, Takayoshi] Akita Univ, Dept Cell Physiol, Sch Med, Akita, Japan; [Miyoshi, Ichirou] Tohoku Univ, Dept Anim Care, Sch Med, Aoba Ku, Sendai, Miyagi, Japan; [Itagaki, Shirou] Sapporo Med Univ, Collaborat Ctr Community & Ind, Sapporo, Hokkaido, Japan; [Sakagami, Hiroyuki] Kitasato Univ, Dept Anat, Sch Med, Sagamihara, Kanagawa, Japan	Hirosaki University; Hirosaki University; Akita University; Tohoku University; Sapporo Medical University; Kitasato University	Murakami, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori, Japan.	mmura0123@hotmail.co.jp		murakami, manabu/0000-0001-6704-1796	JSPS, KAKENHI [25460293, 17K08527, 17H04319]	JSPS, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was sponsored in part by Grants-in-Aid for Scientific Research from JSPS, KAKENHI (25460293 (MM), 17K08527 (KH), and 17H04319(MM)). There was no additional external funding received for this study.	Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bisserier M, 2015, CIRCULATION, V131, P390, DOI 10.1161/CIRCULATIONAHA.114.010686; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P17592; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P11309; Fukushima H, 2008, J NEUROSCI, V28, P9910, DOI 10.1523/JNEUROSCI.2625-08.2008; Grandi E, 2017, J PHYSIOL-LONDON, V595, P2209, DOI 10.1113/JP272864; GRUVER CL, 1993, ENDOCRINOLOGY, V133, P376, DOI 10.1210/en.133.1.376; Han C, 2016, BIOCHEM BIOPH RES CO, V469, P897, DOI 10.1016/j.bbrc.2015.12.057; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; LAPOINTE MC, 1990, HYPERTENSION, V15, P20, DOI 10.1161/01.HYP.15.1.20; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; Murakami M, 2003, J BIOL CHEM, V278, P43261, DOI 10.1074/jbc.M211380200; Murakami M, 2014, BIOL PHARM BULL, V37, P834, DOI 10.1248/bpb.b14-00012; Murakami Manabu, 2008, J Biol Chem, V283, P24554, DOI 10.1074/jbc.M802319200; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; Routledge HC, 2002, J CLIN PHARM THER, V27, P85, DOI 10.1046/j.1365-2710.2002.00404.x; SEI CA, 1991, J BIOL CHEM, V266, P15910; Seya K., 2017, HIROSAKI MED J, V67, P147; Song N, 2013, INT J NEUROPSYCHOPH, V16, P803, DOI 10.1017/S1461145712000570; SONNENBERG H, 1986, FED PROC, V45, P2106; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; Wu TW, 2006, PHARMACOLOGY, V76, P170, DOI 10.1159/000091495	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249932	10.1371/journal.pone.0249932	http://dx.doi.org/10.1371/journal.pone.0249932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857227	gold, Green Published			2022-12-26	WOS:000641474900026
J	Nkansah, C; Addai-Mensah, O; Mensah, K; Owusu, M; Ephraim, RKD; Adu, P; Osei-Boakye, F; Appiah, SK; Serwaa, D; Derigubah, CA; Debrah, AY				Nkansah, Charles; Addai-Mensah, Otchere; Mensah, Kofi; Owusu, Michael; Ephraim, Richard K. D.; Adu, Patrick; Osei-Boakye, Felix; Appiah, Samuel K.; Serwaa, Dorcas; Derigubah, Charles A.; Debrah, Alexander Yaw			Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; 4G/5G POLYMORPHISM; ADIPOSE-TISSUE; OBESE PATIENTS; PAI-1 LEVELS; EXPRESSION; GENE; ASSOCIATION; PROMOTER; RISK	Background Hypofibrinolysis resulting from the up-regulation of plasminogen activator inhibitor-1 (PAI-1) usually occurs in patients with type 2 diabetes mellitus (T2DM), rendering them hypercoagulable. This study assessed the plasma antigen and activity levels of the PAI-1 enzyme in T2DM patients in a district hospital in Ghana. Methods This was a hospital-based case-control study conducted from December 2018 to May 2019 at Nkenkaasu District Hospital. Sixty subjects with T2DM (30 T2DM subjects with good glycemic control and 30 with poor glycemic control), and 30 apparently healthy blood donors were recruited into the study. Blood specimens were collected for complete blood count, lipid profile, PAI-1 Ag and PAI-1 activity levels. A pre-tested questionnaire was used to obtain demographic and clinical information. The data was analyzed using SPSS version 22.0. Results Elevated PAI-1 Ag and activity levels were observed in the T2DM subjects compared to the healthy controls, with the levels and activity significantly higher (PAI-1 Ag; p< 0.001, PAI-1 activity level; p = 0.004) in the T2DM subjects with poor glycemic control in comparison to those with good glycemic control. A significant positive correlation was observed between HbA1c and PAI-1 enzymes. PAI-1 Ag levels significantly increased along with increased total cholesterol (Beta = 0.262, p = 0.033), triglyceride (Beta = -0.273, p = 0.034) and HbA1c (Beta = 0.419, p = 0.001). Similarly, PAI-1 activity level was associated with total cholesterol (Beta = 0.325, p = 0.009), triglyceride (Beta = -0.262, p = 0.042), HbA1c (Beta = 0.389, p = 0.003) and VLDL-c (Beta = -0.227, p = 0.029). Conclusion PAI-1 antigen/activity is enhanced in poorly controlled Ghanaian T2DM subjects. The hypercoagulable state of the affected individuals put them at higher risk of developing cardiovascular diseases. Good glycemic control to regulate plasma PAI-1 levels is essential during T2DM lifelong management. Markers of fibrinolysis should be assessed in these individuals and appropriate anticoagulants given to prevent thrombosis and adverse cardiovascular diseases.	[Nkansah, Charles; Addai-Mensah, Otchere; Mensah, Kofi; Owusu, Michael; Osei-Boakye, Felix; Appiah, Samuel K.; Derigubah, Charles A.; Debrah, Alexander Yaw] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Med Diagnost, Kumasi, Ghana; [Nkansah, Charles] Nkenkaasu Dist Hosp, Clin Lab Dept, Nkenkaasu, Ghana; [Mensah, Kofi] Komfo Anokye Teaching Hosp, Clin Lab Dept, Kumasi, Ghana; [Ephraim, Richard K. D.; Adu, Patrick] Univ Cape Coast, Fac Allied Hlth Sci, Dept Med Lab Technol, Cape Coast, Ghana; [Osei-Boakye, Felix] Mankranso Dist Hosp, Clin Lab Dept, Mankranso, Ghana; [Appiah, Samuel K.] Wenchi Methodist Hosp, Clin Lab Dept, Wenchi, Ghana; [Serwaa, Dorcas] Univ Ibadan, Pan African Univ Life & Earth Sci Inst PAULESI, Coll Med, Dept Obstet & Gynaecol,Reprod Biol Unit, Ibadan, Nigeria; [Derigubah, Charles A.] Tamale Teaching Hosp, Clin Lab Dept, Tamale, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; University of Cape Coast; University of Ibadan	Serwaa, D (corresponding author), Univ Ibadan, Pan African Univ Life & Earth Sci Inst PAULESI, Coll Med, Dept Obstet & Gynaecol,Reprod Biol Unit, Ibadan, Nigeria.	dserwaa0327@stu.ui.edu.ng	Osei-Boakye, Felix/N-5254-2017; Ephraim, Richard KD/X-3000-2019; Adu, Patrick/A-7384-2017	Osei-Boakye, Felix/0000-0001-5126-7424; Adu, Patrick/0000-0002-9686-8300; SERWAA, DORCAS/0000-0001-8583-4415				Abutaleb MH, 2016, PHARM PHARM INT J, V4, P406, DOI [10.15406/ppij.2016.04.00087, DOI 10.15406/PPIJ.2016.04.00087, 10.15406/ ppij.2016.04.00087]; Addai-Mensah O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223171; Aso Y, 2002, METABOLISM, V51, P471, DOI 10.1053/meta.2002.31334; Bastard JP, 2000, INT J OBESITY, V24, P70, DOI 10.1038/sj.ijo.0801087; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Charlton P, 1997, Expert Opin Investig Drugs, V6, P539, DOI 10.1517/13543784.6.5.539; Cheneke Waqtola, 2016, BMC Res Notes, V9, P96, DOI 10.1186/s13104-016-1921-x; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Chudy P, 2011, BLOOD COAGUL FIBRIN, V22, P493, DOI 10.1097/MBC.0b013e328346f8ca; El Sayed ZH., 2018, ARCH INT PHARMACOD T, V2, P252; Ephraim Richard Kd, 2017, Ghana Med J, V51, P101, DOI 10.4314/gmj.v51i3.2; Gatimu SM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3845-8; Gazioglu SB, 2015, INT J CLIN EXP PATHO, V8, P15919; Ghana Statistical Service, 2014, 2010 POPULATION HOUS, P1109, DOI [10.1371/journal.pone.0104053, DOI 10.1371/JOURNAL.PONE.0104053]; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hafer-Macko CE, 2007, NEUROLOGY, V69, P268, DOI 10.1212/01.wnl.0000266391.20707.83; Hoekstra T, 2004, THROMB HAEMOSTASIS, V91, P861, DOI 10.1160/TH03-08-0546; Hoffstedt J, 2002, DIABETOLOGIA, V45, P584, DOI 10.1007/s00125-001-0774-5; Ida S, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0773-1; IDF ADF. IDF, 2017, BELGIUM INT DIABETES; Iida K, 2017, CORONARY ARTERY DIS, V28, P577, DOI 10.1097/MCA.0000000000000521; Jabeen F, 2013, INT J ADV RES, V1, P322; Karim F, 2015, J BANGLADESH SOC PHY, V10, P26, DOI [10.3329/jbsp.v10i1.24614, DOI 10.3329/JBSP.V10I1.24614]; KIRKENDALL WM, 1967, CIRCULATION, V36, P980, DOI 10.1161/01.CIR.36.6.980; Krebs M, 2003, THROMB HAEMOSTASIS, V90, P422, DOI 10.1160/TH03-07-0457; LATRON Y, 1991, ARTERIOSCLER THROMB, V11, P1821, DOI 10.1161/01.ATV.11.6.1821; Luo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36687; Mavri A, 2001, DIABETOLOGIA, V44, P2025, DOI 10.1007/s001250100007; McCormack LJ, 1998, THROMB RES, V92, P199, DOI 10.1016/S0049-3848(98)00132-7; Menges T, 2001, LANCET, V357, P1096, DOI 10.1016/S0140-6736(00)04311-7; Olufadi R, 2006, PATHOPHYSIOL HAEMO T, V35, P281, DOI 10.1159/000093221; Pandolfi A, 1996, DIABETOLOGIA, V39, P1425, DOI 10.1007/s001250050594; Piazza G, 2012, AM J MED, V125, P709, DOI 10.1016/j.amjmed.2011.12.004; Sartori MT, 2001, THROMB HAEMOSTASIS, V86, P1161; Scarabin PY, 1998, THROMB HAEMOSTASIS, V80, P749; Soares Anna Letícia, 2010, Rev. Bras. Hematol. Hemoter., V32, P482, DOI 10.1590/S1516-84842010000600013; Stegenga ME, 2008, DIABETIC MED, V25, P157, DOI 10.1111/j.1464-5491.2007.02348.x; Xu L, 2011, CLIN ENDOCRINOL, V74, P528, DOI 10.1111/j.1365-2265.2010.03948.x; Zhang HF, 2014, INT J CLIN EXP MED, V7, P3777; Zhang JY, 1998, ARTERIOSCL THROM VAS, V18, P1140, DOI 10.1161/01.ATV.18.7.1140	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250090	10.1371/journal.pone.0250090	http://dx.doi.org/10.1371/journal.pone.0250090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857223	gold, Green Published			2022-12-26	WOS:000641474900119
J	Baker, S; Xiang, W; Atkinson, I				Baker, Stephanie; Xiang, Wei; Atkinson, Ian			Determining respiratory rate from photoplethysmogram and electrocardiogram signals using respiratory quality indices and neural networks	PLOS ONE			English	Article							EARLY WARNING SCORE; DERIVATION; ARREST	Continuous and non-invasive respiratory rate (RR) monitoring would significantly improve patient outcomes. Currently, RR is under-recorded in clinical environments and is often measured by manually counting breaths. In this work, we investigate the use of respiratory signal quality quantification and several neural network (NN) structures for improved RR estimation. We extract respiratory modulation signals from the electrocardiogram (ECG) and photoplethysmogram (PPG) signals, and calculate a possible RR from each extracted signal. We develop a straightforward and efficient respiratory quality index (RQI) scheme that determines the quality of each moonddulation-extracted respiration signal. We then develop NNs for the estimation of RR, using estimated RRs and their corresponding quality index as input features. We determine that calculating RQIs for modulation-extracted RRs decreased the mean absolute error (MAE) of our NNs by up to 38.17%. When trained and tested using 60-sec waveform segments, the proposed scheme achieved an MAE of 0.638 breaths per minute. Based on these results, our scheme could be readily implemented into non-invasive wearable devices for continuous RR measurement in many healthcare applications.	[Baker, Stephanie] James Cook Univ, Coll Sci & Engn, Cairns, Qld, Australia; [Xiang, Wei] La Trobe Univ, Sch Engn & Math Sci, Melbourne, Vic, Australia; [Atkinson, Ian] James Cook Univ, eRes Ctr, Townsville, Qld, Australia	James Cook University; La Trobe University; James Cook University	Baker, S (corresponding author), James Cook Univ, Coll Sci & Engn, Cairns, Qld, Australia.	stephanie.baker@jcu.edu.au	Baker, Steph/AAQ-9898-2021	Baker, Stephanie/0000-0003-0467-7791; Atkinson, Ian/0000-0002-2295-6818; Xiang, Wei/0000-0002-0608-065X	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by the Australian Government Research Training Program Scholarship.	[Anonymous], 2010, CAPNOBASE SIGNAL DAT; Ansell Helen, 2014, Br J Nurs, V23, P414; Birrenkott DA, 2018, IEEE T BIO-MED ENG, V65, P2033, DOI 10.1109/TBME.2017.2778265; Birrenkott DA, 2016, IEEE ENG MED BIO, P676, DOI 10.1109/EMBC.2016.7590792; Bureau of Labor Statistics, 2014, OCCUPATIONAL EMPLOYM; Charlton Peter H, 2018, IEEE Rev Biomed Eng, V11, P2, DOI 10.1109/RBME.2017.2763681; Coffey T., 2016, 1 AID MANUAL, V9th ed; FIESELMANN JF, 1993, J GEN INTERN MED, V8, P354, DOI 10.1007/BF02600071; Ginsburg AS, 2018, AM J RESP CRIT CARE, V197, P1116, DOI 10.1164/rccm.201711-2233CI; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldhill DR, 2005, ANAESTHESIA, V60, P547, DOI 10.1111/j.1365-2044.2005.04186.x; Hendrich Ann, 2008, Perm J, V12, P25; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hodgetts TJ, 2002, RESUSCITATION, V54, P125, DOI 10.1016/S0300-9572(02)00100-4; Hogan Jacqueline, 2006, Br J Nurs, V15, P489; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Karlen W, 2015, IEEE J BIOMED HEALTH, V19, P1331, DOI 10.1109/JBHI.2015.2429746; Karlen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099266; Khreis S, 2020, IEEE T BIO-MED ENG, V67, P893, DOI 10.1109/TBME.2019.2923448; King DB, 2015, ACS SYM SER, V1214, P1; McBride J, 2005, RESUSCITATION, V65, P41, DOI 10.1016/j.resuscitation.2004.10.015; Mochizuki K, 2017, ACUTE MED SURG, V4, P172, DOI 10.1002/ams2.252; Orphanidou C, 2017, COMPUT BIOL MED, V81, P45, DOI 10.1016/j.compbiomed.2016.12.005; Orphanidou C, 2015, IEEE J BIOMED HEALTH, V19, P832, DOI 10.1109/JBHI.2014.2338351; Philip Keir, 2013, Br J Nurs, V22, P570; Pimentel MAF, 2017, IEEE T BIO-MED ENG, V64, P1914, DOI 10.1109/TBME.2016.2613124; Pirhonen M, 2020, BIOMED SIGNAL PROCES, V59, DOI 10.1016/j.bspc.2020.101887; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; SILVA I, 2014, J OPEN RES SOFTW, V0002; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x; Talley N., 2014, CLIN EXAMINATION SYS, Vseventh	31	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249843	10.1371/journal.pone.0249843	http://dx.doi.org/10.1371/journal.pone.0249843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831075	Green Accepted, Green Published, gold			2022-12-26	WOS:000639359600074
J	Luo, Y; McAuley, DF; Fulton, CR; Pessoa, JS; McMullan, R; Lundy, FT				Luo, Yu; McAuley, Daniel F.; Fulton, Catherine R.; Pessoa, Joana Sa; McMullan, Ronan; Lundy, Fionnuala T.			Targeting Candida albicans in dual-species biofilms with antifungal treatment reduces Staphylococcus aureus and MRSA in vitro	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; COLONIZATION; INFECTION; PCR; SUSCEPTIBILITY; VIRULENCE; EFFICACY; FARNESOL; ADHESION; HYPHAE	Polymicrobial biofilms consisting of fungi and bacteria are frequently formed on endotracheal tubes and may contribute to development of ventilator associated pneumonia (VAP) in critically ill patients. This study aimed to determine the role of early Candida albicans biofilms in supporting dual-species (dual-kingdom) biofilm formation with respiratory pathogens in vitro, and investigated the effect of targeted antifungal treatment on bacterial cells within the biofilms. Dual-species biofilm formation between C. albicans and three respiratory pathogens commonly associated with VAP (Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus) was studied using quantitative PCR. It was shown that early C. albicans biofilms enhanced the numbers of E. coli and S. aureus (including methicillin resistant S. aureus; MRSA) but not P. aeruginosa within dual-species biofilms. Transwell assays demonstrated that contact with C. albicans was required for the increased bacterial cell numbers observed. Total Internal Reflection Fluorescence microscopy showed that both wild type and hyphal-deficient C. albicans provided a scaffold for initial bacterial adhesion in dual species biofilms. qPCR results suggested that further maturation of the dual-species biofilm significantly increased bacterial cell numbers, except in the case of E.coli with hyphal-deficient C. albicans (Ca_gcn5 Delta/Delta). A targeted preventative approach with liposomal amphotericin (AmBisome (R)) resulted in significantly decreased numbers of S. aureus in dual-species biofilms, as determined by propidium monoazide-modified qPCR. Similar results were observed when dual-species biofilms consisting of clinical isolates of C. albicans and MRSA were treated with liposomal amphotericin. However, reductions in E. coli numbers were not observed following liposomal amphotericin treatment. We conclude that early C. albicans biofilms have a key supporting role in dual-species biofilms by enhancing bacterial cell numbers during biofilm maturation. In the setting of increasing antibiotic resistance, an important and unexpected consequence of antifungal treatment of dual-species biofilms, is the additional benefit of decreased growth of multi-drug resistant bacteria such as MRSA, which could represent a novel future preventive strategy.	[Luo, Yu; McAuley, Daniel F.; Fulton, Catherine R.; Pessoa, Joana Sa; McMullan, Ronan; Lundy, Fionnuala T.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [McAuley, Daniel F.] Belfast Hlth & Social Care Trust, Royal Victoria Hosp, Reg Intens Care Unit, Belfast, Antrim, North Ireland	Queens University Belfast	Lundy, FT (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland.	f.lundy@qub.ac.uk	Sa-Pessoa, Joana/AAA-7759-2022	Sa Pessoa, Joana/0000-0002-0038-2120; Lundy, Fionnuala/0000-0003-3150-1150	Queen's University Belfast International PhD Scholarship; Health and Social Care Research and Development Office, Northern Ireland	Queen's University Belfast International PhD Scholarship; Health and Social Care Research and Development Office, Northern Ireland	This work was supported by a Queen's University Belfast International PhD Scholarship (YL) and by the Health and Social Care Research and Development Office, Northern Ireland (RMcM, DFMcA, FTL). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2006, CHEST, V129, P110, DOI 10.1378/chest.129.1.110; Bandara HMHN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-125; Billard-Pomares T, 2011, J MED MICROBIOL, V60, P157, DOI 10.1099/jmm.0.023838-0; Bor B, 2016, SCI REP-UK, V6, DOI 10.1038/srep27956; Brand A, 2008, FEMS MICROBIOL LETT, V287, P48, DOI 10.1111/j.1574-6968.2008.01301.x; Cairns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014759; CARLSON E, 1983, INFECT IMMUN, V42, P285, DOI 10.1128/IAI.42.1.285-292.1983; CARLSON E, 1983, INFECT IMMUN, V39, P193, DOI 10.1128/IAI.39.1.193-197.1983; Chauvel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045912; Danin PE, 2015, RESP CARE, V60, P21, DOI 10.4187/respcare.02722; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Donnelly L, 2017, PHARM RES-DORDR, V34, P1469, DOI 10.1007/s11095-017-2164-9; Ducas-Mowchun K, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00066-19; Filkins LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005258; Gil-Bona A, 2015, J PROTEOMICS, V127, P340, DOI 10.1016/j.jprot.2015.06.006; Gil-Perotin S, 2012, CRIT CARE, V16, DOI 10.1186/cc11357; Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0; Guennoc CM, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy093; Harriott MM, 2010, ANTIMICROB AGENTS CH, V54, P3746, DOI 10.1128/AAC.00573-10; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Hellyer TP, 2015, THORAX, V70, P41, DOI 10.1136/thoraxjnl-2014-205766; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Hola V, 2010, FEMS IMMUNOL MED MIC, V59, P525, DOI 10.1111/j.1574-695X.2010.00703.x; Jabra-Rizk MA, 2006, FEMS YEAST RES, V6, P1063, DOI 10.1111/j.1567-1364.2006.00121.x; Jenkinson HF., 2002, INTERACTIONS CANDIDA, P357; Kabak E, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4367-7; Kalan L, 2016, MBIO, V7, DOI [10.1128/mBio.01058-16, 10.1128/mbio.01058-16]; Kean R, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.00258; Kong EF, 2015, INFECT IMMUN, V83, P604, DOI 10.1128/IAI.02843-14; Krause J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135404; Kruger W, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8020070; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Kuroda M, 2007, FEMS MICROBIOL LETT, V273, P28, DOI 10.1111/j.1574-6968.2007.00772.x; Lee DH, 2010, J MICROBIOL BIOTECHN, V20, P1463, DOI 10.4014/jmb.1004.04035; Lockhart SR, 1999, J DENT RES, V78, P857, DOI 10.1177/00220345990780040601; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Luo Y, 2017, CHEMBIOCHEM, V18, P111, DOI 10.1002/cbic.201600381; McCall AD, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0094-5; McCoy CP, 2016, MOL PHARMACEUT, V13, P2817, DOI 10.1021/acs.molpharmaceut.6b00402; McDonald RR, 2005, J CLIN MICROBIOL, V43, P6147, DOI 10.1128/JCM.43.12.6147-6149.2005; Negrini TC., 2019, CANDIDA BACTERIAL BI, P119; Nenoff P, 2017, MYCOSES, V60, P552, DOI 10.1111/myc.12620; O'Donnell LE, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov077; Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Pneumatikos IA, 2009, ANESTHESIOLOGY, V110, P673, DOI 10.1097/ALN.0b013e31819868e0; Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13; Ramage G, 2013, ANTIMICROB AGENTS CH, V57, P2369, DOI 10.1128/AAC.02344-12; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Schlecht LM, 2015, MICROBIOL-SGM, V161, P168, DOI 10.1099/mic.0.083485-0; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Shivarathri R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45817-5; Valle J, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00098-19; van Frankenhuyzen JK, 2013, J IND MICROBIOL BIOT, V40, P1251, DOI 10.1007/s10295-013-1319-x	57	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249547	10.1371/journal.pone.0249547	http://dx.doi.org/10.1371/journal.pone.0249547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831044	Green Published, gold			2022-12-26	WOS:000639359600110
J	Kitai, K; Kawaguchi, K; Tomohiro, T; Morita, M; So, T; Imanaka, T				Kitai, Katsuki; Kawaguchi, Kosuke; Tomohiro, Takenori; Morita, Masashi; So, Takanori; Imanaka, Tsuneo			The lysosomal protein ABCD4 can transport vitamin B-12 across liposomal membranes in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURONAL DIFFERENTIATION; EXPRESSION; MATURATION; PHENOTYPES; MODELS; BRAIN	Vitamin B-12 (cobalamin) is an essential micronutrient for human health, and mutation and dysregulation of cobalamin metabolism are associated with serious diseases, such as methylmalonic aciduria and homocystinuria. Mutations in ABCD4 or LMBRD1, which encode the ABC transporter ABCD4 and lysosomal membrane protein LMBD1, respectively, lead to errors in cobalamin metabolism, with the phenotype of a failure to release cobalamin from lysosomes. However, the mechanism of transport of cobalamin across the lysosomal membrane remains unknown. We previously demonstrated that LMBD1 is required for the translocation of ABCD4 from the endoplasmic reticulum to lysosomes. This suggests that ABCD4 performs an important function in lysosomal membrane cobalamin transport. In this study, we expressed human ABCD4 and LMBD1 in methylotrophic yeast and purified them. We prepared ABCD4 and/or LMBD1 containing liposomes loaded with cobalamin and then quantified the release of cobalamin from the liposomes by reverse-phase HPLC. We observed that ABCD4 was able to transport cobalamin from the inside to the outside of liposomes dependent on its ATPase activity and that LMBD1 exhibited no cobalamin transport activity. These results suggest that ABCD4 may be capable of transporting cobalamin from the lysosomal lumen to the cytosol. Furthermore, we examined a series of ABCD4 missense mutations to understand how these alterations impair cobalamin transport. Our findings give insight into the molecular mechanism of cobalamin transport by which ABCD4 involves and its importance in cobalamin deficiency.	[Kitai, Katsuki; Kawaguchi, Kosuke; Tomohiro, Takenori; Morita, Masashi; So, Takanori] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Imanaka, Tsuneo] Hiroshima Int Univ, Fac Pharmaceut Sci, Kure, Japan	University of Toyama	Kawaguchi, K (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Toyama, Japan.	kkawa@pha.u-toyama.ac.jp	So, Takanori/R-6175-2019	So, Takanori/0000-0003-3004-8526; Kawaguchi, Kosuke/0000-0002-5115-7169; Imanaka, Tsuneo/0000-0003-4677-1356	Ministry of Education, Culture, Sports, Science and Technology of Japan [20K15990]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for early-career scientists (20K15990 to Kosuke Kawaguchi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Tamura Science and Technology Foundation (to Kosuke Kawaguchi).	Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Furutachi S, 2013, EMBO J, V32, P970, DOI 10.1038/emboj.2013.50; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Hagihara H, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0522-8; Hagihara Hideo, 2019, Neuropsychopharmacology Reports, V39, P78, DOI 10.1002/npr2.12048; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Imoto Y, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0288-9; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Kang EC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019026; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kobayashi M, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-12; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Nader K, 2019, BRAIN STRUCT FUNCT, V224, P2691, DOI 10.1007/s00429-019-01925-6; Nagashima S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56559-9; Nagashima S, 2011, J BIOL CHEM, V286, P33879, DOI 10.1074/jbc.M111.234997; Oku Y, 2013, J NEUROSCI, V33, P12586, DOI 10.1523/JNEUROSCI.0341-13.2013; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin R, 2013, BIPOLAR DISORD, V15, P405, DOI 10.1111/bdi.12064; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Terashima M, 2010, J NEUROSCI RES, V88, P1387, DOI 10.1002/jnr.22315; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Umemori, 2018, MOL BRAIN, V38; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Xu D, 2019, CELL RES, V29, P1039, DOI 10.1038/s41422-019-0222-z; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542	38	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100654	10.1016/j.jbc.2021.100654	http://dx.doi.org/10.1016/j.jbc.2021.100654			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33845046	gold, Green Published			2022-12-26	WOS:000672866400625
J	Alexeev, EE; Dowdell, AS; Henen, MA; Lanis, JM; Lee, JS; Cartwright, IM; Schaefer, REM; Ornelas, A; Onyiah, JC; Vogeli, B; Colgan, SP				Alexeev, Erica E.; Dowdell, Alexander S.; Henen, Morkos A.; Lanis, Jordi M.; Lee, J. Scott; Cartwright, Ian M.; Schaefer, Rachel E. M.; Ornelas, Alfredo; Onyiah, Joseph C.; Vogeli, Beat; Colgan, Sean P.			Microbial--derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damage	FASEB JOURNAL			English	Article						colitis; inflammation; microbiota; mucosa; polymorphonuclear leukocyte; tryptophan metabolism	INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; ULCERATIVE-COLITIS; EPITHELIAL BARRIER; OXIDATIVE STRESS; TYROSYL RESIDUES; GUT MICROBIOTA; SYSTEM; ASSOCIATION; RESISTANCE	During episodes of acute inflammation, polymorphonuclear leukocytes (PMNs) are actively recruited to sites of inflammation or injury where they provide anti-microbial and wound-healing functions. One enzyme crucial for fulfilling these functions is myeloperoxidase (MPO), which generates hypochlorous acid from Cl- and hydrogen peroxide. The potential exists, however, that uncontrolled the extracellular generation of hypochlorous acid by MPO can cause bystander tissue damage and inhibit the healing response. Previous work suggests that the microbiota-derived tryptophan metabolites 1H-indole and related molecules ("indoles") are protective during intestinal inflammation, although their precise mechanism of action is unclear. In the present work, we serendipitously discovered that indoles are potent and selective inhibitors of MPO. Using both primary human PMNs and recombinant human MPO in a cell-free system, we revealed that indoles inhibit MPO at physiologic concentrations. Particularly, indoles block the chlorinating activity of MPO, a reliable marker for MPO-associated tissue damage, as measured by coulometric-coupled HPLC. Further, we observed direct interaction between indoles and MPO using the established biochemical techniques microscale thermophoresis and STD-NMR. Utilizing a murine colitis model, we demonstrate that indoles inhibit bystander tissue damage, reflected in decreased colon 3-chlorotyrosine and pro-inflammatory chemokine expression in vivo. Taken together, these results identify microbiota-derived indoles that acts as endogenous immunomodulatory compounds through their actions on MPO, suggesting a symbiotic association between the gut microbiota and host innate immune system. Such findings offer exciting new targets for future pharmacological intervention.	[Alexeev, Erica E.; Dowdell, Alexander S.; Lanis, Jordi M.; Lee, J. Scott; Cartwright, Ian M.; Schaefer, Rachel E. M.; Ornelas, Alfredo; Onyiah, Joseph C.; Colgan, Sean P.] Univ Colorado, Dept Med, Mucosal Inflammat Program, Anschutz Med Campus,12700 East 19th Ave MS B-146, Aurora, CO 80045 USA; [Alexeev, Erica E.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Henen, Morkos A.; Vogeli, Beat] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Henen, Morkos A.] Mansoura Univ, Dept Pharmaceut Organ Chem, Mansoura, Egypt	University of Colorado System; University of Colorado Anschutz Medical Campus; Cedars Sinai Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Egyptian Knowledge Bank (EKB); Mansoura University	Colgan, SP (corresponding author), Univ Colorado, Dept Med, Mucosal Inflammat Program, Anschutz Med Campus,12700 East 19th Ave MS B-146, Aurora, CO 80045 USA.	Sean.Colgan@CUAnschutz.edu	Henen, Morkos/M-5995-2018	Henen, Morkos/0000-0003-4835-5583; Vogeli, Beat/0000-0003-1176-3137; Lee, J. Scott/0000-0001-7151-9828; DOWDELL, ALEXANDER/0000-0002-0513-6623	NIH [DK1047893, DK50189, DK095491, DK103639]; VA Merit [BX002182]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit(US Department of Veterans Affairs)	NIH, Grant/Award Number: DK1047893, DK50189, DK095491 and DK103639; VA Merit, Grant/Award Number: BX002182	Aherne CM, 2015, MUCOSAL IMMUNOL, V8, P1324, DOI 10.1038/mi.2015.22; Alexeev EE, 2018, AM J PATHOL, V188, P1183, DOI 10.1016/j.ajpath.2018.01.011; Arora AK, 2011, ADSORPT SCI TECHNOL, V29, P39, DOI 10.1260/0263-6174.29.1.39; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Barry R, 2020, MUCOSAL IMMUNOL, V13, P322, DOI 10.1038/s41385-019-0235-4; BEAN RC, 1968, J GEN PHYSIOL, V52, P495, DOI 10.1085/jgp.52.3.495; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bendheim PE, 2002, J MOL NEUROSCI, V19, P213, DOI 10.1007/s12031-002-0036-0; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Cartwright IM, 2020, MUCOSAL IMMUNOL, V13, P230, DOI 10.1038/s41385-019-0237-2; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chai WD, 2019, AM J PHYSIOL-ENDOC M, V317, pE1063, DOI 10.1152/ajpendo.00203.2019; Chami B, 2018, ARCH BIOCHEM BIOPHYS, V645, P61, DOI 10.1016/j.abb.2018.03.012; Chen MX, 2019, J FORMOS MED ASSOC, V118, pS10, DOI 10.1016/j.jfma.2018.09.007; Chen Y, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01339-3; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Churg A, 2012, AM J RESP CRIT CARE, V185, P34, DOI 10.1164/rccm.201103-0468OC; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Curtis VF, 2018, MOL BIOL CELL, V29, P2687, DOI 10.1091/mbc.E18-06-0377; Darkoh C, 2019, MSYSTEMS, P4; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; DECHATELET LR, 1976, BLOOD, V47, P545; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeRoche TC, 2014, GASTROENTEROL REP, V2, P178, DOI 10.1093/gastro/gou031; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Dowdell AS, 2020, MOL BIOL CELL, V31, P2249, DOI 10.1091/mbc.E20-05-0291; Ehrlich AM, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-02023-y; Elliott SN, 1998, CAN J GASTROENTEROL, V12, P559, DOI 10.1155/1998/398384; FLIGIEL SEG, 1984, AM J PATHOL, V115, P418; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Fu SL, 2000, J BIOL CHEM, V275, P10851, DOI 10.1074/jbc.275.15.10851; Gao RY, 2021, MUCOSAL IMMUNOL, V14, P479, DOI 10.1038/s41385-020-00347-6; Grigorieva DV, 2016, B EXP BIOL MED+, V161, P495, DOI 10.1007/s10517-016-3446-7; Haselhorst Thomas, 2009, V534, P375, DOI 10.1007/978-1-59745-022-5_26; Heinecke JW, 2014, DIABETES, V63, P4001, DOI 10.2337/db14-1273; Hendrikx T, 2019, J INTERN MED, V286, P32, DOI 10.1111/joim.12892; Herraiz T, 2004, FREE RADICAL RES, V38, P323, DOI 10.1080/10611860310001648167; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; Ilyasov IR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031131; Ji Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051579; Ji Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092062; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Kaur H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01365; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; Khan I, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030126; Kim CH, 2018, IMMUNOLOGY, V154, P220, DOI 10.1111/imm.12930; Krishnan S, 2018, CELL REP, V23, P1099, DOI 10.1016/j.celrep.2018.03.109; Kuenzig ME, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0054-z; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z; Lee JS, 2018, J BIOL CHEM, V293, P6039, DOI 10.1074/jbc.RA117.000269; Levy M, 2016, GENE DEV, V30, P1589, DOI 10.1101/gad.284091.116; LYMAR SV, 1995, CHEM RES TOXICOL, V8, P833, DOI 10.1021/tx00048a003; Manchanda K, 2018, ARTERIOSCL THROM VAS, V38, P1859, DOI 10.1161/ATVBAHA.118.311143; Matijasic M, 2020, INT J MOL SCI, P21; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Meddows-Taylor S, 1999, CLIN DIAGN LAB IMMUN, V6, P345, DOI 10.1128/CDLI.6.3.345-351.1999; Mor M, 2003, ADV EXP MED BIOL, V527, P567; Muthas D, 2017, SCAND J GASTROENTERO, V52, P125, DOI 10.1080/00365521.2016.1235224; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Onyiah JC, 2018, J INNATE IMMUN, V10, P228, DOI 10.1159/000488914; Paoliello-Paschoalato AB, 2014, J IMMUNOL METHODS, V412, P70, DOI 10.1016/j.jim.2014.07.001; Phillipson M, 2019, TRENDS IMMUNOL, V40, P635, DOI 10.1016/j.it.2019.05.001; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rosales C, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1469780; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Shurney D, 2019, AM J HEALTH PROMOT, V33, P821, DOI 10.1177/0890117119845711b; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Strzepa A, 2017, CELL IMMUNOL, V317, P1, DOI 10.1016/j.cellimm.2017.05.002; THOMAS EL, 1979, INFECT IMMUN, V25, P110, DOI 10.1128/IAI.25.1.110-116.1979; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Venkitakrishnan Rani Parvathy, 2012, Methods Mol Biol, V914, P47, DOI 10.1007/978-1-62703-023-6_4; Villanacci V, 2013, WORLD J GASTROENTERO, V19, P968, DOI 10.3748/wjg.v19.i7.968; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; Wang RX, 2020, P NATL ACAD SCI USA, V117, P11648, DOI 10.1073/pnas.1917597117; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wei ZL, 2003, J NEUROSCI RES, V73, P364, DOI 10.1002/jnr.10668; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Ximenes VF, 2005, BRAZ J MED BIOL RES, V38, P1575, DOI 10.1590/S0100-879X2005001100003; Yisireyili M, 2017, NAGOYA J MED SCI, V79, P477, DOI 10.18999/nagjms.79.4.477; Zhang DC, 2019, BLOOD, V133, P2168, DOI 10.1182/blood-2018-11-844555; Zhang N, 2018, NUTRITION, V51-52, P80, DOI 10.1016/j.nut.2017.12.005; Zhao ZH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0304-5; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	99	9	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21552	10.1096/fj.202100027R	http://dx.doi.org/10.1096/fj.202100027R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826788	Green Accepted			2022-12-26	WOS:000645260100078
J	Tobias, GC; Mandacaru, PMP; Guimaraes, RA; Morais, OL				Tobias, Gabriela Camargo; Pimenta Mandacaru, Polyana Maria; Guimaraes, Rafael Alves; Morais Neto, Otaliba Libanio			Use of prehospital, hospitalization and presence of sequelae and/or disability in road traffic injury victims in Brazil	PLOS ONE			English	Article							CRASH RATES; CARE; ACCIDENTS; SEVERITY; SYSTEM	Objective To estimate the prevalence and analyze the association between sociodemographic and behavioral variables with the use of prehospital care, hospitalization and sequelae and/or disability in victims of road traffic accidents victims in Brazil. Methods Data from the National Health Survey conducted in 2013 in Brazil were used. Data were collected through a direct household survey. The research sample consisted of 1,840 individuals who reported road traffic accidents in the previous 12 months. Poisson regression analysis was used to evaluate the factors associated with the use of prehospital care services, hospitalization, and the presence of sequelae and/or disability. Results The prevalence of road traffic accidents victims who received prehospital care was 13.0% (95% Confidence Interval [95% CI]: 10.3-16.3) and the factors associated with this outcome were: residing in the Northeast or North region of Brazil; residing in rural areas; and being a motorcycle occupant at the moment of the road traffic accident. The frequency of hospitalization was 7.7% (95% CI: 6.0-10.0) and the associated factors were: age between 40 and 59 years; being a motorcycle occupant or pedestrian and having received on-site care at the moment of the road traffic accident. The prevalence of sequelae and/or disability was 15.1% (95% CI: 12.5-18.2) and the associated factors were: age range between 30 and 39 years or 40 and 59 years; being a motorcycle occupant, being a pedestrian or belonging to other category of modes of transport and having received on-site care at the moment of the road traffic accident. Conclusion The study allowed to evaluate the factors associated with prehospital care, hospitalization and presence of sequelae and/or disability in the victims of road traffic accident and the results can guide the implementation of interventions that prioritize the population exposed to the highest risk of road traffic accident injuries and with less access to prehospital and hospital care services in Brazil.	[Tobias, Gabriela Camargo; Pimenta Mandacaru, Polyana Maria; Guimaraes, Rafael Alves; Morais Neto, Otaliba Libanio] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Guimaraes, Rafael Alves] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Guimaraes, RA (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.; Guimaraes, RA (corresponding author), Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil.	rafaelalvesg5@gmail.com			Ministerio da Saude do Brasil	Ministerio da Saude do Brasil	Funding for Ministerio da Saude do Brasil.	Alfalahi E, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.145.12974; Malvestio MAA, 2008, REV SAUDE PUBL, V42, P639, DOI 10.1590/S0034-89102008000400009; Andrade Silvânia Suely Caribé de Araújo, 2016, Rev. bras. epidemiol., V19, P100, DOI 10.1590/1980-5497201600010009; Balikuddembe JK, 2017, BMC EMERG MED, V17, DOI 10.1186/s12873-016-0112-3; Bhatti Junaid A, 2013, Ann Adv Automot Med, V57, P257; de Souza PRB, 2015, EPIDEMIOL SERV SAUDE, V24, P207, DOI 10.5123/S1679-49742015000200003; Brasil. Ministerio da Saude, SECR VIG SAUD DEP VI; Brasil. Ministerio da Saude. DATASUS, EST VIT; Cabral Amanda Priscila de Santana, 2008, Rev. bras. epidemiol., V11, P530, DOI 10.1590/S1415-790X2008000400002; Andrade SSCD, 2017, EPIDEMIOL SERV SAUDE, V26, P31, DOI [10.5123/s1679-49742017000100004, 10.5123/S1679-49742017000100004]; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; Chokotho L, 2017, PREHOSP DISASTER MED, V32, P14, DOI 10.1017/S1049023X16001175; Cleries Montse, 2015, Gac Sanit, V29 Suppl 1, P36, DOI 10.1016/j.gaceta.2015.03.011; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Dandona R, 2006, J SAFETY RES, V37, P149, DOI 10.1016/j.jsr.2005.11.002; Vera-Lopez JD, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00144916, 10.1590/0102-311X00144916]; de Araujo GL, 2016, ACTA PAUL ENFERM, V29, P178, DOI 10.1590/1982-0194201600025; Minayo MCD, 2008, CAD SAUDE PUBLICA, V24, P1877, DOI 10.1590/S0102-311X2008000800016; Dhondt S, 2013, ACCIDENT ANAL PREV, V50, P659, DOI 10.1016/j.aap.2012.06.019; Hatamabadi HR, 2011, TRAFFIC INJ PREV, V12, P358, DOI 10.1080/15389588.2011.566656; Ibrahim NA, 2017, PREHOSP DISASTER MED, V32, P424, DOI 10.1017/S1049023X17006410; Institute for Health Metrics and Evaluation (IHME), DATA VISUALIZATION; Instituto de Pesquisa Economica Aplicada (IPEA). Instituto de Pesquisa Economica Aplicada, EST CUST AC TRANS BR; Ladeira RM, 2008, CAD SAUDE PUBLICA, V24, P287, DOI 10.1590/S0102-311X2008000200007; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Li Q, 2017, PUBLIC HEALTH, V144, pS57, DOI 10.1016/j.puhe.2016.11.012; Lin T, 2013, J PUBLIC HEALTH-UK, V35, P541, DOI 10.1093/pubmed/fdt003; Machado CV, 2011, REV SAUDE PUBL, V45, P519, DOI 10.1590/S0034-89102011005000022; Macinko J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134153; Mascarenhas MDM, 2016, CIENC SAUDE COLETIVA, V21, P3661, DOI 10.1590/1413-812320152112.24332016; Misra P, 2017, INDIAN J CRIT CARE M, V21, P678, DOI 10.4103/ijccm.IJCCM_197_17; Organizacao Mundial da Saude (OMS), ORG MUND SAUD INF SE; Palmera-Suarez R, 2016, ACCIDENT ANAL PREV, V91, P36, DOI 10.1016/j.aap.2016.02.024; Palmera-Suarez Rocio, 2015, Gac Sanit, V29 Suppl 1, P43, DOI 10.1016/j.gaceta.2015.01.009; Patey AM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1517-z; Ray JJ, 2016, TRAFFIC INJ PREV, V17, P676, DOI 10.1080/15389588.2016.1149580; Rosado J., 2018, MED BUENOS AIRES, V78, P158; Sanchez-Mangas R, 2010, ACCIDENT ANAL PREV, V42, P1048, DOI 10.1016/j.aap.2009.12.012; Shavaleh Rasoul, 2018, Med J Islam Repub Iran, V32, P50, DOI 10.14196/mjiri.32.50; Shults RA, 2004, J SAFETY RES, V35, P447, DOI 10.1016/j.jsr.2004.06.001; Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012; Tavares Fábio Lucio, 2014, Esc. Anna Nery, V18, P656, DOI 10.5935/1414-8145.20140093; Trowbridge MJ, 2009, AM J PREV MED, V37, P428, DOI 10.1016/j.amepre.2009.06.016; Vanderschuren M, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/1476-072X-14-5; World Health Organization, GLOBAL STATUS REPORT; World Health Organization (WHO) . World Health Organization, 2004, WORLD REPORT ROAD TR, DOI [10.1007/978-88-470-2131-0_11, DOI 10.1007/978-88-470-2131-0_11]; Yongchaitrakul T, 2012, SE ASIAN J TROP MED, V43, P785; Zafar SN, 2018, INT J SURG, V52, P245, DOI 10.1016/j.ijsu.2018.02.034; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018	51	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249895	10.1371/journal.pone.0249895	http://dx.doi.org/10.1371/journal.pone.0249895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861788	Green Published, gold			2022-12-26	WOS:000641475400021
J	Yagyuu, T; Funayama, N; Imada, M; Kirita, T				Yagyuu, Takahiro; Funayama, Naoki; Imada, Mitsuhiko; Kirita, Tadaaki			Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study	PLOS ONE			English	Article							RISK	Tobacco smoking is associated with an increased risk of oral leukoplakia and head and neck cancer. Although it has recently been reported that the establishment of an immunosuppressive microenvironment in oral potentially malignant disorders may lead to malignant transformation, it is unclear whether the microenvironments of oral potentially malignant disorders differ according to smoking status. We examined differences in programmed death-ligand 1 (PD-L1) expression and subepithelial CD163+ TAM and CD8+ cell/lymphocyte counts in the microenvironment of oral leukoplakia of smoking and non-smoking patients and investigated their associations with malignant transformation. Pathology reports and original biopsy request forms from 1995-2015 were retrospectively reviewed. Lesions clinically characterized as white plaques/lesions of the oral mucosa and pathologically diagnosed as oral epithelial dysplasia were included. Immunohistochemistry was performed to evaluate PD-L1 expression and subepithelial CD163+/CD8+ cell counts. The significance of prognostic factors in predicting malignant transformation was determined using Cox regression analysis. Statistical significance was defined as P<0.05. In total, 200 patients with oral leukoplakia were selected. The mean age at diagnosis was higher in non-smoking patients (n = 141; 66.9 years) than in smoking patients (n = 59; 60.5 years). The 5-year cumulative malignant transformation rate was higher in non-smoking patients than in smoking patients (9.3% vs. 3.0%, respectively). Oral leukoplakia was associated with significantly higher PD-L1 expression and increased numbers of subepithelial CD163+ cells in the non-smoking group compared with the smoking group. Non-smoking-related oral leukoplakia with positive PD-L1 expression was associated with a 6.97-fold (95% confidence interval: 2.14-22.7) increased risk of malignant transformation. The microenvironment of oral leukoplakia differed according to smoking status. A combination of smoking status and PD-L1 expression may predict malignant transformation in oral leukoplakia patients. This study highlights the importance of understanding the interaction between smoking and the microenvironment in oral leukoplakia.	[Yagyuu, Takahiro; Funayama, Naoki; Imada, Mitsuhiko; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara, Japan	Nara Medical University	Yagyuu, T (corresponding author), Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara, Japan.	t-yagyuu@naramed-u.ac.jp	Yagyuu, Takahiro/GZK-7684-2022					Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Banoczy J, 2001, J Dent Educ, V65, P322; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bokor-Bratic M., 2002, ARCH ONCOL, V10, P67; Bondy SJ, 2009, TOB CONTROL, V18, P317, DOI 10.1136/tc.2008.027276; Chitaladze T, 2018, DENTISTRY, V8, P1000495, DOI DOI 10.4172/2161-1122.1000495; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Collett D., 1994, MODELLING SURVIVAL D, P150; de la Iglesia JV, 2020, CLIN CANCER RES, V26, P1474, DOI 10.1158/1078-0432.CCR-19-1769; Desrichard A, 2018, JNCI-J NATL CANCER I, V110, P1386, DOI 10.1093/jnci/djy060; Dietrich T, 2004, ORAL ONCOL, V40, P158, DOI 10.1016/S1368-8375(03)00145-3; Durr ML, 2013, AM J OTOLARYNG, V34, P388, DOI 10.1016/j.amjoto.2013.01.017; EINHORN J, 1967, CANCER, V20, P2189, DOI 10.1002/1097-0142(196712)20:12<2189::AID-CNCR2820201218>3.0.CO;2-M; EVSTIFEEVA TV, 1992, ORAL ONCOL, V28B, P29; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fujii N, 2012, J ORAL PATHOL MED, V41, P444, DOI 10.1111/j.1600-0714.2012.01127.x; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hashibe M, 2000, INT J CANCER, V88, P129, DOI 10.1002/1097-0215(20001001)88:1&lt;129::AID-IJC20&gt;3.0.CO;2-U; Holmstrup P, 2006, ORAL ONCOL, V42, P461, DOI 10.1016/j.oraloncology.2005.08.011; International Agency for Research on Cancer. World Health Organization, 1988, IARC MONOGRAPHS EVAL, V44, P1; Jones LM, 2016, CANCER RES, V76, P1416, DOI 10.1158/0008-5472.CAN-15-2770; Kawakita D, 2012, ORAL ONCOL, V48, P186, DOI 10.1016/j.oraloncology.2011.09.012; Keiding N., 1997, STAT MODELS BASED CO; Klein JP., 1997, SURVIVAL ANAL TECHNI, P83; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Kuribayashi Y, 2015, ORAL ONCOL, V51, P1020, DOI 10.1016/j.oraloncology.2015.09.004; Lee CH, 2003, BRIT J CANCER, V88, P366, DOI 10.1038/sj.bjc.6600727; Lee SU, 2020, ORAL DIS, V26, P1440, DOI 10.1111/odi.13432; Lim K, 2003, BRIT DENT J, V194, P497, DOI 10.1038/sj.bdj.4810069; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034773; Loftus E R, 1981, Spec Care Dentist, V1, P206, DOI 10.1111/j.1754-4505.1981.tb01254.x; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mori K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1587-0; Morse DE, 2007, CANCER CAUSE CONTROL, V18, P919, DOI 10.1007/s10552-007-9026-4; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Reibel J., 2017, WHO CLASSIFICATION H, P112; Rock LD, 2018, ORAL ONCOL, V78, P119, DOI 10.1016/j.oraloncology.2018.01.028; ROEDPETERSEN B, 1971, J DENT RES, V50, P711; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schepman KP, 1998, ORAL ONCOL, V34, P270, DOI 10.1016/S1368-8375(98)80007-9; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shin MN, 2000, BRIT J CANCER, V82, P1871, DOI 10.1054/bjoc.2000.1208; SILVERMAN S, 1984, CANCER, V53, P563; VEDTOFTE P, 1987, INT J ORAL MAX SURG, V16, P656, DOI 10.1016/S0901-5027(87)80049-8; Warnakulasuriya S, 2020, ORAL ONCOL, V102, DOI 10.1016/j.oraloncology.2019.104550; Warnakulasuriya S, 2015, J ORAL PATHOL MED, V44, P559, DOI [10.1111/jop.12339, 10.1111/jop.12267]; Yagyuu T, 2017, ORAL ONCOL, V68, P36, DOI 10.1016/j.oraloncology.2017.03.006; Yang TZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-248; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	50	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250359	10.1371/journal.pone.0250359	http://dx.doi.org/10.1371/journal.pone.0250359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861793	gold, Green Published			2022-12-26	WOS:000641475400002
J	Kang, BH; Momin, N; Moynihan, KD; Silva, M; Li, YZ; Irvine, DJ; Wittrup, KD				Kang, Byong H.; Momin, Noor; Moynihan, Kelly D.; Silva, Murillo; Li, Yingzhong; Irvine, Darrell J.; Wittrup, K. Dane			Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice	PLOS ONE			English	Article							TERTIARY LYMPHOID STRUCTURES; B-CELLS; COMBINATION IMMUNOTHERAPY; HERV-K; CANCER; ANTIGEN; IMMUNITY; SEQUENCE; PROTEIN; INNATE	Following curative immunotherapy of B16F10 tumors, similar to 60% of mice develop a strong antibody response against cell-surface tumor antigens. Their antisera confer prophylactic protection against intravenous challenge with B16F10 cells, and also cross-react with syngeneic and allogeneic tumor cell lines MC38, EL.4, 4T1, and CT26. We identified the envelope glycoprotein (env) of a murine endogenous retrovirus (ERV) as the antigen accounting for the majority of this humoral response. A systemically administered anti-env monoclonal antibody cloned from such a response protects against tumor challenge, and prophylactic vaccination against the env protein protects a majority of naive mice from tumor establishment following subcutaneous inoculation with B16F10 cells. These results suggest the potential for effective prophylactic vaccination against analogous HERV-K env expressed in numerous human cancers.	[Kang, Byong H.; Momin, Noor; Moynihan, Kelly D.; Silva, Murillo; Li, Yingzhong; Irvine, Darrell J.; Wittrup, K. Dane] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kang, Byong H.; Momin, Noor; Moynihan, Kelly D.; Li, Yingzhong; Irvine, Darrell J.; Wittrup, K. Dane] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moynihan, Kelly D.; Irvine, Darrell J.] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moynihan, Kelly D.; Irvine, Darrell J.] Harvard Univ, Cambridge, MA 02138 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Wittrup, K. Dane] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Wittrup, KD (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Wittrup, KD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Wittrup, KD (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	wittrup@mit.edu		/0000-0003-2398-5896; /0000-0003-3145-6089; Moynihan, Kelly/0000-0001-6200-7863	Ragon Institute of MGH, MIT and Harvard; Koch Institute Frontier Research Program; Kathy and Curt Marble Cancer Research Fund; Mayo Clinic -Koch Institute Cancer Solutions Team Grant; National Cancer Institute [CA174795]	Ragon Institute of MGH, MIT and Harvard; Koch Institute Frontier Research Program; Kathy and Curt Marble Cancer Research Fund; Mayo Clinic -Koch Institute Cancer Solutions Team Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Ragon Institute of MGH, MIT and Harvard, the Koch Institute Frontier Research Program, the Kathy and Curt Marble Cancer Research Fund, and the Mayo Clinic -Koch Institute Cancer Solutions Team Grant funding, and the National Cancer Institute, CA174795.	Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Cegolon L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-4; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chiaruttini G, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1294296; Colbeck EJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01830; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DeFalco J, 2018, CLIN IMMUNOL, V187, P37, DOI 10.1016/j.clim.2017.10.002; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Escolano A, 2019, NATURE, V570, P468, DOI 10.1038/s41586-019-1250-z; Forte G, 2012, J IMMUNOL, V189, P2226, DOI 10.4049/jimmunol.1200744; Gilbert AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019330; Hampton TA, 2000, CANCER GENE THER, V7, P446, DOI 10.1038/sj.cgt.7700124; HAYASHI H, 1992, J IMMUNOL, V149, P1223; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Iglesia MD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw144; Kershaw MH, 2001, CANCER RES, V61, P7920; Kobayashi T, 2019, J INVEST DERMATOL, V139, P1535, DOI 10.1016/j.jid.2019.02.016; Kobayashi T, 2014, AM J PATHOL, V184, P3120, DOI 10.1016/j.ajpath.2014.07.003; Krishnamurthy J, 2015, CLIN CANCER RES, V21, P3241, DOI 10.1158/1078-0432.CCR-14-3197; LEONG SPL, 1988, CANCER RES, V48, P4954; Li MF, 1999, J VIROL, V73, P9178, DOI 10.1128/JVI.73.11.9178-9186.1999; Li M, 2017, CLIN CANCER RES, V23, P5892, DOI 10.1158/1078-0432.CCR-17-0001; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Momin N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2614; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2010, P NATL ACAD SCI USA, V107, P19396, DOI 10.1073/pnas.1014515107; Ottina E, 2018, CANCER IMMUNOL RES, V6, P1292, DOI 10.1158/2326-6066.CIR-18-0038; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Ruddell A, 2011, NEOPLASIA, V13, P748, DOI 10.1593/neo.11756; Sarvaria A, 2017, CELL MOL IMMUNOL, V14, P662, DOI 10.1038/cmi.2017.35; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Smith CC, 2019, NAT REV CANCER, V19, P465, DOI 10.1038/s41568-019-0162-4; Song E, 2020, NATURE, V577, P689, DOI 10.1038/s41586-019-1912-x; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Tokuyama M, 2018, P NATL ACAD SCI USA, V115, P12565, DOI 10.1073/pnas.1814589115; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Tzeng A, 2016, CELL REP, V17, P2503, DOI 10.1016/j.celrep.2016.11.020; Van Deventer JA, 2014, METHODS MOL BIOL, V1131, P151, DOI 10.1007/978-1-62703-992-5_10; Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234; Wang-Johanning F, 2012, JNCI-J NATL CANCER I, V104, P189, DOI 10.1093/jnci/djr540; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; WHITE HD, 1994, J VIROL, V68, P897, DOI 10.1128/JVI.68.2.897-904.1994; Wittrup KD, 2017, TRENDS CANCER, V3, P615, DOI 10.1016/j.trecan.2017.07.001; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064159; Ye X, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1758602; Young GR, 2013, BIOESSAYS, V35, P794, DOI 10.1002/bies.201300049; Yuen GJ, 2016, TRENDS CANCER, V2, P747, DOI 10.1016/j.trecan.2016.10.010; Zhang X., NAT CANCER; Zhou FL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1047582; Zhou P, 2010, J IMMUNOTHER, V33, P789, DOI 10.1097/CJI.0b013e3181ee6ba9; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248903	10.1371/journal.pone.0248903	http://dx.doi.org/10.1371/journal.pone.0248903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857179	gold, Green Published			2022-12-26	WOS:000641474900108
J	Liu, SL; Chen, YS; Xiao, L				Liu, Shulei; Chen, Yasong; Xiao, Lin			Metagenomic insights into mixotrophic denitrification facilitated nitrogen removal in a full-scale A2/O wastewater treatment plant	PLOS ONE			English	Article							AUTOTROPHIC DENITRIFICATION; MICROBIAL STRUCTURES; ACTIVATED-SLUDGE; NUTRIENT REMOVAL; NITRATE REMOVAL; SULFUR; PERFORMANCE; SULFIDE; SEQUENCES; PATHWAYS	Wastewater treatment plants (WWTPs) are important for pollutant removal from wastewater, elimination of point discharges of nutrients into the environment and water resource protection. The anaerobic/anoxic/oxic (A2/O) process is widely used in WWTPs for nitrogen removal, but the requirement for additional organics to ensure a suitable nitrogen removal efficiency makes this process costly and energy consuming. In this study, we report mixotrophic denitrification at a low COD (chemical oxygen demand)/TN (total nitrogen) ratio in a full-scale A2/O WWTP with relatively high sulfate in the inlet. Nitrogen and sulfur species analysis in different units of this A2/O WWTP showed that the internal sulfur cycle of sulfate reduction and reoxidation occurred and that the reduced sulfur species might contribute to denitrification. Microbial community analysis revealed that Thiobacillus, an autotrophic sulfur-oxidizing denitrifier, dominated the activated sludge bacterial community. Metagenomics data also supported the potential of sulfur-based denitrification when high levels of denitrification occurred, and sulfur oxidation and sulfate reduction genes coexisted in the activated sludge. Although most of the denitrification genes were affiliated with heterotrophic denitrifiers with high abundance, the narG and napA genes were mainly associated with autotrophic sulfur-oxidizing denitrifiers. The functional genes related to nitrogen removal were actively expressed even in the unit containing relatively highly reduced sulfur species, indicating that the mixotrophic denitrification process in A2/O could overcome not only a shortage of carbon sources but also the inhibition by reduced sulfur of nitrification and denitrification. Our results indicate that a mixotrophic denitrification process could be developed in full-scale WWTPs and reduce the requirement for additional carbon sources, which could endow WWTPs with more flexible and adaptable nitrogen removal.	[Liu, Shulei; Chen, Yasong; Xiao, Lin] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse SKL, Nanjing, Peoples R China	Nanjing University	Xiao, L (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse SKL, Nanjing, Peoples R China.	xiaolin@nju.edu.cn		xiao, Lin/0000-0002-9200-381X	National Water Pollution Control and Treatment Science and Technology Major Project [2017ZX07204002]	National Water Pollution Control and Treatment Science and Technology Major Project	This research project was made possible through the financial support of the National Water Pollution Control and Treatment Science and Technology Major Project (2017ZX07204002).	Association APH. APHA, 2005, STANDARD METHODS EXA; Berkessa YW, 2019, DESALINATION, V465, P94, DOI 10.1016/j.desal.2019.04.027; Bradley AS, 2011, GEOBIOLOGY, V9, P446, DOI 10.1111/j.1472-4669.2011.00292.x; Bureau NE., 2002, METHODS ANAL WATER W, Vfourth ed; Chen C, 2008, APPL MICROBIOL BIOT, V78, P1057, DOI 10.1007/s00253-008-1396-3; Chen YS, 2019, WATER SCI TECHNOL, V79, P607, DOI 10.2166/wst.2019.078; Chen YS, 2016, BIORESOURCE TECHNOL, V220, P225, DOI 10.1016/j.biortech.2016.07.095; Daigger GT, 2014, WATER ENVIRON RES, V86, P245, DOI 10.2175/106143013X13736496908555; Fike DA, 2015, ANNU REV EARTH PL SC, V43, P593, DOI 10.1146/annurev-earth-060313-054802; Gadekar S, 2006, WATER RES, V40, P2436, DOI 10.1016/j.watres.2006.04.007; Guo JH, 2017, ENZYME MICROB TECH, V102, P16, DOI 10.1016/j.enzmictec.2017.03.009; Hulsen T, 2019, WATER RES, V160, P259, DOI 10.1016/j.watres.2019.05.060; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kong Z, 2016, BIORESOURCE TECHNOL, V211, P125, DOI 10.1016/j.biortech.2016.03.083; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau MCY, 2016, P NATL ACAD SCI USA, V113, pE7927, DOI 10.1073/pnas.1612244113; Lee DU, 2001, PROCESS BIOCHEM, V36, P1215, DOI 10.1016/S0032-9592(01)00163-7; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu YW, 2016, ENVIRON SCI TECHNOL, V50, P9407, DOI 10.1021/acs.est.6b02202; Liu ZF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00185; Ma SJ, 2019, WATER RES, V148, P359, DOI 10.1016/j.watres.2018.10.058; McCarty PL, 2018, ENVIRON SCI TECHNOL, V52, P3835, DOI 10.1021/acs.est.7b05832; Peng YZ, 2011, BIORESOURCE TECHNOL, V102, P6405, DOI 10.1016/j.biortech.2011.03.043; Pokorna D, 2015, BIOTECHNOL ADV, V33, P1246, DOI 10.1016/j.biotechadv.2015.02.007; Sahinkaya E, 2014, WATER RES, V60, P210, DOI 10.1016/j.watres.2014.04.052; Sahinkaya E, 2011, WATER RES, V45, P6661, DOI 10.1016/j.watres.2011.09.056; Salinero KK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-351; SASS H, 1992, ARCH MICROBIOL, V158, P418; Stres B, 2004, APPL ENVIRON MICROB, V70, P301, DOI 10.1128/AEM.70.1.301-309.2004; Vela JD, 2018, WATER RES, V138, P241, DOI 10.1016/j.watres.2018.03.047; Watsuntorn W, 2019, BIORESOURCE TECHNOL, V272, P40, DOI 10.1016/j.biortech.2018.09.125; Wu D, 2016, WATER RES, V100, P496, DOI 10.1016/j.watres.2016.05.052; Wu D, 2013, WATER RES, V47, P3057, DOI 10.1016/j.watres.2013.03.009; Xing W, 2018, ENVIRON SCI TECHNOL, V52, P7867, DOI 10.1021/acs.est.8b01993; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Yu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23221; Zeng H, 2005, WATER RES, V39, P4941, DOI 10.1016/j.watres.2005.09.034; Zhang LL, 2015, WATER RES, V85, P422, DOI 10.1016/j.watres.2015.08.055; Zhang LL, 2015, APPL MICROBIOL BIOT, V99, P2815, DOI 10.1007/s00253-014-6113-9; Zhang RC, 2019, SCI TOTAL ENVIRON, V647, P914, DOI 10.1016/j.scitotenv.2018.07.389; Zhang RC, 2018, WATER RES, V143, P355, DOI 10.1016/j.watres.2018.06.053; Zhang Y, 2019, WATER RES, V148, P219, DOI 10.1016/j.watres.2018.10.061; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11448-x; Zhi W, 2014, WATER RES, V64, P32, DOI 10.1016/j.watres.2014.06.035; Zou G, 2016, CHEM ENG J, V284, P1287, DOI 10.1016/j.cej.2015.09.074	47	3	3	10	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250283	10.1371/journal.pone.0250283	http://dx.doi.org/10.1371/journal.pone.0250283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857258	Green Published			2022-12-26	WOS:000641474900083
J	Wang, JB; Hong, TS; Li, Z; Xue, XY; Lyu, SL				Wang, Jianbo; Hong, Tiansheng; Li, Zhen; Xue, Xiuyun; Lyu, Shilei			Experiment on compaction of air-dried soil under drop shocks	PLOS ONE			English	Article							CONTAINER; RELAXATION; SEEDLINGS; QUALITY	For the requirement in container nursery culture that growing media should be achieved the appropriate degree compaction, this paper presents an experiment on the compaction dynamics of air-dried soil under repetitive drop shocks, as a preliminary step toward the mechanization of this compaction method. The drop height used to adjust the shock intensity included 2 mm, 4 mm, 5 mm and 6 mm. And the overall packing density of soil in a vertically stratified cylinder vessel and the local packing density in each layer were taken as indicators of soil compaction states. The stretched exponential function derived from KWW law than the empirical inverse-logarithmic function has been found to be more suitable for expressing the temporal evolution of soil compaction, according to the results of curve-fitting to test values of the overall and local density. It is inherent in this experimental configuration that the drop shock intensity even at a constant drop height varies with drop times, owing to the interaction between the soil packing itself and drop shocks caused by the combination of the packing and the container. But the function t/tau(f)(t,H) is manifested as a straight line on the drop times t with the line slope related to the drop height H, so the soil compaction dynamics caused by its drop shocks and that under the condition with actively controlled intensity actually share the common relaxation law. In addition, the soil's one-dimensional distribution of local packing density showed a slight positive gradient as similar as monodisperse particles did.	[Wang, Jianbo; Hong, Tiansheng] South China Agr Univ, Coll Engn, Guangzhou, Peoples R China; [Wang, Jianbo; Hong, Tiansheng; Li, Zhen; Xue, Xiuyun; Lyu, Shilei] China Agr Res Syst, Div Citrus Machinery, Guangzhou, Peoples R China; [Li, Zhen; Xue, Xiuyun; Lyu, Shilei] South China Agr Univ, Coll Elect Engn, Guangzhou, Peoples R China	South China Agricultural University; South China Agricultural University	Li, Z (corresponding author), China Agr Res Syst, Div Citrus Machinery, Guangzhou, Peoples R China.; Li, Z (corresponding author), South China Agr Univ, Coll Elect Engn, Guangzhou, Peoples R China.	lizhen@scau.edu.cn		, Wang/0000-0002-8148-796X	National Natural Science Foundation of China [61601189]; Special Fund of Modern Technology System of Agricultural Industry [CARS-26]; Characteristic Innovation Projects of Universities in Guangdong Province [2018KTSCX020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund of Modern Technology System of Agricultural Industry; Characteristic Innovation Projects of Universities in Guangdong Province	This work was supported by the National Natural Science Foundation of China (No. 61601189), the Special Fund of Modern Technology System of Agricultural Industry (No. CARS-26), and the Characteristic Innovation Projects of Universities in Guangdong Province (No. 2018KTSCX020).	Aghai MM, 2014, NEW FOREST, V45, P199, DOI 10.1007/s11056-013-9402-8; Batukaev AA., 2021, EARTH ENV SCI, V624, P12115; de Richter SK, 2015, EUR PHYS J E, V38, DOI 10.1140/epje/i2015-15074-7; Dresboll DB, 2010, SCI HORTIC-AMSTERDAM, V126, P56, DOI 10.1016/j.scienta.2010.06.004; Erkan N, 2017, J ENVIRON BIOL, V38, P1391, DOI [10.22438/jeb/38/6/MRN-424, 10.22438/jeb/38/6/mrn-424]; Fiscina JE, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048001; Grossnickle SC, 2016, NEW FOREST, V47, P1, DOI 10.1007/s11056-015-9476-6; Grossnickle SC, 2012, NEW FOREST, V43, P711, DOI 10.1007/s11056-012-9336-6; Harmen Kamminga, 2013, FLORACULTURE INT, V23, P46; Huang J, 2014, ACTA HORTIC, V1034, P263; Huang J, 2012, 2012 ASHS C 2012 PUB; John Sutton, 2013, FLORACULTURE INT, V23, P34; Knight JB, 1996, PHYS REV E, V54, P5726, DOI 10.1103/PhysRevE.54.5726; KNIGHT JB, 1995, PHYS REV E, V51, P3957, DOI 10.1103/PhysRevE.51.3957; Landis T.D., 1990, AGR HDB, V2, P41; Lu R.K., 2000, AGROCHEMICAL ANAL SO; Ludewig F, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051304; Lumay G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021301; Mathonnet JE, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042904; Nawaz MF, 2013, AGRON SUSTAIN DEV, V33, P291, DOI 10.1007/s13593-011-0071-8; Nowak ER, 1998, PHYS REV E, V57, P1971, DOI 10.1103/PhysRevE.57.1971; O'Kelly BC, 2014, DRY TECHNOL, V32, P631, DOI 10.1080/07373937.2013.849728; Philippe P, 2002, EUROPHYS LETT, V60, P677, DOI 10.1209/epl/i2002-00362-7; .R.C. Ministry of Housing and Urban-Rural Development P.R.C, 2019, 501232019  GBT PRC M; Ribiere P, 2005, EUR PHYS J E, V16, P415, DOI 10.1140/epje/i2004-10096-x; Ribiere P, 2005, J PHYS-CONDENS MAT, V17, pS2743, DOI 10.1088/0953-8984/17/24/024; Ribiere P, 2007, EUR PHYS J E, V22, P249, DOI 10.1140/epje/e2007-00017-x; Richard P, 2005, NAT MATER, V4, P121, DOI 10.1038/nmat1300; Shah AN, 2017, ENVIRON SCI POLLUT R, V24, P10056, DOI 10.1007/s11356-017-8421-y; Szatanik-Kloc A, 2018, SOIL TILL RES, V175, P226, DOI 10.1016/j.still.2017.08.016; Thiffault N, 2014, NEW FOREST, V45, P875, DOI 10.1007/s11056-014-9443-7; Vandewalle N, 2007, EUR PHYS J E, V22, P241, DOI 10.1140/epje/e2007-00031-0; Wilson ER, 2007, NEW FOREST, V34, P163, DOI 10.1007/s11056-007-9046-7; Zhao B, 2017, POWDER TECHNOL, V317, P171, DOI 10.1016/j.powtec.2017.04.048	34	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250076	10.1371/journal.pone.0250076	http://dx.doi.org/10.1371/journal.pone.0250076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857231	Green Published, gold			2022-12-26	WOS:000641474900037
J	d'Argenteuil, CD; Boshuizen, B; Oosterlinck, M; van de Winkel, D; De Spiegelaere, W; de Bruijn, CM; Goethals, K; Vanderperren, K; Delesalle, CJG				d'Argenteuil, Constance de Meeus; Boshuizen, Berit; Oosterlinck, Maarten; van de Winkel, Don; De Spiegelaere, Ward; de Bruijn, Cornelis Marinus; Goethals, Klara; Vanderperren, Katrien; Delesalle, Catherine John Ghislaine			Flexibility of equine bioenergetics and muscle plasticity in response to different types of training: An integrative approach, questioning existing paradigms	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HUMAN SKELETAL-MUSCLE; SUPERFICIAL DIGITAL FLEXOR; PENTOSE-PHOSPHATE PATHWAY; THORACIC AORTIC RUPTURE; VOLATILE FATTY-ACIDS; FIBER-TYPE; WATER TREADMILL; PROTEIN-METABOLISM; INSULIN SENSITIVITY	Equine bioenergetics have predominantly been studied focusing on glycogen and fatty acids. Combining omics with conventional techniques allows for an integrative approach to broadly explore and identify important biomolecules. Friesian horses were aquatrained (n = 5) or dry treadmill trained (n = 7) (8 weeks) and monitored for: evolution of muscle diameter in response to aquatraining and dry treadmill training, fiber type composition and fiber cross-sectional area of the M. pectoralis, M. vastus lateralis and M. semitendinosus and untargeted metabolomics of the M. pectoralis and M. vastus lateralis in response to dry treadmill training. Aquatraining was superior to dry treadmill training to increase muscle diameter in the hindquarters, with maximum effect after 4 weeks. After dry treadmill training, the M. pectoralis showed increased muscle diameter, more type I fibers, decreased fiber mean cross sectional area, and an upregulated oxidative metabolic profile: increased beta-oxidation (key metabolites: decreased long chain fatty acids and increased long chain acylcarnitines), TCA activity (intermediates including succinyl-carnitine and 2-methylcitrate), amino acid metabolism (glutamine, aromatic amino acids, serine, urea cycle metabolites such as proline, arginine and ornithine) and xenobiotic metabolism (especially p-cresol glucuronide). The M. vastus lateralis expanded its fast twitch profile, with decreased muscle diameter, type I fibers and an upregulation of glycolytic and pentose phosphate pathway activity, and increased branched-chain and aromatic amino acid metabolism (cis-urocanate, carnosine, homocarnosine, tyrosine, tryptophan, p-cresol-glucuronide, serine, methionine, cysteine, proline and ornithine). Trained Friesians showed increased collagen and elastin turn-over. Results show that branched-chain amino acids, aromatic amino acids and microbiome-derived xenobiotics need further study in horses. They feed the TCA cycle at steps further downstream from acetyl CoA and most likely, they are oxidized in type IIA fibers, the predominant fiber type of the horse. These study results underline the importance of reviewing existing paradigms on equine bioenergetics.	[d'Argenteuil, Constance de Meeus; Boshuizen, Berit; Delesalle, Catherine John Ghislaine] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Res Grp Comparat Physiol, Merelbeke, Belgium; [Boshuizen, Berit; van de Winkel, Don; de Bruijn, Cornelis Marinus] Wolvega Equine Hosp, Oldeholtpade, Netherlands; [Oosterlinck, Maarten] Univ Ghent, Fac Vet Med, Dept Surg & Anaesthesiol Domest Anim, Merelbeke, Belgium; [De Spiegelaere, Ward] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium; [Goethals, Klara] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Res Grp Biometr, Merelbeke, Belgium; [Vanderperren, Katrien] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthopaed, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University	d'Argenteuil, CD (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Res Grp Comparat Physiol, Merelbeke, Belgium.	Constance.Demeeusdargenteuil@Ugent.be	Delesalle, Catherine/Y-7038-2019; De Spiegelaere, Ward/C-6245-2008	De Spiegelaere, Ward/0000-0003-2097-8439; Delesalle, Catherine/0000-0001-8969-1407	Fonds Wetenschappelijk Onderzoek [1S57617N]	Fonds Wetenschappelijk Onderzoek(FWO)	CDM, grant number: 1S57617N, Fonds Wetenschappelijk Onderzoek, www.fwo.be, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah M, 2017, METABOLITES, V7, DOI 10.3390/metabo7030038; Akazawa N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201789; Alkurdi W., 2010, INT J AQUAT RES ED, V4, P7, DOI [10.25035/ijare.04.01.07, DOI 10.25035/IJARE.04.01.07]; Alves RDAM, 2015, METABOLOMICS, V11, P271, DOI 10.1007/s11306-014-0701-7; Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Aoi W, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0067-x; Arfuso F, 2019, J EQUINE VET SCI, V77, P12, DOI 10.1016/j.jevs.2019.02.006; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; ARGENZIO RA, 1972, J NUTR, V102, P879, DOI 10.1093/jn/102.7.879; Assenza A, 2004, J ANIM PHYSIOL AN N, V88, P172, DOI 10.1111/j.1439-0396.2004.00493.x; Baguet A, 2012, AMINO ACIDS, V43, P13, DOI 10.1007/s00726-011-1197-3; Baguet A, 2010, J APPL PHYSIOL, V109, P1096, DOI 10.1152/japplphysiol.00141.2010; Bakalar B, 2006, CRIT CARE MED, V34, P381, DOI 10.1097/01.CCM.0000196829.30741.D4; Baldelli S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102318; Barlow D. A., 1984, Journal of Equine Veterinary Science, V4, P60, DOI 10.1016/S0737-0806(84)80083-0; Barnicoat F, 2016, COMP EXERC PHYSIOL, V12, P199, DOI 10.3920/CEP160012; Belaunzaran X, 2017, MEAT SCI, V124, P39, DOI 10.1016/j.meatsci.2016.10.014; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Blomstrand E, 1997, ACTA PHYSIOL SCAND, V159, P41, DOI 10.1046/j.1365-201X.1997.547327000.x; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; Bolam KA, 2013, OSTEOPOROSIS INT, V24, P2749, DOI 10.1007/s00198-013-2346-1; Borgia LA, 2010, EQUINE VET J, V42, P665, DOI 10.1111/j.2042-3306.2010.00229.x; Bouwman FG, 2010, COMP BIOCHEM PHYS D, V5, P55, DOI 10.1016/j.cbd.2009.11.001; Bruno C, 2018, J PHARMACEUT BIOMED, V148, P273, DOI 10.1016/j.jpba.2017.10.013; BUCHNER HHF, 1994, VET QUART, V16, pS87; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; BUSE MG, 1977, BIOCHIM BIOPHYS ACTA, V475, P81, DOI 10.1016/0005-2787(77)90341-0; Cabezas H, 1999, MOL CELL BIOCHEM, V201, P57, DOI 10.1023/A:1007042531454; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Castejon-Riber C, 2017, J EQUINE VET SCI, V56, P93, DOI 10.1016/j.jevs.2017.04.011; Castell LM, 1996, EUR J APPL PHYSIOL O, V73, P488, DOI 10.1007/BF00334429; Castell LM, 1999, ADV EXP MED BIOL, V467, P697; Cermak NM, 2009, MED SCI SPORT EXER, V41, P2158, DOI 10.1249/MSS.0b013e3181ac10bf; CHALMERS GR, 1992, J APPL PHYSIOL, V73, P631, DOI 10.1152/jappl.1992.73.2.631; Coligan JKA, 1991, CURRENT PROTOCOLS IM; CONLEE RK, 1976, AM J PHYSIOL, V231, P614, DOI 10.1152/ajplegacy.1976.231.2.614; Cruzat VF., 2019, NUTR SKELETAL MUSCLE, P299, DOI [10.1016/B978-0-12-810422-4.00017, DOI 10.1016/B978-0-12-810422-4.00017]; D'Angelis FHF, 2005, J ANIM SCI, V83, P579; da Silva RP, 2019, AMINO ACIDS, V51, P83, DOI 10.1007/s00726-018-2643-2; Darmaun D, 2004, J CLIN ENDOCR METAB, V89, P1146, DOI 10.1210/jc.2003-031409; DAVIS JM, 1992, EUR J APPL PHYSIOL, V65, P513, DOI 10.1007/BF00602357; Davis JM, 2000, AM J CLIN NUTR, V72, p573S, DOI 10.1093/ajcn/72.2.573S; DAVIS TA, 1985, AM J PHYSIOL, V248, pE337, DOI 10.1152/ajpendo.1985.248.3.E337; de Bruijn CM, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0969-8; De Palo P, 2013, ASIAN AUSTRAL J ANIM, V26, P1637, DOI 10.5713/ajas.2013.13174; Dechelotte P, 2006, CRIT CARE MED, V34, P598, DOI 10.1097/01.CCM.0000201004.30750.D1; Deda O, 2017, METABOLITES, V7, DOI 10.3390/metabo7010010; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Derave W, 2019, AMINO ACIDS, V51, P1, DOI 10.1007/s00726-018-02689-9; Derave W, 2012, AMINO ACIDS, V43, P1, DOI 10.1007/s00726-012-1281-3; DIJKSTRA J, 1994, LIVEST PROD SCI, V39, P61, DOI 10.1016/0301-6226(94)90154-6; DOHM GL, 1977, BIOCHEM J, V164, P705, DOI 10.1042/bj1640705; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Durheim MT, 2008, AM J PHYSIOL-ENDOC M, V295, pE407, DOI 10.1152/ajpendo.90397.2008; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; ESSENGUSTAVSSON B, 1989, EQUINE VET J, V21, P27, DOI 10.1111/j.2042-3306.1989.tb02085.x; Eto D, 2004, RES VET SCI, V76, P139, DOI 10.1016/j.rvsc.2003.08.010; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fazelzadeh P, 2016, J PROTEOME RES, V15, P499, DOI 10.1021/acs.jproteome.5b00840; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Firshman AM, 2015, AM J VET RES, V76, P1058, DOI 10.2460/ajvr.76.12.1058; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Foure A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101047; Fry CS, 2014, J PHYSIOL-LONDON, V592, P2625, DOI 10.1113/jphysiol.2014.271288; Garvey SM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12319; GIDDINGS CJ, 1992, ANAT REC, V233, P178, DOI 10.1002/ar.1092330203; Gorgey AS, 2010, J SPINAL CORD MED, V33, P90, DOI 10.1080/10790268.2010.11689681; GOTTLIEB M, 1989, J APPL PHYSIOL, V67, P570, DOI 10.1152/jappl.1989.67.2.570; Greco-Otto P, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1290-2; Grosicki GJ, 2018, CALCIFIED TISSUE INT, V102, P433, DOI 10.1007/s00223-017-0345-5; Gryp T, 2017, TOXINS, V9, DOI 10.3390/toxins9020052; Guo HF, 2015, NEUROTOXICOLOGY, V48, P180, DOI 10.1016/j.neuro.2015.03.010; GUY PS, 1977, J PHYSIOL-LONDON, V269, P33, DOI 10.1113/jphysiol.1977.sp011891; Hankard RG, 2000, AM J PHYSIOL-ENDOC M, V279, pE608, DOI 10.1152/ajpendo.2000.279.3.E608; Hankard RG, 1997, DIABETES, V46, P1535, DOI 10.2337/diabetes.46.10.1535; HARKINS JD, 1991, J EQUINE VET SCI, V11, P237, DOI 10.1016/S0737-0806(06)80987-1; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; HENDERSON SA, 1985, AM J PHYSIOL, V249, pE137, DOI 10.1152/ajpendo.1985.249.2.E137; HINTZ HF, 1994, ANNU REV NUTR, V14, P243, DOI 10.1146/annurev.nu.14.070194.001331; HODGSON DR, 1985, EQUINE VET J, V17, P300, DOI 10.1111/j.2042-3306.1985.tb02504.x; HODGSON DR, 1986, AM J VET RES, V47, P12; Hodson N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010023; Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1; Hoppeler H, 2011, COMPR PHYSIOL, V1, P1383, DOI 10.1002/cphy.c100042; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; Javierre C, 2010, INT J NEUROSCI, V120, P319, DOI 10.3109/00207450903389404; Jaworowski A, 2002, ACTA PHYSIOL SCAND, V176, P215, DOI 10.1046/j.1365-201X.2002.t01-2-01004.x; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Karp JR, 2001, STRENGTH COND J, V23, P21, DOI 10.1519/1533-4295(2001)023<0021:MFTAT>2.0.CO;2; Kawai M, 2009, ANAT REC, V292, P1663, DOI 10.1002/ar.20961; KENNEDY JM, 1988, AM J ANAT, V181, P203, DOI 10.1002/aja.1001810209; Kiens B, 2003, ACTA PHYSIOL SCAND, V178, P391, DOI 10.1046/j.1365-201X.2003.01156.x; Kim JS, 2005, J APPL PHYSIOL, V98, P334, DOI 10.1152/japplphysiol.00172.2003; Klein DJ, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00110; Klein DJ, 2018, FASEB J, V32; Korhonen M, 2002, J DAIRY SCI, V85, P1533, DOI 10.3168/jds.S0022-0302(02)74223-9; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Kuhl J, 2008, METABOLOMICS, V4, P273, DOI 10.1007/s11306-008-0118-2; Latham CM, 2017, J ANIM SCI, V95, P53, DOI 10.2527/asasann.2017.107; Le Moyec L, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00045; Le Moyec L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090730; Le Moyec L, 2012, ANAL BIOANAL CHEM, V404, P593, DOI 10.1007/s00216-012-6165-6; Lee EC, 2017, J STRENGTH COND RES, V31, P2920, DOI 10.1519/JSC.0000000000002122; LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984; Leisson K, 2008, J EQUINE VET SCI, V28, P395, DOI 10.1016/j.jevs.2008.05.007; Lindner A, 2012, J ANIM PHYSIOL AN N, V96, P563, DOI 10.1111/j.1439-0396.2011.01179.x; Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044375; LOPEZRIVERO JL, 1992, AM J VET RES, V53, P847; LOPEZRIVERO JL, 1991, EQUINE VET J, V23, P91, DOI 10.1111/j.2042-3306.1991.tb02727.x; Luck MM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00198; Mach N, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3571-3; MACLENNAN PA, 1987, FEBS LETT, V215, P187, DOI 10.1016/0014-5793(87)80139-4; McArdle W.D., 2007, EXERCISE PHYSL ENERG; McDonald AE, 2018, COMP BIOCHEM PHYS B, V224, P185, DOI 10.1016/j.cbpb.2017.11.006; Meredith-Jones K, 2011, COMPLEMENT THER MED, V19, P93, DOI 10.1016/j.ctim.2011.02.002; Miyata H, 2018, J PHYSIOL SCI, V68, P639, DOI 10.1007/s12576-017-0575-3; Monirujjaman M., 2014, ADV MOL BIOL, P1, DOI [10.1155/2014/364976, DOI 10.1155/2014/364976]; Mooij MJW, 2013, VET J, V198, pE120, DOI 10.1016/j.tvjl.2013.09.045; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; Murphy JC, 2012, J APPL PHYSIOL, V112, P79, DOI 10.1152/japplphysiol.00355.2011; Muthny T, 2008, INT J EXP PATHOL, V89, P64, DOI 10.1111/j.1365-2613.2007.00553.x; Nagahisa H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1535367; Nankervis KJ, 2017, J EQUINE VET SCI, V53, P108, DOI 10.1016/j.jevs.2017.01.010; Neinast MD, 2019, CELL METAB, V29, P417, DOI 10.1016/j.cmet.2018.10.013; Nygaard E., 1978, SWIMMING MED, P282; Ohmura H, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-59; ORWELL RL, 1977, GASTROENTEROLOGY, V73, P1320; Parkinson S, 2018, COMP EXERC PHYSIOL, V14, P79, DOI 10.3920/CEP170031; PARRYBILLINGS M, 1989, INT J BIOCHEM, V21, P419, DOI 10.1016/0020-711X(89)90366-2; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; Payne RC, 2005, J ANAT, V206, P193, DOI 10.1111/j.1469-7580.2005.00353.x; Pechlivanis A, 2013, J PROTEOME RES, V12, P470, DOI 10.1021/pr300846x; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Plancade S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46118-7; Ploeg M, 2017, EQUINE VET J, V49, P269, DOI 10.1111/evj.12641; Ploeg M, 2015, VET PATHOL, V52, P152, DOI 10.1177/0300985814528219; Poos M., 1999, COMM MIL NUTR RES I; Prada PO, 2007, DIABETOLOGIA, V50, P1949, DOI 10.1007/s00125-007-0723-z; Qatamish MA, 2020, BIOMED RES-TOKYO, V41, P227, DOI 10.2220/biomedres.41.227; Rezende RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211824; Rivero J L, 2006, Equine Vet J Suppl, P311; Rivero JLL, 1996, AM J VET RES, V57, P1412; Rivero JLL, 1996, ANAT RECORD, V246, P195; Rivero JLL, 2007, J APPL PHYSIOL, V102, P1871, DOI 10.1152/japplphysiol.01093.2006; Rivero JLL, 2016, VET J, V209, P5, DOI 10.1016/j.tvjl.2015.11.019; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Rowbottom DG, 1996, SPORTS MED, V21, P80, DOI 10.2165/00007256-199621020-00002; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Saey V, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1454-8; Saey V, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0597-0; Samocha-Bonet D, 2011, J NUTR, V141, P1233, DOI 10.3945/jn.111.139824; Santamaria S, 2005, AM J VET RES, V66, P418, DOI 10.2460/ajvr.2005.66.418; Schaun MI, 2011, CELL BIOCHEM FUNCT, V29, P534, DOI 10.1002/cbf.1781; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Schilling N, 2009, ZOOLOGY, V112, P279, DOI 10.1016/j.zool.2008.09.007; Schurink A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060480; Scott R, 2010, EQUINE VET J, V42, P662, DOI 10.1111/j.2042-3306.2010.00194.x; Scott W, 2001, PHYS THER, V81, P1810, DOI 10.1093/ptj/81.11.1810; Serrano AL, 2000, PFLUG ARCH EUR J PHY, V441, P263, DOI 10.1007/s004240000408; Shaw CS, 2010, ANNU REV NUTR, V30, P13, DOI 10.1146/annurev.nutr.012809.104817; Shimomura Y, 2000, J NUTR SCI VITAMINOL, V46, P71, DOI 10.3177/jnsv.46.71; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Sinha A.K., 1991, EQUINE EXERCISE PHYS, V3, P223; SINHA AK, 1993, RES VET SCI, V54, P147, DOI 10.1016/0034-5288(93)90050-P; Suzuki Y, 2002, JPN J PHYSIOL, V52, P199, DOI 10.2170/jjphysiol.52.199; Talbot J, 2016, WIRES DEV BIOL, V5, P518, DOI 10.1002/wdev.230; TAYLOR AW, 1981, CAN J ANIM SCI, V61, P601, DOI 10.4141/cjas81-072; Santos RVT, 2007, LIFE SCI, V80, P573, DOI 10.1016/j.lfs.2006.10.015; Tipton KD, 2001, INT J SPORT NUTR EXE, V11, P109, DOI 10.1123/ijsnem.11.1.109; Tokuriki M, 1999, Equine Vet J Suppl, P231; Tranquille CA, 2017, J EQUINE VET SCI, V50, P76, DOI 10.1016/j.jevs.2016.10.011; Trombetta MF, 2017, ANIM SCI J, V88, P1107, DOI 10.1111/asj.12737; TULLSON PC, 1991, AM J PHYSIOL, V261, pC342, DOI 10.1152/ajpcell.1991.261.2.C342; Turcotte LP, 2008, PHYS THER, V88, P1279, DOI 10.2522/ptj.20080018; Tyler CM, 1998, PFLUG ARCH EUR J PHY, V436, P391, DOI 10.1007/s004240050648; Valberg S., 1987, Journal of Equine Veterinary Science, V7, P6, DOI 10.1016/S0737-0806(87)80085-0; van de Goor LHP, 2011, ANIM GENET, V42, P627, DOI 10.1111/j.1365-2052.2011.02194.x; Van Der Laarse WJ, 1998, NETH J ZOOL, V48, P213; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; VARNIER M, 1995, AM J PHYSIOL-ENDOC M, V269, pE309, DOI 10.1152/ajpendo.1995.269.2.E309; Violante S, 2013, BBA-MOL BASIS DIS, V1832, P773, DOI 10.1016/j.bbadis.2013.02.012; VIRU A A, 1984, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V70, P1624; Viru AA, 2001, BIOCH MONITORING SPO; Voss B, 2002, J VET MED A, V49, P137, DOI 10.1046/j.1439-0442.2002.00420.x; Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287; Walker DK, 2011, MED SCI SPORT EXER, V43, P2249, DOI 10.1249/MSS.0b013e318223b037; Waller AP, 2010, EQUINE VET J, V42, P274, DOI 10.2746/042516409X479603; Waran NK., 2005, DOMESTIC HORSE ORIGI, P264; Warnberg J, 2010, P NUTR SOC, V69, P400, DOI 10.1017/S0029665110001928; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Wolfe RR, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0184-9; Xiang L, 2018, ANAL CHIM ACTA, V1037, P130, DOI 10.1016/j.aca.2017.11.082; YAMADA S, 1989, MED SCI SPORT EXER, V21, pS173; Yamano S, 2006, RES VET SCI, V80, P109, DOI 10.1016/j.rvsc.2005.04.006; Yamano S, 2002, AM J VET RES, V63, P1408, DOI 10.2460/ajvr.2002.63.1408; Yamano Seiko, 2010, Journal of Equine Science, V21, P59, DOI 10.1294/jes.21.59; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Yarnell K, 2014, J THERM BIOL, V45, P110, DOI 10.1016/j.jtherbio.2014.08.003; Zhang J, 2019, AM J PHYSIOL-ENDOC M, V316, pE43, DOI 10.1152/ajpendo.00156.2018; Zhang SH, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-016-0139-z; Zhou XW, 1997, BBA-MOL CELL RES, V1357, P234, DOI 10.1016/S0167-4889(97)00035-9; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	209	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249922	10.1371/journal.pone.0249922	http://dx.doi.org/10.1371/journal.pone.0249922			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848308	gold, Green Published			2022-12-26	WOS:000640373500003
J	Chang, HL; Guo, JY; Wei, ZQ; Huang, Z; Wang, CN; Qiu, Y; Xu, XB; Zeng, M				Chang, Hailing; Guo, Jiayin; Wei, Zhongqiu; Huang, Zheng; Wang, Chuning; Qiu, Yue; Xu, Xuebin; Zeng, Mei			Aetiology of acute diarrhoea in children in Shanghai, 2015-2018	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; ESCHERICHIA-COLI; MULTICENTER; INFECTIONS; BURDEN; CHINA; PATHOGENS; NOROVIRUS; MORTALITY; DISEASE	Diarrhoea remains a major cause of childhood morbidity and mortality worldwide. This study aimed to monitor the aetiology of acute diarrhoea in children in Shanghai. Paediatric outpatients with acute diarrhoea were enrolled in the study from Jan 2015 to Dec 2018. Faecal samples were collected for testing. Enteric bacteria were identified and typed by culture and serotyping, respectively. Enteric viruses were identified by real-time PCR. Enteric pathogens were identified in 1572 (58.4%) of the 2692 enrolled children with acute diarrhoea. Viruses were detected more frequently than bacteria (41.3% versus 25.0%). Nontyphoidal Salmonella spp. (NTS) was the most common (10.3%) bacteria isolated, followed by enteropathogenic Escherichia coli (EPEC) (6.5%), enteroaggregative Escherichia coli (EAEC) (6.2%), Campylobacter spp. (3.6%), enterotoxigenic Escherichia coli (ETEC) (1.1%), Shigella spp. (0.2%), and enterohemorrhagic Escherichia coli (EHEC) (0.1%). Rotavirus was the most common (16.0%) virus detected, followed by norovirus (15.5%), adenovirus (7.2%), sapovirus (3.0%) and astrovirus (2.7%). Rotavirus, norovirus and NTS were the major pathogens responsible for diarrhoea in Shanghainese children. Improving uptake of the rotavirus vaccine and strengthening foodborne-pathogen prevention will aid in reducing the burden of diarrhoeal disease in children in Shanghai.	[Chang, Hailing; Wei, Zhongqiu; Wang, Chuning; Qiu, Yue; Zeng, Mei] Fudan Univ, Childrens Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Guo, Jiayin; Huang, Zheng] Changning Dist Ctr Dis Control & Prevent, Dept Microbiol, Shanghai, Peoples R China; [Xu, Xuebin] Shanghai Municipal Ctr Dis Control & Prevent, Dept Microbiol, Shanghai, Peoples R China	Fudan University; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zeng, M (corresponding author), Fudan Univ, Childrens Hosp, Dept Infect Dis, Shanghai, Peoples R China.; Xu, XB (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept Microbiol, Shanghai, Peoples R China.	xxb72@sina.com; zengmeigao@163.com			Science and Technology Commission of Shanghai Municipality	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	MZ received support from the Science and Technology Commission of Shanghai Municipality.; The grant number is 16411960200.; The URL of the Science and Technology Commission of Shanghai Municipality is http://stcsm.sh.gov.cn/.; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WKLY EPIDEMIOL REC, V83, P1; Banyai K, 2018, LANCET, V392, P175, DOI 10.1016/S0140-6736(18)31128-0; Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14; Bucardo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098201; Chang HL, 2017, PEDIATR INFECT DIS J, V36, P1057, DOI 10.1097/INF.0000000000001562; Cortes-Penfield NW, 2017, CLIN THER, V39, P1537, DOI 10.1016/j.clinthera.2017.07.002; Duffy G, 2014, MEAT SCI, V97, P375, DOI 10.1016/j.meatsci.2014.01.009; Geissler AL, 2017, CLIN INFECT DIS, V65, P1624, DOI 10.1093/cid/cix624; Huang Zheng, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P614; HUILAN S, 1991, B WORLD HEALTH ORGAN, V69, P549; Khalil IA, 2018, LANCET INFECT DIS, V18, P1229, DOI [10.1016/S1473-3099(18)30475-4, 10.1016/s1473-3099(18)30475-4]; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Liu N, 2014, VACCINE, V32, P4369, DOI 10.1016/j.vaccine.2014.06.018; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Pires SM, 2014, FOODBORNE PATHOG DIS, V11, P667, DOI 10.1089/fpd.2014.1744; Reiner RC, 2018, NEW ENGL J MED, V379, P1128, DOI 10.1056/NEJMoa1716766; Riddle MS, 2018, CLIN MICROBIOL INFEC, V24, P1039, DOI 10.1016/j.cmi.2018.06.023; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Song PG, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020802; Stockmann C, 2017, J PEDIAT INF DIS SOC, V6, P231, DOI 10.1093/jpids/piw020; Tack DM, 2019, MMWR-MORBID MORTAL W, V68, P369, DOI 10.15585/mmwr.mm6816a2; Tan Y, 2019, CHINESE MED J-PEKING, V132, P336, DOI 10.1097/CM9.0000000000000072; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; Thompson CN, 2015, AM J TROP MED HYG, V92, P1045, DOI 10.4269/ajtmh.14-0655; Tobias J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0804-4; Troeger C, 2018, JAMA PEDIATR, V172, P958, DOI 10.1001/jamapediatrics.2018.1960; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; Wang JJ, 2018, J MED VIROL, V90, P1695, DOI 10.1002/jmv.25236; Wang X, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131771, 10.1371/journal.pone.0142136]; Wang Yan-ping, 2005, Zhonghua Yufang Yixue Zazhi, V39, P260; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001	34	2	3	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249888	10.1371/journal.pone.0249888	http://dx.doi.org/10.1371/journal.pone.0249888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831124	gold, Green Published			2022-12-26	WOS:000639359600007
J	Rahman, MA; Rahman, MA; Rawal, LB; Paudel, M; Howlader, MH; Khan, B; Siddiquee, T; Rahman, A; Sarkar, A; Rahman, MS; Botlero, R; Islam, SMS				Rahman, Md Ashfikur; Rahman, Muhammad Aziz; Rawal, Lal B.; Paudel, Mohan; Howlader, Md Hasan; Khan, Bayezid; Siddiquee, Tanjim; Rahman, Abdur; Sarkar, Apurbo; Rahman, Md Sazedur; Botlero, Roslin; Islam, Sheikh Mohammed Shariful			Factors influencing place of delivery: Evidence from three south-Asian countries	PLOS ONE			English	Article							WOMEN; TRENDS	Background High maternal mortality is still a significant public health challenge in many countries of the South-Asian region. The majority of maternal deaths occur due to pregnancy and delivery-related complications, which can mostly be prevented by safe facility delivery. Due to the paucity of existing evidence, our study aimed to examine the factors associated with place of delivery, including women's preferences for such in three selected South-Asian countries. Methods We extracted data from the most recent demographic and health surveys (DHS) conducted in Bangladesh (2014), Nepal (2016), and Pakistan (2017-18) and analyzed to identify the association between the outcome variable and socio-demographic characteristics. A total of 16,429 women from Bangladesh (4278; mean age 24.57 years), Nepal (3962; mean age 26.35 years), and Pakistan (8189; mean age 29.57 years) were included in this study. Following descriptive analyses, bivariate and multivariate logistic regressions were conducted. Results Overall, the prevalence of facility-based delivery was 40%, 62%, and 69% in Bangladesh, Nepal, and Pakistan, respectively. Inequity in utilizing facility-based delivery was observed for women in the highest wealth quintile. Participants from Urban areas, educated, middle and upper household economic status, and with high antenatal care (ANC) visits were significantly associated with facility-based delivery in all three countries. Interestingly, watching TV was also found as a strong determinant for facility-based delivery in Bangladesh (aOR = 1.31, 95% CI:1.09-1.56, P = 0.003), Nepal (aOR = 1.42, 95% CI:1.20-1.67, P<0.001) and Pakistan (aOR = 1.17, 95% CI: 1.03-1.32, P = 0.013). Higher education of husband was a significant predictor for facility delivery in Bangladesh (aOR = 1.73, 95% CI:1.27-2.35, P = 0.001) and Pakistan (aOR = 1.19, 95% CI: 0.99-1.43, P = 0.065); husband's occupation was also a significant factor in Bangladesh (aOR = 1.30, 95% CI:1.04-1.61, P = 0.020) and Nepal (aOR = 1.26, 95% CI:1.01-1.58, P = 0.041). Conclusion Our findings suggest that the educational status of both women and their husbands, household economic situation, and the number of ANC visits influenced the place of delivery. There is an urgent need to promote facility delivery by building more birthing facilities, training and deployment of skilled birth attendants in rural and hard-to-reach areas, ensuring compulsory female education for all women, encouraging more ANC visits, and providing financial incentives for facility deliveries. There is a need to promote facility delivery by encouraging health facility visits through utilizing social networks and continuing mass media campaigns. Ensuring adequate Government funding for free maternal and newborn health care and local community involvement is crucial for reducing maternal and neonatal mortality and achieving sustainable development goals in this region.	[Rahman, Md Ashfikur; Howlader, Md Hasan; Khan, Bayezid] Khulna Univ, Dev Studies Discipline, Khulna, Bangladesh; [Rahman, Muhammad Aziz] Federat Univ Australia, Sch Hlth, Berwick, Vic, Australia; [Rahman, Muhammad Aziz] La Trobe Univ, Australian Inst Primary Care & Ageing AIPCA, Melbourne, Vic, Australia; [Rahman, Muhammad Aziz] Bangladesh Univ Hlth Sci BUHS, Dept Noncommunicable Dis, Dhaka, Bangladesh; [Rawal, Lal B.] Cent Queensland Univ, Coll Sci & Sustainabil, Sch Hlth Med & Appl Sci, Sydney Campus, Sydney, NSW, Australia; [Paudel, Mohan] Adara Dev Australia, Sydney, NSW, Australia; [Siddiquee, Tanjim; Rahman, Abdur; Rahman, Md Sazedur] Khulna Univ, Stat Discipline, Khulna, Bangladesh; [Sarkar, Apurbo] Northwest A&F Univ, Yangling, Shaanxi, Peoples R China; [Botlero, Roslin] Monash Univ, Monash Global & Womens Hlth Unit, Melbourne, Vic, Australia; [Islam, Sheikh Mohammed Shariful] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia	Khulna University; Federation University Australia; La Trobe University; Bangladesh University of Health Sciences (BUHS); Central Queensland University; Khulna University; Northwest A&F University - China; Monash University; Deakin University	Rahman, MA (corresponding author), Khulna Univ, Dev Studies Discipline, Khulna, Bangladesh.	ashfikur@ku.ac.bd	Islam, Mohammed Shariful/B-1219-2011; Rahman, Muhammad Aziz/B-3380-2009; Rahman, Md Ashfikur/AAU-3170-2021; Sarkar, Apurbo/AAO-7476-2020; Howlader, Md. Hasan/AFR-1027-2022	Islam, Mohammed Shariful/0000-0001-7926-9368; Rahman, Muhammad Aziz/0000-0003-1665-7966; Rahman, Md Ashfikur/0000-0002-5517-8557; Sarkar, Apurbo/0000-0001-6520-9217; Howlader, Md. Hasan/0000-0001-6603-7189; Rahman, Abdur/0000-0003-2131-7456; Siddiquee, Tanjim/0000-0002-3799-5182				Afsana K, 2001, REPROD HEALTH MATTER, V9, P79, DOI 10.1016/S0968-8080(01)90094-1; [Anonymous], 2015, AUST J EMERG MANAG, V30, P9; Benova L, 2017, HEALTH POLICY PLANN, V32, P1294, DOI 10.1093/heapol/czx087; Bhattacharyya S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0839-6; Bishanga DR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209672; Boules N., EARLY INTERV PERINAT; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Bruce SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0481-8; Chanda SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232257; Devkota B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228440; Dickson Kwamena Sekyi, 2016, Int J Reprod Med, V2016, P7203980, DOI 10.1155/2016/7203980; Gebregziabher NK, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7253-8; Kamal SMM, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1372, DOI 10.1177/1010539513486178; Kamal SMM, 2013, J HEALTH POPUL NUTR, V31, P96; Kifle MM, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0153-1; Mahumud RA, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020132; Ministry of Health N., 2016, NEP DEM HLTH SURV 20; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; National Institute of Population Research and Training (NIPORT) , BANGL DEM HLTH SURV, P2014; National Institute of Population Research and Training (NIPORT) , BANGL DEM HLTH SURV, P2019; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Nyarko Samuel H, 2015, Fertil Res Pract, V1, P10, DOI 10.1186/s40738-015-0002-5; [Pakistan] NI of PS, PAK DEM HLTH SURV 20; Pardeshi GS, 2011, J HEALTH POPUL NUTR, V29, P71; Paudel M, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3979-3; Paudel M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194328; Prata N, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-78; Rahman MM., 2018, ANWER KHAN MOD MED C, V9, P5, DOI [10.3329/akmmcj.v9i1.35815, DOI 10.1016/S0140-6736(17)32366-8]; Rossi AC, 2018, EUR J OBSTET GYN R B, V222, P102, DOI 10.1016/j.ejogrb.2018.01.016; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Sen A, 2013, LANCET, V382, P1966, DOI 10.1016/S0140-6736(13)62162-5; Shah R, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0454-y; Shahabuddin ASM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012446; Shahabuddin ASM, 2015, TROP MED INT HEALTH, V20, P822, DOI 10.1111/tmi.12503; Shrestha SK, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-25; Thind A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-29; Tsegaye Yegezu R., 2015, J WOMENS HLTH CARE, V04, P1, DOI [10.4172/2167-0420.1000211, DOI 10.4172/2167-0420.1000211]; ul Husnain MI, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1844-8; Vallin J., 1985, ESPACE POPULATIONS S, V1985, P515, DOI [10.3406/espos.1985.1063, DOI 10.3406/ESPOS.1985.1063]; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; World Health Organization, TRENDS MAT MORT 2000, P2019; World Health Organization, MAT MORT N D, V22, P2020; Yaya S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001341; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171573	45	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0250012	10.1371/journal.pone.0250012	http://dx.doi.org/10.1371/journal.pone.0250012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831127	Green Published, gold			2022-12-26	WOS:000639359600134
J	Yeo, SC; Lai, CKY; Tan, J; Gooley, JJ				Yeo, Sing Chen; Lai, Clin K. Y.; Tan, Jacinda; Gooley, Joshua J.			A targeted e-learning approach for keeping universities open during the COVID-19 pandemic while reducing student physical interactions	PLOS ONE			English	Article							SCHOOL CLOSURE	The COVID-19 pandemic led to widespread closure of universities. Many universities turned to e-learning to provide educational continuity, but they now face the challenge of how to reopen safely and resume in-class learning. This is difficult to achieve without methods for measuring the impact of school policies on student physical interactions. Here, we show that selectively deploying e-learning for larger classes is highly effective at decreasing campus-wide opportunities for student-to-student contact, while allowing most in-class learning to continue uninterrupted. We conducted a natural experiment at a large university that implemented a series of e-learning interventions during the COVID-19 outbreak. The numbers and locations of 24,000 students on campus were measured over a 17-week period by analysing >24 million student connections to the university Wi-Fi network. We show that daily population size can be manipulated by e-learning in a targeted manner according to class size characteristics. Student mixing showed accelerated growth with population size according to a power law distribution. Therefore, a small e-learning dependent decrease in population size resulted in a large reduction in student clustering behaviour. Our results suggest that converting a small number of classes to e-learning can decrease potential for disease transmission while minimising disruption to university operations. Universities should consider targeted e-learning a viable strategy for providing educational continuity during periods of low community disease transmission.	[Yeo, Sing Chen; Tan, Jacinda; Gooley, Joshua J.] Duke NUS Med Sch, Neurosci & Behav Disorders Programme, Singapore, Singapore; [Lai, Clin K. Y.; Gooley, Joshua J.] Natl Univ Singapore, Inst Appl Learning Sci & Educ Technol, Singapore, Singapore	National University of Singapore; National University of Singapore	Gooley, JJ (corresponding author), Duke NUS Med Sch, Neurosci & Behav Disorders Programme, Singapore, Singapore.; Gooley, JJ (corresponding author), Natl Univ Singapore, Inst Appl Learning Sci & Educ Technol, Singapore, Singapore.	joshua.gooley@duke-nus.edu.sg	; Yeo, Sing Chen/P-7156-2014	Tan, Jacinda/0000-0003-0040-0509; Yeo, Sing Chen/0000-0002-6930-9677; Lai, Clin/0000-0001-8041-4294	NUS Office of the Senior Deputy President Provost; NUS Institute for Applied Learning Sciences and Educational Technology (ALSET)	NUS Office of the Senior Deputy President Provost; NUS Institute for Applied Learning Sciences and Educational Technology (ALSET)	Data storage and management were supported by the NUS Office of the Senior Deputy President & Provost and the NUS Institute for Applied Learning Sciences and Educational Technology (ALSET). We thank research and administrative staff at ALSET and NUS Information Technology (NUS IT). We thank Kevin Hartman (ALSET) and Yung Shing Gene (NUS IT) for assisting with data management and troubleshooting.	Andersen M.S., 2020, COLL OPENINGS MOBILI, DOI [10.1101/2020.09.22.20196048, DOI 10.1101/2020.09.22.20196048]; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Baras Karolina, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P202, DOI 10.1109/PERCOMW.2010.5470669; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Crawford J, 2020, J APPL LEARNING TEAC, V3, DOI [10.37074/jalt.2020.3.1.7, DOI 10.37074/JALT.2020.3.1.7]; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Esposito S, 2020, JAMA PEDIATR, V174, P921, DOI 10.1001/jamapediatrics.2020.1892; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995; Fumanellil L, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004681; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460; Hartmann K, 2019, CEREBROVASC DIS, V48, P26, DOI 10.1159/000502450; Huang R.H, 2020, HDB FACILITATING FLE; Jackson Charlotte, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002149; Kalogianni E., 2015, P 18 AGILE INT C GEO, P9; Li RQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01882-w; Meselson M, 2020, NEW ENGL J MED, V382, P2063, DOI 10.1056/NEJMc2009324; Mohottige IP, 2018, IEEE INT C INFERIEUR, P1, DOI [10.1109/ICIAFS.2018.8913341, DOI 10.1109/ICIAFS.2018.8913341]; National University of Singapore, NUS EM INF; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Pebesma E, 2018, R J, V10, P439; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; RCore Team, 2020, R LANG ENV STAT COMP; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Sevtsuk A., 2008, HDB RES URBAN INFORM, P325; Simma KCJ, 2019, PROCEDIA COMPUT SCI, V155, P495, DOI 10.1016/j.procs.2019.08.069; Singapore Ministry of Health, MOH UPD COVID 19 LOC; Singapore Ministry of Health, MOH NEWS HIGHL SING; Singapore Ministry of Health, MOH SIT REP SING; Tizzoni M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15111; UNESCO, 2020, SCH CLOS CAUS COR CO; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Walke HT, 2020, JAMA-J AM MED ASSOC, V324, P1727, DOI 10.1001/jama.2020.20027	40	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249839	10.1371/journal.pone.0249839	http://dx.doi.org/10.1371/journal.pone.0249839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831082	Green Published, gold			2022-12-26	WOS:000639359600125
J	Munoz-Culla, M; Roncancio-Clavijo, A; Martinez, B; Gorostidi-Aicua, M; Pineiro, L; Azkune, A; Alberro, A; Monge-Ruiz, J; Castillo-Trivino, T; Prada, A; Otaegui, D				Munoz-Culla, Maider; Roncancio-Clavijo, Andres; Martinez, Bruno; Gorostidi-Aicua, Miriam; Pineiro, Luis; Azkune, Arkaitz; Alberro, Ainhoa; Monge-Ruiz, Jorge; Castillo-Trivino, Tamara; Prada, Alvaro; Otaegui, David			O group is a protective factor for COVID19 in Basque population	PLOS ONE			English	Article								ABO blood groups have recently been related to COVID19 infection. In the present work, we performed this analysis using data from 412 COVID19 patients and 17796 blood donors, all of them from Gipuzkoa, a region in Northern Spain. The results obtained confirmed this relation, in addition to showing a clear importance of group O as a protective factor in COVID19 disease, with an OR = 0.59 (CI95% 0.481-0.7177, p<0.0001) while A, B and AB are risk factors. ABO blood groups are slightly differently distributed in the populations and therefore these results should be replicated in the specific areas with a proper control population.	[Munoz-Culla, Maider; Gorostidi-Aicua, Miriam; Alberro, Ainhoa; Castillo-Trivino, Tamara; Otaegui, David] Biodonostia Hlth Res Inst, Grp Multiple Sclerosis, San Sebastian, Spain; [Roncancio-Clavijo, Andres; Castillo-Trivino, Tamara; Prada, Alvaro] Donostia Univ Hosp, Immunol Dept, Osakidetza Basque Hlth Serv, San Sebastian, Spain; [Martinez, Bruno; Castillo-Trivino, Tamara] Osakidetza Basque Hlth Serv, UGC Labs Gipuzkoa, San Sebastian, Spain; [Pineiro, Luis; Castillo-Trivino, Tamara] Donostia Univ Hosp, Microbiol Dept, Osakidetza Basque Hlth Serv, San Sebastian, Spain; [Azkune, Arkaitz; Castillo-Trivino, Tamara] Donostia Univ Hosp, Infect Dis Dept, Osakidetza Basque Hlth Serv, San Sebastian, Spain; [Monge-Ruiz, Jorge; Castillo-Trivino, Tamara] Basque Ctr Blood Transfus & Human Tissues, Osakidetza Basque Hlth Serv, Galdakao, Spain; [Castillo-Trivino, Tamara] Donostia Univ Hosp, Neurol Dept, Osakidetza Basque Hlth Serv, San Sebastian, Spain	Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University Hospital Donostia; University Hospital Donostia; University Hospital Donostia	Otaegui, D (corresponding author), Biodonostia Hlth Res Inst, Grp Multiple Sclerosis, San Sebastian, Spain.	david.otaegui@biodonostia.org	Alberro, Ainhoa/AAP-2216-2021	Alberro, Ainhoa/0000-0002-9985-5812; Gorostidi-Aicua, Miriam/0000-0002-4868-3280; Martinez Perez, Bruno/0000-0001-6779-9089; Monge-Ruiz, Jorge/0000-0002-7807-2595; Castillo-Trivino, Tamara/0000-0002-9249-3185	Instituto de Salud Carlos III [COV20/00314]; European Support (FEDER)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Support (FEDER)	This project has been supported by Instituto de Salud Carlos III (COV20/00314) that includes European Support (FEDER). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Guillon P, 2008, GLYCOBIOLOGY, V18, P1085, DOI 10.1093/glycob/cwn093; On NHC& SA of TCM, 2020, DIAGNOSIS TREATMENT; Zhao S, 2020, INFECT DIS-NOR, V52, P284, DOI 10.1080/23744235.2020.1717598; Zietz Michael, 2020, medRxiv, DOI 10.1101/2020.04.08.20058073	5	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249494	10.1371/journal.pone.0249494	http://dx.doi.org/10.1371/journal.pone.0249494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826662	Green Submitted, gold, Green Published			2022-12-26	WOS:000638119900024
J	Gantert, T; Henkel, F; Wurmser, C; Oeckl, J; Fischer, L; Haid, M; Adamski, J; Esser-von Bieren, J; Klingenspor, M; Fromme, T				Gantert, Thomas; Henkel, Fiona; Wurmser, Christine; Oeckl, Josef; Fischer, Lena; Haid, Mark; Adamski, Jerzy; Esser-von Bieren, Julia; Klingenspor, Martin; Fromme, Tobias			Fibroblast growth factor induced Ucp1 expression in preadipocytes requires PGE2 biosynthesis and glycolytic flux	FASEB JOURNAL			English	Article						Fgf signaling; Fgf8; glucose metabolism; glycolysis; paracrine fibroblast growth factor; PGE(2); preadipocyte; prostaglandin; Ucp1; uncoupling protein 1	BROWN ADIPOSE-TISSUE; FAT; MOUSE; FGF21; MICE; EVOLUTION; ROLES; CELL	High uncoupling protein 1 (Ucp1) expression is a characteristic of differentiated brown adipocytes and is linked to adipogenic differentiation. Paracrine fibroblast growth factor 8b (FGF8b) strongly induces Ucp1 transcription in white adipocytes independent of adipogenesis. Here, we report that FGF8b and other paracrine FGFs act on brown and white preadipocytes to upregulate Ucp1 expression via a FGFR1-MEK1/2-ERK1/2 axis, independent of adipogenesis. Transcriptomic analysis revealed an upregulation of prostaglandin biosynthesis and glycolysis upon Fgf8b treatment of preadipocytes. Oxylipin measurement by LC-MS/MS in FGF8b conditioned media identified prostaglandin E2 as a putative mediator of FGF8b induced Ucp1 transcription. RNA interference and pharmacological inhibition of the prostaglandin E2 biosynthetic pathway confirmed that PGE2 is causally involved in the control over Ucp1 transcription. Importantly, impairment of or failure to induce glycolytic flux blunted the induction of Ucp1, even in the presence of PGE2. Lastly, a screening of transcription factors identified Nrf1 and Hes1 as required regulators of FGF8b induced Ucp1 expression. Thus, we conclude that paracrine FGFs co-regulate prostaglandin and glucose metabolism to induce Ucp1 expression in a Nrf1/Hes1-dependent manner in preadipocytes, revealing a novel regulatory network in control of Ucp1 expression in a formerly unrecognized cell type.	[Gantert, Thomas; Oeckl, Josef; Fischer, Lena; Klingenspor, Martin; Fromme, Tobias] Tech Univ Munich, TUM Sch Life Sci, Dept Mol Nutr Med, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany; [Henkel, Fiona; Esser-von Bieren, Julia] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Helmholtz Ctr Munich, Munich, Germany; [Wurmser, Christine] Tech Univ Munich, TUM Sch Life Sci, Dept Anim Breeding, Freising Weihenstephan, Germany; [Haid, Mark; Adamski, Jerzy] Helmholtz Ctr Munich, Res Unit Mol Endocrinol & Metab, German Res Ctr Environm Hlth, Neuherberg, Germany; [Adamski, Jerzy] German Ctr Diabet Res DZD, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Inst Expt Genet, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Adamski, Jerzy] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Klingenspor, Martin] Tech Univ Munich, EKFZ Else Kroner Fresenius Ctr Nutr Med, Freising Weihenstephan, Germany; [Klingenspor, Martin] Tech Univ Munich, ZIEL Inst Food Hlth, Freising Weihenstephan, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; National University of Singapore; Technical University of Munich; Technical University of Munich	Gantert, T; Fromme, T (corresponding author), Tech Univ Munich, TUM Sch Life Sci, Dept Mol Nutr Med, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany.	thomas.gantert@tum.de; fromme@tum.de	Haid, Mark/J-4304-2019; Fromme, Tobias/AAU-8982-2020; Klingenspor, Martin/D-6930-2011	Haid, Mark/0000-0001-6118-1333; Fromme, Tobias/0000-0001-9150-2513; Adamski, Jerzy/0000-0001-9259-0199; Gantert, Thomas/0000-0002-0945-3167; Klingenspor, Martin/0000-0002-4502-6664; Esser-von Bieren, Julia/0000-0003-1898-9382	German Research Foundation [FR 3628/2--1]	German Research Foundation(German Research Foundation (DFG))	German Research Foundation, Grant/Award Number: FR 3628/2--1	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fresco VM, 2016, J BIOL CHEM, V291, P18730, DOI 10.1074/jbc.M115.702761; Garcia-Alonso V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153751; Gaviraghi M, 2018, EMBO J, V37, DOI 10.15252/embj.201899179; Gemel J, 1996, GENOMICS, V35, P253, DOI 10.1006/geno.1996.0349; Hazebroek MK, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00389; Henkel FDR, 2019, ALLERGY, V74, P1090, DOI 10.1111/all.13700; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jezek P, 2019, BBA-BIOENERGETICS, V1860, P259, DOI 10.1016/j.bbabio.2018.11.007; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Lagarde D, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016303; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; Maddaluno L, 2017, DEVELOPMENT, V144, P4047, DOI 10.1242/dev.152587; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Maurer S, 2021, FEBS J, V288, P3628, DOI 10.1111/febs.15470; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464; Oelkrug R, 2014, FREE RADICAL BIO MED, V77, P210, DOI 10.1016/j.freeradbiomed.2014.09.004; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rulifson IC, 2017, J BIOL CHEM, V292, P1951, DOI 10.1074/jbc.M116.751404; Shamsi F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15055-9; Sun YK, 2019, J MOL ENDOCRINOL, V62, P79, DOI 10.1530/JME-18-0151; Sunmonu NA, 2011, J CELL PHYSIOL, V226, P1722, DOI 10.1002/jcp.22587; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; Uchii M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2474; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang H, 2019, MOL METAB, V20, P14, DOI 10.1016/j.molmet.2018.11.009; Westphal S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44878-w; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	43	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21572	10.1096/fj.202002795R	http://dx.doi.org/10.1096/fj.202002795R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33826782	hybrid			2022-12-26	WOS:000645260100046
J	Ghosh, S; Lewis, KN; Tulsian, R; Astafev, AA; Buffenstein, R; Kondratov, RV				Ghosh, Soumyaditya; Lewis, Kaitlyn N.; Tulsian, Richa; Astafev, Artem A.; Buffenstein, Rochelle; Kondratov, Roman, V			It's about time; divergent circadian clocks in livers of mice and naked mole-rats	FASEB JOURNAL			English	Article						aging; circadian rhythms; clock; glucose metabolism; longevity; mTOR; naked mole-rat	RHYTHMS; METABOLISM; MTOR; COMPONENTS; GLYCOLYSIS; AKT	Light is the key regulator of circadian clock, the time-keeping system synchronizing organism physiology and behavior with environmental day and night conditions. In its natural habitat, the strictly subterranean naked mole-rat (Heterocephalus glaber) has lived in a light-free environment for millennia. We questioned if this species retains a circadian clock and if the patterns of this clock and concomitant rhythms differed in liver tissue from mice and naked mole-rats. As expected, in mice, the various circadian clock genes peaked at different times of the day; the Period gene (Per) group peaked in the evening, whereas Brain and Muscle ARNT-like1 (Bmal1) gene peaked in the morning; this phase shift is considered to be fundamental for circadian clock function. In sharp contrast, in the naked mole-rat both Per1 and Per2, as well as Bmal1, peaked at the same time in the morning-around ZT2-suggesting the organization of the molecular circadian oscillator was different. Moreover, gene expression rhythms associated with glucose metabolism and mTOR signaling also differed between the species. Although the activity of mTORC1 was lower, while that of mTORC2 was higher in naked mole-rat livers compared to mice, unlike that of mice where the expression profiles of glucose metabolism genes were not synchronized, these were highly synchronized in naked mole-rats and likely linked to their use of feeding times at zeitgebers.	[Ghosh, Soumyaditya; Tulsian, Richa; Astafev, Artem A.; Kondratov, Roman, V] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, BGES Dept, 2121 Euclid Ave,SR271, Cleveland, OH 44115 USA; [Lewis, Kaitlyn N.; Buffenstein, Rochelle] UTHSCSA, Barshop Inst Aging & Longev Studies, San Antonio, TX USA; [Buffenstein, Rochelle] Calico Life Sci LLC, San Francisco, CA USA	University System of Ohio; Cleveland State University; University of Texas System; University of Texas Health San Antonio	Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, BGES Dept, 2121 Euclid Ave,SR271, Cleveland, OH 44115 USA.	r.kondratov@csuohio.edu			HHS | National Institutes of Health (NIH) [R01AG039547]; HHS | NIH | National Institute on Aging (NIA) [T32AG021890, R01AG022891]; Cleveland State University (CSU)	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cleveland State University (CSU)	HHS | National Institutes of Health (NIH), Grant/Award Number: R01AG039547; HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: T32AG021890 and R01AG022891; Cleveland State University (CSU), Grant/Award Number: D.R.A.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bozek K, 2010, BIOSYSTEMS, V102, P61, DOI 10.1016/j.biosystems.2010.07.010; Brett R.A., 1991, P137; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R., 2021, ADV EXPT MED BIOL, V1319; Buffenstein R., 2000, LIFE UNDERGROUND BIO; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cribbet MR, 2016, ANN NY ACAD SCI, V1385, P21, DOI 10.1111/nyas.13188; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAVISWALTON J, 1994, NATURWISSENSCHAFTEN, V81, P272, DOI 10.1007/s001140050071; Dominick G, 2015, ENDOCRINOLOGY, V156, P565, DOI 10.1210/en.2014-1690; Fang XD, 2014, CELL REP, V8, P1354, DOI 10.1016/j.celrep.2014.07.030; Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9; Gaun A, 2021, J PROTEOME RES, V20, P1280, DOI 10.1021/acs.jproteome.0c00681; Giebultowicz J, 2010, CURR BIOL, V20, pR608, DOI 10.1016/j.cub.2010.05.052; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kim SM, 2018, FASEB J, V32, P3085, DOI 10.1096/fj.201700784R; Lavocat V., 2013, EVOLUTION AFRICAN MA, P69, DOI [10.4159/harvard.9780674431263.c6, DOI 10.4159/HARVARD.9780674431263.C6]; Lee BP, 2020, GEROSCIENCE, V42, P633, DOI 10.1007/s11357-019-00150-7; Li S, 2015, DIABETES OBES METAB, V17, P33, DOI 10.1111/dom.12520; Meyuhas O, 2015, INT REV CEL MOL BIO, V320, P41, DOI 10.1016/bs.ircmb.2015.07.006; Millius A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00025; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mukherji A, 2015, P NATL ACAD SCI USA, V112, pE6691, DOI 10.1073/pnas.1519807112; Nojima A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069178; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park TJ, 2017, SCIENCE, V356, P305, DOI 10.1126/science.aab3896; QUAY WB, 1981, J NEURAL TRANSM, V52, P107, DOI 10.1007/BF01253102; Riccio AP, 2000, PHYSIOL BEHAV, V71, P15, DOI 10.1016/S0031-9384(00)00280-8; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Ruby JG, 2018, ELIFE, V7, DOI 10.7554/eLife.31157; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Smith MRB., 2021, ADV EXPT MED BIOL, V1319; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wegrzyn LR, 2017, AM J EPIDEMIOL, V186, P532, DOI 10.1093/aje/kwx140; Xie J, 2014, TRANSLATION, V2, DOI 10.4161/trla.28174; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	48	3	3	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21590	10.1096/fj.202100116R	http://dx.doi.org/10.1096/fj.202100116R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33871093	Green Accepted			2022-12-26	WOS:000645260100024
J	Park, SA; Lee, GH; Hoang, TH; Lee, HY; Kang, IY; Chung, MJ; Jin, JS; Chae, HJ				Park, Seon-Ah; Lee, Geum-Hwa; Hoang, The-Hiep; Lee, Hwa-Young; Kang, In-Yeong; Chung, Myong-Ja; Jin, Jong-Sik; Chae, Han-Jung			Heat-inactivated Lactobacillus plantarum nF1 promotes intestinal health in Loperamide-induced constipation rats	PLOS ONE			English	Article							GUT MICROBIOTA; GASSERI CP2305; SAFETY; CELLS; COLONIZATION; ACTIVATION; BACTERIA; EFFICACY	Constipation is a common condition that affects individuals of all ages, and prolonged constipation needs to be prevented to avoid potential complications and reduce the additional stress on individuals with pre-medical conditions. This study aimed to evaluate the effects of heat-inactivated Lactobacillus plantarum (HLp-nF1) on loperamide-induced constipation in rats. Constipation-induced male rats were treated orally with low to high doses of HLp-nF1 and an anti-constipation medication Dulcolax for five weeks. Study has 8 groups, control group; loperamide-treated group; Dulcolax-treated group; treatment with 3.2 x 10(10), 8 x 10(10) and 1.6 x 10(11), cells/mL HLp-nF1; Loperamide + Dulcolax treated group. HLp-nF1 treated rats showed improvements in fecal pellet number, weight, water content, intestinal transit length, and contractility compared to the constipation-induced rats. Also, an increase in the intestine mucosal layer thickness and the number of mucin-producing crypt epithelial cells were observed in HLp-nF1-treated groups. Further, the levels of inflammatory cytokines levels were significantly downregulated by treatment with HLp-nF1 and Dulcolax. Notably, the metagenomics sequencing analysis demonstrated a similar genus pattern to the pre-preparation group and control with HLp-nF1 treatment. In conclusion, the administration of >3.2 x 10(10) cells/mL HLp-nF1 has a positive impact on the constipated rats overall health.	[Park, Seon-Ah; Lee, Geum-Hwa; Hoang, The-Hiep; Lee, Hwa-Young; Chae, Han-Jung] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Nonclin Evaluat Ctr, Biomed Res Inst,Res Inst Clin Med, Jeonju, South Korea; [Hoang, The-Hiep; Lee, Hwa-Young; Chae, Han-Jung] Jeonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju, South Korea; [Hoang, The-Hiep; Lee, Hwa-Young; Chae, Han-Jung] Jeonbuk Natl Univ, Sch Med, Inst New Drug Dev, Jeonju, South Korea; [Kang, In-Yeong] Biogenicskorea Co Ltd, Seoul, South Korea; [Chung, Myong-Ja] Jeonbuk Natl Univ, Dept Pathol, Med Sch, Jeonju, South Korea; [Jin, Jong-Sik] Jeonbuk Natl Univ, Dept Oriental Med Resources, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Chae, HJ (corresponding author), Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Nonclin Evaluat Ctr, Biomed Res Inst,Res Inst Clin Med, Jeonju, South Korea.	hjchae@jbnu.ac.kr		Chae, Han-Jung/0000-0003-4190-9889; Hoang The, Hiep/0000-0003-4694-7155				Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Ayres-Silva JD, 2011, CELL TISSUE RES, V344, P455, DOI 10.1007/s00441-011-1170-1; Ayyanna R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03063; Bhattarai KR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041059; Burta O, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.09.11; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Chen J, 2016, PEERJ, V4, DOI 10.7717/peerj.1514; Chen W, 2012, WORLD J GASTROENTERO, V18, P1391, DOI 10.3748/wjg.v18.i12.1391; Choi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15878; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; Deshpande G, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070871; Ge XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00612-y; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Haller D, 2000, INFECT IMMUN, V68, P752, DOI 10.1128/IAI.68.2.752-759.2000; Hyun J, 2015, J INNATE IMMUN, V7, P87, DOI 10.1159/000365417; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Jeffery V, 2017, J IMMUNOL, V199, P304, DOI 10.4049/jimmunol.1600960; Jespersen Brian, 2015, J Vis Exp, P52324, DOI 10.3791/52324; Jess T, 2020, CLIN GASTROENTEROL H, V18, P881, DOI 10.1016/j.cgh.2019.07.052; Judd LM, 2015, AM J PHYSIOL-GASTR L, V308, pG12, DOI 10.1152/ajpgi.00172.2014; Khalili Leila, 2019, Iranian Biomedical Journal, V23, P68, DOI [10.29252/.23.1.68, 10.29252/ibj.23.1.68]; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kotani Yoshifumi, 2010, Immun Ageing, V7, P11, DOI 10.1186/1742-4933-7-11; Lee HY, 2012, FOOD CHEM TOXICOL, V50, P895, DOI 10.1016/j.fct.2011.12.001; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nishida K, 2017, J APPL MICROBIOL, V123, P1561, DOI 10.1111/jam.13594; O'Sullivan JB, 2009, INT J NEUROPSYCHOPH, V12, P687, DOI 10.1017/S146114570800967X; Ohkusa T, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00019; Padmanabhan P, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-60; Pique N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102534; Romanato G, 2008, INT J COLORECTAL DIS, V23, P931, DOI 10.1007/s00384-008-0503-3; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Sakai Y, 2006, POULTRY SCI, V85, P273, DOI 10.1093/ps/85.2.273; Sanders ME, 2016, J AM PHARM ASSOC, V56, P680, DOI 10.1016/j.japh.2016.07.001; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sugawara Tomonori, 2016, Microbial Ecology in Health and Disease, V27, P30259, DOI 10.3402/mehd.v27.30259; Sun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128214; Taverniti V, 2011, GENES NUTR, V6, P261, DOI 10.1007/s12263-011-0218-x; Vandenplas Y, 2017, J COMP EFFECT RES, V6, P137, DOI 10.2217/cer-2016-0059; Warda AK, 2019, BEHAV BRAIN RES, V362, P213, DOI 10.1016/j.bbr.2018.12.047; Wegh CAM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194673; Wei D, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008831.pub3; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x	45	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0250354	10.1371/journal.pone.0250354	http://dx.doi.org/10.1371/journal.pone.0250354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP4TZ	33872333	gold, Green Published			2022-12-26	WOS:000641723300019
J	Traphagen, NA; Hosford, SR; Jiang, A; Marotti, JD; Brauer, BL; Demidenko, E; Miller, TW				Traphagen, Nicole A.; Hosford, Sarah R.; Jiang, Amanda; Marotti, Jonathan D.; Brauer, Brooke L.; Demidenko, Eugene; Miller, Todd W.			High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer	ONCOGENE			English	Article							POSTMENOPAUSAL WOMEN; ACQUIRED-RESISTANCE; RANDOMIZED-TRIAL; TAMOXIFEN; DIETHYLSTILBESTROL; ESR1; FULVESTRANT; ESTRADIOL; APOPTOSIS	Estrogen receptor alpha (ER)-positive breast cancer is commonly treated with endocrine therapies, including antiestrogens that bind and inhibit ER activity, and aromatase inhibitors that suppress estrogen biosynthesis to inhibit estrogen-dependent ER activity. Paradoxically, treatment with estrogens such as 17b-estradiol can also be effective against ER+ breast cancer. Despite the known efficacy of estrogen therapy, the lack of a predictive biomarker of response and understanding of the mechanism of action have contributed to its limited clinical use. Herein, we demonstrate that ER overexpression confers resistance to estrogen deprivation through ER activation in human ER+ breast cancer cells and xenografts grown in mice. However, ER overexpression and the associated high levels of ER transcriptional activation converted 17b-estradiol from a growth-promoter to a growth-suppressor, offering a targetable therapeutic vulnerability and a potential means of identifying patients likely to benefit from estrogen therapy. Since ER+ breast cancer cells and tumors ultimately developed resistance to continuous estrogen deprivation or continuous 17b-estradiol treatment, we tested schedules of alternating treatments. Oscillation of ER activity through cycling of 17b-estradiol and estrogen deprivation provided long-term control of patient-derived xenografts, offering a novel endocrine-only strategy to manage ER+ breast cancer.	[Traphagen, Nicole A.; Hosford, Sarah R.; Jiang, Amanda; Brauer, Brooke L.; Miller, Todd W.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH 03755 USA; [Marotti, Jonathan D.] Dartmouth Hitchcock Med Ctr, Dept Pathol & Lab Med, Lebanon, NH USA; [Marotti, Jonathan D.] Geisel Sch Med Dartmouth, Lebanon, NH USA; [Marotti, Jonathan D.; Miller, Todd W.] Norris Cotton Canc Ctr, Comprehens Breast Program, Lebanon, NH 03527 USA; [Demidenko, Eugene] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Miller, TW (corresponding author), Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH 03755 USA.; Miller, TW (corresponding author), Norris Cotton Canc Ctr, Comprehens Breast Program, Lebanon, NH 03527 USA.	Todd.W.Miller@dartmouth.edu		Jiang, Amanda/0000-0002-0327-6980; Miller, Todd/0000-0001-8912-2909	Susan G. Komen [CCR1533084]; NIH [R01CA200994, R01CA211869, F31CA243409]; NIH (Dartmouth College Norris Cotton Cancer Center Support Grant) [P30CA023108]	Susan G. Komen(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Dartmouth College Norris Cotton Cancer Center Support Grant)	This work was supported by Susan G. Komen (CCR1533084 to TWM) and NIH (R01CA200994 and R01CA211869 to TWM, F31CA243409 to NAT, Dartmouth College Norris Cotton Cancer Center Support Grant P30CA023108). We thank the following Norris Cotton Cancer Center Shared Resources for their support: Mouse Modeling; Pathology; Biostatistics; Microscopy; Genomics.	Agrawal Amit, 2006, World J Surg Oncol, V4, P44, DOI 10.1186/1477-7819-4-44; [Anonymous], 1960, JAMA-J AM MED ASSOC, V172, P1271; Ariazi EA, 2011, P NATL ACAD SCI USA, V108, P18879, DOI 10.1073/pnas.1115188108; Basudan A, 2019, MOL CANCER RES, V17, P457, DOI 10.1158/1541-7786.MCR-18-0946; BEEX L, 1981, CANCER TREAT REP, V65, P179; BERKENSTAM A, 1989, MOL ENDOCRINOL, V3, P22, DOI 10.1210/mend-3-1-22; CARTER AC, 1977, JAMA-J AM MED ASSOC, V237, P2079, DOI 10.1001/jama.237.19.2079; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chatterjee P, 2019, J CLIN INVEST, V129, P4245, DOI 10.1172/JCI127613; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Demidenko E., 2013, MIXED MODELS THEORY, Vxxvii; Demidenko E, 2020, ADV STAT APPL R; DeRose Yoko S, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1423s60; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Desmedt C, 2016, J CLIN ONCOL, V34, P1872, DOI 10.1200/JCO.2015.64.0334; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Fan P, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0012-7; Fan P, 2015, MOL CANCER RES, V13, P1367, DOI 10.1158/1541-7786.MCR-14-0494; Fan P, 2013, CANCER RES, V73, P4510, DOI 10.1158/0008-5472.CAN-12-4152; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haddow A, 1944, Br Med J, V2, P393; Hosford SR, 2019, MOL ONCOL, V13, P1778, DOI 10.1002/1878-0261.12528; Ingle JN, 2006, J CLIN ONCOL, V24, P1052, DOI 10.1200/JCO.2005.04.1053; INGLE JN, 1981, NEW ENGL J MED, V304, P16, DOI 10.1056/NEJM198101013040104; Iwase H, 2013, BRIT J CANCER, V109, P1537, DOI 10.1038/bjc.2013.520; Lee, 2017, CUREUS, V9; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Lonning PE, 2001, BREAST CANCER RES TR, V67, P111, DOI 10.1023/A:1010619225209; Ma R, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw236; MATELSKI H, 1985, AM J CLIN ONCOL-CANC, V8, P128, DOI 10.1097/00000421-198504000-00004; Mathew P, 2008, ANN ONCOL, V19, P395, DOI 10.1093/annonc/mdm568; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Nielsen KV, 2011, BREAST CANCER RES TR, V127, P345, DOI 10.1007/s10549-010-0984-y; Peethambaram PP, 1999, BREAST CANCER RES TR, V54, P117, DOI 10.1023/A:1006185805079; PEREIRA B, 2016, P NATL ACAD SCI USA, V7; Perey L, 2007, ANN ONCOL, V18, P64, DOI 10.1093/annonc/mdl341; Robertson JFR, 2004, BRIT J CANCER, V90, pS7, DOI 10.1038/sj.bjc.6601630; Robertson JFR, 2009, J CLIN ONCOL, V27, P4530, DOI 10.1200/JCO.2008.21.1136; SACEDA M, 1988, MOL ENDOCRINOL, V2, P1157, DOI 10.1210/mend-2-12-1157; SANCHEZ C, 2011, MOL CELL BIOL, V13; SCHWEIZER M, 2015, LANCET ONCOL, V7; Schweizer MT, 2016, PROSTATE, V76, P1218, DOI 10.1002/pros.23209; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simoes BM, 2015, CELL REP, V12, P1968, DOI 10.1016/j.celrep.2015.08.050; Szmulewitz R, 2009, EUR UROL, V56, P97, DOI 10.1016/j.eururo.2009.02.022; Teply BA, 2018, LANCET ONCOL, V19, P76, DOI 10.1016/S1470-2045(17)30906-3; Yu NY, 2019, JAMA ONCOL, V5, P1304, DOI 10.1001/jamaoncol.2019.1856; Zucchini G, 2015, EUR J CANCER, V51, P2725, DOI 10.1016/j.ejca.2015.08.028	51	3	3	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2021	40	19					3408	3421		10.1038/s41388-021-01782-w	http://dx.doi.org/10.1038/s41388-021-01782-w		APR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SB1JB	33875787	Green Accepted			2022-12-26	WOS:000641218600004
J	Dessu, S; Samuel, S; Gebremeskel, F; Basazin, A; Tariku, Z; Markos, M				Dessu, Samuel; Samuel, Serawit; Gebremeskel, Feleke; Basazin, Alemu; Tariku, Zerihun; Markos, Meles			Determinants of post cesarean section surgical site infection at public hospitals in Dire Dawa administration, Eastern Ethiopia: Case control study	PLOS ONE			English	Article							RISK-FACTORS; WOUND-INFECTION; MORBIDITY; DELIVERY	Introduction Post cesarean section surgical site infection increases both the duration of a patient's hospital stay and unplanned hospital costs. It can delays recovery, prolongs hospitalization, necessitates readmission, and adds to hospital bills and other morbidities as well as mortalities. Method Facility-based case-control study was conducted from 1(st) March to 20(th) April, 2019 among all the mother records enrolled from 1(st) January to 31(st) December, 2018 at Public hospitals in Dire Dawa administration. The records of the mothers' who had post-cesarean section surgical site infection (119) was extracted by a census and every three consecutive controls (357) for each case were collected by trained data collectors using a structured data extraction tool. Variables which had p-value Result Age 20-34 years (AOR:5.4; 95%CI:2.35,12.7), age >35 years (AOR:8.9; 95%CI:1.8,43.9), >= 4 per vaginal examinations (AOR: 4.2; 95%CI:2.16,8.22), current history of Chorioamnionitis (AOR:5; 95%CI:1.05,23.9), previous history of cesarean section (AOR:6.2; 95%CI: 2.72,14.36), provision of antibiotics prophylaxis (AOR:3.2; 95%CI:1.81,5.62), perioperative HCT level <30% (AOR:6.9; 95%CI:3.45,14.1) and duration of rupture of membrane >12 hours (AOR:5.4; 95%CI:1.84,15.87) were the independent determinants of post-cesarean section surgical site infection. Conclusion Increased in age of the mother, higher number of per vaginal examination, having a history of chorioamnionitis, having previous history of cesarean section, not receiving antibiotics prophylaxis, lower perioperative hematocrit level and longer duration of rupture of membrane were statistically significant in multivariable analysis. Therefore; emphasis should be given for mothers who have higher age category, previous cesarean scar and history of choriamnionitis. In addition; provision of antibiotics should be comprehensive for all mothers undergoing cesarean section.	[Dessu, Samuel] Wolkite Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Wolkite, Ethiopia; [Samuel, Serawit] Wolaita Soddo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Soddo, Ethiopia; [Gebremeskel, Feleke] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Basazin, Alemu] Debre Berhan Univ, Coll Med & Hlth Sci, Dept Nursing, Debre Berhan, Ethiopia; [Tariku, Zerihun; Markos, Meles] Dire Dawa Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dire Dawa, Ethiopia	Arba Minch University	Dessu, S (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Wolkite, Ethiopia.	dessusamuel@yahoo.com	Tariku, Zerihun/AAT-8097-2021	Tariku, Zerihun/0000-0001-9447-4781				Adane F, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0212-6; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; [Anonymous], 2014, Obstet Gynecol, V123, P693, DOI 10.1097/01.AOG.0000444441.04111.1d; Assawapalanggool S, 2016, AM J INFECT CONTROL, V44, P990, DOI 10.1016/j.ajic.2016.01.031; Baranek E., 2015, DEV MED CHILD NEUROL, V57; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bharatnur S., 2018, INT J REPROD CONTRAC, V7, P966; Bilal AI, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1414-6; Bizimana JK., 2016, INT J CURRENT MICROB, V5, P631; Bruce J, 2001, Health Technol Assess, V5, P1; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Center for Disease Prevention and Control (CDC), 1999, GUIDELINE PREVENTION; Cheng KP, 2015, PATIENT PREFER ADHER, V9, P1171, DOI [10.2147/PPA.S66153, 10.2147/PPA.S86153]; Chu K., 2014, WORLD J SURG, P1; Felicia K., 2017, CMAJ, V5, P546; Filbert J., 2014, ANTIMICROB RESIST IN, V3, P2; Farret TCF, 2015, BRAZ J INFECT DIS, V19, P113, DOI 10.1016/j.bjid.2014.09.009; Getnet G., 2018, BMC SAFETY HLTH, V4, P3; HILLAN EM, 1995, J ADV NURS, V22, P1035; Jasim SK, 2015, INT J SCI RES, V6, P1864; Kabore B, 2016, INT J GYNECOL OBSTET, V135, pS107, DOI 10.1016/j.ijgo.2016.08.018; Karl W, 2017, ADV OBSTETR GYNAECOL, V20, P141; Kaye KS, 2004, CLIN INFECT DIS, V39, P1835, DOI 10.1086/425744; Kelemu A., 2017, BMC, V11, P2; Kelley C., 2015, OBG MANAGEMENT, V27; Lijaemiro H., 2019, OBSTET GYNECOLOGY IN; Lyimo FM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-123; Mariam H-A., 2017, SCI REP-UK, P7, DOI [10.1038/s41598-017-00035-9, DOI 10.1038/S41598-017-00035-9]; MARTENS MG, 1995, J REPROD MED, V40, P171; Mitt P, 2005, INFECT CONT HOSP EP, V26, P449, DOI 10.1086/502566; Mpogoro FJ, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-25; Olsen MA, 2008, INFECT CONT HOSP EP, V29, P477, DOI 10.1086/587810; Raka L, 2010, OPEN INFECT DIS J, V4, P125; Schneid-Kofman N, 2005, INT J GYNECOL OBSTET, V90, P10, DOI 10.1016/j.ijgo.2005.03.020; Shakya A, 2010, Kathmandu Univ Med J (KUMJ), V8, P179; Shree R, 2016, AM J PERINAT, V33, P157, DOI 10.1055/s-0035-1563548; Smaill FM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007482.pub2; Teshager M., 2017, BMC PATIENT SAFETY S, V11, P2; Tsehaynesh A-W., 2018, BMC PREGNANCY CHILD, V18, P2; Wodajo S, 2017, ETHIOP J HEALTH SCI, V27, P283, DOI 10.4314/ejhs.v27i3.10; World Health Organization, HLTH CARE ASS INFECT	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250174	10.1371/journal.pone.0250174	http://dx.doi.org/10.1371/journal.pone.0250174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861783	gold, Green Published			2022-12-26	WOS:000641475400051
J	Jin, WJ; Zhao, YL; Zhai, B; Li, YF; Fan, SX; Yuan, PT; Sun, GR; Jiang, RR; Wang, YB; Liu, XJ; Tian, YD; Kang, XT; Li, GX				Jin, Wenjiao; Zhao, Yinli; Zhai, Bin; Li, Yuanfang; Fan, Shengxin; Yuan, Pengtao; Sun, Guirong; Jiang, Ruirui; Wang, Yanbin; Liu, Xiaojun; Tian, Yadong; Kang, Xiangtao; Li, Guoxi			Characteristics and expression profiles of circRNAs during abdominal adipose tissue development in Chinese Gushi chickens	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INHIBITS ADIPOGENIC DIFFERENTIATION; PROMOTES MYOBLAST PROLIFERATION; CIRCULAR RNA; ADIPOCYTE DIFFERENTIATION; FOLLICULAR DEVELOPMENT; MESSENGER-RNA; UP-REGULATION; C/EBP-ALPHA; OBESITY	Circular RNAs (circRNAs) play important roles in adipogenesis. However, studies on circRNA expression profiles associated with the development of abdominal adipose tissue are lacking in chickens. In this study, 12 cDNA libraries were constructed from the abdominal adipose tissue of Chinese domestic Gushi chickens at 6, 14, 22, and 30 weeks. A total of 1,766 circRNAs were identified by Illumina HiSeq 2500 sequencing. These circRNAs were primarily distributed on chr1 through chr10 and sex chromosomes, and 84.95% of the circRNAs were from gene exons. Bioinformatic analysis showed that each circRNA has 35 miRNA binding sites on average, and 62.71% have internal ribosome entry site (IRES) elements. Meanwhile, these circRNAs were primarily concentrated in TPM < 0.1 and TPM > 60, and their numbers accounted for 18.90% and 80.51%, respectively, exhibiting specific expression patterns in chicken abdominal adipose tissue. In addition, 275 differentially expressed (DE) circRNAs were identified by comparison analysis. Functional enrichment analysis showed that the parental genes of DE circRNAs were primarily involved in biological processes and pathways related to lipid metabolism, such as regulation of fat cell differentiation, fatty acid homeostasis, and triglyceride homeostasis, as well as fatty acid biosynthesis, fatty acid metabolism, and glycerolipid metabolism. Furthermore, ceRNA regulatory networks related to abdominal adipose development were constructed. The results of this study indicated that circRNAs can regulate lipid metabolism, adipocyte proliferation and differentiation, and cell junctions during abdominal adipose tissue development in chickens through complex ceRNA networks between circRNAs, miRNAs, genes, and pathways. The results of this study may help to expand the number of known circRNAs in abdominal adipose tissue and provide a valuable resource for further research on the function of circRNAs in chicken abdominal adipose tissue.	[Jin, Wenjiao; Zhai, Bin; Li, Yuanfang; Fan, Shengxin; Yuan, Pengtao; Sun, Guirong; Jiang, Ruirui; Wang, Yanbin; Liu, Xiaojun; Tian, Yadong; Kang, Xiangtao; Li, Guoxi] Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China; [Zhao, Yinli] Henan Univ Technol, Coll Biol Engn, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan University of Technology	Li, GX (corresponding author), Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China.	liguoxi0914@126.com	Li, Yuan/GXV-1310-2022	zhai, bin/0000-0002-2579-0825	National Natural Science Foundation of China [32072692, 31572356]; Program for Innovation Research Team of Ministry of Education [IRT16R23]; Scientific Studio of Zhongyuan Scholars [30601985]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovation Research Team of Ministry of Education; Scientific Studio of Zhongyuan Scholars	This study was funded by a grant from the National Natural Science Foundation of China (32072692 and 31572356), the Program for Innovation Research Team of Ministry of Education (IRT16R23) and the Scientific Studio of Zhongyuan Scholars (No. 30601985).	Ahn J, 2013, EMBO MOL MED, V5, P1602, DOI 10.1002/emmm.201302647; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bose R, 2018, ADV EXP MED BIOL, V1087, P81, DOI 10.1007/978-981-13-1426-1_7; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Chen B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020177; Chen C, 2014, J MOL ENDOCRINOL, V52, P311, DOI 10.1530/JME-14-0013; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; Chen XL, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110199; Chen Y, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6094-2; Cui SS, 2018, INT J CLIN EXP PATHO, V11, P5203; Davoodian N, 2017, CELL BIOL INT, V41, P1083, DOI 10.1002/cbin.10836; Du WW, 2015, MOL THER, V23, P1222, DOI 10.1038/mt.2015.64; Ebbesen KK, 2016, BBA-GENE REGUL MECH, V1859, P163, DOI 10.1016/j.bbagrm.2015.07.007; Enuka Y, 2016, NUCLEIC ACIDS RES, V44, P1370, DOI 10.1093/nar/gkv1367; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fu SY, 2018, J CELL BIOCHEM, V119, P7063, DOI 10.1002/jcb.27024; Gao Y, 2018, BRIEF BIOINFORM, V19, P803, DOI 10.1093/bib/bbx014; HOOD RL, 1982, POULTRY SCI, V61, P117, DOI 10.3382/ps.0610117; Huang JP, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9070403; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Izawa T, 2015, CELL REP, V11, P1625, DOI 10.1016/j.celrep.2015.05.019; Jeong BC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.485; Jiang R, 2020, MOL THER-NUCL ACIDS, V20, P491, DOI 10.1016/j.omtn.2020.03.011; Jin YY, 2019, J CELL PHYSIOL, V234, P11037, DOI 10.1002/jcp.27928; Kartha RV, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00008; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulcheski FR, 2016, J BIOTECHNOL, V238, P42, DOI 10.1016/j.jbiotec.2016.09.011; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li MH, 2015, BIOL CHEM, V396, P235, DOI 10.1515/hsz-2014-0241; Ling HY, 2011, CLIN EXP PHARMACOL P, V38, P239, DOI 10.1111/j.1440-1681.2011.05493.x; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Liu X, 2019, ANIM GENET, V50, P228, DOI 10.1111/age.12781; Liu X, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0292-7; Liu YJ, 2020, THERANOSTICS, V10, P4705, DOI 10.7150/thno.42417; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Ouyang HJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00172; Ouyang HJ, 2018, DNA RES, V25, P71, DOI 10.1093/dnares/dsx039; Pan SF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0193-4; Park UH, 2014, BIOCHEM BIOPH RES CO, V443, P489, DOI 10.1016/j.bbrc.2013.11.124; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Qin T, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00150; Rockstroh D, 2016, ADIPOCYTE, V5, P283, DOI 10.1080/21623945.2016.1195044; Shen LY, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00677; Shen MM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050489; Shen MM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5462-2; Shen XX, 2019, INT J BIOL SCI, V15, P2265, DOI 10.7150/ijbs.36412; Shi CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09930; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Sun WX, 2020, MOL MED REP, V21, P815, DOI 10.3892/mmr.2019.10886; Taulli R, 2013, NAT STRUCT MOL BIOL, V20, P541, DOI 10.1038/nsmb.2580; Wang H, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6757-z; Wang S, 2018, J CELL PHYSIOL, V233, P7343, DOI 10.1002/jcp.26569; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; Wesselhoeft RA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05096-6; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu BB, 2020, GENE, V730, DOI 10.1016/j.gene.2019.144260; Yang Z, 2011, STEM CELLS DEV, V20, P259, DOI 10.1089/scd.2010.0072; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu CY, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0523-z; Zhang L, 2019, GROWTH HORM IGF RES, V46-47, P16, DOI 10.1016/j.ghir.2019.05.002; Zhang M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071405; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang YF, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040414; Zhao J, 2018, J GENET GENOMICS, V45, P403, DOI 10.1016/j.jgg.2018.07.006; Zhao QG, 2017, J CELL BIOCHEM, V118, P4617, DOI 10.1002/jcb.26126; Zheng L, 2010, J GASTROEN HEPATOL, V25, P156, DOI 10.1111/j.1440-1746.2009.05949.x; Zhong D, 2013, CELL SIGNAL, V25, P1429, DOI 10.1016/j.cellsig.2013.03.003; Zhou CC, 2009, J LIPID RES, V50, P2004, DOI 10.1194/jlr.M800608-JLR200; Zhou J, 2015, INT J OBESITY, V39, P1282, DOI 10.1038/ijo.2015.43; Zhu L, 2018, CANCER BIOMARK, V23, P301, DOI 10.3233/CBM-181675; Zhu YY, 2020, EXP CELL RES, V387, DOI 10.1016/j.yexcr.2019.111753	74	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249288	10.1371/journal.pone.0249288	http://dx.doi.org/10.1371/journal.pone.0249288			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857153	Green Published, gold			2022-12-26	WOS:000641474900079
J	la Woo, A; Oh, DK; Park, CJ; Hong, SB				la Woo, A.; Oh, Dong Kyu; Park, Chan-Jeoung; Hong, Sang-Bum			Monocyte distribution width compared with C-reactive protein and procalcitonin for early sepsis detection in the emergency department	PLOS ONE			English	Article							NEONATAL SEPSIS; SEPTIC SHOCK; DIAGNOSIS; MORTALITY; MDW	Purpose Monocyte distribution width (MDW) has been suggested as an early biomarker of sepsis, but few studies have compared MDW with conventional biomarkers, including C-reactive protein (CRP) and procalcitonin (PCT). This study evaluated MDW as a biomarker for sepsis and compared it with CRP and PCT. Materials and methods Patients aged 18-80 years who visited the emergency department were screened and prospectively enrolled in a tertiary medical center. Complete blood count, MDW, CRP, and PCT were examined. Diagnostic performance for sepsis was tested using the area under the curve (AUC) of receiver operating characteristic (ROC) curves, sensitivity, and specificity. Results In total, 665 patients were screened, and 549 patients with valid laboratory test results were included in the analysis. The patients were categorized into three groups according to the Sepsis-3 criteria: non-infection, infection, and sepsis. MDW showed the highest value in the sepsis group (median [interquartile range], 24.0 [20.8-27.8]). The AUC values for MDW, CRP, PCT, and white blood cells for predicting sepsis were 0.71 (95% confidence interval [CI], 0.67-0.75), 0.75 (95% CI, 0.71-0.78], 0.76 (95% CI, 0.72-0.79, and 0.61 (95% CI, 0.57-0.65), respectively. With the optimal cutoff value of the cohort, the sensitivity was 83.0% for MDW (cutoff, 19.8), 69.7% for CRP (cutoff, 4.0), and 76.6% for PCT (cutoff, 0.05). The combination of quick Sequential Organ Failure Assessment (qSOFA) with MDW improved the AUC (0.76; 95% CI, 0.72-0.80) to a greater extent than qSOFA alone (0.67; 95% CI, 0.62-0.72). Conclusions MDW reflected a diagnostic performance comparable to that of conventional diagnostic markers, implying that MDW is an alternative biomarker. The combination of MDW and qSOFA improves the diagnostic performance for early sepsis.	[la Woo, A.; Oh, Dong Kyu; Hong, Sang-Bum] Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea; [Park, Chan-Jeoung] Univ Ulsan, Asan Med Ctr, Dept Lab Med, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Hong, SB (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea.; Park, CJ (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Lab Med, Coll Med, Seoul, South Korea.	cjpark@amc.seoul.kr; sbhong@amc.seoul.kr		WOO, ALA/0000-0002-8818-6115; Hong, Sang-Bum/0000-0003-2737-7695	Beckmann Coulter	Beckmann Coulter	This study was supported by the Beckmann Coulter under the agreement of industry-academy cooperation. The funders provided the automatic blood cell analyzer DxH 900 for the study. The funders had no role in the study design, data collection and analysis, result analysis and interpretation, decision to publish, or preparation of the manuscript.	Agnello L, 2021, ANN CLIN BIOCHEM, V58, P70, DOI 10.1177/0004563220970447; Agnello L, 2020, CLIN CHEM LAB MED, V58, P1951, DOI 10.1515/cclm-2020-0417; Agnello L, 2020, CLIN CHIM ACTA, V510, P272, DOI 10.1016/j.cca.2020.07.036; ARENSON EB, 1980, J CLIN INVEST, V65, P613, DOI 10.1172/JCI109706; Bartoletti M, 2018, CLIN CHEM LAB MED, V56, P1223, DOI 10.1515/cclm-2018-0259; Boxer LA, 2012, HEMATOL-AM SOC HEMAT, P174, DOI 10.1182/asheducation-2012.1.174; Brunkhorst FM, 1998, INTENS CARE MED, V24, P888, DOI 10.1007/s001340050683; Chan T, 2011, EXPERT REV MOL DIAGN, V11, P487, DOI 10.1586/ERM.11.26; Chen HC, 2013, J ANTIMICROB CHEMOTH, V68, P947, DOI 10.1093/jac/dks475; Crouser ED, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00446-3; Crouser ED, 2019, CRIT CARE MED, V47, P1018, DOI 10.1097/CCM.0000000000003799; Crouser ED, 2017, CHEST, V152, P518, DOI 10.1016/j.chest.2017.05.039; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Eduardo Lopez-Collazo J-MC, 2014, MACROPHAGES BIOL ROL, P315; Gilfillan M, 2019, RES REP NEONATOL, V9, P9, DOI 10.2147/RRN.S163082; Haydar S, 2017, AM J EMERG MED, V35, P1730, DOI 10.1016/j.ajem.2017.07.001; Kim J, 2019, CLIN EXP EMERG MED, V6, P49, DOI 10.15441/ceem.18.007; Landry A, 2017, CAN FAM PHYSICIAN, V63, pE316; Liu VX, 2017, AM J RESP CRIT CARE, V196, P856, DOI 10.1164/rccm.201609-1848OC; Meynaar IA, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/594645; Parlato M, 2018, INTENS CARE MED, V44, P1061, DOI 10.1007/s00134-018-5228-3; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Polilli E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227300; Povoa P, 1998, INTENS CARE MED, V24, P1052, DOI 10.1007/s001340050715; Rhee C, 2021, CLIN INFECT DIS, V72, P541, DOI 10.1093/cid/ciaa059; Ruan L, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2236-1; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Seymour CW, 2017, CRIT CARE MED, V45, P759, DOI [10.1097/CCM.0000000000002264, 10.1097/ccm.0000000000002264]; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	29	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250101	10.1371/journal.pone.0250101	http://dx.doi.org/10.1371/journal.pone.0250101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857210	Green Published, gold			2022-12-26	WOS:000641474900055
J	Vasapolli, R; Venerito, M; Schirrmeister, W; Thon, C; Weigt, J; Wex, T; Malfertheiner, P; Link, A				Vasapolli, Riccardo; Venerito, Marino; Schirrmeister, Wiebke; Thon, Cosima; Weigt, Jochen; Wex, Thomas; Malfertheiner, Peter; Link, Alexander			Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTESTINAL METAPLASIA; CANCER; EXPRESSION; PREVENTION; INDUCTION	Gastric carcinogenesis is associated with alterations of microRNAs (miRNAs) and reversal of these alterations may be a crucial element in cancer prevention. Here we evaluate the influence of H. pylori eradication, low-dose aspirin (LDA), non-steroidal anti-inflammatory drugs (NSAIDs) and proton-pump inhibitors (PPI) on modification of inflammatory mucosal miRNAs miR-155 and miR-223 in Helicobacter pylori-infected and non-infected subjects. The study was performed in two parts: 1) interventional study in 20 healthy subjects with and without H. pylori infection or following eradication (each n = 10) where LDA (100 mg) was given daily for 7 days; 2) prospective case-control observational study (n = 188). MiR-155 and miR-223 expression was strongly linked to H. pylori-infection and in short-term view showed a trend for reversal after eradication. Daily LDA as well as regular NSAIDs showed no influence on miRNAs expression both in healthy subjects and patients, while regular PPI intake was associated with lower miR-155 expression in antrum of patients with chronic gastritis independent of density of neutrophils and mononuclear infiltrate. In summary, PPI but not LDA or NSAIDs were associated with modification of inflammatory miRNAs miR-155 and miR-223 in an H. pylori dependent manner. The functional role of inflammatory miR-155 and miR-223 in understanding of H. pylori-related diseases needs further evaluation.	[Vasapolli, Riccardo; Venerito, Marino; Schirrmeister, Wiebke; Thon, Cosima; Weigt, Jochen; Wex, Thomas; Malfertheiner, Peter; Link, Alexander] Otto von Guericke Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Vasapolli, Riccardo] Hosp Ludwig Maximilians Univ Munich, Dept Internal Med 2, Munich, Germany; [Wex, Thomas] Dept Mol Genet, Med Lab Clin Chem Microbiol & Infect Dis, Magdeburg, Germany	Otto von Guericke University; University Hospital Magdeburg; University of Munich	Link, A (corresponding author), Otto von Guericke Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany.	alexander.link@med.ovgu.de		Weigt, Jochen/0000-0002-3334-2168; Malfertheiner, Peter/0000-0001-8439-9036; Link, Alexander/0000-0002-9514-4562	Scuola Superiore of the University from Catania (Italy); BMBF [BMBF-0315905D]; European Commission through the European funds for regional development"(EFRE); regional Ministry of Economy, Science and Digitalization as part of the "Autonomie im Alter" research group for "LiLife"Project	Scuola Superiore of the University from Catania (Italy); BMBF(Federal Ministry of Education & Research (BMBF)); European Commission through the European funds for regional development"(EFRE); regional Ministry of Economy, Science and Digitalization as part of the "Autonomie im Alter" research group for "LiLife"Project	R.V. was supported by Scuola Superiore of the University from Catania (Italy) as part of his diploma thesis. This work was supported in part by a grant from the BMBF (BMBF-0315905D) to P.M. in the frame of ERA-Net PathoGenoMics project and institutional funds. A.L. is supported by the funds of European Commission through the European funds for regional development"(EFRE) as well as by the regional Ministry of Economy, Science and Digitalization as part of the "Autonomie im Alter" research group for "LiLife"Project.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheung KS, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819834511; Cheung KS, 2018, GUT, V67, P28, DOI 10.1136/gutjnl-2017-314605; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Doorakkers E, 2018, GUT, V67, P2092, DOI 10.1136/gutjnl-2017-315363; Fassan M, 2017, AM J CLIN PATHOL, V147, P301, DOI [10.1093/AJCP/AQX004, 10.1093/ajcp/aqx004]; Fehri LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009500; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Liggett JL, 2014, CANCER LETT, V346, P217, DOI 10.1016/j.canlet.2014.01.021; Link A, 2018, WORLD J GASTROENTERO, V24, P3313, DOI 10.3748/wjg.v24.i30.3313; Link A, 2017, WORLD J GASTROENTERO, V23, P4712, DOI 10.3748/wjg.v23.i26.4712; Link A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08270; Link A, 2012, DIGEST DIS, V30, P255, DOI 10.1159/000336919; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; LOGAN RPH, 1995, GUT, V36, P12, DOI 10.1136/gut.36.1.12; Ma LJ, 2014, BIOSCI BIOTECH BIOCH, V78, P602, DOI 10.1080/09168451.2014.895661; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Nardone G, 2004, DIGEST DIS, V22, P320, DOI 10.1159/000083593; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sheu BS, 2013, HELICOBACTER, V18, P117, DOI 10.1111/hel.12013; Steponaitiene R, 2016, MOL CARCINOGEN, V55, P376, DOI 10.1002/mc.22287; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Sung JJY, 2000, AM J PATHOL, V157, P729, DOI 10.1016/S0002-9440(10)64586-5; Venerito M, 2006, ALIMENT PHARM THER, V23, P1225, DOI 10.1111/j.1365-2036.2006.02856.x; Wan JH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050709; Wang J, 2011, DIGESTION, V83, P253, DOI 10.1159/000280318; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Yang P, 2010, DIGEST DIS SCI, V55, P1533, DOI 10.1007/s10620-009-0915-0; Zhou XY, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0145-6	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249282	10.1371/journal.pone.0249282	http://dx.doi.org/10.1371/journal.pone.0249282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857171	Green Published, gold			2022-12-26	WOS:000641474900081
J	Borish, CN; Bertucco, M; Berger, DJ; d'Avella, A; Sanger, TD				Borish, Cassie N.; Bertucco, Matteo; Berger, Denise J.; d'Avella, Andrea; Sanger, Terence D.			Can spatial filtering separate voluntary and involuntary components in children with dyskinetic cerebral palsy?	PLOS ONE			English	Article							MUSCLE SYNERGIES; REACHING MOVEMENTS; EMG SIGNALS; DYSTONIA; CLASSIFICATION; SUPERPOSITION; STIMULATION; PATTERNS; FEEDBACK; DEVICES	The design of myocontrolled devices faces particular challenges in children with dyskinetic cerebral palsy because the electromyographic signal for control contains both voluntary and involuntary components. We hypothesized that voluntary and involuntary components of movements would be uncorrelated and thus detectable as different synergistic patterns of muscle activity, and that removal of the involuntary components would improve online EMG-based control. Therefore, we performed a synergy-based decomposition of EMG-guided movements, and evaluated which components were most controllable using a Fitts' Law task. Similarly, we also tested which muscles were most controllable. We then tested whether removing the uncontrollable components or muscles improved overall function in terms of movement time, success rate, and throughput. We found that removal of less controllable components or muscles did not improve EMG control performance, and in many cases worsened performance. These results suggest that abnormal movement in dyskinetic CP is consistent with a pervasive distortion of voluntary movement rather than a superposition of separable voluntary and involuntary components of movement.	[Borish, Cassie N.] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90007 USA; [Bertucco, Matteo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Berger, Denise J.; d'Avella, Andrea] Fdn Santa Lucia, Lab Neuromotor Physiol, Rome, Italy; [Berger, Denise J.] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Berger, Denise J.] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [d'Avella, Andrea] Univ Messina, Dept Biomed Dent Morphol & Funct Imaging Sci, Messina, Italy; [Sanger, Terence D.] Univ Calif Irvine, Sch Engn, Irvine, CA USA; [Sanger, Terence D.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Sanger, Terence D.] Childrens Hosp Orange Cty, Orange, CA 92668 USA	University of Southern California; University of Verona; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Messina; University of California System; University of California Irvine; University of California System; University of California Irvine; Childrens Hospital of Orange County	Bertucco, M (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	matteo.bertucco@univr.it	Berger, Denise J/K-3694-2018	Berger, Denise J/0000-0002-4416-3659	Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA	Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA	This research was supported by Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Ambrosini E, 2014, J ELECTROMYOGR KINES, V24, P307, DOI 10.1016/j.jelekin.2014.01.006; Berger DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00046; Berger DJ, 2013, J NEUROSCI, V33, P12384, DOI 10.1523/JNEUROSCI.0122-13.2013; Bernstein N, 1967, COORDINATION REGULAT; Bertucco M, 2019, I IEEE EMBS C NEUR E, P53, DOI 10.1109/NER.2019.8717085; Bertucco M, 2018, IEEE T NEUR SYS REH, V26, P1371, DOI 10.1109/TNSRE.2018.2840445; Bertucco M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139988; Bertucco M, 2015, J HAND THER, V28, P185, DOI 10.1016/j.jht.2014.11.002; Bertucco M, 2014, J CHILD NEUROL, V29, P1460, DOI 10.1177/0883073813494265; Bloom R, 2010, J CHILD NEUROL, V25, P1480, DOI 10.1177/0883073810369704; Borish CN, 2020, INT J HUM-COMPUT ST, V140, DOI 10.1016/j.ijhcs.2020.102432; Cappellini G, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00478; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; d'Avella A, 2011, J NEUROPHYSIOL, V106, P2796, DOI 10.1152/jn.00675.2010; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gusman J, 2017, IEEE J TRANSL ENG HE, V5, DOI 10.1109/JTEHM.2017.2776925; Kamavuako EN, 2014, J ELECTROMYOGR KINES, V24, P770, DOI 10.1016/j.jelekin.2014.06.009; Kargo WJ, 2003, J NEUROSCI, V23, P11255; Lee DD, 2001, ADV NEUR IN, V13, P556; Liyanagamage SA, 2017, J CHILD NEUROL, V32, P161, DOI 10.1177/0883073816671830; Lunardini F, 2017, ANN BIOMED ENG, V45, P1949, DOI 10.1007/s10439-017-1838-0; Lunardini F, 2015, IEEE ENG MED BIO, P2099, DOI 10.1109/EMBC.2015.7318802; Lunardini F, 2015, J CHILD NEUROL, V30, P1676, DOI 10.1177/0883073815578526; Lunardini F, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0045-1; MacKenzie I. S., 1992, Human-Computer Interaction, V7, P91, DOI 10.1207/s15327051hci0701_3; Mohammadiha N, 2014, 2014 4TH JOINT WORKSHOP ON HANDS-FREE SPEECH COMMUNICATION AND MICROPHONE ARRAYS (HSCMA), P27, DOI 10.1109/HSCMA.2014.6843245; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Niu CXM, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01077; Sanger TD, 2005, J CHILD NEUROL, V20, P489, DOI 10.1177/08830738050200060401; Sanger TD, 2003, CURR OPIN NEUROL, V16, P529, DOI 10.1097/00019052-200308000-00014; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; Sanger TD, 2007, IEEE T NEUR SYS REH, V15, P458, DOI 10.1109/TNSRE.2007.903969; Sanger TD, 2007, J NEUROPHYSIOL, V97, P1839, DOI 10.1152/jn.00936.2006; Sanger TD, 2006, PEDIATRICS, V118, P2159, DOI 10.1542/peds.2005-3016; Sanger TD, 2006, J CHILD NEUROL, V21, P551, DOI 10.1177/08830738060210070201; Scheme EJ, 2013, IEEE T NEUR SYS REH, V21, P616, DOI 10.1109/TNSRE.2012.2226189; Seifert HM, 2002, J NEUROSCI, V22, P9465; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; Steele KM, 2015, DEV MED CHILD NEUROL, V57, P1176, DOI 10.1111/dmcn.12826; Steele KM, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00105; Tang L, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046017; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Vujaklija I, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0363-1; Williams MR, 2008, IEEE T NEUR SYS REH, V16, P485, DOI 10.1109/TNSRE.2008.2006216; Young SJ, 2014, J CHILD NEUROL, V29, P232, DOI 10.1177/0883073813492385; Young SJ, 2013, J CHILD NEUROL, V28, P1238, DOI 10.1177/0883073812460092; Young SJ, 2011, MOVEMENT DISORD, V26, P1290, DOI 10.1002/mds.23534; Young SJ, 2011, J CHILD NEUROL, V26, P37, DOI 10.1177/0883073810371828	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250001	10.1371/journal.pone.0250001	http://dx.doi.org/10.1371/journal.pone.0250001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852638	gold, Green Published			2022-12-26	WOS:000640604500018
J	Chilambi, GS; Nordstrom, HR; Evans, DR; Kowalski, RP; Dhaliwal, DK; Jhanji, V; Shanks, RMQ; Van Tyne, D				Chilambi, Gayatri Shankar; Nordstrom, Hayley R.; Evans, Daniel R.; Kowalski, Regis P.; Dhaliwal, Deepinder K.; Jhanji, Vishal; Shanks, Robert M. Q.; Van Tyne, Daria			Genomic and phenotypic diversity of Enterococcus faecalis isolated from endophthalmitis	PLOS ONE			English	Article							BACTERIAL ENDOPHTHALMITIS; ANTIMICROBIAL RESISTANCE; FUNCTIONAL-ANALYSIS; VIRULENCE; ADHESIN; CYTOLYSIN; VERSION; SYSTEM; FECES; TOOL	Enterococcus faecalis are hospital-associated opportunistic pathogens and also causative agents of post-operative endophthalmitis. Patients with enterococcal endophthalmitis often have poor visual outcomes, despite appropriate antibiotic therapy. Here we investigated the genomic and phenotypic characteristics of E. faecalis isolates collected from 13 patients treated at the University of Pittsburgh Medical Center Eye Center over 19 years. Comparative genomic analysis indicated that patients were infected with E. faecalis belonging to diverse multi-locus sequence types (STs) and resembled E. faecalis sampled from clinical, commensal, and environmental sources. We identified known E. faecalis virulence factors and antibiotic resistance genes in each genome, including genes conferring resistance to aminoglycosides, erythromycin, and tetracyclines. We assessed all isolates for their cytolysin production, biofilm formation, and antibiotic susceptibility, and observed phenotypic differences between isolates. Fluoroquinolone and cephalosporin susceptibilities were particularly variable between isolates, as were biofilm formation and cytolysin production. In addition, we found evidence of E. faecalis adaptation during recurrent endophthalmitis by identifying genetic variants that arose in sequential isolates sampled over eight months from the same patient. We identified a mutation in the DNA mismatch repair gene mutS that was associated with an increased rate of spontaneous mutation in the final isolate from the patient. Overall this study documents the genomic and phenotypic variability among E. faecalis causing endophthalmitis, as well as possible adaptive mechanisms underlying bacterial persistence during recurrent ocular infection.	[Chilambi, Gayatri Shankar; Nordstrom, Hayley R.; Evans, Daniel R.; Van Tyne, Daria] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Kowalski, Regis P.; Dhaliwal, Deepinder K.; Jhanji, Vishal; Shanks, Robert M. Q.] Univ Pittsburgh, Sch Med,Eye & Ear Inst, Dept Ophthalmol,Ophthalmol & Visual Sci Res Ctr, Charles T Campbell Ophthalm Microbiol Lab,UPMC Ey, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Van Tyne, D (corresponding author), Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	vantyne@pitt.edu	Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Van Tyne, Daria/0000-0001-7284-0103; Evans, Daniel/0000-0002-3553-9263	PHS grant [EY028222]; University of Pittsburgh Department of Medicine	PHS grant; University of Pittsburgh Department of Medicine(University of Pittsburgh)	This study was funded by PHS grant EY028222 to DVT and by the University of Pittsburgh Department of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beukers AG, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0962-1; Callegan MC, 2002, CLIN MICROBIOL REV, V15, P111, DOI 10.1128/CMR.15.1.111-124.2002; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Ch'ng JH, 2019, NAT REV MICROBIOL, V17, P82, DOI 10.1038/s41579-018-0107-z; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Ciulla TA, 2002, OPHTHALMOLOGY, V109, P13, DOI 10.1016/S0161-6420(01)00899-5; CLSI, 2020, M100ED30 CLSI, DOI DOI 10.1016/S0196-4399(01)88009-0; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Comenge Y, 2003, J BACTERIOL, V185, P7184, DOI 10.1128/JB.185.24.7184-7192.2003; Couvin D, 2018, NUCLEIC ACIDS RES, V46, pW246, DOI 10.1093/nar/gky425; De Vuyst L, 2003, INT J FOOD MICROBIOL, V84, P299, DOI 10.1016/S0168-1605(02)00425-7; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Engelbert M, 2004, INFECT IMMUN, V72, P3628, DOI 10.1128/IAI.72.6.3628-3633.2004; Fiore E, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0053-2018; Freitas Ana R, 2020, Microb Genom, V6, DOI 10.1099/mgen.0.000350; Friling E, 2013, J CATARACT REFR SURG, V39, P15, DOI 10.1016/j.jcrs.2012.10.037; Garcia-Solache M, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00058-18; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Han D, 2011, INT J FOOD MICROBIOL, V144, P387, DOI 10.1016/j.ijfoodmicro.2010.10.024; Hancock L.E., 2014, ENTEROCOCCAL CELL WA, P1; Hidano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121189; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; K VM, 2011, J CATARACT REFR SURG, V37, P1355, DOI DOI 10.1016/J.JCRS.2011.04.014; K VS, 2010, PLOS PATHOG, V6, DOI DOI 10.1371/JOURNAL.PPAT.1000716; Katyal I, 2013, MICROB ECOL, V66, P182, DOI 10.1007/s00248-013-0217-0; Kim JK, 2020, EMERG MICROBES INFEC, V9, P1892, DOI 10.1080/22221751.2020.1810134; Kirstahler P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22416-4; Kishimoto T, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01088-19; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Kristich CJ, 2011, MBIO, V2, DOI 10.1128/mBio.00199-11; Kuriyan AE, 2014, AM J OPHTHALMOL, V158, P1018, DOI 10.1016/j.ajo.2014.07.038; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; Lieberman MT, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01336-18; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Melo GB, 2011, EYE, V25, P383, DOI 10.1038/eye.2010.236; Muscholl-Silberhorn A, 1999, MOL MICROBIOL, V34, P620, DOI 10.1046/j.1365-2958.1999.01631.x; Mylonakis E, 2002, INFECT IMMUN, V70, P4678, DOI 10.1128/IAI.70.8.4678-4681.2002; Nallapareddy SR, 2000, INFECT IMMUN, V68, P5218, DOI 10.1128/IAI.68.9.5218-5224.2000; NOSKIN GA, 1995, INFECT CONT HOSP EP, V16, P577; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Onodera Y, 2002, ANTIMICROB AGENTS CH, V46, P1800, DOI 10.1128/AAC.46.6.1800-1804.2002; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Price VJ, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00464-19; Price VJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00064-16; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Roberts AP, 2009, TRENDS MICROBIOL, V17, P251, DOI 10.1016/j.tim.2009.03.002; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Teng YT, 2017, INT OPHTHALMOL, V37, P513, DOI 10.1007/s10792-016-0288-2; Teoh SCB, 2005, J CATARACT REFR SURG, V31, P622, DOI 10.1016/j.jcrs.2004.06.047; Todokoro D, 2018, JPN J OPHTHALMOL, V62, P699, DOI 10.1007/s10384-018-0630-5; Van Tyne D, 2014, ANNU REV MICROBIOL, V68, P337, DOI 10.1146/annurev-micro-091213-113003; Van Tyne D, 2013, TOXINS, V5, P895, DOI 10.3390/toxins5050895; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Willems RJ, 2003, ANTIMICROB AGENTS CH, V47, P3061, DOI 10.1128/AAC.47.10.3061-3066.2003; Wu MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023500; Wurster JI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208518; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	63	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250084	10.1371/journal.pone.0250084	http://dx.doi.org/10.1371/journal.pone.0250084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852628	Green Published, gold, Green Submitted			2022-12-26	WOS:000640604500011
J	Woldesenbet, S; Kufa-Chakezha, T; Lombard, C; Manda, S; Cheyip, M; Ayalew, K; Chirombo, B; Barron, P; Diallo, K; Parekh, B; Puren, A				Woldesenbet, Selamawit; Kufa-Chakezha, Tendesayi; Lombard, Carl; Manda, Samuel; Cheyip, Mireille; Ayalew, Kassahun; Chirombo, Brian; Barron, Peter; Diallo, Karidia; Parekh, Bharat; Puren, Adrian			Recent HIV infection among pregnant women in the 2017 antenatal sentinel cross-sectional survey, South Africa: Assay-based incidence measurement	PLOS ONE			English	Article							YOUNG-WOMEN; RISK; TRANSMISSION; VIREMIA; COHORT	Introduction New HIV infection during pre-conception and pregnancy is a significant contributor of mother-to-child transmission of HIV in South Africa. This study estimated HIV incidence (defined as new infection within the last one year from the time of the survey which included both new infections occurred during pregnancy or just before pregnancy) among pregnant women and described the characteristics of recently infected pregnant women at national level. Methods Between 1 October and 15 November 2017, we conducted a national cross-sectional survey among pregnant women aged 15-49 years old attending antenatal care at 1,595 public facilities. Blood specimens were collected from pregnant women and tested for HIV in a centralised laboratory. Plasma viral load and Limiting Antigen Avidity Enzyme Immunosorbent Assay (LAg) tests were further performed on HIV positive specimens to differentiate between recent and long-term infections. Recent infection was defined as infection that occurred within one year from the date of collection of blood specimen for the survey. Data on age, age of partner, and marital status were collected through interviews. Women whose specimens were classified as recent by LAg assay and with viral loads >1,000 copies/mL were considered as recently infected. The calculated proportion of HIV positive women with recent infection was adjusted for assay-specific parameters to estimate annual incidence. Survey multinomial logistic regression was used to examine factors associated with being recently infected using HIV negative women as a reference group. Age-disparate relationship was defined as having a partner 5 or more years older. Results Of 10,049 HIV positive participants with LAg and viral load data, 1.4% (136) were identified as recently infected. The annual HIV incidence was 1.5% (95% confidence interval (CI): 1.2-1.7). In multivariable analyses, being single (adjusted odds ratio, aOR: 3.4, 95% CI: 1.8-6.2) or cohabiting (aOR: 3.8, 95% CI: 1.8-7.7), compared to being married as well as being in an age-disparate relationship among young women (aOR: 3.1, 95% CI: 2.0-4.7; reference group: young women (15-24years) whose partners were not 5 years or more older) were associated with higher odds of recent infection. Conclusions Compared to previous studies among pregnant women, the incidence estimated in this study was substantially lower. However, the UNAIDS target to reduce incidence by 75% by 2020 (which is equivalent to reducing incidence to <1%) has not been met. The implementation of HIV prevention and treatment interventions should be intensified, targeting young women engaged in age-disparate relationship and unmarried women to fast track progress towards the UNAIDS target.	[Woldesenbet, Selamawit; Kufa-Chakezha, Tendesayi; Puren, Adrian] Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [Woldesenbet, Selamawit; Kufa-Chakezha, Tendesayi; Barron, Peter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Lombard, Carl] South African Med Res Council, Biostat Unit, Cape Town, South Africa; [Manda, Samuel] South African Med Res Council, Biostat Unit, Pretoria, South Africa; [Manda, Samuel] Univ Pretoria, Dept Stat, Pretoria, South Africa; [Cheyip, Mireille; Ayalew, Kassahun] Ctr Dis Control & Prevent, Strateg Informat Unit, Pretoria, South Africa; [Chirombo, Brian] WHO, HIV & Hepatitis Program, Pretoria, South Africa; [Diallo, Karidia] Ctr Dis Control & Prevent, Lab Branch, Pretoria, South Africa; [Parekh, Bharat] Ctr Dis Control & Prevent, Div Global HIV AIDS, Int Lab Branch, Atlanta, GA USA; [Puren, Adrian] Univ Witwatersrand, Div Virol, Sch Pathol, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand; South African Medical Research Council; South African Medical Research Council; University of Pretoria; World Health Organization; Centers for Disease Control & Prevention - USA; University of Witwatersrand	Woldesenbet, S (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa.; Woldesenbet, S (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	selamawitw@nicd.ac.za	Chirombo, Brian/AGM-7799-2022	Chirombo, Brian/0000-0002-9953-6061; Manda, Samuel/0000-0002-9672-3312; PAREKH, BHARAT/0000-0002-1088-4263; Woldesenbet, Selamawit/0000-0002-5023-3561; Lombard, Carl/0000-0002-2136-6533	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5 NU2GGH001631]; World Health organization (WHO); South African Medical Research Council (SAMRC); National Department of Health (NDoH); NICD	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); World Health organization (WHO)(World Health Organization); South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Department of Health (NDoH); NICD	A.Puren received funding from: the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreement 5 NU2GGH001631, https://www.cdc.gov/.In addition, World Health organization (WHO), South African Medical Research Council (SAMRC), National Department of Health (NDoH), and NICD funded the data collection for the survey. Disclaimer: The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the funding agencies.	Akullian A, 2017, AIDS, V31, P1755, DOI [10.1097/QAD.0000000000001553, 10.1097/qad.0000000000001553]; Anoubissi JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208963; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Centers for Disease Control and Prevention Association of Public Health Laboratories, 2014, LAB TEST DIAGN HIV I; Chetty T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1421-6; Christofides NJ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18585; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; Davey DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192982; Davey DLJ, 2019, AIDS, V33, P1391, DOI 10.1097/QAD.0000000000002221; Davies Natasha E.C.G., 2018, South. Afr. j. HIV med. (Online), V19, P1, DOI 10.4102/sajhivmed.v19i1.915; Ditekemena J, 2011, INT J STD AIDS, V22, P165, DOI 10.1258/ijsa.2010.010379; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Duong YT, 2019, AIDS RES HUM RETROV, V35, P896, DOI [10.1089/aid.2018.0284, 10.1089/AID.2018.0284]; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Ejigu Y, 2019, INT J INFECT DIS, V82, P89, DOI 10.1016/j.ijid.2019.02.019; Fatti G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181691; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Graybill LA, 2020, AIDS, V34, P761, DOI 10.1097/QAD.0000000000002487; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Johnson LF, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002468; Kassanjee R, 2016, AIDS, V30, P2361, DOI 10.1097/QAD.0000000000001209; Kassanjee R, 2014, AIDS RES HUM RETROV, V30, P45, DOI [10.1089/aid.2013.0113, 10.1089/AID.2013.0113]; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Kharsany ABM, 2019, HIV INCIDENCE PROVIN; Kim AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155498; Kinuthia J, 2017, JAIDS-J ACQ IMM DEF, V74, P142, DOI 10.1097/QAI.0000000000001225; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lilian Rivka R., 2019, South. Afr. j. HIV med. (Online), V20, P1, DOI 10.4102/sajhivmed.v20i1.963; Machekano R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209782; Matthews LT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-843; Maughan-Brown B, 2018, JAIDS-J ACQ IMM DEF, V78, P155, DOI 10.1097/QAI.0000000000001656; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Moyo S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204840; Moyo S, 2015, VIRUSES-BASEL, V7, P5508, DOI 10.3390/v7102887; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; National Department of Health, 2019, GUID PROV PREEXP PRO; Pintye J, 2017, CLIN INFECT DIS, V64, P751, DOI 10.1093/cid/ciw850; Ramjee G, 2018, J INFECT DIS, V218, P1759, DOI 10.1093/infdis/jiy388; Simbayi L., 2019, S AFRICAN NATL HIV P; Stats-SA, 2017, MID POP EST; Thomson KA, 2018, J INFECT DIS, V218, P16, DOI 10.1093/infdis/jiy113; Dinh TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130321; UNAIDS, PROGR START FREE STA; UNAIDS [Global HIV stratgic information working group], 2018, REC INF TEST ALG TEC; UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance WHO Technical Working Group on HIV Incidence Assays, 2011, US ASS REC INF EST H; WHO, 2017, TECHN BRIEF PREV HIV; Woldesenbet SA, 2018, 2017 NATL ANTENATAL	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249953	10.1371/journal.pone.0249953	http://dx.doi.org/10.1371/journal.pone.0249953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852629	gold, Green Published			2022-12-26	WOS:000640604500069
J	Sugawara, T; Ban, D; Nishino, J; Watanabe, S; Maekawa, A; Ishikawa, Y; Akahoshi, K; Ogawa, K; Ono, H; Kudo, A; Tanaka, S; Tanabe, M				Sugawara, Toshitaka; Ban, Daisuke; Nishino, Jo; Watanabe, Shuichi; Maekawa, Aya; Ishikawa, Yoshiya; Akahoshi, Keiichi; Ogawa, Kosuke; Ono, Hiroaki; Kudo, Atsushi; Tanaka, Shinji; Tanabe, Minoru			Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection	PLOS ONE			English	Article							OPEN-LABEL; CANCER; GEMCITABINE; SECRETOR; PHASE-3; MODELS; LEWIS; SERUM	Background Even after curative resection, pancreatic ductal adenocarcinoma (PDAC) patients suffer a high rate of recurrence. There is an unmet need to predict which patients will experience early recurrence after resection in order to adjust treatment strategies. Methods Data of patients with resectable PDAC undergoing surgical resection between January 2005 and September 2018 were reviewed to stratify for early recurrence defined as occurring within 6 months of resection. Preoperative data including demographics, tumor markers, blood immune-inflammatory factors and clinicopathological data were examined. We employed Elastic Net, a sparse modeling method, to construct models predicting early recurrence using these multiple preoperative factors. As a result, seven preoperative factors were selected: age, duke pancreatic monoclonal antigen type 2 value, neutrophil:lymphocyte ratio, systemic immune-inflammation index, tumor size, lymph node metastasis and is peripancreatic invasion. Repeated 10-fold cross-validations were performed, and area under the receiver operating characteristic curve (AUC) and decision curve analysis were used to evaluate the usefulness of the models. Results A total of 136 patients was included in the final analysis, of which 35 (34%) experienced early recurrence. Using Elastic Net, we found that 7 of 14 preoperative factors were useful for the predictive model. The mean AUC of all models constructed in the repeated validation was superior to the standard marker CA 19-9 (0.718 vs 0.657), whereas the AUC of the model constructed from the entire patient cohort was 0.767. Decision curve analysis showed that the models had a higher mean net benefit across the majority of the range of reasonable threshold probabilities. Conclusion A model using multiple preoperative factors can improve prediction of early resectable PDAC recurrence.	[Sugawara, Toshitaka; Ban, Daisuke; Watanabe, Shuichi; Maekawa, Aya; Ishikawa, Yoshiya; Akahoshi, Keiichi; Ogawa, Kosuke; Ono, Hiroaki; Kudo, Atsushi; Tanaka, Shinji; Tanabe, Minoru] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan; [Nishino, Jo] Natl Canc Ctr Japan, Res Inst, Div Bioinformat, Tokyo, Japan; [Tanaka, Shinji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Ban, D (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan.	dban@ncc.go.jp		Ono, Hiroaki/0000-0001-9230-5714; Ban, Daisuke/0000-0003-0868-8519				Aziz MH, 2019, ANN SURG, V270, P139, DOI 10.1097/SLA.0000000000002660; Barbour AP, 2020, ANN SURG ONCOL, V27, P2506, DOI 10.1245/s10434-020-08205-2; Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Benson AB, 2018, J NATL COMPR CANC NE, V16, P359, DOI 10.6004/jnccn.2018.0021; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Conroy T, 2018, NEW ENGL J MED, V379, P2395, DOI 10.1056/NEJMoa1809775; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Fedorov V, 2009, PHARM STAT, V8, P50, DOI 10.1002/pst.331; Groot VP, 2019, ANN SURG, V269, P1154, DOI 10.1097/SLA.0000000000002734; Guo SW, 2020, BRIT J CANCER, V122, P857, DOI 10.1038/s41416-019-0704-2; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ikuta S, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.08.35; Imaoka H, 2016, PANCREAS, V45, P211, DOI 10.1097/MPA.0000000000000446; Jang JY, 2018, ANN SURG, V268, P215, DOI 10.1097/SLA.0000000000002705; Jang JY, 2014, ANN SURG, V259, P656, DOI 10.1097/SLA.0000000000000384; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kauhanen SP, 2009, ANN SURG, V250, P957, DOI 10.1097/SLA.0b013e3181b2fafa; Komo T, 2016, ANN SURG ONCOL, V23, P2019, DOI 10.1245/s10434-016-5120-8; Krstajic D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-10; Kurahara H, 2018, PANCREAS, V47, P753, DOI 10.1097/MPA.0000000000001066; Loch FN, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01951-3; Matsumoto I, 2015, PANCREATOLOGY, V15, P674, DOI 10.1016/j.pan.2015.09.008; Miyasaka Y, 2019, ANN SURG ONCOL, V26, P1528, DOI 10.1245/s10434-019-07309-8; Miyata T, 2021, ANN SURG ONCOL, V28, P1572, DOI 10.1245/s10434-020-09022-3; Narimatsu H, 1998, CANCER RES, V58, P512; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Nishio K, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-016-1078-z; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Oneda E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111922; Raufi AG, 2019, SEMIN ONCOL, V46, P19, DOI 10.1053/j.seminoncol.2018.12.002; Reni M, 2018, LANCET GASTROENTEROL, V3, P413, DOI [10.1016/S2468-1253(18)30081-5, 10.1016/S2468-1253(18)30196-1]; Richter A, 2003, WORLD J SURG, V27, P324, DOI 10.1007/s00268-002-6659-z; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Sunagawa Y, 2020, ANN SURG ONCOL, V27, P2081, DOI 10.1245/s10434-019-07981-w; Suzuki S, 2018, EUR SURG RES, V59, P329, DOI 10.1159/000494382; Tatarian T, 2018, ANN SURG, V267, P364, DOI 10.1097/SLA.0000000000002088; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Versteijne E, 2018, BRIT J SURG, V105, P946, DOI 10.1002/bjs.10870; Vestergaard EM, 1999, CLIN CHEM, V45, P54; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wannhoff A, 2013, J HEPATOL, V59, P1278, DOI 10.1016/j.jhep.2013.08.005; Ye M, 2020, HPB, V22, P821, DOI 10.1016/j.hpb.2020.01.001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2021	16	4							e0249885	10.1371/journal.pone.0249885	http://dx.doi.org/10.1371/journal.pone.0249885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM7RW	33844700	gold, Green Published			2022-12-26	WOS:000639857200010
J	Klingen, TA; Chen, Y; Aas, H; Wik, E; Akslen, LA				Klingen, Tor A.; Chen, Ying; Aas, Hans; Wik, Elisabeth; Akslen, Lars A.			Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer	PLOS ONE			English	Article							BASAL EPITHELIAL PHENOTYPE; STROMAL ELASTOSIS; PROGNOSIS; BINDING; BLOOD; WOMEN	Stromal elastosis is related to good prognosis in breast cancer and fibulin-2 helps to stabilize elastic fibers in basement membranes. Here, we examined the level of perivascular fibulin-2 expression in relation to elastosis content, vascular invasion, molecular subtypes, tumour detection mode, and patient prognosis in breast cancer. We performed a population based retrospective study of invasive breast cancers from the Norwegian Breast Screening Program (Vestfold County, 2004-2009) including 200 screen-detected and 82 interval cancers. Perivascular fibulin-2 staining was semi-quantitatively graded based on immunohistochemistry (1-3) and dichotomized as high expression (grade 2-3) and low expression (grade 1). Elastosis content was graded on a 4-tiered scale and dichotomized as high (score 3) and low (score 0-2) expression, whereas lymphatic (LVI) and blood vessel invasion (BVI) were recorded as absent or present by immunohistochemistry. High perivascular fibulin-2 expression was strongly related to stromal elastosis (p<0.001), and inversely associated with BVI and LVI (p<0.001 for both). High fibulin-2 was associated with luminal breast cancer subgroups (p<0.001) and inversely with interval cancers compared with screen-detected tumours (p<0.001). By univariate analysis, low perivascular fibulin-2 was associated with reduced recurrence-free survival (p = 0.002) and disease specific survival (p = 0.019). Low perivascular fibulin-2 expression was strongly related to vascular invasion, low stromal elastosis, non-luminal breast cancer subtypes, interval presentation, and adverse prognosis.	[Klingen, Tor A.; Chen, Ying; Wik, Elisabeth; Akslen, Lars A.] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway; [Klingen, Tor A.; Chen, Ying] Vestfold Hosp Trust, Dept Pathol, Tonsberg, Norway; [Chen, Ying] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Aas, Hans] Vestfold Hosp Trust, Dept Surg, Tonsberg, Norway; [Wik, Elisabeth; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; University of Oslo; University of Bergen; Haukeland University Hospital	Wik, E; Akslen, LA (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway.; Wik, E; Akslen, LA (corresponding author), Haukeland Hosp, Dept Pathol, Bergen, Norway.	Elisabeth.wik@uib.no; lars.akslen@uib.no	Wik, E./AAA-9105-2020		Vestfold Hospital Research Fund; Research Council of Norway through its Centres of Excellence funding scheme [223250]	Vestfold Hospital Research Fund; Research Council of Norway through its Centres of Excellence funding scheme	T.A.K. was supported by the Vestfold Hospital Research Fund for this study. This work was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223250 (L.A.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Arnes JB, 2005, CLIN CANCER RES, V11, P4003, DOI 10.1158/1078-0432.CCR-04-2064; Baird BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067054; Chen Y, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0230-8; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Elston C W, 2002, Histopathology, V41, P154; Esserman LJ, 2011, BREAST CANCER RES TR, V130, P725, DOI 10.1007/s10549-011-1748-z; Fontanil T, 2014, ONCOTARGET, V5, P1253, DOI 10.18632/oncotarget.1690; Fukushima M, 2000, PATHOL INT, V50, P1003; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hofvind S, 2016, J MED SCREEN, V23, P89, DOI 10.1177/0969141315604006; Ibrahim AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32507-x; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; Kato T, 2003, BRIT J CANCER, V88, P1900, DOI 10.1038/sj.bjc.6600921; Klingen TA, 2017, J CLIN PATHOL, V70, P313, DOI 10.1136/jclinpath-2016-203861; Klingen TA, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-80; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Kondo T, 2005, HUM PATHOL, V36, P474, DOI 10.1016/j.humpath.2005.03.006; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Mannelqvist M, 2009, HISTOPATHOLOGY, V54, P174, DOI 10.1111/j.1365-2559.2008.03201.x; Moller HD, 2011, MOL CANCER RES, V9, P553, DOI 10.1158/1541-7786.MCR-11-0093; Mook S, 2011, JNCI-J NATL CANCER I, V103, P585, DOI 10.1093/jnci/djr043; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; RASMUSSEN BB, 1985, CANCER RES, V45, P1428; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Senapati S, 2012, ONCOGENE, V31, P3346, DOI 10.1038/onc.2011.505; SHIVAS A A, 1972, Journal of the Royal College of Surgeons of Edinburgh, V17, P315; Tan HS, 2017, ONCOL LETT, V14, P2663, DOI 10.3892/ol.2017.6539; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249767	10.1371/journal.pone.0249767	http://dx.doi.org/10.1371/journal.pone.0249767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836007	Green Published, gold			2022-12-26	WOS:000639361000011
J	Zhang, TY; Wang, YH; Zhang, PX; Xue, F; Zhang, DY; Jiang, BG				Zhang, Tianyu; Wang, Yanhua; Zhang, Peixun; Xue, Feng; Zhang, Dianying; Jiang, Baoguo			Different fixation pattern for thoracolumbar fracture of ankylosing spondylitis: A finite element analysis	PLOS ONE			English	Article							PEDICLE SCREWS; SPINAL FRACTURES; BIOMECHANICS; DISORDERS; STRENGTH; SEGMENT; FUSION	The objective of this study is to establish an ankylosing spondylitis (AS) thoracolumbar fracture finite element (FE) model and provide a proper posterior fixation choice from the biomechanical perspective. The ankylosing spondylitis T9-L5 FE model was built and the range of motion (ROM) was compared to previous studies. The L1 transverse fracture was simulated and was separately fixed by five different patterns. The pull force and yielding force of the screws, the von Mises stress of the internal fixation, and the displacement of fracture site were analyzed to evaluate the proper fixation pattern for thoracolumbar fracture of AS. ROM of AS model was obviously restricted comparing to the normal vertebral experimental data. All the fixation patterns can stabilize the fracture. At least four levels of fixation can reduce the von Mises stress of the internal fixation. Four levels fixation has a higher pull force than the six levels fixation. Skipped level fixation did not reduce the stress, pull force and yielding force. The kyphosis correction did not change the biomechanical load. At least 4 levels fixation was needed for AS thoracolumbar fracture. The cemented screws should be chosen in 4 levels fixation to increase the holding of the screws. The skipped fixation has no advantage. The kyphosis correction can be chosen after weighing the pros and cons.	[Zhang, Tianyu; Wang, Yanhua; Zhang, Peixun; Xue, Feng; Zhang, Dianying; Jiang, Baoguo] Peking Univ Peoples Hosp, Dept Traumat Orthopaed, Beijing, Peoples R China; [Zhang, Peixun; Xue, Feng; Zhang, Dianying; Jiang, Baoguo] Peking Univ Peoples Hosp, Inst Trauma & Nerve Regenerat, Beijing, Peoples R China; [Zhang, Dianying] Peking Univ Binhai Hosp, Dept Orthopaed, Tianjin, Peoples R China		Zhang, PX (corresponding author), Peking Univ Peoples Hosp, Dept Traumat Orthopaed, Beijing, Peoples R China.; Zhang, PX (corresponding author), Peking Univ Peoples Hosp, Inst Trauma & Nerve Regenerat, Beijing, Peoples R China.	drxuefeng@163.com	Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; Wang, Yu/GZL-9655-2022; Wang, Yanbo/HFZ-8018-2022; zhang, tian/GZK-6001-2022; wang, yan/GSE-6489-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yuan/HHC-1520-2022	Xue, Feng/0000-0002-5733-7400	Ministry of Education Key Laboratory of trauma treatment and nerve regeneration [BMU2019XY007-01]	Ministry of Education Key Laboratory of trauma treatment and nerve regeneration	This work was supported by the Ministry of Education Key Laboratory of trauma treatment and nerve regeneration [grant number BMU2019XY007-01]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus M, 2011, ORTHOPADE, V40, P917, DOI 10.1007/s00132-011-1792-8; Basaran R, 2019, WORLD NEUROSURG, V128, pE1109, DOI 10.1016/j.wneu.2019.05.077; Bessant R, 2002, J RHEUMATOL, V29, P1511; Caron T, 2010, SPINE, V35, pE458, DOI 10.1097/BRS.0b013e3181cc764f; Chao CK, 2008, J SPINAL DISORD TECH, V21, P130, DOI 10.1097/BSD.0b013e318073cc4b; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Goffin JM, 2014, J ORTHOP RES, V32, P39, DOI 10.1002/jor.22469; Hak DJ, 2010, ORTHOPEDICS, V33, P752, DOI 10.3928/01477447-20100826-20; Hato T, 2007, J ORTHOP SCI, V12, P354, DOI 10.1007/s00776-007-1144-z; Kiapour A, 2012, SPINE, V37, pE581, DOI 10.1097/BRS.0b013e3182463775; Kim HJ, 2012, SPINE, V37, P1637, DOI 10.1097/BRS.0b013e31823f2115; Larson AN, 2016, J NEUROSURG-SPINE, V24, P116, DOI 10.3171/2015.4.SPINE131119; Leone A, 2016, RHEUMATOL INT, V36, P1335, DOI 10.1007/s00296-016-3524-1; Li CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099156; Liao JC, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1623-0; Lindtner RA, 2017, ARCH ORTHOP TRAUM SU, V137, P531, DOI 10.1007/s00402-017-2653-7; Muheremu A, 2017, J INT MED RES, V45, P639, DOI 10.1177/0300060517699303; Pflugmacher R, 2004, SPINE, V29, P1413, DOI 10.1097/01.BRS.0000129895.90939.1E; Pray C, 2017, CALCIFIED TISSUE INT, V101, P182, DOI 10.1007/s00223-017-0274-3; Reinhold M, 2018, GLOB SPINE J, V8, p56S, DOI 10.1177/2192568217736268; Robinson Y, 2018, GLOB SPINE J, V8, P570, DOI 10.1177/2192568217745068; Rustagi T, 2017, J ORTHOP TRAUMA, V31, pS57, DOI 10.1097/BOT.0000000000000953; Shen FH, 2006, J TRAUMA, V61, P1005, DOI 10.1097/01.ta.0000208125.63010.04; Su YS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012046; Tan S, 2017, J RHEUMATOL, V44, P1004, DOI 10.3899/jrheum.161462; Vosoughi AS, 2019, SPINE J, V19, P931, DOI 10.1016/j.spinee.2018.11.003; Werner BC, 2016, J AM ACAD ORTHOP SUR, V24, P241, DOI 10.5435/JAAOS-D-14-00149; Westerveld LA, 2014, SPINE J, V14, P729, DOI 10.1016/j.spinee.2013.06.038; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0; Widmer J, 2020, COMPUT METHOD BIOMEC, V23, P155, DOI 10.1080/10255842.2019.1709173; Xu M, 2019, MED ENG PHYS, V67, P11, DOI 10.1016/j.medengphy.2019.03.004; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020; Yang M, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0565-x	33	0	0	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0250009	10.1371/journal.pone.0250009	http://dx.doi.org/10.1371/journal.pone.0250009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836027	Green Published, gold			2022-12-26	WOS:000639361000022
J	Lovegrove, CJ; Bannigan, K				Lovegrove, Christopher J.; Bannigan, Katrina			What is the lived experience of anxiety for people with Parkinson's? A phenomenological study	PLOS ONE			English	Article							QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; PEER SUPPORT; COPING STRATEGIES; OLDER-ADULTS; SELF-ESTEEM; DISEASE; DEPRESSION; HEALTH; DISORDERS	Purpose Anxiety is a common non-motor symptom of Parkinson's and there is no specific pharmacological intervention for people with Parkinson's who experience anxiety. Yet there is little specific research documenting how individuals with this condition experience anxiety. It is important to explore the experiences of people with Parkinson's to identify potential issues in developing future non-pharmacological interventions. This study explored the lived experience of anxiety for people with Parkinson's. Materials and methods Six participants were recruited into a descriptive phenomenological study, through the charity Parkinson's UK, using a maximum variation sampling strategy. Face to face interviews were conducted. Data analysis employed thematic analysis. Results Three key themes encapsulated the data: Finding ways to cope to "Try not to let it rule your life", Amplifies symptoms "It's emotionally draining it it's also physically draining" and "Anxiety is a funny thing" experienced in myriad ways. A model of the experience of PWP experience of anxiety is proposed. Conclusions Anxiety is a complex experience constructed of interlinked parts affecting people with Parkinson's in myriad ways. Researchers and healthcare professionals should take these findings into account when designing future studies and interventions.	[Lovegrove, Christopher J.] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Lovegrove, Christopher J.] Univ Plymouth, Fac Hlth & Human Sci, Sch Hlth Profess, Plymouth, Devon, England; [Bannigan, Katrina] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Dept Occupat Therapy & Human Nutr & Dietet, Glasgow, Lanark, Scotland	University of Exeter; University of Plymouth; Glasgow Caledonian University	Lovegrove, CJ (corresponding author), Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England.; Lovegrove, CJ (corresponding author), Univ Plymouth, Fac Hlth & Human Sci, Sch Hlth Profess, Plymouth, Devon, England.	christopher.lovegrove@nhs.net	Lovegrove, Christopher/AAK-3484-2020	Lovegrove, Christopher/0000-0003-2530-1988	National Institute of Health Research [MRES-2015-03-013-105]	National Institute of Health Research(National Institute for Health Research (NIHR))	CL-This research was supported by the National Institute of Health Research (grant number MRES-2015-03-013-105). https://www.nihr.ac.uk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom G, 2007, J CLIN NURS, V16, P76, DOI 10.1111/j.1365-2702.2006.01580.x; [Anonymous], 2018, QUALITATIVE RES DESI; [Anonymous], 2005, MENTAL CAPACITY ACT; Bain SA, 2015, PERS INDIV DIFFER, V75, P85, DOI 10.1016/j.paid.2014.11.003; Barnes J, 2013, J NEUROPSYCHOL, V7, P326, DOI 10.1111/jnp.12016; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Beutler LE, 2003, J CLIN PSYCHOL, V59, P1151, DOI 10.1002/jclp.10216; Bevan MT, 2014, QUAL HEALTH RES, V24, P136, DOI 10.1177/1049732313519710; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Biundo R, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.18; Blonder LX, 2011, BEHAV NEUROL, V24, P201, DOI [10.1155/2011/143857, 10.3233/BEN-2011-0329]; Bower JH, 2010, MOVEMENT DISORD, V25, P2105, DOI 10.1002/mds.23230; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Breen KC, 2013, J NEURAL TRANSM, V120, P531, DOI 10.1007/s00702-012-0928-2; Burn DJ, 2012, MOVEMENT DISORD, V27, P379, DOI 10.1002/mds.24041; Chan ZCY, 2013, QUAL REP, V18; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chinman M, 2014, PSYCHIAT SERV, V65, P429, DOI 10.1176/appi.ps.201300244; Collins RL, 1996, PSYCHOL BULL, V119, P51, DOI 10.1037/0033-2909.119.1.51; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; Cosgrove J, 2015, POSTGRAD MED J, V91, P212, DOI 10.1136/postgradmedj-2015-133247; Coventry PA, 2014, SOC SCI MED, V118, P108, DOI 10.1016/j.socscimed.2014.07.068; Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010; Dahlberg K, 2009, MED HEALTH CARE PHIL, V12, P265, DOI 10.1007/s11019-008-9174-7; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Deane KHO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006434; Delmar C, 2005, SCAND J CARING SCI, V19, P204, DOI 10.1111/j.1471-6712.2005.00334.x; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Drummond S, 2016, PERS INDIV DIFFER, V92, P123, DOI 10.1016/j.paid.2015.12.029; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Easton KL, 2000, QUAL HEALTH RES, V10, P703, DOI 10.1177/104973200129118651; Elmir Rakime, 2011, Nurse Res, V19, P12; Englander M., 2012, J PHENOMENOL PSYCHOL, V43, P13, DOI [10.1163/156916212X632943, DOI 10.1163/156916212X632943]; Erro R, 2013, J NEUROL NEUROSUR PS, V84, P14, DOI 10.1136/jnnp-2012-303419; Finlay L, 2011, PHENOMENOLOGY FOR THERAPISTS: RESEARCHING THE LIVED WORLD, P1, DOI 10.1002/9781119975144; Finlay L, 2014, QUAL RES PSYCHOL, V11, P121, DOI 10.1080/14780887.2013.807899; Finlay L, 2009, PHENOMENOL PRACT, V3, P6; Foster PS, 2010, COGN BEHAV NEUROL, V23, P14, DOI 10.1097/WNN.0b013e3181cc8be9; Frazier LD, 1999, AGING MENT HEALTH, V3, P213, DOI 10.1080/13607869956163; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Galvin KT, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i4.10362; Garriz M, 2015, PERS INDIV DIFFER, V80, P96, DOI 10.1016/j.paid.2015.02.024; Gidugu V, 2015, COMMUNITY MENT HLT J, V51, P445, DOI 10.1007/s10597-014-9801-0; Gino F, 2012, J PERS SOC PSYCHOL, V102, P497, DOI 10.1037/a0026413; Goodwin VA, 2011, J NEUROL NEUROSUR PS, V82, P1232, DOI 10.1136/jnnp-2011-300919; Gov.Uk, 2020, ETHNICITY FACTS FIGU; Green J, 2007, AUST NZ J PUBL HEAL, V31, P545, DOI 10.1111/j.1753-6405.2007.00141.x; Hallion LS, 2013, J ABNORM PSYCHOL, V122, P369, DOI 10.1037/a0031731; Hand A, 2010, PARKINSONISM RELAT D, V16, P172, DOI 10.1016/j.parkreldis.2009.10.007; Hanna KK, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/640707; Hemingway A, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i4.10364; Hofmann SG, 2012, COGNITION EMOTION, V26, P282, DOI 10.1080/02699931.2011.579414; Houghton Catherine, 2013, Nurse Res, V20, P12; Hunter ECM, 2004, SOC PSYCH PSYCH EPID, V39, P9, DOI 10.1007/s00127-004-0701-4; Hurt CS, 2012, INT PSYCHOGERIATR, V24, P1656, DOI 10.1017/S1041610212000749; Husserl E., 1931, IDEAS, P1; International QSR, 2012, NVIVO; Kano O, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/143547; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Kashdan TB, 2011, CLIN PSYCHOL REV, V31, P786, DOI 10.1016/j.cpr.2011.03.012; Kienast T, 2008, NAT NEUROSCI, V11, P1381, DOI 10.1038/nn.2222; Kinderman P, 2015, BRIT J PSYCHIAT, V206, P456, DOI 10.1192/bjp.bp.114.147553; Kolev OI, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/847054; Krohne HW, 2011, PERS INDIV DIFFER, V50, P916, DOI 10.1016/j.paid.2010.08.001; Lee RM, 1998, J COUNS PSYCHOL, V45, P338, DOI 10.1037/0022-0167.45.3.338; Leentjens AFG, 2012, PARKINSONISM RELAT D, V18, P1084, DOI 10.1016/j.parkreldis.2012.06.007; Legg M, 2011, PSYCHO-ONCOLOGY, V20, P1358, DOI 10.1002/pon.1862; Lenze Eric J, 2011, Dialogues Clin Neurosci, V13, P381; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Lindesay J, 2012, REV CLIN GERONTOL, V22, P204, DOI 10.1017/S0959259812000019; Lopez KA, 2004, QUAL HEALTH RES, V14, P726, DOI 10.1177/1049732304263638; Lovegrove CJ, 2017, BRIT J OCCUP THER, V80, P494, DOI 10.1177/0308022617700654; Lutz SG, 2016, OTJR-OCCUP PART HEAL, V36, P134, DOI 10.1177/1539449216661714; MacMahon DG, 1998, J NEUROL, V245, pS19, DOI 10.1007/PL00007732; Maher C, 2018, INT J QUAL METH, V17, DOI 10.1177/1609406918786362; Maillet A, 2016, BRAIN, V139, P2486, DOI 10.1093/brain/aww162; Maloney EA, 2014, WIRES COGN SCI, V5, P403, DOI 10.1002/wcs.1299; Martens KAE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106561; Martens KAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062602; McInnis GJ., 1999, PHENOMENOLOGICAL EXP; Meco G, 2008, PARKINSONISM RELAT D, V14, P451, DOI 10.1016/j.parkreldis.2007.10.008; Michal M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0908-4; Moore O, 2007, MOVEMENT DISORD, V22, P2192, DOI 10.1002/mds.21659; Murphy JM, 2009, PSYCHOL MED, V39, P1055, DOI 10.1017/S0033291708004625; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Odiyoor M, 2009, MOVEMENT DISORD, V24, P2434, DOI 10.1002/mds.22848; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Pachana NA, 2013, MOVEMENT DISORD, V28, P1930, DOI 10.1002/mds.25689; Parkinon's UK, 2016, PEOPLE PARKINSONS FO; Parkinson's UK, 2014, PARK YOU ONL; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Patton MQ, 2015, QUALITATIVE RES EVAL, P832; Peterson DS, 2016, PHYS THER, V96, P659, DOI 10.2522/ptj.20140603; Pontone GM, 2009, MOVEMENT DISORD, V24, P1333, DOI 10.1002/mds.22611; Prediger RDS, 2012, NEUROPHARMACOLOGY, V62, P115, DOI 10.1016/j.neuropharm.2011.08.039; Rahman S, 2011, BEHAV NEUROL, V24, P219, DOI [10.1155/2011/274539, 10.3233/BEN-2011-0330]; Rapee RM, 2015, BEHAV RES THER, V69, P40, DOI 10.1016/j.brat.2015.03.012; Ravenek MJ, 2014, MANAGING UNCERTAINTY; Reilly RC, 2013, QUAL REP, V18; Reynolds J, 2011, AUST FAM PHYSICIAN, V40, P382; Richard Irene H, 2005, Adv Neurol, V96, P42; Richard Irene H, 2004, Cogn Behav Neurol, V17, P201; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Schwartz SJ, 2011, EUR J PERSONALITY, V25, P373, DOI 10.1002/per.798; Shah S., 2006, NZ J OCCUPATIONAL TH, V53, P12; Sheridan NF, 2015, HEALTH EXPECT, V18, P32, DOI 10.1111/hex.12006; Skidmore JR, 2014, AM J HEALTH BEHAV, V38, P699, DOI 10.5993/AJHB.38.5.7; Sokolowski R, 1999, INTRO PHENOMENOLOGY; Sotgiu I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00336; Soundy Andrew, 2014, ScientificWorldJournal, V2014, P613592, DOI 10.1155/2014/613592; Stegemoller EL, 2014, ARCH PHYS MED REHAB, V95, P649, DOI 10.1016/j.apmr.2013.10.031; Strandmark MK, 2004, SCAND J CARING SCI, V18, P135, DOI 10.1111/j.1471-6712.2004.00275.x; Sunvisson H, 2006, INT J QUAL STUD HEAL, V1, P91, DOI [DOI 10.1080/17482620500487547, 10.1080/17482620500487547]; Tan Louis C S, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS74, DOI 10.1016/S1353-8020(11)70024-4; Todorova Antoniya, 2014, Pract Neurol, V14, P310, DOI 10.1136/practneurol-2013-000741; Vaismoradi M., 2019, QUALITATIVE SOZIALFO, V20, P1438; Vaismoradi M, 2016, J NUR ED PR, V6, P100, DOI DOI 10.5430/JNEP.V6N5P100; van Manen M, 2016, NURS HEALTH SCI, V18, P4, DOI 10.1111/nhs.12274; Vanhooren S, 2019, PERS-CENTERED EXP PS, V18, P1, DOI 10.1080/14779757.2019.1572029; Vytal KE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00093; Wagstaff Christopher, 2014, Nurse Res, V21, P8, DOI 10.7748/nr2014.01.21.3.8.e1226; Walsh K, 2001, POSTGRAD MED J, V77, P89, DOI 10.1136/pmj.77.904.89; Wells A, 1999, BEHAV MODIF, V23, P526, DOI 10.1177/0145445599234002; Wen MC, 2016, EUR J NEUROL, V23, P1001, DOI 10.1111/ene.13002; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245; Wolitzky-Taylor KB, 2010, DEPRESS ANXIETY, V27, P190, DOI 10.1002/da.20653; Wressle E, 2007, AUST OCCUP THER J, V54, P131, DOI 10.1111/j.1440-1630.2006.00610.x; Yip JJ, 2013, J APPL SOC PSYCHOL, V43, P591, DOI 10.1111/j.1559-1816.2013.01039.x	129	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249390	10.1371/journal.pone.0249390	http://dx.doi.org/10.1371/journal.pone.0249390			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831029	gold, Green Published, Green Submitted			2022-12-26	WOS:000639359600130
J	Vodonos, A; Novack, V; Waismel-Manor, I; Ezra, Y; Guetta, A; Ifergane, G				Vodonos, Alina; Novack, Victor; Waismel-Manor, Israel; Ezra, Yacov; Guetta, Adi; Ifergane, Gal			Sick of news? Television news exposure, collective stressful events and headache related emergency department visits	PLOS ONE			English	Article							TENSION-TYPE HEADACHE; PRECIPITATING FACTORS; TRIGGER FACTORS; AIR-POLLUTION; MIGRAINE; POPULATION; ASSOCIATION; SLEEP	Stress is a well-known trigger for primary headache yet its impact is difficult to demonstrate in large epidemiological studies. Israeli national TV news is often referred to as the "tribal fire", as many Israelis watch national news coverage following terror attacks or military operations. We examined the association between exposure to television news and their content with headache related Emergency Department visits. This retrospective cohort study included data on daily Emergency Department visits with a chief complaint of headache in Soroka University Medical Center, during 2002-2012. Data on daily television news viewership ratings were obtained from the Israeli Audience Research Board and its content from Channel 2 headlines, the highest rated TV news program. To estimate the short-term effects of news rating during the evening news on the number of daily headache visits, we applied generalized linear mixed models. 16,693 Emergency Department visits were included in the analysis. An increase in five units of daily rating percentages was associated with increase in Emergency Department visits the following day, relative risk (RR) = 1.032, (95% CI 1.014-1.050). This association increased with the age of the patients; RR = 1.119, (95% CI 1.075-1.65) for older than 60-year-old, RR = 1.044 (95% CI 1.010-1.078) for ages 40-60 and RR = 1.000 (95% CI 0.977-1.023) for younger than 40-year-old. We did not find a specific content associated with ED visit for headache. Higher television news ratings were associated with increased incidence of Emergency Department headache related visits. We assume that especially among older persons, news viewership ratings provide an indirect estimate of collective stress, which acts as a headache trigger for susceptible subjects.	[Vodonos, Alina; Novack, Victor] Soroka Univ, Clin Res Ctr, Med Ctr, Beer Sheva, Israel; [Waismel-Manor, Israel] Univ Haifa, Sch Polit Sci, Haifa, Israel; [Ezra, Yacov; Guetta, Adi; Ifergane, Gal] Soroka Univ, Neurol Dept, Med Ctr, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; University of Haifa; Ben Gurion University; Soroka Medical Center	Waismel-Manor, I (corresponding author), Univ Haifa, Sch Polit Sci, Haifa, Israel.	wisrael@poli.haifa.ac.il	waismel-manor, israel/GQA-3701-2022	waismel-manor, israel/0000-0001-6202-8111; guetta, dafne/0000-0002-7349-1109				Ahern J, 2002, PSYCHIATRY, V65, P289, DOI 10.1521/psyc.65.4.289.20240; Berrios-Torres SI, 2003, AM J PREV MED, V25, P79, DOI 10.1016/S0749-3797(03)00110-7; Blendon R, 2014, BURDEN STRESS AM, P1; Boardman HF, 2005, HEADACHE, V45, P657, DOI 10.1111/j.1526-4610.2005.05133.x; Cantor J., 1993, DESERT STORM MASS ME, P325; Codish S, 2014, INFECT CONT HOSP EP, V35, P709, DOI 10.1086/676426; Doron G, 1998, ANN AM ACAD POLIT SS, V555, P163, DOI 10.1177/0002716298555001011; Gilbert JW, 2012, EMERG MED J, V29, P576, DOI 10.1136/emermed-2011-200088; Gillespie David F., 1988, INT J MASS EMERGENCI, V6, P345; Guetti C, 2011, J HEADACHE PAIN, V12, P245, DOI 10.1007/s10194-011-0311-y; Holman EA, 2014, P NATL ACAD SCI USA, V111, P93, DOI 10.1073/pnas.1316265110; Kohut A., 2012, PEW INTERNET AM LIFE; Leor J, 1996, NEW ENGL J MED, V334, P413, DOI 10.1056/NEJM199602153340701; Mann R, 2013, ANN REPORT MEDIA ISR; Marcus G.E., 2000, AFFECTIVE INTELLIGEN; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; RamirezLassepas M, 1997, ARCH NEUROL-CHICAGO, V54, P1506, DOI 10.1001/archneur.1997.00550240058013; RASMUSSEN BK, 1993, PAIN, V53, P65, DOI 10.1016/0304-3959(93)90057-V; ROBBINS L, 1994, HEADACHE, V34, P214, DOI 10.1111/j.1526-4610.1994.hed3404214.x; Schramm SH, 2015, CEPHALALGIA, V35, P853, DOI 10.1177/0333102414563087; Spierings ELH, 2001, HEADACHE, V41, P554, DOI 10.1046/j.1526-4610.2001.041006554.x; Szyszkowicz Mieczyslaw, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P224, DOI 10.2478/v10001-006-0032-7; Trussler M, 2014, INT J PRESS/POLIT, V19, P360, DOI 10.1177/1940161214524832; TURNER LC, 1995, CEPHALALGIA, V15, P523, DOI 10.1046/j.1468-2982.1995.1506523.x; Vodonos A, 2015, CEPHALALGIA, V35, P1085, DOI 10.1177/0333102415570300; Wober Christian, 2006, J Headache Pain, V7, P188, DOI 10.1007/s10194-006-0305-3; Wonneberger A, 2012, J BROADCAST ELECTRON, V56, P55, DOI 10.1080/08838151.2011.648684; Zivadinov R, 2003, CEPHALALGIA, V23, P336, DOI 10.1046/j.1468-2982.2003.00544.x	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249749	10.1371/journal.pone.0249749	http://dx.doi.org/10.1371/journal.pone.0249749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831069	Green Published, gold			2022-12-26	WOS:000639359600037
J	Hong, SJ; Huh, WK				Hong, Sujin; Huh, Won-Ki			Loss of Smi1, a protein involved in cell wall synthesis, extends replicative life span by enhancing rDNA stability in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; NUCLEAR-LOCALIZATION; INTEGRITY PATHWAY; SIGNALING PATHWAY; RIBOSOMAL DNA; KNR4 PROTEIN; YEAST-CELLS; STRESS; SIR2; GENE	In Saccharomyces cerevisiae, replicative life span (RLS) is primarily affected by the stability of ribosomal DNA (rDNA). The stability of the highly repetitive rDNA array is maintained through transcriptional silencing by the NAD(+)-dependent histone deacetylase Sir2. Recently, the loss of Smi1, a protein of unknown molecular function that has been proposed to be involved in cell wall synthesis, has been demonstrated to extend RLS in S. cerevisiae, but the mechanism by which Smi1 regulates RLS has not been elucidated. In this study, we determined that the loss of Smi1 extends RLS in a Sir2-dependent manner. We observed that the smi1 Delta mutation enhances transcriptional silencing at the rDNA locus and promotes rDNA stability. In the absence of Smi1, the stress-responsive transcription factor Msn2 translocates from the cytoplasm to the nucleus, and nuclear-accumulated Msn2 stimulates the expression of nicotinamidase Pnc1, which serves as an activator of Sir2. In addition, we observed that the MAP kinase Hog1 is activated in smi1 Delta. cells and that the activation of Hog1 induces the translocation of Msn2 into the nucleus. Taken together, our findings suggest that the loss of Smi1 leads to the nuclear accumulation of Msn2 and stimulates the expression of Pnc1, thereby enhancing Sir2-mediated rDNA stability and extending RLS in S. cerevisiae.	[Hong, Sujin; Huh, Won-Ki] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Huh, Won-Ki] Seoul Natl Univ, Inst Microbiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Huh, WK (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.; Huh, WK (corresponding author), Seoul Natl Univ, Inst Microbiol, Seoul, South Korea.	wkh@snu.ac.kr		Hong, Sujin/0000-0002-8827-2232; Huh, Won-Ki/0000-0002-9091-6594	National Research Foundation of Korea [2018R1A2B2009169, 2020R1A5A1018081]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2018R1A2B2009169, 2020R1A5A1018081).	Basmaji F, 2006, MOL GENET GENOMICS, V275, P217, DOI 10.1007/s00438-005-0082-8; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bicknell AA, 2010, J BIOL CHEM, V285, P17545, DOI 10.1074/jbc.M109.084681; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dagkessamanskaia A, 2001, FEMS MICROBIOL LETT, V200, P53, DOI 10.1016/S0378-1097(01)00203-8; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; FISHEL BR, 1993, P NATL ACAD SCI USA, V90, P5623, DOI 10.1073/pnas.90.12.5623; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Garcia-Marques S, 2015, FEBS LETT, V589, P2163, DOI 10.1016/j.febslet.2015.06.021; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Ha CW, 2014, NUCLEIC ACIDS RES, V42, P8486, DOI 10.1093/nar/gku570; Ha CW, 2011, NUCLEIC ACIDS RES, V39, P1336, DOI 10.1093/nar/gkq895; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; HONG Z, 1994, MOL CELL BIOL, V14, P1017, DOI 10.1128/MCB.14.2.1017; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Jacquet Michel, 2003, ScientificWorldJournal, V3, P609; Johnston M, 1997, NATURE, V387, P87, DOI 10.1038/387s087; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Koch MR, 2009, P NATL ACAD SCI USA, V106, P11224, DOI 10.1073/pnas.0900809106; KOPECKA M, 1992, ARCH MICROBIOL, V158, P115, DOI 10.1007/BF00245214; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Markovich S, 2004, ANTIMICROB AGENTS CH, V48, P3871, DOI 10.1128/AAC.48.10.3871-3876.2004; Martin H, 1999, MICROBIOL-SGM, V145, P249, DOI 10.1099/13500872-145-1-249; Martin-Yken H, 2003, MOL MICROBIOL, V49, P23, DOI 10.1046/j.1365-2958.2003.03541.x; Martin-Yken H, 2002, CURR GENET, V41, P323, DOI 10.1007/s00294-002-0299-6; Martin-Yken H, 2001, YEAST, V18, pS187; Martin-Yken H, 2016, CELL MICROBIOL, V18, P1217, DOI 10.1111/cmi.12618; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mollapour M, 2006, FEMS YEAST RES, V6, P1274, DOI 10.1111/j.1567-1364.2006.00118.x; Molon M, 2018, BIOGERONTOLOGY, V19, P67, DOI 10.1007/s10522-017-9740-6; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Paredes S, 2018, J BIOL CHEM, V293, P11242, DOI 10.1074/jbc.AC118.003325; Park PU, 2002, METHOD ENZYMOL, V351, P468; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Sadeh A, 2011, MOL BIOL CELL, V22, P3127, DOI 10.1091/mbc.E10-12-1007; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Srivastava R, 2016, MICROBIOL MOL BIOL R, V80, P545, DOI 10.1128/MMBR.00005-16; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Torres-Quiroz F, 2010, J BIOL CHEM, V285, P20088, DOI 10.1074/jbc.M109.063578; Turchini A, 2000, J BACTERIOL, V182, P1167, DOI 10.1128/JB.182.4.1167-1171.2000; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; Yi DG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198619	75	3	3	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100258	10.1016/j.jbc.2021.100258	http://dx.doi.org/10.1016/j.jbc.2021.100258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837734	gold, Green Published			2022-12-26	WOS:000672866400234
J	Jabeena, CA; Govindaraju, G; Rawat, M; Gopi, S; Sethumadhavan, DV; Jaleel, A; Sasankan, D; Karmodiya, K; Rajavelu, A				Jabeena, C. A.; Govindaraju, Gayathri; Rawat, Mukul; Gopi, Soundhararajan; Sethumadhavan, Devadathan Valiyamangalath; Jaleel, Abdul; Sasankan, Dhakshmi; Karmodiya, Krishanpal; Rajavelu, Arumugam			Dynamic association of the H3K64 trimethylation mark with genes encoding exported proteins in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTEMISININ RESISTANCE; COMPARATIVE GENOMICS; CHROMATIN; METHYLATION; EXPRESSION; LANDSCAPE; VIRULENCE	Epigenetic modifications have emerged as critical regulators of virulence genes and stage-specific gene expression in Plasmodium falciparum. However, the specific roles of histone core epigenetic modifications in regulating the stage-specific gene expression are not well understood. In this study, we report an unconventional trimethylation at lysine 64 on histone 3 (H3K64me3) and characterize its functional relevance in P. falciparum. We show that PfSET4 and PfSET5 proteins of P. falciparum methylate H3K64 and that they prefer the nucleosome as a substrate over free histone 3 proteins. Structural analysis of PfSET5 revealed that it interacts with the nucleosome as a dimer. The H3K64me3 mark is dynamic, being enriched in the ring and trophozoite stages and drastically reduced in the schizont stages. Stage-specific global chromatin immunoprecipitation-sequencing analysis of the H3K64me3 mark revealed the selective enrichment of this methyl mark on the genes of exported family proteins in the ring and trophozoite stages and a significant reduction of the same in the schizont stages. Collectively, our data identify a novel epigenetic mark that is associated with the subset of genes encoding for exported proteins, which may regulate their expression in different stages of P. falciparum.	[Jabeena, C. A.; Govindaraju, Gayathri; Sethumadhavan, Devadathan Valiyamangalath; Sasankan, Dhakshmi; Rajavelu, Arumugam] Rajiv Gandhi Ctr Biotechnol RGCB, Pathogen Biol Grp, Thiruvananthapuram, Kerala, India; [Jabeena, C. A.; Govindaraju, Gayathri; Sethumadhavan, Devadathan Valiyamangalath] Manipal Acad Higher Educ MAHE, Manipal, Karnataka, India; [Rawat, Mukul; Karmodiya, Krishanpal] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India; [Gopi, Soundhararajan] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Chennai, Tamil Nadu, India; [Jaleel, Abdul] Rajiv Gandhi Ctr Biotechnol RGCB, Cardiovasc Dis Biol, Thycaud PO, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Manipal Academy of Higher Education (MAHE); Indian Institute of Science Education & Research (IISER) Pune; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Rajavelu, A (corresponding author), Rajiv Gandhi Ctr Biotechnol RGCB, Pathogen Biol Grp, Thiruvananthapuram, Kerala, India.	arajavelu@rgcb.res.in	Naina, Soundhara Rajan G/AAU-8769-2021	Naina, Soundhara Rajan G/0000-0002-7511-2571; Rajavelu, Arumugam/0000-0001-6666-8925; , ABDUL JALEEL/0000-0003-2536-9093; C.A, Jabeena/0000-0003-1629-9556	Department of Science and Technology (DST)-Early Career Research Award [ECR/2015/000117]; DBT-Innovative Young Biotechnologist Award (IYBA) [BT/08/IYBA/2014]; University Grants Commission, Government of India [UGC/Dec 2015/365030, UGC/Dec 2014/371086]; Indian Council for Medical Research; Initiative for Biological Systems Engineering, IIT Madras, India; Genome Engineering Technologies program of the Department of Biotechnology, Government of India [BT/PR25858/GET/119/169/2017]	Department of Science and Technology (DST)-Early Career Research Award(Department of Science & Technology (India)); DBT-Innovative Young Biotechnologist Award (IYBA); University Grants Commission, Government of India(University Grants Commission, India); Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); Initiative for Biological Systems Engineering, IIT Madras, India; Genome Engineering Technologies program of the Department of Biotechnology, Government of India	This work was supported by Department of Science and Technology (DST)-Early Career Research Award (Grant #ECR/2015/000117) and DBT-Innovative Young Biotechnologist Award (IYBA) (Grant #BT/08/IYBA/2014) to A. R. The authors acknowledge University Grants Commission, Government of India, for the senior research fellowship of C. A. J. (UGC/Dec 2015/365030) and D. V. S. (UGC/Dec 2014/371086). G. G. is supported by Senior Research Fellowship from the Indian Council for Medical Research. S. G. acknowledges the Initiative for Biological Systems Engineering, IIT Madras, India, for the IBSE PhD. Studentship. K. K. acknowledges support from the Genome Engineering Technologies program (BT/PR25858/GET/119/169/2017) of the Department of Biotechnology, Government of India.	Adjalley SH, 2016, CELL REP, V14, P2463, DOI 10.1016/j.celrep.2016.02.025; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Batugedara G, 2017, TRENDS PARASITOL, V33, P364, DOI 10.1016/j.pt.2016.12.004; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Bozdech Z, 1998, MOL BIOCHEM PARASIT, V97, P81, DOI 10.1016/S0166-6851(98)00135-2; Bunnik EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04295-5; Chaal BK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000737; Choi SW, 2006, MOL BIOCHEM PARASIT, V150, P350, DOI 10.1016/j.molbiopara.2006.07.003; Coetzee N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00687-7; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cui LW, 2008, INT J PARASITOL, V38, P1083, DOI 10.1016/j.ijpara.2008.01.002; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duffy MF, 2012, CELL MICROBIOL, V14, P819, DOI 10.1111/j.1462-5822.2012.01777.x; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Fingerman I. M., 2008, COLD SPRING HARBOR P, V2008; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fraschka SAK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31965; Gill J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-90; Govindaraju G, 2017, BBA-GENE REGUL MECH, V1860, P1047, DOI 10.1016/j.bbagrm.2017.08.003; Hammam E, 2020, NUCLEIC ACIDS RES, V48, P184, DOI 10.1093/nar/gkz1093; Hoeijmakers WAM, 2012, TRENDS PARASITOL, V28, P486, DOI 10.1016/j.pt.2012.08.006; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Jabeena CA, 2019, CHEMBIOCHEM, V20, P1225, DOI 10.1002/cbic.201800718; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Karmodiya K, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0029-1; Kensche PR, 2016, NUCLEIC ACIDS RES, V44, P2110, DOI 10.1093/nar/gkv1214; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lange UC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3233; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2214-9; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Merrick CJ, 2010, EUKARYOT CELL, V9, P1150, DOI 10.1128/EC.00093-10; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Ponts N, 2013, CELL HOST MICROBE, V14, P696, DOI 10.1016/j.chom.2013.11.007; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Silberhorn E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006080; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Soulard V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8690; Sullivan WJ, 2006, CELL MICROBIOL, V8, P1850, DOI 10.1111/j.1462-5822.2006.00818.x; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100614	10.1016/j.jbc.2021.100614	http://dx.doi.org/10.1016/j.jbc.2021.100614			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839154	Green Published, gold			2022-12-26	WOS:000672866400585
J	Zheng, SM; Matthews, AJ; Rahman, N; Herrick-Reynolds, K; Sible, E; Choi, JE; Wishnie, A; Ng, YK; Rhodes, D; Elledge, SJ; Vuong, BQ				Zheng, Simin; Matthews, Allysia J.; Rahman, Numa; Herrick-Reynolds, Kayleigh; Sible, Emily; Choi, Jee Eun; Wishnie, Alec; Ng, Yan Kee; Rhodes, Daniela; Elledge, Stephen J.; Vuong, Bao Q.			The uncharacterized SANT and BTB domain-containing protein SANBR inhibits class switch recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCES; TARGETED DNA DEAMINATION; SOMATIC HYPERMUTATION; TERMINAL SEQUENCES; CODING SEQUENCES; MOUSE HOMOLOGS; KIAA GENE; C-MYC; AID; TRANSCRIPTION	Class switch recombination (CSR) is the process by which B cells switch production from IgM/IgD to other immunoglobulin isotypes, enabling them to mount an effective immune response against pathogens. Timely resolution of CSR prevents damage due to an uncontrolled and prolonged immune response. While many positive regulators of CSR have been described, negative regulators of CSR are relatively unknown. Using an shRNA library screen targeting more than 28,000 genes in a mouse B cell line, we have identified a novel, uncharacterized protein of 82kD (KIAA1841, NM_027860), which we have named SANBR (SANT and BTB domain regulator of CSR), as a negative regulator of CSR. The purified, recombinant BTB domain of SANBR exhibited characteristic properties such as homodimerization and interaction with corepressor proteins, including HDAC and SMRT. Overexpression of SANBR inhibited CSR in primary mouse splenic B cells, and inhibition of CSR is dependent on the BTB domain while the SANT domain is largely dispensable. Thus, we have identified a new member of the BTB family that serves as a negative regulator of CSR. Future investigations to identify transcriptional targets of SANBR in B cells will reveal further insights into the specific mechanisms by which SANBR regulates CSR as well as fundamental gene regulatory activities of this protein.	[Zheng, Simin] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Zheng, Simin; Ng, Yan Kee; Rhodes, Daniela] Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore; [Matthews, Allysia J.] Yale Univ, Yale Sch Med, New Haven, CT USA; [Matthews, Allysia J.; Sible, Emily; Choi, Jee Eun; Wishnie, Alec; Vuong, Bao Q.] Grad Ctr, Dept Biol, New York, NY 10016 USA; [Matthews, Allysia J.; Sible, Emily; Choi, Jee Eun; Wishnie, Alec; Vuong, Bao Q.] CUNY City Coll, New York, NY 10031 USA; [Rahman, Numa; Herrick-Reynolds, Kayleigh] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Elledge, Stephen J.] Harvard Med Sch, Howard Hughes Med Inst, Dept Genet, Program Virol, Boston, MA 02115 USA; [Elledge, Stephen J.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Yale University; City University of New York (CUNY) System; City College of New York (CUNY); Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Vuong, BQ (corresponding author), Grad Ctr, Dept Biol, New York, NY 10016 USA.; Vuong, BQ (corresponding author), CUNY City Coll, New York, NY 10031 USA.	bvuong@ccny.cuny.edu		Zheng, Simin/0000-0002-3442-1255; Vuong, Bao/0000-0001-5416-9635; Wishnie, Alec/0000-0002-7148-9785	Lee Kuan Yew Postdoctoral Fellowship; American Association of Immunologists Careers in Immunology Fellowship; American Association of Immunologists Early Career Faculty Travel Grant; PSC-CUNY Enhanced Research Award	Lee Kuan Yew Postdoctoral Fellowship; American Association of Immunologists Careers in Immunology Fellowship; American Association of Immunologists Early Career Faculty Travel Grant; PSC-CUNY Enhanced Research Award	S. Z. was supported by the Lee Kuan Yew Postdoctoral Fellowship. A. J. M. was supported by The American Association of Immunologists Careers in Immunology Fellowship. B. Q. V. was supported by The American Association of Immunologists Early Career Faculty Travel Grant and the PSC-CUNY Enhanced Research Award.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Chaharbakhshi E, 2016, GENESIS, V54, P505, DOI 10.1002/dvg.22964; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chi XY, 2020, IMMUNOLOGY, V160, P233, DOI 10.1111/imm.13176; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feng YQ, 2020, TRENDS IMMUNOL, V41, P586, DOI 10.1016/j.it.2020.04.009; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Huang CX, 2015, SCI CHINA LIFE SCI, V58, P1226, DOI 10.1007/s11427-015-4919-z; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lee-Theilen M, 2011, NAT STRUCT MOL BIOL, V18, P75, DOI 10.1038/nsmb.1942; Li GD, 2013, CELL REP, V5, P702, DOI 10.1016/j.celrep.2013.09.031; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Matthews AJ, 2014, J IMMUNOL, V193, P252, DOI 10.4049/jimmunol.1400433; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Mena EL, 2018, SCIENCE, V362, P198, DOI 10.1126/science.aap8236; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nance JP, 2015, J IMMUNOL, V194, P5599, DOI 10.4049/jimmunol.1500200; Nicolas Laura, 2018, F1000Res, V7, P458, DOI 10.12688/f1000research.13247.1; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Okazaki N, 2003, DNA RES, V10, P167, DOI 10.1093/dnares/10.4.167; Okazaki N, 2003, DNA RES, V10, P35, DOI 10.1093/dnares/10.1.35; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Qi H, 2014, CURR OPIN IMMUNOL, V28, P34, DOI 10.1016/j.coi.2014.01.016; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Robert I, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005240; Sadler AJ, 2015, P NATL ACAD SCI USA, V112, P1535, DOI 10.1073/pnas.1409728112; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stead MA, 2014, ACTA CRYSTALLOGR F, V70, P1591, DOI 10.1107/S2053230X14023449; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Vaidyanathan B, 2017, J EXP MED, V214, P197, DOI 10.1084/jem.20160789; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yang JA, 2015, J IMMUNOL, V194, P5604, DOI 10.4049/jimmunol.1500201; Yeap LS, 2019, ADV IMMUNOL, V141, P51, DOI 10.1016/bs.ai.2019.01.002; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zheng S, 2019, FEBS LETT, V593, P80, DOI 10.1002/1873-3468.13290; Zheng SM, 2015, CELL, V161, P762, DOI 10.1016/j.cell.2015.03.020	54	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100625	10.1016/j.jbc.2021.100625	http://dx.doi.org/10.1016/j.jbc.2021.100625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33831416	gold, Green Published			2022-12-26	WOS:000672866400596
J	Nord, A; Metcalfe, NB; Page, JL; Huxtable, A; McCafferty, DJ; Dawson, NJ				Nord, Andreas; Metcalfe, Neil B.; Page, Jennifer L.; Huxtable, Anna; McCafferty, Dominic J.; Dawson, Neal J.			Avian red blood cell mitochondria produce more heat in winter than in autumn	FASEB JOURNAL			English	Article						cellular metabolism; erythrocyte; overwintering; oxygen consumption; thermal biology	ACTIVATED PROTEIN-KINASE; SAURURUS-CHINENSIS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; FATTY-ACID; MANASSANTIN; LIGNANS; AMPK; COA; ATHEROSCLEROSIS	Endotherms in cold regions improve heat-producing capacity when preparing for winter. We know comparatively little about how this change is fueled by seasonal adaptation in cellular respiration. Thus, we studied the changes of mitochondrial function in red blood cells in sympatric Coal (Periparus ater), Blue (Cyanistes caeruleus), and Great (Parus major) tits between autumn and winter. These species differ more than twofold in body mass and in several aspects of their foraging ecology and social dominance, which could require differential seasonal adaptation of energy expenditure. Coal and Great tits in particular upregulated the mitochondrial respiration rate and mitochondrial volume in winter. This was not directed toward ATP synthesis, instead reflecting increased uncoupling of electron transport from ATP production. Because uncoupling is exothermic, this increased heat-producing capacity at the sub-cellular level in winter. This previously unexplored the route of thermogenesis in birds should be addressed in future work.	[Nord, Andreas] Lund Univ, Sect Evolutionary Ecol, Dept Biol, SE-22362 Lund, Sweden; [Nord, Andreas; Page, Jennifer L.; Huxtable, Anna; McCafferty, Dominic J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Scottish Ctr Ecol & Nat Environm, Rowardennan, Scotland; [Metcalfe, Neil B.; Dawson, Neal J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Graham Kerr Bldg, Glasgow, Lanark, Scotland	Lund University; University of Glasgow; University of Glasgow	Nord, A (corresponding author), Lund Univ, Sect Evolutionary Ecol, Dept Biol, SE-22362 Lund, Sweden.	andreas.nord@biol.lu.se		Dawson, Neal/0000-0001-5389-8692; Page, Jennifer/0000-0003-4967-4498; Nord, Andreas/0000-0001-6170-689X; McCafferty, Dominic/0000-0002-3079-3326; Metcalfe, Neil/0000-0002-1970-9349	Birgit and Hellmuth Hertz Foundation/The Royal Physiographic Society of Lund [2017-39034]; Carl Trygger Foundation for Scientific Research [18:280]; Stiftelsen Lunds Djurskyddsfond; NERC [NE/R001510/1]	Birgit and Hellmuth Hertz Foundation/The Royal Physiographic Society of Lund; Carl Trygger Foundation for Scientific Research; Stiftelsen Lunds Djurskyddsfond; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by funds from the Birgit and Hellmuth Hertz Foundation/The Royal Physiographic Society of Lund (grant 2017-39034), the Carl Trygger Foundation for Scientific Research (grant 18:280), and Stiftelsen Lunds Djurskyddsfond (to AN). NJD and NBM were funded by NERC (grant NE/R001510/1)	Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014; Choi HN, 2013, FASEB J, V27; Chow YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38129; Cui H, 2014, J NAT PROD, V77, P100, DOI 10.1021/np400757k; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hwang BY, 2003, PHYTOCHEMISTRY, V64, P765, DOI 10.1016/S0031-9422(03)00391-1; Hwang Ji-Yeon, 2007, Nutr Res Pract, V1, P100, DOI 10.4162/nrp.2007.1.2.100; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Joo HJ, 2006, FOOD SCI BIOTECHNOL, V15, P413; Jung YW, 2019, ARCH PHARM RES, V42, P332, DOI 10.1007/s12272-018-1093-4; Kahn CR, 2019, J CLIN INVEST, V129, P3990, DOI 10.1172/JCI129187; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim JI., 2012, FASEB J, V26; Kim SJ, 2009, BIOCHEM BIOPH RES CO, V389, P437, DOI 10.1016/j.bbrc.2009.08.161; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Kwon DY, 2015, J MED CHEM, V58, P7659, DOI 10.1021/acs.jmedchem.5b01220; Lai K, 2013, ACS CHEM BIOL, V8, P257, DOI 10.1021/cb300495e; Lang LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099584; Li J, 2018, METHODS MOL BIOL, V1773, P167, DOI 10.1007/978-1-4939-7799-4_14; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu ZJ, 2014, ONCOL REP, V32, P659, DOI 10.3892/or.2014.3244; Ma YB, 2017, J BIOL CHEM, V292, P20989, DOI 10.1074/jbc.M117.812925; Muller S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43624-6; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Seo CS, 2008, J NAT PROD, V71, P1771, DOI 10.1021/np8002723; Seo CS, 2009, PHYTOTHER RES, V23, P1531, DOI 10.1002/ptr.2791; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Steinbeck KS, 2018, NAT REV ENDOCRINOL, V14, P331, DOI 10.1038/s41574-018-0002-8; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Wang EC, 1996, HETEROCYCLES, V43, P969, DOI 10.3987/COM-95-7370; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Yang QY, 2016, CELL METAB, V24, P542, DOI 10.1016/j.cmet.2016.08.010; Yu H, 2018, METHODS MOL BIOL, V1773, P273, DOI 10.1007/978-1-4939-7799-4_21; Yun YR, 2007, J MED FOOD, V10, P316, DOI 10.1089/jmf.2006.149; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zeng XY, 2012, BIOCHEM PHARMACOL, V84, P830, DOI 10.1016/j.bcp.2012.07.003; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhou YP, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0268-9	51	11	11	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21490	10.1096/fj.202100107R	http://dx.doi.org/10.1096/fj.202100107R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33829547	Green Accepted, hybrid			2022-12-26	WOS:000645260100103
J	Schadel, P; Troisi, F; Czapka, A; Gebert, N; Pace, S; Ori, A; Werz, O				Schaedel, Patrick; Troisi, Fabiana; Czapka, Anna; Gebert, Nadja; Pace, Simona; Ori, Alessandro; Werz, Oliver			Aging drives organ-specific alterations of the inflammatory microenvironment guided by immunomodulatory mediators in mice	FASEB JOURNAL			English	Article						aging; cytokines; inflammation; lipid mediators; resolution	HEPATIC STELLATE CELLS; EXTRACELLULAR VESICLES; LIVER FIBROSIS; SIGNAL TRANSDUCER; TRANSCRIPTION 3; EXOSOMES; DELIVERY; ACTIVATION; MECHANISMS; STAT3	Aging is accompanied by chronic, low-grade systemic inflammation, termed inflammaging, a main driver of age-associated diseases. Such sterile inflammation is typically characterized by elevated levels of pro-inflammatory mediators, such as cytokines, chemokines and reactive oxygen species causing organ damage. Lipid mediators play important roles in the fine-tuning of both the promotion and the resolution of inflammation. Yet, it remains unclear how lipid mediators fit within the concept of inflammaging and how their biosynthesis and function is affected by aging. Here, we provide comprehensive signature profiles of inflammatory markers in organs afflicted with inflammation of young and old C57BL/6 mice. We reveal an organ-specific footprint of inflammation-related cytokines, chemokines and lipid mediators, which are distinctively affected by aging. While some organs are characterized by a pronounced pro-inflammatory microenvironment and impaired resolution during aging, others display elevated levels of pro-resolving mediators or an overall decrease in inflammatory signaling. Our results demonstrate that it proves difficult to establish a unifying concept for alterations of immunomodulatory mediators as consequence of aging and that organ specificity needs to be considered. Moreover, our data imply that inclusion of lipid mediators into the concept of inflammaging provides a comprehensive tool to characterize the inflammatory microenvironment during aging on a broader and yet, more detailed scope.	[Schaedel, Patrick; Troisi, Fabiana; Czapka, Anna; Pace, Simona; Werz, Oliver] Friedrich Schiller Univ, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany; [Troisi, Fabiana] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Munich, Germany; [Troisi, Fabiana] Helmholtz Ctr Munich, Munich, Germany; [Gebert, Nadja; Ori, Alessandro] Fritz Lipmann Inst FLI, Leibniz Inst Aging, Jena, Germany	Friedrich Schiller University of Jena; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Werz, O (corresponding author), Friedrich Schiller Univ Jena, Inst Pharm, Dept Pharmaceut Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	oliver.werz@uni-jena.de	Ori, Alessandro/M-8586-2019	Ori, Alessandro/0000-0002-3046-0871; Schadel, Patrick/0000-0002-9586-6653	Free State of Thuringia; ProExcellence Initiative 2 ("RegenerAging"); Deutsche Forschungsgemeinschaft; Europaischer Fonds fur regionale Entwicklung [2019FGR0095];  [SFB 1278/1 PolyTarget-316213987];  [C02];  [SFB 1127/2 ChemBioSys-239748522];  [A04]	Free State of Thuringia(European Commission); ProExcellence Initiative 2 ("RegenerAging"); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Europaischer Fonds fur regionale Entwicklung; ; ; ; 	Free State of Thuringia; ProExcellence Initiative 2 ("RegenerAging"); Deutsche Forschungsgemeinschaft; SFB 1278/1 PolyTarget-316213987, Grant/Award Number: C02; SFB 1127/2 ChemBioSys-239748522, Grant/Award Number: A04; Europaischer Fonds fur regionale Entwicklung, Grant/Award Number: 2019FGR0095	Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beebe JD, 2018, PHARMACOL THERAPEUT, V191, P74, DOI 10.1016/j.pharmthera.2018.06.006; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Breitkopf K, 2005, GUT, V54, P673, DOI 10.1136/gut.2004.042911; Busatto S, 2019, BIOMED MICRODEVICES, V21, DOI 10.1007/s10544-019-0396-7; Chakraborty D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01236-6; Choi S, 2019, BIOCHEM BIOPH RES CO, V513, P49, DOI 10.1016/j.bbrc.2019.03.156; Gong XH, 2014, CELL PHYSIOL BIOCHEM, V33, P97, DOI 10.1159/000356653; He WW, 2019, ONCOL LETT, V17, P5608, DOI 10.3892/ol.2019.10236; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krishna Murli, 2017, Clin Liver Dis (Hoboken), V10, P53, DOI 10.1002/cld.653; Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026; LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lou GH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1512-5; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00243; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y; Ogiso H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162183; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Su TH, 2015, P NATL ACAD SCI USA, V112, P7243, DOI 10.1073/pnas.1507499112; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Xiang DM, 2018, GUT, V67, P1704, DOI 10.1136/gutjnl-2016-313392; Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004; Zhai XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49287-7; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240	47	3	3	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21558	10.1096/fj.202002684R	http://dx.doi.org/10.1096/fj.202002684R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855766				2022-12-26	WOS:000645260100073
J	Palayew, A; Schmidt, AM; Saeed, S; Cooper, CL; Wong, A; Martel-Laferriere, V; Walmsley, S; Cox, J; Klein, MB				Palayew, Adam; Schmidt, Alexandra M.; Saeed, Sahar; Cooper, Curtis L.; Wong, Alexander; Martel-Laferriere, Valerie; Walmsley, Sharon; Cox, Joseph; Klein, Marina B.		Canadian Coinfection Cohort Study	Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada	PLOS ONE			English	Article							C VIRUS COINFECTION; HEPATITIS-C; HEALTH INEQUALITIES; HIV	Background HIV-HCV coinfected individuals are often more deprived than the general population. However, deprivation is difficult to measure, often relying on aggregate data which does not capture individual heterogeneity. We developed an individual-level deprivation index for HIV-HCV co-infected persons that encapsulated social, material, and lifestyle factors. Methods We estimated an individual-level deprivation index with data from the Canadian Coinfection Cohort, a national prospective cohort study. We used a predetermined process to select 9 out of 19 dichotomous variables at baseline visit to include in the deprivation model: income >$1500/month; education >high school; employment; identifying as gay or bisexual; Indigenous status; injection drug use in last 6 months; injection drug use ever; past incarceration, and past psychiatric hospitalization. We fitted an item response theory model with: severity parameters (how likely an item was reported), discriminatory parameters, (how well a variable distinguished index levels), and an individual parameter (the index). We considered two models: a simple one with no provincial variation and a hierarchical model by province. The Widely Applicable Information Criterion (WAIC) was used to compare the fitted models. To showcase a potential utility of the proposed index, we evaluated with logistic regression the association of the index with non-attendance to a second clinic visit (as a proxy for disengagement) and using WAIC compared it to a model containing all the individual parameters that compose the index as covariates. Results We analyzed 1547 complete cases of 1842 enrolled participants. According to the WAIC the hierarchical model provided a better fit when compared to the model that does not consider the individual's province. Values of the index were similarly distributed across the provinces. Overall, past incarceration, education, and unemployment had the highest discriminatory parameters. However, in each province different components of the index were associated with being deprived reflecting local epidemiology. For example, Saskatchewan had the highest severity parameter for Indigenous status while Quebec the lowest. For the secondary analysis, 457 (30%) failed to attend a second visit. A one-unit increase in the index was associated with 17% increased odds (95% credible interval, 2% to 34%) of not attending a second visit. The model with just the index performed better than the model with all the components as covariates in terms of WAIC. Conclusion We estimated an individual-level deprivation index in the Canadian Coinfection cohort. The index identified deprivation profiles across different provinces. This index and the methodology used may be useful in studying health and treatment outcomes that are influenced by social disparities in co-infected Canadians. The methodological approach described can be used in other studies with similar characteristics.	[Palayew, Adam; Schmidt, Alexandra M.; Saeed, Sahar; Cox, Joseph; Klein, Marina B.] McGill Univ, Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Cooper, Curtis L.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Cooper, Curtis L.; Walmsley, Sharon; Cox, Joseph; Klein, Marina B.] Canadian Inst Hlth Res, Canadian HIV Trials Network, Vancouver, BC, Canada; [Wong, Alexander] Univ Saskatchewan, Dept Med, Regina, SK, Canada; [Martel-Laferriere, Valerie] Univ Montreal, Ctr Hosp, Ctr Rech, Dept Microbiol & Infect Dis, Montreal, PQ, Canada; [Walmsley, Sharon] Univ Hlth Network, Univ Toronto, Toronto, ON, Canada; [Cox, Joseph; Klein, Marina B.] McGill Univ Hlth Ctr, Dept Med, Div Infect Dis & Chron Viral Illness Serv, Montreal, PQ, Canada	McGill University; University of Ottawa; Ottawa Hospital Research Institute; Institute for Work & Health; University of Saskatchewan; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McGill University	Klein, MB (corresponding author), McGill Univ, Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Klein, MB (corresponding author), Canadian Inst Hlth Res, Canadian HIV Trials Network, Vancouver, BC, Canada.; Klein, MB (corresponding author), McGill Univ Hlth Ctr, Dept Med, Div Infect Dis & Chron Viral Illness Serv, Montreal, PQ, Canada.	marina.klein@mcgill.ca	Wong, Alexander/GZM-2929-2022	Wong, Alexander/0000-0002-5295-2797; Palayew, Adam/0000-0002-1904-5730; Cox, Joseph/0000-0002-7041-1556	Fonds de recherche Quebec-Sante, Reseau SIDA/maladies infectieuses; Canadian Institutes of Health Research [FDN-143270]; CIHR Canadian HIV Trials Network [CTN222]; Tier I Canada Research Chair; Fonds de recherche du Quebec; Canadian Network for Hepatitis C	Fonds de recherche Quebec-Sante, Reseau SIDA/maladies infectieuses; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Tier I Canada Research Chair(Canada Research Chairs); Fonds de recherche du Quebec; Canadian Network for Hepatitis C	The Canadian Co-infection Cohort is funded by Fonds de recherche Quebec-Sante, Reseau SIDA/maladies infectieuses (#n/a; http://www.reseausidami.quebec/), the Canadian Institutes of Health Research (#FDN-143270; http://www.cihr-irsc.gc.ca/), and the CIHR Canadian HIV Trials Network (#CTN222; http://www.hivnet.ubc.ca/); Dr. Marina B. Klein is supported by a Tier I Canada Research Chair (https://www.chairs-chaires.gc.ca/). Adam Palayew is supported by a MSc award from Fonds de recherche du Quebec (http://www.frqs.gouv.qc.ca/en/accueil) and the Canadian Network for Hepatitis C (https://www.canhepc.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie Roberto, 2017, Addict Behav Rep, V5, P29, DOI 10.1016/j.abrep.2017.01.004; Baker FB, 2017, STAT SOC BEHAV SC, P1, DOI 10.1007/978-3-319-54205-8; Bell N, 2012, CAN J PUBLIC HEALTH, V103, pS28, DOI 10.1007/BF03403826; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Butt ZA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183609; March JC, 2007, ENFERM INFEC MICR CL, V25, P91, DOI 10.1157/13098569; Division IS, LOW INC CUT OFFS 200; Ebert U, 1999, EC LETT, V68, P8; Gelman A, 2015, J EDUC BEHAV STAT, V40, P530, DOI 10.3102/1076998615606113; Greenacre M., 2017, CORRES ANAL PRACTICE, V2, DOI [10.1201/9781420011234, DOI 10.1201/9781315369983]; Guillaume E, 2016, J EPIDEMIOL COMMUN H, V70, P493, DOI 10.1136/jech-2015-205729; Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031; Kakchapati S, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0206-8; Klein MB, 2013, HIV MED, V14, P10, DOI 10.1111/j.1468-1293.2012.01028.x; Klein MB, 2010, INT J EPIDEMIOL, V39, P1162, DOI 10.1093/ije/dyp297; Krieger N, 2016, AM J PUBLIC HEALTH, V106, P256, DOI 10.2105/AJPH.2015.302955; Labbe E, 2015, EUR J PUBLIC HEALTH, V25, P604, DOI 10.1093/eurpub/cku231; Martel L., 2015, RECENT CHANGES DEMOG; Meissner EG, 2017, CURR OPIN GASTROEN, V33, P120, DOI 10.1097/MOG.0000000000000347; Pampalon R, 2009, HEALTH REP; Pampalon R, 2000, CHRONIC DIS CAN, V21, P10; Pampalon R, 2012, CAN J PUBLIC HEALTH, V103, pS17, DOI 10.1007/BF03403824; Pampalon R, 2010, HEALTH PLACE, V16, P416, DOI 10.1016/j.healthplace.2009.11.012; Pantalone DW, 2012, J BEHAV MED, V35, P520, DOI 10.1007/s10865-011-9381-1; Pereira M, 2014, AIDS CARE, V26, pS56, DOI 10.1080/09540121.2014.906549; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Quinn KM, 2004, POLIT ANAL, V12, P338, DOI 10.1093/pan/mph022; R Core Team, 2020, R LANG ENV STAT COMP; Rehkopf DH, 2006, AM J PUBLIC HEALTH, V96, P2135, DOI 10.2105/AJPH.2005.075408; Reich B.J., 2019, BAYESIAN STAT METHOD, DOI DOI 10.1201/9780429202292; Reise S. P., 2014, ENCY CLIN PSYCHOL, P1, DOI DOI 10.1002/9781118625392.WBECP357; Ribeiro AI, 2017, ACTA MEDICA PORT, V30, P17, DOI 10.20344/amp.7387; Rourke SB., 2011, OPEN MED-WARSAW, V5, P12; Stan Development Team, RSTAN R INTERFACE ST; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Watanabe S, 2010, J MACH LEARN RES, V11, P3571	38	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0249836	10.1371/journal.pone.0249836	http://dx.doi.org/10.1371/journal.pone.0249836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP4TZ	33872319	gold, Green Published			2022-12-26	WOS:000641723300001
J	Howard-Azzeh, M; Pearl, DL; Swirski, A; Ward, M; Hovdey, R; O'Sullivan, TL; Berke, O				Howard-Azzeh, Mohammad; Pearl, David L.; Swirski, Alexandra; Ward, Madeline; Hovdey, Roksolana; O'Sullivan, Terri L.; Berke, Olaf			The impact of state cannabis legislation, county-level socioeconomic and dog-level characteristics on reported cannabis poisonings of companion dogs in the USA (2009-2014)	PLOS ONE			English	Article							MARIJUANA; ALCOHOL; ADOLESCENTS; DEPENDENCE; ABUSE	With current trends in cannabis legalization, large efforts are being made to understand the effects of less restricted legislation on human consumption, health, and abuse of these products. Little is known about the effects of cannabis legalization and increased cannabis use on vulnerable populations, such as dogs. The objective of this study was to examine the effects of different state-level cannabis legislation, county-level socioeconomic factors, and dog-level characteristics on dog cannabis poisoning reports to an animal poison control center (APCC). Data were obtained concerning reports of dog poisoning events, county characteristics, and state cannabis legislation from the American Society for the Prevention of Cruelty to Animals' (ASPCA) APCC, the US Census Bureau, and various public policy-oriented and government websites, respectively. A multilevel logistic regression model with random intercepts for county and state was fitted to investigate the associations between the odds of a call to the APCC being related to a dog being poisoned by a cannabis product and the following types of variables: dog characteristics, county-level socioeconomic characteristics, and the type of state-level cannabis legislation. There were significantly higher odds of a call being related to cannabis in states with lower penalties for cannabis use and possession. The odds of these calls were higher in counties with higher income variability, higher percentage of urban population, and among smaller, male, and intact dogs. These calls increased throughout the study period (2009-2014). Reporting of cannabis poisonings were more likely to come from veterinarians than dog owners. Reported dog poisonings due to cannabis appear to be influenced by dog-level and community-level factors. This study may increase awareness to the public, public health, and veterinary communities of the effects of recreational drug use on dog populations. This study highlights the need to educate dog owners about safeguarding cannabis products from vulnerable populations.	[Howard-Azzeh, Mohammad; Pearl, David L.; Swirski, Alexandra; Hovdey, Roksolana; O'Sullivan, Terri L.; Berke, Olaf] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Ward, Madeline] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada	University of Guelph; University of Guelph	Howard-Azzeh, M (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON, Canada.	mhowarda@uoguelph.ca		Ward, Madeline/0000-0003-2115-9515; Howard-Azzeh, Mohammad/0000-0003-2496-3058	Natural Sciences and Engineering Research Council (Discovery NSERC grant)	Natural Sciences and Engineering Research Council (Discovery NSERC grant)	This research was supported by a grant to DL Pearl from the Natural Sciences and Engineering Research Council (Discovery NSERC grant) -http://www.nserc-crsng.gc.ca/index_eng.asp.The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrus DG., 2016, TASTY THC PROMISES C, P2016; Berny P, 2010, VET J, V183, P255, DOI 10.1016/j.tvjl.2009.03.034; BLACKSHAW JK, 1991, APPL ANIM BEHAV SCI, V30, P351, DOI 10.1016/0168-1591(91)90140-S; Borodovsky JT, 2016, INT J DRUG POLICY, V36, P141, DOI 10.1016/j.drugpo.2016.02.022; Brohl B., 2015, COLORADO DEP REVENUE, P1; Brook JS, 2013, SUBST ABUS, V34, P298, DOI 10.1080/08897077.2013.775092; Brutlag A, 2018, VET CLIN N AM-SMALL, V48, P1087, DOI 10.1016/j.cvsm.2018.07.008; Deabold KA, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100832; DIXIT VP, 1977, ENDOKRINOLOGIE, V69, P299; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Donaldson CW, 2002, VET MED-US, V97, P437; ElSohly MA, 2016, BIOL PSYCHIAT, V79, P613, DOI 10.1016/j.biopsych.2016.01.004; Fergusson DM, 2008, ADDICTION, V103, P969, DOI 10.1111/j.1360-0443.2008.02221.x; Figueiredo AS, 2013, VET MED-RES REP, V4, P31, DOI 10.2147/VMRR.S41151; Fischer B, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI [10.2105/AJPH.2017.303818, 10.2105/ajph.2017.303818]; Fischer KM, 2013, AM J VET RES, V74, P275, DOI 10.2460/ajvr.74.2.275; Furlow B, 2017, LANCET RESP MED, V5, P385, DOI 10.1016/S2213-2600(17)30107-8; Gamble LJ, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00165; Gorman DA, 2007, INT J DRUG POLICY, V18, P160, DOI 10.1016/j.drugpo.2006.10.001; Grant BF, 1998, J SUBST ABUSE, V10, P255, DOI 10.1016/S0899-3289(99)00006-1; Hall W, 2015, CLIN PHARMACOL THER, V97, P607, DOI 10.1002/cpt.110; Hart BL, 1997, APPL ANIM BEHAV SCI, V52, P331, DOI 10.1016/S0168-1591(96)01133-1; Hasin DS, 2016, AM J PSYCHIAT, V173, P588, DOI 10.1176/appi.ajp.2015.15070907; Howard-Azzeh M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227701; Janczyk P, 2004, VET HUM TOXICOL, V46, P19; KAYMAKCALAN S, 1974, PSYCHOPHARMACOLOGIA, V35, P123, DOI 10.1007/BF00429579; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P172, DOI 10.1007/BF03405467; Leung J., 2018, CURR ADDICT REP, V5, P403, DOI [DOI 10.1007/S40429-018-0224-9, 10.1007/s40429-018-0224-9]; LEWIS G, 1992, LANCET, V340, P137, DOI 10.1016/0140-6736(92)93213-7; Martello E., 2019, ANN CLIN LAB RES, V7, P1; McGrath S., 2018, VET MED-CZECH, V1, P6; Meola SD, 2012, J VET EMERG CRIT CAR, V22, P690, DOI 10.1111/j.1476-4431.2012.00818.x; Mogi C., 2019, PET BEHAV SCI, V7, P11; Pacula RL, 2016, ADDICTION, V111, P973, DOI 10.1111/add.13282; Paphitis K., 2019, Environmental Health Review, V62, P71, DOI 10.5864/d2019-019; Spiegelhalter D., 2017, SIGNIFICANCE, V14, P41; Stevens A, 2016, DRUG-EDUC PREV POLIC, V23, P410, DOI 10.3109/09687637.2015.1136266; Taylor M, 2019, CURR ADDICT REP, V6, P466, DOI 10.1007/s40429-019-00288-6; THOMPSON GR, 1973, TOXICOL APPL PHARM, V25, P363, DOI 10.1016/0041-008X(73)90310-4; von Sydow K, 2002, DRUG ALCOHOL DEPEN, V68, P49, DOI 10.1016/S0376-8716(02)00102-3; Wang GS, 2014, ANN EMERG MED, V63, P684, DOI 10.1016/j.annemergmed.2014.01.017; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913	42	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250323	10.1371/journal.pone.0250323	http://dx.doi.org/10.1371/journal.pone.0250323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861797	gold, Green Published			2022-12-26	WOS:000641475400009
J	Praveen, C; Bhatia, SS; Alaniz, RC; Droleskey, RE; Cohen, ND; Jesudhasan, PR; Pillai, SD				Praveen, Chandni; Bhatia, Sohini S.; Alaniz, Robert C.; Droleskey, Robert E.; Cohen, Noah D.; Jesudhasan, Palmy R.; Pillai, Suresh D.			Assessment of microbiological correlates and immunostimulatory potential of electron beam inactivated metabolically active yet non culturable (MAyNC) Salmonella Typhimurium	PLOS ONE			English	Article							DENDRITIC CELLS; IONIZING-RADIATION; IMMUNE-RESPONSES; LIVE; INFECTION; PROTECTION; VACCINE; IMMUNIZATION; IRRADIATION; CHALLENGE	This study investigates the microbiological and immunological basis underlying the efficacy of electron beam-inactivated immune modulators. The underlying hypothesis is that exposure to eBeam-based ionization reactions inactivate microorganisms without modifying their antigenic properties and thereby creating immune modulators. The immunological correlates of protection induced by such eBeam based Salmonella Typhimurium (EBST) immune modulators in dendritic cell (DC) (in vitro) and mice (in vivo) models were assessed. The EBST stimulated innate pro inflammatory response (TNF alpha) and maturation (MHC-II, CD40, CD80 and CD86) of DC. Immuno-stimulatory potential of EBST was on par with both a commercial Salmonella vaccine, and live Salmonella cells. The EBST cells did not multiply under permissive in vitro and in vivo conditions. However, EBST cells remained metabolically active. EBST immunized mice developed Salmonella-specific CD4+ T-cells that produced the Th1 cytokine IFN gamma at a level similar to that induced by the live attenuated vaccine (AroA(-) ST) formulation. The EBST retained stable immunogenic properties for several months at room temperature, 4 degrees C, and -20 degrees C as well as after lyophilization. Therefore, such eBeam-based immune modulators have potential as vaccine candidates since they offer the safety of a "killed" vaccine, while retaining the immunogenicity of an "attenuated" vaccine. The ability to store eBeam based immune modulators at room temperature without loss of potency is also noteworthy.	[Praveen, Chandni; Bhatia, Sohini S.; Pillai, Suresh D.] Texas A&M Univ, Natl Ctr Electron Beam Res, College Stn, TX 77843 USA; [Alaniz, Robert C.] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA; [Droleskey, Robert E.] USDA ARS, Food & Feed Safety Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA; [Cohen, Noah D.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX USA; [Jesudhasan, Palmy R.] Univ Arkansas, USDA ARS, Poultry Prod & Prod Safety, Fayetteville, AR USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville	Pillai, SD (corresponding author), Texas A&M Univ, Natl Ctr Electron Beam Res, College Stn, TX 77843 USA.; Alaniz, RC (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA.	alaniz@medicine.tamhsc.edu; s-pillai@tamu.edu		Jesudhasan, Palmy R. R./0000-0001-9128-4544; Cohen, Noah/0000-0002-0384-2903	United States Department of Agriculture, National Institute of Food and Agriculture (USDANIFA); Texas A&M AgriLife Research project [H8708]	United States Department of Agriculture, National Institute of Food and Agriculture (USDANIFA)(United States Department of Agriculture (USDA)); Texas A&M AgriLife Research project	This work was supported by funds from the United States Department of Agriculture, National Institute of Food and Agriculture (USDANIFA). The funds were administered through the Texas A&M AgriLife Research project H8708. This research was performed as part of the activities of the IAEA Collaborating Centre at Texas A&M University.	Acharya MM, 2010, FREE RADICAL BIO MED, V49, P1846, DOI 10.1016/j.freeradbiomed.2010.08.021; Alsharifi M, 2010, IMMUNOL CELL BIOL, V88, P103, DOI 10.1038/icb.2009.81; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bhatia SS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00694; Bordin AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105367; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Datta SK, 2006, IMMUNITY, V25, P143, DOI 10.1016/j.immuni.2006.05.013; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Faber G., 1976, INT J RADIAT BIOL, P264, DOI [10.1007/978-3-642-66455-7_32, DOI 10.1007/978-3-642-66455-7_32]; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Galdiero M, 1998, IMMUNOLOGY, V94, P5, DOI 10.1046/j.1365-2567.1998.00492.x; GINOZA W, 1967, ANNU REV MICROBIOL, V21, P325, DOI 10.1146/annurev.mi.21.100167.001545; Harrison JA, 1997, IMMUNOLOGY, V90, P618, DOI 10.1046/j.1365-2567.1997.00158.x; Hiramoto RM, 2002, VACCINE, V20, P2072, DOI 10.1016/S0264-410X(02)00054-3; HORMAECHE CE, 1991, J IMMUNOL METHODS, V142, P113, DOI 10.1016/0022-1759(91)90298-T; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jesudhasan PR, 2015, AVIAN DIS, V59, P165, DOI 10.1637/10917-081014-ResNoteR; Kalupahana RS, 2005, IMMUNOLOGY, V115, P462, DOI 10.1111/j.1365-2567.2005.02180.x; KILLAR LM, 1985, INFECT IMMUN, V47, P605, DOI 10.1128/IAI.47.3.605-612.1985; KIM AY, 1995, RADIAT RES, V144, P36, DOI 10.2307/3579233; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Kogut MH, 2012, PROCEDIA VACCINOL, V6, P47, DOI 10.1016/j.provac.2012.04.008; Kuritzky LA, 2015, J CUTAN MED SURG, V19, P504, DOI 10.1177/1203475415582306; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehmann J, 2006, VACCINE, V24, P4779, DOI 10.1016/j.vaccine.2006.03.024; Magnani DM, 2009, INFECT IMMUN, V77, P5181, DOI 10.1128/IAI.00231-09; Mastroeni P, 2003, J MED MICROBIOL, V52, P453, DOI 10.1099/jmm.0.05173-0; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; Mastroeni P, 2001, VET J, V161, P132, DOI 10.1053/tvjl.2000.0502; McFarland E, 1999, PEDIATR ANN, V28, P487, DOI 10.3928/0090-4481-19990801-06; Miller R.B., 2005, ELECT IRRADIATION FO; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Moustafa D, 2011, VACCINE, V29, P784, DOI 10.1016/j.vaccine.2010.11.018; Norimatsu M, 2004, VET IMMUNOL IMMUNOP, V98, P193, DOI 10.1016/j.vetimm.2003.12.008; Pie S, 1997, INFECT IMMUN, V65, P4509, DOI 10.1128/IAI.65.11.4509-4514.1997; Pillai SD, 2017, TOPICS CURR CHEM, V375, DOI 10.1007/s41061-016-0093-4; Plotkin SA, 2003, J INFECT DIS, V187, P1349, DOI 10.1086/374419; Praveen C, 2013, BIORESOURCE TECHNOL, V144, P652, DOI 10.1016/j.biortech.2013.07.034; ROBERTSSON JA, 1983, INFECT IMMUN, V41, P742, DOI 10.1128/IAI.41.2.742-750.1983; Sanakkayala N, 2005, CLIN DIAGN LAB IMMUN, V12, P1429, DOI 10.1128/CDLI.12.12.1429-1436.2005; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Seubert A, 2014, EXPERT REV VACCINES, V13, P1191, DOI 10.1586/14760584.2014.942641; Smith JS, 2004, FOOD TECHNOL-CHICAGO, V58, P48; SPARROW AH, 1967, RADIAT RES, V32, P915, DOI 10.2307/3572296; Sundquist M, 2004, CELL MICROBIOL, V6, P1, DOI 10.1046/j.1462-5822.2003.00336.x; Surendran N, 2010, FEMS IMMUNOL MED MIC, V60, P147, DOI 10.1111/j.1574-695X.2010.00729.x; Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000; Tahergorabi R, 2012, FOOD RES INT, V45, P685, DOI 10.1016/j.foodres.2011.02.003; THATTE J, 1993, INT IMMUNOL, V5, P1431, DOI 10.1093/intimm/5.11.1431; Trampuz A, 2006, J MED MICROBIOL, V55, P1271, DOI 10.1099/jmm.0.46488-0; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Wolfe S, 2005, J PUBLIC HEALTH MAN, V11, P566; Wolfe S, 2015, EPIDEMIOLOGY PREVENT; Yrlid U, 2001, MICROBES INFECT, V3, P1239, DOI 10.1016/S1286-4579(01)01484-8; Yrlid U, 2000, FEMS IMMUNOL MED MIC, V27, P313, DOI 10.1111/j.1574-695X.2000.tb01445.x	56	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0243417	10.1371/journal.pone.0243417	http://dx.doi.org/10.1371/journal.pone.0243417			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861743	gold, Green Published			2022-12-26	WOS:000641475400045
J	Gong, L; Tang, F; Liu, EN; Liu, XL; Xu, HQ; Wang, YM; Song, YD; Liang, JS				Gong, Lin; Tang, Fei; Liu, Ernan; Liu, Xiaoli; Xu, Huiqiong; Wang, Yimei; Song, Yadong; Liang, Jiansheng			Development of a loop-mediated isothermal amplification assay combined with a nanoparticle-based lateral flow biosensor for rapid detection of plasmid-mediated colistin resistance gene mcr-1	PLOS ONE			English	Article							ESCHERICHIA-COLI; SEQUENCE; EMERGENCE; SPREAD	A loop-mediated isothermal amplification assay combined with a nanoparticle-based lateral flow biosensor (LAMP-LFB) was established for the rapid and accurate detection of the mobilized colistin resistance gene (mcr-1), which causes the loss of colistin antibacterial efficacy in clinical treatments. The amplification stage of the assay was completed in 60 min at 63 degrees C, and the reaction products could be visually detected by employing the LFB, which provided a fast (within 2 min) and objective method to evaluate the amplification results. The LAMP assay amplified the target sequences of mcr-1 with high specificity. In pure strains, the detection limit of the LAMP-LFB assay was 360 fg plasmid DNA/reaction, and in spiked feces samples the value was approximately 6.3x10(3) CFU/mL (similar to 6.3 CFU/reaction), which was tenfold more sensitive than the PCR assay. The results show that the developed LAMP-LFB assay will be a worthy tool for the simple, rapid, specific, and sensitive detection of mcr-1 gene in clinical settings and resource-limited areas.	[Gong, Lin; Liu, Ernan; Liu, Xiaoli; Xu, Huiqiong; Wang, Yimei; Song, Yadong; Liang, Jiansheng] Wuhan Ctr Dis Control & Prevent, Dept Disinfect & Pest Control, Wuhan, Peoples R China; [Tang, Fei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Inst Environm Med,MOE Key Lab Environm & Hlth, Wuhan, Peoples R China	Huazhong University of Science & Technology	Liang, JS (corresponding author), Wuhan Ctr Dis Control & Prevent, Dept Disinfect & Pest Control, Wuhan, Peoples R China.	wh_ljs@sina.com		Gong, Lin/0000-0001-5001-2825	Wuhan Municipal Health Commission, China [WG17Q02]	Wuhan Municipal Health Commission, China	This work was financially supported by the Wuhan Municipal Health Commission, China (WG17Q02 to LG). The foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bontron S, 2016, J ANTIMICROB CHEMOTH, V71, P2318, DOI 10.1093/jac/dkw139; Chen KC, 2017, EUROSURVEILLANCE, V22, P32, DOI 10.2807/1560-7917.ES.2017.22.39.17-00206; Delgado-Blas JF, 2016, ANTIMICROB AGENTS CH, V60, P6356, DOI 10.1128/AAC.01319-16; Dortet L, 2018, J ANTIMICROB CHEMOTH, V73, P3359, DOI 10.1093/jac/dky330; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Gong L, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00226; Kim JH, 2019, J FOOD SCI TECH MYS, V56, P2576, DOI 10.1007/s13197-019-03740-7; Li L, 2019, PLANT DIS, V103, P1967, DOI 10.1094/PDIS-11-18-1964-RE; Li XP, 2017, INT J ANTIMICROB AG, V49, P786, DOI 10.1016/j.ijantimicag.2017.04.004; Li XP, 2016, SCI REP-UK, V6, DOI 10.1038/srep38511; Li ZC, 2016, SCI CHINA LIFE SCI, V59, P971, DOI 10.1007/s11427-016-5111-9; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lodh N, 2017, ACTA TROP, V173, P125, DOI 10.1016/j.actatropica.2017.06.015; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; Nation RL, 2009, CURR OPIN INFECT DIS, V22, P535, DOI 10.1097/QCO.0b013e328332e672; Niu LN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204332; Stoesser N, 2016, LANCET INFECT DIS, V16, P285, DOI 10.1016/S1473-3099(16)00010-4; Sun J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.176, 10.1038/nmicrobiol.2016.176]; Tacao M, 2017, EMERG INFECT DIS, V23, P1419, DOI 10.3201/eid2308.170162; Tian B, 2016, ACS SENSORS, V1, P1228, DOI 10.1021/acssensors.6b00379; Wang QJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0288-0; Wang QJ, 2016, ONCOTARGET, V7, P82112, DOI 10.18632/oncotarget.12621; Wang RB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03205-z; Wang Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00192; Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02047; Xavier BB, 2016, J ANTIMICROB CHEMOTH, V71, P2342, DOI 10.1093/jac/dkw191; Yuan H, 2018, ANAL CHEM, V90, P13173, DOI 10.1021/acs.analchem.8b03673; Zeng KJ, 2016, ANTIMICROB AGENTS CH, V60, P3862, DOI 10.1128/AAC.00345-16; Zhang HM, 2016, SCI BULL, V61, P875, DOI 10.1007/s11434-016-1086-y; Zhao FF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02229-16; Zhao FF, 2016, ANTIMICROB AGENTS CH, V60, P7498, DOI 10.1128/AAC.01165-16; Zurfluh K, 2016, ANTIMICROB AGENTS CH, V60, P5589, DOI 10.1128/AAC.00935-16	32	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249582	10.1371/journal.pone.0249582	http://dx.doi.org/10.1371/journal.pone.0249582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857193	Green Published			2022-12-26	WOS:000641474900051
J	Karydis, A; Sandal, I; Luo, JW; Prislovsky, A; Gamboa, A; Rosloniec, EF; Brand, DD				Karydis, Anastasios; Sandal, Indra; Luo, Jiwen; Prislovsky, Amanda; Gamboa, Amanda; Rosloniec, Edward F.; Brand, David D.			Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; ASSOCIATION; GUT	Our previous studies have shown that inoculation of the oral cavity of "humanized" B6.DR1/4 mice with the periodontal pathogen Porphyromonas gingivalis results in an increase in the percentage of circulating Th17 cells, loss of bone and an exacerbation of experimental autoimmune arthritis. The aim of this study was to assess the role played by the human HLA-DR beta molecule containing the shared epitope supplied as a transgene to I-A (murine class II null) C57BL/6 (B6) mice in driving these findings. We compared various immune response parameters as well as alveolar and peri-articular bone loss between humanized B6.DR1 (or B6.DR4) mice and their WT (B6) counterparts. We found that the presence of the shared epitope in the context of inoculation with P. gingivalis enhanced the percentage of Th17 cells generated, dramatically enhanced bone loss and importantly allowed for the generation of CCP2 ACPAs that are not found in C57BL/6 or DBA/1 arthritic mouse serum. Due to the exceedingly complex nature of environmental factors impacting on genetic elements, it has been difficult to unravel mechanisms that drive autoimmune arthritis in susceptible individuals. The findings in this study may provide one small piece of this puzzle that can help us to better understand part of this complexity.	[Karydis, Anastasios] Univ Tennessee, Dept Periodontol, Hlth Sci Ctr, Memphis, TN USA; [Sandal, Indra; Prislovsky, Amanda; Rosloniec, Edward F.; Brand, David D.] Memphis VA Med Ctr, Memphis, TN 38104 USA; [Luo, Jiwen; Rosloniec, Edward F.; Brand, David D.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA; [Gamboa, Amanda] Oregon State Univ, Corvallis, OR 97331 USA; [Brand, David D.] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Oregon State University; University of Tennessee System; University of Tennessee Health Science Center	Brand, DD (corresponding author), Memphis VA Med Ctr, Memphis, TN 38104 USA.; Brand, DD (corresponding author), Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA.; Brand, DD (corresponding author), Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN 38163 USA.	dbrand@uthsc.edu		Brand, David/0000-0002-9260-7963	U.S. Department of Veterans Affairs [,1BX003487]	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs,1BX003487 - David D. Brand - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Croia C, 2019, CLIN EXP RHEUMATOL, V37, P347; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Hegde R, 2019, DM-DIS MON, V65, P185, DOI 10.1016/j.disamonth.2018.09.011; KATZ J, 1987, J PERIODONTOL, V58, P607, DOI 10.1902/jop.1987.58.9.607; Marchesan JT, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4376; Moller B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01108; Sandal I, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1143-6; Sato K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07196-7; Terao C, 2019, AM J HUM GENET, V105, P616, DOI 10.1016/j.ajhg.2019.08.002; van Tilburg MLJA, 2001, ORAL MICROBIOL IMMUN, V16, P153, DOI 10.1034/j.1399-302x.2001.016003153.x; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694	15	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250177	10.1371/journal.pone.0250177	http://dx.doi.org/10.1371/journal.pone.0250177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857232	Green Published, gold			2022-12-26	WOS:000641474900076
J	Wober, W; Curto, M; Tibihika, P; Meulenbroek, P; Alemayehu, E; Mehnen, L; Meimberg, H; Sykacek, P				Woeber, Wilfried; Curto, Manuel; Tibihika, Papius; Meulenbroek, Paul; Alemayehu, Esayas; Mehnen, Lars; Meimberg, Harald; Sykacek, Peter			Identifying geographically differentiated features of Ethopian Nile tilapia (Oreochromis niloticus) morphology with machine learning	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; MODEL; POPULATIONS; CICHLIDAE	Visual characteristics are among the most important features for characterizing the phenotype of biological organisms. Color and geometric properties define population phenotype and allow assessing diversity and adaptation to environmental conditions. To analyze geometric properties classical morphometrics relies on biologically relevant landmarks which are manually assigned to digital images. Assigning landmarks is tedious and error prone. Predefined landmarks may in addition miss out on information which is not obvious to the human eye. The machine learning (ML) community has recently proposed new data analysis methods which by uncovering subtle features in images obtain excellent predictive accuracy. Scientific credibility demands however that results are interpretable and hence to mitigate the black-box nature of ML methods. To overcome the black-box nature of ML we apply complementary methods and investigate internal representations with saliency maps to reliably identify location specific characteristics in images of Nile tilapia populations. Analyzing fish images which were sampled from six Ethiopian lakes reveals that deep learning improves on a conventional morphometric analysis in predictive performance. A critical assessment of established saliency maps with a novel significance test reveals however that the improvement is aided by artifacts which have no biological interpretation. More interpretable results are obtained by a Bayesian approach which allows us to identify genuine Nile tilapia body features which differ in dependence of the animals habitat. We find that automatically inferred Nile tilapia body features corroborate and expand the results of a landmark based analysis that the anterior dorsum, the fish belly, the posterior dorsal region and the caudal fin show signs of adaptation to the fish habitat. We may thus conclude that Nile tilapia show habitat specific morphotypes and that a ML analysis allows inferring novel biological knowledge in a reproducible manner.	[Woeber, Wilfried; Curto, Manuel; Tibihika, Papius; Alemayehu, Esayas; Meimberg, Harald] Univ Nat Resources & Life Sci, Inst Integrat Nat Conservat Res, Vienna, Austria; [Woeber, Wilfried] Univ Appl Sci Technikum Wien, Dept Ind Engn, Vienna, Austria; [Curto, Manuel] Univ Lisbon, Marine & Environm Sci Ctr, Lisbon, Portugal; [Tibihika, Papius] Natl Environm Management Author, Kampala, Uganda; [Meulenbroek, Paul] Univ Nat Resources & Life Sci, Inst Hydrobiol & Aquat Ecosyst Management, Vienna, Austria; [Meulenbroek, Paul] WasserCluster Lunz Biol Stn, Lunz Am See, Austria; [Alemayehu, Esayas] Natl Fishery & Aquat Life Res Ctr, Sebeta, Ethiopia; [Mehnen, Lars] Univ Appl Sci Technikum Wien, Fac Life Sci Engn, Vienna, Austria; [Sykacek, Peter] Univ Nat Resources & Life Sci, Inst Computat Biol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Universidade de Lisboa; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Sykacek, P (corresponding author), Univ Nat Resources & Life Sci, Inst Computat Biol, Vienna, Austria.	peter.sykacek@boku.ac.at	Meulenbroek, Paul/AAH-2574-2019	Meulenbroek, Paul/0000-0001-9232-2792; Curto, Manuel/0000-0002-1630-4653; Sykacek, Peter/0000-0001-8800-8354; Wober, Wilfried/0000-0002-0881-205X	University of Natural Resources and Life Sciences, Vienna; Austrian Partnership Program in Higher Education and Research for Development - APPEAR, a program of the Austrian Development Cooperation	University of Natural Resources and Life Sciences, Vienna; Austrian Partnership Program in Higher Education and Research for Development - APPEAR, a program of the Austrian Development Cooperation	The publication fee for this paper are provided by the Open Access Publishing Fund of the University of Natural Resources and Life Sciences, Vienna. PT and EA received funding by the Austrian Partnership Program in Higher Education and Research for Development - APPEAR, a program of the Austrian Development Cooperation which is implemented by the Austrian Agency for International Cooperation in Education and Research https://oead.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2017, DEVELOPMENT, V144, P4284, DOI 10.1242/dev.137505; Allken V, 2019, ICES J MAR SCI, V76, P342, DOI 10.1093/icesjms/fsy147; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bishop C. M, 2006, PATTERN RECOGNITION; Bookstein F. L., 1992, MORPHOMETRIC TOOLS L; Breno M, 2011, J MAMMAL, V92, P1395, DOI 10.1644/10-MAMM-A-331.1; Cavalcanti MJ., 2019, TROPICAL DIVERSITY, P48; Chollet F., 2018, DEEP LEARNING PYTHON; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; CORTI M, 1988, CAN J FISH AQUAT SCI, V45, P1548, DOI 10.1139/f88-183; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Cui SX, 2020, APPL COMPUT INTELL S, V2020, DOI 10.1155/2020/3738108; Daley D., 2003, INTRO THEORY POINT P, V1; DAWID AP, 1976, BIOMETRICS, V32, P647, DOI 10.2307/2529753; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Efron B, 2016, INST MATH STAT MG, P1, DOI 10.1017/CBO9781316576533; El-Zaeem S. Y., 2012, African Journal of Agricultural Research, V7, P2946; Fagerland MW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-91; Gagniuc PA, 2020, CHAOS, V30, DOI 10.1063/1.5120818; Ghahramani Z., 2006, ADV NEURAL INFORM PR, P1257; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gulli A., 2019, DEEP LEARNING TENSOR; HADDON M, 1995, MAR BIOL, V123, P19, DOI 10.1007/BF00350319; Hand D. J., 1997, CONSTRUCTION ASSESSM; Ibanez AL, 2007, CAN J FISH AQUAT SCI, V64, P1091, DOI 10.1139/F07-075; Kerschbaumer Michaela, 2011, Int J Evol Biol, V2011, P290245, DOI 10.4061/2011/290245; Kotikalapudi R, 2017, KERAS VIS; Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386; Lapuschkin S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08987-4; Lawrence N, 2005, J MACH LEARN RES, V6, P1783; Lawrence N., 2007, ARTIFICIAL INTELLIGE, V2, P243; Lawrence ND, 2004, ADV NEUR IN, V16, P329; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee SH, 2016, CLEF WORKING NOTES, P502; MacKay D. J. C., 2003, INFORM THEORY INFERE; Maderbacher M, 2008, J ZOOL SYST EVOL RES, V46, P153, DOI 10.1111/j.1439-0469.2007.00447.x; Mardia KV., 2016, WILEY SERIES PROBABI, VSecond Edition; Marini S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32089-8; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MEYER A, 1987, EVOLUTION, V41, P1357, DOI 10.1111/j.1558-5646.1987.tb02473.x; Minka T. P., 2001, P 17 C UNC ART INT, P362; Montavon G., 2018, CORR; Montavon G, 2018, DIGIT SIGNAL PROCESS, V73, P1, DOI 10.1016/j.dsp.2017.10.011; Ndiwa TC, 2016, ENVIRON BIOL FISH, V99, P473, DOI 10.1007/s10641-016-0492-y; Neal R. M., 1998, Neural Networks and Machine Learning. Proceedings, P97; Neal R. M., 1996, LECT NOTES STAT; Olsen A., 2018, CORR; Perez L., 2017, ENVIRON TECHNOL; Qin HW, 2016, NEUROCOMPUTING, V187, P49, DOI 10.1016/j.neucom.2015.10.122; Quinonero-Candela JQ, 2005, J MACH LEARN RES, V6, P1939; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ripley B. D., 1996, PATTERN RECOGNITION; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Salman A, 2020, ICES J MAR SCI, V77, P1295, DOI 10.1093/icesjms/fsz025; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Simonyan K., 2013, DEEP INSIDE CONVOLUT; Simonyan K., 2015, PROC 3 INT C LEARN R; Springenberg J.T., 2014, ARXIV14126806; STEARNS SC, 1983, EVOLUTION, V37, P601, DOI [10.2307/2408273, 10.1111/j.1558-5646.1983.tb05577.x]; Strauss R, 1990, TAXONOMIC METHODS MO, P109; The GPy Authors, 2014, GPY GAUSSIAN PROCESS; Thompson D. W., 1917, GROWTH FORM; Tibihika PD, 2018, ENVIRON BIOL FISH, V101, P363, DOI 10.1007/s10641-017-0704-0; Titsias M., 2009, VARIATIONAL LEARNING, VPMLR, P567; Tong C, 2019, AM STAT, V73, P246, DOI 10.1080/00031305.2018.1518264; Villon S, 2018, ECOL INFORM, V48, P238, DOI 10.1016/j.ecoinf.2018.09.007; Webster M, 2010, PALEONTOLOGICAL SOC, V,, P163, DOI DOI 10.1017/S1089332600001868; Wolpert DH, 1996, NEURAL COMPUT, V8, P1391, DOI 10.1162/neco.1996.8.7.1391; Wright S, 1920, P NATL ACAD SCI USA, V6, P320, DOI 10.1073/pnas.6.6.320; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	75	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249593	10.1371/journal.pone.0249593	http://dx.doi.org/10.1371/journal.pone.0249593			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857176	gold, Green Published, Green Submitted			2022-12-26	WOS:000641474900074
J	Yousef, AF; Ali, MM; Rizwan, HM; Tadda, SA; Kalaji, HM; Yang, H; Ahmed, MAA; Wrobel, J; Xu, Y; Chen, FX				Yousef, Ahmed F.; Ali, Muhammad M.; Rizwan, Hafiz M.; Tadda, Shehu Abubakar; Kalaji, Hazem M.; Yang, Hao; Ahmed, Mohamed A. A.; Wrobel, Jacek; Xu, Yong; Chen, Faxing			Photosynthetic apparatus performance of tomato seedlings grown under various combinations of LED illumination	PLOS ONE			English	Article							LIGHT-EMITTING-DIODES; CHLOROPHYLL-A FLUORESCENCE; OXYGEN-EVOLVING COMPLEX; PHOTOSYSTEM-II; RED-LIGHT; CO2 ASSIMILATION; LETTUCE GROWTH; QUALITY; BLUE; GREEN	It is already known that the process of photosynthesis depends on the quality and intensity of light. However, the influence of the new light sources recently used in horticulture, known as Light Emitting Diodes (LEDs), on this process is not yet fully understood. Chlorophyll a fluorescence measurement has been widely used as a rapid, reliable, and noninvasive tool to study the efficiency of the photosystem II (PSII) and to evaluate plant responses to various environmental factors, including light intensity and quality. In this work, we tested the responses of the tomato photosynthetic apparatus to different light spectral qualities. Our results showed that the best performance of the photosynthetic apparatus was observed under a mixture of red and blue light (R7:B3) or a mixture of red, green and blue light (R3:G2:B5). This was demonstrated by the increase in the effective photochemical quantum yield of PSII (Y[II]), photochemical quenching (qP) and electron transport rate (ETR). On the other hand, the mixture of red and blue light with a high proportion of blue light led to an increase in non-photochemical quenching (NPQ). Our results can be used to improve the production of tomato plants under artificial light conditions. However, since we found that the responses of the photosynthetic apparatus of tomato plants to a particular light regime were cultivar-dependent and there was a weak correlation between the growth and photosynthetic parameters tested in this work, special attention should be paid in future research.	[Yousef, Ahmed F.; Ali, Muhammad M.; Rizwan, Hafiz M.; Tadda, Shehu Abubakar; Ahmed, Mohamed A. A.; Chen, Faxing] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Peoples R China; [Yousef, Ahmed F.] Univ Al Azhar, Coll Agr, Dept Hort, Branch Assiut, Assiut, Egypt; [Tadda, Shehu Abubakar] Federal Univ, Fac Agr & Agr Technol, Dept Crop Prod & Protect, Dutsin Ma, Katsina, Nigeria; [Kalaji, Hazem M.] Warsaw Univ Life Sci SGGW, Inst Biol, Dept Plant Physiol, Warsaw, Poland; [Yang, Hao; Xu, Yong] Fujian Agr & Forestry Univ, Coll Mech & Elect Engn, Fuzhou, Peoples R China; [Ahmed, Mohamed A. A.] Alexandria Univ, Fac Agr Saba Basha, Plant Prod Dept Hort Med & Aromat Plants, Alexandria, Egypt; [Wrobel, Jacek] West Pomeranian Univ Technol Szczecin, Dept Bioengn, Szczecin, Poland; [Xu, Yong] Fujian Univ Technol, Inst Machine Learning & Intelligent Sci, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Egyptian Knowledge Bank (EKB); Al Azhar University; Warsaw University of Life Sciences; Fujian Agriculture & Forestry University; Egyptian Knowledge Bank (EKB); Alexandria University; West Pomeranian University of Technology; Fujian University of Technology	Chen, FX (corresponding author), Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Peoples R China.; Xu, Y (corresponding author), Fujian Agr & Forestry Univ, Coll Mech & Elect Engn, Fuzhou, Peoples R China.; Xu, Y (corresponding author), Fujian Univ Technol, Inst Machine Learning & Intelligent Sci, Fuzhou, Peoples R China.	y.xu@fafu.edu.cn; cfaxing@126.com	Yousef, Ahmed Fathy/AAA-1316-2022; Kalaji, Mohamed Hazem/E-8086-2012; Ali, Muhammad Moaaz/AAT-5134-2021; Yousef, Ahmed/AAQ-9543-2021	Kalaji, Mohamed Hazem/0000-0002-3833-4917; Ali, Muhammad Moaaz/0000-0002-3092-6328; Yousef, Ahmed/0000-0002-6614-5566; ABUBAKAR TADDA, SHEHU/0000-0001-9467-6615; Wrobel, Jacek/0000-0003-0265-8837; Ahmed, Mohamed A. A./0000-0001-7929-968X				Avercheva OV, 2009, RUSS J PLANT PHYSL+, V56, P14, DOI 10.1134/S1021443709010038; Barbagallo RP, 2003, PLANT PHYSIOL, V132, P485, DOI 10.1104/pp.102.018093; Bourget CM, 2008, HORTSCIENCE, V43, P1944, DOI 10.21273/HORTSCI.43.7.1944; Brodersen CR, 2010, FUNCT PLANT BIOL, V37, P403, DOI 10.1071/FP09262; Burling K, 2010, PRECIS AGRIC, V11, P703, DOI 10.1007/s11119-010-9194-1; BUKHOV NG, 1995, J PHOTOCH PHOTOBIO B, V30, P39, DOI 10.1016/1011-1344(95)07124-K; BUTLER WL, 1978, ANNU REV PLANT PHYS, V29, P345, DOI 10.1146/annurev.pp.29.060178.002021; Cartelat A, 2005, FIELD CROP RES, V91, P35, DOI 10.1016/j.fcr.2004.05.002; Chavez-Arias CC, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9050213; Chen XL, 2014, SCI HORTIC-AMSTERDAM, V172, P168, DOI 10.1016/j.scienta.2014.04.009; 장성호, 2003, [Protected Horticulture and Plant Factory, 시설원예‧식물공장], V12, P173; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; DeEll J. R., 2003, Practical applications of chlorophyll fluorescence in plant biology, P203; Dou HJ, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3020036; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; EVANS J, 2011, AM SOC PLANT BIOL, DOI DOI 10.1104/PP.110.900402; Fan XX, 2013, ACTA PHYSIOL PLANT, V35, P2721, DOI 10.1007/s11738-013-1304-z; Folta KM, 2004, PLANT PHYSIOL, V135, P1407, DOI 10.1104/pp.104.038893; Fracheboud Y, 1999, J EXP BOT, V50, P1533, DOI 10.1093/jexbot/50.338.1533; Hamdani S, 2019, PHOTOSYNTH RES, V139, P107, DOI 10.1007/s11120-018-0589-6; Hernandez R, 2016, ENVIRON EXP BOT, V121, P66, DOI 10.1016/j.envexpbot.2015.04.001; Hoffmann AM, 2015, J PLANT RES, V128, P295, DOI 10.1007/s10265-014-0698-z; Hussain S, 2019, SCI TOTAL ENVIRON, V658, P626, DOI 10.1016/j.scitotenv.2018.12.182; Johkan M, 2012, ENVIRON EXP BOT, V75, P128, DOI 10.1016/j.envexpbot.2011.08.010; Johnson GN, 2011, BBA-BIOENERGETICS, V1807, P906, DOI 10.1016/j.bbabio.2011.05.008; Kalaji HM, 2018, PHOTOSYNTH RES, V136, P329, DOI 10.1007/s11120-017-0467-7; Kalaji HM, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2113-y; Kalaji HM, 2014, PLANT PHYSIOL BIOCH, V81, P16, DOI 10.1016/j.plaphy.2014.03.029; Kalaji HM, 2011, ENVIRON EXP BOT, V73, P64, DOI 10.1016/j.envexpbot.2010.10.009; Kalmatskaya OA, 2019, PROC SPIE, V11065, DOI 10.1117/12.2523333; Kardile PB., 2019, INDIAN J AGR RES ALL, V5, P29; Kasajima I, 2011, P NATL ACAD SCI USA, V108, P13835, DOI 10.1073/pnas.1104809108; KAUTSKY H, 1960, BIOCHEM Z, V332, P277; Kim HH, 2004, HORTSCIENCE, V39, P1617, DOI 10.21273/HORTSCI.39.7.1617; Kim HM, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9030157; Kim SJ, 2004, SCI HORTIC-AMSTERDAM, V101, P143, DOI 10.1016/j.scienta.2003.10.003; Kim YJ, 2016, KOREAN J HORTIC SCI, V34, P878, DOI 10.12972/kjhst.20160092; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kobayashi K., 2013, OPTICS PHOTONICS J, V3, P74, DOI DOI 10.4236/OPJ.2013.31012; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Lin KH, 2013, SCI HORTIC-AMSTERDAM, V150, P86, DOI 10.1016/j.scienta.2012.10.002; Liu J, 2019, HORTSCIENCE, V54, pS49; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Lu CM, 2001, J PLANT PHYSIOL, V158, P1423, DOI 10.1078/0176-1617-00501; Matsuda R, 2004, PLANT CELL PHYSIOL, V45, P1870, DOI 10.1093/pcp/pch203; Matsuda R, 2008, PLANT CELL PHYSIOL, V49, P664, DOI 10.1093/pcp/pcn041; Muneer S, 2014, INT J MOL SCI, V15, P4657, DOI 10.3390/ijms15034657; Nanya K, 2012, ACTA HORTIC, V956, P261, DOI 10.17660/ActaHortic.2012.956.29; Nicol L, 2019, NAT PLANTS, V5, P1177, DOI 10.1038/s41477-019-0526-5; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Ouzounis T, 2016, 8 INT S LIGHT HORT; Pandey S. K., 2011, Journal of Botany, V2011, P658240, DOI 10.1155/2011/658240; Pearson K, 1895, LONDON, V58, P240; Robson TM, 2015, PLANT CELL ENVIRON, V38, P856, DOI 10.1111/pce.12374; SAEBO A, 1995, PLANT CELL TISS ORG, V41, P177, DOI 10.1007/BF00051588; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Shimizu H., 2005, ACTA HORTIC, V711, P363, DOI DOI 10.17660/ACTAH0RTIC.2006.711.50; Shimizu H., 2011, IFAC P VOLUMES, V44, P605, DOI [10.3182/20110828-6-IT-1002.02683, DOI 10.3182/20110828-6-IT-1002.02683]; Sitko K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50579-1; Tamulaitis G, 2005, J PHYS D APPL PHYS, V38, P3182, DOI [10.1088/0022-3727/38/17/S20, 10.1088/0022-3727/38/17/020]; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Tikkanen M, 2014, TRENDS PLANT SCI, V19, P10, DOI 10.1016/j.tplants.2013.09.003; Wang H, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00407; Wang Shuai, 2016, Horticultural Plant Journal, V2, P82, DOI 10.1016/j.hpj.2016.03.001; Wang Y, 2017, BIOLOGIA, V72, P735, DOI 10.1515/biolog-2017-0081; Wu Q, 2014, ACTA PHYSIOL PLANT, V36, P1411, DOI 10.1007/s11738-014-1519-7; Xu YY, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02480-7; Yang XL, 2018, ENVIRON EXP BOT, V150, P161, DOI 10.1016/j.envexpbot.2018.03.013; Yang ZhenChao, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P173; Yano A, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-46; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380; Yoshida H, 2016, PLANT BIOTECHNOL-NAR, V33, P267, DOI 10.5511/plantbiotechnology.16.0216a; Yu WW, 2017, J PLANT GROWTH REGUL, V36, P148, DOI 10.1007/s00344-016-9625-y; Zaks J, 2012, P NATL ACAD SCI USA, V109, P15757, DOI 10.1073/pnas.1211017109; Zavafer A, 2015, J PHOTOCH PHOTOBIO B, V152, P247, DOI 10.1016/j.jphotobiol.2015.08.007; Zavafer A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16363; Zhao X, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01968	77	17	17	12	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249373	10.1371/journal.pone.0249373	http://dx.doi.org/10.1371/journal.pone.0249373			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33858008	Green Published			2022-12-26	WOS:000641474900033
J	Alghamdi, AA				Alghamdi, Abdulelah A.			Impact of the COVID-19 pandemic on the social and educational aspects of Saudi university students' lives	PLOS ONE			English	Article							CORONAVIRUS; PERCEPTIONS; WORK; RISK; CARE	The COVID-19 pandemic led to surprising and unexpected experiences for Saudi university students. Precautionary and preventive measures taken to contain this pandemic impacted the social and educational aspects of these students' lives. All Umm Al-Qura University (UQU) students were invited to participate in an online survey on 30 impacts, both positive and negative, of the COVID-19 pandemic on their lives. Social impact theory (SIT) was applied to illustrate these impacts. The survey yielded 1,360 responses. The results showed high to moderate levels of agreement regarding students' perceptions of the positive and negative impact of the COVID-19 pandemic on their lives, with social aspects impacted more than educational ones; and no statistically significant gender differences. Weak correlations were found between the social aspects and the educational aspects of students' lives in relation to the impact of the pandemic, although all aspects were correlated positively. The SIT framework provided insights into how the COVID-19 pandemic impacted students' lives.	[Alghamdi, Abdulelah A.] Umm Al Qura Univ, Fac Educ, Mecca, Saudi Arabia; [Alghamdi, Abdulelah A.] Umm Al Qura Univ, Deanship Sci Res, Mecca, Saudi Arabia	Umm Al Qura University; Umm Al Qura University	Alghamdi, AA (corresponding author), Umm Al Qura Univ, Fac Educ, Mecca, Saudi Arabia.; Alghamdi, AA (corresponding author), Umm Al Qura Univ, Deanship Sci Res, Mecca, Saudi Arabia.	aaghamdi@uqu.edu.sa	Alghamdi, Abdulelah A./ABE-8503-2020	Alghamdi, Abdulelah A./0000-0003-2933-3370				Al-Khudair D., 2020, ARAB NEWS; Al-Rabiaah A, 2020, J INFECT PUBLIC HEAL, V13, P687, DOI 10.1016/j.jiph.2020.01.005; Alghamdi AA., 2021, CASE STUDY FUTURE IN, V13, P20, DOI [10.3390/fi13010020, DOI 10.3390/FI13010020]; Alghamdi AA, 2018, INT J EMERG TECHNOL, V13, P19, DOI 10.3991/ijet.v13i05.7981; Alhamlan FS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011865; Alshammari TM, 2020, SAUDI PHARM J, V28, P898, DOI 10.1016/j.jsps.2020.05.005; Alshehri Y. A., 2020, CREATIVE ED, V11, P985, DOI [10.4236/ce.2020.117071, DOI 10.4236/CE.2020.117071]; Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753; Andel SA, 2020, COMPUT HUM BEHAV, V113, DOI 10.1016/j.chb.2020.106505; [Anonymous], 2020, COVID 19 DASHBOARD S; [Anonymous], 2020, BUSINESS WIRE; [Anonymous], 2020, COVID 19 DIS INTERAC; [Anonymous], 2020, COVID 19 VIRUS PANDE; [Anonymous], 2020, ARAB WEEKLY; Argo JJ, 2005, J CONSUM RES, V32, P207, DOI 10.1086/432230; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Baloran ET, 2020, J LOSS TRAUMA, V25, P635, DOI 10.1080/15325024.2020.1769300; Bensaid B, 2014, CULTURA, V11, P141, DOI 10.5840/cultura20141119; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Chan CL., 2003, NEW GLOBAL THREAT SE, P123; Chang JH, 2018, TELEMAT INFORM, V35, P282, DOI 10.1016/j.tele.2017.11.009; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dhawan S, 2020, J ED TECHNOL SYST, V49, P5, DOI [10.1177/0047239520934018, DOI 10.1177/0047239520934018]; Garfin DR, 2020, STRESS HEALTH, V36, P555, DOI 10.1002/smi.2975; Goh P.S., 2020, MEDEDPUBLISH, V9, P19, DOI 10.15694/mep.2020.000049.1; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Imran M., 2012, J INTERNET BANKING C, V17, P1, DOI DOI 10.2307/1252308?; Kiraly O, 2020, COMPR PSYCHIAT, V100, DOI 10.1016/j.comppsych.2020.152180; LATANE B, 1981, PSYCHOL REV, V88, P438, DOI 10.1037/0033-295X.88.5.438; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Leung TTF, 2007, SOC WORK EDUC, V26, P389, DOI 10.1080/02615470601081704; Lin J., 2019, REV INTEGRATIVE BUSI, V8, P24; Ministry of Interior, 2020, CURFEW ALL MAKKAH MA; Ministry of Interior, 2020, CHANGE TIMES ALLOWED; Ministry of Media, 2020, REPORT NO 2; Onyema E.M., 2020, J ED PRACTICE, V11, P108; Perveen S, 2020, SAUDI PHARM J, V28, P888, DOI 10.1016/j.jsps.2020.06.006; Rapanta C., 2020, POSTDIGITAL SCI EDUC, V2, P923, DOI [10.1007/s42438-020-00155-y, DOI 10.1007/S42438-020-00155-Y]; Rolland JS, 2020, FAM PROCESS, V59, P922, DOI 10.1111/famp.12584; Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541; Seymour-Walsh AE, 2020, RURAL REMOTE HEALTH, V20, DOI 10.22605/RRH6000; Sibai AM, 2012, POPULATION DYNAMICS, P63, DOI DOI 10.1007/978-3-642-27881-5_5; Stirling BV, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0065-y; Tanveer M., 2020, J ENTREP ED, V23, P1; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; WILLIAMS KD, 1989, BASIC APPL SOC PSYCH, V10, P149, DOI 10.1207/s15324834basp1002_5; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060373; Zitoun OA., 2020, INT J MED STUDENTS, V8, P64, DOI [10.5195/ijms.2020.50, DOI 10.5195/IJMS.2020.50]	48	19	19	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250026	10.1371/journal.pone.0250026	http://dx.doi.org/10.1371/journal.pone.0250026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852627	gold, Green Published			2022-12-26	WOS:000640604500060
J	Roberts, JL; Cooper, WJ; Luther, D				Roberts, Jessica L.; Cooper, W. Justin; Luther, David			Global assessment of forest quality for threatened terrestrial vertebrate species in need of conservation translocation programs	PLOS ONE			English	Article							FODIES FOUDIA-RUBRA; LAND-USE-CHANGE; HABITAT LOSS; BIODIVERSITY CONSERVATION; ECOSYSTEM SERVICES; TAXONOMIC BIAS; CLIMATE-CHANGE; REINTRODUCTION; RESTORATION; POPULATION	Conservation actions such as habitat protection, restoration, and translocations are critical actions in preventing further extinctions of threatened species. We used the 152 threatened species on the International Union for the Conservation of Nature's Red List with conservation translocations as a recommended conservation action to access the habitat quality of these species' ranges. We determined where multi-species conservation translocation and forest restoration efforts can be concentrated. To determine the habitat quality of species' ranges, we assessed forest cover, forest restoration potential, protected area status, and invasive species concerns. Forty-four percent (67 species) of species with translocations recommended have part of their range in a protected area, existing forest cover, and currently no invasive species risk. However, the majority (85 species) currently need habitat management (63 species), invasive species control (71 species), or protection (34 species). We also identified key differences between species recommended for reintroductions (115 species) and benign introductions (37 species), such as the percentage of a species' range within a protected area, in which reintroductions (median = 7.4%) had more than benign introductions (median = 0.9%). Mauritius, central Africa, eastern Australia and Himalaya regions each have areas with range overlap of three or more species recommended for translocations and forest restoration potential. For those species with CT programs in place, mean forest cover was 32% and restoration potential was 16%, suggesting potential minimum habitat requirements for initial releases. Results provide a global perspective on reintroduction and translocation needs of threatened species with evidenced-based information on habitat quality, i.e. forest restoration potential, forest cover, protected areas, and invasive species control, to aid conservation translocation scientists and ultimately improve the success of such projects.	[Roberts, Jessica L.] George Mason Univ, Environm Sci & Policy Dept, Fairfax, VA 22030 USA; [Cooper, W. Justin; Luther, David] George Mason Univ, Dept Biol, Fairfax, VA 22030 USA; [Luther, David] George Mason Univ, Smithsonian Mason Sch Conservat, Fairfax, VA 22030 USA	George Mason University; George Mason University; George Mason University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Roberts, JL (corresponding author), George Mason Univ, Environm Sci & Policy Dept, Fairfax, VA 22030 USA.	jrober43@gmu.edu		Cooper, William/0000-0002-5390-1537				Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Barnes R, 2018, DGGRIDR DISCRETE GLO; BARNES TG, 1995, WILDLIFE SOC B, V23, P231; Barnett JM, 2005, BIODIVERS CONSERV, V14, P2265, DOI 10.1007/s10531-004-5290-8; Beck B. B., 1994, P265; Bell BD, 2016, CONSERVATION BEHAV A, P231; Bernardo CSS, 2011, ANIM CONSERV, V14, P676, DOI 10.1111/j.1469-1795.2011.00473.x; Betts MG, 2017, NATURE, V547, P441, DOI 10.1038/nature23285; Bongaarts J, 2019, POPUL DEV REV, V45, P680, DOI 10.1111/padr.12283; Bright EA, 2006, LANDSCAN 2005; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Converse SJ, 2013, J WILDLIFE MANAGE, V77, P1145, DOI 10.1002/jwmg.472; Cristinacce A, 2008, ZOO BIOL, V27, P255, DOI 10.1002/zoo.20182; Cristinacce A, 2010, BIRD CONSERV INT, V20, P365, DOI 10.1017/S095927090999027X; Dickson BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081898; Doherty TS, 2016, P NATL ACAD SCI USA, V113, P11261, DOI 10.1073/pnas.1602480113; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griscom BW, 2017, P NATL ACAD SCI USA, V114, P11645, DOI 10.1073/pnas.1710465114; Handbook of the birds of the world and Birdlife International, 2018, HDB BIRDS WORLD BIRD; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harper GA, 2015, GLOB ECOL CONSERV, V3, P607, DOI 10.1016/j.gecco.2015.02.010; Hill SLL, 2019, FRONT FOR GLOB CHANG, V2, DOI 10.3389/ffgc.2019.00070; Holmes ND, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212128; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Hunter-Ayad J, 2020, J APPL ECOL, V57, P1233, DOI 10.1111/1365-2664.13629; Jantz SM, 2015, CONSERV BIOL, V29, P1122, DOI 10.1111/cobi.12549; Jones Carl G., 2012, P33; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Kok MTJ, 2018, BIOL CONSERV, V221, P137, DOI 10.1016/j.biocon.2018.03.003; Kroner REG, 2019, SCIENCE, V364, P881, DOI 10.1126/science.aau5525; Lipsey MK, 2007, CONSERV BIOL, V21, P1387, DOI 10.1111/j.1523-1739.2007.00806.x; Loss SR, 2011, BIOL CONSERV, V144, P92, DOI 10.1016/j.biocon.2010.11.016; Makan T, 2014, NEW ZEAL J ECOL, V38, P53; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Minnemeyer Susan, 2014, ATLAS FOREST LANDSCA; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Moroni S, 2019, LAND USE POLICY, V86, P104, DOI 10.1016/j.landusepol.2019.04.032; Muller J, 2014, BIOL CONSERV, V177, P210, DOI 10.1016/j.biocon.2014.07.007; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Newmark WD, 2002, CONSERVING BIODIVERS; Newmark WD, 2017, P NATL ACAD SCI USA, V114, P9635, DOI 10.1073/pnas.1705834114; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Osborne Patrick E., 2012, P73; Panta M, 2008, FOREST ECOL MANAG, V256, P1587, DOI 10.1016/j.foreco.2008.07.023; Parkes David, 2003, Ecological Management & Restoration, V4, pS29, DOI 10.1046/j.1442-8903.4.s.4.x; Pfeifer M, 2017, NATURE, V551, P187, DOI 10.1038/nature24457; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pittman K, 2010, REMOTE SENS-BASEL, V2, P1844, DOI 10.3390/rs2071844; Powers RP, 2019, NAT CLIM CHANGE, V9, P323, DOI 10.1038/s41558-019-0406-z; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; QGIS Geographic Information System, 2020, OPEN SOURCE GEOSPATI; R Core Team, 2020, R LANG ENV STAT COMP; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Schwartz MW, 2013, ANN NY ACAD SCI, V1286, P15, DOI 10.1111/nyas.12050; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2005, ANIM CONSERV, V8, P51, DOI 10.1017/S1367943004001799; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Spatz DR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603080; The IUCN Red List of Threatened Species, 2020, IUCN RED LIST THREAT; Troudet J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09084-6; Wallace Michael P., 2000, Conservation Biology Series (Cambridge), V2, P300; White TH, 2012, BIOL CONSERV, V148, P106, DOI 10.1016/j.biocon.2012.01.044; Wintle BA, 2019, P NATL ACAD SCI USA, V116, P909, DOI 10.1073/pnas.1813051115; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x; Woodroffe Rosie, 1997, P100; Zeileis A., 2004, WORLD DATABASE PROTE, V11, P1, DOI 10.18637/jss.v011.i10	75	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249378	10.1371/journal.pone.0249378	http://dx.doi.org/10.1371/journal.pone.0249378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852601	Green Published, gold			2022-12-26	WOS:000640604500028
J	Browning, R; Sulem, D; Mengersen, K; Rivoirard, V; Rousseau, J				Browning, Raiha; Sulem, Deborah; Mengersen, Kerrie; Rivoirard, Vincent; Rousseau, Judith			Simple discrete-time self-exciting models can describe complex dynamic processes: A case study of COVID-19	PLOS ONE			English	Article								Hawkes processes are a form of self-exciting process that has been used in numerous applications, including neuroscience, seismology, and terrorism. While these self-exciting processes have a simple formulation, they can model incredibly complex phenomena. Traditionally Hawkes processes are a continuous-time process, however we enable these models to be applied to a wider range of problems by considering a discrete-time variant of Hawkes processes. We illustrate this through the novel coronavirus disease (COVID-19) as a substantive case study. While alternative models, such as compartmental and growth curve models, have been widely applied to the COVID-19 epidemic, the use of discrete-time Hawkes processes allows us to gain alternative insights. This paper evaluates the capability of discrete-time Hawkes processes by modelling daily mortality counts as distinct phases in the COVID-19 outbreak. We first consider the initial stage of exponential growth and the subsequent decline as preventative measures become effective. We then explore subsequent phases with more recent data. Various countries that have been adversely affected by the epidemic are considered, namely, Brazil, China, France, Germany, India, Italy, Spain, Sweden, the United Kingdom and the United States. These countries are all unique concerning the spread of the virus and their corresponding response measures. However, we find that this simple model is useful in accurately capturing the dynamics of the process, despite hidden interactions that are not directly modelled due to their complexity, and differences both within and between countries. The utility of this model is not confined to the current COVID-19 epidemic, rather this model could explain many other complex phenomena. It is of interest to have simple models that adequately describe these complex processes with unknown dynamics. As models become more complex, a simpler representation of the process can be desirable for the sake of parsimony.	[Browning, Raiha; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Browning, Raiha; Mengersen, Kerrie] Australian Res Council, Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia; [Sulem, Deborah; Rousseau, Judith] Univ Oxford, Dept Stat, Oxford, England; [Rivoirard, Vincent; Rousseau, Judith] Univ Paris 09, CEREMADE, Paris, France	Queensland University of Technology (QUT); University of Oxford; UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	Browning, R (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia.; Browning, R (corresponding author), Australian Res Council, Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia.	raihatuitaura.browning@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Browning, Raiha/0000-0002-6175-2244				Agosto A, 2020, RISKS, V8, DOI 10.3390/risks8030077; Apostolopoulou I., 2018, ADV NEURAL INFORM PR, P5115; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117; Burda Z, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22111236; Burkner PC, 2020, J STAT COMPUT SIM, DOI 10.1080/00949655.2020.1783262; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Chen F, 2018, ANN APPL STAT, V12, P2175, DOI 10.1214/18-AOAS1148; Chen X., 2020, EARLY PREDICTION MOR, DOI 10.1101/2020.04.13.20064329; Chen Y, 2022, APPL ANAL, V101, P146, DOI 10.1080/00036811.2020.1732357; Chiang WH, 2022, INT J FORECASTING, V38, P505, DOI 10.1016/j.ijforecast.2021.07.001; CHORNOBOY ES, 1988, BIOL CYBERN, V59, P265, DOI 10.1007/BF00332915; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Dennis JM, 2021, CRIT CARE MED, V49, P209, DOI 10.1097/CCM.0000000000004747; Detommaso G, 2019, STEIN VARIATIONAL ON; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Fowler JH, 2020, EFFECT STAY AT HOME, DOI 10.1101/2020.04.13.20063628; Funk S, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006785; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; HAWKES AG, 1971, BIOMETRIKA, V58, P83, DOI 10.2307/2334319; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Horwitz LI, 2021, J HOSP MED, V16, P90, DOI 10.12788/jhm.3552; Jia WP, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00169; Kelly JD, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.100354; Killick R, 2014, J STAT SOFTW, V58, P1; Kim M, 2019, P NATL ACAD SCI USA, V116, P401, DOI 10.1073/pnas.1801429116; Koyama S, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008679; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Lee K, 2009, GLOB INST, P1; Lee SY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236860; Lesage l, 2020, HAWKES PROCESS MAKE; Li S, 2017, IEEE T SIGNAL INF PR, V3, P346, DOI 10.1109/TSIPN.2017.2696264; Li Y, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00704-4; Linderman SW, 2015, ARXIV PREPRINT ARXIV; Piccolomini EL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237417; Mbuvha R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237126; Meyer S, 2012, BIOMETRICS, V68, P607, DOI 10.1111/j.1541-0420.2011.01684.x; Mohler G, 2020, ANAL IMPACTS PUBLIC; Mohler G, 2013, ANN APPL STAT, V7, P1525, DOI 10.1214/13-AOAS647; Musa SS, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00718-y; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Paiva HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236386; Park J, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10103612; Peak CM, 2020, LANCET INFECT DIS, V20, P1025, DOI 10.1016/S1473-3099(20)30361-3; Peixoto PS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235732; Plank MJ., 2020, MOL CELL PROTEOMICS; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Reinhart A, 2018, J R STAT SOC C-APPL, V67, P1305, DOI 10.1111/rssc.12277; Reynaud-Bouret P, 2013, IEEE GLOB CONF SIG, P317, DOI 10.1109/GlobalSIP.2013.6736879; Rizoiu MA, 2018, WEB CONFERENCE 2018: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW2018), P419, DOI 10.1145/3178876.3186108; Roberts G.O., 1996, BERNOULLI, V2, P341, DOI DOI 10.2307/3318418; Romero-Severson EO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236776; Roques L, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9050097; Royal Society, 2020, FAC MASKS COV GEN PU; Schoenberg FP, 2019, ANN I STAT MATH, V71, P1271, DOI 10.1007/s10463-018-0690-9; Sharma VK, 2020, ARCH WOMEN MENT HLTH; Tadic B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241163; White G, 2013, J QUANT CRIMINOL, V29, P295, DOI 10.1007/s10940-012-9181-y; Worden L, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007512; Zhan CJ, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0234763, 10.1371/journal.pone.0234763.r001, 10.1371/journal.pone.0234763.r002, 10.1371/journal.pone.0234763.r003, 10.1371/journal.pone.0234763.r004]; Zou Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235247; Zu J, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00709-z	67	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0250015	10.1371/journal.pone.0250015	http://dx.doi.org/10.1371/journal.pone.0250015			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836020	Green Published, Green Submitted, gold			2022-12-26	WOS:000639361000035
J	Jahan, I; Uddin, AMN; Reza, ASMA; Uddin, MG; Hossain, MS; Nasrin, MS; Bin Emran, T; Rahman, MA				Jahan, Ishrat; Uddin, Abul Bashar Mohammad Neshar; Reza, A. S. M. Ali; Uddin, Md Giash; Hossain, Mohammad Shahadat; Nasrin, Mst Samima; Bin Emran, Talha; Rahman, Md Atiar			Tendencies and attitudes towards dietary supplements use among undergraduate female students in Bangladesh	PLOS ONE			English	Article							MEDICAL-STUDENTS; KNOWLEDGE; HEALTH; TRENDS; ADULTS; PREVALENCE; VITAMIN; KARACHI	Background Dietary supplements (DS) are products that improve the overall health and well-being of individuals and reduce the risk of disease. Evidence indicates a rising prevalence of the use of these products worldwide especially among the age group 18-23 years. Aim The study investigates the tendencies and attitudes of Bangladeshi undergraduate female students towards dietary supplements (DS). Methods A three-month (March 2018-May 2018) cross-sectional face-to-face survey was conducted in undergraduate female students in Chittagong, Bangladesh using a pre-validated dietary supplement questionnaire. The study was carried among the four private and three public university students of different disciplines in Chittagong to record their prevalent opinions and attitudes toward using DS. The results were documented and analyzed by SPSS version 22.0. Results Ninety two percent (N = 925, 92.0%) of the respondents answered the survey questions. The prevalence of DS use was high in undergraduate female students. The respondents cited general health and well-being (n = 102, 11.0%) and physician recommendation (n = 101, 10.9%) as a reason for DS use. Majority of the students (n = 817, 88.3%) used DS cost monthly between USD 0.12 and USD 5.90. Most of the students (n = 749, 81.0%) agreed on the beneficial effect of DS and a significant portion (n = 493, 53.3%) recommended for a regular use of DS. Highly prevalent use of dietary supplements appeared in Chittagonian undergraduate female students. They were tremendously positive in using DS. The results demonstrate an increasing trend of using DS by the undergraduate females for both nutritional improvement and amelioration from diseases. Conclusion Dietary supplements prevalence was so much higher in students of private universities as compared to students of public universities. Likewise, maximal prevalence is indicated in pharmacy department compared to other departments. Students preferred brand products, had positive opinions and attitudes towards dietary supplements.	[Jahan, Ishrat; Uddin, Abul Bashar Mohammad Neshar; Reza, A. S. M. Ali; Hossain, Mohammad Shahadat; Nasrin, Mst Samima] Int Islamic Univ Chittagong, Dept Pharm, Kumira, Chittagong, Bangladesh; [Reza, A. S. M. Ali; Nasrin, Mst Samima; Rahman, Md Atiar] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh; [Uddin, Md Giash] Univ Chittagong, Fac Biol Sci, Dept Pharm, Chittagong, Bangladesh; [Bin Emran, Talha] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong, Bangladesh	International Islamic University Chittagong (IIUC); University of Chittagong; University of Chittagong	Rahman, MA (corresponding author), Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh.	atiar@cu.ac.bd	Uddin, Giash/AAI-4908-2021; Rahman, Atiar/ABD-6817-2021; Emran, Talha Bin/P-9184-2016; Reza, A.S.M. Ali/AAH-9640-2021	Uddin, Giash/0000-0003-0792-0902; Rahman, Atiar/0000-0002-4902-8923; Emran, Talha Bin/0000-0003-3188-2272; Reza, A.S.M. Ali/0000-0002-1457-0245				Abbas A, 2015, PHARM EDUC, V15, P57; Abbas A, 2014, PHARMACY, V2, P270, DOI 10.3390/pharmacy2040270; Abbas A, 2015, TROP J PHARM RES, V14, P527, DOI 10.4314/tjpr.v14i3.23; Aina Bolajoko A, 2014, J Basic Clin Pharm, V5, P34, DOI 10.4103/0976-0105.134952; Alfawaz H, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0475-y; Alfawaz HA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0357-7; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Biesalski HK, 2017, NUTRITION, V36, P60, DOI 10.1016/j.nut.2016.06.003; Braun M, 2008, S AFR J CLIN NUTR, V21, P323; Drueke TB, 2012, NEPHROL DIAL TRANSPL, V27, P1704, DOI 10.1093/ndt/gfs046; Dwyer JT, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010041; El Khoury G, 2016, J COMMUN HEALTH, V41, P566, DOI 10.1007/s10900-015-0131-0; Gardiner P, 2008, PHARMACOEPIDEM DR S, V17, P962, DOI 10.1002/pds.1627; Halsted CH, 2000, AM J CLIN NUTR, V71, P399; Ishihara J, 2003, INT J EPIDEMIOL, V32, P546, DOI 10.1093/ije/dyg091; Islam M., 2018, AM J FOOD SCI NUTR R, V5, P64; Jamshed SQ, 2011, J PAK MED ASSOC, V61, P80; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; Karim KMR., 2015, ASIAN J CLIN NUTR, V7, P55; Khan M., 2014, INT J RES PHARM PHAR, V3, P1; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Labadarios D, 2002, ABSTRACT; Lieberman HR, 2015, CLIN NUTR, V34, P976, DOI 10.1016/j.clnu.2014.10.010; Market N, 2015, GROWTH TRENDS FORECA, V2021, P2015; Maughan RJ, 2004, J SPORT SCI, V22, P95, DOI 10.1080/0264041031000140581; Mileva-Peceva R., 2011, SOCIO DEMOGRAPHIC PR, V32, P127; Naqvi AA, 2019, J DIET SUPPL, V16, P166, DOI 10.1080/19390211.2018.1443191; Pouchieu C, 2013, BRIT J NUTR, V110, P1480, DOI 10.1017/S0007114513000615; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Rooney MR, 2017, JAMA-J AM MED ASSOC, V317, P2448, DOI 10.1001/jama.2017.4392; Sabah A., 2014, INT J PHARM ANALYTIC, V3, P118; Sato Y, 2009, J NUTR SCI VITAMINOL, V55, P317, DOI 10.3177/jnsv.55.317; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Solak BB., ENG 2012 HLTH BENEFI, V2, P129; Spencer EH, 2006, J AM DIET ASSOC, V106, P1975, DOI 10.1016/j.jada.2006.09.003; Sung Y, 2018, J AM COLL NUTR, V37, P127, DOI 10.1080/07315724.2017.1370618; Tasfia SZ., 2020, BANGLADESH PHARM J, V23, P39; Wiltgren AR, 2015, NUTRIENTS, V7, P1094, DOI 10.3390/nu7021094; Zehra F, 2017, INT J PHARM INVESTIG, V7, P70, DOI 10.4103/jphi.JPHI_15_17	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249897	10.1371/journal.pone.0249897	http://dx.doi.org/10.1371/journal.pone.0249897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836035	Green Published, gold			2022-12-26	WOS:000639361000030
J	Alzahrani, SM				Alzahrani, Saad M.			Evaluation of triflumuron and pyriproxyfen as alternative candidates to control house fly, Musca domestica L. (Diptera: Muscidae), in Riyadh city, Saudi Arabia	PLOS ONE			English	Article							INSECT GROWTH-REGULATORS; RESISTANCE; ADULTS	This study was conducted to determine the susceptibility and resistance of some house fly strains of Musca domestica L. to the insect growth regulator insecticides triflumuron and pyriproxyfen in some locations in Riyadh city. Field-collected strains of M. domestica L. from five sites in Riyadh city that represented five slaughterhouse sites where flies spread significantly were tested against triflumuron and pyriproxyfen. Triflumuron LC50 values for the five collected strains ranged from 2.6 to 5.5 ppm, and the resistance factors (RFs) ranged from 13-fold to 27-fold that of the susceptible laboratory strain. Pyriproxyfen LC50 values for the field strains ranged from 0.9 to 1.8 ppm with RFs of 3-fold to 5-fold. These results indicate that pyriproxyfen is an effective insecticide to control house flies and should be used in rotation with other insecticides in the control programs applied by Riyadh municipality.	[Alzahrani, Saad M.] King Abdulaziz City Sci & Technol KACST, Life Sci & Environm Inst, Riyadh, Saudi Arabia		Alzahrani, SM (corresponding author), King Abdulaziz City Sci & Technol KACST, Life Sci & Environm Inst, Riyadh, Saudi Arabia.	smzahrni@kacst.edu.sa		Alzahrani, Saad/0000-0003-3696-2044	Deanship of Scientific Research, King Faisal University [122008]	Deanship of Scientific Research, King Faisal University	Financial support for the research was provided by the Deanship of Scientific Research (https://www.kfu.edu.sa/en/deans/research/pages/home-new.aspx), King Faisal University grant, 122008 awarded to SMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Alzahrani S., 2015, Arab Journal of Plant Protection, V33, P66; Alzahrani S.M., 2015, J JAZAN U APPL SCI B, V4, P1; [Anonymous], 2021, IRAC MODE ACTION CLA; Finney D.J., 1971, PROBIT ANAL; GRAF JF, 1993, PARASITOL TODAY, V9, P471, DOI 10.1016/0169-4758(93)90106-P; Greenberg B., 2019, FLIES DIS ECOLOGY CL; Greenberg B., 2019, FLIES DIS 2 BIOL DIS; HOSKINS WM, 1956, ANNU REV ENTOMOL, V1, P89, DOI 10.1146/annurev.en.01.010156.000513; Khan HAA, 2016, PARASITOL RES, V115, P1385, DOI 10.1007/s00436-015-4872-6; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; Kocisova A, 2004, BIOLOGIA, V59, P661; Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019; MULLA MS, 1995, J AM MOSQUITO CONTR, V11, P269; Municipality Riyadh, 2009, INTENSIVE INSECT PES, P33; SAWICKI RM, 1964, B WORLD HEALTH ORGAN, V31, P535; Schneider M, 2008, ECOTOXICOLOGY, V17, P181, DOI 10.1007/s10646-007-0182-9; Siriwattanarungsee S, 2008, PARASITOL RES, V103, P535, DOI 10.1007/s00436-008-1004-6; Smith K.G.V., 1973, P1; Stafford KC., 2008, MANAGEMENT HDB GUIDE; Sukontason Kabkaew L., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P97, DOI 10.1590/S0036-46652004000200008; Sulaiman S, 2008, IRAN J ARTHROPOD-BOR, V2, P1; TAYLOR RN, 1982, PESTIC SCI, V13, P415, DOI 10.1002/ps.2780130412; Tomberlin JK, 2002, J ECON ENTOMOL, V95, P598, DOI 10.1603/0022-0493-95.3.598; Tunaz Hasan, 2004, Turkish Journal of Agriculture and Forestry, V28, P377; Vazirianzadeh B, 2007, IRAN J ARTHROPOD-BOR, V1, P7	26	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249496	10.1371/journal.pone.0249496	http://dx.doi.org/10.1371/journal.pone.0249496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831056	Green Published, gold			2022-12-26	WOS:000639359600026
J	Hogan, JP; Peercy, BE				Hogan, Janita P.; Peercy, Bradford E.			Flipping the switch on the hub cell: Islet desynchronization through cell silencing	PLOS ONE			English	Article							INSULIN-SECRETION; PANCREATIC-ISLETS; ELECTROPHYSIOLOGICAL APPRAISAL; CA2+; HETEROGENEITY; DYNAMICS; LEADER; CONNECTIVITY; OSCILLATIONS; ME	Pancreatic beta cells, responsible for secreting insulin into the bloodstream and maintaining glucose homeostasis, are organized in the islets of Langerhans as clusters of electrically coupled cells. Gap junctions, connecting neighboring cells, coordinate the behavior of the islet, leading to the synchronized oscillations in the intracellular calcium and insulin secretion in healthy islets. Recent experimental work has shown that silencing special hub cells can lead to a disruption in the coordinated behavior, calling into question the democratic paradigm of islet insulin secretion with more or less equal input from each beta cell. Islets were shown to have scale-free functional connectivity and a hub cell whose silencing would lead to a loss of functional connectivity and activity in the islet. A mechanistic model representing the electrical and calcium dynamics of beta cells during insulin secretion was applied to a network of cells connected by gap junctions to test the hypothesis of hub cells. Functional connectivity networks were built from the simulated calcium traces, with some networks classified as scale-free, confirming experimental results. Potential hub cells were identified using previously defined centrality measures, but silencing them was unable to desynchronize the islet. Instead, switch cells, which were able to turn off the activity of the islet but were not highly functionally connected, were found via systematically silencing each cell in the network.	[Hogan, Janita P.; Peercy, Bradford E.] Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Peercy, BE (corresponding author), Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA.	bpeercy@umbc.edu		Peercy, Bradford/0000-0002-8597-2508	NSF-REU [1460652]; U.S. National Science Foundation through the MRI program [CNS-0821258, CNS-1228778, OAC-1726023]; SCREMS program [DMS-0821311]; University of Maryland, Baltimore County (UMBC)	NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); U.S. National Science Foundation through the MRI program; SCREMS program; University of Maryland, Baltimore County (UMBC)	This work was initiated as part of the NSF-REU (\#1460652) project, proposed by Arthur Sherman, with Team 4 \cite {falgout2017investigation}. The hardware used in the computational studies is part of the UMBC High Performance Computing Facility (HPCF). The facility is supported by the U.S. National Science Foundation through the MRI program (grant nos. similar to CNS-0821258, CNS-1228778, and OAC-1726023) and the SCREMS program (grant no. similar to DMS-0821311), with additional substantial support from the University of Maryland, Baltimore County (UMBC). See \url{hpcf.umbc.edu} for more information on HPCF and the projects using its resources.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barua AK, 2016, PHYSICA D, V315, P49, DOI 10.1016/j.physd.2015.07.009; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Benninger RKP, 2018, DIABETES, V67, P537, DOI 10.2337/dbi17-0040; Benninger RKP, 2014, BIOPHYS J, V107, P2723, DOI 10.1016/j.bpj.2014.10.048; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cappon G, 2016, CHAOS, V26, DOI 10.1063/1.4949020; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; GILON P, 1992, J BIOL CHEM, V267, P20713; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gutierrez GD, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00022; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Hodson DJ, 2010, J NEUROENDOCRINOL, V22, P1217, DOI 10.1111/j.1365-2826.2010.02052.x; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Lei CL, 2018, ISLETS, V10, P151, DOI 10.1080/19382014.2018.1493316; Loppini A, 2019, BIOPHYS CHEM, V254, DOI 10.1016/j.bpc.2019.106247; Marinelli I, 2018, J THEOR BIOL, V454, P310, DOI 10.1016/j.jtbi.2018.06.017; Markovic R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07845; MATTHEWS DR, 1983, DIABETOLOGIA, V24, P231; Nittala A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000983; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rutter GA, 2015, CELL MOL LIFE SCI, V72, P453, DOI 10.1007/s00018-014-1755-4; Salem V, 2019, NAT METAB, V1, P615, DOI 10.1038/s42255-019-0075-2; Satin LS, 2020, DIABETES, V69, pE12, DOI 10.2337/dbi20-0027; Satin LS, 2020, DIABETES, V69, P830, DOI 10.2337/dbi19-0012; Scarl RT, 2019, CELL CALCIUM, V83, DOI 10.1016/j.ceca.2019.102081; Sherman A, 1996, AM J PHYSIOL-ENDOC M, V271, pE362, DOI 10.1152/ajpendo.1996.271.2.E362; Stozer A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002923; Westacott MJ, 2017, BIOPHYS J, V113, P1093, DOI 10.1016/j.bpj.2017.07.021; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Xavier GD, 2020, J MOL BIOL, V432, P1395, DOI 10.1016/j.jmb.2019.08.005	36	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0248974	10.1371/journal.pone.0248974	http://dx.doi.org/10.1371/journal.pone.0248974			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831017	gold, Green Published			2022-12-26	WOS:000639359600109
J	Kennedy, AD; Ford, L; Wittmann, B; Conner, J; Wulff, J; Mitchell, M; Evans, AM; Toal, DR				Kennedy, Adam D.; Ford, Lisa; Wittmann, Bryan; Conner, Jesse; Wulff, Jacob; Mitchell, Matthew; Evans, Anne M.; Toal, Douglas R.			Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives	PLOS ONE			English	Article							ACID DECARBOXYLASE DEFICIENCY; IONIZED CALCIUM MEASUREMENTS; INBORN-ERRORS; CLINICAL METABOLOMICS; BIOMARKERS; HEPARIN; IDENTIFICATION; INTERFERENCE; METABOLISM; PLATFORM	Introduction Analysis of blood for the evaluation of clinically relevant biomarkers requires precise collection and sample handling by phlebotomists and laboratory staff. An important consideration for the clinical application of metabolomics are the different anticoagulants utilized for sample collection. Most studies that have characterized differences in metabolite levels in various blood collection tubes have focused on single analytes. We define analyte levels on a global metabolomics platform following blood sampling using five different, but commonly used, clinical laboratory blood collection tubes (i.e., plasma anticoagulated with either EDTA, lithium heparin or sodium citrate, along with no additive (serum), and EDTA anticoagulated whole blood). Methods Using an untargeted metabolomics platform we analyzed five sample types after all had been collected and stored at -80 degrees C. The biochemical composition was determined and differences between the samples established using matched-pair t-tests. Results We identified 1,117 biochemicals across all samples and detected a mean of 1,036 in the sample groups. Compared to the levels of metabolites in EDTA plasma, the number of biochemicals present at statistically significant different levels (p<0.05) ranged from 452 (serum) to 917 (whole blood). Several metabolites linked to screening assays for rare diseases including acylcarnitines, bilirubin and heme metabolites, nucleosides, and redox balance metabolites varied significantly across the sample collection types. Conclusions Our study highlights the widespread effects and importance of using consistent additives for assessing small molecule levels in clinical metabolomics. The biochemistry that occurs during the blood collection process creates a reproducible signal that can identify specimens collected with different anticoagulants in metabolomic studies. Impact statement In this manuscript, normal/healthy donors had peripheral blood collected using multiple anticoagulants as well as serum during a fasted blood draw. Global metabolomics is a new technology being utilized to draw clinical conclusions and we interrogated the effects of different anticoagulants on the levels of biochemicals from each of the donors. Characterizing the effects of the anticoagulants on biochemical levels will help researchers leverage the information using global metabolomics in order to make conclusions regarding important disease biomarkers.	[Kennedy, Adam D.; Ford, Lisa; Wittmann, Bryan; Conner, Jesse; Wulff, Jacob; Mitchell, Matthew; Evans, Anne M.; Toal, Douglas R.] Metabolon, Morrisville, NC 27560 USA	Metabolon	Kennedy, AD (corresponding author), Metabolon, Morrisville, NC 27560 USA.	adamillini4@gmail.com						Adcock DM, 1997, AM J CLIN PATHOL, V107, P105; [Anonymous], 2013, IMMUNOASSAY HDB, V4th ed; Atwal PS, 2015, MOL GENET METAB, V115, P91, DOI 10.1016/j.ymgme.2015.04.008; Bainbridge MN, 2017, MOL GENET METAB, V121, P314, DOI 10.1016/j.ymgme.2017.06.009; BERG JD, 1988, CLIN CHEM, V34, P174; Cappuccio G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184022; Coresh J, 2019, NEPHROL DIAL TRANSPL, V34, P825, DOI 10.1093/ndt/gfy094; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Donti TR, 2016, MOL GENET METAB REP, V8, P61, DOI 10.1016/j.ymgmr.2016.07.007; Duarte D, 2020, METABOLITES, V10, DOI 10.3390/metabo10120515; Dunn WB, 2015, METABOLOMICS, V11, P9, DOI 10.1007/s11306-014-0707-1; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Esteve-Turrillas FA, 2020, J CHROMATOGR A, V1633, DOI 10.1016/j.chroma.2020.461615; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Ford L, 2020, J APPL LAB MED, V5, P342, DOI 10.1093/jalm/jfz026; Freed TA, 2019, CLIN CHEM, V65, P406, DOI 10.1373/clinchem.2018.288092; Glinton KE, 2019, MOL GENET METAB REP, V18, P14, DOI 10.1016/j.ymgmr.2018.12.005; Glinton KE, 2018, MOL GENET METAB, V123, P309, DOI 10.1016/j.ymgme.2017.12.009; Guerrero RB, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.11.05; Jaggard MKJ, 2021, J PHARMACEUT BIOMED, V197, DOI 10.1016/j.jpba.2021.113942; Jain M, 2017, CLIN CHIM ACTA, V466, P105, DOI 10.1016/j.cca.2017.01.005; Kang E, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02016-z; Kennedy AD, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00394; Kennedy AD, 2017, MOL GENET METAB, V121, P83, DOI 10.1016/j.ymgme.2017.04.005; Kennedy AD, 2016, GENET TEST MOL BIOMA, V20, P485, DOI 10.1089/gtmb.2015.0291; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Krumsiek J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003005; LANDT M, 1994, CLIN CHEM, V40, P565; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lima R, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01110-y; Miller MJ, 2016, JIMD REP, V30, P39, DOI 10.1007/8904_2016_539; Miller MJ, 2015, J INHERIT METAB DIS, V38, P1029, DOI 10.1007/s10545-015-9843-7; Narayanan S, 2000, AM J CLIN PATHOL, V113, P429, DOI 10.1309/C0NM-Q7R0-LL2E-B3UY; Pan J, 2020, RESP MED, V173, DOI 10.1016/j.rmed.2020.106158; Pappan KL, 2017, PEDIATR NEUROL, V75, P66, DOI 10.1016/j.pediatrneurol.2017.06.014; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Petersen AK, 2014, HUM MOL GENET, V23, P534, DOI 10.1093/hmg/ddt430; Piskunov D P, 2020, Klin Lab Diagn, V65, P778, DOI 10.18821/0869-2084-2020-65-12-778-784; Pourfarzam M, 2013, J RES MED SCI, V18, P801; REARDON DM, 1991, MED LAB SCI, V48, P72; Schlune A, 2015, AMINO ACIDS, V47, P1751, DOI 10.1007/s00726-015-2032-z; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Singh S, 2018, REV NEUROSCIENCE, V29, P771, DOI 10.1515/revneuro-2017-0097; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tate Jill, 2004, Clin Biochem Rev, V25, P105; Tillmann T, 2020, EUR HEART J, V41, P3325, DOI 10.1093/eurheartj/ehaa571; TOFFALETTI J, 1994, CLIN CHEM, V40, P508; van Waardenburg DA, 2007, AM J CLIN NUTR, V86, P1438, DOI 10.1093/ajcn/86.5.1438; Wangler MF, 2018, GENET MED, V20, P1274, DOI 10.1038/gim.2017.262	53	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249797	10.1371/journal.pone.0249797	http://dx.doi.org/10.1371/journal.pone.0249797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831088	Green Published, gold			2022-12-26	WOS:000639359600129
J	Shakeel, F; Alshehri, S; Ibrahim, MA; Altamimi, M; Haq, N; Elzayat, EM; Shazly, GA				Shakeel, Faiyaz; Alshehri, Sultan; Ibrahim, Mohamed A.; Altamimi, Mohammad; Haq, Nazrul; Elzayat, Ehab M.; Shazly, Gamal A.			Solubilization and thermodynamic properties of simvastatin in various micellar solutions of different non-ionic surfactants: Computational modeling and solubilization capacity	PLOS ONE			English	Article							MAGNESIUM-DL-ASPARTATE; P-TOLUIC ACID; STATIN INHIBITION; SOLID DISPERSIONS; IN-VITRO; WATER; DISSOLUTION; SOLVENTS; BEHAVIOR; SOLUBILITIES	The aim of this work was to solubilize simvastatin (SIM) using different micellar solutions of various non-ionic surfactants such as Tween-80 (T80), Tween-20 (T20), Myrj-52 (M52), Myrj-59 (M59), Brij-35 (B35) and Brij-58 (B58). The solubility of SIM in water (H2O) and different micellar concentrations of T80, T20, M52, M59, B35 and B58 was determined at temperatures T = 300.2 K to 320.2 K under atmospheric pressure p = 0.1 MPa using saturation shake flask method. The experimental solubility data of SIM was regressed using van't Hoff and Apelblat models. The solubility of SIM (mole fraction) was recorded highest in M59 (1.54 x 10(-2)) followed by M52 (6.56 x 10(-3)), B58 (5.52 x 10(-3)), B35 (3.97 x 10(-3)), T80 (1.68 x 10(-3)), T20 (1.16 x 10(-3)) [the concentration of surfactants was 20 mM in H2O in all cases] and H2O (1.94 x 10(-6)) at T = 320.2 K. The same results were also recorded at each temperature and each micellar concentration of T80, T20, M52, M59, B35 and B58. "Apparent thermodynamic analysis" showed endothermic and entropy-driven dissolution/solubilization of SIM in H2O and various micellar solutions of T80, T20, M52, M59, B35 and B58.	[Shakeel, Faiyaz; Alshehri, Sultan; Ibrahim, Mohamed A.; Altamimi, Mohammad; Haq, Nazrul; Elzayat, Ehab M.; Shazly, Gamal A.] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia; [Ibrahim, Mohamed A.] Al Azhar Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Assiut, Egypt; [Shazly, Gamal A.] Al Azhar Univ, Fac Pharm, Dept Ind Pharm, Assiut, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Al Azhar University	Alshehri, S (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia.	salsheri1@ksu.edu.sa	Elzayat, Ehab/AAZ-6628-2021; Ahmad, Ajaz/ABC-8528-2020; BIN JARDAN, YOUSEF A./GYJ-5672-2022; Ibrahim, Mohamed/AFX-3593-2022; Altamimi, Mohammad A./AAH-8244-2020; Shakeel, Faiyaz/ABF-2218-2020; Elzayat, Ehab/GRY-0433-2022	Elzayat, Ehab/0000-0001-5177-4477; BIN JARDAN, YOUSEF A./0000-0003-3302-4036; Altamimi, Mohammad A./0000-0003-4877-864X; Shakeel, Faiyaz/0000-0002-6109-0885; 	King Saud University, Riyadh, Saudi Arabia [RSP-2020/146]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	This research was funded by the Researchers Supporting Project (number RSP-2020/146) at King Saud University, Riyadh, Saudi Arabia.; Authors are thankful to the Researchers Supporting Project Unit at King Saud University, Riyadh, Saudi Arabia for supporting this research.	Aceves-Hernandez JM, 2011, J MOL STRUCT, V995, P41, DOI 10.1016/j.molstruc.2011.03.048; Ahad A, 2018, INT J PHARMACEUT, V544, P165, DOI 10.1016/j.ijpharm.2018.04.024; Akash C, 2017, J PHARM RES, V11, P665; Alanazi A, 2020, J MOL LIQ, V299, DOI 10.1016/j.molliq.2019.112211; Almarri F, 2017, J MOL LIQ, V229, P477, DOI 10.1016/j.molliq.2016.12.105; Alshahrani SM, 2020, MOLECULES, V25, DOI 10.3390/molecules25092124; Alshehri S, 2018, J MOL LIQ, V250, P63, DOI 10.1016/j.molliq.2017.11.167; Apelblat A, 1999, J CHEM THERMODYN, V31, P85, DOI 10.1006/jcht.1998.0424; Craye G, 2015, MOLECULES, V20, P21532, DOI 10.3390/molecules201219784; Ding ZY, 2007, J DISPER SCI TECHNOL, V28, P495, DOI 10.1080/01932690701276924; Dixit RP, 2010, J PHARM SCI-US, V99, P4892, DOI 10.1002/jps.22208; Edwards JE, 2003, BMC FAMILY PRAC, V4, pE18; Geboers S, 2016, INT J PHARMACEUT, V510, P296, DOI 10.1016/j.ijpharm.2016.06.048; Hanaa Mahmoud, 2013, African Journal of Pharmacy and Pharmacology, V7, P1482; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Hildebrand J.H., 1970, REGULAR RELATED SOLU; Holguin AR, 2012, FLUID PHASE EQUILIBR, V314, P134, DOI 10.1016/j.fluid.2011.11.001; International Conference on Harmonization (ICH), 2005, Q2 R1 VALIDATION ANA; Istvan E, 2003, ATHEROSCLEROSIS SUPP, V4, P3, DOI 10.1016/S1567-5688(03)00003-5; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jun SW, 2007, EUR J PHARM BIOPHARM, V66, P413, DOI 10.1016/j.ejpb.2006.11.013; Karolewicz B, 2014, PHARMAZIE, V69, P589, DOI 10.1691/ph.2014.3217; KLEVENS HB, 1950, CHEM REV, V47, P1, DOI 10.1021/cr60146a001; KRUG RR, 1976, J PHYS CHEM-US, V80, P2341, DOI 10.1021/j100562a007; Kulhari H, 2011, INT J PHARMACEUT, V405, P203, DOI 10.1016/j.ijpharm.2010.12.002; Mall S, 1996, J PHARM SCI, V85, P75, DOI 10.1021/js950225l; Manrique YJ, 2008, J SOLUTION CHEM, V37, P165, DOI 10.1007/s10953-007-9228-0; Manzurola E, 2002, J CHEM THERMODYN, V34, P1127, DOI 10.1006/jcht.2002.0975; Merisko-Liversidge EM, 2008, TOXICOL PATHOL, V36, P43, DOI 10.1177/0192623307310946; Murtaza G, 2012, ACTA POL PHARM, V69, P581; Patil MS., 2011, INT J PHARM RES DEV, V2, P219; Patil Pradeep, 2007, Acta Pharmaceutica (Zagreb), V57, P111, DOI 10.2478/v10007-007-0009-5; Rangel-Yagui CO, 2005, J PHARM PHARM SCI, V8, P147; Rao M, 2010, DISSOLUT TECHNOL, V17, P27, DOI 10.14227/DT170210P27; Ruidiaz MA, 2010, FLUID PHASE EQUILIBR, V299, P259, DOI 10.1016/j.fluid.2010.09.027; Sandeep K., 2011, INT RES J PHARM, V2, P100; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Shakeel F, 2020, MOLECULES, V25, DOI 10.3390/molecules25122743; Shakeel F, 2017, J MOL LIQ, V234, P73, DOI 10.1016/j.molliq.2017.03.057; Shakeel F, 2017, INT J PHARMACEUT, V523, P410, DOI 10.1016/j.ijpharm.2017.03.067; Shakeel F, 2017, J MOL LIQ, V230, P511, DOI 10.1016/j.molliq.2017.01.077; Srinivas C, 2012, ASIAN J PHARM CLIN R, V5, P134; Sun H, 2005, J CHEM ENG DATA, V50, P1389, DOI 10.1021/je0500781; TODD PA, 1990, DRUGS, V40, P583, DOI 10.2165/00003495-199040040-00007; Ungaro F, 2011, INT J PHARMACEUT, V404, P49, DOI 10.1016/j.ijpharm.2010.10.050; Vasconcelos T, 2007, DRUG DISCOV TODAY, V12, P1068, DOI 10.1016/j.drudis.2007.09.005; Vinarov Z, 2020, J DRUG DELIV SCI TEC, V57, DOI 10.1016/j.jddst.2020.101688; Vinarov Z, 2018, DRUG DEV IND PHARM, V44, P677, DOI 10.1080/03639045.2017.1408642; Vyas A, 2010, J INCL PHENOM MACRO, V66, P251, DOI 10.1007/s10847-009-9605-y; Winter de Vargas Mara Rubia, 2012, Revista de Ciencias Farmaceuticas Basica e Aplicada, V33, P497; Zhu QN, 2019, MOLECULES, V24, DOI 10.3390/molecules24071346	51	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249485	10.1371/journal.pone.0249485	http://dx.doi.org/10.1371/journal.pone.0249485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831070	gold, Green Published			2022-12-26	WOS:000639359600006
J	Horstmann, M; Fleischmann, A; Tollrian, R; Poppinga, S				Horstmann, Martin; Fleischmann, Andreas; Tollrian, Ralph; Poppinga, Simon			Snapshot prey spectrum analysis of the phylogenetically early-diverging carnivorous Utricularia multifida from U. section Polypompholyx (Lentibulariaceae)	PLOS ONE			English	Article							TRAPS; PLANT; PREDATION; PENINSULA; EVOLUTION; CAPTURE; ECOLOGY; ALGAE	Utricularia multifida is carnivorous bladderwort from Western Australia and belongs to a phylogenetically early-diverging lineage of the genus. We present a prey spectrum analysis resulting from a snapshot sampling of 17 traps-the first of this species to our knowledge. The most abundant prey groups were Ostracoda, Copepoda, and Cladocera. The genus cf. Cypretta (Cyprididae, Ostracoda) was the predominant prey. However, a high variety of other prey organisms with different taxonomic backgrounds was also detected. Our results indicate that U. multifida may potentially be specialized in capturing substrate-bound prey. Future approaches should sample plants from different localities to allow for robust comparative analyses.	[Horstmann, Martin; Tollrian, Ralph] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Fleischmann, Andreas] Botan Staatssammlung Munchen, Munich, Germany; [Poppinga, Simon] Univ Freiburg, Plant Biomech Grp & Bot Garden, Freiburg, Germany; [Poppinga, Simon] Univ Freiburg, Freiburg Mat Res Ctr, Freiburg, Germany	Ruhr University Bochum; University of Freiburg; University of Freiburg	Poppinga, S (corresponding author), Univ Freiburg, Plant Biomech Grp & Bot Garden, Freiburg, Germany.; Poppinga, S (corresponding author), Univ Freiburg, Freiburg Mat Res Ctr, Freiburg, Germany.	simon.poppinga@biologie.uni-freiburg.de	Horstmann, Martin/AAW-1145-2021; Poppinga, Simon/B-7260-2012	Horstmann, Martin/0000-0002-0355-3212; Poppinga, Simon/0000-0001-5341-9188	Academic Research Alliance JONAS ("Joint Research Network on Advanced Materials and Systems"); Baden-Wurttemberg Ministry of Science, Research and Art; University of Freiburg	Academic Research Alliance JONAS ("Joint Research Network on Advanced Materials and Systems"); Baden-Wurttemberg Ministry of Science, Research and Art; University of Freiburg	SP gratefully acknowledges the financial support by the Academic Research Alliance JONAS ("Joint Research Network on Advanced Materials and Systems"). The article processing charge was funded by the Baden-Wurttemberg Ministry of Science, Research and Art and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf Imad Aldeen, 2011, Plant Diversity and Evolution, V129, P125, DOI 10.1127/1869-6155/2011/0129-0037; Alkhalaf IA, 2009, FLORA, V204, P700, DOI 10.1016/j.flora.2008.09.008; Andrikovics S., 1988, OPUSC ZOOL BUDAPEST, V23, P65; BRUMPT E., 1925, Annales de Parasitologie Humaine et Comparee, V3, P403; Caramujo MJ, 2015, REV IDE, V91, P12; Caravieri FA, 2014, AQUAT BOT, V116, P8, DOI 10.1016/j.aquabot.2013.12.008; Ceschin S., 2021, PLANT BIOSYST; Cohuo-Duran S, 2013, ZOOTAXA, V3636, P501, DOI 10.11646/zootaxa.3636.4.1; Couret J, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04084-4; Cranston PS, 2019, ZOOTAXA, V4706, P71, DOI 10.11646/zootaxa.4706.1.3; Darwin C., 1875, INSECTIVOROUS PLANTS; DEDECKKER P, 1983, HYDROBIOLOGIA, V106, P223, DOI 10.1007/BF00008120; Fleischmann A., 2012, MONOGRAPH GENUS GENL; FRYER G, 1974, PHILOS T ROY SOC B, V269, P137, DOI 10.1098/rstb.1974.0044; Gordon E, 2007, REV BIOL TROP, V55, P795; Guiral D, 2007, ANN LIMNOL-INT J LIM, V43, P147, DOI 10.1051/limn:2007009; Harms S, 2002, FRESHWATER BIOL, V47, P1608, DOI 10.1046/j.1365-2427.2002.00897.x; Hegner RW, 1926, BIOL BULL-US, V50, P239, DOI 10.2307/1536673; Horstmann M, 2019, INTEGR ORGANISM BIOL, V1, DOI 10.1093/iob/oby012; Jobson RW, 2001, AUSTRAL ECOL, V26, P680, DOI 10.1046/j.1442-9993.2001.01149.x; Karanovic I., 2012, CRUSTACEA OSTRACODA; Koller-Peroutka M, 2015, ANN BOT-LONDON, V115, P227, DOI 10.1093/aob/mcu236; Krueger T, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3179; Kurbatova SA, 2009, INLAND WATER BIOL, V2, P271, DOI 10.1134/S1995082909030122; Lang F., 1901, FLORA, V88, P149; Leung A., 2011, PHOTOGRAPHIC GUIDE K; Lim R.P., 1975, Verhandlungen Int Verein Theor Angew Limnol, V19, P1390; Lloyd FE., 1942, CARNIVOROUS PLANTS; Lowrie A., 2014, CARNIVOROUS PLANTS A, V3; Madden Chris P., 2010, Museum Victoria Science Reports, V12, P1; Mette Nikolai, 2000, Beitraege zur Biologie der Pflanzen, V72, P1; Muller UK, 2020, NEW PHYTOL, V228, P586, DOI 10.1111/nph.16726; Peroutka M, 2008, PLANT ECOL, V199, P153, DOI 10.1007/s11258-008-9420-3; Plachno BJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00336; Plachno BJ, 2014, AUST J BOT, V62, P528, DOI 10.1071/BT14176; Poppinga S., 2020, CARNIVOROUS PLANT NE, V49, P239; Poppinga S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01954-3; Reifenrath K, 2006, FLORA, V201, P597, DOI 10.1016/j.flora.2005.12.004; Rybak JI., 2016, FRESHWATER CRUSTACEA; Sanabria-Aranda L, 2006, FRESHWATER BIOL, V51, P1999, DOI 10.1111/j.1365-2427.2006.01638.x; SCHUMACHER GEORGE J., 1960, CASTANEA, V25, P62; Sirova D, 2020, J EUKARYOT MICROBIOL, V67, P608, DOI 10.1111/jeu.12812; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; SMIRNOV N N, 1983, Records of the Australian Museum, P1; Taylor P., 1989, KEW B ADDITIONAL SER, VXIV; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292; Walker I., 2004, ACTA LIMNOL BRAS, V16, P183; Westermeier AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12324-4; Winterbourn M.J., 1981, Bulletin of the Entomological Society of New Zealand, P1	49	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249976	10.1371/journal.pone.0249976	http://dx.doi.org/10.1371/journal.pone.0249976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826676	Green Published, gold			2022-12-26	WOS:000638119900014
J	Baade, I; Hutten, S; Sternburg, EL; Porschke, M; Hofweber, M; Dormann, D; Kehlenbach, RH				Baade, Imke; Hutten, Saskia; Sternburg, Erin L.; Poerschke, Marius; Hofweber, Mario; Dormann, Dorothee; Kehlenbach, Ralph H.			The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; FUNCTIONAL-CHARACTERIZATION; PHASE-TRANSITION; DISTINGUISH FTLD; SPLICING FACTORS; PORE COMPLEX; FET PROTEINS; RS DOMAIN; ALS; DEGENERATION	Fused in sarcoma (FUS) is a predominantly nuclear RNA-binding protein with key functions in RNA processing and DNA damage repair. Defects in nuclear import of FUS have been linked to severe neurodegenerative diseases; hence, it is of great interest to understand this process and how it is dysre-gulated in disease. Transportin-1 (TNPO1) and the closely related transportin-2 have been identified as major nuclear import receptors of FUS. They bind to the C-terminal nuclear localization signal of FUS and mediate the protein's nuclear import and at the same time also suppress aberrant phase transitions of FUS in the cytoplasm. Whether FUS can utilize other nuclear transport receptors for the purpose of import and chaperoning has not been examined so far. Here, we show that FUS directly binds to different import receptors in vitro. FUS formed stable complexes not only with TNPO1 but also with transportin-3, importin beta, importin 7, or the importin beta/7 heterodimer. Binding of these alternative import receptors required arginine residues within FUS-RG/RGG motifs and was weakened by arginine methylation. Interaction with these importins suppressed FUS phase separation and reduced its sequestration into stress granules. In a permeabilized cell system, we further showed that transportin-3 had the capacity to import FUS into the nucleus, albeit with lower efficiency than TNPO1. Our data suggest that aggregation-prone RNA-binding proteins such as FUS may utilize a network of importins for chaperoning and import, similar to histones and ribosomal proteins.	[Baade, Imke; Poerschke, Marius; Kehlenbach, Ralph H.] Georg August Univ Gottingen, Fac Med, Dept Mol Biol, GZMB, Gottingen, Germany; [Hutten, Saskia; Sternburg, Erin L.; Hofweber, Mario; Dormann, Dorothee] Ludwig Maximilians Univ Munchen, BioMed Ctr BMC, Cell Biol, Planegg Martinsried, Germany; [Dormann, Dorothee] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Hutten, Saskia; Sternburg, Erin L.; Dormann, Dorothee] Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Physiol, Mainz, Germany; [Hutten, Saskia; Sternburg, Erin L.; Dormann, Dorothee] Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Biol IMB, Mainz, Germany	University of Gottingen; University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz	Kehlenbach, RH (corresponding author), Georg August Univ Gottingen, Fac Med, Dept Mol Biol, GZMB, Gottingen, Germany.; Dormann, D (corresponding author), Ludwig Maximilians Univ Munchen, BioMed Ctr BMC, Cell Biol, Planegg Martinsried, Germany.; Dormann, D (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.; Dormann, D (corresponding author), Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Physiol, Mainz, Germany.; Dormann, D (corresponding author), Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Biol IMB, Mainz, Germany.	ddormann@uni-mainz.de; rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916; Dormann, Dorothee/0000-0002-9260-2775; Porschke, Marius/0000-0003-4129-6058	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [DO 1804/1-1, DO 1804/1-2, DO1804/3-1]; Munich Cluster for Systems Neurology (EXC2145 SyNergy) [390857198]; DFG [KE 660/14-1, SFB860]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Munich Cluster for Systems Neurology (EXC2145 SyNergy); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within Emmy Noether Grants DO 1804/1-1 and DO 1804/1-2 as well as research grant DO1804/3-1 (to D. D.). D. D. is additionally supported by the Munich Cluster for Systems Neurology (EXC2145 SyNergy-ID 390857198). R. H. K. was supported by the DFG (KE 660/14-1 and SFB860).	Alberti S, 2016, BIOESSAYS, V38, P959, DOI 10.1002/bies.201600042; Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Baade I, 2018, MOL CELL PROTEOMICS, V17, P1337, DOI 10.1074/mcp.RA118.000623; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; Bauerle M, 2002, J BIOL CHEM, V277, P32480, DOI 10.1074/jbc.M202765200; Bogaert E., 2018, CELL REP, V24, P529; Bourgeois B, 2020, P NATL ACAD SCI USA, V117, P8503, DOI 10.1073/pnas.1918944117; Brelstaff J, 2011, ACTA NEUROPATHOL, V122, P591, DOI 10.1007/s00401-011-0863-6; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Davidson YS, 2013, NEUROPATH APPL NEURO, V39, P157, DOI 10.1111/j.1365-2990.2012.01274.x; Devoy A, 2017, BRAIN, V140, P2797, DOI 10.1093/brain/awx248; Dolker N, 2013, STRUCTURE, V21, P1350, DOI 10.1016/j.str.2013.05.015; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Ederle H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25007-5; Fallini C, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104835; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Frohnert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088887; Gami-Patel P, 2016, NEUROBIOL AGING, V46, P192, DOI 10.1016/j.neurobiolaging.2016.07.004; Gittings LM, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0673-y; Gonzalez A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83196-y; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Guo L, 2019, TRENDS CELL BIOL, V29, P308, DOI 10.1016/j.tcb.2018.12.004; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Hutten S, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3846; Hutten S, 2020, SEMIN CELL DEV BIOL, V99, P151, DOI 10.1016/j.semcdb.2019.05.020; Ito D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5436; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kimura M, 2017, ELIFE, V6, DOI 10.7554/eLife.21184; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2012, ACTA NEUROPATHOL, V124, P705, DOI 10.1007/s00401-012-1020-6; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Niu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047056; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Port SA, 2015, CELL REP, V13, P690, DOI 10.1016/j.celrep.2015.09.042; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Roloff S, 2013, J BIOL CHEM, V288, P3952, DOI 10.1074/jbc.M112.433243; Scekic-Zahirovic J, 2017, ACTA NEUROPATHOL, V133, P887, DOI 10.1007/s00401-017-1687-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharma A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10465; Springhower CE, 2020, CURR OPIN CELL BIOL, V64, P112, DOI 10.1016/j.ceb.2020.04.003; Suarez-Calvet M, 2016, ACTA NEUROPATHOL, V131, P587, DOI 10.1007/s00401-016-1544-2; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Warda AS, 2016, HUM MOL GENET, V25, P5353, DOI 10.1093/hmg/ddw351; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Wlde S., 2012, TRAFFIC, V13, P218; Wohlwend D, 2007, J BIOL CHEM, V282, P10707, DOI 10.1074/jbc.M610409200; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; ZHANG Y, 2018, CELL, V17, DOI DOI 10.1186/S12943-017-0753-1; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109	78	13	13	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100659	10.1016/j.jbc.2021.100659	http://dx.doi.org/10.1016/j.jbc.2021.100659			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857479	Green Published, gold			2022-12-26	WOS:000672866400630
J	Poria, DK; Sheshadri, N; Balamurugan, K; Sharan, S; Sterneck, E				Poria, Dipak K.; Sheshadri, Namratha; Balamurugan, Kuppusamy; Sharan, Shikha; Sterneck, Esta			The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; ACTIVATION; GLUCONEOGENESIS; AUTOPHAGY; TARGETS	Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor involved in many physiological functions including embryonic development and immune responses and is often activated under pathological conditions such as cancer. Strategies to inactivate STAT3 are being pursued as potential anticancer therapies and have led to the identification of Stattic (6-nitrobenzo[b]thiophene-1, 1-dioxide) as a "specific" STAT3 inhibitor that is often used to interrogate STAT3-mediated gene expression in vitro and in vivo. Here, we show that Stattic exerts many STAT3-independent effects on cancer cells, calling for reassessment of results previously ascribed to STAT3 functions. Studies of the STAT3-deficient prostate cancer cell line PC-3 (PC3) along with STAT3-proficient breast cancer cell lines (MDA-MB-231, SUM149) revealed that Stattic attenuated histone acetylation and neutralized effects of the histone deacetylase (HDAC) inhibitor romidepsin. In PC3 cells, Stattic alone inhibited gene expression of CCL20 and CCL2, but activated expression of TNFA, CEBPD, SOX2, and MYC. In addition, we found that Stattic promoted autophagy and caused cell death. These data point to profound epigenetic effects of Stattic that are independent of its function as a STAT3 inhibitor. Our results demonstrate that Stattic directly or indirectly reduces histone acetylation and suggest reevaluation of Stattic and related compounds as polypharmacological agents through multi-pronged cytotoxic effects on cancer cells.	[Poria, Dipak K.; Sheshadri, Namratha; Balamurugan, Kuppusamy; Sharan, Shikha; Sterneck, Esta] NCI, Lab Cell & Dev Signaling, Ctr Canc Res CCR, NIH, Frederick, MD 21701 USA; [Sheshadri, Namratha] Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick	Sterneck, E (corresponding author), NCI, Lab Cell & Dev Signaling, Ctr Canc Res CCR, NIH, Frederick, MD 21701 USA.	sternecg@nih.org	Kuppusamy, Balamurugan/AAC-6020-2022; Poria, Dipak Kumar/AAM-2084-2021; Sheshadri, Namratha/AAM-7384-2021	Poria, Dipak Kumar/0000-0002-6935-4160; Sheshadri, Namratha/0000-0003-4912-7275; Sharan, Shikha/0000-0001-5885-7304; Sterneck, Esta/0000-0001-7716-8766	Intramural Research Program of the National Institutes of Health, National Cancer Institute [HHSN261200800001E]	Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, in part with Federal Funds under contract no. HHSN261200800001E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baell JB, 2016, FUTURE MED CHEM, V8, P1525, DOI 10.4155/fmc-2016-0151; Balamurugan K, 2019, ONCOGENE, V38, P3765, DOI 10.1038/s41388-018-0516-5; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Busker S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax7945; Cang SD, 2009, INT J ONCOL, V35, P1417, DOI 10.3892/ijo_00000459; Clark J, 2003, ONCOGENE, V22, P1247, DOI 10.1038/sj.onc.1206247; da Hora CC, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0155-9; Dahlin JL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01657-3; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Hahn YI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23840-2; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Ibrahim SA, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0621-z; Jhaveri K, 2016, CLIN BREAST CANCER, V16, P113, DOI 10.1016/j.clbc.2015.11.006; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lasko LM, 2017, NATURE, V550, P128, DOI 10.1038/nature24028; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Olzscha Heidi, 2015, Critical Reviews in Oncogenesis, V20, P1; Petrich A, 2016, LEUKEMIA LYMPHOMA, V57, P1755, DOI 10.3109/10428194.2016.1160082; Robertson Fredika M, 2013, J Exp Ther Oncol, V10, P219; Sanseverino I, 2012, CHEM BIOL, V19, P1213, DOI 10.1016/j.chembiol.2012.08.021; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Seim I, 2017, G3-GENES GENOM GENET, V7, P1731, DOI 10.1534/g3.117.039909; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Shih PC, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117241; Simon RP, 2016, J MED CHEM, V59, P1249, DOI 10.1021/acs.jmedchem.5b01502; Uchihara Y, 2019, PHARMACOL REP, V71, P1067, DOI 10.1016/j.pharep.2019.05.021; Wake MS, 2015, FEBS J, V282, P2600, DOI 10.1111/febs.13285; Wright DE, 2018, ANTIOXID REDOX SIGN, V29, P377, DOI 10.1089/ars.2017.7082; Yang CM, 2012, HORM MOL BIOL CLIN I, V10, P241, DOI 10.1515/hmbci-2012-0003; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	34	4	4	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100220	10.1074/jbc.RA120.016645	http://dx.doi.org/10.1074/jbc.RA120.016645			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839684	Green Published, gold			2022-12-26	WOS:000672866400198
J	Rebbeck, RT; Andrick, AK; Denha, SA; Svensson, B; Guhathakurta, P; Thomas, DD; Hays, TS; Avery, AW				Rebbeck, Robyn T.; Andrick, Anna K.; Denha, Sarah A.; Svensson, Bengt; Guhathakurta, Piyali; Thomas, David D.; Hays, Thomas S.; Avery, Adam W.			Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting beta-III-spectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; HIGH-THROUGHPUT; MUTATIONS; FRET; ALPHA-ACTININ-4; MODULATORS; MECHANISM; DYNAMICS; FILAMIN; SCREENS	Numerous diseases are linked to mutations in the actin-binding domains (ABDs) of conserved cytoskeletal proteins, including beta-III-spectrin, a-actinin, filamin, and dystrophin. A beta-III-spectrin ABD mutation (L253P) linked to spinocerebellar ataxia type 5 (SCA5) causes a dramatic increase in actin binding. Reducing actin binding of L253P is thus a potential therapeutic approach for SCA5 pathogenesis. Here, we validate a high-throughput screening (HTS) assay to discover potential disrupters of the interaction between the mutant beta-III-spectrin ABD and actin in live cells. This assay monitors FRET between fluorescent proteins fused to the mutant ABD and the actin-binding peptide Lifeact, in HEK293-6E cells. Using a specific and high-affinity actin-binding tool compound, swinholide A, we demonstrate HTS compatibility with an excellent Z'-factor of 0.67 +/- 0.03. Screening a library of 1280 pharmacologically active compounds in 1536-well plates to determine assay robustness, we demonstrate high reproducibility across plates and across days. We identified nine Hits that reduced FRET between Lifeact and ABD. Four of those Hits were found to reduce Lifeact cosedimentation with actin, thus establishing the potential of our assay for detection of actin-binding modulators. Concurrent to our primary FRET assay, we also developed a high-throughput compatible counter screen to remove undesirable FRET Hits. Using the FRET Hits, we show that our counter screen is sensitive to undesirable compounds that cause cell toxicity or ABD aggregation. Overall, our FRET-based HTS platform sets the stage to screen large compound libraries for modulators of beta-III-spectrin, or disease-linked spectrin-related proteins, for therapeutic development.	[Rebbeck, Robyn T.; Andrick, Anna K.; Svensson, Bengt; Guhathakurta, Piyali; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Denha, Sarah A.; Avery, Adam W.] Univ Minnesota, Dept Genet Cellular Biol & Dev, Minneapolis, MN 55455 USA; [Hays, Thomas S.; Avery, Adam W.] Oakland Univ, Dept Chem, Rochester, MI 48309 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Oakland University	Avery, AW (corresponding author), Univ Minnesota, Dept Genet Cellular Biol & Dev, Minneapolis, MN 55455 USA.; Avery, AW (corresponding author), Oakland Univ, Dept Chem, Rochester, MI 48309 USA.	awavery@oakland.edu		Rebbeck, Robyn/0000-0003-3840-2286; Avery, Adam/0000-0001-8085-1822; Thomas, David D./0000-0002-8822-2040	NIH [R61NS111075, R33NS111075, R01GM044757, R01HL139065, R37AG026160, R15NS116511]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R61NS111075, R33NS111075, and R01GM044757 to T. S. H., R01HL139065 (formerly GM027906) and R37AG026160 to D. D. T., and R15NS116511 to A. W. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Amin Amit Dipak, 2015, Biomark Cancer, V7, P25, DOI 10.4137/BIC.S29326; Avery AW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01367-w; Avery AW, 2017, P NATL ACAD SCI USA, V114, pE9376, DOI 10.1073/pnas.1707108114; Avery AW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21375; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; BUBB MR, 1995, J BIOL CHEM, V270, P3463, DOI 10.1074/jbc.270.8.3463; Burk K, 2004, NEUROLOGY, V62, P327, DOI 10.1212/01.WNL.0000103293.63340.C1; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; Courtemanche N, 2016, NAT CELL BIOL, V18, P676, DOI 10.1038/ncb3351; Doak AK, 2010, J MED CHEM, V53, P4259, DOI 10.1021/jm100254w; Duff RM, 2011, AM J HUM GENET, V88, P729, DOI 10.1016/j.ajhg.2011.04.021; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Guhathakurta P, 2018, J BIOL CHEM, V293, P12288, DOI 10.1074/jbc.RA118.002702; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JD, 2017, CELL ADHES MIGR, V11, P80, DOI 10.1080/19336918.2016.1187368; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kumar S, 2009, FREE RADICAL BIO MED, V47, P699, DOI 10.1016/j.freeradbiomed.2009.05.028; Kumari A, 2020, EMBO J, V39, DOI 10.15252/embj.2019104006; Liu LZ, 2016, CHINESE MED J-PEKING, V129, P2516, DOI 10.4103/0366-6999.191834; Lo CH, 2019, ALZHEIMERS DEMENT, V15, P1489, DOI 10.1016/j.jalz.2019.06.4954; Lo CH, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5637; Lo CH, 2017, SLAS DISCOV, V22, P950, DOI 10.1177/2472555217706478; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Murphy ACH, 2016, FEBS LETT, V590, P685, DOI 10.1002/1873-3468.12101; Ni SS, 2020, EUR J MED CHEM, V185, DOI 10.1016/j.ejmech.2019.111848; Nicita F, 2019, CLIN GENET, V96, P169, DOI 10.1111/cge.13562; Ohara O, 1998, MOL BRAIN RES, V57, P181, DOI 10.1016/S0169-328X(98)00068-0; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; Rebbeck RT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58461-1; Rebbeck RT, 2017, SLAS DISCOV, V22, P176, DOI 10.1177/1087057116674312; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Schaaf TM, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040099; Schaaf TM, 2017, SLAS DISCOV, V22, P262, DOI 10.1177/1087057116680151; Schaaf TM, 2017, SLAS DISCOV, V22, P250, DOI 10.1177/1087057116679637; Shelley MD, 2000, ANTI-CANCER DRUG, V11, P209, DOI 10.1097/00001813-200003000-00009; Sorensen MG, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-250; Stroik DR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29685-z; Terry DR, 1997, J BIOL CHEM, V272, P7841, DOI 10.1074/jbc.272.12.7841; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706	49	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100215	10.1074/jbc.RA120.015417	http://dx.doi.org/10.1074/jbc.RA120.015417			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839680	Green Published, gold			2022-12-26	WOS:000672866400193
J	Truman, AW				Truman, Andrew W.			Dealing with difficult clients via personalized chaperone inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT P53	The importance of molecular chaperones in cancer is well established, yet several chaperone inhibitors have failed in clinical trials due to toxicity. Recent efforts have focused on targeting chaperone function in cancer by either manipulating the "chaperone code" or inhibiting helper cochaperones, such as DNAJA1. Tong et al. identify a novel inhibitor that specifically disrupts DNAJA1's interaction with p53, promoting p53 degradation. This finding highlights specific DNAJA1 interactions with the potential for less toxicity compared to traditional chaperone inhibitors.	[Truman, Andrew W.] Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Truman, AW (corresponding author), Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA.	atruman1@uncc.edu		Truman, Andrew/0000-0002-6409-3723	National Institutes of Health [R15GM139059, R01GM139885]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (http://www.nih.gov) grant R15GM139059 and R01GM139885. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Moses MA, 2018, CANCER RES, V78, P4022, DOI 10.1158/0008-5472.CAN-17-3728; Nitika, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70764-x; Nitika, 2020, J BIOL CHEM, V295, P10689, DOI 10.1074/jbc.REV120.011666; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Sluder IT, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007462; Tong X., 2021, J BIOL CHEM, V296; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Xu DD, 2019, MOL CARCINOGEN, V58, P2052, DOI 10.1002/mc.23097	10	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100211	10.1016/j.jbc.2020.100211	http://dx.doi.org/10.1016/j.jbc.2020.100211			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837724	gold, Green Published			2022-12-26	WOS:000672866400189
J	Walbaum, S; Ambrosy, B; Schutz, P; Bachg, AC; Horsthemke, M; Leusen, JHW; Mocsai, A; Hanley, PJ				Walbaum, Stefan; Ambrosy, Benjamin; Schuetz, Paula; Bachg, Anne C.; Horsthemke, Markus; Leusen, Jeanette H. W.; Mocsai, Attila; Hanley, Peter J.			Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA RECEPTOR; SYK TYROSINE KINASE; DEFICIENT NEUTROPHILS; MAC-1 CD11B/CD18; MACROPHAGES; ADHESION; MOUSE; REQUIREMENTS; ACTIVATION; ATTACHMENT	A long-standing hypothesis is that complement receptors (CRs), especially CR3, mediate sinking phagocytosis, but evidence is lacking. Alternatively, CRs have been reported to induce membrane ruffles or phagocytic cups, akin to those induced by Fc. receptors (Fc.Rs), but the details of these events are unclear. Here we used real-time 3D imaging and KO mouse models to clarify how particles (human red blood cells) are internalized by resident peritoneal F4/80+ cells (macrophages) via CRs and/or Fc gamma Rs. We first show that Fc.Rs mediate highly efficient, rapid (2-3 min) phagocytic cup formation, which is completely abolished by deletion or mutation of the FcR gamma chain or conditional deletion of the signal transducer Syk. Fc gamma R-mediated phagocytic cups robustly arise from any point of cell-particle contact, including filopodia. In the absence of CR3, Fc.R-mediated phagocytic cups exhibit delayed closure and become aberrantly elongated. Independent of Fc gamma Rs, CR3 mediates sporadic ingestion of complement-opsonized particles by rapid phagocytic cup-like structures, typically emanating from membrane ruffles and largely prevented by deletion of the immunoreceptor tyrosine-based activation motif (ITAM) adaptors FcR. chain and DAP12 or Syk. Deletion of ITAM adaptors or Syk clearly revealed that there is a slow (10-25 min) sinking mode of phagocytosis via a restricted orifice. In summary, we show that (1) CR3 indeed mediates a slow sinking mode of phagocytosis, which is accentuated by deletion of ITAM adaptors or Syk, (2) CR3 induces phagocytic cup-like structures, driven by ITAM adaptors and Syk, and (3) CR3 is involved in forming and closing Fc gamma R-mediated phagocytic cups.	[Walbaum, Stefan; Ambrosy, Benjamin; Schuetz, Paula; Bachg, Anne C.; Horsthemke, Markus; Hanley, Peter J.] Westfalische Wilhems Univ Munster, Inst Mol Zellbiol, Munster, Germany; [Leusen, Jeanette H. W.] Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands; [Mocsai, Attila] Semmelweis Univ, Dept Physiol, Sch Med, Budapest, Hungary; [Hanley, Peter J.] Witten Herdecke Univ, Fac Hlth, Sch Med, Dept Physiol Pathophysiol & Toxicol, Witten, Germany; [Hanley, Peter J.] Witten Herdecke Univ, Fac Hlth, Sch Med, ZBAF Ctr Biomed Educ & Res, Witten, Germany	Utrecht University; Utrecht University Medical Center; Semmelweis University	Hanley, PJ (corresponding author), Westfalische Wilhems Univ Munster, Inst Mol Zellbiol, Munster, Germany.; Hanley, PJ (corresponding author), Witten Herdecke Univ, Fac Hlth, Sch Med, Dept Physiol Pathophysiol & Toxicol, Witten, Germany.; Hanley, PJ (corresponding author), Witten Herdecke Univ, Fac Hlth, Sch Med, ZBAF Ctr Biomed Educ & Res, Witten, Germany.	peter.hanley@uni-wh.de		Mocsai, Attila/0000-0002-0512-1157	Deutsche Forschungsgemeinschaft (DFG) [HA 3271/4-1, HA 3271/4-2]; Cells in Motion (CiM) [FF-2016-05, EXC 1003]; Elvonal program of the Hungarian Research, Development, and Innovation Office [KKP_129954]; DFG [FF-2016-05]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cells in Motion (CiM); Elvonal program of the Hungarian Research, Development, and Innovation Office; DFG(German Research Foundation (DFG))	This work was supported by grants HA 3271/4-1 and HA 3271/4-2 from the Deutsche Forschungsgemeinschaft (DFG) and the grant FF-2016-05 from the EXC 1003 (Cluster of Excellence 1003), Cells in Motion (CiM), and DFG (to P. J. H.). This work was also in part funded by the Elvonal program of the Hungarian Research, Development, and Innovation Office (grant No. KKP_129954 to A. M.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Blainey P, 2014, NAT METHODS, V11, P879, DOI 10.1038/nmeth.3091; Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; BROWN EJ, 1988, J CLIN INVEST, V81, P365, DOI 10.1172/JCI113328; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Gorgani NN, 2008, J IMMUNOL, V181, P7902, DOI 10.4049/jimmunol.181.11.7902; GRAHAM IL, 1989, J IMMUNOL, V142, P2352; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; GRESHAM HD, 1991, J CLIN INVEST, V88, P588, DOI 10.1172/JCI115343; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Horsthemke M, 2018, JOVE-J VIS EXP, DOI 10.3791/57566; Horsthemke M, 2017, J BIOL CHEM, V292, P7258, DOI 10.1074/jbc.M116.766923; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jaumouille V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01097; Jaumouille V, 2019, NAT CELL BIOL, V21, P1357, DOI 10.1038/s41556-019-0414-2; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Konigs V, 2014, J BIOL CHEM, V289, P30772, DOI 10.1074/jbc.M114.563270; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; KUSUNOKI T, 1994, J LEUKOCYTE BIOL, V55, P735, DOI 10.1002/jlb.55.6.735; Lin SY, 2001, SCIENCE, V291, P445, DOI 10.1126/science.291.5503.445; MARTIN BK, 1993, EUR J IMMUNOL, V23, P3037, DOI 10.1002/eji.1830231146; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Metschnikoff E, 1891, Br Med J, V1, P213; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MUNTHEKAAS AC, 1976, EXP CELL RES, V103, P201, DOI 10.1016/0014-4827(76)90256-1; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; Reversat A, 2020, NATURE, V582, P582, DOI 10.1038/s41586-020-2283-z; Rosales C, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9042851; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Uribe-Querol E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01066; van den Bos E, 2020, J BIOL CHEM, V295, P7726, DOI 10.1074/jbc.RA119.011984; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	56	7	7	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100256	10.1016/j.jbc.2021.100256	http://dx.doi.org/10.1016/j.jbc.2021.100256			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839682	gold, Green Published			2022-12-26	WOS:000672866400232
J	Shi, MX; Sekulovski, N; Whorton, AE; MacLean, JA; Greaves, E; Hayashi, K				Shi, Mingxin; Sekulovski, Nikola; Whorton, Allison E.; MacLean, James A., II; Greaves, Erin; Hayashi, Kanako			Efficacy of niclosamide on the intra-abdominal inflammatory environment in endometriosis	FASEB JOURNAL			English	Article						endometriosis; inflammation; macrophages; mice; niclosamide	PERITONEAL-FLUID CONCENTRATIONS; GROWTH-FACTOR-BETA; MOUSE MODEL; SIGNAL TRANSDUCER; MACROPHAGES; EXPRESSION; RECEPTOR; ACTIVATOR; WOMEN; STAT3	Endometriosis, a common gynecological disease, causes chronic pelvic pain and infertility in women of reproductive age. Due to the limited efficacy of current therapies, a critical need exists to develop new treatments for endometriosis. Inflammatory dysfunction, instigated by abnormal macrophage (MF) function, contributes to disease development and progression. However, the fundamental role of the heterogeneous population of peritoneal MF and their potential druggable functions is uncertain. Here we report that GATA6-expressing large peritoneal MF (LPM) were increased in the peritoneal cavity following lesion induction. This was associated with increased cytokine and chemokine secretion in the peritoneal fluid (PF), as well as MF infiltration, vascularization and innervation in endometriosis-like lesions (ELL). Niclosamide, an FDA-approved anti-helminthic drug, was effective in reducing LPM number, but not small peritoneal MF (SPM), in the PF. Niclosamide also inhibits aberrant inflammation in the PF, ELL, pelvic organs (uterus and vagina) and dorsal root ganglion (DRG), as well as MF infiltration, vascularization and innervation in the ELL. PF from ELL mice stimulated DRG outgrowth in vitro, whereas the PF from niclosamide-treated ELL mice lacked the strong stimulatory nerve growth response. These results suggest LPM induce aberrant inflammation in endometriosis promoting lesion progression and establishment of the inflammatory environment that sensitizes peripheral nociceptors in the lesions and other pelvic organs, leading to increased hyperalgesia. Our findings provide the rationale for targeting LPM and their functions with niclosamide and its efficacy in endometriosis as a new non-hormonal therapy to reduce aberrant inflammation which may ultimately diminish associated pain.	[Shi, Mingxin; Sekulovski, Nikola; Whorton, Allison E.; MacLean, James A., II; Hayashi, Kanako] Southern Illinois Univ, Dept Physiol, Sch Med, Carbondale, IL USA; [Shi, Mingxin; MacLean, James A., II; Hayashi, Kanako] Washington State Univ, Ctr Reprod Biol, 1815 Ferdinands Lane, Pullman, WA 99164 USA; [Greaves, Erin] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry, W Midlands, England	Southern Illinois University System; Southern Illinois University; Washington State University; University of Warwick	Hayashi, K (corresponding author), Washington State Univ, Ctr Reprod Biol, 1815 Ferdinands Lane, Pullman, WA 99164 USA.	k.hayashi@wsu.edu		Hayashi, Kanako/0000-0002-5028-799X; MacLean, James/0000-0003-3061-150X; Whorton, Allison/0000-0003-2983-401X	NIH [R21HD092739]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R21HD092739 (to KH)	Adamson GD, 2011, CURR OPIN OBSTET GYN, V23, P213, DOI 10.1097/GCO.0b013e328348a3ba; Al Kadri H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005997.pub2; Alotaibi FT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219064; [Anonymous], 2008, FERTIL STERIL, V90, pS260, DOI 10.1016/j.fertnstert.2008.08.057; Arnold J, 2012, BRAIN BEHAV IMMUN, V26, P132, DOI 10.1016/j.bbi.2011.08.004; As-Sanie S, 2019, AM J OBSTET GYNECOL, V221, P86, DOI 10.1016/j.ajog.2019.02.033; Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Beliard A, 2003, FERTIL STERIL, V79, P724, DOI 10.1016/S0015-0282(02)04819-7; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bulun SE, 2019, ENDOCR REV, V40, P1048, DOI 10.1210/er.2018-00242; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Capobianco A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00009; Capobianco A, 2011, AM J PATHOL, V179, P2651, DOI 10.1016/j.ajpath.2011.07.029; Chen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30404; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Crist AM, 2019, CIRCULATION, V139, P2049, DOI 10.1161/CIRCULATIONAHA.118.036952; DECHERNEY AH, 1992, CLIN THER, V14, P766; Demir AY, 2004, HUM REPROD, V19, P21, DOI 10.1093/humrep/deh042; Ding SJ, 2018, REPROD SCI, V25, P1045, DOI 10.1177/1933719117732161; Dou QC, 1997, MOL HUM REPROD, V3, P383, DOI 10.1093/molehr/3.5.383; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Evers J L, 1991, Br J Clin Pract Suppl, V72, P45; Forster R, 2019, FASEB J, V33, P11210, DOI 10.1096/fj.201900797R; Fortunel NO, 2000, BLOOD, V96, P2022; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gazvani MR, 1998, HUM REPROD, V13, P1957, DOI 10.1093/humrep/13.7.1957; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gonzalez-Ramos R, 2012, FERTIL STERIL, V98, P520, DOI 10.1016/j.fertnstert.2012.06.021; Gonzalez-Ramos R, 2012, FERTIL STERIL, V97, P645, DOI 10.1016/j.fertnstert.2011.12.006; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Greaves E, 2015, AM J PATHOL, V185, P2286, DOI 10.1016/j.ajpath.2015.04.012; Greaves E, 2014, ENDOCRINOLOGY, V155, P4015, DOI 10.1210/en.2014-1086; Greaves E, 2014, AM J PATHOL, V184, P1930, DOI 10.1016/j.ajpath.2014.03.011; Guo MM, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1470-y; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; HILL JA, 1988, FERTIL STERIL, V50, P216; Hogg C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013776118; Hogg C, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00007; Hull ML, 2012, AM J PATHOL, V180, P880, DOI 10.1016/j.ajpath.2011.11.013; Itoh F, 2013, FERTIL STERIL, V99, P1705, DOI 10.1016/j.fertnstert.2013.01.133; Iwabe T, 1998, FERTIL STERIL, V69, P924, DOI 10.1016/S0015-0282(98)00049-1; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Johnson MC, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-45; Jorgensen H, 2017, FERTIL STERIL, V107, P1191, DOI 10.1016/j.fertnstert.2017.03.013; Kalu E, 2007, J OBSTET GYNAECOL RE, V33, P490, DOI 10.1111/j.1447-0756.2007.00569.x; Kim BG, 2015, HUM REPROD, V30, P1069, DOI 10.1093/humrep/dev050; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kobayashi H, 2014, ARCH GYNECOL OBSTET, V289, P13, DOI 10.1007/s00404-013-3049-8; Kras JV, 2013, J NEUROSCI RES, V91, P1312, DOI 10.1002/jnr.23254; Kubala MH, 2018, CELL REP, V25, P2177, DOI 10.1016/j.celrep.2018.10.082; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Laske C, 2007, J PSYCHIATR RES, V41, P600, DOI 10.1016/j.jpsychires.2006.02.007; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Leconte M, 2014, J REPROD IMMUNOL, V103, P45, DOI 10.1016/j.jri.2013.12.121; Liu YG, 2009, MOL HUM REPROD, V15, P665, DOI 10.1093/molehr/gap043; Liu YN, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00095; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Oh HK, 2013, MOL HUM REPROD, V19, P160, DOI 10.1093/molehr/gas055; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Okamoto M, 2015, HUM REPROD, V30, P632, DOI 10.1093/humrep/deu332; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; Ouyang Z, 2018, Zhonghua Yi Xue Za Zhi, V98, P1854, DOI 10.3760/cma.j.issn.0376-2491.2018.23.010; Patel BG, 2018, BEST PRACT RES CL OB, V50, P50, DOI 10.1016/j.bpobgyn.2018.01.006; Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516; Prather GR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140236; Rana N, 1996, FERTIL STERIL, V65, P925, DOI 10.1016/S0015-0282(16)58262-4; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Sasmono RT, 2012, METHODS MOL BIOL, V844, P157, DOI 10.1007/978-1-61779-527-5_11; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekulovski N, 2020, BIOL REPROD, V102, P1011, DOI 10.1093/biolre/ioaa010; Sekulovski N, 2019, BIOL REPROD, V100, P398, DOI 10.1093/biolre/ioy222; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shafrir AL, 2018, BEST PRACT RES CL OB, V51, P1, DOI 10.1016/j.bpobgyn.2018.06.001; Simao AP, 2014, RHEUMATOL INT, V34, P1153, DOI 10.1007/s00296-013-2943-5; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Symons LK, 2018, TRENDS MOL MED, V24, P748, DOI 10.1016/j.molmed.2018.07.004; Tran LVP, 2009, HUM REPROD, V24, P835, DOI 10.1093/humrep/den483; Vallve-Juanico J, 2019, HUM REPROD UPDATE, V25, P565, DOI 10.1093/humupd/dmz018; WALLER KG, 1993, FERTIL STERIL, V59, P511; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125559; WHO, 2002, WHO SPEC EV PUBL HLT; Wu CS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091467; Wu JJ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0828-3; Young VJ, 2017, HUM REPROD UPDATE, V23, P548, DOI 10.1093/humupd/dmx016; Young VJ, 2014, J CLIN ENDOCR METAB, V99, P3450, DOI 10.1210/jc.2014-1026; Yuan M, 2017, HUM REPROD, V32, P94, DOI 10.1093/humrep/dew274; Zhang XM, 2005, BJOG-INT J OBSTET GY, V112, P1153, DOI 10.1111/j.1471-0528.2005.00639.x; Zhao YC, 2016, ENDOCRINOLOGY, V157, P900, DOI 10.1210/en.2015-1324; Zhao YC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010626; Zhao YC, 2014, MOL ENDOCRINOL, V28, P1934, DOI 10.1210/me.2014-1080; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	98	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21584	10.1096/fj.202002541RRR	http://dx.doi.org/10.1096/fj.202002541RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33860549				2022-12-26	WOS:000645260100039
J	Englbrecht, F; Ruider, IE; Bausch, AR				Englbrecht, Fabian; Ruider, Iris E.; Bausch, Andreas R.			Automatic image annotation for fluorescent cell nuclei segmentation	PLOS ONE			English	Article							DEEP; PLATFORM	Dataset annotation is a time and labor-intensive task and an integral requirement for training and testing deep learning models. The segmentation of images in life science microscopy requires annotated image datasets for object detection tasks such as instance segmentation. Although the amount of annotated image data has been steadily reduced due to methods such as data augmentation, the process of manual or semi-automated data annotation is the most labor and cost intensive task in the process of cell nuclei segmentation with deep neural networks. In this work we propose a system to fully automate the annotation process of a custom fluorescent cell nuclei image dataset. By that we are able to reduce nuclei labelling time by up to 99.5%. The output of our system provides high quality training data for machine learning applications to identify the position of cell nuclei in microscopy images. Our experiments have shown that the automatically annotated dataset provides coequal segmentation performance compared to manual data annotation. In addition, we show that our system enables a single workflow from raw data input to desired nuclei segmentation and tracking results without relying on pre-trained models or third-party training datasets for neural networks.	[Englbrecht, Fabian; Ruider, Iris E.; Bausch, Andreas R.] Tech Univ Munchen TUM, Lehrstuhl Biophys E27, Garching, Germany; [Bausch, Andreas R.] Ctr Prot Assemblies CPA, Garching, Germany	Technical University of Munich	Englbrecht, F (corresponding author), Tech Univ Munchen TUM, Lehrstuhl Biophys E27, Garching, Germany.	fabian.englbrecht@tum.de		Englbrecht, Fabian/0000-0001-7743-4593				Acuna D, 2018, PROC CVPR IEEE, P859, DOI 10.1109/CVPR.2018.00096; Beucher S., 1992, SCANNING MICROSCOPY, P28; Bohyung H, 2017, INT C NEUR INF PROC, P5115; Bradski G, 2000, DR DOBBS J, V25, P120; Caicedo JC, 2019, NAT METHODS, V16, P1247, DOI 10.1038/s41592-019-0612-7; Caicedo JC, 2019, CYTOM PART A, V95, P952, DOI 10.1002/cyto.a.23863; Ciresan DC, 2010, NEURAL COMPUT, V22, P3207, DOI 10.1162/NECO_a_00052; Cordts M, 2016, PROC CVPR IEEE, P3213, DOI 10.1109/CVPR.2016.350; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lantuejoul C., 1976, P INT WORKSH IM PROC; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Lin T.-Y., 2017, ICCV, P2980, DOI DOI 10.1109/ICCV.2017.324; Lukinavicius G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9497; Maninis KK, 2018, PROC CVPR IEEE, P616, DOI 10.1109/CVPR.2018.00071; McKinney W., 2010, P 9 PYTH SCI C, P56, DOI [DOI 10.25080/MAJORA-92BF1922-00A, 10.25080/Majora-92bf1922-00a]; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Salvi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43137-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schmidt U, 2018, LECT NOTES COMPUT SC, V11071, P265, DOI 10.1007/978-3-030-00934-2_30; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vittayakorn S, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.109; Zhang WL, 2020, IEEE T BIG DATA, V6, P322, DOI 10.1109/TBDATA.2016.2573280	30	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250093	10.1371/journal.pone.0250093	http://dx.doi.org/10.1371/journal.pone.0250093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861785	Green Published, gold			2022-12-26	WOS:000641475400054
J	Hoang, ATN; Hoe, KL; Lee, SJ				Hoang, Anh Thu Nguyen; Hoe, Kwang-Lae; Lee, Sook-Jeong			CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; GROWTH-FACTOR; PI3K PATHWAY; S6 KINASE; ALPHA; PHOSPHORYLATION; ACTIVATION; GENE; EXPRESSION; REVEALS	Tamoxifen (TAM) is a selective estrogen receptor modulator used for breast cancer patients. Prolonged use of tamoxifen is not recommended for some patients. In this study, we aimed to identify molecular targets sensitive to TAM using a genome-wide gene deletion library screening of fission yeast heterozygous mutants. From the screening, casein kinase 1 gamma 2 (CSNK1G2), a serine-/threonine protein kinase, was the most sensitive target to TAM with a significant cytotoxicity in estrogen receptor-positive (ER+) breast cancer cells but with only a slight toxicity in the case of ER- cells. In addition, tumor sphere formation and expression of breast stem cell marker genes such as CD44/CD2 were greatly inhibited by CSNK1G2 knockdown in ER+ breast cancer cells. Consistently, CSNK1G2 altered ER alpha activity via phosphorylation, specifically at serine (Ser)(167), as well as the regulation of estrogen-responsive element (ERE) of estrogen-responsive genes such as CTSD and GREB1. However, ER alpha silencing almost completely blocked CSNK1G2-induced TAM sensitivity. In ER+ breast cancer cells, combined treatment with TAM and CSNK1G2 knockdown further enhanced the TAM-mediated decrease in phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)/ribosomal protein S6 kinase (S6K) signaling but not extracellular signal-regulated kinase (ERK) signaling. Inversely, in ER- cells treated with TAM, only ERK and PI3K signaling was altered by CSNK1G2 knockdown. The CK1 inhibitor, D4476, partly mimicked the CSNK1G2 knockdown effect in ER+ breast cancer cells, but with a broader repression ranging from PI3K/AKT/mTOR/S6K to ERK signaling. Collectively, these results suggest that CSNK1G2 plays a key role in sensitizing TAM toxicity in ER+ and ER- breast cancer cells via differently regulating PI3K/AKT/mTOR/S6K and ERK signaling.	[Hoang, Anh Thu Nguyen; Lee, Sook-Jeong] Jeonbuk Natl Univ, Dept Bioact Mat Sci, Jeonju, Jeollabuk Do, South Korea; [Hoe, Kwang-Lae] Chungnam Natl Univ, Dept New Drug Discovery & Dev, Daejeon, South Korea	Jeonbuk National University; Chungnam National University	Lee, SJ (corresponding author), Jeonbuk Natl Univ, Dept Bioact Mat Sci, Jeonju, Jeollabuk Do, South Korea.; Hoe, KL (corresponding author), Chungnam Natl Univ, Dept New Drug Discovery & Dev, Daejeon, South Korea.	kwanghoe@cnu.ac.kr; sj@jbnu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1D1A1B04934383]; Jeonbuk National University, Republic of Korea; Brain Korea 21 program at the Department of Bioactive Material Sciences	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Jeonbuk National University, Republic of Korea; Brain Korea 21 program at the Department of Bioactive Material Sciences	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (Grant no. NRF-2016R1D1A1B04934383). This study was also supported by Jeonbuk National University, Republic of Korea. In addition, Ms. Anh Thu Nguyen Hoang was supported by the Brain Korea 21 program at the Department of Bioactive Material Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Bannoud N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201844; Barone I, 2009, CANCER RES, V69, P4724, DOI 10.1158/0008-5472.CAN-08-4194; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Bostner J, 2015, ENDOCR-RELAT CANCER, V22, P331, DOI 10.1530/ERC-14-0513; Brown Karen, 2002, Expert Opin Drug Saf, V1, P253, DOI 10.1517/14740338.1.3.253; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CAVAILLES V, 1993, P NATL ACAD SCI USA, V90, P203, DOI 10.1073/pnas.90.1.203; Cavazzoni A, 2012, CANCER LETT, V323, P77, DOI 10.1016/j.canlet.2012.03.034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Gil EMC, 2014, CANCER TREAT REV, V40, P862, DOI 10.1016/j.ctrv.2014.03.004; Clemons M, 2002, CANCER TREAT REV, V28, P165, DOI 10.1016/S0305-7372(02)00036-1; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Dai XF, 2017, J CANCER, V8, P3131, DOI 10.7150/jca.18457; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Decottignies A, 2003, GENOME RES, V13, P399, DOI 10.1101/gr.636103; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Glaros S, 2006, MOL ENDOCRINOL, V20, P996, DOI 10.1210/me.2005-0285; Gonzalez-Angulo AM, 2011, MOL CANCER THER, V10, P1093, DOI 10.1158/1535-7163.MCT-10-1089; Guo L, 2016, G3-GENES GENOM GENET, V6, P3317, DOI 10.1534/g3.116.033829; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Han S, 2013, BIOCHEM BIOPH RES CO, V436, P613, DOI 10.1016/j.bbrc.2013.05.138; Higgins MJ, 2010, CURR ONCOL REP, V12, P7, DOI 10.1007/s11912-009-0076-5; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Kang J, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920927838; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Lee CH, 2016, ONCOTARGET, V7, P1215, DOI 10.18632/oncotarget.6261; Li WZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14364-2; Li ZS, 2008, MOL CANCER THER, V7, P3056, DOI 10.1158/1535-7163.MCT-07-2142; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Masuda K, 2003, INT J CANCER, V105, P803, DOI 10.1002/ijc.11152; Ohri SS, 2008, INT J ONCOL, V32, P491; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Rozengurt E, 2014, MOL CANCER THER, V13, P2477, DOI 10.1158/1535-7163.MCT-14-0330; Saini KS, 2013, CANCER TREAT REV, V39, P935, DOI 10.1016/j.ctrv.2013.03.009; Schittek B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-231; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063173; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065904	62	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0246264	10.1371/journal.pone.0246264	http://dx.doi.org/10.1371/journal.pone.0246264			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861751	Green Published, gold			2022-12-26	WOS:000641475400022
J	Ngo, TD; Canavati, SE; Dung, DV; Vo, TH; Tran, DT; Tran, LK; Whedbee, RJ; Milgotina, EI; Kelly, GC; Edgel, KA; Martin, NJ				Thang Duc Ngo; Canavati, Sara E.; Dang Viet Dung; Thuan Huu Vo; Duong Thanh Tran; Tran, Long Khanh; Whedbee, Rosalie J.; Milgotina, Ekaterina, I; Kelly, Gerard C.; Edgel, Kimberly A.; Martin, Nicholas J.			Results from a malaria indicator survey highlight the importance of routine data capture in high-risk forest and farm transmission sites in Vietnam to tailor location-specific malaria elimination interventions	PLOS ONE			English	Article							PLASMODIUM-VIVAX; RESISTANCE; EPIDEMIOLOGY; POPULATION; STRATEGIES; CHALLENGE; KNOWLEDGE; PATTERNS; BEHAVIOR; MOBILE	In-line with the World Health Organization's (WHO) Global Technical Strategy for Malaria (2016-2030), Vietnam is striving to eliminate malaria by 2030. Targeting appropriate interventions in high-risk populations such as forest and forest-fringe communities is a critical component of malaria elimination efforts in Vietnam. In 2016, a household-level malaria indicator survey was conducted in Phu Yen Province, Vietnam with the aim of assessing the knowledge, behaviors and associated risks of malaria infection among priority mobile and migrant populations (MMPs) working and sleeping in forests and on farms. A total of 4211 people were included in the survey, comprised of 1074 heads of households and 3137 associated household members. Of the 1074 head-of-household respondents, 472 slept in a forest, 92 slept on a farm, 132 slept in both forests and farms, and 378 slept at their villages within the last 12 months. Age, literacy, and occupation were significantly different among those who slept in a forest versus on a farm. Of 301 respondents who answered questions about malaria risk factors at sleeping sites, 35% were somewhat aware of malaria prevention practices, but only 4% could recall at least four malaria prevention messages. Among the same group of 301 respondents, only 29% used nets and only 11% used treated nets. Ownership and use of nets among forest-goers was significantly lower than those who slept on a farm or in their village. Huts without walls were significantly prominent forest sleeping site locations (POR = 10.3; 95% CI 4.67-22.7). All respondents who slept in a forest requested standby malaria drugs and one-third of them self-treated without blood testing. Results from this study highlight the importance of capturing relevant location-specific data among priority populations such as remote forest and farm going mobile and migrant populations in Vietnam. Data regarding behavioral practices, knowledge, preventative measures, and intervention coverage at remote-area transmission sites must be routinely captured to effectively monitor progress and refine targeted intervention strategies accordingly.	[Thang Duc Ngo; Dang Viet Dung; Duong Thanh Tran] Natl Inst Malariol Parasitol & Entomol, Dept Epidemiol, Hanoi, Vietnam; [Canavati, Sara E.; Thuan Huu Vo; Tran, Long Khanh; Kelly, Gerard C.] Vysnova Partners Inc, Landover, MD 20785 USA; [Canavati, Sara E.] Burnet Inst, Melbourne, Vic, Australia; [Whedbee, Rosalie J.; Milgotina, Ekaterina, I] Global Sci Solut Hlth, Baltimore, MD USA; [Edgel, Kimberly A.; Martin, Nicholas J.] US Naval Med Res Unit TWO, Singapore, Singapore	Burnet Institute	Kelly, GC (corresponding author), Vysnova Partners Inc, Landover, MD 20785 USA.	gerardckelly@gmail.com		Vo, Thuan/0000-0002-8551-4240	US Defense Health Agency Research and Development [D1430]	US Defense Health Agency Research and Development	SEC, THV, LKT and GCK are employed by Vysnova Partners Inc. which was contracted by the US Navy to assist in design, implementation, analysis and report preparation for this project. Vysnova Partners Inc. was not a funder of the study and was not involved in the decision to publish this report. Vysnova Partners Inc. provided support in the form of salaries for authors SEC, THV, LKT and GCK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors (SEC, THV, LKT and GCK) are articulated in the `author contributions' section. This project was funded by the US Defense Health Agency Research and Development (Work Unit Number D1430).	Canavati SE., 2016, MALARIA J, V15; Chinese Ministry of Health, 2012, WHOL BLOOD COMP DON; Dysoley L, 2008, ACTA TROP, V106, P207, DOI 10.1016/j.actatropica.2007.01.007; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Goldlust SM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2372-8; Grietens KP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16837; Gryseels C, 2015, AM J TROP MED HYG, V93, P810, DOI 10.4269/ajtmh.15-0259; Guyant P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0773-5; Imwong M., 2015, MALARIA J, V14; Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8; Koenker H., 2014, MALARIA J, V13; Maia MF, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011595.pub2; Marchand RP, 2011, EMERG INFECT DIS, V17, P1232, DOI 10.3201/eid1707.101551; Maung TM, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0111-z; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Muller O, 2011, MALARIA AFRICA CHALL; Ngo DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007369; Ngo TD., 2019, GEOSPAT HLTH, V14; Panter-Brick C, 2006, SOC SCI MED, V62, P2810, DOI 10.1016/j.socscimed.2005.10.009; Thanh PV, 2015, ANTIMICROB AGENTS CH, V59, P7411, DOI 10.1128/AAC.00791-15; Thanh PV, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0601-y; Phu Yen People's Committee, 2018, GEN INFORM PHU YEN P; Pongvongsa T, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0140-2; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P73; Sochantha T, 2010, TROP MED INT HEALTH, V15, P336, DOI 10.1111/j.1365-3156.2009.02457.x; Suwonkerd W., 2013, PEER REVIEWED CHAPTE; Than WP, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0353-8; Thuan LK, 2001, SCI WORK 2001 2015; Tran DT, 2015, FINAL REPORT NATL MA; Tripura R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1224-7; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; UCSF, 2016, APMEN COUNTRY BRIEFI; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; Wangdi K, 2020, AM J TROP MED HYG, V103, P1540, DOI 10.4269/ajtmh.20-0392; Wangdi K, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2478-z; WHO, 2015, GLOB TECHN STRAT MAL; World Health Organization, 2014, STATUS REPORT ARTEMI	38	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250045	10.1371/journal.pone.0250045	http://dx.doi.org/10.1371/journal.pone.0250045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861798	Green Published, gold			2022-12-26	WOS:000641475400018
J	Durovic, MR; Durovic, M; Jankovic, J; Jankovic, S				Durovic, Milena Raznatovic; Durovic, Milica; Jankovic, Janko; Jankovic, Slavenka			Quality of life in Montenegrin pupils with acne	PLOS ONE			English	Article							DISABILITY INDEX; SKIN CONDITIONS; VULGARIS; IMPACT; ADOLESCENTS; CDLQI; DEPRESSION; PREVALENCE; ANXIETY; SCHOOLCHILDREN	Background Acne is a common skin disease that can affect a person's quality of life (QoL), self-esteem, and mood in an adverse manner. The aim of the current study was to assess QoL among Montenegrin pupils with acne. Methods This cross-sectional survey was conducted over October and November 2020 in four randomly selected secondary schools in Podgorica, Montenegro. All 500 pupils were asked to fill in a short questionnaire which included questions on age, sex, presence of acne, and for those with acne their duration and location, visits to doctors, presence of any other coexisting skin disease, and family history of acne. Only pupils who self-reported acne were asked to complete the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). Results Self reported acne were presented in 49.8% (249/500) of all pupils. The mean CDLQI score of the total sample was 4.27 +/- 5.13. Overall, the CDLQI domains that were most affected by acne were symptoms and feelings (mean score 1.49 +/- 1.43), leisure (mean score 0.94 +/- 1.72), and treatment (0.66 +/- 0.79). The mean total CADI score was 3.53 +/- 3.11 which was higher in girls (4.07 +/- 3.11) than in boys (2.90 +/- 3.00). There was good correlation between the two questionnaires (Rho = 0.76; P < 0.01). According to multiple linear regressions, higher overall CDLQI score was found in pupils with acne who reported other skin diseases, while girls, pupils who reported both acne on face and back, and who had any concomitant skin disease had higher CADI total score. Conclusions Acne affects QoL of young adolescents in Montenegro with greater impact in girls. Our findings should point out the importance of timely diagnosis, treatment, and education of adolescents with acne.	[Durovic, Milena Raznatovic; Durovic, Milica] Clin Ctr Montenegro, Clin Dermatol & Venereol, Podgorica, Montenegro; [Durovic, Milena Raznatovic] Univ Montenegro, Fac Med, Podgorica, Montenegro; [Jankovic, Janko] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Jankovic, Slavenka] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia	University of Montenegro; University of Belgrade; University of Belgrade	Jankovic, J (corresponding author), Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia.	drjankojankovic@yahoo.com		Jankovic, Janko/0000-0002-2387-6596	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministarstvo Prosvete, Nauke i Tehnolos.kog Razvoja RS) [200110]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministarstvo Prosvete, Nauke i Tehnolos.kog Razvoja RS)	This study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Ministarstvo Prosvete, Nauke i Tehnolos.kog Razvoja RS, project No 200110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaei S, 2006, SAUDI MED J, V27, P80; Aktan S, 2000, INT J DERMATOL, V39, P354, DOI 10.1046/j.1365-4362.2000.00907.x; [Anonymous], 2018, GLOBAL ACNE MARKET R; Berg M, 2011, J EUR ACAD DERMATOL, V25, P969, DOI 10.1111/j.1468-3083.2010.03907.x; Bowe Whitney P, 2011, J Clin Aesthet Dermatol, V4, P35; Do JE, 2009, ANN DERMATOL, V21, P125, DOI 10.5021/ad.2009.21.2.125; Dunn Lauren K, 2011, Dermatol Online J, V17, P1; Durai PCT, 2015, INDIAN J DERMATOL, V60, P33, DOI 10.4103/0019-5154.147784; Eyuboglu M, 2018, INDIAN J DERMATOL, V63, P131, DOI 10.4103/ijd.IJD_671_16; Guo F, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022983; Hahm BJ, 2009, J DERMATOL, V36, P255, DOI 10.1111/j.1346-8138.2009.00635.x; Jankovic S, 2013, J CUTAN MED SURG, V17, P316, DOI 10.2310/7750.2013.12114; Jankovic S, 2013, QUAL LIFE RES, V22, P161, DOI 10.1007/s11136-012-0136-4; Jankovic S, 2012, INDIAN J DERMATOL VE, V78, P454, DOI 10.4103/0378-6323.98076; KROWCHUK DP, 1991, PEDIATR DERMATOL, V8, P332, DOI 10.1111/j.1525-1470.1991.tb00945.x; Kubota Y, 2010, J DERMATOL, V37, P617, DOI 10.1111/j.1346-8138.2010.00855.x; Kamamoto CDL, 2014, AN BRAS DERMATOL, V89, P83, DOI 10.1590/abd1806-4841.20142172; LEWISJONES MS, 1995, BRIT J DERMATOL, V132, P942; MOTLEY RJ, 1992, CLIN EXP DERMATOL, V17, P1, DOI 10.1111/j.1365-2230.1992.tb02521.x; Niemeier V, 2002, DERMATOL PSYCHOSOM, V3, P61, DOI [10.1007/s00105-002-0380-6, DOI 10.1007/S00105-002-0380-6]; Olsen JR, 2016, BRIT J DERMATOL, V174, P853, DOI 10.1111/bjd.14361; Pawin H, 2007, DERMATOLOGY, V215, P308, DOI 10.1159/000107624; Peric J, 2013, VOJNOSANIT PREGL, V70, P935, DOI 10.2298/VSP1310935P; Purvis D, 2006, J PAEDIATR CHILD H, V42, P793, DOI 10.1111/j.1440-1754.2006.00979.x; Rapp DA, 2004, BRIT J DERMATOL, V151, P183, DOI 10.1111/j.1365-2133.2004.06078.x; Raljic V, 2014, VOJNOSANIT PREGL, V71, P634, DOI 10.2298/VSP1407634R; Rigopoulos D, 2007, J EUR ACAD DERMATOL, V21, P806, DOI 10.1111/j.1468-3083.2006.02091.x; Safizadeh H, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/571516; Sampogna F, 2013, GIORN ITAL DERMAT V, V148, P255; Stamu-O'Brien C, 2021, J COSMET DERMATOL-US, V20, P1080, DOI 10.1111/jocd.13765; Tan JKL, 2008, J CUTAN MED SURG, V12, P235, DOI 10.2310/7750.2008.07053; Tasoula E, 2012, AN BRAS DERMATOL, V87, P862, DOI 10.1590/S0365-05962012000600007; Tayel K, 2020, J EGYPT PUBLIC HEAL, V95, DOI 10.1186/s42506-020-00056-9; Uslu G, 2008, J EUR ACAD DERMATOL, V22, P462, DOI 10.1111/j.1468-3083.2007.02497.x; Vos T, 2013, LANCET, V381, P628; Walker N, 2006, J EUR ACAD DERMATOL, V20, P45, DOI 10.1111/j.1468-3083.2005.01344.x; Waters A, 2010, BRIT J DERMATOL, V163, P121; Yap FBB, 2012, ANN DERMATOL, V24, P158, DOI 10.5021/ad.2012.24.2.158; Yazici K, 2004, J EUR ACAD DERMATOL, V18, P435, DOI 10.1111/j.1468-3083.2004.00946.x; Yeung CK, 2002, ACTA DERM-VENEREOL, V82, P104, DOI 10.1080/00015550252948121; Yosipovitch G, 2007, ACTA DERM-VENEREOL, V87, P135, DOI 10.2340/00015555-0231; Zauli S, 2014, J EUR ACAD DERMATOL, V28, P46, DOI 10.1111/jdv.12053; Zouboulis CC, 2004, CLIN DERMATOL, V22, P360, DOI 10.1016/j.clindermatol.2004.03.004	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250155	10.1371/journal.pone.0250155	http://dx.doi.org/10.1371/journal.pone.0250155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857237	Green Published, gold			2022-12-26	WOS:000641474900098
J	Wu, SS; Liu, BD; Zhang, YH; Hong, RH; Liu, SH; Xiang, T; Tao, TY; Cai, JC; Wu, JH; Li, MF; Guan, HY				Wu, Shanshan; Liu, Bangdong; Zhang, Youhong; Hong, Ruohui; Liu, Shihua; Xiang, Tao; Tao, Tianyu; Cai, Junchao; Wu, Jueheng; Li, Mengfeng; Guan, Hongyu			Long non-coding RNA LEISA promotes progression of lung adenocarcinoma via enhancing interaction between STAT3 and IL-6 promoter	ONCOGENE			English	Article							CANCER; INFLAMMATION; TRANSCRIPTION; TARGETS; BIOLOGY; CELLS; PTEN; IL6	Long non-coding RNAs (lncRNAs) are emerging as a new class of regulators for a variety of biological processes and have been suggested to play pivotal roles in cancer development and progression. Our current study found that a lncRNA, designated enhancing IL-6/STAT3 signaling activation (LEISA, ENST00000603468), functioned as an oncogenic lncRNA in lung adenocarcinoma (LAD), a major form of non-small cell lung carcinoma, which is one of the most frequently diagnosed malignancies with high morbidity and mortality worldwide, and was involved in the regulation of STAT3 induced IL-6 transcription. Our data showed that LEISA was highly expressed in, and correlated with the clinical progression and prognosis of LAD. Ectopic expression of LEISA promoted the proliferation and suppressed apoptosis of LAD cells in vitro and in vivo. Mechanistically, we demonstrated that LEISA recruited STAT3 to bind the promoter of IL-6 and upregulated IL-6 expression. Taken together, our work identifies LEISA as a potential diagnostic biomarker and therapeutic target for LAD.	[Wu, Shanshan; Liu, Bangdong; Hong, Ruohui; Tao, Tianyu; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Wu, Shanshan] Guangdong Med Univ, Sch Basic Med Sci, Dept Biol, Zhanjiang, Guangdong, Peoples R China; [Zhang, Youhong; Li, Mengfeng] Southern Med Univ, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Liu, Shihua] Sun Yat Sen Univ Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Xiang, Tao; Guan, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Cai, Junchao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Southern Medical University - China; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wu, JH; Li, MF (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.; Li, MF (corresponding author), Southern Med Univ, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China.; Guan, HY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	wujh@mail.sysu.edu.cn; limf@mail.sysu.edu.cn; ghongy@mail.sysu.edu.cn			National Key Research and Development Program of China [2017YFA0106300]; National Natural Science Foundation of China [81972170, 81820108025, 81621004, 81672296, 81922050, 81772473, 81802274]; Science and Technology Program of Guangzhou City [201803010039]; Guangdong MEPP Fund [GDOE [2019]A21]; Natural Science Foundation of Guangdong Province [2019A1515011174]; Fundamental Research Funds for the Central Universities [19ykpy162]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou City; Guangdong MEPP Fund; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Research and Development Program of China (2017YFA0106300) and the National Natural Science Foundation of China (81972170, 81820108025, 81621004, 81672296, 81922050, 81772473, 81802274); the Science and Technology Program of Guangzhou City (201803010039); the Guangdong MEPP Fund (NO. GDOE [2019]A21); the Natural Science Foundation of Guangdong Province (2019A1515011174); the Fundamental Research Funds for the Central Universities (19ykpy162).	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Cai JC, 2018, NAT CELL BIOL, V20, P465, DOI 10.1038/s41556-018-0065-8; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Calabrese LH, 2014, NAT REV RHEUMATOL, V10, P720, DOI 10.1038/nrrheum.2014.127; Chang RX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05852-8; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deng SJ, 2019, CANCER RES, V79, P1398, DOI 10.1158/0008-5472.CAN-18-0419; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Ettinger DS, 2015, J NATL COMPR CANC NE, V13, P515, DOI 10.6004/jnccn.2015.0071; Fang LS, 2019, ONCOGENE, V38, P896, DOI 10.1038/s41388-018-0484-9; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guan HY, 2019, P NATL ACAD SCI USA, V116, P14019, DOI 10.1073/pnas.1900997116; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Jones SA, 2018, NAT REV IMMUNOL, V18, P773, DOI 10.1038/s41577-018-0066-7; Kang SJ, 2019, IMMUNITY, V50, P1007, DOI 10.1016/j.immuni.2019.03.026; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lederle W, 2011, INT J CANCER, V128, P2803, DOI 10.1002/ijc.25621; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Liu WJ, 2020, PHARMACOL THERAPEUT, V206, DOI 10.1016/j.pharmthera.2019.107438; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Silva A, 2015, CANCERS, V7, P2169, DOI 10.3390/cancers7040884; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Tanaka T, 2014, CANCER IMMUNOL RES, V2, P288, DOI 10.1158/2326-6066.CIR-14-0022; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Vinocha A, 2018, J CANCER RES THER, V14, pS758, DOI 10.4103/0973-1482.183217; Wang JX, 2019, MOL ONCOL, V13, P2344, DOI 10.1002/1878-0261.12538; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang X, 2016, J HEPATOL, V64, P1283, DOI 10.1016/j.jhep.2016.01.019; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xing YH, 2017, CELL, V169, P664, DOI 10.1016/j.cell.2017.04.011; Ying Z, 2017, J CLIN INVEST, V127, P1725, DOI 10.1172/JCI90439; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	52	5	6	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2021	40	19					3449	3459		10.1038/s41388-021-01769-7	http://dx.doi.org/10.1038/s41388-021-01769-7		APR 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SB1JB	33859372				2022-12-26	WOS:000640485900001
J	Moloney, GK; Tuke, J; Dal Grande, E; Nielsen, T; Chaber, AL				Moloney, Georgia Kate; Tuke, Jonathan; Dal Grande, Eleonora; Nielsen, Torben; Chaber, Anne-Lise			Is YouTube promoting the exotic pet trade? Analysis of the global public perception of popular YouTube videos featuring threatened exotic animals	PLOS ONE			English	Article							SOCIAL MEDIA; CONSUMPTION; WILDLIFE; EMOJI; NEWS	The exploitation of threatened exotic species via social media challenges efforts to regulate the exotic pet trade and consequently threatens species conservation. To investigate how such content is perceived by the global community, mixed model sentiment analysis techniques were employed to explore variations in attitudes expressed through text and emoji usage in public comments associated with 346 popular YouTube(R) videos starring exotic wild cats or primates in 'free handling' situations. Negative interactions between wild cats and primates with other species were found to be associated with both text and emoji median sentiment reduction, however were still accompanied by a median emoji sentiment above zero. Additionally, although a negative trend in median text sentiment was observed in 2015 for primates, an otherwise consistent positive median text and emoji sentiment score through time across all IUCN Red List categories was revealed in response to both exotic wild cat and primate videos, further implying the societal normalisation and acceptance of exotic pets. These findings highlight the urgency for effective YouTube(R) policy changes and content management to promote public education and conservation awareness, whilst extinguishing false legitimisation and demand for the exotic pet trade.	[Moloney, Georgia Kate; Dal Grande, Eleonora; Nielsen, Torben; Chaber, Anne-Lise] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Tuke, Jonathan] Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Chaber, AL (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	anne-lise.chaber@adelaide.edu.au		Chaber, Anne-Lise/0000-0001-9042-8753; Moloney, Georgia/0000-0001-9717-6384; Nielsen, Torben/0000-0002-8941-7376; Dal Grande, Eleonora/0000-0002-5919-3893				[Anonymous], 2020, YOUTUBE; [Anonymous], 2019, CITES; [Anonymous], 2016, WILDB SOFTW COMB EXT; Arnold J., 2018, J OPEN SOURCE SOFTW, V3, P655, DOI [10.21105/joss.00655, DOI 10.21105/JOSS.00655]; Ashman R, 2018, J BUS RES, V92, P474, DOI 10.1016/j.jbusres.2018.07.055; Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Bergstrom A, 2018, DIGIT JOURNAL, V6, P583, DOI 10.1080/21670811.2018.1423625; Broxton T, 2013, J INTELL INF SYST, V40, P241, DOI 10.1007/s10844-011-0191-2; Burgess J., 2018, YOUTUBE ONLINE VIDEO; Bush ER, 2014, CONSERV BIOL, V28, P663, DOI 10.1111/cobi.12240; Chen YL, 2019, EXPERT SYST APPL, V133, P59, DOI 10.1016/j.eswa.2019.05.015; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; Derraik JGB, 2010, BIOL INVASIONS, V12, P1477, DOI 10.1007/s10530-009-9595-0; Ferrara HM., 2013, GALE BUSINESS INSIGH, P325; Freeman B, 2008, J EPIDEMIOL COMMUN H, V62, P778, DOI 10.1136/jech.2008.073759; Goodrich J., 2015, IUCN RED LIST THREAT; Granot E, 2014, J CONSUM CULT, V14, P66, DOI 10.1177/1469540513485274; Harrington LA, 2015, CONSERV BIOL, V29, P293, DOI 10.1111/cobi.12448; Holtgraves T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232361; Hornik K, 2013, J STAT SOFTW, V52; International Animal Rescue, 2019, SLOW LOR RESC; Jaeger SR, 2017, FOOD QUAL PREFER, V62, P275, DOI 10.1016/j.foodqual.2017.04.009; Kalogeropoulos A, 2018, DIGIT JOURNAL, V6, P651, DOI 10.1080/21670811.2017.1320197; Khan ML, 2017, COMPUT HUM BEHAV, V66, P236, DOI 10.1016/j.chb.2016.09.024; Kitson H, 2017, ORYX, V51, P394, DOI 10.1017/S0030605317000680; Kumar S., 2018, ARXIV180408559; Mills G, 2017, VET REC, V181, P673, DOI 10.1136/vr.j5899; Moorhouse TP, 2017, CONSERV LETT, V10, P337, DOI 10.1111/conl.12270; Nekaris KAI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069215; Nielsen F A., 2011, ARXIV11032903; Nijman Vincent, 2019, Biodiversity, V20, P58; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Novak PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144296; Peterka-Bonetta J., 2017, EMOJI ANAL R; Prada M, 2018, TELEMAT INFORM, V35, P1925, DOI 10.1016/j.tele.2018.06.005; R Studio Team, 2016, RSTUDIO INT DEV ENV; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Silge J., 2016, J OPEN SOURCE SOFTW, V1, P37, DOI [DOI 10.21105/JOSS.00037, 10.1007/s00216-016-9710-x]; Siriwat P, 2018, J ASIA-PAC BIODIVERS, V11, P469, DOI 10.1016/j.japb.2018.09.004; Sood Gaurav, 2019, TUBER ACCESS YOUTUBE; Spee LB, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080480; Stazaker K, 2018, ANTHROZOOS, V31, P761, DOI 10.1080/08927936.2018.1529360; Thompson D, 2016, J COMPUT-MEDIAT COMM, V21, P105, DOI 10.1111/jcc4.12156; Tian Y, 2017, P 5 INT WORKSH NAT L; Uryupina O., 2014, P 9 INT C LANG RES E; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Animal Protection, 2019, WILD HEART CRUELT EX	48	3	3	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0235451	10.1371/journal.pone.0235451	http://dx.doi.org/10.1371/journal.pone.0235451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN5ED	33848287	Green Published, gold, Green Submitted			2022-12-26	WOS:000640373500027
J	Kummerfeld, E				Kummerfeld, Erich			A simple interpretation of undirected edges in essential graphs is wrong	PLOS ONE			English	Article							DIRECTED ACYCLIC GRAPHS	Artificial intelligence for causal discovery frequently uses Markov equivalence classes of directed acyclic graphs, graphically represented as essential graphs, as a way of representing uncertainty in causal directionality. There has been confusion regarding how to interpret undirected edges in essential graphs, however. In particular, experts and non-experts both have difficulty quantifying the likelihood of uncertain causal arrows being pointed in one direction or another. A simple interpretation of undirected edges treats them as having equal odds of being oriented in either direction, but I show in this paper that any agent interpreting undirected edges in this simple way can be Dutch booked. In other words, I can construct a set of bets that appears rational for the users of the simple interpretation to accept, but for which in all possible outcomes they lose money. I put forward another interpretation, prove this interpretation leads to a bet-taking strategy that is sufficient to avoid all Dutch books of this kind, and conjecture that this strategy is also necessary for avoiding such Dutch books. Finally, I demonstrate that undirected edges that are more likely to be oriented in one direction than the other are common in graphs with 4 nodes and 3 edges.	[Kummerfeld, Erich] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kummerfeld, E (corresponding author), Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55455 USA.	erichk@umn.edu		Kummerfeld, Erich/0000-0001-5342-7743	NCRR [1UL1TR002494-01]	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	EK was supported by funding from Grant No. NCRR 1UL1TR002494-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker JJ, 2019, ALCOHOL CLIN EXP RES, V43, P91, DOI 10.1111/acer.13914; Baranczuk Z, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25437; Chickering DM, 2002, J MACH LEARN RES, V2, P445, DOI 10.1162/153244302760200696; Ganin AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19540; Hajek A., 2009, DUTCH BOOK ARGUMENTS; Hyttinen A, 2014, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P340; Kemeny J.G., 1955, J SYMBOLIC LOGIC, V20, P263, DOI [DOI 10.2307/2268222, 10.2307/2268222]; Kummerfeld E, 2019, IEEE INT C BIOINFORM, P2586, DOI 10.1109/BIBM47256.2019.8983327; Lehman R.S., 1955, J SYMBOLIC LOGIC, V20, P251, DOI [10.2307/2268221, DOI 10.2307/2268221]; Ma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106479; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Moffa G, 2017, SCHIZOPHRENIA BULL, V43, P1273, DOI 10.1093/schbul/sbx013; Neuberg LG, 2003, ECONOMET THEOR, V19, P675, DOI 10.1017/S026646603004109; Ramsey Joseph, 2017, Int J Data Sci Anal, V3, P121, DOI 10.1007/s41060-016-0032-z; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schichl H, 2005, J GLOBAL OPTIM, V33, P541, DOI 10.1007/s10898-005-0937-x; Sedgewick AJ, 2019, BIOINFORMATICS, V35, P1204, DOI 10.1093/bioinformatics/bty769; Shen XP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59669-x; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Spirtes P., 2000, CAUSATION PREDICTION; Triantafillou S., 2017, SCI REP-UK, V7, P1; VanderWeele TJ, 2007, AM J EPIDEMIOL, V166, P1096, DOI 10.1093/aje/kwm179; Vineberg S., 2011, STANFORD ENCY PHILOS; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Xue YF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48318-7	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249415	10.1371/journal.pone.0249415	http://dx.doi.org/10.1371/journal.pone.0249415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831048	gold, Green Published			2022-12-26	WOS:000639359600028
J	Long, JM; Trubenbach, LA; Hobbs, KC; Poletti, AE; Steinhauser, CB; Pryor, JH; Long, CR; Wickersham, TA; Sawyer, JE; Miller, RK; Cardoso, RC; Satterfield, MC				Long, John M.; Trubenbach, Levi A.; Hobbs, Kenneth C.; Poletti, Andrew E.; Steinhauser, Chelsie B.; Pryor, Jane H.; Long, Charles R.; Wickersham, Tryon A.; Sawyer, Jason E.; Miller, Rhonda K.; Cardoso, Rodolfo C.; Satterfield, Michael Carey			Maternal nutrient restriction in late pregnancy programs postnatal metabolism and pituitary development in beef heifers	PLOS ONE			English	Article							ADIPOSE-TISSUE; GROWTH-HORMONE; PROTEIN SUPPLEMENTATION; CARCASS CHARACTERISTICS; INSULIN SENSITIVITY; SOMATOTROPIC AXIS; SKELETAL-MUSCLE; FEED-INTAKE; NUTRITION; GESTATION	Maternal undernutrition during pregnancy followed by ad libitum access to nutrients during postnatal life induces postnatal metabolic disruptions in multiple species. Therefore, an experiment was conducted to evaluate postnatal growth, metabolism, and development of beef heifers exposed to late gestation maternal nutrient restriction. Pregnancies were generated via transfer of in vitro embryos produced using X-bearing sperm from a single Angus sire. Pregnant dams were randomly assigned to receive either 100% (control; n = 9) or 70% (restricted; n = 9) of their total energy requirements from gestational day 158 to parturition. From post-natal day (PND) 301 until slaughter (PND485), heifers were individually fed ad libitum in a Calan gate facility. Calves from restricted dams were lighter than controls at birth (P<0.05) through PND70 (P<0.05) with no difference in body weight from PND105 through PND485 (P>0.10). To assess pancreatic function, glucose tolerance tests were performed on PND315 and PND482 and a diet effect was seen with glucose area under the curve being greater (P<0.05) in calves born to restricted dams compared to controls. At slaughter, total internal fat was greater (P<0.05) in heifers born to restricted dams, while whole pituitary weight was lighter (P<0.05). Heifers from restricted dams had fewer growth hormone-positive cells (somatotrophs) compared to controls (P<0.05). Results demonstrate an impaired ability to clear peripheral glucose in heifers born to restricted dams leading to increased deposition of internal fat. A reduction in the number of somatotrophs may contribute to the adipogenic phenotype of heifers born to restricted dams due to growth hormone's known anabolic roles in growth, lipolysis, and pancreatic islet function.	[Long, John M.; Trubenbach, Levi A.; Hobbs, Kenneth C.; Poletti, Andrew E.; Steinhauser, Chelsie B.; Wickersham, Tryon A.; Sawyer, Jason E.; Miller, Rhonda K.; Cardoso, Rodolfo C.; Satterfield, Michael Carey] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Pryor, Jane H.; Long, Charles R.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Sawyer, Jason E.] Texas A&M Univ, King Ranch Inst Ranch Management, Kingsville, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University Kingsville	Satterfield, MC (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	csatterfield@tamu.edu		Steinhauser, Chelsie/0000-0002-6043-8923	Texas A&M AgriLife Research Beef Industry Competitiveness Grant Program	Texas A&M AgriLife Research Beef Industry Competitiveness Grant Program	This work was funded by the Texas A&M AgriLife Research Beef Industry Competitiveness Grant Program (M.C.S). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; BAUER MK, 1995, ENDOCRINOLOGY, V136, P1250, DOI 10.1210/en.136.3.1250; Berryman DE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081621; Boardman CJ, 2020, TRANSL ANIM SCI, V4, DOI 10.1093/tas/txaa108; BONNERWEIR S, 1980, CELL TISSUE RES, V206, P157, DOI 10.1007/BF00233616; Cannata Dara, 2010, Adv Pediatr, V57, P331, DOI 10.1016/j.yapd.2010.09.003; Dellschaft NS, 2015, J ENDOCRINOL, V224, P171, DOI 10.1530/JOE-14-0600; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Diniz WJS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82156-w; DWYER CM, 1994, J ANIM SCI, V72, P911, DOI 10.2527/1994.724911x; FERRELL CL, 1976, J ANIM SCI, V42, P1477, DOI 10.2527/jas1976.4261477x; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Funston RN, 2012, J ANIM SCI, V90, P2301, DOI 10.2527/jas.2011-4568; Funston RN, 2010, J ANIM SCI, V88, pE205, DOI 10.2527/jas.2009-2351; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Golding MC, 2015, THERIOGENOLOGY, V84, P1411, DOI 10.1016/j.theriogenology.2015.07.028; Gonzalez JM, 2013, J ANIM SCI, V91, P4797, DOI 10.2527/jas.2013-6704; Greenwood PL, 2007, ANIMAL, V1, P1283, DOI 10.1017/S175173110700050X; Greenwood PL, 1998, J ANIM SCI, V76, P2354; Holt RIG, 2002, TRENDS ENDOCRIN MET, V13, P392, DOI 10.1016/S1043-2760(02)00697-5; Jiang H, 2014, J ANIM SCI, V92, P21, DOI 10.2527/jas.2013-7095; Larson DM, 2009, J ANIM SCI, V87, P1147, DOI 10.2527/jas.2008-1323; LeMaster CT, 2017, THERIOGENOLOGY, V87, P64, DOI 10.1016/j.theriogenology.2016.08.004; Lemley CO, 2015, BOVINE REPRODUCTION, P245; Levy A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740147; Long JM, 2021, DOMEST ANIM ENDOCRIN, V74, DOI 10.1016/j.domaniend.2020.106580; Long NM, 2012, J ANIM SCI, V90, P197, DOI 10.2527/jas.2011-4237; Long NM, 2010, J ANIM SCI, V88, P3251, DOI 10.2527/jas.2009-2512; Long NM, 2010, J ANIM SCI, V88, P2029, DOI 10.2527/jas.2009-2568; Lutz L, 2006, GROWTH HORM IGF RES, V16, P108, DOI 10.1016/j.ghir.2006.02.003; Martin JL, 2007, J ANIM SCI, V85, P841, DOI 10.2527/jas.2006-337; Micke GC, 2015, THERIOGENOLOGY, V83, P604, DOI 10.1016/j.theriogenology.2014.10.022; Micke GC, 2011, REPRODUCTION, V141, P697, DOI 10.1530/REP-10-0332; NationalResearchCouncil, 2000, NUTR REQ BEEF CATTL; Nolan LA, 2004, J ENDOCRINOL, V181, P521, DOI 10.1677/joe.0.1810521; Olson CA, 2019, J ANIM SCI, V97, P1828, DOI 10.1093/jas/skz029; PARRY DM, 1979, CELL TISSUE RES, V197, P501, DOI 10.1007/BF00233573; Quigley SP, 2005, ANIM REPROD SCI, V87, P241, DOI 10.1016/j.anireprosci.2004.11.005; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Renaville R, 2002, DOMEST ANIM ENDOCRIN, V23, P351, DOI 10.1016/S0739-7240(02)00170-4; Sandoval C, 2021, DOMEST ANIM ENDOCRIN, V74, DOI 10.1016/j.domaniend.2020.106556; Sandoval C, 2020, DOMEST ANIM ENDOCRIN, V72, DOI 10.1016/j.domaniend.2020.106443; Sartori ED, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skaa294; Schlegel ML, 2006, J ANIM SCI, V84, P1176, DOI 10.2527/2006.8451176x; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Steinhauser CB, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142174; Sullivan TM, 2009, REPROD FERT DEVELOP, V21, P773, DOI 10.1071/RD09004; Summers AF, 2015, J ANIM SCI, V93, P1865, DOI 10.2527/jas.2014-8296; Sundrani DP, 2017, REPROD FERT DEVELOP, V29, P2085, DOI 10.1071/RD16265; Symonds ME, 2004, P NUTR SOC, V63, P397, DOI 10.1079/PNS2004366; Tortoriello DV, 2002, J CLIN INVEST, V110, P749, DOI 10.1172/JCI200216700; Trubenbach LA, 2019, TRANSL ANIM SCI, V3, P796, DOI 10.1093/tas/txz039; Underwood KR, 2010, MEAT SCI, V86, P588, DOI 10.1016/j.meatsci.2010.04.008; Vasconcelos JT, 2009, J ANIM SCI, V87, P1540, DOI 10.2527/jas.2008-0934; Yazici D, 2017, ADV EXP MED BIOL, V960, P277, DOI 10.1007/978-3-319-48382-5_12; Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110	57	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249924	10.1371/journal.pone.0249924	http://dx.doi.org/10.1371/journal.pone.0249924			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831110	Green Published, gold			2022-12-26	WOS:000639359600002
J	Lopez-Castro, T; Brandt, L; Anthonipillai, NJ; Espinosa, A; Melara, R				Lopez-Castro, Teresa; Brandt, Laura; Anthonipillai, Nishanthi J.; Espinosa, Adriana; Melara, Robert			Experiences, impacts and mental health functioning during a COVID-19 outbreak and lockdown: Data from a diverse New York City sample of college students	PLOS ONE			English	Article							DISORDER; PTSD	In March 2020, New York City (NYC) experienced an outbreak of coronavirus disease 2019 (COVID-19) which resulted in a 78-day mass confinement of all residents other than essential workers. The aims of the current study were to (1) document the breadth of COVID-19 experiences and their impacts on college students of a minority-serving academic institution in NYC; (2) explore associations between patterns of COVID-19 experiences and psychosocial functioning during the prolonged lockdown, and (3) explore sex and racial/ethnic differences in COVID-19-related experiences and mental health correlates. A total of 909 ethnically and racially diverse students completed an online survey in May 2020. Findings highlight significant impediments to multiple areas of students' daily life during this period (i.e., home life, work life, social environment, and emotional and physical health) and a vast majority reported heightened symptoms of depression and generalized anxiety. These life disruptions were significantly related to poorer mental health. Moreover, those who reported the loss of a close friend or loved one from COVID-19 (17%) experienced significantly more psychological distress than counterparts with other types of infection-related histories. Nonetheless, the majority (96%) reported at least one positive experience since the pandemic began. Our findings add to a growing understanding of COVID-19 impacts on psychological health and contribute the important perspective of the North American epicenter of the pandemic during the time frame of this investigation. We discuss how the results may inform best practices to support students' well-being and serve as a benchmark for future studies of US student populations facing COVID-19 and its aftermath.	[Lopez-Castro, Teresa; Anthonipillai, Nishanthi J.; Espinosa, Adriana; Melara, Robert] CUNY, Psychol Dept, New York, NY 10021 USA; [Brandt, Laura] Columbia Univ, New York State Psychiat Inst, Div Subst Use Disorders, Med Ctr, New York, NY USA; [Brandt, Laura] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA	City University of New York (CUNY) System; Columbia University; New York State Psychiatry Institute; Columbia University	Lopez-Castro, T (corresponding author), CUNY, Psychol Dept, New York, NY 10021 USA.	tlopezcastro@ccny.cuny.edu			New York State Office of Addiction Services and Supports; Erwin Schroedinger Fellowship by the Austrian Science Fund (ASF)	New York State Office of Addiction Services and Supports; Erwin Schroedinger Fellowship by the Austrian Science Fund (ASF)	Research supported by a grant from the New York State Office of Addiction Services and Supports (PI: RM). LB is funded by an Erwin Schroedinger Fellowship by the Austrian Science Fund (ASF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anduiza E, 2017, INT J PUBLIC OPIN R, V29, P497, DOI 10.1093/ijpor/edw007; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bernstein D, 2020, YALE J REGUL; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Castle J, 2003, J LOSS TRAUMA, V8, P41, DOI 10.1080/15325020305876; CCNY Office of Institutional Research, 2019, CITY FACTS FALL 2018; CCNY Office of Institutional Research, 2019, INSTITUTIONAL RES; Chetty R., 2017, NATL BUREAU EC RES W; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P751, DOI 10.15585/mmwr.mm6924e1; Diana C., 2020, EC IMPACT COVID 19 N; Frederiksen B, 2020, KFF CORONAVIRUS POLL; Goldstein RB, 2016, SOC PSYCH PSYCH EPID, V51, P1137, DOI 10.1007/s00127-016-1208-5; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Grasso D.J., 2020, PERSON CTR APPROACH, DOI 10.31234/osf.io/v36hj; Greaney M.L., 2020, IMPACT COVID 19 INFO; Gummer T, 2021, SOCIOL METHOD RES, V50, P238, DOI 10.1177/0049124118769083; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hamel Liz., 2020, KFF CORONAVIRUS POLL; Hasin DS, 2015, SOC PSYCH PSYCH EPID, V50, P1609, DOI 10.1007/s00127-015-1088-0; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Hupkau C., 2020, COVID 19 GENDER GAPS; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li YC, 2021, PSYCHOL MED, V51, P1952, DOI 10.1017/S0033291720001555; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Lobb EA, 2010, J HOSP PALLIAT NURS, V12, P225, DOI 10.1097/NJH.0b013e3181dceadc; Madhusoodanan J, 2020, SCIENCE, V369, P359, DOI 10.1126/science.369.6502.359; New York City Health Department, 2020, AGE ADJUSTED RATE FA; NYC Health, 2020, COVID 19 DATA; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Peng M, 2020, J AFFECT DISORDERS, V275, P119, DOI 10.1016/j.jad.2020.06.035; Pew Research Center, 2020, HALF LOWER INCOME AM; Prins A, 2016, J GEN INTERN MED, V31, P1206, DOI 10.1007/s11606-016-3703-5; Rodriguez-Rey R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01540; Shamon H, 2020, SURV RES METHODS-GER, V14, P54, DOI 10.18148/srm/2020.v14i1.7374; Shanahan L, 2022, PSYCHOL MED, V52, P824, DOI 10.1017/S003329172000241X; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Tang WJ, 2020, J AFFECT DISORDERS, V274, P1, DOI 10.1016/j.jad.2020.05.009; Tull MT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113098; UN Women, 2020, IPSOS SURVEY CONFIRM; Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874; Vinkers CH, 2020, EUR NEUROPSYCHOPHARM, V35, P12, DOI 10.1016/j.euroneuro.2020.05.003; Wang ZH, 2020, J AFFECT DISORDERS, V275, P188, DOI 10.1016/j.jad.2020.06.034; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Zhang SX, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112958; Zimet G, 2016, MULTIDIMENSIONAL SCA; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	54	24	24	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249768	10.1371/journal.pone.0249768	http://dx.doi.org/10.1371/journal.pone.0249768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RK2GO	33826654	Green Submitted, Green Published, gold			2022-12-26	WOS:000638119900003
J	Nam, BH; Kim, H; Seol, D; Kim, H; Noh, ES; Kim, EM; Noh, JK; Kim, YO; Park, JY; Kwak, W				Nam, Bo-Hye; Kim, Hyaekang; Seol, Donghyeok; Kim, Heebal; Noh, Eun Soo; Kim, Eun Mi; Noh, Jae Koo; Kim, Young-Ok; Park, Jung Youn; Kwak, Woori			Genotyping-by-Sequencing of the regional Pacific abalone (Haliotis discus) genomes reveals population structures and patterns of gene flow	PLOS ONE			English	Article							DEPTH PROTEOMIC ANALYSIS; MICROSATELLITE MARKERS; NATURAL-POPULATIONS; SEA-STAR; HANNAI; MOLLUSK; KOREA; MATRIX; WILD; CONNECTIVITY	Continuous monitoring of the present genetic status is essential to preserve the genetic resource of wild populations. In this study, we sequenced regional Pacific abalone Haliotis discus samples from three different locations around the Korean peninsula to assess population structure, utilizing Genotyping-by-Sequencing (GBS) method. Using PstI enzyme for genome reduction, we demonstrated the resultant library represented the whole genome region with even spacing, and as a result 16,603 single nucleotide variants (SNVs) were produced. Genetic diversity and population structure were investigated using several methods, and a strong genetic heterogeneity was observed in the Korean abalone populations. Additionally, by comparison of the variant sets among population groups, we were able to discover 26 Korean abalone population-specific SNVs, potentially associated with phenotype differences. This is the first study demonstrating the feasibility of GBS for population genetic study on H. discus. Our results will provide valuable data for the genetic conservation and management of wild abalone populations in Korea and help future GBS studies on the marine mollusks.	[Nam, Bo-Hye; Noh, Eun Soo; Kim, Eun Mi; Noh, Jae Koo; Kim, Young-Ok; Park, Jung Youn] Natl Inst Fisheries Sci, Biotechnol Res Div, Busan, South Korea; [Kim, Hyaekang; Seol, Donghyeok; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Hyaekang; Seol, Donghyeok; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Seol, Donghyeok; Kim, Heebal; Kwak, Woori] Genome Inc, Seoul, South Korea	National Institute of Fisheries Science; Seoul National University (SNU); Seoul National University (SNU)	Kwak, W (corresponding author), Genome Inc, Seoul, South Korea.	woori@hoonygen.com	Seol, Donghyeok/AAO-5117-2021; Kim, Heebal/A-8889-2016	Seol, Donghyeok/0000-0001-9695-5861; Kim, Heebal/0000-0003-3064-1303	National Institute of Fisheries Science [R2021041]; Collaborative Genome Program of the Korea Institute of Marine Science and Technology Promotion - Ministry of Oceans and Fisheries, Korea [20180430]	National Institute of Fisheries Science; Collaborative Genome Program of the Korea Institute of Marine Science and Technology Promotion - Ministry of Oceans and Fisheries, Korea	This research was supported by the National Institute of Fisheries Science (No. R2021041 to BHN) and the Collaborative Genome Program of the Korea Institute of Marine Science and Technology Promotion funded by the Ministry of Oceans and Fisheries (No. 20180430 to BHN), Korea. WK is affiliated with eGnome, a commercial company. eGnome had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; An HS, 2012, GENET MOL RES, V11, P3904, DOI 10.4238/2012.November.12.8; An HS, 2010, GENES GENOM, V32, P413, DOI 10.1007/s13258-010-0037-2; An HS, 2010, ANIM CELLS SYST, V14, P305, DOI 10.1080/19768354.2010.525813; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Azuma N, 2008, MAR BIOTECHNOL, V10, P39, DOI 10.1007/s10126-007-9033-1; Baus E, 2005, MOL ECOL, V14, P3373, DOI 10.1111/j.1365-294X.2005.02681.x; Nam BH, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix014; Carroll EL, 2018, EVOL APPL, V11, P1094, DOI 10.1111/eva.12600; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Choi J., 2018, EVALUATION TRADE N K; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Cook PA, 2010, J SHELLFISH RES, V29, P569, DOI 10.2983/035.029.0303; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Feng DD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45754; Fuentes-Pardo AP, 2017, MOL ECOL, V26, P5369, DOI 10.1111/mec.14264; Garke C, 2012, ANIM GENET, V43, P419, DOI 10.1111/j.1365-2052.2011.02284.x; Gonzalez R, 2014, J INVERTEBR PATHOL, V116, P13, DOI 10.1016/j.jip.2013.12.002; Gruenthal KM, 2014, CONSERV GENET, V15, P109, DOI 10.1007/s10592-013-0524-5; Gwak WS, 2011, FISHERIES SCI, V77, P945, DOI 10.1007/s12562-011-0403-2; Hara M., 1992, B TOHOKU NATL FISHER; Hara M, 2007, MAR BIOTECHNOL, V9, P74, DOI 10.1007/s10126-006-6060-2; Henriques R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087907; Herten K, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0514-3; Hsu TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179818; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kenchington EL, 2006, MOL ECOL, V15, P1781, DOI 10.1111/j.1365-294X.2006.02915.x; Khalkhali-Evrigh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204028; Kim WJ, 2010, J FISH BIOL, V76, P1958, DOI 10.1111/j.1095-8649.2010.02638.x; Kitamura A, 2001, PALAEOGEOGR PALAEOCL, V172, P81, DOI 10.1016/S0031-0182(01)00272-3; Korunes KL, 2021, MOL ECOL RESOUR, V21, P1359, DOI 10.1111/1755-0998.13326; Lafarga-De la Cruz F, 2013, AQUAC RES, V44, P1206, DOI 10.1111/j.1365-2109.2012.03121.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2011, FISH SHELLFISH IMMUN, V30, P480, DOI 10.1016/j.fsi.2010.11.014; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JQ, 2017, AQUACULTURE, V473, P110, DOI 10.1016/j.aquaculture.2017.01.034; Liao Z, 2015, J PROTEOMICS, V122, P26, DOI 10.1016/j.jprot.2015.03.027; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17269; Mardones A., 2013, LAT AM J AQUAT RES, V41; Marie B, 2013, FEBS J, V280, P214, DOI 10.1111/febs.12062; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller AD, 2013, ECOL EVOL, V3, P1248, DOI 10.1002/ece3.535; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Nie HT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00246-0; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Park Choul-Ji, 2013, Korean Journal of Malacology, V29, P335, DOI 10.9710/kjm.2013.29.4.335; Park CJ, 2012, BIOCHEM SYST ECOL, V44, P86, DOI 10.1016/j.bse.2012.04.006; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rebstock GA, 2003, PROG OCEANOGR, V59, P357, DOI 10.1016/j.pocean.2003.10.002; Sandoval-Castillo J, 2018, MOL ECOL, V27, P1603, DOI 10.1111/mec.14526; Scheben A, 2017, PLANT BIOTECHNOL J, V15, P149, DOI 10.1111/pbi.12645; Schilling MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095292; Sekino M, 2005, AQUACULTURE, V243, P33, DOI 10.1016/j.aquaculture.2004.10.013; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Sunde J, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00218; Symonds J, 2018, P WORLD C GEN APPL L; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Ward RD, 2001, MAR FRESHWATER RES, V52, P563, DOI 10.1071/MF99184; Waters JM, 2004, MOL ECOL, V13, P2797, DOI 10.1111/j.1365-294X.2004.02282.x; Yuewen D., 2007, ACTA OCEANOLOGICASIN; Zhan AB, 2009, MAR BIOTECHNOL, V11, P223, DOI 10.1007/s10126-008-9138-1; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	77	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0247815	10.1371/journal.pone.0247815	http://dx.doi.org/10.1371/journal.pone.0247815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826655	Green Published, gold			2022-12-26	WOS:000638119900041
J	Cardenas, RA; Gonzalez, R; Sanchez, E; Ramos, MA; Cardenas, EI; Rodarte, AI; Alcazar-Felix, RJ; Isaza, A; Burns, AR; Heidelberger, R; Adachi, R				Cardenas, Rodolfo A.; Gonzalez, Ricardo; Sanchez, Elizabeth; Ramos, Marco A.; Cardenas, Eduardo, I; Rodarte, Alejandro, I; Alcazar-Felix, Roberto J.; Isaza, Alejandro; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			SNAP23 is essential for platelet and mast cell development and required in connective tissue mast cells for anaphylaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITANCE MEASUREMENTS; DIFFERENTIAL EXPRESSION; REGULATED EXOCYTOSIS; W/WV MICE; MOUSE; SNARE; SNAP-23; GENE; DEFICIENT; SECRETION	Degranulation, a fundamental effector response from mast cells (MCs) and platelets, is an example of regulated exocytosis. This process is mediated by SNARE proteins and their regulators. We have previously shown that several of these proteins are essential for exocytosis in MCs and platelets. Here, we assessed the role of the SNARE protein SNAP23 using conditional knockout mice, in which SNAP23 was selectively deleted from either the megakaryocyte/platelet or connective tissue MC lineages. We found that removal of SNAP23 in platelets results in severe defects in degranulation of all three platelet secretory granule types, i.e., alpha, dense, and lysosomal granules. The mutation also induces thrombocytopenia, abnormal platelet morphology and activation, and reduction in the number of alpha granules. Therefore, the degranulation defect might not be secondary to an intrinsic failure of the machinery mediating regulated exocytosis in platelets. When we removed SNAP23 expression in MCs, there was a complete developmental failure in vitro and in vivo. The developmental defects in platelets and MCs and the abnormal translocation of membrane proteins to the surface of platelets indicate that SNAP23 is also involved in constitutive exocytosis in these cells. The MC conditional deletant animals lacked connective tissue MCs, but their mucosal MCs were normal and expanded in response to an antigenic stimulus. We used this mouse to show that connective tissue MCs are required and mucosal MCs are not sufficient for an anaphylactic response.	[Cardenas, Rodolfo A.; Sanchez, Elizabeth; Ramos, Marco A.; Cardenas, Eduardo, I; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Cardenas, Rodolfo A.; Rodarte, Alejandro, I; Alcazar-Felix, Roberto J.; Isaza, Alejandro] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico; [Gonzalez, Ricardo; Cardenas, Eduardo, I] Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey, Nuevo Leon, Mexico; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX USA; [Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Tecnologico de Monterrey; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	radachi@mdanderson.org		Alcazar-Felix, Roberto/0000-0003-1214-5576; Cardenas, Eduardo/0000-0001-5973-5675	National Institutes of Health [AI093533, AI137319, CA016672, EY007551]; Vale-Asche Foundation via the Frederic B. Asche Endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vale-Asche Foundation via the Frederic B. Asche Endowment	This project was supported by the National Institutes of Health AI093533, AI137319, CA016672, and EY007551 and the Vale-Asche Foundation via the Frederic B. Asche Endowment. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Agarwal V, 2019, BBA-MOL CELL RES, V1866, P1618, DOI 10.1016/j.bbamcr.2019.06.015; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Boschert U, 1996, J COMP NEUROL, V367, P177, DOI 10.1002/(SICI)1096-9861(19960401)367:2<177::AID-CNE2>3.0.CO;2-2; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Cardenas EI, 2019, J BIOL CHEM, V294, P4784, DOI 10.1074/jbc.RA118.006922; Cardenas EI, 2018, HAEMATOLOGICA, V103, P1235, DOI 10.3324/haematol.2017.185637; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Feng DR, 2018, J CLIN INVEST, V128, P3941, DOI 10.1172/JCI99217; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; French SL, 2018, PLATELETS, V29, P196, DOI 10.1080/09537104.2017.1349310; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gutierrez BA, 2018, J BIOL CHEM, V293, P7148, DOI 10.1074/jbc.RA118.002455; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Kadkova A, 2019, NEUROSCIENCE, V420, P50, DOI 10.1016/j.neuroscience.2018.09.020; Kerris EWJ, 2020, J INVEST MED, V68, P813, DOI 10.1136/jim-2019-001195; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; KITAMURA Y, 1978, BLOOD, V52, P447; Kitamura Y, 2007, P JPN ACAD B-PHYS, V83, P164, DOI 10.2183/pjab.83.164; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Kuster A, 2015, J BIOL CHEM, V290, P28056, DOI 10.1074/jbc.M115.666362; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu ZQ, 2016, AM J TRANSL RES, V8, P2317; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Mehlmann LM, 2019, BIOL REPROD, V101, P338, DOI 10.1093/biolre/ioz106; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Morgan A, 1995, ESSAYS BIOCHEM, V30, P77; Mouton PR, 2011, UNBIASED STEREOLOGY; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Naskar P, 2017, BIOL OPEN, V6, P1257, DOI 10.1242/bio.025791; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; Peschke K, 2015, METHODS MOL BIOL, V1220, P403, DOI 10.1007/978-1-4939-1568-2_25; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, P881, DOI 10.1016/j.jaci.2013.06.008; Ren BH, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150004; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Rizo J, 2018, PROTEIN SCI, V27, P1364, DOI 10.1002/pro.3445; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; ROTH D, 1994, FEBS LETT, V351, P207, DOI 10.1016/0014-5793(94)00833-7; SAGE SO, 1987, J BIOL CHEM, V262, P16364; Sanchez E, 2019, J BIOL CHEM, V294, P3012, DOI 10.1074/jbc.RA118.005532; SCHAEFFER J, 1989, CELL CALCIUM, V10, P101, DOI 10.1016/0143-4160(89)90050-X; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; SORENSEN FB, 1989, AM J DERMATOPATH, V11, P517, DOI 10.1097/00000372-198912000-00002; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; WARREN BA, 1971, BRIT J EXP PATHOL, V52, P378; Williams CM, 2018, BLOOD ADV, V2, P3627, DOI 10.1182/bloodadvances.2018023291; Wong PPC, 1997, BIOCHEM BIOPH RES CO, V230, P64, DOI 10.1006/bbrc.1996.5884; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108	72	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100268	10.1016/j.jbc.2021.100268	http://dx.doi.org/10.1016/j.jbc.2021.100268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837726	gold, Green Published			2022-12-26	WOS:000672866400244
J	Duran, EC; Walter, NG				Duran, Elizabeth C.; Walter, Nils G.			Sisyphus observed: Unraveling the high ATP usage of an RNA chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEAD-BOX PROTEIN; CYT-19; HELIX	DEAD-box proteins are nonprocessive RNA helicases that can function as RNA chaperones by coupling ATP binding and hydrolysis to structural reorganization of RNA. Here, Jarmoskaite et al. quantify the ATP utilization of an RNA chaperone during refolding of a misfolded ribozyme substrate. Strikingly, 100 ATP hydrolysis events are needed per successfully refolded ribozyme, suggesting that each round of unfolding requires ten ATP molecules, since 90% of substrate unfolding cycles only lead back to the kinetically favored misfolded state. This near-Sisyphean effort reveals a potentially conserved model for RNA reorganization by RNA chaperones.	[Duran, Elizabeth C.; Walter, Nils G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Duran, Elizabeth C.; Walter, Nils G.] Univ Michigan, Ctr RNA Biomed, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Walter, NG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Walter, NG (corresponding author), Univ Michigan, Ctr RNA Biomed, Ann Arbor, MI 48109 USA.	nwalter@umich.edu	Walter, Nils/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Duran, Elizabeth C./0000-0002-3988-5091	NIH [GM131922]; NIH IRACDA fellowship [K12 GM111725]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IRACDA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant GM131922 to N. G. W. and an NIH IRACDA fellowship on grant K12 GM111725 to E. C. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Gilman B, 2017, BIOCHEM SOC T, V45, P1313, DOI 10.1042/BST20170095; Henn A, 2012, ANNU REV BIOPHYS, V41, P247, DOI 10.1146/annurev-biophys-050511-102243; Jarmoskaite I., 2021, J BIOL CHEM, V296; Jarmoskaite I, 2014, P NATL ACAD SCI USA, V111, pE2928, DOI 10.1073/pnas.1404307111; Liu YC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0161-z; Mitchell D, 2013, J MOL BIOL, V425, P2670, DOI 10.1016/j.jmb.2013.05.008; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103	10	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100265	10.1016/j.jbc.2021.100265	http://dx.doi.org/10.1016/j.jbc.2021.100265			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837746	Green Published, gold			2022-12-26	WOS:000672866400241
J	Ghodke, PP; Mali, JR; Patra, A; Rizzo, CJ; Guengerich, FP; Egli, M				Ghodke, Pratibha P.; Mali, Jyotirling R.; Patra, Amritraj; Rizzo, Carmelo J.; Guengerich, F. Peter; Egli, Martin			Enzymatic bypass and the structural basis of miscoding opposite the DNA adduct 1,N-2-ethenodeoxyguanosine by human DNA translesion polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERROR-FREE BYPASS; Y-FAMILY; 1,N-2-ETHENOGUANINE; MECHANISM; SITE; 1,N2-ETHENODEOXYGUANOSINE; N2,3-ETHENOGUANINE; 1,N2-ETHENOGUANINE; OLIGONUCLEOTIDES; MISINCORPORATION	Etheno (epsilon)-adducts, e.g., 1,N-2-epsilon-guanine (1,N-2-epsilon-G) and 1,N-6-epsilon-adenine (1,N-6-epsilon-A), are formed through the reaction of DNA with metabolites of vinyl compounds or with lipid peroxidation products. These lesions are known to be mutagenic, but it is unknown how they lead to errors in DNA replication that are bypassed by DNA polymerases. Here we report the structural basis of misincorporation frequencies across from 1,N-2-epsilon-G by human DNA polymerase (hpol) eta. In single-nucleotide insertions opposite the adduct 1,N-2-epsilon-G, hpol. preferentially inserted dGTP, followed by dATP, dTTP, and dCTP. This preference for purines was also seen in the first extension step. Analysis of full-length extension products by LC-MS/MS revealed that G accounted for 85% of nucleotides inserted opposite 1,N-2-epsilon-G in single base insertion, and 63% of bases inserted in the first extension step. Extension from the correct nucleotide pair (C) was not observed, but the primer with A paired opposite 1,N-2-epsilon-G was readily extended. Crystal structures of ternary hpol. insertion-stage complexes with nonhydrolyzable nucleotides dAMPnPP or dCMPnPP showed a syn orientation of the adduct, with the incoming A staggered between adducted base and the 5'-adjacent T, while the incoming C and adducted base were roughly coplanar. The formation of a bifurcated H-bond between incoming dAMPnPP and 1,N-2-epsilon-G and T, compared with the single Hbond formed between incoming dCMPnPP and 1,N-2-epsilon-G, may account for the observed facilitated insertion of dGTP and dATP. Thus, preferential insertion of purines by hpol. across from etheno adducts contributes to distinct outcomes in errorprone DNA replication.	[Ghodke, Pratibha P.; Patra, Amritraj; Rizzo, Carmelo J.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Mali, Jyotirling R.; Rizzo, Carmelo J.] Vanderbilt Univ, Dept Chem, Coll Arts & Sci, Nashville, TN USA; [Rizzo, Carmelo J.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.; Egli, M (corresponding author), Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu		Ghodke, Pratibha P./0000-0002-8402-3933	National Institutes of Health [R01 ES026955, R01 ES010546, P01 CA160032]; Vanderbilt-Ingram Cancer Center [P30 CA-068485]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES026955 (to F. P. G. and M. E.), R01 ES010546 (to F. P. G.), P01 CA160032 (to M. E. and C. J. R.), and Vanderbilt-Ingram Cancer Center (P30 CA-068485). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akasaka S, 1999, CHEM RES TOXICOL, V12, P501, DOI 10.1021/tx980259j; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbin A, 2000, MUTAT RES, V462, P69; Bartsch H, 1997, EUR J CANCER PREV, V6, P529, DOI 10.1097/00008469-199712000-00007; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Chen HJC, 2005, CHEM RES TOXICOL, V18, P1593, DOI 10.1021/tx050145p; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Chowdhury Goutam, 2011, Curr Protoc Nucleic Acid Chem, VChapter 7, DOI 10.1002/0471142700.nc0716s47; Cruet-Hennequart S, 2010, SUBCELL BIOCHEM, V50, P189, DOI 10.1007/978-90-481-3471-7_10; Dechakhamphu S, 2008, CANCER EPIDEM BIOMAR, V17, P1658, DOI 10.1158/1055-9965.EPI-08-0191; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghodke PP, 2020, J BIOL CHEM, V295, P6092, DOI 10.1074/jbc.RA120.012829; Goodenough AK, 2005, CHEM RES TOXICOL, V18, P1701, DOI 10.1021/tx050141k; Guengerich F, 2018, MOL LIFE SCI ENCY RE, P379; Guengerich F. P, 2010, CHEM BIOL DNA DAMAGE, P299; GUENGERICH FP, 1993, CHEM RES TOXICOL, V6, P635, DOI 10.1021/tx00035a008; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; HECHT SS, 1992, CHEM RES TOXICOL, V5, P706, DOI 10.1021/tx00029a018; Jahnz-Wechmann Z, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00019; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KRONBERG L, 1992, CHEM RES TOXICOL, V5, P852, DOI 10.1021/tx00030a019; Langouet S, 1998, BIOCHEMISTRY-US, V37, P5184, DOI 10.1021/bi972327r; Langouet S, 1997, BIOCHEMISTRY-US, V36, P6069, DOI 10.1021/bi962526v; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; Linhart KB, 2015, HEPATOL SURG NUTR, V4, P117, DOI 10.3978/j.issn.2304-3881.2015.01.14; Morinello EJ, 2001, CHEM RES TOXICOL, V14, P327, DOI 10.1021/tx0002076; Nair J, 1999, MUTAT RES-FUND MOL M, V424, P59, DOI 10.1016/S0027-5107(99)00008-1; Njuma OJ, 2019, J BIOL CHEM, V294, P10253, DOI 10.1074/jbc.RA119.008986; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; OTlaherty D K., 2016, CHEM SCI, V7, p4896 ; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patra A, 2016, J BIOL CHEM, V291, P24304, DOI 10.1074/jbc.M116.755462; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2016, CHEMBIOCHEM, V17, P2033, DOI 10.1002/cbic.201600420; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Patra A, 2015, J AM CHEM SOC, V137, P7011, DOI 10.1021/jacs.5b02701; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Petrova KV, 2007, CHEM RES TOXICOL, V20, P1685, DOI 10.1021/tx7001433; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Saparbaev M, 2002, J BIOL CHEM, V277, P26987, DOI 10.1074/jbc.M111100200; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; Shanmugam G, 2007, CHEM RES TOXICOL, V20, P1601, DOI 10.1021/tx7001788; Singer B., 1999, EXOCYCLIC DNA ADDUCT; SODUM RS, 1988, CANCER RES, V48, P320; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; VanderVeen LA, 2005, BIOCHEMISTRY-US, V44, P5024, DOI 10.1021/bi0472898; Yang IY, 2003, J BIOL CHEM, V278, P13989, DOI 10.1074/jbc.M212535200; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	56	1	1	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100642	10.1016/j.jbc.2021.100642	http://dx.doi.org/10.1016/j.jbc.2021.100642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839151	Green Published, gold			2022-12-26	WOS:000672866400613
J	Krepl, M; Dendooven, T; Luisi, B; Sponer, J				Krepl, Miroslav; Dendooven, Tom; Luisi, Ben F.; Sponer, Jiri			MD simulations reveal the basis for dynamic assembly of Hfq-RNA complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; SIDE-CHAIN; STACKING; IDENTIFICATION; RECOGNITION; PARAMETERS; BACKBONE; NMR	The conserved protein Hfq is a key factor in the RNA-mediated control of gene expression in most known bacteria. The transient intermediates Hfq forms with RNA support intricate and robust regulatory networks. In Pseudomonas, Hfq recognizes repeats of adenine-purine-any nucleotide (ARN) in target mRNAs via its distal binding side, and together with the catabolite repression control (Crc) protein, assembles into a translation-repression complex. Earlier experiments yielded static, ensemble-averaged structures of the complex, but details of its interface dynamics and assembly pathway remained elusive. Using explicit solvent atomistic molecular dynamics simulations, we modeled the extensive dynamics of the Hfq-RNA interface and found implications for the assembly of the complex. We predict that syn/anti flips of the adenine nucleotides in each ARN repeat contribute to a dynamic recognition mechanism between the Hfq distal side and mRNA targets. We identify a previously unknown binding pocket that can accept any nucleotide and propose that it may serve as a 'status quo' staging point, providing nonspecific binding affinity, until Crc engages the Hfq-RNA binary complex. The dynamical components of the Hfq-RNA recognition can speed up screening of the pool of the surrounding RNAs, participate in rapid accommodation of the RNA on the protein surface, and facilitate competition among different RNAs. The register of Crc in the ternary assembly could be defined by the recognition of a guanine-specific base-phosphate interaction between the first and last ARN repeats of the bound RNA. This dynamic substrate recognition provides structural rationale for the stepwise assembly of multicomponent ribonucleoprotein complexes nucleated by Hfq-RNA binding.	[Krepl, Miroslav; Sponer, Jiri] Czech Acad Sci, Inst Biophys, Brno, Czech Republic; [Dendooven, Tom; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge, England; [Dendooven, Tom] MRC LMB, Cambridge, England	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Cambridge; MRC Laboratory Molecular Biology	Krepl, M (corresponding author), Czech Acad Sci, Inst Biophys, Brno, Czech Republic.	krepl@seznam.cz	Sponer, Jiri/D-9467-2012; Krepl, Miroslav/F-3868-2019	Dendooven, Tom/0000-0002-9847-0910; Sponer, Jiri/0000-0001-6558-6186; Krepl, Miroslav/0000-0002-9833-4281	Czech Science Foundation [20-16554S]; Praemium Academiae; AstraZeneca; Wellcome Trust [200873/Z/16/Z]	Czech Science Foundation(Grant Agency of the Czech Republic); Praemium Academiae(Czech Academy of Sciences); AstraZeneca(AstraZeneca); Wellcome Trust(Wellcome Trust)	This work was supported by the Czech Science Foundation [Grant number 20-16554S to M. K. and J. S.]; Praemium Academiae to J. S.; AstraZeneca studentship to T. D.; and Wellcome Trust Investigator award [Grant number 200873/Z/16/Z to B. F. L.].	Atakisi H, 2018, ACTA CRYSTALLOGR D, V74, P264, DOI 10.1107/S2059798318000207; Azam MS, 2018, NUCLEIC ACIDS RES, V46, P2585, DOI 10.1093/nar/gkx1286; Banas P, 2012, J CHEM THEORY COMPUT, V8, P2448, DOI 10.1021/ct3001238; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bergonzo C, 2015, RNA, V21, P1578, DOI 10.1261/rna.051102.115; Bergonzo C, 2014, J CHEM THEORY COMPUT, V10, P492, DOI 10.1021/ct400862k; Borisek J, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100633; Borkar AN, 2016, P NATL ACAD SCI USA, V113, P7171, DOI 10.1073/pnas.1521349113; Bottaro S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8521; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Campagne S, 2019, METHOD ENZYMOL, V614, P393, DOI 10.1016/bs.mie.2018.09.002; Casalino L, 2018, P NATL ACAD SCI USA, V115, P6584, DOI 10.1073/pnas.1802963115; Case I.Y.B-S.D.A, 2018, AMBER 18; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daubner GM, 2012, EMBO J, V31, P162, DOI 10.1038/emboj.2011.367; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Ganser LR, 2019, NAT REV MOL CELL BIO, V20, P474, DOI 10.1038/s41580-019-0136-0; Gorecka KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11900-8; Hoekzema M, 2019, EMBO J, V38, DOI 10.15252/embj.2018101199; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Horstmann N, 2012, NUCLEIC ACIDS RES, V40, P11023, DOI 10.1093/nar/gks809; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kligun E, 2015, RNA BIOL, V12, P720, DOI 10.1080/15476286.2015.1040977; Krepl M, 2015, J CHEM THEORY COMPUT, V11, P1220, DOI 10.1021/ct5008108; Krepl M, 2018, NUCLEIC ACIDS RES, V46, P6528, DOI 10.1093/nar/gky490; Krepl M, 2017, NUCLEIC ACIDS RES, V45, P8046, DOI 10.1093/nar/gkx418; Krepl M, 2016, NUCLEIC ACIDS RES, V44, P6452, DOI 10.1093/nar/gkw438; Kuhrova P, 2019, J CHEM THEORY COMPUT, V15, P3288, DOI 10.1021/acs.jctc.8b00955; Kuhrova P, 2016, J CHEM THEORY COMPUT, V12, P4534, DOI 10.1021/acs.jctc.6b00300; Kwiatkowska J, 2018, RNA, V24, P1761, DOI 10.1261/rna.067777.118; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mikulecky P.J., 2004, NAT STRUCT MOL BIOL, V11, P1206; Milojevic T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064609; Mlynsky V, 2020, J CHEM THEORY COMPUT, V16, P3936, DOI 10.1021/acs.jctc.0c00228; Nerenberg PS, 2018, CURR OPIN STRUC BIOL, V49, P129, DOI 10.1016/j.sbi.2018.02.002; Nikulin A, 2005, ACTA CRYSTALLOGR D, V61, P141, DOI 10.1107/S0907444904030008; Noel JK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004794; Palermo G, 2019, J STRUCT BIOL, V206, P267, DOI 10.1016/j.jsb.2019.03.004; Pei XY, 2019, ELIFE, V8, DOI 10.7554/eLife.43158; Richardson JS, 2008, RNA, V14, P465, DOI 10.1261/rna.657708; Ripin N, 2019, P NATL ACAD SCI USA, V116, P2935, DOI 10.1073/pnas.1808696116; Robinson KE, 2014, NUCLEIC ACIDS RES, V42, P2736, DOI 10.1093/nar/gkt1171; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santiago-Frangos A, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1475; Santiago-Frangos A, 2016, P NATL ACAD SCI USA, V113, pE6089, DOI 10.1073/pnas.1613053113; Schulz EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10085-8; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma I\, 2017, SCI REP, V7; Sharma M, 2019, NUCLEIC ACIDS RES, V47, P10564, DOI 10.1093/nar/gkz877; Sonnleitner E, 2018, NUCLEIC ACIDS RES, V46, P1470, DOI 10.1093/nar/gkx1245; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Sponer J, 2006, CHEM-EUR J, V12, P2854, DOI 10.1002/chem.200501239; Sponer J, 1996, J PHYS CHEM-US, V100, P5590, DOI 10.1021/jp953306e; Sponer J, 2008, PHYS CHEM CHEM PHYS, V10, P2595, DOI 10.1039/b719370j; Sponer J, 2018, CHEM REV, V118, P4177, DOI 10.1021/acs.chemrev.7b00427; Sponer J, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1405; Sponer J, 2013, BIOPOLYMERS, V99, P978, DOI 10.1002/bip.22322; Szabla R, 2016, J PHYS CHEM B, V120, P10635, DOI 10.1021/acs.jpcb.6b07551; Van den Bossche A, 2014, J PROTEOME RES, V13, P4446, DOI 10.1021/pr500796n; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wagner EGH, 2013, RNA BIOL, V10, P619, DOI 10.4161/rna.24044; Wang LJ, 2015, NUCLEIC ACIDS RES, V43, P2400, DOI 10.1093/nar/gkv072; Wen B, 2017, PHYS CHEM CHEM PHYS, V19, P21152, DOI 10.1039/c7cp01044c; Wlodawer A, 2008, FEBS J, V275, P1, DOI 10.1111/j.1742-4658.2007.06178.x; WOLFF JA, 1991, J BACTERIOL, V173, P4700, DOI 10.1128/jb.173.15.4700-4706.1991; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zirbel CL, 2009, NUCLEIC ACIDS RES, V37, P4898, DOI 10.1093/nar/gkp468	77	3	3	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100656	10.1016/j.jbc.2021.100656	http://dx.doi.org/10.1016/j.jbc.2021.100656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857481	Green Published, gold			2022-12-26	WOS:000672866400627
J	Mercaldi, GF; Andrade, MD; Zanella, JD; Cordeiro, AT; Benedetti, CE				Mercaldi, Gustavo Fernando; Andrade, Maxuel de Oliveira; Zanella, Jackeline de Lima; Cordeiro, Artur Torres; Benedetti, Celso Eduardo			Molecular basis for diaryldiamine selectivity and competition with tRNA in a type 2 methionyl-tRNA synthetase from a Gram-negative bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBACTERIAL ACTIVITY; ISOLEUCYL ADENYLATES; XANTHOMONAS-CITRI; ANTIFUNGAL AGENT; STRUCTURAL BASIS; INHIBITORS; ANALOGS; RECOGNITION; BINDING; AMINOACYLATION	Gram-negative bacteria are responsible for a variety of human, animal, and plant diseases. The spread of multidrug-resistant Gram-negative bacteria poses a challenge to disease control and highlights the need for novel antimicrobials. Owing to their critical role in protein synthesis, aminoacyl-tRNA synthetases, including the methionyl-tRNA synthetases MetRS1 and MetRS2, are attractive drug targets. MetRS1 has long been exploited as a drug target in Gram-positive bacteria and protozoan parasites. However, MetRS1 inhibitors have limited action upon Gram-negative pathogens or on Gram-positive bacteria that produce MetRS2 enzymes. The underlying mechanism by which MetRS2 enzymes are insensitive to MetRS1 inhibitors is presently unknown. Herein, we report the first structures of MetRS2 from a multidrug-resistant Gram-negative bacterium in its ligand-free state and bound to its substrate or MetRS1 inhibitors. The structures reveal the binding mode of two diaryldiamine MetRS1 inhibitors that occupy the amino acid-binding site and a surrounding auxiliary pocket implicated in tRNA acceptor arm binding. The structural features associated with amino acid polymorphisms found in the methionine and auxiliary pockets reveal the molecular basis for diaryldiamine binding and selectivity between MetRS1 and MetRS2 enzymes. Moreover, we show that mutations in key polymorphic residues in the methionine and auxiliary pockets not only altered inhibitor binding affinity but also significantly reduced enzyme function. Our findings thus reinforce the tRNA acceptor arm binding site as a druggable pocket in class I aminoacyl-tRNA synthetases and provide a structural basis for optimization of MetRS2 inhibitors for the development of new antimicrobials against Gram-negative pathogens.	[Mercaldi, Gustavo Fernando; Andrade, Maxuel de Oliveira; Zanella, Jackeline de Lima; Cordeiro, Artur Torres; Benedetti, Celso Eduardo] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil		Mercaldi, GF; Benedetti, CE (corresponding author), Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.	gustavo.mercaldi@lnbio.cnpem.br; celso.benedetti@lnbio.cnpem.br	Mercaldi, Gustavo Fernando/AGB-3253-2022	Mercaldi, Gustavo Fernando/0000-0003-1445-6060; cordeiro, artur/0000-0002-5676-2456	National Institutes of Health [R01NS118247, R21NS099654, R01CA177272]; National Science Foundation Graduate Research Fellowship [DGE-1762114]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This research was supported by the National Institutes of Health under grant nos. R01NS118247 (to D. L. S.), R21NS099654 (to D. L. S.), and R01CA177272 (to S. H. P.), and by a National Science Foundation Graduate Research Fellowship under grant no. DGE-1762114 (to I. I. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and National Science Foundation.	Abe VY, 2016, MOL PLANT PATHOL, V17, P1223, DOI 10.1111/mpp.12359; Baker SJ, 2006, J MED CHEM, V49, P4447, DOI 10.1021/jm0603724; Brown JR, 2003, EMBO REP, V4, P692, DOI 10.1038/sj.embor.embor881; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buckner FS, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02061-18; CASSIO D, 1971, EUR J BIOCHEM, V20, P283, DOI 10.1111/j.1432-1033.1971.tb01393.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho H.Y., 2017, 5GL7 PROT DAT BANK, V5GI, P7; Crepin T, 2004, BIOCHEMISTRY-US, V43, P2635, DOI 10.1021/bi0356247; Crepin T, 2003, J MOL BIOL, V332, P59, DOI 10.1016/S0022-2836(03)00917-3; Crepin T, 2002, BIOCHEMISTRY-US, V41, P13003, DOI 10.1021/bi026343m; Critchley IA, 2005, ANTIMICROB AGENTS CH, V49, P4247, DOI 10.1128/AAC.49.10.4247-4252.2005; Critchley IA, 2009, J ANTIMICROB CHEMOTH, V63, P954, DOI 10.1093/jac/dkp041; De Oliveira DMP, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00181-19; Devine WG, 2017, ACS INFECT DIS, V3, P225, DOI 10.1021/acsinfecdis.6b00202; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Faghih O, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00999-17; Fang PF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7402; First EA, 2017, METHODS, V113, P3, DOI 10.1016/j.ymeth.2016.10.010; First EA, 2015, ANAL BIOCHEM, V483, P34, DOI 10.1016/j.ab.2015.04.032; Gentry DR, 2003, ANTIMICROB AGENTS CH, V47, P1784, DOI 10.1128/AAC.47.6.1784-1789.2003; Gholami D, 2018, IRAN J FISH SCI, V17, P162; Gomez MAR, 2020, RNA, V26, P910, DOI 10.1261/rna.071720.119; Green LS, 2009, ANTIMICROB AGENTS CH, V53, P86, DOI 10.1128/AAC.00275-08; Huang WL, 2017, BIOORG MED CHEM LETT, V27, P2702, DOI 10.1016/j.bmcl.2017.04.048; Huang WL, 2016, EUR J MED CHEM, V124, P1081, DOI 10.1016/j.ejmech.2016.10.024; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Jarvest RL, 2004, BIOORG MED CHEM LETT, V14, P3937, DOI 10.1016/j.bmcl.2004.05.070; Jarvest RL, 2003, BIOORG MED CHEM LETT, V13, P1265, DOI 10.1016/S0960-894X(03)00093-3; Jarvest RL, 2003, BIOORG MED CHEM LETT, V13, P665, DOI 10.1016/S0960-894X(02)01027-2; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SE, 2005, BIOORG MED CHEM LETT, V15, P3389, DOI 10.1016/j.bmcl.2005.05.035; Koh C.Y., 2012, 4EGA PROT DAT BANK; Koh CY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002775; Koh CY, 2012, STRUCTURE, V20, P1681, DOI 10.1016/j.str.2012.07.011; KOZAK M, 1983, MICROBIOL REV, V47, P1; Lee J, 1998, BIOORG MED CHEM LETT, V8, P3511, DOI 10.1016/S0960-894X(98)00642-8; Lee J, 2003, BIOORG MED CHEM LETT, V13, P1087, DOI 10.1016/S0960-894X(03)00020-9; Lee J, 2001, BIOORG MED CHEM LETT, V11, P961, DOI 10.1016/S0960-894X(01)00095-6; Li X., 2015, 4QRD PROT DAT BANK; Lv PC, 2012, CURR MED CHEM, V19, P3550, DOI 10.2174/092986712801323199; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElwain TF, 2017, REV SCI TECH OIE, V36, P423, DOI 10.20506/rst.36.2.2663; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; MEINNEL T, 1988, NUCLEIC ACIDS RES, V16, P8095, DOI 10.1093/nar/16.16.8095; Michaels SA, 2020, J ANTIMICROB CHEMOTH, V75, P1218, DOI 10.1093/jac/dkz567; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Nakanishi K., 2005, 2CSX PROT DAT BANK; Nakanishi K., 2005, 2CT8 PROT DAT BANK, V2; Nayak SU, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02760-16; Nureki O., 2000, 1QQT PROT DAT BANK, V1QQT; Ochsner UA, 2005, ANTIMICROB AGENTS CH, V49, P4253, DOI 10.1128/AAC.49.10.4253-4262.2005; Ojo KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163641; Organization WH, 2017, PRIOR PATH GUID DISC; Palencia A., 2012, 4AQ7 PROT DAT BANK, V4A07; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Pham JS, 2014, INT J PARASITOL-DRUG, V4, P1, DOI 10.1016/j.ijpddr.2013.10.001; Ranade RM, 2015, ANTIMICROB AGENTS CH, V59, P7128, DOI 10.1128/AAC.01573-15; RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robies S, 2017, CURR DRUG DISCOV TEC, V14, P156; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Seattle Structural Genomics Center for Infectious Disease (SSGCID), 2016, 5K0S PROT DAT BANK; Serre L, 2001, J MOL BIOL, V306, P863, DOI 10.1006/jmbi.2001.4408; Shibata S, 2012, J MED CHEM, V55, P6342, DOI 10.1021/jm300303e; Shibata S, 2011, ANTIMICROB AGENTS CH, V55, P1982, DOI 10.1128/AAC.01796-10; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Timilsina S, 2020, NAT REV MICROBIOL, V18, P415, DOI 10.1038/s41579-020-0361-8; Torrie LS, 2017, ACS INFECT DIS, V3, P718, DOI 10.1021/acsinfecdis.7b00047; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Wang W, 2018, IUCRJ, V5, P478, DOI 10.1107/S2052252518008217; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhang Z, 2016, ACS INFECT DIS, V2, P399, DOI 10.1021/acsinfecdis.6b00036; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	86	3	3	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100658	10.1016/j.jbc.2021.100658	http://dx.doi.org/10.1016/j.jbc.2021.100658			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857480	gold, Green Published			2022-12-26	WOS:000672866400629
J	Oliveira, O; Gaio, R; Correia-Neves, M; Rito, T; Duarte, R				Oliveira, Olena; Gaio, Rita; Correia-Neves, Margarida; Rito, Teresa; Duarte, Raquel			Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000-2016	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; JOHANNESBURG; TB	Treatment of drug-resistant tuberculosis (TB), which is usually less successful than that of drug-susceptible TB, represents a challenge for TB control and elimination. We aimed to evaluate treatment outcomes and to identify the factors associated with death among patients with MDR and XDR-TB in Portugal. We assessed MDR-TB cases reported for the period 2000-2016, using the national TB Surveillance System. Treatment outcomes were defined according to WHO recommendations. We identified the factors associated with death using logistic regression. We evaluated treatment outcomes of 294 MDR- and 142 XDR-TB patients. The treatment success rate was 73.8% among MDR- and 62.7% among XDR-TB patients (p = 0.023). The case-fatality rate was 18.4% among MDR- and 23.9% among XDR-TB patients. HIV infection (OR 4.55; 95% CI 2.31-8.99; p < 0.001) and resistance to one or more second-line injectable drugs (OR 2.73; 95% CI 1.26-5.92; p = 0.011) were independently associated with death among MDR-TB patients. HIV infection, injectable drug use, past imprisonment, comorbidities, and alcohol abuse are conditions that were associated with death early on and during treatment. Early diagnosis of MDR-TB and further monitoring of these patients are necessary to improve treatment outcome.	[Oliveira, Olena; Correia-Neves, Margarida] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Oliveira, Olena; Correia-Neves, Margarida; Rito, Teresa] Univ Minho, PT Govt Associate Lab, ICVS 3B, Braga, Portugal; [Oliveira, Olena; Duarte, Raquel] Univ Porto, Inst Saude Publ, EPIUnit, Porto, Portugal; [Gaio, Rita] Univ Porto, Fac Sci, Dept Math, Porto, Portugal; [Gaio, Rita] Univ Porto, Ctr Math, Porto, Portugal; [Rito, Teresa] Univ Minho, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Duarte, Raquel] Univ Porto, Fac Med, Clin Epidemiol Predict Med & Publ Hlth Dept, Porto, Portugal; [Duarte, Raquel] Ctr Hosp Vila Nova De Gaia, Espinho EPE, Pulmonol Unit, Vila Nova De Gaia, Portugal	Universidade do Minho; Universidade do Minho; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Minho; Universidade do Porto	Oliveira, O (corresponding author), Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.; Oliveira, O (corresponding author), Univ Minho, PT Govt Associate Lab, ICVS 3B, Braga, Portugal.; Oliveira, O (corresponding author), Univ Porto, Inst Saude Publ, EPIUnit, Porto, Portugal.	id7080@alunos.uminho.pt	Rito, Teresa/AAC-9041-2019; Correia-Neves, Margarida/AAH-4636-2020	Rito, Teresa/0000-0002-8374-6347; Correia-Neves, Margarida/0000-0002-2202-5431; Duarte, Raquel/0000-0003-2257-3099	Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER) [NORTE-01-0145-FEDER-000013, NORTE-01-0145-FEDER-000023]; FCT Foundation for Science and Technology, I.P. [UIDB/50026/2020, UIDB/04050/2020]; Operational Program NORTE 2020 [NORTE-08-5369-FSE-000041]; European Social Fund [UMINHO/BD/47/2016]; FCT, I.P. [UIDB/04750/2020];  [PTDC/SAU-PUB/29521/2017]	Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER); FCT Foundation for Science and Technology, I.P.(Portuguese Foundation for Science and Technology); Operational Program NORTE 2020; European Social Fund(European Social Fund (ESF)); FCT, I.P.(Portuguese Foundation for Science and Technology); 	This work was developed under the scope of the project NORTE-01-0145-FEDER-000013 and NORTE-01-0145-FEDER-000023, supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER) and projects PTDC/SAU-PUB/29521/2017. This work was partially supported by "Contratos-Programa" UIDB/50026/2020 and UIDB/04050/2020 funded by national funds through the FCT Foundation for Science and Technology, I.P. OO is supported by the project NORTE-08-5369-FSE-000041, financed by the Operational Program NORTE 2020 and co-financed by the European Social Fund through a doctoral grant (UMINHO/BD/47/2016). This work was also supported by national funds through the FCT, I.P., under the project UIDB/04750/2020.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Alene KA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2662-8; ARS LVT, 2013, PLAN REG SAUD 2013 2; Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016; Bhering M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218299; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; ECD/WHO, 2020, TUB SURV MON EUR 202; Falzon D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02308-2016; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; Khan I, 2019, J INFECT PUBLIC HEAL, V12, P809, DOI 10.1016/j.jiph.2019.04.009; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2020, INT J INFECT DIS, V92, pS15, DOI 10.1016/j.ijid.2020.01.042; Mollel EW, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/9241238; Nkurunziza J, 2018, INT J TUBERC LUNG D, V22, P1469, DOI 10.5588/ijtld.18.0205; Oliveira O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73759-w; Oliveira O, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4189-7; Oliveira O, 2013, EUR RESPIR J, V42, P1747, DOI 10.1183/09031936.00197912; Pradipta IS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0561-z; Riccardi N, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4211-0; Samuels JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23344-z; Suryawanshi SL, 2017, PUBLIC HEALTH ACTION, V7, P116, DOI 10.5588/pha.17.0013; Umanah T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1214-3; WHO, 2019, GLOB TUB REP; WHO, 2015, TUB ACT PLAN WHO EUR; WHO, 2013, BEST PRACT PREV CONT; WHO, 2011, GUID PROGR MAN DRUG; WHO, 2019, COMP GOOD PRACT IMPL; World Health Organization, 2006, WHOHTM2006361	29	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2021	16	4							e0250028	10.1371/journal.pone.0250028	http://dx.doi.org/10.1371/journal.pone.0250028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RQ1EM	33878119	Green Published, gold			2022-12-26	WOS:000642162200013
J	Widdows, K; Roberts, SA; Camacho, EM; Heazell, AEP				Widdows, Kate; Roberts, Stephen A.; Camacho, Elizabeth M.; Heazell, Alexander E. P.			Stillbirth rates, service outcomes and costs of implementing NHS England's Saving Babies' Lives care bundle in maternity units in England: A cohort study	PLOS ONE			English	Article							RISK-FACTORS; HEALTH-CARE	Objective To assess implementation of the Saving Babies Lives (SBL) Care Bundle, a collection of practice recommendations in four key areas, to reduce stillbirth in England. Design A retrospective cohort study of 463,630 births in 19 NHS Trusts in England using routinely collected electronic data supplemented with case note audit (n = 1,658), and surveys of service users (n = 2,085) and health care professionals (n = 1,064). The primary outcome was stillbirth rate. Outcome rates two years before and after the nominal SBL implementation date were derived as a measure of change over the implementation period. Data were collected on secondary outcomes and process outcomes which reflected implementation of the SBL care bundle. Results The total stillbirth rate, declined from 4.2 to 3.4 per 1,000 births between the two time points (adjusted Relative Risk (aRR) 0.80, 95% Confidence Interval (95% CI) 0.70 to 0.91, P<0.001). There was a contemporaneous increase in induction of labour (aRR 1.20 (95%CI 1.18-1.21), p<0.001) and emergency Caesarean section (aRR 1.10 (95%CI 1.07-1.12), p<0.001). The number of ultrasound scans performed (aRR 1.25 (95%CI 1.21-1.28), p<0.001) and the proportion of small for gestational age infants detected (aRR 1.59 (95%CI 1.32-1.92), p<0.001) also increased. Organisations reporting higher levels of implementation had improvements in process measures in all elements of the care bundle. An economic analysis estimated the cost of implementing the care bundle at similar to 140 pound per birth. However, neither the costs nor changes in outcomes could be definitively attributed to implementation of the SBL care bundle. Conclusions Implementation of the SBL care bundle increased over time in the majority of sites. Implementation was associated with improvements in process outcomes. The reduction in stillbirth rates in participating sites exceeded that reported nationally in the same timeframe. The intervention should be refined to identify women who are most likely to benefit and minimise unwarranted intervention.	[Widdows, Kate; Heazell, Alexander E. P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Med Sci,Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Roberts, Stephen A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Biostat, Sch Hlth Sci, Manchester, Lancs, England; [Camacho, Elizabeth M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Ctr Hlth Econ, Sch Hlth Sci, Manchester, Lancs, England; [Heazell, Alexander E. P.] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Heazell, AEP (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Med Sci,Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.; Heazell, AEP (corresponding author), Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England.	alexander.heazell@manchester.ac.uk		Heazell, Alexander/0000-0002-4303-7845	NHS England	NHS England	AH, EC and SR recieved funding for this work from NHS England. NHS England approved the research protocol but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, 8 MAT CHILD HLTH RES; Campbell HE, 2018, BJOG-INT J OBSTET GY, V125, P108, DOI 10.1111/1471-0528.14972; Curtis L, 2016, UNIT COSTS HLTH SOCI; Draper E.S., 2017, MBRRACE UK PERINATAL; Draper E.S., 2018, UK PERINATAL DEATHS; Draper ES, 2015, MBRRACE UK PERINATAL; East of England Neonatal Network, 2015, NECR ENT CAR BUNDL L; England NHS., 2016, SAV BAB LIV CAR BUND; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Harper G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017898; Health D.o, 2016, NAT SCHED REF COSTS; Heazell A.E, 2017, GOING SLEEP SU UNPUB; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Higgins LE, 2018, PAEDIATR PERINAT EP, V32, P474, DOI 10.1111/ppe.12501; Lau YZ, 2020, BMJ OPEN QUAL, V9, DOI 10.1136/bmjoq-2019-000756; Liberati EG, 2019, SOC SCI MED, V223, P64, DOI 10.1016/j.socscimed.2019.01.035; Manktelow BM, 2015, PERINATAL MORTALITY; Manktelow BN, 2016, PERINATAL MORTALITY; Mistry H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-236; National Institute for Health and Care Excellence, 2011, CAES SECT CG162; Norman JE, 2018, LANCET, V392, P1629, DOI 10.1016/S0140-6736(18)31543-5; Office for National Statistics, 2018, BIRTHS ENGL WAL SUMM; Office of National Statistics, 2017, BIRTHS DEATHS ENGL W; RCore Team, 2020, R LANG ENV STAT COMP; Vieira MC, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3242-6; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Widdows K, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1672-x	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0250150	10.1371/journal.pone.0250150	http://dx.doi.org/10.1371/journal.pone.0250150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP4TZ	33872334	Green Published, gold			2022-12-26	WOS:000641723300009
J	Saah, FI; Amu, H; Kissah-Korsah, K				Saah, Farrukh Ishaque; Amu, Hubert; Kissah-Korsah, Kwaku			Prevalence and predictors of work-related depression, anxiety, and stress among waiters: A cross-sectional study in upscale restaurants	PLOS ONE			English	Article							MENTAL-HEALTH; CANNABIS USE; POPULATION; DISORDERS; EMPLOYEES; PERSONALITY; ASSOCIATION; WORKPLACE	Background Poor mental health often interrupts people's regular activities making them unable to work effectively resulting in poor performance and high turnover intention. We examined the prevalence and predictors of depression, anxiety and stress among waiters in upscale restaurants. Methods This descriptive cross-sectional study involved 384 waiters in upscale restaurants in the Accra Metropolis. Data were collected using a pre-tested questionnaire which embedded DASS-21 (Cronbach Alpha = 0.815). The analysis included descriptive and inferential statistics using STATA 15. Statistical significance was set at p-value Results The prevalence of depression was 38.3%, while anxiety and stress were 52.3% and 34.4% respectively. Females (AOR = 1.69, 95%CI = 1.02-2.79), waiters who foresee a better remuneration (AOR = 3.09, 95%CI = 1.95-4.87), consume caffeine (AOR = 1.44, 95%CI = 0.90-2.32), and use non-prescription drugs (AOR = 2.22, 95%CI = 1.39-3.55) were more likely to have depression. Females (AOR = 1.86, 95%CI = 1.17-2.96), those who foresee better remuneration (AOR = 2.85, 95%CI = 1.82-4.49), and those who use non-prescription drugs (AOR = 2.13, 95%CI = 1.38-3.28) were more likely to have anxiety. Females (AOR = 1.74, 95%CI = 1.01-2.99), waiters who are positive of career success (AOR = 1.70, 95%CI = 0.99-2.91), who foresee better remuneration (AOR = 2.99, 95%CI = 1.85-4.83), consume caffeine (AOR = 1.54, 95%CI = 0.93-2.54), and who use non-prescription drugs (AOR = 3.16, 95%CI = 1.93-5.17) were more likely to be stressed. Conclusion There is a high prevalence of poor mental health among waiters. Urgent intervention by hospitality stakeholders is needed to improve their working conditions and psychosocial health to accelerate progress towards the Sustainable Development Goal of promoting mental health and wellbeing.	[Saah, Farrukh Ishaque] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana; [Amu, Hubert] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Hohoe, Ghana; [Kissah-Korsah, Kwaku] Univ Cape Coast, Sch Publ Hlth, Dept Populat & Hlth, Cape Coast, Ghana	University of Cape Coast	Saah, FI (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana.	fsaahpnur14@uhas.edu.gh	Amu, Hubert/H-9446-2019	Amu, Hubert/0000-0003-0218-3843; Saah, Farrukh Ishaque/0000-0001-8395-8369				Amoako G.K., 2012, AFRICAN J MARKETING, V4, P17, DOI [DOI 10.5897/AJMM11.104, 10.5897/AJMM11.104]; [Anonymous], 2010, AGR CONSUMER PROTECT; [Anonymous], 2005, WELLNESS WORK PROTEC; [Anonymous], 2010, DEV CHALLENGES HOSPI; [Anonymous], 2009, INT J STRESS MANAG, DOI DOI 10.1037/A0015710; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Asimah VK., 2018, African Journal of Hospitality, Tourism and Leisure, V7; Belhassen Y, 2013, TOURISM MANAGE, V34, P47, DOI 10.1016/j.tourman.2012.03.008; Blackmore ER, 2007, AM J PUBLIC HEALTH, V97, P2088, DOI 10.2105/AJPH.2006.104406; Blanco C, 2016, JAMA PSYCHIAT, V73, P388, DOI 10.1001/jamapsychiatry.2015.3229; Brook JS, 2016, ADDICT BEHAV, V62, P114, DOI 10.1016/j.addbeh.2016.06.003; Bush D., 2015, CBHSQ REPORT SUBSTAN; Cochran WG., 1963, SAMPLING TECHNIQUES; Constanti P, 2005, SERV IND J, V25, P103, DOI 10.1080/0264206042000302432; Dunnagan T, 2001, J OCCUP ENVIRON MED, V43, P1073; Farfan G, 2017, FOOD POLICY, V72, P146, DOI 10.1016/j.foodpol.2017.08.020; Feingold D, 2016, EUR NEUROPSYCHOPHARM, V26, P493, DOI 10.1016/j.euroneuro.2015.12.037; Fisk K, 2017, GOVERNANCE, V30, P263, DOI 10.1111/gove.12208; Food and Agricultural Organization of the United Nations (FAO), 2016, STREET FOOD URBAN GH; Ghana Statistical Services, 2014, 2010 POP HOUS CENS D; Gilmour H., 2007, PSYCHIAT GENET, V77, P2; Givens JL, 2007, GEN HOSP PSYCHIAT, V29, P182, DOI 10.1016/j.genhosppsych.2006.11.002; Gopalkrishnan N., 2014, SOCIAL WORK PRACTICE, P273; Gopalkrishnan N, 2015, AUSTRALAS PSYCHIATRY, V23, P6, DOI 10.1177/1039856215609769; Hammami Mohammad Bakri Alaa, 2018, Journal of Caffeine and Adenosine Research, V8, P71, DOI 10.1089/caff.2017.0034; Hochschild AR, 2012, MANAGED HEART: COMMERCIALIZATION OF HUMAN FEELING, P1; Jiloha RC., 2019, MILITARY MED RES, V2, P24; Kedzior KK, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-136; Kumar S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224122; Lerner D, 2004, PSYCHIAT SERV, V55, P1371, DOI 10.1176/appi.ps.55.12.1371; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Maideen SFK, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0648-x; McAlpine K. E., 2020, INT J MOL SCI, V101; McDaid D, 2005, INT REV PSYCHIATR, V17, P365, DOI 10.1080/09540260500238397; McLellan TM, 2019, NUTR NEUROSCI, V22, P768, DOI 10.1080/1028415X.2018.1443996; Mkono M, 2011, TOUR ANAL, V16, P361, DOI 10.3727/108354211X13110944387329; Nkansah-Amankra Stephen, 2016, Prev Med Rep, V4, P134, DOI 10.1016/j.pmedr.2016.05.003; Nurminen M, 2007, GUEST EXPERIENCE DES; Osborn D., 2015, UNIVERSAL SUSTAINABL; Packer S., 2010, SUPERHEROES SUPEREGO; Perera CK, 2018, PSYCHOL STUD, V63, P187, DOI 10.1007/s12646-018-0454-x; Redekopp DE, 2019, BRIT J GUID COUNS, V47, P246, DOI 10.1080/03069885.2018.1513451; RitchieH Roser M., 2018, MENTAL HLTH; Ruzungunde VS., 2016, INT BUSINESS EC RES, V15, P219; Setia MS, 2016, INDIAN J DERMATOL, V61, P261, DOI 10.4103/0019-5154.182410; Shani A, 2009, CORNELL HOSP Q, V50, P446, DOI 10.1177/1938965509344294; Sipsma H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-288; Storm-Pallesen E., 2007, WORK RELATED STRESS; Trivellas P, 2013, PROCD SOC BEHV, V73, P718, DOI 10.1016/j.sbspro.2013.02.110; Vearing A, 2007, PERS INDIV DIFFER, V43, P1744, DOI 10.1016/j.paid.2007.05.011; Wadud S., 2013, CUSTOMER SATISFACTIO; WHO, 2017, DEPR OTH COMM MENT D; Wilson J., 2014, ESSENT BUS RES, V2nd; Wirtz J., 2017, ESSENTIALS SERVICES; World Health Organization, 2016, SUSTAINABLE DEV GOAL; Yahaya SN, 2018, WORLD J EMERG MED, V9, P178, DOI 10.5847/wjem.j.1920-8642.2018.03.003; Yusoff MSB, 2013, ASIAN J PSYCHIATR, V6, P128, DOI 10.1016/j.ajp.2012.09.012	57	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249597	10.1371/journal.pone.0249597	http://dx.doi.org/10.1371/journal.pone.0249597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857194	Green Published, gold			2022-12-26	WOS:000641474900064
J	Tontini, JF; Poli, CHEC; Hampel, VD; Farias, MD; Fajardo, NM; da Silva, JA; Farinatti, LHE; Muir, JP				Tontini, Jalise Fabiola; Espirito Candal Poli, Cesar Henrique; Hampel, Viviane da Silva; Farias, Mariana de Souza; Fajardo, Neuza Maria; da Silva, Joseane Anjos; Ebling Farinatti, Luis Henrique; Muir, James Pierre			Influence of tropical upright pasture structural and chemical characteristics on lamb grazing time	PLOS ONE			English	Article							INGESTIVE BEHAVIOR; ENERGY-EXPENDITURE; FEEDING-BEHAVIOR; RUMINANTS; SHEEP; MATURITY; SYSTEM; EXPERIENCE; QUALITY; PANICUM	Tropical pasture canopy characteristics can alter lamb ingestive behavior. Our study evaluated the ingestive behavior of young lambs in different tropical pastures to identify which variables interfere in their grazing activity. Two years of study were carried out with 54 weaned lambs distributed in three different pasture canopies: 1) monoculture of an upright grass, guinea grass (Panicum maximum; GG); 2) monoculture of a shrubby legume pigeon pea (Cajanus cajan; PP) and 3) contiguous paddock with half GG and half PP (GP). The experiment was set out in a randomized complete block design (3 blocks). Lamb ingestive behavior was observed from sunrise to sunset with records every 5 minutes. To identify the main variables that affected lamb grazing activity, a multivariate analysis of the Decision Tree was performed. Our results showed that there was no difference in the ingestive behavior parameters of young lambs in different canopies (P > 0.05). There was interaction among the canopies and the experimental periods for the variables idleness time and biting rate (P <= 0.05). Lambs in all canopies showed more idleness time in the first evaluation period. Lambs in canopies containing grass (GG and GP) exhibited greater bites per minute throughout the experimental period. Lamb grazing time increased 40% as experimental period progressed and plants matured. The Decision Tree identified leaf:stem ratio as the variable that most influenced lamb grazing time in GG and GP canopies while in the PP, grazing time was directly related to canopy height. The behavior of young lambs on tropical pasture is variable as there is a change in the behavioral response to canopy characteristics over time. In addition, the grazing time of these animals can be estimated by means of variables related to canopy structural characteristics (leaf:stem ratio and height) together with chemical variables.	[Tontini, Jalise Fabiola; Espirito Candal Poli, Cesar Henrique; Hampel, Viviane da Silva; Farias, Mariana de Souza; Fajardo, Neuza Maria; da Silva, Joseane Anjos] Univ Fed Rio Grande do Sul, Dept Anim Sci, Porto Alegre, RS, Brazil; [Ebling Farinatti, Luis Henrique] Univ Fed Acre, Dept Anim Sci, Cruzeiro Do Sul, Acre, Brazil; [Muir, James Pierre] Texas A&M Univ, Texas A&M AgriLife Res, Stephenville, TX USA	Universidade Federal do Rio Grande do Sul; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Poli, CHEC (corresponding author), Univ Fed Rio Grande do Sul, Dept Anim Sci, Porto Alegre, RS, Brazil.	cesar.poli@ufrgs.br	Tontini, Jalise/AAN-1157-2020; Poli, Cesar/AAH-9505-2020	Tontini, Jalise/0000-0002-1549-562X; Poli, Cesar/0000-0002-8469-0779	National Council for Scientific and Technological Development (CNPq) of Brazil; Coordination for the Improvement of Higher Education Personnel (CAPES) of Brazil	National Council for Scientific and Technological Development (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES) of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from the National Council for Scientific and Technological Development (CNPq) of Brazil, and by Coordination for the Improvement of Higher Education Personnel (CAPES) of Brazil.	Alcok M. M., 1986, HFRO HILL FARMING RE, P29; Amaral Daniele Francine, 2009, Acta Scientiarum Animal Sciences, V31, P403, DOI 10.4025/actascianimsci.v31i4.4920; Animut G, 2005, SMALL RUMINANT RES, V59, P191, DOI 10.1016/j.smallrumres.2005.05.014; AOAC, 1995, OFF METH AN AOAC INT; Arthington JD, 2005, J ANIM SCI, V83, P1726; Baumont R, 2004, ANIM FEED SCI TECH, V112, P5, DOI 10.1016/j.anifeedsci.2003.10.005; Baumont R, 2000, LIVEST PROD SCI, V64, P15, DOI 10.1016/S0301-6226(00)00172-X; Boval M, 2019, ANIM FEED SCI TECH, V251, P96, DOI 10.1016/j.anifeedsci.2019.03.002; Brosh A, 2006, J ANIM SCI, V84, P1951, DOI 10.2527/jas.2005-315; Carvalho P., 2001, AN 38 REUN AN SOC BR, V1, P853; Carvalho PCF, 2015, ANIM PROD SCI, V55, P319, DOI 10.1071/AN14546; Carvalho PCF, 1999, INT S NUTR HERB SAN, P5; Castro-Montoya JM, 2020, ANIM FEED SCI TECH, V269, DOI 10.1016/j.anifeedsci.2020.114641; Catanese F, 2016, BEHAV PROCESS, V126, P12, DOI 10.1016/j.beproc.2016.02.015; Chapman D. F., 1993, Grasslands for our world., P55; da Silva JA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00643; da Silva SC, 2005, 20 INT GRASSL C GRAS; Silva LFD, 2016, BIOSCI J, V32, P1018; Neto JVE, 2018, S AFR J ANIM SCI, V48, P1073, DOI 10.4314/sajas.v48i6.10; Espirito Candal Poli Cesar Henrique, 2009, Acta Scientiarum Animal Sciences, V31, P235, DOI 10.4025/actascianimsci.v31i3.6014; Euclides VPB., 1991, REUNIAO AN SOC BRASI, V28, P141; Fajardo NM, 2016, ANIM PROD SCI, V56, P1693, DOI 10.1071/AN14698; FLORES ER, 1989, APPL ANIM BEHAV SCI, V23, P279, DOI 10.1016/0168-1591(89)90096-8; FORBES TDA, 1985, GRASS FORAGE SCI, V40, P69, DOI 10.1111/j.1365-2494.1985.tb01721.x; Ginane C, 2015, ANIM PROD SCI, V55, P247, DOI 10.1071/AN14481; Goering HK., 1970, FORAGE FIBER ANAL AP, P10; Goncalves RP, 2018, LIVEST SCI, V214, P202, DOI 10.1016/j.livsci.2018.06.005; GRAHAM NM, 1964, AUST J AGR RES, V15, P969; Hirata M, 2010, J ETHOL, V28, P95, DOI 10.1007/s10164-009-0160-1; Hodgson J., 1990, Grazing management. Science into practice.; Jamieson WS., 1979, GRASS FORAGE SCI, V34, P69, DOI [10.1111/j.1365-2494.1979.tb01478.x, DOI 10.1111/J.1365-2494.1979.TB01478.X]; Jochims F, 2010, REV BRAS ZOOTECN, V39, P572, DOI 10.1590/S1516-35982010000300017; Johnson A.D., 1978, MEASUREMENT GRASSLAN, P96; KILCHER MR, 1981, J RANGE MANAGE, V34, P363, DOI 10.2307/3897904; Miwa M, 2017, J ANIM SCI, V95, P901, DOI 10.2527/jas.2016.0749; Moquin P, 2010, ANIM BEHAV, V79, P1047, DOI 10.1016/j.anbehav.2010.01.020; Mott G. O., 1952, P 11 INT GRASSL C PE, V6, P1380, DOI DOI 10.1055/S-2008-1040325; Nabinger C., 2002, GRASSLAND ECOPHYSIOL, P151; NEWMAN JA, 1994, ANIM BEHAV, V47, P185, DOI 10.1006/anbe.1994.1021; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; OSUJI PO, 1974, J RANGE MANAGE, V27, P437, DOI 10.2307/3896717; Pereira VV., 2013, REV AGRONEG MEIO AMB, V6, P289; Phelan P, 2015, CRIT REV PLANT SCI, V34, P281, DOI 10.1080/07352689.2014.898455; Poli CHEC, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00543; Poppi DP., 1983, LAMB GROWTH, P29; Provenza FD, 2007, CROP SCI, V47, P382, DOI 10.2135/cropsci2006.02.0083; Rambau MD, 2016, S AFR J ANIM SCI, V46, P398, DOI 10.4314/sajas.v46i4.8; Rattray PV, 1987, LIVESTOCK FEEDING PA, P89; Relling EA, 2001, S AFR J ANIM SCI, V31, P85; Sbrissia AF., 2001, REUN AN SOC BRAS ZOO, V38, P731; Silva D.J., 2002, ANALISE ALIMENTOS ME, V3rd; Simioni TA., 2014, PUBVET PUB MED VET Z, V39, P1; SNIFFEN CJ, 1992, J ANIM SCI, V70, P3562, DOI 10.2527/1992.70113562x; Sollenberger LE, 2005, CROP SCI, V45, P896, DOI 10.2135/cropsci2004.0216; Sollenberger LE, 2001, PROCEEDINGS OF THE XIX INTERNATIONAL GRASSLAND CONGRESS, P321; STOBBS TH, 1973, AUST J AGR RES, V24, P821, DOI 10.1071/AR9730821; Tontini JF, 2019, AFR J RANGE FOR SCI, V36, P181, DOI 10.2989/10220119.2019.1679883; Tontini JF, 2019, SMALL RUMINANT RES, V174, P62, DOI 10.1016/j.smallrumres.2019.03.013; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Villalba JJ, 2010, J ANIM SCI, V88, P2189, DOI 10.2527/jas.2009-2272; Wade M. H., 2000, Grassland ecophysiology and grazing ecology, P233, DOI 10.1079/9780851994529.0233; Waghorn GC, 2004, NEW ZEAL VET J, V52, P320, DOI 10.1080/00480169.2004.36448; Wang MY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206664; WELCH JG, 1969, J ANIM SCI, V28, P813, DOI 10.2527/jas1969.286813x; Wollmann CA., 2012, REV BRAS CLIMATOL, V8, P87; Zhang F, 2014, ANIM BEHAV, V88, P13, DOI 10.1016/j.anbehav.2013.11.002	67	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0242642	10.1371/journal.pone.0242642	http://dx.doi.org/10.1371/journal.pone.0242642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857140	gold, Green Published			2022-12-26	WOS:000641474900116
J	Kovacevic, G; Milosevic, V; Nikolic, N; Patic, A; Dopudj, N; Radovanov, J; Cvjetkovic, IH; Petrovic, V; Petrovic, M				Kovacevic, Gordana; Milosevic, Vesna; Nikolic, Natasa; Patic, Aleksandra; Dopudj, Nela; Radovanov, Jelena; Cvjetkovic, Ivana Hrnjakovic; Petrovic, Vladimir; Petrovic, Milena			The prevalence of 30 HPV genotypes detected by EUROArray HPV in cervical samples among unvaccinated women from Vojvodina province, Serbia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; AGE; CARCINOMA	This study evaluates the pre-vaccination prevalence of HPV infection in women from Vojvodina, Serbia, according to age and cytological status. A total of 1,495 women, ranging from 18 to 65 years of age, with different cytological results were enrolled. The HPV genotyping assay was performed using the EUROArray HPV test in order to detect thirty genitally relevant HPV subtypes. In our study, the most prevalent genotypeswere HPV 16, 31, 51, and 53. Among these, HPV 16 was consistently present in all cytological subgroups. Twelve HPV genotypes classified as carcinogenic to humans (Group 1) were detected in 77.8.0% of HSIL/ASCH and 55.0% of NILM with abnormal colposcopy findings. Six possible carcinogens-HRs (group 2B) were often found in women with normal cytology (14.8%) and mild abnormalities (ASCUS and LSIL), but with lower frequence in HSIL/ASCH lesions (7.1%). HPVs 6 and 11(Group 3) were not found in the cases of HSIL/ASCH. Unclassified HPV types were equally distributed in all cytology groups: 20.7%, 19.1%, 16.3% and 13% of NILM, ASCUS, LSIL and HSIL/ASCH, respectively. Our findings highlight that majority of abnormal Pap test results are caused by Group 1 HPVs among women from our region. Low frequency HPVs of group 2A/2B, especially HSIL/ASCH, supports the conclusion that individual genotypes require consideration of each type as an individual agent. We expect a positive impact of HPV vaccine in reducing HPV-associated cervical lesions among women from Vojvodina province, after establishing vaccination programs in our country.	[Kovacevic, Gordana; Milosevic, Vesna; Nikolic, Natasa; Patic, Aleksandra; Dopudj, Nela; Radovanov, Jelena; Cvjetkovic, Ivana Hrnjakovic; Petrovic, Vladimir] Inst Publ Hlth Vojvodina, Novi Sad, Serbia; [Milosevic, Vesna; Nikolic, Natasa; Patic, Aleksandra; Cvjetkovic, Ivana Hrnjakovic; Petrovic, Vladimir] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Petrovic, Milena] Merck Sharp & Dohme DOO, Belgrade, Serbia	University of Novi Sad	Kovacevic, G (corresponding author), Inst Publ Hlth Vojvodina, Novi Sad, Serbia.	gordana.kovacevicns@gmail.com	Kovacevic, Gordana/AAR-2527-2020; Petrovic, Vladimir/L-7149-2018	Kovacevic, Gordana/0000-0002-7626-2571; Petrovic, Vladimir/0000-0002-2052-6232	City of Novi Sad, City Administration for Health [XII-51-46-3/2016, XII-51-46-51/2017, XII-51-52-7/2018]	City of Novi Sad, City Administration for Health	This study was funded by the City of Novi Sad, City Administration for Health, in the period 2016-2018, Project Numbers XII-51-46-3/2016, XII-51-46-51/2017, XII-51-52-7/2018. Publication fee was covered by the Merck Sharp & Dohme D. O.O., Belgrade, Serbia. Merck Sharp & Dohme D.O. O., Belgrade, Serbia provided support in the form of salary for author MP. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency IA for R on, 2012, IARC MON EV CARC RIS, V100; Annunziata C, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0199-0; [Anonymous], 2017, PRAVILNIK IMUNIZACIJ; [Anonymous], NATIONAL REGULATION; Argyri E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-53; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruni L.A.G., 2019, HUMAN PAPILLOMAVIRUS; Burd EM, 2016, CLIN MICROBIOL REV, V29, P291, DOI 10.1128/CMR.00013-15; Clifford GM, 2011, INT J CANCER, V129, P1792, DOI 10.1002/ijc.25833; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Guimera N, 2013, AM J SURG PATHOL, V37, P1299, DOI 10.1097/PAS.0b013e31828b6be4; Hajia Massoud, 2018, Asian Pac J Cancer Prev, V19, P785; Halec G, 2014, J PATHOL, V234, P441, DOI 10.1002/path.4405; Herraez-Hernandez E, 2013, J VIROL METHODS, V193, P9, DOI 10.1016/j.jviromet.2013.04.018; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; Knezevic A, 2012, ARCH BIOL SCI, V64, P1277, DOI 10.2298/ABS1204277K; Kovacevic G, 2019, BIOLOGICALS, V58, P57, DOI 10.1016/j.biologicals.2019.02.001; Kovacevic G, 2016, TURK J MED SCI, V46, P97, DOI 10.3906/sag-1410-47; Latsuzbaia A, 2016, DIAGN MICR INFEC DIS, V85, P318, DOI 10.1016/j.diagmicrobio.2016.04.011; Martins TR, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0594-3; Meloni A, 2014, J PUBLIC HEALTH RES, V3, P21, DOI 10.4081/jphr.2014.157; Nayar R., 2015, ACTA CYTOL, V59, p121, DOI DOI 10.1159/000381842; Otero-Motta AP, 2011, APMIS, V119, P204, DOI 10.1111/j.1600-0463.2010.02711.x; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Stamenkovic M, 2016, BIOLOGICALS, V44, P412, DOI 10.1016/j.biologicals.2016.05.001; Tasic D, 2018, EPIDEMIOL INFECT, V146, P1714, DOI 10.1017/S0950268818001668; TIBCO, 2017, STAT DAT AN SOFTW SY; Viti J, 2018, J CLIN VIROL, V108, P38, DOI 10.1016/j.jcv.2018.09.005	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249134	10.1371/journal.pone.0249134	http://dx.doi.org/10.1371/journal.pone.0249134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852583	gold, Green Published			2022-12-26	WOS:000640604500030
J	van Vliet, AC; Lee, J; van der Poel, M; Mason, MRJ; Noordermeer, JN; Fradkin, LG; Tannemaat, MR; Malessy, MJA; Verhaagen, J; De Winter, F				van Vliet, Arie C.; Lee, Jinhui; van der Poel, Marlijn; Mason, Matthew R. J.; Noordermeer, Jasprina N.; Fradkin, Lee G.; Tannemaat, Martijn R.; Malessy, Martijn J. A.; Verhaagen, Joost; De Winter, Fred			Coordinated changes in the expression of Wnt pathway genes following human and rat peripheral nerve injury	PLOS ONE			English	Article							WNT/BETA-CATENIN; AXON GUIDANCE; NEURAL CREST; BETA-CATENIN; STEM-CELLS; FUNCTIONAL RECOVERY; NEGATIVE REGULATOR; GROWTH-FACTOR; F-SPONDIN; RYK	A human neuroma-in continuity (NIC), formed following a peripheral nerve lesion, impedes functional recovery. The molecular mechanisms that underlie the formation of a NIC are poorly understood. Here we show that the expression of multiple genes of the Wnt family, including Wnt5a, is changed in NIC tissue from patients that underwent reconstructive surgery. The role of Wnt ligands in NIC pathology and nerve regeneration is of interest because Wnt ligands are implicated in tissue regeneration, fibrosis, axon repulsion and guidance. The observations in NIC prompted us to investigate the expression of Wnt ligands in the injured rat sciatic nerve and in the dorsal root ganglia (DRG). In the injured nerve, four gene clusters were identified with temporal expression profiles corresponding to particular phases of the regeneration process. In the DRG up- and down regulation of certain Wnt receptors suggests that nerve injury has an impact on the responsiveness of injured sensory neurons to Wnt ligands in the nerve. Immunohistochemistry showed that Schwann cells in the NIC and in the injured nerve are the source of Wnt5a, whereas the Wnt5a receptor Ryk is expressed by axons traversing the NIC. Taken together, these observations suggest a central role for Wnt signalling in peripheral nerve regeneration.	[van Vliet, Arie C.; Lee, Jinhui; van der Poel, Marlijn; Mason, Matthew R. J.; Tannemaat, Martijn R.; Malessy, Martijn J. A.; Verhaagen, Joost; De Winter, Fred] Inst Royal Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands; [van Vliet, Arie C.; Malessy, Martijn J. A.; De Winter, Fred] Leiden Univ, Dept Neurosurg, Med Ctr, Leiden, Netherlands; [Noordermeer, Jasprina N.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Fradkin, Lee G.] Univ Massachusetts, Dept Neurobiol, Med Sch, Worcester, MA USA; [Tannemaat, Martijn R.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	De Winter, F (corresponding author), Inst Royal Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands.; De Winter, F (corresponding author), Leiden Univ, Dept Neurosurg, Med Ctr, Leiden, Netherlands.	F.de.Winter@nin.knaw.nl	De Winter, Fred/AAZ-8671-2020; Malessy, Martijn/AAZ-9996-2021; Tannemaat, Martijn/S-3445-2016	De Winter, Fred/0000-0002-3042-2429; Malessy, Martijn/0000-0003-1936-3664; Tannemaat, Martijn/0000-0003-2929-0390	NWO-TOP grant [91210058]	NWO-TOP grant	NWO-TOP grant 91210058 (https://www.nwo.nl) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alant JDD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082546; Alant JDDV, 2012, J NEUROTRAUM, V29, P1691, DOI 10.1089/neu.2011.1857; Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110; Aviles EC, 2016, DEV NEUROBIOL, V76, P190, DOI 10.1002/dneu.22307; Bengoa-Vergniory N, 2014, STEM CELLS, V32, P3196, DOI 10.1002/stem.1807; Blakely BD, 2013, STEM CELLS DEV, V22, P2132, DOI 10.1089/scd.2013.0066; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Burstyn-Cohen T, 1998, J NEUROSCI, V18, P8875; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Debby-Brafman A, 1999, NEURON, V22, P475, DOI 10.1016/S0896-6273(00)80703-5; Duan RS, 2018, BIOCHEM BIOPH RES CO, V499, P246, DOI 10.1016/j.bbrc.2018.03.138; Federation of Dutch Medical Scientific Societies (Federa), 2011, HUM TISS MED RES COD; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fradkin LG, 2004, DEV BIOL, V272, P362, DOI 10.1016/j.ydbio.2004.04.034; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050793; Grigoryan T, 2013, P NATL ACAD SCI USA, V110, P18174, DOI 10.1073/pnas.1310490110; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hollis ER, 2012, P NATL ACAD SCI USA, V109, P14663, DOI 10.1073/pnas.1206218109; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katoh M, 2005, INT J MOL MED, V15, P749; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Li X, 2008, BRAIN RES BULL, V77, P178, DOI 10.1016/j.brainresbull.2008.05.011; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MacKinnon S., 1988, SURG PERIPHERAL NERV; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Moffat LL, 2014, DEVELOPMENT, V141, P617, DOI 10.1242/dev.101600; Morello F, 2015, J NEUROSCI, V35, P14205, DOI 10.1523/JNEUROSCI.1840-15.2015; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Onishi K, 2014, CURR OPIN NEUROBIOL, V27, P232, DOI 10.1016/j.conb.2014.05.005; Paganoni S, 2005, J CELL SCI, V118, P433, DOI 10.1242/jcs.01622; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Pondaag W, 2008, J NEUROSURG, V109, P946, DOI 10.3171/JNS/2008/109/11/0946; Qi XY, 2016, GENES CELLS, V21, P325, DOI 10.1111/gtc.12342; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Reynaud E, 2015, CELL REP, V11, P1293, DOI 10.1016/j.celrep.2015.04.035; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Ryu YK, 2013, DEV BIOL, V377, P79, DOI 10.1016/j.ydbio.2013.02.013; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Slater PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078892; Stam FJ, 2007, EUR J NEUROSCI, V25, P3629, DOI 10.1111/j.1460-9568.2007.05597.x; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Strochlic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029976; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Tannemaat MR, 2008, MOLUCULAR NERVE REPA, P39; Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Van Beuge MM, 2015, TRANSL RES, V166, P762, DOI 10.1016/j.trsl.2015.09.006; van Vliet AC, 2015, J NEUROPATH EXP NEUR, V74, P901, DOI 10.1097/NEN.0000000000000229; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanMeeteren NLU, 1997, ARCH PHYS MED REHAB, V78, P70, DOI 10.1016/S0003-9993(97)90013-7; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	81	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249748	10.1371/journal.pone.0249748	http://dx.doi.org/10.1371/journal.pone.0249748			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848304	Green Published, gold			2022-12-26	WOS:000640373500002
J	Wang, HJ; Jiang, B; Gu, JX; Wei, T; Lin, LL; Huang, Y; Liang, D; Huang, JH				Wang, Haojie; Jiang, Bing; Gu, Jingxiao; Wei, Tao; Lin, Liliang; Huang, Yuan; Liang, Dan; Huang, Jianhua			Molecular phylogeny and species delimitation of the genus Tonkinacris (Orthoptera, Acrididae, Melanoplinae) from China	PLOS ONE			English	Article							RIBOSOMAL DNA; EVOLUTIONARY RATES; IQ-TREE; SEQUENCE; PODISMINI; POLYMORPHISMS	Tonkinacris is a small group in Acrididae. While a few species were occasionally sampled in some previous molecular studies, there is no revisionary research devoted to the genus. In this study, we explored the phylogeny of and the relationships among Chinese species of the genus Tonkinacris using the mitochondrial COI barcode and the complete sequences of ITS1 and ITS2 of the nuclear ribosomal DNA. The phylogeny was reconstructed in maximum likelihood and Bayesian inference frameworks, respectively. The overlap range between intraspecific variation and interspecific divergence was assessed via K2P distances. Species boundaries were delimitated using phylogenetic species concept, NJ tree, K2P distance, the statistical parsimony network as well as the GMYC model. The results demonstrate that the Chinese Tonkinacris species is a monophyletic group and the phylogenetic relationship among them is (T. sinensis, (T. meridionalis, (T. decoratus, T. damingshanus))). While T. sinensis, T. meridionalis and T. decoratus were confirmed being good independent species strongly supported by both morphological and molecular evidences, the validity of T. damingshanus was not perfectly supported by molecular evidence in this study.	[Wang, Haojie; Liang, Dan] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Jiang, Bing; Gu, Jingxiao; Huang, Jianhua] Cent South Univ Forestry & Technol, Key Lab Insect Evolut & Pest Management Higher Ed, Changsha, Hunan, Peoples R China; [Jiang, Bing; Gu, Jingxiao; Huang, Jianhua] Cent South Univ Forestry & Technol, Minist Educ, Key Lab Cultivat & Protect Nonwood Forest Trees C, Changsha, Hunan, Peoples R China; [Wei, Tao] Tanxi St Agcy, Liuzhou, Guangxi, Peoples R China; [Lin, Liliang; Huang, Yuan] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China	Beijing Forestry University; Central South University of Forestry & Technology; Central South University of Forestry & Technology; Shaanxi Normal University	Liang, D (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.; Huang, JH (corresponding author), Cent South Univ Forestry & Technol, Key Lab Insect Evolut & Pest Management Higher Ed, Changsha, Hunan, Peoples R China.; Huang, JH (corresponding author), Cent South Univ Forestry & Technol, Minist Educ, Key Lab Cultivat & Protect Nonwood Forest Trees C, Changsha, Hunan, Peoples R China.	liangdanyx2014@163.com; caniscn@aliyun.com	tao, wei/GXN-4445-2022	Wang, Haojie/0000-0001-9357-5601	Open foundation for innovation platform of Education Bureau of Hunan Province [18K056]; Beijing Forestry University Teaching Reform Project [BJFU2017JY021]; National Natural Science Foundation of China [31540055, 31260523, 31801993]	Open foundation for innovation platform of Education Bureau of Hunan Province; Beijing Forestry University Teaching Reform Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the Open foundation for innovation platform of Education Bureau of Hunan Province (18K056), Beijing Forestry University Teaching Reform Project (BJFU2017JY021) and National Natural Science Foundation of China (No. 31540055, 31260523, 31801993).	ALLARD MW, 1991, MOL BIOL EVOL, V8, P71; Bugrov A. G., 2012, Evraziatskii entomologicheskii Zhurnal, V11, P493; Carl J., 1916, Revue Suisse de Zoologie, V24; Chang HH, 2020, MOL PHYLOGENET EVOL, V145, DOI 10.1016/j.ympev.2020.106734; Chang K. S. F., 1937, Notes Ent chinoise Mus Heude Shanghai, V4, P177; CHEN WD, 1992, EXP MYCOL, V16, P22, DOI 10.1016/0147-5975(92)90038-S; Chintauan-Marquier IC, 2014, MOL PHYLOGENET EVOL, V71, P224, DOI 10.1016/j.ympev.2013.09.009; Cigliano M., ORTHOPTERA SPECIES F; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Grzywacz Beata, 2017, Journal of Orthoptera Research, V26, P11, DOI 10.3897/jor.26.14547; Gu JX, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237882; Guzman NV., 2017, PEERJ, V5, P3835, DOI [10.7717/peerj.3835, DOI 10.7717/PEERJ.3835]; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Huang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082400, 10.1371/journal.pone.0068688]; Huo Guangming, 2007, Journal of Genetics and Genomics, V34, P294, DOI 10.1016/S1673-8527(07)60031-9; Husemann M, 2013, J BIOGEOGR, V40, P261, DOI 10.1111/jbi.12007; Ito Gen, 2015, Insecta Matsumurana, V71, P1; Ito Gen, 1999, Entomological Science, V2, P503; Jiang GF., 1998, GRASSHOPPERS LOCUSTS; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; KUPERUS WR, 1994, ANN ENTOMOL SOC AM, V87, P751, DOI 10.1093/aesa/87.6.751; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lan Ma, 2006, Acta Entomologica Sinica, V49, P982; Li HC, 2006, FAUNA SINICA INSECTA, V43; LI TS, 1986, ACTA ENTOMOL SINICA, V29, P70; Li TS, 1991, J GUANGXI ACAD SCI, V7, P65; Liu Dian-Feng, 2005, Acta Entomologica Sinica, V48, P759; Lopez H, 2007, CONSERV GENET, V8, P587, DOI 10.1007/s10592-006-9199-5; Lopez H, 2013, J ZOOL SYST EVOL RES, V51, P173, DOI 10.1111/jzs.12023; Lu Rong-Sheng, 2010, Acta Zootaxonomica Sinica, V35, P782; Mao BY., 2011, FAUNA DISTRIBUTION P; MOLINA FI, 1992, CURR MICROBIOL, V25, P251, DOI 10.1007/BF01575857; Nei M, 2000, MOL EVOLUTION PHYLOG; Pocco ME, 2015, ZOOL J LINN SOC-LOND, V174, P733, DOI 10.1111/zoj.12251; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; TEMPLETON AR, 1992, GENETICS, V132, P619; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Veronica Guzman Noelia, 2010, Journal of Orthoptera Research, V19, P253, DOI 10.1665/034.019.0211; Xia KL, 1958, SYNOPSIS ACRIDIDAE C; Zhang XM, 2017, BIOCHEM SYST ECOL, V70, P147, DOI 10.1016/j.bse.2016.11.002; Zheng ZM., 1993, ACRITAXONOMY; Zheng ZM., 1985, GRASSHOPPERS AREAS Y	53	2	2	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249431	10.1371/journal.pone.0249431	http://dx.doi.org/10.1371/journal.pone.0249431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848300	gold, Green Published			2022-12-26	WOS:000640373500024
J	Fang, R; Wang, XT; Xia, QY; Zhao, M; Zhang, H; Wang, X; Ye, SB; Cheng, K; Liang, Y; Cheng, Y; Gu, YY; Rao, Q				Fang, Ru; Wang, Xiaotong; Xia, Qiuyuan; Zhao, Ming; Zhang, Hao; Wang, Xuan; Ye, Shengbing; Cheng, Kai; Liang, Yan; Cheng, Yang; Gu, Yayun; Rao, Qiu			Nuclear translocation of ASPL-TFE3 fusion protein creates favorable metabolism by mediating autophagy in translocation renal cell carcinoma	ONCOGENE			English	Article								The ASPL-TFE3 fusion gene, resulting from t(X;17)(p11.2;q25.3), is one of the most commonly identified fusion genes in Xp11 translocation renal cell carcinoma (tRCC). However, its roles and underlying mechanism in RCC development are not yet clear. Here, we identified ASPL-TFE3 fusion as the most common tRCC subtype in a Chinese population (29/126, 23.03%). This fusion protein translocated into the nucleus and promoted RCC cell proliferation both in vitro and in vivo. Mechanistically, the fusion protein transcriptionally activated the lysosome-autophagy pathway by binding to the promoters of lysosome-related genes. Autophagy, activated by ASPL-TFE3, enabled RCC cells to escape energy stress by promoting the utilization of proteins and lipids. Moreover, we found that the ASPL-TFE3 fusion escaped regulation by the classic mTOR-TFE3 signal and instead activated phospho-mTOR and its downstream targets. Finally, targeting both autophagy and the mTOR axis resulted in a greater antiproliferative effect than single pathway inhibition. In summary, these results confirmed the ASPL-TFE3 fusion as a master regulator of metabolic adaptation mediated by autophagy in tRCC. The simultaneous manipulation of autophagy and the mTOR axis may represent a novel treatment strategy for ASPL-TFE3 fusion RCC.	[Fang, Ru; Wang, Xiaotong; Xia, Qiuyuan; Wang, Xuan; Ye, Shengbing; Cheng, Kai; Liang, Yan; Rao, Qiu] Nanjing Univ, Jinling Hosp, Dept Pathol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhao, Ming] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Peoples Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hao] Nanjing Med Univ, Nanjing Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Cheng, Yang] Nanjing Med Univ, Hlth Management Ctr, Geriatr Hosp, Nanjing, Jiangsu, Peoples R China; [Gu, Yayun] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Rao, Q (corresponding author), Nanjing Univ, Jinling Hosp, Dept Pathol, Sch Med, Nanjing, Jiangsu, Peoples R China.; Cheng, Y (corresponding author), Nanjing Med Univ, Hlth Management Ctr, Geriatr Hosp, Nanjing, Jiangsu, Peoples R China.; Gu, YY (corresponding author), Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yangchengjsnj@163.com; yayungu@njmu.edu.cn; raoqiu1103@126.com			National Natural Science Foundation of China [81872095, 81903385, 81902836, 81802557]; National Natural Science Foundation of Jiangsu Province [BK20180291]; Natural Science Foundation of Zhejiang Province [LY21H160052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (81872095 to QR, 81903385 to YC, 81902836 to YG, and 81802557 to QX), the National Natural Science Foundation of Jiangsu Province (BK20180291 to QX), and Natural Science Foundation of Zhejiang Province (LY21H160052 to MZ).	Aquila S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071725; Argani P, 2002, AM J SURG PATHOL, V26, P1553, DOI 10.1097/00000478-200212000-00003; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Argani P, 2001, AM J PATHOL, V158, P2089, DOI 10.1016/S0002-9440(10)64680-9; Calio A, 2017, MODERN PATHOL, V30, P407, DOI 10.1038/modpathol.2016.200; Cheng J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15671-5; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Damayanti NP, 2018, CLIN CANCER RES, V24, P5977, DOI 10.1158/1078-0432.CCR-18-0269; Di Malta C, 2017, SCIENCE, V356, P1188, DOI 10.1126/science.aag2553; Ellis CL, 2014, MODERN PATHOL, V27, P875, DOI 10.1038/modpathol.2013.208; Fang R, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.152867; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Ho H, 2011, PIGM CELL MELANOMA R, V24, P595, DOI 10.1111/j.1755-148X.2011.00889.x; Ishiguro N, 2016, NEOPLASIA, V18, P626, DOI 10.1016/j.neo.2016.08.001; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Kepp O, 2020, AUTOPHAGY, V16, P1166, DOI 10.1080/15548627.2020.1758417; Komai Y, 2009, CLIN CANCER RES, V15, P1170, DOI 10.1158/1078-0432.CCR-08-1183; Lim CY, 2016, J CELL BIOL, V214, P653, DOI 10.1083/jcb.201607005; Lopez-Hernandez T, 2020, NAT CELL BIOL, V22, P815, DOI 10.1038/s41556-020-0535-7; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Napolitano G, 2020, NATURE, V585, P597, DOI 10.1038/s41586-020-2444-0; Ozturk DG, 2019, AUTOPHAGY, V15, P375, DOI 10.1080/15548627.2018.1531197; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Rao Q, 2015, AM J SURG PATHOL, V39, P1181, DOI 10.1097/PAS.0000000000000502; Rao Q, 2012, AM J SURG PATHOL, V36, P1327, DOI 10.1097/PAS.0b013e31825aafb5; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Wang XT, 2018, MODERN PATHOL, V31, P1346, DOI 10.1038/s41379-018-0051-5; Wang XT, 2016, HISTOPATHOLOGY, V69, P450, DOI 10.1111/his.12949; Weterman MAJ, 2000, ONCOGENE, V19, P69, DOI 10.1038/sj.onc.1203255; Weterman MAJ, 2001, ONCOGENE, V20, P1414, DOI 10.1038/sj.onc.1204213; Xia QY, 2020, AM J SURG PATHOL, V44, P477, DOI 10.1097/PAS.0000000000001408; Xia QY, 2018, HISTOPATHOLOGY, V72, P786, DOI 10.1111/his.13439; Xia QY, 2017, MODERN PATHOL, V30, P416, DOI 10.1038/modpathol.2016.204; Yin QY, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201911036; Yin XQ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1101-7	40	4	5	1	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3303	3317		10.1038/s41388-021-01776-8	http://dx.doi.org/10.1038/s41388-021-01776-8		APR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33846569				2022-12-26	WOS:000639635100003
J	Abbas, N; Hafez, AM				Abbas, Naeem; Hafez, Abdulwahab M.			Resistance to insect growth regulators and age-stage, two-sex life table in Musca domestica from different dairy facilities	PLOS ONE			English	Article							SPODOPTERA-LITURA LEPIDOPTERA; PERSICAE SULZER HOMOPTERA; L. DIPTERA MUSCIDAE; IN-HOUSE FLIES; CROSS-RESISTANCE; REALIZED HERITABILITY; FITNESS COST; CYROMAZINE RESISTANCE; PLUTELLA-XYLOSTELLA; FIELD POPULATIONS	Among the vectorial insect pests, the domestic house fly (Musca domestica L., Diptera: Muscidae) is a ubiquitous livestock pest with the ability to develop resistance and adapt to diverse climates. Successful management of the house fly in various locations requires information about its resistance development and life table features. The status of insect growth regulators resistance and life table features on the basis of age, stage, and two sexes of the house fly from five different geographical locations of Riyadh, Saudi Arabia: Dirab, Al-Masanie, Al-Washlah, Al-Uraija and Al-Muzahmiya were therefore investigated. The range of resistance levels were 3.77-8.03-fold for methoxyfenozide, 5.50-29.75 for pyriproxyfen, 0.59-2.91-fold for cyromazine, 9.33-28.67-fold for diflubenzuron, and 1.63-8.25-fold for triflumuron in five populations of house fly compared with the susceptible strain. Analysis of life history parameters-such as survival rate, larval duration, pupal duration, pre-female duration, pre-male duration, adult and total pre-oviposition periods, longevity of male, oviposition period, female ratio, and fecundity female(-1)-revealed significant variations among the field populations. Additionally, demographic features-including the generation time, the finite and intrinsic rates of increase, doubling time, and net reproductive rate-varied significantly among the field populations. These results will be helpful in planning the management of the house fly in geographically isolated dairies in Saudi Arabia.	[Abbas, Naeem; Hafez, Abdulwahab M.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Pesticides & Environm Toxicol Lab, Riyadh, Saudi Arabia	King Saud University	Abbas, N; Hafez, AM (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Pesticides & Environm Toxicol Lab, Riyadh, Saudi Arabia.	nnoor.c@ksu.edu.sa; hafez@ksu.edu.sa	Abbas, Naeem/Y-8685-2019; Hafez, Abdulwahab/ABC-9703-2020; Abbas, Naeem/ADH-2281-2022	Hafez, Abdulwahab/0000-0003-4290-5548; Abbas, Naeem/0000-0002-2737-7487	Deputyship for Research & Innovation, Ministry of Education"in Saudi Arabia [IFKSURG-1442-480]	Deputyship for Research & Innovation, Ministry of Education"in Saudi Arabia	The authors extend their appreciation to the Deputyship for Research & Innovation, Ministry of Education"in Saudi Arabia for funding this research work through the project number IFKSURG-1442-480. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abbas N, 2016, VET PARASITOL, V226, P78, DOI 10.1016/j.vetpar.2016.06.035; Abbas N, 2016, VET PARASITOL, V223, P71, DOI 10.1016/j.vetpar.2016.04.026; Abbas N, 2015, PAK J ZOOL, V47, P1663; Abbas N, 2015, J ECON ENTOMOL, V108, P826, DOI 10.1093/jee/tou057; Abbas N, 2015, PARASITOL RES, V114, P247, DOI 10.1007/s00436-014-4186-0; Abbas N, 2014, ECOTOXICOLOGY, V23, P791, DOI 10.1007/s10646-014-1217-7; Abbas N, 2014, PARASITOL RES, V113, P1343, DOI 10.1007/s00436-014-3773-4; Abbas N, 2012, PESTIC BIOCHEM PHYS, V103, P181, DOI 10.1016/j.pestbp.2012.05.001; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Ahmad M, 2007, CROP PROT, V26, P809, DOI 10.1016/j.cropro.2006.07.006; Ahmad M, 2017, CAN ENTOMOL, V149, P649, DOI 10.4039/tce.2017.29; Bell HA, 2010, PEST MANAG SCI, V66, P693, DOI 10.1002/ps.1945; Chen Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173380; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; Chi H, 2003, ENVIRON ENTOMOL, V32, P327, DOI 10.1603/0046-225X-32.2.327; Chi H, 2019, TWOSEX MSCHART COMPU; Chi H, 2020, ENTOMOL GEN, V40, P103, DOI 10.1127/entomologia/2020/0936; Farooq M, 2016, BRAZ J MICROBIOL, V47, P807, DOI 10.1016/j.bjm.2016.06.002; Fasanella A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012219; Forster M, 2007, PARASITOL RES, V101, P243, DOI 10.1007/s00436-007-0522-y; Freeman JC, 2019, PESTIC BIOCHEM PHYS, V158, P61, DOI 10.1016/j.pestbp.2019.04.006; Gul H, 2019, ENTOMOL GEN, V39, P81, DOI 10.1127/entomologia/2019/0861; Gutierrez-Moreno R, 2019, J ECON ENTOMOL, V112, P792, DOI 10.1093/jee/toy372; Honek A, 1996, EUR J ENTOMOL, V93, P303; IRAC, 2020, IRAC MOD ACT CLASS S, P1; Kaufman PE, 2010, PEST MANAG SCI, V66, P290, DOI 10.1002/ps.1872; Khan HAA, 2019, J MED ENTOMOL, V56, P1225, DOI 10.1093/jme/tjz069; Khan HAA, 2018, J MED ENTOMOL, V55, P735, DOI 10.1093/jme/tjx247; Khan HAA, 2017, PARASITOL RES, V116, P3381, DOI 10.1007/s00436-017-5659-8; Khan HAA, 2016, PARASITOL RES, V115, P1385, DOI 10.1007/s00436-015-4872-6; Khan HAA, 2013, ECOTOXICOLOGY, V22, P522, DOI 10.1007/s10646-013-1044-2; Kivela SM, 2011, J ANIM ECOL, V80, P1184, DOI 10.1111/j.1365-2656.2011.01864.x; Kocisova A, 2004, BIOLOGIA, V59, P661; LeOra S., 2003, POLOPLUS USERS GUIDE; Li QF, 2018, REV BRAS ENTOMOL, V62, P311, DOI 10.1016/j.rbe.2018.09.003; Malik A, 2007, J ENVIRON SCI HEAL B, V42, P453, DOI 10.1080/03601230701316481; Matsumura F, 2010, PESTIC BIOCHEM PHYS, V97, P133, DOI 10.1016/j.pestbp.2009.10.001; MIAN LS, 1982, RESIDUE REV, V84, P27; Nazni W.A., 2005, Tropical Biomedicine, V22, P53; Pan QJ, 2014, J PEST SCI, V87, P659, DOI 10.1007/s10340-014-0608-0; Parsons SMA, 2014, OECOLOGIA, V174, P379, DOI 10.1007/s00442-013-2785-6; Saddiq B, 2015, CROP PROT, V74, P24, DOI 10.1016/j.cropro.2015.03.026; Saeed R, 2018, CHEMOSPHERE, V213, P149, DOI 10.1016/j.chemosphere.2018.09.042; Saeed R, 2017, CROP PROT, V93, P143, DOI 10.1016/j.cropro.2016.11.032; Scott JG, 2000, PEST MANAG SCI, V56, P147, DOI 10.1002/1526-4998(200002)56:2<147::AID-PS106>3.0.CO;2-7; Shah RM, 2018, NEOTROP ENTOMOL, V47, P709, DOI 10.1007/s13744-018-0604-9; Shah RM, 2020, PEST MANAG SCI, V76, P1866, DOI 10.1002/ps.5716; Shah RM, 2017, PEST MANAG SCI, V73, P254, DOI 10.1002/ps.4296; Shah RM, 2015, PESTIC BIOCHEM PHYS, V119, P67, DOI 10.1016/j.pestbp.2015.02.003; Shah RM, 2015, PARASITOL RES, V114, P487, DOI 10.1007/s00436-014-4206-0; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Tang JD, 2002, J ECON ENTOMOL, V95, P1251, DOI 10.1603/0022-0493-95.6.1251; Tang JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181030; Tuan SJ, 2014, PEST MANAG SCI, V70, P805, DOI 10.1002/ps.3618; Tunaz Hasan, 2004, Turkish Journal of Agriculture and Forestry, V28, P377; Ullah S, 2016, J ECON ENTOMOL, V109, P345, DOI 10.1093/jee/tov324; Valles SM, 1997, J ECON ENTOMOL, V90, P1254, DOI 10.1093/jee/90.5.1254; Wang JN, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/4851914; Wang L, 2016, PESTIC BIOCHEM PHYS, V132, P102, DOI 10.1016/j.pestbp.2016.02.002; Xiang X, 2019, CROP PROT, V120, P97, DOI 10.1016/j.cropro.2019.02.016; Yuan HG, 2018, J INTEGR AGR, V17, P911, DOI 10.1016/S2095-3119(17)61898-7; Zhang P, 2017, PESTIC BIOCHEM PHYS, V136, P80, DOI 10.1016/j.pestbp.2016.07.007	63	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0248693	10.1371/journal.pone.0248693	http://dx.doi.org/10.1371/journal.pone.0248693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831013	gold, Green Published			2022-12-26	WOS:000639359600105
J	Couch, CE; Wise, BL; Scurlock, BM; Rogerson, JD; Fuda, RK; Cole, EK; Szcodronski, KE; Sepulveda, AJ; Hutchins, PR; Cross, PC				Couch, Claire E.; Wise, Benjamin L.; Scurlock, Brandon M.; Rogerson, Jared D.; Fuda, Rebecca K.; Cole, Eric K.; Szcodronski, Kimberly E.; Sepulveda, Adam J.; Hutchins, Patrick R.; Cross, Paul C.			Effects of supplemental feeding on the fecal bacterial communities of Rocky Mountain elk in the Greater Yellowstone Ecosystem	PLOS ONE			English	Article							GUT MICROBIOME; FUSOBACTERIUM-NECROPHORUM; CERVUS-ELAPHUS; DICHELOBACTER-NODOSUS; WILD; FECES; DIET; EPIDEMIOLOGY; TRANSMISSION; BRUCELLOSIS	Supplemental feeding of wildlife is a common practice often undertaken for recreational or management purposes, but it may have unintended consequences for animal health. Understanding cryptic effects of diet supplementation on the gut microbiomes of wild mammals is important to inform conservation and management strategies. Multiple laboratory studies have demonstrated the importance of the gut microbiome for extracting and synthesizing nutrients, modulating host immunity, and many other vital host functions, but these relationships can be disrupted by dietary perturbation. The well-described interplay between diet, the microbiome, and host health in laboratory and human systems highlights the need to understand the consequences of supplemental feeding on the microbiomes of free-ranging animal populations. This study describes changes to the gut microbiomes of wild elk under different supplemental feeding regimes. We demonstrated significant cross-sectional variation between elk at different feeding locations and identified several relatively low-abundance bacterial genera that differed between fed versus unfed groups. In addition, we followed four of these populations through mid-season changes in supplemental feeding regimes and demonstrated a significant shift in microbiome composition in a single population that changed from natural forage to supplementation with alfalfa pellets. Some of the taxonomic shifts in this population mirrored changes associated with ruminal acidosis in domestic livestock. We discerned no significant changes in the population that shifted from natural forage to hay supplementation, or in the populations that changed from one type of hay to another. Our results suggest that supplementation with alfalfa pellets alters the native gut microbiome of elk, with potential implications for population health.	[Couch, Claire E.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Wise, Benjamin L.; Scurlock, Brandon M.] Wyoming Game & Fish Dept, Jackson, WY USA; [Rogerson, Jared D.] Wyoming Game & Fish Dept, Pinedale, WY USA; [Fuda, Rebecca K.] Oregon Dept Fish & Wildlife, Prineville, OR USA; [Cole, Eric K.] US Fish & Wildlife Serv, Natl Elk Refuge, Jackson, WY USA; [Szcodronski, Kimberly E.; Sepulveda, Adam J.; Hutchins, Patrick R.; Cross, Paul C.] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT USA	Oregon State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Couch, CE (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	claire.couch@oregonstate.edu	Couch, Claire/AAZ-4299-2021	Couch, Claire/0000-0003-4983-3719	NSF Graduate Research Internship Program [pims_id=505127]; USGS Ecosystems and Environmental Health Mission Areas	NSF Graduate Research Internship Program; USGS Ecosystems and Environmental Health Mission Areas	Funding for this project was provided by the NSF Graduate Research Internship Program (https://www.nsf.gov/funding/pgm_summ.jsp? pims_id=505127, awarded to CEC) and the USGS Ecosystems and Environmental Health Mission Areas (https://www.usgs.gov/mission-areas/environmental-health, awarded to PCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WYOMING GAME FISH DE; Apprill A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090785; Bahrndorff S, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/5304028; Bennett G, 2009, ANAEROBE, V15, P173, DOI 10.1016/j.anaerobe.2009.02.002; Bergmann GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142409; Callahan Ben J, 2016, F1000Res, V5, P1492; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Campbell SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150502; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chong R, 2019, ANIM MICROBIOME, V1, DOI 10.1186/s42523-019-0012-4; Clifton R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50822-9; Collins WB, 1979, THESIS; Cortes-Avizanda A, 2009, ANIM CONSERV, V12, P85, DOI 10.1111/j.1469-1795.2008.00231.x; Cotterill GG, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0093; Couch CE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63401-0; Cross PC, 2007, ECOL APPL, V17, P957, DOI 10.1890/06-1603; Cross PC, 2015, J WILDLIFE MANAGE, V79, P739, DOI 10.1002/jwmg.883; D'Argenio V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194704; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Draycott RAH, 2005, WILDLIFE BIOL, V11, P177, DOI 10.2981/0909-6396(2005)11[177:EOSSFO]2.0.CO;2; Elliott GP, 2001, BIOL CONSERV, V99, P121, DOI 10.1016/S0006-3207(00)00191-9; Galbraith JA, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00081; Gao HM, 2020, MICROBIOLOGYOPEN, V9, DOI 10.1002/mbo3.1025; Gentile CL, 2018, SCIENCE, V362, P776, DOI 10.1126/science.aau5812; Guan Y, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0517-8; Hattel AL, 2007, J VET DIAGN INVEST, V19, P334, DOI 10.1177/104063870701900322; Haworth SE, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz095; Hicks AL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04204-w; Hines AM, 2007, VET PARASITOL, V148, P350, DOI 10.1016/j.vetpar.2007.07.006; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Kaltenbrunner M, 2018, FOOD CONTROL, V89, P157, DOI 10.1016/j.foodcont.2018.01.021; Kartzinel TR, 2019, P NATL ACAD SCI USA, V116, P23588, DOI 10.1073/pnas.1905666116; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kim JH, 2019, ANTON LEEUW INT J G, V112, P225, DOI 10.1007/s10482-018-1150-5; Kindt R., 2005, TREE DIVERSITY ANAL, V196; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Lindenberg F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49081-5; Liu JH, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.745; Lourenco JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231533; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Marotz C, 2017, BIOTECHNIQUES, V62, P290, DOI 10.2144/000114559; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McKenzie VJ, 2017, INTEGR COMP BIOL, V57, P690, DOI 10.1093/icb/icx090; Menke S, 2019, WILDLIFE BIOL, DOI 10.2981/wlb.00503; Merkle JA, 2018, J APPL ECOL, V55, P810, DOI 10.1111/1365-2664.13022; Plaizier JC, 2017, MICROB ECOL, V74, P485, DOI 10.1007/s00248-017-0940-z; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; R Core Team, R LANG ENV STAT COMP; Ren TT, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0382-3; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Ricci S, 2019, WILDLIFE BIOL, DOI 10.2981/wlb.00572; Saro C, 2014, LIVEST SCI, V160, P52, DOI 10.1016/j.livsci.2013.12.005; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Steyaert SMJG, 2014, BASIC APPL ECOL, V15, P669, DOI 10.1016/j.baae.2014.10.002; Sun CH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02331; Trevelline BK, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2448; Tung J, 2015, ELIFE, V4, DOI 10.7554/eLife.05224; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xie YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33350; Yao R, 2019, GLOB ECOL CONSERV, V18, DOI 10.1016/j.gecco.2019.e00644; Yeruham I, 2004, J VET MED B, V51, P46, DOI 10.1046/j.1439-0450.2003.00717.x; Youngblut ND, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10191-3	67	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249521	10.1371/journal.pone.0249521	http://dx.doi.org/10.1371/journal.pone.0249521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831062	gold, Green Published			2022-12-26	WOS:000639359600005
J	Gardner, AI; Wu, YQ; Verhaegh, R; Liu, YJ; Wilker, B; Soddemann, M; Keitsch, S; Edwards, MJ; Haq, IJ; Kamler, M; Becker, KA; Brodlie, M; Gulbins, E				Gardner, Aaron Ions; Wu, Yuqing; Verhaegh, Rabea; Liu, Yongjie; Wilker, Barbara; Soddemann, Matthias; Keitsch, Simone; Edwards, Michael J.; Haq, Iram J.; Kamler, Markus; Becker, Katrin Anne; Brodlie, Malcolm; Gulbins, Erich			Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; INFLAMMATION; IDENTIFICATION; SPHINGOSINE; BASES; GENE	Most patients with cystic fibrosis (CF) suffer from acute and chronic pulmonary infections with bacterial pathogens, which often determine their life quality and expectancy. Previous studies have demonstrated a downregulation of the acid ceramidase in CF epithelial cells resulting in an increase of ceramide and a decrease of sphingosine. Sphingosine kills many bacterial pathogens, and the downregulation of sphingosine seems to determine the infection susceptibility of cystic fibrosis mice and patients. It is presently unknown how deficiency of the cystic fibrosis transmembrane conductance regulator (CFTR) connects to a marked downregulation of the acid ceramidase in human and murine CF epithelial cells. Here, we employed quantitative PCR, western blot analysis, and enzyme activity measurements to study the role of IRF8 for acid ceramidase regulation. We report that genetic deficiency or functional inhibition of CFTR/Cftr results in an upregulation of interferon regulatory factor 8 (IRF8) and a concomitant downregulation of acid ceramidase expression with CF and an increase of ceramide and a reduction of sphingosine levels in tracheal and bronchial epithelial cells from both human individuals or mice. CRISPR/Cas9- or siRNA-mediated downregulation of IRF8 prevented changes of acid ceramidase, ceramide, and sphingosine in CF epithelial cells and restored resistance to Pseudomonas aeruginosa infections, which is one of the most important and common pathogens in lung infection of patients with CF. These studies indicate that CFTR deficiency causes a downregulation of acid ceramidase via upregulation of IRF8, which is a central pathway to control infection susceptibility of CF cells.	[Gardner, Aaron Ions; Haq, Iram J.; Brodlie, Malcolm] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Wu, Yuqing; Verhaegh, Rabea; Liu, Yongjie; Wilker, Barbara; Soddemann, Matthias; Keitsch, Simone; Becker, Katrin Anne] Univ Duisburg Essen, Univ Hosp Essen, Dept Mol Biol, Essen, Germany; [Verhaegh, Rabea; Kamler, Markus; Gulbins, Erich] Univ Duisburg Essen, Univ Hosp Essen, Dept Thorac & Cardiovasc Surg, Essen, Germany; [Edwards, Michael J.; Gulbins, Erich] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA; [Haq, Iram J.; Brodlie, Malcolm] Great North Childrens Hosp, Pediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; University of Duisburg Essen; University of Duisburg Essen; University System of Ohio; University of Cincinnati	Brodlie, M (corresponding author), Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.; Gulbins, E (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Thorac & Cardiovasc Surg, Essen, Germany.; Gulbins, E (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA.; Brodlie, M (corresponding author), Great North Childrens Hosp, Pediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England.	malcolm.brodlie@ncl.ac.uk; erich.gulbins@uni-due.de		Kamler, Markus/0000-0001-6608-8496; Haq, Iram/0000-0002-5795-0440; Liu, Yongjie/0000-0001-7259-9495; Brodlie, Malcolm/0000-0003-4591-8299	DFG [Gu-335-35/1]; Medical Research Council Clinician Scientist Fellowship [MR/M008797/1]	DFG(German Research Foundation (DFG)); Medical Research Council Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by DFG grant Gu-335-35/1 to E. G. M. B. and A. I. G. were supported by a Medical Research Council Clinician Scientist Fellowship to M. B. (MR/M008797/1).	Azuma MM, 2018, BIOCHEM BIOPH RES CO, V495, P2383, DOI 10.1016/j.bbrc.2017.12.137; Becker KA, 2021, INFECT IMMUN, V89, DOI 10.1128/IAI.00677-20; Becker KA, 2012, J MOL MED, V90, P1011, DOI 10.1007/s00109-012-0867-2; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; BIBEL DJ, 1992, J INVEST DERMATOL, V98, P269, DOI 10.1111/1523-1747.ep12497842; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Brodlie M, 2010, AM J RESP CRIT CARE, V182, P369, DOI 10.1164/rccm.200905-0799OC; Caretti A, 2014, BBA-GEN SUBJECTS, V1840, P586, DOI 10.1016/j.bbagen.2013.10.018; Carstens Henning, 2019, Cell Physiol Biochem, V53, P1015, DOI 10.33594/000000194; Charizopoulou N, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-18; Charizopoulou N, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-6; CI' Foundation, 2019, PAT REG ANN REP; Dechecchi MC, 2011, AM J RESP CELL MOL, V45, P825, DOI 10.1165/rcmb.2010-0457OC; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Fischer CL, 2013, SKIN PHARMACOL PHYS, V26, P36, DOI 10.1159/000343175; Gardner AI, 2020, AM J RESP CRIT CARE, V202, P1133, DOI 10.1164/rccm.202001-0180OC; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grassme H, 2017, CELL HOST MICROBE, V21, P707, DOI 10.1016/j.chom.2017.05.001; Haq IJ, 2021, AM J PHYSIOL-LUNG C, V320, pL288, DOI 10.1152/ajplung.00137.2020; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kormann MSD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183526; Kreiselmeier NE, 2003, AM J PHYSIOL-LUNG C, V285, pL1286, DOI 10.1152/ajplung.00127.2003; Liessi N, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138722; Loberto N, 2020, GLYCOCONJUGATE J, V37, P623, DOI 10.1007/s10719-020-09935-x; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Nelson N, 1996, J IMMUNOL, V156, P3711; Pewzner-Jung Y, 2014, EMBO MOL MED, V6, P1205, DOI 10.15252/emmm.201404075; RIORDAN JR, 1989, SCIENCE, V245, P1066; Seitz AP, 2019, J MOL MED, V97, P1195, DOI 10.1007/s00109-019-01800-1; Tabazavareh ST, 2016, CELL PHYSIOL BIOCHEM, V38, P2094, DOI 10.1159/000445567; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Verhaegh R, 2020, J BIOL CHEM, V295, P7686, DOI 10.1074/jbc.RA119.012325; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Zhang Y., 2009, J IMMUNOL, V184, P5104	39	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100650	10.1016/j.jbc.2021.100650	http://dx.doi.org/10.1016/j.jbc.2021.100650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839155	gold, Green Published			2022-12-26	WOS:000672866400621
J	Ghosh, G; Sharma, PV; Kumar, A; Jain, S; Sen, R				Ghosh, Gairika; Sharma, Pankaj, V; Kumar, Amit; Jain, Sriyans; Sen, Ranjan			Design of novel peptide inhibitors against the conserved bacterial transcription terminator, Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TERMINATION; DEFECTIVE-MUTANTS; STRUCTURAL BASIS; PROTEIN; RNA; ANTITERMINATION; POLARITY; REVERSE; NUSA	The transcription terminator Rho regulates many physiological processes in bacteria, such as antibiotic sensitivity, DNA repair, RNA remodeling, and so forth, and hence, is a potential antimicrobial target, which is unexplored. The bacteriophage P4 capsid protein, Psu, moonlights as a natural Rho antagonist. Here, we report the design of novel peptides based on the C-terminal region of Psu using phenotypic screening methods. The resultant 38-mer peptides, in addition to containing mutagenized Psu sequences, also contained plasmid sequences, fused to their C termini. Expression of these peptides inhibited the growth of Escherichia coli and specifically inhibited Rhodependent termination in vivo. Peptides 16 and 33 exhibited the best Rho-inhibitory properties in vivo. Direct high-affinity binding of these two peptides to Rho also inhibited the latter's RNA-dependent ATPase and transcription termination functions in vitro. These two peptides remained functional even if eight to ten amino acids were deleted from their C termini. In silico modeling and genetic and biochemical evidence revealed that these two peptides bind to the primary RNA-binding site of the Rho hexamer near its subunit interfaces. In addition, the gene expression profiles of these peptides and Psu overlapped significantly. These peptides also inhibited the growth of Mycobacteria and inhibited the activities of Rho proteins from Mycobacterium tuberculosis, Xanthomonas, Vibrio cholerae, and Salmonella enterica. Our results showed that these novel anti-Rho peptides mimic the Rho-inhibition function of the similar to 42-kDa dimeric bacteriophage P4 capsid protein, Psu. We conclude that these peptides and their C-terminal deletion derivatives could provide a basis on which to design novel antimicrobial peptides.	[Ghosh, Gairika; Sharma, Pankaj, V; Kumar, Amit; Jain, Sriyans; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Lab Transcript, Hyderabad, India; [Ghosh, Gairika; Sharma, Pankaj, V] Manipal Inst Higher Educ, Grad Studies, Manipal, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Transcript, Hyderabad, India.	rsen@cdfd.org.in		Jain, Sriyans/0000-0002-8707-9991; Sen, Ranjan/0000-0001-5693-787X	Department of Science and Technology-Science and Engineering Research Board, India (DST-SERB) [EMR/2015/001620]; Indian Council of Medical Research, India (ICMR) [AMR/INDO/GER/219/2019-ECD-II]	Department of Science and Technology-Science and Engineering Research Board, India (DST-SERB); Indian Council of Medical Research, India (ICMR)(Indian Council of Medical Research (ICMR))	This work is supported by the Department of Science and Technology-Science and Engineering Research Board, India (DST-SERB) Grant EMR/2015/001620 and Indian Council of Medical Research, India (ICMR) Grant AMR/INDO/GER/219/2019-ECD-II to R. S.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Banerjee R, 2012, J BIOL CHEM, V287, P44667, DOI 10.1074/jbc.M112.423202; Banerjee S, 2006, J MICROBIOL, V44, P11; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chen YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44305; Cukuroglu E, 2012, NUCLEIC ACIDS RES, V40, pD829, DOI 10.1093/nar/gkr929; Dutta D, 2008, J BIOL CHEM, V283, P20243, DOI 10.1074/jbc.M801926200; Drago-Serrano ME, 2018, CURR PHARM DESIGN, V24, P1067, DOI 10.2174/1381612824666180327155929; Ghosh G, 2018, J BACTERIOL, V200, DOI [10.1128/JB.00380-17, 10.1128/jb.00380-17]; Goude R., 2008, J VISUALIZED EXPT, V15, P761, DOI [10.3791/761, DOI 10.3791/761]; Gutierrrez P, 2007, J BIOL CHEM, V282, P23348, DOI 10.1074/jbc.M702010200; Haas David W, 2005, Top HIV Med, V13, P90; Hafeezunnisa M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.605305; Harinarayanan R, 2003, J MOL BIOL, V332, P31, DOI 10.1016/S0022-2836(03)00753-8; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Ibrahim HR, 2011, J AGR FOOD CHEM, V59, P10336, DOI 10.1021/jf2020396; Ippel JH, 2009, J BIOL CHEM, V284, P12363, DOI 10.1074/jbc.M808179200; Jain S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09146-5; Kalarickal NC, 2010, J MOL BIOL, V395, P966, DOI 10.1016/j.jmb.2009.12.022; Kalyani BS, 2011, J MOL BIOL, V413, P548, DOI 10.1016/j.jmb.2011.08.053; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kurnaresan V, 2015, MOL IMMUNOL B, V68, P421; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin CH, 2014, PHYTOPATHOLOGY, V104, P340, DOI 10.1094/PHYTO-09-13-0252-R; LINDEROTH NA, 1991, J BACTERIOL, V173, P6722, DOI 10.1128/jb.173.21.6722-6731.1991; Linderoth NA, 1997, VIROLOGY, V227, P131, DOI 10.1006/viro.1996.8325; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mitra P, 2017, ANNU REV MICROBIOL, V71, P687, DOI 10.1146/annurev-micro-030117-020432; Pal K, 2019, J MOL BIOL, V431, p4749 4766; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; Pani B, 2009, J MOL BIOL, V389, P647, DOI 10.1016/j.jmb.2009.04.052; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Qayyum MZ, 2016, J BIOL CHEM, V291, P8090, DOI 10.1074/jbc.M115.701268; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; Ranjan A, 2013, NUCLEIC ACIDS RES, V41, P6839, DOI 10.1093/nar/gkt336; Richardson JP, 2003, CELL, V114, P157, DOI 10.1016/S0092-8674(03)00554-3; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shashni R, 2014, NUCLEIC ACIDS RES, V42, P9677, DOI 10.1093/nar/gku690; Thandar M, 2016, ANTIMICROB AGENTS CH, V60, P2671, DOI 10.1128/AAC.02972-15; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Valabhoju V, 2016, J BIOL CHEM, V291, P22386, DOI 10.1074/jbc.M116.745364; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vasilchenko AS, 2017, J PEPT SCI, V23, P855, DOI 10.1002/psc.3049; Veldkamp AI, 1999, J CHROMATOGR B, V736, P123, DOI 10.1016/S0378-4347(99)00457-0; Wang QY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020600; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094; ZWIEFKA A, 1993, BIOCHEMISTRY-US, V32, P3564, DOI 10.1021/bi00065a007	55	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100653	10.1016/j.jbc.2021.100653	http://dx.doi.org/10.1016/j.jbc.2021.100653			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33845047	Green Published, gold			2022-12-26	WOS:000672866400624
J	Mizsei, R; Li, XL; Chen, WN; Szabo, M; Wang, JH; Wagner, G; Reinherz, EL; Mallis, RJ				Mizsei, Reka; Li, Xiaolong; Chen, Wan-Na; Szabo, Monika; Wang, Jia-Huai; Wagner, Gerhard; Reinherz, Ellis L.; Mallis, Robert J.			A general chemical crosslinking strategy for structural analyses of weakly interacting proteins applied to preTCR-pMHC complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; ALPHA-BETA; THYMIC SELECTION; TCR-BETA; PEPTIDE; RECOGNITION; MECHANISMS; ECTODOMAIN; LIGAND; MECHANOTRANSDUCTION	T lymphocytes discriminate between healthy and infected or cancerous cells via T-cell receptor-mediated recognition of peptides bound and presented by cell-surface-expressed major histocompatibility complex molecules (MHCs). Pre-T-cell receptors (preTCRs) on thymocytes foster development of alpha beta T lymphocytes through their beta chain interaction with MHC displaying self-peptides on thymic epithelia. The specific binding of a preTCR with a peptide-MHC complex (pMHC) has been identified previously as forming a weak affinity complex with a distinct interface from that of mature alpha beta TCR. However, a lack of appropriate tools has limited prior efforts to investigate this unique interface. Here we designed a small-scale linkage screening protocol using bismaleimide linkers for determining residue-specific distance constraints between transiently interacting protein pairs in solution. Employing linkage distance restraint-guided molecular modeling, we report the oriented solution docking geometry of a preTCR beta-pMHC interaction. The linkage model of preTCR beta-pMHC complex was independently verified with paramagnetic pseudocontact chemical shift (PCS) NMR of the unlinked protein mixtures. Using linkage screens, we show that the preTCR binds with differing affinities to peptides presented by MHC in solution. Moreover, the C-terminal peptide segment is a key determinant in preTCR-pMHC recognition. We also describe the process for future large-scale production and purification of the linked constructs for NMR, X-ray crystallography, and single-molecule electron microscopy studies.	[Mizsei, Reka; Li, Xiaolong; Wang, Jia-Huai; Reinherz, Ellis L.; Mallis, Robert J.] Dana Farber Canc Inst, Lab Immunobiol, Boston, MA 02115 USA; [Li, Xiaolong; Wang, Jia-Huai; Reinherz, Ellis L.; Mallis, Robert J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wang, Jia-Huai] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Mizsei, Reka] Semmelweis Univ, Dept Biochem, Budapest, Hungary; [Li, Xiaolong; Reinherz, Ellis L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Chen, Wan-Na; Wang, Jia-Huai; Wagner, Gerhard; Mallis, Robert J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Jia-Huai] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Mallis, Robert J.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Szabo, Monika] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Semmelweis University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Monash University	Reinherz, EL; Mallis, RJ (corresponding author), Dana Farber Canc Inst, Lab Immunobiol, Boston, MA 02115 USA.; Reinherz, EL; Mallis, RJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Reinherz, EL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Mallis, RJ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Mallis, RJ (corresponding author), Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu; robert_mallis@hms.harvard.edu	Li, Xiaolong/AAG-7297-2019; Mizsei, Réka/ABB-7079-2020	Li, Xiaolong/0000-0001-6549-4089; Mizsei, Réka/0000-0003-4519-4307	NIH [PO1 AI143565, P41 GM132079]; NIH R01 grant [AI115698, GM129026, AI0037581]; Claudia Adams Barr award; European National Talent Program [NTP-NFTO-P-15-0693, NTP-NFTO-P-17-C-0139, NTP-NFTO-P-19-B-0270]; Rosztoczy Foundation Scholarship; Semmelweis University [EFOP-3.6.3-VEKOP-16-2017-00009]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr award; European National Talent Program; Rosztoczy Foundation Scholarship; Semmelweis University	This work was supported by NIH PO1 AI143565 to R. J. M., J. H. W., G. W., and E. L. R.; NIH R01 grants AI115698 to E. L. R., GM129026 and AI0037581 to G. W.; NIH P41 GM132079 to G. W.; Claudia Adams Barr award to J.H. W; European National Talent Program (NTP-NFTO-P-15-0693, NTP-NFTO-P-17-C-0139 and NTP-NFTO-P-19-B-0270), Rosztoczy Foundation Scholarship, and Semmelweis University EFOP-3.6.3-VEKOP-16-2017-00009 scholarship to R. M. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bonvin AMJJ, 2018, NAT PROTOC, V13, P1503, DOI 10.1038/s41596-018-0017-6; BRAGG L, 1950, PROC R SOC LON SER-A, V203, P321, DOI 10.1098/rspa.1950.0142; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Bullock JMA, 2018, BIOINFORMATICS, V34, P3584, DOI 10.1093/bioinformatics/bty366; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong D, 2019, NATURE, V573, P546, DOI 10.1038/s41586-019-1537-0; Feng YN, 2018, TRENDS IMMUNOL, V39, P596, DOI 10.1016/j.it.2018.05.005; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Graham B, 2011, BIOCONJUGATE CHEM, V22, P2118, DOI 10.1021/bc200353c; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hwang W, 2020, P NATL ACAD SCI USA, V117, P21336, DOI 10.1073/pnas.2005899117; Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348; Keller R., 2004, COMPUTER AIDED RESON, V1; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koehler J, 2011, PROG NUCL MAG RES SP, V59, P360, DOI 10.1016/j.pnmrs.2011.05.001; KUNZ D, 1983, COLLOID POLYM SCI, V261, P635, DOI 10.1007/BF01415033; La Gruta NL, 2018, NAT REV IMMUNOL, V18, P467, DOI 10.1038/s41577-018-0007-5; Li XL, 2021, SCIENCE, V371, P181, DOI 10.1126/science.abe0918; Mallis RJ, 2018, J BIOL CHEM, V293, P754, DOI 10.1074/jbc.M117.813493; Mallis RJ, 2016, BIOMOL NMR ASSIGN, V10, P35, DOI 10.1007/s12104-015-9632-0; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Ming QQ, 2019, EXP BIOL MED, V244, P1559, DOI 10.1177/1535370219855401; Natarajan K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01657; Orton HW, 2020, MAGN RESON, V1, P1, DOI [10.5194/mr-1-1-2020, DOI 10.5194/MR-1-1-2020]; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Saio T, 2009, J BIOMOL NMR, V45, P335, DOI 10.1007/s10858-009-9370-7; Sasada T, 2001, J EXP MED, V194, P883, DOI 10.1084/jem.194.7.883; Sasada T, 2000, EUR J IMMUNOL, V30, P1281, DOI 10.1002/(SICI)1521-4141(200005)30:5<1281::AID-IMMU1281>3.3.CO;2-4; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Takaba H, 2017, TRENDS IMMUNOL, V38, P805, DOI 10.1016/j.it.2017.07.010; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Zhou B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00005	49	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100255	10.1016/j.jbc.2021.100255	http://dx.doi.org/10.1016/j.jbc.2021.100255			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837736	Green Published, gold			2022-12-26	WOS:000672866400231
J	Cook, C; Blesi, A; Brozak, S; Lenhart, S; Reed, H; Urquhart, C; Moncayo, A; Fryxell, RT				Cook, Cameron; Blesi, Annastashia; Brozak, Samantha; Lenhart, Suzanne; Reed, Hanna; Urquhart, Cassandra; Moncayo, Abelardo; Fryxell, Rebecca Trout			La Crosse virus spread within the mosquito population in Knox County, TN	PLOS ONE			English	Article							CALIFORNIA ENCEPHALITIS GROUP; WEST-NILE-VIRUS; AEDES-ALBOPICTUS; EPIDEMIOLOGY; TEMPERATURE; CULICIDAE; DIPTERA; MODEL; PRECIPITATION; TRANSMISSION	In Appalachia, La Crosse virus (LACV) is a leading pediatric arbovirus and public health concern for children under 16 years. LACV is transmitted via the bite of an infected Aedes mosquito. Thus, it is imperative to understand the dynamics of the local vector population in order to assess risk and transmission. Using entomological data collected from Knox County, Tennessee in 2013, we formulate an environmentally-driven system of ordinary differential equations to model mosquito population dynamics over a single season. Further, we include infected compartments to represent LACV transmission within the mosquito population. Findings suggest that the model, with dependence on degree days and accumulated precipitation, can closely describe field data. This model confirms the need to include these environmental variables when planning control strategies.	[Cook, Cameron; Lenhart, Suzanne] Univ Tennessee, Dept Math, Knoxville, TN 37996 USA; [Blesi, Annastashia] Bowling Green State Univ, Dept Higher Educ & Student Affairs, Bowling Green, OH 43403 USA; [Brozak, Samantha] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA; [Reed, Hanna] Univ Cent Florida, Dept Math, Orlando, FL 32816 USA; [Urquhart, Cassandra; Fryxell, Rebecca Trout] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Moncayo, Abelardo] Tennessee Dept Hlth, Vector Borne Dis Sect, Nashville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University System of Ohio; Bowling Green State University; Arizona State University; Arizona State University-Tempe; State University System of Florida; University of Central Florida; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Tennessee Department Health	Cook, C (corresponding author), Univ Tennessee, Dept Math, Knoxville, TN 37996 USA.	ccook54@vols.utk.edu		Cook, Cameron/0000-0002-2350-2041; Urquhart, Cassandra/0000-0001-9966-6491; Brozak, Samantha/0000-0002-0918-5289	Summer Research Experiences for Undergraduates program at the National Institute for Mathematical and Biological Synthesis, an Institute - National Science Foundation through NSF Award [DBI-1300426]; University of Tennessee, Knoxville	Summer Research Experiences for Undergraduates program at the National Institute for Mathematical and Biological Synthesis, an Institute - National Science Foundation through NSF Award; University of Tennessee, Knoxville	This work was partially supported through the Summer Research Experiences for Undergraduates program at the National Institute for Mathematical and Biological Synthesis, an Institute sponsored by the National Science Foundation through NSF Award DBI-1300426, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; ANNELISE T, 2013, INT J ENV RES PUB HE, V10, P1698, DOI DOI 10.3390/IJERPH10051698; Bevins SN, 2007, J MED ENTOMOL, V44, P945, DOI 10.1603/0022-2585(2007)44[945:EAAOAR]2.0.CO;2; Bewick S, 2016, EMERG INFECT DIS, V22, P1921, DOI 10.3201/eid2211.160308; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Darsie RFJ, 2005, IDENTIFICATION GEOGR; DeFoliart G.R., 1983, Progress in Clinical and Biological Research, V123, P89; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Erwin PC, 2002, AM J EPIDEMIOL, V155, P1060, DOI 10.1093/aje/155.11.1060; Gaensbauer JT, 2014, PEDIATRICS, V134, pE642, DOI 10.1542/peds.2014-0498; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Gu WD, 2006, J VECTOR ECOL, V31, P107, DOI 10.3376/1081-1710(2006)31[107:SEODDO]2.0.CO;2; Healy KB, 2019, J AM MOSQUITO CONTR, V35, P249, DOI 10.2987/19-6841.1; JOCELINE L, 2017, J MED ENTOMOL, V54, P1375, DOI DOI 10.1093/JME/TJX077; Kamimura Kiyoshi, 2002, Medical Entomology and Zoology, V53, P53; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Lambert AJ, 2005, J CLIN MICROBIOL, V43, P1885, DOI 10.1128/JCM.43.4.1885-1889.2005; Lenhart, 2019, LETT BIOMATHEMATICS, V6, P20; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Nance J, 2018, J VECTOR ECOL, V43, P138, DOI 10.1111/jvec.12293; Peterson AT, 2009, EPIDEMICS-NETH, V1, P240, DOI 10.1016/j.epidem.2009.11.003; Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Smith T, 2006, AM J TROP MED HYG, V75, P1; Szumlas DE, 1996, J MED ENTOMOL, V33, P598, DOI 10.1093/jmedent/33.4.598; T YM, 2019, J MATH BIOL, V79, P1077, DOI DOI 10.1007/S00285-019-01390-Z; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Tsai T F, 1991, Infect Dis Clin North Am, V5, P73; Urquhart C, 2016, J AM MOSQUITO CONTR, V32, P24, DOI 10.2987/8756-971X-32.1.24; Wang X, 2016, J THEOR BIOL, V411, P27, DOI 10.1016/j.jtbi.2016.09.015; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; Westby KM, 2015, J AM MOSQUITO CONTR, V31, P233, DOI 10.2987/moco-31-03-233-241.1	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249811	10.1371/journal.pone.0249811	http://dx.doi.org/10.1371/journal.pone.0249811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861763	Green Published, gold			2022-12-26	WOS:000641475400023
J	Zhang, WD; Sakoda, H; Nakazato, Y; Islam, MN; Pattou, F; Kerr-Conte, J; Nakazato, M				Zhang, Weidong; Sakoda, Hideyuki; Nakazato, Yuki; Islam, Md Nurul; Pattou, Francois; Kerr-Conte, Julie; Nakazato, Masamitsu			Neuromedin U uses G alpha(i2) and G alpha(o) to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSDUCTION; MECHANISMS; INHIBITION; BINDING; ACTIVATION; EXPRESSION; PERTUSSIS; PEPTIDES; GLUCAGON	Neuromedin U (NMU), a highly conserved peptide in mammals, is involved in a wide variety of physiological processes, including impairment of pancreatic beta-cell function via induction of mitochondrial dysfunction and endoplasmic reticulum (ER) stress, ultimately suppressing insulin secretion. NMU has two receptors, NMU receptor 1 (NMUR1) and NMUR2, both of which are G-protein-coupled receptors (GPCRs). Only NMUR1 is expressed in mouse islets and beta cell-derived MIN6-K8 cells. The molecular mechanisms underlying the insulinostatic action mediated by NMUR1 in beta cells have yet to be elucidated. In this study, we explored the molecular mechanism driving impairment of insulin secretion in beta cells by the NMU-NMUR1 axis. Pretreatment with the G alpha(i/o) inhibitor Bordetella pertussis toxin (PTX), but not the G alpha(q) inhibitor YM254890, abolished NMU-induced suppression of glucose-stimulated insulin secretion and calcium response in beta cells. Knockdown of G alpha(i2) and G alpha(o) in beta cells counteracted NMU-induced suppression of insulin secretion and gene alterations related to mitochondrial fusion (Mfn1, Mfn2), fission (Fis1, Drp1), mitophagy (Pink1, Park2), mitochondrial dynamics (Pgc-1 alpha, Nrf1, and Tfam), ER stress (Chop, Atp2a3, Ryr2, and Itpr2), intracellular ATP level, and mitochondrial membrane potential. NMU decreased forskolin-stimulated intracellular cAMP in both mouse and human islets. We concluded that NMUR1 coupled to PTX-sensitive G alpha(i2) and G alpha(o) proteins in beta cells reduced intracellular Ca2+ influx and cAMP level, thereby causing beta-cell dysfunction and impairment. These results highlight a novel signaling mechanism of NMU and provide valuable insights into the further investigation of NMU functions in beta-cell biology.	[Zhang, Weidong; Sakoda, Hideyuki; Nakazato, Yuki; Islam, Md Nurul; Nakazato, Masamitsu] Univ Miyazaki, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki, Japan; [Pattou, Francois; Kerr-Conte, Julie] Univ Lille, INSERM, CHU Lille, U1190,Translat Res Lab Diabet,European Genom Inst, Lille, France; [Nakazato, Masamitsu] Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	University of Miyazaki; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Nakazato, M (corresponding author), Univ Miyazaki, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki, Japan.; Nakazato, M (corresponding author), Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.	nakazato@med.miyazaki-u.ac.jp	Islam, Nurul/ABD-4764-2020	Islam, Nurul/0000-0002-2252-6789	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05333]; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) [JP19gm0610016]; Japan foundation for applied enzymology (Front Runner of Future Diabetes Research associated research grant, FFDR 2020)	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Japan foundation for applied enzymology (Front Runner of Future Diabetes Research associated research grant, FFDR 2020)	This study was supported in part by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (16H05333 to M. N.) and the Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (JP19gm0610016 to M. N.). This study was also supported in part by grants from the Japan foundation for applied enzymology (Front Runner of Future Diabetes Research associated research grant, FFDR 2020 to W.Z.).	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Aiyar N, 2004, PHARMACOLOGY, V72, P33, DOI 10.1159/000078630; Al-Amily IM, 2019, PFLUG ARCH EUR J PHY, V471, P633, DOI 10.1007/s00424-019-02262-7; Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Brighton PJ, 2004, MOL PHARMACOL, V66, P1544, DOI 10.1124/mol.104.002337; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; GRADY T, 1987, J BIOL CHEM, V262, P15514; GULBENKIAN A, 1968, ENDOCRINOLOGY, V83, P885, DOI 10.1210/endo-83-4-885; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hsu SH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1021, DOI 10.1152/ajpendo.00003.2007; Jiang MS, 2009, NEUROSIGNALS, V17, P23, DOI 10.1159/000186688; Kaczmarek P, 2006, INT J MOL MED, V18, P951; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Khan D, 2018, PEPTIDES, V100, P212, DOI 10.1016/j.peptides.2017.11.014; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; LAW SF, 1993, J BIOL CHEM, V268, P10721; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V156, P355, DOI 10.1016/S0006-291X(88)80848-9; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Oduori OS, 2020, J CLIN INVEST, V130, P6639, DOI 10.1172/JCI140046; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Park S, 2012, P NATL ACAD SCI USA, V109, P19003, DOI 10.1073/pnas.1209590109; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463; POUYSSEGUR J, 1992, ANNU REV PHYSIOL, V54, P195, DOI 10.1146/annurev.ph.54.030192.001211; Przygodzka P, 2019, CANCERS, V11, DOI 10.3390/cancers11091312; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Scarl RT, 2019, CELL CALCIUM, V83, DOI 10.1016/j.ceca.2019.102081; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; Straub SG, 2012, AM J PHYSIOL-CELL PH, V302, pC1687, DOI 10.1152/ajpcell.00282.2011; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Vantyghem MC, 2019, DIABETES CARE, V42, P2042, DOI 10.2337/dc19-0401; Wang F, 2011, CELL CALCIUM, V49, P12, DOI 10.1016/j.ceca.2010.11.002; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xu YZ, 2009, J RECEPT SIG TRANSD, V29, P318, DOI 10.3109/10799890903295150; YAJIMA M, 1978, J BIOCHEM-TOKYO, V83, P295, DOI 10.1093/oxfordjournals.jbchem.a131904; Zhang WD, 2020, FASEB J, V34, P133, DOI 10.1096/fj.201901743R; Zhang WD, 2017, BIOCHEM BIOPH RES CO, V493, P677, DOI 10.1016/j.bbrc.2017.08.132; Zhang YA, 2010, CELL SIGNAL, V22, P1660, DOI 10.1016/j.cellsig.2010.06.006; Zhao AZ, 2010, DIABETES, V59, P2522, DOI 10.2337/db09-1719	50	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250232	10.1371/journal.pone.0250232	http://dx.doi.org/10.1371/journal.pone.0250232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857254	gold, Green Published			2022-12-26	WOS:000641474900039
J	Owusu, M; Sylverken, AA; El-Duah, P; Ayisi-Boateng, NK; Yeboah, R; Adu, E; Asamoah, J; Frimpong, M; Senyo, J; Acheampong, G; Mutocheluh, M; Amuasi, J; Owusu-Dabo, E; Adu-Sarkodie, Y; Phillips, RO				Owusu, Michael; Sylverken, Augustina Angelina; El-Duah, Philip; Ayisi-Boateng, Nana Kwame; Yeboah, Richmond; Adu, Eric; Asamoah, Jesse; Frimpong, Michael; Senyo, Japhet; Acheampong, Godfred; Mutocheluh, Mohamed; Amuasi, John; Owusu-Dabo, Ellis; Adu-Sarkodie, Yaw; Phillips, Richard Odame			Low risk of SARS-CoV-2 in blood transfusion	PLOS ONE			English	Article							CORONAVIRUS	Background The novel coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), continues to remain a global challenge. There is emerging evidence of SARS-CoV-2 virus found in the blood of patients from China and some developed countries. However, there is inadequate data reported in Ghana and other parts of Africa, where blood transfusion service heavily relies on voluntary and replacement blood donors. This study aimed to investigate whether plasma of infected individuals could pose significant transfusion transmitted risk of COVID-19 in Ghanaian populations. Methods This cross-sectional retrospective study was conducted at the Kumasi Centre for Collaborative Research into Tropical Medicine (KCCR), KNUST, Ghana. Study subjects comprised contacts of COVID-19 individuals, those with classical symptoms of COVID-19 and individuals who had recovered based on the new Ghana discharge criteria. Whole blood, sputum or deep coughed saliva samples were collected and transported to KCCR for SARS-CoV-2 testing. Viral nucleic acid was extracted from sputum/nasopharyngeal samples using Da An Gene column based kit and from plasma using LBP nucleic acid extraction kit. Real-Time PCR was performed specifically targeting the ORF1ab and Nucleocapsid (N) genomic regions of the virus. Results A total of 97 individuals were recruited into the study, with more than half being males (58; 59.7%). The mean age of all subjects was 33 years (SD = 7.7) with minimum being 22 years and maximum 56 years. Majority (76; 78.4%) of all the subjects were asymptomatic, and among the few symptomatic subjects, cough (10; 10.3%) was the most predominant symptom. Of the 97 sputum samples tested, 79 (81.4%) were positive for SARS-CoV-2. We identified SARS-CoV-2 viral RNA in the plasma of 1 (1.03%) subject who had clinically recovered. Conclusion This study reports the identification of SARS-CoV-2 viral RNA in a convalescent individual in Ghana. Due to the low prevalence observed and the marginal cycling thresholds associated, the risk of transfusion transmission of SARS-CoV-2 is negligible. Well-powered studies and advanced diagnostics to determine infectious viremia is recommended to further evaluate the potential risk of hematogenous transmission among recovered patients.	[Owusu, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Med Diagnost, Kumasi, Ghana; [Owusu, Michael; Sylverken, Augustina Angelina; Yeboah, Richmond; Adu, Eric; Asamoah, Jesse; Frimpong, Michael; Phillips, Richard Odame] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Owusu, Michael; Acheampong, Godfred] Ctr Hlth Syst Strengthening, Kumasi, Ghana; [Sylverken, Augustina Angelina] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana; [El-Duah, Philip] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Ayisi-Boateng, Nana Kwame; Phillips, Richard Odame] Kwame Nkrumah Univ Sci & Technol, Dept Med, Kumasi, Ghana; [Frimpong, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Mol Med, Kumasi, Ghana; [Senyo, Japhet; Mutocheluh, Mohamed; Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana; [Amuasi, John; Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Dept Global & Int Hlth, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Owusu, M (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Med Diagnost, Kumasi, Ghana.; Owusu, M (corresponding author), Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana.; Owusu, M (corresponding author), Ctr Hlth Syst Strengthening, Kumasi, Ghana.	michaelowusu80@gmail.com	El-Duah, Philip/AAN-7425-2021; Phillips, Richard Odame/ABD-5394-2021	El-Duah, Philip/0000-0003-1671-0755; Phillips, Richard Odame/0000-0001-8992-0222; Acheampong, Godfred/0000-0003-2495-9235; Kamasah, Japhet Senyo/0000-0003-0369-555X; SYLVERKEN, AUGUSTINA/0000-0002-7691-914X; YEBOAH, RICHMOND/0000-0002-2765-6179				Corman VM, 2020, TRANSFUSION, V60, P1119, DOI 10.1111/trf.15841; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ghana Health Service, 2020, GHANA NATL STRATEGY; Ghana-Health-Service, 2020, DE ISOLATION DISCHAR; Ghana-Health-Service, 2020, UPDATES CORONAVIRUS; Hopkins C, 2020, CORONAVIRUS RESOURCE; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Tho DP., 2020, ANN INTERN MED, V173; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Wang WK, 2005, J CLIN MICROBIOL, V43, P962, DOI 10.1128/JCM.43.2.962-965.2005; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071	12	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249069	10.1371/journal.pone.0249069	http://dx.doi.org/10.1371/journal.pone.0249069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848293	Green Published, gold			2022-12-26	WOS:000640373500008
J	Gichangi, P; Waithaka, M; Thiongo, M; Agwanda, A; Radloff, S; Tsui, A; Zimmerman, L; Temmerman, M				Gichangi, Peter; Waithaka, Michael; Thiongo, Mary; Agwanda, Alfred; Radloff, Scott; Tsui, Amy; Zimmerman, Linea; Temmerman, Marleen			Demand satisfied by modern contraceptive among married women of reproductive age in Kenya	PLOS ONE			English	Article							UNMET NEED; HEALTH; COUNTRIES; TRENDS; IMPACT; DEVOLUTION; SERVICES; COVERAGE; REASONS; EQUITY	Background Demand for family planning met/satisfied with modern contraceptive methods (mDFPS) has been proposed to track progress in Family Planning (FP) programs for Sustainable Development Goals. This study measured mDFPS among married women of reproductive age (MWRA) in Kenya to identify which groups were not being reached by FP programs. Materials and methods Performance, Monitoring and Accountability 2020 (PMA2020) survey data from 2014-2018 was used. PMA2020 surveys are cross-sectional including women 15-49 years. PMA2020 used a 2-stage cluster design with urban/rural regions as strata with random selection of households. Univariate and multivariate analysis was done using stata V15. Results Of the 34,832 respondents interviewed from 2014 to 2018, 60.2% were MWRA. There was a significant decrease in demand for FP from 2014 to 2018, p = 0.012. Lowest demand was among 15-19 and 45-49 years old women. Overall, modern contraceptive prevalence rate increased significantly from 54.6% to 60.8%, p = 0.004, being higher for women from urban areas, home visits by health care worker (HCW), educated, wealthy, visited health facilities and exposed to mass media. Unmet need for FP decreased from 23.0-13.8% over the 5-years, p<0.001. Married adolescent 15-19 had the highest unmet need and those from rural areas, poor, uneducated and not exposed to mass media. mDFPS increased significantly from 69.7-79.4% over the 5-years, p<0.001, with increase in long acting reversible contraception/permanent methods from 19.9-37.2% and decrease in short acting methods from 49.9-42.2%. Significant determinants of mDFPS were age, rural/urban residence, education, wealth, health facility visitation, exposure to FP messages via mass media in the last 12 months, year of study and county of residence. Conclusions Results show a good progress in key FP indicators. However, not all MWRA are being reached and should be reached if Kenya is to achieve the desired universal health coverage as well as Sustainable Development Goals. Targeted home visits by HCW as well increase in mass media coverage could be viable interventions.	[Gichangi, Peter] Tech Univ Mombasa, Mombasa, Kenya; [Gichangi, Peter] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium; [Gichangi, Peter; Waithaka, Michael; Thiongo, Mary; Temmerman, Marleen] Int Ctr Reprod Hlth, Mombasa, Kenya; [Agwanda, Alfred] Univ Nairobi, Populat Serv Res Inst PSRI, Nairobi, Kenya; [Radloff, Scott; Tsui, Amy; Zimmerman, Linea] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Temmerman, Marleen] Aga Khan Univ, Nairobi, Kenya	Technical University of Mombasa; Ghent University; Ghent University Hospital; University of Nairobi; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University	Gichangi, P (corresponding author), Tech Univ Mombasa, Mombasa, Kenya.; Gichangi, P (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium.; Gichangi, P (corresponding author), Int Ctr Reprod Hlth, Mombasa, Kenya.	gichangip@yahoo.com		Gichangi, Peter/0000-0001-9636-165X; Waithaka, Michael/0000-0002-6766-9492; Zimmerman, Linnea A/0000-0002-0118-0889; Thiongo, Mary/0000-0002-0598-995X				Achilles SL, 2018, CONTRACEPTION, V97, P346, DOI 10.1016/j.contraception.2017.09.013; Adam MB, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000665; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alkenbrack S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134905; Bamrah S, 2013, PREHOSP DISASTER MED, V28, P43, DOI 10.1017/S1049023X12001665; Bremner J., 2015, POLICY BRIEF; Cahill N, 2018, LANCET, V391, P870, DOI 10.1016/S0140-6736(17)33104-5; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Choi Y, 2018, GLOB HEALTH-SCI PRAC, V6, P387, DOI 10.9745/GHSP-D-18-00012; Choi Y, 2015, GLOBAL HEALTH ACTION, V8, P3, DOI 10.3402/gha.v8.29734; Ewerling F, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0483-x; Fabic MS, 2015, LANCET, V385, P1928, DOI 10.1016/S0140-6736(14)61055-2; Fagan T, 2017, GLOB HEALTH-SCI PRAC, V5, P382, DOI 10.9745/GHSP-D-17-00057; Furnivall D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019319; Goodkind D, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1423861; Hardee K, 2018, POPUL ENVIRON, V40, P204, DOI 10.1007/s11111-018-0310-x; Hellwig F, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020423; Husain I, 2016, FOSTERING EC GROWTH; Kantorova V, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003026; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kenya National Bureau of Statistics (KNBS), 2015, KENYA DEMOGRAPHIC HL; Machiyama K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0268-z; McCollum R, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0967-5; New JR, 2017, LANCET GLOB HEALTH, V5, pE350, DOI [10.1016/S2214-109X(17)30033-5, 10.1016/s2214-109x(17)30033-5]; Njuguna J, 2015, J HEALTH CARE POOR U, V26, P1200, DOI 10.1353/hpu.2015.0106; Prata N, 2017, J BIOSOC SCI, V49, P713, DOI 10.1017/S0021932016000663; Rana MJ, 2017, J BIOSOC SCI, V49, P773, DOI [10.1017/S0021932016000717, 10.1017/s0021932016000717]; Ross J, 2015, GLOB HEALTH-SCI PRAC, V3, P419, DOI 10.9745/GHSP-D-15-00124; Ruiz M, 2013, J ROY SOC MED, V106, P362, DOI 10.1177/0141076813490685; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Sedgh G, 2014, STUD FAMILY PLANN, V45, P151, DOI 10.1111/j.1728-4465.2014.00382.x; Tsofa B, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0649-0; UNFPA, 2008, FAMILY PLANNING ENV; United States Agency for International Development USAID, 2012, BUILDING RESILIENCE; WHO, 2015, GLOB REF LIST 100 CO; Wulifan JK, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-015-0281-3; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	37	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0248393	10.1371/journal.pone.0248393	http://dx.doi.org/10.1371/journal.pone.0248393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836006	Green Published, gold			2022-12-26	WOS:000639361000016
J	Robinson, EK; Covarrubias, S; Zhou, SM; Carpenter, S				Robinson, Elektra Kantzari; Covarrubias, Sergio; Zhou, Simon; Carpenter, Susan			Generation and utilization of a HEK-293T murine GM-CSF expressing cell line	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; FLT3 LIGAND; DIFFERENTIATION; MACROPHAGES; IDENTIFICATION	Macrophages and dendritic cells (DCs) are innate immune cells that play a key role in defense against pathogens. In vitro cultures of bone marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs) are well-established and valuable methods for immunological studies. Typically, commercially available recombinant GM-CSF is utilized to generate BMDCs and is also used to culture alveolar macrophages. We have generated a new HEK-293T cell line expressing murine GM-CSF that secretes high levels of GM-CSF (similar to 180 ng/ml) into complete media as an alternative to commercial GM-CSF. Differentiation of dendritic cells and expression of various markers were kinetically assessed using the GM-CSF HEK293T cell line, termed supGM-CSF and compared directly to purified commercial GMCSF. After 7-9 days of cell culture the supGM-CSF yielded twice as many viable cells compared to the commercial purified GM-CSF. In addition to differentiating BMDCs, the supGM-CSF can be utilized to culture functionally active alveolar macrophages. Collectively, our results show that supernatant from our GM-CSF HEK293T cell line supports the differentiation of mouse BMDCs or alveolar macrophage culturing, providing an economical alternative to purified GM-CSF.	[Robinson, Elektra Kantzari; Covarrubias, Sergio; Zhou, Simon; Carpenter, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Carpenter, S (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	sucarpen@ucsc.edu		Zhou, Simon/0000-0001-8695-7943; Robinson, Elektra/0000-0003-1427-3897	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21AR070973]; UCSC	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UCSC	Work on this project was supported by R21AR070973 to Susan Carpenter, an award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Additional support was obtained from startup funds from UCSC to the Carpenter lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sergio Covarrubias received partial support from the R21AR070973 for his salary.	Almo SC, 2014, CURR OPIN STRUC BIOL, V26, P39, DOI 10.1016/j.sbi.2014.03.006; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Busch CJL, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3302; Carreras E, 2008, J IMMUNOL, V180, P727, DOI 10.4049/jimmunol.180.2.727; CHEN BD, 1988, J IMMUNOL, V141, P139; Dong YF, 2016, JOVE-J VIS EXP, DOI 10.3791/54194; Erlich Z, 2019, NAT IMMUNOL, V20, P397, DOI 10.1038/s41590-019-0313-5; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Klose D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180305; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Na YR, 2016, MOL CELLS, V39, P734, DOI 10.14348/molcells.2016.0160; Nikolic T, 2003, INT IMMUNOL, V15, P515, DOI 10.1093/intimm/dxg050; Ono Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25837-3; Qin ZH, 1997, J IMMUNOL, V159, P770; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P1617, DOI 10.1128/AAC.49.4.1617-1621.2005; Roney Kelly, 2013, Methods Mol Biol, V1031, P71, DOI 10.1007/978-1-62703-481-4_9; Santin AD, 1999, IMMUNOBIOLOGY, V200, P187, DOI 10.1016/S0171-2985(99)80069-2; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Smith SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026908; ten Broeke T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016873; Wang WG, 2016, MED SCI MONITOR, V22, P244, DOI 10.12659/MSM.896951; Weichart D, 2006, J BIOL CHEM, V281, P2380, DOI 10.1074/jbc.M505986200; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Zaynagetdinov R, 2013, AM J RESP CELL MOL, V49, P180, DOI 10.1165/rcmb.2012-0366MA; Zhang Y, 1998, BLOOD, V92, P118, DOI 10.1182/blood.V92.1.118.413a01_118_128	29	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249117	10.1371/journal.pone.0249117	http://dx.doi.org/10.1371/journal.pone.0249117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836009	Green Submitted, Green Published, gold			2022-12-26	WOS:000639361000027
J	Thiel, BA; Worodria, W; Nalukwago, S; Nsereko, M; Sanyu, I; Rejani, L; Zawedde, J; Canaday, DH; Stein, CM; Chervenak, KA; Malone, LL; Kiyemba, R; Silver, RF; Johnson, JL; Mayanja-Kizza, H; Boom, WH				Thiel, Bonnie A.; Worodria, William; Nalukwago, Sophie; Nsereko, Mary; Sanyu, Ingvar; Rejani, Lalitha; Zawedde, Josephine; Canaday, David H.; Stein, Catherine M.; Chervenak, Keith A.; Malone, LaShaunda L.; Kiyemba, Ronald; Silver, Richard F.; Johnson, John L.; Mayanja-Kizza, Harriet; Boom, W. Henry			Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection	PLOS ONE			English	Article							RESPONSES	Background The search for immune correlates of protection against Mycobacterium tuberculosis (MTB) infection in humans is limited by the focus on peripheral blood measures. Bronchoalveolar lavage (BAL) can safely be done and provides insight into cellular function in the lung where infection is first established. In this study, blood and lung samples were assayed to determine if heavily MTB exposed persons who resist development of latent MTB infection (RSTR) vs those who develop latent MTB infection (LTBI), differ in the make-up of resident BAL innate and adaptive immune cells. Methods Bronchoscopy was performed on 21 healthy long-term Ugandan RSTR and 25 LTBI participants. Immune cell distributions in BAL and peripheral blood were compared by differential cell counting and flow cytometry. Results The bronchoscopy procedure was well tolerated with few adverse reactions. Differential macrophage and lymphocyte frequencies in BAL differed between RSTR and LTBI. When corrected for age, this difference lost statistical significance. BAL CD4+ and CD8+ T cells were almost entirely composed of effector memory T cells in contrast to PBMC, and did not differ between RSTR and LTBI. BAL NKT, gamma delta T cells and NK cells also did not differ between RTSR and LTBI participants. There was a marginally significant increase (p = 0.034) in CD8 T effector memory cells re-expressing CD45RA (T-EMRA) in PBMC of LTBI vs RSTR participants. Conclusion This observational case-control study comparing unstimulated BAL from RSTR vs LTBI, did not find evidence of large differences in the distribution of baseline BAL immune cells. PBMC T-EMRA cell percentage was higher in LTBI relative to RSTR suggesting a role in the maintenance of latent MTB infection. Functional immune studies are required to determine if and how RSTR and LTBI BAL immune cells differ in response to MTB.	[Thiel, Bonnie A.; Nsereko, Mary; Canaday, David H.; Stein, Catherine M.; Chervenak, Keith A.; Malone, LaShaunda L.; Johnson, John L.; Mayanja-Kizza, Harriet; Boom, W. Henry] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA; [Thiel, Bonnie A.; Nsereko, Mary; Canaday, David H.; Stein, Catherine M.; Chervenak, Keith A.; Malone, LaShaunda L.; Johnson, John L.; Mayanja-Kizza, Harriet; Boom, W. Henry] Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; [Thiel, Bonnie A.; Nsereko, Mary; Canaday, David H.; Stein, Catherine M.; Chervenak, Keith A.; Malone, LaShaunda L.; Johnson, John L.; Mayanja-Kizza, Harriet; Boom, W. Henry] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Thiel, Bonnie A.; Worodria, William; Nalukwago, Sophie; Nsereko, Mary; Sanyu, Ingvar; Rejani, Lalitha; Zawedde, Josephine; Stein, Catherine M.; Chervenak, Keith A.; Malone, LaShaunda L.; Kiyemba, Ronald; Johnson, John L.; Mayanja-Kizza, Harriet; Boom, W. Henry] Makerere Univ, Coll Hlth Sci, Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda; [Thiel, Bonnie A.; Worodria, William; Nalukwago, Sophie; Nsereko, Mary; Sanyu, Ingvar; Rejani, Lalitha; Zawedde, Josephine; Stein, Catherine M.; Chervenak, Keith A.; Malone, LaShaunda L.; Kiyemba, Ronald; Johnson, John L.; Mayanja-Kizza, Harriet; Boom, W. Henry] Mulago Hosp, Kampala, Uganda; [Silver, Richard F.] Louis Stokes Cleveland Dept Vet Affairs, Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH USA; [Silver, Richard F.] Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Makerere University; Mulago National Referral Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Thiel, BA (corresponding author), Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA.; Thiel, BA (corresponding author), Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA.; Thiel, BA (corresponding author), Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA.; Thiel, BA (corresponding author), Makerere Univ, Coll Hlth Sci, Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda.; Thiel, BA (corresponding author), Mulago Hosp, Kampala, Uganda.	bonnie.thiel@case.edu		Sanyu, Ingvar/0000-0001-5324-5448; Lalitha, Rejani/0000-0003-0073-9879; Worodria, William/0000-0002-8531-5567	NIAID [UO1AI115642, RO1AI124348, 75N93019C00071]; National Institute of Allergy and Infectious Diseases, National Institute of Health	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIAID grant UO1AI115642 to WHB, NIAID grant RO1AI124348 to WHB and CMS, NIAID contract 75N93019C00071 to WHB. National Institute of Allergy and Infectious Diseases, National Institute of Health https://www.niaid.nih.gov/.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036046; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Burel JG, 2017, J IMMUNOL, V198, P1748, DOI 10.4049/jimmunol.1601750; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Lu LL, 2019, NAT MED, V25, P977, DOI 10.1038/s41591-019-0441-3; Malherbe ST, 2019, TRANSL MED COMMUN, V4, P1; Martinsen EMH, 2016, EUR CLIN RESPIR J, V3, DOI 10.3402/ecrj.v3.29511; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Orlando V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01119; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Seshadri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175844; Silver RF, 2003, AM J RESP CELL MOL, V29, P117, DOI 10.1165/rcmb.4840; Simmons JD, 2018, NAT REV IMMUNOL, V18, P575, DOI 10.1038/s41577-018-0025-3; Stein CM, 2019, CLIN INFECT DIS, V68, P1705, DOI 10.1093/cid/ciy751; Stein CM, 2018, AM J EPIDEMIOL, V187, P1477, DOI 10.1093/aje/kwx380; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249477	10.1371/journal.pone.0249477	http://dx.doi.org/10.1371/journal.pone.0249477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836031	Green Published, Green Submitted, gold			2022-12-26	WOS:000639361000024
J	Dupuis, F; Sole, G; Wassinger, C; Bielmann, M; Bouyer, LJ; Roy, JS				Dupuis, Frederique; Sole, Gisela; Wassinger, Craig; Bielmann, Mathieu; Bouyer, Laurent J.; Roy, Jean-Sebastien			Fatigue, induced via repetitive upper-limb motor tasks, influences trunk and shoulder kinematics during an upper limb reaching task in a virtual reality environment	PLOS ONE			English	Article							MUSCLE FATIGUE; ROTATOR CUFF; INTERNAL-MODELS; MOVEMENT; COORDINATION; ADAPTATIONS; ORIENTATION; PATTERNS; POSITION; EMG	Background Efficient shoulder movement depends on the ability of central nervous system to integrate sensory information and to create an appropriate motor command. Various daily encountered factors can potentially compromise the execution of the command, such as fatigue. This study explored how fatigue influences shoulder movements during upper limb reaching. Methods Forty healthy participants were randomly assigned to one of two groups: Control or Fatigue Group. All participants completed an upper limb reaching task at baseline and post-experimental, during which they reached four targets located at 90 degrees of shoulder abduction, 90 degrees external rotation at 90 degrees abduction, 120 degrees scaption, and 120 degrees flexion in a virtual reality environment. Following the baseline phase, the Fatigue Group completed a shoulder fatigue protocol, while Controls took a 10-minute break. Thereafter, the reaching task was repeated. Upper limb kinematic (joint angles and excursions) and spatiotemporal (speed and accuracy) data were collected during the reaching task. Electromyographic activity of the anterior and middle deltoids were also collected to characterize fatigue. Two-way repeated-measures ANOVA were performed to determine the effects of Time, Group and of the interaction between these factors. Results The Fatigue group showed decreased mean median power frequency and increased electromyographic amplitudes of the anterior deltoid (p < 0.05) following the fatigue protocol. Less glenohumeral elevation, increased trunk flexion and rotation and sternoclavicular elevation were also observed in the Fatigue group (Group x Time interaction, p < 0.05). The Control group improved their movement speed and accuracy in post-experimental phase, while the Fatigue group showed a decrease of movement speed and no accuracy improvement (Group x Time interaction, p < 0.05). Conclusion In a fatigued state, changes in movement strategy were observed during the reaching task, including increased trunk and sternoclavicular movements and less glenohumeral movement. Performance was altered as shown by the lack of accuracy improvement over time and a decrease in movement speed in the Fatigue group.	[Dupuis, Frederique; Bouyer, Laurent J.; Roy, Jean-Sebastien] Univ Laval, Fac Med, Quebec City, PQ, Canada; [Dupuis, Frederique; Bielmann, Mathieu; Bouyer, Laurent J.; Roy, Jean-Sebastien] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Sole, Gisela] Univ Otago, Ctr Hlth Act & Rehabil Res, Sch Physiotherapy, Dunedin, New Zealand; [Wassinger, Craig] East Tennessee State Univ, Dept Phys Therapy, Johnson City, TN USA	Laval University; Laval University; University of Otago; East Tennessee State University	Roy, JS (corresponding author), Univ Laval, Fac Med, Quebec City, PQ, Canada.; Roy, JS (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.	Jean-Sebastien.Roy@fmed.ulaval.ca	; Bouyer, Laurent/A-9255-2010	Sole, Gisela/0000-0002-1632-0338; Roy, Jean-Sebastien/0000-0003-2853-9940; Dupuis, Frederique/0000-0002-0607-2908; Bouyer, Laurent/0000-0003-2034-4516	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05996]; Fonds de recherche du Quebec - Sante (FRQS); Canadian Institutes of Health Research; Fonds de recherche du Quebec-Sante	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (RGPIN-2016-05996). Frederique Dupuis iss supported by a scholarship from Fonds de recherche du Quebec - Sante (FRQS) J-SR is supported by salary awards from the Canadian Institutes of Health Research and from the Fonds de recherche du Quebec-Sante.	Bachasson D, 2015, J SHOULDER ELB SURG, V24, P1322, DOI 10.1016/j.jse.2015.04.004; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BONNARD M, 1994, NEUROSCI LETT, V166, P101, DOI 10.1016/0304-3940(94)90850-8; Brindle TJ, 2006, J ELECTROMYOGR KINES, V16, P236, DOI 10.1016/j.jelekin.2005.06.012; Chopp JN, 2011, CLIN BIOMECH, V26, P40, DOI 10.1016/j.clinbiomech.2010.09.001; Chopp JN, 2010, J SHOULDER ELB SURG, V19, P1137, DOI 10.1016/j.jse.2010.03.017; Cote JN, 2005, CLIN BIOMECH, V20, P581, DOI 10.1016/j.clinbiomech.2005.02.012; Cowley JC, 2017, HUM MOVEMENT SCI, V56, P109, DOI 10.1016/j.humov.2017.10.015; Dube MO, 2019, GAIT POSTURE, V74, P135, DOI 10.1016/j.gaitpost.2019.09.006; Ebaugh DD, 2006, J ELECTROMYOGR KINES, V16, P224, DOI 10.1016/j.jelekin.2005.06.015; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Forestier N, 1998, NEUROSCI LETT, V252, P187, DOI 10.1016/S0304-3940(98)00584-9; Forman DA, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10070445; Fuller JR, 2013, HUM MOVEMENT SCI, V32, P618, DOI 10.1016/j.humov.2013.03.002; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI [10.1016/S1050-6411(00)00027-4, DOI 10.1016/S1050-6411(00)00027-4]; Huysmans MA, 2008, J ELECTROMYOGR KINES, V18, P410, DOI 10.1016/j.jelekin.2006.11.003; Karagiannopoulos C, 2020, J HAND THER, V33, P329, DOI 10.1016/j.jht.2019.03.004; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Lefevre-Colau MM, 2018, ANN PHYS REHABIL MED, V61, P46, DOI 10.1016/j.rehab.2017.09.002; Lewis J, 2015, J ORTHOP SPORT PHYS, V45, P923, DOI 10.2519/jospt.2015.5941; Ludewig PM, 2011, MANUAL THER, V16, P33, DOI 10.1016/j.math.2010.08.004; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Lukasiewicz AC, 1999, J ORTHOP SPORT PHYS, V29, P574, DOI 10.2519/jospt.1999.29.10.574; Marco G, 2017, PHYSIOL MEAS, V38, pR27, DOI 10.1088/1361-6579/aa60b9; McCausland C, 2021, STATPEARLS; McCreesh Karen M, 2017, BMJ Open Sport Exerc Med, V3, pe000279, DOI 10.1136/bmjsem-2017-000279; McDonald AC, 2019, APPL ERGON, V75, P250, DOI 10.1016/j.apergo.2018.11.001; McDonald AC, 2016, J ELECTROMYOGR KINES, V29, P42, DOI 10.1016/j.jelekin.2015.05.005; Mendez-Rebolledo G, 2018, PHYS THER SPORT, V32, P80, DOI 10.1016/j.ptsp.2018.04.015; Monjo F, 2015, HUM MOVEMENT SCI, V44, P225, DOI 10.1016/j.humov.2015.09.006; Niehorster DC, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517708205; Nussbaum MA, 2001, AIHAJ, V62, P446; Pearl M L, 1992, J Shoulder Elbow Surg, V1, P113, DOI 10.1016/S1058-2746(09)80129-8; Poitras I, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081885; Poitras I, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19071555; Pritchard SE, 2019, ERGONOMICS, V62, P1214, DOI 10.1080/00140139.2019.1626491; Proske U, 2019, EXP BRAIN RES, V237, P2447, DOI 10.1007/s00221-019-05634-8; Qin J, 2014, J ELECTROMYOGR KINES, V24, P404, DOI 10.1016/j.jelekin.2014.02.001; Sadler CM, 2019, HUM MOVEMENT SCI, V66, P220, DOI 10.1016/j.humov.2019.04.016; Saey D., 0148639X PRINT; Schmid M, 2006, NEUROSCIENCE, V139, P909, DOI 10.1016/j.neuroscience.2005.12.060; SKINNER HB, 1986, J ORTHOP RES, V4, P112, DOI 10.1002/jor.1100040115; Tomita Y, 2017, NEUROREHAB NEURAL RE, V31, P885, DOI 10.1177/1545968317739998; Urra O, 2015, IEEE ENG MED BIO, P3945, DOI 10.1109/EMBC.2015.7319257; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Veeger HEJ, 2007, J BIOMECH, V40, P2119, DOI 10.1016/j.jbiomech.2006.10.016	47	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249403	10.1371/journal.pone.0249403	http://dx.doi.org/10.1371/journal.pone.0249403			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831037	Green Published, gold			2022-12-26	WOS:000639359600010
J	Hamilton, E; Cicuta, P				Hamilton, Evelyn; Cicuta, Pietro			Changes in geometrical aspects of a simple model of cilia synchronization control the dynamical state, a possible mechanism for switching of swimming gaits in microswimmers	PLOS ONE			English	Article							PARAMECIUM; PROTOZOAN	Active oscillators, with purely hydrodynamic coupling, are useful simple models to understand various aspects of motile cilia synchronization. Motile cilia are used by microorganisms to swim and to control the flow fields in their surroundings; the patterns observed in cilia carpets can be remarkably complex, and can be changed over time by the organism. It is often not known to what extent the coupling between cilia is due to just hydrodynamic forces, and neither is it known if it is biological or physical triggers that can change the dynamical collective state. Here we treat this question from a very simplified point of view. We describe three possible mechanisms that enable a switch in the dynamical state, in a simple scenario of a chain of oscillators. We find that shape-change provides the most consistent strategy to control collective dynamics, but also imposing small changes in frequency produces some unique stable states. Demonstrating these effects in the abstract minimal model proves that these could be possible explanations for gait switching seen in ciliated micro organisms like Paramecium and others. Microorganisms with many cilia could in principle be taking advantage of hydrodynamic coupling, to switch their swimming gait through either a shape change that manifests in decreased coupling between groups of cilia, or alterations to the beat style of a small subset of the cilia.	[Hamilton, Evelyn; Cicuta, Pietro] Univ Cambridge, Cavendish Lab, Cambridge, England	University of Cambridge	Cicuta, P (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge, England.	pc245@cam.ac.uk		Cicuta, Pietro/0000-0002-9193-8496	EU ERC CoG HydroSync; Cambridge Trusts	EU ERC CoG HydroSync; Cambridge Trusts	PC was supported by EU ERC CoG HydroSync and EH by Cambridge Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranson I., 2013, PHYSICS, V6, P61, DOI [DOI 10.1103/PHYSICS.6.61, 10.1103/physics.6.61]; Banerjee T, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.022201; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Battle C, 2016, SCIENCE, V352, P604, DOI 10.1126/science.aac8167; Bayly PV, 2011, BIOPHYS J, V100, P2716, DOI 10.1016/j.bpj.2011.05.001; Bennett RR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1164; BLAKE JR, 1974, BIOL REV, V49, P85, DOI 10.1111/j.1469-185X.1974.tb01299.x; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Brumley DR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1358; Brumley DR, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.268102; Bruot N., 2016, ANN REV CONDENS MATT, V7; Bruot N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0571; Bruot N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.164103; Camalet S, 2000, NEW J PHYS, V2, P241, DOI 10.1088/1367-2630/2/1/324; Cicuta P, 2020, BIOCHEM SOC T, V48, P221, DOI 10.1042/BST20190571; Cochet-Escartin O, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/5/056010; Colin SP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74745-y; Contino M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.258102; Cosentino Lagomarsino M, 2002, EUR PHYS J B, V26, P81, DOI 10.1140/epjb/e20020069; Dey S, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.012403; Elgeti J, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/5/056601; Elgeti J, 2013, P NATL ACAD SCI USA, V110, P4470, DOI 10.1073/pnas.1218869110; Foster KW, 2017, CYTOSKELETON, V74, P260, DOI 10.1002/cm.21372; Gaffney EA, 2011, ANNU REV FLUID MECH, V43, P501, DOI 10.1146/annurev-fluid-121108-145442; Gilpin W, 2017, NAT PHYS, V13, P380, DOI 10.1038/NPHYS3981; Giuffre C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015274; Goldstein RE, 2015, ANNU REV FLUID MECH, V47, P343, DOI 10.1146/annurev-fluid-010313-141426; Guasto JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168102; Gueron S, 1997, P NATL ACAD SCI USA, V94, P6001, DOI 10.1073/pnas.94.12.6001; Hamel A, 2011, P NATL ACAD SCI USA, V108, P7290, DOI 10.1073/pnas.1016687108; Hamilton E, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aae103; Hamilton E, 2017, CHAOS, V27, DOI 10.1063/1.4989466; Hamiltonl E, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0152; Hossain MM, 2019, PHYS FLUIDS, V31, DOI 10.1063/1.5094076; Kotar J, 2010, P NATL ACAD SCI USA, V107, P7669, DOI 10.1073/pnas.0912455107; Lauga E, 2011, P NATL ACAD SCI USA, V108, P7655, DOI 10.1073/pnas.1104613108; Lauga E, 2011, SOFT MATTER, V7, P3060, DOI 10.1039/c0sm00953a; Leoni M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036304; Leptos KC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.158101; Lhermerout R, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105023; Lushi E, 2014, P NATL ACAD SCI USA, V111, P9733, DOI 10.1073/pnas.1405698111; Ma R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.048101; Maestro A, 2018, COMMUN PHYS-UK, V1, DOI 10.1038/s42005-018-0031-6; Mathijssen AJTM, 2018, PHYS REV FLUIDS, V3, DOI 10.1103/PhysRevFluids.3.033103; Narematsu N, 2015, CYTOSKELETON, V72, P633, DOI 10.1002/cm.21266; Omori T, 2020, P NATL ACAD SCI USA, V117, P30201, DOI 10.1073/pnas.2011146117; Osterman N, 2011, P NATL ACAD SCI USA, V108, P15727, DOI 10.1073/pnas.1107889108; Pellicciotta N, 2020, P NATL ACAD SCI USA, V117, P8315, DOI 10.1073/pnas.1910065117; Plattner H, 2012, CELL CALCIUM, V51, P351, DOI 10.1016/j.ceca.2012.01.006; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ryu S, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8010004; Shapiro OH, 2014, P NATL ACAD SCI USA, V111, P13391, DOI 10.1073/pnas.1323094111; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; Veraszto C, 2017, ELIFE, V6, DOI 10.7554/eLife.26000; von Dassow G, 2017, NAT PHYS, V13, P520, DOI 10.1038/nphys4154; Wan KY, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0393; Wan KY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238103; Werner ME, 2012, GENESIS, V50, P176, DOI 10.1002/dvg.20824; Wollin C, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11042-7; Yankura KA, 2013, P NATL ACAD SCI USA, V110, P8591, DOI 10.1073/pnas.1220903110	62	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249060	10.1371/journal.pone.0249060	http://dx.doi.org/10.1371/journal.pone.0249060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831025	Green Published, gold, Green Submitted			2022-12-26	WOS:000639359600043
J	Pastor-Prieto, M; Bahamon, N; Sabates, A; Canepa, A; Gili, JM; Carreton, M; Company, JB				Pastor-Prieto, Marina; Bahamon, Nixon; Sabates, Ana; Canepa, Antonio; Gili, Josep-Maria; Carreton, Marta; Company, Joan B.			Spatial heterogeneity of Pelagia noctiluca ephyrae linked to water masses in the Western Mediterranean	PLOS ONE			English	Article							SHELF-SLOPE FRONT; FISH LARVAE; ALBORAN SEA; ZOOPLANKTON AGGREGATIONS; GELATINOUS ZOOPLANKTON; MESOSCALE VARIABILITY; JELLYFISH BLOOMS; NATURAL DIET; LIGURIAN SEA; CIRCULATION	Pelagia noctiluca is the most common jellyfish in the Western Mediterranean Sea, living in oceanic waters with a holoplanktonic lifecycle. Frequent outbreaks have been well documented in coastal areas, yet little is known about their offshore distribution. In this study we address the relationship between oceanographic structures and the distribution of P. noctiluca ephyrae along the central continental slope of the Western Mediterranean, covering a wide latitudinal gradient, during July-August 2016. The region is characterized by a rich and complex mesoscale surface circulation driven by the inflow of Atlantic Water into the Western Mediterranean through the Strait of Gibraltar. The results revealed a high variability in the ephyrae spatial paterns related with different water masses and the resulting mesoscale hydrographic features. Their horizontal distribution showed a clear latitudinal gradient with high abundances in the south, associated with recent Atlantic Water, and low abundances or absence in the north, in coincidence with the old Atlantic Water transported by the Northern Current. Ephyrae showed diel vertical migrations of short-extent in the first 50 m, with a wide distribution above the thermocline and the Deep Chlorophyll Maximum during daytime, being more concentrated towards the surface at night. The results suggest the population connectivity of P. noctiluca between the Atlantic and the Mediterranean. In that case, the abundance variability of the species in the Mediterranean could be modulated by its entrance associated with the inflow of Atlantic Water through the Strait of Gibraltar.	[Pastor-Prieto, Marina; Bahamon, Nixon; Sabates, Ana; Gili, Josep-Maria; Carreton, Marta; Company, Joan B.] Inst Ciencies Mar ICM CSIC, Barcelona, Spain; [Canepa, Antonio] Univ Burgos, Escuela Politecn Super, Burgos, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidad de Burgos	Gili, JM (corresponding author), Inst Ciencies Mar ICM CSIC, Barcelona, Spain.	gili@icm.csic.es	Bahamon, Nixon/K-8922-2014; Bahamon, Nixon/O-2476-2019; Canepa Oneto, Antonio Jesus/R-5260-2018; Carreton, Marta/K-4273-2017	Bahamon, Nixon/0000-0002-5802-7367; Bahamon, Nixon/0000-0002-5802-7367; Canepa Oneto, Antonio Jesus/0000-0002-0608-2743; Pastor, Marina/0000-0002-0098-7963; Carreton, Marta/0000-0002-9490-1453	project CONECTA - Spanish Ministry of Economy and Competitiveness [CTM2014-54648-C2-1-R]; project WINFISH - Spanish Ministry of Economy and Competitiveness [CTM2015-68543-R]; Spanish Ministry of Education, Culture and Sport [FPU16/06794, FPU2015/04339]; CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)	project CONECTA - Spanish Ministry of Economy and Competitiveness; project WINFISH - Spanish Ministry of Economy and Competitiveness; Spanish Ministry of Education, Culture and Sport(Spanish Government); CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)	This research was supported by the projects CONECTA (CTM2014-54648-C2-1-R) and WINFISH (CTM2015-68543-R) funded by the Spanish Ministry of Economy and Competitiveness. MP-P and MC were supported by a predoctoral fellowship (FPU16/06794 and FPU2015/04339, respectively) from the Spanish Ministry of Education, Culture and Sport. The publication fee was partially supported by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	Alcaraz M, 1985, P 19 EUR MAR BIOL S, P16; Allain C., 1960, REV TRAVAUX I PECHES, V24, P121; Almeda R, 2011, LIMNOL OCEANOGR, V56, P415, DOI 10.4319/lo.2011.56.1.0415; [Anonymous], 2018, EUROPEAN MARINE OBSE; [Anonymous], 2021, NATURAL EARTH; ASTRALDI M, 1992, J GEOPHYS RES-OCEANS, V97, P9531, DOI 10.1029/92JC00114; Atienza D, 2006, MAR ECOL PROG SER, V315, P211, DOI 10.3354/meps315211; Atienza D, 2016, J MARINE SYST, V164, P30, DOI 10.1016/j.jmarsys.2016.08.003; AVIAN M, 1986, B ZOOL, V53, P385; Bernard P., 2011, ZOOPLANKTON SPATIAL, V4, P1; Bethoux J. P., 1988, OCEANOL ACTA, P59; BOLLENS SM, 1989, J PLANKTON RES, V11, P1047, DOI 10.1093/plankt/11.5.1047; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Buecher E, 1999, MAR ECOL PROG SER, V189, P105, DOI 10.3354/meps189105; Canepa Antonio, 2014, P237; Clavel-Henry M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0223396; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Estrada M., 1985, NATO Conference Series I Ecology, V8, P247; Estrada M., 1988, OCEANOL ACTA, VSP, P133; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; Font J., 1988, OCEANOGRAPHIE PELAGI, VSP, P51; FRANQUEVILLE C, 1971, Tethys, V3, P11; Garcia-Ladona E., 1994, SEASONAL INTERANNUAL, P73, DOI [10.1016/0169-328x%2894%2990380-8, DOI 10.1016/0169-328X%2894%2990380-8]; Gili Josep-Maria, 2005, Bolleti de la Societat d'Historia Natural de les Balears, V48, P9; Glynn F, 2016, BIOL J LINN SOC, V117, P252, DOI 10.1111/bij.12654; Gorsky G, 2010, P JOINT ICES CIESM W; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Gravili C, 2020, MEDITERR MAR SCI, V21, P11, DOI 10.12681/mms.17966; Greer AT, 2015, J MARINE SYST, V142, P111, DOI 10.1016/j.jmarsys.2014.10.008; Guerrero E, 2018, J PLANKTON RES, V40, P178, DOI 10.1093/plankt/fby001; Guerrero E, 2016, SCI MAR, V80, P487, DOI 10.3989/scimar.04452.03A; Hamner WM, 1995, MAR FRESHW BEHAV PHY, V26, P71, DOI 10.1080/10236249509378930; Heslop EE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053717; Higgins JE, 2008, BIOL BULL-US, V214, P29, DOI 10.2307/25066657; HOPKINS TS, 1985, KEY ENV W MEDITERRAN, P100; IBANEZ F, 1987, OCEANOL ACTA, V10, P205; Kamiyama T, 2018, J OCEANOGR, V74, P53, DOI 10.1007/s10872-017-0438-9; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; Lamb PD, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171421; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Lilley MKS, 2014, J PLANKTON RES, V36, P1585, DOI 10.1093/plankt/fbu079; Macias D, 2008, ESTUAR COAST SHELF S, V78, P250, DOI 10.1016/j.ecss.2007.12.008; MACKAS DL, 1985, B MAR SCI, V37, P652; MALEJ A, 1992, OLSEN INT S, P215; Mariottini GL, 2008, MAR DRUGS, V6, P496, DOI 10.3390/md20080025; Milisenda G, 2018, ESTUAR COAST SHELF S, V201, P29, DOI 10.1016/j.ecss.2016.01.002; Millot C, 2005, SCI MAR, V69, P5, DOI 10.3989/scimar.2005.69s15; MILLOT C, 1985, J GEOPHYS RES-OCEANS, V90, P7169, DOI 10.1029/JC090iC04p07169; MILLS CE, 1984, BIOL BULL, V166, P216, DOI 10.2307/1541443; MILLS CE, 1984, BIOL BULL, V166, P206, DOI 10.2307/1541442; MILLS CE, 1995, ICES J MAR SCI, V52, P575, DOI 10.1016/1054-3139(95)80072-7; MORAND P, 1987, J PLANKTON RES, V9, P651, DOI 10.1093/plankt/9.4.651; MORAND P, 1992, ANN I OCEANOGR PARIS, V68, P151; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; Ottmann D, 2021, MAR ECOL PROG SER, V658, P75, DOI 10.3354/meps13423; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; Pascual M, 2017, J PLANKTON RES, V39, P836, DOI 10.1093/plankt/fbx043; Pierce J, 2009, ZOO BIOL, V28, P163, DOI 10.1002/zoo.20218; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; PINGREE RD, 1977, NATURE, V265, P266, DOI 10.1038/265266a0; Pinot JM, 2002, PROG OCEANOGR, V55, P335, DOI 10.1016/S0079-6611(02)00139-8; Prieto L, 2013, MAR BIOL, V160, P3241, DOI 10.1007/s00227-013-2293-6; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2014, MAR ECOL PROG SER, V510, P201, DOI 10.3354/meps10790; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; QGIS, 2016, QGIS GEOGR INF SYST; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Core Team, 2020, R LANG ENV STAT COMP; Ramondenc S, 2019, J PLANKTON RES, V41, P207, DOI 10.1093/plankt/fbz013; Reul A, 2005, CONT SHELF RES, V25, P589, DOI 10.1016/j.csr.2004.09.016; Rossi S, 2006, J PLANKTON RES, V28, P551, DOI 10.1093/plankt/fbi140; Rubio A, 2005, PROG OCEANOGR, V66, P142, DOI 10.1016/j.pocean.2004.07.012; Sabates A, 2004, DEEP-SEA RES PT I, V51, P545, DOI 10.1016/j.dsr.2003.11.003; Sabates A, 2018, J MARINE SYST, V187, P52, DOI 10.1016/j.jmarsys.2018.06.013; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Saiz E, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P183, DOI 10.1007/978-94-007-6704-1_11; SALAT J, 1995, OCEANOL ACTA, V18, P227; Schlitzer R., 2020, OCEAN DATA VIEW; Simoncelli S, 2019, **DATA OBJECT**, DOI [10.25423/MEDSEA_REANALYSIS_PHYS_006_004, DOI 10.25423/MEDSEA_REANALYSIS_PHYS_006_004]; Smith BE, 2016, FISH OCEANOGR, V25, P500, DOI 10.1111/fog.12168; Stopar K, 2010, MOL PHYLOGENET EVOL, V57, P417, DOI 10.1016/j.ympev.2010.07.004; Tilves U, 2018, MAR ECOL PROG SER, V591, P101, DOI 10.3354/meps12332; Tilves U, 2016, J PLANKTON RES, V38, P1243, DOI 10.1093/plankt/fbw059; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; Vargas-Yanez M, 2007, J MARINE SYST, V68, P421, DOI 10.1016/j.jmarsys.2007.01.004; Venables MN., 2002, MODERN APPL STAT S, P498; YAMAMOTO T, 1986, DEEP-SEA RES, V33, P1729, DOI 10.1016/0198-0149(86)90076-2; Zuur Alain F., 2009, P1	89	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249756	10.1371/journal.pone.0249756	http://dx.doi.org/10.1371/journal.pone.0249756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826668	Green Published, gold			2022-12-26	WOS:000638119900046
J	Fawkes, C; Carnes, D				Fawkes, Carol; Carnes, Dawn			Patient reported outcomes in a large cohort of patients receiving osteopathic care in the United Kingdom	PLOS ONE			English	Article							LOW-BACK-PAIN; NATURAL-HISTORY; SATISFACTION; GUIDELINES	Objective The use of Patient Reported Outcome Measures (PROMs) to evaluate care is being advocated increasingly in clinical settings. Electronic data capture is both resource and environmentally friendly and convenient. This purpose of this study was to test and implement a nationwide system to collect routine PROM data from osteopathic patients using a web and mobile app. Methods A prospective study design was used to monitor outcomes of care for patients attending osteopathic clinics. Demographic and service data were collected, the primary outcomes were the Bournemouth Questionnaire and a Global Rating of Change score. Data concerning patients' satisfaction and experience of care were collected also. Data were collected at baseline, one week, and six weeks post-treatment. Results A total of 1721 patients completed the PROM app questionnaire. The majority (65.8%) of patients who used the PROM app were between 40 and 69 years old with 11% being 70 years and over. At baseline 39.8% of patients reported they'd had their symptoms for 13 weeks or more. Low back pain was the most common symptom (55.8%). Patients reported high scores for both satisfaction and experience of osteopathic care: 88.1% were very satisfied at six weeks post-baseline and 93.5% reported very good experience at six weeks post-baseline. Data from the Global Rating of Change scale indicated that at one week post-baseline 89.1% of patients reported some measure of improvement, and at six weeks this figure rose to 92.8%. The mean sum score for the Bournemouth Questionnaire went from 30.8 at baseline to 13.3 at six weeks post-baseline. This represented a significant and clinically meaningful positive change score of 56.8%. Conclusion The app was well-completed and the data very encouraging. These data will help to form the basis for standards of care for patients attending osteopathic practices.	[Fawkes, Carol; Carnes, Dawn] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Populat Hlth Sci, London, England; [Carnes, Dawn] Univ Coll Osteopathy, London, England	University of London; Queen Mary University London	Fawkes, C (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Populat Hlth Sci, London, England.	c.fawkes@qmul.ac.uk		Fawkes, Carol/0000-0002-2267-735X	Institute of Osteopathy; professional association for the osteopathic profession; board of the National Council for Osteopathic Research; European Federation and Forum for Osteopathy	Institute of Osteopathy; professional association for the osteopathic profession; board of the National Council for Osteopathic Research; European Federation and Forum for Osteopathy	The development of the app was funded using a grant from the Institute of Osteopathy, the professional association for the osteopathic profession, and the board of the National Council for Osteopathic Research. The translation of the app into additional European languages has been funded by the European Federation and Forum for Osteopathy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	[Anonymous], 1993, OSTEOPATHS ACT; [Anonymous], 2005, MICROSOFT; [Anonymous], LONDON COLL OSTEOPAT; [Anonymous], 2000, APPLE; [Anonymous], 2020, NHS ENGLAND FRIENDS; [Anonymous], 2017, NHS ENGLAND ALLIED H; [Anonymous], 2020, GEN OSTEOPATHIC COUN; [Anonymous], SYSTEMATIC REVIEW ME; [Anonymous], INVESTIGATING OSTEOP; [Anonymous], INVESTIGATING PATIEN; [Anonymous], OSTEOPATHIC TRAINING; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bolton JE, 1999, J MANIP PHYSIOL THER, V22, P503, DOI 10.1016/S0161-4754(99)70001-1; BURTON AK, 1981, RHEUMATOL REHABIL, V20, P239, DOI 10.1093/rheumatology/20.4.239; Cusumano Michael A., 1998, COMPETING INTERNET T; Drysdale IP, 2013, INT J OSTEOPATH MED, V16, pE23; Dunn K M, 2004, Eura Medicophys, V40, P9; Fawkes C, 2016, THESIS QUEEN MARY I; Fawkes CA, 2014, MANUAL THER, V19, P125, DOI 10.1016/j.math.2013.09.001; Fawkes CA., 2007, THESIS LONDON QUEEN; Field J, 2019, PATIENT-RELAT OUTCOM, V10, P233, DOI 10.2147/PROM.S156291; Freyd M, 1923, J EDUC PSYCHOL, V14, P83, DOI 10.1037/h0074329; Froud R, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9828; GBD 2015 Disease and Injury Incidence and Prevalence collaborators and others, 2015, LANCET, V388, P10053; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Griffin B, 2014, INTERFACES, V5; Gurden Mark, 2012, Prim Health Care Res Dev, V13, P204, DOI 10.1017/S1463423611000648; Hill JC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012331; Hinkley H, 1995, BR OSTEOPATH J, V16, P17; Holmes MM, 2017, QUAL LIFE RES, V26, P245, DOI 10.1007/s11136-016-1449-5; Khan M., 2011, INT J SOFTWARE ENG I, V5; Lauridsen HH, 2007, PAIN, V131, P112, DOI 10.1016/j.pain.2006.12.023; Licciardone John, 2002, Journal of the American Osteopathic Association, V102, P13; Licciardone John C., 2002, Journal of the American Osteopathic Association, V102, P219; Licciardone John C., 2001, Journal of the American Osteopathic Association, V101, P374; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; McIlwraith B, 2003, J OSTEOPATH MED, V6, P7; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; National Institute for Health and Care Excellence, 2020, WID EV BAS US BROAD; National Institute for Health and Clinical Excellence (NICE), 2016, LOW BACK PAIN SCIATI; Nelson EC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7818; NHS England, 2018, NATL PATIENT REPORTE; NIELSEN J, 1994, BEHAV INFORM TECHNOL, V13, P3, DOI 10.1080/01449299408914577; Pannucci CJ, 2010, PLAST RECONSTR SURG, V126, P619, DOI 10.1097/PRS.0b013e3181de24bc; Pincus T, 2000, COMPLEMENT THER MED, V8, P180, DOI 10.1054/ctim.2000.0378; PRINGLE M, 1993, BRIT J GEN PRACT, V43, P15; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rutherford C, 2021, APPL RES QUAL LIFE, V16, P1265, DOI 10.1007/s11482-020-09817-2; Strutt R, 2008, MANUAL THER, V13, P456, DOI 10.1016/j.math.2007.05.013; UK Government, 2013, J HUNT CHALL NHS GO; WHITNEY CW, 1992, PAIN, V50, P281, DOI 10.1016/0304-3959(92)90032-7	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249719	10.1371/journal.pone.0249719	http://dx.doi.org/10.1371/journal.pone.0249719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861778	gold, Green Published			2022-12-26	WOS:000641475400042
J	Plante-Hebert, J; Boucher, VJ; Jemel, B				Plante-Hebert, Julien; Boucher, Victor J.; Jemel, Boutheina			The processing of intimately familiar and unfamiliar voices: Specific neural responses of speaker recognition and identification	PLOS ONE			English	Article							ONLY EXPERIENCES; EPISODIC MEMORY; TERM-MEMORY; DISCRIMINATION; RECOLLECTION; IDENTITY; PEOPLE; FACES; ERP; PHONAGNOSIA	Research has repeatedly shown that familiar and unfamiliar voices elicit different neural responses. But it has also been suggested that different neural correlates associate with the feeling of having heard a voice and knowing who the voice represents. The terminology used to designate these varying responses remains vague, creating a degree of confusion in the literature. Additionally, terms serving to designate tasks of voice discrimination, voice recognition, and speaker identification are often inconsistent creating further ambiguities. The present study used event-related potentials (ERPs) to clarify the difference between responses to 1) unknown voices, 2) trained-to-familiar voices as speech stimuli are repeatedly presented, and 3) intimately familiar voices. In an experiment, 13 participants listened to repeated utterances recorded from 12 speakers. Only one of the 12 voices was intimately familiar to a participant, whereas the remaining 11 voices were unfamiliar. The frequency of presentation of these 11 unfamiliar voices varied with only one being frequently presented (the trained-to-familiar voice). ERP analyses revealed different responses for intimately familiar and unfamiliar voices in two distinct time windows (P2 between 200-250 ms and a late positive component, LPC, between 450-850 ms post-onset) with late responses occurring only for intimately familiar voices. The LPC present sustained shifts, and short-time ERP components appear to reflect an early recognition stage. The trained voice equally elicited distinct responses, compared to rarely heard voices, but these occurred in a third time window (N250 between 300-350 ms post-onset). Overall, the timing of responses suggests that the processing of intimately familiar voices operates in two distinct steps of voice recognition, marked by a P2 on right centro-frontal sites, and speaker identification marked by an LPC component. The recognition of frequently heard voices entails an independent recognition process marked by a differential N250. Based on the present results and previous observations, it is proposed that there is a need to distinguish between processes of voice "recognition" and "identification". The present study also specifies test conditions serving to reveal this distinction in neural responses, one of which bears on the length of speech stimuli given the late responses associated with voice identification.	[Plante-Hebert, Julien; Boucher, Victor J.] Univ Montreal, Dept Linguist & Traduct, Lab Sci Phonet, Montreal, PQ, Canada; [Jemel, Boutheina] Hop Riviere Prairies, Lab Rech Neurosci & Electrophysiol Cognit, Montreal, PQ, Canada; [Jemel, Boutheina] Univ Montreal, Fac Med, Ecole Orthophonie & Audiol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Plante-Hebert, J (corresponding author), Univ Montreal, Dept Linguist & Traduct, Lab Sci Phonet, Montreal, PQ, Canada.	julien.plante-hebert@umontreal.ca		Plante-Hebert, Julien/0000-0002-3691-5232				Amino K., 2005, CORRES PERCEPTION SP; Amino K, 2006, ACOUST SCI TECHNOL, V27, P233, DOI 10.1250/ast.27.233; Amino K, 2009, FORENSIC SCI INT, V185, P21, DOI 10.1016/j.forsciint.2008.11.018; [Anonymous], 2011, OXFORD HDB EVENT REL; Atkinson N., 2015, VARIABLE FACTORS AFF; Barton JJS, 2016, CORTEX, V75, P132, DOI 10.1016/j.cortex.2015.11.023; Beauchemin M, 2006, EUR J NEUROSCI, V23, P3081, DOI 10.1111/j.1460-9568.2006.04856.x; Beauchemin M, 2011, CEREB CORTEX, V21, P1705, DOI 10.1093/cercor/bhq242; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Blank H, 2014, NEUROSCI BIOBEHAV R, V47, P717, DOI 10.1016/j.neubiorev.2014.10.022; BRICKER PD, 1966, J ACOUST SOC AM, V40, P1441, DOI 10.1121/1.1910246; BUCHTEL HA, 1989, BRAIN LANG, V37, P12, DOI 10.1016/0093-934X(89)90098-9; Capilla A, 2013, CEREB CORTEX, V23, P1388, DOI 10.1093/cercor/bhs119; Charest I, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-127; Conde T, 2016, COGN AFFECT BEHAV NE, V16, P106, DOI 10.3758/s13415-015-0376-1; Conde T, 2015, BIOL PSYCHOL, V111, P40, DOI 10.1016/j.biopsycho.2015.07.014; Cook S, 1997, APPL COGNITIVE PSYCH, V11, P95; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T., 2006, EVENT RELATED POTENT, P467; De Lucia M, 2010, J NEUROSCI, V30, P11210, DOI 10.1523/JNEUROSCI.2239-10.2010; Focker J, 2012, NEUROPSYCHOLOGIA, V50, P2056, DOI 10.1016/j.neuropsychologia.2012.05.006; Focker J, 2011, BRAIN RES, V1385, P229, DOI 10.1016/j.brainres.2011.02.021; Gainotti G, 2015, NEUROPSYCHOLOGIA, V77, P279, DOI 10.1016/j.neuropsychologia.2015.09.002; Gainotti Guido, 2014, Front Biosci (Elite Ed), V6, P148; Gainotti G, 2011, NEUROPSYCHOLOGIA, V49, P2273, DOI 10.1016/j.neuropsychologia.2011.04.027; Garrido L, 2009, NEUROPSYCHOLOGIA, V47, P123, DOI 10.1016/j.neuropsychologia.2008.08.003; Gilbert AC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00220; GLENN JW, 1968, J ACOUST SOC AM, V43, P368, DOI 10.1121/1.1910788; Graux J, 2015, SOC COGN AFFECT NEUR, V10, P101, DOI 10.1093/scan/nsu031; Graux J, 2013, BRAIN TOPOGR, V26, P72, DOI 10.1007/s10548-012-0233-2; Gunji A, 2003, NEUROSCI LETT, V348, P13, DOI 10.1016/S0304-3940(03)00640-2; Hailstone JC, 2010, NEUROPSYCHOLOGIA, V48, P1104, DOI 10.1016/j.neuropsychologia.2009.12.011; Hanley JR, 2009, MEMORY, V17, P830, DOI 10.1080/09658210903264175; Hanley JR, 1998, Q J EXP PSYCHOL-A, V51, P179, DOI 10.1080/713755751; Hanley JR, 2000, Q J EXP PSYCHOL-A, V53, P1105, DOI 10.1080/02724980050156317; Herzmann G, 2004, PSYCHOPHYSIOLOGY, V41, P688, DOI 10.1111/j.1469-8986.2004.00196.x; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Hollien H, 2014, J VOICE, V28, P170, DOI 10.1016/j.jvoice.2013.06.011; Hollien Harry, 1995, FORENSIC LINGUIST, V2, P143, DOI [10.1558/ijsll.v2i2.143, DOI 10.1558/IJSLL.V2I2.143]; Humble D, 2019, BRAIN RES, V1711, P214, DOI 10.1016/j.brainres.2019.01.028; Kim Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223948; KREIMAN J, 1991, SPEECH COMMUN, V10, P265, DOI 10.1016/0167-6393(91)90016-M; Kreiman J., 2011, FDN VOICE STUDIES IN; Lavner Y., 2001, INT J SPEECH TECHNOL, V4, P63, DOI [10.1023/A:1009656816383, DOI 10.1023/A:1009656816383]; LEGGE GE, 1984, J EXP PSYCHOL LEARN, V10, P298; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; Levy DA, 2003, PSYCHOPHYSIOLOGY, V40, P291, DOI 10.1111/1469-8986.00031; Maguinness C, 2018, NEUROPSYCHOLOGIA, V116, P179, DOI 10.1016/j.neuropsychologia.2018.03.039; Mai XQ, 2012, DEV NEUROPSYCHOL, V37, P400, DOI 10.1080/87565641.2011.650807; MARCUS SM, 1981, PERCEPT PSYCHOPHYS, V30, P247, DOI 10.3758/BF03214280; McGehee F, 1937, J GEN PSYCHOL, V17, P249, DOI 10.1080/00221309.1937.9917999; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; MURRAY D, 1985, CAN PSYCHOL, V26, P235, DOI 10.1037/h0084438; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Nolan F., 1996, INT J SPEECH LANG LA, V3, P74, DOI [10.1558/ijsll.v3i1.74, DOI 10.1558/IJSLL.V3I1.74]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PAPCUN G, 1989, J ACOUST SOC AM, V85, P913, DOI 10.1121/1.397564; Pinheiro AP, 2016, BRAIN LANG, V153, P38, DOI 10.1016/j.bandl.2015.12.003; Plante-Hebert J., 2015, EFFET FAMILIARITE ID; Plante-Hebert J, 2014, JOURNEE ETUDES PAROL; Plante-Hebert J., 2015, 18 INT C PHON SCI; POLLACK I, 1954, J ACOUST SOC AM, V26, P403, DOI 10.1121/1.1907349; Gonzalez IQ, 2011, BRAIN RES, V1407, P13, DOI 10.1016/j.brainres.2011.03.029; Rachman L., 2018, OTHER VOICE EFFECT S; ROEBUCK R, 1993, APPL COGNITIVE PSYCH, V7, P475, DOI 10.1002/acp.2350070603; Rogier O, 2010, INT J PSYCHOPHYSIOL, V75, P44, DOI 10.1016/j.ijpsycho.2009.10.013; Roswandowitz C., 2019, OXFORD HDB VOICE PER; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Schall S, 2015, J COGNITIVE NEUROSCI, V27, P280, DOI 10.1162/jocn_a_00707; Schall S, 2013, NEUROIMAGE, V77, P237, DOI 10.1016/j.neuroimage.2013.03.043; Schweinberger SR, 2001, NEUROPSYCHOLOGIA, V39, P921, DOI 10.1016/S0028-3932(01)00023-9; Schweinberger SR, 1997, J SPEECH LANG HEAR R, V40, P453, DOI 10.1044/jslhr.4002.453; Schweinberger SR, 2011, BRIT J PSYCHOL, V102, P748, DOI 10.1111/j.2044-8295.2011.02048.x; Sidtis D, 2012, INTEGR PSYCHOL BEHAV, V46, P146, DOI 10.1007/s12124-011-9177-4; Skuk VG, 2013, HEARING RES, V296, P131, DOI 10.1016/j.heares.2012.11.004; Spreckelmeyer KN, 2009, BRAIN COGNITION, V69, P121, DOI 10.1016/j.bandc.2008.06.003; Stevenage SV, 2018, NEUROPSYCHOLOGIA, V116, P162, DOI 10.1016/j.neuropsychologia.2017.07.005; Stevenage SV, 2014, PSYCHOL BELG, V54, P266, DOI 10.5334/pb.ar; SU LS, 1974, J ACOUST SOC AM, V56, P1876, DOI 10.1121/1.1903526; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Van Lancker D R, 1982, Brain Cogn, V1, P185, DOI 10.1016/0278-2626(82)90016-1; VANLANCKER D, 1987, NEUROPSYCHOLOGIA, V25, P829, DOI 10.1016/0028-3932(87)90120-5; VANLANCKER D, 1985, J PHONETICS, V13, P19, DOI 10.1016/S0095-4470(19)30723-5; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Wiese H, 2019, J EXP PSYCHOL LEARN, V45, P1583, DOI 10.1037/xlm0000665; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Young AW, 2020, TRENDS COGN SCI, V24, P398, DOI 10.1016/j.tics.2020.02.001; Zaske R, 2014, J NEUROSCI, V34, P10821, DOI 10.1523/JNEUROSCI.0581-14.2014; Zhang CC, 2016, NEUROIMAGE, V124, P536, DOI 10.1016/j.neuroimage.2015.08.064; Zinke K, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00031	95	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250214	10.1371/journal.pone.0250214	http://dx.doi.org/10.1371/journal.pone.0250214			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861789	Green Published, gold			2022-12-26	WOS:000641475400061
J	Schwentner, M; Zahiri, R; Yamamoto, S; Husemann, M; Kullmann, B; Thiel, R				Schwentner, Martin; Zahiri, Reza; Yamamoto, Satoshi; Husemann, Martin; Kullmann, Bjoern; Thiel, Ralf			eDNA as a tool for non-invasive monitoring of the fauna of a turbid, well-mixed system, the Elbe estuary in Germany	PLOS ONE			English	Article							ENVIRONMENTAL DNA; BARCODE; BIODIVERSITY; PATTERNS; PRIMERS	The Elbe is one of the longest European rivers and features a large, turbid and well-mixed estuary, which runs through the inner city of Hamburg. The Elbe has been closely monitored using classical catch techniques in the past. Here we tested a COI-based eDNA approach for assessing the biodiversity within the Elbe. We sampled three stations in the Elbe, included low and high tide events, as well as two adjoining lakes to compare the recovered faunas. To analyze the data, we employed two different pipelines: the automated mBRAVE pipeline utilizing the BOLD database and one including NCBI BLAST. The number of OTUs with species or higher-level identifications were similar between both approaches with 352 OTUs and 355 OTUs for BLAST and mBRAVE, respectively, however, BLAST searches recovered another 942 unidentified metazoan OTUs. Many taxa were well represented; however, fish species were poorly represented, especially in the Elbe estuary samples. This could be a result of the universal COI primers, which also yielded high read numbers for non-metazoan OTUs, and small-bodies taxa like Rotifera, which might have been sampled together with the eDNA. Our results show a strong tidal influence on the recovered taxa. During low tide, downstream stations resembled sites further upstream, but the former showed a very different OTU composition during high tide and early tide. Such differences might be due to varying impacts of upstream-originating eDNA during tide cycles. Such factors need to be considered when routinely employing eDNA for monitoring programs.	[Schwentner, Martin; Zahiri, Reza; Husemann, Martin; Kullmann, Bjoern; Thiel, Ralf] Univ Hamburg, Ctr Nat Hist, Hamburg, Germany; [Schwentner, Martin] Nat Hist Museum Wien, Vienna, Austria; [Zahiri, Reza] Canadian Food Inspect Agcy, Ottawa Plant Lab, Entomol Diagnost Lab, Ottawa, ON, Canada; [Yamamoto, Satoshi] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	University of Hamburg; Canadian Food Inspection Agency; Kyoto University	Schwentner, M (corresponding author), Univ Hamburg, Ctr Nat Hist, Hamburg, Germany.; Schwentner, M (corresponding author), Nat Hist Museum Wien, Vienna, Austria.	martin.schwentner@nhm-wien.ac.at		Schwentner, Martin/0000-0002-1373-456X	mobility program of the University of Hamburg	mobility program of the University of Hamburg	SY was funded by the mobility program of the University of Hamburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASV H, BONITIERUNG WICHTIGE; Bergemann M., 2008, ELBEBERICHT; Bergemann M., 1995, DTSCH GEWASSERKDL MI, V39, P134; Bioconsult, 2019, ANALYSE LANGERFRISTI; Cannon MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep22908; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eick D, 2014, MAR BIODIVERS, V44, P559, DOI 10.1007/s12526-014-0225-4; Elbrecht V, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00011; Elbrecht V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130324; Fernandez S., 2019, ENV DNA, V1, P385, DOI [10.1002/edn3.40, DOI 10.1002/EDN3.40]; Geiger MF, 2016, GENOME, V59, P661, DOI 10.1139/gen-2015-0185; Gleason JE, 2021, MOL ECOL, V30, P3239, DOI 10.1111/mec.15597; Guan X, 2019, T AM FISH SOC, V148, P1043, DOI 10.1002/tafs.10195; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hunter ME, 2018, ENDANGER SPECIES RES, V35, P101, DOI 10.3354/esr00880; IKSE, 2005, ELBE IHR EINZUGSGEBI; Kappenberg J, 2001, ESTUARIES, V24, P699, DOI 10.2307/1352878; Kempe S., 1982, MITT GEOL PAL ONT I, V52, P91; Klymus KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177643; Lacoursiere-Roussel A, 2018, ECOL EVOL, V8, P7763, DOI 10.1002/ece3.4213; Leduc N., 2019, ENV DNA, V1, P342, DOI 10.1002/edn3.35; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Middelburg JJ, 2007, MAR CHEM, V106, P127, DOI 10.1016/j.marchem.2006.02.007; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pont D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28424-8; Ratnasingham S., 2019, BIODIVERSITY INFORM, V3, DOI [10.3897/biss.3.37986, DOI 10.3897/BISS.3.37986]; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rochette NC, 2019, MOL ECOL, V28, P4737, DOI 10.1111/mec.15253; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; Shogren AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05223-1; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Stepien CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0203012; Thiel R., 2011, STRUKTURANALYSE SCHW; Thiel R., 2015, ATLAS FISCHE NEUNAUG; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Valdez-Moreno M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215505; Yamamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40368	45	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250452	10.1371/journal.pone.0250452	http://dx.doi.org/10.1371/journal.pone.0250452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861810	gold, Green Published			2022-12-26	WOS:000641475400065
J	Taddese, AA; Azene, ZN; Merid, MW; Muluneh, AG; Geberu, DM; Kassa, GM; Yenit, MK; Tilahun, SY; Gelaye, KA; Mekonnen, HS; Azagew, AW; Wubneh, CA; Belay, GM; Assimamaw, NT; Agegnehu, CD; Azale, T; Tamiru, AT; Rade, BK; Taye, EB; Andualem, Z; Dagne, H; Gashaye, KT; Kabito, GG; Mekonnen, TH; Daba, S; Azanaw, J; Adane, T; Alemayehu, M				Taddese, Asefa Adimasu; Azene, Zelalem Nigussie; Merid, Mehari Woldemariam; Muluneh, Atalay Goshu; Geberu, Demiss Mulatu; Kassa, Getahun Molla; Yenit, Melaku Kindie; Tilahun, Sewbesew Yitayih; Gelaye, Kassahun Alemu; Mekonnen, Habtamu Sewunet; Azagew, Abere Woretaw; Wubneh, Chalachew Adugna; Belay, Getaneh Mulualem; Assimamaw, Nega Tezera; Agegnehu, Chilot Desta; Azale, Telake; Tamiru, Animut Tagele; Rade, Bayew Kelkay; Taye, Eden Bishaw; Andualem, Zewudu; Dagne, Henok; Gashaye, Kiros Terefe; Kabito, Gebisa Guyasa; Mekonnen, Tesfaye Hambisa; Daba, Sintayehu; Azanaw, Jember; Adane, Tsegaye; Alemayehu, Mekuriaw			Knowledge and attitude of the communities towards COVID-19 and associated factors among Gondar City residents, northwest Ethiopia: A community based cross-sectional study	PLOS ONE			English	Article								Background COVID-19 is the novel coronavirus responsible for the ongoing global outbreak of acute respiratory disease and viral pneumonia. In order to tackle the devastating condition of the virus, countries need to attack the virus with aggressive and targeted tactics. Thus, to strengthen the COVID-19 mitigation measures and to give rapid response, there is an urgent need to understand the public's knowledge and attitude about of the pandemic at this critical moment. Objective This study was aimed to assess the knowledge and attitude of communities about COVID-19 and associated factors among Gondar City residents. Methods A community based cross-sectional study was done among 623 respondents in Gondar city from April 20-27/2020. Data were collected using a structured questionnaire adapted from different literatures. The data were entered using Epi data version 3.1 and then exported into STATA version 14 for analysis. Bi-variable and multivariable binary logistic regression were performed. Adjusted odds ratio with 95% CI was used to declare statistically significant variables on the basis of p value less than 0.05 in the multivariable binary logistic regression model. Results The overall knowledge and attitude of the community towards COVID19 was 51.85% [95% CI (47.91%-55.78%)] and 53.13% [95% CI (49.20, 57.06%)], respectively. In this study, being married [AOR = 0.60 at 95% CI: (0.42, 0.86)], educational level; primary [AOR = 3.14 at 95% CI: (1.78,5.54)], secondary [AOR = 2.81 at 95% CI: (1.70,4.63)], college and above [AOR = 4.49 at 95% CI: 7.92, 13.98)], and family size [AOR = 1.80, at 95% CI: (1.05, 3.08)] were emerged as statistically significant factors impacting the knowledge of the community about COVID-19. Besides, educational level; primary [AOR = 1.76 at 95% CI: (1.03, 3.01)], secondary [AOR = 1.69 at 95% CI: (1.07, 2.68)], and college & above [AOR = 2.38 at 95% CI: (1.50, 3.79)], and family size; four to six members [AOR = 1.84 at 95% CI (1.27, 2.67)], above seven members [AOR = 1.79 at 95% CI (1.08, 2.96)] were factors identified as significantly attribute for positive attitude of the communities towards COVID-19. Conclusion More than half of the respondents had better knowledge and attitude regarding COVID-19. Higher educational level and larger family size were significant factors predominantly affecting the knowledge and attitude of the communities towards COVID-19.	[Taddese, Asefa Adimasu; Merid, Mehari Woldemariam; Muluneh, Atalay Goshu; Kassa, Getahun Molla; Yenit, Melaku Kindie; Gelaye, Kassahun Alemu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Azene, Zelalem Nigussie] Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Dept Womens & Family Hlth, Gondar, Ethiopia; [Geberu, Demiss Mulatu] Univ Gondar, Dept Hlth Syst & Policy, Gondar, Ethiopia; [Tilahun, Sewbesew Yitayih] Univ Gondar, Coll Med & Hlth Sci, Dept Psychiat, Gondar, Ethiopia; [Mekonnen, Habtamu Sewunet; Azagew, Abere Woretaw] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Med Nursing, Gondar, Ethiopia; [Wubneh, Chalachew Adugna; Belay, Getaneh Mulualem; Assimamaw, Nega Tezera] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Pediat & Child Hlth Nursing, Gondar, Ethiopia; [Agegnehu, Chilot Desta] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Gondar, Ethiopia; [Agegnehu, Chilot Desta] Univ Gondar, Comprehens Specialized Hosp, Gondar, Ethiopia; [Azale, Telake] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia; [Tamiru, Animut Tagele; Rade, Bayew Kelkay] Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Dept Gen Midwifery, Gondar, Ethiopia; [Taye, Eden Bishaw] Univ Gondar, Coll Med & Hlth Sci, Sch Midwifery, Dept Clin Midwifery, Gondar, Ethiopia; [Andualem, Zewudu; Dagne, Henok; Kabito, Gebisa Guyasa; Mekonnen, Tesfaye Hambisa; Daba, Sintayehu; Azanaw, Jember; Adane, Tsegaye; Alemayehu, Mekuriaw] Univ Gondar, Coll Med & Hlth Sci, Dept Environm & Occupat Hlth, Gondar, Ethiopia; [Andualem, Zewudu; Dagne, Henok; Kabito, Gebisa Guyasa; Mekonnen, Tesfaye Hambisa; Daba, Sintayehu; Azanaw, Jember; Adane, Tsegaye; Alemayehu, Mekuriaw] Univ Gondar, Coll Med & Hlth Sci, Safety Inst Publ Hlth, Gondar, Ethiopia; [Gashaye, Kiros Terefe] Univ Gondar, Coll Med & Hlth Sci, Dept Gynecol & Obstet, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Merid, MW (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	mehariho19@gmail.com	Mekonnen, Tesfaye/GQP-8197-2022; Guyasa, Gebisa/AAU-1131-2021; Mekonnen, Habtamu/GLN-7652-2022; Wubneh, Chalachew Adugna/CAA-2058-2022; Adane, Tsegaye/HGU-1897-2022; Mekonnen, Tesfaye/ABB-4922-2021	Mekonnen, Habtamu/0000-0001-9396-7437; Adane, Tsegaye/0000-0003-3006-6169; Mekonnen, Tesfaye/0000-0002-4414-6795; Yenit, Melaku Kindie/0000-0002-8982-2814; Azanaw, Jember/0000-0001-5702-1476; Kassa, Getahun Molla/0000-0002-9926-7797; Derso, Henok Dagne/0000-0001-7161-0904; Kelkay, Bayew/0000-0003-3530-6264; Andualem, Zewudu/0000-0002-4731-1696; Bishaw, Eden/0000-0003-2904-2450; Azene, Zelalem Nigussie/0000-0002-3511-7562				Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736; Alemu KA, 2020, PREVENTION PRACTICE; Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; European Centre for Disease Prevention and Control, INF PREV CONTR CAR P; Fijan S, 2005, J HOSP INFECT, V61, P30, DOI 10.1016/j.jhin.2005.02.005; Haque T, 2020, KNOWLEDGE ATTITUDE P; Hussain I, 2021, J COMMUN HEALTH, V46, P441, DOI 10.1007/s10900-020-00879-9; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Joseph T., 2020, INT PULMONOLOGISTS C; Moro Matteo, 2020, Acta Biomed, V91, P29, DOI 10.23750/abm.v91i3-S.9419; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064; Sikder MT., 2020, KNOWLEDGE ATTITUDE P; Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0248821	10.1371/journal.pone.0248821	http://dx.doi.org/10.1371/journal.pone.0248821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861758	gold, Green Published			2022-12-26	WOS:000641475400047
J	Gasperini, B; Pelusi, G; Frascati, A; Sarti, D; Dolcini, F; Espinosa, E; Prospero, E				Gasperini, Beatrice; Pelusi, Gilda; Frascati, Annamaria; Sarti, Donatella; Dolcini, Franco; Espinosa, Emma; Prospero, Emilia			Predictors of adverse outcomes using a multidimensional nursing assessment in an Italian community hospital	PLOS ONE			English	Article							FRAILTY; CARE; PHENOTYPE; MORTALITY	Background There is growing evidence about the role of nurses in patient outcomes in several healthcare settings. However, there is still a lack of evidence about the transitional care setting. We aimed to assess the association between patient characteristics identified in a multidimensional nursing assessment and outcomes of mortality and acute hospitalization during community hospital stay. Methods A retrospective observational study was performed on patients consecutively admitted to a community hospital (CH) in Loreto (Ancona, Italy) between January 1(st), 2018 and May 31st, 2019. The nursing assessment included sociodemographic characteristics, functional status, risk of falls (Conley Score) and pressure damage (Norton scale), nursing diagnoses, presence of pressure sores, feeding tubes, urinary catheters or vascular access devices and comorbidities. Two logistic regression models were developed to assess the association between patient characteristics identified in a multidimensional nursing assessment and outcomes of mortality and acute hospitalization during CH stay. Results We analyzed data from 298 patients. The mean age was 83 +/- 9.9 years; 60.4% (n = 180) were female. The overall mean length of stay was 42.8 +/- 36 days (32 +/- 32 days for patients who died and 33.9 +/- 35 days for patients who had an acute hospitalization, respectively). An acute hospitalization was reported for 13.4% (n = 40) of patients and 21.8% (n = 65) died. An increased risk of death was related to female sex (OR 2.25, 95% CI 1.10-4.62), higher Conley Score (OR 1.19; 95% CI 1.03-1.37) and having a vascular access device (OR 3.64, 95% CI 1.82-7.27). A higher Norton score was associated with a decreased risk of death (OR 0.71, 95% CI 0.62-0.81). The risk for acute hospitalization was correlated with younger age (OR 0.94, 95% CI 0.91-0.97), having a vascular access device (OR 2.33, 95% CI 1.02-5.36), impaired walking (OR 2.50, 95% CI 1.03-6.06) and it is inversely correlated with a higher Conley score (OR 0.84, 95% CI 0.77-0.98). Conclusion Using a multidimensional nursing assessment enables identification of risk of nearness of end of life and acute hospitalization to target care and treatment. The present study adds further knowledge on this topic and confirms the importance of nursing assessment to evaluate the risk of patients' adverse outcome development.	[Gasperini, Beatrice; Sarti, Donatella; Prospero, Emilia] Univ Politecn Marche, Sect Hyg & Publ Hlth, Ancona, Italy; [Gasperini, Beatrice; Espinosa, Emma] Azienda Osped Osped Riuniti Marche Nord, Geriatr, Fano, PU, Italy; [Pelusi, Gilda] Univ Politecn Marche, Sch Nursing, Ancona, Italy; [Frascati, Annamaria] Intermediate Care Community Hosp, Loreto, AN, Italy; [Dolcini, Franco] ASUR Marche, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University	Gasperini, B (corresponding author), Univ Politecn Marche, Sect Hyg & Publ Hlth, Ancona, Italy.; Gasperini, B (corresponding author), Azienda Osped Osped Riuniti Marche Nord, Geriatr, Fano, PU, Italy.	b.gasperini@univpm.it	GASPERINI, BEATRICE/AAE-7339-2022	GASPERINI, BEATRICE/0000-0002-9981-3460; Prospero, Emilia/0000-0002-2387-8639				Allen J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-346; American Nurses Association (ANA), 2010, NURS SOC POL STAT ES, V3rd; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Burston S, 2014, J CLIN NURS, V23, P1785, DOI 10.1111/jocn.12337; Chang SF, 2015, INT J NURS STUD, V52, P1362, DOI 10.1016/j.ijnurstu.2015.04.005; Conley D, 1999, Medsurg Nurs, V8, P348; Coster S, 2018, INT J NURS STUD, V78, P76, DOI 10.1016/j.ijnurstu.2017.10.009; Dwyer R, 2014, AGE AGEING, V43, P759, DOI 10.1093/ageing/afu117; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garasen H, 2008, SCAND J PUBLIC HEALT, V36, P197, DOI 10.1177/1403494808089685; Heslop L, 2014, J ADV NURS, V70, P2469, DOI 10.1111/jan.12503; Infusion Nurses Society (INS), 2021, J INFUS NURS S1, V44, pS1, DOI [DOI 10.1097/NAN.0000000000000396, 10.1097/NAN.0000000000000396, DOI 10.1097/NHH.0000000000000481]; Ingersoll GL, 2000, J ADV NURS, V32, P1272, DOI 10.1046/j.1365-2648.2000.01598.x; Kane Robert L, 2007, Evid Rep Technol Assess (Full Rep), P1; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Kojima G, 2018, AGE AGEING, V47, P193, DOI 10.1093/ageing/afx162; Kunaviktikul Wipada, 2005, Nurs Health Sci, V7, P273, DOI 10.1111/j.1442-2018.2005.00247.x; NANDA International, 2008, NURS DIAGN 2009 2011; National Institute for Health and Care Excellence, 2018, EM AC MED CAR 16 SER; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Norton D., 1962, INVESTIGATION GERIAT, V238, P12; Pilotto A, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.11.004; Pitchforth E., 2017, HEALTH SERV DELIVERY, V5, DOI DOI 10.3310/HSDR05190; Rothman MJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000849; Sezgin D, 2020, EUR GERIATR MED, V11, P961, DOI 10.1007/s41999-020-00365-4; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Winpenny EM, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2463	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249630	10.1371/journal.pone.0249630	http://dx.doi.org/10.1371/journal.pone.0249630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857183	Green Published, gold			2022-12-26	WOS:000641474900063
J	Tong, J; Tan, L; Im, YJ				Tong, Junsen; Tan, Lingchen; Im, Young Jun			Structure of human ORP3 ORD reveals conservation of a key function and ligand specificity in OSBP-related proteins	PLOS ONE			English	Article							PLASMA-MEMBRANE; BINDING; TRANSPORT; METABOLISM; MECHANISM; HOMOLOGS; FAMILY; PI(4)P; DRIVEN	Human ORP3 belongs to the oxysterol-binding protein (OSBP) family of lipid transfer proteins and is involved in lipid trafficking and cell signaling. ORP3 localizes to the ER-PM interfaces and is implicated in lipid transport and focal adhesion dynamics. Here, we report the 2.6-2.7 angstrom structures of the ORD (OSBP-related domain) of human ORP3 in apo-form and in complex with phosphatidylinositol 4-phosphate. The ORP3 ORD displays a helix grip beta-barrel fold with a deep hydrophobic pocket which is conserved in the OSBP gene family. ORP3 binds PI(4)P by the residues around tunnel entrance and in the hydrophobic pocket, whereas it lacks sterol binding due to the narrow hydrophobic tunnel. The heterologous expression of the ORDs of human ORP3 or OSBP1 rescued the lethality of seven ORP (yeast OSH1-OSH7) knockout in yeast. In contrast, the PI(4)P-binding site mutant of ORP3 did not complement the OSH knockout cells. The N-terminal PH domain and FFAT motif of ORP3 are involved in protein targeting but are not essential in yeast complementation. This observation suggests that the essential function conserved in the ORPs of yeast and human is mediated by PI(4)P-binding of the ORD domain. This study suggests that the non-vesicular PI(4)P transport is a conserved function of all ORPs in eukaryotes.	[Tong, Junsen; Tan, Lingchen; Im, Young Jun] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea	Chonnam National University	Im, YJ (corresponding author), Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea.	imyoungjun@jnu.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2019R1A2C1085530]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (grant no. 2019R1A2C1085530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2018, ANNU REV BIOCHEM, V87, P809, DOI 10.1146/annurev-biochem-061516-044924; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; D'Souza RS, 2020, ELIFE, V9, DOI 10.7554/eLife.54113; De Craene JO, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030634; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dong JQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08791-0; Dong X, 2020, BIOCHEM BIOPH RES CO, V529, P1005, DOI 10.1016/j.bbrc.2020.06.090; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Gulyas G, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237388; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lehto M, 2004, CELL TISSUE RES, V315, P39, DOI 10.1007/s00441-003-0817-y; Lehto M, 2001, J LIPID RES, V42, P1203; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lipp NF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00663; Manik MK, 2017, STRUCTURE, V25, P617, DOI 10.1016/j.str.2017.02.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Pemberton JG, 2020, TRAFFIC, V21, P200, DOI 10.1111/tra.12709; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tong J, 2016, BBA-MOL CELL BIOL L, V1861, P928, DOI 10.1016/j.bbalip.2016.01.008; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Weber-Boyvat M, 2015, EXP CELL RES, V331, P278, DOI 10.1016/j.yexcr.2014.10.019; Wong LH, 2019, NAT REV MOL CELL BIO, V20, P85, DOI 10.1038/s41580-018-0071-5; Yang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7129	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248781	10.1371/journal.pone.0248781	http://dx.doi.org/10.1371/journal.pone.0248781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857182	gold, Green Published			2022-12-26	WOS:000641474900065
J	Goto, K; Mineta, K; Miyazaki, S; Gojobori, T				Goto, Kosuke; Mineta, Katsuhiko; Miyazaki, Satoru; Gojobori, Takashi			Significant variants of type 2 diabetes in the Arabian Region through an Integration of exome databases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION	Type 2 diabetes (T2D) is a major global health issue, and it has also become one of the major diseases in Arab countries. In addition to the exome databases that have already been established, whole exome sequencing data for the Greater Middle East are now available. To elucidate the genetic features of T2D in the Arabian Peninsula, we integrated two exome databases (gnomAD exome and the Greater Middle East Variome Project) with clinical information from the ClinVar. After the integration, we obtained 18 single nucleotide polymorphisms and found two statistically and clinically significant variants in two genes, SLC30A8 rs13266634 and KCNJ11 rs5219. Interestingly, the two genes are linked to the uptake of the metals, Zn and K respectively, which indicating the regional features of the genetic variants. The frequency of the risk allele of rs13266634 among individuals in the Arabian Peninsula was higher than among individuals in other regions. On the other hand, the frequency of the risk allele of rs5219 in the Arabian Peninsula was lower than that in other regions. We identified and characterized T2D-related variants that show unique tendencies in the Arabian Peninsula. Our analyses contribute to and provide guidance for the clinical research of T2D in the Arabian Peninsula.	[Goto, Kosuke; Mineta, Katsuhiko; Gojobori, Takashi] King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Thuwal, Saudi Arabia; [Miyazaki, Satoru] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Med & Life Sci, Noda, Chiba, Japan	King Abdullah University of Science & Technology; Tokyo University of Science	Gojobori, T (corresponding author), King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Thuwal, Saudi Arabia.; Miyazaki, S (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Med & Life Sci, Noda, Chiba, Japan.	smiyazak@rs.tus.ac.jp; takashi.gojobori@kaust.edu.sa	Mineta, Katsuhiko/GXW-1434-2022	Mineta, Katsuhiko/0000-0002-4727-045X	King Abdullah University of Science and Technology (KAUST) [BAS/1/1059/01/01, URF/1/1976/03/01, URF/1/1976/20/01]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This work was supported through funding from King Abdullah University of Science and Technology (KAUST) under award numbers BAS/1/1059/01/01, URF/1/1976/03/01 and URF/1/1976/20/01.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Chabosseau P, 2016, ARCH BIOCHEM BIOPHYS, V611, P79, DOI 10.1016/j.abb.2016.05.022; Cook JP, 2016, EUR J HUM GENET, V24, P1175, DOI 10.1038/ejhg.2016.17; Dean L, GENETIC LANDSCAPE DI; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Haghvirdizadeh P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/908152; International Diabetes Federation, 2020, TYPE 2 DIABETES; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Khan AR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-16; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Spracklen CN, 2020, NATURE, V582, P240, DOI 10.1038/s41586-020-2263-3; Xue A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04951-w	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249226	10.1371/journal.pone.0249226	http://dx.doi.org/10.1371/journal.pone.0249226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848288	gold, Green Published			2022-12-26	WOS:000640373500011
J	McCallan, L; Brooks, C; Barry, C; Couzens, C; Young, FJ; McNair, J; Byrne, AW				McCallan, Lyanne; Brooks, Cathy; Barry, Claire; Couzens, Catherine; Young, Fiona J.; McNair, Jim; Byrne, Andrew W.			Serological test performance for bovine tuberculosis in cattle from herds with evidence of on-going infection in Northern Ireland	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; IMMUNE-RESPONSES; DIAGNOSIS; SENSITIVITY	The ability to accurately identify infected hosts is the cornerstone of effective disease control and eradication programs. In the case of bovine tuberculosis, accurately identifying infected individual animals has been challenging as all available tests exhibit limited discriminatory ability. Here we assess the utility of two serological tests (IDEXX Mycobacterium bovis Ab test and Enfer multiplex antibody assay) and assess their performance relative to skin test (Single Intradermal Comparative Cervical Tuberculin; SICCT), gamma-interferon (IFN gamma) and post-mortem results in a Northern Ireland setting. Furthermore, we describe a case-study where one test was used in conjunction with statutory testing. Serological tests using samples taken prior to SICCT disclosed low proportions of animals as test positive (mean 3% positive), despite the cohort having high proportions with positive SICCT test under standard interpretation (121/921; 13%) or IFN gamma (365/922; 40%) results. Furthermore, for animals with a post-mortem record (n = 286), there was a high proportion with TB visible lesions (27%) or with laboratory confirmed infection (25%). As a result, apparent sensitivities within this cohort was very low (<= 15%), however the tests succeeded in achieving very high specificities (96-100%). During the case-study, 7/670 (1.04%) samples from SICCT negative animals from a large chronically infected herd were serology positive, with a further 17 animals being borderline positive (17/670; 2.54%). Nine of the borderline animals were voluntarily removed, none of which were found to be infected post-mortem (no lesions/bacteriology negative). One serology test negative animal was subsequently found to have lesions at slaughter with M. bovis confirmed in the laboratory.	[McCallan, Lyanne; Brooks, Cathy; Barry, Claire; Couzens, Catherine; Young, Fiona J.; McNair, Jim; Byrne, Andrew W.] Agrifood & Biosci Inst, Vet Sci Div, Belfast, Antrim, North Ireland; [Byrne, Andrew W.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Byrne, Andrew W.] Dept Agr Food & Marine DAFM, One Hlth Sci Support Grp, Dublin, Ireland	Agri-Food & Biosciences Institute; Queens University Belfast	McCallan, L (corresponding author), Agrifood & Biosci Inst, Vet Sci Div, Belfast, Antrim, North Ireland.	Lyanne.McCallan@afbini.gov.uk	Byrne, Andrew/N-3894-2015	Byrne, Andrew/0000-0003-0296-4586	Department of Agriculture, Environment and Rural Affairs (DAERA) as part of the Evidence and Innovation Strategy under the grant "An assessment of commercially available serological tests for the detection of cattle infected with bovine tuberculosis" [15/3/09]	Department of Agriculture, Environment and Rural Affairs (DAERA) as part of the Evidence and Innovation Strategy under the grant "An assessment of commercially available serological tests for the detection of cattle infected with bovine tuberculosis"	This study was funded by the Department of Agriculture, Environment and Rural Affairs (DAERA) as part of the Evidence and Innovation Strategy under the grant "An assessment of commercially available serological tests for the detection of cattle infected with bovine tuberculosis" (grant no.: 15/3/09, Project Leaders: Dr. J. McNair and Dr. A. Byrne). The funders had no role in study design, data collection and analysis,	Abernethy DA, 2013, VET REC, V172, DOI 10.1136/vr.100969; Abernethy DA, 2006, VET MICROBIOL, V112, P231, DOI 10.1016/j.vetmic.2005.11.023; Allen AR, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00109; Alvarez J, 2009, VET MICROBIOL, V135, P389, DOI 10.1016/j.vetmic.2008.09.060; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Busch F, 2017, Vet Rec, V180, P68, DOI 10.1136/vr.103930; Byrne AW, 2017, PREV VET MED, V141, P38, DOI 10.1016/j.prevetmed.2017.04.007; Byrne AW, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1321-z; Byrne AW, 2014, VET RES, V45, DOI 10.1186/s13567-014-0109-4; Casal C, 2017, RES VET SCI, V112, P214, DOI 10.1016/j.rvsc.2017.05.012; Casal C, 2014, VET MICROBIOL, V170, P342, DOI 10.1016/j.vetmic.2014.02.036; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de la Rua-Domenech R., 2017, ANAMNESTIC BOOST EFF; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lahuerta-Marin A, 2018, VET J, V238, P15, DOI 10.1016/j.tvjl.2018.04.019; Lahuerta-Marin A, 2016, RES VET SCI, V107, P233, DOI 10.1016/j.rvsc.2016.06.014; Lahuerta-Marin A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0242-8; McCallan L, 2017, VET REC, V181, DOI 10.1136/vr.104272; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; O'Brien A, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00518-16; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Palmer MV, 2007, CURR TOP MICROBIOL, V315, P195; Pollock JM, 2005, VET IMMUNOL IMMUNOP, V108, P37, DOI 10.1016/j.vetimm.2005.08.012; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Stewart LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058374; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; Waters WR, 2014, J COMP PATHOL, V151, P410, DOI 10.1016/j.jcpa.2014.08.007; Waters WR, 2015, CLIN VACCINE IMMUNOL, V22, P641, DOI 10.1128/CVI.00119-15; Waters WR, 2014, VET IMMUNOL IMMUNOP, V159, P113, DOI 10.1016/j.vetimm.2014.02.009; Welsh MD, 2008, CATTLE PRACT, V16, P136; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x; Whelan C, 2010, CLIN VACCINE IMMUNOL, V17, P813, DOI 10.1128/CVI.00489-09; Whelan C, 2008, CLIN VACCINE IMMUNOL, V15, P1834, DOI 10.1128/CVI.00238-08; Wright DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074503; Zinsstag J., 2006, MYCOBACTERIUM BOVIS, P68, DOI DOI 10.1002/9780470344538.CH9	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0245655	10.1371/journal.pone.0245655	http://dx.doi.org/10.1371/journal.pone.0245655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848298	Green Published, gold			2022-12-26	WOS:000640373500016
J	Fischietti, M; Eckerdt, F; Blyth, GT; Arslan, AD; Mati, WM; Oku, CV; Perez, RE; Lee-Chang, C; Kosciuczuk, EM; Saleiro, D; Beauchamp, EM; Lesniak, MS; Verzella, D; Sun, LY; Fish, EN; Yang, GY; Qiang, WA; Platanias, LC				Fischietti, Mariafausta; Eckerdt, Frank; Blyth, Gavin T.; Arslan, Ahmet D.; Mati, William M.; Oku, Chidera, V; Perez, Ricardo E.; Lee-Chang, Catalina; Kosciuczuk, Ewa M.; Saleiro, Diana; Beauchamp, Elspeth M.; Lesniak, Maciej S.; Verzella, Daniela; Sun, Leyu; Fish, Eleanor N.; Yang, Guang-Yu; Qiang, Wenan; Platanias, Leonidas C.			Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article								We provide evidence that a member of the human Schlafen (SLFN) family of proteins, SLFN5, is overexpressed in human pancreatic ductal adenocarcinoma (PDAC). Targeted deletion of SLFN5 results in decreased PDAC cell proliferation and suppresses PDAC tumorigenesis in in vivo PDAC models. Importantly, high expression levels of SLFN5 correlate with worse outcomes in PDAC patients, implicating SLFN5 in the pathophysiology of PDAC that leads to poor outcomes. Our studies establish novel regulatory effects of SLFN5 on cell cycle progression through binding/blocking of the transcriptional repressor E2F7, promoting transcription of key genes that stimulate S phase progression. Together, our studies suggest an essential role for SLFN5 in PDAC and support the potential for developing new therapeutic approaches for the treatment of pancreatic cancer through SLFN5 targeting.	[Fischietti, Mariafausta; Eckerdt, Frank; Blyth, Gavin T.; Arslan, Ahmet D.; Mati, William M.; Oku, Chidera, V; Perez, Ricardo E.; Lee-Chang, Catalina; Kosciuczuk, Ewa M.; Saleiro, Diana; Beauchamp, Elspeth M.; Lesniak, Maciej S.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Fischietti, Mariafausta; Blyth, Gavin T.; Arslan, Ahmet D.; Mati, William M.; Oku, Chidera, V; Perez, Ricardo E.; Kosciuczuk, Ewa M.; Saleiro, Diana; Beauchamp, Elspeth M.; Platanias, Leonidas C.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Eckerdt, Frank; Lee-Chang, Catalina; Lesniak, Maciej S.] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Kosciuczuk, Ewa M.; Beauchamp, Elspeth M.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Chicago, IL 60612 USA; [Verzella, Daniela] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Sun, Leyu; Yang, Guang-Yu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada; [Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Qiang, Wenan] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Evanston, IL USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of L'Aquila; Northwestern University; Feinberg School of Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Northwestern University; Feinberg School of Medicine	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.; Platanias, LC (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.; Platanias, LC (corresponding author), Jesse Brown Vet Affairs Med Ctr, Dept Med, Chicago, IL 60612 USA.	l-platanias@northwestern.edu	Lee-Chang, Catalina/AAA-1808-2021; Kosciuczuk, Ewa Maria/AAD-2815-2022	Lee-Chang, Catalina/0000-0002-7675-2124; Fischietti, Mariafausta/0000-0002-5691-689X; Qiang, Wenan/0000-0001-5068-7128	National Institutes of Health [R01-NS113352, R01CA77816, R01-CA121192]; Department of Veterans Affairs [I01-CX000916]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health [R01-NS113352, R01CA77816, R01-CA121192]; Department of Veterans Affairs [I01-CX000916]	Arslan AD, 2017, ONCOGENE, V36, P6006, DOI 10.1038/onc.2017.205; Back SA, 1999, J NEUROSCI METH, V91, P47, DOI 10.1016/S0165-0270(99)00062-X; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Beauchamp EM, 2019, BLOOD, V133, P1171, DOI 10.1182/blood-2018-08-870089; Brown M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226917; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Chen DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133562; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chung SJ, 2019, CLIN CANCER RES, V25, P2290, DOI 10.1158/1078-0432.CCR-18-1620; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Di Carlo C, 2018, WORLD J STEM CELLS, V10, P172, DOI 10.4252/wjsc.v10.i11.172; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Fischietti M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00053-18; Fletcher SJ, 2015, J CLIN INVEST, V125, P3600, DOI 10.1172/JCI80347; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Grimont A, 2015, GUT, V64, P1790, DOI 10.1136/gutjnl-2014-307075; Guo LJ, 2019, EUR J PHARMACOL, V862, DOI 10.1016/j.ejphar.2019.172630; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Joukov V, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar4195; Katsoulidis E, 2010, J BIOL CHEM, V285, P40333, DOI 10.1074/jbc.M110.151076; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kent LN, 2016, J CLIN INVEST, V126, P2955, DOI 10.1172/JCI85506; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Liu FR, 2018, CELL BIOL INT, V42, P2, DOI 10.1002/cbin.10778; Mavrommatis E, 2013, J BIOL CHEM, V288, P33006, DOI 10.1074/jbc.M113.460741; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Mitxelena J, 2016, NUCLEIC ACIDS RES, V44, P5557, DOI 10.1093/nar/gkw146; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Napoles OC, 2017, J GASTROENTEROL, V52, P39, DOI 10.1007/s00535-016-1202-4; Petropoulos M, 2019, TRENDS BIOCHEM SCI, V44, P752, DOI 10.1016/j.tibs.2019.03.011; Razzak Mina, 2012, Nat Rev Urol, V9, P605, DOI 10.1038/nrurol.2012.188; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sassano A, 2015, MOL CELL BIOL, V35, P2684, DOI 10.1128/MCB.00019-15; Seong RK, 2017, IMMUNOBIOLOGY, V222, P979, DOI 10.1016/j.imbio.2017.07.002; Soper A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01823; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Thurlings I, 2017, ONCOGENE, V36, P829, DOI 10.1038/onc.2016.251; Wan GQ, 2019, CELL SIGNAL, V59, P1, DOI 10.1016/j.cellsig.2019.03.004; WEINERT T, 1993, SEMIN CANCER BIOL, V4, P129; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203; Xia ZQ, 2012, J IMMUNOL, V188, P3315, DOI 10.4049/jimmunol.1102775	44	3	3	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3273	3286		10.1038/s41388-021-01761-1	http://dx.doi.org/10.1038/s41388-021-01761-1		APR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33846574	Green Accepted			2022-12-26	WOS:000639635100001
J	Prados-Bo, A; Casino, G				Prados-Bo, Andreu; Casino, Gonzalo			Microbiome research in general and business newspapers: How many microbiome articles are published and which study designs make the news the most?	PLOS ONE			English	Article							LAY PRESS; CONSUMPTION; CITATIONS; JOURNALS; IMPACT	The microbiome is a matter of interest for science, consumers and business. Our objective is to quantify that interest in academic journals and newspapers, both quantitatively and by study design. We calculated the number of articles on the microbiome from the total number of biomedicine articles featured in both PubMed and Spanish science news agency SINC, from 2008 to 2018. We used the Factiva database to identify news stories on microbiome papers in three general newspapers (The New York Times, The Times and El Pais) and three business newspapers (The Wall Street Journal, the Financial Times and Expansion), from 2007 to 2019. Then, we compared news stories with microbiome papers in PubMed, while also analyzing the frequencies of five study design types, both in the newspapers and in the papers themselves. Microbiome papers represented 0.8% of biomedicine papers in PubMed from 2008 to 2018 (increasing from 0.4% to 1.4%), while microbiome news published by SINC represented 1.6% of total biomedical news stories during the same period (increasing from 0.2% to 2.2%). The number of news stories on microbiome papers correlated with the number of microbiome papers (0.91, p < 0.001) featured in general newspapers, but not in business ones. News stories on microbiome papers represented 78.9% and 42.7% of all microbiome articles in general and business newspapers, respectively. Both media outlet types tended to over-report observational studies in humans while under-reporting environmental studies, while the representation of systematic reviews of randomized controlled trials, randomized controlled trials and animal/laboratory studies was similar when comparing newspapers and PubMed. The microbiome is receiving increasing attention in academic journals and newspapers. News stories on the microbiome in general and business newspapers are mostly based on research findings and are more interested in observational studies in humans and less in environmental studies compared to PubMed.	[Prados-Bo, Andreu; Casino, Gonzalo] Pompeu Fabra Univ, Dept Commun, Barcelona, Spain; [Prados-Bo, Andreu] Ramon Llull Univ, Blanquerna Sch Hlth Sci, Barcelona, Spain; [Casino, Gonzalo] Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain	Pompeu Fabra University; Universitat Ramon Llull	Prados-Bo, A; Casino, G (corresponding author), Pompeu Fabra Univ, Dept Commun, Barcelona, Spain.; Prados-Bo, A (corresponding author), Ramon Llull Univ, Blanquerna Sch Hlth Sci, Barcelona, Spain.; Casino, G (corresponding author), Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain.	andreu@andreuprados.com; gonzalo.casino@upf.edu	Casino, Gonzalo/K-3254-2016	Casino, Gonzalo/0000-0003-1872-4130; Prados-Bo, Andreu/0000-0003-4393-9723				[Anonymous], 2020, BMJ-BRIT MED J; Baethge C, 2009, DTSCH ARZTEBL INT, V106, P413, DOI 10.3238/arztebl.2009.0413; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Bergstrom A, 2018, DIGIT JOURNAL, V6, P583, DOI 10.1080/21670811.2018.1423625; Bik Elisabeth M., 2016, Yale Journal of Biology and Medicine, V89, P363; Brossard D, 2013, P NATL ACAD SCI USA, V110, P14096, DOI 10.1073/pnas.1212744110; Casino G, 2018, PROF INFORM, V27, P692; Casino G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018705; Casino G, 2015, PANACEA, V16, P151; Cavicchioli R, 2019, NAT REV MICROBIOL, V17, P569, DOI 10.1038/s41579-019-0222-5; Chuong KH, 2015, QUAL HEALTH RES, V25, P1359, DOI 10.1177/1049732314568199; Costa T., 2003, J SCI COMMUN, V2, P1, DOI [10.22323/2.02010203, DOI 10.22323/2.02010203]; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Dumas-Mallet E, 2020, SCIENTOMETRICS, V123, P413, DOI 10.1007/s11192-020-03380-1; Dumas-Mallet E, 2018, SCI COMMUN, V40, P124, DOI 10.1177/1075547017752166; Dumas-Mallet E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172650; Fanelli D, 2013, SCIENTOMETRICS, V95, P1167, DOI 10.1007/s11192-012-0925-0; Fraumann G., 2018, OSLO I RES IMPACT SC; Fundacion Espanola para la Ciencia y la Tecnologia (FECYT), 2019, PERC SOC CIENC TECN; Garcia-Puente M, 2020, PROF INFORM, V29, DOI 10.3145/epi.2020.may.36; Gonon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044275; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Groneberg DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226305; Guasch B, 2019, INT J COMMUN-US, V13, P966; Jones S, 2013, NAT BIOTECHNOL, V31, P277, DOI [10.1038/nbt.2546, DOI 10.1038/NBT.2546]; Kiernan V, 2003, SCI COMMUN, V25, P3, DOI 10.1177/1075547003255297; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006103; Lynch SV, 2019, NAT REV GASTRO HEPAT, V16, P656, DOI 10.1038/s41575-019-0204-0; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; Mathelus S, 2012, LEARN PUBL, V25, P207, DOI 10.1087/20120307; National Human Genome Research Institute, 2014, NATL HUMAN GENOME RE; National Science Board, 2018, SCI TECHNOLOGY PUBLI; Nerlich B, 2009, NEW GENET SOC, V28, P19, DOI 10.1080/14636770802670233; Pallari E, 2017, CLIN RESPIR J, V11, P657, DOI 10.1111/crj.12685; Pew Research Center, 2019, NEWSPAPERS FACT SHEE; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Prescott S.L., 2017, HUM MICROBIOME J, V4, P24, DOI [10.1016/J.HUMIC.2017.05.004, DOI 10.1016/J.HUMIC.2017.05.004]; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwitzer G., 2018, HEALTHNEWSREVIEW; Selvaraj S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085355; Shan Y, 2019, NAT MED, V25, P872, DOI 10.1038/s41591-019-0470-y; Shoemaker PJ, 2006, COMMUNICATIONS-GER, V31, P105, DOI 10.1515/COMMUN.2006.007; Singh BK, 2017, MICROB BIOTECHNOL, V10, P50, DOI 10.1111/1751-7915.12592; Stephenson J., 1999, GENETIC INFORM, P201; Stulberg E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.15, 10.1038/nmicrobiol.2015.15]; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Taroncher-Oldenburg G, 2018, NAT BIOTECHNOL, V36, P1037, DOI 10.1038/nbt.4287; Thomas AM, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0667-z; Timmis K, 2019, ENVIRON MICROBIOL, V21, P1513, DOI 10.1111/1462-2920.14611; Wang MTM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145294; Welbers K, 2019, DIGIT JOURNAL, V7, P45, DOI 10.1080/21670811.2018.1493939; Wolf C, 2015, DIGIT JOURNAL, V3, P759, DOI 10.1080/21670811.2014.942497; Zmora N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1815	54	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249835	10.1371/journal.pone.0249835	http://dx.doi.org/10.1371/journal.pone.0249835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0OE	33836022	Green Published, gold			2022-12-26	WOS:000639361000019
J	Nourinejad, M; Berman, O; Larson, RC				Nourinejad, Mehdi; Berman, Oded; Larson, Richard C.			Placing sensors in sewer networks: A system to pinpoint new cases of coronavirus	PLOS ONE			English	Article								We consider a proposed system that would place sensors in a number of wastewater manholes in a community in order to detect genetic remnants of SARS-Cov-2 found in the excreted stool of infected persons. These sensors would continually monitor the manhole's wastewater, and whenever virus remnants are detected, transmit an alert signal. In a recent paper, we described two new algorithms, each sequentially opening and testing successive manholes for genetic remnants, each algorithm homing in on a neighborhood where the infected person or persons are located. This paper extends that work in six important ways: (1) we introduce the concept of in-manhole sensors, as these sensors will reduce the number of manholes requiring on-site testing; (2) we present a realistic tree network depicting the topology of the sewer pipeline network; (3) for simulations, we present a method to create random tree networks exhibiting key attributes of a given community; (4) using the simulations, we empirically demonstrate that the mean and median number of manholes to be opened in a search follows a well-known logarithmic function; (5) we develop procedures for determining the number of sensors to deploy; (6) we formulate the sensor location problem as an integer nonlinear optimization and develop heuristics to solve it. Our sensor-manhole system, to be implemented, would require at least three additional steps in R&D: (a) an accurate, inexpensive and fast SARS-Cov-2 genetic-remnants test that can be done at the manhole; (b) design, test and manufacture of the sensors; (c) in-the-field testing and fine tuning of an implemented system.	[Nourinejad, Mehdi] York Univ, Civil Engn Dept, Toronto, ON, Canada; [Berman, Oded] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada; [Larson, Richard C.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA	York University - Canada; University of Toronto; Massachusetts Institute of Technology (MIT)	Nourinejad, M (corresponding author), York Univ, Civil Engn Dept, Toronto, ON, Canada.	mehdi.nourineiad@lassonde.yorku.ca		Larson, Richard/0000-0003-2776-4900	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was partially funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) to OB. No additional external funding received for this study.	Adedoja OS, 2018, URBAN WATER J, V15, P985, DOI 10.1080/1573062X.2019.1597378; Banik BK, 2017, WATER-SUI, V9, DOI 10.3390/w9110856; Banik BK, 2017, J WATER RES PLAN MAN, V143, DOI 10.1061/(ASCE)WR.1943-5452.0000778; Banik BK, 2017, URBAN WATER J, V14, P416, DOI 10.1080/1573062X.2016.1176220; BERMAN O, 1992, TRANSPORT SCI, V26, P201, DOI 10.1287/trsc.26.3.201; Dietz R., 2011, GEOGRAPHY HOME SIZE; Giudicianni C, 2020, J WATER RES PLAN MAN, V146, DOI 10.1061/(ASCE)WR.1943-5452.0001210; Gruber G, 2006, WATER PRACT TECHNOL, V1, DOI 10.2166/WPT.2006020; Han D, 2016, INT J SUSTAIN TRANSP, V10, P671, DOI 10.1080/15568318.2015.1104565; Hellmer M, 2014, APPL ENVIRON MICROB, V80, P6771, DOI 10.1128/AEM.01981-14; Hovi T, 2001, EPIDEMIOL INFECT, V127, P101, DOI 10.1017/S0950268801005787; Hui Q., 2020, CSCEE, V2, P100064, DOI [10.1016/j.cscee.2020.100064, DOI 10.1016/J.CSCEE.2020.100064]; Johnson S., 2012, CONCRETE CONSTR; Kaplan EH, 2021, HEALTH CARE MANAG SC, V24, P320, DOI 10.1007/s10729-020-09525-1; Karen Steward, 2020, TECHNOLOGY NETW 0714; Katie Lannan, 2021, THE LOWELL SUN 0217; Lambert Anne-Marie, 2017, BELMONT CITIZENS FOR; Larsen DA, 2020, NAT BIOTECHNOL, V38, P1151, DOI 10.1038/s41587-020-0690-1; Larson RC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240007; Mao K, 2020, ENVIRON SCI TECHNOL, V54, P3733, DOI 10.1021/acs.est.0c01174; Medema G, 2020, ENVIRON SCI TECH LET, V7, P511, DOI 10.1021/acs.estlett.0c00357; Moreton N, 2020, SENSORS WATER IND NE; Muscillo M, 2013, FOOD ENVIRON VIROL, V5, P194, DOI 10.1007/s12560-013-9121-5; Nadworny E., 2020, COLL TURN WASTEWATER; Nakamura T, 2015, APPL ENVIRON MICROB, V81, P1850, DOI 10.1128/AEM.03575-14; Ottolini Meghan, 2021, BOSTON HERALD; Paul Marks, 2013, NEWSCIENTIST; Peccia J, 2020, NAT BIOTECHNOL, V38, P1164, DOI 10.1038/s41587-020-0684-z; Robin J, 2020, JERUSALEM POST 1027; Sims N, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105689; Wadman M., 2020, SCIENCE, P1502; Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055; Yang ZG, 2015, ENVIRON SCI TECHNOL, V49, P5845, DOI 10.1021/acs.est.5b01434	34	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0248893	10.1371/journal.pone.0248893	http://dx.doi.org/10.1371/journal.pone.0248893			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831024	gold, Green Published			2022-12-26	WOS:000639359600039
J	Ishida, M; Takebayashi, A; Kimura, F; Nakamura, A; Kitazawa, J; Morimune, A; Hanada, T; Tsuta, K; Murakami, T				Ishida, Mitsuaki; Takebayashi, Akie; Kimura, Fuminori; Nakamura, Akiko; Kitazawa, Jun; Morimune, Aina; Hanada, Tetsuro; Tsuta, Koji; Murakami, Takashi			Induction of the epithelial-mesenchymal transition in the endometrium by chronic endometritis in infertile patients	PLOS ONE			English	Article							EMT	Background The purpose of the present study was to evaluate the relationship between chronic endometritis and the epithelial-mesenchymal transition in the endometrium of infertile patients in the implantation phase. Methods Endometrial biopsy specimens from 66 infertility patients were analyzed. The presence of chronic endometritis was investigated by immunostaining for CD138. Immunohistochemical staining for E-cadherin, N-cadherin, Slug, and Snail was performed, and the expression profiles were statistically analyzed according to the presence of chronic endometritis. When the loss of E-cadherin expression and/or the positive expression of N-cadherin was detected, the specimen was considered epithelial-mesenchymal transition-positive. Epithelial-mesenchymal transition-positive cases were also statistically analyzed according to the presence of chronic endometritis. The characteristics of the patients in the epithelial-mesenchymal transition-positive and epithelial-mesenchymal transition-negative groups were compared. The association between variables, including age, body mass index, gravidity, parity, and each causative factor of infertility and epithelial-mesenchymal transition positivity was analyzed. Results The rates of the loss of E-cadherin expression, the gain of N-cadherin and epithelial-mesenchymal transition positivity were significantly higher in chronic endometritis patients. The expression of Slug, cytoplasmic Snail, and nuclear Snail was also detected at significantly higher rates in chronic endometritis patients. Chronic endometritis were related to the epithelial-mesenchymal transition. Conclusion The epithelial-mesenchymal transition was frequently detected in the endometrium in infertile patients with chronic endometritis. Since the epithelial-mesenchymal transition is associated with chronic endometritis, the epithelial-mesenchymal transition appears to be involved in the alteration of mechanisms of implantation.	[Ishida, Mitsuaki; Tsuta, Koji] Kansai Med Univ, Dept Pathol & Lab Med, Osaka, Japan; [Takebayashi, Akie; Kimura, Fuminori; Nakamura, Akiko; Kitazawa, Jun; Morimune, Aina; Hanada, Tetsuro; Murakami, Takashi] Shiga Univ Med Sci, Dept Obstet & Gynecol, Otsu, Shiga, Japan	Kansai Medical University; Shiga University of Medical Science	Ishida, M (corresponding author), Kansai Med Univ, Dept Pathol & Lab Med, Osaka, Japan.; Kimura, F (corresponding author), Shiga Univ Med Sci, Dept Obstet & Gynecol, Otsu, Shiga, Japan.	ishidamt@hirakata.kmu.ac.jp; kimurafu@belle.shiga-med.ac.jp	Kimura, Fuminori/AAZ-7380-2020	Kimura, Fuminori/0000-0002-9840-4227	Japan Society for the Promotion of Science [16K11083, 19K09752]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science, Grant Number 16K11083 and 19K09752 (to F.K.), supported this study regarding the design of the study and data collection, analysis, interpretation of data and in writing the manuscript. https://www.jsps.go.jp/english/.	Agarwal A, 2021, LANCET, V397, P319, DOI 10.1016/S0140-6736(20)32667-2; Alansari LM, 2012, HUM FERTIL, V15, P129, DOI 10.3109/14647273.2012.711499; Barratt CLR, 2017, HUM REPROD UPDATE, V23, P660, DOI 10.1093/humupd/dmx021; Barriere G, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0055-4; Bartley J, 2014, ARCH GYNECOL OBSTET, V289, P871, DOI 10.1007/s00404-013-3040-4; Bashiri A, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0414-2; Bayer-Garner IB, 2004, ARCH PATHOL LAB MED, V128, P1000; Busnelli A, 2016, HUM REPROD UPDATE, V22, P793, DOI 10.1093/humupd/dmw034; Buzzaccarini G, 2020, J ASSIST REPROD GEN, V37, P2897, DOI 10.1007/s10815-020-01955-8; Chae YK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21061-1; Chan YY, 2011, ULTRASOUND OBST GYN, V38, P371, DOI 10.1002/uog.10056; Chen T, 2017, J CELL PHYSIOL, V232, P3261, DOI 10.1002/jcp.25797; Chi RPA, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz117; Cicinelli E, 2015, HUM REPROD, V30, P323, DOI 10.1093/humrep/deu292; CRUM CP, 1983, AM J OBSTET GYNECOL, V147, P812, DOI 10.1016/0002-9378(83)90045-5; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Denisov EV, 2018, HEPATOLOGY, V68, P807, DOI 10.1002/hep.29784; Deroux A, 2017, CLIN REV ALLERG IMMU, V53, P78, DOI 10.1007/s12016-016-8586-z; Edwards RG, 2006, REPROD BIOMED ONLINE, V13, P887, DOI 10.1016/S1472-6483(10)61454-X; Farquhar CM, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-018-0058-8; Fitzgerald JS, 2008, HUM REPROD UPDATE, V14, P335, DOI 10.1093/humupd/dmn010; Gibbons DL, 2018, DEV DYNAM, V247, P555, DOI 10.1002/dvdy.24485; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Goossens S, 2017, BBA-REV CANCER, V1868, P584, DOI 10.1016/j.bbcan.2017.06.006; Gou JH, 2019, REPROD FERT DEVELOP, V31, P932, DOI 10.1071/RD18314; GREENWOOD SM, 1981, OBSTET GYNECOL, V58, P176; Harigai R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24484-y; Johnston-MacAnanny EB, 2010, FERTIL STERIL, V93, P437, DOI 10.1016/j.fertnstert.2008.12.131; Ju JF, 2014, EXP THER MED, V8, P1896, DOI 10.3892/etm.2014.1990; Kahyaoglu I, 2014, J ASSIST REPROD GEN, V31, P1155, DOI 10.1007/s10815-014-0281-5; Kaku S, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00982-y; Kang SH, 2019, KIDNEY RES CLIN PRAC, V38, P472, DOI 10.23876/j.krcp.19.049; Kim Su-Mi, 2017, Dev Reprod, V21, P351, DOI 10.12717/DR.2017.21.4.351; Kimura F, 2019, J OBSTET GYNAECOL RE, V45, P951, DOI 10.1111/jog.13937; Kitaya K, 2013, EXP THER MED, V5, P485, DOI 10.3892/etm.2012.824; Kitaya K, 2011, AM J REPROD IMMUNOL, V66, P410, DOI 10.1111/j.1600-0897.2011.01051.x; Kitazawa J, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13372; Klatsky PC, 2008, AM J OBSTET GYNECOL, V198, P357, DOI 10.1016/j.ajog.2007.12.039; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li YY, 2020, FERTIL STERIL, V113, P187, DOI 10.1016/j.fertnstert.2019.09.001; Liu LX, 2019, FERTIL STERIL, V111, P1002, DOI 10.1016/j.fertnstert.2019.01.006; Lundberg FE, 2019, EUR J EPIDEMIOL, V34, P499, DOI 10.1007/s10654-018-0474-9; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Minke B, 2017, METHODS MOL BIOL, V1501, P233, DOI 10.1007/978-1-4939-6475-8_11; Moon H, 2017, GASTROENTEROLOGY, V153, P1378, DOI 10.1053/j.gastro.2017.07.014; Morimune A, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13357; Moustafa Sarah, 2020, F1000Res, V9, DOI 10.12688/f1000research.22403.1; Owusu-Akyaw A, 2019, HUM REPROD UPDATE, V25, P114, DOI 10.1093/humupd/dmy035; Paria BC, 1999, DEV BIOL, V208, P488, DOI 10.1006/dbio.1999.9206; Pfeifer S, 2015, FERTIL STERIL, V103, pE44, DOI 10.1016/j.fertnstert.2015.03.019; Polisseni F, 2003, GYNECOL OBSTET INVES, V55, P205, DOI 10.1159/000072075; Prescott J, 2016, HUM REPROD, V31, P1475, DOI 10.1093/humrep/dew085; Proestling K, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0063-7; Quaas Alexander, 2008, Rev Obstet Gynecol, V1, P69; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ricciardi M, 2015, BRIT J CANCER, V112, P1067, DOI 10.1038/bjc.2015.29; Saitoh M, 2018, J BIOCHEM, V164, P257, DOI 10.1093/jb/mvy047; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Strandell A, 1999, HUM REPROD, V14, P2762, DOI 10.1093/humrep/14.11.2762; Tortorella C, 2014, FERTIL STERIL, V101, P242, DOI 10.1016/j.fertnstert.2013.09.041; Uchida H, 2012, J BIOL CHEM, V287, P4441, DOI 10.1074/jbc.M111.286138; Wilson MR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11403-6; Wu D, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0233-x; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xu YH, 2020, AM J REPROD IMMUNOL, V84, DOI 10.1111/aji.13255; Yang HP, 2015, BRIT J CANCER, V112, P925, DOI 10.1038/bjc.2015.24; Yao Y, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1332-8; Yu L, 2014, ONCOL REP, V31, P321, DOI 10.3892/or.2013.2841; Zargar M, 2020, J MINIM INVAS GYN, V27, P116, DOI 10.1016/j.jmig.2019.02.016; Zhang F, 2016, ONCOTARGET, V7, P52294, DOI 10.18632/oncotarget.10561; Zhang JY, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040041; Zhang XH, 2013, REPROD SCI, V20, P354, DOI 10.1177/1933719112472738; Zhou CC, 2012, ORAL ONCOL, V48, P1068, DOI 10.1016/j.oraloncology.2012.06.005	73	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249775	10.1371/journal.pone.0249775	http://dx.doi.org/10.1371/journal.pone.0249775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826645	Green Submitted, Green Published, gold			2022-12-26	WOS:000638119900017
J	Allu, PKR; Paulo, E; Bertholet, AM; Situ, G; Lee, SH; Wu, YX; Gleason, CE; Saha, B; Chawla, A; Wang, BA; Pearce, D				Allu, Prasanna K. R.; Paulo, Esther; Bertholet, Ambre M.; Situ, Gavin; Lee, Seung-Hwan; Wu, Yixuan; Gleason, Catherine E.; Saha, Bidisha; Chawla, Ajay; Wang, Biao; Pearce, David			Role of mTORC2 in biphasic regulation of brown fat metabolism in response to mild and severe cold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BEIGE FAT; THERMOGENESIS; OBESITY; WHITE; SENSITIVITY; ADIPOCYTES; ACTIVATION; LIPOLYSIS; ENERGY	Nonshivering thermogenesis is essential for mammals to maintain body temperature. According to the canonical view, temperature is sensed by cutaneous thermoreceptors and nerve impulses transmitted to the hypothalamus, which generates sympathetic signals to beta-adrenergic receptors in brown adipocytes. The energy for heat generation is primarily provided by the oxidation of fatty acids derived from triglyceride hydrolysis and cellular uptake. Fatty acids also activate the uncoupling protein, UCP1, which creates a proton leak that uncouples mitochondrial oxidative phosphorylation from ATP production, resulting in energy dissipation as heat. Recent evidence supports the idea that in response to mild cold, beta-adrenergic signals stimulate not only lipolysis and fatty acid oxidation, but also act through the mTORC2-Akt signaling module to stimulate de novo lipogenesis. This opposing anabolic effect is thought to maintain lipid fuel stores during increased catabolism. We show here, using brown fat-specific Gs-alpha knockout mice and cultured adipocytes that, unlike mild cold, severe cold directly cools brown fat and bypasses beta-adrenergic signaling to inhibit mTORC2. This cell-autonomous effect both inhibits lipogenesis and augments UCP1 expression to enhance thermogenesis. These findings suggest a novel mechanism for overriding beta-adrenergic-stimulated anabolic activities while augmenting catabolic activities to resolve the homeostatic crisis presented by severe cold.	[Allu, Prasanna K. R.; Situ, Gavin; Gleason, Catherine E.; Saha, Bidisha; Pearce, David] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Paulo, Esther; Lee, Seung-Hwan; Wu, Yixuan; Chawla, Ajay; Wang, Biao; Pearce, David] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bertholet, Ambre M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Allu, Prasanna K. R.] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA; [Lee, Seung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Situ, Gavin] Circle Pharma, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Catholic University of Korea; Seoul St. Mary's Hospital	Allu, PKR; Pearce, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA.; Pearce, D (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Allu, PKR (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA.	Prasanna.allu@joslin.harvard.edu; david.pearce@ucsf.edu	Wu, Yixuan/GXG-9879-2022; Paulo Mirasol, Esther/C-8607-2017	Wu, Yixuan/0000-0001-9637-9219; Paulo Mirasol, Esther/0000-0002-8108-3957	James Hilton Manning and Emma Austin Manning Foundation; NIH [DK094641, DK101064, R01-DK56695, P30DK063720, P30DK098722, DK105175]; American Heart Association; Larry Hillblom Foundation	James Hilton Manning and Emma Austin Manning Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Larry Hillblom Foundation	The authors gratefully acknowledge support from the James Hilton Manning and Emma Austin Manning Foundation (D. P.). The authors also acknowledge grant support from NIH DK094641 and DK101064 (A. C.); R01-DK56695 (D. P.); P30DK063720, P30DK098722, and DK105175 (B. W.). P. K. R. A. is supported by a postdoctoral fellowship grant from American Heart Association. E. P, is supported by a fellowship grant from Larry Hillblom Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albert V, 2016, EMBO MOL MED, V8, P232, DOI 10.15252/emmm.201505610; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Calejman CM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14430-w; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; Gasparetti AL, 2005, PFLUG ARCH EUR J PHY, V449, P537, DOI 10.1007/s00424-004-1359-1; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hung CM, 2014, CELL REP, V8, P256, DOI 10.1016/j.celrep.2014.06.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Li YQ, 2016, P NATL ACAD SCI USA, V113, P446, DOI 10.1073/pnas.1517142113; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Morrison S, 2015, ADIPOCYTE, V4, P295, DOI 10.1080/21623945.2015.1040612; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Oehler-Janne C, 2008, BIOCHEM BIOPH RES CO, V375, P399, DOI 10.1016/j.bbrc.2008.08.035; Paulo E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29333-6; Sanchez-Gurmaches j., 2018, CELL METAB, P27; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sun WP, 2016, EMBO REP, V17, P383, DOI 10.15252/embr.201540819; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	29	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100632	10.1016/j.jbc.2021.100632	http://dx.doi.org/10.1016/j.jbc.2021.100632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865855	Green Published, gold			2022-12-26	WOS:000672866400603
J	Kodera, N; Abe, H; Nguyen, PDN; Ono, S				Kodera, Noriyuki; Abe, Hiroshi; Nguyen, Phuong Doan N.; Ono, Shoichiro			Native cyclase-associated protein and actin from Xenopus laevis oocytes form a unique 4:4 complex with a tripartite structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; COFILIN; MECHANISM; DYNAMICS; DOMAIN; CAP2; TURNOVER; SRV2/CAP; MONOMERS	Cyclase-associated protein (CAP) is a conserved actinbinding protein that regulates multiple aspects of actin dynamics, including polymerization, depolymerization, filament severing, and nucleotide exchange. CAP has been isolated from different cells and tissues in an equimolar complex with actin, and previous studies have shown that a CAP-actin complex contains six molecules each of CAP and actin. Intriguingly, here, we successfully isolated a complex of Xenopus cyclaseassociated protein 1 (XCAP1) with actin from oocyte extracts, which contained only four molecules each of XCAP1 and actin. This XCAP1-actin complex remained stable as a single population of 340 kDa species during hydrodynamic analyses using gel filtration or analytical ultracentrifugation. Examination of the XCAP1-actin complex by high-speed atomic force microscopy revealed a tripartite structure: one middle globular domain and two globular arms. The two arms were observed in high and low states. The arms at the high state were spontaneously converted to the low state by dissociation of actin from the complex. However, when extra Gactin was added, the arms at the low state were converted to the high state. Based on the known structures of the N-terminal helical-folded domain and C-terminal CARP domain, we hypothesize that the middle globular domain corresponds to a tetramer of the N-terminal helical-folded domain of XCAP1 and that each arm in the high state corresponds to a heterotetramer containing a dimer of the C-terminal CARP domain of XCAP1 and two G-actin molecules. This novel configuration of a CAP-actin complex should help to understand how CAP promotes actin filament disassembly.	[Kodera, Noriyuki; Nguyen, Phuong Doan N.] Kanazawa Univ, WPI Nano Life Sci Inst, Kanazawa, Ishikawa, Japan; [Abe, Hiroshi] Chiba Univ, Grad Sch Sci, Dept Biol, Chiba, Japan; [Ono, Shoichiro] Emory Univ, Sch Med, Dept Pathol & Cell Biol, Atlanta, GA 30322 USA; [Ono, Shoichiro] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Kanazawa University; Chiba University; Emory University; Emory University	Ono, S (corresponding author), Emory Univ, Sch Med, Dept Pathol & Cell Biol, Atlanta, GA 30322 USA.; Ono, S (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA.	sono@emory.edu	Kodera, Noriyuki/AAJ-1797-2020; Ono, Shoichiro/A-6475-2015; Kodera, Noriyuki/E-6569-2015	Ono, Shoichiro/0000-0002-4763-0398; Kodera, Noriyuki/0000-0003-4880-8423	JST CREST [JPMJCR1762]; JSPS KAKENHI Grant [20H00327]; National Institutes of Health [R01AR048615]; JSPS Bridge Award	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Bridge Award	This work was supported by grants from JST CREST (JPMJCR1762) to N. K., JSPS KAKENHI Grant (20H00327) to N. K., and the National Institutes of Health (R01AR048615) to S. O. S. O. is a recipient of a JSPS Bridge Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; ANKENBAUER T, 1988, J CELL BIOL, V107, P1489, DOI 10.1083/jcb.107.4.1489; Aspit L, 2019, J MED GENET, V56, P228, DOI 10.1136/jmedgenet-2018-105498; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; Demeler Borries, 2010, Curr Protoc Protein Sci, VChapter 7, DOI 10.1002/0471140864.ps0713s60; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; Field J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17256; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; Hilton DM, 2018, J MOL BIOL, V430, P3323, DOI 10.1016/j.jmb.2018.06.025; Iwase S, 2017, CYTOSKELETON, V74, P343, DOI 10.1002/cm.21385; Iwase S, 2016, BIOCHEM J, V473, P4427, DOI 10.1042/BCJ20160329; Jansen S, 2014, J BIOL CHEM, V289, P30732, DOI 10.1074/jbc.M114.601765; Johnston AB, 2015, NAT CELL BIOL, V17, P1504, DOI 10.1038/ncb3252; Kepser LJ, 2019, P NATL ACAD SCI USA, V116, P8397, DOI 10.1073/pnas.1813351116; KhosrowShahian F, 2002, MECH DEVELOP, V113, P211, DOI 10.1016/S0925-4773(02)00033-3; Kotila T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13213-2; Kotila T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04231-7; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Makkonen M, 2013, J BIOL CHEM, V288, P984, DOI 10.1074/jbc.M112.435719; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Moriyama K, 2002, J CELL SCI, V115, P1591; Mu A, 2020, P NATL ACAD SCI USA, V117, P439, DOI 10.1073/pnas.1914072117; Mu A, 2019, NAT CELL BIOL, V21, P592, DOI 10.1038/s41556-019-0307-4; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Nomura K, 2013, BIOCHEM J, V453, P249, DOI 10.1042/BJ20130491; Nomura K, 2012, J CELL SCI, V125, P4077, DOI 10.1242/jcs.104950; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Okada K, 1999, J CELL SCI, V112, P1553; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Peche V, 2007, CELL MOL LIFE SCI, V64, P2702, DOI 10.1007/s00018-007-7316-3; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Purde V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225647; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Rust MB, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.586631; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shekhar S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13268-1; Shibata M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01466-8; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Wloclawer A., 2005, PROTEINS, V58, P262; Yusof AM, 2006, J MOL BIOL, V362, P1072, DOI 10.1016/j.jmb.2006.08.008; Zhang HT, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00282-19; Zhou GL, 2014, J CELL SCI, V127, P5052, DOI 10.1242/jcs.156059	53	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100649	10.1016/j.jbc.2021.100649	http://dx.doi.org/10.1016/j.jbc.2021.100649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839148	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400620
J	Flormann, DAD; Schu, M; Terriac, E; Thalla, D; Kainka, L; Koch, M; Gad, AKB; Lautenschlaeger, F				Flormann, Daniel A. D.; Schu, Moritz; Terriac, Emmanuel; Thalla, Divyendu; Kainka, Lucina; Koch, Marcus; Gad, Annica K. B.; Lautenschlaeger, Franziska			A novel universal algorithm for filament network tracing and cytoskeleton analysis	FASEB JOURNAL			English	Article						actin; cytoskeleton; image analysis; intermediate filaments; microtubules	ACTIN CYTOSKELETON; ARCHITECTURE	The rapid development of advanced microscopy techniques over recent decades has significantly increased the quality of imaging and our understanding of subcellular structures, such as the organization of the filaments of the cytoskeleton using fluorescence and electron microscopy. However, these recent improvements in imaging techniques have not been matched by similar development of techniques for computational analysis of the images of filament networks that can now be obtained. Hence, for a wide range of applications, reliable computational analysis of such two-dimensional methods remains challenging. Here, we present a new algorithm for tracing of filament networks. This software can extract many important parameters from grayscale images of filament networks, including the mesh hole size, and filament length and connectivity (also known as Coordination Number). In addition, the method allows sub-networks to be distinguished in two-dimensional images using intensity thresholding. We show that the algorithm can be used to analyze images of cytoskeleton networks obtained using different advanced microscopy methods. We have thus developed a new improved method for computational analysis of two-dimensional images of filamentous networks that has wide applications for existing imaging techniques. The algorithm is available as open-source software.	[Flormann, Daniel A. D.; Schu, Moritz; Thalla, Divyendu; Kainka, Lucina; Lautenschlaeger, Franziska] Saarland Univ, Dept Phys, Campus D2-2, D-66123 Saarbrucken, Germany; [Flormann, Daniel A. D.; Terriac, Emmanuel; Thalla, Divyendu; Kainka, Lucina; Koch, Marcus; Lautenschlaeger, Franziska] INM Leibniz Inst New Mat, Saarbrucken, Germany; [Gad, Annica K. B.] Weston Pk Canc Ctr, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Gad, Annica K. B.] Univ Madeira, Ctr Quim Madeira, Funchal, Portugal	Saarland University; Leibniz Institut fur Neue Materialien (INM); Universidade da Madeira	Flormann, DAD (corresponding author), Saarland Univ, Dept Phys, Campus D2-2, D-66123 Saarbrucken, Germany.	Daniel.Florrnann@web.de	Gad, Annica/X-8294-2018	Gad, Annica/0000-0002-1098-9129; Terriac, Emmanuel/0000-0002-8769-242X	Leibniz Institute for New Materials (INM); Saarland University; DFG [CRC 1027]; Fundacao para a Ciencia e a Tecnologia (FCT); Portuguese Government [PEst-OE/QUI/UI0674/2013]; Agencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao (ARDITI); Centro de Quimica da Madeira [M1420-01-0145-FEDER-000005]	Leibniz Institute for New Materials (INM); Saarland University; DFG(German Research Foundation (DFG)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Government(Portuguese Foundation for Science and Technology); Agencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao (ARDITI); Centro de Quimica da Madeira	Leibniz Institute for New Materials (INM); Saarland University; DFG, Grant/Award Number: CRC 1027; Fundacao para a Ciencia e a Tecnologia (FCT); Portuguese Government, Grant/Award Number: PEst-OE/QUI/UI0674/2013; Agencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao (ARDITI); Centro de Quimica da Madeira, Grant/Award Number: M1420-01-0145-FEDER-000005	Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chikina AS, 2019, J CELL BIOL, V218, P445, DOI 10.1083/jcb.201806075; Chugh P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.186254; Chugh P, 2017, NAT CELL BIOL, V19, P689, DOI 10.1038/ncb3525; Cordes A, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.068101; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hecht FM, 2015, SOFT MATTER, V11, P4584, DOI 10.1039/c4sm02718c; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Nasrollahi S, 2017, ACS BIOMATER SCI ENG, V3, P2980, DOI 10.1021/acsbiomaterials.6b00554; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Su R, 2012, PATTERN RECOGN, V45, P3695, DOI 10.1016/j.patcog.2012.04.013; Svitkina TM, 2020, TRENDS CELL BIOL, V30, P556, DOI 10.1016/j.tcb.2020.03.005; Svitkina TM, 2017, INT J BIOCHEM CELL B, V86, P37, DOI 10.1016/j.biocel.2017.03.009; Xia SM, 2019, CELL REP, V28, P1251, DOI 10.1016/j.celrep.2019.06.089; Xu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09081; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	21	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21582	10.1096/fj.202100048R	http://dx.doi.org/10.1096/fj.202100048R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835502	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000645260100033
J	Blumer, N; Pfadenhauer, LM; Burns, J				Blumer, Natasha; Pfadenhauer, Lisa M.; Burns, Jacob			Access to HIV-prevention in female sex workers in Ukraine between 2009 and 2017: Coverage, barriers and facilitators	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; HEALTH-SERVICES; RISK BEHAVIORS; CONDOM USE; EXPERIENCES; PREVALENCE; VULNERABILITY; DETERMINANTS; ENVIRONMENTS; ASSOCIATIONS	The provision of comprehensive prevention services is vital for reducing the high burden of HIV amongst Ukrainian female sex workers (FSWs). To identify barriers and facilitators that influence access to HIV prevention amongst this population between 2009 and 2017, we developed a literature-informed conceptual framework and conducted a document analysis to identify the components of the Ukrainian prevention package (PP). Using the Integrated Bio Behavioural Surveillance Surveys, we then conducted descriptive analyses to explore PP coverage from 2009 to 2017 and the influence of factors, identified by our conceptual framework. After increasing over four years, a drop in PP coverage was observed from 2013 onwards. Being a client of a non-governmental organisation, street and highway solicitation, non-condom use, and knowledge of HIV may influence access to HIV prevention in the Ukrainian context. Future interventions should consider barriers and facilitators to HIV prevention and the multiple structural levels on which they operate.	[Blumer, Natasha; Pfadenhauer, Lisa M.; Burns, Jacob] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany; [Blumer, Natasha; Pfadenhauer, Lisa M.; Burns, Jacob] Pettenkofer Sch Publ Hlth Munich, Munich, Germany; [Blumer, Natasha] Ludwig Maximilians Univ Munchen, Pettenkofer Sch Publ Hlth PSPH, Chair Publ Hlth & Hlth Serv Res, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany	University of Munich; University of Munich	Blumer, N (corresponding author), Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany.; Blumer, N (corresponding author), Pettenkofer Sch Publ Hlth Munich, Munich, Germany.; Blumer, N (corresponding author), Ludwig Maximilians Univ Munchen, Pettenkofer Sch Publ Hlth PSPH, Chair Publ Hlth & Hlth Serv Res, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany.	natasha.blumer@posteo.de	Blumer, Natasha/GQH-2755-2022	Blumer, Natasha/0000-0003-0137-6336	Global Fund to Fight AIDS, Tuberculosis and Malaria (TGF); International Charitable Foundation "Alliance for Public Health" (Alliance)	Global Fund to Fight AIDS, Tuberculosis and Malaria (TGF); International Charitable Foundation "Alliance for Public Health" (Alliance)	The paper summarizes and analyses the data from studies funded by of the Global Fund to Fight AIDS, Tuberculosis and Malaria (TGF) and implemented in Ukraine by the International Charitable Foundation "Alliance for Public Health" (Alliance). The data for analysis were provided to the authors by the data holder the Public Health Centre (PHC) of the Ukrainian Ministry of Health. All opinions presented in this manuscript belong to the authors alone and not represent position of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Alliance for Public Health or the Public Health Centre (PHC) of the Ukrainian Ministry of Health. We would like to thank Ihor Kuzin (PHC), Yana Sazonova (Alliance), Roksolana Kulchynska (CDC) and Tetyana Salyuk (Alliance) for their comments on the manuscript, Oleksandr Korotych (PHC) and Oksana Kovtun (Alliance) for providing us with the IBBS datasets and, Nadiya Yanhol (Alliance) for her insight into the PP. Lastly and most importantly, thank you to the SWs that partook in the IBBS studies.	[Anonymous], 2018, CRIMINAL CODE UKRAIN; Asadi-Aliabadi Mehran, 2018, J Prev Med Public Health, V51, P64, DOI 10.3961/jpmph.17.174; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Bekker LG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007435; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Biradavolu MR, 2012, J EPIDEMIOL COMMUN H, V66, pII95, DOI 10.1136/jech-2011-200508; Cange CW, 2017, CULT HEALTH SEX, V19, P1053, DOI 10.1080/13691058.2017.1291993; Cazabat C, 2019, GEND PERSP INT DISPL; Chanda MM, 2017, AIDS PATIENT CARE ST, V31, P290, DOI 10.1089/apc.2017.0016; Das P, 2015, LANCET, V385, P3, DOI 10.1016/S0140-6736(14)61064-3; Decker MR, 2016, SEX TRANSM INFECT, V92, P599, DOI 10.1136/sextrans-2015-052463; Duby Z, 2018, S AFR J HIV MED, V19, DOI 10.4102/sajhivmed.v19i1.701; Duff P, 2017, OCCUP MED-OXFORD, V67, P515, DOI 10.1093/occmed/kqx092; Erausquin JT, 2011, J INFECT DIS, V204, pS1223, DOI 10.1093/infdis/jir539; European Centre for Disease Prevention and Control, 2017, HIV AIDS SURVEILLANC; Ferguson A, 2017, CONFL HEALTH, V11, DOI 10.1186/s13031-017-0124-y; Gruskin S, 2009, REPROD HEALTH MATTER, V17, P108, DOI 10.1016/S0968-8080(09)34483-3; Holt E, 2018, LANCET HIV, V5, pE273, DOI 10.1016/S2352-3018(18)30106-1; Huang W, 2014, PREV SCI, V15, P329, DOI 10.1007/s11121-013-0423-5; Iakunchykova OP, 2017, AIDS BEHAV, V21, P2306, DOI 10.1007/s10461-016-1495-6; ICF, 2009, ANN REP 2009; ICF, 2008, ANN REP 2008; ICF, 2011, ANN REP 2011; ICF, 2013, ANN REP 2013; ICF, 2016, ANN REP 2016; ICF, 2006, ANN REP 2006; ICF, 2014, ANN REP 2014; ICF, 2017, ANN REP 2017; ICF, 2015, ANN REP 2015; ICF, 2012, ANN REP 2012; ICF, 2004, ANN REP 2004; ICF, 2010, ANN REPORT 2010; Jayanna K, 2010, SEX TRANSM INFECT, V86, P131, DOI 10.1136/sti.2008.035600; Johnston LG, 2017, AIDS BEHAV, V21, P2362, DOI 10.1007/s10461-016-1616-2; Krishnaratne S, 2016, LANCET HIV, V3, pE307, DOI 10.1016/S2352-3018(16)30038-8; Lang DL, 2013, AIDS BEHAV, V17, P551, DOI 10.1007/s10461-012-0245-7; Langa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094838; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Lim RBT, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0358-5; Maclin B, 2015, CULT HEALTH SEX, V17, P119, DOI 10.1080/13691058.2014.951395; Maher L, 2015, HEALTH HUM RIGHTS, V17, P102, DOI 10.2307/healhumarigh.17.1.102; Makarenko I, 2017, J URBAN HEALTH, V94, P104, DOI 10.1007/s11524-016-0119-9; Munoz J, 2010, SAHARA J-J SOC ASP H, V7, P52, DOI 10.1080/17290376.2010.9724957; Nnko S, 2018, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6362-0; Panchanadeswaran S, 2008, INT J DRUG POLICY, V19, P106, DOI 10.1016/j.drugpo.2007.11.013; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Prakash R, 2018, AJAR-AFR J AIDS RES, V17, P99, DOI 10.2989/16085906.2017.1377268; Prakash R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150347; Qiao S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111012; RCore Team, 2020, R LANG ENV STAT COMP; Reeves A, 2017, LANCET HIV, V4, pE134, DOI 10.1016/S2352-3018(16)30217-X; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Shahmanesh M, 2009, SOC SCI MED, V69, P604, DOI 10.1016/j.socscimed.2009.06.020; Shannon K, 2018, LANCET, V392, P698, DOI 10.1016/S0140-6736(18)31439-9; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Shveda Yuriy, 2016, Journal of Eurasian Studies, V7, P85; Smyrnov P, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25040; Strathdee SA, 2015, JAIDS-J ACQ IMM DEF, V69, pS110, DOI 10.1097/QAI.0000000000000624; The World Bank Group, 2019, UKR COUNTR PROF; Tokar A, 2019, SEX TRANSM INFECT, V95, P193, DOI 10.1136/sextrans-2018-053684; Tucker JD, 2007, SEX TRANSM INFECT, V84, P34, DOI 10.1136/sti.2007.027235; Tucker JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024816; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2018, GLOB AIDS MON 2018 I; Vitek CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103657; Wanyenze RK, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0119-1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation, 2017, CONSOLIDATED GUIDELI; World Health Organisation, 2014, COUNTR HIGHL DOM REP, P2; World Health Organization, 2013, CONSOLIDATED GUIDELI; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Zeng H, 2016, HEALTH SOC CARE COMM, V24, pE173, DOI 10.1111/hsc.12266	75	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250024	10.1371/journal.pone.0250024	http://dx.doi.org/10.1371/journal.pone.0250024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861784	Green Published, gold, Green Submitted			2022-12-26	WOS:000641475400040
J	Wiebe, K; Sulser, TB; Dunston, S; Rosegrant, MW; Fuglie, K; Willenbockel, D; Nelson, GC				Wiebe, Keith; Sulser, Timothy B.; Dunston, Shahnila; Rosegrant, Mark W.; Fuglie, Keith; Willenbockel, Dirk; Nelson, Gerald C.			Modeling impacts of faster productivity growth to inform the CGIAR initiative on Crops to End Hunger	PLOS ONE			English	Article							CLIMATE-CHANGE; AGRICULTURE; SCENARIOS; SECURITY	In 2017-2018, a group of international development funding agencies launched the Crops to End Hunger initiative to modernize public plant breeding in lower-income countries. To inform that initiative, USAID asked the International Food Policy Research Institute and the United States Department of Agriculture's Economic Research Service to estimate the impacts of faster productivity growth for 20 food crops on income and other indicators in 106 countries in developing regions in 2030. We first estimated the value of production in 2015 for each crop using data from FAO. We then used the IMPACT and GLOBE economic models to estimate changes in the value of production and changes in economy-wide income under scenarios of faster crop productivity growth, assuming that increased investment will raise annual rates of yield growth by 25% above baseline growth rates over the period 2015-2030. We found that faster productivity growth in rice, wheat and maize increased economy-wide income in the selected countries in 2030 by 59 billion USD, 27 billion USD and 21 billion USD respectively, followed by banana and yams with increases of 9 billion USD each. While these amounts represent small shares of total GDP, they are 2-15 times current public R&D spending on food crops in developing countries. Income increased most in South Asia and Sub-Saharan Africa. Faster productivity growth in rice and wheat reduced the population at risk of hunger by 11 million people and 6 million people respectively, followed by plantain and cassava with reductions of about 2 million people each. Changes in adequacy ratios were relatively large for carbohydrates (already in surplus) and relatively small for micronutrients. In general, we found that impacts of faster productivity growth vary widely across crops, regions and outcome indicators, highlighting the importance of identifying the potentially diverse objectives of different decision makers and recognizing possible tradeoffs between objectives.	[Wiebe, Keith; Sulser, Timothy B.; Dunston, Shahnila; Rosegrant, Mark W.] Int Food Policy Res Inst, Washington, DC 20036 USA; [Fuglie, Keith] USDA, Econ Res Serv, Washington, DC USA; [Willenbockel, Dirk] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Nelson, Gerald C.] Univ Illinois, Urbana, IL 61801 USA	CGIAR; International Food Policy Research Institute (IFPRI); United States Department of Agriculture (USDA); University of Sussex; University of Illinois System; University of Illinois Urbana-Champaign	Wiebe, K (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	k.wiebe@cgiar.org	Sulser, Timothy B./AAJ-1776-2020	Sulser, Timothy B./0000-0001-7128-5283; Wiebe, Keith/0000-0001-6035-620X; Fuglie, Keith/0000-0002-7601-0542	United States Agency for International Development (USAID); International Food Policy Research Institute (IFPRI); CGIAR Research Program on Policies, Institutions, and Markets (PIM)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); International Food Policy Research Institute (IFPRI)(CGIAR); CGIAR Research Program on Policies, Institutions, and Markets (PIM)(CGIAR)	KW, TBS, SD, and MWR received funding from the United States Agency for International Development (USAID; https://www.usaid.gov).DW and GCN received funding from the International Food Policy Research Institute (IFPRI; https://www.ifpri.org/).Funding for model development and maintenance was provided by the CGIAR Research Program on Policies, Institutions, and Markets (PIM; http://pim.cgiar.org/).USAID participated in the selection of crops and countries to be studied and the identification of scenarios to be modeled.	Aguiar A, 2016, J GLOB ECON ANAL, V1, P181, DOI 10.21642/JGEA.010103AF; Alston J.M., 1995, SCI SCARCITY PRINCIP; Beintema N, 2012, ASTI GLOBAL ASSESSME; Bodirsky BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139201; Boyce J.K., 1975, NATL INT AGR RES EXT; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Delzeit R, 2020, J GLOB ECON ANAL, V5, P162, DOI 10.21642/JGEA.050105AF; Evenson R, 1995, PRODUCTIVITY PROJECT; Evenson RE., 1999, 109 INT FOOD POL RES; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fischer T, 2014, ACIAR MONOGR SER, V158, P65; FOSTER J, 1984, ECONOMETRICA, V52, P761, DOI 10.2307/1913475; Fuglie K., 2019, HARVESTING PROSPERIT; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Kruseman G, 2020, CROP SCI, V60, P568, DOI 10.1002/csc2.20114; Lele U, 2016, MEASURING FOOD NUTR; Mason-D'Croz D., 2015, 01483 INT FOOD POL R; McDonald S, 2007, 14 USNA; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nelson G, 2018, NAT SUSTAIN, V1, P773, DOI 10.1038/s41893-018-0192-z; Nelson GC, 2014, P NATL ACAD SCI USA, V111, P3274, DOI 10.1073/pnas.1222465110; O'Neill BC, 2017, GLOBAL ENVIRON CHANG, V42, P169, DOI 10.1016/j.gloenvcha.2015.01.004; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Pradhan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129487; Ray DK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217148; Robinson S, 2014, AGR ECON-BLACKWELL, V45, P21, DOI 10.1111/agec.12087; Rosegrant M.W., 2012, INT MODEL POLICY ANA; Rosegrant M.W., 2018, PRIORITIZING DEV COS, P322, DOI [10.1073/pnas.1721436115, DOI 10.1073/PNAS.1721436115]; Rosegrant M.W., 2017, QUANTITATIVE FORESIG; Ruane AC, 2018, CLIM RES, V76, P17, DOI 10.3354/cr01520; Ruttan VW, 1982, AGR RES POLICY, DOI [10.1126/science.216.4541.23, DOI 10.1126/SCIENCE.216.4541.23]; Smith LC., 2000, 111 INT FOOD POL RES; Valin H, 2014, AGR ECON-BLACKWELL, V45, P51, DOI 10.1111/agec.12089; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; von Lampe M, 2014, AGR ECON-BLACKWELL, V45, P3, DOI 10.1111/agec.12086; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiebe K, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085010; Willenbockel D., 2018, 01738 INT FOOD POL R; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249994	10.1371/journal.pone.0249994	http://dx.doi.org/10.1371/journal.pone.0249994			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857244	Green Submitted, Green Published, gold			2022-12-26	WOS:000641474900062
J	Zhou, Y; Zhong, TY; Wei, WJ; Wu, ZH; Yang, AP; Liu, N; Wang, M; Zhang, XL				Zhou, Ying; Zhong, Tianying; Wei, Wenjing; Wu, Zhuhua; Yang, Anping; Liu, Ning; Wang, Ming; Zhang, Xiaoli			Single START-domain protein Mtsp17 is involved in transcriptional regulation in Mycobacterium smegmatis	PLOS ONE			English	Article							TUBERCULOSIS; OVEREXPRESSION; IDENTIFICATION; ANTIGENS; REGULON	Tuberculosis caused by the pathogen Mycobacterium tuberculosis (MTB), remains a significant threat to global health. Elucidating the mechanisms of essential MTB genes provides an important theoretical basis for drug exploitation. Gene mtsp17 is essential and is conserved in the Mycobacterium genus. Although Mtsp17 has a structure closely resembling typical steroidogenic acute regulatory protein-related lipid transfer (START) family proteins, its biological function is different. This study characterizes the transcriptomes of Mycobacterium smegmatis to explore the consequences of mtsp17 downregulation on gene expression. Suppression of the mtsp17 gene resulted in significant down-regulation of 3% and upregulation of 1% of all protein-coding genes. Expression of desA1, an essential gene involved in mycolic acid synthesis, and the anti-SigF antagonist MSMEG_0586 were down-regulated in the conditional Mtsp17 knockout mutant and up-regulated in the Mtsp17 over-expression strain. Trends in the changes of 70 of the 79 differentially expressed genes (Log(2) fold change > 1.5) in the conditional Mtsp17 knockout strain were the same as in the SigF knockout strain. Our data suggest that Mtsp17 is likely an activator of desA1 and Mtsp17 regulates the SigF regulon by SigF regulatory pathways through the anti-SigF antagonist MSMEG_0586. Our findings indicate the role of Mtsp17 may be in transcriptional regulation, provide new insights into the molecular mechanisms of START family proteins, and uncover a new node in the regulatory network of mycobacteria.	[Zhou, Ying; Liu, Ning] Jinan Univ, Dept Bone & Joint Surg, Affiliated Hosp 1, Guangzhou, Peoples R China; [Zhong, Tianying] Jiangmen Polytech, Guangdong Prov Green & High Performance Novel Mat, Jiangmen, Peoples R China; [Wei, Wenjing; Wu, Zhuhua] Ctr TB Control Guangdong Prov, Guangzhou, Peoples R China; [Yang, Anping; Zhang, Xiaoli] Foshan Univ, Sch Med, Foshan, Guangdong, Peoples R China; [Wang, Ming] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing, Peoples R China	Jinan University; Foshan University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Liu, N (corresponding author), Jinan Univ, Dept Bone & Joint Surg, Affiliated Hosp 1, Guangzhou, Peoples R China.; Zhang, XL (corresponding author), Foshan Univ, Sch Med, Foshan, Guangdong, Peoples R China.; Wang, M (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing, Peoples R China.	385327952@qq.com; wangming@ibp.ac.cn; zhangxiaoli0105@163.com		zhong, tianying/0000-0002-6347-2502				Andrews ESV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236551; Chauhan R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11062; Chen J, 2021, NAT REV MICROBIOL, V19, P95, DOI 10.1038/s41579-020-00450-2; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Ehrt S, 2018, NAT REV MICROBIOL, V16, P496, DOI 10.1038/s41579-018-0013-4; Horenkamp FA, 2018, EMBO J, V37, DOI 10.15252/embj.201798002; Humpel A, 2010, J BACTERIOL, V192, P2491, DOI 10.1128/JB.00035-10; Hurst-Hess K, 2019, MBIO, V10, DOI 10.1128/mBio.00273-19; Ireton GC, 2010, CLIN VACCINE IMMUNOL, V17, P1539, DOI 10.1128/CVI.00198-10; Johnson EO, 2019, NATURE, V571, P72, DOI 10.1038/s41586-019-1315-z; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; Li SM, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-2252-6; Lim JH, 2004, FEMS MICROBIOL LETT, V232, P51, DOI 10.1016/S0378-1097(04)00018-7; Oh Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.588487; Peterson EJR, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188584; Rustad TR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0502-3; Schrick K, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0070-8; Singh A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164253; Singh AK, 2015, MICROBIOLOGYOPEN, V4, P896, DOI 10.1002/mbo3.288; Vishwakarma RK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01798; Zhang Zhuan, 2017, F1000Res, V6, P172, DOI 10.12688/f1000research.10466.1; Zheng SP, 2018, FEBS LETT, V592, P1445, DOI 10.1002/1873-3468.13024; Zhou Y, 2020, INT J BIOCHEM CELL B, V124, DOI 10.1016/j.biocel.2020.105763; Zhu DX, 2019, P NATL ACAD SCI USA, V116, P13573, DOI 10.1073/pnas.1900176116	25	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249379	10.1371/journal.pone.0249379	http://dx.doi.org/10.1371/journal.pone.0249379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857164	gold, Green Published			2022-12-26	WOS:000641474900030
J	Eastman, B; Meaney, C; Przedborski, M; Kohandel, M				Eastman, Brydon; Meaney, Cameron; Przedborski, Michelle; Kohandel, Mohammad			Modeling the impact of public response on the COVID-19 pandemic in Ontario	PLOS ONE			English	Article								The outbreak of SARS-CoV-2 is thought to have originated in Wuhan, China in late 2019 and has since spread quickly around the world. To date, the virus has infected tens of millions of people worldwide, compelling governments to implement strict policies to counteract community spread. Federal, provincial, and municipal governments have employed various public health policies, including social distancing, mandatory mask wearing, and the closure of schools and businesses. However, the implementation of these policies can be difficult and costly, making it imperative that both policy makers and the citizenry understand their potential benefits and the risks of non-compliance. In this work, a mathematical model is developed to study the impact of social behaviour on the course of the pandemic in the province of Ontario. The approach is based upon a standard SEIRD model with a variable transmission rate that depends on the behaviour of the population. The model parameters, which characterize the disease dynamics, are estimated from Ontario COVID-19 epidemiological data using machine learning techniques. A key result of the model, following from the variable transmission rate, is the prediction of the occurrence of a second wave using the most current infection data and disease-specific traits. The qualitative behaviour of different future transmission-reduction strategies is examined, and the time-varying reproduction number is analyzed using existing epidemiological data and future projections. Importantly, the effective reproduction number, and thus the course of the pandemic, is found to be sensitive to the adherence to public health policies, illustrating the need for vigilance as the economy continues to reopen.	[Eastman, Brydon; Meaney, Cameron; Przedborski, Michelle; Kohandel, Mohammad] Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada	University of Waterloo	Eastman, B (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada.	b2eastma@uwaterloo.ca	Eastman, Brydon/AAG-1210-2022; Eastman, Brydon/AFK-2862-2022	Eastman, Brydon/0000-0002-8231-8498; Kohandel, Mohammad/0000-0003-0667-7269; Meaney, Cameron/0000-0003-4606-1872				Berry I, 2020, CAN MED ASSOC J, V192, pE420, DOI 10.1503/cmaj.75262; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Google,, 2020, COVID 19 COMM MOB RE; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Organization WH, 2020, REPORT WHO CHINA JOI; Organization WH, 2020, NOVEL CORONAVIRUS 20; Park Sang Woo, 2020, medRxiv, DOI 10.1101/2020.03.27.20045815; Peng L., 2020, ARXIV PREPRINT ARXIV; Read JM., 2020, MEDRXIV, DOI [10.1101/2020.07.12.20151696, DOI 10.1101/2020.07.12.20151696]; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328	12	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249456	10.1371/journal.pone.0249456	http://dx.doi.org/10.1371/journal.pone.0249456			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852592	gold, Green Published			2022-12-26	WOS:000640604500037
J	Marquez-Curtis, LA; Bokenfohr, R; McGann, LE; Elliott, JAW				Marquez-Curtis, Leah A.; Bokenfohr, Reid; McGann, Locksley E.; Elliott, Janet A. W.			Cryopreservation of human cerebral microvascular endothelial cells and astrocytes in suspension and monolayers	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INTRACELLULAR ICE FORMATION; DIMETHYL-SULFOXIDE DMSO; IN-VITRO MODELS; CRYOPROTECTANT TOXICITY; HYDROXYETHYL STARCH; MEMBRANE INTEGRITY; CULTURE MODELS; LINE HCMEC/D3; ANGIOGENESIS	The blood-brain barrier (BBB) keeps pathogens and toxins out of the brain but also impedes the entry of pharmaceuticals. Human cerebral microvascular endothelial cells (hCMECs) and astrocytes are the main functional cell components of the BBB. Although available commercially as cryopreserved cells in suspension, improvements in their cryopreservation and distribution as cryopreserved monolayers could enhance BBB in vitro studies. Here, we examined the response to slow cooling and storage in liquid nitrogen of immortalized hCMEC/D3 cells and human primary astrocytes in suspension and in monolayers. HCMEC/D3 cells in suspension cryopreserved in 5% dimethyl sulfoxide (DMSO) and 95% fetal bovine serum or in 5% DMSO and 6% hydroxyethyl starch (HES) showed post-thaw membrane integrities above 90%, similar to unfrozen control. Cryopreservation did not affect the time-dependent ability of hCMEC/D3 cells to form tubes on Matrigel. Primary astrocytes in suspension cryopreserved in the presence of 5% DMSO and 6% HES had improved viability over those cryopreserved in 10% DMSO. Monolayers of single cultures or co-cultures of hCMEC/D3 cells and astrocytes on fibronectin-coated Rinzl coverslips retained membrane integrities and metabolic function, after freezing in 5% DMSO, 6% HES, and 2% chondroitin sulfate, that were comparable to those of unfrozen controls even after overnight incubation. Rinzl is better than glass or Thermanox as an underlying solid substrate for cryopreserving hCMEC/D3 monolayers. Cryopreserved hCMEC/D3 monolayers expressed the junction proteins ZO-1 and claudin-5 similar to their unfrozen counterparts. Hence, we describe improved cryopreservation protocols for hCMEC/D3 cells and astrocytes in suspension, and a novel protocol for the cryopreservation of monolayers of hCMEC/D3 cells and astrocytes as single cultures or co-cultures that could expand their distribution for research on disease modeling, drug screening, and targeted therapy pertaining to the BBB.	[Marquez-Curtis, Leah A.; Elliott, Janet A. W.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Marquez-Curtis, Leah A.; McGann, Locksley E.; Elliott, Janet A. W.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Bokenfohr, Reid] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Elliott, JAW (corresponding author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada.; Elliott, JAW (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	janet.elliott@ualberta.ca			Canadian Institutes of Health Research (CIHR) [MOP 133684, PS 166125]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR, MOP 133684 and PS 166125) to JAWE and LEM. JAWE holds a Canada Research Chair in Thermodynamics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders URLs: CIHR: https://cihr-irsc.gc.ca/Canada Research Chairs: www.chairschaires.gc.ca.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abdullahi W, 2018, AM J PHYSIOL-CELL PH, V315, pC343, DOI 10.1152/ajpcell.00095.2018; Acker JP, 1999, CRYOBIOLOGY, V38, P363, DOI 10.1006/cryo.1999.2179; Acker JP, 2000, CRYOBIOLOGY, V40, P54, DOI 10.1006/cryo.1999.2221; Acker JP, 2001, BIOPHYS J, V81, P1389, DOI 10.1016/S0006-3495(01)75794-3; Al-Ahmad AJ, 2017, AM J PHYSIOL-CELL PH, V313, pC421, DOI 10.1152/ajpcell.00116.2017; [Anonymous], 2010, MOL PROBES TM HDB GU, V11th Editi; [Anonymous], CORNING MATRIGEL MAT, P1; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bahari L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192265; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; Baust JG, 2017, BIOPRESERV BIOBANK, V15, P134, DOI 10.1089/bio.2016.0119; Bicker J, 2014, EUR J PHARM BIOPHARM, V87, P409, DOI 10.1016/j.ejpb.2014.03.012; Biemans EALM, 2017, J NEUROSCI RES, V95, P1513, DOI 10.1002/jnr.23964; Biosource, Patent, P1, Patent No. [5,501,959, 5501959]; Carpentier G, 2012, 4 IMAGEJ US DEV C P, P198; Clapisson Gilles, 2004, Bull Cancer, V91, pE97; Crisafuli FAP, 2015, EUR BIOPHYS J BIOPHY, V44, P1, DOI 10.1007/s00249-014-0995-4; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daniels BP, 2013, J NEUROSCI METH, V212, P173, DOI 10.1016/j.jneumeth.2012.10.001; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Elliott JAW, 2013, BIOPHYS J, V105, P1935, DOI 10.1016/j.bpj.2013.10.001; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Eskandari N, 2018, CRYOBIOLOGY, V85, P63, DOI 10.1016/j.cryobiol.2018.10.001; FAHY GM, 1990, CRYOBIOLOGY, V27, P247, DOI 10.1016/0011-2240(90)90025-Y; FAHY GM, 1986, CRYOBIOLOGY, V23, P1, DOI 10.1016/0011-2240(86)90013-1; FARRANT J, 1977, CRYOBIOLOGY, V14, P273, DOI 10.1016/0011-2240(77)90176-6; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Graham B, 2017, ANGEW CHEM INT EDIT, V56, P15941, DOI 10.1002/anie.201706703; Greene C, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0123-z; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; He YR, 2014, STROKE, V45, P2514, DOI 10.1161/STROKEAHA.114.005427; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Higgins AZ, 2013, BIOPHYS J, V105, P2006, DOI 10.1016/j.bpj.2013.09.028; Irimia D, 2002, BIOPHYS J, V82, P1858, DOI 10.1016/S0006-3495(02)75536-7; Kenmochi T, 2008, CELL TRANSPLANT, V17, P61, DOI 10.3727/000000008783907026; KNORPP CT, 1967, SCIENCE, V157, P1312, DOI 10.1126/science.157.3794.1312; Kulczar C, 2017, J PHARM PHARMACOL, V69, P1684, DOI 10.1111/jphp.12803; Linville RM, 2019, BIOMATERIALS, V190, P24, DOI 10.1016/j.biomaterials.2018.10.023; Liu J, 2001, INT IMMUNOPHARMACOL, V1, P63, DOI 10.1016/S1567-5769(00)00016-3; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Marquez-Curtis LA., 2018, PRESERVATION CELLS P, P119, DOI [10.1016/j.cryobiol.2018.10.001, DOI 10.1016/J.CRYOBIOL.2018.10.001]; Marquez-Curtis LA., 2020, CRYOPRESERVATION FRE, V4, DOI [10.1016/j.cryobiol.2020.05.010, DOI 10.1016/J.CRYOBIOL.2020.05.010]; Marquez-Curtis LA, 2020, CRYOBIOLOGY, V97, P168, DOI 10.1016/j.cryobiol.2020.05.010; Marquez-Curtis LA, 2017, CRYOBIOLOGY, V77, P1, DOI 10.1016/j.cryobiol.2017.04.012; Marquez-Curtis LA, 2016, CRYOBIOLOGY, V72, P183, DOI 10.1016/j.cryobiol.2016.05.005; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; MCGANN LE, 1988, CRYOBIOLOGY, V25, P178, DOI 10.1016/0011-2240(88)90024-7; MCGANN LE, 1987, CRYOBIOLOGY, V24, P11, DOI 10.1016/0011-2240(87)90003-4; McInerney MP, 2017, J PHARM SCI-US, V106, P2614, DOI 10.1016/j.xphs.2016.12.017; MERYMAN HT, 1971, CRYOBIOLOGY, V8, P173, DOI 10.1016/0011-2240(71)90024-1; Mitchell M, 2017, BIOPRINTING, P21; MULDREW K, 1994, BIOPHYS J, V66, P532, DOI 10.1016/S0006-3495(94)80806-9; Naaldijk Y, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0315-4; Naaldijk Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-49; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Patabendige A, 2018, MOL CELL NEUROSCI, V89, P60, DOI 10.1016/j.mcn.2018.04.002; PEGG DE, 1988, BIOPHYS J, V54, P471, DOI 10.1016/S0006-3495(88)82980-1; Pless-Petig G, 2018, ORGANOGENESIS, V14, P107, DOI 10.1080/15476278.2018.1501136; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Qi WD, 2008, HEARING RES, V236, P52, DOI 10.1016/j.heares.2007.12.002; Qosa H, 2016, J ALZHEIMERS DIS, V53, P1499, DOI 10.3233/JAD-151179; Reardon AJF, 2015, CRYOBIOLOGY, V71, P306, DOI 10.1016/j.cryobiol.2015.08.004; Ross-Rodriguez LU, 2010, CRYOBIOLOGY, V61, P46, DOI 10.1016/j.cryobiol.2010.04.005; Ross-Rodriguez LU, 2010, CRYOBIOLOGY, V60, P106, DOI 10.1016/j.cryobiol.2009.09.007; Rutt T, 2019, CRYOBIOLOGY, V86, P134, DOI 10.1016/j.cryobiol.2018.10.006; Schacke M, 2009, J VIROL METHODS, V157, P25, DOI 10.1016/j.jviromet.2008.12.004; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Stolzing A, 2012, TRANSFUS APHER SCI, V46, P137, DOI 10.1016/j.transci.2012.01.007; Sultani AB, 2016, SCI REP-UK, V6, DOI 10.1038/srep34393; Sultani AB, 2015, PROTOCOL DESIGNS OPT; TAOCHENG JH, 1988, INT J DEV NEUROSCI, V6, P25, DOI 10.1016/0736-5748(88)90026-3; Tom Roseanne, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4977; Tomas RMF, 2019, BIOMACROMOLECULES, V20, P3864, DOI 10.1021/acs.biomac.9b00951; Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149; van der Valk J, 2018, ALTEX-ALTERN ANIM EX, V35, P99, DOI 10.14573/altex.1705101; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zhang C, 2017, BRAIN RES BULL, V128, P34, DOI 10.1016/j.brainresbull.2016.11.004	83	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249814	10.1371/journal.pone.0249814	http://dx.doi.org/10.1371/journal.pone.0249814			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852594	Green Published, gold			2022-12-26	WOS:000640604500020
J	Peel, E; Cheng, YY; Djordjevic, JT; O'Meally, D; Thomas, M; Kuhn, M; Sorrell, TC; Huston, WM; Belov, K				Peel, Emma; Cheng, Yuanyuan; Djordjevic, Julianne T.; O'Meally, Denis; Thomas, Mark; Kuhn, Michael; Sorrell, Tania C.; Huston, Wilhelmina M.; Belov, Katherine			Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum	PLOS ONE			English	Article							TAMMAR WALLABY; PHASCOLARCTOS-CINEREUS; BACTERICIDAL ACTIVITY; PEPTIDES; POUCH; ENROFLOXACIN; SENSITIVITY; MICROBIOME; INFECTIONS; EXPRESSION	Devastating fires in Australia over 2019-20 decimated native fauna and flora, including koalas. The resulting population bottleneck, combined with significant loss of habitat, increases the vulnerability of remaining koala populations to threats which include disease. Chlamydia is one disease which causes significant morbidity and mortality in koalas. The predominant pathogenic species, Chlamydia pecorum, causes severe ocular, urogenital and reproductive tract disease. In marsupials, including the koala, gene expansions of an antimicrobial peptide family known as cathelicidins have enabled protection of immunologically naive pouch young during early development. We propose that koala cathelicidins are active against Chlamydia and other bacteria and fungi. Here we describe ten koala cathelicidins, five of which contained full length coding sequences that were widely expressed in tissues throughout the body. Focusing on these five, we investigate their antimicrobial activity against two koala C. pecorum isolates from distinct serovars; MarsBar and IPTaLE, as well as other bacteria and fungi. One cathelicidin, PhciCath5, inactivated C. pecorum IPTaLE and MarsBar elementary bodies and significantly reduced the number of inclusions compared to the control (p<0.0001). Despite evidence of cathelicidin expression within tissues known to be infected by Chlamydia, natural PhciCath5 concentrations may be inadequate in vivo to prevent or control C. pecorum infections in koalas. PhciCath5 also displayed antimicrobial activity against fungi and Gram negative and positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Electrostatic interactions likely drive PhciCath5 adherence to the pathogen cell membrane, followed by membrane permeabilisation leading to cell death. Activity against E. coli was reduced in the presence of 10% serum and 20% whole blood. Future modification of the PhciCath5 peptide to enhance activity, including in the presence of serum/blood, may provide a novel solution to Chlamydia infection in koalas and other species.	[Peel, Emma; Cheng, Yuanyuan; Belov, Katherine] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Djordjevic, Julianne T.; Sorrell, Tania C.] Westmead Inst Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Djordjevic, Julianne T.; Sorrell, Tania C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia; [O'Meally, Denis] Beckman Res Inst City Hope, Ctr Gene Therapy, Duarte, CA USA; [Thomas, Mark; Huston, Wilhelmina M.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia; [Kuhn, Michael] Zoetis, Vet Med Res & Dev, Kalamazoo, MI USA	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; City of Hope; Beckman Research Institute of City of Hope; University of Technology Sydney; Zoetis	Belov, K (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	kathy.belov@sydney.edu.au	; O'Meally, Denis/A-3746-2012; Huston, Wilhelmina/B-9984-2008	Djordjevic, Julianne/0000-0003-4207-4115; O'Meally, Denis/0000-0001-7749-9506; Huston, Wilhelmina/0000-0002-0879-1287	ARC Discovery Grant [DP14013260]; Marie Bashir Institute for Infectious Diseases and Biosecurity; Australian Postgraduate Award; NHMRC	ARC Discovery Grant(Australian Research Council); Marie Bashir Institute for Infectious Diseases and Biosecurity; Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an ARC Discovery Grant to K.B (DP14013260) and the Marie Bashir Institute for Infectious Diseases and Biosecurity seed funding. E.P was supported by an Australian Postgraduate Award. T.C.S is a Sydney Medical Foundation Fellow whose work is supported by the NHMRC. M.K hosted E.P at the Zoetis Veterinary Medicine Research and Development facility, Kalamazoo MI USA to complete membrane permeability and serum/blood antibacterial assays.	AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Anderson RC, 2005, INT J ANTIMICROB AG, V25, P205, DOI 10.1016/j.ijantimicag.2004.10.010; Bachmann NL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-667; Bartlett KH, 2004, INT J ANTIMICROB AG, V23, P606, DOI 10.1016/j.ijantimicag.2004.02.018; Basden K, 1997, REPROD FERT DEVELOP, V9, P243, DOI 10.1071/R96032; Belov K, 2007, GENOME RES, V17, P982, DOI 10.1101/gr.6121807; Black LA, 2014, J VET PHARMACOL THER, V37, P301, DOI 10.1111/jvp.12091; Black LA, 2013, J VET PHARMACOL THER, V36, P478, DOI 10.1111/jvp.12024; Blodkamp S, 2016, VET MICROBIOL, V194, P107, DOI 10.1016/j.vetmic.2015.09.018; Bobek G, 2001, LETT PEPT SCI, V8, P133, DOI 10.1023/A:1016257920016; Bodley K., 2008, MED AUSTR MAMMALS; Budd C, 2017, AUST VET J, V95, P343, DOI 10.1111/avj.12617; Chan YR, 2001, J INVEST DERMATOL, V116, P230, DOI 10.1046/j.1523-1747.2001.01231.x; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Cheng YY, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0143-0; Chhour KL, 2010, MICROBIOL-SGM, V156, P798, DOI 10.1099/mic.0.031997-0; Cho HS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00347; Daly KA, 2008, COMP BIOCHEM PHYS B, V149, P524, DOI 10.1016/j.cbpb.2007.12.002; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Desclozeaux M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178786; Devine DA, 2002, CURR PHARM DESIGN, V8, P703, DOI 10.2174/1381612023395501; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Donati M, 2005, ANTIMICROB AGENTS CH, V49, P1201, DOI 10.1128/AAC.49.3.1201-1202.2005; Donati M, 2007, VET MICROBIOL, V123, P269, DOI 10.1016/j.vetmic.2007.02.011; Dong W., 2020, MED SCI MONITOR, V26, DOI [10.12659/MSM.923909, DOI 10.12659/MSM.923909]; Gillett A., 2019, CURRENT THERAPY MED, P463; Govendir M, 2012, J VET PHARMACOL THER, V35, P147, DOI 10.1111/j.1365-2885.2011.01307.x; GraphPad Software, PRISM VERSION 7 0 WI; Griffith JE, 2010, J VET PHARMACOL THER, V33, P595, DOI 10.1111/j.1365-2885.2010.01169.x; Grogan LF, 2018, BIOL CONSERV, V221, P334, DOI 10.1016/j.biocon.2018.03.030; Gunasekera S, 2018, CHEMBIOCHEM, V19, P931, DOI 10.1002/cbic.201700599; Hall T., 2013, IBIS BIOSCIENCES; Hemsley S, 1997, J COMP PATHOL, V116, P273, DOI 10.1016/S0021-9975(97)80003-5; Hobbs M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-786; Hou SP, 2019, MICROBES INFECT, V21, P50, DOI 10.1016/j.micinf.2018.06.003; Hou SP, 2015, INFECT IMMUN, V83, P4701, DOI 10.1128/IAI.00746-15; Huston WM, 2007, FEBS LETT, V581, P3382, DOI 10.1016/j.febslet.2007.06.039; Huston WM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-190; Jackson M, 1999, VET MICROBIOL, V65, P225; Jelocnik M, 2016, PEERJ, V4, DOI 10.7717/peerj.1661; Jelocnik M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2053-8; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Johnson RN, 2018, NAT GENET, V50, P1102, DOI 10.1038/s41588-018-0153-5; Kido N, 2012, MED MYCOL, V50, P291, DOI 10.3109/13693786.2011.594967; Kinney ME, 2016, J ZOO WILDLIFE MED, V47, P387, DOI 10.1638/2015-0185.1; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; Kosikowska P, 2016, EXPERT OPIN THER PAT, V26, P689, DOI 10.1080/13543776.2016.1176149; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lawrence A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31466; Lindenmayer D, 2020, THREATENED SPECIES R; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Morris KM, 2016, SCI REP-UK, V6, DOI 10.1038/srep35011; Nagaoka I, 1997, J BIOL CHEM, V272, P22742, DOI 10.1074/jbc.272.36.22742; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; NSW Government Department of Planning IaE, 2020, NSW GOVENMENT DEP PL, P20; OSAWA R, 1990, AUST VET J, V67, P305, DOI 10.1111/j.1751-0813.1990.tb07805.x; OSAWA R, 1992, J WILDLIFE DIS, V28, P276, DOI 10.7589/0090-3558-28.2.276; Peel E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35019; Peel E, 2017, MICROBIOL-SGM, V163, P1457, DOI 10.1099/mic.0.000536; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221109; Phillips S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00070; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Quigley BL, 2020, FEMS MICROBIOL REV, V44, P583, DOI 10.1093/femsre/fuaa024; Robbins A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209679; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Sorensen O, 1997, J IMMUNOL METHODS, V206, P53, DOI 10.1016/S0022-1759(97)00084-7; Tang LL, 2015, MICROBES INFECT, V17, P402, DOI 10.1016/j.micinf.2015.02.005; The Australian Government DoA, 2020, WAT ENV RAP AN IMP 2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; TyndaleBiscoe H, 2005, LIFE OF MARSUPIALS, P1; Tzitzilis A, 2020, J PEPT SCI, V26, DOI 10.1002/psc.3254; Van Eeden L., 2020, WORLD WIDE FUND NATU; Veldhuizen EJA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061964, 10.1371/journal.pone.0068790]; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030; Wanyonyi SS, 2011, COMP BIOCHEM PHYS A, V160, P431, DOI 10.1016/j.cbpa.2011.07.015; World Health Organization, 2014, ANT RES GLOB REP SUR; Yasin B, 1996, INFECT IMMUN, V64, P4863, DOI 10.1128/IAI.64.11.4863-4866.1996; Yasin B, 1996, INFECT IMMUN, V64, P709, DOI 10.1128/IAI.64.3.709-713.1996	85	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249658	10.1371/journal.pone.0249658	http://dx.doi.org/10.1371/journal.pone.0249658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852625	Green Published, Green Submitted, gold			2022-12-26	WOS:000640604500024
J	Kiss, O; Babity, M; Kovacs, A; Skopal, J; Vago, H; Lakatos, BK; Bognar, C; Rakoczi, R; Zamodics, M; Frivaldszky, L; Menyhart-Hetenyi, A; Dohy, Z; Czimbalmos, C; Szabo, L; Merkely, B				Kiss, Orsolya; Babity, Mate; Kovacs, Attila; Skopal, Judit; Vago, Hajnalka; Lakatos, Balint Karoly; Bognar, Csaba; Rakoczi, Reka; Zamodics, Mark; Frivaldszky, Lorinc; Menyhart-Hetenyi, Anna; Dohy, Zsofia; Czimbalmos, Csilla; Szabo, Liliana; Merkely, Bela			Significance of extended sports cardiology screening of elite handball referees	PLOS ONE			English	Article							PRECOMPETITION MEDICAL ASSESSMENT; RECOMMENDATIONS; DISEASES; SOCIETY	The significance of cardiology screening of referees is not well established. Cardiovascular risk factors and diseases were examined in asymptomatic Hungarian elite handball referees undergoing extended screening: personal/family history, physical examination, 12-lead ECG, laboratory tests, body-composition analysis, echocardiography, and cardiopulmonary exercise testing. Holter-ECG (n = 8), blood pressure monitorization (n = 10), cardiac magnetic resonance imaging (CMR; n = 27) and computer tomography (CCT; n = 4) were also carried out if needed. We examined 100 referees (age: 29.6 +/- 7.9years, male: 64, training: 4.3 +/- 2.0 hours/week), cardiovascular risk factors were: positive medical history: 24%, overweight: 10%, obesity: 3%, dyslipidaemia: 41%. Elevated resting blood pressure was measured in 38%. Stress-ECG was positive due to ECG-changes in 16%, due to elevated exercise blood pressure in 8%. Echocardiography and/or CMR identified abnormalities in 19%. A significant number of premature ventricular contractions was found on the Holter-ECG in two cases. The CCT showed myocardial bridge or coronary plaques in one-one case. We recommended lifestyle changes in 58%, new/modified antihypertensive or lipid-lowering therapy in 5%, iron-supplementation in 22%. By our results, a high percentage of elite Hungarian handball referees had cardiovascular risk factors or diseases, which, combined with physical and psychological stress, could increase the possibility of cardiovascular events. Our study draws attention to the importance of cardiac screening in elite handball referees.	[Kiss, Orsolya; Babity, Mate; Kovacs, Attila; Skopal, Judit; Vago, Hajnalka; Lakatos, Balint Karoly; Bognar, Csaba; Rakoczi, Reka; Zamodics, Mark; Frivaldszky, Lorinc; Menyhart-Hetenyi, Anna; Dohy, Zsofia; Czimbalmos, Csilla; Szabo, Liliana; Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary	Semmelweis University	Merkely, B (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary.	merkely.bela@gmail.com	Babity, Máté/ABB-7087-2020	Babity, Máté/0000-0001-5334-5430; Szabo, Liliana/0000-0002-4699-3648				Ardigo LP, 2010, J STRENGTH COND RES, V24, P2532, DOI 10.1519/JSC.0b013e3181b2c82a; Ardigo LP, 2015, J SPORT SCI, V33, P1853, DOI 10.1080/02640414.2015.1015150; Bagyura Z, 2014, ORVOSI HETILAP, V155, P1344, DOI 10.1556/OH.2014.29969; Bizzini M, 2012, BRIT J SPORT MED, V46, P374, DOI 10.1136/bjsports-2011-090362; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; da Silva JF, 2010, J STRENGTH COND RES, V24, P1960, DOI 10.1519/JSC.0b013e3181ddb019; da Silva VL, 2019, REV BRAS MED ESPORTE, V25, P147, DOI 10.1590/1517-869220192502198030; Keller DI, 2013, BRIT J SPORT MED, V47, P179, DOI 10.1136/bjsports-2012-091436; Leicht AS, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006908; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.15829/1560-4071-2020-3826, 10.1093/eurheartj/ehz455]; Marwick TH, 2015, J AM SOC ECHOCARDIOG, V28, P727, DOI 10.1016/j.echo.2015.05.002; O'Riordan CN, 2018, IRISH J MED SCI, V187, P915, DOI 10.1007/s11845-018-1792-3; Piko P, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82689-0; Caballero JAR, 2011, J SPORT MED PHYS FIT, V51, P633; Sharma S, 2018, EUR HEART J, V39, P1466, DOI 10.1093/eurheartj/ehw631; Tereshchenko TO, 2016, GALICIAN MED J, V23, P139; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339	17	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249923	10.1371/journal.pone.0249923	http://dx.doi.org/10.1371/journal.pone.0249923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836023	Green Published, gold			2022-12-26	WOS:000639361000002
J	Sun, XY; Zhu, HM; Li, WJ; Zhao, L; Li, WH; Li, XY; Xie, ZW				Sun, Xiaoyan; Zhu, Huimin; Li, Wenjuan; Zhao, Li; Li, Wenhua; Li, Xiaoyong; Xie, Zhenwei			Small extracellular vesicles secreted by vaginal fibroblasts exert inhibitory effect in female stress urinary incontinence through regulating the function of fibroblasts	PLOS ONE			English	Article							CELL-PROLIFERATION; EXOSOMES; COLLAGEN; WOMEN; ACTIVATION; EXPRESSION; MYOBLASTS	Stress urinary incontinence (SUI) is a common condition in women and associated with extra-cellular matrix (ECM) reconstruction, which is mainly regulated by fibroblasts. However, the underlying mechanism remains obscure. Small extracellular vesicles (sEVs) play fundamental biological roles in various cellular functions. Some studies suggested that the sEVs were involved in the metabolism of ECM and the function of fibroblasts. The purpose of our study was to investigate the effect of sEVs secreted by vaginal fibroblasts on the pathogenesis of SUI. We showed that the fibroblasts of female anterior vaginal wall secreted sEVs. Moreover, fibroblasts of females with SUI had significantly elevated secretion of sEVs. The collagen contents, proliferation and migration capacity of fibroblasts were decreased when fibroblasts were co-cultured with fibroblasts-derived sEVs (fibroblast-sEVs) from SUI patients. Proteomic analysis revealed that fibroblast-sEVs contained various differentially expressed proteins including TIMP2, TGF-beta and ABCC4, which were involved in signaling pathways of fibroblasts regulation. Therefore, we suggested that fibroblast-sEVs contributed to the pathogenesis of SUI through various proteins including TIMP2, TGF-beta and ABCC4.	[Sun, Xiaoyan; Zhu, Huimin; Li, Wenjuan; Zhao, Li; Li, Wenhua; Li, Xiaoyong; Xie, Zhenwei] Zhejiang Univ, Dept Gynecol, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xie, ZW (corresponding author), Zhejiang Univ, Dept Gynecol, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.	xiezw@zju.edu.cn			Zhejiang Provincial Natural Science Foundation of China; Medical and health science and technology program of Zhejiang Province [2021KY767]; National Natural Science Foundation of China [81500061]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Medical and health science and technology program of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work related to this manuscript was supported by Zhejiang Provincial Natural Science Foundation of China (NO. LQ20H270019), Zhejiang Provincial Natural Science Foundation of China (NO.LY17H040004), Medical and health science and technology program of Zhejiang Province (NO.2021KY767)and National Natural Science Foundation of China (NO. 81500061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Colaco M, 2015, BJU INT, V115, P859, DOI 10.1111/bju.12819; Dolivo DM, 2018, CELL MOL LIFE SCI, V75, P3663, DOI 10.1007/s00018-018-2880-2; Feng R, 2020, J CELL BIOCHEM, V121, P2428, DOI 10.1002/jcb.29465; Gao GM, 2018, CELL PHYSIOL BIOCHEM, V50, P1510, DOI 10.1159/000494650; Geiger A, 2015, BIOCHEM BIOPH RES CO, V467, P303, DOI 10.1016/j.bbrc.2015.09.166; Glazener CMA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001755.pub2; Haj-Salem I, 2018, ALLERGY, V73, P178, DOI 10.1111/all.13234; Herum KM, 2017, MOL BIOL CELL, V28, P1871, DOI 10.1091/mbc.E17-01-0014; Hsu CK, 2018, J DERMATOL SCI, V90, P232, DOI 10.1016/j.jdermsci.2018.03.004; Hsu HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14612-5; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; Imjeti NS, 2017, P NATL ACAD SCI USA, V114, P12495, DOI 10.1073/pnas.1713433114; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Li Y, 2019, CELL SIGNAL, V59, P141, DOI 10.1016/j.cellsig.2019.03.023; Liu XC, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0899-9; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037297; Martin-Medina A, 2018, AM J RESP CRIT CARE, V198, P1527, DOI 10.1164/rccm.201708-1580OC; Nakamura K, 2016, J DERMATOL SCI, V84, P30, DOI 10.1016/j.jdermsci.2016.06.013; Nawaz M, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100167; Novara G, 2007, LANCET, V369, P2139, DOI 10.1016/S0140-6736(07)60990-8; Qiu C, 2018, INVEST OPHTH VIS SCI, V59, P2401, DOI 10.1167/iovs.18-23855; Reynolds W Stuart, 2011, Curr Urol Rep, V12, P370, DOI 10.1007/s11934-011-0206-0; Richards KE, 2017, ONCOGENE, V36, P1770, DOI 10.1038/onc.2016.353; Rilla K, 2019, MATRIX BIOL, V75-76, P201, DOI 10.1016/j.matbio.2017.10.003; Ruiz-Zapata AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22971; Sinha C, 2016, JOVE-J VIS EXP, DOI 10.3791/53973; Strasser H, 2007, LANCET, V369, P2179, DOI 10.1016/S0140-6736(07)61014-9; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Tang JM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2039856; Tang JM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8524353; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Xie ZW, 2020, INT UROGYNECOL J, V31, P2697, DOI 10.1007/s00192-020-04518-8; Yan YL, 2016, KIDNEY INT, V89, P68, DOI 10.1038/ki.2015.293; Yang SJ, 2018, MOL MED REP, V17, P624, DOI 10.3892/mmr.2017.7910; Zhang ZJ, 2017, MOL MED REP, V16, P3503, DOI 10.3892/mmr.2017.7014	39	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249977	10.1371/journal.pone.0249977	http://dx.doi.org/10.1371/journal.pone.0249977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836021	gold, Green Published			2022-12-26	WOS:000639361000020
J	Beeg, M; Battocchio, E; De Luigi, A; Colombo, L; Natale, C; Cagnotto, A; Corbelli, A; Fiordaliso, F; Diomede, L; Salmona, M; Gobbi, M				Beeg, Marten; Battocchio, Elisabetta; De Luigi, Ada; Colombo, Laura; Natale, Carmina; Cagnotto, Alfredo; Corbelli, Alessandro; Fiordaliso, Fabio; Diomede, Luisa; Salmona, Mario; Gobbi, Marco			Nonphosphorylated tau slows down A beta(1-42) aggregation, binds to A beta(1-42) oligomers, and reduces A beta(1-42) toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; A-BETA; ALZHEIMERS-DISEASE; PROTEIN; MECHANISMS; MUTATIONS; TANGLES; BRAIN	The formation of neurofibrillary tangles and amyloid plaques accompanies the progression of Alzheimer's disease. Tangles are made of fibrillar aggregates formed by the microtubule-associated protein tau, whereas plaques comprise fibrillar forms of amyloid-beta (A beta). Both form toxic oligomers during aggregation and are thought to interact synergistically to each promote the accumulation of the other. Recent in vitro studies have suggested that the monomeric nonphosphorylated full-length tau protein hinders the aggregation of A beta(1-40) peptide, but whether the same is true for the more aggregationprone A beta(1-42) was not determined. We used in vitro and in vivo techniques to explore this question. We have monitored the aggregation kinetics of A beta(1-42) by thioflavine T fluorescence in the presence or the absence of different concentrations of nonphosphorylated tau. We observed that elongation of A beta(1-42) fibrils was inhibited by tau in a dose-dependent manner. Interestingly, the fibrils were structurally different in the presence of tau but did not incorporate tau. Surface plasmon resonance indicated that tau monomers bound to A beta(1-42) oligomers (but not monomers) and hindered their interaction with the anti-A beta antibody 4G8, suggesting that tau binds to the hydrophobic central core of A beta recognized by 4G8. Tau monomers also antagonized the toxic effects of A beta oligomers in Caenorhabditis elegans. This suggests that nonphosphorylated tau might have a neuroprotective effect by binding A beta(1-42) oligomers formed during the aggregation and shielding their hydrophobic patches.	[Beeg, Marten; Battocchio, Elisabetta; De Luigi, Ada; Colombo, Laura; Natale, Carmina; Cagnotto, Alfredo; Diomede, Luisa; Salmona, Mario; Gobbi, Marco] Ist Ric Farmacol Mario Negri IRCCS, Dept Mol Biochem & Pharmacol, Milan, Italy; [Corbelli, Alessandro; Fiordaliso, Fabio] Ist Ric Farmacol Mario Negri IRCCS, Dept Cardiovasc Med, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Gobbi, M (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Mol Biochem & Pharmacol, Milan, Italy.	marco.gobbi@marionegri.it	Natale, Carmina/ABE-4340-2021; Natale, Carmina/HHN-5820-2022; Gobbi, Marco/J-2638-2016	Natale, Carmina/0000-0001-8552-9875; Natale, Carmina/0000-0001-8552-9875; Gobbi, Marco/0000-0003-1014-6225; salmona, mario/0000-0002-9098-9873; Battocchio, Elisabetta/0000-0001-7431-2224; De Luigi, Ada/0000-0001-7907-7139	Fondazione Mariani; Banca Intesa-San Paolo; Fondazione Regionale per la Ricerca Biomedica [Care4NeuroRare CP_20/2018]	Fondazione Mariani; Banca Intesa-San Paolo; Fondazione Regionale per la Ricerca Biomedica	This work was partially supported by Fondazione Mariani with a grant to M. S. and Banca Intesa-San Paolo (grant 2014-2015) and Fondazione Regionale per la Ricerca Biomedica (Care4NeuroRare CP_20/2018) to L. D.	Aisen PS, 2019, JPAD-J PREV ALZHEIM, V6, P150, DOI 10.14283/jpad.2019.23; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Beeg M, 2016, J BIOL CHEM, V291, P6958, DOI 10.1074/jbc.M115.689539; Beeg M, 2013, CURR OPIN PHARMACOL, V13, P797, DOI 10.1016/j.coph.2013.05.010; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Chen DL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10355-1; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608917; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Diomede L, 2014, BLOOD, V123, P3543, DOI 10.1182/blood-2013-10-525634; Do TD, 2014, J PHYS CHEM B, V118, P11220, DOI 10.1021/jp506258g; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Giorgino T, 2019, BBA-MOL BASIS DIS, V1865, P648, DOI 10.1016/j.bbadis.2019.01.010; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Han PC, 2017, J NEUROPATH EXP NEUR, V76, P44, DOI 10.1093/jnen/nlw105; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hoglund K, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.252; Holtzman DM, 2011, NEUROBIOL AGING, V32, pS4, DOI 10.1016/j.neurobiolaging.2011.09.003; Knopman DS, 2019, NEW ENGL J MED, V380, P1476, DOI 10.1056/NEJMe1903193; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Meisl G, 2019, ADV EXP MED BIOL, V1174, P1, DOI 10.1007/978-981-13-9791-2_1; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Mullane K, 2013, BIOCHEM PHARMACOL, V85, P289, DOI 10.1016/j.bcp.2012.11.014; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Neddens J, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0557-6; Petersen RC, 2018, NEUROLOGY, V90, P126, DOI 10.1212/WNL.0000000000004826; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Romeo M, 2017, J ALZHEIMERS DIS, V57, P857, DOI 10.3233/JAD-160951; Rossi G, 2014, NEUROBIOL AGING, V35, P408, DOI 10.1016/j.neurobiolaging.2013.08.004; Stravalaci M, 2016, J ALZHEIMERS DIS, V53, P1485, DOI 10.3233/JAD-150882; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Trambauer J, 2020, CURR OPIN NEUROBIOL, V61, P73, DOI 10.1016/j.conb.2020.01.011; Vasconcelos B, 2016, ACTA NEUROPATHOL, V131, P549, DOI 10.1007/s00401-015-1525-x; Wallin C, 2018, J AM CHEM SOC, V140, P8138, DOI 10.1021/jacs.7b13623; Yuksel M, 2019, EUR J PHARMACOL, V856, DOI 10.1016/j.ejphar.2019.172415; Zeinolabediny Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10875-0; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	54	2	2	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100664	10.1016/j.jbc.2021.100664	http://dx.doi.org/10.1016/j.jbc.2021.100664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865852	gold, Green Published			2022-12-26	WOS:000672866400635
J	Zhang, YY; Xu, C; Tang, ZS; Guo, DW; Yao, RJ; Zhao, HN; Chen, ZX; Ni, X				Zhang, Youyi; Xu, Chen; Tang, Zhengshan; Guo, Dewei; Yao, Ruojin; Zhao, Huina; Chen, Zixi; Ni, Xin			Furin is involved in uterine activation for labor	FASEB JOURNAL			English	Article						FN14; furin; parturition; pregnancy; TWEAK	PROTEIN PHOSPHATASE 2A; A-BETA-SUBUNIT; MEIOTIC RECOMBINATION; PPP2R1B GENE; E3 LIGASE; MUTATIONS; HETEROZYGOSITY; PROGRESSION; EXPRESSION; DISTINCT	The uterus undergoes distinct molecular and functional changes during pregnancy and parturition. These processes are associated with the dramatic changes in various proteins. Given that the maturation and activation of many proteins require proteolytic processing by proprotein convertases (PCs), we sought to explore the role of PCs in uterine activation for labor. First, we found that furin was the most dramatically increased PC member in myometrial tissues from the pregnant women after onset of labor at term. Using the model of cultured human myometrial smooth muscle cells (HMSMCs), we showed that furin inhibitor CMK, D6R treatment and furin siRNA transfection suppressed contractility. Inhibition of furin activity or interfering furin expression decreased connexin 43 (CX43), prostaglandin (PG) endoperoxide synthase-2 (COX-2) and PGF2a receptor (FP) expression and NF-kappa B activation. In mouse model, administration of furin inhibitors prolonged gestational length. However, D6R treatment did not affect RU38486-and lipopolysaccharides (LPS)-induced preterm birth. Furthermore, D6R and furin siRNA treatment reduced the release of soluble form of tumor necrosis factor (TNF)-related weak inducer of apoptosis (TWEAK), while furin overexpression led to an increase in soluble TWEAK release in cultured HMSMCs. D6R treatment decreased TWEAK level in blood of pregnant mice. TWEAK treatment promoted contractility and NF-kappa B activation, while TWEAK receptor fibroblast growth factor-inducible 14 (FN14) antagonist treatment inhibited contractility and NF--.B activation in HMSMCs. In pregnant mice, administration of FN14 antagonist prolonged gestational length. Our data suggest that furin can act as a stimulator for uterine activation for labor at term. TWEAK is one of the potential substrates which mediate furin regulation of parturition initiation.	[Zhang, Youyi; Tang, Zhengshan; Guo, Dewei; Yao, Ruojin; Ni, Xin] Cent South Univ, Dept Gynecol & Obstet, Res Ctr Mol Metabol, Xiangya Hosp, Changsha 410008, Peoples R China; [Zhang, Youyi; Chen, Zixi; Ni, Xin] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Zhang, Youyi] Gen Hosp Western Theater Command PLA, Dept Gynecol & Obstet, Chengdu, Peoples R China; [Xu, Chen] Fundan Univ, Dept Physiol & Pathophysiol, Shanghai Med Sch, Shanghai, Peoples R China; [Zhao, Huina] Changhai Hosp, Dept Gynecol & Obstet, Shanghai, Peoples R China; [Zhao, Huina] Shanghai Seventh Peoples Hosp, Dept Gynecol & Obstet, Shanghai, Peoples R China; [Ni, Xin] Cent South Univ, Natl Clin Res Ctr Geriatr Disorders, Xiangya Hosp, Changsha, Peoples R China	Central South University; Naval Medical University; Fudan University; Naval Medical University; Central South University	Ni, X (corresponding author), Cent South Univ, Dept Gynecol & Obstet, Res Ctr Mol Metabol, Xiangya Hosp, Changsha 410008, Peoples R China.	xinni2018@csu.edu.cn		Xu, Chen/0000-0001-5146-5260	Natural Science Foundation of China [81620108013, 31972892]; Sate Key Research and Development Program of China [2017YFC1001404, 2018YFC1002802]; Science and Technology Commission of Shanghai Municipals [1814090300]; Hunan Provincial Science and Technology Department [2018RS3030]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sate Key Research and Development Program of China; Science and Technology Commission of Shanghai Municipals; Hunan Provincial Science and Technology Department	The authors wish to thank all the patients participated in this study, and Mr Jiefeng Luo and Ms Yalin Shan for their assistance in animal studies. This work was supported by Natural Science Foundation of China (No.81620108013&No.31972892), Sate Key Research and Development Program of China (2017YF C1001404&2018YFC1002802), Science and Technology Commission of Shanghai Municipals (1814090300) and Hunan Provincial Science and Technology Department (2018RS3030).	Ali EZ, 2018, MOL GENET METAB REP, V17, P22, DOI 10.1016/j.ymgmr.2018.08.006; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Arafat M, 2017, J MED GENET, V54, P633, DOI 10.1136/jmedgenet-2017-104514; Astashchanka A, 2019, BREAST CANCER RES TR, V173, P289, DOI 10.1007/s10549-018-4989-2; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; CARTER SL, 1994, CANCER RES, V54, P6270; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Choi Y, 2010, HUM MUTAT, V31, P788, DOI 10.1002/humu.21264; Cocuzza M, 2013, CLINICS, V68, P15, DOI 10.6061/clinics/2013(Sup01)03; Colombo R, 2017, GYNECOL OBSTET INVES, V82, P283, DOI 10.1159/000468934; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Davis M, 1996, CANCER RES, V56, P741; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; Esplin ED, 2006, GENE CHROMOSOME CANC, V45, P182, DOI 10.1002/gcc.20284; Faieta M, 2016, CHROMOSOMA, V125, P189, DOI 10.1007/s00412-015-0544-7; Ferlin A, 2012, ASIAN J ANDROL, V14, P807, DOI 10.1038/aja.2012.84; Gabra H, 1996, CANCER RES, V56, P950; Gao JM, 2018, TRENDS GENET, V34, P232, DOI 10.1016/j.tig.2017.12.001; Gopinathan L, 2017, CELL REP, V20, P697, DOI 10.1016/j.celrep.2017.06.033; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Hwang JH, 2013, J BIOL CHEM, V288, P32064, DOI 10.1074/jbc.M113.497644; Jiang Z, 2008, INT J BIOL SCI, V4, P96; Kanthimathi S, 2016, ANN HUM GENET, V80, P241, DOI 10.1111/ahg.12155; Karasu ME, 2019, CHROMOSOMA, V128, P473, DOI 10.1007/s00412-019-00725-5; Kim JH, 2010, J HUM GENET, V55, P358, DOI 10.1038/jhg.2010.34; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee NPY, 2008, ADV EXP MED BIOL, V636, P172, DOI 10.1007/978-0-387-09597-4_10; Lei WL, 2020, CELL DEATH DIFFER, V27, P1952, DOI 10.1038/s41418-019-0472-9; Liao MJ, 2019, EBIOMEDICINE, V41, P200, DOI 10.1016/j.ebiom.2019.01.035; Luddi A, 2016, SYST BIOL REPROD MED, V62, P372, DOI 10.1080/19396368.2016.1238116; Maor-Sagie E, 2015, J ASSIST REPROD GEN, V32, P887, DOI 10.1007/s10815-015-0445-y; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Muller JS, 2006, BRAIN, V129, P2784, DOI 10.1093/brain/awl188; Nakazawa N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217331; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Price NE, 2000, BIOCHEMISTRY-US, V39, P11312, DOI 10.1021/bi0008478; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Sinha N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047623; Sun MM, 2017, CANCER SCI, V108, P267, DOI 10.1111/cas.13128; Tamaki M, 2004, ONCOL REP, V11, P655; Totonchi M, 2012, J ASSIST REPROD GEN, V29, P847, DOI 10.1007/s10815-012-9798-7; Tran TN, 2018, HUM MOL GENET, V27, P3911, DOI 10.1093/hmg/ddy286; Wamelink MMC, 2015, J INHERIT METAB DIS, V38, P889, DOI 10.1007/s10545-014-9809-1; Wang LY, 2017, NUCLEUS-PHILA, V8, P461, DOI 10.1080/19491034.2017.1330237; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, P9681, DOI 10.1093/nar/gkw652; Yatsenko AN, 2015, NEW ENGL J MED, V372, P2097, DOI 10.1056/NEJMoa1406192; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yoneda R, 2013, BIOCHEM BIOPH RES CO, V441, P120, DOI 10.1016/j.bbrc.2013.10.028; Zhang QT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11346-y; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	59	0	0	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21565	10.1096/fj.202002128RR	http://dx.doi.org/10.1096/fj.202002128RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864414				2022-12-26	WOS:000645260100068
J	Zhao, X; Lu, JC; Chen, XB; Gao, ZX; Zhang, C; Chen, CX; Qiao, DF; Wang, HJ				Zhao, Xu; Lu, Jiancong; Chen, Xuebing; Gao, Zhengxiang; Zhang, Cui; Chen, Chuanxiang; Qiao, Dongfang; Wang, Huijun			Methamphetamine exposure induces neuronal programmed necrosis by activating the receptor-interacting protein kinase 3-related signalling pathway	FASEB JOURNAL			English	Article						dynamin-related protein 1; methamphetamine; mixed lineage kinase domain-like protein; programmed necrosis; the receptor-interacting protein kinase 3	ACTIN-ASSOCIATED PROTEIN; F-ACTIN; FILAMIN; PODOCYTES; IDENTIFICATION; EXPRESSION; KIDNEY	Methamphetamine (METH) is a synthetic drug with severe neurotoxicity, however, the regulation of METH-induced neuronal programmed necrosis remains poorly understood. The aim of this study was to identify the molecular mechanisms of METH-induced neuronal programmed necrosis. We found that neuronal programmed necrosis occurred in the striatum of brain samples from human and mice that were exposed to METH. The receptor-interacting protein kinase 3 (RIP3) was highly expressed in the neurons of human and mice exposed to METH, and RIP3-silenced or RIP1-inhibited protected neurons developed neuronal programmed necrosis in vitro and in vivo following METH exposure. Moreover, the RIP1-RIP3 complex causes cell programmed necrosis by regulating mixed lineage kinase domain-like protein (MLKL)-mediated cell membrane rupture and dynamin-related protein 1 (Drp1)-mediated mitochondrial fission. Together, these data indicate that RIP3 plays an indispensable role in the mechanism of METH-induced neuronal programmed necrosis, which may represent a potential therapeutic target for METH-induced neurotoxicity.	[Zhao, Xu; Lu, Jiancong; Chen, Xuebing; Gao, Zhengxiang; Zhang, Cui; Chen, Chuanxiang; Qiao, Dongfang; Wang, Huijun] Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China	Southern Medical University - China	Qiao, DF; Wang, HJ (corresponding author), Southern Med Univ, Sch Forens Med, Guangzhou 510515, Peoples R China.	qiaodf@163.com; hjwang@smu.edu.cn	Zhao, Xiaoshan/GPF-7929-2022; wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022		National Natural Science Foundation of China [81871528]; Guangzhou Science and Technology Project [201803010005]; Natural Science Foundation of Guangdong Province [2019A1515011987]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 81871528 to H. Wang), Guangzhou Science and Technology Project (Grant No. 201803010005 to H. Wang), and Natural Science Foundation of Guangdong Province (Grant No.2019A1515011987 to D. Qiao)	Albrecht T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44492; Artelt N, 2018, J AM SOC NEPHROL, V29, P1662, DOI 10.1681/ASN.2017091039; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Campa Carlo C, 2015, Small GTPases, V6, P71, DOI 10.4161/21541248.2014.989789; Chakarova C, 2000, HUM GENET, V107, P597, DOI 10.1007/s004390000414; Chen H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01642; Cockwell P, 2020, LANCET, V395, P662, DOI 10.1016/S0140-6736(19)32977-0; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; D'Addario M, 2001, J BIOL CHEM, V276, P31969, DOI 10.1074/jbc.M102715200; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Endlich K, 2017, PFLUG ARCH EUR J PHY, V469, P937, DOI 10.1007/s00424-017-2025-8; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; He FF, 2013, CURR GENOMICS, V14, P477, DOI 10.2174/13892029113146660014; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; HOLSTEINRATHLOU NH, 1991, AM J PHYSIOL, V260, pF53, DOI 10.1152/ajprenal.1991.260.1.F53; Hu JJ, 2017, HUM MOL GENET, V26, P1294, DOI 10.1093/hmg/ddx047; Hugo C, 1998, KIDNEY INT, V54, P1934, DOI 10.1046/j.1523-1755.1998.00195.x; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kliewe F., 2019, FASEB J, V33, P14450, DOI DOI 10.1096/fj.201900978RR; Kliewe F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10116-4; KRETZLER M, 1994, VIRCHOWS ARCH, V425, P181; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; Kumar A, 2019, J CELL BIOL, V218, P2481, DOI 10.1083/jcb.201901086; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Lindenmeyer MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011545; Liu JM, 2015, NAT STRUCT MOL BIOL, V22, P383, DOI 10.1038/nsmb.2999; MacPherson M, 2010, AM J PHYSIOL-CELL PH, V298, pC206, DOI 10.1152/ajpcell.00505.2009; Martini S, 2014, J AM SOC NEPHROL, V25, P2559, DOI 10.1681/ASN.2013080906; Mathieson PW, 2012, CLIN KIDNEY J, V5, P498, DOI 10.1093/ckj/sfs153; Mezawa M, 2016, FASEB J, V30, P3613, DOI 10.1096/fj.201600354RR; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto VI, 2014, FASEB J, V28, P453, DOI 10.1096/fj.13-233759; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Pozzi A, 2013, J AM SOC NEPHROL, V24, P1034, DOI 10.1681/ASN.2013010012; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rognoni L, 2012, P NATL ACAD SCI USA, V109, P19679, DOI 10.1073/pnas.1211274109; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schordan S, 2013, AM J PHYSIOL-RENAL, V304, pF1458, DOI 10.1152/ajprenal.00615.2012; Seppala J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136969; Shao QQ, 2016, PATHOL ONCOL RES, V22, P245, DOI 10.1007/s12253-015-9980-1; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; SIMONS JL, 1993, J AM SOC NEPHROL, V3, P1775; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dokkum RPE, 1999, AM J PHYSIOL-REG I, V276, pR855, DOI 10.1152/ajpregu.1999.276.3.R855; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; WANG K, 1977, P NATL ACAD SCI USA, V74, P2021, DOI 10.1073/pnas.74.5.2021; Wang L, 2019, BIOCHEMISTRY-US, V58, P4726, DOI 10.1021/acs.biochem.9b00100; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433	75	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21561	10.1096/fj.202100188R	http://dx.doi.org/10.1096/fj.202100188R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864423				2022-12-26	WOS:000645260100066
J	Pedersen, CJ; Uddin, MJ; Saha, SK; Darmstadt, GL				Pedersen, Courtney J.; Uddin, Mohammad J.; Saha, Samir K.; Darmstadt, Gary L.			Prevalence and psychosocial impact of atopic dermatitis in Bangladeshi children and families	PLOS ONE			English	Article							QUALITY-OF-LIFE; PARTY DIAGNOSTIC-CRITERIA; ORIENTED ECZEMA MEASURE; SKIN-DISEASE; MEASURE POEM; VALIDATION; SEVERITY; INFANTS; HEALTH; ASTHMA	Background Skin conditions are the fourth leading cause of nonfatal disease globally, with atopic dermatitis (AD) a major and rising contributor. Though atopic dermatitis (AD) is rising in prevalence, little is known about its psychosocial effects on children and families in low- and middle-income countries (LMICs). Methods We conducted a community-based, cross-sectional survey of 2242 under-5 children in rural Bangladesh using the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire to measure AD prevalence and severity, the Patient-Oriented Eczema Measure (POEM) to measure severity, and the Infants' Dermatitis Quality of Life index (IDQoL) and Dermatitis Family Index (DFI) to measure quality of life. Findings Overall AD prevalence in under-five children was 11.9% [95% confidence interval (CI) 10.6-13.3%]. Prevalence was highest in children age 30-35 months [16.2% (95% CI 11.4-21.0)]. IDQoL was significantly higher in males (2.67) vs. females (1.95, p = 0.015), the lowest (3.06) vs. highest (1.63) wealth quintile (p<0.001), and among mothers with < primary (2.41) vs. > secondary (1.43) education (p = 0.039). POEM severity was correlated with IDQoL (r = 0.77, p<0.001) and DFI (r = 0.56, p<0.001). Severe disease as rated by caretakers was correlated with POEM (r = 0.73, p<0.001), IDQoL (r = 0.82, p<0.001) and DFI (r = 0.57, p<0.001). Conclusions Severe AD significantly affects quality of life for children and families in Bangladesh. As access to healthcare expands in LMICs, identification and treatment of both the medical and psychosocial morbidities associated with the disease are needed.	[Pedersen, Courtney J.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Uddin, Mohammad J.; Saha, Samir K.] Child Hlth Res Fdn, Dhaka, Bangladesh; [Darmstadt, Gary L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Darmstadt, GL (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	gdarmsta@stanford.edu		Darmstadt, Gary/0000-0002-7522-5824	Stanford University School of Medicine; American Society of Tropical Medicine and Hygiene; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health	Stanford University School of Medicine; American Society of Tropical Medicine and Hygiene; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Pedersen received a Medical Scholars grant from the Stanford University School of Medicine and a Benjamin H. Kean Travel Fellowship from the American Society of Tropical Medicine and Hygiene. The REDCap platform services are made possible by the Stanford University School of Medicine Research Office and are subsidized by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health. The data content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovits W, 2005, J AM ACAD DERMATOL, V53, pS86, DOI 10.1016/j.jaad.2005.04.034; Ang SB, 2014, PROC SINGAP HEALTHC, V23, P100, DOI 10.1177/201010581402300203; [Anonymous], HARMONIZING OUTCOMES; Balkrishnan R, 2003, PEDIATR DERMATOL, V20, P5, DOI 10.1046/j.1525-1470.2003.03002.x; Basra MKA, 2013, BRIT J DERMATOL, V169, P760, DOI 10.1111/bjd.12563; Beattie PE, 2006, BRIT J DERMATOL, V155, P1249, DOI 10.1111/j.1365-2133.2006.07525.x; Beattie PE, 2006, BRIT J DERMATOL, V155, P145, DOI 10.1111/j.1365-2133.2006.07185.x; Camfferman D, 2010, SLEEP MED REV, V14, P359, DOI 10.1016/j.smrv.2010.01.004; Capozza K, 2020, DERMATITIS, V31, P223, DOI 10.1097/DER.0000000000000582; Chalmers DA, 2007, BRIT J DERMATOL, V156, P111, DOI 10.1111/j.1365-2133.2006.07606.x; Chamlin SL, 2005, ARCH PEDIAT ADOL MED, V159, P745, DOI 10.1001/archpedi.159.8.745; Charman CR, 2013, BRIT J DERMATOL, V169, P1326, DOI 10.1111/bjd.12590; Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; Chernyshov PV, 2012, INT J DERMATOL, V51, P290, DOI 10.1111/j.1365-4632.2011.04997.x; Coutanceau C, 2014, DERMATOLOGY, V229, P248, DOI 10.1159/000365075; Dalgard FJ, 2015, J INVEST DERMATOL, V135, P984, DOI 10.1038/jid.2014.530; De D, 2006, J EUR ACAD DERMATOL, V20, P853, DOI 10.1111/j.1468-3083.2006.01664.x; Dodington SR, 2013, BRIT J DERMATOL, V169, P31, DOI 10.1111/bjd.12232; Ellwood P, 2000, ISAAC PHASE 3 MANUAL; Falade AG, 2004, MED PRIN PRACT, V13, P20, DOI 10.1159/000074046; Fleming S, 2001, J INVEST DERMATOL, V117, P1526, DOI 10.1046/j.0022-202x.2001.01579.x; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Gee SN, 2011, ARCH DERMATOL, V147, P967, DOI 10.1001/archdermatol.2011.200; Guo Y, PREVALENCE ATOPIC DE; Haileamlak A, 2005, BRIT J DERMATOL, V152, P735, DOI 10.1111/j.1365-2133.2005.06511.x; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Kabir M L, 2005, Mymensingh Med J, V14, P41; Katayama I, 2017, JAPANESE GUIDELINES, P1440; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; Lewis-Jones MS, 2001, BRIT J DERMATOL, V144, P104, DOI 10.1046/j.1365-2133.2001.03960.x; Lule SA, 2017, PEDIAT ALLERG IMM-UK, V28, P377, DOI 10.1111/pai.12719; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Pedersen CJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042380; REID P, 1995, CLIN EXP DERMATOL, V20, P38, DOI 10.1111/j.1365-2230.1995.tb01280.x; Ricci G, 2007, PEDIATR ALLERGY IMMU, V18, P245, DOI 10.1111/j.1399-3038.2006.00502.x; Saif-Ur-Rahman KM, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0867-6; Sarkar R, ATOPIC DERMATITIS IN; Scott SB, COMBINATIONS STRESSO; Silverberg JI, 2013, PEDIAT ALLERG IMM-UK, V24, P476, DOI 10.1111/pai.12095; Singh S, 2018, CLIN RESPIR J, V12, P547, DOI 10.1111/crj.12561; Spuls PI, 2017, BRIT J DERMATOL, V176, P979, DOI 10.1111/bjd.15179; Su JC, 1997, ARCH DIS CHILD, V76, P159, DOI 10.1136/adc.76.2.159; Tsai TF, 2019, J DERMATOL, V46, P825, DOI 10.1111/1346-8138.15048; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P397, DOI 10.1111/j.1365-2133.1994.tb08531.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams H, 2008, J ALLERGY CLIN IMMUN, V121, P947, DOI 10.1016/j.jaci.2007.11.004	50	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249824	10.1371/journal.pone.0249824	http://dx.doi.org/10.1371/journal.pone.0249824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861780	gold, Green Published			2022-12-26	WOS:000641475400029
J	Zhu, FH; Zhang, BB; Zhu, LQ				Zhu, Fenghua; Zhang, Beibei; Zhu, Lianqin			An up-converting phosphor technology-based lateral flow assay for rapid detection of major mycotoxins in feed: Comparison with enzyme-linked immunosorbent assay and high-performance liquid chromatography-tandem mass spectrometry	PLOS ONE			English	Article							QUANTITATIVE DETECTION; REPORTERS	Current methods for detection of mycotoxin in feed are time-consuming and tedious. An up-converting phosphor technology-based lateral flow (UPT-LF) assay system is a new emerging technique for analytes detection. The aim of this study was to compare the performance of UPT-LF, an enzyme-linked immunosorbent assay (ELISA) and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) for detecting aflatoxin B-1 (AFB(1)), zearalenone (ZEN) and deoxynivalenol (DON) in feed. The results showed that the use of UPT-LF for AFB(1), ZEN and DON detection exhibited the following: limits of detection of 3, 50 and 200 mu g/kg; average recoveries of 104.39%, 102.94% and 103.65%; and precision of 13.96%, 13.71% and 12.56%; respectively. UPT-LF required 45 min to determine one mycotoxin and 1.5 h to determine three mycotoxins in a sample, which took the shortest time. Besides, there were positive correlations between the UPT-LF, ELISA and HPLC/MS/MS methods. In conclusion, UPT-LF can be used to detect and quantify AFB(1), ZEN and DON in feed samples. Though the sensitivity, accuracy and precision of UPT-LF are inferior to those of HPLC-MS/MS and ELISA, the UPT-LF assay is the most convenient and rapid technique for on-site detection among the three methods.	[Zhu, Fenghua; Zhang, Beibei] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Zhu, Lianqin] Qingdao Agr Univ, Coll Vet Med, Qingdao, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University	Zhu, LQ (corresponding author), Qingdao Agr Univ, Coll Vet Med, Qingdao, Peoples R China.	zhulianqin1963@163.com			National Key Research and Development Program of China [2018YFD0501403-2.1]; Major Scientific and Technological Innovation Project of Shandong Province [2019JZZY020609-02]; Modern Agricultural Industry Technology of Shandong Province [SDAIT-11-07]	National Key Research and Development Program of China; Major Scientific and Technological Innovation Project of Shandong Province; Modern Agricultural Industry Technology of Shandong Province	This work was supported by the National Key Research and Development Program of China (2018YFD0501403-2.1); the Major Scientific and Technological Innovation Project of Shandong Province (2019JZZY020609-02); and the Modern Agricultural Industry Technology of Shandong Province (SDAIT-11-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshannaq A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060632; Beyene AM, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4538-z; CAST (Council for Agricultural Science and Technology), 2003, MYCOTOXINS RISKS PLA; Corstjens PLAM, 2008, CLIN BIOCHEM, V41, P440, DOI 10.1016/j.clinbiochem.2007.12.015; Corstjens PLAM, 2003, ANAL BIOCHEM, V312, P191, DOI 10.1016/S0003-2697(02)00505-5; Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902; Hao M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179937; Huang Y, 2019, CLIN CHIM ACTA, V488, P202, DOI 10.1016/j.cca.2018.11.020; Kew MC, 2013, J GASTROINTEST LIVER, V22, P305; Kim S, 2017, J FOOD PROTECT, V80, P1347, DOI [10.4315/0362-028x.jfp-17-006, 10.4315/0362-028X.JFP-17-006]; Kovalsky P, 2016, TOXINS, V8, DOI 10.3390/toxins8120363; Krizova L, 2021, TOXINS, V13, DOI 10.3390/toxins13010032; Li LP, 2009, DIAGN MICR INFEC DIS, V63, P165, DOI 10.1016/j.diagmicrobio.2008.10.020; Liu JD, 2020, TOXINS, V12, DOI 10.3390/toxins12060377; Marin S, 2013, FOOD CHEM TOXICOL, V60, P218, DOI 10.1016/j.fct.2013.07.047; National Standards of China, 2003, 500912003 GBT; National Standards of China, 2017, GB130782017; National Standards of China, 2008, 48892008 GBT; National Standards of China, 2005, 1466912005 GBT; National Standards of China, 2007, GB1307832007; National Standards of China, 2006, GB1307822006; Niedbala RS, 2001, ANAL BIOCHEM, V293, P22, DOI 10.1006/abio.2001.5105; Pereira CS, 2019, TOXINS, V11, DOI 10.3390/toxins11050290; Ropejko K, 2021, TOXINS, V13, DOI 10.3390/toxins13010035; Thiruvengadam M, 2020, ANAL BIOCHEM, V591, DOI 10.1016/j.ab.2019.113546; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029; Zhang PP, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01934-0; Zhang PP, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00147; Zhao Y, 2016, TALANTA, V161, P297, DOI 10.1016/j.talanta.2016.08.058	29	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250250	10.1371/journal.pone.0250250	http://dx.doi.org/10.1371/journal.pone.0250250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861782	Green Published, gold			2022-12-26	WOS:000641475400052
J	Mzobe, GF; Ngcapu, S; Joubert, BC; Sturm, WA				Mzobe, Gugulethu F.; Ngcapu, Sinaye; Joubert, Bronwyn C.; Sturm, Willem A.			Differential expression of groEL-1, incB, pyk-F, tal, hctA and omcB genes during Chlamydia trachomatis developmental cycle	PLOS ONE			English	Article							LYMPHOGRANULOMA-VENEREUM; INFECTION; PROTEINS; GROWTH	Chlamydia trachomatis infects squamous and columnar epithelia at the mucosal surface. Research on gene expression patterns of C. trachomatis has predominantly focused on non-native host cells, with limited data on growth kinetics and gene expression of chlamydia in keratinocytes. Here, we investigated whether early, mid, and late chlamydial genes observed in HeLa cell line studies were co-ordinately regulated at the transcriptional level even in the keratinized cell line model and whether the expression was stage-specific during the developmental cycle. HaCaT cell lines were infected with chlamydia clinical isolates (US151and serovar E) and reference strain (L2 434). Expression of groEL-1, incB, pyk-F, tal, hctA, and omcB genes was conducted with comparative real-time PCR and transcriptional events during the chlamydial developmental cycle using transmission electron microscopy. The relative expression level of each gene and fold difference were calculated using the 2(-Delta Delta CT) method. The expression of groEL-1 and pyk-F genes was highest at 2 hours post-infection (hpi) in the L2 434 and serovar E. The expression of incB gene increased at 2 hpi in L2 434 and serovar E but peaked at 12 hpi in serovar E. L2 434 and US151 had similar tal expression profiles. Increased expression of hctA and omcB genes were found at 2 and 36 hpi in L2 434. Both clinical isolates and reference strains presented the normal chlamydial replication cycle comprising elementary bodies and reticulate bodies within 36 hpi. We show different gene expression patterns between clinical isolates and reference strain during in vitro infection of keratinocytes, with reference strain-inducing consistent expression of genes. These findings confirm that keratinocytes are appropriate cell lines to interrogate cell differentiation, growth kinetics, and gene expression of C. trachomatis infection. Furthermore, more studies with different clinical isolates and genes are needed to better understand the Chlamydial pathogenesis in keratinocytes.	[Mzobe, Gugulethu F.; Ngcapu, Sinaye; Joubert, Bronwyn C.; Sturm, Willem A.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Mzobe, Gugulethu F.; Ngcapu, Sinaye] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Dept Med Microbiol, Durban, South Africa	University of Kwazulu Natal	Mzobe, GF (corresponding author), Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.; Mzobe, GF (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Dept Med Microbiol, Durban, South Africa.	gugulethu.mzobe@caprisa.org		Mzobe, Gugulethu/0000-0003-1850-7371	National Research Foundation [SFH14061869970, SFP180507326699]; University of Kwa-Zulu Natal College of Health Sciences	National Research Foundation; University of Kwa-Zulu Natal College of Health Sciences	This study was funded by grants from the National Research Foundation (SFH14061869970) and The University of Kwa-Zulu Natal College of Health Sciences. GFM is funded with a postdoctoral fellowship from the National Research Foundation (SFP180507326699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; BARRY CE, 1992, SCIENCE, V256, P377, DOI 10.1126/science.256.5055.377; Beagley KW, 2000, J REPROD IMMUNOL, V48, P47, DOI 10.1016/S0165-0378(00)00069-3; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BRICKMAN TJ, 1993, J BACTERIOL, V175, P4274, DOI 10.1128/JB.175.14.4274-4281.1993; CALDWELL HD, 1982, INFECT IMMUN, V35, P1024, DOI 10.1128/IAI.35.3.1024-1031.1982; Faris R, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00399; Hanada H, 2003, MICROB PATHOGENESIS, V34, P57, DOI 10.1016/S0882-4010(02)00189-4; HATCH TP, 1984, J BACTERIOL, V157, P13, DOI 10.1128/JB.157.1.13-20.1984; Joubert B.C., 2010, INTERACTION LYMPHOGR; Joubert BC, 2011, J MED MICROBIOL, V60, P1565, DOI 10.1099/jmm.0.032169-0; Karunakaran KP, 2003, J BACTERIOL, V185, P1958, DOI 10.1128/JB.185.6.1958-1966.2003; Lee V, 2006, J FAM PLAN REPROD H, V32, P104, DOI 10.1783/147118906776276440; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathews S, 2001, MICROB PATHOGENESIS, V30, P337, DOI 10.1006/mpat.2000.0435; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Niehus E, 2008, J BACTERIOL, V190, P6419, DOI 10.1128/JB.00431-08; Nogueira AT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00438; Pedrosa A.T., 2019, BIORXIV, P250563; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Sturm PDJ, 2005, J CLIN MICROBIOL, V43, P2973, DOI 10.1128/JCM.43.6.2973-2975.2005; Tan M, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P149, DOI 10.1128/9781555817329.ch7; Tattersall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047439; Taylor Brandie D, 2011, Infect Drug Resist, V4, P19, DOI 10.2147/IDR.S12715; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; World Health Organization, 2018, REPORT GLOBAL SEXUAL; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1	27	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249358	10.1371/journal.pone.0249358	http://dx.doi.org/10.1371/journal.pone.0249358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857160	Green Published, gold			2022-12-26	WOS:000641474900070
J	Wang, ZJ; Cheng, C; Yang, XY; Zhang, C				Wang, Zhengjun; Cheng, Chen; Yang, Xiaoyu; Zhang, Chen			L-phenylalanine attenuates high salt-induced hypertension in Dahl SS rats through activation of GCH1-BH4	PLOS ONE			English	Article							BLOOD-PRESSURE; NITRIC-OXIDE; SENSITIVE HYPERTENSION; L-ARGININE; RENAL-DISEASE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; OXIDATIVE STRESS; SUPEROXIDE; DETERMINES	Amino acid metabolism plays an important role in controlling blood pressure by regulating the production of NO and ROS. The present study examined amino acid levels in the serum of Dahl SS rats and SS.13(BN) rats fed a low or high salt diet. We observed that 8 of 27 amino acids responded to a high salt diet in SS rats. Thus, we hypothesized that a defect in amino acids may contribute to the development of salt-induced hypertension. L-phenylalanine was used to treat SS rats with a low or high salt diet. The results demonstrated that L-phenylalanine supplementation significantly enhanced the serum nitrite levels and attenuated the high salt-induced hypertension in SS rats. Low levels of BH4 and nitrite and the impaired vascular response to acetylcholine were rescued by L-phenylalanine supplementation. Moreover, increased GTP cyclohydrolase (GCH1) mRNA, levels of BH4 and nitrite, and reduced superoxide production were observed in the kidneys of hypertensive SS rats with L-phenylalanine. The antihypertensive effects of L-phenylalanine might be mediated by enhancing BH4 biosynthesis and decreasing superoxide production from NO synthase, thereby protecting vascular and kidney function with reduced ROS and elevated NO levels. The present study demonstrated that L-phenylalanine supplementation restored vascular function, suggesting L-phenylalanine represented a potential target to attenuate high salt-sensitive hypertension through GCH1-BH4.	[Wang, Zhengjun; Cheng, Chen] Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China; [Wang, Zhengjun; Cheng, Chen] Key Lab Behav & Cognit Neurosci Shaanxi Prov, Xian, Peoples R China; [Yang, Xiaoyu] Shaanxi Normal Univ, Sch Life Sci, Xian, Peoples R China; [Zhang, Chen] Zhejiang Univ, Coll Anim Sci, Hangzhou, Peoples R China; [Zhang, Chen] Northwestern Polytech Univ, Sch Life Sci, Xian, Peoples R China	Shaanxi Normal University; Shaanxi Normal University; Zhejiang University; Northwestern Polytechnical University	Wang, ZJ (corresponding author), Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China.; Wang, ZJ (corresponding author), Key Lab Behav & Cognit Neurosci Shaanxi Prov, Xian, Peoples R China.; Zhang, C (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Peoples R China.; Zhang, C (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Xian, Peoples R China.	zhling307@126.com; poledna@163.com			Youth Fund for Humanities and Social Sciences Research of the Ministry of Education [19YJC190023]; China Postdoctoral Science Foundation [2019M663924XB]; Natural Science Basic Research Plan in Shaanxi Province of China [2018JQ1033, 2021JQ-309]	Youth Fund for Humanities and Social Sciences Research of the Ministry of Education; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Basic Research Plan in Shaanxi Province of China	This work was supported by grants from the Youth Fund for Humanities and Social Sciences Research of the Ministry of Education (Grant No. 19YJC190023), the China Postdoctoral Science Foundation funding project (Grant No. 2019M663924XB), and the Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2018JQ1033, 2021JQ-309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Artigues C, 2000, J CARDIOVASC PHARM, V35, P468, DOI 10.1097/00005344-200003000-00018; ATHERTON ND, 1988, CLIN CHEM, V34, P2241; Cappuccio FP, 2017, J CLIN HYPERTENS, V19, P4, DOI 10.1111/jch.12917; Chan Q, 2016, J ATHEROSCLER THROMB, V23, P276, DOI 10.5551/jat.30000; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; CHEN PY, 1991, J CLIN INVEST, V88, P1559, DOI 10.1172/JCI115467; Cicero AFG, 2013, AM J HYPERTENS, V26, P442, DOI 10.1093/ajh/hps044; Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; De Miguel C, 2011, HYPERTENSION, V57, P269, DOI 10.1161/HYPERTENSIONAHA.110.154302; Deijen JB, 1999, BRAIN RES BULL, V48, P203, DOI 10.1016/S0361-9230(98)00163-4; Franco V, 2006, J AM COLL NUTR, V25, p247S, DOI 10.1080/07315724.2006.10719574; Fujii S, 2003, HYPERTENSION, V42, P1014, DOI 10.1161/01.HYP.0000094557.36656.D0; Heikal L, 2018, JACC-BASIC TRANSL SC, V3, P366, DOI 10.1016/j.jacbts.2018.01.015; Hong HJ, 2001, HYPERTENSION, V38, P1044, DOI 10.1161/hy1101.095331; Hou ET, 2017, CELL REP, V19, P1631, DOI 10.1016/j.celrep.2017.04.071; Jennings A, 2015, J NUTR, V145, P2130, DOI 10.3945/jn.115.214700; Klahr S, 2001, NEPHROL DIAL TRANSPL, V16, P60, DOI 10.1093/ndt/16.suppl_1.60; Laursen JB, 2001, CIRCULATION, V103, P1282; Lin WJ, 2018, AMINO ACIDS, V50, P1407, DOI 10.1007/s00726-018-2615-6; Mattson DL, 2008, AM J PHYSIOL-RENAL, V295, pF837, DOI 10.1152/ajprenal.90341.2008; Mattson DL, 2005, HYPERTENSION, V45, P736, DOI 10.1161/01.HYP.0000153318.74544.cc; Mattson DL, 2004, PHYSIOL GENOMICS, V16, P194, DOI 10.1152/physiolgenomics.00151.2003; Mirmiran P, 2019, ARCH IRANIAN MED AIM, V22; Mitchell BM, 2004, J CARDIOVASC PHARM, V43, P758, DOI 10.1097/00005344-200406000-00004; Miyoshi A, 1997, AM J HYPERTENS, V10, P1083; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; NAKANISHI K, 1992, AM J PHYSIOL, V263, pH1650, DOI 10.1152/ajpheart.1992.263.6.H1650; Pinho MJ, 2007, AM J PHYSIOL-RENAL, V292, pF1452, DOI 10.1152/ajprenal.00465.2006; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; SOARESDASILVA P, 1995, BRIT J PHARMACOL, V114, P1403, DOI 10.1111/j.1476-5381.1995.tb13362.x; Sun T, 2009, CLIN CARDIOL, V32, P649, DOI 10.1002/clc.20616; Szentivanyi M, 2002, AM J PHYSIOL-REG I, V283, pR266, DOI 10.1152/ajpregu.00461.2001; Tanada Y, 2017, PEERJ, V5, DOI 10.7717/peerj.3352; Taylor NE, 2006, HYPERTENSION, V48, P1066, DOI 10.1161/01.HYP.0000248751.11383.7c; Vassileva I, 2003, HYPERTENSION, V41, P1359, DOI 10.1161/01.HYP.0000070958.39174.7E; Wang L, 2015, ANAL CHIM ACTA, V854, P95, DOI 10.1016/j.aca.2014.11.009; Wang L, 2014, BIOCHEM BIOPH RES CO, V450, P863, DOI 10.1016/j.bbrc.2014.06.089; Wang LL, 2015, RSC ADV, V5, P281, DOI 10.1039/c4ra07215d; Wang YJ, 2018, J NUTR BIOCHEM, V56, P133, DOI 10.1016/j.jnutbio.2018.01.007; Wang ZJ, 2017, KIDNEY BLOOD PRESS R, V42, P587, DOI 10.1159/000479846; Yamakado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11918; Yoneyama T, 2001, PROTEIN SCI, V10, P871, DOI 10.1110/ps.38501; Zhang JY, 2019, J AM HEART ASSOC, V8, DOI [10.1161/JAHA.118.010737, 10.1161/jaha.118.010737]	45	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250126	10.1371/journal.pone.0250126	http://dx.doi.org/10.1371/journal.pone.0250126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857222	Green Published, gold			2022-12-26	WOS:000641474900014
J	Overdijk, EJR; Putker, V; Smits, J; Tang, H; Bouwmeester, K; Govers, F; Ketelaar, T				Overdijk, Elysa J. R.; Putker, Vera; Smits, Joep; Tang, Han; Bouwmeester, Klaas; Govers, Francine; Ketelaar, Tijs			Phytophthora infestans RXLR effector AVR1 disturbs the growth of Physcomitrium patens without affecting Sec5 localization	PLOS ONE			English	Article							EXOCYST SUBUNITS; TIP GROWTH; MOSS; INTERACTS; COMPLEXES; IMMUNITY; REVEALS	Plant pathogens often exploit a whole range of effectors to facilitate infection. The RXLR effector AVR1 produced by the oomycete plant pathogen Phytophthora infestans suppresses host defense by targeting Sec5. Sec5 is a subunit of the exocyst, a protein complex that is important for mediating polarized exocytosis during plant development and defense against pathogens. The mechanism by which AVR1 manipulates Sec5 functioning is unknown. In this study, we analyzed the effect of AVR1 on Sec5 localization and functioning in the moss Physcomitrium patens. P. patens has four Sec5 homologs. Two (PpSec5b and PpSec5d) were found to interact with AVR1 in yeast-two-hybrid assays while none of the four showed a positive interaction with AVR1(Delta T), a truncated version of AVR1. In P. patens lines carrying beta-estradiol inducible AVR1 or AVR1(Delta T) transgenes, expression of AVR1 or AVR1(Delta T) caused defects in the development of caulonemal protonema cells and abnormal morphology of chloronema cells. Similar phenotypes were observed in Sec5- or Sec6-silenced P. patens lines, suggesting that both AVR1 and AVR1(Delta T) affect exocyst functioning in P. patens. With respect to Sec5 localization we found no differences between beta-estradiol-treated and untreated transgenic AVR1 lines. Sec5 localizes at the plasma membrane in growing caulonema cells, also during pathogen attack, and its subcellular localization is the same, with or without AVR1 in the vicinity.	[Overdijk, Elysa J. R.; Putker, Vera; Smits, Joep; Tang, Han; Ketelaar, Tijs] Wageningen Univ & Res, Lab Cell Biol, Wageningen, Netherlands; [Overdijk, Elysa J. R.; Bouwmeester, Klaas; Govers, Francine] Wageningen Univ & Res, Lab Phytopathol, Wageningen, Netherlands; [Bouwmeester, Klaas] Wageningen Univ & Res, Biosystemat Grp, Wageningen, Netherlands; [Putker, Vera] Wageningen Univ & Res, Lab Nematol, Wageningen, Netherlands; [Tang, Han] IST Austria, Dev & Cell Biol Plants, Vienna, Austria	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Institute of Science & Technology - Austria	Govers, F (corresponding author), Wageningen Univ & Res, Lab Phytopathol, Wageningen, Netherlands.	francine.govers@wur.nl	Govers, Francine/A-5616-2009	Govers, Francine/0000-0001-5311-929X	Earth and Life Sciences Division of The Netherlands Organization for Scientific Research [831.13.003]	Earth and Life Sciences Division of The Netherlands Organization for Scientific Research	EO grant number 831.13.003 Earth and Life Sciences Division of The Netherlands Organization for Scientific Research https://www.nwo.nl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Bloch D, 2016, PLANT PHYSIOL, V172, P980, DOI 10.1104/pp.16.00690; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bouwmeester K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001327; Bouwmeester K, 2009, ANNU PLANT REV, V34, P102, DOI 10.1111/b.9781405175326.2009.00005.x; Carella P, 2018, PLANT CELL PHYSIOL, V59, P656, DOI 10.1093/pcp/pcx182; Champouret N, 2009, MOL PLANT MICROBE IN, V22, P1535, DOI 10.1094/MPMI-22-12-1535; Du Y, 2018, STUD MYCOL, P85, DOI 10.1016/j.simyco.2018.01.003; Du Y, 2018, J EXP BOT, V69, P655, DOI 10.1093/jxb/erx442; Du Y, 2015, PLANT PHYSIOL, V169, P1975, DOI 10.1104/pp.15.01169; Du Y, 2015, NEW PHYTOL, V207, P735, DOI 10.1111/nph.13355; Fendrych M, 2013, MOL BIOL CELL, V24, P510, DOI 10.1091/mbc.E12-06-0492; Fujisaki K, 2015, PLANT J, V83, P875, DOI 10.1111/tpj.12934; Grebnev G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00154; Guo JP, 2018, NAT GENET, V50, P297, DOI 10.1038/s41588-018-0039-6; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; James P, 1996, GENETICS, V144, P1425; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khan M, 2018, PLANT J, V93, P651, DOI 10.1111/tpj.13780; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Kosetsu K, 2013, PLANT CELL, V25, P4479, DOI 10.1105/tpc.113.117432; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Kubo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077356; Kulich I, 2018, PLANT PHYSIOL, V176, P2040, DOI 10.1104/pp.17.01693; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024; McLellan H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003670; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Nakaoka Y, 2012, PLANT CELL, V24, P1478, DOI 10.1105/tpc.112.098509; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Overdijk EJR, 2020, J EXP BOT, V71, P837, DOI 10.1093/jxb/erz478; Overdijk EJR, 2016, J MICROSC-OXFORD, V263, P171, DOI 10.1111/jmi.12395; Ravikumar R, 2017, CURR OPIN PLANT BIOL, V40, P97, DOI 10.1016/j.pbi.2017.08.009; Rawat A, 2017, NEW PHYTOL, V216, P438, DOI 10.1111/nph.14548; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sekeres J, 2017, PLANT PHYSIOL, V173, P1659, DOI 10.1104/pp.16.01709; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Synek L, 2017, PLANT PHYSIOL, V174, P223, DOI 10.1104/pp.16.01282; Tang H, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222430; van Gisbergen PAC, 2018, J CELL BIOL, V217, P945, DOI 10.1083/jcb.201705084; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vukasinovic N, 2017, NEW PHYTOL, V213, P1052, DOI 10.1111/nph.14267; Wang SM, 2019, J EXP BOT, V70, P343, DOI 10.1093/jxb/ery360; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Whisson SC, 2016, CURR OPIN MICROBIOL, V34, P127, DOI 10.1016/j.mib.2016.09.002; Yamada M, 2016, METHODS MOL BIOL, V1413, P263, DOI 10.1007/978-1-4939-3542-0_17; Zarsky V, 2013, CURR OPIN PLANT BIOL, V16, P726, DOI 10.1016/j.pbi.2013.10.013; Zhang Y, 2013, NEW PHYTOL, V199, P74, DOI 10.1111/nph.12236	50	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249637	10.1371/journal.pone.0249637	http://dx.doi.org/10.1371/journal.pone.0249637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831039	Green Published, gold			2022-12-26	WOS:000639359600053
J	Rufalco-Moutinho, P; Kadri, SM; Alonso, DP; Moreno, M; Carrasco-Escobar, G; Prussing, C; Gamboa, D; Vinetz, JM; Sallum, MAM; Conn, JE; Ribolla, PEM				Rufalco-Moutinho, Paulo; Kadri, Samir Moura; Alonso, Diego Peres; Moreno, Marta; Carrasco-Escobar, Gabriel; Prussing, Catharine; Gamboa, Dionicia; Vinetz, Joseph M.; Mureb Sallum, Maria Anice; Conn, Jan E.; Martins Ribolla, Paulo Eduardo			Ecology and larval population dynamics of the primary malaria vector Nyssorhynchus darlingi in a high transmission setting dominated by fish farming in western Amazonian Brazil	PLOS ONE			English	Article							MOSQUITOS DIPTERA-CULICIDAE; ANOPHELES-DARLINGI; SEASONAL DISTRIBUTION; RURAL SETTLEMENT; PLASMODIUM-VIVAX; URBAN MALARIA; PORTO VELHO; RISK; DIVERSITY; FRONTIER	Vale do Rio Jurua in western Acre, Brazil, is a persistent malaria transmission hotspot partly due to fish farming development that was encouraged to improve local standards of living. Fish ponds can be productive breeding sites for Amazonian malaria vector species, including Nyssorhynchus darlingi, which, combined with high human density and mobility, add to the local malaria burden.This study reports entomological profile of immature and adult Ny. darlingi at three sites in Mancio Lima, Acre, during the rainy and dry season (February to September, 2017). From 63 fishponds, 10,859 larvae were collected, including 5,512 first-instar Anophelinae larvae and 4,927 second, third and fourth-instars, of which 8.5% (n = 420) were Ny. darlingi. This species was most abundant in not-abandoned fishponds and in the presence of emerging aquatic vegetation. Seasonal analysis of immatures in urban landscapes found no significant difference in the numbers of Ny. darlingi, corresponding to equivalent population density during the rainy to dry transition period. However, in the rural landscape, significantly higher numbers of Ny. darlingi larvae were collected in August (IRR = 5.80, p = 0.037) and September (IRR = 6.62, p = 0.023) (dry season), compared to February (rainy season), suggesting important role of fishponds for vector population maintenance during the seasonal transition in this landscape type. Adult sampling detected mainly Ny. darlingi (similar to 93%), with similar outdoor feeding behavior, but different abundance according to landscape profile: urban site 1 showed higher peaks of human biting rate in May (46 bites/person/hour), than February (4) and September (15), while rural site 3 shows similar HBR during the same sampling period (22, 24 and 21, respectively). This study contributes to a better understanding of the larvae biology of the main malaria vector in the Vale do Rio Jurua region and, ultimately will support vector control efforts.	[Rufalco-Moutinho, Paulo; Martins Ribolla, Paulo Eduardo] Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Bioestat Biol Vegetal Parasitol & Zool, Botucatu, SP, Brazil; [Kadri, Samir Moura; Alonso, Diego Peres; Martins Ribolla, Paulo Eduardo] Univ Estadual Paulista, Inst Biotecnol, Botucatu, SP, Brazil; [Moreno, Marta] London Sch Hyg & Trop Med, Dept Infect Biol, London, England; [Carrasco-Escobar, Gabriel; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab ICEMR Amazonia, Labs Invest & Desarrollo, Lima, Peru; [Prussing, Catharine; Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Prussing, Catharine; Conn, Jan E.] Wadsworth Ctr, New York State Dept Hlth, Albany, NY USA; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Gamboa, Dionicia; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Humboldt, Lima, Peru; [Vinetz, Joseph M.] Yale Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT USA; [Mureb Sallum, Maria Anice] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil; [Rufalco-Moutinho, Paulo] Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil	Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Yale University; Universidade de Sao Paulo; Universidade de Brasilia	Rufalco-Moutinho, P (corresponding author), Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Bioestat Biol Vegetal Parasitol & Zool, Botucatu, SP, Brazil.; Rufalco-Moutinho, P (corresponding author), Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil.	paulorufalco@gmail.com	Prussing, Catharine/AAB-4546-2019; Alonso, Diego/GRO-4526-2022; Sallum, Maria Anice Mureb/B-8537-2012	Prussing, Catharine/0000-0001-6425-6839; Alonso, Diego/0000-0003-4992-6253; Sallum, Maria Anice Mureb/0000-0002-7051-2891; Moreno, Marta/0000-0002-9091-5612; Carrasco-Escobar, Gabriel/0000-0002-6945-0419	US National Institutes of Health ICEMR [U19 AI089681]; Tropical Disease Research-WHO Contract [201460655]	US National Institutes of Health ICEMR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tropical Disease Research-WHO Contract	This study was partially funded by grants from the US National Institutes of Health ICEMR U19 AI089681 to Joseph M. Vinetz and Tropical Disease Research-WHO Contract 201460655 to Dionicia Gamboa.	Azrag RS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2350-1; Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265; Barros FSM, 2015, AM J TROP MED HYG, V93, P939, DOI 10.4269/ajtmh.15-0042; Bourke BP, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2483-2; Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Conde M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1002-y; Conn JE, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P81; Conn JE., WIRELESS COMMUNICATI, DOI [10.5772/intechopen.76964, DOI 10.5772/INTECHOPEN.76964]; Correa APSA, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2969-6; Barbosa LMC, 2016, ACTA TROP, V164, P216, DOI 10.1016/j.actatropica.2016.09.018; Costa KMD, 2010, REV PANAM SALUD PUBL, V28, P353, DOI 10.1590/S1020-49892010001100005; Diakite NR, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0871-4; dos Reis IC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0947-1; dos Reis IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137521; Fontoura PS, 2020, J MED ENTOMOL, V57, P942, DOI 10.1093/jme/tjz220; Forattini O.P., 2002, EDUSP, V2, P250; Hutchings RSG, 2013, ZOOLOGIA-CURITIBA, V30, P1, DOI 10.1590/S1984-46702013000100001; Hagenlocher M, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0036-2; Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Houweling TAJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004546; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hutchings RSG, 2016, J MED ENTOMOL, V53, P1330, DOI 10.1093/jme/tjw101; Ilacqua RC, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170522; Kenea O, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1813-x; Lana RM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2045-z; Laporta GZ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002139; Lederberg J, 1997, EMERG INFECT DIS, V3, P417, DOI 10.3201/eid0304.970402; Lima JMT, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0125; Maheu-Giroux M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-477; Maheu-Giroux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071638; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Martins LMO, 2018, J VECTOR ECOL, V43, P235, DOI 10.1111/jvec.12307; Moller-Jacobs LL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0593-4; Monnerat Rose, 2014, International Journal of Mosquito Research, V1, P1; de Barros FSM, 2007, MEM I OSWALDO CRUZ, V102, P299, DOI 10.1590/S0074-02762007005000024; Morais SA, 2012, REV INST MED TROP SP, V54, P331, DOI 10.1590/S0036-46652012000600008; Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174; Nascimento J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006909; Nissen A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2031-5; Oladepo O, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-91; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Packard RM, 2008, EMERG INFECT DIS, V14, P1679; Patrick ML, 2002, PHYSIOL BIOCHEM ZOOL, V75, P223, DOI 10.1086/342002; Pimenta PFP, 2015, MEM I OSWALDO CRUZ, V110, P23, DOI 10.1590/0074-02760140266; Prussing C, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2234-4; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Reece SE, 2009, EVOL APPL, V2, P11, DOI 10.1111/j.1752-4571.2008.00060.x; Reis IC, 2018, NEOTROP ENTOMOL, V47, P412, DOI 10.1007/s13744-018-0595-6; Rejmankova E, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P397, DOI 10.5772/55229; Galardo AKR, 2013, REV SOC BRAS MED TRO, V46, P172, DOI 10.1590/0037-8682-1649-2013; Rufalco-Moutinho P, 2016, ACTA TROP, V164, P243, DOI 10.1016/j.actatropica.2016.08.032; Saavedra MP, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3619-0; Sallum MAM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2753-7; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026; Gil LHS, 2015, REV INST MED TROP SP, V57, P263, DOI 10.1590/S0036-46652015000300014; Buitrago LS, 2013, MEM I OSWALDO CRUZ, V108, P1045, DOI 10.1590/0074-0276130217; SVS-MS Secretaria de Vigilancia em Saude Ministerio da Saude, 2011, NOTA TECNICA NO012 C; Turell MJ, 2008, J MED ENTOMOL, V45, P1165, DOI 10.1603/0022-2585(2008)45[1165:SDBAHA]2.0.CO;2; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Walshe DP, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008090.pub3; World Health Organization, 2013, LARV SOURC MAN SUPPL; Zar J.H., 2010, BIOSTATISCAL ANAL, V5th edition, P434; Zhang S., 2018, MALARIA ELIMINATION	67	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0246215	10.1371/journal.pone.0246215	http://dx.doi.org/10.1371/journal.pone.0246215			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831004	Green Published, gold			2022-12-26	WOS:000639359600068
J	Sichting, F; Ebrecht, F				Sichting, Freddy; Ebrecht, Florian			The rise of the longitudinal arch when sitting, standing, and walking: Contributions of the windlass mechanism	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; PLANTAR FASCIA; NAVICULAR DROP; STANCE PHASE; FOOT MUSCLES; APONEUROSIS	The original windlass mechanism describes a one-to-one coupling between metatarsal joint dorsiflexion and medial longitudinal arch rise. The description assumes a sufficiently stiff plantar aponeurosis and absence of foot muscle activity. However, recent research calls for a broader interpretation of the windlass mechanism that accounts for an extensible plantar aponeurosis and active foot muscles. In this study, we investigate the rise of the arch in response to toe dorsiflexion when sitting, standing, and walking to discuss the windlass mechanism's contributions in static and dynamic load scenarios. 3D motion analysis allowed a kinematic investigation of the rise and drop of the arch relative to the extent of toe dorsiflexion. The results suggest that static windlass effects poorly predict the relationship between arch dynamics and metatarsophalangeal joint motion during dynamic load scenarios, such as walking. We were able to show that toe dorsiflexion resulted in an immediate rise of the longitudinal arch during sitting and standing. In contrast, a decrease in arch height was observed during walking, despite toe dorsiflexion at the beginning of the push-off phase. Further, the longitudinal arch rose almost linearly with toe dorsiflexion in the static loading scenarios, while the dynamic load scenario revealed an exponential rise of the arch. In addition to that, the rate of change in arch height relative to toe motion was significantly lower when sitting and standing compared to walking. Finally, and most surprisingly, arch rise was found to correlate with toe dorsiflexion only in the dynamic loading scenario. These results challenge the traditional perspective of the windlass mechanism as the dominating source of foot rigidity for push-off against the ground during bipedal walking. It seems plausible that other mechanisms besides the windlass act to raise the foot arch.	[Sichting, Freddy; Ebrecht, Florian] Tech Univ Chemnitz, Dept Human Locomot, Chemnitz, Germany	Technische Universitat Chemnitz	Sichting, F (corresponding author), Tech Univ Chemnitz, Dept Human Locomot, Chemnitz, Germany.	freddy.sichting@hsw.tu-chemnitz.de		Ebrecht, Florian/0000-0002-9162-5676; Sichting, Freddy/0000-0002-7032-5025	Saxon State government	Saxon State government	The Saxon State government financed this study out of the State budget approved by the Saxon State Parliament. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; Aquino A, 2001, J AM PODIAT MED ASSN, V91, P245, DOI 10.7547/87507315-91-5-245; BASMAJIAN JV, 1963, J BONE JOINT SURG AM, V45, P1189, DOI 10.2106/00004623-196345060-00006; BASMAJIAN JV, 1954, SURG GYNECOL OBSTET, V98, P662; BOJSENMOLLER F, 1976, J ANAT, V121, P599; Caravaggi P, 2010, J ANAT, V217, P254, DOI 10.1111/j.1469-7580.2010.01261.x; Caravaggi P, 2009, J EXP BIOL, V212, P2491, DOI 10.1242/jeb.025767; Carlson RE, 2000, FOOT ANKLE INT, V21, P18, DOI 10.1177/107110070002100104; Chen DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084347; Cheng HYK, 2008, FOOT ANKLE INT, V29, P845, DOI 10.3113/FAI.2008.0845; Cheng HYK, 2008, J BIOMECH, V41, P1937, DOI 10.1016/j.jbiomech.2008.03.028; Eichelberger P, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-018-0257-2; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; Erdemir A, 2004, J BONE JOINT SURG AM, V86A, P546, DOI 10.2106/00004623-200403000-00013; Farris DJ, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2020.0208; Farris DJ, 2019, P NATL ACAD SCI USA, V116, P1645, DOI 10.1073/pnas.1812820116; Fessel G, 2014, ANN ANAT, V196, P471, DOI 10.1016/j.aanat.2014.07.003; Gefen A, 2003, FOOT ANKLE INT, V24, P238, DOI 10.1177/107110070302400307; GRAY EG, 1968, ANAT RECORD, V161, P1, DOI 10.1002/ar.1091610101; Gray H., 2008, GRAYS ANATOMY ANATOM, VXXIV, P1551; Griffin NL, 2013, J ANAT, V222, P598, DOI 10.1111/joa.12050; HICKS J. H., 1955, ACTA ANAT, V25, P34; HICKS JH, 1954, J ANAT, V88, P25; Holowka NB, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.174425; Kappel-Bargas A, 1998, CLIN BIOMECH, V13, P190, DOI 10.1016/S0268-0033(97)00038-7; Kelly LA, 2018, MED SCI SPORT EXER, V50, P98, DOI 10.1249/MSS.0000000000001420; Kelly LA, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0174; Kelly LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1076; Kelly LA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1188; Kelly LA, 2012, CLIN BIOMECH, V27, P46, DOI 10.1016/j.clinbiomech.2011.07.013; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kern AM, 2019, PEERJ, V7, DOI 10.7717/peerj.7487; Kogler GF, 2001, FOOT ANKLE INT, V22, P433, DOI 10.1177/107110070102200513; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; MANN R, 1964, J BONE JOINT SURG AM, V46, P469, DOI 10.2106/00004623-196446030-00001; McDonald KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152602; McKeon PO, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2013-092690; Paton JS, 2006, J AM PODIAT MED ASSN, V96, P313, DOI 10.7547/0960313; Pavan PG, 2011, SURG RADIOL ANAT, V33, P905, DOI 10.1007/s00276-011-0873-z; Rolian C, 2009, J EXP BIOL, V212, P713, DOI 10.1242/jeb.019885; Sichting F, 2020, J ANAT, V237, P85, DOI 10.1111/joa.13173; Takahashi KZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15218-7; Wager JC, 2016, J BIOMECH, V49, P704, DOI 10.1016/j.jbiomech.2016.02.023; Welte L, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2020.2095; Wright WG, 2012, J NEUROPHYSIOL, V107, P1513, DOI 10.1152/jn.00256.2011; Yawar A, 2017, ARXIV PREPRINT ARXIV; Zelik KE, 2015, EUR J APPL PHYSIOL, V115, P691, DOI 10.1007/s00421-014-3056-x	47	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249965	10.1371/journal.pone.0249965	http://dx.doi.org/10.1371/journal.pone.0249965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831112	Green Published, gold			2022-12-26	WOS:000639359600073
J	Pascoal, PV; Ribeiro, DM; Cereijo, CR; Santana, H; Nascimento, RC; Steindorf, AS; Calsing, LCG; Formighieri, EF; Brasil, BSAF				Pascoal, Patricia Verdugo; Ribeiro, Dagon Manoel; Cereijo, Carolina Ribeiro; Santana, Hugo; Nascimento, Rodrigo Carvalho; Steindorf, Andrei Stecca; Calsing, Lorena C. G.; Formighieri, Eduardo Fernandes; Brasil, Bruno S. A. F.			Biochemical and phylogenetic characterization of the wastewater tolerant Chlamydomonas biconvexa Embrapa|LBA40 strain cultivated in palm oil mill effluent	PLOS ONE			English	Article								The increasing demand for water, food and energy poses challenges for the world ' s sustainability. Tropical palm oil is currently the major source of vegetable oil worldwide with a production that exceeds 55 million tons per year, while generating over 200 million tons of palm oil mill effluent (POME). It could potentially be used as a substrate for production of microalgal biomass though. In this study, the microalgal strain Chlamydomonas biconvexa Embrapa|LBA40, originally isolated from a sugarcane vinasse stabilization pond, was selected among 17 strains tested for growth in POME retrieved from anaerobic ponds of a palm oil industrial plant located within the Amazon rainforest region. During cultivation in POME, C. biconvexa Embrapa|LBA40 biomass productivity reached 190.60 mgDW center dot L-1 center dot d(-1) using 15L airlift flat plate photobioreactors. Carbohydrates comprised the major fraction of algal biomass (31.96%), while the lipidic fraction reached up to 11.3% of dry mass. Reductions of 99% in ammonium and nitrite, as well as 98% reduction in phosphate present in POME were detected after 5 days of algal cultivation. This suggests that the aerobic pond stage, usually used in palm oil industrial plants to reduce POME inorganic load, could be substituted by high rate photobioreactors, significantly reducing the time and area requirements for wastewater treatment. In addition, the complete mitochondrial genome of C. biconvexa Embrapa|LBA40 strain was sequenced, revealing a compact mitogenome, with 15.98 kb in size, a total of 14 genes, of which 9 are protein coding genes. Phylogenetic analysis confirmed the strain taxonomic status within the Chlamydomonas genus, opening up opportunities for future genetic modification and molecular breeding programs in these species.	[Pascoal, Patricia Verdugo; Ribeiro, Dagon Manoel; Cereijo, Carolina Ribeiro; Santana, Hugo; Nascimento, Rodrigo Carvalho; Steindorf, Andrei Stecca; Calsing, Lorena C. G.; Formighieri, Eduardo Fernandes; Brasil, Bruno S. A. F.] Embrapa Agroenergia, Brasilia, DF, Brazil; [Pascoal, Patricia Verdugo; Brasil, Bruno S. A. F.] Univ Fed Bahia, Salvador, BA, Brazil; [Ribeiro, Dagon Manoel] Univ Brasilia, Brasilia, DF, Brazil; [Ribeiro, Dagon Manoel] Univ Zambeze, Sofala, Mozambique; [Nascimento, Rodrigo Carvalho] Univ Fed Tocantins, Gurupi, Tocantins, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal da Bahia; Universidade de Brasilia; Universidade Federal do Tocantins (UFT)	Pascoal, PV (corresponding author), Embrapa Agroenergia, Brasilia, DF, Brazil.; Pascoal, PV (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.	patyverdugobiotec@gmail.com	Formighieri, Eduardo F/F-2993-2012; Steindorff, Andrei Stecca/I-3084-2013; Brasil, Bruno S. A. F./E-8817-2012	Steindorff, Andrei Stecca/0000-0002-2052-2848; Brasil, Bruno S. A. F./0000-0002-8690-2157; Pascoal, Patricia Verdugo/0000-0003-1633-9909; Santana, Hugo/0000-0002-2259-4239	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil) [8882.384467/2019-01]; Financier of Studies and Projects (FINEP - Brazil)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financier of Studies and Projects (FINEP - Brazil)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES finance code 8882.384467/2019-01 - Brazil) and Financier of Studies and Projects (FINEP - Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2016, RENEW SUST ENERG REV, V65, P214, DOI 10.1016/j.rser.2016.06.084; Andrews S., 2010, FASTQC QUALITY CONTR; Benami E., 2018, Environmental Research Letters, V13, P034037, DOI 10.1088/1748-9326/aaa270; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bhujade R, 2017, ANNU REV CHEM BIOMOL, V8, P335, DOI 10.1146/annurev-chembioeng-060816-101630; Brasil BSAF, 2017, NEW BIOTECHNOL, V39, P90, DOI 10.1016/j.nbt.2016.04.007; Calixto CD, 2016, BIORESOURCE TECHNOL, V221, P438, DOI 10.1016/j.biortech.2016.09.066; Center For International Development At Harvard University, 2019, ATL EC COMPL; Cheah WY, 2018, ENERG CONVERS MANAGE, V174, P430, DOI 10.1016/j.enconman.2018.08.057; Chouhan N., AUTOPHAGY INDUCED AC, DOI [10.1101/2020.09.14.296244, DOI 10.1101/2020.09.14.296244]; Das P, 2019, SOIL BIOL, V55, P41, DOI 10.1007/978-3-030-18933-4_3; Ding GT, 2016, INT J HYDROGEN ENERG, V41, P4888, DOI 10.1016/j.ijhydene.2015.12.010; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Ebenezer TE, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0626-8; Fernandes MS, 2019, ALGAL RES, V38, DOI 10.1016/j.algal.2018.101402; Gallaher SD, 2018, PLANT J, V93, P545, DOI 10.1111/tpj.13788; Glaz P, 2016, WATER RES, V101, P64, DOI 10.1016/j.watres.2016.05.060; Greiner S, 2019, NUCLEIC ACIDS RES, V47, pW59, DOI 10.1093/nar/gkz238; Hadi SIIA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149284; Hamaji T, 2017, GENOME BIOL EVOL, V9, P993, DOI 10.1093/gbe/evx060; Hariz HB, 2019, J WATER PROCESS ENG, V32, DOI 10.1016/j.jwpe.2019.100907; Hariz HB, 2018, J APPL PHYCOL, V30, P3017, DOI 10.1007/s10811-018-1488-0; James GO, 2013, BIORESOURCE TECHNOL, V127, P441, DOI 10.1016/j.biortech.2012.09.090; Kamalanathan M, 2016, J APPL PHYCOL, V28, P1509, DOI 10.1007/s10811-015-0726-y; Khalid AAH, 2019, J CLEAN PROD, V210, P673, DOI 10.1016/j.jclepro.2018.11.095; Khalid AAH, 2018, BIORESOURCE TECHNOL, V247, P930, DOI 10.1016/j.biortech.2017.09.195; Khan MI, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0879-x; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kishi M, 2018, J APPL PHYCOL, V30, P401, DOI 10.1007/s10811-017-1226-z; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laurens, 2013, DETERMINATION TOTAL, V303, P275, DOI DOI 10.2172/1118077; Laurens LM, 2015, SUMMATIVE MASS ANAL; Li G, 2019, INT J AGR BIOL ENG, V12, P8, DOI 10.25165/j.ijabe.20191205.3630; Li Z, 2017, GENOME BIOL EVOL, V9, P1130, DOI 10.1093/gbe/evx070; Lorenz C, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020035; Lu N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050694; Manzoor F., 2019, CURR ENV MANAG, V6, P174, DOI [10.2174/2212717806666190716160536, DOI 10.2174/2212717806666190716160536]; Mathieu-Rivet E, 2013, MOL CELL PROTEOMICS, V12, P3160, DOI 10.1074/mcp.M113.028191; MILLER DH, 1974, J CELL BIOL, V63, P420, DOI 10.1083/jcb.63.2.420; Nakada T, 2016, J PHYCOL, V52, P283, DOI 10.1111/jpy.12397; Nwuche C. O., 2014, British Biotechnology Journal, V4, P305; Park JBK, 2011, BIORESOURCE TECHNOL, V102, P35, DOI 10.1016/j.biortech.2010.06.158; Pascher A, 1925, NATURE; Perez-Martinez X, 2000, J BIOL CHEM, V275, P30144, DOI 10.1074/jbc.M003940200; Popescu CE, 2007, GENETICS, V175, P819, DOI 10.1534/genetics.106.063156; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Qari HA, 2020, J BIOENERG BIOMEMBR, V52, P27, DOI 10.1007/s10863-019-09813-8; Qu WY, 2020, BIORESOURCE TECHNOL, V305, DOI 10.1016/j.biortech.2020.123072; Ribeiro D.M., 2020, BIORESOUR TECHNOL RE, V9, DOI 10.1016; Saadaoui I, 2019, J APPL PHYCOL, V31, P457, DOI 10.1007/s10811-018-1539-6; Salama ES, 2013, BIOPROC BIOSYST ENG, V36, P827, DOI 10.1007/s00449-013-0919-1; Santana H, 2017, BIORESOURCE TECHNOL, V228, P133, DOI 10.1016/j.biortech.2016.12.075; Saravanan AP, 2020, FUEL, V272, DOI 10.1016/j.fuel.2020.117635; Saravanan AP, 2018, J CLEAN PROD, V193, P734, DOI 10.1016/j.jclepro.2018.05.033; Semary NAEl, 2017, HDB ENV CHEM, V5, P1, DOI [10.1007/698, DOI 10.1007/698]; Shi K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00793; Silva CEDF, 2016, PROCESS BIOCHEM, V51, P1833, DOI 10.1016/j.procbio.2016.02.016; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Talebi AF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/597198; Vanier G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10698-z; Von Sperling M, 2015, WATER INTELLIGENCE O, DOI [10.2166/9781780402109, DOI 10.2166/9781780402109]; Yang L, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1041-z	62	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249089	10.1371/journal.pone.0249089	http://dx.doi.org/10.1371/journal.pone.0249089			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826653	Green Published, gold			2022-12-26	WOS:000638119900005
J	Brown, RDR; Veerman, BP; Oh, J; Tate, RJ; Torta, F; Cunningham, MR; Adams, DR; Pyne, S; Pyne, NJ				Brown, Ryan D. R.; Veerman, Ben E. P.; Oh, Jeongah; Tate, Rothwelle J.; Torta, Federico; Cunningham, Margaret R.; Adams, David R.; Pyne, Susan; Pyne, Nigel J.			A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-PHOSPHATE RECEPTORS; EXPRESSION; ACTIVATION; ALPHA; STIMULATION	The translocation of sphingosine kinase 1 (SK1) to the plasma membrane (PM) is crucial in promoting oncogenesis. We have previously proposed that SK1 exists as both a monomer and dimer in equilibrium, although it is unclear whether these species translocate to the PM via the same or different mechanisms. We therefore investigated the structural determinants involved to better understand how translocation might potentially be targeted for therapeutic intervention. We report here that monomeric WT mouse SK1 (GFP-mSK1) translocates to the PM of MCF-7L cells stimulated with carbachol or phorbol 12-myristate 13-acetate, whereas the dimer translocates to the PM in response to sphingosine-1-phosphate; thus, the equilibrium between the monomer and dimer is sensitive to cellular stimulus. In addition, carbachol and phorbol 12-myristate 13-acetate induced translocation of monomeric GFP-mSK1 to lamellipodia, whereas sphingosine1-phosphate induced translocation of dimeric GFP-mSK1 to filopodia, suggesting that SK1 regulates different cell biological processes dependent on dimerization. GFP-mSK1 mutants designed to modulate dimerization confirmed this difference in localization. Regulation by the C-terminal tail of SK1 was investigated using GFP-mSK1 truncations. Removal of the last five amino acids (PPEEP) prevented translocation of the enzyme to the PM, whereas removal of the last ten amino acids restored translocation. This suggests that the penultimate five amino acids (SRRGP) function as a translocation brake, which can be released by sequestration of the PPEEP sequence. We propose that these determinants alter the arrangement of N-terminal and C-terminal domains in SK1, leading to unique surfaces that promote differential translocation to the PM.	[Brown, Ryan D. R.; Veerman, Ben E. P.; Tate, Rothwelle J.; Cunningham, Margaret R.; Pyne, Susan; Pyne, Nigel J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Oh, Jeongah; Torta, Federico] Natl Univ Singapore, SLING, Life Sci Inst, Singapore Lipid Incubator, Singapore, Singapore; [Oh, Jeongah; Torta, Federico] Natl Univ Singapore, Dept Biochem, YLL Sch Med, Singapore, Singapore; [Adams, David R.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh, Midlothian, Scotland	University of Strathclyde; National University of Singapore; National University of Singapore; Heriot Watt University	Pyne, NJ (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	n.j.pyne@strath.ac.uk		Brown, Ryan/0000-0003-2880-0301; Cunningham, Margaret/0000-0001-6454-8671; Torta, Federico/0000-0001-7545-7484; Veerman, Ben/0000-0002-0734-5920	University of Strathclyde; NRF [2019-NRF-ISF003-3172]	University of Strathclyde; NRF	R. D. R. B. acknowledges the University of Strathclyde for a scholarship award. J. O. was supported by the NRF 2019-NRF-ISF003-3172 grant.	Adams DR, 2016, TRENDS BIOCHEM SCI, V41, P395, DOI 10.1016/j.tibs.2016.02.007; Barr RK, 2008, J BIOL CHEM, V283, P34994, DOI 10.1074/jbc.M804658200; Brizuela L, 2007, J LIPID RES, V48, P2264, DOI 10.1194/jlr.M700291-JLR200; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Fiszman GL, 2007, CANCER BIOL THER, V6, P1106, DOI 10.4161/cbt.6.7.4330; Gustin DJ, 2013, BIOORG MED CHEM LETT, V23, P4608, DOI 10.1016/j.bmcl.2013.06.030; HAWORTH NL, 2015, RSC ADV, V5, P8630, DOI DOI 10.1039/C5RA10672A; Hengst JA, 2010, ARCH BIOCHEM BIOPHYS, V494, P23, DOI 10.1016/j.abb.2009.11.006; Hengst JA, 2009, ARCH BIOCHEM BIOPHYS, V492, P62, DOI 10.1016/j.abb.2009.09.013; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kiss Z, 1998, BBA-LIPID LIPID MET, V1392, P109, DOI 10.1016/S0005-2760(98)00030-7; Lee MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar4411; Lim KG, 2011, J BIOL CHEM, V286, P18633, DOI 10.1074/jbc.M111.220756; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Maczis Melissa, 2015, Advances in Biological Regulation, V60, P160, DOI 10.1016/j.jbior.2015.09.006; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Ohotski J, 2013, INT J CANCER, V132, P605, DOI 10.1002/ijc.27692; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Pham DH, 2014, ONCOGENE, V33, P5559, DOI 10.1038/onc.2013.502; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pulkoski-Gross MJ, 2018, J LIPID RES, V59, P462, DOI 10.1194/jlr.M081307; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2016, PROG LIPID RES, V62, P93, DOI 10.1016/j.plipres.2016.03.001; SCHMIDT M, 1994, EUR J BIOCHEM, V225, P667, DOI 10.1111/j.1432-1033.1994.00667.x; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stanislaus D, 1997, MOL ENDOCRINOL, V11, P738, DOI 10.1210/me.11.6.738; ter Braak M, 2009, BBA-MOL CELL BIOL L, V1791, P357, DOI 10.1016/j.bbalip.2009.01.019; Wang J, 2014, ACS MED CHEM LETT, V5, P1329, DOI 10.1021/ml5004074; Wang QS, 2014, TUMOR BIOL, V35, P363, DOI 10.1007/s13277-013-1051-1; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Wilson C, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154340; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200	37	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100674	10.1016/j.jbc.2021.100674	http://dx.doi.org/10.1016/j.jbc.2021.100674			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865856	Green Published, Green Accepted, gold			2022-12-26	WOS:000672866400645
J	Gurung, C; Fendereski, M; Sapkota, K; Guo, J; Huang, FQ; Guo, YL				Gurung, Chandan; Fendereski, Mona; Sapkota, Krishna; Guo, Jason; Huang, Faqing; Guo, Yan-Lin			Dicer represses the interferon response and the double-stranded RNA-activated protein kinase pathway in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MECHANISMS; INNATE IMMUNITY; DEFICIENT; DIFFERENTIATION; PKR; PROLIFERATION; PLURIPOTENCY; EXPRESSION; RECEPTORS; ELEMENTS	Recent studies have demonstrated that embryonic stem cells (ESCs) are deficient in expressing type I interferons (IFN), the cytokines that play key roles in antiviral responses. However, the underlying molecular mechanisms and biological implications of this finding are poorly understood. In this study, we developed a synthetic RNA-based assay that can simultaneously assess multiple forms of antiviral responses. Dicer is an enzyme essential for RNA interference (RNAi), which is used as a major antiviral mechanism in invertebrates. RNAi activity is detected in wild-type ESCs but is abolished in Dicer knockout ESCs (D-/-ESCs) as expected. Surprisingly, D-/-ESCs have gained the ability to express IFN, which is otherwise deficient in wild-type ESCs. Furthermore, D-/-ESCs have constitutively active double-stranded RNA (dsRNA)-activated protein kinase (PKR), an enzyme that is also involved in antiviral response. D-/-ESCs show increased sensitivity to the cytotoxicity resulting from RNA transfection. The effects of dsRNA can be partly replicated with a synthetic B2RNA corresponding to the retrotransposon B2 short interspersed nuclear element. B2RNA has secondary structure features of dsRNA and accumulates in D-/-ESCs, suggesting that B2RNA could be a cellular RNA that activates PKR and contributes to the decreased cell proliferation and viability of D-/-ESCs. Treatment of D-/-ESCs with a PKR inhibitor and IFN beta-neutralizing antibodies increased cell proliferation rate and cell viability. Based on these findings, we propose that, in ESCs, Dicer acts as a repressor of antiviral responses and plays a key role in the maintenance of proliferation, viability, and pluripotency of ESCs.	[Gurung, Chandan; Fendereski, Mona; Guo, Jason; Guo, Yan-Lin] Univ Southern Mississippi, Dept Cell & Mol Biol, Hattiesburg, MS 39406 USA; [Sapkota, Krishna; Huang, Faqing] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Guo, Yan-Lin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Southern Mississippi; University of Southern Mississippi; Johns Hopkins University	Guo, YL (corresponding author), Univ Southern Mississippi, Dept Cell & Mol Biol, Hattiesburg, MS 39406 USA.; Guo, YL (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	yanlin.guo@usm.edu			National Institute of General Medical Sciences [R15GM128196]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by the National Institute of General Medical Sciences (R15GM128196).	Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Bodak M, 2017, FEBS OPEN BIO, V7, P204, DOI 10.1002/2211-5463.12174; Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chiappinelli KB, 2012, MOL CANCER RES, V10, P316, DOI 10.1158/1541-7786.MCR-11-0520; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; D'Angelo W, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1033-8; D'Angelo W, 2016, STEM CELLS DEV, V25, P648, DOI 10.1089/scd.2015.0377; Eggenberger J, 2019, P NATL ACAD SCI USA, V116, P1384, DOI 10.1073/pnas.1812449116; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Guo YL, 2007, DEV DYNAM, V236, P3383, DOI 10.1002/dvdy.21374; Guo YL, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13089; Guo YL, 2017, IMMUNOL CELL BIOL, V95, P17, DOI 10.1038/icb.2016.70; Guo YL, 2015, STEM CELLS, V33, P3165, DOI 10.1002/stem.2079; HERTZOG PJ, 1994, MOL REPROD DEV, V39, P226; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang FQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183974; Huang FQ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng008; Hutchins AP, 2015, SCI BULL, V60, P1722, DOI 10.1007/s11434-015-0905-x; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039239; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Li N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni036; Luningschror P, 2012, STEM CELLS, V30, P655, DOI 10.1002/stem.1033; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Maillard PV, 2016, EMBO J, V35, P2505, DOI 10.15252/embj.201695086; Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nallagatla SR, 2011, CURR OPIN STRUC BIOL, V21, P119, DOI 10.1016/j.sbi.2010.11.003; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Pare JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003865; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shen T, 2012, ANTI-CANCER AGENT ME, V12, P631, DOI 10.2174/187152012800617678; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Wang RX, 2014, J BIOL CHEM, V289, P25186, DOI 10.1074/jbc.M113.537746; Wang RX, 2014, STEM CELLS DEV, V23, P594, DOI 10.1089/scd.2013.0417; Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438; White E, 2014, NAT STRUCT MOL BIOL, V21, P552, DOI 10.1038/nsmb.2827; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Witteveldt J, 2019, ELIFE, V8, DOI 10.7554/eLife.44171; Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229	55	8	8	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100264	10.1016/j.jbc.2021.100264	http://dx.doi.org/10.1016/j.jbc.2021.100264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837743	Green Published, gold			2022-12-26	WOS:000672866400240
J	Li, SX; Isiorho, EA; Owens, VL; Donnan, PH; Odili, CL; Mansoorabadi, SO				Li, Shuxin; Isiorho, Eta A.; Owens, Victoria L.; Donnan, Patrick H.; Odili, Chidinma L.; Mansoorabadi, Steven O.			A noncanonical heme oxygenase specific for the degradation of c-type heme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS ISDG; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; IRON-ABSORPTION; PRODUCT; ENZYME; HUTZ; GENE; CLASSIFICATION; METABOLISM	Heme oxygenases (HOs) play a critical role in recouping iron from the labile heme pool. The acquisition and liberation of heme iron are especially important for the survival of pathogenic bacteria. All characterized HOs, including those belonging to the HugZ superfamily, preferentially cleave free b-type heme. Another common form of heme found in nature is c-type heme, which is covalently linked to proteinaceous cysteine residues. However, mechanisms for direct iron acquisition from the c-type heme pool are unknown. Here we identify a HugZ homolog from the oligopeptide permease (opp) gene cluster of Paracoccus denitrificans that lacks any observable reactivity with heme b and show that it instead rapidly degrades c-type hemopeptides. This c-type heme oxygenase catalyzes the oxidative cleavage of the model substrate microperoxidase-11 at the beta- and/or delta-meso position(s), yielding the corresponding peptide-linked biliverdin, CO, and free iron. X-ray crystallographic analysis suggests that the switch in substrate specificity from b-to c-type heme involves loss of the N-terminal alpha/beta domain and C-terminal loop containing the coordinating histidine residue characteristic of HugZ homologs, thereby accommodating a larger substrate that provides its own iron ligand. These structural features are also absent in certain heme utilization/storage proteins from human pathogens that exhibit low or no HO activity with free heme. This study thus expands the scope of known iron acquisition strategies to include direct oxidative cleavage of heme-containing proteolytic fragments of c-type cytochromes and helps to explain why certain oligopeptide permeases show specificity for the import of heme in addition to peptides.	[Li, Shuxin; Isiorho, Eta A.; Owens, Victoria L.; Donnan, Patrick H.; Odili, Chidinma L.; Mansoorabadi, Steven O.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA; [Isiorho, Eta A.] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA	Auburn University System; Auburn University; City University of New York (CUNY) System	Mansoorabadi, SO (corresponding author), Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.	som@auburn.edu		Donnan, Patrick H./0000-0002-8076-2683	National Science Foundation (NSF), Division of Chemistry under CAREER Award [CHE-1555138]; U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0018043]	National Science Foundation (NSF), Division of Chemistry under CAREER Award(National Science Foundation (NSF)); U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE))	Work by S. L. and V. L. O. was supported by the National Science Foundation (NSF), Division of Chemistry under CAREER Award CHE-1555138. Work by E. A. I. was supported by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) under DOE Early Career Award DE-SC0018043.	Acharya G, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1033-6; Ahmed FH, 2015, J MOL BIOL, V427, P3554, DOI 10.1016/j.jmb.2015.09.021; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERGUSON SJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P17, DOI 10.1016/S0005-2728(05)80259-2; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Guo Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-226; Hooda J, 2014, NUTRIENTS, V6, P1080, DOI 10.3390/nu6031080; Hu YL, 2011, J BIOL CHEM, V286, P1537, DOI 10.1074/jbc.M110.172007; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KUTTY RK, 1982, J BIOL CHEM, V257, P9944; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu XH, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-23; Lyles KV, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00198; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Onzuka M, 2017, BBA-GEN SUBJECTS, V1861, P1870, DOI 10.1016/j.bbagen.2017.04.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellet YH, 2016, J INORG BIOCHEM, V154, P103, DOI 10.1016/j.jinorgbio.2015.11.002; Przybyszewska J, 2014, PRZ GASTROENTEROL, V9, P208, DOI 10.5114/pg.2014.45102; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Sachla AJ, 2016, BIOMETALS, V29, P593, DOI 10.1007/s10534-016-9937-1; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Scheepers GH, 2016, FEBS LETT, V590, P4393, DOI 10.1002/1873-3468.12445; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Schneider S, 2006, J BIOL CHEM, V281, P32606, DOI 10.1074/jbc.M607516200; Slamti L, 2019, RES MICROBIOL, V170, P338, DOI 10.1016/j.resmic.2019.07.004; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Tanaka KJ, 2019, J BIOL CHEM, V294, P1070, DOI 10.1074/jbc.RA118.004479; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Traore ES, 2021, MOLECULES, V26, DOI 10.3390/molecules26030549; TU AT, 1968, EXPERIENTIA, V24, P219, DOI 10.1007/BF02152778; Uchida T, 2017, DALTON T, V46, P8104, DOI 10.1039/c7dt01562c; Uchida T, 2017, BIOCHEMISTRY-US, V56, P2723, DOI 10.1021/acs.biochem.7b00152; Uchida T, 2012, CHEM COMMUN, V48, P6741, DOI 10.1039/c2cc31147j; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; Wilks A, 2014, ARCH BIOCHEM BIOPHYS, V544, P87, DOI 10.1016/j.abb.2013.10.013; Wilson BR, 2016, TRENDS MOL MED, V22, P1077, DOI 10.1016/j.molmed.2016.10.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7803; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	50	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100666	10.1016/j.jbc.2021.100666	http://dx.doi.org/10.1016/j.jbc.2021.100666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862082	gold, Green Published			2022-12-26	WOS:000672866400637
J	Okada, M; Unno, H; Emi, KI; Matsumoto, M; Hemmi, H				Okada, Miyako; Unno, Hideaki; Emi, Koh-Ichi; Matsumoto, Mayuko; Hemmi, Hisashi			A versatile cis-prenyltransferase from Methanosarcina mazei catalyzes both C- and O-prenylations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Polyprenyl groups, products of isoprenoid metabolism, are utilized in peptidoglycan biosynthesis, protein N-glycosylation, and other processes. These groups are formed by cis-prenyltransferases, which use allylic prenyl pyrophosphates as prenyldonors to catalyze the C-prenylation of the general acceptor substrate, isopentenyl pyrophosphate. Repetition of this reaction forms (Z,E-mixed)-polyprenyl pyrophosphates, which are converted later into glycosyl carrier lipids, such as undecaprenyl phosphate and dolichyl phosphate. MM_0014 from the methanogenic archaeon Methanosarcina mazei is known as a versatile cis-prenyltransferase that accepts both isopentenyl pyrophosphate and dimethylallyl pyrophosphate as acceptor substrates. To learn more about this enzyme's catalytic activity, we determined the X-ray crystal structures of MM_0014 in the presence or absence of these substrates. Surprisingly, one structure revealed a complex with O-prenylglycerol, suggesting that the enzyme catalyzed the prenylation of glycerol contained in the crystallization buffer. Further analyses confirmed that the enzyme could catalyze the O-prenylation of small alcohols, such as 2-propanol, expanding our understanding of the catalytic ability of cis-prenyltransferases.	[Okada, Miyako; Emi, Koh-Ichi; Matsumoto, Mayuko; Hemmi, Hisashi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Unno, Hideaki] Nagasaki Univ, Grad Sch Engn, Nagasaki, Japan; [Unno, Hideaki] Nagasaki Univ, Org Marine Sci & Technol, Nagasaki, Japan	Nagoya University; Nagasaki University; Nagasaki University	Hemmi, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan.	hhemmi@agr.nagoya-u.ac.jp	Hemmi, Hisashi/I-6868-2014	Hemmi, Hisashi/0000-0002-9538-809X; Unno, Hideaki/0000-0001-5917-269X	JSPS KAKENHI [17H05437, 18K19170, 19H04651, 20H02899]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 17H05437, 18K19170, 19H04651, and 20H02899 for H. H.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yan YM, 2020, NAT PROTOC, V15, P1829, DOI 10.1038/s41596-020-0312-x; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100679	10.1016/j.jbc.2021.100679	http://dx.doi.org/10.1016/j.jbc.2021.100679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33872599	Green Published, gold			2022-12-26	WOS:000672866400650
J	Fukuda, M; Soma, DM; Iwasaki, S; Nakamura, S; Kanda, T; Ouattara, K; Nagumo, F				Fukuda, Monrawee; Soma, Dohan M.; Iwasaki, Shinya; Nakamura, Satoshi; Kanda, Takashi; Ouattara, Korodjouma; Nagumo, Fujio			Site-specific responses of lowland rice to acidulated and calcined phosphate rock fertilizers in the Center-West region of Burkina Faso	PLOS ONE			English	Article							RAIN-FED LOWLAND; SOIL FERTILITY; ORGANIC-MATTER; USE EFFICIENCY; OPPORTUNITIES; MANAGEMENT; BENEFICIATION; RATES	Soil phosphorus (P) deficiency is a major constraint of crop production in Sub-Saharan Africa. In particular, in the Sudano-Sahelian zone of Burkina Faso, P is rarely replenished as fertilizer supplies are limited in rural areas and because of the socio-economic situation of farmers. There is however, an abundance of local phosphate rock resource in the country. The development of local inorganic P fertilizers to improve crop production and replace the nutrients removed after harvesting, as well as to promote to sustainable agriculture, is desired. This study evaluated the efficiency of low-grade Burkina Faso phosphate rock (BPR)-based P fertilizers, produced by acidulation and calcination-the major fertilizer processing methods, on lowland rice production and the soil factors influencing their effectiveness. The results showed that the acidulated P fertilizers were as effective as conventional commercial P fertilizers on various soil types, textures, and fertility. Calcined P fertilizers were consistently effective on fine-textured soils with high basic fertility. It was found that fine soil texture and basic fertility of the initial soils were important factors in agronomic efficiency of BPR-based fertilizers and the resilience of rice production to climatic variability. It is recommended that soil type, with respect to soil texture, soil properties, inherent fertility, and water availability, should be considered when using BPR-based fertilizers for rice cultivation.	[Fukuda, Monrawee; Iwasaki, Shinya; Nakamura, Satoshi; Kanda, Takashi; Nagumo, Fujio] Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan; [Soma, Dohan M.; Ouattara, Korodjouma] Inst Environm & Rech Agr, Dept Gest Ressources Nat Syst Prod, Ouagadougou, Burkina Faso; [Fukuda, Monrawee] Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan; [Kanda, Takashi] Natl Agr & Food Res Org, Inst Agroenvironm Sci, Tsukuba, Ibaraki, Japan	Japan International Research Center for Agricultural Sciences; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Fukuda, M (corresponding author), Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan.; Fukuda, M (corresponding author), Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan.	monrawee@affrc.go.jp		FUKUDA, Monrawee/0000-0002-2162-5398	Science and Technology Research Partnership for Sustainable Development (SATREPS), Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA) [JPMJSA1609]	Science and Technology Research Partnership for Sustainable Development (SATREPS), Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA)	This research was funded by the Science and Technology Research Partnership for Sustainable Development (SATREPS), Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA), project number JPMJSA1609 "Establishment of the model for fertilizing cultivation promotion using Burkina Faso phosphate rock"(Principal Investigator; F. Nagumo).	Bado BV, 2006, BIOL FERT SOILS, V43, P171, DOI 10.1007/s00374-006-0076-7; Bank World., 2006, AGR RURAL DEV DISCUS; Bationo A, 2001, NUTR CYCL AGROECOSYS, V61, P131, DOI 10.1023/A:1013355822946; Bolan NS., 2005, ENCY SOIL ENV; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Buresh R.J., 1997, SSSA SPECIAL PUBLICA, P111, DOI DOI 10.2136/SSSASPECPUB51.C6; Charoenchamratcheep C., 1989, P S PHOSPH REQ SUST; Chien SH, 2011, NUTR CYCL AGROECOSYS, V89, P229, DOI 10.1007/s10705-010-9390-4; Compaore E., 2011, INNOVATION KEY GREEN, P591; De Bauw P, 2019, FIELD CROP RES, V236, P177, DOI 10.1016/j.fcr.2019.03.021; DOAK B. W., 1965, NEW ZEAL J AGR RES, V8, P15; Dobermann A., 2000, RICE NUTR DISORDERS; Donoghue J.R., 2004, RECENT DEV MULTIPLE, P1, DOI DOI 10.1214/LNMS/1196285622; Emam M. M., 2014, Australian Journal of Crop Science, V8, P596; FAMIC, 2013, TEST METH FERT, P370; FAO, 2006, GUID SOIL DESCR; Fixen P., 2014, MANAGING WATER FERTI, DOI DOI 10.1016/J.IJANTIMICAG.2012.09.018; Food and Agriculture Organization of The United Nations (FAO), 2004, FAO FERTILIZER PLANT, V13; Food and Agriculture Organization of The United Nations (FAO), FAOSTAT PRODUCTION Q; Francisco EAB, 2008, AGRON J, V100, P819, DOI 10.2134/agronj2007.0209; Frederick R, 1986, TECHNICAL B INT FERT; Fukuda M, 2013, SOIL SCI PLANT NUTR, V59, P403, DOI 10.1080/00380768.2013.783770; Gruba P, 2015, SCI TOTAL ENVIRON, V511, P655, DOI 10.1016/j.scitotenv.2015.01.013; Haefele SM, 2006, FIELD CROP RES, V98, P39, DOI 10.1016/j.fcr.2005.12.003; Huguenin-Elie O, 2009, ANN BOT-LONDON, V103, P211, DOI 10.1093/aob/mcn199; Ikazaki K, 2018, SOIL SCI PLANT NUTR, V64, P623, DOI 10.1080/00380768.2018.1502604; Iwasaki S, 2017, SOIL SCI PLANT NUTR, V63, P200, DOI 10.1080/00380768.2017.1309255; Jiang WT, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11174799; Kirk GJD, 1998, FIELD CROP RES, V56, P73, DOI 10.1016/S0378-4290(97)00141-X; Lafitte HR, 1998, FIELD CROP RES, V56, P223, DOI 10.1016/S0378-4290(97)00134-2; Lim HH, 2001, AUST J SOIL RES, V39, P397, DOI 10.1071/SR00005; McCauley A., 2017, NUTR MANAGEMENT MODU, V8; Ministry of Agriculture, 2011, IRRIGATION FISHERIES, P48; Ministry of the Environment and fishery resources (MEFR), 2015, BURKINA FASO NATL CL, P152; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nakamura S., 2020, Tropical Agriculture and Development, V64, P97, DOI 10.11248/jsta.64.97; Nakamura S., 2013, African Journal of Agricultural Research, V8, P1779; Nakamura S, 2019, SOIL SCI PLANT NUTR, V65, P267, DOI 10.1080/00380768.2019.1598236; Nakamura S, 2016, NUTR CYCL AGROECOSYS, V106, P47, DOI 10.1007/s10705-016-9788-8; NELSON DW, 1983, COMMUN SOIL SCI PLAN, V14, P1051, DOI 10.1080/00103628309367431; Newborne R., 2017, AGR WATER CLIMATE MI; PALMER B, 1983, FERT RES, V4, P31, DOI 10.1007/BF01049664; Pheav S, 2005, PLANT SOIL, V269, P89, DOI 10.1007/s11104-004-0396-z; Quin BF., 1985, P ANN FERT C NZ FERT, P40; R Core Team, 2021, R LANGUAGE ENV STAT; RAJAN SSS, 1992, FERT RES, V33, P267, DOI 10.1007/BF01050882; RAJAN SSS, 1993, FERT RES, V35, P47, DOI 10.1007/BF00750219; Rajan SSS, 1996, ADV AGRON, V57, P77, DOI 10.1016/S0065-2113(08)60923-2; Rice CW., 2005, ENCY SOIL ENV; Ruan YY, 2019, MINERALS-BASEL, V9, DOI 10.3390/min9040253; Sahrawat KL, 2012, ARCH AGRON SOIL SCI, V58, P423, DOI 10.1080/03650340.2010.522993; Shaddox TW., 2017, FLORIDA FERTILIZER L; Shirvani M, 2005, J PLANT NUTR, V28, P537, DOI 10.1081/PLN-200049235; Simpson PG, 1998, USDA TECHNICAL B; Wade LJ, 1998, FIELD CROP RES, V56, P93, DOI 10.1016/S0378-4290(97)00142-1; White PF, 1999, SOIL SCI PLANT NUTR, V45, P51, DOI 10.1080/00380768.1999.10409323; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yoshida S., 1981, Fundamentals of rice crop science.	59	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0250240	10.1371/journal.pone.0250240	http://dx.doi.org/10.1371/journal.pone.0250240			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP4TZ	33872338	Green Published, gold			2022-12-26	WOS:000641723300010
J	Mullin, HAC; Norkey, EA; Kodwani, A; Vitevitch, MS; Castro, N				Mullin, Hollie A. C.; Norkey, Evan A.; Kodwani, Anisha; Vitevitch, Michael S.; Castro, Nichol			Does age affect perception of the Speech-to-Song Illusion?	PLOS ONE			English	Article							WORD; TRANSFORMATION; YOUNG	The Speech-to-Song Illusion is an auditory illusion that occurs when a spoken phrase is repeatedly presented. After several presentations, listeners report that the phrase seems to be sung rather than spoken. Previous work [1] indicates that the mechanisms-priming, activation, and satiation-found in the language processing model, Node Structure Theory (NST), may account for the Speech-to-Song Illusion. NST also accounts for other language-related phenomena, including increased experiences in older adults of the tip-of-the-tongue state (where you know a word, but can't retrieve it). Based on the mechanism in NST used to account for the age-related increase in the tip-of-the-tongue phenomenon, we predicted that older adults may be less likely to experience the Speech-to-Song Illusion than younger adults. Adults of a wide range of ages heard a stimulus known to evoke the Speech-to-Song Illusion. Then, they were asked to indicate if they experienced the illusion or not (Study 1), to respond using a 5-point song-likeness rating scale (Study 2), or to indicate when the percept changed from speech to song (Study 3). The results of these studies suggest that the illusion is experienced with similar frequency and strength, and after the same number of repetitions by adult listeners regardless of age.	[Mullin, Hollie A. C.; Norkey, Evan A.; Kodwani, Anisha; Vitevitch, Michael S.] Univ Kansas, Lawrence, KS 66045 USA; [Castro, Nichol] Univ Buffalo, Buffalo, NY USA	University of Kansas; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Vitevitch, MS (corresponding author), Univ Kansas, Lawrence, KS 66045 USA.	mvitevit@ku.edu	Castro, Nichol/AGK-6706-2022	Vitevitch, Michael/0000-0002-1209-0838; Castro, Nichol/0000-0001-8691-7968	Center for Undergraduate Research at the University of Kansas	Center for Undergraduate Research at the University of Kansas	We wish to thank the Center for Undergraduate Research at the University of Kansas for their financial support of Hollie A. C. Mullin who worked on Studies 1 and 2 of this project, which also served to partially fulfill the requirements for Departmental Honors in Psychology at the University of Kansas. Study 3 served to partially fulfill the requirements for Departmental Honors in Psychology at the University of Kansas for Evan A. Norkey.	Armitage J, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02883; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2000, DEBATES PSYCHOL, P204; Castro N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198656; der Nederlanden CMV, 2015, COGNITION, V143, P135, DOI 10.1016/j.cognition.2015.06.015; der Nederlanden CMV, 2015, J EXP PSYCHOL GEN, V144, pE43, DOI 10.1037/xge0000056; Deutsch D., 1995, MUSICAL ILLUSIONS PA; Deutsch D, 2008, J ACOUST SOC AM, V124, P589, DOI 10.1121/1.2931957; Deutsch D, 2011, J ACOUST SOC AM, V129, P2245, DOI 10.1121/1.3562174; Diaz MT, 2019, COGN AFFECT BEHAV NE, V19, P829, DOI 10.3758/s13415-018-00671-2; Falk S, 2014, J EXP PSYCHOL HUMAN, V40, P1491, DOI 10.1037/a0036858; GREGORY RL, 1968, PROC R SOC SER B-BIO, V171, P279, DOI 10.1098/rspb.1968.0071; Groenveld G, 2020, PSYCHOL RES-PSYCH FO, V84, P1451, DOI 10.1007/s00426-018-1135-z; Hadad BS, 2018, ATTEN PERCEPT PSYCHO, V80, P1619, DOI 10.3758/s13414-018-1529-4; Huijbers W, 2017, CEREB CORTEX, V27, P4339, DOI 10.1093/cercor/bhw234; Hymers M, 2015, NEUROIMAGE, V108, P225, DOI 10.1016/j.neuroimage.2014.12.010; Jaisin K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00662; JASP Team, 2022, JASP VERS 0 16 2; Jeffreys H., 1961, THEORY OF PROBABILIT; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kennedy R, 2020, POLIT SCI RES METH, V8, P614, DOI 10.1017/psrm.2020.6; Lakens D, 2018, ADV METH PRACT PSYCH, V1, P259, DOI 10.1177/2515245918770963; Lee M.D., 2014, BAYESIAN COGNITIVE M; LEWANDOWSKY S, 1993, PSYCHOL SCI, V4, P236, DOI 10.1111/j.1467-9280.1993.tb00267.x; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Ma WY, 2020, Q J EXP PSYCHOL, V73, P1036, DOI 10.1177/1747021819888982; MacKay D.G., 1990, AGING COGNITION KNOW, V71, P213, DOI [10.1016/S0166-4115(08)60159-4, DOI 10.1016/S0166-4115(08)60159-4]; MacKay D.G., 1987, ORG PERCEPTION ACTIO; MacKay DG, 1998, J MEM LANG, V38, P28, DOI 10.1006/jmla.1997.2544; MACKAY DG, 1992, CONSCIOUS COGN, V1, P199, DOI 10.1016/1053-8100(92)90061-E; MACKAY DG, 1993, J MEM LANG, V32, P624, DOI 10.1006/jmla.1993.1032; Margulis EH, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00048; McGuire AB, 2016, ATTEN PERCEPT PSYCHO, V78, P107, DOI 10.3758/s13414-015-1006-2; Mullennix J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224623; Oberle S, 2013, LANG COGNITIVE PROC, V28, P1378, DOI 10.1080/01690965.2012.685481; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rathcke T., 2010, SPEECH PROSODY 2010, V100169, P1; Regaiolli B, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02220; RICHARDS JE, 1981, J EXP PSYCHOL HUMAN, V7, P382, DOI 10.1037/0096-1523.7.2.382; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; Rowland J, 2019, PSYCHON B REV, V26, P583, DOI 10.3758/s13423-018-1527-5; Simchy-Gross R., 2018, MUSIC SCI, V1, P1, DOI [10.3758/BF03198310, DOI 10.1177/2059204317731992]; Sommers MS, 1999, PSYCHOL AGING, V14, P458, DOI 10.1037/0882-7974.14.3.458; Tierney A, 2018, J EXP PSYCHOL GEN, V147, P888, DOI 10.1037/xge0000455; Tierney A, 2013, CEREB CORTEX, V23, P249, DOI 10.1093/cercor/bhs003; U. S. Food and Drug Administration (FDA), 2001, AN EV PREV CONTR MEA; Vitevitch M.S., 2020, Q J EXP PSYCHOL, DOI [10.1177/1747021820959068, DOI 10.1177/1747021820959068]; Vitevitch M.S., INFLUENCE MEMO UNPUB; Vitevitch MS, 2017, Q J EXP PSYCHOL, V70, P62, DOI 10.1080/17470218.2015.1122070; WARREN RM, 1958, AM J PSYCHOL, V71, P612, DOI 10.2307/1420267	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0250042	10.1371/journal.pone.0250042	http://dx.doi.org/10.1371/journal.pone.0250042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP4TZ	33872326	Green Published, gold			2022-12-26	WOS:000641723300011
J	Eddy, LH; Preston, N; Mon-Williams, M; Bingham, DD; Atkinson, JMC; Ellingham-Khan, M; Otteslev, A; Hill, LJB				Eddy, Lucy H.; Preston, Nick; Mon-Williams, Mark; Bingham, Daniel D.; Atkinson, Jo M. C.; Ellingham-Khan, Marsha; Otteslev, Ava; Hill, Liam J. B.			Developing and validating a school-based screening tool of Fundamental Movement Skills (FUNMOVES) using Rasch analysis	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; PHYSICAL-ACTIVITY; GENDER-DIFFERENCES; MOTOR-SKILLS; ACADEMIC-PERFORMANCE; YOUNG CHILDRENS; PROFICIENCY; ASSOCIATIONS; COMPETENCE; HEALTH	Background A large proportion of children are not able to perform age-appropriate fundamental movement skills (FMS). Thus, it is important to assess FMS so that children needing additional support can be identified in a timely fashion. There is great potential for universal screening of FMS in schools, but research has established that current assessment tools are not fit for purpose. Objective To develop and validate the psychometric properties of a FMS assessment tool designed specifically to meet the demands of universal screening in schools. Methods A working group consisting of academics from developmental psychology, public health and behavioural epidemiology developed an assessment tool (FUNMOVES) based on theory and prior evidence. Over three studies, 814 children aged 4 to 11 years were assessed in school using FUNMOVES. Rasch analysis was used to evaluate structural validity and modifications were then made to FUNMOVES activities after each study based on Rasch results and implementation fidelity. Results The initial Rasch analysis found numerous psychometric problems including multidimensionality, disordered thresholds, local dependency, and misfitting items. Study 2 showed a unidimensional measure, with acceptable internal consistency and no local dependency, but that did not fit the Rasch model. Performance on a jumping task was misfitting, and there were issues with disordered thresholds (for jumping, hopping and balance tasks). Study 3 revealed a unidimensional assessment tool with good fit to the Rasch model, and no further issues, once jumping and hopping scoring were modified. Implications The finalised version of FUNMOVES (after three iterations) meets standards for accurate measurement, is free and able to assess a whole class in under an hour using resources available in schools. Thus FUNMOVES has the potential to allow schools to efficiently screen FMS to ensure that targeted support can be provided and disability barriers removed.	[Eddy, Lucy H.; Mon-Williams, Mark; Hill, Liam J. B.] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Eddy, Lucy H.; Mon-Williams, Mark; Bingham, Daniel D.; Hill, Liam J. B.] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Eddy, Lucy H.; Preston, Nick; Mon-Williams, Mark; Bingham, Daniel D.; Atkinson, Jo M. C.; Ellingham-Khan, Marsha; Otteslev, Ava; Hill, Liam J. B.] Bradford Royal Infirm, Ctr Appl Educ Res, Wolfson Ctr Appl Hlth Res, Bradford, W Yorkshire, England; [Preston, Nick] Univ Leeds, Acad Dept Rehabil Med, Leeds, W Yorkshire, England; [Mon-Williams, Mark] Univ South Eastern Norway, Natl Ctr Opt Vis & Eye Care, Notodden, Norway; [Atkinson, Jo M. C.] Univ Bradford, Sch Allied Hlth Profess & Midwifery, Bradford, W Yorkshire, England	University of Leeds; Bradford Royal Infirmary; Bradford Royal Infirmary; University of Leeds; University College of Southeast Norway; University of Bradford	Eddy, LH (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.; Eddy, LH (corresponding author), Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford, W Yorkshire, England.; Eddy, LH (corresponding author), Bradford Royal Infirm, Ctr Appl Educ Res, Wolfson Ctr Appl Hlth Res, Bradford, W Yorkshire, England.	L.Eddy@leeds.ac.uk		Preston, Nick/0000-0001-8429-7320; Atkinson, Jo/0000-0001-9920-3868; Bingham, Daniel/0000-0002-5809-7357; Mon-Williams, Mark/0000-0001-7595-8545; Eddy, Lucy/0000-0002-3990-1944	ESRC White Rose Doctoral Training Partnership Pathway Award [ES/P000745/1]; Alan Turing Institute; Department for Education through the Bradford Opportunity Area; Medical Research Council [MR/S037527/]; National Institute for Health Research Yorkshire and Humber ARC [NIHR20016]	ESRC White Rose Doctoral Training Partnership Pathway Award; Alan Turing Institute; Department for Education through the Bradford Opportunity Area; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Yorkshire and Humber ARC	The work of the lead author (L.H. Eddy) was supported by an ESRC White Rose Doctoral Training Partnership Pathway Award (ES/P000745/1). M. Mon-Williams was supported by a Fellowship from the Alan Turing Institute. The work was conducted within infrastructure provided by the Centre for Applied Education Research (funded by the Department for Education through the Bradford Opportunity Area) and ActEarly: a City Collaboratory approach to early promotion of good health and wellbeing funded by the Medical Research Council (grant reference MR/S037527/). L.J.B. Hill, M. Mon-Williams, N. Preston and D. D. Bingham's involvement was supported by the National Institute for Health Research Yorkshire and Humber ARC (reference: NIHR20016). The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health Research or the Departments of Health and Social Care or Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi-Walker LJ, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5080110; Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107; ANDRICH D, 1985, SOCIOL METHODOL, P33; Avery LM, 2003, ARCH PHYS MED REHAB, V84, P697, DOI 10.1016/S0003-9993(03)04896-7; Bardid F, 2019, SCAND J MED SCI SPOR, V29, P1980, DOI 10.1111/sms.13527; Bardid F, 2019, J SCI MED SPORT, V22, P311, DOI 10.1016/j.jsams.2018.08.007; Barnett LM, 2014, J SCI MED SPORT, V17, P667, DOI 10.1016/j.jsams.2013.09.013; Barnett LM, 2010, RES Q EXERCISE SPORT, V81, P162; Bolger LE., 2018, J MOT LEARN DEV, V6, P81, DOI [https://doi.org/10.1123/jmld.2017-0003, DOI 10.1123/JMLD.2017-0003]; Boone WJ, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-04-0148; Brian A., 2018, J MOTOR LEARN DEV, V6, pS320, DOI [10.1123/jmld.2016-0071, DOI 10.1123/JMLD.2016-0071]; Brown DMY, 2020, RES DEV DISABIL, V98, DOI 10.1016/j.ridd.2020.103576; Bruininks RH, 2005, MANUAL; Burns RD., 2020, J SPORT HLTH SCI; Camden C, 2019, HEALTH EXPECT, V22, P1156, DOI 10.1111/hex.12947; Chang M, 2018, LEARN INDIVID DIFFER, V61, P250, DOI 10.1016/j.lindif.2018.01.002; Chien CW, 2009, AM J PHYS MED REHAB, V88, P376, DOI 10.1097/PHM.0b013e318198a7c9; de Waal E, 2019, EARLY CHILD EDUC J, V47, P455, DOI 10.1007/s10643-019-00936-6; Duncan MJ, 2020, EUR PHYS EDUC REV, V26, P814, DOI 10.1177/1356336X19888953; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Eddy LH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237919; Estevan I., 2017, J MOTOR LEARN DEV, V5, P69, DOI [10.1123/jmld.2016-0045, DOI 10.1123/JMLD.2016-0045, https://doi.org/10.1123/jmld.2016-0045]; Farmer O, 2017, SPORTS, V5, DOI 10.3390/sports5040074; Finch P, BODY NPR, P2015; Fisher WP., 1992, RASCH MEASURE T, V6, P238; Foulkes JD, 2015, PERCEPT MOTOR SKILL, V121, P260, DOI 10.2466/10.25.PMS.121c14x0; GARCIA C, 1994, RES Q EXERCISE SPORT, V65, P213, DOI 10.1080/02701367.1994.10607622; Goodway JD, 2010, RES Q EXERCISE SPORT, V81, P17; Guan HY, 2020, LANCET CHILD ADOLESC, V4, P416, DOI 10.1016/S2352-4642(20)30131-0; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Hardy LL, 2012, PEDIATRICS, V130, pE390, DOI 10.1542/peds.2012-0345; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Hong I, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.021212; Jaakkola T, 2015, J SPORT SCI, V33, P1719, DOI 10.1080/02640414.2015.1004640; Junaid Kathryn A, 2006, Phys Occup Ther Pediatr, V26, P5; Kelly B, 2017, J PUBLIC HEALTH-UK, V39, pE48, DOI 10.1093/pubmed/fdw064; Klingberg B, 2019, J SPORT SCI, V37, P378, DOI 10.1080/02640414.2018.1504603; Kokstejn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176556; Koutsouris G, 2018, BRIT EDUC RES J, V44, P939, DOI 10.1002/berj.3464; Li YC, 2019, RES DEV DISABIL, V84, P112, DOI 10.1016/j.ridd.2018.04.023; Linacre J., 1994, RASCH MEASUREMENT T, V7, P328; Liong GHE, 2015, PERCEPT MOTOR SKILL, V120, P591, DOI 10.2466/10.25.PMS.120v18x2; Lochte L, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0571-4; Logan SW, 2018, J SPORT SCI, V36, P781, DOI 10.1080/02640414.2017.1340660; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Medd G, RES SQUARE PREPRINT, DOI [10.21203/rs.3.rs-32875/v1, DOI 10.21203/RS.3.RS-32875/V1]; Mickle KJ, 2011, J SCI MED SPORT, V14, P243, DOI 10.1016/j.jsams.2010.11.002; Missiuna Cheryl, 2003, Pediatr Phys Ther, V15, P32, DOI 10.1097/01.PEP.0000051695.47004.BF; Missiuna C, 2017, BRIT J OCCUP THER, V80, P145, DOI 10.1177/0308022616679852; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Morley D, 2015, HUM MOVEMENT SCI, V44, P150, DOI 10.1016/j.humov.2015.08.022; Novak C, 2012, CHILD CARE HLTH DEV, V38, P829, DOI 10.1111/j.1365-2214.2011.01302.x; O' Brien W, 2016, PHYS EDUC SPORT PEDA, V21, P557, DOI 10.1080/17408989.2015.1017451; Ofsted, 2013, 2012 OUTST PHYS ED A; Pentland J, 2016, DISABIL REHABIL, V38, P299, DOI 10.3109/09638288.2015.1037464; Perera N, 2020, ANAL SCH FUNDING BUD; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Rodriguez MC, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00474; Rodriguez-Negro J, 2021, EARLY CHILD DEV CARE, V191, P281, DOI 10.1080/03004430.2019.1617284; Routen AC, 2018, INT J EDUC RES, V88, P48, DOI 10.1016/j.ijer.2018.01.003; Rudd JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140224; Rudgard O, 2018, SCH SCRAP PE TIME EX; Rumsby B, 2015, ALARMING FALL SCH PE, DOI [11343801/Alarming-fall-in-school-PE-lessons-casts-doubt-over-governments-commitment-to-tackling-obesity-crisis.html, DOI 11343801/ALARMING-FALL-IN-SCHOOL-PE-LESSONS-CASTS-DOUBT-OVER-GOVERNMENTS-COMMITMENT-TO-TACKLING-OBESITY-CRISIS.HTML]; Siddique H, NHS PATIENTS WAITING; Sigmundsson H, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017712769; Singh D.K.A., 2015, MALAYS J MED HLTH SC, V11, P63; Soriano CA, 2015, RES DEV DISABIL, V43-44, P11, DOI 10.1016/j.ridd.2015.06.001; Spessato BC, 2013, EARLY CHILD DEV CARE, V183, P916, DOI 10.1080/03004430.2012.689761; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Timmons BW, 2012, APPL PHYSIOL NUTR ME, V37, P773, DOI [10.1139/h2012-070, 10.1139/H2012-070]; Ulrich D.A., 2016, TEST GROSS MOTOR DEV, V3rd ed; Ulrich DA, 2000, TGMD 2 TEST GROSS MO; Utesch T, 2016, PSYCHOL SPORT EXERC, V24, P179, DOI 10.1016/j.psychsport.2016.03.001; van Beurden E, 2002, J SCI MED SPORT, V5, P244, DOI 10.1016/S1440-2440(02)80010-X; Van Niekerk L, 2015, AFRICAN J PHYS HLTH, V21, P1321; Van Waelvelde Hilde, 2008, Pediatr Phys Ther, V20, P30, DOI 10.1097/PEP.0b013e31815ee2b2; Veldman SLC, 2019, EARLY HUM DEV, V132, P39, DOI 10.1016/j.earlhumdev.2019.04.005; WRIGHT B, 1969, EDUC PSYCHOL MEAS, V29, P23, DOI 10.1177/001316446902900102; Wright BD, 1996, STRUCT EQU MODELING, V3, P3, DOI 10.1080/10705519609540026; Wuang YP, 2009, RES DEV DISABIL, V30, P1132, DOI 10.1016/j.ridd.2009.03.003	83	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250002	10.1371/journal.pone.0250002	http://dx.doi.org/10.1371/journal.pone.0250002			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861769	gold, Green Published			2022-12-26	WOS:000641475400013
J	Anand, S; Montez-Rath, ME; Han, JL; Garcia, P; Bozeman, J; Kerschmann, R; Beyer, P; Parsonnet, J; Chertow, GM				Anand, Shuchi; Montez-Rath, Maria E.; Han, Jialin; Garcia, Pablo; Bozeman, Julie; Kerschmann, Russell; Beyer, Paul; Parsonnet, Julie; Chertow, Glenn M.			Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the US	PLOS ONE			English	Article							HEPATITIS-B VACCINE; SERUM-ALBUMIN; PERITONEAL-DIALYSIS; PARATHYROID-HORMONE; HEMODIALYSIS; MORTALITY; PREDICTOR; SURVIVAL; DISEASE; RISK	Patients on dialysis are at high risk for death due to COVID-19, yet a significant proportion do survive as evidenced by presence of SARS-CoV-2 antibodies in 8% of patients in the U.S. in July 2020. It is unclear whether patients with seropositivity represent the subgroup with robust health status, who would be more likely to mount a durable antibody response. Using data from a July 2020 sample of 28,503 patients receiving dialysis, we evaluated the cross-sectional association of SARS-CoV-2 seropositivity with laboratory surrogates of patient health. In separate logistic regression models, we assessed the association of SARS-CoV-2 seropositivity with seven laboratory-based covariates (albumin, creatinine, hemoglobin, sodium, potassium, phosphate, and parathyroid hormone), across the entire range of the laboratory and in comparison to a referent value. Models accounted for age, sex, region, race and ethnicity, and county-level COVID-19 deaths per 100,000. Odds of seropositivity for albumin 3 and 3.5 g/dL were 2.1 (95% CI 1.9-2.3) and 1.3 (1.2-1.4) respectively, compared with 4 g/dL. Odds of seropositivity for serum creatinine 5 and 8 mg/dL were 1.8 (1.6-2.0) and 1.3 (1.2-1.4) respectively, compared with 12.5 mg/dL. Lower values of hemoglobin, sodium, potassium, phosphate, and parathyroid hormone were associated with higher odds of seropositivity. Laboratory values associated with poorer health status and higher risk for mortality were also associated with higher likelihood of SARS-CoV-2 antibodies in patients receiving dialysis.	[Anand, Shuchi; Montez-Rath, Maria E.; Han, Jialin; Garcia, Pablo; Chertow, Glenn M.] Stanford Univ, Dept Med, Div Nephrol, Sch Med, Palo Alto, CA 94304 USA; [Bozeman, Julie; Kerschmann, Russell; Beyer, Paul] Ascend Clin Lab, Redwood City, CA USA; [Parsonnet, Julie] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Sch Med, Palo Alto, CA 94304 USA; [Parsonnet, Julie; Chertow, Glenn M.] Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Anand, S (corresponding author), Stanford Univ, Dept Med, Div Nephrol, Sch Med, Palo Alto, CA 94304 USA.	sanand2@stanford.edu	Han, Jialin/AFQ-6523-2022	Chertow, Glenn/0000-0002-7599-0534; Parsonnet, Julie/0000-0001-7342-5366; han, Jialin/0000-0001-5731-8974; Garcia, Pablo/0000-0002-8482-8192	National Institutes of Diabetes, and Digestive and Kidney Diseases [5K23DK101826]	National Institutes of Diabetes, and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in the form of a career development grant from the National Institutes of Diabetes, and Digestive and Kidney Diseases (Grant No. 5K23DK101826) awarded to SA. Ascend Clinical Laboratories provided support in the form of salaries for authors JK, RK, and PB. The specific roles of these authors are articulated in the `author contributions' section. Ascend Clinical Laboratories supported the remainder plasma testing for SARS-CoV2 antibodies. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abelson R., 2020, NY TIMES; Aburawi EH, 2006, ANN MED, V38, P154, DOI 10.1080/07853890500358343; Alberici F, 2020, KIDNEY INT, V98, P20, DOI 10.1016/j.kint.2020.04.030; Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; Avram MM, 1996, AM J KIDNEY DIS, V28, P924, DOI 10.1016/S0272-6386(96)90396-0; Avram MM, 2001, AM J KIDNEY DIS, V37, pS77, DOI 10.1053/ajkd.2001.20754; Avram MM, 2001, AM J KIDNEY DIS, V38, P1351, DOI 10.1053/ajkd.2001.29254; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Broeders NE, 2011, CLIN J AM SOC NEPHRO, V6, P2573, DOI 10.2215/CJN.04670511; BUTI M, 1992, AM J NEPHROL, V12, P144, DOI 10.1159/000168436; Center for Medicare and Medicaid Services, 2020, PRELIMINARY MEDICARE; Centers for Disease Control and Prevention, 2020, NATIONWIDE COMMERICA; Clarke C, 2020, J AM SOC NEPHROL, V31, P1969, DOI 10.1681/ASN.2020060827; Couchoud C, 2020, KIDNEY INT, V98, P1519, DOI 10.1016/j.kint.2020.07.042; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Edey M, 2010, NEPHROLOGY, V15, P137, DOI 10.1111/j.1440-1797.2009.01268.x; Flythe JE, 2021, AM J KIDNEY DIS, V77, P190, DOI 10.1053/j.ajkd.2020.09.003; Fu Y, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01190-2020; Gauthier J, 2020, BONE MARROW TRANSPL, V55, P675, DOI 10.1038/s41409-019-0679-x; Gelman A., 2007, DATA ANAL USING REGR; Goicoechea M, 2020, KIDNEY INT, V98, P27, DOI 10.1016/j.kint.2020.04.031; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; ISEKI K, 1993, KIDNEY INT, V44, P115, DOI 10.1038/ki.1993.220; Jager KJ, 2020, RESULTS ERA EDTA REG; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kato H, 2020, J INFECT CHEMOTHER, V26, P865, DOI 10.1016/j.jiac.2020.05.005; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Ng JH, 2020, KIDNEY INT, V98, P1530, DOI 10.1016/j.kint.2020.07.030; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Peces R, 1997, AM J KIDNEY DIS, V29, P239, DOI 10.1016/S0272-6386(97)90036-6; Rocco MV, 1996, J AM SOC NEPHROL, V7, P889; Roltgen Katharina, 2020, medRxiv, DOI 10.1101/2020.08.15.20175794; Sanchez E, 2020, MANAGEMENT HEMODIALY; Sosa R, 2021, KIDNEY INT REP, V6, P1110, DOI 10.1016/j.ekir.2021.01.028; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Sun LG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16242-3; Tentori F, 2015, CLIN J AM SOC NEPHRO, V10, P98, DOI 10.2215/CJN.12941213; U.S. Food & Drug Administration, 2020, EUA AUTHORIZED SEROL; Wang Y, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23412; Wi YM, 2014, INT J CLIN PRACT, V68, P222, DOI [10.1111/ijcp.12249, 10.1111/ijcp.12368]; Xia H, 1999, J AM SOC NEPHROL, V10, P1309	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249466	10.1371/journal.pone.0249466	http://dx.doi.org/10.1371/journal.pone.0249466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857168	Green Published, gold			2022-12-26	WOS:000641474900044
J	Deguen, S; Kihal-Talantikite, W; Gilles, M; Danzon, A; Carayol, M; Zmirou-Navier, D				Deguen, Severine; Kihal-Talantikite, Wahida; Gilles, Morgane; Danzon, Arlette; Carayol, Marion; Zmirou-Navier, Denis			Are the effects of air pollution on birth weight modified by infant sex and neighborhood socioeconomic deprivation? A multilevel analysis in Paris (France)	PLOS ONE			English	Article							PRETERM BIRTH; PREGNANCY OUTCOMES; EXPOSURE; ORIGINS; IMPACT	Adverse birth outcomes related to air pollution are well documented; however, few studies have accounted for infant sex. There is also scientific evidence that the neighborhood socioeconomic profile may modify this association even after adjusting for individual socioeconomic characteristics. The objective is to analyze the association between air pollution and birth weight by infant sex and neighborhood socioeconomic index. All birth weights (2008-2011) were geocoded at census block level. Each census block was assigned a socioeconomic deprivation level, as well as daily NO2 and PM10 concentrations. We performed a multilevel model with a multiple statistical test and sensible analysis using the spline function. Our findings suggest the existence of a differential association between air pollution and BW according to both neighborhood socioeconomic level and infant sex. However, due to multiple statistical tests and controlling the false discovery rate (FDR), all significant associations became either not statistically significant or borderline. Our findings reinforce the need for additional studies to investigate the role of the neighborhood socioeconomic which could differentially modify the air pollution effect.	[Deguen, Severine; Gilles, Morgane; Zmirou-Navier, Denis] Sch Publ Hlth EHESP, DSET & GS, Rennes, France; [Deguen, Severine] UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMRS 1136,Dept Social Epidemiol,Inst Pierre Louis, Paris, France; [Kihal-Talantikite, Wahida] Univ Strasbourg, Lab Image Ville Environm, LIVE UMR 7362, CNRS, Strasbourg, France; [Danzon, Arlette; Carayol, Marion] Serv Protect Maternelle & Infantile, Direct Familles & Petite Enfance, Paris, France; [Zmirou-Navier, Denis] Lorraine Univ, Sch Med, Nancy, France; [Zmirou-Navier, Denis] INSERM, Irset Inst Rech Sante Environm & Travail, UMR S 1085, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Franche-Comte; Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm)	Deguen, S (corresponding author), Sch Publ Hlth EHESP, DSET & GS, Rennes, France.; Deguen, S (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMRS 1136,Dept Social Epidemiol,Inst Pierre Louis, Paris, France.	severine.deguen@ehesp.fr		Deguen, severine/0000-0002-9872-3690	Foundation de France [201300040943]	Foundation de France	Foundation de France supported this study: 201300040943.	Arroyo V, 2019, ENVIRON RES, V171, P69, DOI 10.1016/j.envres.2019.01.030; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bell ML, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentayeb M, 2014, ATMOS ENVIRON, V92, P267, DOI 10.1016/j.atmosenv.2014.04.019; Blanchard O, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0416-8; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Deguen S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091895; Deguen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131463; Erickson AC, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0133-0; Ferguson Kelly K, 2017, Curr Epidemiol Rep, V4, P56, DOI 10.1007/s40471-017-0099-7; Genereux M, 2008, J EPIDEMIOL COMMUN H, V62, P695, DOI 10.1136/jech.2007.066167; Ghosh R, 2007, ENVIRON RES, V105, P400, DOI 10.1016/j.envres.2007.03.009; Gray SC, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-4; Ha S, 2014, ENVIRON RES, V134, P198, DOI 10.1016/j.envres.2014.08.002; Hannam K, 2014, SCAND J WORK ENV HEA, V40, P518, DOI 10.5271/sjweh.3423; Lakshmanan A, 2015, ENVIRON RES, V137, P268, DOI 10.1016/j.envres.2014.10.035; Lalloue B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-21; Liu Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6307-7; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; O'Campo P, 2008, AM J EPIDEMIOL, V167, P155, DOI 10.1093/aje/kwm277; Owili PO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071409; Panasevich S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0138-8; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Rhee J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214154; Ritz B, 2008, BASIC CLIN PHARMACOL, V102, P182, DOI 10.1111/j.1742-7843.2007.00161.x; Smith RB, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5299; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; Wahida KT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030319; Wilhelm M, 2003, ENVIRON HEALTH PERSP, V111, P207, DOI 10.1289/ehp.5688; Xu XH, 2011, INT ARCH OCC ENV HEA, V84, P251, DOI 10.1007/s00420-010-0545-z	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0247699	10.1371/journal.pone.0247699	http://dx.doi.org/10.1371/journal.pone.0247699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857144	Green Published, gold			2022-12-26	WOS:000641474900069
J	Pearson, PN; Penny, L				Pearson, Paul N.; Penny, Luke			Coiling directions in the planktonic foraminifer Pulleniatina: A complex eco-evolutionary dynamic spanning millions of years	PLOS ONE			English	Article							SEDIMENT-TRAP; SEASONAL-VARIATIONS; CRYPTIC SPECIATION; INDO-PACIFIC; DIVERSITY	Planktonic foraminifera are heterotrophic sexually reproducing marine protists with an exceptionally complete fossil record that provides unique insights into long-term patterns and processes of evolution. Populations often exhibit strong biases towards either right (dextral) or left (sinistral) shells. Deep-sea sediment cores spanning millions of years reveal that some species show large and often rapid fluctuations in their dominant coiling direction through time. This is useful for biostratigraphic correlation but further work is required to understand the population dynamical processes that drive these fluctuations. Here we address the case of coiling fluctuations in the planktonic foraminifer genus Pulleniatina based on new high-resolution counts from two recently recovered sediment cores from either side of the Indonesian through-flow in the tropical west Pacific and Indian Oceans (International Ocean Discovery Program Sites U1486 and U1483). We use single-specimen stable isotope analyses to show that dextral and sinistral shells from the same sediment samples can show significant differences in both carbon and oxygen isotopes, implying a degree of ecological separation between populations. In one case we detect a significant difference in size between dextral and sinistral specimens. We suggest that major fluctuations in coiling ratio are caused by cryptic populations replacing one another in competitive sweeps, a mode of evolution that is more often associated with asexual organisms than with the classical 'biological species concept'.	[Pearson, Paul N.; Penny, Luke] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, Wales	Cardiff University	Pearson, PN (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, Wales.	pearsonp@cardiff.ac.uk			Natural Environment Research Council [PNP NE/P016375/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PNP NE/P016375/1 Natural Environment Research Council	Aiello IW., P INT OC DISC PROGR, V363, DOI [10.14379/iodp.proc.363.103.2018, DOI 10.14379/IODP.PROC.363.103.2018]; Aiello IW., 2018, PROC INT OCEAN DISCO, V363, DOI [10.14379/iodp.proc.363.104.2018, DOI 10.14379/IODP.PROC.363.104.2018]; Alizon S, 2008, P NATL ACAD SCI USA, V105, P12382, DOI 10.1073/pnas.0805039105; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; ANDERSON OR, 1979, J MAR BIOL ASSOC UK, V59, P791, DOI 10.1017/S002531540004577X; Andre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104641; Andre A, 2013, PALEOBIOLOGY, V39, P21, DOI 10.1666/0094-8373-39.1.21; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; BANDY OL, 1963, SCIENCE, V142, P1290, DOI 10.1126/science.142.3597.1290; BANNER F. T., 1967, MIC ROP ALE ONTOLOGY [NEW YORK], V13, P133, DOI 10.2307/1484667; Barraclough TG., 2019, EVOLUTIONARY BIOL SP; Barraclough TG, 2010, PHILOS T R SOC B, V365, P1801, DOI 10.1098/rstb.2009.0276; Be A. W. H, 1977, Micropaleontology, V23, P369, DOI 10.2307/1485406; BELYEA PR, 1984, J PALEONTOL, V58, P1026; Bolli H.M., 1985, P155; BOLLI HANS, 1950, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V1, P82; Chaisson W.P., 1997, Proceedings of the Ocean Drilling Program Scientific Results, V154, P3; Chiang M., 2018, WEST PAC EARTH SCI, V15, P53; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Dang HW, 2018, MAR MICROPALEONTOL, V145, P28, DOI 10.1016/j.marmicro.2018.11.001; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001189; Darling KF, 1999, PALEOCEANOGRAPHY, V14, P3, DOI 10.1029/1998PA900002; Darling KF, 1996, J FORAMIN RES, V26, P324, DOI 10.2113/gsjfr.26.4.324; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; Davis CV, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb8930; Davison A, 2005, PLOS BIOL, V3, P1559, DOI 10.1371/journal.pbio.0030282; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; ERICSON DB, 1959, SCIENCE, V130, P219, DOI 10.1126/science.130.3369.219; Ericson DB., 1953, DEEP-SEA RES, V2, P153; Ezard THG, 2012, BIOL LETTERS, V8, P139, DOI 10.1098/rsbl.2011.0699; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Fiser C, 2018, MOL ECOL, V27, P613, DOI 10.1111/mec.14486; Fordham BG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204625; Gittenberger E., REPROD CHARACTER DIS; GUTTMAN DS, 1994, GENETICS, V138, P993; HALLOCK P, 1979, MAR MICROPALEONTOL, V4, P33, DOI 10.1016/0377-8398(79)90004-5; HAYS JD, 1969, GEOL SOC AM BULL, V80, P1481, DOI 10.1130/0016-7606(1969)80[1481:PSOTEP]2.0.CO;2; Hemleben C., 2017, PLANKTIC FORAMINIFER; Huber BT, 1997, PALEOBIOLOGY, V23, P33, DOI 10.1017/S0094837300016638; Ishitani Y, 2014, MOL PHYLOGENET EVOL, V78, P215, DOI 10.1016/j.ympev.2014.05.021; Jesson LK, 2002, NATURE, V417, P707, DOI 10.1038/417707a; Jones TR., 1865, PHIL T R SOC LOND, V155, P325; Jonkers L., 2015, BIOGEOSCIENCES, V12, DOI [10.5194/bg-12-2301-2015, DOI 10.5194/BG-12-2301-2015]; Kawahata H, 2002, DEEP-SEA RES PT II, V49, P2783, DOI 10.1016/S0967-0645(02)00058-9; Kennett JP., 1983, NEOGENE PLANKTONIC F; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Latasa M, 2017, LIMNOL OCEANOGR, V62, P665, DOI 10.1002/lno.10452; Levin M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0399; Lin HL, 2007, DEEP-SEA RES PT II, V54, P1634, DOI 10.1016/j.dsr2.2007.05.007; Mayr E, 1942, SYSTEMATICS ORIGIN S; Morard R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225246; Morard R, 2016, SYST BIOL, V65, P925, DOI 10.1093/sysbio/syw031; Motulsky H., 2018, NONMATHEMATICAL GUID, V4th; Norris RD, 2001, PALEOBIOLOGY, V27, P327, DOI 10.1666/0094-8373(2001)027<0327:ETICOT>2.0.CO;2; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0001; Oda M, 2005, J FORAMIN RES, V35, P315, DOI 10.2113/35.4.315; Palmer AR, 2009, CURR BIOL, V19, pR473, DOI 10.1016/j.cub.2009.04.006; PARKER FRANCES L., 1965, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V16, P151; Pearson P., 1998, NATURE, DOI [10.1038/nature28135, DOI 10.1038/NATURE28135]; Pearson P.N., 2012, PALEONTOLOGICAL SOC, V18, P1; Pearson P. N., 1998, UNLOCKING STRATIGRAP, P123; Pearson PN, 2014, PALEOBIOLOGY, V40, P130, DOI 10.1666/13004; Pearson PN, 2009, J FORAMIN RES, V39, P191, DOI 10.2113/gsjfr.39.3.191; Poole CR, 2019, J SYST PALAEONTOL, V17, P1989, DOI 10.1080/14772019.2019.1578831; Poore RZ, 2013, J COASTAL RES, P6, DOI 10.2112/SI63-002.1; Prillo S., 2001, Bulletin of the Geological Society of Greece, V34, P549; Ramsay ATS., 1977, OCEANIC MICROPALAEON, P105, DOI [10.1126/science.198.4320.924, DOI 10.1126/SCIENCE.198.4320.924]; Ravelo AC, 1992, PALEOCEANOGRAPHY, V7, P815, DOI 10.1029/92PA02092; Resig JM, 2001, GEOL SOC SPEC PUBL, V187, P389, DOI 10.1144/GSL.SP.2001.187.01.19; SAITO T, 1976, GEOLOGY, V4, P305, DOI 10.1130/0091-7613(1976)4<305:GSOCDI>2.0.CO;2; SCHIFFELBEIN P, 1984, PALAEOGEOGR PALAEOCL, V48, P197, DOI 10.1016/0031-0182(84)90044-0; Schilthuizen M, 2009, MALACOLOGIA, V51, P379, DOI 10.4002/040.051.0210; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Simpson GG., 1961, PRINCIPLES ANIMAL TA; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Sprintall J, 2014, J GEOPHYS RES-OCEANS, V119, P1161, DOI 10.1002/2013JC009533; Takahashi T, 2008, BIOL LETTERS, V4, P497, DOI 10.1098/rsbl.2008.0244; THOMPSON PR, 1978, NATURE, V276, P29, DOI 10.1038/276029a0; Ujiie Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148847; Ujiie Y, 2012, ECOL EVOL, V2, P1725, DOI 10.1002/ece3.286; Ujiie Y, 2010, MAR MICROPALEONTOL, V77, P145, DOI 10.1016/j.marmicro.2010.09.001; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Winter CJ., 2001, J MICROPALAEONTOL, V27, P327	88	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249113	10.1371/journal.pone.0249113	http://dx.doi.org/10.1371/journal.pone.0249113			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848285	gold, Green Published, Green Accepted			2022-12-26	WOS:000640373500022
J	Born, B; Dietrich, AM; Muller, GJ				Born, Benjamin; Dietrich, Alexander M.; Mueller, Gernot J.			The lockdown effect: A counterfactual for Sweden	PLOS ONE			English	Article							COSTS	While most countries imposed a lockdown in response to the first wave of COVID-19 infections, Sweden did not. To quantify the lockdown effect, we approximate a counterfactual lockdown scenario for Sweden through the outcome in a synthetic control unit. We find, first, that a 9-week lockdown in the first half of 2020 would have reduced infections and deaths by about 75% and 38%, respectively. Second, the lockdown effect starts to materialize with a delay of 3-4 weeks only. Third, the actual adjustment of mobility patterns in Sweden suggests there has been substantial voluntary social restraint, although the adjustment was less strong than under the lockdown scenario. Lastly, we find that a lockdown would not have caused much additional output loss.	[Born, Benjamin] Frankfurt Sch Finance & Management, CEPR, Frankfurt, Germany; [Born, Benjamin] CESifo, Frankfurt, Germany; [Born, Benjamin; Dietrich, Alexander M.] Univ Tubingen, Tubingen, Germany; [Mueller, Gernot J.] Univ Tubingen, CEPR, Tubingen, Germany; [Mueller, Gernot J.] CESifo, Tubingen, Germany	Frankfurt School Finance & Management; Ifo Institut; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ifo Institut	Born, B (corresponding author), Frankfurt Sch Finance & Management, CEPR, Frankfurt, Germany.; Born, B (corresponding author), CESifo, Frankfurt, Germany.; Born, B (corresponding author), Univ Tubingen, Tubingen, Germany.	b.born@fs.de						Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; Abadie A, 2015, AM J POLIT SCI, V59, P495, DOI 10.1111/ajps.12116; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Born B, 2019, ECON J, V129, P2722, DOI 10.1093/ej/uez020; Cho SW, 2020, ECONOMET J, V23, P323, DOI 10.1093/ectj/utaa025; Chudik A., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Dave D, 2020, W26992 NBER; Eichenbaum M. S., 2020, 26882 NBER; Farboodi M., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Feng S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245101; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Forsythe E, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104238; Frey BS, 2020, VOLKSWIRTSCHAFT; Google,, 2020, COVID 19 COMM MOB RE; Graffigna G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238613; Hale T, 2020, WP2020032 BLAV SCH; He SB, 2020, NONLINEAR DYNAM, V101, P1667, DOI 10.1007/s11071-020-05743-y; Hensvik L, 2020, CEPR DISCUSSION PAPE; Juranek S., 2020, EFFECT NONPHAR UNPUB; Juranek S., 2020, COVID EC, V42, P143, DOI [10.1111/kykl.12282, DOI 10.1111/KYKL.12282]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Krueger D., 2020, 20015 PIER; Masters NB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239025; Mitze T, 2020, P NATL ACAD SCI USA, V117, P32293, DOI 10.1073/pnas.2015954117; Radulescu A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77628-4; Testa CC, 2020, HCPDS WORKING PAPER, V19; WHO, 2020, 73 WHO; Yang MJ, 2020, WHAT DRIVES EF UNPUB; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117	30	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249732	10.1371/journal.pone.0249732	http://dx.doi.org/10.1371/journal.pone.0249732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831093	Green Published, gold			2022-12-26	WOS:000639359600092
J	Dejazmach, Z; Alemu, G; Yimer, M; Muluneh, C; Tegegne, B				Dejazmach, Zelalem; Alemu, Getaneh; Yimer, Mulat; Muluneh, Chalachew; Tegegne, Banchamlak			Evaluation of the performance of health extension workers on malaria rapid diagnostic tests and predictor factors in Bahir Dar Zuria district, northwest Ethiopia: A cross-sectional study	PLOS ONE			English	Article							BURKINA-FASO	Background In Ethiopia, anti-malaria treatment is initiated after parasitological confirmation using blood film microscopy at health centers and hospitals, or serological rapid diagnostic tests at health posts. At health posts, the diagnosis is performed by health extension workers using rapid diagnostic tests after little training. However, there is paucity of data about the health extension workers' performance on rapid diagnostic tests. Hence, periodic monitoring of the performances of health extension workers on malaria rapid diagnostic tests and predicted factors plays a pivotal role for the control of malaria. Methods A cross sectional study was conducted in May 2020, among 75 health extension workers working at health posts in Bahir Dar Zuria district, Northwest Ethiopia. Their performance on malaria rapid diagnostic tests was assessed by distributing known positive and negative samples as confirmed by investigators using both rapid diagnostic test and blood film microscopy. Test results from health extension workers were then compared with that of investigators. Procedural errors committed while performing the tests were assessed using observational checklist. Data were analyzed using SPSS software version 20. Results The overall sensitivity and specificity of health extension workers in detecting Plasmodium species were 96.8% and 98.7%, respectively with 97.3% result agreement between the health extension workers and investigators (kappa value = 0.949). The most common procedural errors committed by health extension workers was 'not checking expiry date of the test kits' followed by 'not adhering to the appropriate time of reading results' that 70.7% and 64% of the participants committed these errors, respectively. Total number of procedural errors committed by those who have got in-service training was decreased by 47.3% as compared to those without in-service training. Conclusions Health extension workers had high performance on malaria rapid diagnostic tests. However, in-service training and periodic supervision should be given in order to maximize performance on these tests.	[Dejazmach, Zelalem] Woldia Univ, Coll Hlth Sci, Dept Med Lab Sci, Woldia, Ethiopia; [Alemu, Getaneh; Yimer, Mulat] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia; [Yimer, Mulat; Tegegne, Banchamlak] Amhara Publ Hlth Inst, Med Parasitol, Bahir Dar, Ethiopia; [Muluneh, Chalachew] Bahir Dar Zuria Woreda Hlth Off, Med Parasitol & Vector Control, Bahir Dar, Ethiopia	Bahir Dar University	Dejazmach, Z (corresponding author), Woldia Univ, Coll Hlth Sci, Dept Med Lab Sci, Woldia, Ethiopia.	zelalemdejazmach@gmail.com						Albertini A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-406; Beisel U, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1083-2; BoFED, 2011, REVISED PROJECT DOCU; Boyce MR, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2358-6; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; Donaldson SI, 2002, AM J EVAL, V23, P261, DOI 10.1016/S1098-2140(02)00209-6; Ethiopian Federal Ministry of Health, 2017, MALARIA LAB DIAGNOSI, Vsecond; Ethiopian Federal Ministry of Health, 2012, NATL MALARIA GUIDELI, Vthird; Ethiopian Federal Ministry of Health, 2007, HLTH EXTENSION PROGR; Ethiopian Federal Ministry of Health, 2004, GUIDELINE MALARIA EP, Vsecond; Ethiopian Federal Ministry of Health, 2004, MALARIA DIAGNOSIS TR, V2nd; Gidebo KD, 2015, INDAN J COMMUNITY HE, V27, P66; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Kiemde F, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2468-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luchavez J, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-149; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; PMI, 2019, PRESIDENTS MALARIA I; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Sastry AS, 2018, ESSENTIALS MEDICAL P; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2003, M REPORT WHO REGIONA; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504; World Health Organization, 2015, GUID TREATM MAL, Vthird	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249708	10.1371/journal.pone.0249708	http://dx.doi.org/10.1371/journal.pone.0249708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831059	Green Published, gold			2022-12-26	WOS:000639359600102
J	Gwitira, I; Karumazondo, N; Shekede, MD; Sandy, C; Siziba, N; Chirenda, J				Gwitira, Isaiah; Karumazondo, Norbert; Shekede, Munyaradzi Davis; Sandy, Charles; Siziba, Nicolas; Chirenda, Joconiah			Spatial patterns of pulmonary tuberculosis (TB) cases in Zimbabwe from 2015 to 2018	PLOS ONE			English	Article							FALSE DISCOVERY RATE; MYCOBACTERIUM-TUBERCULOSIS; DISEASE CLUSTERS; MULTIPLE; TRANSMISSION; RISK; HOTSPOTS	Introduction Accurate mapping of spatial heterogeneity in tuberculosis (TB) cases is critical for achieving high impact control as well as guide resource allocation in most developing countries. The main aim of this study was to explore the spatial patterns of TB occurrence at district level in Zimbabwe from 2015 to 2018 using GIS and spatial statistics as a preamble to identifying areas with elevated risk for prioritisation of control and intervention measures. Methods In this study Getis-Ord G(i)* statistics together with SaTscan were used to characterise TB hotspots and clusters in Zimbabwe at district level from 2015 to 2018. GIS software was used to map and visualise the results of cluster analysis. Results Results show that TB occurrence exhibits spatial heterogeneity across the country. The TB hotspots were detected in the central, western and southern part of the country. These areas are characterised by artisanal mining activities as well as high poverty levels. Conclusions and recommendations Results of this study are useful to guide TB control programs and design effective strategies which are important in achieving the United Nations Sustainable Development goals (UNSDGs).	[Gwitira, Isaiah; Karumazondo, Norbert; Shekede, Munyaradzi Davis] Univ Zimbabwe, Fac Sci, Dept Geog Geospatial Sci & Earth Observat, Harare, Zimbabwe; [Sandy, Charles; Siziba, Nicolas] Minist Hlth & Child Care, Natl TB Control Program, Harare, Zimbabwe; [Chirenda, Joconiah] Univ Zimbabwe, Parirenyatwa Hosp, Fac Med & Hlth Sci, Dept Community Med, Harare, Zimbabwe	University of Zimbabwe; University of Zimbabwe	Gwitira, I (corresponding author), Univ Zimbabwe, Fac Sci, Dept Geog Geospatial Sci & Earth Observat, Harare, Zimbabwe.	gwitsakuely@gmail.com	Sandy, Charles/GPO-0717-2022; Shekede, Munyaradzi/AAX-4436-2021	Sandy, Charles/0000-0003-0264-7900; Gwitira, Isaiah/0000-0003-0156-8426				Alene KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226127; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; ANSELIN L, 1992, ANN REGIONAL SCI, V26, P19, DOI 10.1007/BF01581478; Bekara MEA, 2016, TRANSBOUND EMERG DIS, V63, P101, DOI 10.1111/tbed.12224; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Burke SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083387; Burra T, 2002, CAN GEOGR-GEOGR CAN, V46, P160, DOI 10.1111/j.1541-0064.2002.tb00737.x; Chan K.W., 2009, SPATIAL EPIDEMIOLOGI; Chikwaiwa B.K., 2018, AFR J SOC WORK, V8, P93; Chirenda J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231637; Chowdhury AI, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0170-9; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Cromley E.K., 2012, GIS PUBLIC HLTH; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Dangisso MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126369; Davies A.G.R., 2018, BMC INFECT DISEASES, V336, P457; de Castro MC, 2006, GEOGR ANAL, V38, P180; Dietz Noella A, 2011, J Carcinog, V10, P22, DOI 10.4103/1477-3163.85184; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; ESRI, 2011, ARCGIS DESKT REL 10; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Getis A., 1996, SPATIAL ANALYSISMODE; Guo C, 2017, EPIDEMIOL INFECT, V145, P2510, DOI 10.1017/S0950268817001133; Gwitira I, 2019, GEOCARTO INT, V34, P1163, DOI 10.1080/10106049.2018.1478889; Gwitira I, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3513-y; Han J, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0056-6; Harries A.D., 1996, TBHIV CLIN MANUAL; Hassarangsee S, 2015, INT J ENV RES PUB HE, V12, P16005, DOI 10.3390/ijerph121215040; Izumi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138831; Keshavjee S, 2015, LANCET, V386, pE46, DOI 10.1016/S0140-6736(15)00320-7; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Liu Y, 2012, INT J TUBERC LUNG D, V16, P486, DOI 10.5588/ijtld.11.0255; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063447, 10.1371/journal.pone.0076105]; Meehan CJ, 2018, EBIOMEDICINE, V37, P410, DOI 10.1016/j.ebiom.2018.10.013; Metcalfe JZ, 2014, EMERG INFECT DIS, V20, P135, DOI 10.3201/eid2001.130732; MoHCC, 2007, ZIMBABWE NATL TUBERC; MOHCC, 2017, NATONAL TUBERCULOSIS; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nassel AF, 2014, RESUSCITATION, V85, P1667, DOI 10.1016/j.resuscitation.2014.08.029; Noppert Grace, 2015, BMC Res Notes, V8, P575, DOI 10.1186/s13104-015-1568-z; Onozuka D, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-26; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x; Shaweno D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1178-4; Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P524, DOI 10.2105/AJPH.2009.175646; Takarinda KC, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034721; Takarinda KC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-124; Timire C, 2019, INT J INFECT DIS, V87, P119, DOI 10.1016/j.ijid.2019.07.021; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Tiwari N, 2010, ASIAN PAC J TROP MED, V3, P486, DOI 10.1016/S1995-7645(10)60117-4; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; UNDESA, 2015, UN WAT SCARC INT DEC; Unganai LS, 1996, CLIMATE RES, V6, P137, DOI 10.3354/cr006137; Wand H, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-41; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; WARTENBERG D, 1993, STAT MED, V12, P1763, DOI 10.1002/sim.4780121905; Woldeyohannes S.M., 2015, J AIDS CLIN RES, V6, DOI [10.4172/2155-6113.1000452, DOI 10.4172/2155-6113.1000452]; World Bank, 2020, WORLD DEV IND; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Xia J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0650-2; Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083605; Zhou D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8009-1; ZIMSTAT, 2015, ZIMBABWE POPULATION	68	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249523	10.1371/journal.pone.0249523	http://dx.doi.org/10.1371/journal.pone.0249523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831058	gold, Green Published			2022-12-26	WOS:000639359600012
J	Habeck, C; Razlighi, Q; Stern, Y				Habeck, Christian; Razlighi, Qolamreza; Stern, Yaakov			Predictive utility of task-related functional connectivity vs. voxel activation	PLOS ONE			English	Article							ABILITY NEURAL-NETWORKS; ADULT AGE-DIFFERENCES; RESTING-STATE FMRI; REGRESSION; PATTERNS; MRI	Functional connectivity, both in resting state and task performance, has steadily increased its share of neuroimaging research effort in the last 1.5 decades. In the current study, we investigated the predictive utility regarding behavioral performance and task information for 240 participants, aged 20-77, for both voxel activation and functional connectivity in 12 cognitive tasks, belonging to 4 cognitive reference domains (Episodic Memory, Fluid Reasoning, Perceptual Speed, and Vocabulary). We also added a model only comprising brain-structure information not specifically acquired during performance of a cognitive task. We used a simple brain-behavioral prediction technique based on Principal Component Analysis (PCA) and regression and studied the utility of both modalities in quasi out-of-sample predictions, using split-sample simulations (= 5-fold Monte Carlo cross validation) with 1,000 iterations for which a regression model predicting a cognitive outcome was estimated in a training sample, with a subsequent assessment of prediction success in a non-overlapping test sample. The sample assignments were identical for functional connectivity, voxel activation, and brain structure, enabling apples-to-apples comparisons of predictive utility. All 3 models that were investigated included the demographic covariates age, gender, and years of education. A minimal reference model using simple linear regression with just these 3 covariates was included for comparison as well and was evaluated with the same resampling scheme as described above. Results of the comparison between voxel activation and functional connectivity were mixed and showed some dependency on cognitive outcome; however, mean differences in predictive utility between voxel activation and functional connectivity were rather small in terms of within-modality variability or predictive success. More notably, only in the case of Fluid Reasoning did concurrent functional neuroimaging provided compelling about cognitive performance beyond structural brain imaging or the minimal reference model.	[Habeck, Christian; Stern, Yaakov] Columbia Univ, Dept Neurol, Irving Med Ctr, Cognit Neurosci Div, New York, NY 10032 USA; [Habeck, Christian; Stern, Yaakov] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Irving Med Ctr, New York, NY 10032 USA; [Habeck, Christian; Stern, Yaakov] Columbia Univ, GH Sergievsky Ctr, Irving Med Ctr, New York, NY 10032 USA; [Razlighi, Qolamreza] Weill Cornell Med, Dept Radiol, Brain Hlth Imaging Inst, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Cornell University	Habeck, C (corresponding author), Columbia Univ, Dept Neurol, Irving Med Ctr, Cognit Neurosci Div, New York, NY 10032 USA.; Habeck, C (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Irving Med Ctr, New York, NY 10032 USA.; Habeck, C (corresponding author), Columbia Univ, GH Sergievsky Ctr, Irving Med Ctr, New York, NY 10032 USA.	ch629@columbia.edu		Habeck, Christian/0000-0001-9961-7446	NIH/NIA [RF1 AG038465]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH/NIA RF1 AG038465.	Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; DeSalvo MN, 2020, BRAIN CONNECT, V10, P578, DOI 10.1089/brain.2020.0854; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Habeck C, 2016, NEUROIMAGE, V125, P693, DOI 10.1016/j.neuroimage.2015.10.077; Habeck C, 2018, NEUROIMAGE, V172, P51, DOI 10.1016/j.neuroimage.2018.01.031; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Hastie T., 2009, ELEMENTS STAT LEARNI, VXXII, P745; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kopal J, 2020, HUM BRAIN MAPP, V41, P5325, DOI 10.1002/hbm.25195; MOELLER JR, 1987, J CEREBR BLOOD F MET, V7, P649, DOI 10.1038/jcbfm.1987.118; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raven J., 1962, ADV PROGR MATRICES S; Salthouse TA, 1998, DEV PSYCHOL, V34, P851, DOI 10.1037/0012-1649.34.5.851; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; SALTHOUSE TA, 1993, J GERONTOL, V48, pP29, DOI 10.1093/geronj/48.1.P29; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Shen XL, 2017, NAT PROTOC, V12, P506, DOI 10.1038/nprot.2016.178; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smitha KA, 2017, NEURORADIOL J, V30, DOI 10.1177/1971400917697342; Strang G, 2006, LINEAR ALGEBRA APPL, Vviii, P487; Tomasi D, 2019, CEREB CORTEX, V29, P1984, DOI 10.1093/cercor/bhy077; Tomasi D, 2014, CEREB CORTEX, V24, P2619, DOI 10.1093/cercor/bht119; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara VM, 2017, NEUROIMAGE, V145, P365, DOI 10.1016/j.neuroimage.2016.03.038; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Woodcock R.W., 1989, WOODCOCK JOHNSON PSY	33	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249947	10.1371/journal.pone.0249947	http://dx.doi.org/10.1371/journal.pone.0249947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831098	gold, Green Published			2022-12-26	WOS:000639359600098
J	Liu, Y; Guan, L; Tan, Z; Yang, K; Guo, F; Chen, Y; Liu, RL; Zheng, F				Liu, Yao; Guan, Lin; Tan, Zhe; Yang, Kun; Guo, Fang; Chen, Yong; Liu, Renliang; Zheng, Feng			Design of a multifunction novel flexible fault current limiter for AC distribution network	PLOS ONE			English	Article							CONVERTER	Based on the separation voltage type of cascaded H bridge-modular multilevel converters (CHB-MMC) and current predictive model control (CPMC) technology, a novel flexible fault-current limiter (NFFCL) is firstly proposed for restraining the negative impact of the distribution network's disturbance in this paper. When a disturbance occurs, the inner-loop CPMC of the multilevel converters establish the value function to offer the specific current, thus increasing the voltage deviation at both ends of the series capacitor or generating reverse harmonic compensation voltage. In that case, three single-phase MNFFCLs can be regarded as variable voltage sources to eliminate the negative effects of faults or harmonics. Owing to the multi-capacitance series structure, the maximum voltage drops of the single capacitance can be predetermined by the number of capacitors. And with the low voltage drop of single capacitance, the output current of the CHB-MMC can also be controlled within an acceptable range. Through the simulation results, the disturbance's negative impact on the non-fault area can be eliminated almost 100%.	[Liu, Yao; Guan, Lin] South China Univ Technol, Sch Elect Power, Guangzhou, Guangdong, Peoples R China; [Tan, Zhe; Yang, Kun; Chen, Yong; Liu, Renliang] State Grid Corp China, Zhuhai Power Supply Co, Zhuhai, Guangdong, Peoples R China; [Guo, Fang] Foshan Univ, Coll Automat, Foshan, Guangdong, Peoples R China; [Zheng, Feng] Fuzhou Univ, Sch Elect Engn & Automat, Fuzhou, Fujian, Peoples R China	South China University of Technology; State Grid Corporation of China; Foshan University; Fuzhou University	Guo, F (corresponding author), Foshan Univ, Coll Automat, Foshan, Guangdong, Peoples R China.	fsu_guof@163.com						Chen BC, 2017, IEEE T POWER DELIVER, V32, P1049, DOI 10.1109/TPWRD.2016.2601141; Chen L, 2018, IEEE ACCESS, V6, P36699, DOI 10.1109/ACCESS.2018.2847463; Chen L, 2015, INT J ELEC POWER, V69, P160, DOI 10.1016/j.ijepes.2015.01.007; Firouzi M, 2013, INT J ELEC POWER, V46, P49, DOI 10.1016/j.ijepes.2012.09.011; Guillen D, 2020, ELECTR POW SYST RES, V186, DOI 10.1016/j.epsr.2020.106419; [郭谋发 Guo Moufa], 2017, [电工技术学报, Transactions of China Electrotechnical Society], V32, P48; Heidary A, 2015, FRONT INFORM TECH EL, V16, P769, DOI 10.1631/FITEE.1400428; Islam MR, 2020, ENERGIES, V13, DOI 10.3390/en13071696; Kouro S, 2009, IEEE T IND ELECTRON, V56, P1826, DOI 10.1109/TIE.2008.2008349; Li R, 2020, IEEE T POWER DELIVER, V35, P1876, DOI 10.1109/TPWRD.2019.2956265; Qin JC, 2015, IEEE T POWER DELIVER, V30, P385, DOI 10.1109/TPWRD.2014.2351794; Radmanesh H, 2015, IEEE T SMART GRID, V6, P1983, DOI 10.1109/TSG.2015.2398365; Salem M, 2020, IEEE ACCESS, V8, P22386, DOI 10.1109/ACCESS.2020.2969546; Sharma S, 2020, ENERG SOURCE PART A, DOI [10.1080/15567036.2020.1758248, 10.1007/s40974-020-00199-7]; Wang HL, 2018, IEEE T POWER ELECTR, V33, P370, DOI 10.1109/TPEL.2017.2661066; Wang M, 2016, IET RENEW POWER GEN, V10, P824, DOI 10.1049/iet-rpg.2015.0444; Xyngi I, 2009, IEEE T POWER SYST, V24, P1102, DOI 10.1109/TPWRS.2008.2012280; Zheng F, 2019, IEEE ACCESS, V7, P124196, DOI 10.1109/ACCESS.2019.2937845; Zheng F, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2015.2391120; Zhou SZ, 2019, IEEE T POWER ELECTR, V34, P1580, DOI 10.1109/TPEL.2018.2833503	20	0	0	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0245956	10.1371/journal.pone.0245956	http://dx.doi.org/10.1371/journal.pone.0245956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33830996	gold, Green Published			2022-12-26	WOS:000639359600060
J	Ruess, RW; Winton, LM; Adams, GC				Ruess, Roger W.; Winton, Loretta M.; Adams, Gerard C.			Widespread mortality of trembling aspen (Populus tremuloides) throughout interior Alaskan boreal forests resulting from a novel canker disease	PLOS ONE			English	Article							BELOW-GROUND CARBON; SOUTHWESTERN COLORADO; SEVERE DROUGHT; CLIMATE-CHANGE; FIRE; EMBOLISM; VULNERABILITY; DECLINE; PRODUCTIVITY; TEMPERATURE	Over the past several decades, growth declines and mortality of trembling aspen throughout western Canada and the United States have been linked to drought, often interacting with outbreaks of insects and fungal pathogens, resulting in a "sudden aspen decline" throughout much of aspen's range. In 2015, we noticed an aggressive fungal canker causing widespread mortality of aspen throughout interior Alaska and initiated a study to quantify potential drivers for the incidence, virulence, and distribution of the disease. Stand-level infection rates among 88 study sites distributed across 6 Alaska ecoregions ranged from <1 to 69%, with the proportion of trees with canker that were dead averaging 70% across all sites. The disease is most prevalent north of the Alaska Range within the Tanana Kuskokwim ecoregion. Modeling canker probability as a function of ecoregion, stand structure, landscape position, and climate revealed that smaller-diameter trees in older stands with greater aspen basal area have the highest canker incidence and mortality, while younger trees in younger stands appear virtually immune to the disease. Sites with higher summer vapor pressure deficits had significantly higher levels of canker infection and mortality. We believe the combined effects of this novel fungal canker pathogen, drought, and the persistent aspen leaf miner outbreak are triggering feedbacks between carbon starvation and hydraulic failure that are ultimately driving widespread mortality. Warmer early-season temperatures and prolonged late summer drought are leading to larger and more severe wildfires throughout interior Alaska that are favoring a shift from black spruce to forests dominated by Alaska paper birch and aspen. Widespread aspen mortality fostered by this rapidly spreading pathogen has significant implications for successional dynamics, ecosystem function, and feedbacks to disturbance regimes, particularly on sites too dry for Alaska paper birch.	[Ruess, Roger W.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Winton, Loretta M.] USDA, Forest Serv, Forest Hlth Protect, Fairbanks, AK USA; [Adams, Gerard C.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of Agriculture (USDA); United States Forest Service; University of Nebraska System; University of Nebraska Lincoln	Ruess, RW (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	rwruess@alaska.edu		Ruess, Roger/0000-0003-4557-6161	National Science Foundation through the Bonanza Creek Long-Term Ecological Research program (NSFDEB) [1636476]; United States Forest Service, Forest Health Monitoring Program [WC-EM-B-14-1]	National Science Foundation through the Bonanza Creek Long-Term Ecological Research program (NSFDEB); United States Forest Service, Forest Health Monitoring Program	RWR received funding from National Science Foundation through the Bonanza Creek Long-Term Ecological Research program (NSFDEB #1636476). RWR&WMW received funding from the United States Forest Service, Forest Health Monitoring Program (#WC-EM-B-14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agne MC, 2018, FOREST ECOL MANAG, V409, P317, DOI 10.1016/j.foreco.2017.11.004; Alexander HD, 2016, ECOSYSTEMS, V19, P98, DOI 10.1007/s10021-015-9920-7; Anderegg WRL, 2015, NAT GEOSCI, V8, P367, DOI [10.1038/ngeo2400, 10.1038/NGEO2400]; Anderegg WRL, 2014, OECOLOGIA, V175, P11, DOI 10.1007/s00442-013-2875-5; Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P1491, DOI 10.1111/j.1365-2486.2009.01877.x; Barrett K, 2011, ECOL APPL, V21, P2380, DOI 10.1890/10-0896.1; Bieniek PA, 2014, J CLIMATE, V27, P2800, DOI 10.1175/JCLI-D-13-00342.1; Boyd MA, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab215f; Buermann W, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024027; Cahoon SMP, 2018, ECOLOGY, V99, P1284, DOI 10.1002/ecy.2223; Chen L, 2017, GLOBAL CHANGE BIOL, V23, P2887, DOI 10.1111/gcb.13595; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Conway AJ, 2017, FOREST ECOL MANAG, V391, P154, DOI 10.1016/j.foreco.2017.02.018; Crous P, 2020, PERSOONIA MOL PHYLOG, V45; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dudley MM, 2015, FOREST ECOL MANAG, V353, P240, DOI 10.1016/j.foreco.2015.06.002; Ghelardini L, 2017, BIOL INVASIONS, V19, P3183, DOI 10.1007/s10530-017-1487-0; Giardina CP, 2014, NAT CLIM CHANGE, V4, P822, DOI [10.1038/nclimate2322, 10.1038/NCLIMATE2322]; Gleason SM, 2016, NEW PHYTOL, V209, P123, DOI 10.1111/nph.13646; Hajek P, 2014, TREE PHYSIOL, V34, P744, DOI 10.1093/treephys/tpu048; He YA, 2019, REMOTE SENS ENVIRON, V231, DOI 10.1016/j.rse.2019.111238; Hennon PE, 2020, FOREST PATHOL, V50, DOI 10.1111/efp.12649; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Imanyfar S, 2019, INT J REMOTE SENS, V40, P8705, DOI 10.1080/01431161.2019.1620375; Jansen S, 2009, AM J BOT, V96, P409, DOI 10.3732/ajb.0800248; Johnstone JF, 2016, FRONT ECOL ENVIRON, V14, P369, DOI 10.1002/fee.1311; Johnstone JF, 2010, CAN J FOREST RES, V40, P1302, DOI 10.1139/X10-061; Johnstone JF, 2010, GLOBAL CHANGE BIOL, V16, P1281, DOI 10.1111/j.1365-2486.2009.02051.x; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kaczynski KM, 2014, BOTANY, V92, P485, DOI 10.1139/cjb-2014-0019; Kautz M, 2018, GLOBAL CHANGE BIOL, V24, P2079, DOI 10.1111/gcb.13974; Kelly R, 2013, P NATL ACAD SCI USA, V110, P13055, DOI 10.1073/pnas.1305069110; Landhausser SM, 2012, TREES-STRUCT FUNCT, V26, P653, DOI 10.1007/s00468-011-0633-z; Lens F, 2013, CURR OPIN PLANT BIOL, V16, P287, DOI 10.1016/j.pbi.2013.02.005; Li P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46635-5; Lian X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax0255; Lindroth RL, 2013, FOREST ECOL MANAG, V299, P14, DOI 10.1016/j.foreco.2012.11.018; Litton CM, 2008, FUNCT ECOL, V22, P941, DOI 10.1111/j.1365-2435.2008.01479.x; Love DM, 2018, TREE PHYSIOL, V38, P1006, DOI 10.1093/treephys/tpy007; MADAR Z, 1990, PHYSIOL MOL PLANT P, V37, P389, DOI 10.1016/0885-5765(90)90121-D; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Malone T, 2009, PNWGTR785 DEP AGR; Mann DH, 2012, ARCT ANTARCT ALP RES, V44, P319, DOI 10.1657/1938-4246-44.3.319; Marchetti SB, 2011, CAN J FOREST RES, V41, P2315, DOI [10.1139/X11-106, 10.1139/x11-106]; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Melvin AM, 2015, ECOSYSTEMS, V18, P1472, DOI 10.1007/s10021-015-9912-7; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Najar A, 2014, J CHEM ECOL, V40, P21, DOI 10.1007/s10886-013-0374-0; Nicklen EF, 2019, GLOBAL CHANGE BIOL, V25, P911, DOI 10.1111/gcb.14511; Olnes J, 2019, CAN J FOREST RES, V49, P1392, DOI 10.1139/cjfr-2019-0150; Ostry ME, 2009, FOREST ECOL MANAG, V257, P390, DOI 10.1016/j.foreco.2008.09.053; OSTRY ME, 1995, CAN J FOREST RES, V25, P813, DOI 10.1139/x95-088; Panzavolta T, 2018, GLOB ECOL CONSERV, V15, DOI 10.1016/j.gecco.2018.e00437; Pastick NJ, 2017, ECOL APPL, V27, P1383, DOI 10.1002/eap.1538; Rogers BM, 2018, GLOBAL CHANGE BIOL, V24, P2284, DOI 10.1111/gcb.14107; Seidl R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04096-w; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Sinclair W.A., 2005, DIS TREES SHRUBS; Singer JA, 2019, FORESTS, V10, DOI 10.3390/f10080671; SPERRY JS, 1994, ECOLOGY, V75, P1736, DOI 10.2307/1939633; SPERRY JS, 1991, J EXP BOT, V42, P1399, DOI 10.1093/jxb/42.11.1399; Tai X, 2017, NEW PHYTOL, V213, P113, DOI 10.1111/nph.14098; Thoman R., 2019, ALASKAS CHANGING ENV; Trugman AT, 2018, GLOBAL CHANGE BIOL, V24, P1097, DOI 10.1111/gcb.13952; Vaughn NR, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040502; VIERECK LA, 1983, CAN J FOREST RES, V13, P703, DOI 10.1139/x83-101; Wagner D, 2008, OECOLOGIA, V157, P259, DOI 10.1007/s00442-008-1067-1; Wagner D, 2020, TREE PHYSIOL, V40, P580, DOI 10.1093/treephys/tpz109; Wagner D, 2013, CAN J FOREST RES, V43, P563, DOI 10.1139/cjfr-2012-0486; Wang JZ, 2019, SCIENCE, V364, P44, DOI 10.1126/science.aav5870; Winton L, CANADIAN J FOREST PA; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; Worrall JJ, 2015, CAN J FOREST RES, V45, P1768, DOI 10.1139/cjfr-2015-0225; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Wyka SA, 2018, FOREST ECOL MANAG, V423, P18, DOI 10.1016/j.foreco.2018.03.011; Wylie B., 2016, SOIL CARBON PERMAFRO; Young B, 2010, J CHEM ECOL, V36, P369, DOI 10.1007/s10886-010-9763-9; Young B, 2010, AM J BOT, V97, P601, DOI 10.3732/ajb.0900281	81	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0250078	10.1371/journal.pone.0250078	http://dx.doi.org/10.1371/journal.pone.0250078			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831122	gold, Green Published			2022-12-26	WOS:000639359600035
J	Stuurman, AL; Rizzo, C; Haag, M				Stuurman, Anke L.; Rizzo, Caterina; Haag, Mendel			Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe	PLOS ONE			English	Article								Background Timely knowledge of which influenza vaccine brands are procured and where is of interest to inform site-selection for brand-specific influenza vaccine effectiveness (VE) studies. Vaccine procurement is a key determinant of brand availability. We therefore sought to understand how the procurement for seasonal influenza vaccine in Europe is organized, how this drives brand availability and how procurement data could enable to determine brand availability pre-season. Methods Structured telephone interviews were conducted with 15 experts in 16 European countries between 2017 and 2019 to collect information on the influenza vaccine procurement systems. Sources of (brand-specific) procurement data were identified and assessed on public accessibility. Vaccine type and brand availability and timelines were determined for the 2019-20 season to understand how procurement systems drive brand availability and diversity. Results Four main types of procurement systems for seasonal influenza vaccination campaigns were identified: national public tenders (Croatia, Denmark, Finland, Ireland, Lithuania, Netherlands, Norway, Scotland, Slovenia), regional public tenders (Italy, Spain, Sweden), direct purchase of vaccines by GPs (England, Wales) or pharmacies (Belgium, France, Germany, Greece) from manufacturers or wholesalers. National public tender outcomes are publicly available and timely; brand availability at clinic level can generally be deduced or narrowed down to two brands. Regional tender outcomes are more difficult to find, known very late or not available. In Italian and Spanish regions tenders may be awarded only a few weeks before the seasonal campaign. No public procurement information is available for countries with direct purchase. Conclusion At the country-level, brand diversity is generally lower for countries with national public tenders than for countries with regional public tenders or direct purchase. In only a few countries, procurement data at the brand level is both publicly available and timely. Therefore the usefulness of procurement data for prospective site-selection for brand-specific VE studies is limited.	[Stuurman, Anke L.] P95 Epidemiol & Pharmacovigilance, Leuven, Belgium; [Rizzo, Caterina] Bambino Gesu Pediat Hosp, ECDC Natl Focal Point Influenza & Other Resp Viru, Rome, Italy; [Haag, Mendel] Seqirus, Amsterdam, Netherlands	IRCCS Bambino Gesu	Stuurman, AL (corresponding author), P95 Epidemiol & Pharmacovigilance, Leuven, Belgium.	anke.stuurman@p-95.com	Rizzo, Caterina/H-4092-2012	Rizzo, Caterina/0000-0002-5583-7508; Stuurman, Anke/0000-0002-4157-1315	EU/EFPIA IMI-2 Joint Undertaking (DRIVE) [777363]	EU/EFPIA IMI-2 Joint Undertaking (DRIVE)	EU/EFPIA IMI-2 Joint Undertaking (DRIVE, grant n degrees 777363). The funder provided support in the form of salaries for authors AS, CR, MH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Committee for Medicinal Products for Human Use, 2016, EMACHMPBWP3108342012; CVP, SUT 2019; Diario Farma, SANIDAD ADJUDICA ACU; DRIVE consortium, DRIVE DEV ROB INN VA; EUR-LEX Access to European Union Law, 52011XC011404 EUR LE; European Commission, AUTH PROC CENTR PROC; EUROSTAT, POP 1 JAN AG SEX 201; Generalitat Valenciana, 2019, CAMP VAC GRIP EST 20; Generalitatde Catalunya, 2018, GUIA TECN CAMP VAC A; House of Commons Science and Technology Committee for Medicinal Products for Human Use, FLU VACC PROGR ENGL; Iacobucci G, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5350; Mes Vaccins, LANCEMENT CAMPAGNE 2; Ministerio de Sanidad CyBS, MIN SAN CONS BIEN SO; Ministero della Salute (Direzione Generale della Prevenzione Sanitaria), PREV CONTR INFL RACC; Muller C, 1 GRIPPEIMPFSTOFFE K; NHS and PHE and Dept of Health & Social Care, NATL FLU IMM PROGR 2; NHS Business Authority, ADV SERV FLU REP; NHS Business Authority, PRESCRIPTION COST AN; NHS Wales, COMM PHARM SEAS INFL; Office for National Statistics, POPULATION ESTIMATES; Oglasnik, EL OGL JAVN NAB RH; Palache A, 2017, VACCINE, V35, P4681, DOI 10.1016/j.vaccine.2017.07.053; Scotland PC, SEARCH NOTICES; Vax Info, GRIEP ADV HOG GEZ WI; Welsh Government, 2019, 2019015 WHC WELSH GO; Wilsdon T, 2020, EXPERT REV VACCINES, V19, P123, DOI 10.1080/14760584.2020.1717952	26	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0248943	10.1371/journal.pone.0248943	http://dx.doi.org/10.1371/journal.pone.0248943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831021	gold, Green Published			2022-12-26	WOS:000639359600052
J	Wen, Z; Nair, P; Deng, CY; Lu, XH; Moseley, E; George, N; Lindvall, C; Li, Y				Wen, Zhi; Nair, Pratheeksha; Deng, Chih-Ying; Lu, Xing Han; Moseley, Edward; George, Naomi; Lindvall, Charlotta; Li, Yue			Mining heterogeneous clinical notes by multi-modal latent topic model	PLOS ONE			English	Article							SYSTEMS	Latent knowledge can be extracted from the electronic notes that are recorded during patient encounters with the health system. Using these clinical notes to decipher a patient's underlying comorbidites, symptom burdens, and treatment courses is an ongoing challenge. Latent topic model as an efficient Bayesian method can be used to model each patient's clinical notes as "documents" and the words in the notes as "tokens". However, standard latent topic models assume that all of the notes follow the same topic distribution, regardless of the type of note or the domain expertise of the author (such as doctors or nurses). We propose a novel application of latent topic modeling, using multi-note topic model (MNTM) to jointly infer distinct topic distributions of notes of different types. We applied our model to clinical notes from the MIMIC-III dataset to infer distinct topic distributions over the physician and nursing note types. Based on manual assessments made by clinicians, we observed a significant improvement in topic interpretability using MNTM modeling over the baseline single-note topic models that ignore the note types. Moreover, our MNTM model led to a significantly higher prediction accuracy for prolonged mechanical ventilation and mortality using only the first 48 hours of patient data. By correlating the patients' topic mixture with hospital mortality and prolonged mechanical ventilation, we identified several diagnostic topics that are associated with poor outcomes. Because of its elegant and intuitive formation, we envision a broad application of our approach in mining multi-modality text-based healthcare information that goes beyond clinical notes. Code available at https://github.com/li-labmcgill/heterogeneous_ehr.	[Wen, Zhi; Nair, Pratheeksha; Lu, Xing Han; Li, Yue] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Wen, Zhi; Nair, Pratheeksha; Lu, Xing Han; Li, Yue] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Deng, Chih-Ying; Moseley, Edward; Lindvall, Charlotta] Dana Farber Canc Inst, Boston, MA 02115 USA; [George, Naomi] Brigham & Womens Faulkner Hosp, Boston, MA USA	McGill University; McGill University; Harvard University; Dana-Farber Cancer Institute	Li, Y (corresponding author), McGill Univ, Sch Comp Sci, Montreal, PQ, Canada.; Li, Y (corresponding author), McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada.; Lindvall, C (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	charlotta_lindvall@dfci.harvard.edu; yueli@cs.mcgill.ca		Li, Yue/0000-0003-3844-4865	Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2019-0621]; Fonds de recherche Nature et technologies (FRQNT) [NC-268592]; Microsoft Research	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche Nature et technologies (FRQNT); Microsoft Research(Microsoft)	YL is supported by Natural Sciences and Engineering Research Council (NSERC) Discovery Grant (RGPIN-2019-0621), Fonds de recherche Nature et technologies (FRQNT) New Career (NC-268592), and Microsoft Research. b) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. c) No author receives salary from any of the above funders.	Alsentzer E, 2019, ABS190403323 CORR; Asuncion A., 2009, P 25 C UNCERTAINTY A, P27, DOI DOI 10.1080/10807030390248483; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Chen Y, 2015, J BIOMED INFORM, V55, P82, DOI 10.1016/j.jbi.2015.03.011; Dieng AB, 2016, ABS161101702 CORR; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Huang K., 2019, CHIL WORKSH; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Li Y, 2018, LATENT TOPIC MODEL M; Li Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16378-3; Mcauliffe J. D., 2008, ADV NEURAL INFORM PR, P121; Minka TP, 2000, ESTIMATING DIRICHLET; Pappalardo F, 2004, EUR J CARDIO-THORAC, V25, P548, DOI 10.1016/j.ejcts.2003.11.034; Pivovarov R, 2015, J BIOMED INFORM, V58, P156, DOI 10.1016/j.jbi.2015.10.001; Teh YW, 2006, P 19 INT C NEUR INF; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Xiao C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195024	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249622	10.1371/journal.pone.0249622	http://dx.doi.org/10.1371/journal.pone.0249622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831055	Green Published, gold			2022-12-26	WOS:000639359600042
J	Cheng, CL; Wong, MK; Li, YJ; Hochstrasser, M				Cheng, Chin Leng; Wong, Michael K.; Li, Yanjie; Hochstrasser, Mark			Conserved proline residues in the coiled coil-OB domain linkers of Rpt proteins facilitate eukaryotic proteasome base assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS PEPTIDE-BONDS; REGULATORY PARTICLE; STRUCTURAL INSIGHTS; 20S PROTEASOME; 26S PROTEASOME; PATHWAY; SUBSTRATE; TRANSLOCATION; BINDING; SEM1	The proteasome is a large protease complex that degrades many different cellular proteins. In eukaryotes, the 26S proteasome contains six different subunits of the ATPases associated with diverse cellular activities family, Rpt1-Rpt6, which form a hexameric ring as part of the base subcomplex that drives unfolding and translocation of substrates into the proteasome core. Archaeal proteasomes contain only a single Rpt-like ATPases associated with diverse cellular activities ATPase, the proteasome-activating nucleotidase, which forms a trimer of dimers. A key proteasome-activating nucleotidase proline residue (P91) forms cis- and trans-peptide bonds in successive subunits around the ring, allowing efficient dimerization through upstream coiled coils. However, the importance of the equivalent Rpt prolines for eukaryotic proteasome assembly was unknown. Here we showed that the equivalent proline is highly conserved in Rpt2, Rpt3, and Rpt5, and loosely conserved in Rpt1, in deeply divergent eukaryotes. Although in no case was a single Pro-to-Ala substitution in budding yeast strongly deleterious to growth, the rpt5-P76A mutation decreased levels of the protein and induced a mild proteasome assembly defect. Moreover, the rpt2-P103A, rpt3-P93A, andrpt5-P76Amutations all caused synthetic defects when combined with deletions of specific proteasome base assembly chaperones. The rpt2-P103A rpt5-P76A double mutant had uniquely strong growth defects attributable to defects in proteasome base formation. Several Rpt subunits in this mutant formed aggregates thatwere cleared, at least in part, byHsp42 chaperone-mediated protein quality control. We propose that the conserved Rpt linker prolines promote efficient 26S proteasome base assembly by facilitating specific ATPase heterodimerization.	[Cheng, Chin Leng; Wong, Michael K.; Li, Yanjie; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hochstrasser, Mark] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Wong, Michael/0000-0002-0645-9061; Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [GM083050, GM136325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants (GM083050 and GM136325) to M. H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2004, FRONT BIOSCI, V9, p2420 2446; [Anonymous], 2018, ANNU REV BIOCHEM, V82, P415; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Fu XY, 2018, P NATL ACAD SCI USA, V115, P13246, DOI 10.1073/pnas.1805353115; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; Guthrie, 2002, METHOD ENZYMOL, V194, P933; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; Hurt E, 2009, J CELL BIOL, V184, p833 S46; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Li Y., 2015, CURR PROTOC CELL BIO, V67; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Panasenko OO, 2019, NAT STRUCT MOL BIOL, V26, P110, DOI 10.1038/s41594-018-0179-5; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Peters LZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005178; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Satoh T, 2014, STRUCTURE, V22, P731, DOI 10.1016/j.str.2014.02.014; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Tomko RJ, 2014, MOL CELL, V53, P433, DOI 10.1016/j.molcel.2013.12.009; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Velichutina I, 2004, EMBO J, V23, P500, DOI 10.1038/sj.emboj.7600059; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Wehmer M, 2017, P NATL ACAD SCI USA, V114, P1305, DOI 10.1073/pnas.1621129114; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	45	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100660	10.1016/j.jbc.2021.100660	http://dx.doi.org/10.1016/j.jbc.2021.100660			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862083	gold, Green Published			2022-12-26	WOS:000672866400631
J	Tohda, R; Tanaka, H; Mutoh, R; Zhang, XH; Lee, YH; Konuma, T; Ikegami, T; Migita, CT; Kurisu, G				Tohda, Rei; Tanaka, Hideaki; Mutoh, Risa; Zhang, Xuhong; Lee, Young-Ho; Konuma, Tsuyoshi; Ikegami, Takahisa; Migita, Catharina T.; Kurisu, Genji			Crystal structure of higher plant heme oxygenase-1 and its mechanism of interaction with ferredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; SYNECHOCYSTIS SP PCC-6803; ELECTRON-TRANSFER COMPLEX; GRAM-NEGATIVE BACTERIA; RAT HEME; GENE; EXPRESSION; PRODUCT; BINDING; MUTANT	Heme oxygenase (HO) converts heme to carbon monoxide, biliverdin, and free iron, products that are essential in cellular redox signaling and iron recycling. In higher plants, HO is also involved in the biosynthesis of photoreceptor pigment precursors. Despite many common enzymatic reactions, the amino acid sequence identity between plant-type and other HOs is exceptionally low (similar to 19.5%), and amino acids that are catalytically important in mammalian HO are not conserved in plant-type HOs. Structural characterization of plant-type HO is limited to spectroscopic characterization by electron spin resonance, and it remains unclear how the structure of plant-type HO differs from that of other HOs. Here, we have solved the crystal structure of Glycine max (soybean) HO-1 (GmHO-1) at a resolution of 1.06 angstrom and carried out the isothermal titration calorimetry measurements and NMR spectroscopic studies of its interaction with ferredoxin, the plant-specific electron donor. The high-resolution X-ray structure of GmHO-1 reveals several novel structural components: an additional irregularly structured region, a new water tunnel from the active site to the surface, and a hydrogenbonding network unique to plant-type HOs. Structurally important features in other HOs, such as His ligation to the bound heme, are conserved in GmHO-1. Based on combined data from X-ray crystallography, isothermal titration calorimetry, and NMR measurements, we propose the evolutionary fine-tuning of plant-type HOs for ferredoxin dependency in order to allow adaptation to dynamic pH changes on the stroma side of the thylakoid membrane in chloroplast without losing enzymatic activity under conditions of fluctuating light.	[Tohda, Rei; Tanaka, Hideaki; Mutoh, Risa; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka, Japan; [Tohda, Rei; Tanaka, Hideaki; Kurisu, Genji] Osaka Univ, Dept Macromol Sci, Toyonaka, Osaka, Japan; [Zhang, Xuhong] Yamagata Univ, Grad Sch Med Sci, Yamagata, Yamagata, Japan; [Lee, Young-Ho] Korea Basic Sci Inst, Res Ctr Bioconvergence Anal, Cheongju, Chungbuk, South Korea; [Lee, Young-Ho] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon, South Korea; [Lee, Young-Ho] Korea Brain Res Inst, Res Headquarters, Daegu, South Korea; [Lee, Young-Ho] Univ Sci & Technol, Bioanalyt Sci, Daejeon, South Korea; [Konuma, Tsuyoshi; Ikegami, Takahisa] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Migita, Catharina T.] Yamaguchi Univ, Dept Biol Chem, Yoshida, Yamaguchi, Japan; [Mutoh, Risa] Fukuoka Univ, Fac Sci, Jonan, Fukuoka 8140180, Japan	Osaka University; Osaka University; Yamagata University; Korea Basic Science Institute (KBSI); Chungnam National University; Korea Brain Research Institute (KBRI); University of Science & Technology (UST); Yokohama City University; Yamaguchi University; Fukuoka University	Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka, Japan.; Kurisu, G (corresponding author), Osaka Univ, Dept Macromol Sci, Toyonaka, Osaka, Japan.	gkurisu@protein.osaka-u.ac.jp	KURISU, GENJI/ABA-5960-2020; KURISU, GENJI/AAD-7109-2022; Tanaka, Hideaki/AGY-8426-2022; Ikegami, Takahisa/I-9626-2017	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Ikegami, Takahisa/0000-0002-1429-1844; Konuma, Tsuyoshi/0000-0002-4412-2849; TOHDA, REI/0000-0001-5644-1399	National Research Foundation of Korea - Korean government [16H06560];  [2018K1A3A1A39088040];  [2019R1A2C1004954]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); ; 	This work was supported by a Grant-in-Aid for Scientific Research (16H06560 to G. K.), National Research Foundation of Korea grants funded by the Korean government (2018K1A3A1A39088040 and 2019R1A2C1004954 to Y.-H. L.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balestrasse KB, 2008, BIOMETALS, V21, P433, DOI 10.1007/s10534-008-9132-0; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; BEALE SI, 1984, ARCH BIOCHEM BIOPHYS, V235, P371, DOI 10.1016/0003-9861(84)90210-8; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Brewitz HH, 2017, BBA-GEN SUBJECTS, V1861, P683, DOI 10.1016/j.bbagen.2016.12.021; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; De Montellano PRO, 1998, ACCOUNTS CHEM RES, V31, P543; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Gohya T, 2008, BIOCHEM BIOPH RES CO, V376, P293, DOI 10.1016/j.bbrc.2008.08.141; Gohya T, 2006, FEBS J, V273, P5384, DOI 10.1111/j.1742-4658.2006.05531.x; Harada E, 2015, BIOCHEMISTRY-US, V54, P340, DOI 10.1021/bi5009694; HASE T, 1991, PLANT PHYSIOL, V97, P1395, DOI 10.1104/pp.97.4.1395; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JY, 2016, J BIOCHEM, V160, P101, DOI 10.1093/jb/mvw016; Kinoshita M, 2017, BIOCHEM BIOPH RES CO, V482, P909, DOI 10.1016/j.bbrc.2016.11.132; Kobayashi N, 2012, J BIOMOL NMR, V53, P311, DOI 10.1007/s10858-012-9641-6; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Lad L, 2003, J MOL BIOL, V330, P527, DOI 10.1016/S0022-2836(03)00578-3; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Linley PJ, 2006, FEBS J, V273, P2594, DOI 10.1111/j.1742-4658.2006.05264.x; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Noriega GO, 2004, BIOCHEM BIOPH RES CO, V323, P1003, DOI 10.1016/j.bbrc.2004.08.199; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozen M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00084; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RHIE GE, 1992, J BIOL CHEM, V267, P16088; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; Schuller JM, 2019, SCIENCE, V363, P257, DOI 10.1126/science.aau3613; Shekhawat GS, 2010, J EXP BOT, V61, P2255, DOI 10.1093/jxb/erq074; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shinohara F, 2017, PHOTOSYNTH RES, V134, P281, DOI 10.1007/s11120-016-0331-1; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Sugishima M, 2005, BIOCHEMISTRY-US, V44, P4257, DOI 10.1021/bi0480483; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Sugishima M, 2003, BIOCHEMISTRY-US, V42, P9898, DOI 10.1021/bi027268i; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Sugishima M, 2019, FEBS LETT, V593, P868, DOI 10.1002/1873-3468.13360; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; TROXLER RF, 1979, J BIOL CHEM, V254, P3411; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Wang JL, 2005, J BIOL CHEM, V280, P2797, DOI 10.1074/jbc.M411229200; YOSHIDA T, 1979, J BIOL CHEM, V254, P4487; Zhou H, 2000, J AM CHEM SOC, V122, P8311, DOI 10.1021/ja0002868; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	66	4	4	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100217	10.1074/jbc.RA120.016271	http://dx.doi.org/10.1074/jbc.RA120.016271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839679	gold, Green Published			2022-12-26	WOS:000672866400195
J	Sakunrangsit, N; Metheepakornchai, P; Kumpunya, S; Greenblatt, MB; Leelahavanichkul, A; Pisitkun, P; Lotinun, S				Sakunrangsit, Nithidol; Metheepakornchai, Piyanuch; Kumpunya, Sarinya; Greenblatt, Matthew Blake; Leelahavanichkul, Asada; Pisitkun, Prapaporn; Lotinun, Sutada			Etanercept prevents TNF-alpha mediated mandibular bone loss in Fc gamma RIIb(-/-) lupus model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FC-GAMMA RECEPTORS; ERYTHEMATOSUS; MICE; DISEASE; PERIODONTITIS; OSTEOPOROSIS; ARTHRITIS; THERAPY; SALIVA	Patients with systemic lupus erythematosus are at increased risk for alveolar bone loss due to periodontitis possibly as a result of a pathogenic immune response to oral bacteria and inflammation. The aim of the present study was to investigate whether an anti-TNF-alpha antagonist could prevent mandibular bone loss in the Fc gamma RIIb(-/-) mouse model of lupus. Mice lacking Fc gamma RIIb had decreased cancellous and cortical bone volume at 6 months of age. Etanercept increased cancellous but not cortical bone volume in WT and increased both cancellous bone volume and cortical thickness in Fc gamma RIIb-deficient mice. Fc gamma RIIb deficiency decreased mRNA levels for osteoblast marker genes, Osx, Col1a1 and Alp without any change in osteoclast marker genes. Etanercept increased Osx, Alp, and Ocn in both WT and Fc gamma RIIb(-/-) mice. Osteoclast marker genes including TNF-alpha, Trap and RANKL/OPG ratio was decreased in WT. Serum markers of proinflammatory cytokines, TNF-alpha, IFN gamma, IL-6, and IL-17A, were increased in Fc gamma RIIb(-/-) mice and etanercept antagonized these effects in Fc gamma RIIb(-/-) mice. Etanercept increased serum PTH levels in the Fc gamma RIIb(-/-) mouse model of lupus. Our results suggest that deletion of Fc gamma RIIb induces osteopenia by increasing the level of proinflammatory cytokines. Etanercept is effective in preventing mandibular bone loss in Fc gamma RIIb(-/-) mice, suggesting that anti-TNF-alpha therapy may be able to ameliorate mandibular bone loss in SLE patients with periodontitis.	[Sakunrangsit, Nithidol; Metheepakornchai, Piyanuch; Lotinun, Sutada] Chulalongkorn Univ, Fac Dent, Dept Physiol, Skeletal Disorders Res Unit, Bangkok, Thailand; [Kumpunya, Sarinya] Chulalongkorn Univ, Grad Sch, Interdisciplinary Program Biomed Sci, Bangkok, Thailand; [Greenblatt, Matthew Blake] Hosp Special Surg, Dept Pathol & Lab Med, Weill Cornell Med, Res Div, 535 E 70th St, New York, NY 10021 USA; [Leelahavanichkul, Asada] Chulalongkorn Univ, Fac Med, Dept Microbiol, Div Immunol, Bangkok, Thailand; [Pisitkun, Prapaporn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Allergy Immunol & Rheumatol,Dept Med, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Cornell University; Chulalongkorn University; Mahidol University	Lotinun, S (corresponding author), Chulalongkorn Univ, Fac Dent, Dept Physiol, Skeletal Disorders Res Unit, Bangkok, Thailand.	sutada.l@chula.ac.th	Sakunrangsit, Nithidol/Y-1852-2019		Second Century Fund (C2F); Ratchadapisek Sompoch Endowment Fund (2014) [CU-57-091-IC]; Faculty Research Grant, Faculty of Dentistry, Chulalongkorn University [DRF 64009]; Thailand Research Fund [RSA6280023]	Second Century Fund (C2F); Ratchadapisek Sompoch Endowment Fund (2014); Faculty Research Grant, Faculty of Dentistry, Chulalongkorn University; Thailand Research Fund(Thailand Research Fund (TRF))	This research was supported by the Second Century Fund (C2F), the Ratchadapisek Sompoch Endowment Fund (2014, CU-57-091-IC), and the Faculty Research Grant, Faculty of Dentistry (DRF 64009), Chulalongkorn University, and Thailand Research Fund (RSA6280023) to SL.	Adami G, 2016, CALCIFIED TISSUE INT, V99, P360, DOI 10.1007/s00223-016-0161-3; Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Aringer M, 2020, RHEUMATOLOGY, V59, P4, DOI 10.1093/rheumatology/keaa379; Augustine MV, 2014, J CLIN ENDOCR METAB, V99, pE991, DOI 10.1210/jc.2013-3846; Bagavant H, 2019, CLIN EXP RHEUMATOL, V37, P106; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Duque G, 2011, J BONE MINER RES, V26, P1472, DOI 10.1002/jbmr.350; Edwards CK, 1996, J IMMUNOL, V157, P1758; Fredman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024422; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Gumus P, 2014, J PERIODONTOL, V85, P270, DOI 10.1902/jop.2013.130117; Jacobi AM, 2010, ANN RHEUM DIS, V69, P305, DOI 10.1136/ard.2008.096495; Kobayashi T, 2001, INFECT IMMUN, V69, P2935, DOI 10.1128/IAI.69.5.2935-2942.2001; Kobayashi T, 2007, J PERIODONTOL, V78, P467, DOI 10.1902/jop.2007.060194; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; Ma L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0091-4; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Mendonca SMS, 2019, CLIN EXP RHEUMATOL, V37, P208; Namba T, 2019, EXP BIOL MED, V244, P333, DOI 10.1177/1535370219832810; Nicu EA, 2007, J CLIN PERIODONTOL, V34, P938, DOI 10.1111/j.1600-051X.2007.01136.x; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Pessoa L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02602; Rhodus N L, 1990, Quintessence Int, V21, P461; Saiworn W, 2018, CALCIFIED TISSUE INT, V103, P686, DOI 10.1007/s00223-018-0464-7; Schapira D, 2001, LUPUS, V10, P431, DOI 10.1191/096120301678646182; Sete MRC, 2019, LUPUS, V28, P189, DOI 10.1177/0961203318819134; Umare V, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/385297; Varghese Sheeja S, 2015, Contemp Clin Dent, V6, pS152, DOI 10.4103/0976-237X.166816; Visitchanakun P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53963-z; Vogelpoel LTC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00079; Yoshitaka T, 2014, J BONE MINER RES, V29, P1170, DOI 10.1002/jbmr.2125; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187; Zhu LJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/465898; Zwerina K, 2012, EUR J IMMUNOL, V42, P413, DOI 10.1002/eji.201141871	37	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250215	10.1371/journal.pone.0250215	http://dx.doi.org/10.1371/journal.pone.0250215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861790	Green Published, gold			2022-12-26	WOS:000641475400059
J	Ahmed, HR; Waly, NGFM; Abd El-Baky, RM; Yahia, R; Hetta, HF; Elsayed, AM; Ibrahem, RA				Ahmed, Hala Rady; Waly, Nancy G. F. M.; Abd El-Baky, Rehab Mahmoud; Yahia, Ramadan; Hetta, Helal F.; Elsayed, Amr M.; Ibrahem, Reham Ali			Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C	PLOS ONE			English	Article							POLYMERASE INHIBITOR; VIRUS-INFECTION; CHRONIC HCV; SOFOSBUVIR; PREVALENCE; RIBAVIRIN; EPIDEMIOLOGY; LEDIPASVIR; GENOTYPES; SUBTYPES	Background NS5B polymerase inhibitors represent the cornerstone of the present treatment of Hepatitis C virus infection (HCV). Naturally occurring substitution mutations to NS5B inhibitors have been recorded. The current study intended to demonstrate possible natural direct acting antiviral (DAA)-mutations of the HCV NS5B region in HCV patients in Minia governorate, Egypt. Methods Samples were collected from 27 treatment-naive HCV patients and 8 non-responders. Out of 27 treatment-naive patients, 17 NS5B sequences (amino acids 221-345) from treatment-naive patients and one sample of non-responders were successfully amplified. Nucleotide sequences have been aligned, translated into amino acids, and compared to drug resistance mutations reported in the literature. Results NS5B amino acid sequence analysis ensures several novel NS5B mutations existence (more than 40 substitution mutations) that have not been previously documented to be correlated with a resistant phenotype. It was found that K304R (82.4%), E327D and P300T (76.5% each) substitutions were the most distributed in the tested samples, respectively. S282T, the major resistance mutation that induces high sofosbuvir-resistance level in addition to other reported mutations (L320F/C) and (C316Y/N) were not recognized. Q309R mutation is a ribavirin-associated resistance, which was recognized in one strain (5.9%) of genotype 1g sequences. Besides, one substitution mutation (E237G) was identified in the successfully amplified non-responder sample. Conclusion Our study showed various combinations of mutations in the analyzed NS5B genes which could enhance the possibility of therapy failure in patients administered regimens including multiple DAA.	[Ahmed, Hala Rady; Waly, Nancy G. F. M.; Abd El-Baky, Rehab Mahmoud; Ibrahem, Reham Ali] Minia Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt; [Abd El-Baky, Rehab Mahmoud; Yahia, Ramadan] Deraya Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt; [Hetta, Helal F.] Assiut Univ, Fac Med, Dept Med Microbiol & Immunol, Assiut, Egypt; [Hetta, Helal F.] Merit Univ, Fac Med, Dept Med Microbiol & Immunol, Sohag, Egypt; [Elsayed, Amr M.] Minia Univ, Fac Med, Trop Med & Gastroenterol, Al Minya, Egypt	Egyptian Knowledge Bank (EKB); Minia University; Deraya University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Minia University	Abd El-Baky, RM (corresponding author), Minia Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt.; Abd El-Baky, RM (corresponding author), Deraya Univ, Fac Pharm, Dept Microbiol & Immunol, Al Minya, Egypt.	rehab.mahmoud@mu.edu.eg		Mahmoud Abd El-Baky, Rehab/0000-0001-6094-5653				AASLD-IDSA Hepatitis C Guidance, 2020, HEPATOLOGY, V71, P686, DOI 10.1002/hep.31060; Abd Ellah NH, 2019, NANOMEDICINE-UK, V14, P1471, DOI 10.2217/nnm-2018-0348; Abdel-Aty M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005647; Abdel-Hameed EA, 2016, VIRAL IMMUNOL, V29, P252, DOI 10.1089/vim.2015.0093; Abdel-Hamid M, 2007, J GEN VIROL, V88, P1526, DOI 10.1099/vir.0.82626-0; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Alavian SM, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.guideline; Patino-Galindo JA, 2016, ANTIMICROB AGENTS CH, V60, P2402, DOI 10.1128/AAC.02776-15; Asadpour L., 2019, STUDY NS5B GENE MUTA, V11, P332; Asselah T, 2012, LIVER INT, V32, P88, DOI 10.1111/j.1478-3231.2011.02699.x; Bartolini B, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080212; Castilho MCB, 2011, MEM I OSWALDO CRUZ, V106, P968, DOI 10.1590/S0074-02762011000800011; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Breban R, 2013, J VIRAL HEPATITIS, V20, P294, DOI 10.1111/j.1365-2893.2012.01650.x; Catalli Lisa, 2019, Clin Liver Dis (Hoboken), V13, P74, DOI 10.1002/cld.768; Chen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142543; Daw MA, 2012, SCI WORLD J, DOI 10.1100/2012/719494; Donaldson EF, 2015, HEPATOLOGY, V61, P56, DOI 10.1002/hep.27375; Elsharkawy A, 2017, ALIMENT PHARM THER, V45, P681, DOI 10.1111/apt.13923; Fourati S, 2019, HEPATOLOGY, V69, P513, DOI 10.1002/hep.30225; Franco S, 2013, J CLIN VIROL, V58, P726, DOI 10.1016/j.jcv.2013.09.022; Gane EJ, 2017, HEPATOL COMMUN, V1, P538, DOI 10.1002/hep4.1060; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; GURAKAR A, 1995, HEPATOLOGY, V22, P1109, DOI 10.1016/0270-9139(95)90616-9; Hedskog C, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz076; Heim MH, 2016, J HEPATOL, V65, pS22, DOI 10.1016/j.jhep.2016.07.037; Hetta Helal F, 2017, Egypt J Immunol, V24, P79; Hetta HF, 2016, J MED MICROBIOL, V65, P703, DOI 10.1099/jmm.0.000272; Hetta HF, 2015, J GASTROEN HEPATOL, V30, P1543, DOI 10.1111/jgh.12936; Hetta HF, 2014, WORLD J IMMUNOL, V4, P52, DOI DOI 10.5411/WJI.V4.I2.52; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Ji HZ, 2015, VIROLOGY, V477, P1, DOI 10.1016/j.virol.2014.12.037; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; Kirby BJ, 2015, CLIN PHARMACOKINET, V54, P677, DOI 10.1007/s40262-015-0261-7; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Li ZY, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006830, 10.1097/md.0000000000006830]; Makhlouf NA., 2021, AUTOPHAGY, V11, P1; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Margeridon S, 2011, HEPATOLOGY, V54, p532A; Martinez AP, 2019, J MED VIROL, V91, P1970, DOI 10.1002/jmv.25536; Mehta M, 2016, ARCH VIROL, V161, P3161, DOI 10.1007/s00705-016-3015-4; Mekky MA, 2019, INFECT DRUG RESIST, V12, P273, DOI 10.2147/IDR.S181638; Mekky MA, 2019, CLIN RES HEPATOL GAS, V43, P82, DOI 10.1016/j.clinre.2018.08.003; Na SK, 2019, CLIN MOL HEPATOL, V25, P234, DOI 10.3350/cmh.2018.0108; Nei M., 2000, MOL EVOLUTION PHYLOG; Niya MHK, 2017, MICROB PATHOGENESIS, V105, P166, DOI 10.1016/j.micpath.2017.01.060; Omar H, 2018, ALIMENT PHARM THER, V47, P421, DOI 10.1111/apt.14428; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Tabata K, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a037093; Tameshkel FS, 2020, ARCH VIROL, V165, P2193, DOI 10.1007/s00705-020-04728-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Warkad SD, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103423; Welzel TM, 2017, J HEPATOL, V67, P224, DOI 10.1016/j.jhep.2017.03.014; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073615	60	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249770	10.1371/journal.pone.0249770	http://dx.doi.org/10.1371/journal.pone.0249770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857212	Green Published, gold			2022-12-26	WOS:000641474900031
J	Blondonnet, R; Quinson, A; Lambert, C; Audard, J; Godet, T; Zhai, R; Pereira, B; Futier, E; Bazin, JE; Constantin, JM; Jabaudon, M				Blondonnet, Raiko; Quinson, Audrey; Lambert, Celine; Audard, Jules; Godet, Thomas; Zhai, Ruoyang; Pereira, Bruno; Futier, Emmanuel; Bazin, Jean-Etienne; Constantin, Jean-Michel; Jabaudon, Matthieu			Use of volatile agents for sedation in the intensive care unit: A national survey in France	PLOS ONE			English	Article							ANESTHETIC-CONSERVING DEVICE; CLINICAL-PRACTICE GUIDELINES; ISOFLURANE SEDATION; ADULT PATIENTS; DEAD SPACE; SEVOFLURANE; DESFLURANE; ANACONDA(R); REPERFUSION; MECHANISMS	Background Current intensive care unit (ICU) sedation guidelines recommend strategies using non-benzodiazepine sedatives. This survey was undertaken to explore inhaled ICU sedation practice in France. Methods In this national survey, medical directors of French adult ICUs were contacted by phone or email between July and August 2019. ICU medical directors were questioned about the characteristics of their department, their knowledge on inhaled sedation, and practical aspects of inhaled sedation use in their department. Results Among the 374 ICUs contacted, 187 provided responses (50%). Most ICU directors (73%) knew about the use of inhaled ICU sedation and 21% used inhaled sedation in their unit, mostly with the Anaesthetic Conserving Device (AnaConDa, Sedana Medical). Most respondents had used volatile agents for sedation for <5 years (63%) and in <20 patients per year (75%), with their main indications being: failure of intravenous sedation, severe asthma or bronchial obstruction, and acute respiratory distress syndrome. Sevoflurane and isoflurane were mainly used (88% and 20%, respectively). The main reasons for not using inhaled ICU sedation were: "device not available" (40%), "lack of medical interest" (37%), "lack of familiarity or knowledge about the technique" (35%) and "elevated cost" (21%). Most respondents (80%) were overall satisfied with the use of inhaled sedation. Almost 75% stated that inhaled sedation was a seducing alternative to intravenous sedation. Conclusion This survey highlights the widespread knowledge about inhaled ICU sedation in France but shows its limited use to date. Differences in education and knowledge, as well as the recent and relatively scarce literature on the use of volatile agents in the ICU, might explain the diverse practices that were observed. The low rate of mild adverse effects, as perceived by respondents, and the users' satisfaction, are promising for this potentially important tool for ICU sedation.	[Blondonnet, Raiko; Quinson, Audrey; Audard, Jules; Godet, Thomas; Futier, Emmanuel; Bazin, Jean-Etienne; Jabaudon, Matthieu] CHU Clermont Ferrand, Dept Perioperat Med, Clermont Ferrand, France; [Blondonnet, Raiko; Audard, Jules; Zhai, Ruoyang; Futier, Emmanuel; Jabaudon, Matthieu] Univ Clermont Auvergne, INSERM, CNRS, GReD, Clermont Ferrand, France; [Lambert, Celine; Pereira, Bruno] CHU Clermont Ferrand, Biostat & Data Management Unit, Dept Clin Res & Innovat, Clermont Ferrand, France; [Constantin, Jean-Michel] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, DMU DREAM,Dept Anesthesiol & Crit Care,GRC 29, Paris, France; [Jabaudon, Matthieu] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Vanderbilt University	Blondonnet, R (corresponding author), CHU Clermont Ferrand, Dept Perioperat Med, Clermont Ferrand, France.; Blondonnet, R (corresponding author), Univ Clermont Auvergne, INSERM, CNRS, GReD, Clermont Ferrand, France.	rblondonnet@chu-clermontferrand.fr	Jabaudon, Matthieu/GLQ-8455-2022	Jabaudon, Matthieu/0000-0002-8121-1680; BLONDONNET, Raiko/0000-0001-9881-8422	Department of Perioperative medicine, CHU Clermont-Ferrand, France	Department of Perioperative medicine, CHU Clermont-Ferrand, France	This work was supported by internal funding of the Department of Perioperative medicine, CHU Clermont-Ferrand, France.	Barr J, 2013, AM J HEALTH-SYST PH, V70, P53, DOI 10.1093/ajhp/70.1.53; Bellgardt M, 2016, EUR J ANAESTH, V33, P6, DOI 10.1097/EJA.0000000000000252; Bomberg H, 2014, ANAESTHESIA, V69, P1241, DOI 10.1111/anae.12798; Bomberg H, 2018, J CLIN MONIT COMPUT, V32, P1073, DOI 10.1007/s10877-018-0105-8; Bomberg H, 2019, ANESTH ANALG, V129, P371, DOI 10.1213/ANE.0000000000003452; Bomberg H, 2018, J CLIN MONIT COMPUT, V32, P639, DOI 10.1007/s10877-018-0146-z; Bomberg H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2065-0; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Chabanne R, 2014, ANESTHESIOLOGY, V121, P808, DOI 10.1097/ALN.0000000000000394; Chung W, 2017, KOREAN J ANESTHESIOL, V70, P642, DOI 10.4097/kjae.2017.70.6.642; COUSINS MJ, 1973, JAMA-J AM MED ASSOC, V225, P1611, DOI 10.1001/jama.225.13.1611; DAS-Taskforce 2015, 2015, Ger Med Sci, V13, pDoc19, DOI 10.3205/000223; De Hert SG, 2004, ANESTHESIOLOGY, V101, P9, DOI 10.1097/00000542-200407000-00005; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Dikmen Y, 2003, ANAESTHESIA, V58, P745, DOI 10.1046/j.1365-2044.2003.03285.x; Ecoffey C, 2017, DEMOGRAPHIE MED ANES; Fukazawa K, 2014, J AM SOC NEPHROL, V25, P884, DOI 10.1681/ASN.2013111215; Gupta S, 1997, BRIT J ANAESTH, V79, P469, DOI 10.1093/bja/79.4.469; Hashiguchi H, 2005, ANESTH ANALG, V101, P1584, DOI [10.1213/01.ANE.0000184044.517549.B8, 10.1213/01.ANE.0000184044.51749.B8]; Herzog-Niescery J, 2018, J CLIN MONIT COMPUT, V32, P667, DOI 10.1007/s10877-017-0055-6; HIGUCHI H, 1995, ANESTHESIOLOGY, V83, P449, DOI 10.1097/00000542-199509000-00003; Jabaudon M, 2017, AM J RESP CRIT CARE, V195, P792, DOI 10.1164/rccm.201604-0686OC; Jackson DL, 2009, CRIT CARE, V13, DOI 10.1186/cc8212; Jerath A, 2017, ANESTH ANALG, V124, P1190, DOI 10.1213/ANE.0000000000001634; Jerath A, 2016, AM J RESP CRIT CARE, V193, P1202, DOI 10.1164/rccm.201512-2435CP; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; L'Her E, 2008, RESP CARE, V53, P1295; L'Heude M, 2019, BRIT J ANAESTH, V122, pE73, DOI 10.1016/j.bja.2019.02.009; Lee S, 2017, PEDIATR ANESTH, V27, P742, DOI 10.1111/pan.13139; Leone M, 2018, ANAESTH CRIT CARE PA, V37, P625, DOI 10.1016/j.accpm.2018.10.011; Long AC, 2014, INTENS CARE MED, V40, P820, DOI 10.1007/s00134-014-3306-8; Lv X, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-31; Mesnil M, 2011, INTENS CARE MED, V37, P933, DOI 10.1007/s00134-011-2187-3; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Obal D, 2006, BRIT J ANAESTH, V97, P783, DOI 10.1093/bja/ael245; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Perbet S, 2014, MINERVA ANESTESIOL, V80, P655; Perbet S, 2018, ANAESTH CRIT CARE PA, V37, P551, DOI 10.1016/j.accpm.2018.02.001; Roberts RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8145; Rohm KD, 2008, INTENS CARE MED, V34, P1683, DOI 10.1007/s00134-008-1157-x; Romagnoli S, 2017, CRIT CARE MED, V45, pE925, DOI 10.1097/CCM.0000000000002465; Sackey PV, 2004, CRIT CARE MED, V32, P2241, DOI 10.1097/01.CCM.0000145951.76082.77; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Schlaepfer M, 2012, CLIN EXP IMMUNOL, V168, P125, DOI 10.1111/j.1365-2249.2012.04562.x; Shahian DM, 2012, ACAD MED, V87, P701, DOI 10.1097/ACM.0b013e318253676a; Steurer M, 2009, CLIN EXP IMMUNOL, V155, P224, DOI 10.1111/j.1365-2249.2008.03807.x; Sturesson LW, 2014, BRIT J ANAESTH, V113, P508, DOI 10.1093/bja/aeu102; Voigtsberger S, 2009, ANESTHESIOLOGY, V111, P1238, DOI 10.1097/ALN.0b013e3181bdf857; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Weinert CR, 2007, CRIT CARE MED, V35, P393, DOI 10.1097/01.CCM.0000254339.18639.1D	50	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249889	10.1371/journal.pone.0249889	http://dx.doi.org/10.1371/journal.pone.0249889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857185	Green Published, gold			2022-12-26	WOS:000641474900002
J	Klise, K; Beyeler, W; Finley, P; Makvandi, M				Klise, Katherine; Beyeler, Walt; Finley, Patrick; Makvandi, Monear			Analysis of mobility data to build contact networks for COVID-19	PLOS ONE			English	Article								As social distancing policies and recommendations went into effect in response to COVID-19, people made rapid changes to the places they visit. These changes are clearly seen in mobility data, which records foot traffic using location trackers in cell phones. While mobility data is often used to extract the number of customers that visit a particular business or business type, it is the frequency and duration of concurrent occupancy at those sites that governs transmission. Understanding the way people interact at different locations can help target policies and inform contact tracing and prevention strategies. This paper outlines methods to extract interactions from mobility data and build networks that can be used in epidemiological models. Several measures of interaction are extracted: interactions between people, the cumulative interactions for a single person, and cumulative interactions that occur at particular businesses. Network metrics are computed to identify structural trends which show clear changes based on the timing of stay-at-home orders. Measures of interaction and structural trends in the resulting networks can be used to better understand potential spreading events, the percent of interactions that can be classified as close contacts, and the impact of policy choices to control transmission.	[Klise, Katherine; Beyeler, Walt; Finley, Patrick; Makvandi, Monear] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Klise, K (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	kaklise@sandia.gov			DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19; Coronavirus CARES Act; U.S. Department of Energy's National Nuclear Security Administration [DE-NA0003525]	DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19(United States Department of Energy (DOE)); Coronavirus CARES Act; U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	Research was supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory (https://science.osti.gov/nvbl), a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sandia National Laboratories is a multimission laboratory managed and operated by National Technology and Engineering Solutions of Sandia, LLC., a wholly owned subsidiary of Honeywell International, Inc., for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-NA0003525. This paper describes objective technical results and analysis. Any subjective views or opinions that might be expressed in the paper do not necessarily represent the views of the U.S. Department of Energy or the United States Government.	[Anonymous], 2021, NEW YORK TIMES; Bassett DS, 2017, NEUROSCIENTIST, V23, P499, DOI 10.1177/1073858416667720; Beyeler W, 2020, ADAPTIVE RECOVERY MO; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759; Dave D, 2020, IZA DP NO 13670; Fisher KA, 2020, MMWR-MORBID MORTAL W, V69, P1258, DOI 10.15585/mmwr.mm6936a5; Google llc, 2020, GOOGLE; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hogg R., 2019, INTRO MATH STAT, Veighth; Kumar N, 2020, ARXIV PREPRINT 20060; Lasry A, 2020, MMWR-MORBID MORTAL W, V69, P451, DOI 10.15585/mmwr.mm6915e2; Ma KC, 2020, BIG DATA SIMPLE MODE; Maheshwari P, 2020, APPL NETW SCI, V5, DOI 10.1007/s41109-020-00344-5; McMinn S, 2020, MOBILE PHONE DATA SH; Muller SA., 2020, MEDRXIV PREPRINT; Newzoo, 2019, GLOBAL MOBILE MARKET; Nishiura H., 2020, MEDRXIV, DOI 10.1101/2020.02.28.20029272; Pan YX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77751-2; Rechtin M, 2020, ARXIV PREPRINT 20060; SafeGraph, 2021, SOCIAL DISTANCING ME; SafeGraph, 2021, CENSUS BLOCK GROUP D; SafeGraph, 2021, CORE PLACES; SafeGraph, 2021, WEEKLY PATTERNS V2; Schlosser F, 2020, P NATL ACAD SCI USA, V117, P32883, DOI 10.1073/pnas.2012326117; Soures N, 2020, ARXIV PREPRINT 20041; Squire R. F, 2019, WHAT BIAS SAFEGRAPH; United States Centers for Disease Control and Prevention, 2020, CONTACT TRACING COVI; United States Centers for Disease Control and Prevention (U.S. CDC), 2020, SCI BRIEF SARS COV 2; Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117; Yi H., 2020, J TRAVEL MED	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249726	10.1371/journal.pone.0249726	http://dx.doi.org/10.1371/journal.pone.0249726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857208	Green Published, gold			2022-12-26	WOS:000641474900077
J	Komolafe, AO; Olowokere, AE; Irinoye, OO				Komolafe, Abiola Olubusola; Olowokere, Adekemi Eunice; Irinoye, Omolola Oladunni			Assessment of integration of emergency obstetric and newborn care in maternal and newborn care in healthcare facilities in Osun State, Nigeria	PLOS ONE			English	Article							IMPLEMENTATION; MORTALITY; DELIVERY	The integration of emergency obstetric and newborn care (EmONC) into maternal and newborn care is essential for its effectiveness to avert preventable maternal and newborn deaths in healthcare facilities. This study used a theory-oriented quantitative approach to document the reported extent of EmONC integration, and its relationship with EmONC training, guidelines availability and level of healthcare facility. A descriptive cross-sectional study was conducted among five hundred and five (505) healthcare providers and facility managers across the three levels of healthcare delivery. An adapted questionnaire from NoMad instrument was used to collect data on the integration of EmONC from the study participants. Ethical approval was obtained and informed consents taken from the participants. Both descriptive (frequency, percentage, mean and median) and inferential analyses (Kruskal Wallis and Mann Whitney tests) were done with statistical significance level of p<0.05 using STATA 14. The mean age of respondents was 38.68 +/- 8.27. The results showed that the EmONC integration median score at the three levels of healthcare delivery was high (77 (IQR = 83-71)). The EmONC integration median score were 76 (IQR = 84-70), 76 (IQR = 80-68) and 78 (IQR = 84-74) in the primary, secondary and tertiary healthcare facilities respectively. Integration of EmONC was highest (83 (IQR = 87-78)) among healthcare providers who had EmONC training and also had EmONC guidelines made available to them. There were significant differences in EmONC integration at the three levels of healthcare delivery (p = 0.046), among healthcare providers who had EmONC training and those with EmONC guidelines available in their maternity units (p = 0.001). EmONC integration was reportedly high and significantly associated with EmONC training and availability of guidelines. However, the congruence of reported and actual extent of integration of EmONC at the three levels of healthcare delivery still need validation as such would account for the implementation success and maternal-neonatal outcomes.	[Komolafe, Abiola Olubusola; Olowokere, Adekemi Eunice; Irinoye, Omolola Oladunni] Obafemi Awolowo Univ, Dept Nursing Sci, Ife, Osun State, Nigeria	Obafemi Awolowo University	Komolafe, AO (corresponding author), Obafemi Awolowo Univ, Dept Nursing Sci, Ife, Osun State, Nigeria.	abiolakomolafe2016@gmail.com		Komolafe, Abiola/0000-0002-2123-7782; OLOWOKERE, Adekemi/0000-0002-0499-6015; Irinoye, Omolola/0000-0001-6806-1000	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100113]; DELTAS Africa Initiative [107768/Z/15/Z]; Deutscher Akademischer Austauschdienst (DAAD); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK); UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100113), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z) and Deutscher Akademischer Austauschdienst (DAAD). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) and the UK government. The statements made and views expressed are solely the responsibility of the Fellow. A.O. received fellowship grant for PhD from the Consortium for Advanced Research Training in Africa (CARTA). The funders have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aluko JO, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3819-x; Ameh CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167270; Ameh CA, 2015, BEST PRACT RES CL OB, V29, P1077, DOI 10.1016/j.bpobgyn.2015.03.019; Banke-Thomas A., 2017, BMC PREGNANCY CHILDB, V17, P1, DOI [10.1186/s12884-016-1183-6, DOI 10.1186/S12884-016-1183-6]; Banke-Thomas A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31880; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Calvello EJ, 2015, B WORLD HEALTH ORGAN, V93, P417, DOI 10.2471/BLT.14.146571; Diffin J, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0382-5; Ebuehi OM., 2013, CLIN MED DIAGN, V3, P29, DOI DOI 10.5923/J.CMD.20130302.03; Fatiregun A., 2015, ANN COMMUNITY MED PR, V1, P1; Finch TL, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0591-x; Ijadunola KT, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-6; Johnson MJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017727; Koce F, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4046-9; Mahato P.K., 2017, J ASIAN MIDWIVES, V4, P25; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Mirkuzie AH, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-354; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20, P1; National Population Commission (NPC) [Nigeria] and ICF International, 2019, NIG DEM HLTH SURV 20, P1; National Primary Health Care Development Agency (NPHCDA), NAT PRIM HLTH CAR DE, P1; Ntambue AM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1224-9; Ntoimo OF, 2018, INT J WOMENS HEALTH, V10, P69, DOI 10.2147/IJWH.S151784; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Obembe TA, 2014, AM J SOC MANAG SCI, V5, P84; Okoli Henry, 2017, Pan Afr Med J, V26, P105, DOI 10.11604/pamj.2017.26.105.11483; Okonafua F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188392; Okonofua F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213719; Olsen S, 2010, VET CLIN N AM-FOOD A, V26, P15, DOI 10.1016/j.cvfa.2009.10.006; Otolorin E, 2015, INT J GYNECOL OBSTET, V130, pS46, DOI 10.1016/j.ijgo.2015.03.007; Pattinson RC, 2015, SAMJ S AFR MED J, V105, P256, DOI [10.7196/SAMJ.9181, 10.7196/samj.9181]; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Rasanathan K, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0493-7; Roos N, 2016, BEST PRACT RES CL OB, V36, P30, DOI 10.1016/j.bpobgyn.2016.06.002; Smith JD, 2017, FAM SYST HEALTH, V35, P125, DOI 10.1037/fsh0000252; WHO UNICEF UNFPA World_Bank_Group UNPD, 2015, TRENDS MAT MORT 1990, P14; Wolfenden L, 2016, AUST NZ J PUBL HEAL, V40, P209, DOI 10.1111/1753-6405.12518; Wong KLM, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3225-4	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249334	10.1371/journal.pone.0249334	http://dx.doi.org/10.1371/journal.pone.0249334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857184	Green Published, gold			2022-12-26	WOS:000641474900088
J	Rahman, G; Rahman, AU; Ullah, S; Dawood, M; Ul Moazzam, MF; Lee, BG				Rahman, Ghani; Rahman, Atta-ur; Ullah, Sami; Dawood, Muhammad; Ul Moazzam, Muhammad Farhan; Lee, Byung Gul			Spatio-temporal characteristics of meteorological drought in Khyber Pakhtunkhwa, Pakistan	PLOS ONE			English	Article							PRECIPITATION; CLIMATE; VARIABILITY; INDEXES; RISK	This study analysed spatio-temporal fluctuations in rainfall to assess drought and wet spells in Khyber Pakhtunkhwa, Pakistan. Temporal changes in rainfall were assessed using a linear regression method, while aridity conditions at each meteorological station were measured using the United Nations Environment Programme climate aridity index. In this study, drought and wet spell patterns were identified using the Standardized Precipitation Evapotranspiration Index (SPEI). The Spearman's Rho (SR) test was applied to find trends in the temporal 1-month and 12-month SPEI data. Balakot, Dir, Kakul, Kalam, Malam Jabba, Parachinar, Patan and Saidu were humid whereas Cherat and Timergara were sub-humid meteorological stations while Bannu, Chitral, Drosh and Peshawar were semi-arid and D.I. Khan was found to be the only arid meteorological station in the study area. The regression results revealed that the amount of rainfall is decreasing at Balakot, Kakul and Dir, while in the southern part of the province the amount of rainfall is increasing, such as in Parachinar and Cherat. The SPEI results revealed distinct drought spells in 1971-1974, 1984-1989, 1998-2004 and recently in 2017-2018, in almost all met-stations results. The SR results indicated a significant wet trend at met-station Parachinar, located in the west, while a significant drying trend has been noted at Balakot in the north-eastern part of the study area. Detailed knowledge about rainfall variability can provide a foundation for the planning and use of water resources.	[Rahman, Ghani; Dawood, Muhammad] Univ Gujrat, Dept Geog, Gujrat, Pakistan; [Rahman, Atta-ur; Ullah, Sami] Univ Peshawar, Dept Geog, Peshawar, Pakistan; [Ul Moazzam, Muhammad Farhan; Lee, Byung Gul] Jeju Natl Univ, Coll Ocean Sci, Dept Civil Engn, Jeju, South Korea	University of Gujrat; University of Peshawar; Jeju National University	Rahman, G (corresponding author), Univ Gujrat, Dept Geog, Gujrat, Pakistan.; Lee, BG (corresponding author), Jeju Natl Univ, Coll Ocean Sci, Dept Civil Engn, Jeju, South Korea.	ghanigeo@gmail.com; leebg@jejunu.ac.kr	Moazzam, Muhammad Farhan Ul/B-1949-2018; Rahman, Atta-ur/D-7320-2014	Rahman, Atta-ur/0000-0002-5932-2288; Moazzam, Muhammad Farhan Ul/0000-0002-5201-9649; Rahman, Ghani/0000-0002-5091-2337	Jeju Sea Grant, Ministry of Ocean and Fisheries, South Korea	Jeju Sea Grant, Ministry of Ocean and Fisheries, South Korea	This study was supported by Jeju Sea Grant, Ministry of Ocean and Fisheries, South Korea, Dr Byung Gul Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan S, 2018, CLIM DYNAM, V51, P1885, DOI 10.1007/s00382-017-3987-0; Adnanu S, 2020, NAT HAZARDS, V103, P2989, DOI 10.1007/s11069-020-04116-3; Ahmed K, 2018, ATMOS RES, V214, P364, DOI 10.1016/j.atmosres.2018.08.020; Ali Z, 2017, ADV METEOROL, V2017, DOI 10.1155/2017/5681308; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2012, 1090 WMO; Ashraf M, 2015, NAT HAZARDS, V77, P229, DOI 10.1007/s11069-015-1593-1; Atta-ur-Rahman, 2013, NAT HAZARDS, V66, P887, DOI 10.1007/s11069-012-0528-3; Belayneh A., 2012, SHORT TERM LONG TERM; Durrani ZK., 2018, LESSONS PAKISTAN DRO; GoP, 2018, ANN FLOOD REPORT 201; GoP Department PM, 2018, DROUGHT B PAKISTAN; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Khadr M, 2017, HYDROL RES, V48, P265, DOI 10.2166/nh.2016.194; Khan GD, 2003, IRRIG DRAIN, V52, P147, DOI 10.1002/ird.83; Khan N, 2020, ADV WATER RESOUR, V139, DOI 10.1016/j.advwatres.2020.103562; Kiani, 2019, ASIA PAC J ATMOS SCI, V56, P1; Komuscu AU, 1999, DROUGHT NETWORK NEWS, V49, P7; Kostopoulou E, 2017, SPRINGER ATMOS SCI, P475, DOI 10.1007/978-3-319-35095-0_68; Liu Y, 2016, J HYDROL, V538, P817, DOI 10.1016/j.jhydrol.2016.04.073; Mishra A. K., 2010, J HYDROL, V391, P202, DOI [DOI 10.1016/J.JHYDROL.2010.07.012, 10.1016/j.jhydrol.2010.07.012, DOI 10.1016/j.jhydrol.2010.07.012]; Miyan MA, 2015, WEATHER CLIM EXTREME, V7, P8, DOI 10.1016/j.wace.2014.06.003; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Qasim S, 2015, INT J DISAST RISK RE, V14, P373, DOI 10.1016/j.ijdrr.2015.09.001; Rahman G, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-018-3396-7; Shiel Mark., 2001, P COMSATS 1 M WAT RE, P1; Shiru MS, 2019, ATMOS RES, V223, P60, DOI 10.1016/j.atmosres.2019.03.010; Sivakumar MVK, 2011, CLIMATE CHANGE AND FOOD SECURITY IN SOUTH ASIA, P13, DOI 10.1007/978-90-481-9516-9_2; Sonmez FK, 2005, NAT HAZARDS, V35, P243, DOI 10.1007/s11069-004-5704-7; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Ullah W., 2017, INT J CLIM CHANG STR; UNEP, 1997, ARNOLD HODDER HEADLI; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wilhite DA, 2000, WORLD METEO, P1; Wilhite DA, 2014, WEATHER CLIM EXTREME, V3, P4, DOI 10.1016/j.wace.2014.01.002; Zhang Q, 2009, THEOR APPL CLIMATOL, V95, P53, DOI 10.1007/s00704-007-0375-4	36	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249718	10.1371/journal.pone.0249718	http://dx.doi.org/10.1371/journal.pone.0249718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857189	gold, Green Published			2022-12-26	WOS:000641474900109
J	Wanga, V; Peebles, K; Obiero, A; Mogaka, F; Omollo, V; Odoyo, JB; Morton, JF; Bukusi, EA; Celum, C; Baeten, JM; Barnabas, RV				Wanga, Valentine; Peebles, Kathryn; Obiero, Alfred; Mogaka, Felix; Omollo, Victor; Odoyo, Josephine B.; Morton, Jennifer F.; Bukusi, Elizabeth A.; Celum, Connie; Baeten, Jared M.; Barnabas, Ruanne, V			Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya	PLOS ONE			English	Article								Introduction Oral pre-exposure prophylaxis (PrEP) is increasingly being implemented in sub-Saharan Africa. Adolescent girls and young women (AGYW) in Kenya contribute more than half of all new infections among young people aged 15-24 years, highlighting the need for evidence on the cost of PrEP in real-world implementation to inform the budget impact, cost-effectiveness, and financial sustainability of PrEP programs. Methods We estimated the cost of delivering PrEP to AGYW enrolled in a PrEP implementation study in two family planning clinics in Kisumu county, located in western Kenya. We derived total annual costs and the average cost per client-month of PrEP by input type (variable or fixed) and visit type (initiation or follow-up). We estimated all costs as implemented in the study, and under implementation by the Kenyan Ministry of Health (MoH), both at the program volume observed and if the facilities were delivering PrEP at full capacity (scaled-MoH). Results For the costing period between March 2018 and March 2019, 615 HIV-negative women contributed 1,128 (502 initiation and 626 follow-up) visits. The average cost per client-month of PrEP dispensed per study protocol and per the MoH scenario was $28.92 and $14.52, respectively. If the MoH scaled the program so that facilities could see PrEP clients at capacity, the average cost per client-month of PrEP was $10.88. Medication costs accounted for the largest proportion of the total annual costs (48% in MoH scenario and 65% in the scaled-MoH scenario). Conclusions Using data from a PrEP implementation program, we found that the cost per client-month of PrEP dispensed is reduced by 62% if PrEP delivery at the two clinics is scaled up by the MoH. Our findings are valuable for informing local resource allocation and budgetary cost projections for scale-up of PrEP delivery to AGYW. Additionally, previous cost-effectiveness studies have been limited by the use of fixed assumptions of the cost of PrEP per person-month. Our study provides cost estimates from practical data which will better inform cost-effectiveness and budget impact analyses.	[Wanga, Valentine; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wanga, Valentine; Peebles, Kathryn; Morton, Jennifer F.; Bukusi, Elizabeth A.; Celum, Connie; Baeten, Jared M.; Barnabas, Ruanne, V] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Obiero, Alfred; Mogaka, Felix; Omollo, Victor; Odoyo, Josephine B.; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Bukusi, Elizabeth A.] Univ Washington, Dept Obstet, Seattle, WA 98195 USA; [Bukusi, Elizabeth A.] Univ Washington, Dept Gynecol, Seattle, WA 98195 USA; [Baeten, Jared M.; Barnabas, Ruanne, V] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wanga, V (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Wanga, V (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	wangav@uw.edu	Mogaka, Felix/GPX-1622-2022; Wanga, Valentine/W-8553-2019	Wanga, Valentine/0000-0002-9104-0125; Mogaka, Felix/0000-0002-7750-0404	USAID by PEPFAR [AID-OAA-A-15-0034]	USAID by PEPFAR	The POWER Project is funded by USAID, made possible by PEPFAR, under Cooperative Agreement AID-OAA-A-15-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Vaccine Advocacy Coalition, 2019, ONG PLANN PREP OP DE; AIDS Vaccine Advocacy Coalition, GLOB PREP US LANDSC; Alsallaq RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175447; Amico KR, 2019, LANCET HIV, V6, pE137, DOI 10.1016/S2352-3018(19)30002-5; Celum C, 2019 C RETR OPP INF; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Francis SC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002512; Hartmann M, 2018, AIDS BEHAV, V22, P3468, DOI 10.1007/s10461-018-2044-2; Irungu EM, 2019, AIDS RES TREAT, V2019, DOI 10.1155/2019/4170615; Ministry of Health National AIDS & STI Control Programme, 2020, GUIDELINES USE ANTIR; Ministry of Health National AIDS & STI Control Programme, 2018, KEN NAT GUID PREV MA, P2020; Ministry of Health National AIDS & STI Control Programme, 2020, KEN AIDS RESP PROGR; Morton Jennifer F, 2020, Gates Open Res, V4, P29, DOI 10.12688/gatesopenres.13103.1; Mywage Kenya, CIV SERV SAL SCAL AL; Ong JJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17134; Pinto RM, 2018, AIDS BEHAV, V22, P3681, DOI 10.1007/s10461-018-2184-4; Roberts DA, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25296; Suraratdecha C, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25129; Torrone Elizabeth A, 2018, PLoS Med, V15, pe1002608, DOI 10.1371/journal.pmed.1002608; Torrone EA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002511; UNAIDS, FACT SHEET LAT GLOB; Vassall A., 2017, REFERENCE CASE ESTIM, P2018; Venter WDF, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00188; Walensky RP, 2016, J INFECT DIS, V213, P1523, DOI 10.1093/infdis/jiv523; WHO, WHO EXP REC OR PREEX; World Bank, 2018, WHO IMPL TOOL PREEXP	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249625	10.1371/journal.pone.0249625	http://dx.doi.org/10.1371/journal.pone.0249625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857195	Green Published, gold			2022-12-26	WOS:000641474900042
J	Bauer, JM; Schroder, M; Vecchi, M; Bake, T; Dickson, SL; Belot, M				Bauer, Jan M.; Schroder, Marina; Vecchi, Martina; Bake, Tina; Dickson, Suzanne L.; Belot, Michele			Rewarding behavior with a sweet food strengthens its valuation	PLOS ONE			English	Article							ADULTHOOD; CHILDHOOD; HABITS; LIKING; HUMANS; LIKES	Sweet foods are commonly used as rewards for desirable behavior, specifically among children. This study examines whether such practice may contribute to reinforce the valuation of these foods. Two experiments were conducted, one with children, the other with rats. The first study, conducted with first graders (n = 214), shows that children who receive a food reward for performing a cognitive task subsequently value the food more compared to a control group who received the same food without performing any task. The second study, conducted on rats (n = 64), shows that rewarding with food also translates into higher calorie intake over a 24-hour period. These results suggest that the common practice of rewarding children with calorie-dense sweet foods is a plausible contributing factor to obesity and might therefore be ill advised.	[Bauer, Jan M.] Copenhagen Business Sch, Dept Management Soc & Commun, Frederiksberg, Denmark; [Schroder, Marina] Leibniz Univ Hannover, Fac Econ & Management, Hannover, Germany; [Vecchi, Martina] Penn State Univ, Dept Agr Econ Sociol & Educ AESE, University Pk, PA USA; [Bake, Tina; Dickson, Suzanne L.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol Endocrine, Sahlgrenska Acad, Gothenburg, Sweden; [Belot, Michele] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA	Copenhagen Business School; Leibniz University Hannover; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Gothenburg; Cornell University	Belot, M (corresponding author), Cornell Univ, Dept Econ, Ithaca, NY 14853 USA.	mb2693@cornell.edu		Vecchi, Martina/0000-0002-8239-3180; Bauer, Jan Michael/0000-0002-6331-4061; Schroder, Marina/0000-0002-3265-6317; Dickson, Suzanne/0000-0002-3822-5294; Belot, Michele/0000-0002-6953-1200	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding received by M.B., S.D. Funder: European Commission, 7tfh framework programme https://ec.europa.eu/research/fp7/index_en.cfm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Anzman-Frasca S, 2012, APPETITE, V58, P543, DOI 10.1016/j.appet.2011.11.012; Bell ML, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-118; Benozio A, 2015, PSYCHOL SCI, V26, P1423, DOI 10.1177/0956797615589585; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Brug J, 2008, BRIT J NUTR, V99, pS7, DOI 10.1017/S0007114508892458; Brunstrom JM, 2007, APPETITE, V49, P268, DOI 10.1016/j.appet.2006.11.007; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Johnson AW, 2011, P ROY SOC B-BIOL SCI, V278, P1450, DOI 10.1098/rspb.2010.1581; Lanfer A, 2011, INT J OBESITY, V35, pS61, DOI 10.1038/ijo.2011.36; LOEWENSTEIN G, 1994, J BEHAV DECIS MAKING, V7, P157, DOI 10.1002/bdm.3960070302; Lydall ES, 2010, J EXP SOC PSYCHOL, V46, P1134, DOI 10.1016/j.jesp.2010.05.011; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Rogers WH, 1993, STATA TECHN B, V13, P19; ROZIN P, 1985, ANN NY ACAD SCI, V443, P189, DOI 10.1111/j.1749-6632.1985.tb27073.x; Schoeller DA, 2017, ADVANCES IN THE ASSESSMENT OF DIETARY INTAKE, P185; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2011, PEPTIDES, V32, P2265, DOI 10.1016/j.peptides.2011.05.016; Vereecken CA, 2004, APPETITE, V43, P93, DOI 10.1016/j.appet.2004.04.002; Yeomans MR, 2012, PHYSIOL BEHAV, V106, P345, DOI 10.1016/j.physbeh.2012.03.013	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0242461	10.1371/journal.pone.0242461	http://dx.doi.org/10.1371/journal.pone.0242461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852568	gold, Green Published			2022-12-26	WOS:000640604500023
J	Mizuno, K; Haga, H; Okumoto, K; Hoshikawa, K; Katsumi, T; Nishina, T; Saito, T; Katagiri, H; Ueno, Y				Mizuno, Kei; Haga, Hiroaki; Okumoto, Kazuo; Hoshikawa, Kyoko; Katsumi, Tomohiro; Nishina, Taketo; Saito, Takafumi; Katagiri, Hideki; Ueno, Yoshiyuki			Intrahepatic distribution of nerve fibers and alterations due to fibrosis in diseased liver	PLOS ONE			English	Article							MAC-2 BINDING-PROTEIN; HEPATOCELLULAR-CARCINOMA; ACETYLCHOLINE-RECEPTOR; LIPID-METABOLISM; VAGUS NERVE; HEPATITIS-C; SYSTEM; TRANSPLANTATION; REGENERATION; ASSOCIATION	Autonomic nerve fibers in the liver are distributed along the portal tract, being involved in the regulation of blood flow, bile secretion and hepatic metabolism, thus contributing to systemic homeostasis. The present study investigated changes in hepatic nerve fibers in liver biopsy specimens from patients with normal liver, viral hepatitis and non-alcoholic steatohepatitis, in relation to clinical background. The areal ratio of nerve fibers to the total portal area was automatically calculated for each sample. The nerve fiber areal ratios (NFAR) for total nerve fibers and sympathetic nerve fibers were significantly lower in liver affected by chronic hepatitis, particularly viral hepatitis, and this was also the case for advanced liver fibrosis. However, the degree of inflammatory activity did not affect NFAR for either whole nerves or sympathetic nerves. Comparison of samples obtained before and after antiviral treatment for HCV demonstrated recovery of NFAR along with improvement of liver fibrosis.	[Mizuno, Kei; Haga, Hiroaki; Okumoto, Kazuo; Hoshikawa, Kyoko; Katsumi, Tomohiro; Nishina, Taketo; Saito, Takafumi; Ueno, Yoshiyuki] Yamagata Univ, Dept Gastroenterol, Fac Med, Yamagata, Japan; [Mizuno, Kei; Haga, Hiroaki; Hoshikawa, Kyoko; Katsumi, Tomohiro; Nishina, Taketo; Ueno, Yoshiyuki] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol CREST, Tokyo, Japan; [Katagiri, Hideki] Tohoku Univ, Dept Metab & Diabet, Grad Sch Med, Sendai, Miyagi, Japan	Yamagata University; Japan Science & Technology Agency (JST); Tohoku University	Mizuno, K (corresponding author), Yamagata Univ, Dept Gastroenterol, Fac Med, Yamagata, Japan.; Mizuno, K (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol CREST, Tokyo, Japan.	k.mizuno@med.id.yamagata-u.c.jp		Ueno, Yoshiyuki/0000-0001-5623-4250	JST CREST [16gm0610001h0205]; JSPS KAKENHI [26870066, 17K15919]	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JST CREST Grant Number 16gm0610001h0205, and Grants-in-Aid for Young Scientists (B) from JSPS KAKENHI Grant Number 26870066 and 17K15919 (to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Alkhouri N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205541; AMENTA F, 1981, HISTOCHEM J, V13, P419, DOI 10.1007/BF01005057; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BOON AP, 1992, J PATHOL, V167, P217, DOI 10.1002/path.1711670210; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cassiman D, 2002, AM J PATHOL, V161, P521, DOI 10.1016/S0002-9440(10)64208-3; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; DHILLON AP, 1992, J PATHOL, V167, P211, DOI 10.1002/path.1711670209; Fukuda Y, 1996, J INT MED RES, V24, P466, DOI 10.1177/030006059602400603; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hirako S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21481; Izumi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07747-0; Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018; Kandilis AN, 2015, J SURG RES, V194, P511, DOI 10.1016/j.jss.2014.12.006; Kobayashi M, 2017, J MED VIROL, V89, P476, DOI 10.1002/jmv.24663; Laish I, 2011, LIVER TRANSPLANT, V17, P15, DOI 10.1002/lt.22198; Mizuno K, 2017, HEPATOL RES, V47, P160, DOI 10.1111/hepr.12760; MORITA H, 1993, CIRC RES, V72, P552, DOI 10.1161/01.RES.72.3.552; Munshi VN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226873; Nam SW, 2007, GUT LIVER, V1, P165, DOI 10.5009/gnl.2007.1.2.165; Nishio T, 2017, J GASTROENTEROL, V52, P965, DOI 10.1007/s00535-016-1304-z; Oben JA, 2004, ANAT REC PART A, V280A, P874, DOI 10.1002/ar.a.20081; Ohtake M, 1993, HPB Surg, V6, P277, DOI 10.1155/1993/59691; Sakamoto I, 2003, TRANSPL P, V35, P573, DOI 10.1016/S0041-1345(02)03809-5; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Takahashi T, 2001, LIVER, V21, P300, DOI 10.1034/j.1600-0676.2001.210502.x; TANAKA K, 1987, AM J PHYSIOL, V253, pG439, DOI 10.1152/ajpgi.1987.253.4.G439; Toshima T, 2015, J GASTROENTEROL, V50, P76, DOI 10.1007/s00535-014-0946-y; Uno K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8940; Watanabe S, 2015, J GASTROENTEROL, V50, P364, DOI 10.1007/s00535-015-1050-7; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Zanchi A, 2020, VIRCHOWS ARCH, V477, P385, DOI 10.1007/s00428-020-02761-4	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249556	10.1371/journal.pone.0249556	http://dx.doi.org/10.1371/journal.pone.0249556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852613	gold, Green Published			2022-12-26	WOS:000640604500070
J	Verschuur, J; Koks, EE; Hall, JW				Verschuur, Jasper; Koks, Elco E.; Hall, Jim W.			Global economic impacts of COVID-19 lockdown measures stand out in high-frequency shipping data	PLOS ONE			English	Article								The implementation of large-scale containment measures by governments to contain the spread of the COVID-19 virus has resulted in large impacts to the global economy. Here, we derive a new high-frequency indicator of economic activity using empirical vessel tracking data, and use it to estimate the global maritime trade losses during the first eight months of the pandemic. We go on to use this high-frequency dataset to infer the effect of individual non-pharmaceutical interventions on maritime exports, which we use as a proxy of economic activity. Our results show widespread port-level trade losses, with the largest absolute losses found for ports in China, the Middle-East and Western Europe, associated with the collapse of specific supply-chains (e.g. oil, vehicle manufacturing). In total, we estimate that global maritime trade reduced by -7.0% to -9.6% during the first eight months of 2020, which is equal to around 206-286 million tonnes in volume losses and up to 225-412 billion USD in value losses. We find large sectoral and geographical disparities in impacts. Manufacturing sectors are hit hardest, with losses up to 11.8%, whilst some small islands developing states and low-income economies suffered the largest relative trade losses. Moreover, we find a clear negative impact of COVID-19 related school and public transport closures on country-wide exports. Overall, we show how real-time indicators of economic activity can inform policy-makers about the impacts of individual policies on the economy, and can support economic recovery efforts by allocating funds to the hardest hit economies and sectors.	[Verschuur, Jasper; Koks, Elco E.; Hall, Jim W.] Univ Oxford, Environm Change Inst, Oxford, England; [Koks, Elco E.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands	University of Oxford; Vrije Universiteit Amsterdam	Verschuur, J (corresponding author), Univ Oxford, Environm Change Inst, Oxford, England.	jasper.verschuur@keble.ox.ac.uk	Koks, Elco/ABE-7946-2020	Koks, Elco/0000-0002-4953-4527; Verschuur, Jasper/0000-0002-5277-4353	University of Oxford COVID-19 Research Response Fund; Engineering and Physical Sciences Research Council (EPSRC) [EP/R513295/1]; Netherlands Organization for Scientific Research NOW [VI.Veni.194.033]	University of Oxford COVID-19 Research Response Fund; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Netherlands Organization for Scientific Research NOW(Netherlands Organization for Scientific Research (NWO))	This research is supported by the University of Oxford COVID-19 Research Response Fund. J.V. acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC) under grant number EP/R513295/1. E.E.K. was further supported by the Netherlands Organization for Scientific Research NOW (grant no. VI.Veni.194.033).	Acemoglu D., 2020, MULTIRISK SIR MODEL, DOI [10.3386/w27102, DOI 10.3386/W27102]; Adam C, 2020, OXFORD REV ECON POL, V36, pS338, DOI 10.1093/oxrep/graa023; Adland R, 2017, MARIT POLICY MANAG, V44, P657, DOI 10.1080/03088839.2017.1309470; Arslanalp S., 2019, IMF WORK PAP, V2019, DOI [10.5089/9781513521121.001, DOI 10.5089/9781513521121.001]; Beyer RCM, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105287; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; BRIGUGLIO L, 1995, WORLD DEV, V23, P1615, DOI 10.1016/0305-750X(95)00065-K; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Buenos Aires Times, 2020, ECONOMY; Cacciapaglia G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72611-5; Cerdeiro DA, SUPPLY SPILOVERS PAN; Cerdeiro DA, 2020, WP2057; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Chen SCI, 2020, AIP CONF PROC, V2293, DOI 10.1063/5.0026976; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Deb P., 2020, WP20158 IMF; Fezzi C, 2020, ENVIRON RESOUR ECON, V76, P885, DOI 10.1007/s10640-020-00467-4; Freightwaves, 2020, MORE AIR CARGO FINDS; Furceri D, INITAL OUTPUT LOSSES; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Gondwe G., 2020, ASSESSING IMPACT COV; Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708; Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Hummels D, 2001, J INT ECON, V54, P75, DOI 10.1016/S0022-1996(00)00093-3; Inoue H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239251; Koks EE, 2016, ECON SYST RES, V28, P429, DOI 10.1080/09535314.2016.1232701; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lenzen M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235654; Liu F, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142533; Maloney W., 2020, Policy Research Working Paper - World Bank; Mathews JA, 2016, NATURE, V531, P440, DOI 10.1038/531440a; Nikkei Asian Review, 2020, CORONAVIRUS; Petherick A, 2020, VARIATION GOVT RESPO; Romer CD, 2010, AM ECON REV, V100, P763, DOI 10.1257/aer.100.3.763; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Santamaria C, 2020, SAFETY SCI, V132, DOI 10.1016/j.ssci.2020.104925; Tanzania Invest, 2020, TANZANIA TRADE; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; UN, 2020, UN COMTR DAT; UNCTAD, 2021, LEAST DEV COUNTR REP; UNCTAD, 2017, UNCTAD FRAM SUST FRI; UNCTAD RPB Code, 2020, RESTR BUS PRACT RBP; Verschuur J, 2020, TRANSPORT RES D-TR E, V85, DOI 10.1016/j.trd.2020.102393; Zheng B, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd4998	46	33	33	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0248818	10.1371/journal.pone.0248818	http://dx.doi.org/10.1371/journal.pone.0248818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852593	Green Published, gold			2022-12-26	WOS:000640604500048
J	Sani, L; Vispa, A; Loretoni, R; Duranti, M; Ghavami, N; Sanchez-Bayuela, DA; Caschera, S; Paoli, M; Bigotti, A; Badia, M; Scorsipa, M; Raspa, G; Ghavami, M; Tiberi, G				Sani, Lorenzo; Vispa, Alessandro; Loretoni, Riccardo; Duranti, Michele; Ghavami, Navid; Sanchez-Bayuela, Daniel Alvarez; Caschera, Stefano; Paoli, Martina; Bigotti, Alessandra; Badia, Mario; Scorsipa, Michele; Raspa, Giovanni; Ghavami, Mohammad; Tiberi, Gianluigi			Breast lesion detection through MammoWave device: Empirical detection capability assessment of microwave images' parameters	PLOS ONE			English	Article							CANCER	MammoWave is a microwave imaging device for breast lesions detection, which operates using two (azimuthally rotating) antennas without any matching liquid. Images, subsequently obtained by resorting to Huygens Principle, are intensity maps, representing the homogeneity of tissues' dielectric properties. In this paper, we propose to generate, for each breast, a set of conductivity weighted microwave images by using different values of conductivity in the Huygens Principle imaging algorithm. Next, microwave images' parameters, i.e. features, are introduced to quantify the non-homogenous behaviour of the image. We empirically verify on 103 breasts that a selection of these features may allow distinction between breasts with no radiological finding (NF) and breasts with radiological findings (WF), i.e. with lesions which may be benign or malignant. Statistical significance was set at p<0.05. We obtained single features Area Under the receiver operating characteristic Curves (AUCs) spanning from 0.65 to 0.69. In addition, an empirical rule-of-thumb allowing breast assessment is introduced using a binary score S operating on an appropriate combination of features. Performances of such rule-of-thumb are evaluated empirically, obtaining a sensitivity of 74%, which increases to 82% when considering dense breasts only.	[Sani, Lorenzo; Vispa, Alessandro; Ghavami, Navid; Sanchez-Bayuela, Daniel Alvarez; Caschera, Stefano; Paoli, Martina; Bigotti, Alessandra; Badia, Mario; Scorsipa, Michele; Raspa, Giovanni; Tiberi, Gianluigi] UBT Umbria Bioengn Technol, Perugia, Italy; [Loretoni, Riccardo] AUSL Umbria 2, Breast Screening & Diagnost Breast Canc Unit, Foligno, Italy; [Duranti, Michele] Perugia Hosp, Dept Diagnost Imaging, Perugia, Italy; [Ghavami, Mohammad; Tiberi, Gianluigi] London South Bank Univ, Sch Engn, London, England	London South Bank University	Tiberi, G (corresponding author), UBT Umbria Bioengn Technol, Perugia, Italy.; Tiberi, G (corresponding author), London South Bank Univ, Sch Engn, London, England.	tiberig@lsbu.ac.uk	Tiberi, Gianluigi/K-5995-2016	Tiberi, Gianluigi/0000-0001-8787-1295; Alvarez Sanchez-Bayuela, Daniel/0000-0003-4972-0853; Ghavami, Mohammad/0000-0001-8887-5052	European Union's Horizon 2020 research and innovation programme [830265]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [793449, 872752]	European Union's Horizon 2020 research and innovation programme; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 830265. This project leading to this application has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 793449. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 872752. Lorenzo Sani, Alessandro Vispa, Daniel Alvarez Sa ' nchez-Bayuela, Stefano Caschera, Martina Paoli, Alessandra Bigotti, Mario Badia, Michele Scorsipa and Giovanni Raspa are employed by UBT -Umbria Bioengineering Technologies. The funder provided support in the form of salaries for such authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aldhaeebi MA, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20082390; Assi HA, 2013, J THORAC DIS, V5, pS2, DOI 10.3978/j.issn.2072-1439.2013.05.24; Chen THH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005684; Conceicao R.C., 2016, INTRO MICROWAVE IMAG; da Silva D, 2018, CHEM ENG J, V340, P9, DOI 10.1016/j.cej.2018.01.010; Ferlay J, 2018, GLOBAL CANC OBSERVAT; Ghavami N, 2012, IEEE T ANTENN PROPAG, V60, P231, DOI 10.1109/TAP.2011.2167905; Hanley JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188947; Joy JE, 2005, SAVING WOMENS LIVES; Lakhani SR, 2012, WHO CLASSIFICATION T; Lavoie BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160849; Lazebnik M, 2007, PHYS MED BIOL, V52, P6093, DOI 10.1088/0031-9155/52/20/002; Lazebnik M, 2007, PHYS MED BIOL, V52, P2637, DOI 10.1088/0031-9155/52/10/001; Nikolova NK, 2011, IEEE MICROW MAG, V12, P78, DOI 10.1109/MMM.2011.942702; O'Loughlin D, 2019, IEEE T MED IMAGING, V38, P303, DOI 10.1109/TMI.2018.2864150; Parekh VS, 2020, BREAST CANCER RES TR, V180, P407, DOI 10.1007/s10549-020-05533-5; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Preece AW, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.3.033502; Rana SP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46974-3; Sani L, 2019, BIOMED SIGNAL PROCES, V52, P257, DOI 10.1016/j.bspc.2019.04.025; Shah Tajammal Abbas, 2017, J Microsc Ultrastruct, V5, P59, DOI 10.1016/j.jmau.2016.10.002; Shere M, 2019, EUR J RADIOL, V116, P61, DOI 10.1016/j.ejrad.2019.04.017; Tavassoli FA, 2003, WHO CLASSIFICATION T; Vispa A, 2019, MEASUREMENT, V146, P582, DOI 10.1016/j.measurement.2019.05.109	24	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0250005	10.1371/journal.pone.0250005	http://dx.doi.org/10.1371/journal.pone.0250005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848318	Green Accepted, gold, Green Published			2022-12-26	WOS:000640373500015
J	Jung, HR; Oh, Y; Na, D; Min, S; Kang, J; Jang, D; Shin, S; Kim, J; Lee, SE; Jeong, EM; An, JY; Sung, CO; Lee, WS; Lee, C; Cho, SY				Jung, Hae Rim; Oh, Yumi; Na, Deukchae; Min, Seoyeon; Kang, Jinjoo; Jang, Dongjun; Shin, Seungjae; Kim, Jiwon; Lee, Sang Eun; Jeong, Eui Man; An, Joon Yong; Sung, Chang Ohk; Lee, Won-Suk; Lee, Charles; Cho, Sung-Yup			CRISPR screens identify a novel combination treatment targeting BCL-X-L and WNT signaling for KRAS/BRAF-mutated colorectal cancers	ONCOGENE			English	Article								Metastatic or recurrent colorectal cancer (CRC) patients require systemic chemotherapy, but the therapeutic options of targeted agents remain limited. CRC patients with KRAS or BRAF gene mutations exhibit a worse prognosis and are resistant to anti-EGFR treatment. Previous studies have shown that the expression of anti-apoptotic protein BCL-X-L is increased in CRC patients with KRAS/BRAF mutations, suggesting BCL-X-L as a therapeutic target for this subgroup. Here, we performed genome-wide CRISPR/Cas9 screens of cell lines with KRAS mutations to investigate the factors required for sensitivity to BCL-X-L inhibitor ABT-263 using single-guide RNAs (sgRNAs) that induce loss-of-function mutations. In the presence of ABT-263, sgRNAs targeting negative regulators of WNT signaling (resulting in WNT activation) were enriched, whereas sgRNAs targeting positive regulators of WNT signaling (resulting in WNT inhibition) were depleted in ABT-263-resistant cells. The activation of WNT signaling was highly associated with an increased expression ratio of anti- to pro-apoptotic BCL-2 family genes in CRC samples. Genetic and pharmacologic inhibition of WNT signaling using beta-catenin short hairpin RNA or TNIK inhibitor NCB-0846, respectively, augmented ABT-263-induced cell death in KRAS/BRAF-mutated cells. Inhibition of WNT signaling resulted in transcriptional repression of the anti-apoptotic BCL-2 family member, MCL1, via the functional inhibition of the beta-catenin-containing complex at the MCL1 promoter. In addition, the combination of ABT-263 and NCB-0846 exhibited synergistic effects in in vivo patient-derived xenograft (PDX) models with KRAS mutations. Our data provide a novel targeted combination treatment strategy for the CRC patient subgroup with KRAS or BRAF mutations.	[Jung, Hae Rim; Oh, Yumi] Seoul Natl Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Jung, Hae Rim; Oh, Yumi; Cho, Sung-Yup] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Coll Med, Seoul, South Korea; [Na, Deukchae] Ewha Womans Univ, Ewha Inst Convergence Med, Mokdong Hosp, Seoul, South Korea; [Min, Seoyeon; Kang, Jinjoo; Lee, Charles] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Jang, Dongjun; Shin, Seungjae; Kim, Jiwon; Lee, Sang Eun; Cho, Sung-Yup] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Jeong, Eui Man] Jeju Natl Univ, Coll Pharm, Dept Pharm, Jeju City, Jeju Special Se, South Korea; [Jeong, Eui Man] Jeju Natl Univ, Interdisciplinary Grad Program Adv Convergence Te, Jeju City, Jeju Special Se, South Korea; [Jeong, Eui Man] Jeju Natl Univ, Biohlth Mat Core Facil Ctr, Jeju City, Jeju Special Se, South Korea; [Jeong, Eui Man] Jeju Natl Univ, Pract Translat Res Ctr, Jeju City, Jeju Special Se, South Korea; [An, Joon Yong] Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Seoul, South Korea; [Sung, Chang Ohk] Univ Ulsan, Asan Med Ctr, Dept Pathol, Coll Med, Seoul, South Korea; [Lee, Won-Suk] Gachon Univ, Gil Med Ctr, Dept Surg, Incheon, South Korea; [Lee, Charles] Jackson Lab Genom Med, Farmington, CT USA; [Cho, Sung-Yup] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Jeju National University; Jeju National University; Jeju National University; Jeju National University; Korea University; University of Ulsan; Asan Medical Center; Gachon University; Jackson Laboratory; Seoul National University (SNU)	Cho, SY (corresponding author), Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Coll Med, Seoul, South Korea.; Cho, SY (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea.; Cho, SY (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	csybio@snu.ac.kr		Sung, Chang Ohk/0000-0002-8567-456X; An, Joon-Yong/0000-0001-8839-6297	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2017R1C1B2002183]; Bio & Medical Technology Development Program of the NRF - Ministry of Science ICT [2018M3A9F3056902, 2019M3E5D4066900]; Creative-Pioneering Researchers Program through Seoul National University [800-20200510]; Collaborative Research Program of SNU Boramae Medical Center [800-20200005]; Basic Medical Science from Seoul National University College of Medicine [800-20200005]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Bio & Medical Technology Development Program of the NRF - Ministry of Science ICT; Creative-Pioneering Researchers Program through Seoul National University; Collaborative Research Program of SNU Boramae Medical Center; Basic Medical Science from Seoul National University College of Medicine	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant No. 2017R1C1B2002183); the Bio & Medical Technology Development Program of the NRF funded by the Ministry of Science & ICT (grant No. 2018M3A9F3056902 and 2019M3E5D4066900); Creative-Pioneering Researchers Program through Seoul National University (grant No. 800-20200510); and the Collaborative Research Program of SNU Boramae Medical Center and Basic Medical Science from Seoul National University College of Medicine (grant No. 800-20200005).	Bendell J, 2018, ANN ONCOL, V29, P123, DOI 10.1093/annonc/mdy208.003; Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cho SY, 2017, MOL CANCER THER, V16, P2178, DOI 10.1158/1535-7163.MCT-16-0735; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Croce CM, 2016, CANCER RES, V76, P5914, DOI 10.1158/0008-5472.CAN-16-1248; DeStefanis RA, 2019, CURR COLORECT CANC R, V15, P61, DOI 10.1007/s11888-019-00430-6; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Eguchi M, 2005, MED CHEM, V1, P467, DOI 10.2174/1573406054864098; Faber AC, 2014, CANCER DISCOV, V4, P42, DOI 10.1158/2159-8290.CD-13-0315; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gui JH, 2011, HUM CELL, V24, P121, DOI 10.1007/s13577-011-0023-2; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Ho SY, 2015, BIOORG MED CHEM LETT, V25, P5472, DOI 10.1016/j.bmcl.2015.10.032; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Jung YS, 2020, EXP MOL MED, V52, P183, DOI 10.1038/s12276-020-0380-6; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krishnamurthy N, 2018, CANCER TREAT REV, V62, P50, DOI 10.1016/j.ctrv.2017.11.002; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Martini G, 2017, WORLD J GASTROENTERO, V23, P4675, DOI 10.3748/wjg.v23.i26.4675; Masuda M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12586; McBride A, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00192; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038; Punt CJA, 2017, NAT REV CLIN ONCOL, V14, P235, DOI 10.1038/nrclinonc.2016.171; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Senichkin VV, 2019, TRENDS CELL BIOL, V29, P549, DOI 10.1016/j.tcb.2019.03.004; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Shkoda A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001376; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wang BB, 2019, NAT PROTOC, V14, P756, DOI 10.1038/s41596-018-0113-7; Wang L, 2020, ACS MED CHEM LETT, V11, P1829, DOI 10.1021/acsmedchemlett.9b00568; Yeung P., 2014, CANCER RES, V74, pS1907; Yoshida N, 2015, ANTICANCER RES, V35, P4403; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	49	5	5	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3287	3302		10.1038/s41388-021-01777-7	http://dx.doi.org/10.1038/s41388-021-01777-7		APR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33846570				2022-12-26	WOS:000639635100005
J	Delil, R; Zinab, B; Mosa, H; Ahmed, R; Hassen, H				Delil, Romedan; Zinab, Beakal; Mosa, Hassen; Ahmed, Ritbano; Hassen, Habtamu			Determinants of dietary diversity practice among pregnant women attending antenatal clinic at Wachemo University Nigist Eleni Mohammed memorial referral hospital, Southern Ethiopia	PLOS ONE			English	Article								Background Dietary diversity has continued to receive a global attention among pregnant women as they have been considered susceptible to malnutrition because of their increased nutrient demands. Thus, a variety of foodstuffs in their diet are necessary for ensuring the appropriateness of their nutrient consumptions. This study, therefore assessed the dietary diversity practice and its determinants among pregnant women attending antenatal clinic at Wachemo University Nigist Eleni Mohammed memorial referral hospital, Southern Ethiopia. Methods A hospital-based cross-sectional study was carried out on 303 participants from May 1 to June 15, 2019 using a systematic random sampling technique. Data were entered and analyzed using SPSS (version24.0). Both bivariate and multivariable logistic regression analyses were used to decide the association of each explanatory variable with the outcome variable. Odds ratio with their 95% confidence intervals was calculated to identify the presence and strength of association, and statistical significance was declared at p < 0.05. Results The overall prevalence of adequate dietary diversity practices was observed to be 42.6%. The determinants of dietary diversity practice included earning of a monthly income >= 2000 Ethiopian birr (AOR = 1.62; 95%CI:1.19-2.85), maternal educational level (AOR = 2.50; 95% CI: 1.05-6.12), educational status of partner (AOR = 2.45; 95% CI:1.20, 9.57), having a partner who was a government employee (AOR = 4; 95% CI:2.18-7.21), and the receiving of nutritional information (AOR = 1.35; 95% CI: 3.39-6.94). Conclusions The study indicated that the overall consumption of adequate dietary diversity practice was found to be low. Therefore, increasing household income, enhancing nutritional related information, advancing the academic level of both wife and her partner is essential to improve women's dietary diversity practice.	[Delil, Romedan] Hossana Coll Hlth Sci, Dept Clin Nursing, Hossana, Ethiopia; [Zinab, Beakal] Jimma Univ, Inst Hlth, Dept Nutr & Dietet, Jimma, Ethiopia; [Mosa, Hassen; Ahmed, Ritbano] Wachemo Univ, Coll Med & Hlth Sci, Dept Midwifery, Hossana, Ethiopia; [Hassen, Habtamu] Hossana Coll Hlth Sci, Dept Med Emergency, Hossana, Ethiopia	Jimma University	Mosa, H (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Dept Midwifery, Hossana, Ethiopia.	hassenmosa17@gmail.com						Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Aliwo S, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4159-6; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Been JV, 2008, NEW ENGL J MED, V359, P1523; Daba G, 2013, SCI TECHNOLOGY ARTS, V2, P105; Darnton-Hill I, 2015, NUTRIENTS, V7, P1744, DOI 10.3390/nu7031744; Demilew YM, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-019-2702-z; Desta M, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/3916864; Ethiopia F.D.R.E., 2016, NAT NUTR PROGR; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Haider BA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub5; Harris-Fry H, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0022-0; Kennedy G., 2010, GUID MEAS HOUS IND D; Kiboi W., 2016, INT J HLTH SCI RES, P378; Lee SE, 2013, PUBLIC HEALTH NUTR, V16, P1340, DOI 10.1017/S1368980012004417; Mekonnen S., 2015, INT J NUTR FOOD SCI, V4, P707, DOI [10.11648/j.ijnfs.20150406.27, DOI 10.11648/J.IJNFS.20150406.27]; Mirsanjari M, 2012, INT C NUTR FOOD SCI, P39; Nana A, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1822-1; Saaka M, 2012, INT J CHILD HEALTH N, V1, P148, DOI 10.6000/1929-4247.2012.01.02.6; Shashikantha S, 2016, INT J COMMUNITY MED, P746, DOI [10.18203/2394-6040.ijcmph20160644, DOI 10.18203/23946040.IJCMPH20160644]; Shehab L., 2012, J AM SCI, V8; Shenka A., 2018, E AFRICAN J HLTH BIO, V2, P10; Tafera B., 2018, ETHIOPIAN J REPROD H, V10, P43; Taruvinga A., 2013, INT J DEV SUSTAIN, V2, P2233; Tenaw Z., 2018, INT J NURS MIDWIFERY, V10, P81, DOI [DOI 10.5897/IJNM2017.0289, 10.5897/IJNM2017.0289]; Zerfu TA, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0059-8	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0250037	10.1371/journal.pone.0250037	http://dx.doi.org/10.1371/journal.pone.0250037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836030	Green Published, gold			2022-12-26	WOS:000639361000034
J	Campos-Silva, JV; Peres, CA; Hawes, JE; Abrahams, MI; Andrade, PCM; Davenport, L				Campos-Silva, Joao Vitor; Peres, Carlos A.; Hawes, Joseph E.; Abrahams, Mark, I; Andrade, Paulo C. M.; Davenport, Lisa			Community-based conservation with formal protection provides large collateral benefits to Amazonian migratory waterbirds	PLOS ONE			English	Article							SKIMMERS RYNCHOPS-NIGER; LIMNOLOGICAL CONDITIONS; RIO NEGRO; BIODIVERSITY; BEHAVIOR; HABITAT; TURTLES; SUSTAINABILITY; COMANAGEMENT; ABUNDANCE	Populations of migratory waterbirds are facing dramatic declines worldwide due to illegal hunting, habitat loss and climate change. Conservation strategies to reverse these trends are imperative, especially in tropical developing countries, which almost invariably allocate insufficient levels of investment for environmental protection. Here, we compared the effectiveness of sustainable-use Protected Areas (PAs) and Community-based Conservation (CBC) arrangements for the conservation of migratory waterbirds that breed on seasonal riverine sandy beaches in Brazilian Amazonia. We modeled local population responses of four migratory waterbird species on 155 beaches along a similar to 1,600 km section of a major tributary of the Amazon, as a function of community enforcement, official protection status, human pressure and landscape features. We show that 21 community-protected beaches within the study area host more than 80% of all sampled birds. Black Skimmers showed the most dramatic response, with breeding numbers 135-fold larger in CBC arrangements compared to beaches with no official protection status. The same pattern was observed for nesting Large-Billed and Yellow-Billed Terns. For the Near Threatened Orinoco Goose, PA status was the strongest predictor of local population size. These dramatic results demonstrate the value of protected refugia, achieved through the concerted action of participating local communities, to support breeding populations of key waterbird species. This highly-effective and low-cost conservation model can potentially be replicated in other regions of the developing world experiencing increasingly intensive exploitation of riverine natural resources.	[Campos-Silva, Joao Vitor; Hawes, Joseph E.] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Campos-Silva, Joao Vitor] Univ Fed Alagoas, Inst Biol & Hlth Sci, Maceio, Alagoas, Brazil; [Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Norwich Res Pk, Norwich, Norfolk, England; [Hawes, Joseph E.] Anglia Ruskin Univ, Sch Life Sci, Appl Ecol Res Grp, Cambridge, England; [Abrahams, Mark, I] Bristol Zool Soc, Field Conservat & Sci Dept, Bristol, Avon, England; [Andrade, Paulo C. M.] Univ Fed Amazonas, Dept Prod Anim & Vegetal, Lab Anim Silvestres, Manaus, Amazonas, Brazil; [Davenport, Lisa] Univ Florida, Dept Biol, Gainesville, FL USA; [Davenport, Lisa] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Davenport, Lisa] James Cook Univ, Coll Sci & Engn, Cairns, Qld, Australia	Norwegian University of Life Sciences; Universidade Federal de Alagoas; University of East Anglia; Anglia Ruskin University; Universidade Federal de Amazonas; State University System of Florida; University of Florida; State University System of Florida; University of Florida; James Cook University	Campos-Silva, JV (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway.; Campos-Silva, JV (corresponding author), Univ Fed Alagoas, Inst Biol & Hlth Sci, Maceio, Alagoas, Brazil.	jvpiedade@gmail.com	Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020	Peres, Carlos A./0000-0002-1588-8765; Davenport, Lisa/0000-0002-2573-1622; campos e silva, joao vitor/0000-0003-4998-7216; Hawes, Joseph/0000-0003-0053-2018	Darwin Initiative for the Survival of Species grant (DEFRA, UK) [20-001]; CAPES [1144985, 1530532]; Belmont Forum and BiodivERsA joint call for research proposals, under the BiodivScen ERA-Net COFUND programme [295650]; French National Research Agency (ANR); Sao Paulo Research Foundation (FAPESP); National Science Foundation (NSF); Research Council of Norway; German Federal Ministry of Education and Research (BMBF); Anglia Ruskin University; National Geographic Society [WW1-277R-18]	Darwin Initiative for the Survival of Species grant (DEFRA, UK); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Belmont Forum and BiodivERsA joint call for research proposals, under the BiodivScen ERA-Net COFUND programme; French National Research Agency (ANR)(French National Research Agency (ANR)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Research Council of Norway(Research Council of Norway); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Anglia Ruskin University; National Geographic Society(National Geographic Society)	This study was funded by a Darwin Initiative for the Survival of Species grant (DEFRA, UK; Ref. 20-001) awarded to C.A.P., a CAPES Ph.D. scholarship (Ref. 1144985) and a postdoctoral grant to JVC-S (no. 295650) through the Belmont Forum and BiodivERsA joint call for research proposals, under the BiodivScen ERA-Net COFUND programme, and with the funding organisations French National Research Agency (ANR), Sao Paulo Research Foundation (FAPESP), National Science Foundation (NSF), the Research Council of Norway and the German Federal Ministry of Education and Research (BMBF), a CAPES postdoctoral grant (Ref. 1530532) and internal funding from Anglia Ruskin University to J.E.H., and a National Geographic Society grant (Ref. WW1-277R-18) to L.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2018, NATURE, V553, P199, DOI 10.1038/nature25139; Andrade PCM, 2008, CRIACAO MANEJO QUELO; Antunes AP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600936; Bairlein F, 2016, SCIENCE, V354, P547, DOI 10.1126/science.aah6647; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; Barton K, 2020, MUMIN MULTIMODEL INF; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burger J., 1981, Colonial Waterbirds, V4, P28, DOI 10.2307/1521108; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Campos-Silva JV, 2018, NAT SUSTAIN, V1, P650, DOI 10.1038/s41893-018-0170-5; Campos-Silva JV, 2017, PERSPECT ECOL CONSER, V15, P266, DOI 10.1016/j.pecon.2017.08.004; Campos-Silva JV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34745; Cantarelli VH, 2014, CHELONIAN CONSERV BI, V13, P124, DOI 10.2744/CCB-0926.1; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Cintra R, 2019, HYDROBIOLOGIA, V826, P43, DOI 10.1007/s10750-018-3676-y; Cintra R, 2015, HYDROBIOLOGIA, V747, P235, DOI 10.1007/s10750-014-2148-2; Cvitanovic C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05977-w; Davenport LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144994; de Freitas CT, 2020, PEOPLE NAT, V2, P61, DOI 10.1002/pan3.10064; DUDGEON D, 1992, HYDROBIOLOGIA, V248, P167, DOI 10.1007/BF00006146; Endo W, 2014, BIRD CONSERV INT, V24, P518, DOI 10.1017/S0959270914000173; Evans L, 2011, J ENVIRON MANAGE, V92, P1938, DOI 10.1016/j.jenvman.2011.03.010; GOTMARK F, 1984, ANIM BEHAV, V32, P485, DOI 10.1016/S0003-3472(84)80285-7; GROOM MJ, 1992, ECOLOGY, V73, P785, DOI 10.2307/1940157; Hawes JE, 2016, BIOTROPICA, V48, P465, DOI 10.1111/btp.12315; Hawes JE, 2014, J TROP ECOL, V30, P381, DOI 10.1017/S0266467414000261; Hawes JE, 2012, FOREST ECOL MANAG, V281, P163, DOI 10.1016/j.foreco.2012.06.023; Horns JJ, 2018, CURR BIOL, V28, pR980, DOI 10.1016/j.cub.2018.06.032; Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960; Legendre P., DEV ENV MODELLING, V20, P2089; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; Levis C, 2020, NAT ECOL EVOL, V4, P172, DOI 10.1038/s41559-019-1093-x; Martinez-Abrain A, 2016, ARDEOLA, V63, P79, DOI 10.13157/arla.63.1.2016.rp4; Ministerio do Meio Ambiente,, SIST NAC UN CONS SNU; Newton P, 2011, FOREST ECOL MANAG, V261, P255, DOI 10.1016/j.foreco.2010.10.014; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Palestis BG, 2014, CURR ZOOL, V60, P500, DOI 10.1093/czoolo/60.4.500; PALMEIRIM JM, 1994, J FIELD ORNITHOL, V65, P17; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PERES CA, 1995, CONSERV BIOL, V9, P34, DOI 10.1046/j.1523-1739.1995.09010034.x; Pezzuti JCB, 2010, J ETHNOBIOL, V30, P153, DOI 10.2993/0278-0771-30.1.153; Prestes-Carneiro G, 2016, J ARCHAEOL SCI-REP, V8, P454, DOI 10.1016/j.jasrep.2015.10.033; Raeder F. L., 2003, Braz. J. Biol., V63, P545; Rebelo G.H., 2000, AMBIENT SOC, V6, P85, DOI [10.1590/S1414-753X2000000100005, DOI 10.1590/S1414-753X2000000100005]; Runge CA, 2015, SCIENCE, V350, P1255, DOI 10.1126/science.aac9180; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schneider L, 2011, CHELONIAN CONSERV BI, V10, P149, DOI 10.2744/CCB-0848.1; Schuchmann KL, 2018, STUD NEOTROP FAUNA E, V53, P219, DOI 10.1080/01650521.2018.1479951; Sekercioglu CH, 2012, BIOL CONSERV, V151, P69, DOI 10.1016/j.biocon.2011.10.024; SMITH NJH, 1979, BIOL CONSERV, V16, P165, DOI 10.1016/0006-3207(79)90019-3; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wood KA, 2019, BIOL CONSERV, V230, P67, DOI 10.1016/j.biocon.2018.12.010; Young HS, 2015, BIOL CONSERV, V181, P226, DOI 10.1016/j.biocon.2014.10.027; Zarza R, 2013, WATERBIRDS, V36, P470, DOI 10.1675/063.036.0404; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	56	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0250022	10.1371/journal.pone.0250022	http://dx.doi.org/10.1371/journal.pone.0250022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831125	Green Accepted, Green Published, gold			2022-12-26	WOS:000639359600120
J	Son, J; Kim, D				Son, Jeongtae; Kim, Dongsup			Development of a graph convolutional neural network model for efficient prediction of protein-ligand binding affinities	PLOS ONE			English	Article							SCORING FUNCTIONS	Prediction of protein-ligand interactions is a critical step during the initial phase of drug discovery. We propose a novel deep-learning-based prediction model based on a graph convolutional neural network, named GraphBAR, for protein-ligand binding affinity. Graph convolutional neural networks reduce the computational time and resources that are normally required by the traditional convolutional neural network models. In this technique, the structure of a protein-ligand complex is represented as a graph of multiple adjacency matrices whose entries are affected by distances, and a feature matrix that describes the molecular properties of the atoms. We evaluated the predictive power of GraphBAR for protein-ligand binding affinities by using PDBbind datasets and proved the efficiency of the graph convolution. Given the computational efficiency of graph convolutional neural networks, we also performed data augmentation to improve the model performance. We found that data augmentation with docking simulation data could improve the prediction accuracy although the improvement seems not to be significant. The high prediction performance and speed of GraphBAR suggest that such networks can serve as valuable tools in drug discovery.	[Son, Jeongtae; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kim, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea.	kds@kaist.ac.kr		Kim, Dongsup/0000-0002-5916-6799	National Research Foundation of Korea (NRF) [2017M3A9C4065952, 2019R1A2C1007951]; Korea Government (MSIT)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Government (MSIT)(Korean Government)	This work was supported by the National Research Foundation of Korea (NRF) grants (2017M3A9C4065952, 2019R1A2C1007951) funded by the Korea Government (MSIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Alhossary A, 2015, BIOINFORMATICS, V31, P2214, DOI 10.1093/bioinformatics/btv082; Altae-Tran H, 2017, ACS CENTRAL SCI, V3, P283, DOI 10.1021/acscentsci.6b00367; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Francoeur P., 2020, J CHEM INF MODEL; Gomes J., 2017, ARXIV PREPRINT ARXIV; Hinton GE., 2017, ADV NEURAL INFORM PR; Karimi M, 2019, BIOINFORMATICS, V35, P3329, DOI 10.1093/bioinformatics/btz111; Li Y, 2014, J CHEM INF MODEL, V54, P1700, DOI 10.1021/ci500080q; Li Y, 2014, J CHEM INF MODEL, V54, P1717, DOI 10.1021/ci500081m; Lio P, 2017, STAT-US; Liu ZH, 2015, BIOINFORMATICS, V31, P405, DOI 10.1093/bioinformatics/btu626; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ryu S., 2019, ARXIV PREPRINT ARXIV; Stepniewska-Dziubinska MM, 2018, BIOINFORMATICS, V34, P3666, DOI 10.1093/bioinformatics/bty374; Nguyen T, 2021, BIOINFORMATICS, V37, P1140, DOI 10.1093/bioinformatics/btaa921; Torng W, 2019, J CHEM INF MODEL, V59, P4131, DOI 10.1021/acs.jcim.9b00628; Wallach I., 2016, ABSTR PAP AM CHEM S, P251	18	16	16	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249404	10.1371/journal.pone.0249404	http://dx.doi.org/10.1371/journal.pone.0249404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831016	Green Published, gold			2022-12-26	WOS:000639359600008
J	Jud, NA; Allen, SE; Nelson, CW; Bastos, CL; Chery, JG				Jud, Nathan A.; Allen, Sarah E.; Nelson, Chris W.; Bastos, Carolina L.; Chery, Joyce G.			Climbing since the early Miocene: The fossil record of Paullinieae (Sapindaceae)	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; PANAMA CENTRAL-AMERICA; MID-BURDIGALIAN PART; WOOD-ANATOMY; NEOTROPICAL PALEOBOTANY; SAO-PAULO; PHYTOGEOGRAPHIC HISTORY; CUCARACHA FORMATION; VASCULAR CYLINDER; TROPICAL LIANAS	Paullinieae are a diverse group of tropical and subtropical climbing plants that belong to the soapberry family (Sapindaceae). The six genera in this tribe make up approximately one-quarter of the species in the family, but a sparse fossil record limits our understanding of their diversification. Here, we provide the first description of anatomically preserved fossils of Paullinieae and we re-evaluate other macrofossils that have been attributed to the tribe. We identified permineralized fossil roots in collections from the lower Miocene Cucaracha Formation where it was exposed along the Culebra Cut of the Panama Canal. We prepared the fossils using the cellulose acetate peel technique and compared the anatomy with that of extant Paullinieae. The fossil roots preserve a combination of characters found only in Paullinieae, including peripheral secondary vascular strands, vessel dimorphism, alternate intervessel pitting with coalescent apertures, heterocellular rays, and axial parenchyma strands of 2-4 cells, often with prismatic crystals. We also searched the paleontological literature for other occurrences of the tribe. We re-evaluated leaf fossils from western North America that have been assigned to extant genera in the tribe by comparing their morphology to herbarium specimens and cleared leaves. The fossil leaves that were assigned to Cardiospermum and Serjania from the Paleogene of western North America are likely Sapindaceae; however, they lack diagnostic characters necessary for inclusion in Paullinieae and should be excluded from those genera. Therefore, the fossils described here as Ampelorhiza heteroxylon gen. et sp. nov. are the oldest macrofossil evidence of Paullinieae. They provide direct evidence of the development of a vascular cambial variant associated with the climbing habit in Sapindaceae and provide strong evidence of the diversification of crown-group Paullinieae in the tropics by 18.5-19 million years ago.	[Jud, Nathan A.] William Jewell Coll, Dept Biol, Liberty, MO 64068 USA; [Allen, Sarah E.] Penn State Altoona, Dept Biol, Altoona, PA USA; [Jud, Nathan A.; Nelson, Chris W.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Bastos, Carolina L.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Lab Plant Anat, Sao Paulo, SP, Brazil; [Chery, Joyce G.] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Biol & LH Bailey Hortorium, Ithaca, NY 14850 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; State University System of Florida; University of Florida; Universidade de Sao Paulo; Cornell University	Jud, NA (corresponding author), William Jewell Coll, Dept Biol, Liberty, MO 64068 USA.; Jud, NA (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.; Chery, JG (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Biol & LH Bailey Hortorium, Ithaca, NY 14850 USA.	judn@william.jewell.edu; jgc235@cornell.edu		Allen, Sarah/0000-0003-3269-3174; Onyenedum, Joyce/0000-0002-1047-9807; Jud, Nathan/0000-0001-6100-9779	National Science Foundation (NSF) [0966884]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	This study received support from the National Science Foundation (NSF) Award Number 0966884. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acevedo-Rodriguez P., 2011, V10, P357; Acevedo-Rodriguez P, 2017, SYST BOT, V42, P96, DOI 10.1600/036364417X694926; ACEVEDORODRIGUEZ P, 1993, SYST BOT, V18, P379, DOI 10.2307/2419414; Allen SE, 2017, UPPERMOST LOWER EOCE; [Anonymous], 1974, EARLY MIDDLE EOCENE; Bastos CL, 2016, ANN BOT-LONDON, V118, P733, DOI 10.1093/aob/mcw091; Bastos CL, 2015, THESIS U SAO PAULO; Becker HF., 1961, OLIGOCENE PLANTS UPP, V82; Bellonzi TK, 2020, ACTA BOT BRAS, V34, P327, DOI 10.1590/0102-33062020abb0022; Berry EW, 1918, NATL MUSEUM B, V103, P15; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brown R. W., 1929, ADDITIONS FLORA GREE, P279; Brown RW, 1934, RECOGNIZABLE SPECIES; Buchs DM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37790-2; Buerki S, 2013, ANN BOT-LONDON, V112, P151, DOI 10.1093/aob/mct106; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Buerki S, 2010, PLANT ECOL EVOL, V143, P148, DOI 10.5091/plecevo.2010.437; Buerki S, 2009, MOL PHYLOGENET EVOL, V51, P238, DOI 10.1016/j.ympev.2009.01.012; CARLQUIST S, 1981, B TORREY BOT CLUB, V108, P324, DOI 10.2307/2484711; CARLQUIST S, 1985, Aliso, V11, P139; Carlquist S., 2001, COMP WOOD ANATOMY; Carlquist S., 1991, BIOL VINES, P53, DOI DOI 10.1017/CBO9780511897658.004; Chery JG, 2020, IAWA J, V41, P278, DOI 10.1163/22941932-bja10027; Chery JG, 2020, CURR BIOL, V30, P237, DOI 10.1016/j.cub.2019.11.003; Chery JG, 2019, MOL PHYLOGENET EVOL, V140, DOI 10.1016/j.ympev.2019.106577; Neto ILD, 2018, BOT J LINN SOC, V186, P66, DOI 10.1093/botlinnean/box080; Neto ILD, 2017, FLORA, V235, P29, DOI 10.1016/j.flora.2017.09.001; dos Santos DB, 2010, REV BRAS PALEONTOLOG, V13, P205, DOI 10.4072/rbp.2010.3.05; Dos Santos MA, 2013, REV BRAS PALEONTOLOG, V16, P465, DOI 10.4072/rbp.2013.3.07; DUARTE L, 1983, AN ACAD BRAS CIENC, V55, P109; Edwards WN, 1928, FOSSILUM CATALOGUS, P1; Enquist B.J., 2016, PEERJ, V4, DOI DOI 10.7287/PEERJ.PREPRINTS.2615V2; ERWIN DM, 1990, CAN J BOT, V68, P2025, DOI 10.1139/b90-265; Ewers FW, 1997, IAWA J, V18, P261, DOI 10.1163/22941932-90001490; EWERS FW, 1990, OECOLOGIA, V84, P544, DOI 10.1007/BF00328172; Ferrucci MS, 1993, BONPLANDIA, V6, P211; Fittipaldi FC., 1989, B IG USP PUBLICAO ES, V7, P183; Gandolfo MA, 2008, ANN MO BOT GARD, V95, P34, DOI 10.3417/2007064; Gasson PE, 1989, IAWA J; GBIF.org, 2021, GBIF OCC DOWNL, DOI [10.15468/dl.7yscgt, DOI 10.15468/DL.7YSCGT]; Gentry A.H., 1991, BIOL VINES, P3; Gildenhuys E., 2013, NeoBiota, P45; Gildenhuys E, 2015, DIVERS DISTRIB, V21, P163, DOI 10.1111/ddi.12261; GRAHAM A, 1985, ANN MO BOT GARD, V72, P504, DOI 10.2307/2399101; GRAHAM A, 1991, ANN MO BOT GARD, V78, P465, DOI 10.2307/2399574; GRAHAM A, 1976, ANN MO BOT GARD, V63, P787, DOI 10.2307/2395250; GRAHAM A, 1987, AM J BOT, V74, P1519, DOI 10.2307/2444046; GRAY J, 1960, SCIENCE, V132, P808, DOI 10.1126/science.132.3430.808; Harrington MG, 2005, SYST BOT, V30, P366, DOI 10.1600/0363644054223549; Hendy AJW, 2013, PALAIOS, V28, P210, DOI 10.2110/palo.2012.p12-024r; HERRERA F, 2014, PALEOBOTANY BIOGEOGR, P124; Herrera F, 2014, THESIS U FLORIDA GAI; Herrera F, 2019, INT J PLANT SCI, V180, P479, DOI 10.1086/703551; Herrera F, 2010, INT J PLANT SCI, V171, P392, DOI 10.1086/651229; Hohna S, 2016, SYST BIOL, V65, P726, DOI 10.1093/sysbio/syw021; Jaramillo C., 2019, MORPHOLOGICAL ELECT; Jaramillo C.A., 2014, PALEOBOTANY BIOGEOGR, P134; Johnson KR., 1995, GREEN RIVER FORMATIO, P121; JOHNSON MA, 1956, AM J BOT, V43, P509, DOI 10.2307/2438891; JOY K. W., 1956, ANN BOT, V20, P635; Jud NA, 2017, AM J BOT, V104, P685, DOI 10.3732/ajb.1700080; Jud NA, 2016, AM J BOT, V103, P277, DOI 10.3732/ajb.1500425; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; Klaassen R., 1999, IAWA J; Knowlton FH., 1923, REVISION FLORA GREEN, P131; Leopold E.B., 1972, FLORISTICS PALEOFLOR, P147; Lesquereux L, 1883, REPORT US GEOLOGICAL, V8, P1; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lielke Kevin, 2012, Acta Palaeobotanica, V52, P317; Lira Lopes Willian Adriano, 2017, Journal of the Botanical Research Institute of Texas, V11, P421; MacFadden BJ, 2014, J GEOL, V122, P113, DOI 10.1086/675244; MacGinitie H.D., 1969, EOCENE GREEN RIVER F; MacGinitie HD, 1953, CARNEGIE I WASHINGTO, V599; Maitner BS, 2018, METHODS ECOL EVOL, V9, P373, DOI 10.1111/2041-210X.12861; Manchester S. R., 2001, PROC DENVER MUS NAT, V4, P137; McClain AM, 2001, AM J BOT, V88, P1316, DOI 10.2307/3558343; Metcalfe C.R., 1950, ANATOMY DICOTYLEDONS; Montes C, 2012, GEOL SOC AM BULL, V124, P780, DOI 10.1130/B30528.1; Muellner-Riehl AN, 2016, TAXON, V65, P1019, DOI 10.12705/655.5; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Nelson CW, 2017, INT J PLANT SCI, V178, P241, DOI 10.1086/689618; Obaton M., 1960, Ann. Sci. nat., Bot., V1, P1; Pellissari LCO, 2018, FLORA, V246, P71, DOI 10.1016/j.flora.2018.07.002; PATEL RN, 1965, HOLZFORSCHUNG, V19, P72, DOI 10.1515/hfsg.1965.19.3.72; Pfeiffer HH, 1926, HDB PFLANZENANATOMIE, V9; R Core Team, 2020, R LANG ENV STAT COMP; Radlkofer L, 1933, SAPINDACEAE; Radlkofer L., 1895, NATURLICHEN PFLANZEN, V3, P277; Ramirez DA, 2016, GEOCHEM GEOPHY GEOSY, V17, P1758, DOI 10.1002/2016GC006289; Retallack GJ, 2007, PALAIOS, V22, P667, DOI 10.2110/palo.2006.p06-130r; Rodriguez-Reyes O, 2017, IAWA J, V38, P437, DOI 10.1163/22941932-20170178; Rodriguez-Reyes O, 2017, REV PALAEOBOT PALYNO, V246, P44, DOI 10.1016/j.revpalbo.2017.06.005; Rodriguez-Reyes O, 2014, REV PALAEOBOT PALYNO, V209, P11, DOI 10.1016/j.revpalbo.2014.05.006; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosell JA, 2014, PERSPECT PLANT ECOL, V16, P288, DOI 10.1016/j.ppees.2014.08.001; Rzedowski J, 1993, ACTA BOTANICA MEXICA, V24, P1; Schenck H, 1892, BEITRAGE BIOL ANATOM, P4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Scrucca L, 2016, R J, V8, P289; Tamaio N, 2011, FLORA, V206, P987, DOI 10.1016/j.flora.2011.07.006; Tamaio N, 2011, CERNE, V17, P533, DOI 10.1590/S0104-77602011000400012; Tamaio N, 2010, J TORREY BOT SOC, V137, P319, DOI 10.3159/10-RA-047.1; van der Heijden GMF, 2009, J BIOGEOGR, V36, P1561, DOI 10.1111/j.1365-2699.2009.02099.x; Van der Walt JJA., 1973, KIRKIA, V9, P109; VANDERHAM RWJM, 1994, REV PALAEOBOT PALYNO, V83, P43, DOI 10.1016/0034-6667(94)90056-6; Wolfe J.A., 1987, S GEO SURV B, V1597, P1	109	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0248369	10.1371/journal.pone.0248369	http://dx.doi.org/10.1371/journal.pone.0248369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826635	Green Published, gold			2022-12-26	WOS:000638119900015
J	Pannewick, B; Baier, C; Schwab, F; Vonberg, RP				Pannewick, Beke; Baier, Claas; Schwab, Frank; Vonberg, Ralf-Peter			Infection control measures in nosocomial MRSA outbreaks-Results of a systematic analysis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PRECAUTIONS; CULTURES	There is a lack of data on factors that contribute to the implementation of hygiene measures during nosocomial outbreaks (NO) caused by Methicillin-resistant Staphylococcus aureus (MRSA). Therefore, we first conducted a systematic literature analysis to identify MRSA outbreak reports. The expenditure for infection control in each outbreak was then evaluated by a weighted cumulative hygiene score (WCHS). Effects of factors on this score were determined by multivariable linear regression analysis. 104 NO got included, mostly from neonatology (n = 32), surgery (n = 27), internal medicine and burn units (n = 10 each), including 4,361 patients (thereof 657 infections and 73 deaths) and 279 employees. The outbreak sources remained unknown in 10 NO and were not reported from further 61 NO. The national MRSA prevalence did not correlate with the WCHS (p = .714). There were significant WCHS differences for internal medicine (p = 0.014), burn units (p<0.01), for Japanese NO (p<0.01), and NO with an unknown source (p<0.01). In sum, management of a NO due to MRSA does not depend on the local MRSA burden. However, differences of MRSA management among medical departments do exist. Strict adherence to the Outbreak Reports and Intervention Studies Of Nosocomial infection (ORION) statement is highly recommended for. The WCHS may also serve as a useful tool to quantify infection control effort and could therefore be used for further investigations.	[Pannewick, Beke; Baier, Claas; Vonberg, Ralf-Peter] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Schwab, Frank] Charite Univ Med Berlin, Inst Hyg & Environm Hlth, Berlin, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Vonberg, RP (corresponding author), Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany.	Vonberg.Ralf@mh-hannover.de		Vonberg, Ralf-Peter/0000-0001-7706-8511; Baier, Claas/0000-0003-3895-5446				Demling Robert H, 2007, J Burns Wounds, V7, pe8; Eriksson BKG, 2019, EUR J CLIN MICROBIOL, V38, P2221, DOI 10.1007/s10096-019-03664-2; European Centre for Disease Prevention and Control, 2018, ANN REPORT EUROPEAN; Gastmeier P, 2006, AM J INFECT CONTROL, V34, P603, DOI 10.1016/j.ajic.2006.01.014; German Society for Burn Medicine, 2020, REC STRUCT STAFF BUR; Hansen S, 2010, INFECTION, V38, P159, DOI 10.1007/s15010-010-0001-8; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Imataki O, 2006, AM J HEMATOL, V81, P664, DOI 10.1002/ajh.20668; Kanerva M, 2007, J HOSP INFECT, V66, P22, DOI 10.1016/j.jhin.2007.02.014; Karchmer TB, 2002, J HOSP INFECT, V51, P126, DOI 10.1053/jhin.2002.1200; Kobayashi T, 2020, J INFECT CHEMOTHER, V26, P76, DOI 10.1016/j.jiac.2019.07.009; Kock R, 2014, EUROSURVEILLANCE, V19, P23, DOI 10.2807/1560-7917.ES2014.19.29.20860; Lachiewicz AM, 2017, CLIN INFECT DIS, V65, P2130, DOI 10.1093/cid/cix682; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lopez-Alcalde J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007087.pub2; McKinnell JA, 2015, INFECT CONT HOSP EP, V36, P2, DOI 10.1017/ice.2014.1; Mitani N, 2005, JPN J INFECT DIS, V58, P250; Mizuno S, 2018, J HOSP INFECT, V100, P280, DOI 10.1016/j.jhin.2018.06.026; Nagao M, 2010, AM J INFECT CONTROL, V38, pE37, DOI 10.1016/j.ajic.2010.04.214; Nakano M, 2002, MICROBIOL IMMUNOL, V46, P277, DOI 10.1111/j.1348-0421.2002.tb02696.x; National Reference Center for the Surveillance of Nosocomial Infection [Nationales Referenzzentrum fur Surveillance von nosokomialen Infektionen]. German, GERM NAT POINT PREV; Pasricha J, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-17; Rampling A, 2001, J HOSP INFECT, V49, P109, DOI 10.1053/jhin.2001.1013; Singh K, 2003, J CLIN MICROBIOL, V41, P2755, DOI 10.1128/JCM.41.6.2755-2757.2003; Stone SP, 2007, J ANTIMICROB CHEMOTH, V59, P833, DOI 10.1093/jac/dkm055; Turner NA, 2019, NAT REV MICROBIOL, V17, P203, DOI 10.1038/s41579-018-0147-4; VandenbrouckeGrauls CMJE, 1996, INFECT CONT HOSP EP, V17, P512; Verhoef J, 1999, EUR J CLIN MICROBIOL, V18, P461, DOI 10.1007/s100960050324; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Vonberg RP, 2011, INFECTION, V39, P29, DOI 10.1007/s15010-010-0064-6	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249837	10.1371/journal.pone.0249837	http://dx.doi.org/10.1371/journal.pone.0249837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826678	gold, Green Published			2022-12-26	WOS:000638119900034
J	Zhang, WZ; Azibani, F; Okello, E; Kayima, J; Sinabulya, I; Leeta, J; Walusansa, V; Orem, J; Sliwa, K				Zhang, Wanzhu; Azibani, Feriel; Okello, Emmy; Kayima, James; Sinabulya, Isaac; Leeta, Joseph; Walusansa, Victoria; Orem, Jackson; Sliwa, Karen			Clinical characterization, cardiovascular risk factor profile and cardiac strain analysis in a Uganda cancer population: The SATRACD study	PLOS ONE			English	Article							LEFT-VENTRICULAR STRAIN; SPECKLE TRACKING	Background The link between cancer and cardiovascular disease is firmly established. We sought to investigate the prevalence of cardiovascular disease (CVD) risk factors in Uganda cancer patients, their pre-chemotherapy left ventricular strain echocardiographic pattern and its associations with the CVD risk factors. Methods and results Baseline pre-chemotherapy data of patients who were enrolled in the SATRACD study (a cancer cohort, who were planned for anthracycline therapy), were analyzed. The prevalence of cardiovascular risk factors and baseline strain echocardiographic images were assessed. Among the 355 patients who were recruited over a period of 15 months, 283 (79.7%) were female, with a mean age of 43 years. The types of cancer of the study patients included breast cancer (70.6%), lymphomas, sarcomas, leukemias and hepatocellular carcinoma. Hypertension was the most common comorbidity (27.0%). The prevalence of obesity was 12.1% and that of HIV was 18.3%. All patients had a normal left ventricular ejection fraction (LVEF). The mean global longitudinal strain (GLS) was -20.92 2.43%, with females having a significantly higher GLS than males (-21.09 +/- 2.42 vs -20.25 +/- 2.39, p = 0.008). Fifty-three patients (14.9%) had suboptimal GLS (absolute GLS <= 18.00%), which was associated with obesity (POR = 3.07; 95% CI, 1.31-6.98; p = 0.003), alcohol use (POR = 1.94; 95% CI, 1.01-3.74; p = 0.044), long QTc interval in electrocardiogram (POR = 2.54; 95% CI, 1.06-5.74; p = 0.015,) and impaired left ventricular relaxation (POR = 2.24; 95% CI, 1.17-4.25; p = 0.007). On multivariable logistic regression analysis, obesity (POR = 2.95; 95% CI, 1.24-7.03; p = 0.014) was the only independent factor associated with suboptimal GLS. Conclusion There is high prevalence and a unique pattern of cardiovascular risk factors in Uganda cancer patients. In cancer patients with cardiovascular risk conditions, there is reduction in GLS despite preserved LVEF. Longitudinal research is needed to study the predictive value of cardiovascular risk factors and baseline GLS for post chemotherapy cardiac dysfunction.	[Zhang, Wanzhu; Azibani, Feriel; Sliwa, Karen] Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa; [Zhang, Wanzhu; Okello, Emmy; Kayima, James; Sinabulya, Isaac] Uganda Heart Inst, Kampala, Uganda; [Zhang, Wanzhu; Okello, Emmy; Kayima, James; Sinabulya, Isaac] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Azibani, Feriel] UMRS 942 Inserm, Paris, France; [Leeta, Joseph; Walusansa, Victoria; Orem, Jackson] Uganda Canc Inst, Kampala, Uganda	Makerere University; UDICE-French Research Universities; Universite Paris Cite	Zhang, WZ (corresponding author), Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa.; Zhang, WZ (corresponding author), Uganda Heart Inst, Kampala, Uganda.; Zhang, WZ (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.	zhangwanzhu2012@gmail.com	Zhang, Wanzhu/HHZ-3159-2022	Zhang, Wanzhu/0000-0002-9164-1772	NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences [D43TW010132]	NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences	The study is funded by NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences. WZ is the author who was awarded with the Grant. The Grant Number is D43TW010132. The founder had a role in study design.	Bahendeka S, 2016, TROP MED INT HEALTH, V21, P405, DOI 10.1111/tmi.12663; Blanco JG, 2012, J CLIN ONCOL, V30, P1415, DOI 10.1200/JCO.2011.34.8987; Bogaert J, 2001, AM J PHYSIOL-HEART C, V280, pH610; Csige I, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3407306; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Iyengar NM, 2016, J CLIN ONCOL, V34, P4270, DOI 10.1200/JCO.2016.67.4283; Kou S, 2014, EUR HEART J-CARD IMG, V15, P680, DOI 10.1093/ehjci/jet284; Kuznetsova T, 2008, EUR HEART J, V29, P2014, DOI 10.1093/eurheartj/ehn280; Mornos C, 2013, CAN J PHYSIOL PHARM, V91, P601, DOI 10.1139/cjpp-2012-0398; Narayanan A, 2009, CIRC-CARDIOVASC IMAG, V2, P382, DOI 10.1161/CIRCIMAGING.108.811620; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; Plana JC, 2014, J AM SOC ECHOCARDIOG, V27, P911, DOI [10.1016/j.echo.2014.07.012, 10.1093/ehjci/jeu192]; Schwartz JI, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0077-5; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Triant VA, 2013, CURR HIV-AIDS REP, V10, P199, DOI 10.1007/s11904-013-0168-6; Ugandan Bureau of Statistics, 2014, NAT CENS MAIN REP; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Xia HM, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01559-1; Yang H, 2018, JACC-CARDIOVASC IMAG, V11, P1196, DOI 10.1016/j.jcmg.2018.07.005; Yuan LJ, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-7	20	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249717	10.1371/journal.pone.0249717	http://dx.doi.org/10.1371/journal.pone.0249717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826674	gold, Green Published			2022-12-26	WOS:000638119900042
J	Adamus, K; Reboul, C; Voss, J; Huang, C; Schittenhelm, RB; Le, SN; Ellisdon, AM; Elmlund, H; Boudes, M; Elmlund, D				Adamus, Klaudia; Reboul, Cyril; Voss, Jarrod; Huang, Cheng; Schittenhelm, Ralf B.; Le, Sarah N.; Ellisdon, Andrew M.; Elmlund, Hans; Boudes, Marion; Elmlund, Dominika			SAGA and SAGA-like SLIK transcriptional coactivators are structurally and biochemically equivalent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2B DEUBIQUITINATION; SACCHAROMYCES-CEREVISIAE; ACETYLATED HISTONES; COMPLEX; BINDING; PROTEIN; SPT3; RECRUITMENT; ACTIVATION; COMPONENTS	The SAGA-like complex SLIK is a modified version of the Spt-Ada-Gcn5-Acetyltransferase (SAGA) complex. SLIK is formed through C-terminal truncation of the Spt7 SAGAsubunit, causing loss of Spt8, one of the subunits that interacts with the TATA-binding protein (TBP). SLIK and SAGA are both coactivators of RNA polymerase II transcription in yeast, and both SAGA and SLIK perform chromatin modifications. The two complexes have been speculated to uniquely contribute to transcriptional regulation, but their respective contributions are not clear. To investigate, we assayed the chromatinmodifying functions of SAGA and SLIK, revealing identical kinetics on minimal substrates in vitro. We also examined the binding of SAGA and SLIK to TBP and concluded that interestingly, both protein complexes have similar affinity for TBP. Additionally, despite the loss of Spt8 and C-terminus of Spt7 in SLIK, TBPprebound to SLIKis not released in the presence of TATA-box DNA, just like TBP prebound to SAGA. Furthermore, we determined a low-resolution cryo-EM structure of SLIK, revealing a modular architecture identical to SAGA. Finally, we performed a comprehensive study of DNA-binding properties of both coactivators. Purified SAGA and SLIK both associate with ssDNA and dsDNA with high affinity (K-D = 10-17 nM), and the binding is sequence-independent. In conclusion, our study shows that the cleavage of Spt7 and the absence of the Spt8 subunit in SLIK neither drive any major conformational differences in its structure comparedwith SAGA, nor significantly affect HAT, DUB, or DNA-binding activities in vitro.	[Adamus, Klaudia; Reboul, Cyril; Voss, Jarrod; Le, Sarah N.; Ellisdon, Andrew M.; Elmlund, Hans; Boudes, Marion; Elmlund, Dominika] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Huang, Cheng; Schittenhelm, Ralf B.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Monash Prote & Metabol Facil, Clayton, Vic, Australia; [Elmlund, Dominika] FB Rice, 33-477 Collins St, Melbourne, Vic 3000, Australia; [Le, Sarah N.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA	Monash University; Monash University; Harvard University; Harvard Medical School	Boudes, M; Elmlund, D (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia.; Elmlund, D (corresponding author), FB Rice, 33-477 Collins St, Melbourne, Vic 3000, Australia.	marion.boudes@monash.edu; dominika.elmlund@monash.edu		Boudes, Marion/0000-0003-2577-710X; LE, SARAH/0000-0003-1156-2597; Reboul, Cyril/0000-0002-6258-2697; Schittenhelm, Ralf/0000-0001-8738-1878	Australian Research Council [DP170101850]; National Health and Medical Research Council, Australia [APP1125909, APP1122769]	Australian Research Council(Australian Research Council); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	H. E. acknowledges the Australian Research Council grant DP170101850 and the National Health and Medical Research Council, Australia, grant APP1125909. C. R. acknowledges Early Career Fellowship (APP1122769).	Aakio T, 2020, J CELL SCI, V133; Adamus K, 2019, J STRUCT BIOL, V207, P327, DOI 10.1016/j.jsb.2019.07.004; Baptista T, 2017, MOL CELL, V68, P130, DOI 10.1016/j.molcel.2017.08.016; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Clouaire T, 2018, MOL CELL, V72, P250, DOI 10.1016/j.molcel.2018.08.020; Diaz-Santin LM, 2017, ELIFE, V6, DOI 10.7554/eLife.28384; Doriczew R, 2020, LIFE, V9, P28; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; EISENMANN DM, 1994, GENETICS, V137, P647; Eopytova D, 2018, CELL CYCLE, V17, P1870; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoke Stephen Mt, 2007, BMC Biochemistry, V8, P16, DOI 10.1186/1471-2091-8-16; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Koehler C, 2014, J BIOL CHEM, V289, P8989, DOI 10.1074/jbc.M113.500868; Laprade L, 2007, GENETICS, V177, P2007, DOI 10.1534/genetics.107.081976; Lim S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3641; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mittal C, 2018, J BIOL CHEM, V293, P13736, DOI 10.1074/jbc.RA118.004487; Mohan RD, 2014, GENE DEV, V28, P259, DOI 10.1101/gad.225151.113; Morari F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00314; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Papai G, 2020, NATURE, V577, P711, DOI 10.1038/s41586-020-1944-2; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Ramachandran S, 2016, CELL REP, V15, P1554, DOI 10.1016/j.celrep.2016.04.041; Reboul CF, 2018, PROTEIN SCI, V27, P51, DOI 10.1002/pro.3266; Reboul CF, 2016, STRUCTURE, V24, P988, DOI 10.1016/j.str.2016.04.006; Ringel AE, 2015, P NATL ACAD SCI USA, V112, pE5461, DOI 10.1073/pnas.1508449112; Roberts SM, 1997, GENETICS, V147, P451; Samara NL, 2012, STRUCTURE, V20, P1414, DOI 10.1016/j.str.2012.05.015; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Setiaputra D, 2015, J BIOL CHEM, V290, P10057, DOI 10.1074/jbc.M114.624684; Sharif H, 2017, P NATL ACAD SCI USA, V114, P7367, DOI 10.1073/pnas.1707386114; Sharov G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01564-7; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Spedale G, 2010, J BIOL CHEM, V285, P22791, DOI 10.1074/jbc.M110.108787; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Strahl BD, 2021, BBA-GENE REGUL MECH, V1864, DOI 10.1016/j.bbagrm.2020.194600; Sun J, 2018, P NATL ACAD SCI USA, V115, P10010, DOI 10.1073/pnas.1805343115; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Wang HB, 2020, NATURE, V577, P717, DOI 10.1038/s41586-020-1933-5; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	58	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100671	10.1016/j.jbc.2021.100671	http://dx.doi.org/10.1016/j.jbc.2021.100671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864814	Green Published, gold			2022-12-26	WOS:000672866400642
J	Guo, X; Ramirez, I; Garcia, YA; Velasquez, EF; Gholkar, AA; Cohn, W; Whitelegge, JP; Tofig, B; Damoiseaux, R; Torres, JZ				Guo, Xiao; Ramirez, Ivan; Garcia, Yenni A.; Velasquez, Erick F.; Gholkar, Ankur A.; Cohn, Whitaker; Whitelegge, Julian P.; Tofig, Bobby; Damoiseaux, Robert; Torres, Jorge Z.			DUSP7 regulates the activity of ERK2 to promote proper chromosome alignment during cell division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ACTIVATED PROTEIN-KINASE; MAP KINASE; PHOSPHATASES; CYCLE; PHOSPHORYLATION; IDENTIFICATION; PROTEOMICS; PEPTIDES; PATHWAY	Human cell division is a highly regulated process that relies on the accurate capture and movement of chromosomes to the metaphase plate. Errors in the fidelity of chromosome congression and alignment can lead to improper chromosome segregation, which is correlated with aneuploidy and tumorigenesis. These processes are known to be regulated by extracellular signal-regulated kinase 2 (ERK2) in other species, but the role of ERK2 in mitosis in mammals remains unclear. Here, we have identified the dual-specificity phosphatase 7 (DUSP7), known to display selectivity for ERK2, as important in regulating chromosome alignment. During mitosis, DUSP7 bound to ERK2 and regulated the abundance of active phospho-ERK2 through its phosphatase activity. Overexpression of DUSP7, but not catalytically inactive mutants, led to a decrease in the levels of phospho-ERK2 and mitotic chromosome misalignment, while knockdown of DUSP7 also led to defective chromosome congression that resulted in a prolonged mitosis. Consistently, knockdown or chemical inhibition of ERK2 or chemical inhibition of the MEK kinase that phosphorylates ERK2 led to chromosome alignment defects. Our results support a model wherein MEK-mediated phosphorylation and DUSP7-mediated dephosphorylation regulate the levels of active phospho-ERK2 to promote proper cell division.	[Guo, Xiao; Ramirez, Ivan; Garcia, Yenni A.; Velasquez, Erick F.; Gholkar, Ankur A.; Torres, Jorge Z.] Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cohn, Whitaker; Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.; Torres, Jorge Z.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.; Torres, Jorge Z.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Tofig, Bobby; Damoiseaux, Robert] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Damoiseaux, Robert] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Torres, JZ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.	torres@chem.ucla.edu	; Damoiseaux, Robert/F-1086-2011	Torres, Jorge/0000-0002-2158-889X; Gholkar, Ankur/0000-0002-3490-234X; Whitelegge, Julian/0000-0003-2763-7733; Damoiseaux, Robert/0000-0002-7611-7534	NIH-NIGMS [R35GM139539, R01GM117475]; USHHS [T32CA009056]; HHMI through the James H. Gilliam Fellowships for Advanced Study Program; HHMI through the MBI Whitcome Fellowship; NIH [P30DK063491]; NCI [P30CA016042]	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USHHS; HHMI through the James H. Gilliam Fellowships for Advanced Study Program; HHMI through the MBI Whitcome Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported by NIH-NIGMS R35GM139539, R01GM117475 (J. Z. T.); USHHS T32CA009056 (Y. A. G.); a grant to the University of California, Los Angeles from the HHMI through the James H. Gilliam Fellowships for Advanced Study Program and an MBI Whitcome Fellowship (E. F. V); NIH P30DK063491 (J. P. W.) and NCI P30CA016042 (R. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bradley M, 2016, JOVE-J VIS EXP, DOI 10.3791/54870; Bryja V, 2017, CRIT REV BIOCHEM MOL, V52, P614, DOI 10.1080/10409238.2017.1350135; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Cheung K, 2016, MOL CELL PROTEOMICS, V15, P1658, DOI 10.1074/mcp.M115.056465; Combes G, 2017, ONCOGENE, V36, P4819, DOI 10.1038/onc.2017.113; Cuyas E, 2014, METHODS MOL BIOL, V1170, P113, DOI 10.1007/978-1-4939-0888-2_7; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Dowd S, 1998, J CELL SCI, V111, P3389; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Eblen ST, 2018, ADV CANCER RES, V138, P99, DOI 10.1016/bs.acr.2018.02.004; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Gholkar AA, 2016, CELL REP, V14, P180, DOI 10.1016/j.celrep.2015.12.035; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; HAYSTEAD TAJ, 1992, FEBS LETT, V306, P17, DOI 10.1016/0014-5793(92)80828-5; Heim A, 2017, ADV EXP MED BIOL, V953, P83, DOI 10.1007/978-3-319-46095-6_3; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844; Kim HS, 2016, MOL CELLS, V39, P654, DOI 10.14348/molcells.2016.0214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnaghi-Jaulin L, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010028; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Nichols A, 2000, J BIOL CHEM, V275, P24613, DOI 10.1074/jbc.M001515200; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Ong JY, 2020, CYTOSKELETON, V77, P558, DOI 10.1002/cm.21649; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pfender S, 2015, NATURE, V524, P239, DOI 10.1038/nature14568; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saurin AT, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00062; Seternes OM, 2019, BBA-MOL CELL RES, V1866, P124, DOI 10.1016/j.bbamcr.2018.09.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tischer T, 2016, CELL REP, V17, P1426, DOI 10.1016/j.celrep.2016.10.007; Torres JZ, 2011, CELL, V147, P1309, DOI 10.1016/j.cell.2011.11.020; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007	51	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100676	10.1016/j.jbc.2021.100676	http://dx.doi.org/10.1016/j.jbc.2021.100676			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865857	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400647
J	Hamilton, J; Brustovetsky, T; Brustovetsky, N				Hamilton, James; Brustovetsky, Tatiana; Brustovetsky, Nickolay			The effect of mitochondrial calcium uniporter and cyclophilin D knockout on resistance of brain mitochondria to Ca2+-induced damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CHAIN FATTY-ACIDS; CYCLOSPORINE-A; UPTAKE CAPACITY; INNER MEMBRANE; HEART-MITOCHONDRIA; CYTOCHROME-C; CA2+ RELEASE; MOUSE MODEL; LIVER	The mitochondrial calcium uniporter (MCU) and cyclophilin D (CyD) are key players in induction of the permeability transition pore (PTP), which leads to mitochondrial depolarization and swelling, the major signs of Ca2+-induced mitochondrial damage. Mitochondrial depolarization inhibits ATP production, whereas swelling results in the release of mitochondrial pro-apoptotic proteins. The extent to which simultaneous deletion of MCU and CyD inhibits PTP induction and prevents damage of brain mitochondria is not clear. Here, we investigated the effects of MCU and CyD deletion on the propensity for PTP induction using mitochondria isolated from the brains of MCU-KO, CyD-KO, and newly created MCU/CyD-double knockout (DKO) mice. Neither deletion of MCU nor of CyD affected respiration or membrane potential in mitochondria isolated from the brains of these mice. Mitochondria from MCU-KO and MCU/CyD-DKO mice displayed reduced Ca2+ uptake and diminished extent of PTP induction. The Ca2+ uptake by mitochondria from CyD-KO mice was increased compared with mitochondria from WT mice. Deletion of CyD prevented mitochondrial swelling and resulted in transient depolarization in response to Ca2+, but it did not prevent Ca2+-induced delayed mitochondrial depolarization. Mitochondria from MCU/CyD-DKO mice did not swell in response to Ca2+, but they did exhibit mild sustained depolarization. Dibucaine, an inhibitor of the Ca2+-activated mitochondrial phospholipase A2, attenuated and bovine serum albumin completely eliminated the sustained depolarization. This suggests the involvement of phospholipase A2 and free fatty acids. Thus, in addition to induction of the classical PTP, alternative deleterious mechanisms may contribute to mitochondrial damage following exposure to elevated Ca2+.	[Hamilton, James; Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Brustovetsky, Nickolay] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Brustovetsky, N (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Brustovetsky, N (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	nbrous@iu.edu		Brustovetsky, Nickolay/0000-0002-6564-2560	National Institutes of Health NINDS [R01 NS098772]	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a the National Institutes of Health NINDS grant R01 NS098772 to N. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bambrick LL, 2006, J BIOENERG BIOMEMBR, V38, P43, DOI 10.1007/s10863-006-9004-7; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 2002, VITAM HORM, V65, P97, DOI 10.1016/S0083-6729(02)65061-7; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardi P, 2020, P NATL ACAD SCI USA, V117, P2743, DOI 10.1073/pnas.1921035117; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bertholet A.M., 2019, ARCH BIOCHEM BIOPHYS, V571, p515; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Bisbach CM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72708-x; BJORNTORP P, 1964, J BIOL CHEM, V239, P339; BROEKEMEIER KM, 1985, J BIOL CHEM, V260, P105; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2017, NEUROMETHODS, V123, P199, DOI 10.1007/978-1-4939-6890-9_10; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; COX DA, 1993, TRENDS PHARMACOL SCI, V14, P408, DOI 10.1016/0165-6147(93)90063-P; CROMPTON M, 1988, BIOCHEM J, V255, P357; CROMPTON M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P214, DOI 10.1016/0005-2728(92)90228-T; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hamilton J, 2018, J BIOL CHEM, V293, P15652, DOI 10.1074/jbc.RA118.002926; HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kannurpatti SS, 2017, J CEREBR BLOOD F MET, V37, P381, DOI 10.1177/0271678X16680637; KRONER H, 1986, ARCH BIOCHEM BIOPHYS, V251, P525, DOI 10.1016/0003-9861(86)90360-7; Lai J.C.K., 1989, NEUROMETHODS, P43; Li T, 2010, BBA-BIOENERGETICS, V1797, P52, DOI 10.1016/j.bbabio.2009.07.012; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2017, NEUROCHEM INT, V109, P5, DOI 10.1016/j.neuint.2016.12.018; Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; NISHIDA T, 1989, J BIOCHEM-TOKYO, V106, P533, DOI 10.1093/oxfordjournals.jbchem.a122887; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pellman JJ, 2015, J NEUROCHEM, V134, P652, DOI 10.1111/jnc.13165; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; Perry GM, 2010, HUM MOL GENET, V19, P3354, DOI 10.1093/hmg/ddq247; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rustenbeck I, 1996, BBA-LIPID LIPID MET, V1304, P129, DOI 10.1016/S0005-2760(96)00113-0; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SCHONFELD P, 1989, BIOCHIM BIOPHYS ACTA, V977, P266, DOI 10.1016/S0005-2728(89)80080-5; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; SPECTOR AA, 1969, J LIPID RES, V10, P56; Sultan A, 2001, ARCH BIOCHEM BIOPHYS, V386, P37, DOI 10.1006/abbi.2000.2194; VODYANOY I, 1993, BIOPHYS J, V65, P2097, DOI 10.1016/S0006-3495(93)81245-1; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; ZURINI M, 1981, EUR J BIOCHEM, V119, P517, DOI 10.1111/j.1432-1033.1981.tb05638.x	67	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100669	10.1016/j.jbc.2021.100669	http://dx.doi.org/10.1016/j.jbc.2021.100669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864812	Green Published, gold			2022-12-26	WOS:000672866400640
J	Greiten, JK; Kliewe, F; Schnarre, A; Artelt, N; Schroder, S; Rogge, H; Amann, K; Daniel, C; Lindenmeyer, MT; Cohen, CD; Endlich, K; Endlich, N				Greiten, Jonas K.; Kliewe, Felix; Schnarre, Annabel; Artelt, Nadine; Schroeder, Sindy; Rogge, Henrik; Amann, Kerstin; Daniel, Christoph; Lindenmeyer, Maja T.; Cohen, Clemens D.; Endlich, Karlhans; Endlich, Nicole			The role of filamins in mechanically stressed podocytes	FASEB JOURNAL			English	Article						diabetic nephropathy; Flna; mechanosensor; mechanotransducer; mechanical load	ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; MONOCYTE SUBSETS; PROGNOSTIC-SIGNIFICANCE; HEART-FAILURE; RECRUITMENT; FRACTALKINE; KINETICS; CELLS; IDENTIFICATION	Glomerular hypertension induces mechanical load to podocytes, often resulting in podocyte detachment and the development of glomerulosclerosis. Although it is well known that podocytes are mechanosensitive, the mechanosensors and mechanotransducers are still unknown. Since filamin A, an actin-binding protein, is already described to be a mechanosensor and mechanotransducer, we hypothesized that filamins could be important for the outside-in signaling as well as the actin cytoskeleton of podocytes under mechanical stress. In this study, we demonstrate that filamin A is the main isoform of the filamin family that is expressed in cultured podocytes. Together with filamin B, filamin A was significantly up-regulated during mechanical stretch (3 days, 0.5 Hz, and 5% extension). To study the role of filamin A in cultured podocytes under mechanical stress, filamin A was knocked down (Flna KD) by specific siRNA. Additionally, we established a filamin A knockout podocyte cell line (Flna KO) by CRISPR/Cas9. Knockdown and knockout of filamin A influenced the expression of synaptopodin, a podocyte-specific protein, focal adhesions as well as the morphology of the actin cytoskeleton. Moreover, the cell motility of Flna KO podocytes was significantly increased. Since the knockout of filamin A has had no effect on cell adhesion of podocytes during mechanical stress, we simultaneously knocked down the expression of filamin A and B. Thereby, we observed a significant loss of podocytes during mechanical stress indicating a compensatory mechanism. Analyzing hypertensive mice kidneys as well as biopsies of patients suffering from diabetic nephropathy, we found an up-regulation of filamin A in podocytes in contrast to the control. In summary, filamin A and B mediate matrix-actin cytoskeleton interactions which are essential for the adaptation of cultured podocyte to mechanical stress.	[Greiten, Jonas K.; Kliewe, Felix; Schnarre, Annabel; Artelt, Nadine; Schroeder, Sindy; Rogge, Henrik; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Amann, Kerstin; Daniel, Christoph] Friedrich Alexander Univ FAU Erlangen Nuremberg, Dept Nephropathol, Erlangen, Germany; [Lindenmeyer, Maja T.] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany; [Cohen, Clemens D.] Univ Munich, Nephrol Ctr, Med Clin & Policlin 4, Munich, Germany	Greifswald Medical School; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Endlich, N (corresponding author), Univ Med Greifswald, Inst Anat & Zellbiol, Friedrich Loeffler Str 23c, D-17489 Greifswald, Germany.	nicole.endlich@uni-greifswald.de		Endlich, Karlhans/0000-0001-6052-6061	Research Network Molecular Medicine of the University Medicine Greifswald [FOVB-2018-02, FOVB-2019-04]; Federal Ministry of Education and Research (BMBF) [01GM1518B]; Else Kroner-Fresenius Foundation; Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (Germany); Martini et al JASN [11, 2559-2572]	Research Network Molecular Medicine of the University Medicine Greifswald; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Else Kroner-Fresenius Foundation; Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (Germany); Martini et al JASN	The authors thank Mandy Weise and Claudia Weber for technical assistance. The eGFP--synaptopodin plasmid was kindly provided by Anja Konietzny and Marina Mikhaylova (DFG Emmy Noether Group "Neuronal Protein Transport", Center for Molecular Neurobiology, University Medical Center Hamburg--Eppendorf, Hamburg, Germany). This work was supported by the Research Network Molecular Medicine of the University Medicine Greifswald [FOVB-2018-02 and FOVB-2019-04] and by a grant of the Federal Ministry of Education and Research (BMBF, grant 01GM1518B, STOP-FSGS) to Nicole Endlich. C.D.C and M.T.L are supported by the Else Kroner-Fresenius Foundation. We thank all participating centers of the European Renal cDNA Bank-Kroner-Fresenius Biopsy Bank (ERCB-KFB) and their patients for their cooperation. Active members at the time of the study are listed in ref. (Martini et al JASN 2014, Vol 25, No 11, 2559-2572). Part of the work was also supported by an Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) (Germany).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bianchini M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aar3054; Boag SE, 2015, J CLIN INVEST, V125, P3063, DOI 10.1172/JCI80055; Buscher K, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00080; Cahill TJ, 2017, WORLD J CARDIOL, V9, P407, DOI 10.4330/wjc.v9.i5.407; Chapman GA, 2000, EUR J PHARMACOL, V392, P189, DOI 10.1016/S0014-2999(00)00117-5; Chimen M, 2017, J IMMUNOL, V198, P2834, DOI 10.4049/jimmunol.1601281; Frangogiannis NG, 2015, CURR OPIN CARDIOL, V30, P240, DOI 10.1097/HCO.0000000000000158; Halkin A, 2005, AM J CARDIOL, V96, P325, DOI 10.1016/j.amjcard.2005.03.069; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jung K, 2013, CIRC RES, V112, P891, DOI 10.1161/CIRCRESAHA.111.300484; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lewis EF, 2003, J AM COLL CARDIOL, V42, P1446, DOI 10.1016/S0735-1097(03)01057-X; Liebetrau C, 2015, CIRC RES, V116, P867, DOI 10.1161/CIRCRESAHA.116.304653; Lonborg J, 2013, EUR HEART J-CARD IMG, V14, P387, DOI 10.1093/ehjci/jes271; Maekawa Y, 2002, J AM COLL CARDIOL, V39, P241, DOI 10.1016/S0735-1097(01)01721-1; Meghraoui-Kheddar A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01117; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Redgrave RE, 2017, STEM CELL REP, V8, P1287, DOI 10.1016/j.stemcr.2017.04.015; Ruparelia N, 2015, EUR HEART J, V36, P1923, DOI 10.1093/eurheartj/ehv195; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; STONE PH, 1988, J AM COLL CARDIOL, V11, P453, DOI 10.1016/0735-1097(88)91517-3; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Toor IS, 2019, CLIN EXP IMMUNOL, V198, P83, DOI 10.1111/cei.13330; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; van der Laan AM, 2012, AM HEART J, V163, P57, DOI 10.1016/j.ahj.2011.09.002; Weber C, 2016, THROMB HAEMOSTASIS, V116, P626, DOI 10.1160/TH16-02-0091; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Zhou X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003466; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	35	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21560	10.1096/fj.202001179RR	http://dx.doi.org/10.1096/fj.202001179RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33860543				2022-12-26	WOS:000645260100065
J	Yuniarti, I; Glenk, K; McVittie, A; Nomosatryo, S; Triwisesa, E; Suryono, T; Santoso, AB; Ridwansyah, I				Yuniarti, Ivana; Glenk, Klaus; McVittie, Alistair; Nomosatryo, Sulung; Triwisesa, Endra; Suryono, Tri; Santoso, Arianto Budi; Ridwansyah, Iwan			An application of Bayesian Belief Networks to assess management scenarios for aquaculture in a complex tropical lake system in Indonesia	PLOS ONE			English	Article							ECOSYSTEM SERVICES; RESOURCE-MANAGEMENT; PHOSPHORUS RELEASE; FISH KILLS; TRADE-OFFS; SEDIMENT; RESTORATION; PREDICTION; REDUCTION; COASTAL	A Bayesian Belief Network, validated using past observational data, is applied to conceptualize the ecological response of Lake Maninjau, a tropical lake ecosystem in Indonesia, to tilapia cage farms operating on the lake and to quantify its impacts to assist decision making. The model captures ecosystem services trade-offs between cage farming and native fish loss. It is used to appraise options for lake management related to the minimization of the impacts of the cage farms. The constructed model overcomes difficulties with limited data availability to illustrate the complex physical and biogeochemical interactions contributing to triggering mass fish kills due to upwelling and the loss in the production of native fish related to the operation of cage farming. The model highlights existing information gaps in the research related to the management of the farms in the study area, which is applicable to other tropical lakes in general. Model results suggest that internal phosphorous loading (IPL) should be recognized as one of the primary targets of the deep eutrophic tropical lake restoration efforts. Theoretical and practical contributions of the model and model expansions are discussed. Short- and longer-term actions to contribute to a more sustainable management are recommended and include epilimnion aeration and sediment capping.	[Yuniarti, Ivana] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Yuniarti, Ivana; Glenk, Klaus; McVittie, Alistair] Scotlands Rural Coll, Dept Rural Econ Environm & Soc, Edinburgh, Midlothian, Scotland; [Yuniarti, Ivana; Nomosatryo, Sulung; Triwisesa, Endra; Suryono, Tri; Santoso, Arianto Budi; Ridwansyah, Iwan] Indonesian Inst Sci, Res Ctr Limnol, Cibinong, Indonesia; [Nomosatryo, Sulung] GFZ German Res Ctr Geosci, Sect Geomicrobiol, Potsdam, Germany	University of Edinburgh; Scotland's Rural College; Indonesian Institute of Sciences; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Yuniarti, I (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.; Yuniarti, I (corresponding author), Scotlands Rural Coll, Dept Rural Econ Environm & Soc, Edinburgh, Midlothian, Scotland.; Yuniarti, I (corresponding author), Indonesian Inst Sci, Res Ctr Limnol, Cibinong, Indonesia.	S1779544@ed.ac.uk	Glenk, Klaus/B-8743-2014; McVittie, Alistair/G-7087-2012	Glenk, Klaus/0000-0002-2472-0235; Yuniarti, Ivana/0000-0002-8303-3590; McVittie, Alistair/0000-0002-7128-7446	Indonesian Endowment Fund for Education (LPDP) [FR972019182170]; UKRI block grant	Indonesian Endowment Fund for Education (LPDP); UKRI block grant(UK Research & Innovation (UKRI))	We disclose that the field study was granted by the Indonesian Endowment Fund for Education (LPDP) with grant number FR972019182170 and the publication fee was financed by the UKRI block grant.	Abdel-Tawwab M, 2015, AQUACULT INT, V23, P1261, DOI 10.1007/s10499-015-9882-y; Agam Regency Fisheries Department, 2017, DATA KARAMBA DAN PER; Agam Regency Statistical Bureau, 2016, AGAM DALAM ANGKA; Aguilera PA, 2011, ENVIRON MODELL SOFTW, V26, P1376, DOI 10.1016/j.envsoft.2011.06.004; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anwar LA, 2018, ANALISIS KELEMBAGAAN; Apip F., 2003, LIMNOTEK, VX, P1; Apipattanavis S, 2018, IRRIG DRAIN, V67, P113, DOI 10.1002/ird.2207; Arismendi I, 2009, FRESHWATER BIOL, V54, P1135, DOI 10.1111/j.1365-2427.2008.02157.x; Asnil, 2012, THESIS I PERTANIAN B; Badjoeri M., 2013, P ANN M IND LIM SOC, P53; Baldock TE, 2019, ENVIRON MODELL SOFTW, V119, P327, DOI 10.1016/j.envsoft.2019.07.001; Barton DN, 2016, ECOSYST SERV, V18, P165, DOI 10.1016/j.ecoser.2016.03.002; Bashari H, 2008, AGR SYST, V99, P23, DOI 10.1016/j.agsy.2008.09.003; Berg U, 2004, APPL GEOCHEM, V19, P1759, DOI 10.1016/j.apgeochem.2004.05.004; Bondad-Reantaso MG., 2010, P FAO EXP WORKSH HAN; Borsuk ME, 2004, ECOL MODEL, V173, P219, DOI 10.1016/j.ecolmodel.2003.08.020; Braaten B, 2007, AQUACULTURAL ENG ENV; Cain J, 2001, ECOLOGY, V44, P132; Cali C, 2015, RIC MAT, V64, P391, DOI 10.1007/s11587-015-0246-8; Cavalcante H, 2018, SCI TOTAL ENVIRON, V619, P1022, DOI 10.1016/j.scitotenv.2017.11.204; Celio E, 2014, ENVIRON MODELL SOFTW, V52, P222, DOI 10.1016/j.envsoft.2013.10.014; De Silva SS., 2007, CAGE AQUACULTURE REG, P1; Delgado PC, 2003, AQUACULTURE, V217, P235, DOI 10.1016/S0044-8486(02)00231-4; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demetrio JA, 2012, AQUACULTURE, V330, P172, DOI 10.1016/j.aquaculture.2011.11.026; Dlamini WM, 2010, ENVIRON MODELL SOFTW, V25, P199, DOI 10.1016/j.envsoft.2009.08.002; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Endah NH., 2017, J EKON DAN PEMBANG, V25, P55; Erlania R., 2010, PROS FORUM INOV TEKN, P621; Fakhrudin M, 2002, PROSIDING SEMINAR NA, P65; Gibbs M.M., 2018, LAKE RESTORATION HDB, P207, DOI DOI 10.1007/978-3-319-93043-5; Gonzalez-Redin J, 2016, ENVIRON RES, V144, P15, DOI 10.1016/j.envres.2015.11.009; Haapasaari P, 2010, MAR POLICY, V34, P477, DOI 10.1016/j.marpol.2009.10.002; Hecicy R. E., 2000, AQUAT ECOSYST HEALTH, V3, P23, DOI [10.1080/14634980008656988, DOI 10.1080/14634980008656988]; Henny C, 2016, IOP C SER EARTH ENV, V31, DOI 10.1088/1755-1315/31/1/012027; Henny C., 2009, LIMNOTEK, VXVI, P74; Henny C., 2012, LIMNOTEK, V19, P91; Hishamunda N, 2009, FOOD POLICY, V34, P102, DOI 10.1016/j.foodpol.2008.06.006; Hofer Solveig, 2020, Environment Systems & Decisions, V40, P67, DOI 10.1007/s10669-019-09742-2; Hoshino E, 2016, ECOL SOC, V21, DOI 10.5751/ES-08285-210216; Hurtgen MT, 1999, AM J SCI, V299, P556, DOI 10.2475/ajs.299.7-9.556; Islam MS, 2005, MAR POLLUT BULL, V50, P48, DOI 10.1016/j.marpolbul.2004.08.008; Jackson S, 2020, GEOFORUM, V109, P44, DOI 10.1016/j.geoforum.2019.12.020; Jeppesen E, 2007, HYDROBIOLOGIA, V584, P239, DOI 10.1007/s10750-007-0596-7; Kaikkonen L, 2021, INTEGR ENVIRON ASSES, V17, P62, DOI 10.1002/ieam.4332; KILHAM P, 1990, FRESHWATER BIOL, V23, P379, DOI 10.1111/j.1365-2427.1990.tb00280.x; Kragt ME, 2009, LANDSC LOG TECH REP; Landis WG, 2021, INTEGR ENVIRON ASSES, V17, P79, DOI 10.1002/ieam.4351; Landuyt D, 2016, ECOL INDIC, V71, P327, DOI 10.1016/j.ecolind.2016.07.015; Landuyt D, 2013, ENVIRON MODELL SOFTW, V46, P1, DOI 10.1016/j.envsoft.2013.03.011; Laurila-Pant M, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134026; Lehmusoto P., 1997, NATL INVENTORY MAJOR; Lumbantobing DN, 2014, ZOOTAXA, V 3764, P1, DOI 10.11646/zootaxa.3764.1.1; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Marganof, 2007, THESIS BOGOR AGR U; Martinez-Cordova LR, 1997, AQUACULT ENG, V16, P85, DOI 10.1016/S0144-8609(96)01010-2; McCann RK, 2006, CAN J FOREST RES, V36, P3053, DOI 10.1139/X06-238; McVittie A, 2015, ECOL ECON, V110, P15, DOI 10.1016/j.ecolecon.2014.12.004; Mendoza M. U., 2019, Philippine Journal of Science, V148, P565; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Moe SJ, 2021, INTEGR ENVIRON ASSES, V17, P53, DOI 10.1002/ieam.4369; Moe SJ, 2019, WATER-SUI, V11, DOI 10.3390/w11091767; Moe SJ, 2016, ECOL MODEL, V337, P330, DOI 10.1016/j.ecolmodel.2016.07.004; Molina JL, 2010, ENVIRON MODELL SOFTW, V25, P383, DOI 10.1016/j.envsoft.2009.10.007; Molina-Navarro E, 2020, LIMNOLOGICA, V80, DOI 10.1016/j.limno.2019.125742; MoPW . Ministry of Public Work , 2013, LAPORAN AKHIR PEKERJ, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Nastiti AS., 2018, BAWAL, P99, DOI [10.15578/bawal.10.2.2018.83-93, DOI 10.15578/BAWAL.10.2.2018.83]; Nikolai SJ, 2014, LIMNOLOGICA, V49, P33, DOI 10.1016/j.limno.2014.08.005; Nyberg JB, 2006, CAN J FOREST RES, V36, P3104, DOI 10.1139/X06-108; OCHUMBA PBO, 1990, HYDROBIOLOGIA, V208, P93, DOI 10.1007/BF00008448; Orihel DM, 2017, CAN J FISH AQUAT SCI, V74, P2005, DOI 10.1139/cjfas-2016-0500; Panidhapu A, 2020, WATER RES, V170, DOI 10.1016/j.watres.2019.115349; Pant J, 2014, AQUACULTURE, V418, P1, DOI 10.1016/j.aquaculture.2013.09.027; Pemerintah Republik Indonesia, 2009, PER PEM REP IND 55 T; Phan TD, 2016, ENVIRON MODELL SOFTW, V85, P98, DOI 10.1016/j.envsoft.2016.08.006; Phillips G, 2005, FRESHWATER BIOL, V50, P1628, DOI 10.1111/j.1365-2427.2005.01434.x; Pollino CA, 2007, ENVIRON MODELL SOFTW, V22, P1140, DOI 10.1016/j.envsoft.2006.03.006; Read JS, 2011, ENVIRON MODELL SOFTW, V26, P1325, DOI 10.1016/j.envsoft.2011.05.006; Reddy M. S., 2006, Lakes & Reservoirs Research and Management, V11, P227, DOI 10.1111/j.1440-1770.2006.00311.x; Rigosi A, 2015, ECOL APPL, V25, P186, DOI 10.1890/13-1677.1; Roesma DI., 2013, P SEM SCH SCI U LAMP, P197; Santoso AB, 2018, IOP C SER EARTH ENV, V118, DOI 10.1088/1755-1315/118/1/012024; Setiawan F, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11232875; Small K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094524; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Sondergaard M, 1999, HYDROBIOLOGIA, V408, P145, DOI 10.1023/A:1017063431437; Sondergaard M., 2012, ENCY LAKES RESERVOIR, DOI [10.1007/978-1-4020-4410-6, DOI 10.1007/978-1-4020-4410-6]; Sondergaard M, 2007, J APPL ECOL, V44, P1095, DOI 10.1111/j.1365-2664.2007.01363.x; Stelzenmuller V, 2010, MAR POLLUT BULL, V60, P1743, DOI 10.1016/j.marpolbul.2010.06.024; Streiner D.L., 2013, SPRINGER SER RELIAB, V59, P187, DOI [10.1007/978-1-4471-2966-0_10, DOI 10.1007/978-1-4471-2966-0_10]; Su CW, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-6; Sugiarti, 2011, OSEANOLOGI DAN LIMNO, V37, P139; Sulastri, 2002, P INT S LAND MAN BIO; Sulastri S., 2015, OSEANOLOGI LIMNOLOGI, V41, P339; Sunarto A., 2006, MEDIA AKUAKULTUR, V1, P13; Syandri H., 2014, J AQUAC RES DEV, V5, P1, DOI [10.4172/2155-9546.1000278, DOI 10.4172/2155-9546.1000278]; Tacon A.G.J., 2007, CAGE AQUACULTURE REG, P1; Tanjung LR., 2015, OSEAONOLOGI DAN LIMN, V41, P191; The World Bank, 2018, IMPROVING WATER QUAL, DOI [10.1596/32196, DOI 10.1596/32196]; Tomscha SA, 2016, ECOL SOC, V21, DOI 10.5751/ES-08345-210143; Troell M, 1997, AQUAC RES, V28, P527; Unal I, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/3762651; Vollenweider RA, 1980, P INT S INL WAT LAK, P26, DOI [10.1016/B978-0-08-026024-2.50005-5, DOI 10.1016/B978-0-08-026024-2.50005-5]; Welch EB, 2005, LAKE RESERV MANAGE, V21, P209, DOI 10.1080/07438140509354430; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; White P. G., 2013, FAO Fisheries and Aquaculture Technical Paper, P553; Woodberry O, 2004, LECT NOTES ARTIF INT, V3339, P1101; Yang S., 2017, SW RESPIR CRIT CARE, V5, P34, DOI [10.12746/swrccc.v5i19.391, DOI 10.12746/SWRCCC.V5I19.391]; Yu PP, 2019, SCI TOTAL ENVIRON, V663, P654, DOI 10.1016/j.scitotenv.2019.01.265; Yuniarti I., 2012, INDONESIAN FISEHERIE, V18, P1, DOI [10.15578/ifrj.18.1.2012.1-12, DOI 10.15578/IFRJ.18.1.2012.1-12]; Yuniarti I., 2020, PROG; Zhang WQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156488; Zhang XF, 2017, HYDROBIOLOGIA, V794, P49, DOI 10.1007/s10750-016-3079-x	115	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250365	10.1371/journal.pone.0250365	http://dx.doi.org/10.1371/journal.pone.0250365			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861801	Green Published, gold			2022-12-26	WOS:000641475400017
J	Lanman, RB; Hylkema, L; Boone, CM; Allee, B; Castillo, RO; Moreno, SA; Flores, MF; DeSilva, U; Bingham, B; Kemp, BM				Lanman, Richard B.; Hylkema, Linda; Boone, Cristie M.; Allee, Brian; Castillo, Roger O.; Moreno, Stephanie A.; Flores, Mary Faith; DeSilva, Upuli; Bingham, Brittany; Kemp, Brian M.			Ancient DNA analysis of archaeological specimens extends Chinook salmon's known historic range to San Francisco Bay's tributaries and southernmost watershed	PLOS ONE			English	Article							COHO SALMON; CALIFORNIA; FISHERIES; REMAINS	Understanding a species' historic range guides contemporary management and habitat restoration. Chinook salmon (Oncorhynchus tshawytscha) are an important commercial and recreational gamefish, but nine Chinook subspecies are federally threatened or endangered due to anthropogenic impacts. Several San Francisco Bay Area streams and rivers currently host spawning Chinook populations, but government agencies consider these non-native hatchery strays. Through the morphology-based analysis of 17,288 fish specimens excavated from Native American middens at Mission Santa Clara (CA-SCL-30H), Santa Clara County, circa 1781-1834 CE, 88 salmonid vertebrae were identified. Ancient DNA sequencing identified three separate individuals as Chinook salmon and the remainder as steelhead/rainbow trout (Oncorhynchus mykiss). These findings comprise the first physical evidence of the nativity of salmon to the Guadalupe River in San Jose, California, extending their documented historic range to include San Francisco Bay's southernmost tributary watershed.	[Lanman, Richard B.; Moreno, Stephanie A.] Guadalupe Coyote Resource Conservat Dist, San Jose, CA 95112 USA; [Lanman, Richard B.] Inst Hist Ecol, Los Altos, CA 94022 USA; [Hylkema, Linda] Santa Clara Univ, Univ Operat, Cultural Resource Management Program, Santa Clara, CA USA; [Boone, Cristie M.] Albion Environm Inc, Santa Cruz, CA USA; [Allee, Brian] South Bay Clean Creeks Coalit, San Jose, CA USA; [Castillo, Roger O.] Salmon & Steelhead Restorat Grp Inc, San Jose, CA USA; [Flores, Mary Faith; DeSilva, Upuli; Bingham, Brittany; Kemp, Brian M.] Univ Oklahoma, Dept Anthropol, Norman, OK USA	Santa Clara University; University of Oklahoma System; University of Oklahoma - Norman	Lanman, RB (corresponding author), Guadalupe Coyote Resource Conservat Dist, San Jose, CA 95112 USA.; Lanman, RB (corresponding author), Inst Hist Ecol, Los Altos, CA 94022 USA.	ricklanman@gmail.com	Lanman, Richard B/D-8290-2016	Lanman, Richard B/0000-0001-8122-4329; Moreno, Stephanie/0000-0003-4519-1464	Guadalupe Coyote Resource Conservation District (GCRCD), a non-profit California State Agency	Guadalupe Coyote Resource Conservation District (GCRCD), a non-profit California State Agency	The ancient DNA sequencing analysis was funded by a grant from the Guadalupe Coyote Resource Conservation District (GCRCD), a non-profit California State Agency to BMK. Stephanie A. Moreno is Executive Director and Richard B. Lanman is President of the Board of Directors of the GCRCD and were co-authors involved in study design, data analysis, decision to publish and preparation of the manuscript. The funder provided support in the form of salary for author SAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, FISHERIES, V32, P441, DOI 10.1577/1548-8446(2007)32[441:CSANSO]2.0.CO;2; Allen Grover, 2015, NOAA T MEMO SWFSC, P1; Anglers Rejoicing Over Recent Freshets, 1904, SAN JOSE DAILY MERCU; Atkins Charles G, 1879, REPORT COMMISSIONER, P832; Behnke R., 2010, TROUT SALMON N AM; Blount C., SANTA CLARA U CULTUR; Cannon A, 2006, AM ANTIQUITY, V71, P123, DOI 10.2307/40035324; Carlson Catherine C., 1988, HOLOCENE HUMAN ECOLO; Carlson SM, 2011, CAN J FISH AQUAT SCI, V68, P1579, DOI 10.1139/F2011-084; Chase SD, 2007, CALIF FISH GAME, V93, P130; Chassaing O, 2013, J BIOGEOGR, V40, P382, DOI 10.1111/j.1365-2699.2012.02785.x; Crandall Eric, 2013, GENETIC ANAL CHINOOK; Daniels RA, 1998, GLOBAL ECOL BIOGEOGR, V7, P467, DOI 10.1046/j.1466-822X.1998.00313.x; David J., 2015, MASTER CULTURAL RESO, P241; Devon Pearse, 2008, FINAL REPORT SANTA C; Edsall Arwen L., 2005, NOAATMNMFSSWFSC369, P25; Ellison J., 2018, REPORT PREPARED SANT; Gobalet Kenneth W., 2000, Bulletin Southern California Academy of Sciences, V99, P32; Gobalet Kenneth W., 2020, FISH REMAINS ARCHAEO, P230; GOBALET KW, 1990, COPEIA, P680, DOI 10.2307/1446434; GOBALET KW, 1990, CALIF FISH GAME, V76, P244; GOBALET KW, 1993, SOUTHWEST NAT, V38, P218, DOI 10.2307/3671426; Gobalet KW, 2004, T AM FISH SOC, V133, P801, DOI 10.1577/T02-084.1; Grier C, 2013, J ARCHAEOL SCI, V40, P544, DOI 10.1016/j.jas.2012.07.013; Gunther E, 1926, AM ANTHROPOL, V28, P605, DOI 10.1525/aa.1926.28.4.02a00020; Hammel, 1963, U CALIFORNIA PUBLICA, Vvol. 49, P155; Harrington JP., 1942, U CALIFORNIA ANTHR R, V7, P1; Hedgecock Dennis, 2002, REPORT SANTA CLARA V; Jordan D. S., 1881, Proceedings of the United States National Museum, Viv, P29; Jordan LG, 2010, MOL ECOL RESOUR, V10, P225, DOI 10.1111/j.1755-0998.2009.02739.x; Kaczynski VW, 2006, FISHERIES, V31, P374, DOI 10.1577/1548-8446(2006)31[374:AOTSRL]2.0.CO;2; Keefer ML, 2014, REV FISH BIOL FISHER, V24, P333, DOI 10.1007/s11160-013-9334-6; Lanman RB, 2012, CALIF FISH GAME, V98, P65; Leidy Robert A, 2007, SFEI CONTRIBUTION, P194; Leitritz Earl. A, 1970, FISH B, P1; Moss ML, 2014, J ARCHAEOL SCI, V41, P879, DOI 10.1016/j.jas.2013.10.017; Munsch SH, 2020, CAN J FISH AQUAT SCI, V77, P1487, DOI 10.1139/cjfas-2020-0075; Nielsen Jennifer L, 1999, WARDS EUROPEAN ISLAM; Nikulina EA, 2016, DIVERS DISTRIB, V22, P1036, DOI 10.1111/ddi.12461; NOAA, 2020, CLIM GLANC STAT TIM; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Rees MJ., 2011, HERE INFINITY SCI HO; Rostlund Erhard., 1952, FRESHWATER FISH FISH; Skinner John E., 1962, 1 RES AG CAL DEP FIS, P226; Smith C.L., 1876, HIST ATLAS MAP SANTA; Snyder JohnOtterbein, 1912, B BUR FISH, VXXXII, P1; Stevenson Alexander E., 2011, THESIS PORTLAND STAT, DOI [10.15760/etd.444, DOI 10.15760/ETD.444]; Swezey S.L, 1977, J CALIF ANTHR, V4, P1; Swift Camm C., 1993, Bulletin Southern California Academy of Sciences, V92, P101; Willmes M, 2021, FISHERIES, V46, P22, DOI 10.1002/fsh.10516; Yoshiyama Ronald M., 1998, North American Journal of Fisheries Management, V18, P487, DOI 10.1577/1548-8675(1998)018<0487:HAADOC>2.0.CO;2; Yoshiyama Ronald M., 1999, Reviews in Fisheries Science, V7, P197, DOI 10.1080/10641269908951361; Zivaljevic I, 2017, J ARCHAEOL SCI, V79, P1, DOI 10.1016/j.jas.2017.01.002	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0244470	10.1371/journal.pone.0244470	http://dx.doi.org/10.1371/journal.pone.0244470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857143	Green Published, gold			2022-12-26	WOS:000641474900006
J	Lee, H; Kim, I; Kang, BH; Um, SJ				Lee, Heock; Kim, Insu; Kang, Bo Hyoung; Um, Soo-Jung			Prognostic value of serial neutrophil-to-lymphocyte ratio measurements in hospitalized community-acquired pneumonia	PLOS ONE			English	Article							LOW-RISK; PROCALCITONIN; SEVERITY	Introduction Several serum inflammatory markers are associated with poor clinical outcomes in community-acquired pneumonia (CAP). However, the prognosis and early treatment response in hospitalized CAP patients based on serial neutrophil-to-lymphocyte ratio (NLR) measurement has never been investigated. Methods We performed a retrospective observational study for 175 consecutive patients hospitalized with CAP between February 2016 and February 2018. NLR, C-reactive protein (CRP) and procalcitonin levels were measured on admission day (D1) and on hospital day 4 (D4). The Pneumonia Severity Index (PSI) was also assessed on admission. The primary endpoint was all-cause death within 30 days after admission. The secondary endpoint was early treatment response such as intensive care unit (ICU) admission during hospitalization and clinical unstability on day 4. Results The 30-day mortality rate was 9.7%. In multivariate analysis, NLR D4 (OR: 1.11; 95% CI: 1.04-1.18; P = 0.003) and its incremental change (NLR D4/D1 >1) (OR: 7.10; 95% CI: 2.19-23.06; P = 0.001) were significant predictors of 30-day mortality. NLR D4 and its incremental change were significant predictors of ICU admission and clinical unstability on day 4 in multivariate analyses. Adding of incremental NLR change significantly improved the prognostic ability of the PSI. The additive value of incremental NLR change for the prognostic ability of the PSI was larger than that of incremental CRP change. Conclusion Serial NLR measurement represents useful laboratory tool to predict the prognosis and early treatment response of hospitalized CAP patients.	[Lee, Heock; Kim, Insu; Kang, Bo Hyoung; Um, Soo-Jung] Dong A Univ, Dept Internal Med, Pulmonol Div, Dong A Univ Hosp,Coll Med, Busan, South Korea	Dong A University	Um, SJ (corresponding author), Dong A Univ, Dept Internal Med, Pulmonol Div, Dong A Univ Hosp,Coll Med, Busan, South Korea.	sjum@dau.ac.kr			Dong-A University	Dong-A University	Corresponding author received unrestricted research fund from Dong-A University.	Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Cataudella E, 2017, J AM GERIATR SOC, V65, P1796, DOI 10.1111/jgs.14894; Chalmers JD, 2008, AM J MED, V121, P219, DOI 10.1016/j.amjmed.2007.10.033; Chalmers JD, 2011, J ANTIMICROB CHEMOTH, V66, P416, DOI 10.1093/jac/dkq426; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Ge YL, 2019, CLIN LAB, V65, P839, DOI 10.7754/Clin.Lab.2018.181042; Guo SR, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0877-x; Ito A, 2020, INT J INFECT DIS, V92, P228, DOI 10.1016/j.ijid.2020.01.018; Ito A, 2016, RESPIROLOGY, V21, P1459, DOI 10.1111/resp.12846; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kruger S, 2008, EUR RESPIR J, V31, P349, DOI 10.1183/09031936.00054507; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Sambataro G, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10090619; Schuetz P, 2011, EUR RESPIR J, V37, P384, DOI 10.1183/09031936.00035610; Tamura M, 2014, J INFECT CHEMOTHER, V20, P97, DOI 10.1016/j.jiac.2013.09.005; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105; Zhang H, 2019, CLIN LAB, V65, P1867, DOI 10.7754/Clin.Lab.2019.190226; Zheng N, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01207-6; Zhydkov A, 2015, CLIN CHEM LAB MED, V53, P559, DOI 10.1515/cclm-2014-0456	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250067	10.1371/journal.pone.0250067	http://dx.doi.org/10.1371/journal.pone.0250067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857241	gold, Green Published			2022-12-26	WOS:000641474900057
J	Milano, N; Nolfi, S				Milano, Nicola; Nolfi, Stefano			Autonomous learning of features for control: Experiments with embodied and situated agents	PLOS ONE			English	Article								The efficacy of evolutionary or reinforcement learning algorithms for continuous control optimization can be enhanced by including an additional neural network dedicated to features extraction trained through self-supervision. In this paper we introduce a method that permits to continue the training of the features extracting network during the training of the control network. We demonstrate that the parallel training of the two networks is crucial in the case of agents that operate on the basis of egocentric observations and that the extraction of features provides an advantage also in problems that do not benefit from dimensionality reduction. Finally, we compare different feature extracting methods and we show that sequence-to-sequence learning outperforms the alternative methods considered in previous studies.	[Milano, Nicola; Nolfi, Stefano] Natl Res Council CNR ISTC, Inst Cognit Sci & Technol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Milano, N (corresponding author), Natl Res Council CNR ISTC, Inst Cognit Sci & Technol, Rome, Italy.	nicola.milano@istc.cnr.it		Milano, Nicola/0000-0002-1604-5161				Andrychowicz M., 2019, ARXIV180800177V5; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bohmer W, 2015, KUNSTL INTELL, V29, P353, DOI 10.1007/s13218-015-0356-1; Brockman Greg, 2016, arXiv; Cho K., 2014, C EMPIRICAL METHODS, P1724; Coumans E, 2016, PYBULLET PYTHON MODU, P2016; Edu P.B., 2016, ARXIV PREPRINT ARXIV; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Ha David, 2018, ICLR; Hansen N, 2001, EVOL COMPUT, V9, P159, DOI 10.1162/106365601750190398; Klimov O., 2016, CARRACING V0; Lake BM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16001837; Lange S, 2012, IEEE IJCNN; Lesort T., 2018, STATE REPRESENTATION; Lesort T., 2017, CORR ABS170905185; Mattner J, 2012, LECT NOTES COMPUT SC, V7667, P126, DOI 10.1007/978-3-642-34500-5_16; Srivastava N, 2015, PR MACH LEARN RES, V37, P843; Sutskever I, 2014, ADV NEUR IN, V27; Todorov E, 2012, IEEE INT C INT ROBOT, P5026, DOI 10.1109/IROS.2012.6386109	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250040	10.1371/journal.pone.0250040	http://dx.doi.org/10.1371/journal.pone.0250040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857220	gold, Green Submitted, Green Published			2022-12-26	WOS:000641474900082
J	Parmley, LE; Hartsough, K; Eleeza, O; Bertin, A; Sesay, B; Njenga, A; Toure, M; Egesimba, G; Bah, H; Bayoh, A; Yakubu, A; Morrison, EAB; Michaels-Strasser, S				Parmley, Lauren E.; Hartsough, Kieran; Eleeza, Oliver; Bertin, Akopon; Sesay, Bockarie; Njenga, Amon; Toure, Mame; Egesimba, Ginika; Bah, Haja; Bayoh, Alex; Yakubu, Abdulraheem; Morrison, Ellen A. B.; Michaels-Strasser, Susan			COVID-19 preparedness at health facilities and community service points serving people living with HIV in Sierra Leone	PLOS ONE			English	Article							EBOLA EPIDEMIC; GUINEA; LIBERIA; CARE	After a decade of civil war and the 2014-2016 West African Ebola outbreak, Sierra Leone now faces the COVID-19 pandemic with a fragile health system. As was demonstrated during Ebola, preparedness is key to limiting a health crisis' spread and impact on health systems and ensuring continued care for vulnerable populations including people living with HIV (PLHIV). To assess COVID-19 preparedness and inform interventions to ensure continuity of HIV services at health facilities (HFs) and community service points (CSPs), we conducted site readiness assessments in Freetown, the epicenter of COVID-19 in Sierra Leone. Data were collected at nine high-volume HIV HFs and seven CSPs in April 2020, a month after COVID-19 was declared a pandemic. CSPs comprised three community drop-in centers providing HIV counseling and testing services as well as HIV prevention services (e.g., condoms and lubricants) for key and priority populations and four community-based support groups serving PLHIV. At the time of assessment, CSPs did not provide antiretroviral therapy (ART) but were considered potential sites for expansion of differentiated service delivery (DSD)-a client-centered approach to HIV care-in the context of COVID-19. Overall, 5/9 HFs had trained staff on use of personal protective equipment (PPE) and prevention of COVID-19 transmission. Most had access to masks (5/9) and gloves (7/9) for management of suspected/confirmed COVID-19 cases, and 4/9 HFs had triage procedures for isolation of suspected cases. Conversely, few CSPs had access to masks (2/7) or gloves (2/7) and no staff were trained on PPE use or COVID-19 transmission. 7/9 HFs had adequate ART stock for multi-month dispensing though few had procedures for (3/9) or had trained staff in providing DSD (2/9). Among CSPs where measures were applicable, 2/4 had procedures for DSD, 1/3 had staff trained on DSD and none had adequate ART stock. Identification of gaps in COVID-19 preparedness is a critical step in providing support for infection control and modified service delivery. Findings from this assessment highlight gaps in COVID-19 preparedness measures at sites supporting PLHIV in Sierra Leone and indicate CSPs may require intensive supervision and training to ensure HIV services are uninterrupted while minimizing COVID-19 risk, especially if used as sites to scale up DSD.	[Parmley, Lauren E.; Hartsough, Kieran; Morrison, Ellen A. B.; Michaels-Strasser, Susan] Columbia Univ, ICAP, New York, NY 10027 USA; [Eleeza, Oliver; Bertin, Akopon; Sesay, Bockarie; Njenga, Amon; Toure, Mame; Egesimba, Ginika; Bah, Haja; Bayoh, Alex; Yakubu, Abdulraheem] Columbia Univ, ICAP, Freetown, Sierra Leone	Columbia University	Parmley, LE (corresponding author), Columbia Univ, ICAP, New York, NY 10027 USA.	lp2786@cumc.columbia.edu		Parmley, Lauren/0000-0001-5119-5811	President's Emergency Plan for AIDS Relief through HRSA [UH6HA30740]	President's Emergency Plan for AIDS Relief through HRSA	This project was supported by the President's Emergency Plan for AIDS Relief through HRSA under the cooperative agreement #UH6HA30740. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the funding agencies.	[Anonymous], 2014, BBC; [Anonymous], 2021, COVID 19 DASHBOARD C; Bailey E, 2020, RESPONDING COVID 19; Bank W, 2019, WORLD DEV IND; Bressan S, 2020, ANN EMERG MED, V76, P788, DOI 10.1016/j.annemergmed.2020.05.018; Burki T, 2020, LANCET INFECT DIS, V20, P785, DOI 10.1016/S1473-3099(20)30501-6; Corona Virus Disease (COVID-19), 2020, 134 MIN HLTH SAN; Dahl BA, 2016, MMWR-MORBID MORTAL W, V65, P12, DOI 10.15585/mmwr.su6503a3; De Cock KM, 2015, AIDS, V29, P989, DOI [10.1097/QAD.0000000000000726, 10.1097/QAD.0000000000000732]; El-Sadr WM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008193; Evans DK, 2015, LANCET GLOB HEALTH, V3, pE439, DOI 10.1016/S2214-109X(15)00065-0; Hogan AB, 2020, LANCET GLOB HEALTH, V8, pE1132, DOI 10.1016/S2214-109X(20)30288-6; Inveen C., 2020, REUTERS; Jewell BL, 2020, LANCET HIV, V7, pE629, DOI 10.1016/S2352-3018(20)30211-3; Kamara V., 2016, C RETR OPP INF; Leuenberger D, 2015, AIDS, V29, P1883, DOI 10.1097/QAD.0000000000000784; Maclean R, 2020, NRELTP6A2077610; Marsh K, 2019, AIDS, V33, pS213, DOI 10.1097/QAD.0000000000002355; McNamara LA, 2016, MMWR-MORBID MORTAL W, V65, P35, DOI 10.15585/mmwr.su6503a6; MoHS, 2020, HLTH FACILITY CATCHM; Nagel E, 2019, INT J STD AIDS, V30, P106, DOI 10.1177/0956462418797843; Oladipo EK, 2020, DRUG DISCOV THER, V14, P153, DOI 10.5582/ddt.2020.03067; PAHO, 2020, HOSP READINESS CHECK; Paladino L, 2017, J GLOB INFECT DIS, V9, P45, DOI 10.4103/jgid.jgid_24_17; Raven J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3072-3; Shultz JM, 2015, JAMA-J AM MED ASSOC, V313, P567, DOI 10.1001/jama.2014.17934; Songo I, 2020, AIDS 2020 VIRTUAL; Tattevin P, 2015, AIDS, V29, pN1, DOI 10.1097/QAD.0000000000000614; UNAIDS, 2014, FAST TRACK ENDING AI; UNAIDS, 2019, COUNTRY FACTSHEETS S; Vandy A, 2020, AIDS 2020 VIRTUAL; Wadvalla BA, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2830; WHO, 2020, CONTR SIGN ROLL COVI; WHO, 2015, THEMATIC REPORT AGR; WHO, 2016, KEY COUNTRY INDICATO; WHO calls for healthy, 2020, SAFE DECENT WORKING; *WHO UNICEF UNFPA, 2019, MATERNAL MORTALITY L; World Health Organization, 2015, EBOLA SITUATION REPO	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250236	10.1371/journal.pone.0250236	http://dx.doi.org/10.1371/journal.pone.0250236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857253	Green Published, gold			2022-12-26	WOS:000641474900036
J	Rubio-Garrido, M; Reina, G; Ndarabu, A; Rodriguez-Galet, A; Valades-Alcaraz, A; Barquin, D; Carlos, S; Holguin, A				Rubio-Garrido, Marina; Reina, Gabriel; Ndarabu, Adolphe; Rodriguez-Galet, Ana; Valades-Alcaraz, Ana; Barquin, David; Carlos, Silvia; Holguin, Africa			High drug resistance levels could compromise the control of HIV infection in paediatric and adolescent population in Kinshasa, the Democratic Republic of Congo	PLOS ONE			English	Article							MUTATIONS; ZIDOVUDINE; DIVERSITY; CHILDREN; AFRICA; RNA	Background The inadequacy of HIV viraemia and resistance monitoring in Africa leads to uncontrolled circulation of HIV strains with drug resistance mutations (DRM), compromising antiretroviral therapy (ART) effectiveness. This study describes the DRM prevalence and its therapeutic impact in HIV-infected pediatric patients from Kinshasa (Democratic Republic of Congo, DRC). Methods From 2016-2018, dried blood were collected from 71 HIV-infected children and adolescents under ART in two hospitals in Kinshasa for HIV-1 DRM pol analysis, predicted ARV-susceptibility by Stanford and phylogenetic characterization. Results HIV-1 sequences were recovered from 55 children/adolescents with 14 years of median-age. All had received nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTI, NNRTI), 9.1% protease inhibitors (PI) and only one integrase inhibitor (INI). Despite the use of ART, 89.1% showed virological failure and 67.3% carried viruses with major-DRM to one (12.7%), two (47.3%), or three (5.5%) ARV-families. Most children/adolescents harbored DRM to NNRTI (73.5%) or NRTI (61.2%). Major-DRM to PI was present in 8.3% and minor-DRM to INI in 15%. Dual-class-NRTI+NNRTI resistance appeared in 53.1% of patients. Viruses presented high/intermediate resistance to nevirapine (72.9% patients), efavirenz (70.9%), emtricitabine/lamivudine (47.9%), rilpivirine (41.7%), etravirine (39.6%), doravidine (33.3%), zidovudine (22.9%), among others. Most participants were susceptible to INI and PI. Great diversity of variants was found, with a high rate (40%) of unique recombinants. Conclusion The high DRM prevalence observed among HIV-infected children and adolescents in Kinshasa could compromise the 95-95-95-UNAIDS targets in the DRC. It also reinforces the need for routine resistance monitoring for optimal rescue therapy election in this vulnerable population to control the spread of resistant HIV in the country.	[Rubio-Garrido, Marina; Rodriguez-Galet, Ana; Valades-Alcaraz, Ana; Holguin, Africa] Hosp Ramon & Cajal, Microbiol & Parasitol Dept, HIV 1 Mol Epidemiol Lab, IRYCIS & CIBEREsp RITIP CoRISPe, Madrid, Spain; [Reina, Gabriel; Barquin, David] Univ Navarra, Clin Univ Navarra, Navarra Inst Hlth Res, Inst Trop Hlth,Microbiol Dept, Pamplona, Spain; [Ndarabu, Adolphe] Monkole Hosp, Kinshasa, DEM REP CONGO; [Carlos, Silvia] Univ Navarra, Dept Prevent Med & Publ Hlth, Navarra Inst Hlth Res, Inst Trop Hlth, Pamplona, Spain	Hospital Universitario Ramon y Cajal; University of Navarra; University of Navarra	Holguin, A (corresponding author), Hosp Ramon & Cajal, Microbiol & Parasitol Dept, HIV 1 Mol Epidemiol Lab, IRYCIS & CIBEREsp RITIP CoRISPe, Madrid, Spain.	africa.holguin@salud.madrid.org	Alcaraz, Ana Valadés/AAF-9276-2021; , Ana Rodríguez Galet/AAM-4316-2021; Reina, Gabriel/F-2709-2017	Alcaraz, Ana Valadés/0000-0002-5257-4992; , Ana Rodríguez Galet/0000-0001-9352-8063; Reina, Gabriel/0000-0003-4079-9753; Holguin, Africa/0000-0002-1330-8050	Bomberos Ayudan Association; Instituto de Salud Carlos III [PI16/01908, PI18/00904]; European Regional Development Fund "A way to make Europe"/"Investing in your future"; Government of Navarra [045-2015]; Spanish HIV infected Paediatric Cohort (CoRISpe) integrated in the Spanish AIDS Research Network; Instituto de Salud Carlos III, Spanish Health Ministry [RD06/0025-ISCIII FEDER]	Bomberos Ayudan Association; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund "A way to make Europe"/"Investing in your future"; Government of Navarra; Spanish HIV infected Paediatric Cohort (CoRISpe) integrated in the Spanish AIDS Research Network; Instituto de Salud Carlos III, Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government)	This study was funded by fundraising activities and donations (mainly from Bomberos Ayudan Association), and by Instituto de Salud Carlos III through the Projects PI16/01908 and PI18/00904"(Co-funded by European Regional Development Fund "A way to make Europe"/"Investing in your future") and the Government of Navarra (grant 045-2015).; We thank the children/adolescents who participated in the study as well as the local professionals responsible for the DBS and data collection of enrolled patients at Monkole and Kalembelembe hospitals in Kinshasa. We also thank Paul Devlin for his proofreading of the manuscript. We thank Jose Maria Lopez-Pintor for his technical support during the lab processing of some DBS samples. We thank Samclide Mbikayi and Beni Makonda for their clinical support and help in updating the clinical data of the participants. The study was integrated in the research supported by the Spanish HIV infected Paediatric Cohort (CoRISpe) integrated in the Spanish AIDS Research Network and by the Instituto de Salud Carlos III, Spanish Health Ministry (Grant no. RD06/0025-ISCIII FEDER). This study is also included in the "Subprograma de Inmigracion y Salud" from CIBERESP (Spain) and in Red de Investigacion Translacional en Infectologia Pediatrica (RITIP)."	[Anonymous], 2015, AIDS CHANG EV; Boillot F, 2016, JAIDS-J ACQ IMM DEF, V71, pE9, DOI 10.1097/QAI.0000000000000844; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; de Waal R, 2018, J VIRUS ERAD, V4, P55; Djoko CF, 2011, AIDS RES HUM RETROV, V27, P323, DOI 10.1089/aid.2010.0201; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), 2014, UNAIDS ISSUES NEW FA; Gils T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191294; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Holguin A, 2013, CLIN MICROBIOL INFEC, V19, pE523, DOI 10.1111/1469-0691.12264; Kwon EH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228670; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Miller V, 1998, J INFECT DIS, V177, P1521, DOI 10.1086/515304; Muwonga J, 2011, JAIDS-J ACQ IMM DEF, V57, pS27, DOI 10.1097/QAI.0b013e31821f596c; National Agency for AIDS Research (ANRS), 2015, ANRS AC11 RESISTANCE; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oliveira M, 2016, AIDS, V30, P2267, DOI 10.1097/QAD.0000000000001191; Phillips AN, 2017, J INFECT DIS, V215, P1362, DOI 10.1093/infdis/jix089; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Programme National Multisectoriel de Lutte contre le Sida (RDCongo), 2018, PLAN STRAT GIQUE NAT; Rey D, 1998, J ACQ IMMUN DEF SYND, V17, P203, DOI 10.1097/00042560-199803010-00003; Robins EB, 2007, AM J HEMATOL, V82, P611, DOI 10.1002/ajh.20848; Rubio-Garrido M., 2020, SCI REP-UK, V10, DOI [10.1038/s41598-019-56089-4, DOI 10.1038/S41598-019-56089-4]; Sigaloff KCE, 2011, LANCET INFECT DIS, V11, P769, DOI 10.1016/S1473-3099(11)70141-4; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; UNAIDS, AIDSINFO UNAIDS; United Nations International Children's Emergency Fund (UNICEF), 2019, HIV AIDS ADOLESCENTS; United Nations Programme on HIV/AIDS (UNAIDS), 2020, UNDESTANDING FAST TR; Vidal N, 2006, AIDS RES HUM RETROV, V22, P202, DOI 10.1089/aid.2006.22.202; Wensing Annemarie M, 2019, Top Antivir Med, V27, P111; WHO, 2010, WHO MANUAL HIV DRUG; WHO, 2017, GLOBAL ACTION PLAN H; World Health Organization (WHO) , 2013, HIV ADOLESCENTS GUID; World Health Organization (WHO), 2019, HIV DRUG RESISTANCE; World Health Organization (WHO), 2016, GLOBAL REPORT EARLY; World Health Organization (WHO), 2017, HIV DRUG RESISTANCE	40	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248835	10.1371/journal.pone.0248835	http://dx.doi.org/10.1371/journal.pone.0248835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857166	Green Published, gold			2022-12-26	WOS:000641474900001
J	Lin, PH; Lin, YP; Chen, KL; Yang, SY; Shih, YH; Wang, PY				Lin, Pin-Hsuan; Lin, Yuan-Ping; Chen, Kai-Li; Yang, Shang-Yu; Shih, Yin-Hwa; Wang, Po-Yu			Effect of aromatherapy on autonomic nervous system regulation with treadmill exercise-induced stress among adolescents	PLOS ONE			English	Article							HEART-RATE; INHALATION AROMATHERAPY; PHYSICAL STRESS; ANXIETY; PERFORMANCE; SYMPTOMS; PRESSURE; MASSAGE; MUSIC; CARE	Introduction Stress is a major health issue in adolescents owing to the important transitions experienced during this period. Aromatherapy is an effective method for the reduction of stress in adolescents. Purpose The aims of this study were to examine the effect of aromatherapy on the regulation of the autonomic nervous system (ANS) along with stress relief and to explore the effect of aromatherapy on adolescents with different levels of stress. Methods This quasi-experimental study comprised three types of treatments: control (no essential oil), pure essential oil therapy (sandalwood), and blended essential oil therapy (sandalwood-lavender). The heart rate variability (HRV) was calculated to evaluate the post-exercise recovery of the ANS to the baseline level in the recruited adolescents. To examine the efficiency of aromatherapy, Friedman test was used to assess the significance of difference in all parameters (i.e., mean heart rate, SDNN, normalized LF, normalized HF, and LF/HF) between baseline and after exercise among the three treatment conditions. Results The participants comprised 43 junior college students (8 males and 35 females) with a mean age of 18.21 +/- 0.99. Significant differences in changes of two HRV parameters (normalized LF and LF/HF) were associated with both essential oil therapies compared to those in the control group (p<0.05), and one more HRV parameter (normalized HF) exhibited significant difference related to blended essential oil therapy compared to that of the control group. Besides, changes in two HRV parameters (mean heart rate and normalized HF) of both essential oil therapies in the low level stress subgroup showed significant differences compared to those of the control group (p<0.05). Conclusions This study demonstrated that aromatherapy could be used for ANS regulation with stress-relieving effects in adolescents. The participants with a low stress level appeared to respond better to the blended essential oil therapy, whereas those with medium to high levels of stress appeared to respond poorly to aromatherapy compared to the control.	[Lin, Pin-Hsuan; Lin, Yuan-Ping] Shu Zen Jr Coll Med & Management, Dept Hlth & Beauty, Kaohsiung, Taiwan; [Chen, Kai-Li] Tajen Univ, Coll Pharm & Hlth Care, Dept Nursing, Pingtung, Taiwan; [Yang, Shang-Yu; Shih, Yin-Hwa] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Wang, Po-Yu] Changhua Christian Children Hosp, Dept Pediat Emergency, Changhua, Taiwan	Asia University Taiwan	Yang, SY (corresponding author), Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan.	henry879019@yahoo.com.tw		Lin, Yuan-Ping/0000-0003-4592-017X				Bikmoradi A, 2015, COMPLEMENT THER MED, V23, P331, DOI 10.1016/j.ctim.2014.12.001; BRUCE RA, 1974, AM J CARDIOL, V33, P715, DOI 10.1016/0002-9149(74)90211-2; Cavanagh HMA, 2005, INFECT DIS HEALTH, V10, P35, DOI 10.1071/HI05035; Blasquez JCC, 2009, PSICOTHEMA, V21, P531; Chang KM, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/946537; Chen JY, 2011, HEART VESSELS, V26, P282, DOI 10.1007/s00380-010-0048-6; Chen MC, 2015, INT J NURS PRACT, V21, P87, DOI 10.1111/ijn.12229; Choi SY., 2016, EVID BASED COMPLEMEN, V2016; Cohen J., STAT POWER ANAL BEHA, V2nd; Cooke M, 2007, J CLIN NURS, V16, P1695, DOI 10.1111/j.1365-2702.2007.01709.x; Das R, 2011, HOLIST NURS PRACT, V25, P97, DOI 10.1097/HNP.0b013e31820d784a; Frison E, 2015, COMPUT HUM BEHAV, V44, P315, DOI 10.1016/j.chb.2014.11.070; Gandhi S., 2015, 2015 COMP CARD C CIN; Greenberg Martha J, 2018, JBI Database System Rev Implement Rep, V16, P2109, DOI 10.11124/JBISRIR-2017-003823; Haugland S, 2003, RES Q EXERCISE SPORT, V74, P127, DOI 10.1080/02701367.2003.10609074; Health Promotion Administration, 2018, STRESS IND SCAL; Huang L, 2017, J ALTERN COMPLEM MED, V23, P214, DOI 10.1089/acm.2016.0061; Javorka M, 2008, CLIN NEUROPHYSIOL, V119, P1071, DOI 10.1016/j.clinph.2007.12.017; Johnson K, 2017, INTENS CRIT CARE NUR, V40, P18, DOI 10.1016/j.iccn.2017.01.006; Joo HM, 2010, J KOREAN NEUROSURG S, V47, P345, DOI 10.3340/jkns.2010.47.5.345; Kim HJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101870; Koch A, 2014, PSYCHOPHYSIOLOGY, V51, P932, DOI 10.1111/psyp.12233; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; Kyle Gaye, 2006, Complement Ther Clin Pract, V12, P148, DOI 10.1016/j.ctcp.2005.11.003; Lee CT, 2017, PEDIATR NEONATOL, V58, P313, DOI 10.1016/j.pedneo.2016.04.004; Lee CH, 2017, QUAL LIFE RES, V26, P1819, DOI 10.1007/s11136-017-1525-5; Lee MS, 2012, MATURITAS, V71, P257, DOI 10.1016/j.maturitas.2011.12.018; Lin CY, 2016, APPL RES QUAL LIFE, V11, P907, DOI 10.1007/s11482-015-9410-2; Liu SH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/853809; Maritta V, 2017, J CHILD HEALTH CARE, V21, P222, DOI 10.1177/1367493517708476; Okugawa H, 1995, PHYTOMEDICINE, V2, P119, DOI 10.1016/S0944-7113(11)80056-5; Olapour Alireza, 2013, Anesth Pain Med, V3, P203, DOI 10.5812/aapm.9570; Seo JY, 2009, J KOREAN ACAD NURS, V39, P357, DOI 10.4040/jkan.2009.39.3.357; Seyyed-Rasooli A, 2016, BURNS, V42, P1774, DOI 10.1016/j.burns.2016.06.014; Strong C, 2016, CHILD PSYCHIAT HUM D, V47, P347, DOI 10.1007/s10578-015-0570-y; Stroud LR, 2009, DEV PSYCHOPATHOL, V21, P47, DOI 10.1017/S0954579409000042; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; Trambert R, 2017, WORLDV EVID-BASED NU, V14, P394, DOI 10.1111/wvn.12229; Tsai MC, 2015, J ADOLESCENCE, V42, P87, DOI 10.1016/j.adolescence.2015.03.016; von Rosenberg W, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00360; Wang HM, 2012, MOD SIMUL ENG, V2012, DOI 10.1155/2012/931943; Ye L, 2019, NEW DIR CHILD ADOLES, V163, P81, DOI 10.1002/cad.20265; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009; Zeller A, 2004, BLOOD PRESSURE, V13, P20, DOI 10.1080/08037050310025645	45	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249795	10.1371/journal.pone.0249795	http://dx.doi.org/10.1371/journal.pone.0249795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN5ED	33848307	Green Published, gold			2022-12-26	WOS:000640373500021
J	Tang, SY; Yonezawa, T; Maeda, Y; Ono, M; Maeba, T; Miyoshi, T; Momota, R; Tomono, Y; Oohashi, T				Tang, Shaoying; Yonezawa, Tomoko; Maeda, Yukihide; Ono, Mitsuaki; Maeba, Takahiro; Miyoshi, Toru; Momota, Ryusuke; Tomono, Yasuko; Oohashi, Toshitaka			Lack of collagen alpha 6(IV) chain in mice does not cause severe-to-profound hearing loss or cochlear malformation, a distinct phenotype from nonsyndromic hearing loss with COL4A6 missense mutation	PLOS ONE			English	Article							BASEMENT-MEMBRANE COLLAGEN; LINKED ALPORT SYNDROME; IV COLLAGEN; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; ALPHA-CHAINS; INNER-EAR; GENES; BARRIER; CELLS	Congenital hearing loss affects 1 in every 1000 births, with genetic mutations contributing to more than 50% of all cases. X-linked nonsyndromic hereditary hearing loss is associated with six loci (DFNX1-6) and five genes. Recently, the missense mutation (c.1771G>A, p.Gly591Ser) in COL4A6, encoding the basement membrane (BM) collagen alpha 6(IV) chain, was shown to be associated with X-linked congenital nonsyndromic hearing loss with cochlear malformation. However, the mechanism by which the COL4A6 mutation impacts hereditary hearing loss has not yet been elucidated. Herein, we investigated Col4a6 knockout (KO) effects on hearing function and cochlear formation in mice. Immunohistochemistry showed that the collagen alpha 6(IV) chain was distributed throughout the mouse cochlea within subepithelial BMs underlying the interdental cells, inner sulcus cells, basilar membrane, outer sulcus cells, root cells, Reissner's membrane, and perivascular BMs in the spiral limbus, spiral ligament, and stria vascularis. However, the click-evoked auditory brainstem response analysis did not show significant changes in the hearing threshold of Col4a6 KO mice compared with wild-type (WT) mice with the same genetic background. In addition, the cochlear structures of Col4a6 KO mice did not exhibit morphological alterations, according to the results of high-resolution micro-computed tomography and histology. Hence, loss of Col4a6 gene expression in mice showed normal click ABR thresholds and normal cochlear formation, which differs from humans with the COL4A6 missense mutation c.1771G>A, p.Gly591Ser. Therefore, the deleterious effects in the auditory system caused by the missense mutation in COL4A6 are likely due to the dominant-negative effects of the alpha 6(IV) chain and/or alpha 5 alpha 6 alpha 5(IV) heterotrimer with an aberrant structure that would not occur in cases with loss of gene expression.	[Tang, Shaoying; Yonezawa, Tomoko; Ono, Mitsuaki; Maeba, Takahiro; Oohashi, Toshitaka] Okayama Univ, Dept Mol Biol & Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Maeda, Yukihide] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Miyoshi, Toru] Okayama Univ, Dept Cardiovasc Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Momota, Ryusuke] Okayama Univ, Dept Human Morphol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Tomono, Yasuko] Shigei Med Res Inst, Div Mol & Cell Biol, Okayama, Japan; [Maeba, Takahiro] Japanese Red Cross Fukuoka Hosp, Dept Plast Surg, Fukuoka, Japan	Okayama University; Okayama University; Okayama University; Okayama University	Yonezawa, T (corresponding author), Okayama Univ, Dept Mol Biol & Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	tomoy@cc.okayama-u.ac.jp		Oohashi, Toshitaka/0000-0002-9302-1913	JSPS KAKENHI [JP20K09867, JP19H04754]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the JSPS KAKENHI (Grant Numbers: JP20K09867 to T.Y., and JP19H04754 to T.O.).	Booth KT, 2019, GENET MED, V21, P948, DOI 10.1038/s41436-018-0285-0; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; Cosgrove D, 1998, HEARING RES, V121, P84, DOI 10.1016/S0378-5955(98)00069-0; Cosgrove D, 1996, HEARING RES, V97, P54; Ekdale EG, 2016, J ANAT, V228, P324, DOI 10.1111/joa.12308; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Fuchs JC, 2015, CURR TOP DEV BIOL, V115, P213, DOI 10.1016/bs.ctdb.2015.07.007; Funk SD, 2018, MATRIX BIOL, V71-72, P250, DOI 10.1016/j.matbio.2018.04.008; Gross O, 2002, NEPHROL DIAL TRANSPL, V17, P1218, DOI 10.1093/ndt/17.7.1218; Hasegawa H, 2007, ARCH HISTOL CYTOL, V70, P255, DOI 10.1679/aohc.70.255; Hashimura Y, 2014, KIDNEY INT, V85, P1208, DOI 10.1038/ki.2013.479; Hibino H, 2010, PFLUG ARCH EUR J PHY, V459, P521, DOI 10.1007/s00424-009-0754-z; Ishiyama G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00330-5; Jung J, 2019, CELL HOST MICROBE, V25, P513, DOI 10.1016/j.chom.2019.02.001; Khattab HM, 2014, BONE, V69, P165, DOI 10.1016/j.bone.2014.09.011; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kohda T, 2004, KIDNEY INT, V66, P177, DOI 10.1111/j.1523-1755.2004.00719.x; Komori T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21000-0; Maeda Y, 2018, OTOL NEUROTOL, V39, pe593, DOI 10.1097/MAO.0000000000001874; Maeda Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058775; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Meehan DT, 2016, HEARING RES, V341, P100, DOI 10.1016/j.heares.2016.08.003; Murata T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29450; Naito I, 1996, KIDNEY INT, V50, P304, DOI 10.1038/ki.1996.316; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Omachi K, 2018, CELL CHEM BIOL, V25, P634, DOI 10.1016/j.chembiol.2018.02.003; OOHASHI T, 1994, J BIOL CHEM, V269, P7520; Pakdaman MN, 2016, AM J NEURORADIOL, V37, P1903, DOI 10.3174/ajnr.A4822; Peeleman N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.580639; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Rheault MN, 2020, PEDIATR NEPHROL, V35, P733, DOI 10.1007/s00467-019-04241-7; Rost S, 2014, EUR J HUM GENET, V22, P208, DOI 10.1038/ejhg.2013.108; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; Saito K, 2000, J BIOCHEM, V128, P427, DOI 10.1093/oxfordjournals.jbchem.a022770; Saito K, 2011, CONNECT TISSUE RES, V52, P147, DOI 10.3109/03008207.2010.492062; Seki T, 1998, HISTOCHEM CELL BIOL, V110, P359, DOI 10.1007/s004180050296; Shi XR, 2016, HEARING RES, V338, P52, DOI 10.1016/j.heares.2016.01.010; Shodo R, 2017, BIOMED RES-TOKYO, V38, P239, DOI 10.2220/biomedres.38.239; Suzuki M, 2016, EUR ARCH OTO-RHINO-L, V273, P57, DOI 10.1007/s00405-014-3478-4; Takeuchi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005587; Takeuchi S, 2001, HEARING RES, V155, P103, DOI 10.1016/S0378-5955(01)00252-0; Tsuprun V, 2001, HEARING RES, V157, P65, DOI 10.1016/S0378-5955(01)00278-7; Urabe N, 2002, ARCH HISTOL CYTOL, V65, P133, DOI 10.1679/aohc.65.133; Yonezawa T, 2003, GLIA, V44, P190, DOI 10.1002/glia.10279; Yonezawa T, 2010, GLIA, V58, P755, DOI 10.1002/glia.20959; ZHOU J, 1994, J BIOL CHEM, V269, P13193	52	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249909	10.1371/journal.pone.0249909	http://dx.doi.org/10.1371/journal.pone.0249909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848312	Green Published, gold, Green Submitted			2022-12-26	WOS:000640373500028
J	Trenevska, I; Anderson, AP; Bentley, C; Hassanali, T; Wiblin, S; Maguire, S; Pezzella, F; Banham, AH; Li, DM				Trenevska, Iva; Anderson, Amanda P.; Bentley, Carol; Hassanali, Tasneem; Wiblin, Sarah; Maguire, Shaun; Pezzella, Francesco; Banham, Alison H.; Li, Demin			Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201	PLOS ONE			English	Article							EPITOPES; TARGET; COMPLEX	T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoclonal antibodies, to include peptides derived from intracellular proteins that are presented by major histocompatibility complex class I (MHC-I) molecules on the cell surface. We have previously used this approach to target p53, which represents a valuable target for cancer immunotherapy because of the high frequency of its deregulation by mutation or other mechanisms. The T1-116C TCRm antibody targets the wild type p53(65-73) peptide (RMPEAAPPV) presented by HLA-A*0201 (HLA-A2) and exhibited in vivo efficacy against triple receptor negative breast cancer xenografts. Here we report a comprehensive mutational analysis of the p53 RMPEAAPPV peptide to assess the T1-116C epitope and its peptide specificity. Antibody binding absolutely required the N-terminal arginine residue, while amino acids in the center of the peptide contributed little to specificity. Data mining the immune epitope database with the T1-116C binding consensus and validation of peptide recognition using the T2 stabilization assay identified additional tumor antigens targeted by T1-116C, including WT1, gp100, Tyrosinase and NY-ESO-1. Most peptides recognized by T1-116C were conserved in mice and human HLA-A2 transgenic mice showed no toxicity when treated with T1-116C in vivo. We conclude that comprehensive validation of TCRm antibody target specificity is critical for assessing their safety profile.	[Trenevska, Iva; Anderson, Amanda P.; Bentley, Carol; Hassanali, Tasneem; Wiblin, Sarah; Maguire, Shaun; Pezzella, Francesco; Banham, Alison H.; Li, Demin] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England	University of Oxford	Banham, AH; Li, DM (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England.	alison.banham@ndcls.ox.ac.uk; demin.li@ndcls.ox.ac.uk		Li, Demin/0000-0002-7118-3401; Anderson, Amanda/0000-0001-7036-3358; Hassanali, Tasneem/0000-0002-8680-6456	Medical Research Council [BRR00080]; Cancer Research UK Programme Grant [A10702, A21667]; Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Programme Grant(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	I.T. supported by Medical Research Council scholarship A.P.A., C.B., T.H. S.W., A.H.B, D.L. sponsored by Cancer Research UK Programme Grant A10702 and Project grant A21667 S.M. sponsored by Medical Research Council Confidence in Concept grant BRR00080 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataie N, 2016, J MOL BIOL, V428, P194, DOI 10.1016/j.jmb.2015.12.002; Bijen HM, 2018, MOL THER, V26, P1206, DOI 10.1016/j.ymthe.2018.02.017; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bromberg Y, 2008, BIOINFORMATICS, V24, pI207, DOI 10.1093/bioinformatics/btn268; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Chames P, 2000, P NATL ACAD SCI USA, V97, P7969, DOI 10.1073/pnas.97.14.7969; Chames P, 2002, J IMMUNOL, V169, P1110, DOI 10.4049/jimmunol.169.2.1110; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Denkberg G, 2002, J IMMUNOL, V169, P4399, DOI 10.4049/jimmunol.169.8.4399; Geluk A, 2000, J IMMUNOL, V165, P6463, DOI 10.4049/jimmunol.165.11.6463; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; Konishi S, 1999, FEBS LETT, V461, P315, DOI 10.1016/S0014-5793(99)01490-8; Li DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176642; Li DM, 2017, CANCER RES, V77, P2699, DOI 10.1158/0008-5472.CAN-16-3247; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peh CA, 2000, J IMMUNOL, V164, P292, DOI 10.4049/jimmunol.164.1.292; Qin L, 2003, J BACTERIOL, V185, P3429, DOI 10.1128/JB.185.11.3429-3435.2003; Sastry KSR, 2011, J VIROL, V85, P1935, DOI 10.1128/JVI.01990-10; Sergeeva A, 2011, BLOOD, V117, P4262, DOI 10.1182/blood-2010-07-299248; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Street MD, 2002, IMMUNOLOGY, V106, P526, DOI 10.1046/j.1365-2567.2002.01442.x; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Trenevska I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01001; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weidanz JA, 2011, INT REV IMMUNOL, V30, P328, DOI 10.3109/08830185.2011.604880; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Yang SX, 2000, CELL IMMUNOL, V204, P29, DOI 10.1006/cimm.2000.1695	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249967	10.1371/journal.pone.0249967	http://dx.doi.org/10.1371/journal.pone.0249967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836029	Green Published, gold			2022-12-26	WOS:000639361000003
J	Foubister, C; van Sluijs, EMF; Vignoles, A; Wilkinson, P; Wilson, ECF; Croxson, CHD; Brown, HE; Corder, K				Foubister, Campbell; van Sluijs, Esther M. F.; Vignoles, Anna; Wilkinson, Paul; Wilson, Edward C. F.; Croxson, Caroline H. D.; Brown, Helen Elizabeth; Corder, Kirsten			The school policy, social, and physical environment and change in adolescent physical activity: An exploratory analysis using the LASSO	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; BUILT-ENVIRONMENT; HEALTH BEHAVIOR; ASSOCIATIONS; SELECTION; IMPLEMENTATION; INEQUALITIES; TRANSITION; MULTILEVEL; SHRINKAGE	Purpose We examined the association between the school policy, social and physical environment and change in adolescent physical activity (PA) and explored how sex and socioeconomic status modified potential associations. Methods Data from the GoActive study were used for these analyses. Participants were adolescents (n = 1765, mean age +/- SD 13.2 +/- 0.4y) from the East of England, UK. Change in longitudinal accelerometer assessed moderate-to-vigorous physical activity (MVPA) was the outcome. School policy, social and physical environment features (n = 267) were exposures. The least absolute shrinkage and selection operator variable selection method (LASSO) was used to determine exposures most relevant to the outcome. Exposures selected by the LASSO were added to a multiple linear regression model with estimates of change in min/day of MVPA per 1-unit change in each exposure reported. Post-hoc analyses, exploring associations between change in variables selected by the LASSO and change in MVPA, were undertaken to further explain findings. Findings No school policy or physical environment features were selected by the LASSO as predictors of change in MVPA. The LASSO selected two school social environment variables (participants asking a friend to do physical activity; friend asking a participant to do physical activity) as potential predictors of change in MVPA but no significant associations were found in subsequent linear regression models for all participants (beta [95%CI] -1.01 [-2.73;0.71] and 0.65 [-2.17;0.87] min/day respectively). In the post-hoc analyses, for every unit increase in change in participants asking a friend to do PA and change in a friend asking participants to do PA, an increase in MVPA of 2.78 (1.55;4.02) and 1.80 (0.48;3.11) min/day was predicted respectively. Conclusions The school social environment is associated with PA during adolescence. Further exploration of how friendships during adolescence may be leveraged to support effective PA promotion in schools is warranted.	[Foubister, Campbell; van Sluijs, Esther M. F.; Brown, Helen Elizabeth; Corder, Kirsten] Univ Cambridge, UKCRC Ctr Diet & Act Res Cedar, MRC, Epidemiol Unit, Cambridge, England; [Vignoles, Anna] Univ Cambridge, Fac Educ, Cambridge, England; [Wilkinson, Paul] Univ Cambridge, Cambridgeshire & Peterborough NHS Fdn Trust, Dept Psychiat, Cambridge, England; [Wilson, Edward C. F.] Univ East Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich, Norfolk, England; [Croxson, Caroline H. D.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Cambridge; University of Cambridge; University of Cambridge; University of East Anglia; University of Oxford	Foubister, C (corresponding author), Univ Cambridge, UKCRC Ctr Diet & Act Res Cedar, MRC, Epidemiol Unit, Cambridge, England.	cf469@medschl.cam.ac.uk	; Wilson, Edward/A-6973-2010	van Sluijs, Esther/0000-0001-9141-9082; Wilson, Edward/0000-0002-8369-1577	National Institute for Health Research (NIHR) Public Health Research Programme [13/90/18]; Medical Research Council [MC_UU_12015/7]; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under UK Clinical Research Collaboration [087636/Z/08/Z, ES/G007462/1, MR/K023187/1]; NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme [IS-BRC-121520014]; NIHR SPHR PhD studentship	National Institute for Health Research (NIHR) Public Health Research Programme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under UK Clinical Research Collaboration(Wellcome Trust); NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme; NIHR SPHR PhD studentship	This study is funded by the National Institute for Health Research (NIHR) Public Health Research Programme (https://www.nihr.ac.uk/explore-nihr/funding-programmes/publichealthresearch.htm; award number: 13/90/18; awarded to: KC, EvS, PW, AV, CC, EW). This work was additionally supported by the Medical Research Council [https://mrc.ukri.org/; Unit Programme number MC_UU_12015/7; awarded to EvS], and undertaken under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged [https://www.ukcrc.org/researchcoordination/joint-funding-initiatives/public-health-research/; award numbers: 087636/Z/08/Z; ES/G007462/1; MR/K023187/1; awarded to EvS]. This work was also supported by NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme (Grant IS-BRC-121520014) to KC, EvS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CF is funded by a NIHR SPHR PhD studentship.	Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Bell JA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002649; Biddle SJH, 2019, PSYCHOL SPORT EXERC, V42, P146, DOI 10.1016/j.psychsport.2018.08.011; Bonell C., 2013, PUBLIC HLTH RES, V1, P1, DOI [10.3310/phr01010, DOI 10.3310/PHR01010]; BRECHWALD WA, 2011, ADV CHILD DEV BEHAV, V21, P166, DOI DOI 10.1111/J.1532-7795.2010.00721.X; Brown HE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014419; Cassar S, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0876-4; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Corder K, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003210; Corder K, 2019, BRIT J SPORT MED, V53, P496, DOI 10.1136/bjsports-2016-097330; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; FAROOQ A, 2020, PSYCHOL SPORT EXERC, V21, DOI DOI 10.1111/OBR.12953; Gentile A, 2018, PSYCHOL SPORT EXERC, V39, P95, DOI 10.1016/j.psychsport.2018.07.013; Gov.UK, 2018, SCH INSPECTION HDB H; Graham DJ, 2014, J PHYS ACT HEALTH, V11, P51, DOI 10.1123/jpah.2011-0239; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Harrison F, 2016, HEALTH PLACE, V39, P34, DOI 10.1016/j.healthplace.2016.02.004; Hunter RF, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002890; Jaeschke L, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0627-3; Laird Y, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0405-7; Langford R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008958.pub2; Lawler M, 2020, J YOUTH ADOLESCENCE, V49, P1503, DOI 10.1007/s10964-019-01187-9; Lawler M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4677-x; Loh VHY, 2020, HEALTH PLACE, V63, DOI 10.1016/j.healthplace.2020.102328; Loh VHY, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0898-y; Love R, 2019, OBES REV, V20, P859, DOI 10.1111/obr.12823; Maturo CC, 2013, AM J PUBLIC HEALTH, V103, pE23, DOI 10.2105/AJPH.2013.301366; McGrath LJ, 2015, SPORTS MED, V45, P841, DOI 10.1007/s40279-015-0301-3; Mendonca G, 2014, HEALTH EDUC RES, V29, P822, DOI 10.1093/her/cyu017; Messing S, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00055; Moore GF, 2017, BRIT EDUC RES J, V43, P310, DOI 10.1002/berj.3265; Morton KL, 2016, OBES REV, V17, P142, DOI 10.1111/obr.12352; Morton KL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013340; Morton KL, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0378-6; Nathan N, 2018, PREV MED, V107, P45, DOI 10.1016/j.ypmed.2017.11.012; Ommundsen Y, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-29; Owen KB, 2014, PREV MED, V67, P270, DOI 10.1016/j.ypmed.2014.07.033; Prochnow T, 2020, J PHYS ACT HEALTH, V17, P250, DOI 10.1123/jpah.2019-0350; Reimers AK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223928; Sallis JF, 2018, PREV MED, V110, P47, DOI 10.1016/j.ypmed.2018.02.009; Salway RE, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0653-9; Schmidt SCE, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030415; Simpkins SD, 2013, J RES ADOLESCENCE, V23, P537, DOI 10.1111/j.1532-7795.2012.00836.x; Singh AS, 2019, BRIT J SPORT MED, V53, P640, DOI [10.1186/s12870-018-1476-1, 10.1136/bjsports-2017-098136]; Singh A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4201-3; Sterdt E, 2014, HEALTH EDUC J, V73, P72, DOI 10.1177/0017896912469578; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Tarp J, 2018, INT J OBESITY, V42, P1639, DOI 10.1038/s41366-018-0152-8; TELZER EH, 2018, INT J BEHAV NUTR PHY, V54, P215, DOI DOI 10.1016/BS.ACDB.2017.10.003; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Voracova J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101034; Weatherson KA, 2019, TRANSL BEHAV MED, V9, P246, DOI 10.1093/tbm/iby053; Weinberg D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6908-9	54	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249328	10.1371/journal.pone.0249328	http://dx.doi.org/10.1371/journal.pone.0249328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831061	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000639359600069
J	Madut, A; Fuchsova, V; Man, H; Askar, S; Trivedi, R; Elder, E; Clarke, CL; Wain, G; Brand, A; DeFazio, A; Amis, T; Kairaitis, K				Madut, Ayey; Fuchsova, Veronika; Man, Hong; Askar, Shabeel; Trivedi, Ritu; Elder, Elisabeth; Clarke, Christine L.; Wain, Gerard; Brand, Alison; DeFazio, Anna; Amis, Terence; Kairaitis, Kristina			Increased prevalence of obstructive sleep apnea in women diagnosed with endometrial or breast cancer	PLOS ONE			English	Article							STOP-BANG SCORE; ASSOCIATION; IMPACT; RISK; POPULATION; SEX; INFLAMMATION; DEPRESSION; MORTALITY; SYMPTOMS	Background Epidemiological studies demonstrate associations between obstructive sleep apnea (OSA) and cancer incidence and mortality. The aim of this study was to measure OSA in women with breast (BC) or endometrial cancer (EC) and associations with clinico-pathological tumor variables. Methods and findings In a cross sectional study, women with BC (12 months) or EC (3 months) post-diagnosis were recruited from cancer clinics. We collected demographic, anthropometric data, cancer stage, grade, histopathology and history of cancer treatment and all subjects had in-laboratory polysomnography. Sleepiness was assessed with the Epworth Sleepiness Scale (ESS). We compared anthropometric and polysomnographic data between cancer groups (unpaired t-tests), and assessed relationships between cancer characteristics and OSA variables (Fishers exact test). There were no significant differences between average age (BC:59 +/- 68.7 years(n = 50); EC:60.3 +/- 7.7 years(n = 37)), or ESS score (BC:6.4 +/- 4.4; EC 6.8 +/- 4.7; mean +/- SD; all p > 0.2), however, BMI was higher in EC (BC: 29.7 +/- 7.9kgm(-)2; EC: 34.2 +/- 8.0 kgm(-)2; p < 0.05). BC had longer sleep latency (BC:31.8 +/- 32minutes; EC:19.3 +/- 17.9 minutes), less Stage 3 sleep (BC:20.0 +/- 5.2%; EC:23.6 +/- 8.2%) and more REM sleep (BC:21.1 +/- 6.9%; EC: 16.6 +/- 5.7%), all p<0.05. EC had lower average awake and asleep oxygen saturation levels (BC: 95.6 +/- 1.3%; EC: 94.6 +/- 1.9% [awake]: BC: 94.8 +/- 2.1%; EC: 93.3 +/- 2.4% [asleep]; both p < 0.05). Apnea-Hypopnea Index (AHI) (BC: 21.2(7.3-36.9) events/hr; EC: 15.7 (10-33.5) events/hour (median (interquartile range)) was not different p = 0.7), however, 58% and 57% of women with BC and EC respectively, had an AHI > 15 events/hour. In this small sample size group, no significant associations (all p >.1) were detected between OSA metrics and clinico-pathological tumor variables. Conclusion In postmenopausal women with breast or endometrial cancer there is high prevalence of OSA, with no association with specific tumor characteristics detected. Recognition of the high prevalence of OSA in women with cancer is important to recognise as it may impact on surgical risk and quality of life.	[Madut, Ayey; Fuchsova, Veronika; Man, Hong; Askar, Shabeel; Trivedi, Ritu; Elder, Elisabeth; Amis, Terence; Kairaitis, Kristina] Westmead Inst Med Res, Ludwig Engel Ctr Resp Res, Sydney, NSW, Australia; [Madut, Ayey; Fuchsova, Veronika; Man, Hong; Askar, Shabeel; Trivedi, Ritu; Elder, Elisabeth; Clarke, Christine L.; Wain, Gerard; Brand, Alison; DeFazio, Anna; Amis, Terence; Kairaitis, Kristina] Univ Sydney, Fac Med & Hlth, Westmead Clin Sch, Sydney, NSW, Australia; [Elder, Elisabeth] Westmead Hosp, Breast Canc Inst, Sydney, NSW, Australia; [Clarke, Christine L.; DeFazio, Anna] Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW, Australia; [Wain, Gerard; Brand, Alison] Westmead Hosp, Dept Gynecol Oncol, Sydney, NSW, Australia; [DeFazio, Anna; Amis, Terence; Kairaitis, Kristina] Sydney West Translat Canc Res Ctr, Sydney, NSW, Australia; [Amis, Terence; Kairaitis, Kristina] Westmead Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Kairaitis, K (corresponding author), Westmead Inst Med Res, Ludwig Engel Ctr Resp Res, Sydney, NSW, Australia.; Kairaitis, K (corresponding author), Univ Sydney, Fac Med & Hlth, Westmead Clin Sch, Sydney, NSW, Australia.; Kairaitis, K (corresponding author), Sydney West Translat Canc Res Ctr, Sydney, NSW, Australia.; Kairaitis, K (corresponding author), Westmead Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia.	kristina.kairaitis@sydney.edu.au	Trivedi, Ritu/GYQ-7603-2022; DeFazio, Anna/D-3939-2013	Trivedi, Ritu/0000-0002-5128-3202; DeFazio, Anna/0000-0003-0057-4744; Kairaitis, Kristina/0000-0002-8808-3183; Brand, Alison/0000-0001-7975-6326	Strategic Priority Area for Research Collaboration (Cancer) from the University of Sydney; ResMed Foundation	Strategic Priority Area for Research Collaboration (Cancer) from the University of Sydney; ResMed Foundation	Supported by a Strategic Priority Area for Research Collaboration (Cancer) from the University of Sydney (EE CC GW AB AD TA KK), the ResMed Foundation (EE CC GW AB AD TA KK), and a donation from the Hill Foundation (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2014, SUPPORT CARE CANCER, V22, P2535, DOI 10.1007/s00520-014-2204-5; Martinez-Garcia MA, 2018, CHEST, V154, P1348, DOI 10.1016/j.chest.2018.07.015; Anttalainen U, 2006, ACTA OBSTET GYN SCAN, V85, P1381, DOI 10.1080/00016340600935649; Armbruster SD, 2018, GYNECOL ONCOL, V149, P133, DOI 10.1016/j.ygyno.2018.01.028; Aune D, 2015, ANN ONCOL, V26, P1635, DOI 10.1093/annonc/mdv142; Baker FC, 2018, NAT SCI SLEEP, V10, P73, DOI 10.2147/NSS.S125807; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bouloukaki I, 2019, J CLIN SLEEP MED, V15, P1737, DOI 10.5664/jcsm.8074; Bower JE, 2011, J CLIN ONCOL, V29, P3517, DOI 10.1200/JCO.2011.36.1154; Cabezas E, 2019, RESPIRATION, V97, P119, DOI 10.1159/000492273; Campos-Rodriguez F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207591; Chai-Coetzer CL, 2017, ANN INTERN MED, V166, P332, DOI 10.7326/M16-1301; Chan MTV, 2019, JAMA-J AM MED ASSOC, V321, P1788, DOI 10.1001/jama.2019.4783; Chang WP, 2014, SLEEP MED, V15, P1016, DOI 10.1016/j.sleep.2014.05.026; Choi JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55551-7; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2013, OBES SURG, V23, P2050, DOI 10.1007/s11695-013-1006-z; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gouveris H, 2018, J WOMENS HEALTH, V27, P920, DOI 10.1089/jwh.2017.6819; Gozal D, 2016, SLEEP, V39, P1493, DOI 10.5665/sleep.6004; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Huang TY, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02421-2017; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lindberg E, 2017, SLEEP MED, V35, P17, DOI 10.1016/j.sleep.2017.02.032; Ljunggren M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy099; Lozo T, 2017, RESP PHYSIOL NEUROBI, V245, P65, DOI 10.1016/j.resp.2016.11.001; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1661, DOI 10.1183/09031936.00115413; Morrell MJ, 2012, EUR RESPIR J, V40, P386, DOI 10.1183/09031936.00177411; Mutch DG., 2009, GYNECOL ONCOL, V115, P325, DOI [10.1016/j.ygyno.2009.10.050, DOI 10.1016/J.YGYNO.2009.10.050, DOI 10.1016/J.YGYN0.2009.10.050]; Nagle CM, 2013, EUR J CANCER, V49, P2717, DOI 10.1016/j.ejca.2013.03.015; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Pataka A, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00091-2019; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Rao MN, 2009, SLEEP, V32, P483, DOI 10.1093/sleep/32.4.483; Reinsel RA, 2015, J CLIN SLEEP MED, V11, P1361, DOI 10.5664/jcsm.5264; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; Resta O, 2004, DIABETES NUTR METAB, V17, P296; Verduzco D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120958; Yetton BD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194604; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	45	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249099	10.1371/journal.pone.0249099	http://dx.doi.org/10.1371/journal.pone.0249099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826649	Green Published, gold			2022-12-26	WOS:000638119900022
J	Endo, R; Uchiyama, K; Lim, SY; Itakura, M; Adachi, T; Uchida, K				Endo, Ryunosuke; Uchiyama, Kazuki; Lim, Sei-Young; Itakura, Masanori; Adachi, Takahiro; Uchida, Koji			Recognition of acrolein-specific epitopes by B cell receptors triggers an innate immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-SPECIFIC EPITOPES; NATURAL ANTIBODIES; B-1A; IMMUNOGLOBULIN; REPERTOIRES; GENERATION; PRODUCTS; MARKERS; RANGE	Natural antibodies, predominantly immunoglobulin M (IgM), play an important role in the defense against pathogens and in maintaining homeostasis against oxidized molecules known as oxidation-specific epitopes, such as those contained in oxidized low-density lipoproteins. However, owing to the complexity of the oxidized products, very few individual epitopes have been characterized in detail. In the present study, to identify endogenous sources of oxidation-specific epitopes, we stimulated mouse spleen and peritoneal cavity (PerC) cells in vitro with bovine serum albumin modified with a variety of lipid peroxidation-related carbonyl compounds and identified the acrolein-modified bovine serum albumin as the most efficient trigger studied for the production of IgM in PerC cells. The acrolein-specific epitopes accelerated the differentiation of B-1a cells, a fetal-derived B cell lineage, to plasma cells. In addition, acrolein-modified bovine serum albumin was specifically bound to B-1a cells, suggesting the presence of an acrolein-specific IgM-B cell receptor (BCR). A hybridoma, REG25, producing an acrolein-specific IgM, was established from the PerC cells and was indeed identified as a population of B cells expressing a specific IgM-BCR. In addition, we analyzed the BCR repertoire of acrolein-specific B cells and identified the most frequent IgM heavy chain gene segments of the B cells. These data established the presence of innate B cells expressing the acrolein-specific BCR and suggested that in addition to our understanding of acrolein as a toxic aldehyde, it may play a role as a trigger of the innate immune response.	[Endo, Ryunosuke; Uchiyama, Kazuki; Lim, Sei-Young; Itakura, Masanori; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Adachi, Takahiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo, Japan; [Uchida, Koji] CREST, Japan Agcy Med Res & Dev, Tokyo, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Uchida, K (corresponding author), CREST, Japan Agcy Med Res & Dev, Tokyo, Japan.	a-uchida@g.ecc.u-tokyo.ac.jp			Ministry of Education, Sciences, Sports, Technology (MEXT), Japan [JP17H06170];  [JP20gm0910013]	Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; 	This study was supported in part by a Grant-in-Aid for Scientific Research (S) (JP17H06170) (K. U.) from the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan. This research was also supported by AMED-CREST from AMED (JP20gm0910013) (K. U.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; Binder CJ, 2005, SPRINGER SEMIN IMMUN, V26, P385, DOI 10.1007/s00281-004-0185-z; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; DEMONTARBY L, 1988, TETRAHEDRON LETT, V29, P3937, DOI 10.1016/S0040-4039(00)80387-1; Faderl M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00016; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Furuhata A, 2003, J BIOL CHEM, V278, P48658, DOI 10.1074/jbc.M309401200; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hara Y, 2013, ANAL CHIM ACTA, V793, P107, DOI 10.1016/j.aca.2013.07.024; Kantor AB, 1997, J IMMUNOL, V158, P1175; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Maeshima T, 2012, CHEM RES TOXICOL, V25, P1384, DOI 10.1021/tx3000818; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Papac-Milicevic NR, 2010, ADV IMMUNOL, V131, P1; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Tomitori H, 2005, STROKE, V36, P2609, DOI 10.1161/01.STR.0000190004.36793.2d; TORNBERG UC, 1995, EMBO J, V14, P1680, DOI 10.1002/j.1460-2075.1995.tb07157.x; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; Uchida K, 2013, REDOX BIOL, V1, P94, DOI 10.1016/j.redox.2012.12.005; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Yoshikawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18738; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	34	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100648	10.1016/j.jbc.2021.100648	http://dx.doi.org/10.1016/j.jbc.2021.100648			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839149	gold, Green Published			2022-12-26	WOS:000672866400619
J	Fernandes, LDM; Lansky, S; Passos, HR; Bozlak, CT; Shaw, BA				Fernandes, Luisa da Matta Machado; Lansky, Sonia; Passos, Hozana Reis; Bozlak, Christine T.; Shaw, Benjamin A.			Brazilian women's use of evidence-based practices in childbirth after participating in the Senses of Birth intervention: A mixed-methods study	PLOS ONE			English	Article							PLANNED BEHAVIOR; SELF-EFFICACY; HEALTH-CARE; MATERNITY CARE; DELIVERY; IMPLEMENTATION; CHALLENGES; ADOPTION; LABOR; EDUCATION	Brazil has a cesarean rate of 56% and low use of Intrapartum Evidence-based Practices (IEBP) of 3.4%, reflecting a medically centered and highly interventionist maternal health care model. The Senses of Birth (SoB) is a health education intervention created to promote normal birth, use of EBP, and reduce unnecessary c-sections. This study aimed to understand the use of intrapartum EBP by Brazilian women who participated in the SoB intervention. 555 women answered the questionnaire between 2015 and 2016. Bivariate analysis and ANOVA test were used to identify if social-demographic factors, childbirth information, and perceived knowledge were associated with the use of EBP. A qualitative analysis was performed to explore women's experiences. Research participants used the following EBP: birth plan (55.2%), companionship during childbirth (81.6%), midwife care (54.2%), freedom of mobility during labor (57.7%), choice of position during delivery (57.2%), and non-pharmacological pain relief methods (74.2%). Doula support was low (26.9%). Being a black woman was associated with not using a birth plan or having doula support. Women who gave birth in private hospitals were more likely not to use the EBP. Barriers to the use of EBP identified by women were an absence of individualized care, non-respect for their choices or provision of EBP by health care providers, inadequate structure and ambiance in hospitals to use EBP, and rigid protocols not centered on women's needs. The SoB intervention was identified as a potential facilitator. Women who used EBP described a sense of control over their bodies and perceived self-efficacy to advocate for their chosen practices. Women saw the strategies to overcome barriers as a path to become their childbirth protagonist. Health education is essential to increase the use of EBP; however, it should be implemented combined with changes in the maternal care system, promoting woman-centered and evidence-based models.	[Fernandes, Luisa da Matta Machado] Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Lansky, Sonia; Passos, Hozana Reis] Dept Hlth, Belo Horizonte, MG, Brazil; [Bozlak, Christine T.; Shaw, Benjamin A.] SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, Albany, NY USA	Fundacao Oswaldo Cruz; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Fernandes, LDM (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Rene Rachou, Belo Horizonte, MG, Brazil.	luisa@mattamachado.org	da Matta Machado Fernandes, Luisa/ABG-9429-2021	da Matta Machado Fernandes, Luisa/0000-0002-5440-7928; Reis Passos, Hozana/0000-0002-9845-593X	National Council of Technological and Scientific Development (CNPq) [05/2013]; Ministry of Health [05/2013]; Bill and Melinda Gates Foundation [05/2013]; Pan-American Health Organization [05/2013]; Funding Agency of the State of Minas Gerais (FAPEMIG) [05/2013]	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Pan-American Health Organization; Funding Agency of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by funding from a group of organizations list bellow, part of the call MCTI/CNPq/MS/SCTIE/Decit/Fundacao Bill e Melinda Gates N o 05/2013 Organizations: National Council of Technological and Scientific Development (CNPq)-http://www.cnpq.br/web/guest/fomento-tecnologico, -Ministry of Health https://www.saude.gov.br/trabalho-educacao-e-qualificacao/gestao-e-regulacao-do-trabalho-emsaude/premio-inovasus, -Bill and Melinda Gates Foundation -https://www.gatesfoundation.org/, Pan-American Health Organization -https://www.paho.org/bra/, -Funding Agency of the State of Minas Gerais (FAPEMIG) -https://fapemig.br/pt/. The funding was directed to implement the health education intervention and data collection. Authors did not receive personal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agencia Nacional de Saude Suplementar (ANS),, 2017, BR SET SUPL 2019 TAX; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 2012, DEMOGR RES, V29; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2018, RECOMMENDATIONS INTR; Benoit C., 2007, J MENT HEALTH, V16, P719, DOI [10.1080/09638230701506846, DOI 10.1080/09638230701506846]; Berghella V, 2008, AM J OBSTET GYNECOL, V199, P445, DOI 10.1016/j.ajog.2008.06.093; Boatin AA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k55; BRASIL, 2017, MINISTERIO SAUDE SEC; BRASIL, 2011, PORTARIA N 1459 24 J, P1; BRASIL Lei., 1990, DISPOE CONDICOES PRO, P1; BRASIL "Ministerio da Saude, 2019, SVS INFORMA O AN LIS; BRASIL Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia de Doencas e Agravos Nao Transmissiveis e Promocao da Saude, 2015, SAUDE BRASIL 2014 AN; Brixval CS, 2016, SEX REPROD HEALTHC, V10, P32, DOI 10.1016/j.srhc.2016.03.003; Cabral FB, 2013, REV ESC ENFERM USP, V47, P281, DOI 10.1590/S0080-62342013000200002; Carlsson IM, 2015, MIDWIFERY, V31, P1000, DOI 10.1016/j.midw.2015.05.005; Castro Jamile Claro de, 2005, Rev. Latino-Am. Enfermagem, V13, P960; Cavalcanti Pauline Cristine da Silva, 2013, Physis, V23, P1297, DOI 10.1590/S0103-73312013000400014; Cortes CT, 2015, REV ESC ENFERM USP, V49, P716, DOI 10.1590/S0080-623420150000500002; da Costa PB, 2013, REV PESQUI-CUID FUND, V5, P671, DOI 10.9789/2175-5361.2013v5n4p671; de Carvalho VF, 2014, SAUDE SOC-SAO PAULO, V23, P572, DOI 10.1590/S0104-12902014000200017; de Castro M.R., 2014, RESSIGNIFICANDO SE C; Santos FSD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00143718, 10.1590/0102-311X00143718]; DeSisto CL, 2018, ANN EPIDEMIOL, V28, P225, DOI 10.1016/j.annepidem.2018.01.012; Dias Marcos Augusto Bastos, 2005, Ciênc. saúde coletiva, V10, P699, DOI 10.1590/S1413-81232005000300026; Diniz Carmen Simone Grilo, 2005, Ciênc. saúde coletiva, V10, P627; Ebrahimipour S, 2016, J INT SOC PREV COMMU, V6, P584, DOI 10.4103/2231-0762.195514; Fernandes L.daM.M., 2019, PREGNANT WOMENS KNOW; Fernandes LMM, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02874-3; Fertonani HP, 2015, CIENC SAUDE COLETIVA, V20, P1869, DOI 10.1590/1413-81232015206.13272014; Diniz CSG, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00127013; Gruber KJ, 2013, J PERINAT EDUC, V22, P49, DOI 10.1891/1058-1243.22.1.49; Hardeman RR, 2016, J MIDWIFERY WOM HEAL, V61, P773, DOI 10.1111/jmwh.12497; Hussein SAAA, 2016, WOMEN BIRTH, V29, P321, DOI 10.1016/j.wombi.2015.12.006; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2018, ESTATISTICAS GENERO; Ip WY, 2009, J CLIN NURS, V18, P2125, DOI 10.1111/j.1365-2702.2008.02720.x; Isbir GG, 2016, APPL NURS RES, V32, P227, DOI 10.1016/j.apnr.2016.07.013; Nagahama EEI, 2008, CAD SAUDE PUBLICA, V24, P1859, DOI 10.1590/S0102-311X2008000800014; Kara N, 2017, GLOB HEALTH-SCI PRAC, V5, P232, DOI 10.9745/GHSP-D-16-00411; KENNELL J, 1991, JAMA-J AM MED ASSOC, V265, P2197, DOI 10.1001/jama.265.17.2197; Lansky S., 2010, REV TEMPUS ACTAS SAU, V4, P191; Lansky S, 2019, CIENC SAUDE COLETIVA, V24, P2811, DOI 10.1590/1413-81232018248.30102017; Lansky S, 2019, INT J GYNECOL OBSTET, V145, P91, DOI 10.1002/ijgo.12765; Lansky S, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00133213; Leal MD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00223018, 10.1590/0102-311x00223018]; Leal MD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00151513; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; Leal MD, 2005, REV SAUDE PUBL, V39, P100, DOI 10.1590/S0034-89102005000100013; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Lu MC, 2010, ETHNIC DIS, V20, P62; Macinko James, 2015, N Engl J Med, V372, P2177, DOI 10.1056/NEJMp1501140; McLemore MR, 2018, SOC SCI MED, V201, P127, DOI 10.1016/j.socscimed.2018.02.013; Merighi Miriam Aparecida Barbosa, 2007, Acta paul. enferm., V20, P434, DOI 10.1590/S0103-21002007000400008; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Nakamura-Pereira M, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0228-7; da Gama SGN, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0236-7; Occhi GM, 2018, LANCET, V392, P1290, DOI 10.1016/S0140-6736(18)32407-3; ONU, 2015, RESOLUTION ADOPTED G, DOI DOI 10.1007/S13398-014-0173-7.2; Pereira Rui Pedro Gomes, 2012, Rev. Enf. Ref., VserIII, P55, DOI 10.12707/RIII11146; Rebelo F, 2010, ACTA OBSTET GYN SCAN, V89, P903, DOI 10.3109/00016349.2010.484044; Rogelberg S.G., 2007, ENCY IND ORG PSYCHOL, P1168; Sakala C., 2008, EVIDENCED BASED MATE; Fernandes RZS, 2014, CIENC SAUDE COLETIVA, V19, P4457, DOI 10.1590/1413-812320141911.21662013; Scaffidi RM, 2014, J MIDWIFERY WOM HEAL, V59, P246, DOI 10.1111/jmwh.12173; Souza S.R.R.K., 2016, TEXTO CONTEXTO ENFER, V25, P1, DOI [10.1590/0104-0707201600004080014, DOI 10.1590/0104-0707201600004080014]; Spitz R., 2018, J SEMEST DEP DISEN U, V1, P126; Suarez-Cortes M, 2015, REV LAT-AM ENFERM, V23, P520, DOI 10.1590/0104-1169.0067.2583; Torloni MR, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0247-4; Turan JM, 2006, SOC SCI MED, V62, P2196, DOI 10.1016/j.socscimed.2005.10.005; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Whitaker KM, 2016, J BEHAV MED, V39, P41, DOI 10.1007/s10865-015-9672-z; Windau-Melmer T., 2013, GUIDE ADVOCATING RES; World Health Organization,, 1996, CAR NORM BIRTH PRACT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Yazlle MEHD, 2001, REV SAUDE PUBL, V35, P202, DOI 10.1590/S0034-89102001000200015	76	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0248740	10.1371/journal.pone.0248740	http://dx.doi.org/10.1371/journal.pone.0248740			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861756	Green Published, gold			2022-12-26	WOS:000641475400046
J	Kollamparambil, U; Oyenubi, A				Kollamparambil, Umakrishnan; Oyenubi, Adeola			Behavioural response to the Covid-19 pandemic in South Africa	PLOS ONE			English	Article							HEALTH; MODEL	Background Given the economic and social divide that exists in South Africa, it is critical to manage the health response of its residents to the Covid-19 pandemic within the different socio-economic contexts that define the lived realities of individuals. Objective The objective of this study is to analyse the Covid-19 preventive behaviour and the socio-economic drivers behind the health-response behaviour. Data The study employs data from waves 1 and 2 of South Africa's nationally representative National Income Dynamics Study (NIDS)-Coronavirus Rapid Mobile Survey (CRAM). The nationally representative panel data has a sample of 7073 individuals in Wave 1 and 5676 individuals in Wave 2. Methods The study uses bivariate statistics, concentration indices and multivariate estimation techniques, ranging from a probit, control-function approach, special-regressor method and seemingly unrelated regression to account for endogeneity while identifying the drivers of the response behaviour. Findings The findings indicate enhanced behavioural responsiveness to Covid-19. Preventive behaviour is evolving over time; the use of face mask has overtaken handwashing as the most utilised preventive measure. Other measures, like social distancing, avoiding close contact, avoiding big groups and staying at home, have declined between the two periods of the study. There is increased risk perception with significant concentration among the higher income groups, the educated and older respondents. Our findings validate the health-belief model, with perceived risk, self-efficacy, perceived awareness and barriers to preventive strategy adoption identified as significant drivers of health-response behaviour. Measures such as social distancing, avoiding close contact, and the use of sanitisers are practised more by the rich and educated, but not by the low-income respondents. Conclusion The respondents from lower socio-economic backgrounds are associated with optimism bias and face barriers to the adoption of preventive strategies. This requires targeted policy attention in order to make response behaviour effective.	[Kollamparambil, Umakrishnan; Oyenubi, Adeola] Univ Witwatersrand, Sch Econ & Finance, Johannesburg, South Africa	University of Witwatersrand	Kollamparambil, U (corresponding author), Univ Witwatersrand, Sch Econ & Finance, Johannesburg, South Africa.	uma.kollamparambil@wits.ac.za	Oyenubi, Adeola/AAH-6843-2021; Oyenubi, Adeola/GRX-4841-2022; Kollamparambil, Umakrishnan/ABB-1918-2021	Oyenubi, Adeola/0000-0001-6068-1723; Kollamparambil, Umakrishnan/0000-0002-6201-1923	CRAM Project	CRAM Project	This study was funded by The CRAM Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Anaki D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244534; [Anonymous], 2020, **DROPPED REF**, DOI [10.25828/7tn9-1998, DOI 10.25828/7TN9-1998]; Bakry HM, 2020, J INFECT DEV COUNTR, V14, P817, DOI 10.3855/jidc.13160; Baum CF., 2012, STAT C; BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407; Bengali S., 2020, LOS ANGELES TIMES, V8; Benham JL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246941; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Bontemps C, 2016, AM J AGR ECON, V98, P297, DOI 10.1093/ajae/aav046; Branson N., 2019, 9 NIDS; Burger R., 2020, NATL INCOME DYNAMICS; CDC, RISK COVID 19 INF HO; Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P389, DOI 10.1007/s10654-020-00649-w; Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161; Daniels R. C., 2020, DETERMINANTS ATTRITI; Daysal NM, 2015, BE J ECON ANAL POLI, V15, P179, DOI 10.1515/bejeap-2013-0038; Dong YY, 2015, ECONOMET REV, V34, P82, DOI 10.1080/07474938.2014.944470; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Gebretsadik D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246154; Gershuny J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245551; HECKMAN JJ, 1976, ANN ECON SOC MEAS, V5, P475; Hevey D, 1998, IRISH J PSYCHOL, V19, P248, DOI 10.1080/03033910.1998.10558189; Ingle K., 2020, TECHNICAL NOTE VERSI, V1; Jain Ronak, 2020, LABOR MARKET POVERTY; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jose R, 2021, CLIN EPIDEMIOL GLOB, V9, P41, DOI 10.1016/j.cegh.2020.06.009; Kerr A., 2020, NATL INCOME DYNAMICS; Kingdon G, 2004, REV DEV ECON, V8, P198; Kollamparambil U, 2021, J HAPPINESS STUD, V22, P555, DOI 10.1007/s10902-020-00240-w; Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977; Leibbrandt M, 2012, DEV SO AFR, V29, P19, DOI 10.1080/0376835X.2012.645639; Leigh JP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241259; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; Lewbel A, 2000, J ECONOMETRICS, V97, P145, DOI 10.1016/S0304-4076(00)00015-4; Lewbel A., 2014, OXFORD HDB APPL NONP, DOI [10.1093/oxfordhb/9780199857944.013.002, DOI 10.1093/OXFORDHB/9780199857944.013.002]; Margraf J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243523; Mein SA, 2020, J GEN INTERN MED, V35, P2439, DOI 10.1007/s11606-020-05880-5; Monod M, 2021, SCIENCE, V371, P1336, DOI 10.1126/science.abe8372; Nowak B, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110232; Plumper T., 2020, WEALTHIER DISTRICTS, V11; Ropeik D., 2002, NIEMAN REPORTS, V56, P52; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Tenkorang EY, 2013, J HIV-AIDS SOC SERV, V12, P125, DOI 10.1080/15381501.2013.764489; WEINSTEIN ND, 1995, HEALTH PSYCHOL, V14, P132, DOI 10.1037/0278-6133.14.2.132; Wills G., 2020, WORKING PAPER SERIES, V1; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250269	10.1371/journal.pone.0250269	http://dx.doi.org/10.1371/journal.pone.0250269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861811	Green Published, gold			2022-12-26	WOS:000641475400037
J	Chaiklieng, S				Chaiklieng, Sunisa			Risk assessment of workers' exposure to BTEX and hazardous area classification at gasoline stations	PLOS ONE			English	Article							ORGANIC-COMPOUNDS VOCS; PETROL STATION; BANGKOK; EMISSIONS	Vaporization of benzene, toluene, ethylbenzene, and xylene (BTEX) compounds pollutes the air and causes health hazards at gasoline stations. This study revealed the risk of BTEX exposure according to the hazardous area classification at gasoline stations. The risk assessment of gasoline workers from a representative group of 47 stations, which followed the United States Environmental Protection Agency-IRIS method of assessing BTEX exposure, was expressed as the hazard index (HI). A result of matrix multipliers of the hazardous exposure index and fire possibility from flammable gas classified hazardous area-I and area-II at the fuel dispensers. BTEX concentrations were actively sampled in ambient air and a flammable gas detector was used to measure the flammability level. Results showed that the BTEX concentrations from ambient air monitoring were in the range of 0.1-136.9, 8.1-406.0, 0.8-24.1 and 0.4-105.5 ppb for benzene, toluene, ethylbenzene, and xylene, respectively, which exceeded the NIOSH exposure limit of 100 ppb of benzene concentration. The risk assessment indicated that five stations reached an unacceptable risk of worker exposure to BTEX (HI>1), which correlated with the numbers of gasoline dispensers and daily gasoline sold. The risk matrix classified hazardous area-I at 4 meters and hazardous area-II at 4-8 meters in radius around the fuel dispensers. This study revealed the hazardous areas at gasoline stations and suggests that entrepreneurs must strictly control the safety operation practice of workers, install vapor recovery systems on dispenser nozzles to control BTEX vaporization and keep the hazardous areas clear of fire ignition sources within an eight-meter radius of the dispensers.	[Chaiklieng, Sunisa] Khon Kaen Univ, Fac Publ Hlth, Dept Environm Hlth Occupat Hlth & Safety, Khon Kaen, Thailand	Khon Kaen University	Chaiklieng, S (corresponding author), Khon Kaen Univ, Fac Publ Hlth, Dept Environm Hlth Occupat Hlth & Safety, Khon Kaen, Thailand.	csunis@kku.ac.th	Chaiklieng, Sunisa/AAO-9644-2020	Chaiklieng, Sunisa/0000-0003-4190-4930	National Research Council of Thailand [NRCT610007]	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This study was partially supported by research funding from The National Research Council of Thailand (NRCT610007). No additional external funding received for this study.	Agency for Toxic Substances and Disease Registry (ATSDR), 2010, TOX PROF ETH XYL; Agency for Toxic Substances and Disease Registry (ATSDR), 2015, TOX PROF BENZ ADD TO; Al-Harbi M, 2020, ATMOS ENVIRON, V241, DOI 10.1016/j.atmosenv.2020.117847; [Anonymous], 2019, 60079101 IEC; AS/NZS, 2019, RISK MAN STAND; Ashley K., 2016, NIOSH MAN AN METH NM, V5th; Chaiklieng S., 2015, Environment Asia, V8, P56; Chaiklieng S, 2020, J OCCUP HEALTH, V62, DOI 10.1002/1348-9585.12137; Chaiklieng S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142545; Correa SM, 2012, ATMOS POLLUT RES, V3, P163, DOI 10.5094/APR.2012.016; Dacherngkhao T., 2019, INT J ENV RES PUB HE, V10, P2036; Fandi NFM, 2020, AEROSOL AIR QUAL RES, V20, P1922, DOI 10.4209/aaqr.2019.11.0574; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Kitwattanavong M, 2013, HUM ECOL RISK ASSESS, V19, P1424, DOI 10.1080/10807039.2012.685814; Latif MT, 2019, CHEMOSPHERE, V237, DOI 10.1016/j.chemosphere.2019.124451; Ministry of Energy,, 2013, EL LAW SYST EL INST; NFPA, 2019, 497 NFPA; OSHA, 2020, HAZARDOUS, V307; Pang YB, 2014, ATMOS ENVIRON, V83, P127, DOI 10.1016/j.atmosenv.2013.11.002; Preuktharatikul V., 2020, PUBLIC HLTH J BURAPH, V15, P26; Rattanajongjitrakorn P, 2014, AGRIC AGRIC SCI PROC, V10, P37, DOI 10.1016/j.apcbee.2014.10.011; Singh R., 2016, J ENV PROTECTION, V7, P670; Tunsaringkarn T, 2012, INT J OCCUP ENV MED, V3, P117; USEPA, 2009, RISK ASS GUID SUP; USEPA, 2019, AIR EM FACT QUANT AP; Zheng H, 2018, ATMOS CHEM PHYS, V18, P4567, DOI 10.5194/acp-18-4567-2018	26	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249913	10.1371/journal.pone.0249913	http://dx.doi.org/10.1371/journal.pone.0249913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857202	Green Published, gold			2022-12-26	WOS:000641474900058
J	Gihr, G; Horvath-Rizea, D; Hekeler, E; Ganslandt, O; Henkes, H; Hoffmann, KT; Scherlach, C; Schob, S				Gihr, Georg; Horvath-Rizea, Diana; Hekeler, Elena; Ganslandt, Oliver; Henkes, Hans; Hoffmann, Karl-Titus; Scherlach, Cordula; Schob, Stefan			Diffusion weighted imaging in high-grade gliomas: A histogram-based analysis of apparent diffusion coefficient profile	PLOS ONE			English	Article							MGMT PROMOTER METHYLATION; CENTRAL-NERVOUS-SYSTEM; PROGNOSTIC VALUE; GLIOBLASTOMA; PREDICTION; MRI; CLASSIFICATION; HETEROGENEITY; CELLULARITY; SURVIVAL	Purpose Glioblastoma and anaplastic astrocytoma represent the most commonly encountered high-grade-glioma (HGG) in adults. Although both neoplasms are very distinct entities in context of epidemiology, clinical course and prognosis, their appearance in conventional magnetic resonance imaging (MRI) is very similar. In search for additional information aiding the distinction of potentially confusable neoplasms, histogram analysis of apparent diffusion coefficient (ADC) maps recently proved to be auxiliary in a number of entities. Therefore, our present exploratory retrospective study investigated whether ADC histogram profile parameters differ significantly between anaplastic astrocytoma and glioblastoma, reflect the proliferation index Ki-67, or are associated with the prognostic relevant MGMT (methylguanine-DNA methyl-transferase) promotor methylation status. Methods Pre-surgical ADC volumes of 56 HGG patients were analyzed by histogram-profiling. Association between extracted histogram parameters and neuropathology including WHO-grade, Ki-67 expression and MGMT promotor methylation status was investigated due to comparative and correlative statistics. Results Grade IV gliomas were more heterogeneous than grade III tumors. More specifically, ADCmin and the lowest percentile ADCp10 were significantly lower, whereas ADCmax, ADC standard deviation and Skewness were significantly higher in the glioblastoma group. ADCmin, ADCmax, ADC standard deviation, Kurtosis and Entropy of ADC histogram were significantly correlated with Ki-67 expression. No significant difference could be revealed by comparison of ADC histogram parameters between MGMT promotor methylated and unmethylated HGG. Conclusions ADC histogram parameters differ significantly between glioblastoma and anaplastic astrocytoma and show distinct associations with the proliferative activity in both HGG. Our results suggest ADC histogram profiling as promising biomarker for differentiation of both, however, further studies with prospective multicenter design are wanted to confirm and further elaborate this hypothesis.	[Gihr, Georg; Horvath-Rizea, Diana; Henkes, Hans] Katharinenhosp Stuttgart, Clin Neuroradiol, Stuttgart, Germany; [Hekeler, Elena] Katharinenhosp Stuttgart, Dept Pathol, Stuttgart, Germany; [Ganslandt, Oliver] Katharinenhosp Stuttgart, Clin Neurosurg, Stuttgart, Germany; [Hoffmann, Karl-Titus; Scherlach, Cordula] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany; [Schob, Stefan] Univ Hosp Halle Saale, Dept Radiol, Halle, Saale, Germany	Klinikum Stuttgart; Klinikum Stuttgart; Klinikum Stuttgart; Leipzig University; Martin Luther University Halle Wittenberg	Gihr, G (corresponding author), Katharinenhosp Stuttgart, Clin Neuroradiol, Stuttgart, Germany.	ggihr@gmx.de						Charles-Edwards Elizabeth M, 2006, Cancer Imaging, V6, P135, DOI 10.1102/1470-7330.2006.0021; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Choi YS, 2016, RADIOLOGY, V281, P175, DOI 10.1148/radiol.2016151913; Cui Y, 2014, J NEURO-ONCOL, V119, P377, DOI 10.1007/s11060-014-1490-6; Gihr GA, 2018, MOL IMAGING BIOL, V20, P632, DOI 10.1007/s11307-018-1166-2; Gihr GA, 2018, TRANSL ONCOL, V11, P957, DOI 10.1016/j.tranon.2018.05.009; Gupta A, 2013, AJNR Am J Neuroradiol, V34, pE10, DOI 10.3174/ajnr.A3467; Han Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4114-2; Horvath-Rizea Diana, 2018, Oncotarget, V9, P18148, DOI 10.18632/oncotarget.24454; Jain KK, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00419; Just N, 2014, BRIT J CANCER, V111, P2205, DOI 10.1038/bjc.2014.512; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Lemee JM, 2015, NEURO-ONCOLOGY, V17, P1322, DOI 10.1093/neuonc/nov119; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Meyer HJ, 2019, MOL IMAGING BIOL, V21, P740, DOI 10.1007/s11307-018-1283-y; Meyer HJ, 2019, ACAD RADIOL, V26, pE208, DOI 10.1016/j.acra.2018.09.008; Meyer HJ, 2018, MOL IMAGING BIOL, V20, P318, DOI 10.1007/s11307-017-1115-5; Mori S, 1999, ANAT REC, V257, P102; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Pope WB, 2011, AM J NEURORADIOL, V32, P882, DOI 10.3174/ajnr.A2385; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P867, DOI 10.1007/s00401-015-1438-8; Romano A, 2013, EUR RADIOL, V23, P513, DOI 10.1007/s00330-012-2601-4; Schob S, 2018, TRANSL ONCOL, V11, P504, DOI 10.1016/j.tranon.2018.02.006; Schob S, 2017, MOL IMAGING BIOL, V19, P953, DOI 10.1007/s11307-017-1073-y; Schob S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040821; Schob S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161386; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Surov A, 2017, ONCOTARGET, V8, P59492, DOI 10.18632/oncotarget.17752; Surov A, 2017, ANTICANCER RES, V37, P3807, DOI 10.21873/anticanres.11758; Surov A, 2015, TRANSL ONCOL, V8, P517, DOI 10.1016/j.tranon.2015.11.012; Surov A, 2015, ANTICANCER RES, V35, P6841; van den Bent MJ, 2017, NEURO-ONCOLOGY, V19, P614, DOI 10.1093/neuonc/now277; Woo S, 2014, ACTA RADIOL, V55, P1270, DOI 10.1177/0284185113514967; Yin Yue, 2012, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V34, P503, DOI 10.3881/j.issn.1000-503X.2012.05.012; Zhao HL, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-1012-4	35	3	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249878	10.1371/journal.pone.0249878	http://dx.doi.org/10.1371/journal.pone.0249878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857203	gold, Green Published			2022-12-26	WOS:000641474900059
J	Kwon, T; Lee, SP; Kim, D; Jang, J; Lee, M; Kang, SU; Kim, H; Oh, K; On, J; Kim, YJ; Yun, SJ; Jin, KN; Kim, EY; Kim, KG				Kwon, TaeWoo; Lee, Sang Pyo; Kim, Dongmin; Jang, Jinseong; Lee, Myungjae; Kang, Shin Uk; Kim, Heejin; Oh, Keunyoung; On, Jinhee; Kim, Young Jae; Yun, So Jeong; Jin, Kwang Nam; Kim, Eun Young; Kim, Kwang Gi			Diagnostic performance of artificial intelligence model for pneumonia from chest radiography	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA	Objective The chest X-ray (CXR) is the most readily available and common imaging modality for the assessment of pneumonia. However, detecting pneumonia from chest radiography is a challenging task, even for experienced radiologists. An artificial intelligence (AI) model might help to diagnose pneumonia from CXR more quickly and accurately. We aim to develop an AI model for pneumonia from CXR images and to evaluate diagnostic performance with external dataset. Methods To train the pneumonia model, a total of 157,016 CXR images from the National Institutes of Health (NIH) and the Korean National Tuberculosis Association (KNTA) were used (normal vs. pneumonia = 120,722 vs.36,294). An ensemble model of two neural networks with DenseNet classifies each CXR image into pneumonia or not. To test the accuracy of the models, a separate external dataset of pneumonia CXR images (n = 212) from a tertiary university hospital (Gachon University Gil Medical Center GUGMC, Incheon, South Korea) was used; the diagnosis of pneumonia was based on both the chest CT findings and clinical information, and the performance evaluated using the area under the receiver operating characteristic curve (AUC). Moreover, we tested the change of the AI probability score for pneumonia using the follow-up CXR images (7 days after the diagnosis of pneumonia, n = 100). Results When the probability scores of the models that have a threshold of 0.5 for pneumonia, two models (models 1 and 4) having different pre-processing parameters on the histogram equalization distribution showed best AUC performances of 0.973 and 0.960, respectively. As expected, the ensemble model of these two models performed better than each of the classification models with 0.983 AUC. Furthermore, the AI probability score change for pneumonia showed a significant difference between improved cases and aggravated cases (Delta = -0.06 +/- 0.14 vs. 0.06 +/- 0.09, for 85 improved cases and 15 aggravated cases, respectively, P = 0.001) for CXR taken as a 7-day follow-up. Conclusions The ensemble model combined two different classification models for pneumonia that performed at 0.983 AUC for an external test dataset from a completely different data source. Furthermore, AI probability scores showed significant changes between cases of different clinical prognosis, which suggest the possibility of increased efficiency and performance of the CXR reading at the diagnosis and follow-up evaluation for pneumonia.	[Kwon, TaeWoo; Kim, Dongmin; Jang, Jinseong; Lee, Myungjae; Kang, Shin Uk] JLK Inc, Eonju Ro, Seoul, South Korea; [Lee, Sang Pyo] Gachon Univ, Gil Med Ctr, Dept Internal Med, Coll Med, Incheon, South Korea; [Kim, Heejin; Oh, Keunyoung; On, Jinhee] Korea Natl TB Assoc KNTA, Seoul, South Korea; [Kim, Young Jae; Yun, So Jeong; Kim, Kwang Gi] Gachon Univ, Dept Biomed Engn, Coll Med, Incheon, South Korea; [Jin, Kwang Nam] Seoul Natl Univ, Dept Radiol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Kim, Eun Young] Gachon Univ, Gil Med Ctr, Dept Radiol, Coll Med, Incheon, South Korea	Gachon University; Gachon University; Seoul National University (SNU); Seoul National University Hospital; Gachon University	Kim, KG (corresponding author), Gachon Univ, Dept Biomed Engn, Coll Med, Incheon, South Korea.; Kim, EY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Radiol, Coll Med, Incheon, South Korea.	oneshot0229@gmail.com; kimkg@gachon.ac.kr	Kim, Hee Jin/AAU-6368-2021	Kim, Hee Jin/0000-0002-0128-2789; Kim, Dongmin/0000-0003-4121-5035; jang, jinseong/0000-0002-0042-9304	Gachon University [GCU 2018-0669]; Korea ResearchDriven Hospital [2018-5287]	Gachon University; Korea ResearchDriven Hospital	This research was supported by grants from Gachon University to KGK (GCU 2018-0669) and Korea ResearchDriven Hospital to EYK (Grant No. 2018-5287). The funder has no commercial interest in it. JLK Inc. provided support in the form of salaries for authors TK, DK, JJ, ML, and SUK. The specific roles of these authors are articulated in the `author contributions' section. JLK Inc. was involved in data collection, but had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Agarap A.F, 2018, DEEP LEARNING USING, DOI DOI 10.1007/3-540-49430-8_2; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Chassagnon G, 2020, EUR J RADIOL, V123, DOI 10.1016/j.ejrad.2019.108774; Cicek O, 2016, INT C MED IM COMP CO; DIEHR P, 1984, J CHRON DIS, V37, P215, DOI 10.1016/0021-9681(84)90149-8; Franquet T, 2001, EUR RESPIR J, V18, P196, DOI 10.1183/09031936.01.00213501; Oliveira LLG, 2008, INT J MED INFORM, V77, P555, DOI 10.1016/j.ijmedinf.2007.10.010; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Hwang EJ, 2019, RADIOLOGY, V293, P573, DOI 10.1148/radiol.2019191225; Hwang EJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.1095; Hwang EJ, 2019, CLIN INFECT DIS, V69, P739, DOI 10.1093/cid/ciy967; Mahomed N, 2017, PEDIATR RADIOL, V47, P1399, DOI 10.1007/s00247-017-3834-9; Malhotra P., 2019, J COMPUTATIONAL THE, V16, P4202, DOI [DOI 10.1166/JCTN.2019.8501, 10.1166/jctn.2019.8501]; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Nam JG, 2019, RADIOLOGY, V290, P218, DOI 10.1148/radiol.2018180237; Omar H, 2019, P BOOK, P183; Qin CL, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0544-y; Riquelme R, 1997, AM J RESP CRIT CARE, V156, P1908, DOI 10.1164/ajrccm.156.6.9702005; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sharma S, 2007, CURR OPIN PULM MED, V13, P159, DOI 10.1097/MCP.0b013e3280f3bff4; Shi YH, 2008, IEEE T MED IMAGING, V27, P481, DOI 10.1109/TMI.2007.908130; Wang X, 2017, PROC CVPR IEEE, P7178, DOI 10.1109/CVPR.2017.759; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; YOUNG M, 1994, ARCH INTERN MED, V154, P2729, DOI 10.1001/archinte.1994.00420230122014	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249399	10.1371/journal.pone.0249399	http://dx.doi.org/10.1371/journal.pone.0249399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857181	gold, Green Published			2022-12-26	WOS:000641474900111
J	Magami, K; Hachiya, N; Morikawa, K; Fujii, N; Takata, T				Magami, Kosuke; Hachiya, Naomi; Morikawa, Kazuo; Fujii, Noriko; Takata, Takumi			Isomerization of Asp is essential for assembly of amyloid-like fibrils of alpha A-crystallin-derived peptide	PLOS ONE			English	Article							ASPARTIC-ACID RESIDUES; ALPHA-A66-80 PEPTIDE; PROTEIN; DIFFERENTIATION; ISOMERS; DEAMIDATION; METHYLTRANSFERASE; RACEMIZATION; AGGREGATION; DEFICIENCY	Post-translational modifications are often detected in age-related diseases associated with protein misfolding such as cataracts from aged lenses. One of the major post-translational modifications is the isomerization of aspartate residues (L-isoAsp), which could be non-enzymatically and spontaneously occurring in proteins, resulting in various effects on the structure and function of proteins including short peptides. We have reported that the structure and function of an alpha A66-80 peptide, corresponding to the 66-80 ((SDRDKFVIFLDVKHF80)-S-66) fragment of human lens alpha A-crystallin, was dramatically altered by the isomerization of aspartate residue (Asp) at position 76. In the current study, we observed amyloid-like fibrils of L-isoAsp containing alpha A66-80 using electron microscopy. The contribution of each amino acid for the peptide structure was further evaluated by circular dichroism (CD), bis-ANS, and thioflavin T fluorescence using 14 alanine substituents of alpha A66-80, including L-isoAsp at position 76. CD of 14 alanine substituents demonstrated random coiled structures except for the substituents of positively charged residues. Bis-ANS fluorescence of peptide with substitution of hydrophobic residue with alanine revealed decreased hydrophobicity of the peptide. Thioflavin T fluorescence also showed that the hydrophobicity around Asp76 of the peptide is important for the formation of amyloid-like fibrils. One of the substitutes, H79A (SDRDKFVIFL(L-isoD)VKAF) demonstrated an exact beta-sheet structure in CD and highly increased Thioflavin T fluorescence. This phenomenon was inhibited by the addition of protein-L-isoaspartate O-methyltransferase (PIMT), which is an enzyme that changes L-isoAsp into Asp. These interactions were observed even after the formation of amyloid-like fibrils. Thus, isomerization of Asp in peptide is key to form fibrils of alpha A-crystallin-derived peptide, and L-isoAsp on fibrils can be a candidate for disassembling amyloid-like fibrils of alpha A-crystallin-derived peptides.	[Magami, Kosuke; Takata, Takumi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto, Japan; [Hachiya, Naomi; Morikawa, Kazuo] Tokyo Metropolitan Ind Technol Res Inst, Koto Ku, Tokyo, Japan; [Fujii, Noriko; Takata, Takumi] Kyoto Univ, Inst Integrated Radiat & Nucl Sci, Kumatori, Osaka, Japan	Kyoto University; Kyoto University	Takata, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto, Japan.; Takata, T (corresponding author), Kyoto Univ, Inst Integrated Radiat & Nucl Sci, Kumatori, Osaka, Japan.	takumi@rri.ktoto-u.ac.jp			JSPS KAKENHI [20K11646]; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the JSPS KAKENHI Grant Numbers (20K11646) (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-20K11646/) to TT. This work was also supported by the Takeda Science Foundation to TT. The funders had no have roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058515; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Cournoyer JJ, 2005, PROTEIN SCI, V14, P452, DOI 10.1110/ps.041062905; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; Fujii N, 1999, BIOCHEM BIOPH RES CO, V263, P322, DOI 10.1006/bbrc.1999.1279; Fujii N, 1999, BIOCHEM BIOPH RES CO, V265, P746, DOI 10.1006/bbrc.1999.1748; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663, DOI 10.1093/oxfordjournals.jbchem.a124577; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fujii N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.399972; Fujii N, 2020, ACS OMEGA, V5, P27626, DOI 10.1021/acsomega.0c04197; Fujii N, 2010, AMINO ACIDS, V39, P1393, DOI 10.1007/s00726-010-0597-0; GEIGER T, 1987, J BIOL CHEM, V262, P785; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Hurtado PP, 2012, MASS SPECTROM REV, V31, P609, DOI 10.1002/mas.20357; Kannan R, 2014, AMYLOID, V21, P103, DOI 10.3109/13506129.2014.888994; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Magami K, 2020, EXP EYE RES, V192, DOI 10.1016/j.exer.2020.107930; MCFADDEN PN, 1986, MECH AGEING DEV, V34, P91, DOI 10.1016/0047-6374(86)90107-7; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; O'Connor PB, 2006, J AM SOC MASS SPECTR, V17, P15, DOI 10.1016/j.jasms.2005.08.019; Raju M, 2016, BBA-GEN SUBJECTS, V1860, P246, DOI 10.1016/j.bbagen.2015.06.010; Raju M, 2015, EXP EYE RES, V132, P151, DOI 10.1016/j.exer.2015.01.024; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Wakankar AA, 2006, J PHARM SCI-US, V95, P2321, DOI 10.1002/jps.20740; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yamazaki Y, 2010, ANAL CHEM, V82, P6384, DOI 10.1021/ac100310x	30	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250277	10.1371/journal.pone.0250277	http://dx.doi.org/10.1371/journal.pone.0250277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857260	Green Published, gold			2022-12-26	WOS:000641474900097
J	Ngcamphalala, C; Ostensson, E; Ginindza, TG				Ngcamphalala, Cebisile; Ostensson, Ellinor; Ginindza, Themba G.			The economic burden of cervical cancer in Eswatini: Societal perspective	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; COST-EFFECTIVENESS; GLOBAL BURDEN; HPV; PRODUCTIVITY; MORTALITY	Background Cervical cancer imposes considerable economic burden on societies and individuals. There is lack of evidence regarding this from the developing world and particularly from sub-Saharan Africa. Therefore, the study aimed to estimate the societal costs of cervical cancer in Eswatini. Materials and methods The cost of illness study (CoI) was applied using national specific clinical and registry data from hospitals, registries and reports to determine the prevalence of cervical intraepithelial neoplasia (CIN) and cervical cancer in Eswatini in 2018. Cost data included direct medical costs (health care utilization in inpatient and outpatient care), direct non-medical costs (patient costs for traveling) and indirect costs based on productivity loss due to morbidity (patient time during diagnosis and treatment) and premature mortality. Results The estimated total annual cost for cervical cancer was $19 million (ranging between $14 million and $24 million estimated with lower and upper bounds). Direct cost represented the majority of the costs at 72% ($13.7 million) out of which total pre-cancerous treatment costs accounted for 0.7% ($94,161). The management of invasive cervical cancer was the main cost driver with costs attributable to treatment for FIGO III and FIGO IV representing $1.7 million and $8.7 million respectively. Indirect costs contributed 27% ($5.3 million) out of which productivity loss due to premature mortality represented the majority at 67% ($3.5 million). Conclusion The economic burden of cervical cancer in Eswatini is substantial. National public health prevention strategies with prophylactic HPV vaccine and screening for cervical lesions should therefore be prioritized to limit the extensive costs associated with cervical cancer.	[Ngcamphalala, Cebisile; Ginindza, Themba G.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Ostensson, Ellinor] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Kwazulu Natal; Karolinska Institutet; Karolinska Institutet	Ngcamphalala, C (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.	xcebie@gmail.com		Ngcamphalala, Cebisile/0000-0003-2960-1558	University of KwaZulu-Natal College of Health Sciences Doctoral Research Scholarship grant	University of KwaZulu-Natal College of Health Sciences Doctoral Research Scholarship grant	The study was funded by the University of KwaZulu-Natal College of Health Sciences Doctoral Research Scholarship grant. The funder had no role in the study design, data collection and analysis, or decision to publish.	Badial RM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009545; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Daroudi R, 2015, IRAN J PUBLIC HEALTH, V44, P1225; de Oliveira Claire, 2018, CMAJ Open, V6, pE1, DOI 10.9778/cmajo.20170144; Drummond MF, 2015, METHODS EC EVALUATIO; Ferreira M, 2008, MODERN PATHOL, V21, P968, DOI 10.1038/modpathol.2008.91; Fox PA, 2005, SEX TRANSM INFECT, V81, P142, DOI 10.1136/sti.2003.008318; Ginindza TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177762; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; Gold M, 1996, Med Care, V34, pDS197; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hatswell AJ, 2018, PHARMACOECONOMICS, V36, P1421, DOI 10.1007/s40273-018-0697-3; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Insinga RP, 2006, WOMEN HEALTH ISS, V16, P236, DOI 10.1016/j.whi.2006.06.005; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Kaye DR, 2018, ONCOLOGIST, V23, P798, DOI 10.1634/theoncologist.2017-0481; Laytragoon-Lewin N, 2007, ANTICANCER RES, V27, P4473; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; Lipsy Robert J, 2008, Am J Manag Care, V14, pS177; Liu N, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.021; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Mamo G, 2017, HLTH EC OUTCOME RES, V3, P1, DOI [10.4172/2471-268x.1000142, DOI 10.4172/2471-268X.1000142]; Ministry of Health Kingdom of Eswatini, 2018, SEX REPR HLTH SRH AN; Ministry-of-Health, 2018, ESW NAT CANC REG; Ministry-of-Health, 2018, PHAL FUND ANN REP; Ministry-of-Health, 2020, ESW STAND CANC CAR G; Mogyorosy Z., 2005, MAIN METHODOLOGICAL; Nwankwo C., 2019, HSR19 102 DIRECT IND, V17, pHSR19; Ostensson E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179520; Ostensson E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200554; Ostensson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139062; Ostensson E, 2013, ACTA OBSTET GYN SCAN, V92, P830, DOI 10.1111/aogs.12143; Patel H, 2018, VALUE HEALTH, V21, pS224, DOI 10.1016/j.jval.2018.09.1340; Pearce A, 2018, CANCER EPIDEMIOL, V53, P27, DOI 10.1016/j.canep.2017.12.013; Pisu M, 2018, CANCER-AM CANCER SOC, V124, P4181, DOI 10.1002/cncr.31643; Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7; Serrano B, 2018, BEST PRACT RES CL OB, V47, P14, DOI 10.1016/j.bpobgyn.2017.08.006; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Vijayaraghavan A, 2008, VALUE HEALTH, V11, pA68, DOI 10.1016/S1098-3015(10)70225-4; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; Wu QH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232129	42	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250113	10.1371/journal.pone.0250113	http://dx.doi.org/10.1371/journal.pone.0250113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857233	gold, Green Published			2022-12-26	WOS:000641474900035
J	Yang, XF; Li, MQ; Liao, LL; Feng, H; Zhao, S; Wu, S; Yin, P				Yang, Xiu-Fen; Li, Meng-qi; Liao, Lu-lu; Feng, Hui; Zhao, Si; Wu, Shuang; Yin, Ping			A qualitative study of the first batch of medical assistance team's first-hand experience in supporting the nursing homes in Wuhan against COVID-19	PLOS ONE			English	Article								Background The pandemic of coronavirus disease 2019 (COVID-19) has global impact, Wuhan in Hubei province is a high-risk area. And the older people in nursing homes are the most susceptible group to COVID-19. The aim of this study was to describe the practice and experience of the first-line medical team, to provide insights of coping with COVID-19 in China. Method This qualitative study used a descriptive phenomenological design to describe the experience of medical staff supported the nursing homes in Wuhan fighting against COVID-19. Unstructured interviews via online video were conducted with seven medical staffs who supported the nursing homes in Wuhan. Data were analyzed using content analysis in five main themes: for nursing homes, we interviewed the difficulties faced at the most difficult time, services for the older people, and prevention and management strategies, for the medical staff, the psychological experience were interviewed, and the implications for public health emergencies were also reported. Conclusions It is imperative that effective preventive and response measures be implemented to face the outbreak of COVID-19 and meet the care needs of older people in the context of COVID-19. Implications Findings will inform managers of some reasonable instructional strategies for implementing effective infection management. Nursing homes need to provide targeted services to help alleviating their bad psychology for residents.	[Yang, Xiu-Fen; Li, Meng-qi; Liao, Lu-lu; Feng, Hui; Zhao, Si; Wu, Shuang; Yin, Ping] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China	Central South University	Feng, H (corresponding author), Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China.	1757083108@qq.com		Li, Mengqi/0000-0001-5751-7164				[Anonymous], 2020, MORTALITY ASS COVID; Becker Edmund R, 2002, J Health Care Finance, V29, P23; Berlowitz DR, 2003, HEALTH SERV RES, V38, P65, DOI 10.1111/1475-6773.00105; Chan TC, 2013, J AM MED DIR ASSOC, V14, P849, DOI 10.1016/j.jamda.2013.08.007; Cleary M, 2014, J ADV NURS, V70, P473, DOI 10.1111/jan.12163; Davidson PM, 2020, J CLIN NURS, V29, P2758, DOI 10.1111/jocn.15297; Dey I., 1993, QUALITATIVE DATA ANA; Drevinja F., 2014, EUR PSYCHIAT, V29, P1, DOI [10.1016/j.eurpsy.2013.08.001, DOI 10.1016/J.EURPSY.2013.08.001]; Drobyazko Svetlana, 2020, E3S Web of Conferences, V211, DOI 10.1051/e3sconf/202021104011; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Rada AG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1554; Hongyuan T., 2003, CHINA NURSING MANAGE, V04, P31; Huang WC, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12218970; Jones KM, 2020, J AM GERIATR SOC, V68, P937, DOI 10.1111/jgs.16490; Ju Oh， Young, 2020, [Korean Journal of Adult Nursing, 성인간호학회지], V32, P235, DOI 10.7475/kjan.2020.32.3.235; Kennedy NA, 2020, GUT, V69, P984, DOI 10.1136/gutjnl-2020-321244; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kyngas H., 1999, CONTENT ANAL FINNISH, V11, P3; Lee JY., 2015, HEALTHCARE NURSING; Lei Z., 2020, CHINESE NURSING RES, V34, P759, DOI [10.12102/j.issn.1009-6493.2020.05.007, DOI 10.12102/J.ISSN.1009-6493.2020.05.007]; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V9, P438; Maben J, 2020, J CLIN NURS, V29, P2742, DOI 10.1111/jocn.15307; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Potter RF., 2017, INT ENCY COMMUNICATI, P1, DOI [10.1037/met0000160, 10.1002/9781118901731]; Robson C., 1993, REAL WORLD RES RESOU; Roxby AC, 2020, MMWR-MORBID MORTAL W, V69, P416, DOI 10.15585/mmwr.mm6914e2; Silva CN, 2008, FORUM QUALITATIVE SO, V9, DOI [10.17169/fqs-9.3.996, DOI 10.17169/FQS-9.3.996]; Trotter RT, 2012, PREV MED, V55, P398, DOI 10.1016/j.ypmed.2012.07.003; Vaivio J, 2012, EUR ACCOUNT REV, V21, P186, DOI 10.1080/09638180.2012.675165; Wang ZY., 1984, SHANGHAI PSYCHOL; Xiao Lily, 2015, Aust Nurs Midwifery J, V22, P37; Xu Chen, 2020, Journal of Third Military Medical University, V42, P1613, DOI 10.16016/j.1000-5404.202003174	32	0	0	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249656	10.1371/journal.pone.0249656	http://dx.doi.org/10.1371/journal.pone.0249656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DC	33857214	gold, Green Published			2022-12-26	WOS:000641474900027
J	Hervas-Raluy, S; Gomez-Benito, MJ; Borau-Zamora, C; Condor, M; Garcia-Aznar, JM				Hervas-Raluy, Silvia; Jose Gomez-Benito, Maria; Borau-Zamora, Carlos; Condor, Mar; Manuel Garcia-Aznar, Jose			A new 3D finite element-based approach for computing cell surface tractions assuming nonlinear conditions	PLOS ONE			English	Article							MECHANICAL FORCES; MATRIX STIFFNESS; ADAPTATION; MIGRATION; MICROSCOPY; ADHESION; FIELDS	Advances in methods for determining the forces exerted by cells while they migrate are essential for attempting to understand important pathological processes, such as cancer or angiogenesis, among others. Precise data from three-dimensional conditions are both difficult to obtain and manipulate. For this purpose, it is critical to develop workflows in which the experiments are closely linked to the subsequent computational postprocessing. The work presented here starts from a traction force microscopy (TFM) experiment carried out on microfluidic chips, and this experiment is automatically joined to an inverse problem solver that allows us to extract the traction forces exerted by the cell from the displacements of fluorescent beads embedded in the extracellular matrix (ECM). Therefore, both the reconstruction of the cell geometry and the recovery of the ECM displacements are used to generate the inputs for the resolution of the inverse problem. The inverse problem is solved iteratively by using the finite element method under the hypothesis of finite deformations and nonlinear material formulation. Finally, after mathematical postprocessing is performed, the traction forces on the surface of the cell in the undeformed configuration are obtained. Therefore, in this work, we demonstrate the robustness of our computational-based methodology by testing it under different conditions in an extreme theoretical load problem and then by applying it to a real case based on experimental results. In summary, we have developed a new procedure that adds value to existing methodologies for solving inverse problems in 3D, mainly by allowing for large deformations and not being restricted to any particular material formulation. In addition, it automatically bridges the gap between experimental images and mechanical computations.	[Hervas-Raluy, Silvia; Jose Gomez-Benito, Maria; Borau-Zamora, Carlos; Manuel Garcia-Aznar, Jose] Univ Zaragoza, Dept Mech Engn, Zaragoza, Spain; [Borau-Zamora, Carlos] Univ Ctr Def, Zaragoza, Spain; [Condor, Mar] Katholieke Univ Leuven, Biomech Sect, Dept Mech Engn, Leuven, Belgium	University of Zaragoza; KU Leuven	Gomez-Benito, MJ (corresponding author), Univ Zaragoza, Dept Mech Engn, Zaragoza, Spain.	gomezmj@unizar.es	Cóndor, Mar/AAJ-1329-2020; Gomez-Benito, Maria Jose/A-5368-2010; Borau Zamora, Carlos/A-7688-2018	Cóndor, Mar/0000-0002-8656-7846; Gomez-Benito, Maria Jose/0000-0002-1878-8997; Borau Zamora, Carlos/0000-0002-3784-1140; Hervas-Raluy, Silvia/0000-0001-8324-5596	European Research Council [ERC-2016-PoC 737543]; Spanish Ministry of Economy and Competitiveness [RTI2018-094494-B-C21]; Government of Aragon [2019-23]; JMGA [285283]; FWO fellowship [12ZR120N]	European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Government of Aragon(Gobierno de Aragon); JMGA; FWO fellowship(FWO)	The project was supported by the European Research Council in the form of a grant through project IMAGO (Grant No. ERC-2016-PoC 737543) awarded to JMGA, by the Spanish Ministry of Economy and Competitiveness through project Grant No. RTI2018-094494-B-C21 awarded to JMGA and MJGB, by the Government of Aragon in the form of grants awarded to SHR (Grant No. 2019-23) and JMGA (Grant No. Cellbioprint project 285283), and by a FWO fellowship (Grant No. 12ZR120N) awarded to MC. The authors also would like to thank Diego Sainz-DeMena and Francisco Merino-Casallo for their technical help and support.	Ayachit U., 2015, PARAVIEW GUIDE PARAL, DOI 10.5555/2789330; Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Boldock L, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12361; Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Carey SP, 2012, BIOMATERIALS, V33, P4157, DOI 10.1016/j.biomaterials.2012.02.029; Condor M, 2019, COMPUT METH PROG BIO, V182, DOI 10.1016/j.cmpb.2019.105056; Condor M., 2017, CURRENT PROTOCOLS CE, V2017; Condor M, 2019, BIOPHYS J, V116, P1305, DOI 10.1016/j.bpj.2019.02.029; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; Dong L, 2017, COMPUT METHOD APPL M, V314, P296, DOI 10.1016/j.cma.2016.05.020; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Germain S., 2014, ADV MODEL SIMUL ENG, V1, P1, DOI [10.1186/2213-7467-1-10, DOI 10.1186/2213-7467-1-10]; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Holenstein CN, 2019, COMPUT METHOD BIOMEC, V22, P853, DOI 10.1080/10255842.2019.1599866; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Jorge-Penas A, 2017, BIOMATERIALS, V136, P86, DOI 10.1016/j.biomaterials.2017.05.015; Jorge-Penas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144184; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Lang NR, 2015, ACTA BIOMATER, V13, P61, DOI 10.1016/j.actbio.2014.11.003; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Palacio J, 2013, J BIOMECH, V46, P50, DOI 10.1016/j.jbiomech.2012.10.009; Roy P, 2002, NAT CELL BIOL, V4, pE91, DOI 10.1038/ncb0402-e91; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Schwarz US, 2015, BBA-MOL CELL RES, V1853, P3095, DOI 10.1016/j.bbamcr.2015.05.028; Si H, 2015, ACM T MATH SOFTWARE, V41, DOI 10.1145/2629697; Slomka N, 2010, J BIOMECH, V43, P1806, DOI 10.1016/j.jbiomech.2010.02.011; Soine JRD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004076; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Song DW, 2019, COMPUT METHOD APPL M, V357, DOI 10.1016/j.cma.2019.112579; Steinwachs J, 2016, NAT METHODS, V13, P171, DOI [10.1038/NMETH.3685, 10.1038/nmeth.3685]; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Vitale G, 2012, INVERSE PROBL, V28, DOI 10.1088/0266-5611/28/9/095013; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang HL, 2014, BIOPHYS J, V107, P2592, DOI 10.1016/j.bpj.2014.09.044; Wang J. H.-C., 2010, MICROSCOPY SCI TECHN, P449; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005	51	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249018	10.1371/journal.pone.0249018	http://dx.doi.org/10.1371/journal.pone.0249018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852586	gold, Green Published			2022-12-26	WOS:000640604500035
J	Park, JW; Jeong, JM; Cho, KS; Cho, SY; Cheon, JH; Choi, DH; Park, SJ; Kim, HK				Park, Jun Won; Jeong, Jong Min; Cho, Kye Soo; Cho, Soo Young; Cheon, Jae Hee; Choi, Dong Ho; Park, Sang Jae; Kim, Hark Kyun			MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases	PLOS ONE			English	Article							GASTRIC-CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; UNKNOWN PRIMARY; EXPRESSION; INVASION; ADENOCARCINOMA; MIGRATION; GROWTH	Prior studies have demonstrated the utility of microRNA assays for predicting some cancer tissue origins, but these assays need to be further optimized for predicting the tissue origins of adenocarcinomas of the liver. We performed microRNA profiling on 195 frozen primary tumor samples using 14 types of tumors that were either adenocarcinomas or differentiated from adenocarcinomas. The 1-nearest neighbor method predicted tissue-of-origin in 33 samples of a test set, with an accuracy of 93.9% at feature selection p values ranging from 10(-4) to 10(-10). According to binary decision tree analyses, the overexpression of miR-30a and the underexpression of miR-200 family members (miR-200c and miR-141) differentiated intrahepatic cholangiocarcinomas from extrahepatic adenocarcinomas. When binary decision tree analyses were performed using the test set, the prediction accuracy was 84.8%. The overexpression of miR-30a and the reduced expressions of miR-200c, miR-141, and miR-425 could distinguish intrahepatic cholangiocarcinomas from liver metastases from the gastrointestinal tract.	[Park, Jun Won; Jeong, Jong Min; Cho, Kye Soo; Cho, Soo Young; Park, Sang Jae; Kim, Hark Kyun] Natl Canc Ctr Korea, Goyang, South Korea; [Park, Jun Won] Kangwon Natl Univ, Dept Biomed Convergence, Kangwon, South Korea; [Cho, Kye Soo; Cheon, Jae Hee] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Cho, Kye Soo; Cheon, Jae Hee] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea; [Choi, Dong Ho] Hanyang Univ, Dept Surg, Sch Med, Seoul, South Korea	National Cancer Center - Korea (NCC); Kangwon National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University	Kim, HK (corresponding author), Natl Canc Ctr Korea, Goyang, South Korea.	hkim@ncc.re.kr	Cheon, Jae Hee/B-4523-2015	Cheon, Jae Hee/0000-0002-2282-8904	Korea Health Industry Development Institute [HI19C0027]; National Research Foundation of Korea(NRF) [2019R1A2C2010523]; National Cancer Center (NCC) [1910021/181095]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea(NRF)(National Research Foundation of Korea); National Cancer Center (NCC)	This work was supported by Korea Health Industry Development Institute (HI19C0027), National Research Foundation of Korea(NRF) (2019R1A2C2010523) and National Cancer Center (NCC) (1910021/181095) Grants.	Bayrak R, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-9; Chiu CT, 2008, DIGEST LIVER DIS, V40, P749, DOI 10.1016/j.dld.2008.01.018; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Chu PG, 2005, AM J SURG PATHOL, V29, P359, DOI 10.1097/01.pas.0000149708.12335.6a; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; Collins AL, 2014, ANN SURG ONCOL, V21, P133, DOI 10.1245/s10434-013-3240-y; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; Ferracin M, 2011, J PATHOL, V225, P43, DOI 10.1002/path.2915; Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Liu X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07193-w; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meiri E, 2012, ONCOLOGIST, V17, P801, DOI 10.1634/theoncologist.2011-0466; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Mordant P, 2012, EUR J CARDIO-THORAC, V41, P617, DOI 10.1093/ejcts/ezr042; Mun DG, 2019, CANCER CELL, V35, P111, DOI 10.1016/j.ccell.2018.12.003; Oki E, 2016, GASTRIC CANCER, V19, P968, DOI 10.1007/s10120-015-0530-z; Panarelli NC, 2012, AM J CLIN PATHOL, V138, P211, DOI 10.1309/AJCPKSHXI3XEHW1J; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pentheroudakis G, 2007, EUR J CANCER, V43, P2026, DOI 10.1016/j.ejca.2007.06.023; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Rubin P, 2006, SEMIN RADIAT ONCOL, V16, P120, DOI 10.1016/j.semradonc.2005.12.007; Saito Y., 2011, FRONT GENET, V2, P1, DOI [10.3389/fgene.2011.00001, DOI 10.3389/FGENE.2011.00001]; Sasaki A, 1999, J SURG ONCOL, V70, P103, DOI 10.1002/(SICI)1096-9098(199902)70:2<103::AID-JSO8>3.3.CO;2-8; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Shin HR, 2010, J KOREAN MED SCI, V25, P1011, DOI 10.3346/jkms.2010.25.7.1011; Simon R, 2007, CANCER INFORM, V3, P11; Sokilde R, 2014, J MOL DIAGN, V16, P106, DOI 10.1016/j.jmoldx.2013.10.001; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Toiyama Y, 2014, ANN SURG, V259, P735, DOI 10.1097/SLA.0b013e3182a6909d; Yang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06747-4; Zang Y, 2017, NEOPLASMA, V64, P579, DOI 10.4149/neo_2017_412; Zhang JW, 2020, J CANCER, V11, P3604, DOI 10.7150/jca.41437; Zhang J, 2013, INT J MED SCI, V10, P585, DOI 10.7150/ijms.5794; Zhu QH, 2017, HUM CELL, V30, P290, DOI 10.1007/s13577-017-0170-1	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250083	10.1371/journal.pone.0250083	http://dx.doi.org/10.1371/journal.pone.0250083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852640	gold, Green Published			2022-12-26	WOS:000640604500012
J	Reeve, C; Wilson, C; Hanna, D; Gadbois, S				Reeve, Catherine; Wilson, Clara; Hanna, Donncha; Gadbois, Simon			Dog Owners' Survey reveals Medical Alert Dogs can alert to multiple conditions and multiple people	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; HUMAN HEALTH; CANINE DETECTION; CANCER; CLASSIFICATION; HYPOGLYCEMIA; FREQUENCY; DIAGNOSIS; BEHAVIOR; THERAPY	Medical Alert Dogs (MADs) are a promising support system for a variety of medical conditions. Emerging anecdotal reports suggest that dogs may alert to additional health conditions and different people other than those that they were trained for or initially began alerting. As the use of medical alert dogs increases, it is imperative that such claims are documented empirically. The overall aims of this study were to record the proportion of MAD owners who have a dog that alerts to multiple health conditions or to people other than the target person and to determine whether any sociodemographic variables were associated with dogs alerting to multiple conditions, multiple people, or both. MAD owners completed an online survey that contained a series of forced choice questions. Sixty-one participants reported a total of 33 different conditions to which dogs alerted. Eighty-four percent of participants reported that their dog alerted to multiple conditions and 54% reported that their dog alerted to multiple people. This is the first study to document that a large percentage of people report that their MAD alerts to multiple conditions and/or to multiple people. We present a discussion of how these alerting abilities could develop, but questions about the underlying mechanisms remain.	[Reeve, Catherine; Wilson, Clara; Hanna, Donncha] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland; [Gadbois, Simon] Dalhousie Univ, Life Sci Ctr, Dept Psychol & Neurosci, Halifax, NS, Canada	Queens University Belfast; Dalhousie University	Reeve, C (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.	c.reeve@qub.ac.uk	Hanna, Donncha/GRR-7928-2022	Hanna, Donncha/0000-0003-3382-4842; Gadbois, Simon/0000-0003-3678-8234; Reeve, Catherine/0000-0002-9522-903X; Wilson, Clara/0000-0002-1965-9599				Allergen Detection Dogs, MEDICAL DETECTION DO; Allergen Detection Service Dogs, THERES CURE; Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Amici F., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Amor RE, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0002-2019; Angle C, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00047; [Anonymous], POTS DOG ARCH INTERN; [Anonymous], DOG CAN SENSE OWNERS; [Anonymous], MEDICAL ALERT DOGS; Banks MR, 2005, ANTHROZOOS, V18, P396, DOI 10.2752/089279305785593983; Catala A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40721-4; Chu HT, 2018, HEADACHE, V58, P407, DOI 10.1111/head.13215; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Craven BA, 2010, J R SOC INTERFACE, V7, P933, DOI 10.1098/rsif.2009.0490; Csoltova E, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02131; Cutt H, 2007, HEALTH PLACE, V13, P261, DOI 10.1016/j.healthplace.2006.01.003; D'Aniello B, 2018, ANIM COGN, V21, P67, DOI 10.1007/s10071-017-1139-x; Dalziel DJ, 2003, SEIZURE-EUR J EPILEP, V12, P115, DOI 10.1016/S105913110200225X; Davis PRN, 2017, INVEST HUM SCENT EPI, DOI [10.25148/etd.FIDC004043, DOI 10.25148/ETD.FIDC004043]; Friesen L, 2010, EARLY CHILD EDUC J, V37, P261, DOI 10.1007/s10643-009-0349-5; Gadbois S., 2016, Dog Behavior, V2, P26; Gadbois S, 2014, DOMESTIC DOG COGNITI, P3, DOI DOI 10.1007/978-3-642-53994-7_1; Gonder-Frederick Linda A, 2017, J Diabetes Sci Technol, V11, P714, DOI 10.1177/1932296816685580; Hardin DS, 2015, DIABETES THER, V6, P509, DOI 10.1007/s13300-015-0135-x; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hart LA, 2010, HANDBOOK ON ANIMAL-ASSISTED THERAPY: THEORETICAL FOUNDATIONS AND GUIDELINES FOR PRACTICE, 3RD EDITION, P59, DOI 10.1016/B978-0-12-381453-1.10005-4; Herzog H, 2011, CURR DIR PSYCHOL SCI, V20, P236, DOI 10.1177/0963721411415220; Jezierski T, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/027001; Kaminski M, 2002, CHILD HEALTH CARE, V31, P321, DOI 10.1207/S15326888CHC3104_5; Karen and Coco, MEDICAL DETECTION DO; Katcher AH, 2010, HANDBOOK ON ANIMAL-ASSISTED THERAPY: THEORETICAL FOUNDATIONS AND GUIDELINES FOR PRACTICE, 3RD EDITION, P49, DOI 10.1016/B978-0-12-381453-1.10004-2; Kimiskidis VK, 2012, EPILEPTIC DISORD, V14, P248, DOI 10.1684/epd.2012.0524; Lesniak A, 2008, J HERED, V99, P518, DOI 10.1093/jhered/esn057; Los Evan A, 2017, J Diabetes Sci Technol, V11, P506, DOI 10.1177/1932296816666537; Marcus DA, 2013, J ALTERN COMPLEM MED, V19, P501, DOI 10.1089/acm.2012.0234; Martinez-Caja AM, 2019, EPILEPSY BEHAV, V94, P104, DOI 10.1016/j.yebeh.2019.02.001; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; MERIKANGAS KR, 1990, ARCH GEN PSYCHIAT, V47, P849; Nakhleh MK, 2017, ACS NANO, V11, P112, DOI 10.1021/acsnano.6b04930; Neupane S, 2016, DIABETES CARE, V39, pE97, DOI 10.2337/dc16-0461; Novak BJ, 2007, P NATL ACAD SCI USA, V104, P15613, DOI 10.1073/pnas.0706533104; Reeve C, 2019, ANIMALS PUBLIC EYE I; Reeve C, 2020, CAN J DIABETES, V44, P37, DOI 10.1016/j.jcjd.2019.04.020; Roelofs S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00119; Rooney NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210092; Rooney NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069921; Rudnicka J, 2014, SENSOR ACTUAT B-CHEM, V202, P615, DOI 10.1016/j.snb.2014.06.006; Rufo JC, 2016, ALLERGY, V71, P175, DOI 10.1111/all.12793; Sacharczuk M, 2019, APPL ANIM BEHAV SCI, V215, P52, DOI 10.1016/j.applanim.2019.04.006; Serpell J, 1990, PETS BENEFITS PRACTI, V1st, P1; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Siegel AP, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa6ac6; SKINNER BF, 1963, AM PSYCHOL, V18, P503, DOI 10.1037/h0045185; Strong V, 2002, SEIZURE-EUR J EPILEP, V11, P402, DOI 10.1053/seiz.2001.0656; Tauveron I, 2006, DIABETIC MED, V23, P335, DOI 10.1111/j.1464-5491.2006.01820.x; Walker DB, 2006, APPL ANIM BEHAV SCI, V97, P241, DOI 10.1016/j.applanim.2005.07.009; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Wells DL, 2008, J ALTERN COMPLEM MED, V14, P1235, DOI 10.1089/acm.2008.0288; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6; WILLIAMS H, 1989, LANCET, V1, P734; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Wilson C, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00091; Zamkah A, 2020, BIOSENSORS-BASEL, V10, DOI 10.3390/bios10040040	64	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249191	10.1371/journal.pone.0249191	http://dx.doi.org/10.1371/journal.pone.0249191			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852599	gold, Green Published			2022-12-26	WOS:000640604500073
J	Crooke-Rosado, JL; Diaz-Mendez, SC; Claudio-Roman, YE; Rivera, NM; Sosa, MA				Crooke-Rosado, Jonathan L.; Diaz-Mendez, Sara C.; Claudio-Roman, Yamil E.; Rivera, Nilsa M.; Sosa, Maria A.			De novo assembly of the freshwater prawn Macrobrachium carcinus brain transcriptome for identification of potential targets for antibody development	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LITOPENAEUS-VANNAMEI; GROWTH-PERFORMANCE; CRUSTACEAN; HEPATOPANCREAS; CRAB; AUTORECEPTORS; ACTIVATION; EXPRESSION; TERMINALS	Crustaceans are major constituents of aquatic ecosystems and, as such, changes in their behavior and the structure and function of their bodies can serve as indicators of alterations in their immediate environment, such as those associated with climate change and anthropogenic contamination. We have used bioinformatics and a de novo transcriptome assembly approach to identify potential targets for developing specific antibodies to serve as nervous system function markers for freshwater prawns of the Macrobrachium spp. Total RNA was extracted from brain ganglia of Macrobrachium carcinus freshwater prawns and Illumina Next Generation Sequencing was performed using an Eel Pond mRNA Seq Protocol to construct a de novo transcriptome. Sequencing yielded 97,202,662 sequences: 47,630,546 paired and 1,941,570 singletons. Assembly with Trinity resulted in 197,898 assembled contigs from which 30,576 were annotated: 9,600 by orthology, 17,197 by homology, and 3,779 by transcript families. We looked for glutamate receptors contigs, due to their main role in crustacean excitatory neurotransmission, and found 138 contigs related to ionotropic receptors, 32 related to metabotropic receptors, and 18 to unidentified receptors. After performing multiple sequence alignments within different biological organisms and antigenicity analysis, we were able to develop antibodies for prawn AMPA ionotropic glutamate receptor 1, metabotropic glutamate receptor 1 and 4, and ionotropic NMDA glutamate receptor subunit 2B, with the expectation that the availability of these antibodies will help broaden knowledge regarding the underlying structural and functional mechanisms involved in prawn behavioral responses to environmental impacts. The Macrobrachium carcinus brain transcriptome can be an important tool for examining changes in many other nervous system molecules as a function of developmental stages, or in response to particular conditions or treatments.	[Crooke-Rosado, Jonathan L.; Rivera, Nilsa M.; Sosa, Maria A.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA; [Crooke-Rosado, Jonathan L.; Rivera, Nilsa M.; Sosa, Maria A.] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA; [Diaz-Mendez, Sara C.; Claudio-Roman, Yamil E.] Univ Puerto Rico, Dept Biol, Cayey Campus, Cayey, PR USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico at Cayey	Sosa, MA (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.; Sosa, MA (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA.	maria.sosa@upr.edu		Diaz-Mendez, Sara/0000-0002-3261-5881	National Science Foundation (NSF) Centers of Research Excellence in Science and Technology (CREST) [HRD-1137725, HRD-1736019]	National Science Foundation (NSF) Centers of Research Excellence in Science and Technology (CREST)(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This work was supported by the National Science Foundation (NSF) Centers of Research Excellence in Science and Technology (CREST) awards HRD-1137725 and HRD-1736019.	AMBROSINI A, 1995, MOL PHARMACOL, V47, P1057; [Anonymous], 2010, FRESHWATER PRAWNS BI; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Atwood HL, 2009, ENCY NEUROSCIENCE, V2, P1185, DOI [DOI 10.1016/B978-00804, 10.1016/B978-00804]; Christie Andrew E, 2019, Invert Neurosci, V19, P12, DOI 10.1007/s10158-019-0232-z; Christie AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145964; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Feinstein N, 1998, J NEUROPHYSIOL, V80, P2893, DOI 10.1152/jn.1998.80.6.2893; Feinstein N, 2003, J COMP NEUROL, V465, P250, DOI 10.1002/cne.10847; Gallus L, 2012, MICROSC RES TECHNIQ, V75, P1613, DOI 10.1002/jemt.22106; Gard AL, 2009, GEN COMP ENDOCR, V160, P271, DOI 10.1016/j.ygcen.2008.12.014; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Hepp Y, 2016, LEARN MEMORY, V23, P427, DOI 10.1101/lm.041707.116; Hepp Y, 2013, J COMP NEUROL, V521, P2279, DOI 10.1002/cne.23285; Jaramillo ML, 2019, COMPUT BIOL CHEM, V78, P205, DOI 10.1016/j.compbiolchem.2018.12.004; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Jung H, 2013, REV AQUACULT, V5, P77, DOI 10.1111/raq.12005; Kivi K, 1996, MAR ECOL PROG SER, V136, P59, DOI 10.3354/meps136059; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kozma MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203935; Krenz WD, 2000, J NEUROPHYSIOL, V83, P1188, DOI 10.1152/jn.2000.83.3.1188; Lv JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175315; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Manfrin C, 2015, GENE, V557, P28, DOI 10.1016/j.gene.2014.12.001; McCoole MD, 2012, COMP BIOCHEM PHYS D, V7, P124, DOI 10.1016/j.cbd.2012.01.001; McGrath LL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2373-3; Miyakawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121324; Mohd-Shamsudin MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060839; Moshtaghi A, 2016, PEERJ, V4, DOI 10.7717/peerj.2520; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Northcutt AJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3215-z; Nunez-Acuna G, 2019, GENE, V697, P35, DOI 10.1016/j.gene.2019.02.012; Nunez-Acuna G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060700; Nunez-Acuna G, 2014, EXP PARASITOL, V145, P99, DOI 10.1016/j.exppara.2014.08.003; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Perez-Acevedo NL, 2005, BRAIN RES, V1062, P1, DOI 10.1016/j.brainres.2005.06.061; Perrot-Minnot MJ, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171558; PFEIFFERLINN C, 1991, SYNAPSE, V9, P35, DOI 10.1002/syn.890090106; Qiao HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01313-2; Santos CA, 2018, PEERJ, V6, DOI 10.7717/peerj.5154; Schramm M, 1997, NEUROSCI LETT, V234, P31, DOI 10.1016/S0304-3940(97)00661-7; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; SHINOZAKI H, 1992, COMP BIOCHEM PHYS C, V103, P13, DOI 10.1016/0742-8413(92)90220-2; SHINOZAKI H, 1974, NEUROPHARMACOLOGY, V13, P665, DOI 10.1016/0028-3908(74)90056-2; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Sun SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1701-3; Suwansa-ard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123848; TAKEUCHI A, 1964, J PHYSIOL-LONDON, V170, P296, DOI 10.1113/jphysiol.1964.sp007332; Tan TT, 2013, FISH SHELLFISH IMMUN, V35, P1061, DOI 10.1016/j.fsi.2013.06.017; Toyota K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1392-9; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Van Son TC., 2007, EVOL ECOL, P415; Ventura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097323; Xu QH, 2010, J EXP MAR BIOL ECOL, V394, P105, DOI 10.1016/j.jembe.2010.08.002; Young SS, 2014, INT J ENV RES PUB HE, V11, P7116, DOI 10.3390/ijerph110707116; Zhu QH, 2018, AQUAT TOXICOL, V195, P1, DOI 10.1016/j.aquatox.2017.11.020	56	0	0	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249801	10.1371/journal.pone.0249801	http://dx.doi.org/10.1371/journal.pone.0249801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836025	gold, Green Published			2022-12-26	WOS:000639361000004
J	Arashi, M; Roozbeh, M; Hamzah, NA; Gasparini, M				Arashi, M.; Roozbeh, M.; Hamzah, N. A.; Gasparini, M.			Ridge regression and its applications in genetic studies	PLOS ONE			English	Article							VARIABLE SELECTION; EXPRESSION	With the advancement of technology, analysis of large-scale data of gene expression is feasible and has become very popular in the era of machine learning. This paper develops an improved ridge approach for the genome regression modeling. When multicollinearity exists in the data set with outliers, we consider a robust ridge estimator, namely the rank ridge regression estimator, for parameter estimation and prediction. On the other hand, the efficiency of the rank ridge regression estimator is highly dependent on the ridge parameter. In general, it is difficult to provide a satisfactory answer about the selection for the ridge parameter. Because of the good properties of generalized cross validation (GCV) and its simplicity, we use it to choose the optimum value of the ridge parameter. The GCV function creates a balance between the precision of the estimators and the bias caused by the ridge estimation. It behaves like an improved estimator of risk and can be used when the number of explanatory variables is larger than the sample size in high-dimensional problems. Finally, some numerical illustrations are given to support our findings.	[Arashi, M.] Ferdowsi Univ Mashhad, Fac Math Sci, Dept Stat, Mashhad, Razavi Khorasan, Iran; [Roozbeh, M.] Semnan Univ, Fac Math Stat & Comp Sci, Dept Stat, Semnan, Iran; [Hamzah, N. A.] Univ Malaya, UM Ctr Data Analyt, Inst Math Sci, Kuala Lumpur, Malaysia; [Gasparini, M.] Polytech Torino Univ, Fac Math, Turin, Italy	Ferdowsi University Mashhad; Semnan University; Universiti Malaya	Roozbeh, M (corresponding author), Semnan Univ, Fac Math Stat & Comp Sci, Dept Stat, Semnan, Iran.	mahdi.roozbeh@semnan.ac.ir	HAMZAH, NOR A/B-9299-2010; Arashi, Mohammad/ABD-3395-2020	Arashi, Mohammad/0000-0002-5881-9241; roozbeh, mahdi/0000-0001-8381-738X; HAMZAH, NOR AISHAH/0000-0002-8309-625X	Iran National Science Foundation (INSF) [97019472]; National Research Foundation (NRF) of South Africa SARChI Research Chair [IFR170227223754, UID:71199, 109214]; University of Malaya [RP009B-13AFR, IIRG009C-19FNW]	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); National Research Foundation (NRF) of South Africa SARChI Research Chair; University of Malaya(Universiti Malaya)	This study was supported in part by Iran National Science Foundation (INSF) in the form of a grant awarded to M. Arashi (97019472), the National Research Foundation (NRF) of South Africa SARChI Research Chair (UID:71199, Ref.: IFR170227223754) in the form of a grant awarded to M. Arashi (109214), and the University of Malaya Research in the form of grants awarded to N.A. Hanzah and M. Roozbeh (RP009B-13AFR, IIRG009C-19FNW).	Akdeniz F, 2009, COMMUN STAT-THEOR M, V38, P1852, DOI 10.1080/03610920802470109; Amini M, 2015, J MULTIVARIATE ANAL, V136, P26, DOI 10.1016/j.jmva.2015.01.005; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; GIBBONS DG, 1981, J AM STAT ASSOC, V76, P131, DOI 10.2307/2287058; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Hellton KH, 2018, STAT MED, V37, P1290, DOI 10.1002/sim.7576; Hettmansperger T. P., 2011, ROBUST NONPARAMETRIC; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; JAECKEL LA, 1972, ANN MATH STAT, V43, P1449, DOI 10.1214/aoms/1177692377; JURECKOVA J, 1971, ANN MATH STAT, V42, P1328, DOI 10.1214/aoms/1177693245; Kibria BMG, 2012, J STAT COMPUT SIM, V82, P1, DOI 10.1080/00949655.2010.519705; Lee JM, 2001, J BACTERIOL, V183, P7371, DOI 10.1128/JB.183.24.7371-7380.2001; MCDONALD GC, 1975, J AM STAT ASSOC, V70, P407, DOI 10.2307/2285832; Roozbeh M, 2020, J COMPUT APPL MATH, V378, DOI 10.1016/j.cam.2020.112940; Roozbeh M, 2020, IRAN J SCI TECHNOL A, V44, P473, DOI 10.1007/s40995-020-00851-1; Roozbeh M, 2018, COMPUT STAT DATA AN, V117, P45, DOI 10.1016/j.csda.2017.08.002; Roozbeh M, 2016, J MULTIVARIATE ANAL, V147, P127, DOI 10.1016/j.jmva.2016.01.005; Saleh A.K.M.E., 2019, THEORY RIDGE REGRESS; Saleh AK., 2006, THEORY PRELIMINARY T, DOI [10.1002/0471773751, DOI 10.1002/0471773751]; SPECKMAN P, 1988, J ROY STAT SOC B MET, V50, P413; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TIKHONOV AN, 1963, DOKL AKAD NAUK SSSR+, V151, P501; Zamboni N, 2005, BIOTECHNOL BIOENG, V89, P219, DOI 10.1002/bit.20338; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729	24	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0245376	10.1371/journal.pone.0245376	http://dx.doi.org/10.1371/journal.pone.0245376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831027	Green Published, gold			2022-12-26	WOS:000639359600087
J	Bin Sayeed, MS; Joshy, G; Paige, E; Banks, E; Korda, R				Bin Sayeed, Muhammad Shahdaat; Joshy, Grace; Paige, Ellie; Banks, Emily; Korda, Rosemary			Cardiovascular disease subtypes, physical disability and workforce participation: A cross-sectional study of 163,562 middle-aged Australians	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ILL-HEALTH; RISK; UNEMPLOYMENT; POPULATION; WORK; RETIREMENT; POVERTY; EVENTS; IMPACT	Background Workforce participation is reduced among people with cardiovascular disease (CVD). However, detailed quantitative evidence on this is limited. We examined the relationship of CVD to workforce participation in older working-age people, by CVD subtype, within population subgroups and considering the role of physical disability. Methods Questionnaire data (2006-2009) for participants aged 45-64 years (n = 163,562) from the population-based 45 and Up Study (n = 267,153) were linked to hospitalisation data through the Centre for Health Record Linkage. Prior CVD was from self-report or hospitalisation. Modified Poisson regression estimated adjusted prevalence ratios (PRs) for non-participation in the workforce in people with versus without CVD, adjusting for sociodemographic factors. Results There were 19,161 participants with CVD and 144,401 without. Compared to people without CVD, workforce non-participation was greater for those with CVD (40.0% vs 23.5%, PR = 1.36, 95%CI = 1.33-1.39). The outcome varied by CVD subtype: myocardial infarction (PR = 1.46, 95%CI = 1.36-1.55); cerebrovascular disease (PR = 1.92, 95%CI = 1.80-2.06); heart failure (PR = 1.83, 95%CI = 1.68-1.98) and peripheral vascular disease (PR = 1.76, 95%CI = 1.65-1.88). Workforce non-participation in those with CVD versus those without was at least 21% higher in all population subgroups examined, with PRs ranging from 1.75 (95%CI = 1.65-1.85) in people aged 50-55 years to 1.21 (95%CI = 1.19-1.24) among those aged 60-64. Compared to people with neither CVD nor physical functioning limitations, those with physical functional limitations were around three times as likely to be out of the workforce regardless of CVD diagnosis; participants with CVD but without physical functional limitations were 13% more likely to be out of the workforce (PR = 1.13, 95%CI = 1.07-1.20). Conclusions While many people with CVD participate in the workforce, participation is substantially lower, especially for people with cerebrovascular disease, than for people without CVD, highlighting priority areas for research and support, particularly for people experiencing physical functioning limitations.	[Bin Sayeed, Muhammad Shahdaat; Joshy, Grace; Paige, Ellie; Banks, Emily; Korda, Rosemary] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia	Australian National University	Bin Sayeed, MS (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia.	muhammad-shahdaat.bin-sayeed@anu.edu.au	Bin Sayeed, Muhammad Shahdaat Shahdaat/M-7055-2014	Bin Sayeed, Muhammad Shahdaat Shahdaat/0000-0003-0027-9614; Banks, Emily/0000-0002-4617-1302; Paige, Ellie/0000-0003-0855-9872; Joshy, Grace/0000-0002-0718-6368	Australian Government Research and Training scholarship; National Health and Medical Research Council of Australia [1136128, 1139539]; National Heart Foundation of Australia [102131]	Australian Government Research and Training scholarship(Australian Government); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	Muhammad Shahdaat Bin Sayeed is supported by an Australian Government Research and Training scholarship to undertake a PhD at the Australian National University, Canberra, ACT, Australia. Emily Banks is supported by a Principal Research Fellowship from the National Health and Medical Research Council of Australia (reference 1136128). Ellie Paige is supported by a Postdoctoral Fellowship (reference: 102131) from the National Heart Foundation of Australia. This project was supported by a Project Grant from the National Health and Medical Research Council of Australia (reference 1139539).	ABS, 2008, AUSTR BUR STAT LAB F; AIHW, 2017, AUSTR HLTH EXP DEM D; AIHW. Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI, P53; AIHW. Australian Institute of Health and Welfare, 2011, CARD DIS AUSTR FACTS; AIHW. Australian Institute of Health and Welfare, 2016, AIHW AUSTR HLTH SER, V15; AIHW. Australian Institute of Health and Welfare, 2009, CHRON DIS PART WORK; AIHW. Australian Institute of Health and Welfare, 2019, PEOPL DIS AUSTR 2019; Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; [Anonymous], EC BEN INCR EMPL PEO; [Anonymous], 2009, AUSTR GUID RED HLTH; Audelin MC, 2008, J CARDIOPULM REHABIL, V28, P163, DOI 10.1097/01.HCR.0000320066.58599.e5; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Blake HL, 2018, INT J SPEECH-LANG PA, V20, P202, DOI 10.1080/17549507.2016.1229031; Britton A, 2012, EUR J PUBLIC HEALTH, V22, P831, DOI 10.1093/eurpub/ckr150; Callander EJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3240-5; Feigl AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211940; Garland A, 2019, CAN MED ASSOC J, V191, pE3, DOI 10.1503/cmaj.181238; Goodman N, IMPACT EMPLOYMENT HL; Gubhaju L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139364; HALEY SM, 1994, J CLIN EPIDEMIOL, V47, P671, DOI 10.1016/0895-4356(94)90215-1; Hengel KO, 2019, OCCUP ENVIRON MED, V76, P718, DOI 10.1136/oemed-2019-105788; Holden L, 2011, J OCCUP ENVIRON MED, V53, P253, DOI 10.1097/JOM.0b013e31820d1007; Jonsson B, 1996, EUR HEART J, V17, P2, DOI 10.1093/eurheartj/17.suppl_A.2; Jorgensen MB, 2019, EUR J EPIDEMIOL, V34, P397, DOI 10.1007/s10654-018-0476-7; Joshy G, 2015, PUBLIC HEALTH RES PR, V25, DOI 10.17061/phrp2531532; Korda RJ, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0471-0; Kouwenhoven-Pasmooij TA, 2016, INT J CARDIOL, V215, P332, DOI 10.1016/j.ijcard.2016.04.090; Kruse M, 2009, EUR J CARDIOV PREV R, V16, P387, DOI 10.1097/HJR.0b013e32832a3333; Kucharska-Newton A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004144; Li Ranzi T, 2013, INT ARCH OCC ENV HEA, V86, P295, DOI 10.1007/s00420-012-0765-5; Maaijwee NAMM, 2014, NEUROLOGY, V83, P1132, DOI 10.1212/WNL.0000000000000817; Majeed T, 2017, AUSTRALAS J AGEING, V36, P158, DOI 10.1111/ajag.12382; Majeed T, 2015, J VOCAT BEHAV, V87, P108, DOI 10.1016/j.jvb.2014.12.004; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Nakaya N, 2016, OCCUP MED-OXFORD, V66, P143, DOI 10.1093/occmed/kqv159; Norrback M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6627-2; Paige E, 2018, PREV MED, V114, P217, DOI 10.1016/j.ypmed.2018.07.011; Paradise MB, 2012, AUST NZ J PSYCHIAT, V46, P249, DOI 10.1177/0004867411427807; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez-Santana M., 2018, COHORT STUDIES HLTH, DOI [10.5772/intechopen.74324, DOI 10.5772/INTECHOPEN.74324]; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Schnitzler A, 2019, ANN PHYS REHABIL MED, V62, P351, DOI 10.1016/j.rehab.2019.04.005; Schofield D, 2013, INT J CARDIOL, V166, P68, DOI 10.1016/j.ijcard.2011.09.066; Schofield DJ, 2012, INT J CARDIOL, V156, P80, DOI 10.1016/j.ijcard.2011.03.020; Smedegaard L, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006486; Webber DA, 2015, HEALTH ECON, V24, P333, DOI 10.1002/hec.3020; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249738	10.1371/journal.pone.0249738	http://dx.doi.org/10.1371/journal.pone.0249738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831054	gold, Green Published			2022-12-26	WOS:000639359600080
J	Chen, L; Luo, MY; Xu, Y; Xia, Y; Zhou, X; Chen, WJ; Wang, H; Jiang, TT; Chen, WY; Luo, Y; Ma, QQ; Jiang, JM; Pan, XH				Chen, Lin; Luo, Mingyu; Xu, Yun; Xia, Yan; Zhou, Xin; Chen, Wanjun; Wang, Hui; Jiang, Tingting; Chen, Weiyong; Luo, Yan; Ma, Qiaoqin; Jiang, Jianmin; Pan, Xiaohong			The first 90: Progress in HIV detection in Zhejiang Province, 2008-2018	PLOS ONE			English	Article							MEN; SEX; CHINA; MSM; HANGZHOU; VCT	To analyze the results of HIV screening and the HIV-positive rate based on different HIV detection strategies in Zhejiang Province, China. Data were downloaded from the AIDS Prevention and Control Information System on May 1, 2019. HIV screening, prevalence, and incidence data were analyzed from 2008 to 2018. The incidence of HIV was calculated from the results of BED testing. SPSS software (ver. 19.0) was used for the analysis. The number of people screened for HIV increased by 229.7% from 2008 to 2018, while the incidence of HIV increased from 1.14 parts per thousand (2010) to 1.67 parts per thousand (2018), peak by 2015 (2.28 parts per thousand). The proportion of people screened for HIV in medical institutions increased from 62.0% in 2008 to 67.1% in 2018, while of all positive tests, 47.9% were conducted at medical institutions in 2008, which increased to 63.2% in 2018. VCT and STD clinic attendees, who had only 4.5% of all those undergoing HIV tests, accounted for 23.7% of all HIV positive in 2018. The rate of HIV-positive people and incidence of HIV both increased in Zhejiang Province between 2008 and 2015. The most effective strategy for detecting HIV new cases is screening visitors to VCT and STD clinics.	[Chen, Lin; Luo, Mingyu; Xu, Yun; Xia, Yan; Zhou, Xin; Chen, Wanjun; Wang, Hui; Jiang, Tingting; Chen, Weiyong; Ma, Qiaoqin; Jiang, Jianmin; Pan, Xiaohong] Zhejiang Prov Ctr Dis Control, Dept AIDS STD Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Luo, Yan] Hangzhou Ctr Dis Control & Prevent, Dept AIDS STD Control & Prevent, Hangzhou, Zhejiang, Peoples R China		Pan, XH (corresponding author), Zhejiang Prov Ctr Dis Control, Dept AIDS STD Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	xhpan@cdc.zj.cn		Chen, Lin/0000-0003-2197-2733	Key Projects in the National Science & Technology Pillar Program during the Thirteen Five-year Plan Period [2017ZX10201101, 2018ZX10721102]	Key Projects in the National Science & Technology Pillar Program during the Thirteen Five-year Plan Period	This study was supported by Key Projects in the National Science & Technology Pillar Program during the Thirteen Five-year Plan Period (Grant No. 2017ZX10201101, Grant No. 2018ZX10721102).	Abdala N, 2016, AIDS BEHAV, V20, P512, DOI 10.1007/s10461-015-1043-9; Akachi Y, 2017, B WORLD HEALTH ORGAN, V95, P465, DOI 10.2471/BLT.16.180190; Chen L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42366; Chen X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126320; Chirwa Z, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00069; Han M, 2017, BIOMED ENVIRON SCI, V30, P913, DOI 10.3967/bes2017.122; Hayes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002292; He L, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3091-z; Hu HY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080795; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Li MJ, 2018, AIDS BEHAV, V22, P2480, DOI 10.1007/s10461-018-2169-3; Li RH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3806-2; Longo JD, 2018, J MED VIROL, V90, P1549, DOI 10.1002/jmv.25209; Ma QQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2591-7; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Olp LN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv189; Pan XH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008466; Pinto AN, 2018, AIDS RES HUM RETROV, V34, P936, DOI [10.1089/aid.2017.0284, 10.1089/AID.2017.0284]; Singh K, 2012, AIDS BEHAV, V16, P818, DOI 10.1007/s10461-011-0103-z; St Lawrence JS, 2015, AIDS EDUC PREV, V27, P195, DOI 10.1521/aeap.2015.27.3.195; Traynor SM, 2018, J COMMUN HEALTH, V43, P1128, DOI 10.1007/s10900-018-0531-z; UNAIDS, 2014, 90 90 90 AMB TREATM; Wafaa ME., 2019, NEW ENGL J MED, V380, P1985, DOI [10.1056/NEJMp1904113, 10.1056/NEJMp1904113 31042822]; Yan H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04512; Yang Chaojun, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P70; Yang H, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P1649, DOI 10.3760/cma.j.issn.0254-6450.2017.12.014; Zhang JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14108-2; Zhao Y, 2019, CHINA CDC WEEKLY, V1, P5	28	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249517	10.1371/journal.pone.0249517	http://dx.doi.org/10.1371/journal.pone.0249517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831067	Green Published, gold			2022-12-26	WOS:000639359600051
J	Ding, MY; Wang, LJ; Zhan, WM; Sun, GH; Jia, XL; Chen, SZ; Ding, WS; Yang, JP				Ding, Mengyue; Wang, Lijian; Zhan, Weimin; Sun, Guanghua; Jia, Xiaolin; Chen, Shizhan; Ding, Wusi; Yang, Jianping			Genome-wide identification and expression analysis of late embryogenesis abundant protein-encoding genes in rye (Secale cereale L.)	PLOS ONE			English	Article							LEA PROTEINS; WATER-DEFICIT; STRESS; FAMILY; ARABIDOPSIS; SEQUENCE; INSIGHTS; ACID; PERFORMANCE; RESISTANCE	Late embryogenesis abundant (LEA) proteins are members of a large and highly diverse family that play critical roles in protecting cells from abiotic stresses and maintaining plant growth and development. However, the identification and biological function of genes of Secale cereale LEA (ScLEA) have been rarely reported. In this study, we identified 112 ScLEA genes, which can be divided into eight groups and are evenly distributed on all rye chromosomes. Structure analysis revealed that members of the same group tend to be highly conserved. We identified 12 pairs of tandem duplication genes and 19 pairs of segmental duplication genes, which may be an expansion way of LEA gene family. Expression profiling analysis revealed obvious temporal and spatial specificity of ScLEA gene expression, with the highest expression levels observed in grains. According to the qRT-PCR analysis, selected ScLEA genes were regulated by various abiotic stresses, especially PEG treatment, decreased temperature, and blue light. Taken together, our results provide a reference for further functional analysis and potential utilization of the ScLEA genes in improving stress tolerance of crops.	[Ding, Mengyue; Wang, Lijian; Zhan, Weimin; Sun, Guanghua; Jia, Xiaolin; Chen, Shizhan; Ding, Wusi; Yang, Jianping] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China; [Wang, Lijian] Henan Police Coll, Dept Criminal Sci & Technol, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Police College	Wang, LJ; Yang, JP (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China.; Wang, LJ (corresponding author), Henan Police Coll, Dept Criminal Sci & Technol, Zhengzhou, Peoples R China.	wanglijian2012@163.com; jpyang@henau.edu.cn		Wang, Lijian/0000-0002-9273-8779	National Natural Science Foundation of China [31871709]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China to JP (General Program, 31871709).	Amara I, 2012, PLANT CELL PHYSIOL, V53, P312, DOI 10.1093/pcp/pcr183; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bauer E, 2017, PLANT J, V89, P853, DOI 10.1111/tpj.13436; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Brini F, 2011, PLANT CELL PHYSIOL, V52, P676, DOI 10.1093/pcp/pcr030; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Cao J, 2015, PLANTA, V241, P757, DOI 10.1007/s00425-014-2215-y; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; Chen YK, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020148; CLOSE TJ, 1993, PLANT PHYSIOL, V101, P773, DOI 10.1104/pp.101.3.773; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Crespo-Herrera LA, 2017, HEREDITAS, V154, P1, DOI 10.1186/s41065-017-0033-5; Daughdrill GW, 2012, MOL BIOSYST, V8, P308, DOI 10.1039/c1mb05243h; Dong CN, 2002, PLANT PHYSIOL, V129, P1368, DOI 10.1104/pp.001925; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; ESPELUND M, 1992, PLANT J, V2, P241; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Gonzalez RM, 2014, PLANTA, V239, P941, DOI 10.1007/s00425-014-2039-9; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hatanaka R, 2015, PLANTA, V242, P451, DOI 10.1007/s00425-015-2284-6; He S, 2012, MOL GENET GENOMICS, V287, P39, DOI 10.1007/s00438-011-0660-x; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hubner M, 2013, THEOR APPL GENET, V126, P475, DOI 10.1007/s00122-012-1994-4; Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Huwaidi A, 2018, BIOCHEM BIOPH RES CO, V503, P910, DOI 10.1016/j.bbrc.2018.06.095; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim W, 2004, CROP SCI, V44, P1254, DOI 10.2135/cropsci2004.1254; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li GW, 2021, NAT GENET, V53, P574, DOI 10.1038/s41588-021-00808-z; Liang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24265; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Ling H, 2016, SCI REP-UK, V6, DOI 10.1038/srep39693; Liu DT, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090696; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; SACHS MM, 1986, ANNU REV PLANT PHYS, V37, P363, DOI 10.1146/annurev.pp.37.060186.002051; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Sharma S, 2009, THEOR APPL GENET, V119, P783, DOI 10.1007/s00122-009-1088-0; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wetzler DE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202808; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Zan T, 2020, GENE, V736, DOI 10.1016/j.gene.2020.144422	55	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249757	10.1371/journal.pone.0249757	http://dx.doi.org/10.1371/journal.pone.0249757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831102	gold, Green Published			2022-12-26	WOS:000639359600055
J	Gebere, YF; Bimerew, LG; Malko, WA; Fenta, DA				Gebere, Yidnekachew Fiseha; Bimerew, Lealem Gedefaw; Malko, Wondimagegn Adissu; Fenta, Demissie Assegu			Hematological and CD4+ T- cell count reference interval for pregnant women attending antenatal care at Hawassa University Comprehensive Specialized Hospital, Hawassa Southern Ethiopia	PLOS ONE			English	Article							ANEMIA	Background Pregnancy is a state characterized by physiological, hematological, and immunological changes. However, the reference intervals (RI) being used in clinical practice in Ethiopia are derived from non-local general populations. Therefore; this study was aimed to determine the reference interval of hematological and immunological profiles among healthy pregnant mothers attending Hawassa University Hospital. Methods A cross-sectional study in a total of 360 healthy pregnant women was enrolled from January to April 2019, at Hawassa University hospital. Sociodemographic and obstetric data were collected using a structured questionnaire. Blood samples collected from each participant were used to define the hematological parameters. The median and 95% intervals were calculated for the immunological and hematological profiles. P-value 0.05 was considered statistically significant. Result A total of 360 healthy pregnant women were enrolled in this study. The age range of the participants was 18-45 years. 342(95%) were married and 270 (75%) of the participants were multigravida. The overall median CD4+ T-cell and total WBC counts (cells/mm3) were 602 and 7.58 respectively. The overall median value for lymphocytes, neutrophils, monocytes, eosinophils, and basophil count was (cells/mm3) was 2.21, 6.74, .63, .53, and 0.09 respectively. Whereas the median RBC and platelet count was 4.48x10(6)/mu Land 212x10(6)/mu L. The median value of hematological profiles in the first, second, and third trimesters was TWBC (10(3)/mu L) (7.90, 8.30, 8.65), RBC (10(6)/mu L) (4.5, 4.6, 4.62), and PLT (10(3)/mu L) (210, 209,161) respectively. The CD4 T cell count median value was (600, 598, and 591) in the first, second, and third trimesters. Significant changes were observed in hematological and immunological parameters between trimesters (P < 0.05). Conclusion Significant changes were observed in hematological and immunological parameters between trimesters (P < 0.05). Considerable differences were also seen between the values in this study and other studies from Ethiopia and other countries, indicated the need for the development of local reference intervals for pregnant women.	[Gebere, Yidnekachew Fiseha] Hawassa Univ, Comprehens Specialized Hosp, Coll Med & Hlth Sci, Dept Med Lab, Hawassa, Sidama Region, Ethiopia; [Bimerew, Lealem Gedefaw; Malko, Wondimagegn Adissu] Jimma Univ, Inst Hlth, Sch Med Lab Sci, Fac Hlth, Jimma, Oromiya Region, Ethiopia; [Fenta, Demissie Assegu] Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Sidama Region, Ethiopia	Hawassa University; Jimma University; Hawassa University	Fenta, DA (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Sidama Region, Ethiopia.	demissieasegu@yahoo.com	Adissu, Wondimagegn/AAY-2236-2021	Adissu, Wondimagegn/0000-0003-1624-3114; Assegu, Demissie/0000-0003-3914-838X	Jimma University	Jimma University	This research has been supported by Jimma University by finance for sample collectors and reagent purchases, material support was obtained from Hawassa University College of medicine and health science and no other external fund was secured for this work. The funder has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. No additional external funding was received for this study.	Abdelrahman EG, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-168; Akinbami AA, 2015, HIV AIDS-RES PALLIAT, V7, P115, DOI 10.2147/HIV.S80137; Akinbami AA, 2013, INT J WOMENS HEALTH, V5, P227, DOI 10.2147/IJWH.S42110; [Anonymous], 2008, CLSI DEFINING EST, V3rd Edn; Azab AE AM., 2017, TEACHING HOSP NW LIB, V1, P61; Babatope I., 2018, INT J BASIC APPL INN, V7, P18; Bakrim S, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.169.13042; Banhidy F, 2011, NUTRITION, V27, P65, DOI 10.1016/j.nut.2009.12.005; Bayeh Abera AA., 2012, ETHIOP J HEALTH DEV, V26; Bernstein IM, 2001, OBSTET GYNECOL, V97, P669, DOI 10.1016/S0029-7844(00)01222-9; BF R., 2011, HEMATOLOGY CLIN PRIN, V4th Edn; Chandra S, 2012, INDIAN J HEMATOL BLO, V28, P144, DOI 10.1007/s12288-012-0175-6; (CLSI), CALS DEF DET REF INT, V15; DM T, 2013, SEMIN HEMATOL, V50, P22231; Enawgaw B, 2018, TROP MED INT HEALTH, V23, P765, DOI 10.1111/tmi.13071; Furlong C, 2016, WORLD BANK GROUP SFD; Gebreweld Angesom, 2018, BMC Hematol, V18, P15, DOI 10.1186/s12878-018-0111-6; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Genetu M, 2017, INT J WOMENS HEALTH, V9, P145, DOI 10.2147/IJWH.S126916; GL H., 2008, DEFINING ESTABLISHIN; Hove C, 2020, EVOL MED PUBLIC HLTH, P114, DOI 10.1093/emph/eoaa022; Ifeanyi OE, 2014, INT J CURR MICROBIOL, V3, P713; Irani RA, 2008, PLACENTA, V29, P763, DOI 10.1016/j.placenta.2008.06.011; Kone B, 2017, J Blood Lymph, V7, DOI 10.4172/2165-7831.1000154; LETSKY EA, 1995, J PERINAT MED, V23, P39, DOI 10.1515/jpme.1995.23.1-2.39; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; Mohamed A O, 2016, INT J MED SCI PUBLIC, V5, P525; Mulu W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181268; Panteghini M, 2015, REFERENCE INTERVALS; PETERS WH, 1984, ETHIOPIAN MED J, V22, P17; Purohit GST., 2015, SCH J APP MED SCI, V3, P2195; Rayis DA, 2017, CLINICS PRACT, V7, P1, DOI 10.4081/cp.2017.888; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Tameika RJ, 2008, BMC PREGNANCY CHILDB, V8, P8, DOI [10.1186/1471-2393-8-8, DOI 10.1186/1471-2393-8-8]; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; von Dadelszen P, 1999, AM J OBSTET GYNECOL, V181, P408, DOI 10.1016/S0002-9378(99)70570-3; Witkin SS, 2011, BJOG-INT J OBSTET GY, V118, P145, DOI 10.1111/j.1471-0528.2010.02773.x; Yalew Aregawi, 2016, BMC Res Notes, V9, P483; Zewdineh Sahlemariam WA., 2010, SAGE OPEN MED, V6, P1	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249185	10.1371/journal.pone.0249185	http://dx.doi.org/10.1371/journal.pone.0249185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831053	Green Published, gold			2022-12-26	WOS:000639359600046
J	Kuroda, H; Fujiwara, Y; Abe, T; Nagasawa, T; Oguri, T; Noguchi, S; Kamiyama, N; Takikawa, Y				Kuroda, Hidekatsu; Fujiwara, Yudai; Abe, Tamami; Nagasawa, Tomoaki; Oguri, Takuma; Noguchi, Sachiyo; Kamiyama, Naohisa; Takikawa, Yasuhiro			Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MAGNETIC-RESONANCE ELASTOGRAPHY; CLINICAL-USE; FIBROSIS; STEATOSIS; GUIDELINES; DIAGNOSIS; BIOPSY; RECOMMENDATIONS; MANAGEMENT	Background and aims We investigated the usefulness of combining two-dimensional shear wave elastography and the ultrasound-guided attenuation parameter for assessing the risk of progressive non-alcoholic steatohepatitis, defined as non-alcoholic steatohepatitis with a non-alcoholic fatty liver disease activity score of >= 4 and a fibrosis stage of >= 2. Methods This prospective study included 202 patients with non-alcoholic fatty liver disease who underwent two-dimensional shear wave elastography, ultrasound-guided attenuation parameter, vibration-controlled transient elastography, the controlled attenuation parameter, and liver biopsy on the same day. Patients were grouped according to liver stiffness measurement using two-dimensional shear wave elastography and the attenuation coefficient, assessed using the ultrasound-guided attenuation parameter: A, low liver stiffness measurement/low attenuation coefficient; B, low liver stiffness measurement/high attenuation coefficient; C, high liver stiffness measurement/low attenuation coefficient; and D, high liver stiffness measurement/high attenuation coefficient. Results Two-dimensional shear wave elastography and vibration-controlled transient elastography had equivalent diagnostic performance for fibrosis. The areas under the curve of the ultrasound-guided attenuation parameter for identifying steatosis grades >= S1, >= S2, and S3 were 0.89, 0.91, and 0.92, respectively, which were significantly better than those of the controlled attenuation parameter (P<0.05). The percentages of progressive non-alcoholic steatohepatitis in Groups A, B, C, and D were 0.0%, 7.7%, 35.7%, and 50.0%, respectively (P<0.001). The prediction model was established as logit (p) = 0.5414 x liver stiffness measurement (kPa) + 7.791 x attenuation coefficient (dB/cm/MHz)-8.401, with area under the receiver operating characteristic curve, sensitivity, and specificity values of 0.832, 80.9%, and 74.6%, respectively; there was no significant difference from the FibroScan-aspartate aminotransferase score. Conclusion Combined assessment by two-dimensional shear wave elastography and the ultrasound-guided attenuation parameter is useful for risk stratification of progressive non-alcoholic steatohepatitis and may be convenient for evaluating the necessity of specialist referral and liver biopsy.	[Kuroda, Hidekatsu; Fujiwara, Yudai; Abe, Tamami; Nagasawa, Tomoaki; Takikawa, Yasuhiro] Iwate Med Univ, Dept Internal Med, Div Hepatol, Yahaba, Iwate, Japan; [Oguri, Takuma; Noguchi, Sachiyo; Kamiyama, Naohisa] GE Healthcare, Ultrasound Gen Imaging, Tokyo, Japan	Iwate Medical University; General Electric	Kuroda, H (corresponding author), Iwate Med Univ, Dept Internal Med, Div Hepatol, Yahaba, Iwate, Japan.	hikuro@iwate-med.ac.jp			JSPS KAKENHI [JP 19K08400]; GE Healthcare Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); GE Healthcare Japan(General ElectricGE Healthcare)	This work was supported by JSPS KAKENHI [grant number JP 19K08400]. T.O., S.N. and N.K. are paid employees of GE Healthcare Japan. The funder provided support in the form of salaries for authors [H.K.]. However, it did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173; Berger Daniel, 2019, Clin Liver Dis (Hoboken), V13, P114, DOI 10.1002/cld.740; Castera L, 2019, GASTROENTEROLOGY, V156, P1264, DOI 10.1053/j.gastro.2018.12.036; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chan WK, 2014, J GASTROEN HEPATOL, V29, P1470, DOI 10.1111/jgh.12557; Corey KE, 2016, AM J GASTROENTEROL, V111, P671, DOI 10.1038/ajg.2016.44; de Ledinghen V, 2016, J GASTROEN HEPATOL, V31, P848, DOI 10.1111/jgh.13219; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dietrich CF, 2017, ULTRASCHALL MED, V38, pE16, DOI 10.1055/s-0043-103952; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Fujiwara Y, 2018, ULTRASOUND MED BIOL, V44, P2223, DOI 10.1016/j.ultrasmedbio.2018.06.017; Furlan A, 2020, AM J ROENTGENOL, V214, pW20, DOI 10.2214/AJR.19.21267; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kaswala DH, 2016, DIGEST DIS SCI, V61, P1356, DOI 10.1007/s10620-016-4079-4; Kinoshita M, 2018, J ATHEROSCLER THROMB, V25, P846, DOI 10.5551/jat.GL2017; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Naveau S, 2017, EUR J GASTROEN HEPAT, V29, P1022, DOI 10.1097/MEG.0000000000000919; Newsome PN, 2020, LANCET GASTROENTEROL, V5, P362, DOI 10.1016/S2468-1253(19)30383-8; Oeda S, 2020, HEPATOL RES, V50, P831, DOI 10.1111/hepr.13508; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8; Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Tsochatzis EA, 2018, LANCET GASTROENTEROL, V3, P509, DOI 10.1016/S2468-1253(18)30077-3; Umemura S, 2019, HYPERTENS RES, V42, P1235, DOI 10.1038/s41440-019-0284-9; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302; YAO LX, 1990, ULTRASONIC IMAGING, V12, P58, DOI 10.1016/0161-7346(90)90221-I; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Zhou JH, 2019, WORLD J GASTROENTERO, V25, P1307, DOI 10.3748/wjg.v25.i11.1307	37	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249493	10.1371/journal.pone.0249493	http://dx.doi.org/10.1371/journal.pone.0249493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826669	gold, Green Published			2022-12-26	WOS:000638119900025
J	Sasaki, M; Tanaka, M; Ichikawa, H; Suzuki, T; Nishie, H; Ozeki, K; Shimura, T; Kubota, E; Tanida, S; Kataoka, H				Sasaki, Makiko; Tanaka, Mamoru; Ichikawa, Hiroshi; Suzuki, Taketo; Nishie, Hirotada; Ozeki, Keiji; Shimura, Takaya; Kubota, Eiji; Tanida, Satoshi; Kataoka, Hiromi			5-aminolaevulinic acid (5-ALA) accumulates in GIST-T1 cells and photodynamic diagnosis using 5-ALA identifies gastrointestinal stromal tumors (GISTs) in xenograft tumor models	PLOS ONE			English	Article							PROTOPORPHYRIN IX ACCUMULATION; INDUCED FLUORESCENCE; IN-VITRO; THERAPY; PHOTOSENSITIZATION; IMPROVEMENT; RECURRENCE; MECHANISMS; ESOPHAGEAL; RESECTION	Gastrointestinal stromal tumor (GIST) diagnosis using conventional gastrointestinal endoscopy is difficult because such malignancies cannot be distinguished from other types of submucosal tumors. Photodynamic diagnosis (PDD) is based on the preferential uptake of photosensitizers by tumor tissues and its detection by fluorescence emission upon laser excitation. In this study, we investigated whether PDD using 5-aminolevulinic acid (5-ALA), a standard photosensitizer used worldwide, could be used for GIST diagnosis. 5-ALA is metabolized to endogenous fluorescent protoporphyrin IX (PpIX). We examined the accumulation of PpIX in GIST-T1 cells using flow cytometry and immunofluorescent staining. Furthermore, we established GIST-T1 xenograft mouse models and examined PpIX accumulation in the resultant tumors. PpIX accumulated in GIST-T1 cells and was localized mainly to lysosomes. PpIX accumulation was also observed in murine xenograft tumors. Moreover, tumor and normal tissues could be distinctly identified by relative PpIX fluorescence. Thus, our results demonstrated that PDD with 5-ALA has substantial clinical potential for GIST diagnosis.	[Sasaki, Makiko; Tanaka, Mamoru; Ichikawa, Hiroshi; Suzuki, Taketo; Nishie, Hirotada; Ozeki, Keiji; Shimura, Takaya; Kubota, Eiji; Tanida, Satoshi; Kataoka, Hiromi] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan	Nagoya City University	Tanaka, M (corresponding author), Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan.	mtanaka@med.nagoya-cu.ac.jp	Tanida, Satoshi/HDO-0229-2022	Tanida, Satoshi/0000-0003-0068-1283; Tanaka, Mamotu/0000-0001-8416-5774; KUBOTA, EIJI/0000-0002-6694-8772; Sasaki, Makiko/0000-0002-4196-7766	JSPS KAKENHI [18K08013, 20K08361, 20K16965, 20K16997, 18K15758, 20K083919]; Takeda Science Foundation; Kobayashi International Scholarship Foundation; Nitto Foundation; Murata Science Foundation; Research Foundation for Opto Science and Technology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi International Scholarship Foundation; Nitto Foundation; Murata Science Foundation; Research Foundation for Opto Science and Technology	This work was partially supported by JSPS KAKENHI (2017-2019) (grant number 18K08013) (to M. Tanaka); JSPS KAKENHI (2020-2022) (grant number 20K08361) (to M. Tanaka); Takeda Science Foundation (2018-2019) (to M. Tanaka); Kobayashi International Scholarship Foundation (2019) (to M. Tanaka); The Nitto Foundation (2019) (to M. Tanaka); The Murata Science Foundation (2019-2020) (to M. Tanaka); Research Foundation for Opto Science and Technology (2020) (to M. Tanaka); JSPS KAKENHI (2020-2021) grant number 20K16965 (to H. Ichikawa); JSPS KAKENHI (2020-2021) (grant number 20K16997) (to T. Suzuki); JSPS KAKENHI (2018-2020) (grant number 18K15758) (to H. Nishie); JSPS KAKENHI (2020-2022) (grant number 20K083919) (to H. Kataoka). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2020, WORLD J CLIN CASES, V8, P3142, DOI 10.12998/wjcc.v8.i15.3142; Akahoshi K, 2018, WORLD J GASTROENTERO, V24, P2806, DOI 10.3748/wjg.v24.i26.2806; Ali-Seyed M, 2011, INT J ONCOL, V39, P821, DOI 10.3892/ijo.2011.1109; Buytaert E, 2006, FASEB J, V20, P756, DOI 10.1096/fj.05-4305fje; Chen JY, 2000, PHOTOCHEM PHOTOBIOL, V72, P114, DOI 10.1562/0031-8655(2000)072<0114:SLOMMA>2.0.CO;2; Chen XH, 2011, LASER MED SCI, V26, P69, DOI 10.1007/s10103-010-0810-0; Crow P, 2003, BJU INT, V92, P400, DOI 10.1046/j.1464-410X.2003.04368.x; Datta SN, 1998, BRIT J CANCER, V78, P1113, DOI 10.1038/bjc.1998.637; Denzinger S, 2007, UROLOGY, V69, P675, DOI 10.1016/j.urology.2006.12.023; El-Khatib M, 2015, INT J MOL SCI, V16, P9936, DOI 10.3390/ijms16059936; Fujimoto S, 2018, THERANOSTICS, V8, P2313, DOI 10.7150/thno.22027; GEZE M, 1993, J PHOTOCH PHOTOBIO B, V20, P23, DOI 10.1016/1011-1344(93)80128-V; Hamblin MR, 2001, CANCER RES, V61, P7155; Hinnen P, 1998, BRIT J CANCER, V78, P679, DOI 10.1038/bjc.1998.559; Hino H, 2013, J SURG RES, V185, P119, DOI 10.1016/j.jss.2013.05.048; Hirano T, 2013, PHOTODIAGN PHOTODYN, V10, P28, DOI 10.1016/j.pdpdt.2012.06.002; Hwang JH, 2004, GASTROENTEROLOGY, V126, P301, DOI 10.1053/j.gastro.2003.11.040; Inoue K, 2017, INT J UROL, V24, P97, DOI 10.1111/iju.13291; Inoue K, 2012, CANCER-AM CANCER SOC, V118, P1062, DOI 10.1002/cncr.26378; Inoue Y, 2014, WORLD J SURG, V38, P1786, DOI 10.1007/s00268-014-2463-9; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Kaneko S, 2016, INT J BIOMED IMAGING, V2016, DOI 10.1155/2016/6135293; Kawai N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216503; Kim CH, 2011, INT J NANOMED, V6, P1357, DOI 10.2147/IJN.S21395; Kitajima Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44981-y; Kobuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050082; Kondo Y, 2014, INT J ONCOL, V45, P41, DOI 10.3892/ijo.2014.2417; Kurumi H, 2018, PHOTODIAGN PHOTODYN, V22, P79, DOI 10.1016/j.pdpdt.2018.02.005; Kushibiki T, 2017, IN VIVO, V31, P905, DOI 10.21873/invivo.11145; Li PX, 2015, ONCOL REP, V33, P125, DOI 10.3892/or.2014.3593; Mohammadi Z, 2013, PHOTODIAGN PHOTODYN, V10, P382, DOI 10.1016/j.pdpdt.2013.03.010; Motoori M, 2015, ONCOL LETT, V10, P3035, DOI 10.3892/ol.2015.3685; Nakamura M, 2015, WORLD J GASTROENTERO, V21, P6706, DOI 10.3748/wjg.v21.i21.6706; Namikawa T, 2018, MED MOL MORPHOL, V51, P187, DOI 10.1007/s00795-018-0190-2; Namikawa T, 2015, WORLD J GASTROENTERO, V21, P8769, DOI 10.3748/wjg.v21.i29.8769; Nishie H, 2016, ONCOTARGET, V7, P74259, DOI 10.18632/oncotarget.12366; Ohgari Y, 2011, PHOTOCHEM PHOTOBIOL, V87, P1138, DOI 10.1111/j.1751-1097.2011.00950.x; REGULA J, 1995, GUT, V36, P67, DOI 10.1136/gut.36.1.67; Rodriguez L, 2006, INT J BIOCHEM CELL B, V38, P1530, DOI 10.1016/j.biocel.2006.03.002; Rud E, 2000, PHOTOCHEM PHOTOBIOL, V71, P640, DOI 10.1562/0031-8655(2000)071<0640:AABNAA>2.0.CO;2; Sailer R, 2007, PHOTOCH PHOTOBIO SCI, V6, P145, DOI 10.1039/b611715e; Schwartz L, 2017, ANTI-CANCER AGENT ME, V17, P164, DOI 10.2174/1871520616666161031143301; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Suzuki C, 2014, J NUCL MED, V55, P1671, DOI 10.2967/jnumed.114.145086; Suzuki T, 2013, J NEUROSURG, V119, P1331, DOI 10.3171/2013.7.JNS122340; Tanaka M, 2014, MOL CANCER THER, V13, P767, DOI 10.1158/1535-7163.MCT-13-0393; Tanaka M, 2011, ANTICANCER RES, V31, P763; Teng L, 2011, BRIT J CANCER, V104, P798, DOI 10.1038/bjc.2011.12; Tipirneni KE, 2017, MOL IMAGING BIOL, V19, P645, DOI 10.1007/s11307-017-1050-5; White B, 2016, PHOTOMED LASER SURG, V34, P400, DOI 10.1089/pho.2016.4091; Yamamoto M, 2013, ACTA MED OKAYAMA, V67, P153; Yang X, 2015, INT J MOL SCI, V16, P25865, DOI 10.3390/ijms161025865; Yonemura Y, 2017, CANCERS, V9, DOI 10.3390/cancers9030023; Zakaria S, 2014, PHOTODIAGN PHOTODYN, V11, P227, DOI 10.1016/j.pdpdt.2014.03.001	55	4	4	7	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249650	10.1371/journal.pone.0249650	http://dx.doi.org/10.1371/journal.pone.0249650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826667	Green Published, gold			2022-12-26	WOS:000638119900013
J	Chapman, JM; Muday, GK				Chapman, Jordan M.; Muday, Gloria K.			Flavonols modulate lateral root emergence by scavenging reactive oxygen species in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPARENT-TESTA MUTANTS; NADPH OXIDASE ATRBOHD; AUXIN TRANSPORT; DIHYDROETHIDIUM FLUORESCENCE; CELL-DEATH; REDOX; ACCUMULATION; SUPEROXIDE; RESPONSES; PROTEINS	Flavonoids are a class of specialized metabolites with subclasses including flavonols and anthocyanins, which have unique properties as antioxidants. Flavonoids modulate plant development, but whether and how they impact lateral root development is unclear. We examined potential roles for flavonols in this process using Arabidopsis thaliana mutants with defects in genes encoding key enzymes in flavonoid biosynthesis. We observed the tt4 and fls1 mutants, which produce no flavonols, have increased lateral root emergence. The tt4 root phenotype was reversed by genetic and chemical complementation. To more specifically define the flavonoids involved, we tested an array of flavonoid biosynthetic mutants, eliminating roles for anthocyanins and the flavonols quercetin and isorhamnetin in modulating lateral root development. Instead, two tt7 mutant alleles, with defects in a branchpoint enzyme blocking quercetin biosynthesis, formed reduced numbers of lateral roots and tt7-2 had elevated levels of kaempferol. Using a flavonol-specific dye, we observed that in the tt7-2 mutant, kaempferol accumulated within lateral root primordia at higher levels than wild-type. These data are consistent with kaempferol, or downstream derivatives, acting as a negative regulator of lateral root emergence. We examined ROS accumulation using ROS-responsive probes and found reduced fluorescence of a superoxide-selective probe within the primordia of tt7-2 compared with wild-type, but not in the tt4 mutant, consistent with opposite effects of these mutants on lateral root emergence. These results support a model in which increased level of kaempferol in the lateral root primordia of tt7-2 reduces superoxide concentration and ROS-stimulated lateral root emergence.	[Chapman, Jordan M.; Muday, Gloria K.] Wake Forest Univ, Biol Dept, Winston Salem, NC 27109 USA	Wake Forest University	Muday, GK (corresponding author), Wake Forest Univ, Biol Dept, Winston Salem, NC 27109 USA.	muday@wfu.edu		Chapman, Jordan/0000-0001-6755-9341; Muday, Gloria/0000-0002-0377-4517	National Science Foundation [IOS-1558046]; National Institutes of Health [T32 GM127261]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Science Foundation IOS-1558046 to G. K. M. and a National Institutes of Health T32 GM127261 fellowship to J. M. C. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2013, PLANTA, V238, P171, DOI 10.1007/s00425-013-1883-3; Buer CS, 2008, PLANT SIGNAL BEHAV, V3, P415, DOI 10.4161/psb.3.6.5440; Buer CS, 2009, J EXP BOT, V60, P751, DOI 10.1093/jxb/ern323; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Burko Y, 2020, PLANT COMMUN, V1, DOI 10.1016/j.xplc.2020.100078; CABELLI DE, 1983, J PHYS CHEM-US, V87, P1809, DOI 10.1021/j100233a031; Caverzan A, 2012, GENET MOL BIOL, V35, P1011, DOI 10.1590/S1415-47572012000600016; Chapman JM, 2019, CHEM RES TOXICOL, V32, P370, DOI 10.1021/acs.chemrestox.9b00028; Chen J, 2013, ANN BIOMED ENG, V41, P327, DOI 10.1007/s10439-012-0653-x; Csepregi K, 2018, PHYTOCHEM ANALYSIS, V29, P129, DOI 10.1002/pca.2720; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Du YJ, 2018, J EXP BOT, V69, P155, DOI 10.1093/jxb/erx223; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 2020, ANNU REV PLANT BIOL, V71, P157, DOI 10.1146/annurev-arplant-050718-095955; Gayomba SR, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.185819; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; Grierson Claire, 2014, Arabidopsis Book, V12, pe0172, DOI 10.1199/tab.0172; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Jang JY, 2012, PLANT SIGNAL BEHAV, V7, P1180, DOI 10.4161/psb.21178; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kapoor D., 2019, PLANT GENE, V19, P100182, DOI [DOI 10.1016/J.PLGENE.2019.100182, 10.1016/j.plgene.2019.100182]; Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642; Kim HJ, 2008, PLANT SIGNAL BEHAV, V3, P1119, DOI 10.4161/psb.3.12.7039; Krieger G, 2016, PLANT PHYSIOL, V172, P1209, DOI 10.1104/pp.16.00660; Kudla, 2019, ROS PRODUCTION LOCAL; Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lee Y, 2013, CELL, V153, P402, DOI 10.1016/j.cell.2013.02.045; Lewis DR, 2013, PLANT CELL, V25, P3329, DOI 10.1105/tpc.113.114868; Lewis DR, 2011, PLANT PHYSIOL, V156, P144, DOI 10.1104/pp.111.172502; Li N, 2015, PLANTA, V241, P591, DOI 10.1007/s00425-014-2204-1; Liu B, 2017, PLANT CELL REP, V36, P947, DOI 10.1007/s00299-017-2128-x; Liu P, 2014, PROTEOMICS, V14, P750, DOI 10.1002/pmic.201300307; Liu XH, 2019, INT J MOL MED, V43, P199, DOI 10.3892/ijmm.2018.3962; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2018, J EXP BOT, V69, P3279, DOI 10.1093/jxb/ery048; Ma LY, 2012, J EXP BOT, V63, P305, DOI 10.1093/jxb/err280; Mabuchi K, 2018, P NATL ACAD SCI USA, V115, pE4710, DOI 10.1073/pnas.1804233115; Malamy JE, 1997, DEVELOPMENT, V124, P33; Maloney GS, 2014, PLANT PHYSIOL, V166, P614, DOI 10.1104/pp.114.240507; Manzano C, 2014, PLANT PHYSIOL, V165, P1105, DOI 10.1104/pp.114.238873; Mendez-Bravo A, 2010, PLANT CELL PHYSIOL, V51, P1612, DOI 10.1093/pcp/pcq117; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Muhlemann JK, 2018, P NATL ACAD SCI USA, V115, pE11188, DOI 10.1073/pnas.1811492115; Munne-Bosch S, 2013, PLANT PHYSIOL, V161, P5, DOI 10.1104/pp.112.205690; Nadarajah KK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155208; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Okuma E, 2011, J PLANT PHYSIOL, V168, P2048, DOI 10.1016/j.jplph.2011.06.002; Orman-Ligeza B, 2016, DEVELOPMENT, V143, P3328, DOI 10.1242/dev.136465; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41; Passaia G, 2015, PLANT SCI, V234, P22, DOI 10.1016/j.plantsci.2015.01.017; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Porco S, 2016, DEVELOPMENT, V143, P3340, DOI 10.1242/dev.136283; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; Preuss A, 2009, FEBS LETT, V583, P1981, DOI 10.1016/j.febslet.2009.05.006; Quideauessor S, 2017, RECENT ADV POLYPHENO, P143, DOI DOI 10.1002/9781118883303.CH7; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Richter GL, 2009, PLANT PHYSIOL, V151, P1855, DOI 10.1104/pp.109.142448; Ringli C, 2008, PLANT CELL, V20, P1470, DOI 10.1105/tpc.107.053249; Rounds CM, 2011, PLANT PHYSIOL, V157, P175, DOI 10.1104/pp.111.182196; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schopfer P, 1996, PLANTA, V199, P43, DOI 10.1007/BF00196879; SHEAHAN JJ, 1992, BIOTECHNIQUES, V13, P880; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Silva-Navas J, 2016, PLANT CELL, V28, P1372, DOI 10.1105/tpc.15.00857; Soubeyrand E, 2018, PLANT CELL, V30, P2910, DOI 10.1105/tpc.18.00688; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Teixeira JAS, 2019, MOL PLANT, V12, P784, DOI 10.1016/j.molp.2019.03.015; Tognetti VB, 2012, PLANT CELL ENVIRON, V35, P321, DOI 10.1111/j.1365-3040.2011.02324.x; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Tuominen H, 2019, CELL DEATH CELLS OVE; Ursache R, 2018, PLANT J, V93, P399, DOI 10.1111/tpj.13784; Watkins JM, 2017, PLANT PHYSIOL, V175, P1807, DOI 10.1104/pp.17.01010; Watkins JM, 2014, PLANT PHYSIOL, V164, P1707, DOI 10.1104/pp.113.233528; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Xie HT, 2014, PLANT CELL, V26, P2007, DOI 10.1105/tpc.114.125427; Xu F, 2018, MOL PLANT, V11, P523, DOI 10.1016/j.molp.2017.12.003; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040	93	13	13	4	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100222	10.1074/jbc.RA120.014543	http://dx.doi.org/10.1074/jbc.RA120.014543			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839683	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400200
J	Chatterjee, T; Zhang, S; Posey, TA; Jacob, J; Wu, L; Yu, WS; Francisco, LE; Liu, QJ; Carmon, KS				Chatterjee, Treena; Zhang, Sheng; Posey, Tressie A.; Jacob, Joan; Wu, Ling; Yu, Wangsheng; Francisco, Liezl E.; Liu, Qingyun J.; Carmon, Kendra S.			Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ACUTE MYELOID-LEUKEMIA; TUMOR PROGRESSION; GPR56; KINASE; GPR56/ADGRG1; CARCINOMA; ACTIVATION; INHIBITOR; DOMAINS	GPR56 is a member of the adhesion G-protein-coupled receptor family shown to play important roles in cell adhesion, brain development, immune function, and tumorigenesis. GPR56 is highly upregulated in colorectal cancer and correlates with poor prognosis. Several studies have shown GPR56 couples to the G alpha(12/13) class of heterotrimeric G-proteins to promote RhoA activation. However, due to its structural complexity and lack of a high-affinity receptor-specific ligand, the complete GPR56 signaling mechanism remains largely unknown. To delineate the activation mechanism and intracellular signaling functions of GPR56, we generated a monoclonal antibody (mAb) that binds with high affinity and specificity to the extracellular domain (ECD). Using deletion mutants, we mapped the mAb binding site to the GAIN domain, which mediates membrane-proximal autoproteolytic cleavage of the ECD. We showed that GPR56 overexpression in 293T cells leads to increased phosphorylation of Src, Fak, and paxillin adhesion proteins and activation of the G alpha(12/13)-RhoA-mediated serum response factor (SRF) pathway. Treatment with the mAb potentiated Src-Fak phosphorylation, RhoA-SRF signaling, and cell adhesion. Consistently, GPR56 knockdown in colorectal cancer cells decreased Src-Fak pathway phosphorylation and cell adhesion. Interestingly, GPR56-mediated activation of Src-Fak phosphorylation occurred independent of RhoA, yet mAb-induced potentiation of RhoA-SRF signaling was Src-dependent. Furthermore, we show that the C-terminal portion of the Serine-Threonine-Proline-rich (STP) region, adjacent to the GAIN domain, was required for Src-Fak activation. However, autoproteolytic cleavage of the ECD was dispensable. These data support a new ECD-dependent mechanism by which GPR56 functions to regulate adhesion through activation of Src-Fak signaling.	[Carmon, Kendra S.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Ctr Translat Canc Res, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Carmon, KS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	Kendra.S.Carmon@uth.tmc.edu		Francisco, Liezl/0000-0002-3680-3767; Posey, Tressie Alexandra Capri/0000-0002-8141-4760	National Institutes of Health [R01CA226894, R01GM102485]; Welch Foundation Endowment Fund Award [L-AU-0002-19940421]; Cancer Prevention and Research Institute of Texas [RP170245]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation Endowment Fund Award; Cancer Prevention and Research Institute of Texas	This work was supported by funding from the National Institutes of Health (R01CA226894) and Welch Foundation Endowment Fund Award (L-AU-0002-19940421) to K. S. C. and National Institutes of Health (R01GM102485) and Cancer Prevention and Research Institute of Texas (RP170245) to Q. J. L.	Ackerman SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7122; Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Azhdarinia A, 2018, MOL PHARMACEUT, V15, P2448, DOI 10.1021/acs.molpharmaceut.8b00275; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Carmon KS, 2017, J BIOL CHEM, V292, P14989, DOI 10.1074/jbc.M117.786798; Chang GW, 2016, CELL REP, V15, P1757, DOI 10.1016/j.celrep.2016.04.053; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Daria D, 2016, LEUKEMIA, V30, P1734, DOI 10.1038/leu.2016.76; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gargalionis AN, 2014, INT J CANCER, V134, P2019, DOI 10.1002/ijc.28299; Gong X, 2016, MOL CANCER THER, V15, P1580, DOI 10.1158/1535-7163.MCT-16-0114; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Hutchings CJ, 2014, MABS-AUSTIN, V6, P246, DOI 10.4161/mabs.27226; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jeong SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068781; Ji B, 2018, ONCOL REP, V40, P1885, DOI 10.3892/or.2018.6582; Jin GC, 2017, ONCOTARGET, V8, P40606, DOI 10.18632/oncotarget.16506; Ke N, 2008, BIOCHEM BIOPH RES CO, V366, P314, DOI 10.1016/j.bbrc.2007.11.071; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lark AL, 2003, CLIN CANCER RES, V9, P215; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Liu Z, 2017, NEOPLASMA, V64, P32, DOI 10.4149/neo_2017_104; Luo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029818; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Millar MW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00008; Ohta S, 2015, BIOL PHARM BULL, V38, P594, DOI 10.1248/bpb.b14-00752; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Pabst C, 2016, BLOOD, V127, P2018, DOI 10.1182/blood-2015-11-683649; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Saito Y, 2013, LEUKEMIA, V27, P1637, DOI 10.1038/leu.2013.75; Salzman GS, 2017, P NATL ACAD SCI USA, V114, P10095, DOI 10.1073/pnas.1708810114; Salzman GS, 2016, NEURON, V91, P1292, DOI 10.1016/j.neuron.2016.08.022; Sewda K, 2016, ONCOTARGET, V7, P17773, DOI 10.18632/oncotarget.7402; Spring FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062654; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Yeung J, 2020, P NATL ACAD SCI USA, V117, P28275, DOI 10.1073/pnas.2008921117; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Yu J, 2017, BIOCHEM J, V474, P589, DOI 10.1042/BCJ20160998; Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhang S, 2019, MOL CANCER RES, V17, P2196, DOI 10.1158/1541-7786.MCR-19-0436; Zhu BK, 2019, J BIOL CHEM, V294, P19246, DOI 10.1074/jbc.RA119.008234	59	8	8	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100261	10.1016/j.jbc.2021.100261	http://dx.doi.org/10.1016/j.jbc.2021.100261			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837725	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400237
J	Harris, LD; Le Pen, J; Scholz, N; Mieszczanek, J; Vaughan, N; Davis, S; Berridge, G; Kessler, BM; Bienz, M; Licchesi, JDF				Harris, Lee D.; Le Pen, Janic; Scholz, Nico; Mieszczanek, Juliusz; Vaughan, Natalie; Davis, Simon; Berridge, Georgina; Kessler, Benedikt M.; Bienz, Mariann; Licchesi, Julien D. F.			The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTROMETRY ENABLES CHARACTERIZATION; AFFINITY PURIFICATION; MULTIUBIQUITIN CHAIN; POLYUBIQUITIN; PROTEIN; REVEALS; AUTOUBIQUITINATION; DEGRADATION; SPECIFICITY; PROTEASOME	Ubiquitin is a versatile posttranslational modification, which is covalently attached to protein targets either as a single moiety or as a ubiquitin chain. In contrast to K48 and K63-linked chains, which have been extensively studied, the regulation and function of most atypical ubiquitin chains are only starting to emerge. The deubiquitinase TRABID/ZRANB1 is tuned for the recognition and cleavage of K29 and K33-linked chains. Yet, substrates of TRABID and the cellular functions of these atypical ubiquitin signals remain unclear. We determined the interactome of two TRABID constructs rendered catalytic dead either through a point mutation in the catalytic cysteine residue or through removal of the OTU catalytic domain. We identified 50 proteins trapped by both constructs and which therefore represent candidate substrates of TRABID. The E3 ubiquitin ligase HECTD1 was then validated as a substrate of TRABID and used UbiCREST and Ub-AQUA proteomics to show that HECTD1 preferentially assembles K29- and K48-linked ubiquitin chains. Further in vitro autoubiquitination assays using ubiquitin mutants established that while HECTD1 can assemble short homotypic K29 and K48-linked chains, it requires branching at K29/K48 in order to achieve its full ubiquitin ligase activity. We next used transient knockdown and genetic knockout of TRABID in mammalian cells in order to determine the functional relationship between TRABID and HECTD1. This revealed that upon TRABID depletion, HECTD1 is readily degraded. Thus, this study identifies HECTD1 as a mammalian E3 ligase that assembles branched K29/K48 chains and also establishes TRABID-HECTD1 as a DUB/E3 pair regulating K29 linkages.	[Harris, Lee D.; Scholz, Nico; Vaughan, Natalie; Licchesi, Julien D. F.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Le Pen, Janic; Mieszczanek, Juliusz; Bienz, Mariann] Cambridge Biomed Campus, MRC Lab Mol Biol, Cambridge, England; [Davis, Simon; Berridge, Georgina; Kessler, Benedikt M.] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Oxford, England	University of Bath; MRC Laboratory Molecular Biology; University of Oxford	Licchesi, JDF (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	j.licchesi@bath.ac.uk	Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Licchesi, Julien/0000-0003-3786-3013; Davis, Simon/0000-0001-7840-2411	Royal Society [RG130469]; Alzheimer's Research UK pilot grant [ARUK-PPG2015A-16]; Alzheimer's Research UK [ARUK-PhD2017-28]; ARUK network grants and travel awards; University of Bath; Cancer Research UK [C7379/A15291]; Medical Research Council [U105192713]; University of Bath Research Studentship; MRC GW4 BioMed Doctoral Training Partnership; MRC [MC_U105192713, 2110681] Funding Source: UKRI	Royal Society(Royal Society of London); Alzheimer's Research UK pilot grant; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); ARUK network grants and travel awards; University of Bath; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bath Research Studentship; MRC GW4 BioMed Doctoral Training Partnership; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Royal Society Grant to J. D. F. L. (RG130469), an Alzheimer's Research UK pilot grant to J. D. F. L. (ARUK-PPG2015A-16), an Alzheimer's Research UK PhD studentship to L. D. H./J. D. F. L. (ARUK-PhD2017-28), ARUK network grants and travel awards to J. D. F. L., a start-up grant from the University of Bath to J. D. F. L., Cancer Research UK (Grant C7379/A15291 to M. B.), and the Medical Research Council (Grant U105192713, to M. B.). N. V. was funded through a University of Bath Research Studentship and N. S. by a studentship from the MRC GW4 BioMed Doctoral Training Partnership.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676; Byrne R, 2017, CHEMBIOCHEM, V18, P1415, DOI 10.1002/cbic.201700006; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Crowe SO, 2017, ANAL CHEM, V89, P4428, DOI 10.1021/acs.analchem.6b03675; Deol KK, 2020, MOL CELL, V80, DOI 10.1016/j.molcel.2020.10.017; Duhamel S, 2018, CELL REP, V22, P1016, DOI 10.1016/j.celrep.2017.12.096; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Fei C, 2013, MOL CELL BIOL, V33, P4095, DOI 10.1128/MCB.00418-13; Feng X, 2019, AUTOPHAGY, V15, P1130, DOI 10.1080/15548627.2019.1570063; Fernando MDA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004117; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Haakonsen DL, 2019, TRENDS CELL BIOL, V29, P704, DOI 10.1016/j.tcb.2019.06.003; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hospenthal MK, 2015, NAT PROTOC, V10, P349, DOI 10.1038/nprot.2015.018; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang FT, 2013, P NATL ACAD SCI USA, V110, P15722, DOI 10.1073/pnas.1308014110; Huguenin-Dezot N, 2016, CELL REP, V16, P1180, DOI 10.1016/j.celrep.2016.06.064; Jin J, 2016, NAT IMMUNOL, V17, P259, DOI 10.1038/ni.3347; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kristariyanto YA, 2015, MOL CELL, V58, P83, DOI 10.1016/j.molcel.2015.01.041; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee Min Jae, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.R110.003871; Leto DE, 2019, MOL CELL, V73, P377, DOI 10.1016/j.molcel.2018.11.015; Li WB, 2015, MOL CELL, V59, P188, DOI 10.1016/j.molcel.2015.06.002; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Lips C, 2020, EMBO J, V39, DOI 10.15252/embj.2020104863; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14274; Liu XL, 2016, FEBS LETT, V590, P4213, DOI 10.1002/1873-3468.12471; Longworth J., 1977, METHODS MOL BIOL, P36; Mansour W, 2015, J BIOL CHEM, V290, P4688, DOI 10.1074/jbc.M114.568295; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; McGouran JF, 2013, CHEM BIOL, V20, P1447, DOI 10.1016/j.chembiol.2013.10.012; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; Pao KC, 2016, NAT CHEM BIOL, V12, P324, DOI [10.1038/nchembio.2045, 10.1038/NCHEMBIO.2045]; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Sarkar AA, 2012, J CELL BIOL, V196, P789, DOI 10.1083/jcb.201105101; Schubert OT, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.015; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Segref A, 2014, CELL METAB, V19, P642, DOI 10.1016/j.cmet.2014.01.016; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Shi Tong, 2012, BMC Chemical Biology, V12, P4, DOI 10.1186/1472-6769-12-4; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Swatek KN, 2019, NATURE, V572, P533, DOI 10.1038/s41586-019-1482-y; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Tsuchiya H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02869-x; Tsuchiya H, 2017, MOL CELL, V66, P488, DOI 10.1016/j.molcel.2017.04.024; Valkevich EM, 2014, BIOCHEMISTRY-US, V53, P4979, DOI 10.1021/bi5006305; van Tienen LM, 2017, ELIFE, V6, DOI [10.7554/eLife.20882.001, 10.7554/eLife.20882]; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zhang PJ, 2018, CELL REP, V23, P823, DOI 10.1016/j.celrep.2018.03.078; Zhu YK, 2019, CELL DEATH DIFFER, V26, P306, DOI 10.1038/s41418-018-0119-2	107	8	8	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100246	10.1074/jbc.RA120.015162	http://dx.doi.org/10.1074/jbc.RA120.015162			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33853758	Green Published, gold			2022-12-26	WOS:000672866400223
J	Kuliyev, E; Zhang, C; Sui, DX; Hu, J				Kuliyev, Eziz; Zhang, Chi; Sui, Dexin; Hu, Jian			Zinc transporter mutations linked to acrodermatitis enteropathica disrupt function and cause mistrafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; SLC39A4; CFTR; ROLES; ZIP4; COLOCALIZATION; IDENTIFICATION; DEFICIENCY; STABILITY; MANGANESE	ZIP4 is a representative member of the Zrt-/Irt-like protein (ZIP) transporter family and responsible for zinc uptake from diet. Loss-of-function mutations of human ZIP4 (hZIP4) drastically reduce zinc absorption, causing a life-threatening autosomal recessive disorder, acrodermatitis enteropathica (AE). These mutations occur not only in the conserved trans-membrane zinc transport machinery, but also in the extracellular domain (ECD) of hZIP4, which is only present in a fraction of mammalian ZIPs. How these AE-causing ECD mutations lead to ZIP4 malfunction has not be fully clarified. In this work, we characterized all seven confirmed AE-causing missense mutations in hZIP4-ECD and found that the variants exhibited completely abolished zinc transport activity in a cell-based transport assay. Although the variants were able to be expressed in HEK293T cells, they failed to traffic to the cell surface and were largely retained in the ER with immature glycosylation. When the corresponding mutations were introduced in the ECD of ZIP4 from Pteropus Alecto, a close homolog of hZIP4, the variants exhibited structural defects or reduced thermal stability, which likely accounts for intracellular mistrafficking of the AE-associated variants and as such a total loss of zinc uptake activity. This work provides a molecular pathogenic mechanism for AE.	[Kuliyev, Eziz; Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Zhang, Chi; Sui, Dexin; Hu, Jian] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Hu, J (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.; Hu, J (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	hujian1@msu.edu			National Institutes of Health [GM115373, GM129004]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health GM115373 and GM129004 (to J. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bin BH, 2014, EMBO MOL MED, V6, P1028, DOI 10.15252/emmm.201303809; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; FISCHER PWF, 1984, AM J CLIN NUTR, V40, P743, DOI 10.1093/ajcn/40.4.743; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Hara T, 2017, J PHYSIOL SCI, V67, P283, DOI 10.1007/s12576-017-0521-4; Hoch E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030734; HOOGENRAAD TU, 1985, SCI TOTAL ENVIRON, V42, P37, DOI 10.1016/0048-9697(85)90005-1; Hu J, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010004; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jeong J, 2012, P NATL ACAD SCI USA, V109, pE3530, DOI 10.1073/pnas.1211775110; Jung AG, 2011, J DTSCH DERMATOL GES, V9, P999, DOI 10.1111/j.1610-0387.2011.07742.x; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Kury S., 2012, EUR J HUM GENET, V20; Kury Sebastien, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9178; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu FY, 2019, SCIENCE, V364, P1184, DOI 10.1126/science.aaw7611; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Nakano A, 2003, J INVEST DERMATOL, V120, P963, DOI 10.1046/j.1523-1747.2003.12243.x; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Perafan-Riveros C, 2002, PEDIATR DERMATOL, V19, P426, DOI 10.1046/j.1525-1470.2002.00200.x; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Prasad AS, 2003, BMJ-BRIT MED J, V326, P409, DOI 10.1136/bmj.326.7386.409; Schmitt S, 2009, HUM MUTAT, V30, P926, DOI 10.1002/humu.20988; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zhang C, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107582; Zhang T, 2020, FASEB J, V34, P237, DOI 10.1096/fj.201902043R; Zhang T, 2019, BIOCHEM J, V476, P1791, DOI 10.1042/BCJ20190108; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11979; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	55	5	5	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100269	10.1016/j.jbc.2021.100269	http://dx.doi.org/10.1016/j.jbc.2021.100269			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837739	gold, Green Published			2022-12-26	WOS:000672866400245
J	Liao, ZJ; Gingras, AR; Lagarrigue, F; Ginsberg, MH; Shattil, SJ				Liao, Zhongji; Gingras, Alexandre R.; Lagarrigue, Frederic; Ginsberg, Mark H.; Shattil, Sanford J.			Optogenetics-based localization of talin to the plasma membrane promotes activation of beta 3 integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; PLATELET; PROTEIN; DOMAIN; BINDING; RIAM; AGGREGATION; RECOGNITION; COMPLEX; HEAD	Interaction of talin with the cytoplasmic tails of integrin beta triggers integrin activation, leading to an increase of integrin affinity/avidity for extracellular ligands. In talin KO mice, loss of talin interaction with platelet integrin alpha IIb beta 3 causes a severe hemostatic defect, and loss of talin interaction with endothelial cell integrin alpha V beta 3 affects angiogenesis. In normal cells, talin is autoinhibited and localized in the cytoplasm. Here, we used an optogenetic platform to assess whether recruitment of fulllength talin to the plasma membrane was sufficient to induce integrin activation. A dimerization module (Arabidopsis cryptochrome 2 fused to the N terminus of talin; N-terminal of cryptochrome-interacting basic helix-loop-helix domain ended with a CAAX box protein [C: cysteine; A: aliphatic amino acid; X: any C-terminal amino acid]) responsive to 450 nm (blue) light was inserted into Chinese hamster ovary cells and endothelial cells also expressing alpha IIb beta 3 or alpha V beta 3, respectively. Thus, exposure of the cells to blue light caused a rapid and reversible recruitment of Arabidopsis cryptochrome 2-talin to the N-terminal of cryptochrome-interacting basic helix-loop-helix domain ended with a CAAX box protein [C: cysteine; A: aliphatic amino acid; X: any C-terminal amino acid]-decorated plasma membrane. This resulted in beta 3 integrin activation in both cell types, as well as increasing migration of the endothelial cells. However, membrane recruitment of talin was not sufficient for integrin activation, as membraneassociated Ras-related protein 1 (Rap1)-GTP was also required. Moreover, talin mutations that interfered with its direct binding to Rap1 abrogated beta 3 integrin activation. Altogether, these results define a role for the plasma membrane recruitment of talin in beta 3 integrin activation, and they suggest a nuanced sequence of events thereafter involving Rap1-GTP.	[Liao, Zhongji; Gingras, Alexandre R.; Lagarrigue, Frederic; Ginsberg, Mark H.; Shattil, Sanford J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Liao, ZJ; Shattil, SJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	zhliao@health.ucsd.edu; sshattil@health.ucsd.edu		Liao, Zhongji/0000-0003-2180-5329; Lagarrigue, Frederic/0000-0002-4660-8666	University of Strathclyde; NRF [2019-NRF-ISF003-3172]	University of Strathclyde; NRF	R. D. R. B. acknowledges the University of Strathclyde for a scholarship award. J. O. was supported by the NRF 2019-NRF-ISF003-3172 grant.	ABRAMS C, 1994, J BIOL CHEM, V269, P18781; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; Bennett JS, 2015, BIOPOLYMERS, V104, P323, DOI 10.1002/bip.22679; Bromberger T, 2018, BLOOD, V132, P2754, DOI 10.1182/blood-2018-04-846766; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Camp D, 2018, J CELL SCI, V131, DOI 10.1242/jcs.225144; Chinthalapudi K, 2018, P NATL ACAD SCI USA, V115, P10339, DOI 10.1073/pnas.1806275115; Coller BS, 2015, J THROMB HAEMOST, V13, pS17, DOI 10.1111/jth.12915; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dedden D, 2019, CELL, V179, P120, DOI 10.1016/j.cell.2019.08.034; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; FROJMOVIC MM, 1991, BLOOD, V78, P369; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2019, J CELL BIOL, V218, P1799, DOI 10.1083/jcb.201810061; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Haydari Z, 2020, BIOPHYS J, V118, P1977, DOI 10.1016/j.bpj.2020.02.023; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; KAWATA M, 1990, P NATL ACAD SCI USA, V87, P8960, DOI 10.1073/pnas.87.22.8960; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Klapproth S, 2015, BLOOD, V126, P2592, DOI 10.1182/blood-2015-04-639310; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lagarrigue F, 2020, BLOOD, V136, P1180, DOI 10.1182/blood.2020005348; Lagarrigue F, 2018, BLOOD ADV, V2, P2358, DOI 10.1182/bloodadvances.2018020487; Lagarrigue F, 2016, BLOOD, V128, P479, DOI 10.1182/blood-2015-12-638700; Li HD, 2017, P NATL ACAD SCI USA, V114, P9349, DOI 10.1073/pnas.1703064114; Liao ZJ, 2017, J CELL SCI, V130, P3532, DOI 10.1242/jcs.205203; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Park H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00060-2; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Peurois F, 2019, BIOCHEM SOC T, V47, P13, DOI 10.1042/BST20170525; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangarajan ES, 2020, J BIOL CHEM, V295, P12885, DOI 10.1074/jbc.RA119.010789; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Stefanini L, 2018, BLOOD, V132, P1951, DOI 10.1182/blood-2018-03-838714; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Su WJ, 2015, BLOOD, V126, P2695, DOI 10.1182/blood-2015-05-644104; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Zhang PF, 2020, P NATL ACAD SCI USA, V117, P32402, DOI 10.1073/pnas.2014583117; Zhu L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01822-8	54	3	3	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100675	10.1016/j.jbc.2021.100675	http://dx.doi.org/10.1016/j.jbc.2021.100675			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865854	Green Published, gold			2022-12-26	WOS:000672866400646
J	Li, ZY; Wang, Y; Xu, ZL; Cao, Y				Li, Zongying; Wang, Yao; Xu, Zhonglin; Cao, Yue'e			Characteristics and sources of atmospheric pollutants in typical inland cities in arid regions of central Asia: A case study of Urumqi city	PLOS ONE			English	Article							AIR-POLLUTION INDEX; YANGTZE-RIVER DELTA; METEOROLOGICAL FACTORS; URBANIZATION STRATEGY; TERM EXPOSURE; CHINA; PM2.5; QUALITY; PM10; MORTALITY	The arid zone of central Asia secluded inland and has the typical features of the atmosphere. Human activities have had a significant impact on the air quality in this region. Urumqi is a key city in the core area of the Silk Road and an important economic center in Northwestern China. The urban environment is playing an increasingly important role in regional development. To study the characteristics and influencing factors of the main atmospheric pollutants in Urumqi, this study selected Urumqi's daily air quality index (AQI) data and observation data of six major pollutants including fine particulate matter (PM2.5), breathable particulate matter (PM10), sulfur dioxide (SO2), nitrogen dioxide (NO2), carbon monoxide (CO), and ozone (O-3_8h) from 2014 to 2018 in conjunction with meteorological data to use a backward trajectory analysis method to study the main characteristics of atmospheric pollutants and their sources in Urumqi from 2014 to 2018. The results showed that: (1) From 2014 to 2018, the annual average of PM2.5, PM10, SO2, NO2 and CO concentrations showed a downward trend, and O-3_8h concentrations first increased, then decreased, and then increased, reaching the highest value in 2018 (82.15 mu g.m(-3)); The seasonal changes of PM2.5, PM10, SO2, NO2 and CO concentrations were characterized by low values in summer and fall seasons and high values in winter and spring seasons. The concentration of O-3_8h, however, was in the opposite trend, showing the high values in summer and fall seasons, and low values in winter and spring seasons. From 2014 to 2018, with the exception of O-3_8h, the concentration changes of the other five major air pollutants were high in December, January, and February, and low in May, June, and July; the daily changes showed a "U-shaped" change during the year. The high-value areas of the "U-shaped" mode formed around the 50th day and the 350th day. (2) The high-value area of AQI was from the end of fall (November) to the beginning of the following spring (March), and the low-value area was from April to October. It showed a U-shaped change trend during the year and the value was mainly distributed between 50 and 100. (3) The concentrations of major air pollutants in Urumqi were significantly negatively correlated with precipitation, temperature, and humidity (P<0.01), and had the highest correlation coefficients with temperature. (4) Based on the above analysis results, this study analyzed two severe pollution events from late November to early December. Analysis showed that the PM2.5/PM10 ratio in two events remained at about 0.1 when the pollution occurred, but was higher before and after the pollution (up to 1.46). It was shown that the pollution was a simple sandstorm process. Backward trajectory analysis clustered the airflow trajectories reaching Urumqi into 4 categories, and the trajectories from central Asia contributed the maximum values of average PM2.5 and PM10 concentrations.	[Li, Zongying; Xu, Zhonglin] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China; [Li, Zongying; Xu, Zhonglin] Minist Educ, Key Lab Oasis Ecol, Urumqi, Peoples R China; [Wang, Yao] China Meteorol Adm, Inst Desert Meteorol, Urumqi, Peoples R China; [Cao, Yue'e] Shanghai Normal Univ, Sch Environm & Geog Sci, Shanghai, Peoples R China	Xinjiang University; China Meteorological Administration; Shanghai Normal University	Xu, ZL (corresponding author), Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China.; Xu, ZL (corresponding author), Minist Educ, Key Lab Oasis Ecol, Urumqi, Peoples R China.; Cao, Y (corresponding author), Shanghai Normal Univ, Sch Environm & Geog Sci, Shanghai, Peoples R China.	galinwa@gmail.com; caoyuee@shnu.edu.cn	Xu, Zhonglin/GQH-1906-2022		Strategic Priority Research Program of Chinese Academy of Sciences [XDA20040400]; Research Plan of Universities in Xinjiang Province [XJEDU2020Y008]; Research and Innovation Program for Postgraduates in Xinjiang Province [XJ2019g054]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Research Plan of Universities in Xinjiang Province; Research and Innovation Program for Postgraduates in Xinjiang Province	This research was funded by Strategic Priority Research Program of Chinese Academy of Sciences, Pan-Third Pole Environment Study for a Green Silk Road, grant number XDA20040400; Research Plan of Universities in Xinjiang Province, grand number XJEDU2020Y008 and Research and Innovation Program for Postgraduates in Xinjiang Province, grant number XJ2019g054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J DESERT RES; [Anonymous], 2018, J CLEANER PRODUCTION; [Anonymous], 2018, J SAFETY ENV; [Anonymous], 2017, URBANIZATION PROCESS; [Anonymous], 2019, J ARID LAND RESOURCE; [Anonymous], 2018, IMPACTS RELOCATION D; [Anonymous], 2019, ENV ENG; [Anonymous], 2004, ARID ENV MONITORING; [Anonymous], 2019, ENV SCI; Becken S., 2017, Journal of Sustainable Tourism, V25, P130, DOI 10.1080/09669582.2016.1177067; Bongaarts J, 2006, POPUL DEV REV, V32, P594; Breast carcinoma, 2018, CLIN LAB MED, V38, P401; Cairncross EK, 2007, ATMOS ENVIRON, V41, P8442, DOI 10.1016/j.atmosenv.2007.07.003; Carlsen L., 2013, INT J BIOL CHEM, V5, P49; Chen X, 2016, SCI TOTAL ENVIRON, V571, P855, DOI 10.1016/j.scitotenv.2016.07.064; Cheng Y, 2015, ENVIRON POLLUT, V197, P68, DOI 10.1016/j.envpol.2014.11.028; Chin M, 2017, ISSI SCI REP SER, V16, P87, DOI 10.1007/978-3-319-59489-7_5; Cogliani E, 2001, ATMOS ENVIRON, V35, P2871, DOI 10.1016/S1352-2310(01)00071-1; Costabile F, 2006, ATMOS ENVIRON, V40, P6380, DOI 10.1016/j.atmosenv.2006.05.056; Cuhadaroglu B, 1997, ENERG BUILDINGS, V25, P179, DOI 10.1016/S0378-7788(96)00992-9; Domros M., 2012, CLIMATE CHINA; Fan H, 2020, ATMOS ENVIRON, V220, DOI 10.1016/j.atmosenv.2019.117066; Fang L, 1998, INDOOR AIR, V8, P80, DOI 10.1111/j.1600-0668.1998.t01-2-00003.x; Fu QY, 2008, ATMOS ENVIRON, V42, P2023, DOI 10.1016/j.atmosenv.2007.12.002; Gao JJ, 2018, ENVIRON POLLUT, V233, P714, DOI 10.1016/j.envpol.2017.10.123; Gou HE, 2016, ENVIRON POLLUT, V214, P202, DOI 10.1016/j.envpol.2016.03.073; Guan XL, 2018, HABITAT INT, V71, P97, DOI 10.1016/j.habitatint.2017.11.009; Han LJ, 2018, SCI TOTAL ENVIRON, V642, P789, DOI 10.1016/j.scitotenv.2018.06.094; He KB, 2002, ANNU REV ENERG ENV, V27, P397, DOI 10.1146/annurev.energy.27.122001.083421; [贺祥 He Xiang], 2016, [地理学报, Acta Geographica Sinica], V71, P1119; Hien PD, 2011, SCI TOTAL ENVIRON, V409, P5063, DOI 10.1016/j.scitotenv.2011.08.049; Hu JL, 2014, ATMOS ENVIRON, V95, P598, DOI 10.1016/j.atmosenv.2014.07.019; Hu M, 2015, NATL SCI REV, V2, P257, DOI 10.1093/nsr/nwv003; Huang Z, 2019, SCAND J CLIN LAB INV, V79, P601, DOI 10.1080/00365513.2019.1683764; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Ilten N, 2008, ENVIRON MONIT ASSESS, V140, P267, DOI 10.1007/s10661-007-9865-1; Kang SC, 2019, NATL SCI REV, V6, P796, DOI 10.1093/nsr/nwz031; Li JX, 2018, J ARID LAND, V10, P686, DOI 10.1007/s40333-018-0096-9; Li L, 2014, ENVIRON POLLUT, V190, P75, DOI 10.1016/j.envpol.2014.03.020; Lin BQ, 2018, J CLEAN PROD, V188, P312, DOI 10.1016/j.jclepro.2018.03.293; Ma L, 2016, J CLEAN PROD, V112, P1319, DOI 10.1016/j.jclepro.2015.04.054; Mamtimin B, 2011, SCI TOTAL ENVIRON, V409, P1277, DOI 10.1016/j.scitotenv.2010.12.010; Meng XY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030396; Pongkiatkul P, 2007, ATMOS RES, V85, P3, DOI 10.1016/j.atmosres.2006.10.003; Rupakheti D, 2021, ENVIRON POLLUT, V268, DOI 10.1016/j.envpol.2020.115907; Shen FZ, 2017, ENVIRON RES, V156, P625, DOI 10.1016/j.envres.2017.04.026; Shie RH, 2013, J HAZARD MATER, V261, P72, DOI 10.1016/j.jhazmat.2013.07.017; Sowlat MH, 2011, ATMOS ENVIRON, V45, P2050, DOI 10.1016/j.atmosenv.2011.01.060; Tan YT, 2016, CITIES, V55, P82, DOI 10.1016/j.cities.2016.04.002; Tolkacheva GA, 2006, NATO SCI S SS IV EAR, V62, P379; Uno I, 2009, NAT GEOSCI, V2, P557, DOI 10.1038/NGEO583; Voutsa D, 2014, ENVIRON SCI POLLUT R, V21, P4995, DOI 10.1007/s11356-013-2445-8; Wang YQ, 2014, METEOROL APPL, V21, P360, DOI 10.1002/met.1345; Wang YQ, 2009, ENVIRON MODELL SOFTW, V24, P938, DOI 10.1016/j.envsoft.2009.01.004; Wu X, 2020, SCI TOTAL ENVIRON, V707, DOI 10.1016/j.scitotenv.2019.136194; Zhan DS, 2018, J CLEAN PROD, V197, P1342, DOI 10.1016/j.jclepro.2018.06.108; Zhang XX, 2017, ATMOS CHEM PHYS, V17, P1699, DOI 10.5194/acp-17-1699-2017; Zhang XX, 2014, J ARID LAND, V6, P668, DOI 10.1007/s40333-014-0069-6; Zhou J, 2016, J CLEAN PROD, V112, P1767, DOI 10.1016/j.jclepro.2015.08.015; Zhu CS, 2012, AEROSOL AIR QUAL RES, V12, P1157, DOI 10.4209/aaqr.2012.01.0003	60	9	9	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2021	16	4							e0249563	10.1371/journal.pone.0249563	http://dx.doi.org/10.1371/journal.pone.0249563			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RQ1EM	33878117	gold, Green Published			2022-12-26	WOS:000642162200005
J	Al-Rajab, M; Lu, J; Xu, Q				Al-Rajab, Murad; Lu, Joan; Xu, Qiang			A framework model using multifilter feature selection to enhance colon cancer classification	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; GENE SELECTION; MICROARRAY DATA; MUTUAL INFORMATION; HYBRID; ALGORITHM; PREDICTION; OPTIMIZATION; SYSTEM	Gene expression profiles can be utilized in the diagnosis of critical diseases such as cancer. The selection of biomarker genes from these profiles is significant and crucial for cancer detection. This paper presents a framework proposing a two-stage multifilter hybrid model of feature selection for colon cancer classification. Colon cancer is being extremely common nowadays among other types of cancer. There is a need to find fast and an accurate method to detect the tissues, and enhance the diagnostic process and the drug discovery. This paper reports on a study whose objective has been to improve the diagnosis of cancer of the colon through a two-stage, multifilter model of feature selection. The model described deals with feature selection using a combination of Information Gain and a Genetic Algorithm. The next stage is to filter and rank the genes identified through this method using the minimum Redundancy Maximum Relevance (mRMR) technique. The final phase is to further analyze the data using correlated machine learning algorithms. This two-stage approach, which involves the selection of genes before classification techniques are used, improves success rates for the identification of cancer cells. It is found that Decision Tree, K-Nearest Neighbor, and Naive Bayes classifiers had showed promising accurate results using the developed hybrid framework model. It is concluded that the performance of our proposed method has achieved a higher accuracy in comparison with the existing methods reported in the literatures. This study can be used as a clue to enhance treatment and drug discovery for the colon cancer cure.	[Al-Rajab, Murad; Lu, Joan; Xu, Qiang] Univ Huddersfield, Sch Comp & Engn, Huddersfield, W Yorkshire, England	University of Huddersfield	Al-Rajab, M (corresponding author), Univ Huddersfield, Sch Comp & Engn, Huddersfield, W Yorkshire, England.	m.al-rajab2@hud.ac.uk	xu, qiang/AAE-1647-2019; Al-Rajab, Murad/AAT-2503-2021	xu, qiang/0000-0002-5903-9781; Lu, Joan/0000-0002-0585-2806; Al-Rajab, Murad/0000-0002-6821-6575				Abdi MJ, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/320698; Al Snousy MB, 2011, EGYPT INFORM J, V12, P73, DOI 10.1016/j.eij.2011.04.003; Al-Rajab M., 2014, BIOINFORMATICS RES A, V8492, DOI [10.1007/s00299-014-1629-0, DOI 10.1007/S00299-014-1629-0]; Al-Rajab M, 2017, COMPUT METH PROG BIO, V146, P11, DOI 10.1016/j.cmpb.2017.05.001; Al-Rajab MM, 2016, INT J DATA MIN BIOIN, V14, P159, DOI 10.1504/IJDMB.2016.074685; Alba E, 2007, IEEE C EVOL COMPUTAT, P284, DOI 10.1109/CEC.2007.4424483; Alcala-Fdez J, 2009, SOFT COMPUT, V13, P307, DOI 10.1007/s00500-008-0323-y; Ali S, 2006, EMERGING TRENDS CHAL, P281; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alshamlan H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/604910; Alshamlan HM, 2015, COMPUT BIOL CHEM, V56, P49, DOI 10.1016/j.compbiolchem.2015.03.001; Ammu P.K., 2014, INT J RES STUDIES BI, V3, P201; Ayyad SM, 2019, BIOSYSTEMS, V176, P41, DOI 10.1016/j.biosystems.2018.12.009; Bolon-Canedo V, 2015, APPL SOFT COMPUT, V30, P136, DOI 10.1016/j.asoc.2015.01.035; Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Bolon-Canedo V, 2012, PATTERN RECOGN, V45, P531, DOI 10.1016/j.patcog.2011.06.006; Bolon-Canedo V., 2010, 2010 INT JOINT C NEU, P1, DOI 10.1109/IJCNN.2010.5596825; Cahyaningrum K., 2020, 2020 INT C DATA SCI, P1, DOI [10.1109/ICoDSA50139.2020.9213051, DOI 10.1109/ICODSA50139.2020.9213051]; Chitode K., 2013, INT J COMPUTER APPL, V81, P0975, DOI [10.5120/14198-2392, DOI 10.5120/14198-2392]; Chuang LY, 2011, COMPUT BIOL MED, V41, P228, DOI 10.1016/j.compbiomed.2011.02.004; Chuang LY, 2009, OMICS, V13, P127, DOI 10.1089/omi.2008.0083; Dash S., 2012, P INT C BIOINF COMP, P268; Dash Sujata, 2012, IOSR J ENG IOSRJEN, V2, P112, DOI [10.9790/3021-0281112119, DOI 10.9790/3021-0281112119]; El Akadi A, 2009, 2009 IEEE/ACS INTERNATIONAL CONFERENCE ON COMPUTER SYSTEMS AND APPLICATIONS, VOLS 1 AND 2, P69, DOI 10.1109/AICCSA.2009.5069306; El Akadi A., 2009, INFOCOMP J COMPUTER, V8, P28; El Akadi A, 2011, KNOWL INF SYST, V26, P487, DOI 10.1007/s10115-010-0288-x; Elyasigomari V, 2017, J BIOMED INFORM, V67, P11, DOI 10.1016/j.jbi.2017.01.016; Fang OH, 2010, INT C COMPUT ENG APP, P330, DOI 10.1109/ICCEA.2010.215; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Ghosh M, 2019, EXPERT SYST APPL, V116, P172, DOI 10.1016/j.eswa.2018.06.057; Hoque N, 2014, EXPERT SYST APPL, V41, P6371, DOI 10.1016/j.eswa.2014.04.019; Horng JT, 2009, EXPERT SYST APPL, V36, P9072, DOI 10.1016/j.eswa.2008.12.037; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Huang HL, 2007, BIOSYSTEMS, V90, P516, DOI 10.1016/j.biosystems.2006.12.003; Jaeger J., 2003, PAC S BIOCOMPUT, V8, P53, DOI DOI 10.1142/9789812776303_0006; Jeyachidra J, 2013, 2013 INTERNATIONAL CONFERENCE ON INFORMATION COMMUNICATION AND EMBEDDED SYSTEMS (ICICES), P1088, DOI 10.1109/ICICES.2013.6508165; Jinn-Yi Yeh, 2007, 2007 International Conference on Convergence Information Technology - ICCIT '07, P703, DOI 10.1109/ICCIT.2007.153; Karabulut EM, 2012, PROC TECH, V1, P323, DOI 10.1016/j.protcy.2012.02.068; Kim KJ, 2004, NEUROCOMPUTING, V61, P361, DOI 10.1016/j.neucom.2003.11.008; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Lavanya C., 2014, INT J INNOVATIVE RES, V3; Leoshchenko S, 2019, CEUR WORKSHOP PROCEE, V2386, P11; Leung Y, 2010, IEEE ACM T COMPUT BI, V7, P108, DOI 10.1109/TCBB.2008.46; Li JY, 2003, BIOINFORMATICS, V19, pII93, DOI 10.1093/bioinformatics/btg1066; Li LB, 2005, GENOMICS, V85, P16, DOI 10.1016/j.ygeno.2004.09.007; Li ST, 2008, SOFT COMPUT, V12, P1039, DOI 10.1007/s00500-007-0272-x; Li ST, 2008, SOFT COMPUT, V12, P693, DOI 10.1007/s00500-007-0251-2; Li T, 2004, BIOINFORMATICS, V20, P2429, DOI 10.1093/bioinformatics/bth267; Liu Huiqing, 2002, Genome Inform, V13, P51; Lorena Ana C., 2008, 2008 8th International Conference on Hybrid Intelligent Systems (HIS), P825, DOI 10.1109/HIS.2008.163; Lorena AC, 2012, NEUROCOMPUTING, V75, P33, DOI 10.1016/j.neucom.2011.03.054; Lovato P, 2012, LECT NOTES COMPUT SC, V7626, P629, DOI 10.1007/978-3-642-34166-3_69; Lu HJ, 2017, NEUROCOMPUTING, V256, P56, DOI 10.1016/j.neucom.2016.07.080; Maniruzzaman M, 2019, COMPUT METH PROG BIO, V176, P173, DOI 10.1016/j.cmpb.2019.04.008; Mishra A., 2015, INT J ADV RES SCI EN, V4; Mohamad M.S., 2010, INT SYST MOD SIM ISM, P15, DOI [10.1109/ISMS.2010.14, DOI 10.1109/ISMS.2010.14]; Mohamad MS, 2005, INT J COMPUT INTELL, V5, P91, DOI 10.1142/S1469026805001465; Mohamad MS, 2009, ARTIF LIFE ROBOT, V13, P414, DOI 10.1007/s10015-008-0534-4; Nakariyakul S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212333; Notterman DA, 2001, CANCER RES, V61, P3124; Ong H. F., 2011, COMPUTER INFORM SCI, V4, P55, DOI [10.5539/cis.v4n2p55, DOI 10.5539/CIS.V4N2P55]; Othman R. M, 2009, 5 POSTGR ANN RES JOH; Patil S., 2014, INT J EMERG TECHNOL, V4, P110; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Poole J., 2015, CANC REGISTRATION ST; Pratama RFW, 2018, PROCEDIA COMPUT SCI, V144, P174, DOI [10.1016/j.proes.2018.10.517, 10.1016/j.procs.2018.10.517]; Qiu P, 2005, BIOINFORMATICS, V21, P3114, DOI 10.1093/bioinformatics/bti483; Rathore S, 2014, IEEE ACM T COMPUT BI, V11, P1131, DOI 10.1109/TCBB.2014.2344655; Rathore S, 2013, IEEE ACM T COMPUT BI, V10, P545, DOI 10.1109/TCBB.2013.84; Salem H, 2017, APPL SOFT COMPUT, V50, P124, DOI 10.1016/j.asoc.2016.11.026; Shang Lei, 2012, Proceedings of the 2012 International Conference on Computer Science and Electronics Engineering (ICCSEE 2012), P355, DOI 10.1109/ICCSEE.2012.97; Shekar BH, 2018, 2018 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1515, DOI 10.1109/ICACCI.2018.8554465; Shukla AK, 2019, INFORM SCIENCES, V503, P238, DOI 10.1016/j.ins.2019.06.063; Shukla AK, 2019, MATH BIOSCI, V315, DOI 10.1016/j.mbs.2019.108230; Shukla AK, 2018, CHEMOMETR INTELL LAB, V183, P47, DOI 10.1016/j.chemolab.2018.10.009; Sreepada RS, 2015, IEEE INT ADV COMPUT, P263, DOI 10.1109/IADCC.2015.7154710; Tan Aik Choon, 2003, Appl Bioinformatics, V2, pS75; Tan F, 2006, IEEE C EVOL COMPUTAT, P2514; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Victo Sudha G, 2011, INT J COMPUT SCI ENG, DOI [DOI 10.5121/IJCSES.2011.2302, 10.5121/ijcses.2011.2302]; Wang XS, 2009, CANCER INFORM, V7, P123; Wang YH, 2005, BIOINFORMATICS, V21, P1530, DOI 10.1093/bioinformatics/bti192; Witten IH, 2011, MOR KAUF D, P1; World Health Organization, 2017, MED CTR; Yang PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S5; Zeng Xue-Qiang G, 2010, IEEE INT C BIOINF BI, DOI [10.1109/BIBMW, DOI 10.1109/BIBMW]; Zhang BT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214406; Zhang H, 2013, 2013 10TH WEB INFORMATION SYSTEM AND APPLICATION CONFERENCE (WISA 2013), P446, DOI 10.1109/WISA.2013.90; Zhang ZL, 2009, IEEE INTELL SYST, V24, P53, DOI 10.1109/MIS.2009.92; Zhu ZX, 2007, PATTERN RECOGN, V40, P3236, DOI 10.1016/j.patcog.2007.02.007	90	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249094	10.1371/journal.pone.0249094	http://dx.doi.org/10.1371/journal.pone.0249094			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861766	gold, Green Published			2022-12-26	WOS:000641475400026
J	Chantanahom, N; Phupong, V				Chantanahom, Nipp; Phupong, Vorapong			Clinical risk factors for preeclampsia in twin pregnancies	PLOS ONE			English	Article							HYPERTENSIVE DISORDERS; WEIGHT-GAIN; GESTATIONS; AMERICAN	Background Preeclampsia is a common obstetric complication. The rate of preeclampsia is increased in twin pregnancies. The aim of this study was to assess the clinical risk factors for developing preeclampsia in twin pregnancies. Methods A case-control study was carried out among women with twin pregnancies who delivered at gestational age more than 23 weeks at King Chulalongkorn Memorial Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, from 2003 to 2019. The data were retrieved from electronic medical records. Multivariate logistic regression analysis was used to find the risk factors. Results A total of 1,568 twin pregnancies were delivered during the study period and 182 cases (11.6%) developed preeclampsia. 172 cases with preeclampsia and 516 controls were selected for analysis. After certain variables were adjusted in the multivariate logistic regression analysis, the clinical factors associated with preeclampsia in twin pregnancies were nulliparity (adjusted odds ratio (OR) 1.57, 95% confidence interval (CI) 1.02-2.41) and chronic hypertension (adjusted OR 6.22, 95%CI 1.98-19.57). Low gestational weight gain was a significant protective factor against the development of preeclampsia (adjusted OR 0.50; 95%CI 0.32-0.77). Conclusion The clinical risk factors for developing preeclampsia in twin pregnancies were nulliparity and chronic hypertension. These risk factors are of value to identify twin pregnant women at risk for preeclampsia and in implementing primary prevention.	[Chantanahom, Nipp; Phupong, Vorapong] Chulalongkorn Univ, Dept Obstet & Gynecol, Fac Med, Bangkok, Thailand	Chulalongkorn University	Phupong, V (corresponding author), Chulalongkorn Univ, Dept Obstet & Gynecol, Fac Med, Bangkok, Thailand.	vorapong.p@chula.ac.th		Phupong, Vorapong/0000-0003-0151-9595	Grant for International Research Integration: Research Pyramid, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University; Placental Related Diseases Research Unit, Chulalongkorn University [12/60]	Grant for International Research Integration: Research Pyramid, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University; Placental Related Diseases Research Unit, Chulalongkorn University(Chulalongkorn University)	This work was supported by a Grant for International Research Integration: Research Pyramid, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University and Placental Related Diseases Research Unit, Chulalongkorn University. Grant no. 12/60. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksornphusitaphong A, 2013, J OBSTET GYNAECOL RE, V39, P627, DOI 10.1111/j.1447-0756.2012.02010.x; American College of Obstetricians and Gynecologists' Committee on Practice BulletinsObstetrics, 2018, Obstet Gynecol, V132, pe228, DOI 10.1097/AOG.0000000000002960; [Anonymous], 2020, Obstet Gynecol, V135, P1492, DOI 10.1097/AOG.0000000000003892; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Campbell DM, 1999, HYPERTENS PREGNANCY, V18, P197, DOI 10.3109/10641959909016193; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; COONROD DV, 1995, OBSTET GYNECOL, V85, P645, DOI 10.1016/0029-7844(95)00049-W; Erez O, 2006, J MATERN-FETAL NEO M, V19, P141, DOI 10.1080/14767050500246045; Fox NS, 2014, AM J PERINAT, V31, P163, DOI 10.1055/s-0033-1343775; Francisco C, 2017, ULTRASOUND OBST GYN, V50, P88, DOI 10.1002/uog.17470; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Lal AK, 2015, J PERINATOL, V35, P405, DOI 10.1038/jp.2014.237; Lucovnik M, 2016, HYPERTENS PREGNANCY, V35, P542, DOI 10.1080/10641955.2016.1197936; Lucovnik M, 2012, J PERINAT MED, V40, P379, DOI 10.1515/jpm-2011-0252; Luealon Phanida, 2010, Journal of the Medical Association of Thailand, V93, P661; Pecheux O, 2019, EUR J OBSTET GYN R B, V234, P190, DOI 10.1016/j.ejogrb.2019.01.010; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sparks TN, 2013, J MATERN-FETAL NEO M, V26, P1273, DOI 10.3109/14767058.2013.777701; Suzuki S, 2009, ARCH GYNECOL OBSTET, V280, P389, DOI 10.1007/s00404-009-0932-4; Taguchi T, 2014, J OBSTET GYNAECOL RE, V40, P1584, DOI 10.1111/jog.12408; VILLAR J, 2003, PREECLAMPSIA, P57; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249555	10.1371/journal.pone.0249555	http://dx.doi.org/10.1371/journal.pone.0249555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857157	Green Published, gold			2022-12-26	WOS:000641474900118
J	Parrello, B; Butler, R; Chlenski, P; Pusch, GD; Overbeek, R				Parrello, Bruce; Butler, Rory; Chlenski, Philippe; Pusch, Gordon D.; Overbeek, Ross			Supervised extraction of near-complete genomes from metagenomic samples: A new service in PATRIC	PLOS ONE			English	Article							ALGORITHM; QUALITY	Large amounts of metagenomically-derived data are submitted to PATRIC for analysis. In the future, we expect even more jobs submitted to PATRIC will use metagenomic data. One in-demand use case is the extraction of near-complete draft genomes from assembled contigs of metagenomic origin. The PATRIC metagenome binning service utilizes the PATRIC database to furnish a large, diverse set of reference genomes. We provide a new service for supervised extraction and annotation of high-quality, near-complete genomes from metagenomically-derived contigs. Reference genomes are assigned to putative draft genome bins based on the presence of single-copy universal marker roles in the sample, and contigs are sorted into these bins by their similarity to reference genomes in PATRIC. Each set of binned contigs represents a draft genome that will be annotated by RASTtk in PATRIC. A structured-language binning report is provided containing quality measurements and taxonomic information about the contig bins. The PATRIC metagenome binning service emphasizes extraction of high-quality genomes for downstream analysis using other PATRIC tools and services. Due to its supervised nature, the binning service is not appropriate for mining novel or extremely low-coverage genomes from metagenomic samples.	[Parrello, Bruce; Butler, Rory; Chlenski, Philippe; Pusch, Gordon D.; Overbeek, Ross] Fellowship Interpretat Genomes, Burr Ridge, IL 60527 USA; [Parrello, Bruce; Butler, Rory; Overbeek, Ross] Univ Chicago, Chicago, IL 60637 USA; [Chlenski, Philippe] Columbia Univ, New York, NY 10032 USA	University of Chicago; Columbia University	Chlenski, P (corresponding author), Columbia Univ, New York, NY 10032 USA.	pac@cs.columbia.edu		Chlenski, Philippe/0000-0002-2951-4385	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400027C]; U.S. Department of Energy, Office of Science [DE-AC02-06CH11357]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Energy, Office of Science(United States Department of Energy (DOE))	This project has been funded in whole with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201400027C, awarded to RL Stevens. The funding body did not play any role in the design of the study, the collection, analysis, and interpretation of data, or in writing this manuscript. This material was based upon work supported by the U.S. Department of Energy, Office of Science, under contract DE-AC02-06CH11357.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Davis JJ, 2020, NUCLEIC ACIDS RES, V48, pD606, DOI 10.1093/nar/gkz943; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lan YM, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0162-5; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Parrello B, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3068-y; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	11	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250092	10.1371/journal.pone.0250092	http://dx.doi.org/10.1371/journal.pone.0250092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857229	Green Submitted, Green Published, gold			2022-12-26	WOS:000641474900120
J	Sigmund, EC; Baur, L; Schineis, P; Arasa, J; Collado-Diaz, V; Vranova, M; Stahl, RAK; Thelen, M; Halin, C				Sigmund, Elena C.; Baur, Lilian; Schineis, Philipp; Arasa, Jorge; Collado-Diaz, Victor; Vranova, Martina; Stahl, Rolf A. K.; Thelen, Marcus; Halin, Cornelia			Lymphatic endothelial-cell expressed ACKR3 is dispensable for postnatal lymphangiogenesis and lymphatic drainage function in mice	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR7; ADRENOMEDULLIN; MIGRATION; PROLIFERATION; SURVIVAL; SYSTEM	Atypical chemokine receptor ACKR3 (formerly CXCR7) is a scavenging receptor that has recently been implicated in murine lymphatic development. Specifically, ACKR3-deficiency was shown to result in lymphatic hyperplasia and lymphedema, in addition to cardiac hyperplasia and cardiac valve defects leading to embryonic lethality. The lymphatic phenotype was attributed to a lymphatic endothelial cell (LEC)-intrinsic scavenging function of ACKR3 for the vascular peptide hormone adrenomedullin (AM), which is also important during postnatal lymphangiogenesis. In this study, we investigated the expression of ACKR3 in the lymphatic vasculature of adult mice and its function in postnatal lymphatic development and function. We show that ACKR3 is widely expressed in mature lymphatics and that it exerts chemokine-scavenging activity in cultured murine skin-derived LECs. To investigate the role of LEC-expressed ACKR3 in postnatal lymphangiogenesis and function during adulthood, we generated and validated a lymphatic-specific, inducible ACKR3 knockout mouse. Surprisingly, in contrast to the reported involvement of ACKR3 in lymphatic development, our analyses revealed no contribution of LEC-expressed ACKR3 to postnatal lymphangiogenesis, lymphatic morphology and drainage function.	[Sigmund, Elena C.; Baur, Lilian; Schineis, Philipp; Arasa, Jorge; Collado-Diaz, Victor; Vranova, Martina; Halin, Cornelia] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Stahl, Rolf A. K.] Univ Hamburg, Univ Klinikum, Hamburg, Germany; [Thelen, Marcus] Univ Svizzera Italiana, Fac Biomed Sci, Inst Res Biomed IRB, Bellinzona, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hamburg; Universita della Svizzera Italiana	Halin, C (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	cornelia.halin@pharma.ethz.ch		Arasa, Jorge/0000-0002-3092-3186; Sigmund, Elena/0000-0001-5647-879X	Swiss National Fund Sinergia program [CRSII3_160719/1]; ETH Zurich	Swiss National Fund Sinergia program; ETH Zurich(ETH Zurich)	C.H. and M.T. gratefully acknowledge common financial support from the Swiss National Fund Sinergia program (CRSII3_160719/1). C.H. is supported by the ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameti R, 2018, J LEUKOCYTE BIOL, V104, P391, DOI 10.1002/JLB.2MA1217-509R; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Bachmann SB, 2018, METHODS MOL BIOL, V1846, P197, DOI 10.1007/978-1-4939-8712-2_13; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Berahovich RD, 2014, IMMUNOLOGY, V141, P111, DOI 10.1111/imm.12176; Betterman KL, 2014, DEV CELL, V30, P490, DOI 10.1016/j.devcel.2014.08.021; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Davis RB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92465; Dunworth WP, 2008, PEPTIDES, V29, P2243, DOI 10.1016/j.peptides.2008.09.009; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Gustavsson M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14135; Hampton HR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8139; Hay DL, 2018, BRIT J PHARMACOL, V175, P3, DOI 10.1111/bph.14075; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Hoopes SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045261; Humpert ML, 2014, EUR J IMMUNOL, V44, P694, DOI 10.1002/eji.201343907; Ikeda Y, 2013, CELL, V155, P1323, DOI 10.1016/j.cell.2013.10.052; Iring A, 2019, J CLIN INVEST, V129, P2775, DOI 10.1172/JCI123825; Jin DH, 2008, CARDIOVASC RES, V80, P339, DOI 10.1093/cvr/cvn228; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Karaman S, 2015, ANGIOGENESIS, V18, P489, DOI 10.1007/s10456-015-9479-0; Klein KR, 2014, DEV CELL, V30, P528, DOI 10.1016/j.devcel.2014.07.012; LIPPTON H, 1994, J APPL PHYSIOL, V76, P2154, DOI 10.1152/jappl.1994.76.5.2154; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Meyrath M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16664-0; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miyashita K, 2003, HYPERTENS RES, V26, pS93, DOI 10.1291/hypres.26.S93; Montoya-Zegarra JA, 2019, ANGIOGENESIS, V22, P223, DOI 10.1007/s10456-018-9652-3; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neusser MA, 2010, KIDNEY INT, V77, P801, DOI 10.1038/ki.2010.6; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Ochoa-Callejero L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33495; Ochsenbein AM, 2016, ANGIOGENESIS, V19, P513, DOI 10.1007/s10456-016-9523-8; Puddinu V, 2017, ONCOTARGET, V8, P85068, DOI 10.18632/oncotarget.18844; Radice E, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107951; Russo E, 2016, CELL REP, V14, P1723, DOI 10.1016/j.celrep.2016.01.048; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Salazar N, 2018, MOL THER, V26, P1354, DOI 10.1016/j.ymthe.2018.02.030; Schineis P, 2019, VASC PHARMACOL, V112, P31, DOI 10.1016/j.vph.2018.08.001; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Szpakowska M, 2018, BIOCHEM PHARMACOL, V153, P299, DOI 10.1016/j.bcp.2018.03.007; Temmesfeld-Wollbruck B, 2007, INTENS CARE MED, V33, P703, DOI 10.1007/s00134-007-0561-y; Totonchy JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069828; Trincot CE, 2019, CIRC RES, V124, P101, DOI 10.1161/CIRCRESAHA.118.313835; Ulvmar MH, 2016, CARDIOVASC RES, V111, P310, DOI 10.1093/cvr/cvw175; Wang C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00641; Wang HS, 2012, BLOOD, V119, P465, DOI 10.1182/blood-2011-03-343608; Wang XN, 2014, J INVEST DERMATOL, V134, P965, DOI 10.1038/jid.2013.481; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wetzel-Strong SE, 2014, DEV DYNAM, V243, P243, DOI 10.1002/dvdy.24065; Xian X, 2017, ENDOCRINOLOGY, V158, P1359, DOI 10.1210/en.2016-1531; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249068	10.1371/journal.pone.0249068	http://dx.doi.org/10.1371/journal.pone.0249068			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857173	gold, Green Published			2022-12-26	WOS:000641474900045
J	Gebrehiwot, AN; Kato, T; Nakazawa, K				Gebrehiwot, Adonay N.; Kato, Tatsuya; Nakazawa, Kimitaka			Inducing lateralized phosphenes over the occipital lobe using transcranial magnetic stimulation to navigate a virtual environment	PLOS ONE			English	Article							INTRACORTICAL MICROSTIMULATION; ELECTRICAL-STIMULATION; RETINAL PROSTHESIS; ARTIFICIAL VISION; BLIND; SYSTEM	Electrical stimulation involving visual areas of the brain produces artificial light percepts called phosphenes. These visual percepts have been extensively investigated in previous studies involving intracortical microsimulation (ICMS) and serve as the basis for developing a visual prosthesis for the blind. Although advances have been achieved, many challenges still remain with implementing a functional ICMS for visual rehabilitation purposes. Transcranial magnetic stimulation (TMS) over the primary occipital lobe offers an alternative method to produce phosphenes non-invasively. A main challenge facing blind individuals involves navigation. Within the scientific community, methods to evaluate the ability of a visual prosthesis to facilitate in navigation has been neglected. In this study, we investigate the effectiveness of evoking lateralized phosphenes to navigate a computer simulated virtual environment. More importantly, we demonstrate how virtual environments along with the development of a visual prosthesis share a mutual relationship benefiting both patients and researchers. Using two TMS devices, a pair of 40mm figure-of-eight coils were placed over each occipital hemisphere resulting in lateralized phosphene perception. Participants were tasked with making a series of left and right turns using peripheral devices depending on the visual hemifield in which a phosphene is present. If a participant was able to accurately perceive all ten phosphenes, the simulated target is able to advance and fully exit the virtual environment. Our findings demonstrate that participants can interpret lateralized phosphenes while highlighting the integration of computer based virtual environments to evaluate the capability of a visual prosthesis during navigation.	[Gebrehiwot, Adonay N.; Kato, Tatsuya; Nakazawa, Kimitaka] Univ Tokyo, Dept Life Sci, Tokyo, Japan; [Kato, Tatsuya] Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Nakazawa, K (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	nakazawa@idaten.c.u-tokyo.ac.jp		Nakazawa, Kimitaka/0000-0001-5483-8659; Kato, Tatsuya/0000-0002-4493-2200	Japan Society for the Promotion of Science Kakenhi [18H04082]; Uehara Memorial Foundation; Core Research for Evolutional Science and Technology program by the Japan Science and Technology Agency	Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Core Research for Evolutional Science and Technology program by the Japan Science and Technology Agency	This research was funded by the Japan Society for the Promotion of Science Kakenhi grant number 18H04082, research grant by the Uehara Memorial Foundation, and the Core Research for Evolutional Science and Technology program by the Japan Science and Technology Agency.	BAK M, 1990, MED BIOL ENG COMPUT, V28, P257, DOI 10.1007/BF02442682; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Barnes N, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036013; Bonmassar G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1914; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; Chader GJ, 2016, INVEST OPHTH VIS SCI, V57, DOI 10.1167/iovs.16-19125; Chen SC, 2009, VISION RES, V49, P1493, DOI 10.1016/j.visres.2009.02.003; Christie BP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/025003; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Cover T. M., 1991, ELEMENTS INFORM THEO; da Cruz L, 2016, OPHTHALMOLOGY, V123, P2248, DOI 10.1016/j.ophtha.2016.06.049; Dagnelie G, 2008, ANNU REV BIOMED ENG, V10, P339, DOI 10.1146/annurev.bioeng.10.061807.160529; DOBELLE WH, 1974, SCIENCE, V183, P440, DOI 10.1126/science.183.4123.440; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; Elkin-Frankston Seth, 2010, J Vis Exp, DOI 10.3791/1762; Farnum A, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00036; Fernandez Eduardo, 2018, Bioelectron Med, V4, P12, DOI 10.1186/s42234-018-0013-8; Gaub BM, 2015, MOL THER, V23, P1562, DOI 10.1038/mt.2015.121; Gothe J, 2002, BRAIN, V125, P479, DOI 10.1093/brain/awf045; Gulino M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00689; Kammer T, 2005, EXP BRAIN RES, V160, P129, DOI 10.1007/s00221-004-1992-0; Kuder GF, 1937, PSYCHOMETRIKA, V2, P151, DOI 10.1007/BF02288391; Lee SW, 2017, IEEE T NEUR SYS REH, V25, P1375, DOI 10.1109/TNSRE.2016.2631446; Lewis PM, 2015, BRAIN RES, V1595, P51, DOI 10.1016/j.brainres.2014.11.020; Losey DM, 2016, FRONT ROBOT AI, V3, DOI 10.3389/frobt.2016.00072; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; Margalit E, 2002, SURV OPHTHALMOL, V47, P335, DOI 10.1016/S0039-6257(02)00311-9; Minusa S, 2018, IEEE T BIO-MED ENG, V65, P1301, DOI 10.1109/TBME.2017.2748136; Park HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3463; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Rao RPN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111332; Real S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19153404; Rizou ME, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aaa0dd; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Salminen-Vaparanta N, 2014, CEREB CORTEX, V24, P2751, DOI 10.1093/cercor/bht131; Schiller PH, 2008, PERCEPTION, V37, P1529, DOI 10.1068/p6100; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Shepherd RK, 2013, TRENDS BIOTECHNOL, V31, P562, DOI 10.1016/j.tibtech.2013.07.001; Stocco A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137303; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Terhune DB, 2015, CEREB CORTEX, V25, P4341, DOI 10.1093/cercor/bhv015	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249996	10.1371/journal.pone.0249996	http://dx.doi.org/10.1371/journal.pone.0249996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852643	Green Published, gold			2022-12-26	WOS:000640604500071
J	Kong, L; Karns, R; Shata, MTM; Brown, JL; Lyons, MS; Sherman, KE; Blackard, JT				Kong, Ling; Karns, Rebekah; Shata, Mohamed Tarek M.; Brown, Jennifer L.; Lyons, Michael S.; Sherman, Kenneth E.; Blackard, Jason T.			The synthetic opioid fentanyl enhances viral replication in vitro	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NF-KAPPA-B; UP-REGULATION; OVERDOSE DEATHS; DOWN-REGULATION; INDUCED APOPTOSIS; LIVER FIBROSIS; UNITED-STATES; MGC-803 CELLS; MU-OPIATE	The US is in the midst of a major drug epidemic fueled in large part by the widespread recreational use of synthetic opioids such as fentanyl. Persons with opioid use disorder are at significant risk for transmission of injection-associated infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV). Commonly abused substances may antagonize immune responses and promote viral replication. However, the impact of synthetic opioids on virus replication has not been well explored. Thus, we evaluated the impact of fentanyl and carfentanil using in vitro systems that replicate infectious viruses. Fentanyl was used in cell lines replicating HBV or HCV at concentrations of 1 ng, 100 ng, and 10 ug. Viral protein synthesis was quantified by ELISA, while apoptosis and cell death were measured by M30 or MTT assays, respectively. HCV replicative fitness was evaluated in a luciferase-based system. RNAseq was performed to evaluate cellular gene regulation in the presence of fentanyl. Low dose fentanyl had no impact on HCV replication in Huh7.5JFH1 hepatocytes; however, higher doses significantly enhanced HCV replication. Similarly, a dose-dependent increase in HCV replicative fitness was observed in the presence of fentanyl. In the HepG2.2.15 hepatocyte cell line, fentanyl caused a dose-dependent increase in HBV replication, although only a higher doses than for HCV. Addition of fentanyl resulted in significant apoptosis in both hepatocyte cell lines. Cell death was minimal at low drug concentrations. RNAseq identified a number of hepatocyte genes that were differentially regulated by fentanyl, including those related to apoptosis, the antiviral / interferon response, chemokine signaling, and NF kappa B signaling. Collectively, these data suggest that synthetic opioids promote viral replication but may have distinct effects depending on the drug dose and the viral target. As higher viral loads are associated with pathogenesis and virus transmission, additional research is essential to an enhanced understanding of opioid-virus pathogenesis and for the development of new and optimized treatment strategies.	[Kong, Ling; Shata, Mohamed Tarek M.; Sherman, Kenneth E.; Blackard, Jason T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45267 USA; [Karns, Rebekah] Cincinnati Childrens Hosp, Digest Hlth Ctr, Cincinnati, OH USA; [Brown, Jennifer L.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Addict Sci Div, Coll Med, Cincinnati, OH USA; [Brown, Jennifer L.; Lyons, Michael S.; Sherman, Kenneth E.; Blackard, Jason T.] Univ Cincinnati, Coll Med, Ctr Addict Res, Cincinnati, OH 45267 USA; [Lyons, Michael S.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45267 USA.; Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Ctr Addict Res, Cincinnati, OH 45267 USA.	jason.blackard@uc.edu	Shata, Mohamed/ABB-3392-2021	Blackard, Jason/0000-0003-2876-3811	National Institute on Drug Abuse [DA048439]; National Institute of General Medical Sciences [GM105414]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute on Drug Abuse (grant DA048439 to JTB) and the National Institute of General Medical Sciences (grant GM105414 to JTB). These data were presented at the Conference on Retroviruses and Opportunistic Infections held in Seattle, WA from March 4-7, 2019.	Armenian P, 2018, NEUROPHARMACOLOGY, V134, P121, DOI 10.1016/j.neuropharm.2017.10.016; Banerjee A, 2011, J NEUROVIROL, V17, P291, DOI 10.1007/s13365-011-0037-2; Beltran JA, 2006, INT IMMUNOPHARMACOL, V6, P1459, DOI 10.1016/j.intimp.2006.04.018; Blackard JT, 2019, CURR HIV RES, V17, P94, DOI 10.2174/1570162X17666190618154534; Blackard JT, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0905-3; Borner C, 2002, MOL PHARMACOL, V61, P800, DOI 10.1124/mol.61.4.800; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Celik F, 2019, CELL MOL BIOL, V65, P21, DOI 10.14715/cmb/2019.65.7.5; Chakass D, 2007, GUT, V56, P974, DOI 10.1136/gut.2006.105122; Chang SL, 2007, J VIROL, V81, P8406, DOI 10.1128/JVI.00155-07; Cranston K, 2019, MMWR-MORBID MORTAL W, V68, P253, DOI 10.15585/mmwr.mm6810a6; Daniulaityte R, 2017, MMWR-MORBID MORTAL W, V66, P904, DOI 10.15585/mmwr.mm6634a3; De Minicis S, 2008, GUT, V57, DOI 10.1136/gut.2007.120303; Delogu G, 2004, J TRAUMA, V57, P75, DOI 10.1097/01.TA.0000075349.66640.3E; Ebrahimkhani MR, 2006, GUT, V55, P1606, DOI 10.1136/gut.2005.076778; Ellis CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197734; He GD, 2016, ONCOL LETT, V12, P563, DOI 10.3892/ol.2016.4619; Helander A, 2016, CLIN TOXICOL, V54, P324, DOI 10.3109/15563650.2016.1139715; Huang XP, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.97222; Jaume M, 2004, HEPATOLOGY, V40, P1136, DOI 10.1002/hep.20428; Jia KQ, 2014, MOL MED REP, V10, P839, DOI 10.3892/mmr.2014.2301; Kanamori T, 2018, BIOL PHARM BULL, V41, P106, DOI 10.1248/bpb.b17-00709; Kocak Nadir, 2017, Asian Pac J Cancer Prev, V18, P735; Kraus J, 2003, MOL PHARMACOL, V64, P876, DOI 10.1124/mol.64.4.876; Kraus J, 2006, J NEUROIMMUNOL, V181, P13, DOI 10.1016/j.jneuroim.2006.07.012; Kraus Jurgen, 2009, Front Biosci (Schol Ed), V1, P164, DOI 10.2741/e16; Labroo RB, 1997, DRUG METAB DISPOS, V25, P1072; Leen JLS, 2019, CAN J ANESTH, V66, P414, DOI 10.1007/s12630-019-01294-y; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Li Y, 2007, J INFECT DIS, V196, P719, DOI 10.1086/520093; Lipinski Piotr F. J., 2019, MOLECULES, V24; Lu J, 2013, ONCOL REP, V30, P1731, DOI 10.3892/or.2013.2640; Ma K, 2017, SCAND J IMMUNOL, V85, P343, DOI 10.1111/sji.12538; Mattson CL, 2021, MMWR-MORBID MORTAL W, V70, P202, DOI 10.15585/mmwr.mm7006a4externalicon; McIntyre IM, 2015, J ANAL TOXICOL, V39, P490, DOI 10.1093/jat/bkv043; Middleton T, 2007, J VIROL METHODS, V145, P137, DOI 10.1016/j.jviromet.2007.05.016; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P897, DOI 10.15585/mmwr.mm6634a2; Peterson AB, 2016, MMWR-MORBID MORTAL W, V65, P844, DOI 10.15585/mmwr.mm6533a3; Qin Y, 2012, ONCOL RES, V20, P61, DOI 10.3727/096504012X13473664562501; Samji H, 2020, INT J DRUG POLICY, V86, DOI 10.1016/j.drugpo.2020.102989; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Strayer KE, 2018, ACS OMEGA, V3, P514, DOI 10.1021/acsomega.7b01536; Tahamtan A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00970; Talu A, 2010, INT J DRUG POLICY, V21, P56, DOI 10.1016/j.drugpo.2009.02.007; Tang B, 2013, INT J ONCOL, V43, P1281, DOI 10.3892/ijo.2013.2046; Tang B, 2011, INT J MOL MED, V28, P1077, DOI 10.3892/ijmm.2011.784; Tiscione NB, 2017, J ANAL TOXICOL, V41, P313, DOI 10.1093/jat/bkx005; Turchan-Cholewo J, 2008, J NEUROSCI RES, V86, P2100, DOI 10.1002/jnr.21653; Wang CQ, 2005, AM J PATHOL, V167, P1333, DOI 10.1016/S0002-9440(10)61220-5; Wang YY, 2017, MED SCI MONITOR, V23, P3276, DOI 10.12659/MSM.902245; Wilde M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00238; Wu F, 2017, J ANAL TOXICOL, V41, P289, DOI 10.1093/jat/bkx003; Ye L, 2008, J VIRAL HEPATITIS, V15, P261, DOI 10.1111/j.1365-2893.2007.00940.x; ZADINA JE, 1994, J PHARMACOL EXP THER, V270, P1086; ZADINA JE, 1993, J PHARMACOL EXP THER, V265, P254; Zhang L, 2012, J NEUROIMMUNE PHARM, V7, P835, DOI 10.1007/s11481-012-9396-6; Zhang XL, 2014, ASIAN PAC J CANCER P, V15, P10015, DOI 10.7314/APJCP.2014.15.22.10015; Zhou Y, 2015, J NEUROIMMUNE PHARM, V10, P102, DOI 10.1007/s11481-014-9577-6	58	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249581	10.1371/journal.pone.0249581	http://dx.doi.org/10.1371/journal.pone.0249581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852610	gold, Green Published			2022-12-26	WOS:000640604500058
J	Sharma, A; Abbas, H; Siddiqui, MQ				Sharma, Anshuman; Abbas, Haidar; Siddiqui, Muhammad Qutubuddin			Modelling the inhibitors of cold supply chain using fuzzy interpretive structural modeling and fuzzy MICMAC analysis	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; TRACEABILITY SYSTEM; MANAGEMENT; FRAMEWORK; BARRIERS; COUNTRIES; QUALITY; IMPACT; SUSTAINABILITY; OPERATIONS	The Cold Supply Chain (CSC) is an integral part of the supply chain of perishable products. The aim of this research is to examine the inhibitors that have a major impact on the performance of CSC operations in the United Arab Emirates (UAE). This study provides a synthesis and suggests a hierarchical model among CSC inhibitors and their respective relevance. The hierarchical synthesis of twelve (12) primary CSC inhibitors is achieved through a comprehensive literature review and consultation with academics and CSC professionals. This study used semi-structured interviews, a fuzzy interpretive structural modeling (FISM) and a Fuzzy-MICMAC (FMICMAC) analysis to explore and establish the relationship between and among identified inhibitors. FISM is used to examine the interaction between inhibitors, while FMICMAC analysis is used to examine the nature of inhibitors on the basis of their dependence and driving power. The results of the FISM and FMICMAC analysis show the inter-relationships and relative dominance of identified inhibitors. The results show that some inhibitors are of high strategic importance due to their high driving power and low dependence. These inhibitors seek more management attention in order to improve their effectiveness. The result of a hierarchical model helps to understand the influence of a particular inhibitor on others. 'Higher capital and operating costs' occupy the highest level in the FISM model. The 'fragmented cold supply chains', 'lack of skilled labor', 'inadequate information system infrastructure' and 'lack of commitment by top level management' had strong driving power but weak dependence, which characterizes them as independent inhibitors. Management should be extra careful when dealing with these inhibitors as they influence the effects of other variables at the top of the FISM hierarchy in the overall management of the cold supply chain. The study also suggests a number of recommendations for addressing these inhibitors in cold supply chains operating in the UAE. With due attention and care for these inhibitors, the operation of the cold supply chains is likely to be even more successful.	[Sharma, Anshuman; Siddiqui, Muhammad Qutubuddin] Ajman Univ, Coll Business Adm, Ajman, U Arab Emirates; [Abbas, Haidar] Univ Technol & Appl Sci, Salalah Coll Appl Sci, Salalah, Oman	Ajman University	Sharma, A (corresponding author), Ajman Univ, Coll Business Adm, Ajman, U Arab Emirates.	profasharma@gmail.com	; Siddiqui, Muhammad Qutubuddin/J-1469-2014	Abbas, Haidar/0000-0001-8063-879X; Sharma, Anshuman/0000-0002-0762-6853; Siddiqui, Muhammad Qutubuddin/0000-0003-4704-6105	Ajman University, Ajman, UAE [2018-A-BN-01]	Ajman University, Ajman, UAE	This study received Internal Research Grant (IRG) (Ref: 2018-A-BN-01) from Ajman University, Ajman, UAE.	Abbas Haidar, 2018, International Journal of Business Excellence, V16, P47; Abdul-Rasoul MM, 2012, AV DIABETOL, V28, P64, DOI 10.1016/j.avdiab.2012.04.001; Abiad MG, 2018, FOOD SECUR, V10, P311, DOI 10.1007/s12571-018-0782-7; Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Agrawal Amit Kumar, 2017, International Journal of Business Excellence, V12, P23; Ahmad M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9020233; Akkerman R, 2010, OR SPECTRUM, V32, P863, DOI 10.1007/s00291-010-0223-2; Al-Refaie A, 2020, TECHNOL ECON DEV ECO, V26, P675, DOI 10.3846/tede.2020.12866; Albrecht Antonia, 2020, J Packag Technol Res, V4, P23, DOI 10.1007/s41783-019-00080-x; Ali A, 2018, BRIT FOOD J, V120, P2, DOI 10.1108/BFJ-05-2017-0278; Amjadian S., 2020, ARCH PHARM PRACT, V1, P140; Anand N., 2015, IUP J SUPPLY CHAIN M, V12, P48; Anin E.K., 2015, EUR J BUS MANAGE, V7, P59; [Anonymous], 2012, ALPEN CAPITAL REPORT; Aung MM, 2014, FOOD CONTROL, V39, P172, DOI 10.1016/j.foodcont.2013.11.007; Azanedo L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083364; Bag Surajit, 2016, International Journal of Procurement Management, V9, P398; Bag S., 2014, AFR J BUS MANAGE, V8, P1053, DOI DOI 10.5897/AJBM2013.7307; Beck F., IN PRESS; Behl Abhishek, 2016, International Journal of Business Excellence, V10, P209; Berger H, 2007, TRENDS FOOD SCI TECH, V18, pS64, DOI 10.1016/j.tifs.2006.10.024; Das S.K., 2020, JINDAL J BUSINESS RE, V9, P41; Das S, 2020, J AMB INTEL HUM COMP, V11, P5017, DOI 10.1007/s12652-020-01808-3; David V, 2019, ECOL MODEL, V398, P55, DOI 10.1016/j.ecolmodel.2019.02.008; de Haan-Hoek J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083189; Dubey R., 2014, GLOBAL J FLEXIBLE SY, V15, P131, DOI DOI 10.1007/S40171-014-0058-9; Dunne AJ, 2008, BRIT FOOD J, V110, P361, DOI 10.1108/00070700810868906; Faisal MN, 2017, J ENTREP EMERG ECON, V9, P161, DOI 10.1108/JEEE-07-2016-0026; Farooq U, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8090839; Fawcett SE, 2008, SUPPLY CHAIN MANAG, V13, P35, DOI 10.1108/13598540810850300; Freiboth HW, 2013, J TRANSP SUPPLY CHAI, V7, DOI 10.4102/jtscm.v7i1.99; Ganguly KK, 2020, INT J APPL MANAG SCI, V12, P242; Gardas BB., 2017, INT J BUS EXCELL, V11, P505, DOI [DOI 10.1504/IJBEX.2017.082576, 10.1504/IJBEX.2017.082576]; Ghadge A, 2021, PROD PLAN CONTROL, V32, P1191, DOI 10.1080/09537287.2020.1796140; Gligor D, 2018, INT J LOGIST MANAG, V29, P942, DOI 10.1108/IJLM-02-2017-0026; Gorane SJ, 2013, ASIA PAC J MARKET LO, V25, P263, DOI 10.1108/13555851311314059; Guntalee R., 2005, BUS REV, V4, P274; Halder PS., 2011, ASIAN J AGR RURAL DE, V1-20; Haroun D, 2016, ARAB J NUTR EXERCISE, P85; Hingley M, 2008, BRIT FOOD J; Hoffmann P, 2013, J PURCH SUPPLY MANAG, V19, P199, DOI 10.1016/j.pursup.2013.06.002; Hutton L., 2017, FOOD COLD CHAIN OPTI; Joshi R, 2009, BRIT FOOD J, V111, P1260, DOI 10.1108/00070700911001077; Kartoglu U, 2014, EXPERT REV VACCINES, V13, P843, DOI 10.1586/14760584.2014.923761; Kelepouris T, 2007, IND MANAGE DATA SYST, V107, P183, DOI 10.1108/02635570710723804; Kiaya V., 2014, POSTHARVEST LOSSES S, V25; Konovalenko I, 2021, DECIS SUPPORT SYST, V141, DOI 10.1016/j.dss.2020.113451; Kumar S, 2008, INT J RETAIL DISTRIB, V36, P192, DOI 10.1108/09590550810859150; Li XW, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8040423; Liu Lu, 2018, Information Processing in Agriculture, V5, P47, DOI 10.1016/j.inpa.2017.12.001; Love DC, 2020, AQUACULTURE, V515, DOI 10.1016/j.aquaculture.2019.734569; Luthra S, 2017, RESOUR CONSERV RECY, V125, P198, DOI 10.1016/j.resconrec.2017.02.018; Mahajan R, 2017, J ADV MANAG RES, V14, P91, DOI 10.1108/JAMR-05-2016-0035; McCrory MA, 2019, J ACAD NUTR DIET, V119, P921, DOI 10.1016/j.jand.2018.12.004; Mirza UK, 2009, RENEW SUST ENERG REV, V13, P927, DOI 10.1016/j.rser.2007.11.006; MOCCAE, 2017, STABILITY CLIMATE CH, P2017; Montanari R, 2008, TRENDS FOOD SCI TECH, V19, P425, DOI 10.1016/j.tifs.2008.03.009; Mudgal R.K., 2010, INT J LOGIST SYST MA, V7, P81, DOI [10.1504/IJLSM.2010.033891, DOI 10.1504/IJLSM.2010.033891]; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Oliva F, 2008, MATH COMPUT SCI ENG, P361; Oskarsdottir K, 2019, J FOOD ENG, V240, P153, DOI 10.1016/j.jfoodeng.2018.07.013; Ovca A, 2009, FOOD CONTROL, V20, P167, DOI 10.1016/j.foodcont.2008.03.010; Ping-Ho Ting, 2013, International Journal of Information Engineering and Electronic Business, V5, P1, DOI 10.5815/ijieeb.2013.06.01; Plambeck EL, 2012, ENERG ECON, V34, pS64, DOI 10.1016/j.eneco.2012.08.031; Porter SD, 2016, SCI TOTAL ENVIRON, V571, P721, DOI 10.1016/j.scitotenv.2016.07.041; Pramod V. R., 2015, International Journal of Business Excellence, V8, P537; Rathore J, 2013, IUP J SUPPLY CHAIN M, V10; Ray A, 2020, J GLOB OPER STRATEG, V13, P251, DOI 10.1108/JGOSS-03-2020-0012; Regattieri A, 2007, J FOOD ENG, V81, P347, DOI 10.1016/j.jfoodeng.2006.10.032; Salin V., 2003, INT J PHYS DISTRIBUT; Shakeri H, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04430; Sharma S.K., 2021, CHALLENGES COMMON SE; Sharma S, 2015, BUS PROCESS MANAG J, V21, P722, DOI 10.1108/BPMJ-10-2014-0105; Sharma SK, 2018, J RETAIL CONSUM SERV, V45, P52, DOI 10.1016/j.jretconser.2018.08.008; Shashi S, 2018, INT J LOGIST MANAG; Shen Xin, 2013, Journal of Applied Sciences, V13, P2670, DOI 10.3923/jas.2013.2670.2675; Siddh MM, 2015, J ADV MANAG RES, V12, P292, DOI 10.1108/JAMR-01-2015-0002; Singh Binod Kumar, 2018, International Journal of Logistics Economics and Globalisation, V7, P332; Singh RK, 2020, GLOB BUS REV, DOI 10.1177/0972150920923075; Sinha S, 2019, J STRATEGY MANAG, V12, P382, DOI 10.1108/JSMA-12-2018-0140; Srivastava SK, 2015, INT J LOGIST MANAG, V26, P568, DOI 10.1108/IJLM-02-2014-0032; Sundarakani Balan, 2012, International Journal of Logistics Systems and Management, V11, P306, DOI 10.1504/IJLSM.2012.045916; Tamimi M, STUDY COLD CHAIN LOG; Taylor DH, 2006, SUPPLY CHAIN MANAG, V11, P379, DOI 10.1108/13598540610682381; Tsang YP, 2017, INT J ENG BUS MANAG, V9, DOI 10.1177/1847979017749063; van der Merwe D, 2013, INT J CONSUM STUD, V37, DOI 10.1111/ijcs.12052; van Donk DP, 2008, BRIT FOOD J, V110, P218, DOI 10.1108/00070700810849925; Vermeulen WJV, 2006, SUSTAIN DEV, V14, P245, DOI 10.1002/sd.270; Vrat P., 2006, POLICY STRATEGY FORM; Wang ZG, 2016, J CLEAN PROD, V117, P19, DOI 10.1016/j.jclepro.2015.09.142; WARFIELD JN, 1974, IEEE T SYST MAN CYB, VSMC4, P81, DOI 10.1109/TSMC.1974.5408524; Wu JY, 2021, FOOD CONTROL, V120, DOI 10.1016/j.foodcont.2020.107501; Wu WT, 2019, APPL ENERG, V254, DOI 10.1016/j.apenergy.2019.113586; Zhang WS, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083440; Zhao XX, 2019, LWT-FOOD SCI TECHNOL, V109, P207, DOI 10.1016/j.lwt.2019.04.032; Zhu LJ, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9050682; Zokaei AK, 2006, INT J LOGIST MANAG	97	5	5	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249046	10.1371/journal.pone.0249046	http://dx.doi.org/10.1371/journal.pone.0249046			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848286	Green Published, gold			2022-12-26	WOS:000640373500009
J	Kakumani, PK; Guitart, T; Houle, F; Harvey, LM; Goyer, B; Germain, L; Gebauer, F; Simard, MJ				Kakumani, Pavan Kumar; Guitart, Tanit; Houle, Francois; Harvey, Louis-Mathieu; Goyer, Benjamin; Germain, Lucie; Gebauer, Fatima; Simard, Martin J.			CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma	ONCOGENE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; TRANSLATIONAL REPRESSION; DROSOPHILA UNR; HUR; UPSTREAM; PHOSPHORYLATION; PROGRESSION; DOMAINS; TARGETS	MicroRNAs and RNA-binding proteins (RBPs) primarily target the 3 ' UTR of mRNAs to control their translation and stability. However, their co-regulatory effects on specific mRNAs in physiology and disease are yet to be fully explored. CSDE1 is an RBP that promotes metastasis in melanoma and mechanisms underlying its oncogenic activities need to be completely defined. Here we report that CSDE1 interacts with specific miRNA-induced silencing complexes (miRISC) in melanoma. We find an association of CSDE1 with AGO2, the essential component of miRISC, which is facilitated by target mRNAs and depends on the first cold shock domain of CSDE1. Both CSDE1 and AGO2 bind to 3 ' UTR of PMEPA1. CSDE1 counters AGO2 binding, leading to an increase of PMEPA1 expression. We also identify a miRNA, miR-129-5p, that represses PMEPA1 expression in melanoma. Collectively, our results show that PMEPA1 promotes tumorigenic traits and that CSDE1 along with miR-129-5p/AGO2 miRISC act antagonistically to fine-tune PMEPA1 expression toward the progression of melanoma.	[Kakumani, Pavan Kumar; Houle, Francois; Harvey, Louis-Mathieu; Simard, Martin J.] Univ Laval, Res Ctr, Oncol Div, CHU Quebec, Quebec City, PQ, Canada; [Kakumani, Pavan Kumar; Houle, Francois; Harvey, Louis-Mathieu; Simard, Martin J.] Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada; [Guitart, Tanit; Gebauer, Fatima] Barcelona Inst Sci & Technol, Gene Regulat Stem Cells & Canc Programme, Ctr Genom Regulat CRG, Barcelona, Spain; [Goyer, Benjamin; Germain, Lucie] Univ Laval, Ctr Rech, Axe Med Regeneratrice, CHU Quebec Univ Laval, Quebec City, PQ, Canada; [Goyer, Benjamin; Germain, Lucie] Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada; [Goyer, Benjamin; Germain, Lucie] Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ, Canada; [Gebauer, Fatima] Univ Pompeu Fabra UPF, Barcelona, Spain	Laval University; Laval University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Laval University; Laval University; Laval University; Pompeu Fabra University	Kakumani, PK; Simard, MJ (corresponding author), Univ Laval, Res Ctr, Oncol Div, CHU Quebec, Quebec City, PQ, Canada.; Kakumani, PK; Simard, MJ (corresponding author), Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada.	pavan-kumar.kakumani@crchudequebec.ulaval.ca; Martin.Simard@crchudequebec.ulaval.ca	Kakumani, Pavan Kumar/AFH-9007-2022; Guitart, Tanit/G-9772-2015; Gebauer, Fatima/E-7725-2015	Kakumani, Pavan Kumar/0000-0002-8755-860X; Guitart, Tanit/0000-0003-2992-9895; Harvey, Louis-Mathieu/0000-0002-4745-7820; Gebauer, Fatima/0000-0001-7563-0013; Germain, Lucie/0000-0001-8883-6491; Simard, Martin/0000-0002-3189-9309	Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-Sante (FRQ-S); CIHR [FDN-143213]; Spanish Ministry of Science and Innovation (MICINN) [PGC2018-099697-B-I00]; "la Caixa" Foundation [100010434, LCF/PR/HR17/52150016]; Catalan Government [2017SGR534]; Center of Excellence Severo Ochoa	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQ-S); CIHR(Canadian Institutes of Health Research (CIHR)); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "la Caixa" Foundation(La Caixa Foundation); Catalan Government; Center of Excellence Severo Ochoa	The Canadian Institutes of Health Research (CIHR) supported this work. PKK and LMH are recipients of scholarship from Fonds de Recherche du Quebec-Sante (FRQ-S). MJS is a Research Chair from FRQ-S. LG was supported by the CIHR (FDN-143213). FG was supported by grants from the Spanish Ministry of Science and Innovation (MICINN, PGC2018-099697-B-I00), "la Caixa" Foundation (ID:100010434) under the agreement LCF/PR/HR17/52150016, the Catalan Government (2017SGR534) and the Center of Excellence Severo Ochoa.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; Abaza I, 2008, RNA, V14, P482, DOI 10.1261/rna.802908; Abdelaziz M, 2019, J BIOCHEM, V165, P411, DOI 10.1093/jb/mvz022; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ahuja D, 2016, RNA BIOL, V13, P1152, DOI 10.1080/15476286.2016.1229734; Aksenenko M, 2019, BMC DERMATOL, V19, DOI 10.1186/s12895-018-0081-1; Amalia R, 2019, CELL SIGNAL, V59, P24, DOI 10.1016/j.cellsig.2019.03.016; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bohn JA, 2018, NUCLEIC ACIDS RES, V46, P362, DOI 10.1093/nar/gkx1120; Bottini S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01126-x; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Connerty P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010031; Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611; Dinur M, 2006, MOL ENDOCRINOL, V20, P1652, DOI 10.1210/me.2005-0333; Dormoy-Raclet Virginie, 2005, RNA Biol, V2, pe27; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Elatmani H, 2011, STEM CELLS, V29, P1504, DOI 10.1002/stem.712; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fattore L, 2019, CELL DEATH DIFFER, V26, P1267, DOI 10.1038/s41418-018-0205-5; Feng SJ, 2016, MOL MED REP, V13, P4030, DOI 10.3892/mmr.2016.5033; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Gebert LFR, 2019, NAT REV MOL CELL BIO, V20, P21, DOI 10.1038/s41580-018-0045-7; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Goyer B, 2019, J TISSUE ENG REGEN M, V13, P2300, DOI 10.1002/term.2959; Hollmann NM, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107930; Huberdeau MQ, 2019, FEBS J, V286, P642, DOI 10.1111/febs.14666; Huberdeau MQ, 2017, EMBO J, V36, P2088, DOI 10.15252/embj.201696386; Iadevaia V, 2015, BIOMOLECULES, V5, P2207, DOI 10.3390/biom5042207; Jannot G, 2011, METHODS MOL BIOL, V725, P233, DOI 10.1007/978-1-61779-046-1_16; Ji JX, 2020, ONCOGENE, V39, P1125, DOI 10.1038/s41388-019-1050-9; Jiang Peng, 2012, Microrna, V1, P70; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kakumani PK, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900632; Kamenska A, 2016, NUCLEIC ACIDS RES, V44, P6318, DOI 10.1093/nar/gkw565; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelly TJ, 2019, RNA, V25, P1291, DOI 10.1261/rna.071621.119; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Lee HJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01744-5; Li G, 2019, ONCOL LETT, V17, P5777, DOI 10.3892/ol.2019.10241; Li YH, 2018, J MOL BIOL, V430, P285, DOI 10.1016/j.jmb.2017.12.006; Li ZZ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1923-4; Liu Q, 2018, BIOMED PHARMACOTHER, V105, P420, DOI 10.1016/j.biopha.2018.05.105; Ma LJ, 2019, J CELL BIOCHEM, V120, P7527, DOI 10.1002/jcb.28027; Martinez-Useros J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040560; Mihailovich M, 2010, BIOESSAYS, V32, P109, DOI 10.1002/bies.200900122; Militti C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5762; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Qian H, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.28; Qiu ZS, 2019, ACTA BIOCH BIOPH SIN, V51, P997, DOI 10.1093/abbs/gmz096; Schadendorf D, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.3; Schepens B, 2007, EMBO J, V26, P158, DOI 10.1038/sj.emboj.7601468; Sternburg EL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33596-4; Nguyen TTV, 2014, CANCER SCI, V105, P334, DOI 10.1111/cas.12355; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wan P, 2020, J CELL PHYSIOL, V235, P5689, DOI 10.1002/jcp.29501; Wang SC, 2019, PATHOL RES PRACT, V215, P676, DOI 10.1016/j.prp.2018.12.024; Wurth L, 2016, CANCER CELL, V30, P694, DOI 10.1016/j.ccell.2016.10.004; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337	72	5	5	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3231	3244		10.1038/s41388-021-01767-9	http://dx.doi.org/10.1038/s41388-021-01767-9		APR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33833398				2022-12-26	WOS:000638023600002
J	Cheng, S; Bo, ZY; Hollenberg, P; Osawa, Y; Zhang, HM				Cheng, Shen; Bo, Zhiyuan; Hollenberg, Paul; Osawa, Yoichi; Zhang, Haoming			Amphipol-facilitated elucidation of the functional tetrameric complex of full-length cytochrome P450 CYP2B4 and NADPH-cytochrome P450 oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-450 REDUCTASE; LIVER-MICROSOMES; NANODISCS; PROTEINS; ENZYME; SYSTEM	Interactions of membrane-bound mammalian cytochromes P450 (CYPs) with NADPH-cytochrome P450 oxidoreductase (POR), which are required for metabolism of xenobiotics, are facilitated by membrane lipids. A variety of membrane mimetics, such as phospholipid liposomes and nanodiscs, have been used to simulate the membrane to form catalytically active CYP:POR complexes. However, the exact mechanism(s) of these interactions are unclear because of the absence of structural information of full-length mammalian CYP:POR complexes in membranes. Herein, we report the use of amphipols (APols) to form a fully functional, soluble, homogeneous preparation of full-length CYP:POR complexes amenable to biochemical and structural study. Incorporation of CYP2B4 and POR into APols resulted in a CYP2B4:POR complex with a stoichiometry of 1:1, which was fully functional in demethylating benzphetamine at a turnover rate of 37.7 +/- 2.2 min(-1), with a coupling efficiency of 40%. Interestingly, the stable complex had a molecular weight (M-w) of 338 +/- 22 kDa determined by multiangle light scattering, suggestive of a tetrameric complex of 2CYP2B4:2POR embedded in one APol nanoparticle. Moreover, negative stain electron microscopy (EM) validated the homogeneity of the complex and allowed us to generate a three-dimensional EM map and model consistent with the tetramer observed in solution. This first report of the full-length mammalian CYP:POR complex by transmission EM not only reveals the architecture that facilitates electron transfer but also highlights a potential use of APols in biochemical and structural studies of functional CYP complexes with redox partners.	[Cheng, Shen; Bo, Zhiyuan; Hollenberg, Paul; Osawa, Yoichi; Zhang, Haoming] Univ Michigan, Dept Pharmacol, Med Sch, Ann Arbor, MI 48109 USA; [Cheng, Shen] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities	Zhang, HM (corresponding author), Univ Michigan, Dept Pharmacol, Med Sch, Ann Arbor, MI 48109 USA.	haom@umich.edu	Cheng, Shen/GWQ-6903-2022; Zhang, Haoming/AAE-3749-2020; Hollenberg, Paul F/A-7538-2009	Cheng, Shen/0000-0002-7493-4784; Zhang, Haoming/0000-0002-8765-4394; Bo, Zhiyuan/0000-0001-8759-1349	National Institutes of Health [GM077430, ES030791]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful for technical assistance from the staff scientists, Drs. Min Su, Amy Bondy, and Laura Koepping, at the Microscopy Core Facilities of Life Sciences Institute to acquire EM images. This work was supported by grants from the National Institutes of Health (GM077430 and ES030791). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; BLACK SD, 1979, BIOCHEM BIOPH RES CO, V91, P1528, DOI 10.1016/0006-291X(79)91238-5; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2011, BBA-PROTEINS PROTEOM, V1814, P223, DOI 10.1016/j.bbapap.2010.05.017; Duan JJ, 2018, P NATL ACAD SCI USA, V115, pEB201, DOI 10.1073/pnas.1810719115; Gohon Y, 2006, LANGMUIR, V22, P1281, DOI 10.1021/la052243g; GRIFFITH IP, 1972, BIOCHEM J, V126, P553, DOI 10.1042/bj1260553; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F. P., 1995, CYTOCHROME P, P473; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hulse RE, 2018, ELIFE, V7, DOI 10.7554/eLife.36931; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Laursen T, 2013, BIOTECHNOL APPL BIOC, V60, P119, DOI 10.1002/bab.1092; LU AYH, 1969, J BIOL CHEM, V244, P3714; Mahajan M, 2019, CHEM COMMUN, V55, P5777, DOI 10.1039/c9cc01630a; Martinez SE, 2019, DRUG METAB DISPOS, V47, P1314, DOI 10.1124/dmd.119.088070; Mukherjee G, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01568-y; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1962, J BIOL CHEM, V237, P1375; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; Pearl NM, 2016, BIOCHEMISTRY-US, V55, P6558, DOI 10.1021/acs.biochem.6b00996; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Prade E, 2018, ANGEW CHEM INT EDIT, V57, P8458, DOI 10.1002/anie.201802210; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sellner M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031023; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Su M, 2020, J BIOL CHEM, V295, P1637, DOI 10.1074/jbc.RA119.011305; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2018, J BIOL CHEM, V293, P7727, DOI 10.1074/jbc.RA117.000600; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u; Zhang M, 2016, ANGEW CHEM INT EDIT, V55, P4497, DOI 10.1002/anie.201600073	36	1	1	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100645	10.1016/j.jbc.2021.100645	http://dx.doi.org/10.1016/j.jbc.2021.100645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839156	gold, Green Published			2022-12-26	WOS:000672866400616
J	Rollen, K; Granzin, J; Remeeva, A; Davari, MD; Gensch, T; Nazarenko, VV; Kovalev, K; Bogorodskiy, A; Borshchevskiy, V; Hemmer, S; Schwaneberg, U; Gordeliy, V; Jaeger, KE; Batra-Safferling, R; Gushchin, I; Krauss, U				Roellen, Katrin; Granzin, Joachim; Remeeva, Alina; Davari, Mehdi D.; Gensch, Thomas; Nazarenko, Vera V.; Kovalev, Kirill; Bogorodskiy, Andrey; Borshchevskiy, Valentin; Hemmer, Stefanie; Schwaneberg, Ulrich; Gordeliy, Valentin; Jaeger, Karl-Erich; Batra-Safferling, Renu; Gushchin, Ivan; Krauss, Ulrich			The molecular basis of spectral tuning in blue- and red-shifted flavin-binding fluorescent proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPORTER PROTEINS; ILOV; PHOTOPHYSICS; SIMULATION; GENERATION; LIBRARIES; TOOLS; MODEL; FBFP	Photoactive biological systems modify the optical properties of their chromophores, known as spectral tuning. Determining the molecular origin of spectral tuning is instrumental for understanding the function and developing applications of these biomolecules. Spectral tuning in flavin-binding fluorescent proteins (FbFPs), an emerging class of fluorescent reporters, is limited by their dependency on protein-bound flavins, whose structure and hence electronic properties cannot be altered by mutation. A blue-shifted variant of the plant-derived improved light, oxygen, voltage FbFP has been created by introducing a lysine within the flavin-binding pocket, but the molecular basis of this shift remains unconfirmed. We here structurally characterize the blue-shifted improved light, oxygen, voltage variant and construct a new blue-shifted CagFbFP protein by introducing an analogous mutation. X-ray structures of both proteins reveal displacement of the lysine away from the chromophore and opening up of the structure as instrumental for the blue shift. Site saturation mutagenesis and high-throughput screening yielded a red-shifted variant, and structural analysis revealed that the lysine side chain of the blue-shifted variant is stabilized close to the flavin by a secondary mutation, accounting for the red shift. Thus, a single additional mutation in a blue-shifted variant is sufficient to generate a red-shifted FbFP. Using spectroscopy, X-ray crystallography, and quantum mechanics molecular mechanics calculations, we provide a firm structural and functional understanding of spectral tuning in FbFPs. We also show that the identified blue- and red-shifted variants allow for two-color microscopy based on spectral separation. In summary, the generated blue- and red-shifted variants represent promising new tools for application in life sciences.	[Roellen, Katrin; Hemmer, Stefanie; Jaeger, Karl-Erich; Krauss, Ulrich] Heinrich Heine Univ Dusseldorf, Inst Mol Enzymtechnol, Dusseldorf, Germany; [Granzin, Joachim; Kovalev, Kirill; Borshchevskiy, Valentin; Gordeliy, Valentin; Batra-Safferling, Renu] Forschungszentrum Julich, IBI 7 Struct Biochem, Julich, Germany; [Granzin, Joachim; Kovalev, Kirill; Borshchevskiy, Valentin; Gordeliy, Valentin; Batra-Safferling, Renu] Forschungszentrum Julich, JuStruct Julich Ctr Struct Biol, Julich, Germany; [Remeeva, Alina; Nazarenko, Vera V.; Kovalev, Kirill; Bogorodskiy, Andrey; Borshchevskiy, Valentin; Gordeliy, Valentin; Gushchin, Ivan] Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia; [Davari, Mehdi D.; Schwaneberg, Ulrich] Rhein Westfal TH Aachen, Inst Biotechnol, Aachen, Germany; [Gensch, Thomas] Forschungszentrum Julich, IBI 1 Mol & Cellular Physiol, Julich, Germany; [Kovalev, Kirill; Gordeliy, Valentin] Univ Grenoble Alpes, CNRS, Commissariat Energie Atom & Energies Alternat, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Kovalev, Kirill] Rhein Westfal TH Aachen, Inst Crystallog, Aachen, Germany; [Hemmer, Stefanie; Jaeger, Karl-Erich; Krauss, Ulrich] Forschungszentrum Julich, IBG 1 Biotechnol, Julich, Germany; [Schwaneberg, Ulrich] DWI Leibniz Inst Interact Mat, Aachen, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Moscow Institute of Physics & Technology; RWTH Aachen University; Helmholtz Association; Research Center Julich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); RWTH Aachen University; Helmholtz Association; Research Center Julich; DWI Leibniz Institute for Interactive Materials	Krauss, U (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Mol Enzymtechnol, Dusseldorf, Germany.; Gushchin, I (corresponding author), Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia.; Krauss, U (corresponding author), Forschungszentrum Julich, IBG 1 Biotechnol, Julich, Germany.	ivan.gushchin@phystech.edu; u.krauss@fz-juelich.de	Bogorodskiy, Andrey/R-7690-2016; Remeeva, Alina/F-2772-2018; Borshchevskiy, Valentin I./F-2287-2014; Batra-Safferling, Renu/G-2918-2013; Schwaneberg, Ulrich/E-7234-2014; Nazarenko, Vera/F-5649-2017	Bogorodskiy, Andrey/0000-0002-7589-7823; Borshchevskiy, Valentin I./0000-0003-4398-9712; Batra-Safferling, Renu/0000-0002-8597-4335; Schwaneberg, Ulrich/0000-0003-4026-701X; Kovalev, Kirill/0000-0002-2229-181X; Remeeva, Alina/0000-0003-3977-3679; Hemmer, Stefanie/0000-0001-6539-0562; Nazarenko, Vera/0000-0001-8966-9146; Gensch, Thomas/0000-0002-3903-4705	Deutsche Forschungsgemeinschaft (DFG) Training Group 1166 "BioNoCo" (Biocatalysis in Non-conventional Media); Julich Aachen Research Alliance for High Performance Computing (JARA-HPC) from RWTH Aachen University [JARA0065]	Deutsche Forschungsgemeinschaft (DFG) Training Group 1166 "BioNoCo" (Biocatalysis in Non-conventional Media)(German Research Foundation (DFG)); Julich Aachen Research Alliance for High Performance Computing (JARA-HPC) from RWTH Aachen University	M. D. D. thanks Deutsche Forschungsgemeinschaft (DFG) Training Group 1166 "BioNoCo" (Biocatalysis in Non-conventional Media) for the financial support and computing resources granted by the Julich Aachen Research Alliance for High Performance Computing (JARA-HPC) from RWTH Aachen University under project JARA0065.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahlrichs R., 1989, TURBOMOLE V6 2 2010; Autour A, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8040128; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Becker W, 2005, ADV TIME CORRELATED; Bourenkov GP, 2010, ACTA CRYSTALLOGR D, V66, P409, DOI 10.1107/S0907444909054961; Bunzel HA, 2018, CURR OPIN STRUC BIOL, V48, P149, DOI 10.1016/j.sbi.2017.12.010; Case D., 2015, AMBER, V14; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Choi CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018499; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Copp JN, 2014, METHODS MOL BIOL, V1179, P3, DOI 10.1007/978-1-4939-1053-3_1; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Davari MD, 2016, J PHYS CHEM B, V120, P3344, DOI 10.1021/acs.jpcb.6b01512; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; de Vries AH, 1999, J PHYS CHEM B, V103, P6133, DOI 10.1021/jp9913012; Dennig A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026222; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endres S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33291-4; Ferrer FJA, 2013, J CHEM THEORY COMPUT, V9, P2072, DOI 10.1021/ct301107m; Geiger A, 2012, BIOPHYS J, V102, P2401, DOI 10.1016/j.bpj.2012.03.065; Hilgers F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184608; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastner J, 2009, J PHYS CHEM A, V113, P11856, DOI 10.1021/jp9028968; Khrenova MG, 2017, J PHYS CHEM B, V121, P10018, DOI 10.1021/acs.jpcb.7b07533; Khrenova MG, 2015, J PHYS CHEM B, V119, P5176, DOI 10.1021/acs.jpcb.5b01299; Klaumunzer B, 2010, J PHYS CHEM B, V114, P10826, DOI 10.1021/jp100642c; Kopka B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13420-1; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li DY, 2020, METHOD ENZYMOL, V643, P225, DOI 10.1016/bs.mie.2020.04.055; Lin JY, 2013, NEURON, V79, P241, DOI 10.1016/j.neuron.2013.05.022; Lobo LA, 2011, FEMS MICROBIOL LETT, V317, P67, DOI 10.1111/j.1574-6968.2011.02212.x; Losi A, 2018, CHEM REV, V118, P10659, DOI 10.1021/acs.chemrev.8b00163; Mathes T, 2009, J MOL BIOL, V385, P1511, DOI 10.1016/j.jmb.2008.11.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nazarenko VV, 2019, PHOTOCH PHOTOBIO SCI, V18, P1793, DOI 10.1039/c9pp00067d; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Potzkei J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-28; Ravikumar Y, 2017, ANAL BIOCHEM, V525, P38, DOI 10.1016/j.ab.2017.02.012; Remeeva A, 2021, PROTEINS, V89, P1005, DOI 10.1002/prot.26078; Rupprecht C, 2017, J BIOTECHNOL, V258, P25, DOI 10.1016/j.jbiotec.2017.05.006; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Shin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097817; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Smith W, 2006, MOL SIMULAT, V32, P935, DOI 10.1080/08927020600939830; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tickle I.J., 2018, STARANISO; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Walter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043921; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wingen M, 2014, PHOTOCH PHOTOBIO SCI, V13, P875, DOI 10.1039/c3pp50414j; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang LC, 2013, RES MICROBIOL, V164, P710, DOI 10.1016/j.resmic.2013.05.004	64	5	5	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100662	10.1016/j.jbc.2021.100662	http://dx.doi.org/10.1016/j.jbc.2021.100662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862085	Green Published, gold			2022-12-26	WOS:000672866400633
J	Soares, AC; Ferreira, A; Marien, J; Delay, C; Lee, E; Trojanowski, JQ; Moechars, D; Annaert, W; De Muynck, L				Soares, Alberto Carpinteiro; Ferreira, Andreia; Marieen, Jonas; Delay, Charlotte; Lee, Edward; Trojanowski, John Q.; Moechars, Dieder; Annaert, Wim; De Muynck, Louis			PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; PTDINS(4,5)P-2 SYNTHESIS; ALZHEIMER-DISEASE; ACTIN DYNAMICS; PROTEIN-KINASE; SYNTHETIC TAU; PATHOLOGY; NEURONS; IDENTIFICATION; TELENCEPHALIN	Tauopathies, such as Alzheimer's disease (AD), are neuro-degenerative disorders characterized by the deposition of hyperphosphorylated tau aggregates. Proteopathic tau seeds spread through the brain in a temporospatial pattern, indicative of transsynaptic propagation. It is hypothesized that reducing the uptake of tau seeds and subsequent induction of tau aggregation could be a potential approach for abrogating disease progression in AD. Here, we studied to what extent different endosomal routes play a role in the neuronal uptake of preformed tau seeds. Using pharmacological and genetic tools, we identified dynamin-1, actin, and Rac1 as key players. Furthermore, inhibition of PIKfyve, a protein downstream of Rac1, reduced both the trafficking of tau seeds into lysosomes and the induction of tau aggregation. Our work shows that tau aggregates are internalized by a specific endocytic mechanism and that their fate once internalized can be pharmacologically modulated to reduce tau seeding in neurons.	[Soares, Alberto Carpinteiro; Ferreira, Andreia; Marieen, Jonas; Delay, Charlotte; Moechars, Dieder; De Muynck, Louis] Janssen Res & Dev, Div Janssen Pharmaceut NV, Neurosci Dept, Beerse, Belgium; [Soares, Alberto Carpinteiro; Annaert, Wim] VIB Ctr Brain & Dis Res, Leuven, Belgium; [Soares, Alberto Carpinteiro; Annaert, Wim] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Ferreira, Andreia] VIB Ctr Med Biotechnol, Ghent, Belgium; [Ferreira, Andreia] Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium; [Lee, Edward; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA USA; [Lee, Edward; Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA	Johnson & Johnson; Janssen Pharmaceuticals; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	De Muynck, L (corresponding author), Janssen Res & Dev, Div Janssen Pharmaceut NV, Neurosci Dept, Beerse, Belgium.; Annaert, W (corresponding author), VIB Ctr Brain & Dis Res, Leuven, Belgium.; Annaert, W (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium.	wim.annaert@kuleuven.vib.be; ldemuync@its.jnj.com		Ferreira, Andreia/0000-0002-6049-2399; De Muynck, Louis/0000-0003-4432-945X	VLAIO Baekeland mandate [HBC.2016.0219]; VIB, KU Leuven [C16/15/073]; FWO [S006617N, G078117N, G056017N, G0C422N, G0C3620N]; FWO-Hercules Foundation [AKUL/11/30, 13/39]; SAO-FRA [2020030]	VLAIO Baekeland mandate; VIB, KU Leuven; FWO(FWO); FWO-Hercules Foundation; SAO-FRA	A. C. S is the recipient of a VLAIO Baekeland mandate (HBC.2016.0219). W. A. is financially supported by VIB, KU Leuven (C16/15/073), FWO (S006617N, G078117N, G056017N, G0C422N, and G0C3620N), the FWO-Hercules Foundation (AKUL/11/30, 13/39), and SAO-FRA (S#2020030).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Balklava Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130485; Bissig C, 2017, TRAFFIC, V18, P747, DOI 10.1111/tra.12525; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Chen JJ, 2019, J BIOL CHEM, V294, P18952, DOI 10.1074/jbc.RA119.009432; Clavaguera F, 2015, NEUROPATH APPL NEURO, V41, P47, DOI 10.1111/nan.12197; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Currinn H, 2016, CELL MOL LIFE SCI, V73, P393, DOI 10.1007/s00018-015-1993-0; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Demaegd K, 2018, CHEMBIOCHEM, V19, P2424, DOI 10.1002/cbic.201800288; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Evans LD, 2018, CELL REP, V22, P3612, DOI 10.1016/j.celrep.2018.03.021; Falcon B, 2018, J BIOL CHEM, V293, P2438, DOI 10.1074/jbc.M117.809293; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gayle S, 2017, BLOOD, V129, P1768, DOI 10.1182/blood-2016-09-736892; Gibbons GS, 2017, J NEUROSCI, V37, P11485, DOI 10.1523/JNEUROSCI.2393-17.2017; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Goggs R, 2015, BIOCHEM J, V466, P431, DOI 10.1042/BJ20141404; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Karch Celeste M, 2015, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Li JG, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0350-4; Liu AZ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600925; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; McNally KE, 2018, TRENDS CELL BIOL, V28, P807, DOI 10.1016/j.tcb.2018.06.005; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Peric A, 2015, ACTA NEUROPATHOL, V129, P363, DOI 10.1007/s00401-014-1379-7; Polanco JC, 2021, ACTA NEUROPATHOL, V141, P235, DOI 10.1007/s00401-020-02254-3; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Senju Y, 2019, CURR OPIN CELL BIOL, V56, P7, DOI 10.1016/j.ceb.2018.08.003; Sharma G, 2019, AUTOPHAGY, V15, P1694, DOI 10.1080/15548627.2019.1586257; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Staats K.A., 2019, BIORXIV, DOI DOI 10.1101/685800; Stopschinski BE, 2020, J BIOL CHEM, V295, P2974, DOI 10.1074/jbc.RA119.010353; Uemura N, 2020, TRENDS MOL MED, V26, P936, DOI 10.1016/j.molmed.2020.03.012; Van Acker ZP, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0323-7; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Young JE, 2018, STEM CELL REP, V10, P1046, DOI 10.1016/j.stemcr.2018.01.031; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	77	8	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100636	10.1016/j.jbc.2021.100636	http://dx.doi.org/10.1016/j.jbc.2021.100636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33831417	Green Published, gold			2022-12-26	WOS:000672866400607
J	Nash, Y; Ganoth, A; Borenstein-Auerbach, N; Levy-Barazany, H; Goldsmith, G; Kopelevich, A; Pozyuchenko, K; Sakhneny, L; Lazdon, E; Blanga-Kanfi, S; Alhadeff, R; Benromano, T; Landsman, L; Tsfadia, Y; Frenkel, D				Nash, Yuval; Ganoth, Assaf; Borenstein-Auerbach, Nofit; Levy-Barazany, Hilit; Goldsmith, Guy; Kopelevich, Adi; Pozyuchenko, Katia; Sakhneny, Lina; Lazdon, Ekaterina; Blanga-Kanfi, Shani; Alhadeff, Raphael; Benromano, Tali; Landsman, Limor; Tsfadia, Yossi; Frenkel, Dan			From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment	FASEB JOURNAL			English	Article							WEB SERVER; T-CELLS; PROTEIN; PEPTIDE; DYNAMICS; BINDING; GENE; PROLIFERATION; RECOGNITION; PREVALENCE	Inhibition of insulin-degrading enzyme (IDE) is a possible target for treating diabetes. However, it has not yet evolved into a medical intervention, mainly because most developed inhibitors target the zinc in IDE's catalytic site, potentially causing toxicity to other essential metalloproteases. Since IDE is a cellular receptor for the varicella-zoster virus (VZV), we constructed a VZV-based inhibitor. We computationally characterized its interaction site with IDE showing that the peptide specifically binds inside IDE's central cavity, however, not in close proximity to the zinc ion. We confirmed the peptide's effective inhibition on IDE activity in vitro and showed its efficacy in ameliorating insulin-related defects in types 1 and 2 diabetes mouse models. In addition, we suggest that inhibition of IDE may ameliorate the pro-inflammatory profile of CD4(+) T-cells toward insulin. Together, we propose a potential role of a designed VZV-derived peptide to serve as a selectively-targeted and as an efficient diabetes therapy.	[Nash, Yuval; Borenstein-Auerbach, Nofit; Levy-Barazany, Hilit; Goldsmith, Guy; Kopelevich, Adi; Pozyuchenko, Katia; Lazdon, Ekaterina; Blanga-Kanfi, Shani; Benromano, Tali; Frenkel, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Neurobiol, Biochem & Biophys Sch,Dept Neurobiol, Tel Aviv, Israel; [Nash, Yuval; Frenkel, Dan] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Ganoth, Assaf] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Ganoth, Assaf] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel; [Sakhneny, Lina; Landsman, Limor] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel; [Alhadeff, Raphael] Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA; [Tsfadia, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Neurobiol Biochem & Biophys, Dept Biochem & Mol Biol, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Reichman University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University of Southern California; Tel Aviv University	Frenkel, D (corresponding author), George S Wise Fac Life Sci, Dept Neurobiol, Sherman Bldg,Room 424, IL-69978 Tel Aviv, Israel.	dfrenkel@tauex.tau.ac.il		Landsman, Limor/0000-0002-8974-1344	Colton Family Next Generation Technological institute [590046]; SAIA Fund Tel Aviv University [590117]	Colton Family Next Generation Technological institute; SAIA Fund Tel Aviv University	The Colton Family Next Generation Technological institute, Grant/Award Number: 590046; SAIA Fund Tel Aviv University, Grant/Award Number: 590117	Abdul-Hay SO, 2013, J MED CHEM, V56, P2246, DOI 10.1021/jm301280p; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Abraham M., 2014, GROMACS USER MANUAL, V5, P1; AFFHOLTER JA, 1990, BIOCHEMISTRY-US, V29, P7727, DOI 10.1021/bi00485a022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; AUTHIER F, 1994, J BIOL CHEM, V269, P3010; BACKER JM, 1990, J BIOL CHEM, V265, P14828; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bora RP, 2010, BIOCHEMISTRY-US, V49, P3947, DOI 10.1021/bi1002103; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chermak E, 2015, BIOINFORMATICS, V31, P1481, DOI 10.1093/bioinformatics/btu837; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Culina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088365; da Cruz CHB, 2014, J CHEM INF MODEL, V54, P1380, DOI 10.1021/ci400695m; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies M, 2004, INT J OBESITY, V28, pS14, DOI 10.1038/sj.ijo.0802745; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Deprez-Poulain R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9250; DIMITRIADIS GD, 1983, DIABETES CARE, V6, P374, DOI 10.2337/diacare.6.4.374; Dirice E, 2019, NAT METAB, V1, P509, DOI 10.1038/s42255-019-0061-8; DORER FE, 1974, CIRC RES, V34, P824, DOI 10.1161/01.RES.34.6.824; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Durham TB, 2015, J BIOL CHEM, V290, P20044, DOI 10.1074/jbc.M115.638205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fernandez-Diaz CM, 2019, AM J PHYSIOL-ENDOC M, V317, pE805, DOI 10.1152/ajpendo.00040.2019; Golan Y, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006503; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hess B, 1998, J COMPUT CHEM, P18; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; Jimenez-Garcia B, 2013, BIOINFORMATICS, V29, P1698, DOI 10.1093/bioinformatics/btt262; KAHN CR, 1986, NEW ENGL J MED, V315, P252, DOI 10.1056/NEJM198607243150410; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; LEE FS, 1993, J COMPUT CHEM, V14, P161, DOI 10.1002/jcc.540140205; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Levy-Barazany H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-120; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Li QX, 2007, J VIROL, V81, P8525, DOI 10.1128/JVI.00286-07; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Malhotra S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0572-6; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Mehta SN, 2010, ENDOCRIN METAB CLIN, V39, P573, DOI 10.1016/j.ecl.2010.05.002; Miners JS, 2008, J NEUROSCI METH, V169, P177, DOI 10.1016/j.jneumeth.2007.12.003; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SEMPLE JW, 1992, INT IMMUNOL, V4, P1161, DOI 10.1093/intimm/4.10.1161; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Shuto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136840; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sofer Y, 2021, ENDOCRINE, V71, P357, DOI 10.1007/s12020-020-02548-2; Son SM, 2016, AUTOPHAGY, V12, P784, DOI 10.1080/15548627.2016.1159375; Song ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133114; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tang WJ, 2016, TRENDS ENDOCRIN MET, V27, P24, DOI 10.1016/j.tem.2015.11.003; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tundo GR, 2016, FEBS J, V283, P3755, DOI 10.1111/febs.13841; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Vangone A, 2015, ELIFE, V4, DOI 10.7554/eLife.07454; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Yang D, 2018, J MED CHEM, V61, P8174, DOI 10.1021/acs.jmedchem.8b00418; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yang MY, 2017, CHEM REV, V117, P10377, DOI 10.1021/acs.chemrev.7b00100; Zeng C, 2012, J MOL MED, V90, P175, DOI 10.1007/s00109-011-0816-5; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZN, 2018, ELIFE, V7, DOI 10.7554/eLife.33572; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001	93	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21374	10.1096/fj.201901945R	http://dx.doi.org/10.1096/fj.201901945R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835493				2022-12-26	WOS:000645260100095
J	Bernas, A; Breuer, LEM; Aldenkamp, AP; Zinger, S				Bernas, Antoine; Breuer, Lisanne E. M.; Aldenkamp, Albert P.; Zinger, Svitlana			Emulative, coherent, and causal dynamics between large-scale brain networks are neurobiomarkers of Accelerated Cognitive Ageing in epilepsy	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; WAVELET COHERENCE; NEURAL-NETWORK; FMRI; CLASSIFICATION; SCHIZOPHRENIA; SYSTEMS; MRI; ARCHITECTURE	Accelerated cognitive ageing (ACA) is an ageing co-morbidity in epilepsy that is diagnosed through the observation of an evident IQ decline of more than 1 standard deviation (15 points) around the age of 50 years old. To understand the mechanism of action of this pathology, we assessed brain dynamics with the use of resting-state fMRI data. In this paper, we present novel and promising methods to extract brain dynamics between large-scale resting-state networks: the emulative power, wavelet coherence, and granger causality between the networks were extracted in two resting-state sessions of 24 participants (10 ACA, 14 controls). We also calculated the widely used static functional connectivity to compare the methods. To find the best biomarkers of ACA, and have a better understanding of this epilepsy co-morbidity we compared the aforementioned between-network neurodynamics using classifiers and known machine learning algorithms; and assessed their performance. Results show that features based on the evolutionary game theory on networks approach, the emulative powers, are the best descriptors of the co-morbidity, using dynamics associated with the default mode and dorsal attention networks. With these dynamic markers, linear discriminant analysis could identify ACA patients at 82.9% accuracy. Using wavelet coherence features with decision-tree algorithm, and static functional connectivity features with support vector machine, ACA could be identified at 77.1% and 77.9% accuracy respectively. Granger causality fell short of being a relevant biomarker with best classifiers having an average accuracy of 67.9%. Combining the features based on the game theory, wavelet coherence, Granger-causality, and static functional connectivity- approaches increased the classification performance up to 90.0% average accuracy using support vector machine with a peak accuracy of 95.8%. The dynamics of the networks that lead to the best classifier performances are known to be challenged in elderly. Since our groups were age-matched, the results are in line with the idea of ACA patients having an accelerated cognitive decline. This classification pipeline is promising and could help to diagnose other neuropsychiatric disorders, and contribute to the field of psychoradiology.	[Bernas, Antoine; Aldenkamp, Albert P.; Zinger, Svitlana] Eindhoven Univ Technol, Dept Elect Engn, Eindhoven, Netherlands; [Bernas, Antoine; Aldenkamp, Albert P.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Cognit Neuropsychiat & Clin Neurosci, Maastricht, Netherlands; [Breuer, Lisanne E. M.; Aldenkamp, Albert P.] Epilepsy Ctr Kempenhaeghe, Dept Res & Dev, Heeze, Netherlands	Eindhoven University of Technology; Maastricht University	Bernas, A (corresponding author), Eindhoven Univ Technol, Dept Elect Engn, Eindhoven, Netherlands.; Bernas, A (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Cognit Neuropsychiat & Clin Neurosci, Maastricht, Netherlands.	antoine.bernas1@gmail.com						Alam S, 2017, INT J IMAG SYST TECH, V27, P133, DOI 10.1002/ima.22217; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Bastin C, 2012, NEUROIMAGE, V63, P713, DOI 10.1016/j.neuroimage.2012.06.074; Beason-Held LL, 2009, BRAIN IMAGING BEHAV, V3, P123, DOI 10.1007/s11682-008-9054-z; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beckmann CF, 2009, HUM BRAIN MAPP C, P181; Bernas A, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.878; Bernas A, 2018, COMPUT METH PROG BIO, V154, P143, DOI 10.1016/j.cmpb.2017.11.017; Besseling RMH, 2013, NEUROIMAGE-CLIN, V2, P239, DOI 10.1016/j.nicl.2013.01.004; Braakman HMH, 2013, EPILEPSIA, V54, P446, DOI 10.1111/epi.12044; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Breuer LEM, 2016, NEUROSCI BIOBEHAV R, V64, P1, DOI 10.1016/j.neubiorev.2016.02.004; Breuer LEM, 2019, ARCH CLIN NEUROPSYCH, V34, P301, DOI 10.1093/arclin/acy042; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Chand GB, 2017, BRAIN CONNECT, V7, P401, DOI 10.1089/brain.2017.0509; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Choe AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140134; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Dipasquale O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173289; Du YH, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00525; Ezaki T, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0774-y; Farras-Permanyer L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01095; Ferreira LK, 2016, CEREB CORTEX, V26, P3851, DOI 10.1093/cercor/bhv190; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Helmstaedter C, 2014, EPILEPSY BEHAV, V31, P43, DOI 10.1016/j.yebeh.2013.11.010; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Hermann B, 2008, EPILEPSIA, V49, P731, DOI 10.1111/j.1528-1167.2007.01435.x; Hindriks R, 2016, NEUROIMAGE, V127, P242, DOI 10.1016/j.neuroimage.2015.11.055; Holdnack JA., 2013, PREDICTING PREMORBID, DOI [10.1080/09297049.2012.705822, DOI 10.1080/09297049.2012.705822]; Hull JV., 2017, FRONT PSYCHIATRY, P7, DOI [10.3389/fpsyt.2017.00007, DOI 10.3389/FPSYT.2017.00007]; Kaiser RH, 2016, NEUROPSYCHOPHARMACOL, V41, P1822, DOI 10.1038/npp.2015.352; Kim J, 2016, NEUROIMAGE, V124, P127, DOI 10.1016/j.neuroimage.2015.05.018; Ktena SI, 2018, NEUROIMAGE, V169, P431, DOI 10.1016/j.neuroimage.2017.12.052; Kundu P, 2017, NEUROIMAGE, V154, P59, DOI 10.1016/j.neuroimage.2017.03.033; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; La Corte V, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00204; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Li CH, 2019, J AFFECT DISORDERS, V246, P338, DOI 10.1016/j.jad.2018.12.079; Li HJ, 2015, NEUROSCI BIOBEHAV R, V57, P156, DOI 10.1016/j.neubiorev.2015.08.013; Liegeois R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10317-7; Liu ZY, 2012, IEEE ENG MED BIO, P5454, DOI 10.1109/EMBC.2012.6347228; Lombardo MV, 2016, NEUROIMAGE, V142, P55, DOI 10.1016/j.neuroimage.2016.07.022; Lui S, 2016, RADIOLOGY, V281, P357, DOI 10.1148/radiol.2016152149; Luo N, 2020, HUM BRAIN MAPP, V41, P1725, DOI 10.1002/hbm.24905; Madeo D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15865-w; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meszlenyi RJ, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00061; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Nieuwenhuis M, 2012, NEUROIMAGE, V61, P606, DOI 10.1016/j.neuroimage.2012.03.079; Nomi JS, 2015, NEUROIMAGE-CLIN, V7, P732, DOI 10.1016/j.nicl.2015.02.024; Onoda K., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), P119, DOI 10.1109/ICCME.2012.6275599; Onoda K, 2012, J COGNITIVE NEUROSCI, V24, P2186, DOI 10.1162/jocn_a_00269; Park BY, 2016, IEEE ENG MED BIO, P1127, DOI 10.1109/EMBC.2016.7590902; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rashid B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00897; Rashid B, 2016, NEUROIMAGE, V134, P645, DOI 10.1016/j.neuroimage.2016.04.051; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rolls ET, 2018, BIOL PSYCHIAT-COGN N, V3, P187, DOI 10.1016/j.bpsc.2017.10.004; Sala-Llonch R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00663; Sen A, 2018, BRAIN, V141, P1592, DOI 10.1093/brain/awy022; Shakil S, 2016, NEUROIMAGE, V133, P111, DOI 10.1016/j.neuroimage.2016.02.074; Siman-Tov T, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00330; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Suk HI, 2016, NEUROIMAGE, V129, P292, DOI 10.1016/j.neuroimage.2016.01.005; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tsvetanov KA, 2016, J NEUROSCI, V36, P3115, DOI 10.1523/JNEUROSCI.2733-15.2016; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Wechsler D., 2008, WAIS 4 WECHSLER ADUL, DOI [10.1016/S0043-1354(02)00019-2, DOI 10.1016/S0043-1354(02)00019-2]; Xiong T, 2005, IEEE IJCNN, P1455; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	82	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250222	10.1371/journal.pone.0250222	http://dx.doi.org/10.1371/journal.pone.0250222			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861794	Green Published, gold			2022-12-26	WOS:000641475400041
J	Denning, M; Goh, ET; Tan, B; Kanneganti, A; Almonte, M; Scott, A; Martin, G; Clarke, J; Sounderajah, V; Markar, S; Przybylowicz, J; Chan, YH; Sia, CH; Chua, YX; Sim, K; Lim, L; Tan, LF; Tan, M; Sharma, V; Ooi, S; Beatty, JW; Flott, K; Mason, S; Chidambaram, S; Yalamanchili, S; Zbikowska, G; Fedorowski, J; Dykowska, G; Wells, M; Purkayastha, S; Kinross, J				Denning, Max; Goh, Ee Teng; Tan, Benjamin; Kanneganti, Abhiram; Almonte, Melanie; Scott, Alasdair; Martin, Guy; Clarke, Jonathan; Sounderajah, Viknesh; Markar, Sheraz; Przybylowicz, Jan; Chan, Yiong Huak; Sia, Ching-Hui; Chua, Ying Xian; Sim, Kang; Lim, Lucas; Tan, Lifeng; Tan, Melanie; Sharma, Vijay; Ooi, Shirley; Beatty, Jasmine Winter; Flott, Kelsey; Mason, Sam; Chidambaram, Swathikan; Yalamanchili, Seema; Zbikowska, Gabriela; Fedorowski, Jaroslaw; Dykowska, Grazyna; Wells, Mary; Purkayastha, Sanjay; Kinross, James			Determinants of burnout and other aspects of psychological well-being in healthcare workers during the Covid-19 pandemic: A multinational cross-sectional study	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION SCALE; SAFETY CULTURE; VALIDITY; SARS; VALIDATION; STRESS; IMPACT; PREVALENCE; SINGAPORE	The Covid-19 pandemic has placed unprecedented pressure on healthcare systems and workers around the world. Such pressures may impact on working conditions, psychological wellbeing and perception of safety. In spite of this, no study has assessed the relationship between safety attitudes and psychological outcomes. Moreover, only limited studies have examined the relationship between personal characteristics and psychological outcomes during Covid-19. From 22nd March 2020 to 18th June 2020, healthcare workers from the United Kingdom, Poland, and Singapore were invited to participate using a self-administered questionnaire comprising the Safety Attitudes Questionnaire (SAQ), Oldenburg Burnout Inventory (OLBI) and Hospital Anxiety and Depression Scale (HADS) to evaluate safety culture, burnout and anxiety/depression. Multivariate logistic regression was used to determine predictors of burnout, anxiety and depression. Of 3,537 healthcare workers who participated in the study, 2,364 (67%) screened positive for burnout, 701 (20%) for anxiety, and 389 (11%) for depression. Significant predictors of burnout included patient-facing roles: doctor (OR 2.10; 95% CI 1.49-2.95), nurse (OR 1.38; 95% CI 1.04-1.84), and 'other clinical' (OR 2.02; 95% CI 1.45-2.82); being redeployed (OR 1.27; 95% CI 1.02-1.58), bottom quartile SAQ score (OR 2.43; 95% CI 1.98-2.99), anxiety (OR 4.87; 95% CI 3.92-6.06) and depression (OR 4.06; 95% CI 3.04-5.42). Significant factors inversely correlated with burnout included being tested for SARS-CoV-2 (OR 0.64; 95% CI 0.51-0.82) and top quartile SAQ score (OR 0.30; 95% CI 0.22-0.40). Significant factors associated with anxiety and depression, included burnout, gender, safety attitudes and job role. Our findings demonstrate a significant burden of burnout, anxiety, and depression amongst healthcare workers. A strong association was seen between SARS-CoV-2 testing, safety attitudes, gender, job role, redeployment and psychological state. These findings highlight the importance of targeted support services for at risk groups and proactive SARS-CoV-2 testing of healthcare workers.	[Denning, Max; Goh, Ee Teng; Almonte, Melanie; Scott, Alasdair; Martin, Guy; Clarke, Jonathan; Sounderajah, Viknesh; Markar, Sheraz; Przybylowicz, Jan; Beatty, Jasmine Winter; Flott, Kelsey; Mason, Sam; Chidambaram, Swathikan; Yalamanchili, Seema; Zbikowska, Gabriela; Wells, Mary; Purkayastha, Sanjay; Kinross, James] Imperial Coll London, Dept Surg & Canc, London, England; [Tan, Benjamin; Sia, Ching-Hui; Sharma, Vijay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Kanneganti, Abhiram] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore, Singapore; [Chan, Yiong Huak] Natl Univ Singapore, Yong Loo Lin Sch Med, Biostat Unit, Singapore, Singapore; [Sia, Ching-Hui] Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore; [Chua, Ying Xian] Natl Univ Hlth Syst, Natl Univ Polyclin, Pioneer Polyclin, Singapore, Singapore; [Sim, Kang] Inst Mental Hlth, Singapore, Singapore; [Sim, Kang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Lim, Lucas] Inst Mental Hlth, Dept Forens Psychiat, Singapore, Singapore; [Tan, Lifeng] Alexandra Hosp, Div Hlth Ageing, Singapore, Singapore; [Tan, Melanie] Ng Teng Fong Gen Hosp, Dept Geriatr Med, Singapore, Singapore; [Ooi, Shirley] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore, Singapore; [Ooi, Shirley] Natl Univ Singapore Hosp, Emergency Med Dept, Singapore, Singapore; [Fedorowski, Jaroslaw] Polish Hosp Federat, Warsaw, Poland; [Dykowska, Grazyna] Med Univ Warsaw, Dept Econ Hlth & Med Law, Warsaw, Poland	Imperial College London; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Medical University of Warsaw	Purkayastha, S (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.	s.purkayastha@imperial.ac.uk	Abhiram, Kanneganti/AAK-7912-2021; Dykowska, Grazyna/AAQ-6019-2021; Dykowska, Grazyna/T-4000-2018	Abhiram, Kanneganti/0000-0002-5559-4534; Sounderajah, Viknesh/0000-0002-4595-8402; Wells, Mary/0000-0001-5789-2773; Tan, Benjamin YQ/0000-0003-1824-9077; Denning, Max/0000-0001-6215-6885; Dykowska, Grazyna/0000-0001-5644-627X; Scott, Alasdair/0000-0003-4621-9756; Clarke, Jonathan/0000-0003-1495-7746; Chua, Ying Xian/0000-0003-4090-084X; Martin, Guy/0000-0002-5759-962X; Almonte, Melanie/0000-0003-2448-4866; Kinross, James/0000-0002-0427-7643; Sim, Kang/0000-0003-3209-9626	Johnson and Johnson	Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA)	JK has received an educational grant from Johnson and Johnson.	Alderwick H, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1937; Asher MC, 2006, INT SOC SECUR REV, V59, P75, DOI 10.1111/j.1468-246X.2005.00234.x; Bhugra D, 2019, INT REV PSYCHIATR, V31, P563, DOI 10.1080/09540261.2019.1648621; Britnell, 2019, HUMAN SOLVING GLOBAL; Buchan J, 2019, FALLING SHORT NHS WO; Caci H, 2003, PSYCHIAT RES, V118, P89, DOI 10.1016/S0165-1781(03)00044-1; Carayon P, 2014, APPL ERGON, V45, P14, DOI 10.1016/j.apergo.2013.04.023; Central Intelligence Agency, 2020, WORLD FACTBOOK; Chemali Z, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7713-1; Deilkas ET, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-191; Demerouti E, 2003, EUR J PSYCHOL ASSESS, V19, P12, DOI 10.1027//1015-5759.19.1.12; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E., 2008, HDB STRESS BURNOUT H, P66; Eysenck MW, 2018, COGNITION EMOTION, V32, P1391, DOI 10.1080/02699931.2017.1330255; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Farrell SM, 2019, INT REV PSYCHIATR, V31, P555, DOI 10.1080/09540261.2019.1688047; Farrell SM, 2019, INT REV PSYCHIATR, V31, P579, DOI 10.1080/09540261.2019.1675960; Goulia P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-322; Grace SL, 2005, PSYCHOSOMATICS, V46, P385, DOI 10.1176/appi.psy.46.5.385; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Halbesleben JRB, 2005, WORK STRESS, V19, P208, DOI 10.1080/02678370500340728; Hale T., 2020, OXFORD COVID 19 GOVT; Hall LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159015; Havyer RDA, 2014, J GEN INTERN MED, V29, P894, DOI 10.1007/s11606-013-2686-8; Heinen MM, 2013, INT J NURS STUD, V50, P174, DOI 10.1016/j.ijnurstu.2012.09.019; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Ji D, 2017, ONCOTARGET, V8, P12784, DOI 10.18632/oncotarget.14498; Kaya S, 2010, QUAL SAF HEALTH CARE, V19, P572, DOI 10.1136/qshc.2008.032003; Khoshakhlagh Amir Hossein, 2019, BMC Health Serv Res, V19, P1009, DOI 10.1186/s12913-019-4863-x; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Koh D, 2020, OCCUP MED-OXFORD, V70, P322, DOI 10.1093/occmed/kqaa073; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee WC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-234; Lee YC, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/4268781; Linzer M, 2015, J GEN INTERN MED, V30, P1105, DOI 10.1007/s11606-015-3235-4; Liu CY, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001107; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Low ZX, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091479; Lyndon A, 2015, BURNOUT HEALTHCARE P; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; Maneze D, 2016, J IMMIGR MINOR HEALT, V18, P779, DOI 10.1007/s10903-015-0233-x; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Mattei A, 2017, PSYCHOL HEALTH MED, V22, P1262, DOI 10.1080/13548506.2017.1327667; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406; McGuire AL, 2020, AM J BIOETHICS, V20, P15, DOI 10.1080/15265161.2020.1764138; McKinley N, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-031765; Ministry of Health Singapore, 2019, HEALTHC WORKF STAT; Nguyen G, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0951-8; NHS digital, 2018, NARR NHS GEND DIV ME; Norden-Hagg Annika, 2010, BMC Clin Pharmacol, V10, P8, DOI 10.1186/1472-6904-10-8; Ong SE, 2018, HEALTH POLICY, V122, P431, DOI 10.1016/j.healthpol.2018.02.005; Oxford Martin Programme on Global Development , 2020, OUR WORLD DAT STAT R; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Peterson U, 2008, J ADV NURS, V62, P84, DOI 10.1111/j.1365-2648.2007.04580.x; Pronovost P, 2005, QUAL SAF HEALTH CARE, V14, P231, DOI 10.1136/qshc.2005.015180; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; Sexton JB, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-44; Shanafelt T, 2011, J AM COLL SURGEONS, V212, P421, DOI 10.1016/j.jamcollsurg.2010.11.006; Staines A., 2020, INT J QUALITY HLTH C; Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247; Tan B.Y.Q., 2020, ANN INTERN MED; Tay WY, 2014, PROC SINGAP HEALTHC, V23, P93, DOI 10.1177/201010581402300202; The World Bank Group, 2020, GDP PER CAP; The World Bank Group, 2020, CURR HLTH EXP POL SI; The World Bank Group, 2021, NURS MIDW PER 1000 P; The World Bank Group, 2021, PHYS PER 1000 PEOPL; Weaver MD, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12722; Westwood S, 2017, J MENT HEALTH, V26, P172, DOI 10.1080/09638237.2016.1276540; Williams Roger D, 2020, J Health Serv Psychol, V46, P65, DOI 10.1007/s42843-020-00011-4; Wu AW., 2020, ANN INTERN MED; Wu KK, 2005, J TRAUMA STRESS, V18, P39, DOI 10.1002/jts.20004; Yamamoto-Furusho JK, 2018, GASTROENT HEPAT-BARC, V41, P477, DOI 10.1016/j.gastrohep.2018.05.009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	77	87	87	15	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0238666	10.1371/journal.pone.0238666	http://dx.doi.org/10.1371/journal.pone.0238666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861739	gold, Green Published, Green Submitted			2022-12-26	WOS:000641475400056
J	Shuldiner, SR; Boland, MV; Ramulu, PY; De Moraes, CG; Elze, T; Myers, J; Pasquale, L; Wellik, S; Yohannan, J				Shuldiner, Scott R.; Boland, Michael, V; Ramulu, Pradeep Y.; De Moraes, C. Gustavo; Elze, Tobias; Myers, Jonathan; Pasquale, Louis; Wellik, Sarah; Yohannan, Jithin			Predicting eyes at risk for rapid glaucoma progression based on an initial visual field test using machine learning	PLOS ONE			English	Article								Objective To assess whether machine learning algorithms (MLA) can predict eyes that will undergo rapid glaucoma progression based on an initial visual field (VF) test. Design Retrospective analysis of longitudinal data. Subjects 175,786 VFs (22,925 initial VFs) from 14,217 patients who completed >= 5 reliable VFs at academic glaucoma centers were included. Methods Summary measures and reliability metrics from the initial VF and age were used to train MLA designed to predict the likelihood of rapid progression. Additionally, the neural network model was trained with point-wise threshold data in addition to summary measures, reliability metrics and age. 80% of eyes were used for a training set and 20% were used as a test set. MLA test set performance was assessed using the area under the receiver operating curve (AUC). Performance of models trained on initial VF data alone was compared to performance of models trained on data from the first two VFs. Main outcome measures Accuracy in predicting future rapid progression defined as MD worsening more than 1 dB/year. Results 1,968 eyes (8.6%) underwent rapid progression. The support vector machine model (AUC 0.72 [95% CI 0.70-0.75]) most accurately predicted rapid progression when trained on initial VF data. Artificial neural network, random forest, logistic regression and naive Bayes classifiers produced AUC of 0.72, 0.70, 0.69, 0.68 respectively. Models trained on data from the first two VFs performed no better than top models trained on the initial VF alone. Based on the odds ratio (OR) from logistic regression and variable importance plots from the random forest model, older age (OR: 1.41 per 10 year increment [95% CI: 1.34 to 1.08]) and higher pattern standard deviation (OR: 1.31 per 5-dB increment [95% CI: 1.18 to 1.46]) were the variables in the initial VF most strongly associated with rapid progression. Conclusions MLA can be used to predict eyes at risk for rapid progression with modest accuracy based on an initial VF test. Incorporating additional clinical data to the current model may offer opportunities to predict patients most likely to rapidly progress with even greater accuracy.	[Shuldiner, Scott R.; Ramulu, Pradeep Y.; Yohannan, Jithin] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Boland, Michael, V; Elze, Tobias] Harvard Med Sch, Massachusetts Eye & Ear, Boston, MA 02115 USA; [De Moraes, C. Gustavo] Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA; [Myers, Jonathan] Thomas Jefferson Univ, Wills Eye Hosp, Philadelphia, PA 19107 USA; [Pasquale, Louis] Icahn Sch Med Mt Sinai Sch, Eye & Vis Res Inst, New York Eye & Ear Infirm Mt Sinai, New York, NY USA; [Wellik, Sarah] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Columbia University; Jefferson University; Icahn School of Medicine at Mount Sinai; New York Eye & Ear Infirmary of Mount Sinai; Bascom Palmer Eye Institute; University of Miami	Yohannan, J (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	jithin@jhmi.edu		Yohannan, Jithin/0000-0002-4741-0782	National Institutes of Health [5K12EY015025-14, R01 EY030575]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health, grant 5K12EY015025-14 to JY and the grant R01 EY030575 to TE.	Asaoka R, 2016, OPHTHALMOLOGY, V123, P1974, DOI 10.1016/j.ophtha.2016.05.029; ASMAN P, 1992, ARCH OPHTHALMOL-CHIC, V110, P812, DOI 10.1001/archopht.1992.01080180084033; Bengtsson B, 2008, AM J OPHTHALMOL, V145, P343, DOI 10.1016/j.ajo.2007.09.038; Bommakanti N, 2020, J GLAUCOMA, V29, P31, DOI 10.1097/IJG.0000000000001401; Bowd C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085941; Breiman L., 2001, MACH LEARN, V45, P5; BROWN RH, 1994, CONTROL CLIN TRIALS, V15, P299; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Cerentini A, 2017, STUD HEALTH TECHNOL, V245, P318, DOI 10.3233/978-1-61499-830-3-318; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Chauhan BC, 2014, INVEST OPHTH VIS SCI, V55, P4135, DOI 10.1167/iovs.14-14643; De Moraes CG, 2017, PROG RETIN EYE RES, V56, P107, DOI 10.1016/j.preteyeres.2016.10.001; Fogagnolo P, 2011, BRIT J OPHTHALMOL, V95, P189, DOI 10.1136/bjo.2010.182758; Gardiner SK, 2017, AM J OPHTHALMOL, V176, P148, DOI 10.1016/j.ajo.2017.01.013; Garway-Heath David F, 2017, Trans Am Ophthalmol Soc, V115, pT4; GOLDBAUM MH, 1994, INVEST OPHTH VIS SCI, V35, P3362; Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162; Goldbaum Michael H, 2009, Trans Am Ophthalmol Soc, V107, P136; Health USD of Human Services HR.  Administration S.  Analysis NC for HW, 2016, NAT REG PROJ SUPPL D; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2012, FIELD ANAL PRIMER EF; Henson DB, 2000, INVEST OPHTH VIS SCI, V41, P417; Horani A, 2002, J GLAUCOMA, V11, P511, DOI 10.1097/00061198-200212000-00011; Karakawa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078630; Lee AC, 2002, OPHTHALMOLOGY, V109, P1059, DOI 10.1016/S0161-6420(02)01043-6; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Li F, 2018, BMC MED IMAGING, V18, DOI 10.1186/s12880-018-0273-5; Lietman T, 1999, J GLAUCOMA, V8, P77; MCNAUGHT AI, 1995, GRAEF ARCH CLIN EXP, V233, P750, DOI 10.1007/BF00184085; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; Muhammad H, 2017, J GLAUCOMA, V26, P1086, DOI 10.1097/IJG.0000000000000765; Musch DC, 1999, OPHTHALMOLOGY, V106, P653, DOI 10.1016/S0161-6420(99)90147-1; Nouri-Mahdavi K, 2004, INVEST OPHTH VIS SCI, V45, P4346, DOI 10.1167/iovs.04-0204; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Nouri-Mahdavi K, 2007, ARCH OPHTHALMOL-CHIC, V125, P1176, DOI 10.1001/archopht.125.9.1176; NouriMahdavi K, 1997, OPHTHALMOLOGY, V104, P1228, DOI 10.1016/S0161-6420(97)30153-5; O'Leary N, 2012, INVEST OPHTH VIS SCI, V53, P6776, DOI 10.1167/iovs.12-10049; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Simundic Ana-Maria, 2009, EJIFCC, V19, P203; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Spry PGD, 2002, SURV OPHTHALMOL, V47, P158, DOI 10.1016/S0039-6257(01)00299-5; Stewart WC, 2000, AM J OPHTHALMOL, V130, P274, DOI 10.1016/S0002-9394(00)00487-6; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Taketani Y, 2015, INVEST OPHTH VIS SCI, V56, P4076, DOI 10.1167/iovs.14-16341; Ting DSW, 2019, PROG RETIN EYE RES, V72, DOI 10.1016/j.preteyeres.2019.04.003; Tolles J, 2016, JAMA-J AM MED ASSOC, V316, P533, DOI 10.1001/jama.2016.7653; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vesti E, 2003, INVEST OPHTH VIS SCI, V44, P3873, DOI 10.1167/iovs.02-1171; Webb GI, 2005, MACH LEARN, V58, P5, DOI 10.1007/s10994-005-4258-6; Wen JC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214875; Yohannan J, 2017, OPHTHALMOLOGY, V124, P1612, DOI 10.1016/j.ophtha.2017.04.035; Yousefi S, 2015, J BIOMED INFORM, V58, P96, DOI 10.1016/j.jbi.2015.09.019; Yousefi S, 2014, IEEE T BIO-MED ENG, V61, P1143, DOI 10.1109/TBME.2013.2295605; Zheng CJ, 2019, CURR OPIN OPHTHALMOL, V30, P97, DOI 10.1097/ICU.0000000000000552; Zhu HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085654	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249856	10.1371/journal.pone.0249856	http://dx.doi.org/10.1371/journal.pone.0249856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861775	gold, Green Published			2022-12-26	WOS:000641475400020
J	Billa, PA; Faulconnier, Y; Ye, T; Bourdon, C; Pires, JAA; Leroux, C				Billa, Pierre-Alexis; Faulconnier, Yannick; Ye, Tao; Bourdon, Celine; Pires, Jose A. A.; Leroux, Christine			Nutrigenomic analyses reveal miRNAs and mRNAs affected by feed restriction in the mammary gland of midlactation dairy cows	PLOS ONE			English	Article							BOVINE-MILK FAT; NUTRIENT METABOLISM; HOLSTEIN; EXPRESSION; MICRORNAS; STRESS; TRANSITION; GENES; LIVER; TRANSCRIPTOME	The objective of this study was to investigate the effects of feed restriction on mammary miRNAs and coding gene expression in midlactation cows. Five Holstein cows and 6 Montbeliarde cows underwent 6 days of feed restriction, during which feed allowance was reduced to meet 50% of their net energy for lactation requirements. Mammary biopsies were performed before and at the end of the restriction period. Mammary miRNA and mRNA analyses were performed using high-throughput sequencing and microarray analyses, respectively. Feed restriction induced a negative energy balance and decreased milk production and fat and protein yields in both breeds. Feed restriction modified the expression of 27 miRNAs and 374 mRNAs in mammary glands from Holstein cows, whereas no significant miRNA change was observed in Montbeliarde cows. Among the 27 differentially expressed miRNAs, 8 miRNAs were associated with dairy QTL. Analysis of target genes indicate that the 8 most abundantly expressed miRNAs control transcripts related to lipid metabolism, mammary remodeling and stress response. A comparison between the mRNAs targeted by the 8 most strongly expressed miRNAs and 374 differentially expressed mRNAs identified 59 mRNAs in common. The bioinformatic analyses of these 59 mRNAs revealed their implication in lipid metabolism and endothelial cell proliferation. These effects of feed restriction on mammary miRNAs and mRNAs observed in Holstein cows suggest a potential role of miRNAs in mammary structure and lipid biosynthesis that could explain changes in milk production and composition.	[Billa, Pierre-Alexis; Faulconnier, Yannick; Pires, Jose A. A.; Leroux, Christine] Univ Clermont Auvergne, UMR Herbivores, VetAgro Sup, INRAE, St Genes Champanelle, France; [Ye, Tao] Univ Strasbourg, INSERM, CNRS,U964, Inst Genet & Biol Mol & Cellulaire IGBMC,UMR7104, Illkirch Graffenstaden, France; [Bourdon, Celine] Univ Paris Saclay, UMR Genet Anim & Biol Integrat, AgroParisTech, INRAE, Jouy En Josas, France	INRAE; Universite Clermont Auvergne (UCA); VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Leroux, C (corresponding author), Univ Clermont Auvergne, UMR Herbivores, VetAgro Sup, INRAE, St Genes Champanelle, France.	christine.leroux@inrae.fr	Pires, José A.A./D-4019-2015	Pires, José A.A./0000-0002-3773-9293; Bourdon, Celine/0000-0001-5068-1551; Leroux, Christine/0000-0001-6835-3978	Region Auvergne S3 [23000794/1130]; FEDER [23000794/1130]; ApisGene; GISA meta-program of INRAE (Ruminflame project); GISA meta-program of INRAE (Longhealth project)	Region Auvergne S3; FEDER(European Commission); ApisGene; GISA meta-program of INRAE (Ruminflame project); GISA meta-program of INRAE (Longhealth project)	We thank the Region Auvergne S3 and FEDER for the funding of P-A Billa's thesis grants (project nr. 23000794/1130 entitled "Innovative biomarkers for the quality products of tomorrow's cattle farming ") awarded to PAB, and ApisGene for the funding of Celine Bourdon's thesis grants. This research was funded by GISA meta-program of INRAE (Ruminflame and Longhealth projects).	Abdelatty AM, 2017, J DAIRY SCI, V100, P4000, DOI 10.3168/jds.2016-11130; Akbar H, 2013, J DAIRY SCI, V96, P2201, DOI 10.3168/jds.2012-6036; Al-Husseini W, 2016, ASIAN AUSTRAL J ANIM, V29, P1371, DOI 10.5713/ajas.15.0605; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard L, 2015, LIVEST SCI, V176, P188, DOI 10.1016/j.livsci.2015.03.016; Betterman KL, 2012, AM J PATHOL, V181, P2225, DOI 10.1016/j.ajpath.2012.08.035; Billa PA, 2020, J DAIRY SCI, V103, P3133, DOI 10.3168/jds.2019-17466; Billa PA, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5987-4; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Chen CJ, 2012, BIOINFORMATICS, V28, P3147, DOI 10.1093/bioinformatics/bts587; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cunningham HC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194104; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; Dessauge F, 2011, J DAIRY SCI, V94, P4623, DOI 10.3168/jds.2010-4012; Du XL, 2017, ONCOTARGET, V8, P91362, DOI 10.18632/oncotarget.20523; Fatima A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-279; Ferlay A, 2010, ANIMAL, V4, P627, DOI 10.1017/S1751731109991224; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritz S, 2014, P 10 WORLD C GEN APP, P1; Gross J, 2011, J DAIRY SCI, V94, P1820, DOI 10.3168/jds.2010-3707; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Hilmarsdottir B, 2014, GENES-BASEL, V5, P804, DOI 10.3390/genes5030804; Institut National de la Recherche Agronomique (INRA), 2007, ALIMENTATION BOVINS; Ji ZB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12297-4; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Le Guillou S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56690-7; Le Guillou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091938; Li R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1965-7; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Lian S, 2016, J DAIRY SCI, V99, P3916, DOI 10.3168/jds.2015-10484; Ma LA, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0262-0; Miller AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072324; Mobuchon L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185511; Mobuchon L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140111; Ollier S, 2007, J NUTR, V137, P560, DOI 10.1093/jn/137.3.560; Pires JAA, 2016, J DAIRY SCI, V99, P2297, DOI 10.3168/jds.2015-10308; Pomies D, 2007, ANIMAL, V1, P1497, DOI 10.1017/S1751731107000778; Radisky DC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2885; Sanchez MP, 2019, GENET SEL EVOL, V51, DOI 10.1186/s12711-019-0473-7; Sengar GS, 2018, CELL STRESS CHAPERON, V23, P155, DOI 10.1007/s12192-017-0833-6; Skibiel AL, 2018, J DAIRY SCI, V101, P705, DOI 10.3168/jds.2017-13258; Sordillo LM, 2014, ANIM PROD SCI, V54, P1204, DOI 10.1071/AN14503; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang M, 2012, J DAIRY SCI, V95, P6529, DOI 10.3168/jds.2012-5748; Wicik Z, 2016, J ANIM BREED GENET, V133, P31, DOI 10.1111/jbg.12172; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Williams A, 2013, COLD SH Q B, V78, P223, DOI 10.1101/sqb.2013.78.020024; Zhang L, 2015, J IMMUNOL, V195, P5404, DOI 10.4049/jimmunol.1402933; Zhao CP, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-12; Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8	58	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248680	10.1371/journal.pone.0248680	http://dx.doi.org/10.1371/journal.pone.0248680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857151	Green Published, gold			2022-12-26	WOS:000641474900032
J	McGovern, OL; Stenger, M; Oliver, SE; Anderson, TC; Isenhour, C; Mauldin, MR; Williams, N; Griggs, E; Bogere, T; Edens, C; Curns, AT; Lively, JY; Zhou, YT; Xu, SL; Diaz, MH; Waller, JL; Clarke, KR; Evans, ME; Hesse, EM; Morris, SB; McClung, RP; Cooley, LA; Logan, N; Boyd, AT; Taylor, AW; Bajema, KL; Lindstrom, S; Elkins, CA; Jones, C; Hall, AJ; Graitcer, S; Oster, AM; Fry, AM; Fischer, M; Conklin, L; Gokhale, RH				McGovern, Olivia L.; Stenger, Mark; Oliver, Sara E.; Anderson, Tara C.; Isenhour, Cheryl; Mauldin, Matthew R.; Williams, Nia; Griggs, Eric; Bogere, Tonny; Edens, Chris; Curns, Aaron T.; Lively, Joana Y.; Zhou, Yingtao; Xu, Songli; Diaz, Maureen H.; Waller, Jessica L.; Clarke, Kevin R.; Evans, Mary E.; Hesse, Elisabeth M.; Morris, Sapna Bamrah; McClung, Robert P.; Cooley, Laura A.; Logan, Naeemah; Boyd, Andrew T.; Taylor, Allan W.; Bajema, Kristina L.; Lindstrom, Stephen; Elkins, Christopher A.; Jones, Christopher; Hall, Aron J.; Graitcer, Samuel; Oster, Alexandra M.; Fry, Alicia M.; Fischer, Marc; Conklin, Laura; Gokhale, Runa H.			Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020	PLOS ONE			English	Article							PUBLIC-HEALTH RESPONSE; UNITED-STATES; COVID-19	Background The Coronavirus Disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), evolved rapidly in the United States. This report describes the demographic, clinical, and epidemiologic characteristics of 544 U.S. persons under investigation (PUI) for COVID-19 with complete SARS-CoV-2 testing in the beginning stages of the pandemic from January 17 through February 29, 2020. Methods In this surveillance cohort, the U.S. Centers for Disease Control and Prevention (CDC) provided consultation to public health and healthcare professionals to identify PUI for SARS-CoV-2 testing by quantitative real-time reverse-transcription PCR. Demographic, clinical, and epidemiologic characteristics of PUI were reported by public health and healthcare professionals during consultation with on-call CDC clinicians and subsequent submission of a CDC PUI Report Form. Characteristics of laboratory-negative and laboratory-positive persons were summarized as proportions for the period of January 17-February 29, and characteristics of all PUI were compared before and after February 12 using prevalence ratios. Results A total of 36 PUI tested positive for SARS-CoV-2 and were classified as confirmed cases. Confirmed cases and PUI testing negative for SARS-CoV-2 had similar demographic, clinical, and epidemiologic characteristics. Consistent with changes in PUI evaluation criteria, 88% (13/15) of confirmed cases detected before February 12, 2020, reported travel from China. After February 12, 57% (12/21) of confirmed cases reported no known travel- or contact-related exposures. Conclusions These findings can inform preparedness for future pandemics, including capacity for rapid expansion of novel diagnostic tests to accommodate broad surveillance strategies to assess community transmission, including potential contributions from asymptomatic and presymptomatic infections.	[McGovern, Olivia L.; Stenger, Mark; Oliver, Sara E.; Anderson, Tara C.; Isenhour, Cheryl; Mauldin, Matthew R.; Williams, Nia; Griggs, Eric; Bogere, Tonny; Edens, Chris; Curns, Aaron T.; Lively, Joana Y.; Zhou, Yingtao; Xu, Songli; Diaz, Maureen H.; Waller, Jessica L.; Clarke, Kevin R.; Evans, Mary E.; Hesse, Elisabeth M.; Morris, Sapna Bamrah; McClung, Robert P.; Cooley, Laura A.; Logan, Naeemah; Boyd, Andrew T.; Taylor, Allan W.; Bajema, Kristina L.; Lindstrom, Stephen; Elkins, Christopher A.; Jones, Christopher; Hall, Aron J.; Graitcer, Samuel; Oster, Alexandra M.; Fry, Alicia M.; Fischer, Marc; Conklin, Laura; Gokhale, Runa H.] Ctr Dis Control & Prevent, CDC COVID 19 Response Team, Atlanta, GA 30333 USA; [McGovern, Olivia L.; Bajema, Kristina L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Lively, Joana Y.] IHRC Inc, Atlanta, GA USA; [Zhou, Yingtao] Maximus Fed, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	McGovern, OL (corresponding author), Ctr Dis Control & Prevent, CDC COVID 19 Response Team, Atlanta, GA 30333 USA.; McGovern, OL (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	okp3@cdc.gov		Edens, William/0000-0002-7563-6201; Mauldin, Matt/0000-0002-3807-2339; Taylor, Allan/0000-0001-7496-8768				[Anonymous], 2002, Bull World Health Organ, V80, P983; Bajema KL, 2020, MMWR-MORBID MORTAL W, V69, P166, DOI 10.15585/mmwr.mm6906e1; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6; Centers for Disease Control and Prevention, 2020, INF HLTH DEP REP PER; Centers for Disease Control and Prevention, 2020, CDCHAN00428; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; Jernigan DB, 2020, MMWR-MORBID MORTAL W, V69, P216, DOI 10.15585/mmwr.mm6908e1; Jorden MA, 2020, MMWR-MORBID MORTAL W, V69, P680, DOI 10.15585/mmwr.mm6922e1; Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; Schuchat A, 2020, MMWR-MORBID MORTAL W, V69, P551, DOI 10.15585/mmwr.mm6918e2; Toki S, 2020, ALLERGY, V75, P1606, DOI 10.1111/all.14196; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131; Xu F, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05138-9	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249901	10.1371/journal.pone.0249901	http://dx.doi.org/10.1371/journal.pone.0249901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857209	gold, Green Published			2022-12-26	WOS:000641474900041
J	Zhuo, XM; Wang, Q; Vossaert, L; Salman, R; Kim, A; Van den Veyver, I; Breman, A; Beaudet, A				Zhuo, Xinming; Wang, Qun; Vossaert, Liesbeth; Salman, Roseen; Kim, Adriel; Van den Veyver, Ignatia; Breman, Amy; Beaudet, Arthur			Use of amplicon-based sequencing for testing fetal identity and monogenic traits with Single Circulating Trophoblast (SCT) as one form of cell-based NIPT	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; BLOOD; DNA	A major challenge for cell-based non-invasive prenatal testing (NIPT) is to distinguish individual presumptive fetal cells from maternal cells in female pregnancies. We have sought a rapid, robust, versatile, and low-cost next-generation sequencing method to facilitate this process. Toward this goal, single isolated cells underwent whole genome amplification prior to genotyping. Multiple highly polymorphic genomic regions (including HLA-A and HLA-B) with 10-20 very informative single nucleotide polymorphisms (SNPs) within a 200 bp interval were amplified with a modified method based on other publications. To enhance the power of cell identification, approximately 40 Human Identification SNP (Applied Biosystems) test amplicons were also utilized. Using SNP results to compare to sex chromosome data from NGS as a reliable standard, the true positive rate for genotyping was 83.4%, true negative 6.6%, false positive 3.3%, and false negative 6.6%. These results would not be sufficient for clinical diagnosis, but they demonstrate the general validity of the approach and suggest that deeper genotyping of single cells could be completely reliable. A paternal DNA sample is not required using this method. The assay also successfully detected pathogenic variants causing Tay Sachs disease, cystic fibrosis, and hemoglobinopathies in single lymphoblastoid cells, and disease-causing variants in three cell-based NIPT cases. This method could be applicable for any monogenic diagnosis.	[Zhuo, Xinming; Wang, Qun; Vossaert, Liesbeth; Salman, Roseen; Van den Veyver, Ignatia; Beaudet, Arthur] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kim, Adriel] MD Anderson Canc Ctr, Grad Program Diagnost Genet, Houston, TX USA; [Van den Veyver, Ignatia] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Breman, Amy] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Indiana University System; Indiana University Bloomington	Zhuo, XM; Beaudet, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	xmzhuo@gmail.com; abeaudet@bcm.edu		Vossaert, Liesbeth/0000-0002-8888-8563	Baylor College of Medicine; National Institutes of Health [HD055651-12S1]	Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by internal institutional funds at Baylor College of Medicine awarded to AB and National Institutes of Health in the form of a grant awarded to IVdV (HD055651-12S1) at Baylor College of Medicine.	[Anonymous], 2015, Obstet Gynecol, V126, pe31, DOI 10.1097/AOG.0000000000001051; Benn P, 2015, PRENATAL DIAG, V35, P725, DOI 10.1002/pd.4608; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Breman AM, 2016, PRENATAL DIAG, V36, P1009, DOI 10.1002/pd.4924; Chang MY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21236-w; Debeljak M, 2014, J MOL DIAGN, V16, P495, DOI 10.1016/j.jmoldx.2014.04.003; Handyside AH, 2010, J MED GENET, V47, P651, DOI 10.1136/jmg.2009.069971; Hudecova I, 2017, BEST PRACT RES CL OB, V39, P63, DOI 10.1016/j.bpobgyn.2016.10.016; Kolvraa S, 2016, PRENATAL DIAG, V36, P1127, DOI 10.1002/pd.4948; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Vermeulen C, 2017, AM J HUM GENET, V101, P326, DOI 10.1016/j.ajhg.2017.07.012; Vestergaard EM, 2017, PRENATAL DIAG, V37, P1120, DOI 10.1002/pd.5150; Vossaert L, 2019, AM J HUM GENET, V105, P1262, DOI 10.1016/j.ajhg.2019.11.004; Vossaert L, 2018, PRENATAL DIAG, V38, P1069, DOI 10.1002/pd.5377; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang JL, 2019, NAT MED, V25, P439, DOI 10.1038/s41591-018-0334-x	17	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249695	10.1371/journal.pone.0249695	http://dx.doi.org/10.1371/journal.pone.0249695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857205	Green Published, gold, Green Submitted			2022-12-26	WOS:000641474900090
J	Omori, H; Otsu, M; Nogami, H; Shibata, M				Omori, Hiroyuki; Otsu, Masahiro; Nogami, Haruo; Shibata, Masayoshi			Heat shock response enhanced by cell culture treatment in mouse embryonic stem cell-derived proliferating neural stem cells	PLOS ONE			English	Article							NEURONAL CELLS; DIFFERENTIATION; HSP90; HYPERTHERMIA; INDUCTION; SURVIVAL; PROTEIN; HSP70; HEAT-SHOCK-PROTEIN-70; FIBROBLASTS	Cells have a regulatory mechanism known as heat shock (HS) response, which induces the expression of HS genes and proteins in response to heat and other cellular stresses. Exposure to moderate HS results in beneficial effects, such as thermotolerance and promotes survival, whereas excessive HS causes cell death. The effect of HS on cells depends on both exogenous factors, including the temperature and duration of heat application, and endogenous factors, such as the degree of cell differentiation. Neural stem cells (NSCs) can self-renew and differentiate into neurons and glial cells, but the changes in the HS response of symmetrically proliferating NSCs in culture are unclear. We evaluated the HS response of homogeneous proliferating NSCs derived from mouse embryonic stem cells during the proliferative phase and its effect on survival and cell death in vitro. The number of adherent cells and the expression ratios of HS protein (Hsp)40 and Hsp70 genes after exposure to HS for 20 min at temperatures above 43 degrees C significantly increased with the extension of the culture period before exposure to HS. In contrast, caspase activity was significantly decreased by extension of the culture period before exposure to HS and suppressed the decrease in cell viability. These results suggest that the culture period before HS remarkably affects the HS response, influencing the expression of HS genes and cell survival of proliferating NSCs in culture.	[Omori, Hiroyuki; Nogami, Haruo] Japan Univ Hlth Sci, Sch Hlth Sci, Dept Phys Therapy, Saitama, Japan; [Otsu, Masahiro] Braizon Therapeut Inc, Tokyo, Japan; [Shibata, Masayoshi] Univ Human Arts & Sci, Fac Hlth Sci, Dept Rehabil, Course Phys Therapy, Saitama, Japan		Omori, H (corresponding author), Japan Univ Hlth Sci, Sch Hlth Sci, Dept Phys Therapy, Saitama, Japan.	h-omori@jhsu.ac.jp		Otsu, Masahiro/0000-0001-8764-1617; Omori, Hiroyuki/0000-0002-3111-7311	JSPS KAKENHI [JP18K17685]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number JP18K17685 to HO. Braizon Therapeutics Inc. provided support in the form of salaries for authors (MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Braizon Therapeutics Inc. provided support in the form of salaries for authors (MO) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the `author contributions' section.	Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Brooker SM, 2016, GLIA, V64, P1235, DOI 10.1002/glia.22996; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Edwards MJ, 2006, BIRTH DEFECTS RES A, V76, P507, DOI 10.1002/bdra.20277; Edwards MJ, 1997, INT J DEV BIOL, V41, P345; EDWARDS MJ, 1974, J EMBRYOL EXP MORPH, V32, P593; Fink SL, 1997, J NEUROCHEM, V68, P961; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hossain ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190356; Isono M, 2012, NEUROSCI RES, V73, P263, DOI 10.1016/j.neures.2012.04.005; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MAILHOS C, 1993, NEUROSCIENCE, V55, P621, DOI 10.1016/0306-4522(93)90428-I; MAILHOS C, 1994, J NEUROCHEM, V63, P1787; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nakayama T, 2004, NEUROREPORT, V15, P487, DOI 10.1097/00001756-200403010-00021; Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4; Nakayama Takashi, 2006, V330, P1; Nishimura K, 2015, STEM CELL TRANSL MED, V4, P932, DOI 10.5966/sctm.2014-0197; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; O'Reilly AM, 2010, MOL NEUROBIOL, V42, P124, DOI 10.1007/s12035-010-8143-3; Ohtsuka K, 2000, BRAIN RES BULL, V53, P141, DOI 10.1016/S0361-9230(00)00325-7; Omori H, 2014, NEUROSCI RES, V79, P13, DOI 10.1016/j.neures.2013.11.005; Otsu M, 2011, NEUROSCI RES, V69, P314, DOI 10.1016/j.neures.2010.12.014; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samakovli D, 2007, J EXP BOT, V58, P3513, DOI 10.1093/jxb/erm191; Samali A, 2001, CELL STRESS CHAPERON, V6, P49, DOI 10.1379/1466-1268(2001)006<0049:HPMOTC>2.0.CO;2; San Gil R, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0208-6; Sato K, 2002, NEUROSCIENCE, V109, P745, DOI 10.1016/S0306-4522(01)00494-8; Shibata M, 2016, EFFECTS CONTINUOUS E, V18, P1, DOI [10.24531/jhsaiih.18.4_187, DOI 10.24531/JHSAIIH.18.4_187]; SHIOTA K, 1988, BIOL NEONATE, V53, P86; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vishwakarma Sandeep Kumar, 2017, Basic Clin Neurosci, V8, P453, DOI 10.29252/NIRP.BCN.8.6.453; Vogel P, 1997, BRAIN RES, V764, P205, DOI 10.1016/S0006-8993(97)00458-7; Walsh D, 1997, CELL MOL LIFE SCI, V53, P198, DOI 10.1007/PL00000592; WANNER RA, 1976, J PATHOL, V118, P235, DOI 10.1002/path.1711180406; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weis F, 2010, J BIOL CHEM, V285, P9525, DOI 10.1074/jbc.M109.096586; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhao HP, 2012, ADV PHARMACOL, V64, P1, DOI 10.1016/B978-0-12-394816-8.00001-5	59	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249954	10.1371/journal.pone.0249954	http://dx.doi.org/10.1371/journal.pone.0249954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852623	gold, Green Published			2022-12-26	WOS:000640604500066
J	Yuwen, L; Chen, SY; Yuan, XH				Yuwen, Lu; Chen, Shuyu; Yuan, Xiaohan			G2Basy: A framework to improve the RNN language model and ease overfitting problem	PLOS ONE			English	Article								Recurrent neural networks are efficient ways of training language models, and various RNN networks have been proposed to improve performance. However, with the increase of network scales, the overfitting problem becomes more urgent. In this paper, we propose a framework-G2Basy-to speed up the training process and ease the overfitting problem. Instead of using predefined hyperparameters, we devise a gradient increasing and decreasing technique that changes the parameters training batch size and input dropout simultaneously by a user-defined step size. Together with a pretrained word embedding initialization procedure and the introduction of different optimizers at different learning rates, our framework speeds up the training process dramatically and improves performance compared with a benchmark model of the same scale. For the word embedding initialization, we propose the concept of "artificial features" to describe the characteristics of the obtained word embeddings. We experiment on two of the most often used corpora-the Penn Treebank and WikiText-2 datasets-and both outperform the benchmark results and show potential towards further improvement. Furthermore, our framework shows better results with the larger and more complicated WikiText-2 corpus than with the Penn Treebank. Compared with other state-of-the-art results, we achieve comparable results with network scales hundreds of times smaller and within fewer training epochs.	[Yuwen, Lu; Chen, Shuyu; Yuan, Xiaohan] ChongQing Univ, Sch Big Data & Software Engn, Chongqing, Peoples R China	Chongqing University	Chen, SY (corresponding author), ChongQing Univ, Sch Big Data & Software Engn, Chongqing, Peoples R China.	sychen@cqu.edu.cn		Yuwen, Lu/0000-0002-1402-6469	National Natural Science Foundation of China [61572090]; Chongqing Science and Technology Project [cstc2018jscx-mszdX0109]; Fundamental Research Funds for the Central Universities [2020CDJYGRH-YJ04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	1. Shuyu Chen. National Natural Science Foundation of China. Grant No. 61572090; url: http://www.nsfc.gov.cn/ 2. Shuyu Chen. Chongqing Science and Technology Project. Grant No. cstc2018jscx-mszdX0109; 3. Shuyu Chen, Fundamental Research Funds for the Central Universities, Project No. 2020CDJYGRH-YJ04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel H, 2018, LECT NOTES COMPUT SC, V10761, P3, DOI 10.1007/978-3-319-77113-7_1; Balles L., 2016, ABS161205086 CORR; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Billa J, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P5879; Cavalieri DC, 2016, IEEE-ACM T AUDIO SPE, V24, P1481, DOI 10.1109/TASLP.2016.2547743; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Cui GX, 2019, IEEE ACCESS, V7, P156848, DOI 10.1109/ACCESS.2019.2949611; De S., 2016, ABS161005792 CORR; Gal Y, 2016, ADV NEUR IN, V29; Grave E., 2016, ABS161204426 CORR; He K., 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, DOI 10.1109/ICCV.2017.322]; HIRSCHBERG J, 1988, AT&T TECH J, V67, P41, DOI 10.1002/j.1538-7305.1988.tb00232.x; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Inan H., 2016, ARXIV161101462; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Mikolov T., 2013, P ICLR WORKSH POST S; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Mnih A., 2008, P 21 INT C NEURAL IN, P1081; Pennington J, 2014, EMNLP, V14, P1532, DOI DOI 10.3115/V1/D14-1162; Pietron M, 2019, 2019 SEVENTH INTERNATIONAL SYMPOSIUM ON COMPUTING AND NETWORKING WORKSHOPS (CANDARW 2019), P162, DOI 10.1109/CANDARW.2019.00036; Polyak B. T, 1964, USSR COMP MATH MATH, V4, P1, DOI [10.1016/0041-5553(64)90137-5, DOI 10.1016/0041-5553(64)90137-5]; POLYAK BT, 1992, SIAM J CONTROL OPTIM, V30, P838, DOI 10.1137/0330046; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Shi ZJ, 2017, 2017 16TH IEEE/ACIS INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION SCIENCE (ICIS 2017), P613; Shuang K., 2019, IEEE T NEURAL NETW L, P1; Smith S. L., 2017, ABS171100489 CORR; Socher R., 2016, ABS160907843 CORR; Song ZR, 2019, DES AUT TEST EUROPE, P108, DOI 10.23919/DATE.2019.8715135; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Verwimp L, 2020, COMPUT SPEECH LANG, V61, DOI 10.1016/j.csl.2019.101034; Xiong ZY, 2021, NEURAL COMPUT APPL, V33, P3757, DOI 10.1007/s00521-020-05198-7; Xu W., 2000, 6 INT C SPOKEN LANGU, P202; Yang Zhilin, 2017, ABS171103953 CORR; Zaremba W., 2014, ABS14092329 CORR; Zeiler M. D, 2012, ARXIV12125701	38	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249820	10.1371/journal.pone.0249820	http://dx.doi.org/10.1371/journal.pone.0249820			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852595	Green Published, gold			2022-12-26	WOS:000640604500057
J	Yang, WT; Chen, M; Xu, R; Zheng, PS				Yang, Wen-Ting; Chen, Mei; Xu, Rui; Zheng, Peng-Sheng			PRDM4 inhibits cell proliferation and tumorigenesis by inactivating the PI3K/AKT signaling pathway through targeting of PTEN in cervical carcinoma	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; TROPHOBLAST INVASION; STEM-CELLS; CANCER; GENE; METHYLATION; EXPRESSION; MUTATION; FAMILY	PR domain zinc finger protein 4 (PRDM4) is a transcription factor that plays key roles in stem cell self-renewal and tumorigenesis. However, its biological role and exact mechanism in cervical cancer remain unknown. Here, both immunohistochemistry (IHC) and Western blot assays demonstrated that the expression of PRDM4 in cervical cancer tissues was much lower than that in the normal cervix. A xenograft assay showed that PRDM4 overexpression in the cervical cancer cell lines SiHa and HeLa dramatically inhibited cell proliferation and tumorigenic potential in vivo. Conversely, the silencing of PRDM4 promoted cervical cancer cell proliferation and tumorigenic potential. Mechanistically, PRDM4 induced cell cycle arrest at the transition from G0/G1 phase to S phase by upregulating p27 and p21 expression and downregulating Cyclin D1 and CDK4 expression. Furthermore, the PI3K/AKT signaling pathway was inactivated in PRDM4-overexpressing cells, which decreased the levels of p-AKT and upregulated the expression of PTEN, an inhibitor of the PI3K/AKT signaling pathway, at both the transcriptional and translational levels. Dual-luciferase reporter assays and qChIP assays confirmed that PRDM4 transactivated the expression of PTEN by binding to two specific regions in the PTEN promoter. Furthermore, PTEN silencing or a PTEN inhibitor rescued the cell defects induced by PRDM4 overexpression. Therefore, our data suggest that PRDM4 inhibits cell proliferation and tumorigenesis by downregulating the activity of the PI3K/AKT signaling pathway by directly transactivating PTEN expression in cervical cancer.	[Yang, Wen-Ting; Chen, Mei; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Yang, Wen-Ting; Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Xu, Rui] Xi An Jiao Tong Univ, Shaanxi Canc Hosp, Coll Med, Dept Internal Med 1, Xian, Peoples R China	Xi'an Jiaotong University; Ministry of Education, China; Xi'an Jiaotong University	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.; Zheng, PS (corresponding author), Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China.	zpsheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [81472728, 81672910, 81602307]; Xi'an Municipal Science and Technology Bureau [2019115213YX007SF040(6)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Municipal Science and Technology Bureau	This work was supported by a grant from the National Natural Science Foundation of China (Nos 81472728, 81672910, and 81602307) and the Xi'an Municipal Science and Technology Bureau (No. 2019115213YX007SF040(6)).	Bikoff EK, 2008, NAT GENET, V40, P934, DOI 10.1038/ng0808-934; Bogani D, 2013, MOL CELL BIOL, V33, P3936, DOI 10.1128/MCB.00498-13; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Carnero A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00252; Casamassimi A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072648; Chittka A, 2012, J BIOL CHEM, V287, P42995, DOI 10.1074/jbc.M112.392746; Cui N, 2016, ONCOTARGET, V7, P26152, DOI 10.18632/oncotarget.8434; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Di Zazzo Erika, 2013, Biology (Basel), V2, P107, DOI 10.3390/biology2010107; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Hadziselimovic F, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080391; Harima Y, 2001, INT J ONCOL, V18, P493; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; LI L, 2018, CELL DEATH DIS, V9; Liu H, 2018, EMBO REP, V19, DOI 10.15252/embr.201745180; Liu XL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0081-9; Ma X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171612; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naseem A, 2019, J CELL BIOCHEM, V120, P15851, DOI 10.1002/jcb.28856; Orel N, 2007, J Stem Cells Regen Med, V2, P216; Rizvi MMA, 2011, J CANCER RES CLIN, V137, P1255, DOI 10.1007/s00432-011-0994-0; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song NJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0904-3; Su TH, 2000, GYNECOL ONCOL, V76, P193, DOI 10.1006/gyno.1999.5659; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wen SY, 2015, ONCOGENE, V34, P717, DOI 10.1038/onc.2014.9; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yang XH, 1999, GENOMICS, V61, P319, DOI 10.1006/geno.1999.5967; Zeng YT, 2019, ONCOGENE, V38, P6940, DOI 10.1038/s41388-019-0906-3; Zhang J, 2018, BIOMED PHARMACOTHER, V100, P168, DOI 10.1016/j.biopha.2018.02.016; Zhang Y, 2020, MOL THER, V28, P631, DOI 10.1016/j.ymthe.2019.11.025; Zhang Y, 2017, MOL THER, V25, P2394, DOI 10.1016/j.ymthe.2017.06.028; Zhu Zhaohui, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P354	35	3	3	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3318	3330		10.1038/s41388-021-01765-x	http://dx.doi.org/10.1038/s41388-021-01765-x		APR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33846573	Green Published, hybrid			2022-12-26	WOS:000639635100004
J	Parker, M; Fang, XM; Self-Brown, SR; Rahimi, A				Parker, Marie; Fang, Xiangming; Self-Brown, Shannon Renee; Rahimi, Ali			Establishing how social capital is studied in relation to cardiovascular disease and identifying gaps for future research-A scoping review protocol	PLOS ONE			English	Review								Introduction Though the relationship between social capital and health has been widely studied, the evidence of this relationship in cardiovascular disease is limited, with varied and inconsistent measures. This scoping review seeks to address this gap by answering the following questions: (1) How has social capital been characterized and measured in the literature related to cardiovascular disease? and (2) What gaps exist in the evaluation of the relationship between social capital and cardiovascular disease? Materials and methods A scoping review will be used to answer the research questions. The scoping review will apply established methods described by Arksey and O'Malley, Levac and colleagues, and the Joanne Briggs Institute: (1) identifying the research question(s); (2) identifying relevant studies; (3) selecting the studies; (4) charting the data; and (5) collating, summarizing, and reporting the results. Results Our findings will be reported in accordance with the guidance provided in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement. Discussion The synthesis of this evidence base is intended to provide a framework for how social capital has been defined and measured in the cardiovascular literature, with additional guidance for future research and evaluation. The findings will be disseminated through peer-reviewed publication and presentations at relevant seminars.	[Parker, Marie; Fang, Xiangming; Self-Brown, Shannon Renee] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Rahimi, Ali] Southeast Permanente Med Grp, Cardiol, Atlanta, GA USA	University System of Georgia; Georgia State University; Permanente Medical Groups	Parker, M (corresponding author), Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA.	bparker24@student.gsu.edu	Fang, Xiangming/B-8650-2014	Fang, Xiangming/0000-0001-9922-8977; Parker, Brenda/0000-0002-6209-1628				[Anonymous], 2020, SOCIAL DETERMINANTS; Bourdieu P, 2001, SOCIOLOGY OF ECONOMIC LIFE, SECOND EDITION, P96; Bramer WM, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0644-y; Coleman J., 1990, FDN SOCIAL THEORY; Ellaway RH, 2018, MED TEACH, V40, P219, DOI 10.1080/0142159X.2017.1406662; Hu FY, 2014, BIOSCI TRENDS, V8, P290, DOI 10.5582/bst.2014.01138; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Macinko J, 2001, MILBANK Q, V79, P387, DOI 10.1111/1468-0009.00213; Munn Z, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0611-x; Peters M.D.J., 2020, JBI MANUAL EVIDENCE, DOI [DOI 10.46658/JBIMES-20-01, 10.46658/JBIMES-20-12,%20JBI,%202020, DOI 10.46658/JBIMES-20-12]; Putnam RD., 2000, BOWLING ALONE COLLAP; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Woolf SH., 2013, BOARD POPULATION HLT, Vxxv, P394	14	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249751	10.1371/journal.pone.0249751	http://dx.doi.org/10.1371/journal.pone.0249751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831051	gold, Green Published			2022-12-26	WOS:000639359600064
J	Sario, S; Santos, C; Goncalves, F; Torres, L				Sario, Sara; Santos, Conceicao; Goncalves, Fatima; Torres, Laura			DNA screening of Drosophila suzukii predators in berry field orchards shows new predatory taxonomical groups	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; COLEOPTERA CARABIDAE; PUPATION BEHAVIOR; NATURAL ENEMIES; PEST; PARASITOIDS; HYMENOPTERA; DIVERSITY; ABUNDANCE; EFFICACY	Drosophila suzukii (spotted wing drosophila, SWD) is a pandemic quarantine pest that attacks mostly red fruits. The high number of life cycles per year, its ability to rapidly invade and spread across new habitats, and highly polyphagous nature, makes this a particularly aggressive invasive species, for which efficient control methods are currently lacking. The use of native natural predators is particularly promising to anchor sustainable and efficient measures to control SWD. While several field studies have suggested the presence of potential predatory species in infested orchards, only a few confirmed the presence of SWD DNA in predators' gut content. Here, we use a DNA-based approach to identify SWD predators among the arthropod diversity in South Europe, by examining the gut content of potential predator specimens collected in SWD-infested berry fields in North Portugal. These specimens were morphologically identified to the family/order, and their gut content was screened for the presence of SWD DNA using PCR. New SWD predatory taxonomical groups were identified, as Opiliones and Hemerobiidae, in addition to known SWD predators, such as Hemerobiidae, Chrysopidae, Miridae, Carabidae, Formicidae and Araneae. Additionally, the presence of a spider family, Uloboridae, in the orchards was recorded for the first time, posing this family as another SWD-candidate predator. This study sets important bases to further investigate the potential large-scale use of some of these confirmed predator taxa for SWD control in South Europe.	[Sario, Sara; Santos, Conceicao] Univ Porto FCUP, Dept Biol, iB2Lab, Fac Sci, Rua Campo Alegre, Porto, Portugal; [Sario, Sara; Santos, Conceicao] Univ Porto, LAQV REQUIMTE, Porto, Portugal; [Sario, Sara; Goncalves, Fatima; Torres, Laura] Univ Tras Os Montes & Alto Douro UTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, Vila Real, Portugal; [Goncalves, Fatima] Inst Politecn Braganca, Ctr Invest Montanha CIMO, Braganca, Portugal	Universidade do Porto; Universidade do Porto; University of Tras-os-Montes & Alto Douro; Instituto Politecnico de Braganca	Sario, S (corresponding author), Univ Porto FCUP, Dept Biol, iB2Lab, Fac Sci, Rua Campo Alegre, Porto, Portugal.; Sario, S (corresponding author), Univ Porto, LAQV REQUIMTE, Porto, Portugal.; Sario, S (corresponding author), Univ Tras Os Montes & Alto Douro UTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, Vila Real, Portugal.	sara.sario@fc.up.pt	santos, conceição/GQQ-7378-2022; Santos, Conceição/ABE-6172-2020	Santos, Conceição/0000-0003-4129-6381; Sario, Sara/0000-0002-3695-9227; Goncalves, Fatima/0000-0001-7770-4477	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/138186/2018, UID/QUI/50006/2019, UIDB/04033/2020, UIDB/00690/2020, NORTE-01-0247-FEDER-047034]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Fundacao para a Ciencia e a Tecnologia, SFRH/BD/138186/2018, Dr. Sara Sario Fundacao para a Ciencia e a Tecnologia, UID/QUI/50006/2019, Dr. Conceicao Santos Fundacao para a Ciencia e a Tecnologia, UIDB/04033/2020, Dr. Fatima Goncalves, Dr. Laura Torres Fundacao para a Ciencia e a Tecnologia, UIDB/00690/2020, Dr. Fatima Goncalves European Regional Development Fund, NORTE-01-0247-FEDER-047034, Dr. Conceicao Santos.	Perez-Aguilar DA, 2019, BIOL CONTROL, V132, P29, DOI 10.1016/j.biocontrol.2018.12.009; Andreazza F, 2017, NEOTROP ENTOMOL, V46, P591, DOI 10.1007/s13744-017-0554-7; Anonymous, 2013, Bulletin OEPP, V43, P417, DOI 10.1111/epp.12059; Sanchez JA, 2020, MYRMECOL NEWS, V30, P93, DOI 10.25849/myrmecol.news_030:093; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Ballman ES, 2017, J ECON ENTOMOL, V110, P2308, DOI 10.1093/jee/tox233; Bonneau P, 2019, INSECTS, V10, DOI 10.3390/insects10030068; Bourne A, 2019, PEST MANAG SCI, V75, P3340, DOI 10.1002/ps.5459; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Choate Beth, 2011, Terrestrial Arthropod Reviews, V4, P157, DOI 10.1163/187498311X571979; Cuello EM, 2019, BIOCONTROL SCI TECHN, V29, P1159, DOI 10.1080/09583157.2019.1660958; Cuthbertson Andrew G.S., 2014, Insects, V5, P952, DOI 10.3390/insects5040952; De Heij SE, 2020, BIOSCIENCE, V70, P490, DOI 10.1093/biosci/biaa039; Englert C, 2019, J APPL ENTOMOL, V143, P387, DOI 10.1111/jen.12613; EPPO, 2010, DROS SUZ DROSSU WORL; EPPO, DROS SUZ DROSSU CAT; Frizzo TLM, 2020, BIOL CONTROL, V151, DOI 10.1016/j.biocontrol.2020.104378; Gabarra R, 2015, BIOCONTROL, V60, P331, DOI 10.1007/s10526-014-9646-z; Goncalves MF, 2012, PHYTOPARASITICA, V40, P17, DOI 10.1007/s12600-011-0195-z; Gonzalez-Chang M., 2016, FOOD WEBS, V9, P4, DOI 10.1016/j.fooweb.2016.04.003; Gress BE, 2019, PEST MANAG SCI, V75, P1270, DOI 10.1002/ps.5240; Grumiaux C, 2019, J INSECT PHYSIOL, V113, P33, DOI 10.1016/j.jinsphys.2019.01.001; Ioriatti C., 2020, Acta Horticulturae, P387, DOI 10.17660/ActaHortic.2020.1277.55; Ismoilov K, 2020, INSECTS, V11, DOI 10.3390/insects11050286; Kamiyama MT, 2019, BIOCONTROL, V64, P665, DOI 10.1007/s10526-019-09966-w; Kenis M, 2016, J PEST SCI, V89, P735, DOI 10.1007/s10340-016-0755-6; Khfif K, 2020, ARCH PHYTOPATH PLANT, V53, P749, DOI 10.1080/03235408.2020.1795608; Kundoo Ajaz Ahmad, 2017, Journal of Entomology and Zoology Studies, V5, P1362; Lee JC, 2019, J INTEGR PEST MANAG, V10, DOI [10.1093/jipm/pmz012, 10.33519/kwea.2019.10.4.002]; Luna-Espino HM, 2020, INSECTS, V11, DOI 10.3390/insects11020087; Mabin MD, 2020, AGR ECOSYST ENVIRON, V287, DOI 10.1016/j.agee.2019.106689; Mazzetto F, 2016, J PEST SCI, V89, P837, DOI 10.1007/s10340-016-0746-7; Michalko R, 2019, OECOLOGIA, V189, P21, DOI 10.1007/s00442-018-4313-1; Moreau CS, 2013, INVERTEBR SYST, V27, P81, DOI 10.1071/IS12067; Morris JR, 2018, MYRMECOL NEWS, V26, P1; Nentwig W, ARANEAE SPIDERS EURO; Papura D, 2020, BIOL CONTROL, V150, DOI 10.1016/j.biocontrol.2020.104358; Perez-Aguilar DA, 2018, ECOTOXICOLOGY, V27, P719, DOI 10.1007/s10646-018-1954-0; Perez-Hedo M, 2021, PEST MANAG SCI, V77, P33, DOI 10.1002/ps.6043; Pineda S, 2020, B ENTOMOL RES, V110, P270, DOI 10.1017/S0007485319000579; Poyet M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142785; Ramirez-Soria MJ, 2019, PEST MANAG SCI, V75, P3293, DOI 10.1002/ps.5451; Renkema JM, 2012, BIOL CONTROL, V60, P46, DOI 10.1016/j.biocontrol.2011.10.004; Renkema JM, 2018, PEST MANAG SCI, V74, P2076, DOI 10.1002/ps.4904; Renkema JM, 2015, BIOL CONTROL, V89, P1, DOI 10.1016/j.biocontrol.2015.04.024; Renkema JM, 2014, BIOCONTROL, V59, P749, DOI 10.1007/s10526-014-9614-7; RIECHERT SE, 1984, ANNU REV ENTOMOL, V29, P299, DOI 10.1146/annurev.en.29.010184.001503; Rocca M, 2017, J APPL ENTOMOL, V141, P402, DOI 10.1111/jen.12355; Rocha FH, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev096; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Sanjuana Delgado-Ramirez Carmen, 2019, Florida Entomologist, V102, P24; Schetelig MF, 2018, J APPL ENTOMOL, V142, P3, DOI 10.1111/jen.12469; Schmidt JM, 2019, AGR ECOSYST ENVIRON, V272, P86, DOI 10.1016/j.agee.2018.11.014; Seree L, 2020, AGR FOREST ENTOMOL, V22, P274, DOI 10.1111/afe.12380; Shrader ME, 2019, J ECON ENTOMOL, V112, P139, DOI 10.1093/jee/toy305; Stacconi MVR, 2018, BIOL CONTROL, V117, P188, DOI 10.1016/j.biocontrol.2017.11.013; Triplehorn C. A., 2005, BORROR DELONGS INTRO, V7th; Van Mele P., 2007, AGR FOREST ENTOMOL; Wang XingEng, 2020, CAB Reviews, V15, P1, DOI 10.1079/PAVSNNR202015054; Wantuch HA, 2019, CAN ENTOMOL, V151, P73, DOI 10.4039/tce.2018.53; Wolf S, 2018, J PEST SCI, V91, P927, DOI 10.1007/s10340-017-0948-7; Woltz JM, 2015, J APPL ENTOMOL, V139, P759, DOI 10.1111/jen.12200; Woltz JM, 2017, BIOL CONTROL, V110, P62, DOI 10.1016/j.biocontrol.2017.04.007; Yayla M, 2020, J ENTOMOL RES SOC, V22, P1	65	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249673	10.1371/journal.pone.0249673	http://dx.doi.org/10.1371/journal.pone.0249673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831041	Green Published, gold			2022-12-26	WOS:000639359600127
J	Gravdal, A; Xiao, XJ; Cnop, M; El Jellas, K; Johansson, S; Njolstad, PR; Lowe, ME; Johansson, BB; Molven, A; Fjeld, K				Gravdal, Anny; Xiao, Xunjun; Cnop, Miriam; El Jellas, Khadija; Johansson, Stefan; Njolstad, Pal R.; Lowe, Mark E.; Johansson, Bente B.; Molven, Anders; Fjeld, Karianne			The position of single-base deletions in the VNTR sequence of the carboxyl ester lipase (CEL) gene determines proteotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-STIMULATED LIPASE; TANDEM REPEATS; PROTEIN; GLYCOSYLATION; EXPRESSION; NUMBER; RISK; POLYMORPHISMS; PANCREATITIS; VARIANTS	Variable number of tandem repeat (VNTR) sequences in the genome can have functional consequences that contribute to human disease. This is the case for the CEL gene, which is specifically expressed in pancreatic acinar cells and encodes the digestive enzyme carboxyl ester lipase. Rare single-base deletions (DELs) within the first (DEL1) or fourth (DEL4) VNTR segment of CEL cause maturity-onset diabetes of the young, type 8 (MODY8), an inherited disorder characterized by exocrine pancreatic dysfunction and diabetes. Studies on the DEL1 variant have suggested that MODY8 is initiated by CEL protein misfolding and aggregation. However, it is unclear how the position of single-base deletions within the CEL VNTR affects pathogenic properties of the protein. Here, we investigated four naturally occurring CEL variants, arising from single-base deletions in different VNTR segments (DEL1, DEL4, DEL9, and DEL13). When the four variants were expressed in human embryonic kidney 293 cells, only DEL1 and DEL4 led to significantly reduced secretion, increased intracellular aggregation, and increased endoplasmic reticulum stress compared with normal CEL protein. The level of Oglycosylation was affected in all DEL variants. Moreover, all variants had enzymatic activity comparable with that of normal CEL. We conclude that the longest aberrant protein tails, resulting from single-base deletions in the proximal VNTR segments, have highest pathogenic potential, explaining why DEL1 and DEL4 but not DEL9 and DEL13 have been observed in patients with MODY8. These findings further support the view that CEL mutations cause pancreatic disease through protein misfolding and proteotoxicity, leading to endoplasmic reticulum stress and activation of the unfolded protein response.	[Gravdal, Anny; El Jellas, Khadija; Molven, Anders; Fjeld, Karianne] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Gravdal, Anny; El Jellas, Khadija; Johansson, Stefan; Njolstad, Pal R.; Johansson, Bente B.; Molven, Anders; Fjeld, Karianne] Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Gravdal, Anny; Johansson, Stefan; Fjeld, Karianne] Haukeland Hosp, Dept Med Genet, Bergen, Norway; [Xiao, Xunjun; Lowe, Mark E.] Washington Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, St Louis, MO 63110 USA; [Cnop, Miriam] Univ Libre Bruxelles, ULB Erasmus Hosp, ULB Ctr Diabet Res, Brussels, Belgium; [Cnop, Miriam] Univ Libre Bruxelles, ULB Erasmus Hosp, Div Endocrinol, Brussels, Belgium; [Njolstad, Pal R.; Johansson, Bente B.] Haukeland Hosp, Dept Pediat & Adolescent Med, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Washington University (WUSTL); Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Molven, A (corresponding author), Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway.; Molven, A (corresponding author), Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway.; Molven, A (corresponding author), Haukeland Hosp, Dept Pathol, Bergen, Norway.	anders.molven@uib.no	Johansson, Stefan/C-4394-2011; Johansson, Bente Berg/AAE-7666-2022; Fjeld, Karianne/Q-7122-2018	Johansson, Stefan/0000-0002-2298-7008; Fjeld, Karianne/0000-0003-0441-1475; El Jellas, Khadija/0000-0003-4473-1422; Molven, Anders/0000-0003-1847-3079; Lowe, Mark/0000-0002-5116-3841	University of Bergen; Western Norway Regional Health Authority [Helse Vest 912057]; Research Council of Norway [289534]; Translational Medical Center grant from Stiftelsen Kristian Gerhard Jebsen; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK124415]; Fonds National de la Recherche Scientifique (FNRS); Brussels Region Innoviris project DiaType; Fonds Erasme for Medical Research	University of Bergen; Western Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Translational Medical Center grant from Stiftelsen Kristian Gerhard Jebsen; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Brussels Region Innoviris project DiaType; Fonds Erasme for Medical Research	This research was funded by a PhD fellowship to A. G. from the University of Bergen and by grants to A. M. from Western Norway Regional Health Authority (Helse Vest 912057) and the Research Council of Norway (FRIMEDBIO program 289534). This research was also supported by a Translational Medical Center grant from Stiftelsen Kristian Gerhard Jebsen to P. R. N., by a grant to M. E. L. from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124415), and by grants from the Fonds National de la Recherche Scientifique (FNRS), the Brussels Region Innoviris project DiaType, and the Fonds Erasme for Medical Research to M. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABOUAKIL N, 1993, J BIOL CHEM, V268, P25755; Amarasinghe C, 2015, PROTEIN PEPTIDE LETT, V22, P885, DOI 10.2174/0929866522666150728115307; [Anonymous], 2015, NAT GENET; BLACKBERG L, 1995, EUR J BIOCHEM, V228, P817, DOI 10.1111/j.1432-1033.1995.tb20327.x; Brookes KJ, 2013, GENOMICS, V101, P273, DOI 10.1016/j.ygeno.2013.03.003; Bruneau N, 1997, J BIOL CHEM, V272, P27353, DOI 10.1074/jbc.272.43.27353; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Cai CQ, 2011, DIABETES, V60, P336, DOI 10.2337/db10-0255; Cassidy BM, 2020, HUM MUTAT, V41, P1967, DOI 10.1002/humu.24105; Dalva M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010244; Dalva M, 2017, PANCREATOLOGY, V17, P83, DOI 10.1016/j.pan.2016.10.006; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; El Jellas K, 2018, J BIOL CHEM, V293, P19476, DOI 10.1074/jbc.RA118.001934; Fjeld K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165567; Hegyi E, 2019, GUT, V68, P301, DOI 10.1136/gutjnl-2018-315994; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; Johansson BB, 2018, PANCREATOLOGY, V18, P12, DOI 10.1016/j.pan.2017.12.001; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kosobokova EN, 2016, BIOCHEMISTRY-MOSCOW+, V81, P187, DOI 10.1134/S0006297916030019; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Mayerle J, 2019, GASTROENTEROLOGY, V156, P1951, DOI 10.1053/j.gastro.2018.11.081; Pandol SJ, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00008; Rabdano SO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10574-w; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2014, DIABETES, V63, P259, DOI 10.2337/db13-1012; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; Sahin-Toth M, 2017, CURR OPIN GASTROEN, V33, P390, DOI 10.1097/MOG.0000000000000380; Simpson J, 2010, AM J MED GENET B, V153B, P1228, DOI 10.1002/ajmg.b.31084; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Terzyan S, 2000, PROTEIN SCI, V9, P1783, DOI 10.1110/ps.9.9.1783; Torsvik J, 2014, J BIOL CHEM, V289, P29097, DOI 10.1074/jbc.M114.574244; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; WANG CS, 1995, BIOCHEMISTRY-US, V34, P10639, DOI 10.1021/bi00033a039; Xiao XJ, 2016, J BIOL CHEM, V291, P23224, DOI 10.1074/jbc.M116.734384	41	5	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100661	10.1016/j.jbc.2021.100661	http://dx.doi.org/10.1016/j.jbc.2021.100661			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862081	Green Published, gold			2022-12-26	WOS:000672866400632
J	Neijssen, J; Cardoso, RMF; Chevalier, KM; Wiegman, L; Valerius, T; Anderson, GM; Moores, SL; Schuurman, J; Parren, PWHI; Strohl, WR; Chiu, ML				Neijssen, Joost; Cardoso, Rosa M. F.; Chevalier, Kristen M.; Wiegman, Luus; Valerius, Thomas; Anderson, G. Mark; Moores, Sheri L.; Schuurman, Janine; Parren, Paul W. H., I; Strohl, William R.; Chiu, Mark L.			Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PHASE-III; ONARTUZUMAB; RESISTANCE; ERLOTINIB; INVASION; DOMAIN	A bispecific antibody (BsAb) targeting the epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET) pathways represents a novel approach to overcome resistance to targeted therapies in patients with nonsmall cell lung cancer. In this study, we sequentially screened a panel of BsAbs in a combinatorial approach to select the optimal bispecific molecule. The BsAbs were derived from different EGFR and MET parental monoclonal antibodies. Initially, molecules were screened for EGFR and MET binding on tumor cell lines and lack of agonistic activity toward MET. Hits were identified and further screened based on their potential to induce untoward cell proliferation and crossphosphorylation of EGFR by MET via receptor colocalization in the absence of ligand. After the final step, we selected the EGFR and MET arms for the lead BsAb and added low fucose Fc engineering to generate amivantamab (JNJ-61186372). The crystal structure of the anti-MET Fab of amivantamab bound to MET was solved, and the interaction between the two molecules in atomic details was elucidated. Amivantamab antagonized the hepatocyte growth factor (HGF)-induced signaling by binding to MET Sema domain and thereby blocking HGF beta-chain-Sema engagement. The amivantamab EGFR epitope was mapped to EGFR domain III and residues K443, K465, I467, and S468. Furthermore, amivantamab showed superior antitumor activity over small molecule EGFR and MET inhibitors in the HCC827-HGF in vivo model. Based on its unique mode of action, amivantamab may provide benefit to patients with malignancies associated with aberrant EGFR and MET signaling.	[Neijssen, Joost; Wiegman, Luus; Schuurman, Janine; Parren, Paul W. H., I] Genmab, Utrecht, Netherlands; [Cardoso, Rosa M. F.; Chevalier, Kristen M.; Anderson, G. Mark; Moores, Sheri L.; Strohl, William R.; Chiu, Mark L.] Janssen Res & Dev, Spring House, PA 19477 USA; [Valerius, Thomas] Univ Kiel, Sect Stem Cell Transplantat & Immunotherapy, Dept Med 2, Kiel, Germany; [Valerius, Thomas] Univ Hosp Schleswig Holstein, Kiel, Germany; [Anderson, G. Mark] Genome Profiling LLC, Wayne, PA USA; [Parren, Paul W. H., I] Lava Therapeut, Utrecht, Netherlands; [Strohl, William R.] BiStro Biotech Consulting LLC, Bridgewater, NJ USA; [Chiu, Mark L.] Tavotek Biotherapeut, Spring House, PA 19477 USA	Genmab; Johnson & Johnson; Janssen Pharmaceuticals; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Chiu, ML (corresponding author), Janssen Res & Dev, Spring House, PA 19477 USA.; Chiu, ML (corresponding author), Tavotek Biotherapeut, Spring House, PA 19477 USA.	markchiu03@gmail.com	Valerius, Thomas/A-3086-2011	Parren, Paul/0000-0002-4365-3859; Valerius, Thomas/0000-0001-9181-8067; Neijssen, Joost/0000-0001-6697-4324	Janssen Research and Development, LLC	Janssen Research and Development, LLC	The study was funded by Janssen Research and Development, LLC.	Agarwal S, 2009, BRIT J CANCER, V100, P941, DOI 10.1038/sj.bjc.6604937; Arrieta O, 2015, J THORAC ONCOL, V10, P838, DOI 10.1097/JTO.0000000000000481; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Chemical Computing Group ULC, 2021, MOL OP ENV MOE 2019; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Dulak AM, 2011, ONCOGENE, V30, P3625, DOI 10.1038/onc.2011.84; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gonzalez A, 2016, INT J CANCER, V139, P1851, DOI 10.1002/ijc.30174; Grugan KD, 2017, MABS-AUSTIN, V9, P114, DOI 10.1080/19420862.2016.1249079; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haura EB, 2019, J CLIN ONCOL, V37; Husain B, 2018, BIODRUGS, V32, P441, DOI 10.1007/s40259-018-0299-9; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Labrijn AF, 2014, NAT PROTOC, V9, P2450, DOI 10.1038/nprot.2014.169; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Lee BS, 2016, ANN SURG ONCOL, V23, P2046, DOI 10.1245/s10434-015-5084-0; Lee DH, 2015, IMMUNOTARGETS THER, V4, P35, DOI 10.2147/ITT.S37409; Lee JM, 2016, ONCOGENE, V35, P4437, DOI 10.1038/onc.2015.514; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liu L, 2014, CLIN CANCER RES, V20, P6059, DOI 10.1158/1078-0432.CCR-14-0543; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997, 10.1517/13543784.17.7.997 ]; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Luraghi P, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00164; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Moores SL, 2016, CANCER RES, V76, P3942, DOI 10.1158/0008-5472.CAN-15-2833; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Niemann HH, 2013, BBA-PROTEINS PROTEOM, V1834, P2195, DOI 10.1016/j.bbapap.2012.10.012; Oxnard GR, 2018, JAMA ONCOL, V4, P1527, DOI 10.1001/jamaoncol.2018.2969; Patnaik A, 2018, CANCER CHEMOTH PHARM, V82, P407, DOI 10.1007/s00280-018-3623-7; Puri Neelu, 2008, J Carcinog, V7, P9; Scagliotti GV, 2018, J THORAC ONCOL, V13, P849, DOI 10.1016/j.jtho.2017.12.009; Scagliotti GV, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9019; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Spigel DR, 2017, J CLIN ONCOL, V35, P412, DOI 10.1200/JCO.2016.69.2160; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; van Bueren JJL, 2008, P NATL ACAD SCI USA, V105, P6109, DOI 10.1073/pnas.0709477105; Vijayaraghavan S, 2020, MOL CANCER THER, V19, P2044, DOI 10.1158/1535-7163.MCT-20-0071; Voigt M, 2012, NEOPLASIA, V14, P1023, DOI 10.1593/neo.121242; Xiang H, 2013, CLIN CANCER RES, V19, P5068, DOI 10.1158/1078-0432.CCR-13-0260; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yun J, 2020, CANCER DISCOV, V10, P1194, DOI 10.1158/2159-8290.CD-20-0116	48	41	41	9	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100641	10.1016/j.jbc.2021.100641	http://dx.doi.org/10.1016/j.jbc.2021.100641			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839159	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400612
J	Perazza, LR; Mitchell, PL; Lizotte, F; Jensen, BAH; St-Pierre, P; Trottier, J; Barbier, O; Mathieu, P; Geraldes, PM; Marette, A				Perazza, Lais R.; Mitchell, Patricia L.; Lizotte, Farah; Jensen, Benjamin A. H.; St-Pierre, Philippe; Trottier, Jocelyn; Barbier, Olivier; Mathieu, Patrick; Geraldes, Pedro M.; Marette, Andre			Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice	FASEB JOURNAL			English	Article						CVD; diabetic nephropathy; end-stage renal disease; omega-3 fatty acids; protectin DX	LEFT-VENTRICULAR HYPERTROPHY; POLYUNSATURATED FATTY-ACIDS; GROWTH-FACTOR-II; CARDIOVASCULAR-DISEASE; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; LIPID MEDIATORS; KIDNEY-DISEASE; BLOOD-PRESSURE; OMEGA-3-FATTY-ACIDS	Diabetic nephropathy (DN) remains the major cause of end-stage renal disease (ESRD). We used high-fat/high-sucrose (HFHS)-fed LDLr-/- /ApoB(100/100) mice with transgenic overexpression of IGFII in pancreatic beta-cells (LRKOB100/IGFII) as a model of ESRD to test whether dietary long chain omega-3 polyunsaturated fatty acids LC omega 3FA-rich fish oil (FO) could prevent ESRD development. We further evaluated the potential of docosahexaenoic acid (DHA)-derived pro-resolving lipid mediators, 17-hydroxy-DHA (17-HDHA) and Protectin DX (PDX), to reverse established ESRD damage. HFHS-fed vehicle-treated LRKOB100/IGFII mice developed severe kidney dysfunction leading to ESRD, as revealed by advanced glomerular fibrosis and mesangial expansion along with reduced percent survival. The kidney failure outcome was associated with cardiac dysfunction, revealed by reduced heart rate and prolonged diastolic and systolic time. Dietary FO prevented kidney damage, lean mass loss, cardiac dysfunction, and death. 17-HDHA reduced podocyte foot process effacement while PDX treatment alleviated kidney fibrosis and mesangial expansion as compared to vehicle treatment. Only PDX therapy was effective at preserving the heart function and survival rate. These results show that dietary LC omega 3FA intake can prevent ESRD and cardiac dysfunction in LRKOB100/IGFII diabetic mice. Our data further reveals that PDX can protect against renal failure and cardiac dysfunction, offering a potential new therapeutic strategy against ESRD.	[Perazza, Lais R.; Mitchell, Patricia L.; Jensen, Benjamin A. H.; St-Pierre, Philippe; Mathieu, Patrick; Marette, Andre] Laval Univ, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Perazza, Lais R.; Mitchell, Patricia L.; St-Pierre, Philippe; Marette, Andre] Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Lizotte, Farah; Geraldes, Pedro M.] Univ Sherbrook, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Jensen, Benjamin A. H.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Human Genom & Metagen Metab, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Trottier, Jocelyn; Barbier, Olivier] Laval Univ, CHU Quebec, Res Ctr, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute; Laval University; Novo Nordisk Foundation; University of Copenhagen; Laval University	Marette, A (corresponding author), Laval Univ, Quebec Heart & Lung Inst, Fac Med, Dept Med, Quebec City, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	; Jensen, Benjamin/M-4661-2014	Marette, Andre/0000-0003-3950-5973; Mitchell, Patricia/0000-0002-0773-1047; Barbier, Olivier/0000-0002-3067-1134; Jensen, Benjamin/0000-0001-6991-0828	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC); Diabetes Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Diabetes Canada	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC); Diabetes Canada	Abbate M, 1998, J AM SOC NEPHROL, V9, P1213; Berl T, 2006, CLIN J AM SOC NEPHRO, V1, P8, DOI 10.2215/CJN.00730805; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Cabo J, 2012, BRIT J NUTR, V107, pS195, DOI 10.1017/S0007114512001584; Casanova MA, 2017, J AM SOC HYPERTENS, V11, P10, DOI 10.1016/j.jash.2016.10.004; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; Chou HH, 2012, NEPHRON CLIN PRACT, V121, pC30, DOI 10.1159/000341929; Dalla Vestra M, 2001, J NEPHROL, V14, pS51; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; de Boer IH, 2019, JAMA-J AM MED ASSOC, V322, P1899, DOI 10.1001/jama.2019.17380; DECATERINA R, 1993, KIDNEY INT, V44, P843, DOI 10.1038/ki.1993.320; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; EBIHARA I, 1993, J AM SOC NEPHROL, V3, P1387; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; El-Sherif N, 2011, CARDIOL J, V18, P233; Elajami TK, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004740; FLOEGE J, 1991, KIDNEY INT, V40, P477, DOI 10.1038/ki.1991.235; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forclaz A, 2003, HYPERTENSION, V41, P31, DOI 10.1161/01.HYP.0000047512.58862.A9; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26428; Garman JH, 2009, AM J PHYSIOL-RENAL, V296, pF306, DOI 10.1152/ajprenal.90326.2008; GULER HP, 1988, P NATL ACAD SCI USA, V85, P4889, DOI 10.1073/pnas.85.13.4889; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ilyas Z, 2017, REV ENDOCR METAB DIS, V18, P21, DOI 10.1007/s11154-017-9422-3; KERJASCHKI D, 1994, KIDNEY INT, V45, P300, DOI 10.1038/ki.1994.39; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Le Quang K, 2014, ARTERIOSCL THROM VAS, V34, P2283, DOI 10.1161/ATVBAHA.114.304205; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Lee CC, 2012, CURR ATHEROSCLER REP, V14, P535, DOI 10.1007/s11883-012-0279-3; Lee CC, 2010, DIABETES CARE, V33, P1454, DOI 10.2337/dc09-2245; Lee GSL, 1998, KIDNEY INT, V53, P1389, DOI 10.1046/j.1523-1755.1998.00871.x; Li GB, 2017, J LIPID RES, V58, P1080, DOI [10.1194/jlr.M072587, 10.1194/jlr.m072587]; Losi MA, 2010, NEPHROL DIAL TRANSPL, V25, P1950, DOI 10.1093/ndt/gfp747; Marcello T, 2016, CIRCULATION, V133, P518, DOI 10.1161/CIRCULATIONAHA.115.018713; Meeus F, 2000, KIDNEY INT, V58, pS140, DOI 10.1046/j.1523-1755.2000.07618.x; Micakovic T, 2018, KIDNEY INT, V94, P937, DOI 10.1016/j.kint.2018.06.006; Middleton JP, 2010, KIDNEY INT, V77, P753, DOI 10.1038/ki.2010.19; Miller ER, 2009, AM J CLIN NUTR, V89, P1937, DOI 10.3945/ajcn.2008.26867; Miller PE, 2014, AM J HYPERTENS, V27, P885, DOI 10.1093/ajh/hpu024; Montford JR, 2017, J AM SOC NEPHROL, V28, P3155, DOI 10.1681/ASN.2016121344; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pighin D, 2003, J NUTR, V133, P4095, DOI 10.1093/jn/133.12.4095; Powell DW, 2013, LIFE SCI, V93, P257, DOI 10.1016/j.lfs.2013.06.016; pubmeddev al G-IC- et, 2019, PREVALENCE PROTEIN E; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Robinson BM, 2016, LANCET, V388, P294, DOI 10.1016/S0140-6736(16)30448-2; ROGERS SA, 1991, J CELL BIOL, V113, P1447, DOI 10.1083/jcb.113.6.1447; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; Rozenbaum Z, 2019, INT J CARDIOL, V277, P147, DOI 10.1016/j.ijcard.2018.08.008; Saran R, 2018, AM J KIDNEY DIS, V71, pS1, DOI 10.1053/j.ajkd.2018.01.002; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Srinivasan M, 2010, AM J PHYSIOL-ENDOC M, V299, pE910, DOI 10.1152/ajpendo.00339.2010; Svensson J, 2007, J ENDOCRINOL, V193, P359, DOI 10.1677/JOE-07-0024; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Vallon V, 2011, COMPR PHYSIOL, V1, P1175, DOI 10.1002/cphy.c100049; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; WOLF E, 1994, ENDOCRINOLOGY, V135, P1877, DOI 10.1210/en.135.5.1877; Xia HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00103-0	71	3	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21559	10.1096/fj.202100073R	http://dx.doi.org/10.1096/fj.202100073R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33835594				2022-12-26	WOS:000645260100075
J	Segarra, L; Simmens, SJ; Castel, AD; Kharfen, M; Masur, H; Greenberg, AE				Segarra, Lorena; Simmens, Samuel J.; Castel, Amanda D.; Kharfen, Michael; Masur, Henry; Greenberg, Alan E.			Highly variable trends in rates of newly diagnosed HIV cases in US hotspots, 2008-2017	PLOS ONE			English	Article							EPIDEMIC; STATES	The U.S. Ending the HIV Epidemic (EHE) initiative was announced in early 2019 and rapidly became a focal point for domestic HIV prevention and treatment programs. Using publicly available data from CDC, we examined historical trends in the average annual percent change (AAPC) in HIV diagnosis rates for the 57 EHE high incidence "hotspots" using Joinpoint analysis. We then assessed the ecologic association of various hotspot characteristics with changes in these rates over time using a multivariable regression model. From 2008-2017, the overall rate of newly diagnosed HIV cases in the U.S. declined from 19 to 14 per 100,000 persons, with the AAPC declining significantly in the U.S. overall (-3.1%; 95% CI: -3.7, -2.4) and in the 57 hotspots (-3.3%; 95% CI: -4.6, -2.8). There were large (AAPC <-5.0), moderate (-5.0 to -2.5) and small (-2.5 to 0.0) rates of decline in 14, 19 and 17 hotspots respectively, with increasing trends (AAPC >0.0) noted in seven hotspots. In the multivariable regression analysis, higher initial HIV diagnosis rate and location in the Northeast region were significantly associated with declining AAPC rates whereas no significant differences were found by hotspot gender, age, or race/ethnicity distribution. This analysis demonstrates that the rate of decline in HIV diagnosis rates in hotspots across the U.S. has been highly variable. Further exploration is warranted to assess the correlation between programmatic factors such as HIV testing and antiretroviral therapy and pre-exposure prophylaxis coverage with HIV trends across the hotspots.	[Segarra, Lorena; Castel, Amanda D.; Greenberg, Alan E.] George Washington Univ, Dept Epidemiol, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA; [Simmens, Samuel J.] George Washington Univ, Dept Biostat & Bioinformat, Milken Inst Sch Publ Hlth, Washington, DC USA; [Kharfen, Michael] DC Dept Hlth, HIV AIDS Hepatitis STD & TB Adm, Washington, DC USA; [Masur, Henry] NIH, Bldg 10, Bethesda, MD 20892 USA	George Washington University; George Washington University; National Institutes of Health (NIH) - USA	Greenberg, AE (corresponding author), George Washington Univ, Dept Epidemiol, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.	aeg1@gwu.edu		Simmens, Samuel/0000-0001-7830-8003	District of Columbia Center for AIDS Research, an NIH - NIAID [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NCI [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NICHD [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NHLBI [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NIDA [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NIMH [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NIA [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NIDDK [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NIMHD [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NIDCR [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - NINR [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - FIC [P30AI117970]; District of Columbia Center for AIDS Research, an NIH - OAR [P30AI117970]	District of Columbia Center for AIDS Research, an NIH - NIAID; District of Columbia Center for AIDS Research, an NIH - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); District of Columbia Center for AIDS Research, an NIH - NICHD; District of Columbia Center for AIDS Research, an NIH - NHLBI; District of Columbia Center for AIDS Research, an NIH - NIDA; District of Columbia Center for AIDS Research, an NIH - NIMH; District of Columbia Center for AIDS Research, an NIH - NIA; District of Columbia Center for AIDS Research, an NIH - NIDDK; District of Columbia Center for AIDS Research, an NIH - NIMHD; District of Columbia Center for AIDS Research, an NIH - NIDCR; District of Columbia Center for AIDS Research, an NIH - NINR; District of Columbia Center for AIDS Research, an NIH - FIC; District of Columbia Center for AIDS Research, an NIH - OAR	This manuscript was facilitated by the services provided by the District of Columbia Center for AIDS Research, an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NIDDK, NIMHD, NIDCR, NINR, FIC and OAR.	[Anonymous], GUIDELINES USE ANTIR; [Anonymous], 1981, MORBIDITY MORTALITY, V30, P250; [Anonymous], 2020, UNAIDS DAT; Beyrer C, 2021, LANCET, V397, P1151, DOI 10.1016/S0140-6736(21)00390-1; Castel AD, 2014, INFECT DIS CLIN N AM, V28, P563, DOI 10.1016/j.idc.2014.08.001; Centers for Disease Control and Prevention, 2018, HIV SURV REP, V31; Centers for Disease Control and Prevention, NCHHSTP ATLASPLUS; Centers for Disease Control and Prevention, 2020, HIV SURVEILLANCE S, V25; Chapin-Bardales J, 2018, ANN EPIDEMIOL, V28, P874, DOI 10.1016/j.annepidem.2018.09.006; Chapin-Bardales J, 2017, ANN EPIDEMIOL, V27, P329, DOI 10.1016/j.annepidem.2017.04.002; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; HHS Press Office, 2020, HHS AW 117 MILL END; HIV.gov, 2020, WHAT IS END HIV EP P; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kates J, 2020, AM J PUBLIC HEALTH, V110, P58, DOI 10.2105/AJPH.2019.305429; Marston HD, 2018, ANN INTERN MED, V169, P411, DOI 10.7326/M18-1944; NIH, 2019, NIH BOLST FUND HIV I; Pitasi MA, 2019, MMWR-MORBID MORTAL W, V68, P561, DOI 10.15585/mmwr.mm6825a2; Statistical Methodology and Applications Branch  Surveillance Research Program  National Cancer Institute, 2019, JOINP REGR PROGR VER; Sullivan PS, 2021, LANCET, V397, P1095, DOI 10.1016/S0140-6736(21)00395-0; Sullivan PS, 2020, ANN EPIDEMIOL, V44, P16, DOI 10.1016/j.annepidem.2020.01.004; US Census Bureau, 2010 CENS REG DIV US	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2021	16	4							e0250179	10.1371/journal.pone.0250179	http://dx.doi.org/10.1371/journal.pone.0250179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP4TZ	33872328	Green Published, gold			2022-12-26	WOS:000641723300016
J	Ghavam, M				Ghavam, Mansureh			Relationships of irrigation water and soil physical and chemical characteristics with yield, chemical composition and antimicrobial activity of Damask rose essential oil	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; MICROSATELLITE ANALYSIS; FOLIAR APPLICATION; MASS-SPECTROMETRY; MILL. ACCESSIONS; SALINITY STRESS; GROWTH; VARIABILITY; LAMIACEAE; REGIONS	Damask rose (Rosa damascena Mill.) is an aromatic medicinal plant rich in bioactive compounds with high value in the food, pharmaceutical and cosmetic industries. Knowledge of the factors affecting the quantitative and qualitative properties of the compounds in its essential oil (EO) and the bioactivity of this EO is important in optimizing Damask rose cultivation and production. This research studied, for the first time, the effects of irrigation water and soil chemical and physical characteristics on the EO yield of this important commercial species and on it chemical composition and antimicrobial activity. The results showed the significant effect of crop cultivation site on yield, chemical composition and inhibition zone diameter (IZD) at the 1% significance level. The highest EO yield (similar to 0.0266%), which belonged to the Noushabad site (EON), resulted from the increased soil electrical conductivity (EC) and the higher sand, gypsum and lime contents and irrigation water salinity. Analysis of the chemical composition of the EOs showed that their main compounds at all three crop sites were citronellol, nonadecane, heneicosane and geraniol. The EO obtained from the Yazdel site (EOY) had the highest contents of citronellol and geraniol (similar to 29.05% and similar to 6.85%) that were directly correlated with soil potassium and phosphorus contents and inversely correlated with soil acidity and EC and its lime, nitrogen, and organic carbon contents. Antimicrobial assays indicated that the EO extracted from the Sefidshahr site (EOS), which had the largest inhibition zone diameter (similar to 14.67 mm) for Aspergillus brasiliensis (IZD similar to 14.67 mm) and the lowest MIC (similar to 31.25 mu g/mL) for Staphylococcus aureus and Pseudomonas aeruginosa, exhibited efficacy similar to that of rifampin, probably due to the dominance of the alkanes in it. The EOY and EOS also exhibited the strongest inhibitory and lethal activity against Candida albicans (MIC and MBC <15.63 mu g/mL for EOY and MIC and MBC = 62.5 mu g/mL for EOS), which were six and four times stronger than those of nystatin, respectively. Therefore, the selected EOs can act as a potentially promising strategy for fighting microbial strains.	[Ghavam, Mansureh] Univ Kashan, Fac Nat Resources & Earth Sci, Dept Range & Watershed Management, Kashan, Iran	University Kashan	Ghavam, M (corresponding author), Univ Kashan, Fac Nat Resources & Earth Sci, Dept Range & Watershed Management, Kashan, Iran.	mghavam@kashanu.ac.ir						Adams R.P, 2007, CAROL STREAM, VIL, P804; Agrawal PK, 1988, P INT C PLANT PHYS, V2, P1369; Ahmed A.M.A., 2017, CROP SCI, V9, P40; Al-Yasi H, 2020, PLANT PHYSIOL BIOCH, V150, P133, DOI 10.1016/j.plaphy.2020.02.038; Alizadeh A, 2010, J MED PLANTS RES, V4, P33; AMES GR, 1968, TROP SCI, V10, P136; Andrade-Ochoa S, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0858-2; [Anonymous], 2013, ASIAN J PLANT SCI RE; [Anonymous], 2005, AL QANOON FI AL TIBB, V1st ed.; Arvin P., 2019, J PLANT RES, V32, P464; Azarnivand H., 2003, Iranian Journal of Natural Resources, V56, P93; Azarnivand H., 2010, Iranian Journal of Medicinal and Aromatic Plants, V25, P556; Babaei A, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-12; Basal H, 2009, J AGRON CROP SCI, V195, P19, DOI 10.1111/j.1439-037X.2008.00340.x; BASER K H C, 1992, Perfumer and Flavorist, V17, P45; BAYRAK A, 1994, J SCI FOOD AGR, V64, P441, DOI 10.1002/jsfa.2740640408; Becerro MA, 2004, MAR ECOL PROG SER, V280, P115, DOI 10.3354/meps280115; BIALCZYK J, 1994, J PLANT NUTR, V17, P801, DOI 10.1080/01904169409364768; Bonacina C., 2017, Australian Journal of Crop Science, V11, P1665, DOI 10.21475/ajcs.17.11.12.pne921; Boskabady MH, 2011, IRAN J BASIC MED SCI, V14, P295; Buckle J, 2015, BASIC PLANT TAXONOMY; Chrysargyris A, 2019, SCI HORTIC-AMSTERDAM, V256, DOI 10.1016/j.scienta.2019.108581; CLSI. Clinical and Laboratory Standard Institute, 2012, NATL COMMITTEE CLIN, V29, P1; Cordeiro RA, 2013, MED MYCOL, V51, P53, DOI 10.3109/13693786.2012.692489; Duarte MCT, 2007, J ETHNOPHARMACOL, V111, P197, DOI 10.1016/j.jep.2006.11.034; Dadkhah A, 2019, TURK J PHARM SCI, V16, P416, DOI 10.4274/tjps.galenos.2018.58815; Daferera DJ, 2000, J AGR FOOD CHEM, V48, P2576, DOI 10.1021/jf990835x; Dannenberg GD, 2016, INNOV FOOD SCI EMERG, V36, P120, DOI 10.1016/j.ifset.2016.06.009; Demirci F, 2008, FOOD CONTROL, V19, P1159, DOI 10.1016/j.foodcont.2008.01.001; DUKE JA, 2016, NATURAL PRODUCTS PLA; El-Gohary A. E., 2015, Genetics and Plant Physiology, V5, P170; Elhidar N, 2019, IND CROP PROD, V130, P310, DOI 10.1016/j.indcrop.2018.12.097; Fairchild J. A., 2001, J RANG MANA, V33, P150; Fakhr Tabatabai S.M, 2005, PRODUCTION PROCESSIN; Farsaraei S, 2020, SCI HORTIC-AMSTERDAM, V271, DOI 10.1016/j.scienta.2020.109465; Fatemi F, 2020, TURK J PHARM SCI, V17, P99, DOI 10.4274/tjps.galenos.2018.24381; Feng XP, 2021, IND CROP PROD, V159, DOI 10.1016/j.indcrop.2020.113032; Galeshi S, 2001, AGR NATURAL RES J, V8, P87; Ghavam M., 2021, SCI REP-UK; Ghavam M, 2021, J ETHNOPHARMACOL, V267, DOI 10.1016/j.jep.2020.113513; Ghavam M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73193-y; Guenther, 1952, ESSENTIAL OILS, V5; Gul HI, 2002, BIOL PHARM BULL, V25, P1307, DOI 10.1248/bpb.25.1307; Habibi D, 2011, NEW FIND AGR, V1, P5; Habibi H, 2007, PAJOUHESH SAZANDEGI, V19, P2; Hashempur MH, 2017, JAMA DERMATOL, V153, P70, DOI 10.1001/jamadermatol.2016.0144; Heydarirad G, 2019, COMPLEMENT THER CLIN, V35, P57, DOI 10.1016/j.ctcp.2019.01.017; Huber DM, 2007, MINERAL NUTR PLANT D, P31; Jin-Tun Zhang, 2002, Plant Ecology, V162, P23, DOI 10.1023/A:1020355921982; Jirovetz L., 2006, Recent Research Developments in Agronomy & Horticulture. Vol. 2, P1; Karray-Bouraoui N, 2009, IND CROP PROD, V30, P338, DOI 10.1016/j.indcrop.2009.06.003; Kepenek K., 2015, INFRASTRUCTURE ECOLO, V2, P745; Keyhanmehr AS, 2018, RES J PHARMACOGN, V5, P41; Kim E, 2012, MOLECULES, V17, P10459, DOI 10.3390/molecules170910459; Konovalova O., 2013, NUTT UKRAINIAN FLORA, V2, P7; KOVATS ES, 1987, J CHROMATOGR, V406, P185; Kumar N, 2009, FOOD CHEM TOXICOL, V47, P361, DOI 10.1016/j.fct.2008.11.036; Kumar R, 2016, IND CROP PROD, V83, P596, DOI 10.1016/j.indcrop.2015.12.065; Kumar R, 2013, SCI HORTIC-AMSTERDAM, V154, P102, DOI 10.1016/j.scienta.2013.02.002; Loghmani-Khouzani H, 2007, SCI IRAN, V14, P316; Mahmood N, 1996, BIOCHEM BIOPH RES CO, V229, P73, DOI 10.1006/bbrc.1996.1759; Mahmoodreza M., 2010, IRAN J PHARM SCI, V6, P59; Mansoorkhani AR, 2012, GLOB J RES MED PLANT, V1, P258; Mirali N., 2012, International Journal of Medicinal and Aromatic Plants, V2, P41; Momeni T., 1991, ESSENTIAL OILS THEIR; Moradi Hossein, 2020, Biotechnology Reports, V25, pe00408, DOI 10.1016/j.btre.2019.e00408; Naeini A, 2009, J MYCOL MED, V19, P168, DOI 10.1016/j.mycmed.2009.04.004; Naquvi K.J., 2014, J PHARMACOGN PHYTOCH, V2, P130; Nedeltcheva-Antonova D, 2017, IND CROP PROD, V108, P36, DOI 10.1016/j.indcrop.2017.06.007; Niazi M, 2017, COMPLEMENT THER MED, V34, P35, DOI 10.1016/j.ctim.2017.07.009; Nik Baher Z., 2014, ECHO PHYTO MEDI, V3, P22; Nooshkam A, 2017, J APPL RES MED AROMA, V6, P126, DOI 10.1016/j.jarmap.2017.04.002; Opalchenova G, 2003, J MICROBIOL METH, V54, P105, DOI 10.1016/S0167-7012(03)00012-5; Pal P. K., 2013, Australian Journal of Crop Science, V7, P196; Panda H, 2006, CULTIVATION UTILIZAT, P14; Parvaiz A, 2008, PLANT SOIL ENVIRON, V54, P89, DOI 10.17221/2774-PSE; Popovic-Djordjevic J, 2019, IND CROP PROD, V128, P162, DOI 10.1016/j.indcrop.2018.11.003; Rahman MS, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-017-3543-x; Rebey IB, 2017, J FOOD DRUG ANAL, V25, P391, DOI 10.1016/j.jfda.2016.10.001; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Rusanov K, 2005, THEOR APPL GENET, V111, P804, DOI 10.1007/s00122-005-2066-9; Rusanov K, 2012, IND CROP PROD, V37, P6, DOI 10.1016/j.indcrop.2011.11.010; Sadraei H., 2013, RES PHARM SCI, V8; Sampaio B.L., 2017, REV BRASIL FARMACO, V28, P1; Sangwan NS, 2001, PLANT GROWTH REGUL, V34, P3, DOI 10.1023/A:1013386921596; Sefidkon F., 2007, IRANIAN J MED AROM P, V22, P351; Sell C. S., 2003, FRAGRANT INTRO TERPE; Shirazi A, 2009, MAKHZAN AL ADVIYAH; Shohayeb M., 2014, GLOB J PHARM, V8, P1, DOI DOI 10.1016/J.ADDR.2005.01.020; Slavov A.M, 2020, J ESSENTIAL OIL RES; Slavov A, 2017, REV ENVIRON SCI BIO, V16, P309, DOI 10.1007/s11157-017-9430-5; Tabaei-Aghdaei SR, 2007, SCI HORTIC-AMSTERDAM, V113, P44, DOI 10.1016/j.scienta.2007.01.010; Thakur M, 2020, IND CROP PROD, V158, DOI 10.1016/j.indcrop.2020.113024; Thakur M, 2019, J APPL RES MED AROMA, V13, DOI 10.1016/j.jarmap.2019.100202; UEYAMA Y, 1990, Flavour and Fragrance Journal, V5, P115, DOI 10.1002/ffj.2730050212; Ulusoy S, 2009, CURR MICROBIOL, V59, P554, DOI 10.1007/s00284-009-9475-y; Vaiciulyte V, 2017, IND CROP PROD, V95, P422, DOI 10.1016/j.indcrop.2016.10.052; Verma RS, 2011, NAT PROD RES, V25, P1577, DOI 10.1080/14786419.2010.520162; Walia S, 2020, IND CROP PROD, V150, DOI 10.1016/j.indcrop.2020.112449; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Yassa N, 2009, DARU, V17, P175; Yi FP, 2019, LWT-FOOD SCI TECHNOL, V102, P310, DOI 10.1016/j.lwt.2018.12.051; Yousefi B., 2018, INT J HORTIC SCI TEC, V1, P81; Yousefi B, 2009, SCI HORTIC-AMSTERDAM, V121, P333, DOI 10.1016/j.scienta.2009.02.004; Yu X, 2015, SCI HORTIC-AMSTERDAM, V197, P579, DOI 10.1016/j.scienta.2015.10.023; Zargari A., 1992, MED PLANTS, Vfifth; Zargoosh Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52605-8; Zgheib R, 2020, J ESSENT OIL BEAR PL, V23, P1161, DOI 10.1080/0972060X.2020.1843544; Zheljazkov VD, 2010, J AGR FOOD CHEM, V58, P11400, DOI 10.1021/jf1022077; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008; Zu YG, 2010, MOLECULES, V15, P3200, DOI 10.3390/molecules15053200	111	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249363	10.1371/journal.pone.0249363	http://dx.doi.org/10.1371/journal.pone.0249363			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861759	Green Published, gold			2022-12-26	WOS:000641475400005
J	Peter, EL; Nagendrappa, PB; Ajayi, CO; Sesaazi, CD				Peter, Emanuel L.; Nagendrappa, Prakash B.; Ajayi, Clement Olusoji; Sesaazi, Crispin Duncan			Total polyphenols and antihyperglycemic activity of aqueous fruits extract of Abelmoschus esculentus: Modeling and optimization of extraction conditions	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; INSULIN SENSITIVITY; IDENTIFICATION; QUERCETIN; MYRICETIN	Aqueous fruits extract of Abelmoschus esculentus (L.) Moench (Malvaceae) has been used traditionally in several communities to alleviate elevated blood glucose levels. However, optimized extraction conditions have not been reported. Thus, this study determined the optimal extraction conditions for extracting polyphenols from A. esculentus fruits and evaluated antihyperglycemic activity in vivo. Extraction time, temperature, and solid-to-solvent ratio were optimized using Response Surface Methodology (RSM). Total polyphenols and flavonoids were quantified using the Folin-Ciocalteu and aluminium chloride colorimetric methods, respectively. The fingerprint and quantification of quercetin-a major flavonoid with an antihyperglycemic effect was done using the chromatographic method. The antihyperglycemic activity was determined in a high-fat diet-Streptozotocin rat model. The rats were assigned to five groups (n = 6): Group 1 and 2 were normal and diabetic control received distilled water 1 mL/100g; Treatment group 3 and 4 received standardized A. esculentus fruit extract (AEFE) at a dose of 100 and 200 mg/kg, respectively; Group 5 received 5 mg/kg glibenclamide. All treatments were given orally for 14 days. Measurements of fasting plasma glucose (FPG) and body weight were done weekly. The RSM quadratic model predicted total polyphenols of 22.16 mg GAE/g DW. At optimal conditions of a solid-to-solvent ratio of 5%, extraction time 1 h, and extraction temperature of 70 degrees C, confirmation experiments yield 20.2 [95% CI; 16.7 to 27.6] mg GAE/g DW, implying the model successfully predicted total polyphenols. The extract HPLC fingerprint showed 13 characteristic peaks with 0.45 +/- 0.02 mu g/g DW of quercetin. Compared with diabetic control, the standardized AEFE reduced FPG level dose-dependently (P < 0.001) with an EC50 of 141.4 mg/kg. Together, at optimal extraction conditions, extract with a high content of total polyphenols and good antihyperglycemic activity can be obtained. Studies are needed to identify additional polyphenolic compounds and determine their antidiabetic effects.	[Peter, Emanuel L.] Natl Inst Med Res, Dept Innovat Technol Transfer & Commercializat, Dar Es Salaam, Tanzania; [Nagendrappa, Prakash B.] Univ Transdisciplinary Hlth Sci & Technol TDU, Ctr Local Hlth Tradit & Policy, Bengaluru, India; [Peter, Emanuel L.; Ajayi, Clement Olusoji] Mbarara Univ Sci & Technol, Fac Med, Dept Pharm, Mbarara, Uganda; [Sesaazi, Crispin Duncan] Mbarara Univ Sci & Technol, Fac Med, Dept Pharmaceut Sci, Mbarara, Uganda	National Institute of Medical Research; Mbarara University of Science & Technology; Mbarara University of Science & Technology	Peter, EL (corresponding author), Natl Inst Med Res, Dept Innovat Technol Transfer & Commercializat, Dar Es Salaam, Tanzania.	epeter@std.must.ac.ug	Peter, Emanuel L./AAA-7297-2020	Peter, Emanuel L./0000-0002-8162-4784	PHARMBIOTRAC-ACEII, Mbarara University of Science and Technology	PHARMBIOTRAC-ACEII, Mbarara University of Science and Technology	This work was financially supported by PHARMBIOTRAC-ACEII, Mbarara University of Science and Technology.	Amirabbasi S, 2021, J FOOD MEAS CHARACT, V15, P717, DOI 10.1007/s11694-020-00641-8; Ansari NM, 2005, PHYTOTHER RES, V19, P907, DOI 10.1002/ptr.1756; Arapitsas P, 2008, FOOD CHEM, V110, P1041, DOI 10.1016/j.foodchem.2008.03.014; AVMA, 2020, AVMA GUIDELINES EUTH; Azahar NF, 2017, CHEM CENT J, V11, DOI 10.1186/s13065-017-0324-y; Baba SA, 2015, J TAIBAH UNIV SCI, V9, P449, DOI 10.1016/j.jtusci.2014.11.001; Capello C, 2007, GREEN CHEM, V9, P927, DOI 10.1039/b617536h; Chen L, 2020, ACTA ENDOCRINOL-BUCH, V16, P9, DOI 10.4183/aeb.2020.9; Chotimah H. E. N. C., 2013, Biodiversitas: Journal of Biological Diversity, V14, P106; Cujic N, 2016, FOOD CHEM, V194, P135, DOI 10.1016/j.foodchem.2015.08.008; Evans W.C., 2009, TEASE EVANS PHARMACO; Geng S, 2015, TROP J PHARM RES, V14, P807, DOI 10.4314/tjpr.v14i5.10; Guasch-Ferre M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6723931; Hachi M, 2016, LAZAROA, V37, P135, DOI 10.5209/LAZAROA.51854; HMPC, 2007, COMMITTEE HERBAL MED; Hu LM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/341291; Jain N., 2012, PHARMACIA, V1, P84; Kasole R, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/2835691; Liao HB, 2012, PHARMACOGN MAG, V8, P156, DOI 10.4103/0973-1296.96570; Liao HB, 2012, PHARMACOGN MAG, V8, P12, DOI 10.4103/0973-1296.93303; Liu IM, 2007, PLANTA MED, V73, P1054, DOI 10.1055/s-2007-981577; Liu IM, 2005, PLANTA MED, V71, P617, DOI 10.1055/s-2005-871266; Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050; Lu YY, 2016, J FUNCT FOODS, V20, P463, DOI 10.1016/j.jff.2015.10.037; Mahindrakar KV, 2020, CHEM ENG PROCESS, V149, DOI 10.1016/j.cep.2020.107841; Palma M, 2001, J CHROMATOGR A, V921, P169, DOI 10.1016/S0021-9673(01)00882-2; Pawar Shubhangi, 2011, Current Botany, V2, P15; Ramic M, 2015, ULTRASON SONOCHEM, V23, P360, DOI 10.1016/j.ultsonch.2014.10.002; Saha D., 2011, INT J PHARM PHARM SC, V3, P183; Shen DD, 2019, J FOOD SCI TECH MYS, V56, P1275, DOI 10.1007/s13197-019-03592-1; Shirsath SR, 2017, ULTRASON SONOCHEM, V38, P437, DOI 10.1016/j.ultsonch.2017.03.040; Shui GH, 2004, J CHROMATOGR A, V1048, P17, DOI 10.1016/j.chroma.2004.07.032; Silva EM, 2007, SEP PURIF TECHNOL, V55, P381, DOI 10.1016/j.seppur.2007.01.008; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sivasankari B, 2014, J ETHNOPHARMACOL, V153, P408, DOI 10.1016/j.jep.2014.02.040; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Thanakosai W, 2013, NAT PROD COMMUN, V8, P1085; Tuszynska Magdalena, 2014, Journal of Horticultural Research, V22, P131, DOI 10.2478/johr-2014-0016; Vessal M, 2003, COMP BIOCHEM PHYS C, V135, P357, DOI 10.1016/S1532-0456(03)00140-6; World Health Organization, 2011, QUAL CONTR METH HERB, P173; Wu L, 2020, FOOD SCI TECH-BRAZIL, V40, P972, DOI 10.1590/fst.28619; X AJ., 2016, IJRPP, V5, P142; Xie PS, 2006, J CHROMATOGR A, V1112, P171, DOI 10.1016/j.chroma.2005.12.091; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; Zhang QW, 2018, CHIN MED-UK, V13, DOI 10.1186/s13020-018-0177-x	46	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250405	10.1371/journal.pone.0250405	http://dx.doi.org/10.1371/journal.pone.0250405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861803	Green Published, gold			2022-12-26	WOS:000641475400044
J	Evangelista, FF; Costa-Ferreira, W; Mantelo, FM; Beletini, LF; de Souza, AH; Sant'Ana, PD; de Lima, KK; Crestani, CC; Falavigna-Guilherme, AL				Evangelista, Fernanda Ferreira; Costa-Ferreira, Willian; Mantelo, Francini Martini; Beletini, Lucimara Fatima; de Souza, Amanda Hinobu; Sant'Ana, Priscilla de Laet; de Lima, Keller Karla; Crestani, Carlos Cesar; Falavigna-Guilherme, Ana Lucia			Rosuvastatin revert memory impairment and anxiogenic-like effect in mice infected with the chronic ME-49 strain of Toxoplasma gondii	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; PSYCHIATRIC-DISORDERS; RH STRAIN; BEHAVIOR; SEROPOSITIVITY; PROLIFERATION; MANIPULATION; ASSOCIATION; SIMVASTATIN; PRAVASTATIN	The aim of this study was to investigate the effect of rosuvastatin treatment on memory impairment, and anxiogenic-like effects in mice chronically infected with Toxoplasma gondii. For this, Balb/c mice were infected orally with chronic ME-49 strain of Toxoplasma gondii. Oral treatment with rosuvastatin (40mg/kg/day) started on the 51(st) day post-infection and was performed daily for 21 days. After completion of treatment, anxiety-like effects and locomotion were investigated in the open field (OF) test, whereas novel object recognition (NOR) test was used for evaluation of short- and long-term memory. At the end of the experiments, the brain was collected for Toxoplasma gondii DNA quantification and histopathological analysis. Infection with ME-49 strain decreased the time spent in the center of OF, indicating an anxiogenic effect, without affecting total and peripheral locomotion. Rosuvastatin treatment inhibited the change in the center time. Besides, pharmacological treatment increased total and central locomotion in both non-infected and infected animals. Infection also impaired both short- and long-term memory in the NOR test, and these effects were reverted by rosuvastatin treatment. In addition to effects in behavioral changes, rosuvastatin also reduced parasite load in the brain and attenuated signs of brain inflammation such as perivascular cuffs, inflammatory cell infiltration and tissue damage. These findings indicate for the first time the efficacy of rosuvastatin in treatment of memory impairment and anxiogenic effect evoked by infection with Toxoplasma gondii. These effects might be mediated by reduced cyst load, which in turn decrease inflammation and damage in the brain.	[Evangelista, Fernanda Ferreira; Mantelo, Francini Martini; Beletini, Lucimara Fatima; Sant'Ana, Priscilla de Laet; Falavigna-Guilherme, Ana Lucia] State Univ Maringa UEM, Hlth Sci Dept, Maringa, Parana, Brazil; [Costa-Ferreira, Willian; Crestani, Carlos Cesar] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Araraquara, SP, Brazil; [de Souza, Amanda Hinobu] State Univ Maringa UEM, Pharmaceut Sci Program, Maringa, Parana, Brazil; [de Lima, Keller Karla] Municipal Hlth Author Apucarana, Obstetr Nursing, Apucarana, PR, Brazil	Universidade Estadual de Maringa; Universidade Estadual Paulista; Universidade Estadual de Maringa	Evangelista, FF (corresponding author), State Univ Maringa UEM, Hlth Sci Dept, Maringa, Parana, Brazil.	fer.evangelista@hotmail.com	Ferreira, Willian Costa/V-3268-2017; Crestani, Carlos Cesar/E-4161-2012	de Laet Santana, Priscilla/0000-0001-6462-9631; Crestani, Carlos Cesar/0000-0002-1942-858X; Costa-Ferreira, willian/0000-0001-6506-2331	Sao Paulo State Research Support Foundation (FAPESP); Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo State Research Support Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Sao Paulo State Research Support Foundation (FAPESP) in the form of a scholarship awarded to WCF and Coordination for the Improvement of Higher Education Personnel (CAPES) in the form of scholarships awarded to FFE, FMM, LFB, and AHdS.	Bay-Richter C, 2019, BEHAV BRAIN RES, V364, P133, DOI 10.1016/j.bbr.2019.02.018; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Bhadra R, 2013, SCHIZOPHRENIA BULL, V39, P485, DOI 10.1093/schbul/sbt006; Boillat M, 2020, CELL REP, V30, P320, DOI 10.1016/j.celrep.2019.12.019; Bottari NB, 2016, MICROB PATHOGENESIS, V95, P166, DOI 10.1016/j.micpath.2016.04.002; Burgdorf KS, 2019, BRAIN BEHAV IMMUN, V79, P152, DOI 10.1016/j.bbi.2019.01.026; Chen XJ, 2019, ACTA TROP, V192, P82, DOI 10.1016/j.actatropica.2019.02.001; Chew WK, 2012, ANTIMICROB AGENTS CH, V56, P1762, DOI 10.1128/AAC.05183-11; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Costa-Ferreira M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00705; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; Duffy AR, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193732; Dunay IR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00057-17; El-Zawawy LA, 2015, ACTA TROP, V141, P103, DOI 10.1016/j.actatropica.2014.09.020; Fenta DA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4694-8; Ferreira EC, 2013, T ROY SOC TROP MED H, V107, P390, DOI 10.1093/trstmh/trt026; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Gay-Andrieu F, 2009, DIAGN MICR INFEC DIS, V65, P279, DOI 10.1016/j.diagmicrobio.2009.07.013; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; HAY J, 1984, ANN TROP MED PARASIT, V78, P611, DOI 10.1080/00034983.1984.11811872; HAY J, 1983, ANN TROP MED PARASIT, V77, P483, DOI 10.1080/00034983.1983.11811741; Ihara F, 2016, INFECT IMMUN, V84, P2861, DOI 10.1128/IAI.00217-16; Jauregui LH, 2001, J CLIN MICROBIOL, V39, P2065, DOI 10.1128/JCM.39.6.2065-2071.2001; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Li ZH, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02628-16; Li ZH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003665; Bezerra ECM, 2019, MICROB PATHOGENESIS, V126, P279, DOI 10.1016/j.micpath.2018.11.021; Martynowicz J, 2019, MBIO, V10, DOI [10.1128/mBio.00381-19, 10.1128/mbio.00381-19]; Mendez OA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006351; Moncada PA, 2012, EXPERT REV ANTI-INFE, V10, P815, DOI [10.1586/ERI.12.58, 10.1586/eri.12.58]; Morais-Silva G, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20155009; Nanassy OZ, 2007, ANAL BIOCHEM, V365, P240, DOI 10.1016/j.ab.2007.03.017; Neto-Ferreira R, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-32; Nishi L, 2020, PARASITOLOGY, V147, P303, DOI 10.1017/S0031182019001604; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Petersen Eskild, 2003, Expert Rev Anti Infect Ther, V1, P175, DOI 10.1586/14787210.1.1.175; Pittman KJ, 2015, MICROBIOL MOL BIOL R, V79, P387, DOI 10.1128/MMBR.00027-15; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Sanders AP, 2017, PEDIATR INFECT DIS J, V36, P817, DOI 10.1097/INF.0000000000001614; Sanfelice RA, 2018, J APPL BIOMED, V16, P29, DOI 10.1016/j.jab.2017.10.009; Sanfelice RA, 2017, ACTA TROP, V167, P208, DOI 10.1016/j.actatropica.2016.12.006; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Serranti D, 2011, EUR REV MED PHARMACO, V15, P193; Shwab EK, 2018, P NATL ACAD SCI USA, V115, pE6956, DOI 10.1073/pnas.1722202115; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Sutterland AL, 2015, ACTA PSYCHIAT SCAND, V132, P161, DOI 10.1111/acps.12423; Wang ZD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00389; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; Wilson C., 2011, INFECT DIS FETUS NEW, DOI [10.1016/C2009-0-50442-4, DOI 10.1016/C2009-0-50442-4]; Worth AR, 2014, ADV PARASIT, V85, P109, DOI 10.1016/B978-0-12-800182-0.00003-9; Xiao JC, 2020, TRENDS PARASITOL, V36, P317, DOI 10.1016/j.pt.2020.01.005; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250079	10.1371/journal.pone.0250079	http://dx.doi.org/10.1371/journal.pone.0250079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857221	Green Submitted, gold, Green Published			2022-12-26	WOS:000641474900038
J	Mobarez, AM; Khalili, M; Mostafavi, E; Esmaeili, S				Mobarez, Ashraf Mohabati; Khalili, Mohammad; Mostafavi, Ehsan; Esmaeili, Saber			Molecular detection of Coxiella burnetii infection in aborted samples of domestic ruminants in Iran	PLOS ONE			English	Article							Q-FEVER; DIAGNOSIS; FETUSES; SHEEP	Background Coxiella burnetii is the causative agent of Q fever which is a highly infectious zoonotic disease. C. burnetii has become one of the most important causes of abortion in livestock, which can lead to widespread abortions in these animals. There are very limited studies on the prevalence of C. burnetii infection in cases of animal abortion in Iran. The aim of this study was to investigate the occurrence of C. burnetii in ruminant abortion samples in Iran. Methods Abortion samples from cattle, sheep and goats were collected from different parts of Iran and were tested using Real-time PCR targeting the IS1111 element of C. burnetii. Results In this study, 36 samples (24.7%) of the 146 collected samples were positive for C. burnetii. The prevalence of C. burnetii was 21.3% (20 of 94 samples) in sheep samples. Also, 10 of 46 cattle samples (21.7%) were positive. All six goat abortion samples were positive for C. burnetii. Conclusions The findings of the study demonstrate that C. burnetii plays an important role in domestic ruminant abortions in Iran, suggesting that more attention should be paid to the role of C. burnetii in domestic animal abortions by veterinary organizations. The risk of transmitting the infection to humans due to abortion of animals should also be considered.	[Mobarez, Ashraf Mohabati] Tarbiat Modares Univ, Fac Med Sci, Dept Bacteriol, Tehran, Iran; [Khalili, Mohammad] Shahid Bahonar Univ Kerman, Fac Vet Med, Dept Pathobiol, Kerman, Iran; [Mostafavi, Ehsan; Esmaeili, Saber] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Dept Epidemiol & Biostat, Tehran, Iran; [Mostafavi, Ehsan; Esmaeili, Saber] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Natl Reference Lab Plague Tularemia & Q Fever, Kabudar Ahang, Hamadan, Iran	Tarbiat Modares University; Shahid Bahonar University of Kerman (SBUK); Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Esmaeili, S (corresponding author), Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Dept Epidemiol & Biostat, Tehran, Iran.; Esmaeili, S (corresponding author), Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Natl Reference Lab Plague Tularemia & Q Fever, Kabudar Ahang, Hamadan, Iran.	dr.saberesmaeili@gmail.com	Esmaeili, Saber/F-2620-2017; Mostafavi, Ehsan/A-7627-2011; Khalili, Mohammad/AAA-8809-2022	Esmaeili, Saber/0000-0003-1920-1737; Mostafavi, Ehsan/0000-0002-1997-517X; Khalili, Mohammad/0000-0003-0534-2774	Tarbiat Modares University (Tehran, Iran); Centre for Communicable Diseases Control in Ministry of Health [810]; Iranian National Scientific Foundation (INSF) [91004716]; Pasteur Institute of Iran	Tarbiat Modares University (Tehran, Iran); Centre for Communicable Diseases Control in Ministry of Health; Iranian National Scientific Foundation (INSF); Pasteur Institute of Iran	This work was supported financially by Tarbiat Modares University (Tehran, Iran), Pasteur Institute of Iran and Centre for Communicable Diseases Control in Ministry of Health (grant 810), and also, Iranian National Scientific Foundation (INSF; Contracted No.91004716). The funders not had any role in study design, conducting survey and results analysis.	Abiri Z., 2016, INT J ENTERIC PATHOG, V4, P9; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Cantas H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-13; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Esmaeili S, 2019, COMP IMMUNOL MICROB, V63, P127, DOI 10.1016/j.cimid.2019.01.015; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; Gunaydin E, 2015, KAFKAS UNIV VET FAK, V21, P69, DOI 10.9775/kvfd.2014.11729; Heidari S, 2018, TROP ANIM HEALTH PRO, V50, P779, DOI 10.1007/s11250-017-1494-2; Kilic A, 2016, IRAN J VET RES, V17, P41; Kreizinger Z, 2015, J VET DIAGN INVEST, V27, P206, DOI 10.1177/1040638714563566; Magouras I, 2017, TRANSBOUND EMERG DIS, V64, P204, DOI 10.1111/tbed.12362; Million M, 2015, J INFECTION, V71, pS2, DOI 10.1016/j.jinf.2015.04.024; Mobarez AM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005521; Moradnejad P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51600-3; Parisi A, 2006, VET MICROBIOL, V118, P101, DOI 10.1016/j.vetmic.2006.06.023; Rodolakis A, 2009, ANN NY ACAD SCI, V1166, P90, DOI 10.1111/j.1749-6632.2009.04511.x; Roest HIJ, 2013, VET QUART, V33, P148, DOI 10.1080/01652176.2013.843809; Roshan HM, 2018, IRAN J VET RES, V19, P128; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Selim A, 2018, MICROB PATHOGENESIS, V125, P272, DOI 10.1016/j.micpath.2018.09.034; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250116	10.1371/journal.pone.0250116	http://dx.doi.org/10.1371/journal.pone.0250116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852632	gold, Green Published			2022-12-26	WOS:000640604500043
J	Sriraman, K; Shaikh, A; Parikh, S; Udupa, S; Chatterjee, N; Shastri, J; Mistry, N				Sriraman, Kalpana; Shaikh, Ambreen; Parikh, Swapneil; Udupa, Shreevatsa; Chatterjee, Nirjhar; Shastri, Jayanthi; Mistry, Nerges			Non-invasive adapted N-95 mask sampling captures variation in viral particles expelled by COVID-19 patients: Implications in understanding SARS-CoV2 transmission	PLOS ONE			English	Article							EXPOSURE; AEROSOLS	Infectious respiratory particles expelled by SARS-CoV-2 positive patients are attributed to be the key driver of COVID-19 transmission. Understanding how and by whom the virus is transmitted can help implement better disease control strategies. Here we have described the use of a noninvasive mask sampling method to detect and quantify SARS-CoV-2 RNA in respiratory particles expelled by COVID-19 patients and discussed its relationship to transmission risk. Respiratory particles of 31 symptomatic SARS-CoV-2 positive patients and 31 asymptomatic healthy volunteers were captured on N-95 masks layered with a gelatin membrane in a 30-minute process that involved talking/reading, coughing, and tidal breathing. SARS-CoV-2 viral RNA was detected and quantified using rRT-PCR in the mask and in concomitantly collected nasopharyngeal swab (NPS) samples. The data were analyzed with respect to patient demographics and clinical presentation. Thirteen of 31(41.9%) patients showed SARS-COV-2 positivity in both the mask and NPS samples, while 16 patients were mask negative but NPS positive. Two patients were both mask and NPS negative. All healthy volunteers except one were mask and NPS negative. The mask positive patients had significantly lower NPS Ct value (26) compared to mask negative patients (30.5) and were more likely to be rapid antigen test positive. The mask positive patients could be further grouped into low emitters (expelling <100 viral copies) and high emitters (expelling >1000 viral copies). The study presents evidence for variation in emission of SARS-CoV-2 virus particles by COVID-19 patients reflecting differences in infectivity and transmission risk among individuals. The results conform to reported secondary infection rates and transmission and also suggest that mask sampling could be explored as an effective tool to assess individual transmission risks, at different time points and during different activities.	[Sriraman, Kalpana; Shaikh, Ambreen; Mistry, Nerges] Fdn Med Res, Mumbai, Maharashtra, India; [Parikh, Swapneil; Udupa, Shreevatsa; Chatterjee, Nirjhar; Shastri, Jayanthi] Kasturba Hosp Infect Dis, Mol Lab Viral Res & Diagnost Lab, Sane Guruji Marg, Mumbai, Maharashtra, India; [Shastri, Jayanthi] BYL Nair Charitable Hosp, Dept Microbiol, Mumbai, Maharashtra, India	Topiwala National Medical College & B Y L Nair Charitable Hospital	Mistry, N (corresponding author), Fdn Med Res, Mumbai, Maharashtra, India.	fmr@fmrindia.org		Sriraman, Kalpana/0000-0001-8012-0149; Shaikh, Ambreen/0000-0001-6037-9137; Mistry, Nerges/0000-0003-3509-4994	Godrej Agrovet Limited-Mumbai; Zoroastrian Charity Funds of Hong Kong, Canton and Macao; Vashketu FoundationMumbai	Godrej Agrovet Limited-Mumbai; Zoroastrian Charity Funds of Hong Kong, Canton and Macao; Vashketu FoundationMumbai	This study was supported by grants and donations from Godrej Agrovet Limited-Mumbai, Zoroastrian Charity Funds of Hong Kong, Canton and Macao, and The Vashketu FoundationMumbai. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; CDC CDC, 2020, DURATION ISOLATION P; Centers for Disease Control and Prevention, 2020, SCI BRIEF SARS COV 2; Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Fang FC, 2020, CLIN INFECT DIS, V71, P2996, DOI 10.1093/cid/ciaa742; Fennelly KP, 2020, LANCET RESP MED, V8, P914, DOI 10.1016/S2213-2600(20)30323-4; Goyal Ashish, 2020, medRxiv, DOI 10.1101/2020.08.07.20169920; Hamner L, 2020, MMWR-MORBID MORTAL W, V69, P606, DOI 10.15585/mmwr.mm6919e6; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; Jang S, 2020, EMERG INFECT DIS, V26, P1917, DOI 10.3201/eid2608.200633; Kanaujia R, 2020, CLIN MICROBIOL INFEC, V26, P1701, DOI 10.1016/j.cmi.2020.06.034; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Laxminarayan R, 2020, SCIENCE, V370, P691, DOI 10.1126/science.abd7672; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; Meyerowitz EA, 2021, ANN INTERN MED, V174, P69, DOI 10.7326/M20-5008; Miller D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19248-0; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Patrucco F, 2019, J BREATH RES, V13, DOI 10.1088/1752-7163/aaf010; Shaikh A, 2019, INT J INFECT DIS, V86, P5, DOI 10.1016/j.ijid.2019.06.006; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Tsang TK, 2016, TRENDS MICROBIOL, V24, P123, DOI 10.1016/j.tim.2015.10.012; van Kampen JJA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20568-4; Williams C, 2020, MEDRXIV; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2021	16	4							e0249525	10.1371/journal.pone.0249525	http://dx.doi.org/10.1371/journal.pone.0249525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM7RW	33844696	gold, Green Published			2022-12-26	WOS:000639857200006
J	Watson, MJ; Berger, PL; Banerjee, K; Frank, SB; Tang, L; Ganguly, SS; Hostetter, G; Winn, M; Miranti, CK				Watson, M. J.; Berger, P. L.; Banerjee, K.; Frank, S. B.; Tang, L.; Ganguly, S. S.; Hostetter, G.; Winn, M.; Miranti, C. K.			Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation	ONCOGENE			English	Article								The molecular mechanisms of luminal cell differentiation are not understood well enough to determine how differentiation goes awry during oncogenesis. Using RNA-Seq analysis, we discovered that CREB1 plays a central role in maintaining new luminal cell survival and that oncogenesis dramatically changes the CREB1-induced transcriptome. CREB1 is active in luminal cells, but not basal cells. We identified ING4 and its E3 ligase, JFK, as CREB1 transcriptional targets in luminal cells. During luminal cell differentiation, transient induction of ING4 expression is followed by a peak in CREB1 activity, while JFK increases concomitantly with CREB1 activation. Transient expression of ING4 is required for luminal cell induction; however, failure to properly down-regulate ING4 leads to luminal cell death. Consequently, blocking CREB1 increased ING4 expression, suppressed JFK, and led to luminal cell death. Thus, CREB1 is responsible for the suppression of ING4 required for luminal cell survival and maintenance. Oncogenic transformation by suppressing PTEN resulted in constitutive activation of CREB1. However, the tumor cells could no longer fully differentiate into luminal cells, failed to express ING4, and displayed a unique CREB1 transcriptome. Blocking CREB1 in tumorigenic cells suppressed tumor growth in vivo, rescued ING4 expression, and restored luminal cell formation, but ultimately induced luminal cell death. IHC of primary prostate tumors demonstrated a strong correlation between loss of ING4 and loss of PTEN. This is the first study to define a molecular mechanism whereby oncogenic loss of PTEN, leading to aberrant CREB1 activation, suppresses ING4 expression causing disruption of luminal cell differentiation.	[Watson, M. J.; Berger, P. L.; Hostetter, G.; Winn, M.; Miranti, C. K.] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Banerjee, K.; Frank, S. B.; Tang, L.; Ganguly, S. S.; Miranti, C. K.] Univ Arizona, Dept Cellular & Mol Med, Canc Ctr, Tucson, AZ 85724 USA	Van Andel Institute; University of Arizona	Miranti, CK (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA.; Miranti, CK (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Canc Ctr, Tucson, AZ 85724 USA.	cmiranti@email.arizona.edu		Watson, McLane/0000-0001-5778-7690; Frank, Sander/0000-0001-7591-944X	DOD; VAI	DOD(United States Department of Defense); VAI	MJW, PLB, KB, SBF, TL, SSG CKM -2 grants from DOD; GH, MW -VAI.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Berger PL, 2017, PROSTATE, V77, P49, DOI 10.1002/pros.23249; Berger PL, 2014, CANCER RES, V74, P3357, DOI 10.1158/0008-5472.CAN-13-3076; Bhat NR, 2007, NEUROCHEM RES, V32, P293, DOI 10.1007/s11064-006-9274-9; Brandi F, 2018, ONCOL LETT, V16, P6238, DOI 10.3892/ol.2018.9417; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Capaldo CT, 2015, SEMIN CELL DEV BIOL, V42, P22, DOI 10.1016/j.semcdb.2015.04.003; Chang H, 2015, ANN DIAGN PATHOL, V19, P330, DOI 10.1016/j.anndiagpath.2015.06.010; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Chhabra A, 2007, ONCOL REP, V18, P953; Cizmecioglu O, 2008, CELL CYCLE, V7, P3548, DOI 10.4161/cc.7.22.7071; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Edick MJ, 2007, MOL BIOL CELL, V18, P2481, DOI 10.1091/mbc.E06-04-0261; Fang ZJ, 2016, ONCOTARGET, V7, P78055, DOI 10.18632/oncotarget.12938; Frank SB, 2017, J CELL SCI, V130, P1952, DOI 10.1242/jcs.197152; Frank SB, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0341-x; Garcia GE, 2006, NEOPLASIA, V8, P523, DOI 10.1593/neo.05745; Garcia-Hernandez V, 2017, ANN NY ACAD SCI, V1397, P66, DOI 10.1111/nyas.13360; Gmyrek GA, 2001, AM J PATHOL, V159, P579, DOI 10.1016/S0002-9440(10)61729-4; Gu TT, 2011, CANCER RES, V71, P2821, DOI 10.1158/0008-5472.CAN-10-3399; Henry GH, 2018, CELL REP, V25, P3530, DOI 10.1016/j.celrep.2018.11.086; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jeong SG, 2017, BIOCHEM BIOPH RES CO, V482, P182, DOI 10.1016/j.bbrc.2016.11.031; Kim JH, 2018, BONE, V107, P188, DOI 10.1016/j.bone.2017.12.005; Kirschner N, 2013, J INVEST DERMATOL, V133, P1161, DOI 10.1038/jid.2012.507; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Kwon OJ, 2016, STEM CELLS, V34, P191, DOI 10.1002/stem.2217; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Landeira BS, 2018, CEREB CORTEX, V28, P538, DOI 10.1093/cercor/bhw387; Liu WN, 2013, CANCER-AM CANCER SOC, V119, P2405, DOI 10.1002/cncr.27954; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Melnikova VO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012452; Mochizuki M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005920; Palacios A, 2010, J MOL BIOL, V396, P1117, DOI 10.1016/j.jmb.2009.12.049; Rahman F, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600506; REHFUSS RP, 1991, J BIOL CHEM, V266, P18431; Ruan K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12720; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Steven A, 2016, ONCOTARGET, V7, P35454, DOI 10.18632/oncotarget.7721; Sunkel B, 2016, NUCLEIC ACIDS RES, V44, P4105, DOI 10.1093/nar/gkv1528; Thangapazham R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-16; Thway K, 2012, AM J SURG PATHOL, V36, pE1, DOI 10.1097/PAS.0b013e31825485c5; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Xiao GQ, 2020, AM J CLIN PATHOL, V153, P407, DOI 10.1093/ajcp/aqz183; Yan JL, 2007, P NATL ACAD SCI USA, V104, P1841, DOI 10.1073/pnas.0605562104; Yan RR, 2015, GENE DEV, V29, P672, DOI 10.1101/gad.254292.114; Zhang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06177-2; Zhu Q, 2017, ACTA BIOCH BIOPH SIN, V49, P609, DOI 10.1093/abbs/gmx053	54	4	4	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3260	3272		10.1038/s41388-021-01772-y	http://dx.doi.org/10.1038/s41388-021-01772-y		APR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33846571				2022-12-26	WOS:000639635100002
J	Navarro-Guillen, C; Pereira, GD; Lopes, A; Colen, R; Engrola, S				Navarro-Guillen, Carmen; Pereira, Gabriella do Vale; Lopes, Andre; Colen, Rita; Engrola, Sofia			Egg nutritional modulation with amino acids improved performance in zebrafish larvae	PLOS ONE			English	Article							DIETARY ARGININE; GROWTH-PERFORMANCE; ENZYME-ACTIVITIES; DIGESTIVE ENZYME; JUVENILE JIAN; GLUTAMINE; FISH; ULTRASOUND; CHOLECYSTOKININ; MICROINJECTION	New and more efficient methods to sustainably intensify Aquaculture production are essential to attain the seafood demand for direct human consumption in the near future. Nutrition has been identified as one strategy of early exposure that might affect animal early development and later phenotype. This strategy may have positive consequences in the modulation of fish digestive physiology, which will correlate with higher performance outputs. Thus, improving fish digestive efficiency will lead to higher productivity and lower biogenic emission from aquaculture facilities, minimising the impact on the environment while increasing the biological efficiency. An innovative in ovo nutritional modulation technique based on low-frequency ultrasounds was used to enhance the transport of amino acids across the embryo membranes. An early stimulus with either arginine or glutamine, both involved in gut maturation, was applied in zebrafish (Danio rerio) embryos at 3.5 hours post-fertilization (hpf). At 22 days post-fertilization (dpf), growth performance, digestive enzyme activities and gut microbiota composition were analysed to evaluate the larval nutrition-induced metabolic plasticity and the effects on fish digestive efficiency. Results showed that fish survival was not affected either by the sonophoresis technique or amino acid supplementation. Final dry weight at 22 dpf was statistically higher in larvae from glutamine treatment when compared to the control even with lower trypsin activity, suggesting a higher nutrient digestion capacity, due to a slightly modulation of gut microbiota. Higher arginine supplementation levels should be tested as strategy to enhance growth at later developmental stages. In conclusion, this study demonstrated the efficiency of sonophoresis technique for in ovo nutritional modulation and suggests that in ovo glutamine supplementation might promote growth at later developmental stage through a positive microbiota modulation.	[Navarro-Guillen, Carmen; Lopes, Andre; Colen, Rita; Engrola, Sofia] Ctr Ciencias Mar Algarve CCMAR, Aquaculture Res Grp, Faro, Portugal; [Pereira, Gabriella do Vale] SPAROS Lda, Olhao, Portugal; [Navarro-Guillen, Carmen] CSIC, Inst Ciencias Marinas Andalucia ICMAN, Dept Marine Biol & Aquaculture, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Engrola, S (corresponding author), Ctr Ciencias Mar Algarve CCMAR, Aquaculture Res Grp, Faro, Portugal.	sengrola@ualg.pt	Colen, Rita I. P. B./D-7999-2016; Navarro, Carmen/GON-7706-2022; Engrola, Sofia/A-2485-2012	Colen, Rita I. P. B./0000-0001-7104-1844; Engrola, Sofia/0000-0002-5244-5541	FCT -Foundation for Science and Technology [ALG-01-0145-FEDER029151, UIDB/04326/2020]; European Social Fund [IF/00482/2014/CP1217/CT0005]; Operational Programme Human Potential; FCT	FCT -Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Operational Programme Human Potential; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study received Portuguese national funds from FCT -Foundation for Science and Technology through project ALG-01-0145-FEDER029151 "PROLAR -Early metabolic programming in fish through nutritional modulation", and UIDB/04326/2020. The funder provided support in the form of salaries for author CNG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SE acknowledges a FCT investigator grant (IF/00482/2014/CP1217/CT0005) funded by the European Social Fund, the Operational Programme Human Potential and FCT. The specific roles of all authors are articulated in the `author contributions' section. The commercial affiliation participating in the present study (SPAROS Lda.) did not participate in the research funding, the author GVP contributed to microbiota data analysis.	Allon G, 2016, AQUACULTURE, V451, P93, DOI 10.1016/j.aquaculture.2015.08.040; Bart AN, 2001, AQUACULTURE, V196, P189, DOI 10.1016/S0044-8486(00)00579-2; Beirao J, 2006, AQUACULTURE, V261, P897, DOI 10.1016/j.aquaculture.2006.07.039; Buentello JA, 2007, J AQUAT ANIM HEALTH, V19, P195, DOI 10.1577/H07-004.1; Butt RL, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00009; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho AP, 2006, AQUAC RES, V37, P1107, DOI 10.1111/j.1365-2109.2006.01534.x; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Cheng ZY, 2011, AQUACULTURE, V319, P247, DOI 10.1016/j.aquaculture.2011.06.025; Conceicao LEC, 1998, FISH PHYSIOL BIOCHEM, V19, P43, DOI 10.1023/A:1007738228055; Conceicao LEC, 2003, AQUACULTURE, V227, P221, DOI 10.1016/S0044-8486(03)00505-2; Costas B, 2012, AMINO ACIDS, V43, P327, DOI 10.1007/s00726-011-1082-0; Egerton S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00873; Engrola S, 2014, AQUACULTUE EUROPE, V14; Engrola S, 2014, 16 INT S FISH NUTR F; Engrola S, 2016, AQ EUR 16 EAS 2016 2; Farias M., 2016, INT J MARINE BIOL RE, V1, P1, DOI DOI 10.15226/24754706/1/1/00101; Fernandez-Alonso M, 2001, VACCINE, V19, P3067, DOI 10.1016/S0264-410X(01)00046-9; Fjellheim AJ, 2012, AQUAC RES, V43, P1499, DOI 10.1111/j.1365-2109.2011.02952.x; Frenkel V, 2000, J CONTROL RELEASE, V68, P251, DOI 10.1016/S0168-3659(00)00264-9; Fuiman LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1414; HALVER JE, 1957, J NUTR, V63, P95, DOI 10.1093/jn/63.1.95; Hara H, 2000, J NUTR BIOCHEM, V11, P52, DOI 10.1016/S0955-2863(99)00071-6; HARA H, 1995, J NUTR, V125, P1143; Hou ZX, 2020, REV FISH BIOL FISHER, V30, P67, DOI 10.1007/s11160-019-09590-y; Karau A, 2014, ADV BIOCHEM ENG BIOT, V143, P189, DOI 10.1007/10_2014_269; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Lauzon HL, 2010, J APPL MICROBIOL, V108, P624, DOI 10.1111/j.1365-2672.2009.04454.x; Lin Y, 2006, AQUACULTURE, V256, P389, DOI 10.1016/j.aquaculture.2006.02.011; Liu JW, 2015, AQUACULTURE, V446, P48, DOI 10.1016/j.aquaculture.2015.04.012; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Lopes A, 2016, EFFECTS GROWTH NUTRI; Nadal AL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00114; Loser C, 1999, GUT, V44, P12, DOI 10.1136/gut.44.1.12; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Ma N, 2019, COMPR REV FOOD SCI F, V18, P221, DOI 10.1111/1541-4337.12401; Martins G, 2019, ZEBRAFISH, V16, P300, DOI 10.1089/zeb.2018.1691; McBride M.J., 2014, PROKARYOTES OTHER MA, P577, DOI DOI 10.1007/978-3-642-38954-2_382; MITRAGOTRI S, 1995, SCIENCE, V269, P850, DOI 10.1126/science.7638603; Morais S, 2014, AQUACULTURE, V432, P374, DOI 10.1016/j.aquaculture.2014.04.033; Navarro-Guillen C., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4537443, DOI 10.5281/ZENODO.4537443]; Navarro-Guillen C, 2019, COMP BIOCHEM PHYS A, V228, P1, DOI 10.1016/j.cbpa.2018.10.019; Otani S, 2008, FISHERIES SCI, V74, P208, DOI 10.1111/j.1444-2906.2007.01512.x; Peres A, 1997, FISH PHYSIOL BIOCHEM, V16, P479, DOI 10.1023/A:1007786128254; Popovic PJ, 2007, J NUTR, V137, p1681S, DOI 10.1093/jn/137.6.1681S; Qiyou X, 2011, J APPL ICHTHYOL, V27, P721, DOI 10.1111/j.1439-0426.2011.01710.x; Rahardja DP, 2018, IOP C SER EARTH ENV, V157, DOI 10.1088/1755-1315/157/1/012071; Rocha F, 2014, J EXP BIOL, V217, P1139, DOI 10.1242/jeb.095463; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Ronnestad I., 2005, PHYSL ECOLOGICAL ADA, P434; Rotllant G, 2008, AQUACULTURE, V282, P90, DOI 10.1016/j.aquaculture.2008.06.004; Salmanzadeh M, 2016, ARCH ANIM BREED, V59, P235, DOI 10.5194/aab-59-235-2016; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shirakashi R, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4936573; Singh K, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00066; Song ZD, 2016, CHIN J OCEANOL LIMN, V34, P1013, DOI 10.1007/s00343-016-5031-3; Stagaman K, 2020, LAB ANIMAL, V49, P201, DOI 10.1038/s41684-020-0573-6; TACHIBANA K, 1991, J PHARM PHARMACOL, V43, P270, DOI 10.1111/j.2042-7158.1991.tb06681.x; Vadstein O, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01820; Valente LMP, 2013, REV AQUACULT, V5, pS168, DOI 10.1111/raq.12020; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wu Q, 2019, BRAZ J POULTRY SCI, V21, DOI 10.1590/1806-9061-2019-1123; Yang ZY, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00169; Young J. Z., 1933, Pubblicazioni della Stazione Zoologica di Napoli, V12, P425; Zhou YC, 2002, AQUACULTURE, V203, P229, DOI 10.1016/S0044-8486(01)00634-2	66	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0248356	10.1371/journal.pone.0248356	http://dx.doi.org/10.1371/journal.pone.0248356			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33835997	gold, Green Published			2022-12-26	WOS:000639361000014
J	Yun, SA; Kim, SC				Yun, Seon A.; Kim, Seung-Chul			Genetic diversity and structure of Saussurea polylepis (Asteraceae) on continental islands of Korea: Implications for conservation strategies and management	PLOS ONE			English	Article							POPULATION-SIZE; SELF-INCOMPATIBILITY; INBREEDING DEPRESSION; WIND DISPERSAL; FLOW; DIVERSIFICATION; SPECIATION; DIFFERENTIATION; CONSEQUENCES; BOTTLENECK	Saussurea polylepis Nakai is an herbaceous perennial endemic to Korea and is highly restricted to several continental islands in the southwestern part of the Korean Peninsula. Given its very narrow geographical distribution, it is more vulnerable to anthropogenic activities and global climate changes than more widely distributed species. Despite the need for comprehensive genetic information for conservation and management, no such population genetic studies of S. polylepis have been conducted. In this study, genetic diversity and population structure were evaluated for 97 individuals from 5 populations (Gwanmaedo, Gageodo, Hongdo, Heusando, and Uido) using 19 polymorphic microsatellites. The populations were separated by a distance of 20-90 km. We found moderate levels of genetic diversity in S. polylepis (Ho = 0.42, He = 0.43). This may be due to long lifespans, outcrossing, and gene flow, despite its narrow range. High levels of gene flow (Nm = 1.76, mean Fst = 0.09), especially from wind-dispersed seeds, would contribute to low levels of genetic differentiation among populations. However, the small population size and reduced number of individuals in the reproductive phase of S. polylepis can be a major threat leading to inbreeding depression and genetic diversity loss. Bayesian cluster analysis revealed three significant structures at K = 3, consistent with DAPC and UPGMA. It is thought that sea level rise after the last glacial maximum may have acted as a geographical barrier, limiting the gene flow that would lead to distinct population structures. We proposed the Heuksando population, which is the largest island inhabited by S. polylepis, as a source population because of its large population size and high genetic diversity. Four management units (Gwanmaedo, Gageodo, Hongdo-Heuksando, and Uido) were suggested for conservation considering population size, genetic diversity, population structure, unique alleles, and geographical location (e.g., proximity).	[Yun, Seon A.; Kim, Seung-Chul] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU)	Kim, SC (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea.	sonchus96@skku.edu		Kim, Seung-Chul/0000-0003-0559-6782	National Research Foundation of Korea [NRF-2019R1A2C2009841]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported in part by the National Research Foundation of Korea (NRF-2019R1A2C2009841) and there was no additional external funding received for this study.	Abbott RE, 2017, ECOLOGY, V98, P1071, DOI 10.1002/ecy.1738; Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Backs JR, 2016, AM J BOT, V103, P2115, DOI 10.3732/ajb.1600259; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Baute GJ, 2016, AM J BOT, V103, P2170, DOI 10.3732/ajb.1600295; Bittkau C, 2009, J BIOGEOGR, V36, P1346, DOI 10.1111/j.1365-2699.2008.02003.x; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Calvino-Cancela M, 2012, J BIOGEOGR, V39, P1996, DOI 10.1111/j.1365-2699.2012.02732.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chaves CL, 2019, PLANT SYST EVOL, V305, P675, DOI 10.1007/s00606-019-01598-y; Chung Myong Gi, 1994, Journal of Plant Biology, V37, P141; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Drygala F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153098; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forrest A, 2017, BOT J LINN SOC, V183, P260, DOI 10.1093/botlinnean/bow002; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Fu YB, 1998, CONSERV BIOL, V12, P856, DOI 10.1046/j.1523-1739.1998.97057.x; Gailite Agnese, 2010, Acta Biologica Universitatis Daugavpiliensis, V10, P37; Garot E, 2019, HEREDITY, V122, P833, DOI 10.1038/s41437-018-0168-9; George S, 2009, AM J BOT, V96, P2022, DOI 10.3732/ajb.0800368; Gillespie R. G., 2007, ENCY BIODIVERSITY, P1, DOI 10.1016/b978-0-12-384719-5.00231-8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gundersen G, 2001, ECOL LETT, V4, P14, DOI 10.1046/j.1461-0248.2001.00182.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HAMRICK JL, 1982, AM J BOT, V69, P1685, DOI 10.2307/2442923; Hatmaker EA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00943; Hedrick PW, 2016, TRENDS ECOL EVOL, V31, P940, DOI 10.1016/j.tree.2016.09.005; Hiscock SJ, 1999, INT REV CYTOL, V193, P165; Hiscock SJ, 2003, J EXP BOT, V54, P169, DOI 10.1093/jxb/54.380.169; INOUE K, 1990, AM J BOT, V77, P1440, DOI 10.2307/2444754; Jaros U, 2018, ANN BOT-LONDON, V121, P241, DOI 10.1093/aob/mcx150; Jehle R, 2005, J EVOLUTION BIOL, V18, P619, DOI 10.1111/j.1420-9101.2004.00864.x; Jeong JH, 2012, BIOCHEM SYST ECOL, V43, P14, DOI 10.1016/j.bse.2012.02.015; Jha S, 2010, P NATL ACAD SCI USA, V107, P13760, DOI 10.1073/pnas.1002490107; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kang SK, 2000, AM J BOT, V87, P1634, DOI 10.2307/2656740; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; La Haye MJJ, 2017, CONSERV GENET, V18, P877, DOI 10.1007/s10592-017-0940-z; Law W, 2010, PLANT ECOL, V210, P343, DOI 10.1007/s11258-010-9761-6; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; Liu FM, 2019, FORESTS, V10, DOI 10.3390/f10030225; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Meyer L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176197; Mix C, 2006, MOL ECOL, V15, P1749, DOI 10.1111/j.1365-294X.2006.02887.x; Nakai T, 1931, BOT MAG TOKYO, V45, P522; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; National Institute of Biological Research, 2014, KOREAN RED LIST THRE, V2; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; Pannell JR, 2014, NEW PHYTOL, V201, P417, DOI 10.1111/nph.12495; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peng DL, 2019, GLOB ECOL CONSERV, V17, DOI 10.1016/j.gecco.2019.e00565; Pickup M, 2008, HEREDITY, V100, P268, DOI 10.1038/sj.hdy.6801070; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Price JP, 2004, EVOLUTION, V58, P2185; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; RAIJMANN LL, 1994, CONSERV BIOL, V8, P1014, DOI 10.1046/j.1523-1739.1994.08041014.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; REINARTZ JA, 1994, AM J BOT, V81, P446, DOI 10.2307/2445494; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sagnard F, 2011, THEOR APPL GENET, V123, P1231, DOI 10.1007/s00122-011-1662-0; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schoen DJ, 2001, BIOSCIENCE, V51, P960, DOI 10.1641/0006-3568(2001)051[0960:TCOWPS]2.0.CO;2; Semwal P, 2019, S AFR J BOT, V121, P435, DOI 10.1016/j.sajb.2018.12.015; Soons MB, 2008, J ECOL, V96, P581, DOI 10.1111/j.1365-2745.2008.01370.x; Steinbauer MJ, 2013, ACTA OECOL, V47, P52, DOI 10.1016/j.actao.2012.11.004; Sutherland C, 2012, ECOLOGY, V93, P2465, DOI 10.1890/12-0172.1; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Takayama K, 2013, J PLANT RES, V126, P323, DOI 10.1007/s10265-012-0529-z; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Umme Amara, 2017, American Journal of Plant Sciences, V8, P602; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wei S, 2017, CONSERV GENET, V18, P1435, DOI 10.1007/s10592-017-0991-1; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wright S, 1931, GENETICS, V16, P0097; Yamada T, 2012, J BIOGEOGR, V39, P901, DOI 10.1111/j.1365-2699.2011.02634.x; Yang EC, 2009, BOT MAR, V52, P307, DOI 10.1515/BOT.2009.005; Yoichi W, 2016, ECOL EVOL, V6, P8800, DOI 10.1002/ece3.2576; Young AG, 2010, J APPL ECOL, V47, P541, DOI 10.1111/j.1365-2664.2010.01798.x; Yun SA, 2019, APPL PLANT SCI, V7, DOI 10.1002/aps3.11270; Zeng LY, 2012, AM J BOT, V99, pE326, DOI 10.3732/ajb.1200019; Zhao XF, 2012, INT J MOL SCI, V13, P4396, DOI 10.3390/ijms13044396	99	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249752	10.1371/journal.pone.0249752	http://dx.doi.org/10.1371/journal.pone.0249752			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831066	gold, Green Published			2022-12-26	WOS:000639359600063
J	Capone, R; Tiwari, A; Hadziselimovic, A; Peskova, Y; Hutchison, JM; Sanders, CR; Kenworthy, AK				Capone, Ricardo; Tiwari, Ajit; Hadziselimovic, Arina; Peskova, Yelena; Hutchison, James M.; Sanders, Charles R.; Kenworthy, Anne K.			The C99 domain of the amyloid precursor protein resides in the disordered membrane phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; DETERGENT-RESISTANT MEMBRANES; LIPID RAFT COMPOSITION; PLASMA-MEMBRANE; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; ALPHA-SECRETASE; BETA-PROTEIN; STRUCTURAL DETERMINANTS; CHOLESTEROL BINDING	Processing of the amyloid precursor protein (APP) via the amyloidogenic pathway is associated with the etiology of Alzheimer's disease. The cleavage of APP by beta-secretase to generate the transmembrane 99-residue C-terminal fragment (C99) and subsequent processing of C99 by alpha-secretase to yield amyloid-beta (A beta) peptides are essential steps in this pathway. Biochemical evidence suggests that amyloidogenic processing of C99 occurs in cholesterol- and sphingolipid-enriched liquidordered phase membrane rafts. However, direct evidence that C99 preferentially associates with these rafts has remained elusive. Here, we tested this by quantifying the affinity of C99GFP for raft domains in cell-derived giant plasma membrane vesicles (GPMVs). We found that C99 was essentially excluded from ordered domains in vesicles from HeLa cells, undifferentiated SH-SY5Y cells, or SH-SY5Y-derived neurons; instead, similar to 90% of C99 partitioned into disordered domains. The strong association of C99 with disordered domains occurred independently of its cholesterol-binding activity or homodimerization, or of the presence of the familial Alzheimer disease Arctic mutation (APP E693G). Finally, through biochemical studies we confirmed previous results, which showed that C99 is processed in the plasma membrane by alpha-secretase, in addition to the well-known alpha-secretase. These findings suggest that C99 itself lacks an intrinsic affinity for raft domains, implying that either i) amyloidogenic processing of the protein occurs in disordered regions of the membrane, ii) processing involves a marginal subpopulation of C99 found in rafts, or iii) as-yetunidentified protein-protein interactions with C99 in living cells drive this protein into membrane rafts to promote its cleavage therein.	[Capone, Ricardo; Hadziselimovic, Arina; Hutchison, James M.; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Capone, Ricardo; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capone, Ricardo; Tiwari, Ajit; Kenworthy, Anne K.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Tiwari, Ajit; Peskova, Yelena; Kenworthy, Anne K.] Univ Virginia, Ctr Membrane & Cell Physiol, Charlottesville, VA 22903 USA; [Sanders, Charles R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Tiwari, Ajit; Kenworthy, Anne K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Virginia; Vanderbilt University; University of Virginia	Kenworthy, AK (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.; Kenworthy, AK (corresponding author), Univ Virginia, Ctr Membrane & Cell Physiol, Charlottesville, VA 22903 USA.; Kenworthy, AK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA.	akk7hp@virginia.edu		Hutchison, James/0000-0002-5529-3248; Sanders, Charles/0000-0003-2046-2862; Kenworthy, Anne/0000-0001-6567-9059	NIH [T32 CA00958229, F31 AG061984, CA68485, DK20593, DK58404, DK59637, EY08126, 1RF1 AG056147]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The CISR is supported by NIH grants CA68485, DK20593, DK58404, DK59637, and EY08126. This work was supported by NIH 1RF1 AG056147 to A. K. K. and C. R. S. J. M. H. was supported by NIH T32 CA00958229 and by F31 AG061984. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Andrew RJ, 2017, P NATL ACAD SCI USA, V114, pE9665, DOI 10.1073/pnas.1708568114; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Araki W, 2015, FRONT BIOSCI-LANDMRK, V20, P314, DOI 10.2741/4311; Audagnotto M, 2016, J PHYS CHEM LETT, V7, P3572, DOI 10.1021/acs.jpclett.6b01721; Barnes NY, 1998, J NEUROSCI, V18, P5869; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Barros M, 2020, LANGMUIR, V36, P6569, DOI 10.1021/acs.langmuir.0c01178; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Beel AJ, 2010, BBA-MOL CELL BIOL L, V1801, P975, DOI 10.1016/j.bbalip.2010.03.008; Bell N, 2013, BBA-MOL CELL RES, V1833, P643, DOI 10.1016/j.bbamcr.2012.11.025; Bhattacharyya R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166400; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; Bredesen DE, 2010, J ALZHEIMERS DIS, V22, P57, DOI 10.3233/JAD-2010-100537; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Castro MA, 2019, PROTEIN SCI, V28, P1177, DOI 10.1002/pro.3606; Chen AC, 2015, J CELL BIOL, V211, P1157, DOI 10.1083/jcb.201502001; Chen TY, 2006, BIOCHEM BIOPH RES CO, V342, P266, DOI 10.1016/j.bbrc.2006.01.156; Chen WL, 2014, ACS SYM SER, V1174, P5; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5; Dominguez L, 2016, P NATL ACAD SCI USA, V113, pE5281, DOI 10.1073/pnas.1606482113; Dominguez L, 2014, J AM CHEM SOC, V136, P9619, DOI 10.1021/ja503150x; Eckert GP, 2009, BIOCHEM BIOPH RES CO, V382, P673, DOI 10.1016/j.bbrc.2009.03.070; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fabiani C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00309; Florean C, 2008, BBA-MOL CELL RES, V1783, P1551, DOI 10.1016/j.bbamcr.2008.03.012; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Gerstle Z, 2018, METHOD ENZYMOL, V603, P129, DOI 10.1016/bs.mie.2018.02.007; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Gotz A, 2019, BIOPHYS J, V116, P2103, DOI 10.1016/j.bpj.2019.04.030; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grimm MOW, 2006, ACTA NEUROL SCAND, V114, P27, DOI 10.1111/j.1600-0404.2006.00682.x; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Grimm MOW, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00063; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; Gutierrez E, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900521; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Heberle FA, 2020, P NATL ACAD SCI USA, V117, P19943, DOI 10.1073/pnas.2002200117; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Huang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121777; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Hutchison JM, 2020, J AM CHEM SOC, V142, P12715, DOI 10.1021/jacs.0c04669; Itkin A, 2017, ACS OMEGA, V2, P6525, DOI 10.1021/acsomega.7b00619; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jayne T, 2016, J ALZHEIMERS DIS, V52, P781, DOI 10.3233/JAD-151186; Johnson SA, 2010, BBA-BIOMEMBRANES, V1798, P1427, DOI 10.1016/j.bbamem.2010.03.009; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; KAMINO K, 1992, AM J HUM GENET, V51, P998; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Kraft ML, 2013, MOL BIOL CELL, V24, P2765, DOI 10.1091/mbc.E13-03-0165; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kusumi A, 2020, TRAFFIC, V21, P106, DOI 10.1111/tra.12718; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lemmin T, 2014, J BIOL CHEM, V289, P6763, DOI 10.1074/jbc.M113.470781; Levental I, 2020, TRENDS CELL BIOL, V30, P341, DOI 10.1016/j.tcb.2020.01.009; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental KR, 2015, METHODS MOL BIOL, V1232, P65, DOI 10.1007/978-1-4939-1752-5_6; Levental KR, 2015, CURR TOP MEMBR, V75, P25, DOI 10.1016/bs.ctm.2015.03.009; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Li CD, 2019, J CHEM INF MODEL, V59, P339, DOI 10.1021/acs.jcim.8b00559; Li GT, 2020, J LIPID RES, V61, P758, DOI 10.1194/jlr.RA119000565; Li S, 2017, ACS CHEM NEUROSCI, V8, P1279, DOI 10.1021/acschemneuro.6b00425; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lorent JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01328-3; Lorent JH, 2015, CHEM PHYS LIPIDS, V192, P23, DOI 10.1016/j.chemphyslip.2015.07.022; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Mahammad S, 2008, BBA-BIOMEMBRANES, V1778, P1251, DOI 10.1016/j.bbamem.2008.02.010; Marinko JT, 2020, P NATL ACAD SCI USA, V117, P14168, DOI 10.1073/pnas.2000508117; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; Montesinos J, 2020, EMBO J, V39, DOI 10.15252/embj.2019103791; Motoki K, 2012, BRAIN BEHAV, V2, P270, DOI 10.1002/brb3.52; Mouilleron H, 2016, NUCLEIC ACIDS RES, V44, P14, DOI 10.1093/nar/gkv1218; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nierzwicki L, 2015, J PHYS CHEM LETT, V6, P784, DOI 10.1021/acs.jpclett.5b00197; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Panahi A, 2016, J PHYS CHEM LETT, V7, P3535, DOI 10.1021/acs.jpclett.6b01624; Parkin ET, 1999, BIOCHEM J, V344, P23, DOI 10.1042/0264-6021:3440023; Parkin ET, 1997, J NEUROCHEM, V69, P2179; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Raghunathan K, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00872-17; Raghunathan K, 2016, BIOPHYS J, V111, P2547, DOI 10.1016/j.bpj.2016.11.008; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Rivera-Dictter A, 2013, PLOS ONE, V8; Rushworth Jo V, 2010, Int J Alzheimers Dis, V2011, P603052, DOI 10.4061/2011/603052; Sakurai T, 2008, J CELL BIOL, V183, P339, DOI 10.1083/jcb.200804075; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schlebach JP, 2016, BIOCHEMISTRY-US, V55, P985, DOI 10.1021/acs.biochem.5b01154; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Sengupta P, 2019, NAT CELL BIOL, V21, P452, DOI 10.1038/s41556-019-0300-y; Seno K, 2017, J BIOL CHEM, V292, P15321, DOI 10.1074/jbc.M117.804880; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Skinkle AD, 2020, BIOPHYS J, V118, P1292, DOI 10.1016/j.bpj.2019.12.040; Song YL, 2014, J AM CHEM SOC, V136, P4093, DOI 10.1021/ja4114374; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Stone MB, 2017, ELIFE, V6, DOI 10.7554/eLife.19891; Sun FD, 2017, J CHEM INF MODEL, V57, P1375, DOI 10.1021/acs.jcim.7b00196; Tan JZA, 2019, J BIOL CHEM, V294, P1618, DOI 10.1074/jbc.RA118.005222; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Vivas MG, 2015, RSC ADV, V5, P74531, DOI 10.1039/c5ra10719a; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang C, 2019, ADV EXP MED BIOL, V1135, P67, DOI 10.1007/978-3-030-14265-0_4; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Wang X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00294; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Wolfe MS, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.07.004; Yan Y, 2017, J BIOL CHEM, V292, P15826, DOI 10.1074/jbc.M117.789669; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	145	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100652	10.1016/j.jbc.2021.100652	http://dx.doi.org/10.1016/j.jbc.2021.100652			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839158	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400623
J	Truman, AW; Bourboulia, D; Mollapour, M				Truman, Andrew W.; Bourboulia, Dimitra; Mollapour, Mehdi			Decrypting the chaperone code	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; HSP90		[Truman, Andrew W.] Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA; [Bourboulia, Dimitra; Mollapour, Mehdi] SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA; [Bourboulia, Dimitra; Mollapour, Mehdi] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Bourboulia, Dimitra; Mollapour, Mehdi] SUNY Upstate Med Univ, Upstate Canc Ctr, Syracuse, NY 13210 USA	University of North Carolina; University of North Carolina Charlotte; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Truman, AW (corresponding author), Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA.; Bourboulia, D; Mollapour, M (corresponding author), SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA.; Bourboulia, D; Mollapour, M (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.; Bourboulia, D; Mollapour, M (corresponding author), SUNY Upstate Med Univ, Upstate Canc Ctr, Syracuse, NY 13210 USA.	aruman1@uncc.edu; bourmpod@upstate.edu; mollapom@upstate.edu		Mollapour, Mehdi/0000-0002-2144-1361; Truman, Andrew/0000-0002-6409-3723	National Institute of General Medical Sciences of the National Institutes of Health [R15GM139059, R01GM139885, R01GM139932, R35GM139584, R01GM124256]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R15GM139059 and R01GM139885 (A. W. T.), R01GM139932 (D. B.), R35GM139584, and R01GM124256 (M. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alaalm L., 2020, NOVEL HSP90 PHOSPHO; Baker-Williams AJ, 2019, CELL REP, V28, P1894, DOI 10.1016/j.celrep.2019.07.045; Dunn DM, 2015, CELL REP, V12, P1006, DOI 10.1016/j.celrep.2015.07.004; Himanen SV, 2019, J CELL SCI, V132, DOI 10.1242/jcs.238402; Jakobsson ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11464; Jakobsson ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140168; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Lotz SK, 2019, CURR GENET, V65, P1127, DOI 10.1007/s00294-019-00978-8; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Masgras I, 2017, CELL REP, V18, P659, DOI 10.1016/j.celrep.2016.12.056; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Moss SM, 2019, CELL HOST MICROBE, V25, P454, DOI 10.1016/j.chom.2019.01.006; Mukherjee M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao2464; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nitika, 2020, J BIOL CHEM, V295, P10689, DOI 10.1074/jbc.REV120.011666; Rehn A, 2016, J MOL BIOL, V428, P4559, DOI 10.1016/j.jmb.2016.09.014; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Sanchez-Pozo J, 2018, ISCIENCE, V1, P87, DOI 10.1016/j.isci.2018.02.004; Sanyal A., 2018, KINETIC STRUCTURAL P, DOI [10.1101/494930, DOI 10.1101/494930]; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Schmid PWN, 2021, NAT STRUCT MOL BIOL, V28, P143, DOI 10.1038/s41594-020-00543-9; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Szewczyk MM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16271-z; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Truttmann MC, 2018, P NATL ACAD SCI USA, V115, pE5008, DOI 10.1073/pnas.1801989115; Vihervaara A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00151-0; Weissman Z, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2018.09.001; Woodford MR, 2016, CURR TOP MED CHEM, V16, P2792, DOI 10.2174/1568026616666160413141753; Xu WP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10463-y; Zachara N., 2015, ESSENTIALS GLYCOBIOL, P239, DOI DOI 10.1101/GLYCOBIOLOGY.3E.019; Zemanovic S, 2018, CELL REP, V25, P2605, DOI 10.1016/j.celrep.2018.11.015	31	7	7	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100293	10.1016/j.jbc.2021.100293	http://dx.doi.org/10.1016/j.jbc.2021.100293			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837727	Green Published, gold			2022-12-26	WOS:000672866400267
J	Das, H; Sarkar, S; Paidi, RK; Biswas, SC				Das, Hrishita; Sarkar, Sukanya; Paidi, Ramesh K.; Biswas, Subhas C.			Subtle genomic DNA damage induces intraneuronal production of amyloid-beta (1-42) by increasing beta-secretase activity	FASEB JOURNAL			English	Article						amyloid-beta; DNA damage; BACE1; PERK; eIF2 alpha 0; 5xFAD; MFN2	UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; A-BETA; ENDOPLASMIC-RETICULUM; GAMMA-SECRETASE; INTRACELLULAR ACCUMULATION; MITOCHONDRIAL DYNAMICS; PRECURSOR PROTEIN; ALZHEIMERS; NEURONS	Aberrant accumulation of amyloid-beta (A beta) in brain is the major trigger for pathogenesis in Alzheimer's disease (AD). It is imperative to understand how A beta attains such toxic levels in the brain parenchyma. We detected that a subtle and tolerable amount of DNA damage, related to aging, increased intraneuronal A beta(1-42) production both in cultured neuron and in cortex of rodent brain. Strikingly, we also observed elevated levels of mitochondrial fusion and of its major driver protein, MFN2. Hyperfusion of mitochondria may be seen as an adaptive stress response resulting from the induction of ER stress since we detected the activation of both PERK and IRE1a arms of unfolded protein response of ER stress. We found increased phosphorylation of PERK substrate eukaryotic initiation factor 2 alpha (eIF2 alpha), and upregulation of the downstream effector proteins, ATF4 and CHOP. Concomitantly, increased XBP1 level, the direct effecter protein of IRE-1 alpha, was observed. Reports suggest that eIF2 alpha phosphorylation can increase BACE1 activity, the rate limiting enzyme in A beta production. Here, we show that inhibiting PERK, decreased A beta(1-42) level while direct BACE1 inhibition, reduced the mitochondrial fusion. We found increased MFN2 expression in young 5xFAD mice when A beta plaques and neurodegeneration were absent. Thus, our study indicates that mild DNA damage leads to increased A beta(1-42) production almost as a consequence of an initial ER stress-directed protective mitochondrial fusion in brain. We propose that an age-related subtle genomic DNA damage may trigger enhanced intraneuronal A beta(1-42) production in an apparently healthy neuron way before the appearance of clinical symptoms in AD.	[Das, Hrishita; Sarkar, Sukanya; Paidi, Ramesh K.; Biswas, Subhas C.] CSIR Indian Inst Chem Biol, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Biswas, SC (corresponding author), CSIR Indian Inst Chem Biol, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	biswassc@gmail.com	Paidi, Ramesh Kumar/HHC-0353-2022	Paidi, Ramesh Kumar/0000-0003-3340-8056	SERB [EEQ/2018/000997]	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	SERB Projects, Grant/Award Number: EEQ/2018/000997	Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Bradley-Whitman MA, 2014, J NEUROCHEM, V128, P294; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Cheng SY, 2004, TOXICOL LETT, V146, P139, DOI 10.1016/j.toxlet.2003.09.009; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Strooper B, 2012, EMBO J, V31, P4095, DOI 10.1038/emboj.2012.279; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hegde ML, 2011, J ALZHEIMERS DIS, V24, P183, DOI 10.3233/JAD-2011-110281; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin SM, 2008, CELL DEATH DIFFER, V15, P1375, DOI 10.1038/cdd.2008.49; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuo LJ, 2008, IN VIVO, V22, P305; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manchon JFM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25705; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Misonou H, 2000, BIOCHEMISTRY-US, V39, P6951, DOI 10.1021/bi000169p; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pan L, 2014, J MOL BIOL, V426, P3376, DOI 10.1016/j.jmb.2014.08.001; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Patil S, 2006, NEUROSCI LETT, V406, P55, DOI 10.1016/j.neulet.2006.07.015; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Wang DB, 2013, J NEUROSCI, V33, P1357, DOI 10.1523/JNEUROSCI.3365-12.2013; Wang J, 2015, J ALZHEIMERS DIS, V43, P465, DOI 10.3233/JAD-140078; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343	62	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21569	10.1096/fj.202001676RR	http://dx.doi.org/10.1096/fj.202001676RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864420				2022-12-26	WOS:000645260100057
J	Yu, YT; Xiao, LJ; Ren, ZY; Zhu, GY; Wang, WW; Jia, YT; Peng, A; Wang, XY				Yu, Yanting; Xiao, Leijuan; Ren, Zhiyun; Zhu, Gangyi; Wang, Weiwan; Jia, Yutao; Peng, Ai; Wang, Xiaoyan			Glucose-induced decrease of cystathionine beta-synthase mediates renal injuries	FASEB JOURNAL			English	Article						cystathionine beta-synthase; diabetic kidney disease; glucose; hydrogen sulfide; proteasome; ubiquitination	UBIQUITIN PROTEASOME SYSTEM; HYDROGEN-SULFIDE; HOMOCYSTEINE; EXPRESSION; PROTECTS; DISEASE; ENZYMES; STRESS; LEVEL	Exogenous hydrogen sulfide (H2S) protects kidneys from diabetic injuries in animal models. In order to explore the role of endogenous H2S in diabetic nephropathy, we determined the renal H2S producing enzymes in vivo and in vitro. In diabetic mice, H2S levels in blood and kidney were decreased while cystathionine beta-synthase (CBS), mainly located in mouse renal proximal convoluted tubules (PCT), was reduced selectively. In cultured mouse PCT cells treated with high glucose, CBS protein and activity was reduced while ubiquitinated CBS was increased, which was abolished by a proteasome inhibitor MG132 at 1 hour; high glucose drove CBS colocalized with proteasome 26S subunit ATPase6, indicating an involvement of ubiquitination proteasome degradation. At 48 hours, high glucose also selectively decreased CBS protein, concentration-dependently, but increased the ubiquitination of CBS; silence of CBS by siRNA increased nitrotyrosine, a marker for protein oxidative injury. Nitrotyrosine was also increased by high glucose treatments. The increases of nitrotyrosine either by cbs-siRNA or by glucose were restored by GYY4137, indicating that the H2S donor may protect kidney from oxidative injury induced by CBS deficiency. In diabetic kidneys, ubiquitinated CBS and nitrotyrosine were increased but restored by GYY4137. The treatment also ameliorated albuminuria and renal morphologic changes in diabetic mice. Our findings suggest that high glucose induces reduction of renal CBS protein and activity in vivo and in vitro that is critical to the pathogenesis of diabetic kidney disease.	[Yu, Yanting; Xiao, Leijuan; Jia, Yutao; Wang, Xiaoyan] Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Dept Nephrol, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China; [Yu, Yanting; Ren, Zhiyun; Zhu, Gangyi; Wang, Weiwan; Wang, Xiaoyan] Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Core Lab, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China; [Peng, Ai] Nanjing Med Univ, Affiliated Shanghai Clin Med Coll 10, Dept Nephrol & Rheumatol, 301 Yan Chang Middle Rd, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, XY (corresponding author), Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Dept Nephrol, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China.; Wang, XY (corresponding author), Nanjing Med Univ, Affiliated BenQ Hosp, Nanjing BenQ Med Ctr, Core Lab, 71 Hexi Da Jie, Nanjing, Jiangsu, Peoples R China.; Peng, A (corresponding author), Nanjing Med Univ, Affiliated Shanghai Clin Med Coll 10, Dept Nephrol & Rheumatol, 301 Yan Chang Middle Rd, Nanjing, Peoples R China.	pengai@tongji.edu.cn; Xiaoyan.wang@benqmedicalcenter.com	Wang, Xiaoyan/GOK-1663-2022	Wang, Xiaoyan/0000-0001-7406-5008; Yu, Yanting/0000-0002-1631-2928	Natural Science Foundation of China [81900650, 81970605]; Natural Science Foundation of Jiangsu Province [BK20190128]; Nanjing Science and Technology Development Foundation [201715065]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Nanjing Science and Technology Development Foundation	This work was supported by grants from the Natural Science Foundation of China (81900650 and 81970605), Natural Science Foundation of Jiangsu Province (BK20190128), and Nanjing Science and Technology Development Foundation (201715065).	Beeken M, 2014, J AM SOC NEPHROL, V25, P2511, DOI 10.1681/ASN.2013050522; Beltowski J, 2019, METHODS MOL BIOL, V2007, P1, DOI 10.1007/978-1-4939-9528-8_1; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Chen H, 2015, CURR ALZHEIMER RES, V12, P88, DOI 10.2174/1567205012666141218144035; Dai YN, 2016, J CLIN BIOCHEM NUTR, V58, P76, DOI 10.3164/jcbn.15-54; Diao ZY, 2017, FREE RADICAL BIO MED, V106, P80, DOI 10.1016/j.freeradbiomed.2017.02.021; Elbassuoni EA, 2020, J CELL PHYSIOL, V235, P5223, DOI 10.1002/jcp.29403; Feliers D, 2016, ANTIOXID REDOX SIGN, V25, P720, DOI 10.1089/ars.2015.6596; FRIEDMAN P A, 1991, Journal of the American Society of Nephrology, V2, P737; Goru SK, 2017, PHARMACOL RES, V120, P170, DOI 10.1016/j.phrs.2017.03.024; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Holwerda KM, 2014, J AM SOC NEPHROL, V25, P717, DOI 10.1681/ASN.2013030291; Huang CW, 2015, HANDB EXP PHARMACOL, V230, P3, DOI 10.1007/978-3-319-18144-8_1; Kasinath BS, 2018, BIOCHEM PHARMACOL, V149, P29, DOI 10.1016/j.bcp.2017.12.005; Lee HJ, 2017, J BIOL CHEM, V292, P5665, DOI 10.1074/jbc.M116.766758; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Liu M, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13630; Lu DZ, 2018, INT J BIOL MACROMOL, V117, P1211, DOI 10.1016/j.ijbiomac.2018.06.039; Luo RF, 2019, FASEB J, V33, P469, DOI 10.1096/fj.201800436R; Pushpakumar S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38467-6; Sardina F, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000799; Sjakste T, 2016, MOL GENET GENOMICS, V291, P891, DOI 10.1007/s00438-015-1153-0; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Sun HJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24152857; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Wallace JL, 2018, ANTIOXID REDOX SIGN, V28, P1533, DOI 10.1089/ars.2017.7068; Wang T, 2001, AM J PHYSIOL-RENAL, V281, pF288, DOI 10.1152/ajprenal.2001.281.2.F288; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Yuan XN, 2017, KIDNEY BLOOD PRESS R, V42, P428, DOI 10.1159/000479295; Yuan YQ, 2018, BRAIN BEHAV IMMUN, V67, P77, DOI 10.1016/j.bbi.2017.07.159; Zhang HX, 2016, CELL PHYSIOL BIOCHEM, V40, P1603, DOI 10.1159/000453210; Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593; Zientara-Rytter K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010040; Zuhra K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080828	37	4	4	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21576	10.1096/fj.202002696RR	http://dx.doi.org/10.1096/fj.202002696RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33864412				2022-12-26	WOS:000645260100050
J	Doghish, AS; Elkhatib, WF; Hassan, EA; Elkhateeb, AF; Mahmoud, EE; Ahmed, MI; Khalil, MAF				Doghish, Ahmed S.; Elkhatib, Walid F.; Hassan, Essam A.; Elkhateeb, Ahmed F.; Mahmoud, Eman E.; Ahmed, Mona, I; Khalil, Mahmoud A. F.			Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome	PLOS ONE			English	Article								Background Coronavirus disease 2019 (COVID-19) is a serious caused by (SARS-CoV-2) and in severe cases associated with acute respiratory distress syndrome (ARDS). Objective To describe the clinical characteristics of patients with ARDS-COVID-19. Materials and methods This study involved 197 male Egyptian participants, among them111 COVID-19 patients presented with ARDS, 60 COVID-19 patients presented with non-ARDS, and 26 Non-COVID-19 patients. We reported the analysis results of clinical and laboratory information, including blood routine tests, blood biochemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine and C-reactive protein (CRP)], thrombotic activity (D-dimer) and serum ferritin and lactate dehydrogenase (LDH). Results The levels of hemoglobin, AST, creatinine, monocyte count, monocyte %, RBC count, TLC, and platelet count were not significantly different among the groups. The lymphopenia and increased CRP, ALT, D-dimer, ferritin, and LDH were observed in patients with ARDS-COVID-19. Conclusion COVID-19 patients with ARDS presented with lymphopenia, increased thrombotic activity, increased CRP, LDH, and ferritin levels. The results revealed that CRP, D-dimer, LDH levels, and lymphopenia have a significant association with the COVID-19 severity and can be used as biomarkers to predict the disease severity.	[Doghish, Ahmed S.] Al Azhar Univ, Fac Pharm Boys, Dept Biochem, Cairo, Egypt; [Doghish, Ahmed S.] Badr Univ Cairo BUC, Fac Pharm, Dept Biochem, Cairo, Egypt; [Elkhatib, Walid F.] Ain Shams Univ, Fac Pharm, Microbiol & Immunol Dept, African Union Org St, Cairo, Egypt; [Elkhatib, Walid F.] Galala Univ, Fac Pharm, Dept Microbiol & Immunol, New Galala City, Suez, Egypt; [Hassan, Essam A.] Fayoum Univ, Fac Med, Dept Trop Med, Al Fayyum, Egypt; [Elkhateeb, Ahmed F.] Fayoum Univ, Fac Med, Dept Crit Care Med, Al Fayyum, Egypt; [Mahmoud, Eman E.] Fayoum Univ, Fac Med, Dept Clin & Chem Pathol, Al Fayyum, Egypt; [Ahmed, Mona, I] Fayoum Univ, Fac Med, Dept Chest Dis, Al Fayyum, Egypt; [Khalil, Mahmoud A. F.] Fayoum Univ, Fac Pharm, Dept Microbiol & Immunol, Al Fayyum, Egypt	Egyptian Knowledge Bank (EKB); Al Azhar University; Badr University in Cairo; Egyptian Knowledge Bank (EKB); Ain Shams University; Galala University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University	Doghish, AS (corresponding author), Al Azhar Univ, Fac Pharm Boys, Dept Biochem, Cairo, Egypt.; Doghish, AS (corresponding author), Badr Univ Cairo BUC, Fac Pharm, Dept Biochem, Cairo, Egypt.; Elkhatib, WF (corresponding author), Ain Shams Univ, Fac Pharm, Microbiol & Immunol Dept, African Union Org St, Cairo, Egypt.; Elkhatib, WF (corresponding author), Galala Univ, Fac Pharm, Dept Microbiol & Immunol, New Galala City, Suez, Egypt.	ahmed_doghish@azhar.edu.eg; walid-elkhatib@gu.edu.eg	Doghish, Ahmed Soliman/AAB-4004-2021; Elkhatib, Walid/AAT-2062-2021	Doghish, Ahmed Soliman/0000-0002-0136-7096; Elkhatib, Walid/0000-0001-5815-3200				[Anonymous], 2012, JAMA-J AM MED ASSOC, DOI 10.1001/jama.2012.5669; [Anonymous], 2020, J PLANT PATHOL, DOI DOI 10.1007/s42161-019-00480-7; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Gao Y, 2020, J MED VIROL, V92, P791, DOI 10.1002/jmv.25770; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang YH, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101606; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kernan KF, 2017, INT IMMUNOL, V29, P401, DOI 10.1093/intimm/dxx031; Lin Z, 2020, J INFECTION, V81, P670, DOI 10.1016/j.jinf.2020.06.053; Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; Masuda S, 2016, ANN CLIN BIOCHEM, V53, P365, DOI 10.1177/0004563215617212; Ortega-Paz L, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019650; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Rong XM, 2020, MATH BIOSCI ENG, V17, P2725, DOI 10.3934/mbe.2020149; Shang Y, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00689-1; Wang L, 2020, MED MALADIES INFECT, V50, P332, DOI 10.1016/j.medmal.2020.03.007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yin SY, 2021, J THROMB THROMBOLYS, V51, P1107, DOI 10.1007/s11239-020-02105-8; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2	25	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249346	10.1371/journal.pone.0249346	http://dx.doi.org/10.1371/journal.pone.0249346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861750	gold, Green Published			2022-12-26	WOS:000641475400034
J	Fridman, A; Gershon, R; Gneezy, A				Fridman, Ariel; Gershon, Rachel; Gneezy, Ayelet			COVID-19 and vaccine hesitancy: A longitudinal study	PLOS ONE			English	Article							RISK PERCEPTION; DETERMINANTS; INFLUENZA; MEASLES	How do attitudes toward vaccination change over the course of a public health crisis? We report results from a longitudinal survey of United States residents during six months (March 16 -August 16, 2020) of the COVID-19 pandemic. Contrary to past research suggesting that the increased salience of a disease threat should improve attitudes toward vaccines, we observed a decrease in intentions of getting a COVID-19 vaccine when one becomes available. We further found a decline in general vaccine attitudes and intentions of getting the influenza vaccine. Analyses of heterogeneity indicated that this decline is driven by participants who identify as Republicans, who showed a negative trend in vaccine attitudes and intentions, whereas Democrats remained largely stable. Consistent with research on risk perception and behavior, those with less favorable attitudes toward a COVID-19 vaccination also perceived the virus to be less threatening. We provide suggestive evidence that differential exposure to media channels and social networks could explain the observed asymmetric polarization between self-identified Democrats and Republicans.	[Fridman, Ariel; Gershon, Rachel; Gneezy, Ayelet] Univ Calif San Diego, Rady Sch Management, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Fridman, A (corresponding author), Univ Calif San Diego, Rady Sch Management, La Jolla, CA 92093 USA.	afridman@ucsd.edu		Fridman, Ariel/0000-0002-2778-2474	UC San Diego Global Health Initiative (GHI) [1001288]	UC San Diego Global Health Initiative (GHI)	UC San Diego Global Health Initiative (GHI): awarded to all authors; Project number: 1001288. The funders had no role in study design,	Anderson J., 2020, NEW YORK TIMES; [Anonymous], 2020, NPR; Baumgaertner B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191728; Bowles S, 2003, DAHL WS ENV, P429; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Bump P., 2020, WASH POST; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Chen RT, 1998, PEDIATR ANN, V27, P445, DOI 10.3928/0090-4481-19980701-11; Chintagunta P., 2020, J ASS CONSUMER RES, V5, P240, DOI [10.1086/709858, DOI 10.1086/709858]; Del Vicario M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37825; Drury J., 2009, INT J MASS EMERGENCI, V27, P66, DOI DOI 10.1007/S13398-014-0173-7.2; Drury J, 2009, BEHAV RES METHODS, V41, P957, DOI 10.3758/BRM.41.3.957; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Elflein J., 2020, STATE HLTH, DOI [1103185/cumulative-coronavirus-covid19-cases-number-us-by-day/, DOI 1103185/CUMULATIVE-CORONAVIRUS-COVID19-CASES-NUMBER-US-BY-DAY]; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Garrett RK, 2009, J COMPUT-MEDIAT COMM, V14, P265, DOI 10.1111/j.1083-6101.2009.01440.x; Gilligan MJ, 2014, AM J POLIT SCI, V58, P604, DOI 10.1111/ajps.12067; Gneezy A, 2012, P ROY SOC B-BIOL SCI, V279, P219, DOI 10.1098/rspb.2011.0805; Goldman RD, 2021, J PEDIATR-US, V228, P87, DOI 10.1016/j.jpeds.2020.08.005; Harris KM, 2010, NEW ENGL J MED, V363, P2183, DOI 10.1056/NEJMp1012333; Horne Z, 2015, P NATL ACAD SCI USA, V112, P10321, DOI 10.1073/pnas.1504019112; Hornsey MJ, 2020, J EXP SOC PSYCHOL, V88, DOI 10.1016/j.jesp.2019.103947; Hornsey MJ, 2018, HEALTH PSYCHOL, V37, P307, DOI 10.1037/hea0000586; Hsiao C, 2007, TEST-SPAIN, V16, P1, DOI 10.1007/s11749-007-0046-x; Immunization Safety Review Committee, 2004, IMMUNIZATION SAFETY; Jurkowitz M., 2020, CABLE TV COVID 19 AM; Kestenbaum LA, 2015, PEDIATR ANN, V44, pE71, DOI 10.3928/00904481-20150410-07; Kohlhammer Y, 2007, PUBLIC HEALTH, V121, P742, DOI 10.1016/j.puhe.2007.02.011; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Luton R, 2015, WASH POST; Miton H, 2015, TRENDS COGN SCI, V19, P633, DOI 10.1016/j.tics.2015.08.007; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Orenstein WA, 2017, P NATL ACAD SCI USA, V114, P4031, DOI 10.1073/pnas.1704507114; Ortiz JL., 2020, USA TODAY; Paules CI, 2019, NEW ENGL J MED, V380, P2185, DOI 10.1056/NEJMp1905099; Quinn, 2020, CBS NEWS; Reinhart R. J., 2020, FEWER US CONTINUE SE; Sarathchandra D, 2018, PREV MED, V109, P1, DOI 10.1016/j.ypmed.2018.01.006; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith TW, 2020, GEN SOCIAL SURVEYS; Timmermans DRM, 2005, VACCINE, V23, P3329, DOI 10.1016/j.vaccine.2005.01.075; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Uddin M, 2010, J EPIDEMIOL COMMUN H, V64, P808, DOI 10.1136/jech.2009.090852; United States Census Bureau, 2019, QUICK FACTS; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Vandermeulen C, 2008, EUR J PEDIATR, V167, P1161, DOI 10.1007/s00431-007-0652-3; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; World Health Organization, 2019, IMPROVING VACCINATIO; World Health Organization, 2020, POWER VACCINES STILL	52	170	170	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250123	10.1371/journal.pone.0250123	http://dx.doi.org/10.1371/journal.pone.0250123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861765	Green Published, gold			2022-12-26	WOS:000641475400015
J	Owings, CG; Gilhooly, WP; Picard, CJ				Owings, Charity G.; Gilhooly, William P., III; Picard, Christine J.			Blow fly stable isotopes reveal larval diet: A case study in community level anthropogenic effects	PLOS ONE			English	Article							PHORMIA-REGINA DIPTERA; CAMERA TRAP; CARBON; NITROGEN; MAMMALS; FRACTIONATION; CALLIPHORIDAE; INSECT; DISCRIMINATION; CONSUMPTION	Response to human impacts on the environment are typically initiated too late to remediate negative consequences. We present the novel use of stable isotope analysis (SIA) of blow flies to determine human influences on vertebrate communities in a range of human-inhabited environments, from a pristine national park to a dense metropolitan area. The refrain "you are what you eat" applies to the dietary isotope record of all living organisms, and for carrion-breeding blow flies, this translates to the type of carcasses present in an environment. Specifically, we show that carnivore carcasses make up a large proportion of the adult fly's prior larval diet, which contrasts to what has been reportedly previously for the wild adult fly diet (which consists of mostly herbivore resources). Additionally, we reveal the potential impact of human food on carcasses that were fed on by blow flies, underscoring the human influences on wild animal populations. Our results demonstrate that using SIA in conjunction with other methods (e.g., DNA analysis of flies) can reveal a comprehensive snapshot of the vertebrate community in a terrestrial ecosystem.	[Owings, Charity G.; Picard, Christine J.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; [Gilhooly, William P., III] Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA; [Owings, Charity G.] Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Tennessee System; University of Tennessee Knoxville	Owings, CG (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA.; Owings, CG (corresponding author), Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA.	cowings1@utk.edu			Indiana University Collaborative Research Grant from the Office of the Vice Chancellor for Research at IUPUI	Indiana University Collaborative Research Grant from the Office of the Vice Chancellor for Research at IUPUI	CJP and WPG recieved the Indiana University Collaborative Research Grant from the Office of the Vice Chancellor for Research at IUPUI.	Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; AVANCINI RMP, 1988, MED VET ENTOMOL, V2, P73, DOI 10.1111/j.1365-2915.1988.tb00050.x; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; Bernhardt V, 2018, INT J LEGAL MED, V132, P915, DOI 10.1007/s00414-017-1753-9; Calvignac-Spencer S, 2013, MOL ECOL, V22, P915, DOI 10.1111/mec.12183; Catling PC, 1997, WILDLIFE RES, V24, P417, DOI 10.1071/WR96073; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; DeVault TL, 2008, P INDIANA ACAD SCI; Ditmer MA, 2016, J MAMMAL, V97, P54, DOI 10.1093/jmammal/gyv153; Doi H, 2007, RAPID COMMUN MASS SP, V21, P997, DOI 10.1002/rcm.2925; Ehrich D, 2015, ECOSYSTEMS, V18, P404, DOI 10.1007/s10021-014-9834-9; Folke C, 2002, AMBIO, V31, P437, DOI 10.1639/0044-7447(2002)031[0437:RASDBA]2.0.CO;2; Foundation CM, 2019, CITY MAYORS STAT; Gratton C, 2006, OECOLOGIA, V147, P615, DOI 10.1007/s00442-005-0322-y; HEATH ACG, 1982, NZ ENTOMOL, V7, P343, DOI 10.1080/00779962.1982.9722422; Hocking MD, 2006, CAN J FISH AQUAT SCI, V63, P2076, DOI 10.1139/F06-110; Hocking MD, 2009, ECOL RES, V24, P1091, DOI 10.1007/s11284-009-0586-5; Hopkins JB, 2014, ISOT ENVIRON HEALT S, V50, P322, DOI 10.1080/10256016.2014.922555; Hulbert AJ, 2004, EXP GERONTOL, V39, P1485, DOI 10.1016/j.exger.2004.08.008; Lee PS, 2016, GENOME, V59, P1008, DOI 10.1139/gen-2015-0193; Lee PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123871; MACKLEY JW, 1983, ANN ENTOMOL SOC AM, V76, P839, DOI 10.1093/aesa/76.5.839; Matos MPV, 2018, ANAL BIOANAL CHEM, V410, P7943, DOI 10.1007/s00216-018-1416-9; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Michener R, 2007, ECOL METHOD CONCEPT, pXVII; Mohr RM, 2015, INT J LEGAL MED, V129, P851, DOI 10.1007/s00414-014-1094-x; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Munoz-Lozano C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221890; Newsome SD, 2012, J MAMMAL, V93, P329, DOI 10.1644/11-MAMM-S-187.1; Newsome SD, 2010, J MAMMAL, V91, P1313, DOI 10.1644/09-MAMM-A-362.1; NORRIS KR, 1965, ANNU REV ENTOMOL, V10, P47, DOI 10.1146/annurev.en.10.010165.000403; Owings CG., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Owings CG, 2018, ENVIRON ENTOMOL, V47, P586, DOI 10.1093/ee/nvy027; Pekin BK, 2012, DIVERS DISTRIB, V18, P909, DOI 10.1111/j.1472-4642.2012.00928.x; Picard CJ, 2012, J FORENSIC SCI, V57, P535, DOI 10.1111/j.1556-4029.2011.01975.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quinby BM, 2020, ECOL ENTOMOL, V45, P1231, DOI 10.1111/een.12934; RCore Team, 2020, R LANG ENV STAT COMP; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Rodgers TW, 2017, MOL ECOL RESOUR, V17, pe133, DOI 10.1111/1755-0998.12701; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Saunders DS, 1995, EUR J ENTOMOL, V92, P615; Schubert G, 2015, MOL ECOL RESOUR, V15, P285, DOI 10.1111/1755-0998.12306; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Srbek-Araujo AC, 2005, J TROP ECOL, V21, P121, DOI 10.1017/S0266467404001956; Stahler D, 2002, ANIM BEHAV, V64, P283, DOI 10.1006/anbe.2002.3047; Stoffolano JG, 2000, ANN ENTOMOL SOC AM, V93, P673, DOI 10.1603/0013-8746(2000)093[0673:RBSAMS]2.0.CO;2; STOFFOLANO JG, 1995, MED VET ENTOMOL, V9, P388, DOI 10.1111/j.1365-2915.1995.tb00010.x; Therrien JF, 2011, CAN J ZOOL, V89, P343, DOI 10.1139/Z11-008; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tiunov AV, 2007, BIOL BULL+, V34, P395, DOI 10.1134/S1062359007040127; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Transportation IDo, 2019, IND STAT TRANSP MAP; Ujvari B, 2009, COMP BIOCHEM PHYS A, V154, P383, DOI 10.1016/j.cbpa.2009.07.012; Wehi PM, 2010, J INSECT PHYSIOL, V56, P1877, DOI 10.1016/j.jinsphys.2010.08.005; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249422	10.1371/journal.pone.0249422	http://dx.doi.org/10.1371/journal.pone.0249422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852607	Green Published, gold			2022-12-26	WOS:000640604500050
J	Mavroutsikos, C; Giannakas, K; Walters, C				Mavroutsikos, Charalampos; Giannakas, Konstantinos; Walters, Cory			The role of premium subsidies in crop insurance	PLOS ONE			English	Article							RISK-AVERSION; ATTITUDES	This study develops a novel framework of heterogeneous producer attitudes towards risk to analyze different, stated and revealed, roles of crop insurance premium subsidies and underlying policy objectives of the government. The analysis reveals a strong connection and a complementarity between the roles of premium subsidies in increasing producer participation in crop insurance, inducing a desired separating equilibrium in the presence of asymmetric information, and transferring income to agricultural producers participating in the program. Developing an alternative design of premium subsidies that can achieve the stated government objective of increased producer participation and induce any desired separating equilibrium at significantly reduced costs, our study rejects the idea that the income redistribution taking place under the current policy design is necessary for increasing producer participation in crop insurance. Indeed, the current policy design reveals that premium subsidies are either a means of income redistribution or a policy failure.	[Mavroutsikos, Charalampos; Giannakas, Konstantinos; Walters, Cory] Univ Nebraska, Dept Agr Econ, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Giannakas, K (corresponding author), Univ Nebraska, Dept Agr Econ, Lincoln, NE 68588 USA.	kgiannakas@unl.edu		Mavroutsikos, Charalampos/0000-0001-5432-0411	US Department of Agriculture (USDA), National Institute for Food and Agriculture [201638504-25569]; USDA Hatch Projects [NEB-24-182, NEB-24-187]	US Department of Agriculture (USDA), National Institute for Food and Agriculture; USDA Hatch Projects	This work was supported by the US Department of Agriculture (USDA), National Institute for Food and Agriculture (No. 201638504-25569; Walters), and USDA Hatch Projects NEB-24-182 (Walters) and NEB-24-187 (Giannakas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock B. A., 2015, IOWA AG REV, V12, P1; Babcock BA, 2004, AM J AGR ECON, V86, P563, DOI 10.1111/j.0002-9092.2004.00601.x; Babcock BA, 2012, INTENDED UNINTENDED, P83, DOI DOI 10.7208/CHICAGO/9780226988061.003.0004; Barnett BJ, 2000, CAN J AGR ECON, V48, P539, DOI 10.1111/j.1744-7976.2000.tb00409.x; Coble KH, 2013, AM J AGR ECON, V95, P498, DOI 10.1093/ajae/aas093; Du XD, 2017, AM J AGR ECON, V99, P732, DOI 10.1093/ajae/aaw035; GARDNER B, 1983, AM J AGR ECON, V65, P225, DOI 10.2307/1240868; Gardner BL., 1994, EC AGR CROP INSURANC, P17; Glauber J. W., 2004, American Journal of Agricultural Economics, V86, P1179, DOI 10.1111/j.0002-9092.2004.00663.x; Glauber J. W., 2002, Agricultural Finance Review, V62, P81; Glauber JW, 2013, AM J AGR ECON, V95, P482, DOI 10.1093/ajae/aas091; Goodwin BK, 2013, AM J AGR ECON, V95, P489, DOI 10.1093/ajae/aas092; GOODWIN BK, 1994, J AGR RESOUR ECON, V19, P382; Goodwin BK, 2001, AM J AGR ECON, V83, P643, DOI 10.1111/0002-9092.00184; HARWOOD JL, 1999, MANAGING RISK FARMIN; Innes R, 2003, AM J AGR ECON, V85, P318, DOI 10.1111/1467-8276.00122; Knight, 2002, COMPREHENSIVE ASSESS, P445; Knight T. O., 1997, Review of Agricultural Economics, V19, P128, DOI 10.2307/1349683; KRAMER RA, 1983, AGR HIST, V57, P181; Laffont JJ., 1993, THEORY INCENTIVES PR, P732; Lusk JL, 2017, APPL ECON PERSPECT P, V39, P1, DOI 10.1093/aepp/ppw002; Menapace L, 2013, AM J AGR ECON, V95, P384, DOI 10.1093/ajae/aas107; O'Donoghue T, 2018, J ECON PERSPECT, V32, P91, DOI 10.1257/jep.32.2.91; Pennings JME, 2000, AM J AGR ECON, V82, P908, DOI 10.1111/0002-9092.00090; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; Rabin M, 2001, J ECON PERSPECT, V15, P219, DOI 10.1257/jep.15.1.219; Roe BE, 2015, APPL ECON PERSPECT P, V37, P553, DOI 10.1093/aepp/ppv022; Sumner DA, 2010, AM J AGR ECON, V92, P403, DOI 10.1093/ajae/aaq015; Tirole J., 1988, THEORY IND ORG; United States Department of Agriculture Risk Management Agency (USDA-RMA), 2020, STATE COUNTY CROP SU; United States Government Accountability Office (US-GAO), 2014, CROP INS CONS RED FE	31	0	0	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0250129	10.1371/journal.pone.0250129	http://dx.doi.org/10.1371/journal.pone.0250129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN5ED	33848302	Green Published, gold			2022-12-26	WOS:000640373500019
J	Chiu, YC; Lee, SW; Liu, CW; Lin, RCJ; Huang, YC; Lan, TY; Wu, LSH				Chiu, Yu-Chi; Lee, Shih-Wei; Liu, Chi-Wei; Lin, Rebecca Chou-Jui; Huang, Yung-Chia; Lan, Tzuo-Yun; Wu, Lawrence Shih-Hsin			Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity	PLOS ONE			English	Article							LUNG MICROBIOME; COPD; EXACERBATIONS; INFLAMMATION; EOSINOPHILS; DIET	Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease that reduces lung and respiratory function, with a high mortality rate. Severe and acute deterioration of COPD can easily lead to respiratory failure, resulting in personal, social, and medical burden. Recent studies have shown a high correlation between the gut microbiota and lung inflammation. In this study, we investigated the relationship between gut microbiota and COPD severity. A total of 60 COPD patients with varying severity according to GOLD guidelines were enrolled in this study. DNA was extracted from patients' stool and 16S rRNA data analysis conducted using high-throughput sequencing followed by bioinformatics analysis. The richness of the gut microbiota was not associated with COPD severity. The gut microbiome is more similar in stage 1 and 2 COPD than stage 3+4 COPD. Fusobacterium and Aerococcus were more abundant in stage 3+4 COPD. Ruminococcaceae NK4A214 group and Lachnoclostridium were less abundant in stage 2-4, and Tyzzerella 4 and Dialister were less abundant in stage 1. However, the abundance of a Bacteroides was associated with blood eosinophils and lung function. This study suggests that no distinctive gut microbiota pattern is associated with the severity of COPD. The gut microbiome could affect COPD by gut inflammation shaping the host immune system.	[Chiu, Yu-Chi; Lee, Shih-Wei; Liu, Chi-Wei; Lin, Rebecca Chou-Jui; Huang, Yung-Chia] Minist Hlth & Welf, Dept Internal Med, Taoyuan Gen Hosp, Taoyuan, Taiwan; [Chiu, Yu-Chi; Lan, Tzuo-Yun] Natl Yang Ming Chiao Tung Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Wu, Lawrence Shih-Hsin] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan	Lan, TY (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan.; Wu, LSH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	tylan@nycu.edu.tw; lshwu@hotmail.com		Wu, Lawrence Shih Hsin/0000-0001-6275-8368	Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan [PTH10702]	Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan	This work was supported by Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan (PTH10702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais L, 2016, ENVIRON MICROBIOL, V18, P1352, DOI 10.1111/1462-2920.12934; Anand S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02147; [Anonymous], 2017, PNEUMOLOGIE, V71, P9; Bafadhel M, 2017, LANCET RESP MED, V5, P747, DOI 10.1016/S2213-2600(17)30217-5; Bashir A, 2016, TUMOR BIOL, V37, P2805, DOI 10.1007/s13277-015-4724-0; Benjamin JL, 2012, INFLAMM BOWEL DIS, V18, P1092, DOI 10.1002/ibd.21864; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; Bowerman KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19701-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Gold PM, 2009, RESP CARE, V54, P1040; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hirschmann JV, 2000, CHEST, V118, P193, DOI 10.1378/chest.118.1.193; Iino C, 2019, HEPATOL INT, V13, P748, DOI 10.1007/s12072-019-09987-8; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kolsum U, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0570-5; Lee SH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090282; Ma BJ, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00040; Mammen MJ, 2016, RESPIROLOGY, V21, P590, DOI 10.1111/resp.12732; Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW; Nguyen TT, 2021, SCHIZOPHR RES, V234, P24, DOI 10.1016/j.schres.2019.08.026; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Perera WR, 2007, EUR RESPIR J, V29, P527, DOI 10.1183/09031936.00092506; Rapozo DCM, 2017, WORLD J GASTROENTERO, V23, P2124, DOI 10.3748/wjg.v23.i12.2124; Rasmussen M, 2016, CLIN MICROBIOL INFEC, V22, P22, DOI 10.1016/j.cmi.2015.09.026; Rognes T, 2016, **DATA OBJECT**, DOI [10.5281/zenodo.44512, DOI 10.5281/ZENODO.44512]; Rutten EPA, 2014, CHEST, V145, P245, DOI 10.1378/chest.13-0584; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Takagi T, 2019, J GASTROENTEROL, V54, P53, DOI 10.1007/s00535-018-1488-5; Tito RY, 2017, ARTHRITIS RHEUMATOL, V69, P114, DOI 10.1002/art.39802; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030	36	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249944	10.1371/journal.pone.0249944	http://dx.doi.org/10.1371/journal.pone.0249944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836012	Green Published, Green Submitted, gold			2022-12-26	WOS:000639361000005
J	Ying, FB; O'Clery, N				Ying, Fabian; O'Clery, Neave			Modelling COVID-19 transmission in supermarkets using an agent-based model	PLOS ONE			English	Article							RISK	Since the outbreak of COVID-19 in early March 2020, supermarkets around the world have implemented different policies to reduce the virus transmission in stores to protect both customers and staff, such as restricting the maximum number of customers in a store, changes to the store layout, or enforcing a mandatory face covering policy. To quantitatively assess these mitigation methods, we formulate an agent-based model of customer movement in a supermarket (which we represent by a network) with a simple virus transmission model based on the amount of time a customer spends in close proximity to infectious customers (which we call the exposure time). We apply our model to synthetic store and shopping data to show how one can use our model to estimate exposure time and thereby the number of infections due to human-to-human contact in stores and how to model different store interventions. The source code is openly available under . We encourage retailers to use the model to find the most effective store policies that reduce virus transmission in stores and thereby protect both customers and staff.	[Ying, Fabian] G Res, Quantitat Res, London, England; [O'Clery, Neave] UCL, Ctr Adv Spatial Anal, London, England	University of London; University College London	O'Clery, N (corresponding author), UCL, Ctr Adv Spatial Anal, London, England.	n.oclery@ucl.ac.uk						[Anonymous], EUROPES CORONAVIRUS; [Anonymous], WHAT GROCERY FOOD RE; [Anonymous], 2020, KEEPING WORKERS CUST; [Anonymous], CORONAVIRUS DIS COVI; Birnir B, 2020, BUILD UP DROPLETAERO; Buonanno G, 2020, ENVIRON INT, V141, DOI 10.1016/j.envint.2020.105794; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Dai H., 2020, ASS INFECTED PROBABI; Finewax Z, 2020, AEROSOL SCI TECH, V54, P1567, DOI 10.1080/02786826.2020.1808186; Griffiths I.M., 2020, ARXIV PREPRINT ARXIV; Hale T., 2020, BLAVATNIK SCH GOV; Li T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237691; Office for National Statistics:, CORONAVIRUS COVID 19; Plata S, 2020, ARXIV PREPRINT ARXIV; Pringle JC, 2020, MMWR-MORBID MORTAL W, V69, P1569, DOI 10.15585/mmwr.mm6943e1; Shao SY, 2021, J AEROSOL SCI, V151, DOI 10.1016/j.jaerosci.2020.105661; Sorensen H, 2017, J RETAIL CONSUM SERV, V37, P182, DOI 10.1016/j.jretconser.2017.02.003; Sun CJ, 2020, SUSTAIN CITIES SOC, V62, DOI 10.1016/j.scs.2020.102390; Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001; Vuorinen V, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104866; Ying F, 2019, CUSTOMER MOBILITY CO; Ying FB, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.062304	22	17	17	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249821	10.1371/journal.pone.0249821	http://dx.doi.org/10.1371/journal.pone.0249821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836017	Green Published, gold, Green Submitted			2022-12-26	WOS:000639361000013
J	Chen, C; Yu, SB; Chi, YY; Tan, GY; Yan, BC; Zheng, N; Sui, HJ				Chen, Cheng; Yu, Sheng-bo; Chi, Yan-yan; Tan, Guang-yuan; Yan, Bao-cheng; Zheng, Nan; Sui, Hong-jin			Existence and features of the myodural bridge in Gentoo penguins: A morphological study	PLOS ONE			English	Article							POSTERIOR MINOR MUSCLE; DURA-MATER; TISSUE; MORPHOMETRY; CONNECTION	Recent studies have evidenced that the anatomical structure now known as the myodural bridge (MDB) connects the suboccipital musculature to the cervical spinal dura mater (SDM). In humans, the MDB passes through both the posterior atlanto-occipital and the posterior atlanto-axial interspaces. The existence of the MDB in various mammals, including flying birds (Rock pigeons and Gallus domesticus) has been previously validated. Gentoo penguins are marine birds, able to make 450 dives per day, reaching depths of up to 660 feet. While foraging, this penguin is able to reach speeds of up to 22 miles per hour. Gentoo penguins are also the world's fastest diving birds. The present study was therefore carried out to investigate the existence and characteristics of the MDB in Gentoo penguin (Pygoscelis papua), a non-flying, marine bird that can dive. For this study, six Gentoo penguin specimens were dissected to observe the existence and composition of their MDB. Histological staining was also performed to analyze the anatomic relationships and characteristic of the MDB in the Gentoo penguin. In this study, it was found that the suboccipital musculature in the Gentoo penguin consists of the rectus capitis dorsalis minor (RCDmi) muscle and rectus capitis dorsalis major (RCDma) muscle. Dense connective tissue fibers were observed connecting these two suboccipital muscles to the spinal dura mater (SDM). This dense connective tissue bridge consists of primarily type I collagen fibers. Thus, this penguin's MDB appears to be analogous to the MDB previously observed in humans. The present study evidences that the MDB not only exists in penguins but it also has unique features that distinguishes it from that of flying birds. Thus, this study advances the understanding of the morphological characteristics of the MDB in flightless, marine birds.	[Chen, Cheng; Yu, Sheng-bo; Chi, Yan-yan; Zheng, Nan; Sui, Hong-jin] Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China; [Tan, Guang-yuan; Yan, Bao-cheng] Haichang Ocean Pk Holdings Ltd, Biol Conservat Ctr, Shanghai, Peoples R China; [Sui, Hong-jin] Dalian Hoffen Preservat Inst, Dalian, Peoples R China	Dalian Medical University	Zheng, N; Sui, HJ (corresponding author), Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China.; Sui, HJ (corresponding author), Dalian Hoffen Preservat Inst, Dalian, Peoples R China.	zhengnan831016@163.com; suihj@hotmail.com			National Natural Science Foundation of China [NSFC31871213]; Department of Education of Liaoning Province [LZ2020048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of Liaoning Province	This research was supported by the National Natural Science Foundation of China (NSFC31871213 to HJS); and Department of Education of Liaoning Province (LZ2020048 to NZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hospitaleche CA, 2006, POLAR BIOL, V29, P728, DOI 10.1007/s00300-006-0109-6; ADAMS NJ, 1983, CONDOR, V85, P503, DOI 10.2307/1368002; Bogduk N, 2001, Curr Pain Headache Rep, V5, P382, DOI 10.1007/s11916-001-0029-7; Dou YR, 2019, ANAT SCI INT, V94, P184, DOI 10.1007/s12565-018-00470-2; Fernandez-de-las-Penas C, 2007, CEPHALALGIA, V27, P355, DOI 10.1111/j.1468-2982.2007.01293.x; Fernandez-De-Las-Penas C, 2008, AM J PHYS MED REHAB, V87, P197, DOI 10.1097/PHM.0b013e3181619766; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hack GD, 2004, HEADACHE, V44, P84, DOI 10.1111/j.1526-4610.2004.04015.x; Liu P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200260; Liu P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173630; Liu ZD., 1998, J 4 MILITARY MED U, P108; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; Okoye CS, 2018, J MORPHOL, V279, P1524, DOI 10.1002/jmor.20890; Palomeque-del-Cerro L, 2017, SPINE, V42, P49, DOI 10.1097/BRS.0000000000001655; Pontell ME, 2013, ANN ANAT, V195, P522, DOI 10.1016/j.aanat.2013.04.013; Pontell ME, 2013, CLIN ANAT, V26, P450, DOI 10.1002/ca.22134; Rutten HP, 1997, SPINE, V22, P924, DOI 10.1097/00007632-199704150-00018; Scali F, 2013, SPINE J, V13, P558, DOI 10.1016/j.spinee.2013.01.015; Scali F, 2013, CLIN ANAT, V26, P444, DOI 10.1002/ca.22094; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Shadwick Robert E., 1995, Symposia of the Society for Experimental Biology, V49, P243; [隋鸿锦 Sui Hongjin], 2013, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V31, P489; WILLIAMS TD, 1992, AUK, V109, P223, DOI 10.2307/4088190; Yuan XY, 2017, CEPHALALGIA, V37, P1051, DOI 10.1177/0333102416664775; Zhang JH, 2016, ANAT REC, V299, P1402, DOI 10.1002/ar.23445; Zhao HF, 2019, INT J MORPHOL, V37, P1353, DOI 10.4067/S0717-95022019000401353; Zheng N, 2018, SPINE J, V18, P1081, DOI 10.1016/j.spinee.2018.02.006; Zheng N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06863-z; Zheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103451; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	31	3	3	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0244774	10.1371/journal.pone.0244774	http://dx.doi.org/10.1371/journal.pone.0244774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831002	Green Published, gold, Green Submitted			2022-12-26	WOS:000639359600097
J	Pachu, JKS; Macedo, FCO; Malaquias, JB; Ramalho, FS; Oliveira, RF; Franco, FP; Godoy, WAC				Pachu, Jessica K. S.; Macedo, Francynes C. O.; Malaquias, Jose B.; Ramalho, Francisco S.; Oliveira, Ricardo F.; Franco, Flavia Pereira; Godoy, Wesley A. C.			Electrical signalling on Bt and non-Bt cotton plants under stress by Aphis gossypii	PLOS ONE			English	Article							ACTION-POTENTIALS; ORAL SECRETIONS; LONG-DISTANCE; EARLY EVENTS; LEAVES; MECHANISMS; INHIBITOR; RESPONSES	Plants have developed various mechanisms to respond specifically to each biotrophic attack. It has been shown that the electrical signals emitted by plants are associated with herbivory stress responses and can lead to the activation of multiple defences. Bt cotton is a genetically modified pest-resistant plant that produces an insecticide from Bacillus thuringiensis (Bt) to control Lepidopteran species. Surprisingly, there is no study-yet, that characterizes the signalling mechanisms in transgenic cotton plants attacked by non-target insects, such as aphids. In this study, we characterized the production of electrical signals on Bt and non-Bt cotton plants infested with Aphis gossypii and, in addition, we characterized the dispersal behaviour of aphids to correlate this behaviour to plant signalling responses. Electrical signalling of the plants was recorded with an extracellular measurement technique. Impressively, our results showed that both Bt and non-Bt cotton varieties, when attacked by A. gossypii, emitted potential variation-type electrical signals and clearly showed the presence of distinct responses regarding their perception and the behaviour of aphids, with evidence of delay, in terms of signal amount, and almost twice the amount of Cry1F protein was observed on Bt cotton plants at the highest density of insects/plant. We present in our article some hypotheses that are based on plant physiology and insect behaviour to explain the responses found on Bt cotton plants under aphid stress.	[Pachu, Jessica K. S.; Franco, Flavia Pereira; Godoy, Wesley A. C.] Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Macedo, Francynes C. O.; Oliveira, Ricardo F.] Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Dept Biol Sci, Sao Paulo, SP, Brazil; [Malaquias, Jose B.] Sao Paulo State Univ UNESP, Dept Biostat, Botucatu, SP, Brazil; [Ramalho, Francisco S.] Embrapa Algodao, Biol Control Unit, Campina Grande, Paraiba, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Pachu, JKS (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil.	jessikapachu@gmailc.om	; Pachu, Jessica/F-3326-2016	Pereira Franco, Flavia/0000-0003-3739-8625; Pachu, Jessica/0000-0001-5224-4814	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) [001, 88882.328551/2019-01]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/20435-5, 2017/05953-7, 2015/20380-8, 2014/16609-7 347, 2017/21097-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brazil (CAPES)-Finance Code 001 to JP (CAPES process number: 88882.328551/2019-01), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo in the form of Ph.D. and postdoctorate scholarships for JBM (FAPESP process: 2018/20435-5, 2017/05953-7, 2015/20380-8) and for financing Projects 2014/16609-7 347 and 2017/21097-3 (FAPESP process), and Conselho Nacional de Desenvolvimento Cientifico e Tecnolo ' gico (CNPq) to WACG and FSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Baluska F, 2005, TRENDS PLANT SCI, V10, P106, DOI 10.1016/j.tplants.2005.01.002; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Brenner ED, 2006, TRENDS PLANT SCI, V11, P413, DOI 10.1016/j.tplants.2006.06.009; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Canty A., 2021, R PACKAGE VERSION 1; Davies E, 2006, COMMUNICATION IN PLANTS: NEURONAL ASPECTS OF PLANT LIFE, P309; Demidchik V, 2018, FUNCT PLANT BIOL, V45, P9, DOI [10.1071/FP16420, 10.1071/fp16420]; Dziubinska H, 2003, J PLANT PHYSIOL, V160, P1203, DOI 10.1078/0176-1617-00914; Dziubinska H, 2001, J PLANT PHYSIOL, V158, P1167, DOI 10.1078/S0176-1617(04)70143-1; Ebel J, 1998, PLANTA, V206, P335, DOI 10.1007/s004250050409; EVERT RF, 1982, BIOSCIENCE, V32, P789, DOI 10.2307/1308972; Galle A, 2015, ENVIRON EXP BOT, V114, P15, DOI 10.1016/j.envexpbot.2014.06.013; Hagenbucher S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0042; Hilker M, 2019, PLANT CELL ENVIRON, V42, P753, DOI 10.1111/pce.13526; Hilker M, 2016, BIOL REV, V91, P1118, DOI 10.1111/brv.12215; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Lautner S, 2005, PLANT PHYSIOL, V138, P2200, DOI 10.1104/pp.105.064196; Liu XD, 2005, ECOL ENTOMOL, V30, P307, DOI 10.1111/j.0307-6946.2005.00690.x; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Maischak H, 2007, FEBS LETT, V581, P898, DOI 10.1016/j.febslet.2007.01.067; Malaquias JB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16094-x; Malaquias JB, 2017, SCI REP-UK, V7, DOI 10.1038/srep41740; Malaquias JB, 2020, J PEST SCI, V93, P329, DOI 10.1007/s10340-019-01145-1; Martinez-Medina A, 2016, TRENDS PLANT SCI, V21, P818, DOI 10.1016/j.tplants.2016.07.009; Mithofer A, 2009, MOL ASPECTS PLANT DI; Moral RA, 2017, J STAT SOFTW, V81, P1, DOI 10.18637/jss.v081.i10; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Macedo FDO, 2021, METHODSX, V8, DOI 10.1016/j.mex.2021.101214; Pachu JKS, 2021, CHEMOSPHERE, V263, DOI 10.1016/j.chemosphere.2020.127561; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Pelagio-Flores R, 2011, PLANT CELL PHYSIOL, V52, P490, DOI 10.1093/pcp/pcr006; Russell L, 2020, **DATA OBJECT**; Schulz A, 1998, PROG BOT, V59, P429; Shabala S., 2006, PLANT ELECTROPHYSIOL, P35; Stahlberg R, 2006, COMMUNICATION IN PLANTS: NEURONAL ASPECTS OF PLANT LIFE, P291; Toyota M, 2018, SCIENCE, V361, P1112, DOI 10.1126/science.aat7744; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Vodeneev V, 2018, FUNCT PLANT BIOL, V45, P160, DOI [10.1071/fp16342, 10.1071/FP16342]; Vodeneev V, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1057365; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; ZAWADZKI T, 1995, PHYSIOL PLANTARUM, V93, P291, DOI 10.1111/j.1399-3054.1995.tb02231.x; Zebelo SA, 2015, J EXP BOT, V66, P435, DOI 10.1093/jxb/eru480; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177; Zimmermann MR, 2009, PLANT PHYSIOL, V149, P1593, DOI 10.1104/pp.108.133884	46	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249699	10.1371/journal.pone.0249699	http://dx.doi.org/10.1371/journal.pone.0249699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831084	Green Published, gold, Green Submitted			2022-12-26	WOS:000639359600093
J	Castellano, S; Claxton, DP; Ficici, E; Kusakizako, T; Stix, R; Zhou, WC; Nureki, O; Mchaourab, HS; Faraldo-Gomez, JD				Castellano, Steven; Claxton, Derek P.; Ficici, Emel; Kusakizako, Tsukasa; Stix, Robyn; Zhou, Wenchang; Nureki, Osamu; Mchaourab, Hassane S.; Faraldo-Gomez, Jose D.			Conserved binding site in the N-lobe of prokaryotic MATE transporters suggests a role for Na+ in ion-coupled drug efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ALTERNATING ACCESS; MEMBRANE-PROTEIN STRUCTURE; MULTIDRUG-RESISTANCE; CONFORMATIONAL DYNAMICS; MOLECULAR-DYNAMICS; NA+/CA2+ EXCHANGER; EXTRUSION; PUMPS; MECHANISM; NORM	In both prokaryotes and eukaryotes, multidrug and toxic-compound extrusion (MATE) transporters catalyze the efflux of a broad range of cytotoxic compounds, including human-made antibiotics and anticancer drugs. MATEs are secondary-active antiporters, i.e., their drug-efflux activity is coupled to, and powered by, the uptake of ions down a preexisting transmembrane electrochemical gradient. Key aspects of this mechanism, however, remain to be delineated, such as its ion specificity and stoichiometry. We previously revealed the existence of a Na+-binding site in a MATE transporter from Pyroccocus furiosus (PfMATE) and hypothesized that this site might be broadly conserved among prokaryotic MATEs. Here, we evaluate this hypothesis by analyzing VcmN and ClbM, which along with PfMATE are the only three prokaryotic MATEs whose molecular structures have been determined at atomic resolution, i.e. better than 3 A. Reinterpretation of existing crystallographic data and molecular dynamics simulations indeed reveal an occupied Na+-binding site in the N-terminal lobe of both structures, analogous to that identified in PfMATE. We likewise find this site to be strongly selective against K+, suggesting it is mechanistically significant. Consistent with these computational results, DEER spectroscopy measurements for multiple doubly-spin-labeled VcmN constructs demonstrate Na+-dependent changes in protein conformation. The existence of this binding site in three MATE orthologs implicates Na+ in the ion-coupled drug-efflux mechanisms of this class of transporters. These results also imply that observations of H+-dependent activity likely stem either from a site elsewhere in the structure, or from H+ displacing Na+ under certain laboratory conditions, as has been noted for other Na+-driven transport systems.	[Castellano, Steven; Ficici, Emel; Stix, Robyn; Zhou, Wenchang; Faraldo-Gomez, Jose D.] NHLBI, Theoret Mol Biophys Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Claxton, Derek P.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Kusakizako, Tsukasa; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University; University of Tokyo	Faraldo-Gomez, JD (corresponding author), NHLBI, Theoret Mol Biophys Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.; Claxton, DP (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	derek.p.claxton@vanderbilt.edu; jose.faraldo@nih.gov		Claxton, Derek P/0000-0002-1374-7176	Division of Intramural Research of the National Heart, Lung and Blood Institute of the National Institutes of Health; National Institutes of Health [R01 GM077659]	Division of Intramural Research of the National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported with funds from the Division of Intramural Research of the National Heart, Lung and Blood Institute of the National Institutes of Health (S. C., E. F., R. S., W. Z., J. D. F.-G.) and from National Institutes of Health with grant number R01 GM077659 (D. P. C. and H. S. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Claxton DP, 2018, P NATL ACAD SCI USA, V115, pE6182, DOI 10.1073/pnas.1802417115; Claxton DP, 2015, METHOD ENZYMOL, V564, P349, DOI 10.1016/bs.mie.2015.07.026; Dastvan R, 2019, SCIENCE, V364, P689, DOI 10.1126/science.aav9406; Dastvan R, 2016, P NATL ACAD SCI USA, V113, P1220, DOI 10.1073/pnas.1520431113; Debruycker V, 2020, NAT STRUCT MOL BIOL, V27, P829, DOI 10.1038/s41594-020-0464-y; Duraes F, 2018, CURR MED CHEM, V25, P6030, DOI 10.2174/0929867325666180209142612; Eicher T, 2014, ELIFE, V3, DOI 10.7554/eLife.03145; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficici E, 2018, P NATL ACAD SCI USA, V115, pE6172, DOI 10.1073/pnas.1802080115; Guskov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13420; Hariharan P, 2017, J GEN PHYSIOL, V149, P1029, DOI 10.1085/jgp.201711788; Hashimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059525; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huda MN, 2001, FEMS MICROBIOL LETT, V203, P235, DOI 10.1111/j.1574-6968.2001.tb10847.x; Hustedt EJ, 2018, BIOPHYS J, V115, P1200, DOI 10.1016/j.bpj.2018.08.008; Jagessar KL, 2020, P NATL ACAD SCI USA, V117, P4732, DOI 10.1073/pnas.1917139117; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jin Y, 2014, J BIOL CHEM, V289, P14624, DOI 10.1074/jbc.M113.546770; Kazmier K, 2017, CURR OPIN STRUC BIOL, V45, P100, DOI 10.1016/j.sbi.2016.12.006; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krah A, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.183137; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Kuk ACY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09658-0; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Kusakizako T, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.183154; Kusakizako T, 2019, STRUCTURE, V27, P293, DOI 10.1016/j.str.2018.10.004; Leone V, 2015, P NATL ACAD SCI USA, V112, pE1057, DOI 10.1073/pnas.1421202112; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Luoto HH, 2013, P NATL ACAD SCI USA, V110, P1255, DOI 10.1073/pnas.1217816110; Marinelli F, 2014, P NATL ACAD SCI USA, V111, pE5354, DOI 10.1073/pnas.1415751111; Masureel M, 2014, NAT CHEM BIOL, V10, P149, DOI 10.1038/nchembio.1408; Matthies D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6286; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Miyauchi H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01541-0; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Mousa JJ, 2017, BIOCHEM BIOPH RES CO, V482, P1233, DOI 10.1016/j.bbrc.2016.12.018; Mousa JJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.9, 10.1038/nmicrobiol.2015.9]; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Nie LY, 2016, J BIOL CHEM, V291, P15503, DOI 10.1074/jbc.M116.728618; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Paz A, 2018, P NATL ACAD SCI USA, V115, pE2742, DOI 10.1073/pnas.1718451115; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picollo A, 2012, NAT STRUCT MOL BIOL, V19, P525, DOI 10.1038/nsmb.2277; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schulz S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001596; Shlosman I, 2018, J GEN PHYSIOL, V150, P51, DOI 10.1085/jgp.201711897; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Staritzbichler R, 2011, J CHEM THEORY COMPUT, V7, P1167, DOI 10.1021/ct100576m; Stein RA, 2015, METHOD ENZYMOL, V563, P531, DOI 10.1016/bs.mie.2015.07.031; Tanaka Y, 2017, STRUCTURE, V25, P1455, DOI 10.1016/j.str.2017.07.009; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Xu XJ, 2003, MICROBIOL IMMUNOL, V47, P937, DOI 10.1111/j.1348-0421.2003.tb03467.x; Zakrzewska S, 2019, P NATL ACAD SCI USA, V116, P12275, DOI 10.1073/pnas.1904210116	74	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100262	10.1016/j.jbc.2021.100262	http://dx.doi.org/10.1016/j.jbc.2021.100262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837745	gold, Green Published			2022-12-26	WOS:000672866400238
J	Deng, ZH; Zeng, QY; Tang, J; Zhang, B; Chai, JW; Andersen, JF; Chen, X; Xu, XQ				Deng, Zhenhui; Zeng, Qingye; Tang, Jie; Zhang, Bei; Chai, Jinwei; Andersen, John F.; Chen, Xin; Xu, Xueqing			Anti-inflammatory effects of FS48, the first potassium channel inhibitor from the salivary glands of the flea Xenopsylla cheopis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; ANIMAL TOXINS; KV1.3; MACROPHAGES; ALPHA; INFLAMMATION; ACTIVATION; DOCKING	The voltage-gated potassium (Kv) 1.3 channel plays a crucial role in the immune responsiveness of T-lymphocytes and macrophages, presenting a potential target for treatment of immune- and inflammation related-diseases. FS48, a protein from the rodent flea Xenopsylla cheopis, shares the three disulfide bond feature of scorpion toxins. However, its threedimensional structure and biological function are still unclear. In the present study, the structure of FS48 was evaluated by circular dichroism and homology modeling. We also described its in vitro ion channel activity using patch clamp recording and investigated its anti-inflammatory activity in LPS-induced Raw 264.7 macrophage cells and carrageenaninduced paw edema in mice. FS48 was found to adopt a common alpha beta beta structure and contain an atypical dyad motif. It dose-dependently exhibited the Kv1.3 channel in Raw 264.7 and HEK 293T cells, and its ability to block the channel pore was demonstrated by the kinetics of activation and competition binding with tetraethylammonium. FS48 also downregulated the secretion of proinflammatory molecules NO, IL-1 beta, TNF-alpha, and IL-6 by Raw 264.7 cells in a manner dependent on Kv1.3 channel blockage and the subsequent inactivation of the MAPK/NF-kappa B pathways. Finally, we observed that FS48 inhibited the paw edema formation, tissue myeloperoxidase activity, and inflammatory cell infiltrations in carrageenantreated mice. We therefore conclude that FS48 identified from the flea saliva is a novel potassium channel inhibitor displaying anti-inflammatory activity. This discovery will promote understanding of the bloodsucking mechanism of the flea and provide a new template molecule for the design of Kv1.3 channel blockers.	[Deng, Zhenhui; Chen, Xin] Zhujiang Hosp, Dept Pulm & Crit Care Med, Guangzhou, Peoples R China; [Deng, Zhenhui; Zeng, Qingye; Zhang, Bei; Chai, Jinwei; Xu, Xueqing] Southern Med Univ, Guangdong Prov Key Lab New Drug Screening, Guangzhou, Peoples R China; [Tang, Jie] Southern Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou, Peoples R China; [Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chen, X (corresponding author), Zhujiang Hosp, Dept Pulm & Crit Care Med, Guangzhou, Peoples R China.; Xu, XQ (corresponding author), Southern Med Univ, Guangdong Prov Key Lab New Drug Screening, Guangzhou, Peoples R China.	chen_xin1020@163.com; xu2003@smu.edu.cn	Tang, Jie/GNW-2318-2022	Tang, Jie/0000-0001-7882-4462	National Natural Science Foundation of China [31370782, 31861143050, 82070038, 31772476, 31911530077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded in part by the National Natural Science Foundation of China (No. 31370782, 31861143050, 82070038, 31772476, and 31911530077).	Andersen JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-102; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Chen PC, 2009, BIOPHYS J, V96, P2577, DOI 10.1016/j.bpj.2008.12.3952; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dan A, 1999, J MED ENTOMOL, V36, P875, DOI 10.1093/jmedent/36.6.875; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Deng ZH, 2019, INT J BIOL MACROMOL, V129, P1155, DOI 10.1016/j.ijbiomac.2019.01.073; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fajloun Z, 2000, J BIOL CHEM, V275, P39394, DOI 10.1074/jbc.M006810200; Gulbins E, 2010, BBA-BIOENERGETICS, V1797, P1251, DOI 10.1016/j.bbabio.2010.01.018; Jouirou B, 2004, BIOCHEM J, V377, P37, DOI 10.1042/BJ20030977; Kan XH, 2016, ARCH BIOCHEM BIOPHYS, V591, P150, DOI 10.1016/j.abb.2015.12.013; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; LAMBERT P, 1990, BIOCHEM BIOPH RES CO, V170, P684, DOI 10.1016/0006-291X(90)92145-P; Leanza L, 2012, CURR MED CHEM, V19, P5394, DOI 10.2174/092986712803833281; Leanza L, 2012, EMBO MOL MED, V4, P577, DOI 10.1002/emmm.201200235; Li WF, 2013, EUR J PHARMACOL, V715, P62, DOI 10.1016/j.ejphar.2013.06.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loram LC, 2007, J PAIN, V8, P127, DOI 10.1016/j.jpain.2006.06.010; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mouhat S, 2004, BIOCHEM J, V377, P25, DOI 10.1042/BJ20030115; Nguyen T, 2020, BIOMED PHARMACOTHER, V123, DOI 10.1016/j.biopha.2019.109753; Norton RS, 2017, NEUROPHARMACOLOGY, V127, P124, DOI 10.1016/j.neuropharm.2017.07.002; Paesen GC, 2009, J MOL BIOL, V389, P734, DOI 10.1016/j.jmb.2009.04.045; Ribeiro JMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044612; Roome T, 2008, J ETHNOPHARMACOL, V120, P248, DOI 10.1016/j.jep.2008.08.025; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Serrano-Albarras A, 2018, EXPERT OPIN THER TAR, V22, P101, DOI 10.1080/14728222.2017.1420170; Stehling EG, 2012, BIOCHEMISTRY-US, V51, P1885, DOI 10.1021/bi201713z; Takac P, 2006, J EXP BIOL, V209, P343, DOI 10.1242/jeb.02003; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Vicente R, 2003, J BIOL CHEM, V278, P46307, DOI 10.1074/jbc.M304388200; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Villalonga N, 2007, BIOCHEM BIOPH RES CO, V352, P913, DOI 10.1016/j.bbrc.2006.11.120; Villalonga N, 2010, J GEN PHYSIOL, V135, P135, DOI 10.1085/jgp.200910334; VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96; Wu BM, 2020, INT J MOL MED, V45, P103, DOI 10.3892/ijmm.2019.4395; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu XQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36574; Zeng BS, 2018, J MED CHEM, V61, P10709, DOI 10.1021/acs.jmedchem.8b01358; Zhang B, 2018, ANTI-CANCER DRUG, V29, P880, DOI 10.1097/CAD.0000000000000662; Zhou QL, 2018, INT IMMUNOPHARMACOL, V63, P110, DOI 10.1016/j.intimp.2018.07.009; Zhu H, 2015, SCI CHINA LIFE SCI, V58, P867, DOI 10.1007/s11427-015-4915-3	46	3	3	7	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100670	10.1016/j.jbc.2021.100670	http://dx.doi.org/10.1016/j.jbc.2021.100670			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864815	Green Published, gold			2022-12-26	WOS:000672866400641
J	Takatani, T; Shirakawa, J; Shibue, K; Gupta, MK; Kim, H; Lu, SS; Hu, J; White, MF; Kennedy, RT; Kulkarni, RN				Takatani, Tomozumi; Shirakawa, Jun; Shibue, Kimitaka; Gupta, Manoj K.; Kim, Hyunki; Lu, Shusheng; Hu, Jiang; White, Morris F.; Kennedy, Robert T.; Kulkarni, Rohit N.			Insulin receptor substrate 1, but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; BETA-CELLS; CRYSTAL-STRUCTURE; GLUCAGON-SECRETION; B30.2 DOMAIN; ISLETS; PHOSPHOANTIGENS; RESTRICTION; KINASE	Dysregulated glucagon secretion deteriorates glycemic control in type 1 and type 2 diabetes. Although insulin is known to regulate glucagon secretion via its cognate receptor (insulin receptor, INSR) in pancreatic alpha cells, the role of downstream proteins and signaling pathways underlying insulin's activities are not fully defined. Using in vivo (knockout) and in vitro (knockdown) studies targeting insulin receptor substrate (IRS) proteins, we compared the relative roles of IRS1 and IRS2 in regulating alpha cell function. Alpha cell-specific IRS1-knockout mice exhibited glucose intolerance and inappropriate glucagon suppression during glucose tolerance tests. In contrast, alpha cell-specific IRS2-knockout animals manifested normal glucose tolerance and suppression of glucagon secretion after glucose administration. Alpha cell lines with stable IRS1 knockdown could not repress glucagon mRNA expression and exhibited a reduction in phosphorylation of AKT Ser/Thr kinase (AKT, at Ser-473 and Thr-308). AlphaIRS1KD cells also displayed suppressed global protein translation, including reduced glucagon expression, impaired cytoplasmic Ca2+ response, and mitochondrial dysfunction. This was supported by the identification of novel IRS1-specific downstream target genes, Trpc3 and Cartpt, that are associated with glucagon regulation in alpha cells. These results provide evidence that IRS1, rather than IRS2, is a dominant regulator of pancreatic alpha cell function.	[Takatani, Tomozumi; Shibue, Kimitaka; Gupta, Manoj K.; Kim, Hyunki; Hu, Jiang; Kulkarni, Rohit N.] Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA; [Takatani, Tomozumi] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Shirakawa, Jun] Gunma Univ, Inst Mol & Cellular Regulat IMCR, Lab Diabet & Metab Disorders, Gunma, Japan; [Gupta, Manoj K.] Takeda Pharmaceut, Cell Therapy Translat Engine Cite, Cambridge, MA USA; [Lu, Shusheng; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lu, Shusheng; Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [White, Morris F.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Kulkarni, Rohit N.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Chiba University; Gunma University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Kulkarni, RN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA.; Kulkarni, RN (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA.	rohit.kulkarni@joslin.harvard.edu		Kulkarni, Rohit/0000-0001-5029-6119; Shirakawa, Jun/0000-0002-0822-8750	National Institutes of Health [R01 DK67536, R01 DK103215, R01 DK046960]; Manpei Suzuki Diabetes Foundation; Iacocca Foundation; Japan Society for the Promotion of Science; Uehara Memorial Foundation; MSD Life Science Foundation; JDRF advanced postdoctoral fellowship grant [3-APF-2017-393-A-N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; Iacocca Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); MSD Life Science Foundation; JDRF advanced postdoctoral fellowship grant	This work was supported by grants from the National Institutes of Health R01 DK67536 and in part from R01 DK103215 (R. N. K.) and R01 DK046960 (R. T. K.). T. T. was supported by Manpei Suzuki Diabetes Foundation and the Iacocca Foundation. J. S. is supported by the Japan Society for the Promotion of Science and Uehara Memorial Foundation. K. S. was supported by MSD Life Science Foundation. M. K. G. is supported by JDRF advanced postdoctoral fellowship grant 3-APF-2017-393-A-N.	Abels M, 2016, DIABETOLOGIA, V59, P1928, DOI 10.1007/s00125-016-4020-6; Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; Araujo EP, 2002, FEBS LETT, V531, P437, DOI 10.1016/S0014-5793(02)03580-9; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Bozadjieva N, 2017, J CLIN INVEST, V127, P4379, DOI 10.1172/JCI90004; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Gazit N, 2016, NEURON, V89, P583, DOI 10.1016/j.neuron.2015.12.034; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007983; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Nishiki Y, 2013, MOL ENDOCRINOL, V27, P336, DOI 10.1210/me.2012-1230; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Ozoe A, 2013, FEBS LETT, V587, P2319, DOI 10.1016/j.febslet.2013.05.066; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Park K, 2013, MOL CELL BIOL, V33, P3227, DOI 10.1128/MCB.00506-13; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Riehle C, 2014, MOL CELL BIOL, V34, P3450, DOI 10.1128/MCB.00426-14; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Shen XX, 2012, ENDOCR RES, V37, P12, DOI 10.3109/07435800.2011.610855; Shiota C, 2017, DIABETOLOGIA, V60, P2399, DOI 10.1007/s00125-017-4425-x; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tang CY, 2017, MOL CELLS, V40, P123, DOI 10.14348/molcells.2017.2228; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Vergari E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08193-8; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Xavier GD, 2011, DIABETOLOGIA, V54, P819, DOI 10.1007/s00125-010-2010-7; Yan YM, 2020, NAT PROTOC, V15, P1829, DOI 10.1038/s41596-020-0312-x; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014; Zhou A, 2014, DIABETOLOGIA, V57, P801, DOI 10.1007/s00125-013-3148-x; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	74	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100646	10.1016/j.jbc.2021.100646	http://dx.doi.org/10.1016/j.jbc.2021.100646			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839150	gold, Green Published			2022-12-26	WOS:000672866400617
J	Xie, W; Chen, MZ; Zhai, ZD; Li, HJ; Song, T; Zhu, YG; Dong, D; Zhou, P; Duan, LW; Zhang, Y; Li, DW; Liu, XQ; Zhou, J; Liu, M				Xie, Wei; Chen, Mingzhen; Zhai, Zhaodong; Li, Hongjie; Song, Ting; Zhu, Yigao; Dong, Dan; Zhou, Peng; Duan, Liangwei; Zhang, You; Li, Dengwen; Liu, Xinqi; Zhou, Jun; Liu, Min			HIV-1 exposure promotes PKG1-mediated phosphorylation and degradation of stathmin to increase epithelial barrier permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MICROTUBULES; INFECTION; AUTOPHAGY; JUNCTIONS; CYLD	Exposure of mucosal epithelial cells to the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp120 is known to disrupt epithelial cell junctions by impairing stathmin-mediated microtubule depolymerization. However, the pathological significance of this process and its underlying molecular mechanism remain unclear. Here we show that treatment of epithelial cells with pseudotyped HIV-1 viral particles or recombinant gp120 protein results in the activation of protein kinase G 1 (PKG1). Examination of epithelial cells by immunofluorescence microscopy reveals that PKG1 activation mediates the epithelial barrier damage upon HIV-1 exposure. Immunoprecipitation experiments show that PKG1 interacts with stathmin and phosphorylates stathmin at serine 63 in the presence of gp120. Immunoprecipitation and immunofluorescence microscopy further demonstrate that PKG1-mediated phosphorylation of stathmin promotes its autophagic degradation by enhancing the interaction between stathmin and the autophagy adaptor protein p62. Collectively, these results suggest that HIV-1 exposure exploits the PKG1/stathmin axis to affect the microtubule cytoskeleton and thereby perturbs epithelial cell junctions. Our findings reveal a novel molecular mechanism by which exposure to HIV-1 increases epithelial permeability, which has implications for the development of effective strategies to prevent mucosal HIV-1 transmission.	[Xie, Wei; Chen, Mingzhen; Zhai, Zhaodong; Li, Hongjie; Song, Ting; Zhu, Yigao; Dong, Dan; Zhou, Peng; Zhou, Jun; Liu, Min] Shandong Normal Univ, Coll Life Sci, Inst Biomed Sci, Shandong Prov Key Lab Anim Resistance Biol,Collab, Jinan, Shandong, Peoples R China; [Duan, Liangwei; Zhang, You; Li, Dengwen; Liu, Xinqi; Zhou, Jun] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Shandong Normal University; Nankai University	Zhou, J; Liu, M (corresponding author), Shandong Normal Univ, Coll Life Sci, Inst Biomed Sci, Shandong Prov Key Lab Anim Resistance Biol,Collab, Jinan, Shandong, Peoples R China.; Zhou, J (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China.	junzhou@sdnu.edu.cn; minliu@sdnu.edu.cn	Zhang, You/GYU-9078-2022	Zhang, You/0000-0002-5401-4593	National Key R&D Program of China [2018YFA0107001]; National Natural Science Foundation of China [31701209, 31471262]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key R&D Program of China [2018YFA0107001] and the National Natural Science Foundation of China [31701209 and 31471262].	Angulo-Urarte A, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183316; Basu R, 2017, J BIOL CHEM, V292, P14747, DOI 10.1074/jbc.M117.786491; Beena Vt, 2013, J Oral Maxillofac Pathol, V17, P76, DOI 10.4103/0973-029X.110741; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chen M, 2021, SCI CHINA LIFE SCI, V64, P575, DOI 10.1007/s11427-020-1765-6; Chen PW, 2010, J BIOL CHEM, V285, P10053, DOI 10.1074/jbc.M109.044420; Cicala C, 2016, CURR DRUG TARGETS, V17, P122, DOI 10.2174/1389450116666150825120735; De Clercq E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00276; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Dong D, 2020, THORAC CANCER, V11, P519, DOI 10.1111/1759-7714.13344; Duan LW, 2017, SCI REP-UK, V7, DOI 10.1038/srep46733; Eshun-Wilson L, 2019, P NATL ACAD SCI USA, V116, P10366, DOI 10.1073/pnas.1900441116; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; France MM, 2017, J CELL SCI, V130, P307, DOI 10.1242/jcs.193482; Garcia MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029181; Gavilan MP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002087; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hu Z, 2017, FRONT NEUROSCI, V11, P150; Li J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00921; Lin X., 2016, CANCER BIOTHER RADI, V31, P37; Liu M, 2018, PHARMACOL THERAPEUT, V182, P28, DOI 10.1016/j.pharmthera.2017.08.013; Lu Nu T, 2018, J Cell Death, V11, p1179066018785141, DOI 10.1177/1179066018785141; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Melar M, 2007, J VIROL, V81, P1773, DOI 10.1128/JVI.01316-06; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Odenwald MA, 2017, J CELL SCI, V130, P243, DOI 10.1242/jcs.188185; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pinkse MWH, 2004, J AM SOC MASS SPECTR, V15, P1392, DOI 10.1016/j.jasms.2004.06.015; RAN JX, 2020, DEV CELL, V53, DOI DOI 10.1088/1361-6463/AB9A9B; Ranek MJ, 2019, NATURE, V566, P264, DOI 10.1038/s41586-019-0895-y; Shaik MM, 2019, NATURE, V565, P318, DOI 10.1038/s41586-018-0804-9; Sun S, 2020, ACTA PHARMACOL SIN, V41, P1310, DOI 10.1038/s41401-020-0470-y; Tugizov S, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1159276; Vasileva E, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1539596; Xie W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0175-1; Xie W, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0540; Xie W, 2017, J GENET GENOMICS, V44, P343, DOI 10.1016/j.jgg.2017.06.002; Xu KW, 2015, J BIOL CHEM, V290, P19245, DOI 10.1074/jbc.M115.639625; Yang Y, 2021, SCI BULL, V66, P727, DOI 10.1016/j.scib.2020.10.014; Yang YF, 2016, J CELL SCI, V129, P2289, DOI 10.1242/jcs.183319; Yano T, 2013, J CELL BIOL, V203, P605, DOI 10.1083/jcb.201304194; Yip YY, 2014, J BIOL CHEM, V289, P2157, DOI 10.1074/jbc.M113.470682; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Zhang Y, 2018, VIROLOGY, V518, P293, DOI 10.1016/j.virol.2018.02.003	52	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100644	10.1016/j.jbc.2021.100644	http://dx.doi.org/10.1016/j.jbc.2021.100644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839152	gold, Green Published			2022-12-26	WOS:000672866400615
J	Yokoyama, T; Niinae, T; Tsumagari, K; Imami, K; Ishihama, Y; Hizukuri, Y; Akiyama, Y				Yokoyama, Tatsuhiko; Niinae, Tomoya; Tsumagari, Kazuya; Imami, Koshi; Ishihama, Yasushi; Hizukuri, Yohei; Akiyama, Yoshinori			The Escherichia coli S2P intramembrane protease RseP regulates ferric citrate uptake by cleaving the sigma factor regulator FecR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT-SYSTEM; TRANSCRIPTIONAL REGULATION; DICITRATE-TRANSPORT; STRESS-RESPONSE; GENE; PROTEOLYSIS; YAEL; BACTERIA; ACTIVATION; CLEAVAGE	Escherichia coli RseP, a member of the site-2 protease family of intramembrane proteases, is involved in the activation of the sE extracytoplasmic stress response and elimination of signal peptides from the cytoplasmic membrane. However, whether RseP has additional cellular functions is unclear. In this study, we used mass spectrometry-based quantitative proteomic analysis to search for new substrates that might reveal unknown physiological roles for RseP. Our data showed that the levels of several Fec system proteins encoded by the fecABCDE operon (fec operon) were significantly decreased in an RsePdeficient strain. The Fec system is responsible for the uptake of ferric citrate, and the transcription of the fec operon is controlled by FecI, an alternative sigma factor, and its regulator FecR, a single-pass transmembrane protein. Assays with a fec operon expression reporter demonstrated that the proteolytic activity of RseP is essential for the ferric citrate-dependent upregulation of the fec operon. Analysis using the FecR protein and FecR-derived model proteins showed that FecR undergoes sequential processing at the membrane and that RseP participates in the last step of this sequential processing to generate the N-terminal cytoplasmic fragment of FecR that participates in the transcription of the fec operon with FecI. A shortened FecR construct was not dependent on RseP for activation, confirming this cleavage step is the essential and sufficient role of RseP. Our study unveiled that E. coli RseP performs the intramembrane proteolysis of FecR, a novel physiological role that is essential for regulating iron uptake by the ferric citrate transport system.	[Yokoyama, Tatsuhiko; Hizukuri, Yohei; Akiyama, Yoshinori] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan; [Niinae, Tomoya; Tsumagari, Kazuya; Imami, Koshi; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan	Kyoto University; Kyoto University	Hizukuri, Y; Akiyama, Y (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan.	yhizukur@infront.kyoto-u.ac.jp; yakiyama@infront.kyoto-u.ac.jp	Ishihama, Yasushi/B-3101-2016	Ishihama, Yasushi/0000-0001-7714-203X; Imami, Koshi/0000-0002-7451-4982; YOKOYAMA, Tatsuhiko/0000-0003-3122-6822; Tsumagari, Kazuya/0000-0001-8464-7829	JSPS KAKENHI [JP21J15841, JP18K14674, JP20H03241, JP20H04844, JP17H05667, JP17K15091, JP19K06562, JP18H02404]; JST Strategic Basic Research Program CREST [18070870]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST Strategic Basic Research Program CREST	This work was supported by JSPS KAKENHI Grant Numbers JP21J15841 (to T. Y.), JP18K14674, JP20H03241, JP20H04844 (to K. I.), JP17H05667 (to Y. I.), JP17K15091, JP19K06562 (to Y. H.), JP18H02404 (to Y. A.) and by JST Strategic Basic Research Program CREST (No. 18070870) to Y. I.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akiyama K, 2015, ELIFE, V4, DOI 10.7554/eLife.08928; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; ANGERER A, 1995, MOL MICROBIOL, V18, P163, DOI 10.1111/j.1365-2958.1995.mmi_18010163.x; Arends J, 2016, PROTEOMICS, V16, P3161, DOI 10.1002/pmic.201600316; Bastiaansen KC, 2015, ENVIRON MICROBIOL, V17, P3263, DOI 10.1111/1462-2920.12776; Bastiaansen KC, 2014, ENVIRON MICROBIOL, V16, P2433, DOI 10.1111/1462-2920.12371; Beard HA, 2019, ACS CHEM BIOL, V14, P2372, DOI 10.1021/acschembio.9b00404; Began J, 2020, EMBO J, V39, DOI 10.15252/embj.2019102935; Braun V, 2005, FEMS MICROBIOL REV, V29, P673, DOI 10.1016/j.femsre.2004.10.001; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Braun V, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00058-20; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Delgado C, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00215-18; Deu E, 2017, FEBS J, V284, P2604, DOI 10.1111/febs.14130; Draper RC, 2011, MOL MICROBIOL, V82, P1444, DOI 10.1111/j.1365-2958.2011.07901.x; Dunny GM, 2013, ANNU REV GENET, V47, P457, DOI 10.1146/annurev-genet-111212-133449; ENZ S, 1995, GENE, V163, P13, DOI 10.1016/0378-1119(95)00380-O; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Grass G, 2002, J BACTERIOL, V184, P864, DOI 10.1128/JB.184.3.864-866.2002; HARLE C, 1995, EMBO J, V14, P1430, DOI 10.1002/j.1460-2075.1995.tb07129.x; Hizukuri Y, 2014, STRUCTURE, V22, P326, DOI 10.1016/j.str.2013.12.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inaba K, 2008, J BIOL CHEM, V283, P35042, DOI 10.1074/jbc.M806603200; Kanehara K, 2001, GENE, V281, P71, DOI 10.1016/S0378-1119(01)00823-X; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; King-Lyons ND, 2007, J BACTERIOL, V189, P6266, DOI 10.1128/JB.00629-07; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Konovalova A, 2014, FEMS MICROBIOL REV, V38, P493, DOI 10.1111/1574-6976.12050; Kroos L, 2013, BIOCHIM BIOPHYS ACTA, V1828, P2873; Kuhnle N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.217745; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Miyake T, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.607381; Muller C, 2009, MOL MICROBIOL, V71, P1228, DOI 10.1111/j.1365-2958.2009.06597.x; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Ochs M, 1996, MOL GEN GENET, V250, P455; Otero-Asman JR, 2019, ENVIRON MICROBIOL, V21, P4629, DOI 10.1111/1462-2920.14773; Pennetzdorfer N, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00214; Saha R, 2013, J BASIC MICROB, V53, P303, DOI 10.1002/jobm.201100552; SAIKI K, 1993, J BIOL CHEM, V268, P26041; SAIKI K, 1992, BIOCHEM BIOPH RES CO, V189, P1491, DOI 10.1016/0006-291X(92)90243-E; Saito A, 2011, P NATL ACAD SCI USA, V108, P13740, DOI 10.1073/pnas.1108376108; Salta S., 2017, NAT CELL BIOL, V19, P318; Schneider JS, 2013, BBA-BIOMEMBRANES, V1828, P2808, DOI 10.1016/j.bbamem.2013.04.019; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Sun LF, 2016, CURR OPIN STRUC BIOL, V37, P97, DOI 10.1016/j.sbi.2015.12.008; Tsumagari K, 2017, GENES CELLS, V22, P237, DOI 10.1111/gtc.12466; VANHOVE B, 1990, J BACTERIOL, V172, P6749, DOI 10.1128/jb.172.12.6749-6758.1990; WAGEGG W, 1981, J BACTERIOL, V145, P156, DOI 10.1128/JB.145.1.156-163.1981; Welz D, 1998, J BACTERIOL, V180, P2387, DOI 10.1128/JB.180.9.2387-2394.1998; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yu YTN, 2000, J BACTERIOL, V182, P3305, DOI 10.1128/JB.182.11.3305-3309.2000	55	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100673	10.1016/j.jbc.2021.100673	http://dx.doi.org/10.1016/j.jbc.2021.100673			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865858	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400644
J	Chen, SS; Du, YY; Xu, B; Li, Q; Yang, L; Jiang, Z; Zeng, ZX; Chen, LF				Chen, Sisi; Du, Yunyan; Xu, Bin; Li, Qing; Yang, Le; Jiang, Zi; Zeng, Zhaoxia; Chen, Leifeng			Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance	ONCOGENE			English	Article							CANCER; VRK2; PHOSPHORYLATION; RESISTANCE; MECHANISMS; EXPRESSION; CROSSTALK; STABILITY; CELLS	Hepatocellular carcinoma (HCC) is a lethal malignancy with limited treatment options. Sorafenib is the only Food and Drug Administration (FDA)-approved first-line targeted drug for the treatment of advanced HCC. However, its effect on patient survival is limited. Recently, studies have demonstrated that the imbalance between apoptosis and autophagy plays a critical role in chemoresistance, and it is hypothesised that restoring the balance between these processes is a potential treatment strategy for improving chemoresistance in cancer. However, there is currently no evidence supporting this hypothesis. We aimed to investigate if vaccinia-related kinase 2 (VRK2), a serine/threonine protein kinase, confers sorafenib resistance in HCC cells. Here, we found that VRK2 was enriched in sorafenib-resistant HCC cells and patient-derived xenografts. Both in vivo and in vitro evidences showed that VRK2 blunts the efficacy of sorafenib against hepatocellular carcinoma by disturbing the balance between apoptosis and autophagy. Mechanistically, VRK2 promotes the phosphorylation of Bcl-2 by activating JNK1/MAPK8, thereby enhancing the dissociation of Bcl-2 from Beclin-1 and promoting the formation of the Beclin-1-Atg14-Vps34 complex, which facilitates autophagy. Furthermore, VRK2-induced phosphorylation of Bcl-2 promotes the interaction of Bcl-2 with BAX, thereby inhibiting apoptosis. In conclusion, targeting VRK2 for modulation of the balance between autophagy and apoptosis may be a novel strategy for overcoming sorafenib resistance in HCC.	[Chen, Sisi; Chen, Leifeng] Nanchang Univ, Affiliated Hosp 2, Dept Gen Surg, Nanchang, Jiangxi, Peoples R China; [Du, Yunyan] Nanchang Univ, Jiangxi Prov Peoples Hosp, Dept Med, Nanchang, Jiangxi, Peoples R China; [Xu, Bin] Nanchang Univ, Dept Burns, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Li, Qing] Nanchang Univ, Affiliated Hosp 2, Dept Pathol, Nanchang, Jiangxi, Peoples R China; [Yang, Le; Jiang, Zi] Nanchang Univ, Affiliated Hosp 2, Dept Pharm, Nanchang, Jiangxi, Peoples R China; [Zeng, Zhaoxia] Nanchang Univ, Affiliated Hosp 2, Dept Radiol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Nanchang University; Nanchang University; Nanchang University	Chen, LF (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Gen Surg, Nanchang, Jiangxi, Peoples R China.	18770099029@126.com		Chen, Sisi/0000-0002-1908-5054; chen, Leifeng/0000-0001-8305-1900	National Natural Science Foundation of China [81760523]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81760523).	Almarzooq S, 2020, MOL BIOL REP, V47, P5127, DOI 10.1007/s11033-020-05584-3; Amaravadi R, 2016, GENE DEV, V30, P1913, DOI 10.1101/gad.287524.116; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Birendra KC, 2017, MOL BIOL CELL, V28, P2241, DOI 10.1091/mbc.E17-03-0138; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cabral LKD, 2020, CANCERS, V12, DOI 10.3390/cancers12061576; Choo SP, 2016, CANCER-AM CANCER SOC, V122, P3430, DOI 10.1002/cncr.30237; Fernandez IF, 2010, MOL CELL BIOL, V30, P4687, DOI 10.1128/MCB.01581-09; Gao LX, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0478-9; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Goyal L, 2019, CLIN CANCER RES, V25, P80, DOI 10.1158/1078-0432.CCR-18-0847; Ho CJ, 2019, CANCERS, V11, DOI 10.3390/cancers11111775; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Keating GM, 2017, TARGET ONCOL, V12, P243, DOI 10.1007/s11523-017-0484-7; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Kim S, 2015, MOL CELL BIOL, V35, P1754, DOI 10.1128/MCB.01325-14; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li Ming, 2018, Mol Neuropsychiatry, V4, P119, DOI 10.1159/000493941; Li Y, 2015, BASIC CLIN PHARMACOL, V116, P216, DOI 10.1111/bcpt.12365; Liu J, 2019, ACS CHEM NEUROSCI, V10, P792, DOI 10.1021/acschemneuro.8b00356; Liu J, 2018, AUTOPHAGY, V14, P845, DOI 10.1080/15548627.2017.1390636; Lu S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0681-z; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meyer T, 2017, LANCET GASTROENTEROL, V2, P565, DOI 10.1016/S2468-1253(17)30156-5; Mokdad AA, 2017, CHIN CLIN ONCOL, V6, DOI 10.21037/cco.2017.04.04; Monsalve DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.40; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Ou JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08902-x; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perez-Hernandez M, 2019, CANCERS, V11, DOI 10.3390/cancers11101599; Rubinstein AD, 2012, J CELL SCI, V125, P5259, DOI 10.1242/jcs.115865; Sisinni L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040857; Tong M, 2018, J HEPATOL, V69, P826, DOI 10.1016/j.jhep.2018.05.034; Vasilevskaya IA, 2016, MOL CANCER RES, V14, P753, DOI 10.1158/1541-7786.MCR-16-0035; Vazquez-Cedeira M, 2012, J BIOL CHEM, V287, P42739, DOI 10.1074/jbc.M112.404285; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang XW, 2015, INT J CLIN PHARM-NET, V37, P1047, DOI 10.1007/s11096-015-0151-y; Zhao XL, 2013, CANCER INVEST, V31, P555, DOI 10.3109/07357907.2013.834925; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5	48	2	2	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2021	40	19					3378	3393		10.1038/s41388-021-01780-y	http://dx.doi.org/10.1038/s41388-021-01780-y		APR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SB1JB	33875785	hybrid			2022-12-26	WOS:000641218600003
J	Dan, K; Lee, JE; Han, D; Kim, SM; Hong, S; Kim, HJ; Park, KH				Dan, Kisoon; Lee, Ji Eun; Han, Dohyun; Kim, Sun Min; Hong, Subeen; Kim, Hyeon Ji; Park, Kyo Hoon			Proteomic identification of biomarkers in maternal plasma that predict the outcome of rescue cerclage for cervical insufficiency	PLOS ONE			English	Article							SPONTANEOUS PRETERM DELIVERY; EMERGENCY CERCLAGE; MULTIPLE-PROTEINS; AMNIOTIC-FLUID; WOMEN; LATEXIN; LABOR; INTERLEUKIN-6; INFLAMMATION; PLACENTA	Objective We sought to identify plasma protein biomarkers that are predictive of the outcome of rescue cerclage in patients with cervical insufficiency. Methods This retrospective cohort study included 39 singleton pregnant women undergoing rescue cerclage for cervical insufficiency (17-25 weeks) who gave plasma samples. Three sets of pooled plasma samples from controls (cerclage success, n = 10) and cases (cerclage failure, n = 10, defined as spontaneous preterm delivery at <33 weeks) were labeled with 6-plex tandem mass tag (TMT) reagents and analyzed by liquid chromatography-tandem mass spectrometry. Differentially expressed proteins between the two groups were selected from the TMT-based quantitative analysis. Multiple reaction monitoring-mass spectrometry (MRM-MS) analysis was further used to verify the candidate proteins of interest in patients with cervical insufficiency in the final cohort (n = 39). Results From MRM-MS analysis of the 40 proteins showing statistically significant changes (P < 0.05) from the TMT-based quantitative analysis, plasma IGFBP-2, PSG4, and PGLYRP2 levels were found to be significantly increased, whereas plasma MET and LXN levels were significantly decreased in women with cerclage failure. Of these, IGFBP-2, PSG4, and LXN levels in plasma were independent of cervical dilatation. A multiple-biomarker panel was developed for the prediction of cerclage failure, using a stepwise regression procedure, which included the plasma IGFBP-2, PSG4, and LXN (area under the curve [AUC] = 0.916). The AUC for this multiple-biomarker panel was significantly greater than the AUC for any single biomarker included in the multi-biomarker model. Conclusions Proteomic analysis identified useful and independent plasma biomarkers (IGFBP-2, PSG4, and LXN; verified by MRM) that predict poor pregnancy outcome following rescue cerclage. Their combined analysis in a multi-biomarker panel significantly improved predictability.	[Dan, Kisoon; Han, Dohyun] Seoul Natl Univ Hosp, Biomed Res Inst, Prote Core Facil, Seoul, South Korea; [Lee, Ji Eun] Korea Inst Sci & Technol, Theragnosis Res Ctr, Biomed Res Div, Seoul, South Korea; [Kim, Sun Min] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Seoul, South Korea; [Hong, Subeen] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Hyeon Ji; Park, Kyo Hoon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org			Seoul National University Bundang Hospital Research Fund [13-2016-006]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1F1A1048362]	Seoul National University Bundang Hospital Research Fund; National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	KHP received two grants as described below. This study was supported by the Seoul National University Bundang Hospital Research Fund (Grant No. 13-2016-006), and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2020R1F1A1048362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; Aslam B, 2017, J CHROMATOGR SCI, V55, P182, DOI 10.1093/chromsci/bmw167; Berghella V, 2010, AM J OBSTET GYNECOL, V203, P416, DOI 10.1016/j.ajog.2010.05.042; Brou L, 2012, BJOG-INT J OBSTET GY, V119, P458, DOI 10.1111/j.1471-0528.2011.03266.x; Brown R, 2013, J OBSTET GYNAECOL CA, V35, P1115, DOI 10.1016/S1701-2163(15)30764-7; Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; Chow SSW, 2008, CYTOKINE, V44, P78, DOI 10.1016/j.cyto.2008.06.009; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Renzo GC, 2011, J MATERN-FETAL NEO M, V24, P659, DOI 10.3109/14767058.2011.553694; Ehsanipoor RM, 2015, OBSTET GYNECOL, V126, P125, DOI 10.1097/AOG.0000000000000850; Esplin S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.021; Gillette MA, 2013, NAT METHODS, V10, P28, DOI 10.1038/nmeth.2309; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Han VKM, 1996, J CLIN ENDOCR METAB, V81, P2680, DOI 10.1210/jc.81.7.2680; Hill DJ, 1992, GROWTH FACTORS, V6, P315, DOI 10.3109/08977199209021543; Holmes RP, 1999, HUM REPROD, V14, P1879, DOI 10.1093/humrep/14.7.1879; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Jung EY, 2016, INT J GYNECOL OBSTET, V132, P165, DOI 10.1016/j.ijgo.2015.07.011; Kacerovsky M, 2014, REPROD SCI, V21, P283, DOI 10.1177/1933719113503415; Kennedy JJ, 2014, NAT METHODS, V11, P149, DOI [10.1038/NMETH.2763, 10.1038/nmeth.2763]; Laudanski P, 2012, J MATERN-FETAL NEO M, V25, P2696, DOI 10.3109/14767058.2012.699116; Lee J, 2020, REPROD SCI, V27, P1318, DOI 10.1007/s43032-019-00110-8; Lee KY, 2004, AM J OBSTET GYNECOL, V191, P784, DOI 10.1016/j.ajog.2004.04.019; Lidegaard O., 1994, ACTA OBSTET GYN SCAN, V73, P35, DOI [10.3109/00016349409013390, DOI 10.3109/00016349409013390]; Manuck TA, 2016, AM J OBSTET GYNECOL, V214, pS9, DOI 10.1016/j.ajog.2015.10.034; Molinari N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00477; Moore T, 2014, INT J DEV BIOL, V58, P273, DOI 10.1387/ijdb.130329gd; Muthusamy V, 2013, J INVEST DERMATOL, V133, P1827, DOI 10.1038/jid.2013.48; Park H, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1780-7; Park JW, 2019, ARCH GYNECOL OBSTET, V299, P725, DOI 10.1007/s00404-019-05061-8; Park JC, 2011, AM J REPROD IMMUNOL, V66, P310, DOI 10.1111/j.1600-0897.2011.00991.x; Parry S, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.035; Pereira L, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.048; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Raba G, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8073476; Rutanen EM, 2000, CURR OPIN OBSTET GYN, V12, P163, DOI 10.1097/00001703-200006000-00001; Saade GR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.001; Street ME, 2006, EUR J ENDOCRINOL, V155, P567, DOI 10.1530/eje.1.02251; TABOR A, 1986, LANCET, V1, P1287; TOWLER CM, 1977, BRIT J OBSTET GYNAEC, V84, P258, DOI 10.1111/j.1471-0528.1977.tb12573.x; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; Weiner CP, 2005, AM J OBSTET GYNECOL, V192, P710, DOI 10.1016/j.ajog.2004.10.588; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Wu P, 2015, INT J MOL SCI, V16, P23035, DOI 10.3390/ijms160923035; Xue ZX, 2016, ONCOL REP, V35, P50, DOI 10.3892/or.2015.4353	47	3	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250031	10.1371/journal.pone.0250031	http://dx.doi.org/10.1371/journal.pone.0250031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857242	Green Published			2022-12-26	WOS:000641474900093
J	Friedlander, AM; Ballesteros, E; Goodell, W; Hune, M; Munoz, A; Salinas-de-Leon, P; Velasco-Charpentier, C; Sala, E				Friedlander, Alan M.; Ballesteros, Enric; Goodell, Whitney; Hune, Mathias; Munoz, Alex; Salinas-de-Leon, Pelayo; Velasco-Charpentier, Catalina; Sala, Enric			Marine communities of the newly created Kawesqar National Reserve, Chile: From glaciers to the Pacific Ocean	PLOS ONE			English	Article							KELP MACROCYSTIS-PYRIFERA; SOUTH-AMERICA; BENTHIC COMMUNITIES; CLIMATE-CHANGE; SHALLOW-WATER; TEMPERATURE; HABITAT; LAND; ABUNDANCE; CNIDARIA	The newly created Kawesqar National Park (KNP) and National Reserve (KNR) in southern Chile consists of diverse terrestrial and marine habitats, which includes the southern terminus of the Andes, the Southern Patagonia Ice Fields, sub-Antarctic rainforests, glaciers, fjords, lakes, wetlands, valleys, channels, and islands. The marine environment is influenced by wide ranging hydrological factors such as glacier melt, large terrigenous inputs, high precipitation, strong currents, and open ocean water masses. Owing to the remoteness, rugged terrain, and harsh environmental conditions, little is known about this vast region, particularly the marine realm. To this end, we conducted an integrated ecological assessment using SCUBA and remote cameras down to 600 m to examine this unique and largely unexplored ecosystem. Kelp forests (primarily Macrocystis pyrifera) dominate the nearshore ecosystem and provide habitat for myriad benthic organisms. In the fjords, salinity was low and both turbidity and nutrients from terrigenous sources were high, with benthic communities dominated by active suspension feeders (e.g., Bivalvia, Ascidiacea, and Bryozoa). Areas closer to the Pacific Ocean showed more oceanic conditions with higher salinity and lower turbidity, with benthic communities experiencing more open benthic physical space in which predators (e.g., Malacostraca and Asteroidea) and herbivorous browsers (e.g., Echinoidea and Gastropoda) were more conspicuous components of the community compared to the inner fjords. Hagfish (Myxine sp.) was the most abundant and frequently occurring fish taxa observed on deep-sea cameras (80% of deployments), along with several taxa of sharks (e.g., Squaliformes, Etmopteridae, Somniosidae, Scyliorhinidae), which collectively were also observed on 80% of deep-sea camera deployments. The kelp forests, deep fjords, and other nearshore habitats of the KNR represent a unique ecosystem with minimal human impacts at present. The KNR is part of the ancestral territory of the indigenous Kawesqar people and their traditional knowledge, including the importance of the land-sea connection in structuring the marine communities of this region, is strongly supported by our scientific findings.	[Friedlander, Alan M.; Goodell, Whitney; Munoz, Alex; Salinas-de-Leon, Pelayo; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Friedlander, Alan M.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Ballesteros, Enric] Ctr Estudis Avancats Blanes CSIC, Blanes, Girona, Spain; [Goodell, Whitney] Natl Geog Soc, Explorat Technol Lab, Washington, DC USA; [Hune, Mathias] Ctr Invest Conservac Ecosistemas Australes ICEA, Punta Arenas, Chile; [Salinas-de-Leon, Pelayo] Charles Darwin Fdn, Charles Darwin Res Stn, Puerto Ayora, Galapagos, Ecuador; [Velasco-Charpentier, Catalina] Univ Magallanes, Inst Patagonia, Punta Arenas, Chile	National Geographic Society; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); National Geographic Society; Universidad de Magallanes	Friedlander, AM (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA.; Friedlander, AM (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	alan.friedlander@hawaii.edu	Hüne, Mathias/ABE-6000-2020		National Geographic Society and Pristine Seas donors	National Geographic Society and Pristine Seas donors	We received funding from the National Geographic Society and Pristine Seas donors. The funder provided support in the form of salaries for AF, WG, AM, PS, and ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions.	Aguilera OE, 2016, MAGALLANIA, V44, P85, DOI 10.4067/S0718-22442016000100006; Aguilera MA, 2018, WORLD SEAS ENV EVALU, VI, P673, DOI [10.1016/B978-0-12-805068-2.00046, 10.1016/B978-0-12-805068-2.00046-2, DOI 10.1016/B978-0-12-805068-2.00046]; Andrade C, 2016, POLAR BIOL, V39, P2281, DOI 10.1007/s00300-016-1895-0; Antezana T, 1999, SCI MAR, V63, P23, DOI 10.3989/scimar.1999.63s123; Antezana T, 1996, CRUISE REPORT JOINT, P16; Aravena JC, 2018, MAGALLANIA, V46, P49, DOI 10.4067/S0718-22442018000100049; Borrero L. A., 2013, ANUARIO ARQUEOLOGIA, V5, P17; Braco P, 2011, CARACTERIZACION PESQ; Bruno DO, 2018, POLAR BIOL, V41, P365, DOI 10.1007/s00300-017-2196-y; Buschmann AH, 2004, MAR BIOL, V145, P849, DOI 10.1007/s00227-004-1393-8; Capella JJ, 2014, POLAR BIOL, V37, P1533, DOI 10.1007/s00300-014-1535-5; Cattaneo-Vietti R, 1999, SCI MAR, V63, P113, DOI 10.3989/scimar.1999.63s1113; Chong L, 2019, PROGRAMA SEGUIMIENTO; Ciancio JE, 2008, LIMNOL OCEANOGR, V53, P788, DOI 10.4319/lo.2008.53.2.0788; CLAPPERTON CM, 1995, QUATERNARY RES, V44, P133, DOI 10.1006/qres.1995.1058; Connell SD, 2018, ECOLOGY, V99, P1005, DOI 10.1002/ecy.2209; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; DAYTON PK, 1985, ECOL MONOGR, V55, P447, DOI 10.2307/2937131; Emperaire J, 1963, LOS NOMADES DEL MAR; Fraser CI, 2018, NAT CLIM CHANGE, V8, P704, DOI 10.1038/s41558-018-0209-7; Friedlander AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229259; Friedlander AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189930; Fuentes J.V, 2020, PROGRAMA SEGUIMIENTO; Garreaud R, 2013, J CLIMATE, V26, P215, DOI 10.1175/JCLI-D-12-00001.1; Gerard VA, 1997, J PHYCOL, V33, P800, DOI 10.1111/j.0022-3646.1997.00800.x; Giddens J, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00388; Glasser NF, 2008, QUATERNARY SCI REV, V27, P365, DOI 10.1016/j.quascirev.2007.11.011; Gleisner C, 2014, KAWESQAR SERIE INTRO; Gonzalez HE, 2013, PROG OCEANOGR, V119, P32, DOI 10.1016/j.pocean.2013.06.003; Haussermann V, 2014, CORAL REEFS, V33, P29, DOI 10.1007/s00338-013-1088-z; Hall BL, 2013, QUATERNARY SCI REV, V62, P49, DOI 10.1016/j.quascirev.2012.11.026; Haro D, 2020, ECOL INDIC, V109, DOI 10.1016/j.ecolind.2019.105796; Haussermann V., 2009, MARINE BENTHIC FAUNA; Haussermann V, 2007, POLAR BIOL, V30, P487, DOI 10.1007/s00300-006-0207-5; Huovinen P, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.135531; IFOP, 2020, PROGR SEG PRINC PESQ; Iriarte JL, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00360; Iriarte JL, 2014, PROG OCEANOGR, V129, P1, DOI 10.1016/j.pocean.2014.10.004; Jones CD, 2011, MAR POLICY, V35, P732, DOI 10.1016/j.marpol.2011.02.004; Legoupil D, 2004, MAGALLANIA, V32, P115; Lloris Domingo, 1991, Publicaciones Especiales Instituto Espanol de Oceanografia, V8, P1; Ludwig JA, 1988, STAT ECOLOGY; Iriarte JL, 2018, ARCT ANTARCT ALP RES, V50, DOI 10.1080/15230430.2018.1525186; Iriarte JL, 2010, AMBIO, V39, P463, DOI 10.1007/s13280-010-0049-9; Mardones FO, 2009, DIS AQUAT ORGAN, V84, P105, DOI 10.3354/dao02040; McConnaughey RA, 2020, FISH FISH, V21, P319, DOI 10.1111/faf.12431; Meier WJH, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00062; Mora-Soto A, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12040694; MORENO CA, 1984, MAR ECOL PROG SER, V15, P99, DOI 10.3354/meps015099; Muto M, 2013, REMOTE SENS ENVIRON, V139, P50, DOI 10.1016/j.rse.2013.07.034; Niklitschek EJ, 2013, REV AQUACULT, V5, P172, DOI 10.1111/raq.12012; Ojeda J, 2018, MAGALLANIA, V46, P155, DOI 10.4067/S0718-22442018000100155; Palacios M, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141810; Panella S., 1991, Bollettino di Oceanologia Teorica ed Applicata, V9, P107; Perez-Santos I, 2014, PROG OCEANOGR, V129, P35, DOI 10.1016/j.pocean.2014.03.012; Pickard GL., 1973, OCEANOGRAPHY S PACIF, P96; Pinochet P., 1996, CIENC TECNOL MAR, V19, P93; Reyes P., 2012, PECES CHILE; Rios C, 2005, SCI MAR, V69, P225, DOI 10.3989/scimar.2005.69s2225; Ríos Carlos, 2003, Rev. biol. mar. oceanogr., V38, P1; Rivera A, 2013, J S AM EARTH SCI, V45, P345, DOI 10.1016/j.jsames.2013.02.004; Rosenfeld S, 2014, POLAR RES, V33, DOI 10.3402/polar.v33.21636; Rozzi R, 2012, BIOSCIENCE, V62, P226, DOI 10.1525/bio.2012.62.3.4; Rubilar P, 1999, ANALISIS ESTRUCTURA; Sala E, 2021, NATURE, V592, DOI 10.1038/s41586-021-03371-z; Servicio Nacional de Pesca y Acuicultura, 2018, AN EST PESC; Silva-S. Nelson, 1995, Revista de Biologia Marina, V30, P207; Soto D, 2007, REV CHIL HIST NAT, V80, P81; Soto D, 2019, REV AQUACULT, V11, P354, DOI 10.1111/raq.12336; Tegner MJ, 1996, TRENDS ECOL EVOL, V11, P278, DOI 10.1016/0169-5347(96)30029-3; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tissot BN, 2007, J EXP MAR BIOL ECOL, V352, P50, DOI 10.1016/j.jembe.2007.06.032; Turchik AJ, 2015, OCEANS-IEEE; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Vila AR, 2016, ORYX, V50, P308, DOI 10.1017/S0030605314000908; Wang ZM, 2013, J GEOPHYS RES-OCEANS, V118, P1070, DOI 10.1002/jgrc.20111; WARREN CR, 1993, ARCTIC ALPINE RES, V25, P316, DOI 10.2307/1551915; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Zagami G, 2011, POLAR BIOL, V34, P1319, DOI 10.1007/s00300-011-0962-9	81	5	5	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249413	10.1371/journal.pone.0249413	http://dx.doi.org/10.1371/journal.pone.0249413			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852615	Green Published, gold			2022-12-26	WOS:000640604500036
J	Jeong, HC; Kim, HY; Kim, HY; Wang, EJ; Ahn, KH; Oh, MJ; Choi, BM; Kim, HJ				Jeong, Hyun Chul; Kim, Ho Yeon; Kim, Hee Youn; Wang, Eun-Jin; Ahn, Ki Hoon; Oh, Min-Jeong; Choi, Byung Min; Kim, Hai-Joong			Changes in gene expression of cervical collagens, metalloproteinases, and tissue inhibitors of metalloproteinases after partial cervical excision-induced preterm labor in mice	PLOS ONE			English	Article							PRIOR CONE BIOPSY; MATRIX METALLOPROTEINASES; SYSTEMATIC ANALYSIS; FETAL MEMBRANES; TIME TRENDS; BIRTH; PREGNANCY; PREDICTION; DECIDUA; ENZYMES	We investigated changes in gene expression of cervical collagens, matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases (TIMPs) during pre-gestational uterine cervical excision and/or inflammation-induced preterm labor in mice. Forty sexually mature female mice were uniformly divided into four groups: sham, cervical excision, lipopolysaccharide (LPS) injection, and cervical excision plus LPS injection. Partial cervical tissue excision was performed at five weeks of age before mating. LPS was injected into the lower right uterine horn near the cervix on gestational day 16. Mice were sacrificed immediately postpartum. Uterine cervices were collected and subjected to quantitative real-time PCR. Col4 alpha 1 and Col5 alpha 1 expression increased significantly in the cervical excision plus LPS injection group compared to the sham group (p < 0.01 and p = 0.024, respectively). MMP-14 expression levels increased in the cervical excision plus LPS injection group compared to the sham group (p < 0.01). TIMP-1 expression was not significantly decreased in this group. Increased expression levels of Col4 alpha 1, Col5 alpha 1, and MMP-14 were associated with cervical excision plus inflammation-induced preterm labor. Thus, pre-gestational cervical remodeling through specific collagen metabolism and MMP activation may involve the pathogenesis of spontaneous preterm labor.	[Jeong, Hyun Chul; Kim, Ho Yeon; Kim, Hee Youn; Wang, Eun-Jin; Ahn, Ki Hoon; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Choi, Byung Min] Korea Univ, Ansan Hosp, Dept Pediat, Coll Med, Ansan, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Ahn, KH; Kim, HJ (corresponding author), Korea Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.	akh1220@hanmail.net; haijkim@korea.ac.kr		Choi, Byung Min/0000-0003-0931-2353	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT40 [2014R1A1A1002300, 2018R1D1A1B07]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT40	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Science and ICT40 (2014R1A1A1002300 and 2018R1D1A1B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KH, 2017, AM J PERINAT, V34, P1072, DOI 10.1055/s-0037-1603816; Barisic A, 2018, GENE, V647, P48, DOI 10.1016/j.gene.2018.01.010; Berghella V, 2004, AM J OBSTET GYNECOL, V191, P1393, DOI 10.1016/j.ajog.2004.06.087; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Castagnino A, 2018, ONCOGENE, V37, P6425, DOI 10.1038/s41388-018-0422-x; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Cockle JV, 2007, REPROD SCI, V14, P629, DOI 10.1177/1933719107304563; Crane JMG, 2006, OBSTET GYNECOL, V107, P37, DOI 10.1097/01.AOG.0000192169.44775.76; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Fischer RL, 2010, ULTRASOUND OBST GYN, V36, P613, DOI 10.1002/uog.7682; Fortunato SJ, 1998, AM J REPROD IMMUNOL, V40, P395, DOI 10.1111/j.1600-0897.1998.tb00424.x; Geng JN, 2016, MOL REPROD DEV, V83, P276, DOI 10.1002/mrd.22626; Gomez R, 2005, AM J OBSTET GYNECOL, V192, P678, DOI 10.1016/j.ajog.2004.10.624; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Gong J, 2014, ARCH GYNECOL OBSTET, V289, P85, DOI 10.1007/s00404-013-2955-0; Heng YJJ, 2012, REPROD SCI, V19, P55, DOI 10.1177/1933719111413299; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Koscica KL, 2007, AM J OBSTET GYNECOL, V196, P551, DOI 10.1016/j.ajog.2007.01.043; Leeming DJ, 2016, BIOCHEMISTRY OF COLLAGENS, LAMININS AND ELASTIN: STRUCTURE, FUNCTION AND BIOMARKERS, P43, DOI 10.1016/B978-0-12-809847-9.00005-2; Li KL, 2020, REPRODUCTION, V159, pR97, DOI 10.1530/REP-19-0268; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Locksmith GJ, 2001, AM J OBSTET GYNECOL, V184, P159, DOI 10.1067/mob.2001.108860; Lombardi A, 2018, REPROD SCI, V25, P938, DOI 10.1177/1933719117732158; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Miller ES, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.004; MINAMOTO T, 1987, AM J OBSTET GYNECOL, V156, P138, DOI 10.1016/0002-9378(87)90225-0; Ndinguri MW, 2012, MOLECULES, V17, P14230, DOI 10.3390/molecules171214230; Nishihara S, 2008, REPROD SCI, V15, P156, DOI 10.1177/1933719107310308; Riley SC, 1999, J ENDOCRINOL, V162, P351, DOI 10.1677/joe.0.1620351; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; Tency I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049042; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; Vink J, 2016, SEMIN FETAL NEONAT M, V21, P106, DOI 10.1016/j.siny.2015.12.009; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Yoo HN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180878	38	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250108	10.1371/journal.pone.0250108	http://dx.doi.org/10.1371/journal.pone.0250108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852644	gold, Green Published			2022-12-26	WOS:000640604500027
J	Nishida-Fukuda, H; Tokuhiro, K; Ando, Y; Matsushita, H; Wada, M; Tanaka, H				Nishida-Fukuda, Hisayo; Tokuhiro, Keizo; Ando, Yukio; Matsushita, Hiroaki; Wada, Morimasa; Tanaka, Hiromitsu			Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines	PLOS ONE			English	Article							AURORA B; KINASE HASPIN; HISTONE H3; THR-3 PHOSPHORYLATION; IDENTIFICATION; VRK1; CENTROMERES; PROGRESSION; GENE	HASPIN is a serine/threonine kinase that regulates mitosis by phosphorylating histone H3 at threonine 3. The expression levels of HASPIN in various cancers are associated with tumor malignancy and poor survival, suggesting that HASPIN inhibition may suppress cancer growth. As HASPIN mRNA levels are elevated in human breast cancer tissues compared with adjacent normal tissues, we examined the growth-suppressive effects of CHR-6494, a potent HASPIN inhibitor, in breast cancer cell lines in vitro and in vivo. We found that HASPIN was expressed in breast cancer cells of all molecular subtypes, as well as in immortalized mammary epithelial cells. HASPIN expression levels appeared to be correlated with the cell growth rate but not the molecular subtype of breast cancer. CHR-6494 exhibited potent antiproliferative effects against breast cancer cell lines and immortalized mammary epithelial cells in vitro, but failed to inhibit the growth of MDA-MB-231 xenografted tumors under conditions that have significant effects in a colorectal cancer model. These results imply that CHR-6494 does have antiproliferative effects in some situations, and further drug screening efforts are anticipated to identify more potent and selective HASPIN inhibition for use as an anticancer agent in breast cancer patients.	[Nishida-Fukuda, Hisayo; Tokuhiro, Keizo] Kansai Med Univ, Inst Biomed Sci, Dept Genome Editing, Hirakata, Osaka, Japan; [Ando, Yukio; Matsushita, Hiroaki; Wada, Morimasa; Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo, Nagasaki, Japan	Kansai Medical University; Nagasaki International University	Nishida-Fukuda, H (corresponding author), Kansai Med Univ, Inst Biomed Sci, Dept Genome Editing, Hirakata, Osaka, Japan.; Tanaka, H (corresponding author), Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo, Nagasaki, Japan.	fukudahs@hirakata.kmu.ac.jp; h-tanaka@niu.ac.jp	Tokuhiro, Keizo/HDM-4295-2022	Nishida-Fukuda, Hisayo/0000-0002-4661-779X	JSPS KAKENHI [JP20K06476, JP18K08574]; Takeda Science Foundation; Sumitomo Foundation; Ichiro Kanehara Foundation; Kanzawa Medical Research Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Ichiro Kanehara Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation)	This work was partially supported by JSPS KAKENHI (JP18K08574), Takeda Science Foundation to H.N.F, and JSPS KAKENHI (JP20K06476), Takeda Science Foundation, The Sumitomo Foundation, The Ichiro Kanehara Foundation, and Kanzawa Medical Research Foundation to T.K.	Amoussou NG, 2018, DRUG DISCOV TODAY, V23, P409, DOI 10.1016/j.drudis.2017.10.005; Balzano D, 2011, CHEM BIOL, V18, P966, DOI 10.1016/j.chembiol.2011.04.013; Chen YH, 2020, AGING-US, V12, P8858, DOI 10.18632/aging.103005; Cuny GD, 2012, BIOORG MED CHEM LETT, V22, P2015, DOI 10.1016/j.bmcl.2012.01.028; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; De Antoni A, 2012, J CELL BIOL, V199, P269, DOI 10.1083/jcb.201205119; Fukuda S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20209; Han LL, 2017, J CANCER, V8, P2933, DOI 10.7150/jca.20319; Han X, 2019, EXP CELL RES, V385, DOI 10.1016/j.yexcr.2019.111605; Higgins JMG, 2003, CELL MOL LIFE SCI, V60, P446, DOI 10.1007/s000180300038; Higgins JMG, 2001, GENE, V267, P55, DOI 10.1016/S0378-1119(01)00387-0; Higgins JMG, 2010, CHROMOSOMA, V119, P137, DOI 10.1007/s00412-009-0250-4; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Karanika E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54350-4; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Melms JC, 2020, CANCER RES, V80, P798, DOI 10.1158/0008-5472.CAN-19-2330; Moura DS, 2018, CELL MOL LIFE SCI, V75, P2591, DOI 10.1007/s00018-018-2746-7; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Shimada M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12059; Tanaka H, 1999, J BIOL CHEM, V274, P17049, DOI 10.1074/jbc.274.24.17049; Tanaka H, 2001, MOL HUM REPROD, V7, P211, DOI 10.1093/molehr/7.3.211; Tanaka H., 2019, EUR J CANCER PREV; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang FW, 2012, J CELL BIOL, V199, P251, DOI 10.1083/jcb.201205106; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang PL, 2020, J CELL PHYSIOL, V235, P4508, DOI 10.1002/jcp.29328; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Ye Z, 2019, OPEN LIFE SCI, V14, P688, DOI 10.1515/biol-2019-0078; Zhu DW, 2020, EXP CELL RES, V390, DOI 10.1016/j.yexcr.2020.111863	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249912	10.1371/journal.pone.0249912	http://dx.doi.org/10.1371/journal.pone.0249912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852630	gold, Green Published			2022-12-26	WOS:000640604500062
J	Padgett, LR; Kennington, LA; Ahls, CL; Samarasinghe, DK; Tu, YP; Wallander, ML; Cooper, SD; Elliott, JS; Rains, D				Padgett, Leah R.; Kennington, Lauren A.; Ahls, Charlotte L.; Samarasinghe, Delini K.; Tu, Yuan-Po; Wallander, Michelle L.; Cooper, Shawna D.; Elliott, James S.; Rains, Douglas			Polyester nasal swabs collected in a dry tube are a robust and inexpensive, minimal self-collection kit for SARS-CoV-2 testing	PLOS ONE			English	Article								Background In order to identify an inexpensive yet highly stable SARS-CoV-2 collection device as an alternative to foam swabs stored in transport media, both contrived ("surrogate") CoV-positive and patient-collected spun polyester swabs stored in dry tubes were evaluated for time- and temperature-stability using qPCR. Methods Surrogate specimens were prepared by combining multiple, residual SARS-CoV-2-positive clinical specimens and diluting to near-LOD levels in either porcine or human mucus ("matrix"), inoculating foam or polyester nasal swabs, and sealing in dry tubes. Swabs were then subjected to one of three temperature excursions: (1) 4 degrees C for up to 72 hours; (2) 40 degrees C for 12 hours, followed by 32 degrees C for up to 60 hours; or (3) multiple freeze-thaw cycles (-20 degrees C). The stability of extracted SARS-CoV-2 RNA for each condition was evaluated by qPCR. Separate usability studies for the dry polyester swab-based HealthPulse@home COVID-19 Specimen Collection Kit were later conducted in both adult and pediatric populations. Results Polyester swabs stored dry demonstrated equivalent performance to foam swabs for detection of low and moderate SARS-CoV-2 viral loads. Mimicking warm- and cold- climate shipment, surrogate specimens were stable following either 72 hours of a high-temperature excursion or two freeze-thaw cycles. In addition, usability studies comprised of self-collected patient specimens yielded sufficient material for molecular testing, as demonstrated by RNase P detection. Conclusions Polyester nasal swabs stored in dry collection tubes offer a robust and inexpensive self-collection method for SARS-CoV-2 viral load testing, as viral RNA remains stable under conditions required for home collection and shipment to the laboratory.	[Padgett, Leah R.; Kennington, Lauren A.; Ahls, Charlotte L.; Samarasinghe, Delini K.; Elliott, James S.; Rains, Douglas] Quantigen Biosci, Fishers, IN 46038 USA; [Tu, Yuan-Po] Everett Clin Part Optum, Everett, WA USA; [Wallander, Michelle L.] Sciest, Mooresville, NC USA; [Cooper, Shawna D.] Audere, Seattle, WA USA		Rains, D (corresponding author), Quantigen Biosci, Fishers, IN 46038 USA.	doug.rains@quantigen.com			Bill and Melinda Gates Foundation [INV-016831]; Audere	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Audere	Funding for this project was provided primarily by the Bill and Melinda Gates Foundation, through a direct award (BMGF COVID Grant Investment ID: INV-016831) to Quantigen Biosciences (LRP, LAK, CLA, DKS, JSE, and DR) and Audere (SDC). The funder provided support in the form of salaries for authors (LRP, LAK, CLA, DKS, MLW, SDC, JSE, and DR) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Some reagents and consumables were provided free of charge to Quantigen by ThermoFisher. LRP, LAK, CLA, DKS, JSE, and DR are employed by Quantigen. YT is employed by The Everett Clinic-Part of Optum and MLW is employed by Sciest LLC.	Altamirano J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12005; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; IRVING S, 2012, NATURE, V10, P215, DOI DOI 10.3121/CMR.2012.1084; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tu YP, 2020, NEW ENGL J MED, V383, P494, DOI 10.1056/NEJMc2016321; van Kampen JJA, 2020, PREPRINT, DOI [10.1101/2020.06.08.20125310, DOI 10.1101/2020.06.08.20125310]; Van Wesenbeeck Liesbeth, 2014, Virol J, V11, P233, DOI 10.1186/s12985-014-0233-9; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3	8	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0245423	10.1371/journal.pone.0245423	http://dx.doi.org/10.1371/journal.pone.0245423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852576	gold, Green Published, Green Submitted			2022-12-26	WOS:000640604500046
J	Ravindra, VM; Grandhi, R; Delic, A; Hohmann, S; Shippey, E; Tirschwell, D; Frontera, JA; Yaghi, S; Majersik, JJ; Anadani, M; de Havenon, A				Ravindra, Vijay M.; Grandhi, Ramesh; Delic, Alen; Hohmann, Samuel; Shippey, Ernie; Tirschwell, David; Frontera, Jennifer A.; Yaghi, Shadi; Majersik, Jennifer J.; Anadani, Mohammad; de Havenon, Adam			Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States	PLOS ONE			English	Article							STROKE	Objective To examine the outcomes of adult patients with spontaneous intracranial and subarachnoid hemorrhage diagnosed with comorbid COVID-19 infection in a large, geographically diverse cohort. Methods We performed a retrospective analysis using the Vizient Clinical Data Base. We separately compared two cohorts of patients with COVID-19 admitted April 1-October 31, 2020-patients with intracerebral hemorrhage (ICH) and those with subarachnoid hemorrhage (SAH)-with control patients with ICH or SAH who did not have COVID-19 admitted at the same hospitals in 2019. The primary outcome was in-hospital death. Favorable discharge and length of hospital and intensive-care stay were the secondary outcomes. We fit multivariate mixed-effects logistic regression models to our outcomes. Results There were 559 ICH-COVID patients and 23,378 ICH controls from 194 hospitals. In the ICH-COVID cohort versus controls, there was a significantly higher proportion of Hispanic patients (24.5% vs. 8.9%), Black patients (23.3% vs. 20.9%), nonsmokers (11.5% vs. 3.2%), obesity (31.3% vs. 13.5%), and diabetes (43.4% vs. 28.5%), and patients had a longer hospital stay (21.6 vs. 10.5 days), a longer intensive-care stay (16.5 vs. 6.0 days), and a higher in-hospital death rate (46.5% vs. 18.0%). Patients with ICH-COVID had an adjusted odds ratio (aOR) of 2.43 [1.96-3.00] for the outcome of death and an aOR of 0.55 [0.44-0.68] for favorable discharge. There were 212 SAH-COVID patients and 5,029 controls from 119 hospitals. The hospital (26.9 vs. 13.4 days) and intensive-care (21.9 vs. 9.6 days) length of stays and in-hospital death rate (42.9% vs. 14.8%) were higher in the SAH-COVID cohort compared with controls. Patients with SAH-COVID had an aOR of 1.81 [1.26-2.59] for an outcome of death and an aOR of 0.54 [0.37-0.78] for favorable discharge. Conclusions Patients with spontaneous ICH or SAH and comorbid COVID infection were more likely to be a racial or ethnic minority, diabetic, and obese and to have higher rates of death and longer hospital length of stay when compared with controls.	[Ravindra, Vijay M.] Naval Med Ctr San Diego, Dept Neurosurg, San Diego, CA USA; [Ravindra, Vijay M.; Grandhi, Ramesh] Univ Utah, Dept Neurosurg, Clin Neurosci, Salt Lake City, UT USA; [Delic, Alen; Majersik, Jennifer J.; de Havenon, Adam] Univ Utah, Clin Neurosci Ctr, Dept Neurol, Salt Lake City, UT 84112 USA; [Hohmann, Samuel; Shippey, Ernie] Vizient Inc, Res Analyt, Irving, TX USA; [Tirschwell, David] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Frontera, Jennifer A.; Yaghi, Shadi] NYU Langone Hlth, Dept Neurol, New York, NY USA; [Yaghi, Shadi] Brown Univ, Dept Neurol, Providence, RI 02912 USA; [Anadani, Mohammad] Washington Univ, Dept Neurol, St Louis, MO 63110 USA	United States Department of Defense; United States Navy; Naval Medical Center San Diego; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; NYU Langone Medical Center; Brown University; Washington University (WUSTL)	de Havenon, A (corresponding author), Univ Utah, Clin Neurosci Ctr, Dept Neurol, Salt Lake City, UT 84112 USA.	adam.dehavenon@hsc.utah.edu	Anadani, Mohammad/J-6012-2019	Anadani, Mohammad/0000-0002-7813-2949	National Institutes of Health/National Institute of Neurololgical Disorders and Stroke	National Institutes of Health/National Institute of Neurololgical Disorders and Stroke	AdH received funding from National Institutes of Health/National Institute of Neurololgical Disorders and Stroke. The funder did not have a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. SH and ES are employees of Vizient, Inc. The funder provided support in the form of salaries for authors SH and ES but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agarwal A, 2020, EMERG RADIOL, V27, P747, DOI 10.1007/s10140-020-01837-7; Al Saiegh F, 2020, J NEUROL NEUROSUR PS, V91, P846, DOI 10.1136/jnnp-2020-323522; Belani P, 2020, AM J NEURORADIOL, V41, P1361, DOI 10.3174/ajnr.A6650; Bernat AL, 2020, J NEUROSURG SCI, V64, P409, DOI 10.23736/S0390-5616.20.04963-2; de Havenon A, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105535; de Havenon A, 2020, J NEUROINTERV SURG, V12, P1045, DOI 10.1136/neurintsurg-2020-016777; de Havenon Adam, 2020, medRxiv, DOI 10.1101/2020.05.07.20083386; Douglas JA, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106282; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Frontera JA, 2021, NEUROLOGY, V96, pE575, DOI 10.1212/WNL.0000000000010979; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS261, DOI 10.2105/AJPH.2009.161505; Katsanos AH, 2021, ANN NEUROL, V89, P380, DOI [10.1002/ana.25967, 10.1002/ana.25967Citations:1]; Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; McNett M, 2020, NEUROCRIT CARE, V33, P793, DOI 10.1007/s12028-020-01100-4; Melmed KR, 2021, J THROMB THROMBOLYS, V51, P953, DOI 10.1007/s11239-020-02288-0; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Parcha Vibhu, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P703, DOI 10.1016/j.mayocpiqo.2020.09.005; Reddy ST, 2020, CASE REP NEUROL, V12, P199, DOI 10.1159/000508958; Rinaldo L, 2019, STROKE, V50, P2428, DOI 10.1161/STROKEAHA.118.024651; Shahjouei S, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102939; Sharifi-Razavi A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100669; Smati S, 2021, DIABETES OBES METAB, V23, P391, DOI 10.1111/dom.14228; Tsivgoulis G, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420978004; Tsivgoulis G, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420932036; U.S. Centers for Disease Control and Prevention, COVID 19 RAC ETHN MI; Vizient, 2020, CLIN DAT BAS	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0248728	10.1371/journal.pone.0248728	http://dx.doi.org/10.1371/journal.pone.0248728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852591	gold, Green Published			2022-12-26	WOS:000640604500026
J	Rashid, MA; Muneer, S; Wang, T; Alhamhoom, Y; Rintoul, L; Izake, EL; Islam, N				Rashid, Md Abdur; Muneer, Saiqa; Wang, Tony; Alhamhoom, Yahya; Rintoul, Llew; Izake, Emad L.; Islam, Nazrul			Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization	PLOS ONE			English	Article							DRUG-DELIVERY; CARRIER; PERFORMANCE; LACTOSE; RAT	This study aims at developing and characterizing the puerarin dry powder inhaler (DPI) formulations for pulmonary delivery. The inhalable particles size (<2 mu m) was accomplished by micronization and its morphology was examined by scanning electron microscopy (SEM). The puerarin-excipient interaction in powder mixtures was analyzed by using Fourier transform infrared spectroscopy (FTIR), Raman confocal microscopy, X-Ray powder Diffraction (XRD), and differential scanning calorimetry (DSC) methods. Using a Twin stage impinger (TSI), the in-vitro aerosolization of the powder formulations was carried out at a flow rate of 60 L/min and the drug was quantified by employing a validated HPLC method. No significant interactions between the drug and the excipients were observed in the powder formulations. The fine particle fraction (FPF) of the drug alone was 4.2% which has increased five to six-fold for the formulations with aerosolization enhancers. Formulation containing lactose as large carriers produced 32.7% FPF, which further increased with the addition of dispersibility enhancers, leucine and magnesium stearate (40.8% and 41.2%, respectively). The Raman and FTIR techniques are very useful tool for understanding structural integrity and stability of the puerarin in the powder formulations. The puerarin was found to be compatible with the excipients used and the developed DPI formulation may be considered as an efficient formulation for pulmonary delivery for the management of various diseases at a very low dose.	[Rashid, Md Abdur; Alhamhoom, Yahya] King Khalid Univ, Sch Pharm, Dept Pharmaceut, Abha, Saudi Arabia; [Muneer, Saiqa; Izake, Emad L.] Queensland Univ Technol, Sci & Engn Fac, Sch Chem & Phys, Brisbane, Qld, Australia; [Muneer, Saiqa] Univ Queensland, Fac Sci, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Wang, Tony; Rintoul, Llew] Queensland Univ Technol, Inst Future Environm, Cent Analyt Res Facil, Brisbane, Qld, Australia; [Islam, Nazrul] Queensland Univ Technol, Fac Hlth, Sch Clin Sci, Pharm Discipline, Brisbane, Qld, Australia; [Islam, Nazrul] Queensland Univ Technol, Ctr Immunol & Infect, Tier Res Ctr 2, Brisbane, Qld, Australia	King Khalid University; Queensland University of Technology (QUT); University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Rashid, MA (corresponding author), King Khalid Univ, Sch Pharm, Dept Pharmaceut, Abha, Saudi Arabia.; Islam, N (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Clin Sci, Pharm Discipline, Brisbane, Qld, Australia.; Islam, N (corresponding author), Queensland Univ Technol, Ctr Immunol & Infect, Tier Res Ctr 2, Brisbane, Qld, Australia.	mdrashid@kku.edu.sa; nazrul.islam@qut.edu.au	Alhamhoom, Yahya/CAF-8994-2022	WANG, XIAODONG/0000-0003-4278-0888; MUNEER, SAIQA/0000-0001-7120-2863; Rashid, Md Abdur/0000-0001-9404-5186; Islam, Nazrul/0000-0001-6751-6915				Afrose A, 2018, J PHARM SCI-US, V107, P3060, DOI 10.1016/j.xphs.2018.07.030; Alway B, 1996, INT J PHARM, V130, P213, DOI 10.1016/0378-5173(95)04303-9; Anukunwithaya T, 2018, BMC PHARMACOL TOXICO, V19, DOI 10.1186/s40360-018-0216-3; Chandeying Verapol, 2007, Journal of the Medical Association of Thailand, V90, P1720; Coelho AA, 2018, J APPL CRYSTALLOGR, V51, P210, DOI 10.1107/S1600576718000183; Corrigan DO, 2006, INT J PHARM, V322, P22, DOI 10.1016/j.ijpharm.2006.05.022; Fang WJ, 2012, PHARM RES-DORDR, V29, P3278, DOI 10.1007/s11095-012-0820-7; Farkas DR, 2015, ANN BIOMED ENG, V43, P2804, DOI 10.1007/s10439-015-1335-2; Gonzalez VM, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040078; Hsu HH, 2002, PLANTA MED, V68, P999, DOI 10.1055/s-2002-35656; Islam N, 2004, J PHARM SCI-US, V93, P1030, DOI 10.1002/jps.10583; Islam N, 2008, INT J PHARMACEUT, V360, P1, DOI 10.1016/j.ijpharm.2008.04.044; Jetzer MW, 2018, J PHARM SCI-US, V107, P984, DOI 10.1016/j.xphs.2017.12.006; Jiang L, 2013, J CHROMATOGR B, V915, P8, DOI 10.1016/j.jchromb.2012.12.011; Jiantao H., 2004, DETERMINATION PUERAR, V32, P519; Kwon YB, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12080765; Li HW, 2014, INT J PHARMACEUT, V466, P133, DOI 10.1016/j.ijpharm.2014.03.014; Lin C-C., 2005, DETERMINATION 7 PUER, V13; Luo CF, 2011, INT J PHARMACEUT, V410, P138, DOI 10.1016/j.ijpharm.2011.02.064; Molina C, 2018, DRUG DELIV TRANSL RE, V8, P1769, DOI 10.1007/s13346-017-0462-8; Muneer S, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10091756; Muneer S, 2020, INT J PHARMACEUT, V587, DOI 10.1016/j.ijpharm.2020.119684; Nokhodchi AJDD., COSPRAYING CARRIERS, V2020, P1; Peng TT, 2016, ACTA PHARM SIN B, V6, P308, DOI 10.1016/j.apsb.2016.03.011; Rashid MA, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11050207; Sagheer A, 2017, HIGH PERFORMANCE LIQ, V8, P1; Shen J., 2007, DIFFERENT KINETICS P, V12, P394; Son YJ, 2013, INT J PHARMACEUT, V443, P137, DOI 10.1016/j.ijpharm.2013.01.003; Suthon S, 2016, J NAT MED-TOKYO, V70, P225, DOI 10.1007/s11418-016-0965-5; Wang Fu-Wen, 2006, Zhongguo Zhong Yao Za Zhi, V31, P504; Wang Q, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004196.pub2; Wei SY, 2014, CHIN J NAT MEDICINES, V12, P407, DOI 10.1016/S1875-5364(14)60064-9; Wu HF, 2011, EUR J PHARM SCI, V42, P348, DOI 10.1016/j.ejps.2010.12.010; Zeng XM, 2000, INT J PHARM, V200, P93, DOI 10.1016/S0378-5173(00)00347-1; Zeng XM, 2001, J PHARM SCI, V90, P1424, DOI 10.1002/jps.1094; Zhang L, 2019, DRUG DELIV, V26, P860, DOI 10.1080/10717544.2019.1660732; Zhang SY, 2006, BIOL PHARM BULL, V29, P945, DOI 10.1248/bpb.29.945; Zhang X., 2010, PUERARIN MONOCRYSTAL; Zhang XD, 2019, J PHARMACOL SCI, V141, P97, DOI 10.1016/j.jphs.2019.09.010; Zhang Y, 2012, INT J PHARMACEUT, V427, P337, DOI 10.1016/j.ijpharm.2012.02.013; Zhao L., 2011, ENHANCEMENT ORAL BIO, P2011; Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083	42	2	2	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2021	16	4							e0249683	10.1371/journal.pone.0249683	http://dx.doi.org/10.1371/journal.pone.0249683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN5ED	33848310	Green Published, gold			2022-12-26	WOS:000640373500010
J	Enomoto, H; Yeatts, J; Carbajal, L; Krishnan, BR; Madan, JP; Laumas, S; Blikslager, AT; Messenger, KM				Enomoto, Hiroko; Yeatts, James; Carbajal, Liliana; Krishnan, B. Radha; Madan, Jay P.; Laumas, Sandeep; Blikslager, Anthony T.; Messenger, Kristen M.			In vivo assessment of a delayed release formulation of larazotide acetate indicated for celiac disease using a porcine model	PLOS ONE			English	Article								There is no FDA approved therapy for the treatment of celiac disease (CeD), aside from avoidance of dietary gluten. Larazotide acetate (LA) is a first in class oral peptide developed as a tight junction regulator, which is a lead candidate for management of CeD. A delayed release formulation was tested in vitro and predicted release in the mid duodenum and jejunum, the target site of CeD. The aim of this study was to follow the concentration versus time profile of orally administered LA in the small intestine using a porcine model. A sensitive liquid chromatography/tandem mass spectrometry method was developed to quantify LA concentrations in porcine intestinal fluid samples. Oral dosing of LA (1 mg total) in overnight fasted pigs resulted in time dependent appearance of LA in the distal duodenum and proximal jejunum. Peak LA concentrations (0.32-1.76 mu M) occurred at 1 hour in the duodenum and in proximal jejunum following oral dosing, with the continued presence of LA (0.02-0.47 mu M) in the distal duodenum and in proximal jejunum (0.00-0.43 mu M) from 2 to 4 hours following oral dosing. The data shows that LA is available in detectable concentrations at the site of CeD.	[Enomoto, Hiroko; Yeatts, James; Carbajal, Liliana; Blikslager, Anthony T.; Messenger, Kristen M.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Krishnan, B. Radha; Madan, Jay P.; Laumas, Sandeep] Innovate Biopharmaceut Inc, Raleigh, NC USA	University of North Carolina; North Carolina State University	Messenger, KM (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.	kmmessen@ncsu.edu		Blikslager, Anthony/0000-0002-0867-7310; Messenger, Kristen/0000-0001-8161-4482	NIDDK NIH HHS [P30 DK034987] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alhakamy NA, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12070652; Alhassan E, 2019, CELL MOL GASTROENTER, V8, P335, DOI 10.1016/j.jcmgh.2019.04.017; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Donnelly SC, 2011, EXPERT OPIN PHARMACO, V12, P1731, DOI 10.1517/14656566.2011.592140; Freeman HJ, 2015, GUT LIVER, V9, P28, DOI 10.5009/gnl14288; Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004; Gopalakrishnan S, 2012, PEPTIDES, V35, P95, DOI 10.1016/j.peptides.2012.02.016; Gopalakrishnan S, 2012, PEPTIDES, V35, P86, DOI 10.1016/j.peptides.2012.02.015; Hall NJ, 2013, APPETITE, V68, P56, DOI 10.1016/j.appet.2013.04.016; Henze LJ, 2019, J PHARM PHARMACOL, V71, P581, DOI 10.1111/jphp.12912; Hosny KM, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12111124; Ibekwe VC, 2008, PHARM RES-DORDR, V25, P1828, DOI 10.1007/s11095-008-9580-9; Janet CG., GUIDE CARE USE LAB A, VEighth; Jin Y, 2019, GASTROENTEROLOGY, V156, pS487; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kelly CP, 2013, ALIMENT PHARM THER, V37, P252, DOI 10.1111/apt.12147; Khaleghi S, 2016, THER ADV GASTROENTER, V9, P37, DOI 10.1177/1756283X15616576; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Leffler DA, 2015, GASTROENTEROLOGY, V148, P1311, DOI 10.1053/j.gastro.2015.02.008; Leffler DA, 2012, AM J GASTROENTEROL, V107, P1554, DOI 10.1038/ajg.2012.211; Merchant HA, 2015, J PHARM PHARMACOL, V67, P630, DOI 10.1111/jphp.12361; Merchant HA, 2011, EUR J PHARM SCI, V42, P3, DOI 10.1016/j.ejps.2010.09.019; Messenger KM, 2016, J VET PHARMACOL THER, V39, P32, DOI 10.1111/jvp.12233; Messenger KM, 2012, J VET PHARMACOL THER, V35, P452, DOI 10.1111/j.1365-2885.2011.01338.x; Mzyk DA, 2018, J DAIRY SCI, V101, P10414, DOI 10.3168/jds.2018-14849; Naiserova Martina, 2019, Ceska Slov Farm, V68, P183; Naveen NR, 2020, PROCESSES, V8, DOI 10.3390/pr8030316; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Papich MG, 2010, AM J VET RES, V71, P1484, DOI 10.2460/ajvr.71.12.1484; Paterson BM, 2007, ALIMENT PHARM THER, V26, P757, DOI 10.1111/j.1365-2036.2007.03413.x; Therrien A, 2020, J CLIN GASTROENTEROL, V54, P8, DOI 10.1097/MCG.0000000000001267; Ting YW, 2015, J AGR FOOD CHEM, V63, P1332, DOI 10.1021/jf5047464; Torborg L, 2015, MAYO CLIN Q A DIAGNO; Underwood C, 2014, VET J, V202, P314, DOI 10.1016/j.tvjl.2014.05.007; Valitutti F, 2019, DIGEST DIS SCI, V64, P1748, DOI 10.1007/s10620-019-05646-y; Vaquero L, 2019, EXPERT OPIN DRUG DIS, V14, P957, DOI 10.1080/17460441.2019.1642321; Warren CD, 2014, RES VET SCI, V97, P611, DOI 10.1016/j.rvsc.2014.10.012; Yadav S, 2014, CARBOHYD POLYM, V99, P601, DOI 10.1016/j.carbpol.2013.08.068; Yan L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03970-9	39	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2021	16	4							e0249179	10.1371/journal.pone.0249179	http://dx.doi.org/10.1371/journal.pone.0249179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM7RW	33844694	gold, Green Published			2022-12-26	WOS:000639857200003
J	Ye, H; Mukherjee, UK; Chhajed, D; Hirsbrunner, J; Roloff, C				Ye, Han; Mukherjee, Ujjal Kumar; Chhajed, Dilip; Hirsbrunner, Jason; Roloff, Collin			Recommending encounters according to the sociodemographic characteristics of patient strata can reduce risks from type 2 diabetes	PLOS ONE			English	Article								Objectives Physician encounters with patients with type 2 diabetes act as motivation for self-management and lifestyle adjustments that are indispensable for diabetes treatment. We elucidate the sociodemographic sources of variation in encounter usage and the impact of encounter usage on glucose control, which can be used to recommend encounter usage for different sociodemographic strata of patients to reduce risks from Type 2 diabetes. Data and methods We analyzed data from a multi-facility clinic in the Midwestern United States on 2124 patients with type 2 diabetes, from 95 ZIP codes. A zero-inflated Poisson model was used to estimate the effects of various ZIP-code level sociodemographic variables on the encounter usage. A multinomial logistic regression model was built to estimate the effects of physical and telephonic encounters on patients' glucose level transitions. Results from the two models were combined in marginal effect analyses. Results and conclusions Conditional on patients' clinical status, demographics, and insurance status, significant inequality in patient encounters exists across ZIP codes with varying sociodemographic characteristics. One additional physical encounter in a six-month period marginally increases the probability of transition from a diabetic state to a pre-diabetic state by 4.3% and from pre-diabetic to the non-diabetic state by 3.2%. Combined marginal effect analyses illustrate that a ZIP code in the lower quartile of high school graduate percentage among all ZIP codes has 1 fewer physical encounter per six months marginally compared to a ZIP code at the upper quartile, which gives 5.4% average increase in the probability of transitioning from pre-diabetic to diabetic. Our results suggest that policymakers can target particular patient groups who may have inadequate encounters to engage in diabetes care, based on their immediate environmental sociodemographic characteristics, and design programs to increase their encounters to achieve better care outcomes.	[Ye, Han; Mukherjee, Ujjal Kumar] Univ Illinois, Dept Business Adm, Champaign, IL USA; [Chhajed, Dilip] Purdue Univ, Krannert Sch Management, W Lafayette, IN 47907 USA; [Hirsbrunner, Jason; Roloff, Collin] Christie Clin, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ye, H (corresponding author), Univ Illinois, Dept Business Adm, Champaign, IL USA.	hanye@illinois.edu						Augustin NH, 2001, J APPL ECOL, V38, P991, DOI 10.1046/j.1365-2664.2001.00653.x; Bizzotto R, 2010, J PHARMACOKINET PHAR, V37, P137, DOI 10.1007/s10928-009-9148-2; BOHNING D, 1992, ANN I STAT MATH, V44, P197, DOI 10.1007/bf00048682; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Centers for Disease Control and Prevention, 2018, PROVISIONAL MORTALIT; Cheng YLJ, 2019, JAMA-J AM MED ASSOC, V322, P2389, DOI 10.1001/jama.2019.19365; Choi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149886; Dixon RF, 2010, HEALTH AFFAIR, V29, P1364, DOI 10.1377/hlthaff.2010.0110; Ellis DA, 2017, LANCET PUBLIC HEALTH, V2, pE551, DOI 10.1016/S2468-2667(17)30217-7; Fenton JJ, 2006, ANN FAM MED, V4, P32, DOI 10.1370/afm.421; Fenwick EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080593; Fisher-Hoch SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133135; Gaskin DJ, 2014, AM J PUBLIC HEALTH, V104, P2147, DOI 10.2105/AJPH.2013.301420; Graffigna G, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2974521; Grant RW, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.29068; Hastie T., 2009, MATH INTELL; Holman H, 2004, JAMA-J AM MED ASSOC, V292, P1057, DOI 10.1001/jama.292.9.1057; Hu JH, 2014, HEALTH AFFAIR, V33, P778, DOI 10.1377/hlthaff.2013.0816; Jin C, 2017, DIABETES CARE, V40, P1565, DOI 10.2337/dc17-0610; Kanter Michael, 2010, Perm J, V14, P38; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; Kuwata H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172890; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lieberman Jonathon, 2008, Br J Community Nurs, V13, P123; Morrison F, 2011, ARCH INTERN MED, V171, P1542, DOI 10.1001/archinternmed.2011.400; Moscrop A, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1014-2; Negandhi PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083292; Nordin JD, 2010, ANN FAM MED, V8, P511, DOI 10.1370/afm.1188; Patel NK, 2011, J AM BOARD FAM MED, V24, P26, DOI 10.3122/jabfm.2011.01.100137; Paton L, 2014, COMM COM INF SC, V444, P476; Peek ME, 2007, MED CARE RES REV, V64, p101S, DOI 10.1177/1077558707305409; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Ramos-Rivers C, 2014, CLIN GASTROENTEROL H, V12, P986, DOI 10.1016/j.cgh.2013.11.015; Rodriguez KM, 2013, CLIN THER, V35, P170, DOI 10.1016/j.clinthera.2013.01.002; Sambamoorthi U, 2003, PREV MED, V37, P475, DOI 10.1016/S0091-7435(03)00172-5; Sarkar U, 2008, J GEN INTERN MED, V23, P459, DOI 10.1007/s11606-007-0398-7; Wagner EH., 1998, EFF CLIN PRACT; Weinzimer S, 2010, DIABETES CARE, V33, P17, DOI 10.2337/dc09-1502; Williams DR, 2016, HEALTH PSYCHOL, V35, P407, DOI 10.1037/hea0000242; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2021	16	4							e0249084	10.1371/journal.pone.0249084	http://dx.doi.org/10.1371/journal.pone.0249084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM7RW	33844693	gold, Green Published			2022-12-26	WOS:000639857200012
J	Albuquerque, L; Valente, ARS; Teixeira, A; Figueiredo, D; Sa-Couto, P; Oliveira, C				Albuquerque, Luciana; Valente, Ana Rita S.; Teixeira, Antonio; Figueiredo, Daniela; Sa-Couto, Pedro; Oliveira, Catarina			Association between acoustic speech features and non-severe levels of anxiety and depression symptoms across lifespan	PLOS ONE			English	Article							PSYCHOMOTOR RETARDATION; FUNDAMENTAL-FREQUENCY; VOCAL INDICATORS; HOSPITAL ANXIETY; PAUSE TIME; FEAR; AGE; VALIDITY; EMOTION; DISORDERS	Background Several studies have investigated the acoustic effects of diagnosed anxiety and depression. Anxiety and depression are not characteristics of the typical aging process, but minimal or mild symptoms can appear and evolve with age. However, the knowledge about the association between speech and anxiety or depression is scarce for minimal/mild symptoms, typical of healthy aging. As longevity and aging are still a new phenomenon worldwide, posing also several clinical challenges, it is important to improve our understanding of non-severe mood symptoms' impact on acoustic features across lifetime. The purpose of this study was to determine if variations in acoustic measures of voice are associated with non-severe anxiety or depression symptoms in adult population across lifetime. Methods Two different speech tasks (reading vowels in disyllabic words and describing a picture) were produced by 112 individuals aged 35-97. To assess anxiety and depression symptoms, the Hospital Anxiety Depression Scale (HADS) was used. The association between the segmental and suprasegmental acoustic parameters and HADS scores were analyzed using the linear multiple regression technique. Results The number of participants with presence of anxiety or depression symptoms is low (>7: 26.8% and 10.7%, respectively) and non-severe (HADS-A: 5.4 +/- 2.9 and HADS-D: 4.2 +/- 2.7, respectively). Adults with higher anxiety symptoms did not present significant relationships associated with the acoustic parameters studied. Adults with increased depressive symptoms presented higher vowel duration, longer total pause duration and short total speech duration. Finally, age presented a positive and significant effect only for depressive symptoms, showing that older participants tend to have more depressive symptoms. Conclusions Non-severe depression symptoms can be related to some acoustic parameters and age. Depression symptoms can be explained by acoustic parameters even among individuals without severe symptom levels.	[Albuquerque, Luciana; Valente, Ana Rita S.; Teixeira, Antonio; Oliveira, Catarina] Univ Aveiro, Inst Elect & Informat Engn Aveiro, Aveiro, Portugal; [Albuquerque, Luciana; Figueiredo, Daniela] Univ Aveiro, Ctr Hlth Technol & Serv Res, Aveiro, Portugal; [Albuquerque, Luciana; Valente, Ana Rita S.; Teixeira, Antonio] Univ Aveiro, Dept Elect Telecommun & Informat, Aveiro, Portugal; [Albuquerque, Luciana] Univ Aveiro, Dept Educ & Psychol, Aveiro, Portugal; [Figueiredo, Daniela; Oliveira, Catarina] Univ Aveiro, Sch Hlth Sci, Aveiro, Portugal; [Sa-Couto, Pedro] Univ Aveiro, Ctr Res & Dev Math & Applicat, Aveiro, Portugal; [Sa-Couto, Pedro] Univ Aveiro, Dept Math, Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Albuquerque, L (corresponding author), Univ Aveiro, Inst Elect & Informat Engn Aveiro, Aveiro, Portugal.; Albuquerque, L (corresponding author), Univ Aveiro, Ctr Hlth Technol & Serv Res, Aveiro, Portugal.; Albuquerque, L (corresponding author), Univ Aveiro, Dept Elect Telecommun & Informat, Aveiro, Portugal.; Albuquerque, L (corresponding author), Univ Aveiro, Dept Educ & Psychol, Aveiro, Portugal.	lucianapereira@ua.pt	Albuquerque, Luciana Patrícia Martins Nunes Pereira/AAR-7445-2021; Teixeira, António J. S./A-4958-2012; Figueiredo, Daniela/K-3226-2013	Albuquerque, Luciana Patrícia Martins Nunes Pereira/0000-0003-1654-3272; Teixeira, António J. S./0000-0002-7675-1236; Figueiredo, Daniela/0000-0002-3160-7871; Sa-Couto, Pedro/0000-0002-5673-8683	FEDER through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao (POCI) [Vox Senes POCI-01-0145-FEDER-03082]; national funds (OE), through FCT/MCTES [Vox Senes POCI-01-0145-FEDER-03082]; IEETA Research Unit funding [UIDB/00127/2020]; CIDMA [UID/MAT/04106/2019]; FCT (Fundacao para a Ciencia e a Tecnologia) - FSE [SFRH/BD/115381/2016]; FCT (Fundacao para a Ciencia e a Tecnologia) - CENTRO2020	FEDER through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao (POCI); national funds (OE), through FCT/MCTES; IEETA Research Unit funding; CIDMA; FCT (Fundacao para a Ciencia e a Tecnologia) - FSE; FCT (Fundacao para a Ciencia e a Tecnologia) - CENTRO2020	This research was funded by the project Vox Senes POCI-01-0145-FEDER-03082 (funded by FEDER, through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao (POCI), and by national funds (OE), through FCT/MCTES), by IEETA Research Unit funding (UIDB/00127/2020), and by CIDMA (UID/MAT/04106/2019). The research of LA is supported by the FCT (Fundacao para a Ciencia e a Tecnologia) through grant SFRH/BD/115381/2016 (funded by FSE and by CENTRO2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque L., 2019, INTERSPEECH, P3965; Albuquerque Luciana, 2020, J Voice, DOI 10.1016/j.jvoice.2020.10.021; Albuquerque L, 2014, INTERSPEECH, P940; Alghowinem S, 2012, 25 INT FLOR ART INT; Alpert M, 2001, J AFFECT DISORDERS, V66, P59, DOI 10.1016/S0165-0327(00)00335-9; Balabanova D, 2002, INT J HEALTH PLAN M, V17, P377, DOI 10.1002/hpm.687; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Barbosa P. A., 2013, TRASP, P86; Barbosa PA, 2010, SPEECH PROSODY, P1; Barbosa PA, 2006, INCURSOES TORNO RITM; Bennabi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/158746; Bischoff-Ferrari HAc, 2019, DO HLTH; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Boersma P., 2013, PRAAT DOING PHONETIC; BREZNITZ Z, 1992, J GEN PSYCHOL, V119, P351, DOI 10.1080/00221309.1992.9921178; Bromet EJ, 2005, SOC PSYCH PSYCH EPID, V40, P681, DOI 10.1007/s00127-005-0927-9; Cannizzaro M, 2004, BRAIN COGNITION, V56, P30, DOI 10.1016/j.bandc.2004.05.003; Cummins N, 2015, SPEECH COMMUN, V71, P10, DOI 10.1016/j.specom.2015.03.004; Cummins N, 2013, INT CONF ACOUST SPEE, P7542, DOI 10.1109/ICASSP.2013.6639129; Cummins N, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P3008; de Jong NH, 2009, BEHAV RES METHODS, V41, P385, DOI 10.3758/BRM.41.2.385; Diamond GM, 2010, J COUNS PSYCHOL, V57, P402, DOI 10.1037/a0021115; Dietrich M, 2008, J VOICE, V22, P472, DOI 10.1016/j.jvoice.2006.08.007; Draxler C., 2017, SPEECHRECORDER; Drioli C, 2003, EMOTIONS VOICE QUALI; Eichhorn JT, 2018, J VOICE, V32, DOI 10.1016/j.jvoice.2017.08.003; Ellgring H, 1996, J NONVERBAL BEHAV, V20, P83, DOI 10.1007/BF02253071; Escudero P, 2009, J ACOUST SOC AM, V126, P1379, DOI 10.1121/1.3180321; Esposito A, 2016, SMART INNOV SYST TEC, V48, P73, DOI 10.1007/978-3-319-28109-4_8; FLINT AJ, 1993, J PSYCHIAT RES, V27, P309, DOI 10.1016/0022-3956(93)90041-Y; France DJ, 2000, IEEE T BIO-MED ENG, V47, P829, DOI 10.1109/10.846676; FULLER BF, 1992, RES NURS HEALTH, V15, P379, DOI 10.1002/nur.4770150507; Gillam R. B., 2009, TEST CHILDHOOD STUTT; Girgus JS, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2040035; Girgus JS, 2015, CURR OPIN PSYCHOL, V4, P53, DOI 10.1016/j.copsyc.2015.01.019; Goberman AM, 2011, SPEECH COMMUN, V53, P867, DOI 10.1016/j.specom.2011.02.005; GODFREY HPD, 1984, BRIT J PSYCHIAT, V145, P159, DOI 10.1192/bjp.145.2.159; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; GREDEN JF, 1993, J PSYCHIAT RES, V27, P285, DOI 10.1016/0022-3956(93)90039-5; GREDEN JF, 1981, BIOL PSYCHIAT, V16, P851; Hagenaars MA, 2005, J ANXIETY DISORD, V19, P521, DOI 10.1016/j.janxdis.2004.04.008; HALL JA, 1995, APPL PREV PSYCHOL, V4, P21, DOI 10.1016/S0962-1849(05)80049-6; HARDY P, 1984, J AFFECT DISORDERS, V6, P123, DOI 10.1016/0165-0327(84)90014-4; Hoenig F, 2014, INTERSPEECH, P1248; Hopkins W.G., 2002, SCALE MAGNITUDES EFF; Horwitz R, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON BODY SENSOR NETWORKS (BSN); IBM Corp, 2017, SPSS STAT WIND; Jorm AF, 2000, PSYCHOL MED, V30, P11, DOI 10.1017/S0033291799001452; Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634; Kisler T, 2017, COMPUT SPEECH LANG, V45, P326, DOI 10.1016/j.csl.2017.01.005; Klumpp H, 2010, INT J PSYCHOPHYSIOL, V75, P77, DOI 10.1016/j.ijpsycho.2009.10.003; Kraepelin E., 1921, J NERV MENT DIS, V53, P350, DOI [10.1097/00005053-192104000-00057, DOI 10.1097/00005053-192104000-00057]; Kuehner C, 2017, LANCET PSYCHIAT, V4, P146, DOI 10.1016/S2215-0366(16)30263-2; KUNY S, 1993, J PSYCHIAT RES, V27, P289, DOI 10.1016/0022-3956(93)90040-9; Laukka P, 2008, J NONVERBAL BEHAV, V32, P195, DOI 10.1007/s10919-008-0055-9; Low DM, 2020, LARYNGOSCOPE INVEST, V5, P96, DOI 10.1002/lio2.354; Mortensen L, 2006, LANG COGNITIVE PROC, V21, P238, DOI 10.1080/01690960444000278; Mundt JC, 2007, J NEUROLINGUIST, V20, P50, DOI 10.1016/j.jneuroling.2006.04.001; Mundt JC, 2012, BIOL PSYCHIAT, V72, P580, DOI 10.1016/j.biopsych.2012.03.015; MURRAY IR, 1993, J ACOUST SOC AM, V93, P1097, DOI 10.1121/1.405558; NILSONNE A, 1987, ACTA PSYCHIAT SCAND, V76, P235, DOI 10.1111/j.1600-0447.1987.tb02891.x; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Oliveira C, 2012, COMM COM INF SC, V328, P129; Ozdas A, 2004, IEEE T BIO-MED ENG, V51, P1530, DOI 10.1109/TBME.2004.827544; Ozseven T, 2018, ARCH ACOUST, V43, P625, DOI 10.24425/aoa.2018.125156; Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088; Protopapas A, 1997, J ACOUST SOC AM, V101, P2267, DOI 10.1121/1.418247; Quatieri TF, 2012, 13TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2012 (INTERSPEECH 2012), VOLS 1-3, P1058; Roy N, 2009, J COMMUN DISORD, V42, P124, DOI 10.1016/j.jcomdis.2008.10.001; Salk RH, 2017, PSYCHOL BULL, V143, P783, DOI 10.1037/bul0000102; SATALOFF RT, 2005, TREATMENT VOICE DISO; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Scherer S, 2013, IEEE INT CONF AUTOMA; Scherer S, 2015, INT CONF ACOUST SPEE, P4789, DOI 10.1109/ICASSP.2015.7178880; Schiel, 1999, P 14 INT C PHON SCI, V14, P607, DOI DOI 10.5282/UBM/EPUB.13682; SIEGMAN AW, 1993, J ABNORM PSYCHOL, V102, P430, DOI 10.1037/0021-843X.102.3.430; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Sobin C, 1999, J PSYCHOLINGUIST RES, V28, P347, DOI 10.1023/A:1023237014909; Stassen HH, 1998, EUR NEUROPSYCHOPHARM, V8, P303, DOI 10.1016/S0924-977X(97)00090-4; Taguchi T, 2018, J AFFECT DISORDERS, V225, P214, DOI 10.1016/j.jad.2017.08.038; TOLKMITT F, 1982, J COMMUN DISORD, V15, P209, DOI 10.1016/0021-9924(82)90034-X; Trevino AC, 2011, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2011-42; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; Ververidis D, 2006, SPEECH COMMUN, V48, P1162, DOI 10.1016/j.specom.2006.04.003; Vicsi Klara, 2012, 2012 IEEE 3rd International Conference on Cognitive Infocommunications (CogInfoCom 2012), P511; Wang X, 2022, RELC J, V53, P194, DOI 10.1177/0033688220925926; Weeks JW, 2012, J ANXIETY DISORD, V26, P811, DOI 10.1016/j.janxdis.2012.07.005; Wortwein T, 2015, INT CONF AFFECT, P187, DOI 10.1109/ACII.2015.7344570; Won E, 2016, CURR NEUROPHARMACOL, V14, P665, DOI 10.2174/1570159X14666151208113006; World Health Organization, 2018, MENT DIS; Yang Y, 2013, IEEE T AFFECT COMPUT, V4, P142, DOI 10.1109/T-AFFC.2012.38; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	93	8	8	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0248842	10.1371/journal.pone.0248842	http://dx.doi.org/10.1371/journal.pone.0248842			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831018	Green Published, gold			2022-12-26	WOS:000639359600027
J	Aldohbeyb, AA; Vigh, J; Lear, KL				Aldohbeyb, Ahmed A.; Vigh, Jozsef; Lear, Kevin L.			New methods for quantifying rapidity of action potential onset differentiate neuron types	PLOS ONE			English	Article							MAMMALIAN NEURONS; INITIATION; RAT; FREQUENCY; THRESHOLD; LOCATION	Two new methods for quantifying the rapidity of action potential onset have lower relative standard deviations and better distinguish neuron cell types than current methods. Action potentials (APs) in most central mammalian neurons exhibit sharp onset dynamics. The main views explaining such an abrupt onset differ. Some studies suggest sharp onsets reflect cooperative sodium channels activation, while others suggest they reflect AP backpropagation from the axon initial segment. However, AP onset rapidity is defined subjectively in these studies, often using the slope at an arbitrary value on the phase plot. Thus, we proposed more systematic methods using the membrane potential's second-time derivative (<(V)double over dot>V-m) peak width. Here, the AP rapidity was measured for four different cortical and hippocampal neuron types using four quantification methods: the inverse of full-width at the half maximum of the <(V)double over dot>V-m peak (IFWd(2)), the inverse of half-width at the half maximum of the <(V)double over dot>V-m peak (IHWd(2)), the phase plot slope, and the error ratio method. The IFWd(2) and IHWd(2) methods show the smallest variation among neurons of the same type. Furthermore, the AP rapidity, using the <(V)double over dot>V-m peak width methods, significantly differentiates between different types of neurons, indicating that AP rapidity can be used to classify neuron types. The AP rapidity measured using the IFWd(2) method was able to differentiate between all four neuron types analyzed. Therefore, the <(V)double over dot>V-m peak width methods provide another sensitive tool to investigate the mechanisms impacting the AP onset dynamics.	[Aldohbeyb, Ahmed A.; Vigh, Jozsef; Lear, Kevin L.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA; [Aldohbeyb, Ahmed A.] King Saud Univ, Dept Biomed Technol, Riyadh, Saudi Arabia; [Vigh, Jozsef] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO USA; [Lear, Kevin L.] Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA	Colorado State University; King Saud University; Colorado State University; Colorado State University	Lear, KL (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.; Lear, KL (corresponding author), Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA.	kllear@engr.colostate.edu	Aldohbeyb, Ahmed/GXZ-9176-2022	Vigh, Jozsef/0000-0001-9862-5049; Aldohbeyb, Ahmed/0000-0001-8324-1122	Colorado State University Libraries Open Access Research and Scholarship Fund; King Saud University; Colorado State University, College of Veterinary Medicine and Biomedical Sciences Research Council; National Eye Institute	Colorado State University Libraries Open Access Research and Scholarship Fund; King Saud University(King Saud University); Colorado State University, College of Veterinary Medicine and Biomedical Sciences Research Council; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors acknowledge support from the Colorado State University Libraries Open Access Research and Scholarship Fund for partial coverage of publication charges. Ahmed A. Aldohbeyb acknowledges support from King Saud University for his PhD studies. Jozsef Vigh acknowledges support from Colorado State University, College of Veterinary Medicine and Biomedical Sciences Research Council Award and National Eye Institute.; The authors thank David Darevsky and Sierra Lear for their helpful comments on the manuscript. Ahmed A. Aldohbeyb acknowledges support from King Saud University for his PhD studies. Jozsef Vigh acknowledges support from Colorado State University, College of Veterinary Medicine and Biomedical Sciences Research Council Award.	Aldohbeyb AA, 2020, BIOMED SCI INSTRUM, V56, P402; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Baranauskas G, 2010, NEUROSCIENCE, V167, P1070, DOI 10.1016/j.neuroscience.2010.02.072; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bekkers JM, 2011, CURR BIOL, V21, pR975, DOI 10.1016/j.cub.2011.10.037; Brette R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003338; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; da Silva Lantyer A, 2018, **DATA OBJECT**, DOI [10.5524/100535, DOI 10.5524/100535]; Eyal G, 2014, J NEUROSCI, V34, P8063, DOI 10.1523/JNEUROSCI.5431-13.2014; Hamada MS, 2016, P NATL ACAD SCI USA, V113, P14841, DOI 10.1073/pnas.1607548113; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037629; Ilin V, 2013, J NEUROSCI, V33, P2281, DOI 10.1523/JNEUROSCI.0771-12.2013; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kole MHP, 2018, CURR OPIN NEUROBIOL, V51, P52, DOI 10.1016/j.conb.2018.02.016; Kress GJ, 2008, J NEUROPHYSIOL, V100, P281, DOI 10.1152/jn.90295.2008; Lantyer AD, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy147; Lee JCF, 2005, J NEUROPHYSIOL, V93, P2012, DOI 10.1152/jn.01017.2004; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Lee SH., 2016, **DATA OBJECT**, DOI [10.6080/K00P0WXQ, DOI 10.6080/K00P0WXQ]; Lien CC, 2003, J NEUROSCI, V23, P2058; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McCormick DA, 2007, NATURE, V445, pE1, DOI 10.1038/nature05523; Meyer M, 2019, PROBABILITY MATH STA, V162; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Oz P, 2015, J COMPUT NEUROSCI, V39, P63, DOI 10.1007/s10827-015-0561-9; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Pineda JC, 1998, J NEUROPHYSIOL, V79, P2522, DOI 10.1152/jn.1998.79.5.2522; Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009; Sekerli M, 2004, IEEE T BIO-MED ENG, V51, P1665, DOI 10.1109/TBME.2004.827531; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Volgushev M, 2007, ELUSIVE ACTION POTEN, DOI [10.1093/cercor/bhj157, DOI 10.1093/CERCOR/BHJ157]; Volgushev M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001962; Wang J, 2017, CHANNELS, V11, P534, DOI 10.1080/19336950.2017.1380758; Watson PL, 1997, BRAIN RES, V775, P134, DOI 10.1016/S0006-8993(97)00893-7; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	43	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0247242	10.1371/journal.pone.0247242	http://dx.doi.org/10.1371/journal.pone.0247242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831000	gold, Green Published			2022-12-26	WOS:000639359600108
J	Laghi, L; Zagonari, S; Patuelli, G; Zhu, CL; Foschi, C; Morselli, S; Pedna, MF; Sambri, V; Marangoni, A				Laghi, Luca; Zagonari, Sara; Patuelli, Giulia; Zhu, Chenglin; Foschi, Claudio; Morselli, Sara; Pedna, Maria Federica; Sambri, Vittorio; Marangoni, Antonella			Vaginal metabolic profiles during pregnancy: Changes between first and second trimester	PLOS ONE			English	Article							MATERNAL MICROBIOME; DIVERSITY; BIOMARKERS	During pregnancy, the vaginal microbiome plays an important role in both maternal and neonatal health outcomes. Throughout pregnancy, the vaginal microbial composition undergoes significant changes, including a decrease in overall diversity and enrichment with Lactobacillus spp. In turn, the modifications in the microbial profiles are associated with shifts in the composition of vaginal metabolites. In this study, we characterized the vaginal metabolic profiles throughout pregnancy at two different gestational ages, correlating them with a microscopic evaluation of the vaginal bacterial composition. A total of 67 Caucasian pregnant women presenting to the Family Advisory Health Centres of Ravenna (Italy) were enrolled and a vaginal swab was collected at gestational ages 9-13 weeks (first trimester) and 20-24 weeks (second trimester). The composition of the vaginal microbiome was assessed by Nugent score and women were divided in 'H' (normal lactobacilli-dominated microbiota), 'I' (intermediate microbiota), and 'BV' (bacterial vaginosis) groups. Starting from the cell-free supernatants of the vaginal swabs, a metabolomic analysis was performed by means of a H-1-NMR spectroscopy. From the first to the second trimester, a greater number of women showed a normal lactobacilli-dominated microbiota, with a reduction of cases of dysbiosis. These microbial shifts were associated with profound changes in the vaginal metabolic profiles. Over the weeks, a significant reduction in the levels of BV-associated metabolites (e.g. acetate, propionate, tyramine, methylamine, putrescine) was observed. At the same time, the vaginal metabolome was characterized by higher concentrations of lactate and of several amino acids (e.g. tryptophan, threonine, isoleucine, leucine), typically found in healthy vaginal conditions. Over time, the vaginal metabolome became less diverse and more homogeneous: in the second trimester, women with BV showed metabolic profiles more similar to the healthy/intermediate groups, compared to the first trimester. Our data could help unravel the role of vaginal metabolites in the pathophysiology of pregnancy.	[Laghi, Luca; Zhu, Chenglin] Univ Bologna, Ctr Food, Dept Agrofood Sci & Technol, Cesena, Italy; [Zagonari, Sara; Patuelli, Giulia] Family Advisory Hlth Ctr, Ravenna, Italy; [Foschi, Claudio; Morselli, Sara; Sambri, Vittorio; Marangoni, Antonella] Univ Bologna, DIMES, Microbiol, Bologna, Italy; [Pedna, Maria Federica; Sambri, Vittorio] Greater Romagna Hub Lab, Unit Microbiol, Pievesestina Di Cesena, Italy	University of Bologna; University of Bologna	Foschi, C (corresponding author), Univ Bologna, DIMES, Microbiol, Bologna, Italy.	claudio.foschi@gmail.com	Zhu, Chenglin/AAR-9197-2021; Foschi, Claudio/A-7299-2016	Foschi, Claudio/0000-0001-7253-8799; Marangoni, Antonella/0000-0002-7397-6560; SAMBRI, VITTORIO/0000-0002-5012-7355	Fondazione del Monte di Bologna e Ravenna [329bis/2017]	Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna)	AM received funding from 'Fondazione del Monte di Bologna e Ravenna' (Prot. No 329bis/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Ansari A, 2020, METABOLITES, V10, DOI 10.3390/metabo10090349; Ceccarani C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50410-x; Di Simone N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.528202; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Donders GGG, 2011, BJOG-INT J OBSTET GY, V118, P1163, DOI 10.1111/j.1471-0528.2011.03020.x; Fanos V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/720514; Foschi C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194827; Foschi C, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00502; Foschi C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172483; Fox C, 2015, FERTIL STERIL, V104, P1358, DOI 10.1016/j.fertnstert.2015.09.037; Ghartey J, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.03.052; Gupta P, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00326; Hickey RJ, 2012, TRANSL RES, V160, P267, DOI 10.1016/j.trsl.2012.02.008; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Li D, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201766; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; McMillan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14174; Mikamo H, 2018, J OBSTET GYNAECOL, V38, P226, DOI 10.1080/01443615.2017.1343810; Mutaguchi Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01540; Nardini P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29024; Nelson DB, 2016, ANAEROBE, V42, P67, DOI 10.1016/j.anaerobe.2016.09.001; Nelson TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-14943-3; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; Oliver A, 2020, MBIO, V11, DOI 10.1128/mBio.01851-20; Parolin C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00600; Parolin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131220; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; Prince AL, 2014, J REPROD IMMUNOL, V104, P12, DOI 10.1016/j.jri.2014.03.006; Rasmussen MA, 2020, ISME J, V14, P2325, DOI 10.1038/s41396-020-0686-3; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Song SID, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00593-20; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Ventrella D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157623; Vinturache AE, 2016, SEMIN FETAL NEONAT M, V21, P94, DOI 10.1016/j.siny.2016.02.004; Vitali B, 2015, EUR J CLIN MICROBIOL, V34, P2367, DOI 10.1007/s10096-015-2490-y; Yano J, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0748-8; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zhu CL, 2019, METABOLITES, V9, DOI 10.3390/metabo9010015; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249925	10.1371/journal.pone.0249925	http://dx.doi.org/10.1371/journal.pone.0249925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831087	Green Published, gold			2022-12-26	WOS:000639359600001
J	Yamamoto, S; Okamura, K; Fujii, R; Kawano, T; Ueda, K; Yajima, Y; Shiba, K				Yamamoto, Satoshi; Okamura, Kohji; Fujii, Risa; Kawano, Takamasa; Ueda, Koji; Yajima, Yasutomo; Shiba, Kiyotaka			Specimen-specific drift of densities defines distinct subclasses of extracellular vesicles from human whole saliva	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MEMBRANE MICROPARTICLES; EXOSOMES; IDENTIFICATION; PROTEIN; ANTIGEN; PROSTASOMES; POPULATIONS; SECRETION	Extracellular vesicles (EVs) in body fluids constitute heterogenous populations, which mirror their diverse parental cells as well as distinct EV-generation pathways. Various methodologies have been proposed to differentiate EVs in order to deepen the current understanding of EV biology. Equilibrium density-gradient centrifugation has often been used to separate EVs based on their buoyant densities; however, the standard conditions used for the method do not necessarily allow all EVs to move to their equilibrium density positions, which complicates the categorization of EVs. Here, by prolonging ultracentrifugation time to 96 h and fractionating EVs both by floating up or spinning down directions, we allowed 111 EV-associated protein markers from the whole saliva of three healthy volunteers to attain equilibrium. Interestingly, the determined buoyant densities of the markers drifted in a specimen-specific manner, and drift patterns differentiated EVs into at least two subclasses. One class carried classical exosomal markers, such as CD63 and CD81, and the other was characterized by the molecules involved in membrane remodeling or vesicle trafficking. Distinct patterns of density drift may represent the differences in generation pathways of EVs.	[Yamamoto, Satoshi; Kawano, Takamasa; Shiba, Kiyotaka] Japanese Fdn Canc Res, Canc Inst, Div Prot Engn, Tokyo, Japan; [Yamamoto, Satoshi; Yajima, Yasutomo] Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo, Japan; [Okamura, Kohji] Natl Ctr Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan; [Fujii, Risa; Ueda, Koji] Japanese Fdn Canc Res, Canc Precis Med Ctr, Tokyo, Japan; [Kawano, Takamasa] Tokyo Dent Coll, Dept Oral Oncol Oral & Maxillofacial Surg, Chiba, Japan	Japanese Foundation for Cancer Research; Tokyo Dental College; National Center for Child Health & Development - Japan; Japanese Foundation for Cancer Research; Tokyo Dental College	Shiba, K (corresponding author), Japanese Fdn Canc Res, Canc Inst, Div Prot Engn, Tokyo, Japan.	kshiba@jfcr.or.jp	Shiba, Kiyotaka/I-9588-2014; OKAMURA, Kohji/AFT-7287-2022	Shiba, Kiyotaka/0000-0001-6459-0204; OKAMURA, Kohji/0000-0001-9747-5069	JSPS KAKENHI [17H06255]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 17H06255 to KS.	Aalberts M, 2014, REPRODUCTION, V147, pR1, DOI 10.1530/REP-13-0358; Aalberts M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095760; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; Bingle L, 2011, BIOCHEM SOC T, V39, P1023, DOI 10.1042/BST0391023; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; Bryksin AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P619, DOI 10.1134/S0006297908060011; Castagnola M, 2011, ACTA OTORHINOLARYNGO, V31, P347; Chen X, 2017, ONCOTARGET, V8, P27943, DOI 10.18632/oncotarget.15847; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Garcia BA, 2005, J PROTEOME RES, V4, P1516, DOI 10.1021/pr0500760; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Hiraga C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82451-6; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Hurwitz SN, 2016, ONCOTARGET, V7, P86999, DOI 10.18632/oncotarget.13569; Iwai K, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.30829; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Joy AP, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1438727; Kaczor-Urbanowicz KE, 2017, EXP BIOL MED, V242, P459, DOI 10.1177/1535370216681550; Kidokoro M, 2014, AM J PHYSIOL-RENAL, V306, pF1155, DOI 10.1152/ajprenal.00709.2012; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kussendrager KD, 2000, BRIT J NUTR, V84, pS19, DOI 10.1155/2014/517164; Lazaro-Ibanez E, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1656993; Livshts MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17319; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Manconi B, 2017, J PROTEOME RES, V16, P4196, DOI 10.1021/acs.jproteome.7b00567; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Matsumoto K, 2021, GENES CELLS, V26, P65, DOI 10.1111/gtc.12824; Matsumura S, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1579541; Mattie M, 2016, MOL CANCER THER, V15, P2679, DOI 10.1158/1535-7163.MCT-16-0225; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Nemeth A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08392-1; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Oliveira-Rodriguez M, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31803; Overbye A, 2015, ONCOTARGET, V6, P30357, DOI 10.18632/oncotarget.4851; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Peterson DB, 2008, PROTEOMICS, V8, P2430, DOI 10.1002/pmic.200701029; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ryan CM, 2010, J AM SOC MASS SPECTR, V21, P908, DOI 10.1016/j.jasms.2010.01.025; Sato S, 2018, ESSAYS BIOCHEM, V62, P149, DOI 10.1042/EBC20170080; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Slrnalley DM, 2008, J PROTEOME RES, V7, P2088, DOI 10.1021/pr700775x; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Utleg AG, 2003, PROSTATE, V56, P150, DOI 10.1002/pros.10255; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; van 't Hof W, 2014, MONOGR ORAL SCI, V24, P40, DOI 10.1159/000358783; Wang Z, 2012, PROTEOMICS, V12, P329, DOI 10.1002/pmic.201100477; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yoshida M, 2018, BIOTECHNOL BIOENG, V115, P536, DOI 10.1002/bit.26489; Yuana Y, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23262; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	67	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249526	10.1371/journal.pone.0249526	http://dx.doi.org/10.1371/journal.pone.0249526			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831057	Green Published, gold			2022-12-26	WOS:000639359600003
J	Karatzas, E; Kakouri, AC; Kolios, G; Delis, A; Spyrou, GM				Karatzas, Evangelos; Kakouri, Andrea C.; Kolios, George; Delis, Alex; Spyrou, George M.			Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action	PLOS ONE			English	Article							ORAL SUBMUCOUS FIBROSIS; EXTRACELLULAR-MATRIX; LIVER FIBROSIS; NETWORK INTEGRATION; ATRIAL-FIBRILLATION; PULMONARY-FIBROSIS; GENE-EXPRESSION; CAPTOPRIL; CELECOXIB; INHIBITOR	Fibrotic diseases cover a spectrum of systemic and organ-specific maladies that affect a large portion of the population, currently without cure. The shared characteristic these diseases feature is their uncontrollable fibrogenesis deemed responsible for the accumulated damage in the susceptible tissues. Idiopathic Pulmonary Fibrosis, an interstitial lung disease, is one of the most common and studied fibrotic diseases and still remains an active research target. In this study we highlight unique and common (i) genes, (ii) biological pathways and (iii) candidate repurposed drugs among 9 fibrotic diseases. We identify 7 biological pathways involved in all 9 fibrotic diseases as well as pathways unique to some of these diseases. Based on our Drug Repurposing results, we suggest captopril and ibuprofen that both appear to slow the progression of fibrotic diseases according to existing bibliography. We also recommend nafcillin and memantine, which haven't been studied against fibrosis yet, for further wet-lab experimentation. We also observe a group of cardiomyopathy-related pathways that are exclusively highlighted for Oral Submucous Fibrosis. We suggest digoxin to be tested against Oral Submucous Fibrosis, since we observe cardiomyopathy-related pathways implicated in Oral Submucous Fibrosis and there is bibliographic evidence that digoxin may potentially clear myocardial fibrosis. Finally, we establish that Idiopathic Pulmonary Fibrosis shares several involved genes, biological pathways and candidate inhibiting-drugs with Dupuytren's Disease, IgG4-related Disease, Systemic Sclerosis and Cystic Fibrosis. We propose that treatments for these fibrotic diseases should be jointly pursued.	[Karatzas, Evangelos; Delis, Alex] Univ Athens, Dept Informat & Telecommun, Athens, Greece; [Kakouri, Andrea C.; Spyrou, George M.] Cyprus Inst Neurol & Genet, Dept Bioinformat, Nicosia, Cyprus; [Kakouri, Andrea C.] Cyprus Inst Neurol & Genet, Dept Neurogenet, Nicosia, Cyprus; [Kakouri, Andrea C.; Spyrou, George M.] Cyprus Sch Mol Med, Nicosia, Cyprus; [Kolios, George] Democritus Univ Thrace, Dept Med, Alexandroupolis, Greece	National & Kapodistrian University of Athens; Democritus University of Thrace	Spyrou, GM (corresponding author), Cyprus Inst Neurol & Genet, Dept Bioinformat, Nicosia, Cyprus.; Spyrou, GM (corresponding author), Cyprus Sch Mol Med, Nicosia, Cyprus.	georges@cing.ac.cy	Kolios, George/N-6641-2013	Kolios, George/0000-0002-2066-4782; Kakouri, Andrea/0000-0003-2982-679X	IKY (State Scholarships Foundation) scholarship under the Action "Strengthening Human Resources, Education and Lifelong Learning", 2014-2020; European Social Fund (ESF); European Commission Research Executive Agency Grant BIORISE [669026]; European Commission Research Executive Agency (REA) Grant BIORISE [669026];  [MIS 5000432]	IKY (State Scholarships Foundation) scholarship under the Action "Strengthening Human Resources, Education and Lifelong Learning", 2014-2020; European Social Fund (ESF)(European Social Fund (ESF)); European Commission Research Executive Agency Grant BIORISE; European Commission Research Executive Agency (REA) Grant BIORISE; 	Evangelos Karatzas is a PhD student in the National and Kapodistrian University of Athens. His doctoral thesis is being funded by the IKY (State Scholarships Foundation) scholarship under the Action "Strengthening Human Resources, Education and Lifelong Learning", 2014-2020, cofunded by the European Social Fund (ESF) and the Greek State (MIS 5000432). Andrea Kakouri holds a PhD Student fellow position funded by the European Commission Research Executive Agency Grant BIORISE (No. 669026), under the Spreading Excellence, Widening Participation, Science with and for Society Framework. George M. Spyrou holds the Bioinformatics ERA Chair Position funded by the European Commission Research Executive Agency (REA) Grant BIORISE (Num. 669026), under the Spreading Excellence, Widening Participation, Science with and for Society Framework.	Abbaszadeh S, 2018, BIOMED PHARMACOTHER, V108, P1237, DOI 10.1016/j.biopha.2018.09.153; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; Bajusz D, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0069-3; Baybutt RC, 2007, CURR PHARM DESIGN, V13, P1327, DOI 10.2174/138161207780618803; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Borkham-Kamphorst E, 2011, LIVER INT, V31, P656, DOI 10.1111/j.1478-3231.2011.02495.x; Brown AS, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.29; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carlile GW, 2015, J CYST FIBROS, V14, P16, DOI 10.1016/j.jcf.2014.06.001; Chavez E, 2010, LIVER INT, V30, P969, DOI 10.1111/j.1478-3231.2010.02256.x; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065544; [陈悦 Chen Yue], 2016, [玻璃钢/复合材料, Fiber Reinforced Plastics/Composites], P5; COATES AL, 1982, CHEST, V82, P543, DOI 10.1378/chest.82.5.543; Cohen EP, 1996, LAB INVEST, V75, P349; Cotto Kelsy C, 2018, Nucleic Acids Res, V46, pD1068, DOI 10.1093/nar/gkx1143; DESA J V, 1957, Ann Otol Rhinol Laryngol, V66, P1143; Duan QN, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.15; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Ftahy MM., 2013, COMP CLIN PATHOL, V22, P425, DOI DOI 10.1007/s00580-012-1427-4; Gao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069309; Ge Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09496; Ghazi-Khansari M, 2007, J APPL TOXICOL, V27, P342, DOI 10.1002/jat.1212; Hallberg P, 2007, EUR J CLIN PHARMACOL, V63, P959, DOI 10.1007/s00228-007-0346-9; Haller ST, 2012, AM J HYPERTENS, V25, P690, DOI 10.1038/ajh.2012.17; Hansen ML, 2013, CARDIOLOGY, V126, P202, DOI 10.1159/000354217; Harris TR, 2018, MOL PHARMACOL, V94, P834, DOI 10.1124/mol.118.111831; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Hui AY, 2006, LIVER INT, V26, P125, DOI 10.1111/j.1478-3231.2005.01202.x; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Jaffar J., 2012, C103 PATHOGENESIS BI, pA5173; Jaffer J, 2014, CHEST, V146, P1055, DOI 10.1378/chest.13-2688; JALIL JE, 1991, AM J HYPERTENS, V4, P51, DOI 10.1093/ajh/4.1.51; Jiang XW, 2009, J ORAL MAXIL SURG, V67, P1510, DOI 10.1016/j.joms.2008.12.056; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karatzas E., 2020, PATHWALKS IDENTIFYIN, DOI [10.1093/bioinformatics/btaa291, DOI 10.1093/BIOINFORMATICS/BTAA291]; Karatzas E, 2020, BIOINFORMATICS, V36, P4070, DOI 10.1093/bioinformatics/btaa291; Karatzas E, 2020, BIOINFORMATICS, V36, P2602, DOI 10.1093/bioinformatics/btz976; Karatzas E, 2019, COMPUT STRUCT BIOTEC, V17, P939, DOI 10.1016/j.csbj.2019.05.010; Kim JW, 2010, TOHOKU J EXP MED, V222, P319, DOI 10.1620/tjem.222.319; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; LAI DR, 1995, J ORAL PATHOL MED, V24, P402, DOI 10.1111/j.1600-0714.1995.tb01209.x; Lands LC, 2007, J PEDIATR-US, V151, P249, DOI 10.1016/j.jpeds.2007.04.009; Lau JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013360; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Li X, 1998, Hua Xi Kou Qiang Yi Xue Za Zhi, V16, P50; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125873; Lindroos PM, 2001, AM J PHYSIOL-LUNG C, V280, pL354, DOI 10.1152/ajplung.2001.280.2.L354; Lindstrom DR, 2007, J OTOLARYNGOL, V36, P309, DOI 10.2310/7070.2007.0049; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86380; Liu H, 2009, PROSTAG OTH LIPID M, V88, P63, DOI 10.1016/j.prostaglandins.2008.10.002; Lussier YA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001512; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Mitani H, 1999, PHOTOCHEM PHOTOBIOL, V69, P41, DOI 10.1562/0031-8655(1999)069<0041:AOHMSE>2.3.CO;2; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; MOSS AJ, 1975, WESTERN J MED, V122, P471; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakagawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136994; Okada M, 2010, BIOL PHARM BULL, V33, P1517, DOI 10.1248/bpb.33.1517; Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420; Parapuram SK, 2011, J INVEST DERMATOL, V131, P1996, DOI 10.1038/jid.2011.156; Pavlopoulos GA., 2020, ARENA3DWEB INTERACTI; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; PECKHAM DG, 1995, CLIN SCI, V89, P277, DOI 10.1042/cs0890277; POWIS G, 1994, CANCER RES, V54, P2419; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Rajendran R, 2006, Indian J Dent Res, V17, P190; RAMOS SG, 1994, PATHOL INT, V44, P655; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHARMA JK, 1987, INT J ORAL MAX SURG, V16, P695, DOI 10.1016/S0901-5027(87)80055-3; Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438; Singh M, 2010, INDIAN J MED RES, V131, P665; Spyrou G, 2019, 2019 IEEE 19 INT C B; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Takahashi T, 2015, BRIT J DERMATOL, V173, P681, DOI 10.1111/bjd.13779; Tanabe T, 2006, INTERNAL MED, V45, P1243, DOI 10.2169/internalmedicine.45.1759; Tanramluk D, 2009, CHEM BIOL DRUG DES, V74, P16, DOI 10.1111/j.1747-0285.2009.00832.x; Tepper RS, 1997, PEDIATR PULM, V24, P48, DOI 10.1002/(SICI)1099-0496(199707)24:1<48::AID-PPUL8>3.3.CO;2-8; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Tuncer I, 2003, EXP TOXICOL PATHOL, V55, P159, DOI 10.1078/0940-2993-00309; Ursu O, 2019, NUCLEIC ACIDS RES, V47, pD963, DOI 10.1093/nar/gky963; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; VIDT DG, 1982, NEW ENGL J MED, V306, P214; Wang YB, 2014, SCI CHINA LIFE SCI, V57, P201, DOI 10.1007/s11427-013-4604-z; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wen SL, 2014, J GASTROEN HEPATOL, V29, P1932, DOI 10.1111/jgh.12641; Wengrower D, 2004, INFLAMM BOWEL DIS, V10, P536, DOI 10.1097/00054725-200409000-00007; Wernig G, 2017, P NATL ACAD SCI USA, V114, P4757, DOI 10.1073/pnas.1621375114; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; WOODRUFF HB, 1975, ANAL CHEM, V47, P2027, DOI 10.1021/ac60362a002; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu M, 2007, J ETHNOPHARMACOL, V112, P292, DOI 10.1016/j.jep.2007.03.011; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Yu J, 2009, LIVER INT, V29, P25, DOI 10.1111/j.1478-3231.2008.01760.x; Zacharia L., 1957, ACTA RHEUMATOLOGICA, V3, P76; Zhang C, 2016, J CELL MOL MED, V20, P116, DOI 10.1111/jcmm.12709; Zhang XL, 2016, BIOL TRACE ELEM RES, V173, P372, DOI 10.1007/s12011-016-0661-z; Zhi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081612; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	110	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249687	10.1371/journal.pone.0249687	http://dx.doi.org/10.1371/journal.pone.0249687			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826640	Green Published, gold			2022-12-26	WOS:000638119900010
J	Moller, MS; El Bouaballati, S; Henrissat, B; Svensson, B				Moller, Marie Sofie; El Bouaballati, Souad; Henrissat, Bernard; Svensson, Birte			Functional diversity of three tandem C-terminal carbohydrate-binding modules of a beta-mannanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS SUBSP CELLULOSA; STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS XYLANASE; BETA-1,4-MANNANASE; SEQUENCE; CLONING; DOMAIN; DEGRADATION; STABILITY; BACTERIUM	Carbohydrate active enzymes, such as those involved in plant cell wall and storage polysaccharide biosynthesis and deconstruction, often contain repeating noncatalytic carbohydrate-binding modules (CBMs) to compensate for low-affinity binding typical of protein-carbohydrate interactions. The bacterium Saccharophagus degradans produces an endo-beta-mannanase of glycoside hydrolase family 5 subfamily 8 with three phylogenetically distinct family 10 CBMs located C-terminally from the catalytic domain (SdGH5_8-CBM10x3). However, the functional roles and cooperativity of these CBM domains in polysaccharide binding are not clear. To learn more, we studied the full-length enzyme, three stepwise CBM family 10 (CBM10) truncations, and GFP fusions of the individual CBM10s and all three domains together by pull-down assays, affinity gel electrophoresis, and activity assays. Only the C-terminal CBM10-3 was found to bind strongly to microcrystalline cellulose (dissociation constant, K-d = 1.48 mu M). CBM10-3 and CBM10-2 bound galactomannan with similar affinity (K-d = 0.2-0.4 mg/ml), but CBM10-1 had 20-fold lower affinity for this substrate. CBM10 truncations barely affected specific activity on carob galactomannan and konjac glucomannan. Full-length SdGH5_8-CBM10x3 was twofold more active on the highly galactose-decorated viscous guar gum galactomannan and crystalline ivory nut mannan at high enzyme concentrations, but the specific activity was fourfold to ninefold reduced at low enzyme and substrate concentrations compared with the enzyme lacking CBM10-2 and CBM10-3. Comparison of activity and binding data for the different enzyme forms indicates unproductive and productive polysaccharide binding to occur. We conclude that the C-terminal most CBM10-3 secures firm binding, with contribution from CBM10-2, which with CBM10-1 also provides spatial flexibility.	[Moller, Marie Sofie; El Bouaballati, Souad; Svensson, Birte] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia	Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Moller, MS (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	msmo@dtu.dk	Møller, Marie Sofie/GRE-9135-2022; Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Svensson, Birte/0000-0002-2993-8196; Moller, Marie Sofie/0000-0001-9017-3367	Independent Research Fund Denmark|Natural Sciences (FNU) [6108-00476B]	Independent Research Fund Denmark|Natural Sciences (FNU)	We thank Karina Jansen (Technical University of Denmark) for technical assistance. We also thank Prof Jens Preben Morth (Technical University of Denmark) for introduction to the JASCO FP-8500 Fluorescence Spectrometer. This work was supported by Independent Research Fund Denmark|Natural Sciences (FNU) by a grant to the project "Roles and structural determinants of low-affinity carbohydrate-protein interactions" (grant no. 6108-00476B).	ARCAND N, 1993, BIOCHEM J, V290, P857, DOI 10.1042/bj2900857; Attia M, 2016, FEBS J, V283, P1701, DOI 10.1111/febs.13696; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cockburn D., 2017, METHONDS MOL BIOL 15, V1; Conway JM, 2018, AICHE J, V64, P4218, DOI 10.1002/aic.16354; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; DEY PM, 1978, ADV CARBOHYD CHEM BI, V35, P341; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Duan CJ, 2017, APPL MICROBIOL BIOT, V101, P5723, DOI 10.1007/s00253-017-8320-7; Ebringerova A, 2006, MACROMOL SYMP, V232, P1, DOI 10.1002/masy.200551401; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekborg NA, 2007, APPL ENVIRON MICROB, V73, P7785, DOI 10.1128/AEM.00876-07; FERREIRA LMA, 1991, BIOCHEM J, V279, P793, DOI 10.1042/bj2790793; Gardner JG, 2014, MOL MICROBIOL, V94, P1121, DOI 10.1111/mmi.12821; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; GILBERT HJ, 1990, MOL MICROBIOL, V4, P759, DOI 10.1111/j.1365-2958.1990.tb00646.x; Gill J, 1999, BIOCHEM J, V342, P473, DOI 10.1042/0264-6021:3420473; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Heux L, 2005, BIOMACROMOLECULES, V6, P324, DOI 10.1021/bm0495349; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hori R, 2007, CARBOHYD POLYM, V70, P298, DOI 10.1016/j.carbpol.2007.04.011; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Jin Y, 2016, ACS CENTRAL SCI, V2, P896, DOI 10.1021/acscentsci.6b00232; Kari J, 2018, ACS CATAL, V8, P11966, DOI 10.1021/acscatal.8b03547; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Kim DY, 2011, BIORESOURCE TECHNOL, V102, P9185, DOI 10.1016/j.biortech.2011.06.073; Krska D, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01709-9; Ktunagai Y, 2013, BIOCHEM BIOPH RES CO, V301, P307; Liu HX, 2015, PROCESS BIOCHEM, V50, P712, DOI 10.1016/j.procbio.2015.02.011; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Low KE, 2021, GLYCOBIOLOGY, V31, P681, DOI 10.1093/glycob/cwaa050; MCCLEARY BV, 1985, CARBOHYD RES, V139, P237; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Morrill J, 2018, APPL MICROBIOL BIOT, V102, P5149, DOI 10.1007/s00253-018-8997-2; Morrill J, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0055-4; O'Connor RM, 2014, P NATL ACAD SCI USA, V111, pE5096, DOI 10.1073/pnas.1413110111; Park SR, 2002, BIOCHEM BIOPH RES CO, V291, P425, DOI 10.1006/bbrc.2002.6437; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pires VMR, 2017, J BIOL CHEM, V292, P4847, DOI 10.1074/jbc.M116.767541; Ponyi T, 2000, BIOCHEMISTRY-US, V39, P985, DOI 10.1021/bi9921642; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Sakai K, 2018, J BIOSCI BIOENG, V125, P287, DOI 10.1016/j.jbiosc.2017.10.009; Shi PJ, 2011, J IND MICROBIOL BIOT, V38, P451, DOI 10.1007/s10295-010-0789-3; TAKEO K, 1972, ARCH BIOCHEM BIOPHYS, V153, P1, DOI 10.1016/0003-9861(72)90413-4; Tamaru Y, 1997, J FERMENT BIOENG, V83, P201, DOI 10.1016/S0922-338X(97)83584-2; Von Ereiesleben P., 2018, BIOTECHNOL BIOFUELS, V11, P194; Wang YJ, 2009, BIORESOURCE TECHNOL, V100, P345, DOI 10.1016/j.biortech.2008.06.001; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wei XY, 2020, FOOD CHEM, V329, DOI 10.1016/j.foodchem.2020.127179; Xu CL, 2010, CARBOHYD RES, V345, P810, DOI 10.1016/j.carres.2010.01.007; Zhao D, 2020, INT J BIOL MACROMOL, V154, P826, DOI 10.1016/j.ijbiomac.2020.03.157; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	55	2	2	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100638	10.1016/j.jbc.2021.100638	http://dx.doi.org/10.1016/j.jbc.2021.100638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33838183	Green Published, gold			2022-12-26	WOS:000672866400609
J	Tang, M; Chen, Y; Li, BR; Sugimoto, H; Yang, SJ; Yang, CQ; LeBleu, VS; McAndrews, KM; Kalluri, R				Tang, Min; Chen, Yang; Li, Bingrui; Sugimoto, Hikaru; Yang, Sujuan; Yang, Changqing; LeBleu, Valerie S.; McAndrews, Kathleen M.; Kalluri, Raghu			Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis	FASEB JOURNAL			English	Article						engineered exosomes; liver fibrosis; mesenchymal stromal cells; STAT3	HEPATIC STELLATE CELLS; EXTRACELLULAR VESICLES; SIGNAL TRANSDUCER; TRANSCRIPTION 3; ACTIVATION; DELIVERY; MECHANISMS; SIRNA; BETA	Hepatic fibrosis is a wound healing response that results in excessive extracellular matrix (ECM) accumulation in response to chronic hepatic injury. Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor associated with the pathogenesis of liver fibrosis. Though a promising potential therapeutic target, there are no specific drug candidates for STAT3. Exosomes are extracellular vesicles generated by all cell types with a capacity to efficiently enter cells across different biological barriers. Here, we utilize exosomes as delivery conduit to specifically target STAT3 in liver fibrosis. Exosomes derived from clinical grade fibroblast-like mesenchymal stem cells (MSCs) were engineered to carry siRNA or antisense oligonucleotide (ASO) targeting STAT3 (iExo(siRNA-STAT3) or iExo(mASO-STAT3)). Compared to scrambled siRNA control, siRNA-STAT3, or ASO-STAT3, iExo(siRNA-STAT3) or iExomASO-STAT(3) showed enhanced STAT3 targeting efficiency. iExo(siRNA-STAT3) or iExo(mASO-STAT3) treatments suppressed STAT3 levels and ECM deposition in established liver fibrosis in mice, and significantly improved liver function. iExo(mASO-Stat3) restored liver function more efficiently when compared to iExo(siRNA-STAT3). Our results identify a novel anti-fibrotic approach for direct targeting of STAT3 with exosomes with immediate translational potential.	[Tang, Min; Chen, Yang; Li, Bingrui; Sugimoto, Hikaru; Yang, Sujuan; LeBleu, Valerie S.; McAndrews, Kathleen M.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Yang, Changqing] Tongji Univ, Tongji Hosp, Sch Med, Div Gastroenterol, Shanghai, Peoples R China; [Yang, Changqing] Tongji Univ, Tongji Hosp, Sch Med, Inst Digest Dis, Shanghai, Peoples R China; [LeBleu, Valerie S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Kalluri, Raghu] Rice Univ, Dept Bioengn, Houston, TX USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tongji University; Tongji University; Northwestern University; Feinberg School of Medicine; Rice University; Baylor College of Medicine	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1906, 1881 East Rd,4SCR5-1180, Houston, TX 77054 USA.	rkalluri@mdanderson.org	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; McAndrews, Kathleen/0000-0002-4092-4991	MD Anderson Cancer Center	MD Anderson Cancer Center	MD Anderson Cancer Center, Grant/Award Number: N/A	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Bartneck Matthias, 2014, Hepatobiliary Surg Nutr, V3, P364, DOI 10.3978/j.issn.2304-3881.2014.11.02; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beebe JD, 2018, PHARMACOL THERAPEUT, V191, P74, DOI 10.1016/j.pharmthera.2018.06.006; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Breitkopf K, 2005, GUT, V54, P673, DOI 10.1136/gut.2004.042911; Busatto S, 2019, BIOMED MICRODEVICES, V21, DOI 10.1007/s10544-019-0396-7; Chakraborty D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01236-6; Choi S, 2019, BIOCHEM BIOPH RES CO, V513, P49, DOI 10.1016/j.bbrc.2019.03.156; Gong XH, 2014, CELL PHYSIOL BIOCHEM, V33, P97, DOI 10.1159/000356653; He WW, 2019, ONCOL LETT, V17, P5608, DOI 10.3892/ol.2019.10236; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krishna Murli, 2017, Clin Liver Dis (Hoboken), V10, P53, DOI 10.1002/cld.653; Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026; LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lou GH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1512-5; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00243; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y; Ogiso H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162183; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Su TH, 2015, P NATL ACAD SCI USA, V112, P7243, DOI 10.1073/pnas.1507499112; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Xiang DM, 2018, GUT, V67, P1704, DOI 10.1136/gutjnl-2016-313392; Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004; Zhai XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49287-7; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240	47	17	17	13	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21557	10.1096/fj.202002777RR	http://dx.doi.org/10.1096/fj.202002777RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855751				2022-12-26	WOS:000645260100072
J	Xiao, CY; Sun, ZB; Gao, JX; Bai, YX; Zhang, C; Pang, BY; Qiao, HJ; Fu, M; Dang, EL; Wang, G				Xiao, Chunying; Sun, Zhongbin; Gao, Jixin; Bai, Yaxing; Zhang, Chen; Pang, Bingyu; Qiao, Hongjiang; Fu, Meng; Dang, Erle; Wang, Gang			Enhanced phenotype of calcipotriol-induced atopic dermatitis in filaggrin-deficient mice	FASEB JOURNAL			English	Article						atopic dermatitis; emollient; filaggrin; inflammation; skin barrier	THYMIC STROMAL LYMPHOPOIETIN; BARRIER; MOISTURIZERS; PATHOGENESIS; EXPRESSION; EMOLLIENTS; CYTOKINES; EFFICACY; TRIGGER; CELLS	Impaired function of filaggrin (FLG) is a major predisposing factor for atopic dermatitis (AD). Several studies on FLG-deficient (Flg(-/-)) mice have indicated an essential role for FLG in the skin barrier and the development of AD, but none of the studies have described the characteristics on Flg(-/-) mice with calcipotriol (CPT)-induced atopic dermatitis, which restricts the comprehensive understanding of functions of FLG. The present study sought to generate Flg(-/-) mice and applied CPT to produce AD-like dermatitis for in vivo analysis of the FLG functions. CPT was applied on the skin of Flg(-/-) mice to establish the AD-like dermatitis mouse model. The lesion inflammation was evaluated by gross ear thickness, histopathology, immunofluorescence, and cytokine production. Also, mucopolysaccharide polysulfate (MPS) and ceramide were used to observe the therapeutic function in this model. The results showed that the inflammation of CPT-induced dermatitis in Flg(-/-) mice was more severer than that of wild-type (WT) mice, as evident by the increased level of gross appearance, ear thickness, inflammatory cell infiltration (mast cells and CD3(+) T cells), and inflammatory cytokine expression (interleukin (IL)-4, IL-6, IL-13, and thymic stromal lymphopoietin (TSLP)). The emollients MPS and ceramide partially restored the epidermal function and alleviated the skin inflammation in Flg(-/-) mice with CPT-induced AD--like dermatitis. The current study demonstrated that skin barrier protein FLG is critical in the pathogenesis of AD. Also, the AD mouse model induced by CPT in Flg(-/-) mice could be utilized to search for drug targets in AD.	[Xiao, Chunying; Sun, Zhongbin; Gao, Jixin; Bai, Yaxing; Zhang, Chen; Pang, Bingyu; Qiao, Hongjiang; Fu, Meng; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Dang, EL; Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China.	dangerle@fmmu.edu.cn; wanggangxjyy@163.com	fu, meng/GZG-3120-2022; Wang, Gang/H-6710-2019	Xiao, Chunying/0000-0002-3847-715X	National Natural Science Foundation of China [81803125, 81903192]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81803125 and 81903192	Bagherani N, 2016, DERMATOL THER, V29, P69, DOI 10.1111/dth.12244; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; DALE BA, 1985, ANN NY ACAD SCI, V455, P330, DOI 10.1111/j.1749-6632.1985.tb50420.x; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hart VA, 2017, BRIT J DERMATOL, V176, P553, DOI 10.1111/bjd.15184; Hayama K, 2015, AUSTRALAS J DERMATOL, V56, P36, DOI 10.1111/ajd.12179; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li QY, 2020, J DERMATOL SCI, V97, P2, DOI 10.1016/j.jdermsci.2019.12.002; Malik K, 2017, DERMATOL CLIN, V35, P317, DOI 10.1016/j.det.2017.02.006; Man G, 2015, J INVEST DERMATOL, V135, P1184, DOI 10.1038/jid.2014.486; Orfali RL, 2017, GIORN ITAL DERMAT V, V152, P140, DOI 10.23736/S0392-0488.16.05533-4; Otsuka A, 2017, IMMUNOL REV, V278, P246, DOI 10.1111/imr.12545; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Proksch E, 2008, SKIN PHARMACOL PHYS, V21, P75, DOI 10.1159/000112957; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schwartz C, 2019, ALLERGY, V74, P1920, DOI 10.1111/all.13801; Schwartz C, 2016, J ALLERGY CLIN IMMUN, V138, P1443, DOI 10.1016/j.jaci.2016.04.031; Sekiguchi K, 2018, JPN J CLIN ONCOL, V48, P450, DOI 10.1093/jjco/hyy045; Sekiguchi K, 2015, JPN J CLIN ONCOL, V45, P1146, DOI 10.1093/jjco/hyv155; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; Watanabe S, 2017, CLIN COSMET INV DERM, V10, P353, DOI 10.2147/CCID.S140796; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Yang G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082867; Yao Y, 2019, EXP DERMATOL, V28, P956, DOI 10.1111/exd.13985	30	3	3	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2021	35	5							e21574	10.1096/fj.202002709R	http://dx.doi.org/10.1096/fj.202002709R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RU6MM	33855746				2022-12-26	WOS:000645260100052
J	Badgery, GJ; Lawes, JC; Leggett, KEA				Badgery, Georgia J.; Lawes, Jasmin C.; Leggett, Keith E. A.			Short-beaked echidna (Tachyglossus aculeatus) home range at Fowlers Gap Arid Zone Research Station, NSW	PLOS ONE			English	Article							BIODIVERSITY; ECOLOGY; HABITAT; DECLINE; FAUNA	Echidnas (Tachyglossus aculeatus) are found Australia-wide and appear to be remarkably well-adapted to the arid zone, yet nearly all echidna research has been conducted in temperate, tropical and alpine zones. This study investigated the home range and movement of echidnas in western New South Wales. Radio telemetry tracking was used to locate the echidnas daily during the study period (March-May 2018, November 2018, March-May 2019 and August 2019); the observed home range was 1.47 +/- 1.21km(2). This is over twice the reported home range of temperate environments (<0.65km(2)), suggesting that echidnas exhibit larger home ranges in arid zones. The home range of individual echidnas ranged from 0.02km(2) to 3.56km(2). Echidnas exhibited a small degree of overlap (6.6%+/- 19.8%) but this varied considerably between individuals (between 0 to 84.2% overlap.) Four out of the thirteen echidnas died during this study, likely due to the severe drought that occurred during the study. This study provides insight into the movement and home range of echidnas in arid zones, revealing that desert echidnas have large home ranges, probably dependent on the availability of resources.	[Badgery, Georgia J.; Lawes, Jasmin C.; Leggett, Keith E. A.] UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Badgery, Georgia J.; Leggett, Keith E. A.] UNSW, NSW Sch Biol Earth & Environm Sci, Fowlers Gap Arid Zone Res Stn, Fowlers Gap, NSW, Australia; [Badgery, Georgia J.; Lawes, Jasmin C.; Leggett, Keith E. A.] UNSW Sydney, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Lawes, Jasmin C.] Surf Life Saving Australia, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Badgery, GJ (corresponding author), UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.; Badgery, GJ (corresponding author), UNSW, NSW Sch Biol Earth & Environm Sci, Fowlers Gap Arid Zone Res Stn, Fowlers Gap, NSW, Australia.; Badgery, GJ (corresponding author), UNSW Sydney, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia.	g.badgery@unsw.edu.au	Lawes, Jasmin/S-2025-2019	Lawes, Jasmin/0000-0002-6652-3053; Badgery, Georgia/0000-0002-1180-3648				ABENSPERG-TRAUN M, 1991, Australian Mammalogy, V14, P13; ABENSPERGTRAUN M, 1991, BIOL CONSERV, V58, P317, DOI 10.1016/0006-3207(91)90098-T; Alarcon PAE, 2018, MOV ECOL, V6, DOI 10.1186/s40462-018-0133-5; AUGEE M L, 1975, Australian Wildlife Research, V2, P93; Augee M.L., 1992, P225; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Burrell JP, 1973, LANDS FOWLERS GAP ST, P175; Clemente CJ, 2017, INTEGR COMP BIOL, V57, pE227; Duda JJ, 1999, J WILDLIFE MANAGE, V63, P1181, DOI 10.2307/3802836; Eldridge DJ, 2007, SOIL BIOL BIOCHEM, V39, P1055, DOI 10.1016/j.soilbio.2006.11.016; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Griffiths M., 1978, BIOLOGY MONOTREMES B; Hancock CN, 1996, FOREST ECOL MANAG, V85, P239, DOI 10.1016/S0378-1127(96)03761-9; Kingsford R, 2006, ECOLOGY OF DESERT RIVERS, P1, DOI 10.2277/ 0521818257; Leggett KEA., 2004, AFRICAN ZOOLOGY, V39; Macdonald BCT, 2000, RANGELAND J, V22, P5, DOI 10.1071/RJ0000005; Macdonald D.W., 1978, P192; Marlow N. J., 2016, Conservation Science Western Australia, V10, P3; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; McNeely JA, 2003, J ARID ENVIRON, V54, P61, DOI 10.1006/jare.2001.0890; Meteorology Bo, 2021, SUMM STAT FOWL GAP A; Moskowitz D, 2017, J INSECT CONSERV, V21, P885, DOI 10.1007/s10841-017-0027-7; Nicol SC, 2011, J MAMMAL, V92, P101, DOI 10.1644/09-MAMM-A-398.1; Rismiller PD, 2000, J MAMMAL, V81, P1, DOI 10.1644/1545-1542(2000)081<0001:FOBARI>2.0.CO;2; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Sandell M., 1989, P164; Sprent J, 2012, AUST J ZOOL, V60, P46, DOI 10.1071/ZO11098; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; Wilkinson DA, 1998, WILDLIFE RES, V25, P219, DOI 10.1071/WR97072; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	31	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0242298	10.1371/journal.pone.0242298	http://dx.doi.org/10.1371/journal.pone.0242298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861740	Green Submitted, gold, Green Published			2022-12-26	WOS:000641475400001
J	Xiao, Q; Gan, YQ; Li, YM; Fan, LL; Liu, JQ; Lu, PY; Liu, JX; Chen, AA; Shu, G; Yin, G				Xiao, Qing; Gan, Yaqi; Li, Yimin; Fan, Lili; Liu, Jiaqi; Lu, Pengyan; Liu, Jiaxin; Chen, Aoao; Shu, Guang; Yin, Gang			MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; METASTASIS; DEGRADATION; DOWNSTREAM; ACTIVATION; TRANSITION; REPRESSOR; P38	Colorectal cancer (CRC) is one of the leading cancers worldwide, accounting for high morbidity and mortality. The mechanisms governing tumor growth and metastasis in CRC require detailed investigation. The results of the present study indicated that the transcription factor (TF) myocyte enhancer factor 2A (MEF2A) plays a dual role in promoting proliferation and metastasis of CRC by inducing the epithelial-mesenchymal transition (EMT) and activation of WNT/beta-catenin signaling. Aberrant expression of MEF2A in CRC clinical specimens was significantly associated with poor prognosis and metastasis. Functionally, MEF2A directly binds to the promoter region to initiate the transcription of ZEB2 and CTNNB1. Simultaneous activation of the expression of EMT-related TFs and Wnt/beta-catenin signaling by MEF2A overexpression induced the EMT and increased the frequency of tumor formation and metastasis. The present study identified a new critical oncogene involved in the growth and metastasis of CRC, providing a potential novel therapeutic target for CRC intervention.	[Xiao, Qing; Gan, Yaqi; Li, Yimin; Fan, Lili; Liu, Jiaqi; Lu, Pengyan; Liu, Jiaxin; Yin, Gang] Cent South Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Peoples R China; [Chen, Aoao] Cent South Univ, Sch Basic Med Sci, Dept Immunol, Changsha, Peoples R China; [Shu, Guang] Cent South Univ, Sch Basic Med Sci, Dept Histol & Embryol, Changsha, Peoples R China; [Yin, Gang] Cent South Univ, Sch Basic Med Sci, China Africa Res Ctr Infect Dis, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University	Yin, G (corresponding author), Cent South Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha, Peoples R China.; Yin, G (corresponding author), Cent South Univ, Sch Basic Med Sci, China Africa Res Ctr Infect Dis, Changsha, Peoples R China.	gangyin@csu.edu.cn		Liu, Jiaxin/0000-0002-8903-114X; Gan, Yaqi/0000-0001-8097-4603; Yin, Gang/0000-0003-3753-0753	National Key RAMP;D Program of China, Stem Cell and Translational Research [2016YFA0102000]; National Natural Science Foundation of China [81572900]; Student Innovation Project of Central South University [1053320183731]	National Key RAMP;D Program of China, Stem Cell and Translational Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Student Innovation Project of Central South University	This work was supported by the National Key R&D Program of China, Stem Cell and Translational Research (no. 2016YFA0102000); National Natural Science Foundation of China (no. 81572900); and Student Innovation Project of Central South University (no. 1053320183731).	[Anonymous], 2016, MOL CELL BIOL, V36, P330; Bai XL, 2015, ONCOGENE, V34, P4089, DOI 10.1038/onc.2014.337; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brown FC, 2018, CANCER DISCOV, V8, P478, DOI 10.1158/2159-8290.CD-17-1271; Chen DL, 2017, THERANOSTICS, V7, P4836, DOI 10.7150/thno.20942; Chen HH, 2015, CIRC RES, V117, P671, DOI 10.1161/CIRCRESAHA.114.305777; Chen SX, 2012, CELL, V151, P41, DOI 10.1016/j.cell.2012.08.028; Clark RI, 2013, CELL, V155, P435, DOI 10.1016/j.cell.2013.09.007; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; Di Giorgio E, 2018, BBA-REV CANCER, V1870, P261, DOI 10.1016/j.bbcan.2018.05.007; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Gjyshi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26670-4; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; He Y, 2017, ONCOGENE, V36, P3490, DOI 10.1038/onc.2016.492; Herglotz J, 2016, BLOOD, V127, P572, DOI 10.1182/blood-2015-04-643270; Hua F, 2019, GASTROENTEROLOGY, V156, P708, DOI 10.1053/j.gastro.2018.10.031; Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387; Kim JM, 2017, INTEGR CANCER THER, V16, P360, DOI 10.1177/1534735416670987; Li L, 2018, PHYSIOL GENOMICS, V50, P10, DOI 10.1152/physiolgenomics.00076.2017; Liu JJ, 2015, CELL PHYSIOL BIOCHEM, V36, P155, DOI 10.1159/000374060; Ma LN, 2014, CANCER RES, V74, P1452, DOI 10.1158/0008-5472.CAN-13-2171; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mehta PB, 2001, ONCOGENE, V20, P5359, DOI 10.1038/sj.onc.1204688; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Ryan RJH, 2015, CANCER DISCOV, V5, P1058, DOI 10.1158/2159-8290.CD-15-0370; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; She H, 2012, J NEUROCHEM, V122, P1203, DOI 10.1111/j.1471-4159.2012.07860.x; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Sreekumar R, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3115; Su L, 2016, CANCER RES, V76, P5054, DOI 10.1158/0008-5472.CAN-16-0246; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tung B, 2017, P NATL ACAD SCI USA, V114, pE707, DOI 10.1073/pnas.1610383114; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang FF, 2017, CANCER LETT, V388, P85, DOI 10.1016/j.canlet.2016.11.031; Xiang JY, 2020, GASTROENTEROLOGY, V158, P664, DOI 10.1053/j.gastro.2019.10.025; Xiang JY, 2017, CANCER LETT, V400, P117, DOI 10.1016/j.canlet.2017.04.037; Yaeger R, 2018, CANCER CELL, V33, P125, DOI 10.1016/j.ccell.2017.12.004; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhang L, 2014, AUTOPHAGY, V10, P1015, DOI 10.4161/auto.28477; Zhang M, 2015, HYPERTENSION, V65, P335, DOI 10.1161/HYPERTENSIONAHA.114.04467	43	6	6	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2021	40	19					3364	3377		10.1038/s41388-021-01774-w	http://dx.doi.org/10.1038/s41388-021-01774-w		APR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SB1JB	33863999	Green Published, hybrid			2022-12-26	WOS:000640748600001
J	Belkadi, A; Thareja, G; Dadhania, D; Lee, JR; Muthukumar, T; Snopkowski, C; Li, C; Halama, A; Abdelkader, S; Abdulla, S; Mahmoud, Y; Malek, J; Suthanthiran, M; Suhre, K				Belkadi, Aziz; Thareja, Gaurav; Dadhania, Darshana; Lee, John R.; Muthukumar, Thangamani; Snopkowski, Catherine; Li, Carol; Halama, Anna; Abdelkader, Sara; Abdulla, Silvana; Mahmoud, Yasmin; Malek, Joel; Suthanthiran, Manikkam; Suhre, Karsten			Deep sequencing of DNA from urine of kidney allograft recipients to estimate donor/recipient-specific DNA fractions	PLOS ONE			English	Article							CELL-FREE DNA; TRANSPLANT REJECTION; DONOR; ASSAY; CONTAMINATION; VALIDATION; PLASMA; MARKER	Kidney transplantation is the treatment of choice for patients with end-stage kidney failure, but transplanted allograft could be affected by viral and bacterial infections and by immune rejection. The standard test for the diagnosis of acute pathologies in kidney transplants is kidney biopsy. However, noninvasive tests would be desirable. Various methods using different techniques have been developed by the transplantation community. But these methods require improvements. We present here a cost-effective method for kidney rejection diagnosis that estimates donor/recipient-specific DNA fraction in recipient urine by sequencing urinary cell DNA. We hypothesized that in the no-pathology stage, the largest tissue types present in recipient urine are donor kidney cells, and in case of rejection, a larger number of recipient immune cells would be observed. Extensive in-silico simulation was used to tune the sequencing parameters: number of variants and depth of coverage. Sequencing of DNA mixture from 2 healthy individuals showed the method is highly predictive (maximum error < 0.04). We then demonstrated the insignificant impact of familial relationship and ethnicity using an in-house and public database. Lastly, we performed deep DNA sequencing of urinary cell pellets from 32 biopsy-matched samples representing two pathology groups: acute rejection (AR, 11 samples) and acute tubular injury (ATI, 12 samples) and 9 samples with no pathology. We found a significant association between the donor/recipient-specific DNA fraction in the two pathology groups compared to no pathology (P = 0.0064 for AR and P = 0.026 for ATI). We conclude that deep DNA sequencing of urinary cells from kidney allograft recipients offers a noninvasive means of diagnosing acute pathologies in the human kidney allograft.	[Belkadi, Aziz; Thareja, Gaurav; Halama, Anna; Abdelkader, Sara; Abdulla, Silvana; Mahmoud, Yasmin; Malek, Joel; Suhre, Karsten] Weill Cornell Med Qatar, Dept Physiol & Biophys, Doha, Qatar; [Dadhania, Darshana; Lee, John R.; Muthukumar, Thangamani; Suthanthiran, Manikkam] New York Presbyterian Hosp Weill Cornell Med, Dept Transplantat Med, New York, NY USA; [Dadhania, Darshana; Lee, John R.; Muthukumar, Thangamani; Snopkowski, Catherine; Li, Carol; Suthanthiran, Manikkam] Weill Cornell Med Coll, Dept Med, Div Nephrol & Hypertens, New York, NY USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; NewYork-Presbyterian Hospital; Cornell University	Suhre, K (corresponding author), Weill Cornell Med Qatar, Dept Physiol & Biophys, Doha, Qatar.	kas2049@qatar-med.cornell.edu	Thareja, Gaurav/GRE-8285-2022; Suhre, Karsten/AAF-1778-2020	Suhre, Karsten/0000-0001-9638-3912; Belkadi, Abdelaziz/0000-0003-1564-0468; Halama, Anna/0000-0003-4910-6255	Biomedical Research Program at Weill Cornell Medicine-Qatar - Qatar Foundation; National Priority Research program of the Qatar National research fund [NPRP12S-0227-190173]; National Institute of Health [K08DK087824, R37AI051652]	Biomedical Research Program at Weill Cornell Medicine-Qatar - Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); National Priority Research program of the Qatar National research fund(Qatar National Research Fund (QNRF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Biomedical Research Program at Weill Cornell Medicine-Qatar, a program funded by the Qatar Foundation (https://www.qf.org.qa) [to AB, GT, AH, Sa A, Si A, Y M, J M and K S], the National Priority Research program of the Qatar National research fund (https://www.qnrf.org/en-us/) [grant #NPRP12S-0227-190173 to AB and MS], the National Institute of Health (https://www.nih.gov) [grants #K08DK087824 and R37AI051652 to MS], The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Augustus E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231058; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Bloom RD, 2017, J AM SOC NEPHROL, V28, P2221, DOI 10.1681/ASN.2016091034; Burnham P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04745-0; Cheng AP, 2019, P NATL ACAD SCI USA, V116, P18738, DOI 10.1073/pnas.1906320116; De Vlaminck I, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007803; Flickinger M, 2015, AM J HUM GENET, V97, P284, DOI 10.1016/j.ajhg.2015.07.002; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Moreira VG, 2009, CLIN CHEM, V55, P1958, DOI 10.1373/clinchem.2009.129072; Gordon PMK, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00033; Gray PN, 2015, CANCERS, V7, P1313, DOI 10.3390/cancers7030837; Grskovic M, 2016, J MOL DIAGN, V18, P890, DOI 10.1016/j.jmoldx.2016.07.003; Hidestrand M, 2014, J AM COLL CARDIOL, V63, P1224, DOI 10.1016/j.jacc.2013.09.029; HUME DM, 1955, J CLIN INVEST, V34, P327, DOI 10.1172/JCI103085; Jalalzadeh Mojgan, 2015, Nephrourol Mon, V7, pe24439, DOI 10.5812/numonthly.24439; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kumar Pankaj, 2014, BMC Res Notes, V7, P747, DOI 10.1186/1756-0500-7-747; Kwon S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S9-S10; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; Li XF, 2014, ANAL BIOCHEM, V451, P18, DOI 10.1016/j.ab.2014.01.016; Ling XB, 2010, J AM SOC NEPHROL, V21, P646, DOI 10.1681/ASN.2009080876; Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3; Macher HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113987; McDonald S, 2007, AM J TRANSPLANT, V7, P1201, DOI 10.1111/j.1600-6143.2007.01759.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakorchevsky A, 2010, J AM SOC NEPHROL, V21, P362, DOI 10.1681/ASN.2009060628; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; OLSEN S, 1989, MEDICINE, V68, P173, DOI 10.1097/00005792-198905000-00005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Roufosse C, 2018, TRANSPLANTATION, V102, P1795, DOI 10.1097/TP.0000000000002366; Rush D, 2009, Transplant Proc, V41, pS6, DOI 10.1016/j.transproceed.2009.06.092; Sharon E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005629; Sigdel TK, 2013, TRANSPLANTATION, V96, P97, DOI 10.1097/TP.0b013e318295ee5a; Sigdel TK, 2010, PROTEOM CLIN APPL, V4, P32, DOI 10.1002/prca.200900124; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Suhre K, 2016, J AM SOC NEPHROL, V27, P626, DOI 10.1681/ASN.2015010107; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; Thareja G, 2018, AM J TRANSPLANT, V18, P2429, DOI 10.1111/ajt.14870; Tsai MK, 2009, INT J ARTIF ORGANS, V32, P371, DOI 10.1177/039139880903200608; Verma A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131552; Zhong XY, 2001, ANN NY ACAD SCI, V945, P250	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249930	10.1371/journal.pone.0249930	http://dx.doi.org/10.1371/journal.pone.0249930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857204	Green Published, gold			2022-12-26	WOS:000641474900029
J	Odoi, A; Samuels, R; Carter, CN; Smith, J				Odoi, Agricola; Samuels, Ronita; Carter, Craig N.; Smith, Jackie			Antibiotic prescription practices and opinions regarding antimicrobial resistance among veterinarians in Kentucky, USA	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; FOOD ANIMALS; GROWTH PROMOTION; PRESCRIBING PATTERNS; SELECTION PRESSURE; ESCHERICHIA-COLI; PREVALENCE; CANINE; BACTERIA; STUDENTS	Background Inappropriate antimicrobial use (AMU) is a global concern. Opinions of veterinarians regarding AMU and its role in the development of antimicrobial resistance (AMR) may influence their prescription practices. It is important to understand these opinions, prescription practices and their potential impact on the development of AMR in order to guide efforts to curb the problem. Therefore, the objective of this study was to investigate the antimicrobial prescription practices and opinions of veterinarians in Kentucky regarding AMU and AMR. Methods This cross-sectional study used a 30-question survey questionnaire administered to veterinarians who were members of the Kentucky Veterinary Medical Association. Survey responses from 101 participants were included in the study. Descriptive statistics were computed and associations between categorical variables assessed using Chi-square or Fisher's exact tests. Firth logistic models were used to investigate predictors of "Compliance with prescription policies" and "Cost of antimicrobial affects prescription decisions". Results Almost all (93%) respondents indicated that improper AMU contributed to selection for AMR. A total of 52% of the respondents believed that antimicrobials were appropriately prescribed, while the remaining 48% believed that antimicrobials were inappropriately prescribed. Significant predictors of compliance with prescription policies were availability of prescription policy at the veterinary facility (Odds Ratio (OR) = 4.2; p<0.001) and over-prescription (OR = 0.35; p = 0.025). Similarly, significant predictors of cost of antimicrobials affecting prescription decisions were lack of post-graduate training (OR = 8.3; p = 0.008) and practice type, with large animal practices having significantly lower odds of the outcome (OR = 0.09; p = 0.004) than small animal practices. Conclusion Most veterinarians indicated that improper AMU contributed to selection for AMR. Since the odds of compliance with prescription policies were 4-times higher among veterinarians working at facilities that had prescription policies compared to those at facilities that didn't, more veterinary facilities should be encouraged to adopt prescription policies to help improve compliance and reduce AMR. Veterinarians would also benefit from continued professional education to help improve prescription practices, antimicrobial stewardship and curb AMR.	[Odoi, Agricola; Samuels, Ronita] Univ Tennessee, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Carter, Craig N.; Smith, Jackie] Univ Kentucky, Vet Diagnost Lab, Lexington, KY USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Kentucky	Odoi, A (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737				Aarestrup FM, 2000, MICROB DRUG RESIST, V6, P63, DOI 10.1089/mdr.2000.6.63; Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001; Ahmad A, 2015, PHARM PRACT, P13; Ahmad A, 2015, J RES PHARM PRACT, V4, P37, DOI 10.4103/2279-042X.150057; Ahmed MO, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-12; Anyanwu M. U., 2018, Notulae Scientia Biologicae, V10, P156, DOI 10.15835/nsb10210258; AVMA, 2018, EST ANT POL VET MED; Ball KR, 2008, CAN VET J, V49, P985; Barbarossa A, 2017, VET REC, V181, P69, DOI 10.1136/vr.104128; Bennett C., 2017, ANTIBIOTIC PRESCRIBI; Busscher JF, 2006, VET MICROBIOL, V113, P131, DOI 10.1016/j.vetmic.2005.10.028; Castro-Sanchez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150056; Centers for Disease Control and Prevention, 2016, CDC 1 3 ANT PRESCR U; Cohn LA, 2003, J VET DIAGN INVEST, V15, P338, DOI 10.1177/104063870301500406; Coyne LA, 2016, J ANTIMICROB CHEMOTH, V71, P3300, DOI 10.1093/jac/dkw300; Donabedian S, 2003, J MICROBIOL METH, V55, P739, DOI 10.1016/j.mimet.2003.07.002; Dyar OJ, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7010010; Ekakoro JE., 2017, PEERJ PREPRINTS; Escher M, 2011, J ANTIMICROB CHEMOTH, V66, P920, DOI 10.1093/jac/dkq543; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Founou LL, 2018, MICROB DRUG RESIST, V24, P648, DOI 10.1089/mdr.2017.0383; Fowler H, 2016, VET REC, V179, P651, DOI [10.1136/vr.103916, 1]; Haque M, 2016, THER CLIN RISK MANAG, V12, P413, DOI 10.2147/TCRM.S102013; Hardefeldt L, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7020034; Hardefeldt LY, 2018, J VET INTERN MED, V32, P1092, DOI 10.1111/jvim.15083; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Hoque R, 2016, J YOUNG PHARM, V8, P447, DOI 10.5530/jyp.2016.4.22; Hughes LA, 2012, PREV VET MED, V104, P309, DOI 10.1016/j.prevetmed.2011.12.003; Hur BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230049; Jacob ME, 2015, JAVMA-J AM VET MED A, V247, P938, DOI 10.2460/javma.247.8.938; Jessen LR, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0350-8; Joosten P, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9020087; Katsunuma Y, 2007, J GEN APPL MICROBIOL, V53, P273, DOI 10.2323/jgam.53.273; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Lindmeier C., 2017, STOP USING ANTIBIOTI; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Maddox TW, 2012, EQUINE VET J, V44, P289, DOI 10.1111/j.2042-3306.2011.00441.x; Mateus A, 2011, IN PRACTICE, V33, P194, DOI 10.1136/inp.d2873; Mateus ALP, 2014, PREV VET MED, V117, P68, DOI 10.1016/j.prevetmed.2014.05.007; Mathew AG, 2007, FOODBORNE PATHOG DIS, V4, P115, DOI 10.1089/fpd.2006.0066; Meroni G, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120702; Oz T, 2014, MOL BIOL EVOL, V31, P2387, DOI 10.1093/molbev/msu191; Pozza G, 2020, ITAL J ANIM SCI, V19, P905, DOI 10.1080/1828051X.2020.1807419; Qualtrics USA, 2014, QUALTR LLC JU QUALTR; Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001; Sandegren L, 2014, UPSALA J MED SCI, V119, P103, DOI 10.3109/03009734.2014.904457; SAS Institute Inc, 2017, SAS 9 4 SOFTW SAS 9 4 SOFTW; Scaioli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122476; Seid MA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3199-1; Shah AH, 2013, TRANSBOUND EMERG DIS, V60, P9, DOI 10.1111/j.1865-1682.2012.01311.x; Silva K. C. da, 2013, Brazilian Journal of Veterinary Research and Animal Science, V50, P171, DOI 10.11606/issn.1678-4456.v50i3p171-183; Singleton DA, 2017, VET J, V224, P18, DOI 10.1016/j.tvjl.2017.03.010; U.S. Food & Drug Administration, 2017, VET FEED DIR VFD; Van Boeckel TP, 2019, SCIENCE, V365, P1266, DOI 10.1126/science.aaw1944; Williams R, 2017, ANAL RARE EVENTS LOG; Yang K, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3454-0; Yoon JW, 2010, J MICROBIOL BIOTECHN, V20, P1764, DOI 10.4014/jmb.1001.01011; Yousefi A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4180490; Zhang LX, 2015, ANTIMICROB AGENTS CH, V59, P6733, DOI 10.1128/AAC.01094-15; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	62	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249653	10.1371/journal.pone.0249653	http://dx.doi.org/10.1371/journal.pone.0249653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857198	Green Published, gold			2022-12-26	WOS:000641474900020
J	Chaves-Torres, NM; Fadul, S; Patino, J; Netto, E				Chaves-Torres, Ninfa Marlen; Fadul, Santiago; Patino, Jesus; Netto, Eduardo			Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study	PLOS ONE			English	Article								Background Multidrug- and rifampicin (RMP)-resistant tuberculosis (MDR/RR-TB) requires prolonged and expensive treatment, which is difficult to sustain in the Colombian health system. This requires the joint action of different providers to provide timely health services to people with TB. Identifying factors associated with unfavorable treatment outcomes in patients with MDR/RR-TB who received drug therapy between 2013 and 2015 in Colombia can help guide the strengthening of the national TB control program. Method A retrospective cohort study was conducted with all patients who received treatment for MDR/RR-TB between January 2013 and December 2015 in Colombia who were registered and followed up by the national TB control program. A multivariate logistic regression model was used to estimate the associations between the exposure variables with the response variable (treatment outcome). Results A total of 511 patients with MDR/RR-TB were registered and followed up by the national TB control program in Colombia, of whom 16 (3.1%) had extensive drug resistance, 364 (71.2%) had multidrug resistance, and 131 (25.6%) had RMP monoresistance. The mean age was 39.9 years (95% confidence interval (CI): 38.5-41.3), most patients were male 285 (64.6%), and 299 (67.8%) were eligible for subsidized health services. The rate of unfavorable treatment outcomes in the RR-TB cohort was 50.1%, with rates of 85.7% for patients with extensive drug resistance, 47.6% for patients with multidrug resistance, and 52.6% for patients with RMP monoresistance. The 511 MDR/RR-TB patients were included in bivariate and multivariate analyses, patients age >= 60 years (crude odds ratio (ORc) = 2.4, 95% CI 1.1-5.8; adjusted odds ratio (ORa) = 2.7, 95% CI 1.1-6.8) and subsidized health regime affiliation (ORc = 3.6, 95% CI 2.3-5.6; ORa = 3.4, 95% CI 2.0-6.0) were associated with unfavorable treatment outcomes. Conclusion More than 50% of the patients with MDR/RR-TB in Colombia experienced unfavorable treatment outcomes. The patients who were eligible for subsidized care were more likely to experience unfavorable treatment outcomes. Those who were older than 60 years were also more likely to experience unfavorable treatment outcomes.	[Chaves-Torres, Ninfa Marlen; Patino, Jesus] Univ Fed Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil; [Chaves-Torres, Ninfa Marlen] Mil Univ Nueva Granada, Fac Med & Hlth Sci, Bogota, Colombia; [Fadul, Santiago] Natl Inst Hlth, Dept Communicable Dis, Resp Dis Team, Bogota, Colombia; [Netto, Eduardo] Univ Fed Bahia, Jose Silveira Fdn, Postgrad Program Med & Hlth, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidad Militar Nueva Granada; Universidade Federal da Bahia	Chaves-Torres, NM (corresponding author), Univ Fed Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil.; Chaves-Torres, NM (corresponding author), Mil Univ Nueva Granada, Fac Med & Hlth Sci, Bogota, Colombia.	marlenchaveztdoc@yahoo.es	Netto, Eduardo/D-1432-2013; Patino Escarcina, Jesus Enrique/T-5982-2018	Netto, Eduardo/0000-0003-1691-6761; Patino Escarcina, Jesus Enrique/0000-0003-2948-5550; CHAVES TORRES, NINFA MARLEN/0000-0003-2660-207X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)" -Finance Code 001. There was no additional external funding received for this study.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Alene KA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227100; Lara JLA, 2011, INT J HEALTH CARE FI, V11, P83, DOI 10.1007/s10754-011-9089-3; Bastos ML, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2810-1; Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016; Bhering M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218299; Calle AM., 2014, FACTORS ASS SUCCESSF; Carter DJ, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001029; Cuervo JM, 2001, REV NEUMOLOGIA, V13; Grupo de Micobacterias Subdireccion Laboratorio Nacional de Referencia, 2015, CAP RED LAB PROGR TU; Grupo de Micobacterias Subdireccion Laboratorio Nacional de Referencia Direccion de Redes en Salud Publica, 2013, INF ACT REAL RED NAC; Guerrero R, 2011, SALUD PUBLICA MEXICO, V53, pS144; Hilarión-Gaitán Liliana, 2019, Biomed., V39, P737, DOI 10.7705/biomedica.4453; Instituto Nacional de Salud Republica de Colombia, LIN MAN PROGR TUB FA; Machado-Alba Jorge E, 2013, Infect., V17, P73; Martinez-Sanchez Lina Maria Mejia-CardonaLaura., AN FAC MED, V78, P37, DOI [10.15381/anales.v78i1.13019, DOI 10.15381/ANALES.V78I1.13019]; Martins LD, 2019, LANCET GLOB HEALTH, V7, pE565, DOI 10.1016/S2214-109X(19)30152-4; Ministerio de Salud y Proteccion Social Republica de Colombia, 2013, COB REG SUBS; Ministerio de Salud y Proteccion Social Republica de Colombia, 00007 MIN SAL PROT S; Ministerio de Salud y Proteccion Social Republica de Colombia, PLAN DEC SAL PUBL 20; Ministerio de Salud y Proteccion Social Republica de Colombia, POL TICA NACL PREST, P1; Ministerio de Salud y Proteccion Social Republica de Colombia, 2018, COMP AS SAL; Obregon G, 2018, INT J TUBERC LUNG D, V22, P1350, DOI 10.5588/ijtld.17.0894; Pan American Health Organization, 2008, PERF SIST SAL, V3, P1; Pan American Health Organization, 2018, TUB AM 2018; Programa de las Naciones Unidas para el Desarrollo (PNUD), INF DES HUM; Rojas CM., 2010, BIOMEDICA, V30; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2018, GLOBAL TUBERCULOSIS; World Health Organization, 2020, COL PERF TUB	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249565	10.1371/journal.pone.0249565	http://dx.doi.org/10.1371/journal.pone.0249565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852619	Green Published, gold			2022-12-26	WOS:000640604500005
J	Hensel, DJ; von Hippel, CD; Lapage, CC; Perkins, RH				Hensel, Devon J.; von Hippel, Christiana D.; Lapage, Charles C.; Perkins, Robert H.			Women's techniques for making vaginal penetration more pleasurable: Results from a nationally representative study of adult women in the United States	PLOS ONE			English	Article							SEXUAL SATISFACTION; PROBABILITY SAMPLE; THEMATIC ANALYSIS; IDENTIFIED WOMEN; AGES 18; FEMALE; HEALTH; ORGASM; COMMUNICATION; EXPERIENCES	The study purpose was to assess, in a U.S. probability sample of women, the specific ways women have discovered to make vaginal penetration more pleasurable. Through qualitative pilot research with women that informed the development of the survey instrument used in this study, we identified four previously unnamed, but distinct, techniques women use to make vaginal penetration more pleasurable: Angling, Rocking, Shallowing and Pairing. This study defines each technique and describes its prevalence among U.S. adult women. Weighted frequencies were drawn from the Second OMGYES Pleasure Report-a cross-sectional, online, national probability survey of 3017 American women's (age 18-93) sexual experiences and discoveries. Participants were recruited via the Ipsos KnowledgePanel (R). Data suggest that 87.5% of women make vaginal penetration more pleasurable using 'Angling': rotating, raising, or lowering the pelvis/hips during penetration to adjust where inside the vagina the toy or penis rubs and what it feels like. Approximately 76% of women make vaginal penetration more pleasurable using 'Rocking': the base of a penis or sex toy rubbing against the clitoris constantly during penetration, by staying all the way inside the vagina rather than thrusting in and out. About 84% of women make vaginal penetration more pleasurable using 'Shallowing': penetrative touch just inside of the entrance of the vagina-not on the outside, but also not deep inside-with a fingertip, sex toy, penis tip, tongue, or lips. Finally, 69.7% of women orgasm more often or make vaginal penetration more pleasurable using 'Pairing': when a woman herself (Solo Pairing) or her partner (Partner Pairing) reaches down to stimulate her clitoris with a finger or sex toy at the same time as her vagina is being penetrated. These data provide techniques that are at women's disposal to make penetration more pleasurable-which can enable women to better identify their own preferences, communicate about them and advocate for their sexual pleasure.	[Hensel, Devon J.; von Hippel, Christiana D.; Lapage, Charles C.; Perkins, Robert H.] Goodness Sake LLC, OMGYES Res Grp, Berkeley, CA 94705 USA; [Hensel, Devon J.] Indiana Univ Sch Med, Dept Pediat, Div Adolescent Med, Indianapolis, IN 46202 USA; [Hensel, Devon J.] Indiana Univ Purdue Univ, Dept Sociol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Hensel, DJ (corresponding author), Goodness Sake LLC, OMGYES Res Grp, Berkeley, CA 94705 USA.; Hensel, DJ (corresponding author), Indiana Univ Sch Med, Dept Pediat, Div Adolescent Med, Indianapolis, IN 46202 USA.; Hensel, DJ (corresponding author), Indiana Univ Purdue Univ, Dept Sociol, Indianapolis, IN 46202 USA.	djhensel@iu.edu		Hensel, Devon/0000-0002-2267-1038; Lapage, Charles/0000-0003-0961-0617	For Goodness Sake, LLC	For Goodness Sake, LLC	This study was funded by For Goodness Sake, LLC (https://www.fgsake.org/). The funders had a role in study design, data collection and analysis, decision to publish, and in preparation of the manuscript.	Armstrong EA, 2012, AM SOCIOL REV, V77, P435, DOI 10.1177/0003122412445802; Bakaroudis M, 2014, AM J SEX EDUC, V9, P381, DOI 10.1080/15546128.2014.944736; Blunt-Vinti H, 2019, J SEX MARITAL THER, V45, P206, DOI 10.1080/0092623X.2018.1501446; Braun V, 2001, J SEX RES, V38, P146, DOI 10.1080/00224490109552082; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Brody S, 2009, J SEX MED, V6, P1947, DOI 10.1111/j.1743-6109.2009.01303.x; Cabrera C, 2013, SEX CULT, V17, P193, DOI 10.1007/s12119-012-9147-0; Cacchioni T., 2007, SEXUALITIES, V10, P299, DOI [10.1177/1363460707078320, DOI 10.1177/1363460707078320]; Chatton D, 2005, PSYCHOTH RAPIES, V25, P3; Cherkasskaya E, 2019, ARCH SEX BEHAV, V48, P1659, DOI 10.1007/s10508-018-1212-9; Davison SL, 2009, J SEX MED, V6, P2690, DOI 10.1111/j.1743-6109.2009.01406.x; de Visser RO, 2003, AUST NZ J PUBL HEAL, V27, P146, DOI 10.1111/j.1467-842X.2003.tb00802.x; Sanchez-Fuentes MD, 2014, INT J CLIN HLTH PSYC, V14, P67, DOI 10.1016/S1697-2600(14)70038-9; Diamond LM, 2012, SOC PERSONAL PSYCHOL, V6, P54, DOI 10.1111/j.1751-9004.2011.00408.x; Doering N, 2020, J SEX RES, V57, P885, DOI 10.1080/00224499.2019.1578329; Ford JV, 2019, INT J SEX HEALTH, V31, P217, DOI 10.1080/19317611.2019.1654587; Frederick DA, 2017, J SEX RES, V54, P186, DOI 10.1080/00224499.2015.1137854; Frith H, 2013, CULT HEALTH SEX, V15, P494, DOI 10.1080/13691058.2013.767940; Fugl-Meyer KS, 2006, J SEX MED, V3, P56, DOI 10.1111/j.1743-6109.2005.00170.x; Giami A, 2015, SEXOLOGIES, V24, pE45, DOI 10.1016/j.sexol.2015.07.002; Gordon M., 1993, WOMEN LANGUAGE, V16, P16; Gruskin S, 2020, AM J PUBLIC HEALTH, V110, P159, DOI 10.2105/AJPH.2019.305497; Gruskin S, 2019, SEX REPROD HLTH MATT, V27, P29, DOI 10.1080/26410397.2019.1593787; Hensel DJ, 2016, J ADOLESCENT HEALTH, V59, P416, DOI 10.1016/j.jadohealth.2016.06.003; Hensel DJ, 2015, J SEX MED, V12, P1257, DOI 10.1111/jsm.12873; Hensel DJ., 2020, J ADOLESCENT HEALTH, DOI [10.1177/1363459318785696, DOI 10.1177/1363459318785696]; Hensel DJ, 2013, APA HDB SEXUALITY PS; Herbenick D, 2019, J SEX MARITAL THER, V45, P424, DOI 10.1080/0092623X.2018.1549634; Herbenick D, 2018, J SEX MARITAL THER, V44, P201, DOI 10.1080/0092623X.2017.1346530; Herbenick D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181198; Herbenick D, 2010, J SEX MED, V7, P346, DOI 10.1111/j.1743-6109.2010.02020.x; Herbenick D, 2009, J SEX MED, V6, P1857, DOI 10.1111/j.1743-6109.2009.01318.x; Hess JA, 2012, J SEX RES, V49, P603, DOI 10.1080/00224499.2011.619282; Hirst J, 2013, SEX EDUC-SEX SOC LEA, V13, P423, DOI 10.1080/14681811.2012.747433; Hull TH, 2008, INT J SEX HEALTH, V20, P133, DOI 10.1080/19317610802157234; Arcos-Romero AI, 2020, J SEX MARITAL THER, V46, P314, DOI 10.1080/0092623X.2019.1711273; Krejcova L, 2020, SEX MED-UK, V8, P767, DOI 10.1016/j.esxm.2020.07.003; La France BH, 2010, SOUTH COMMUN J, V75, P195, DOI 10.1080/10417940902787939; Marcus JL, 2020, SEX TRANSM DIS, V47, P1, DOI 10.1097/OLQ.0000000000001065; McCormick NB, 2010, SEX RELATSH THER, V25, P96, DOI 10.1080/14681990903550167; McNulty JK, 2016, ARCH SEX BEHAV, V45, P85, DOI 10.1007/s10508-014-0444-6; Milstein S, 2020, AM J SEX EDUC, V15, P99, DOI 10.1080/15546128.2019.1675563; O'Leary KD, 2012, SOC PSYCHOL PERS SCI, V3, P241, DOI 10.1177/1948550611417015; Opperman E, 2014, J SEX RES, V51, P503, DOI 10.1080/00224499.2012.753982; Pascoal PM, 2014, J SEX RES, V51, P22, DOI 10.1080/00224499.2013.815149; Perkins R, 2020, 2018 OMGYES WOMENS P; Pierce AP, 2000, J SEX MARITAL THER, V26, P257, DOI 10.1080/00926230050084650; Rehor JE, 2015, ARCH SEX BEHAV, V44, P825, DOI 10.1007/s10508-015-0524-2; Richters J, 2003, AUST NZ J PUBL HEAL, V27, P180, DOI 10.1111/j.1467-842X.2003.tb00806.x; Richters J, 2014, SEX HEALTH, V11, P461, DOI 10.1071/SH14116; Salisbury CMA, 2014, J SEX RES, V51, P616, DOI 10.1080/00224499.2013.838934; Schick V, 2012, J BISEXUALITY, V12, P198, DOI 10.1080/15299716.2012.674856; Shahhosseini Zohreh, 2014, Mater Sociomed, V26, P378, DOI 10.5455/msm.2014.26.378-381; Sprecher S, 2004, HANDBOOK OF SEXUALITY IN CLOSE RELATIONSHIPS, P235; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; SWIECZKOWSKI JB, 1978, J NERV MENT DIS, V166, P335, DOI 10.1097/00005053-197805000-00004; Tao P, 2011, J SEX MED, V8, P455, DOI 10.1111/j.1743-6109.2010.02129.x; Towne A, 2019, CAN J HUM SEX, V28, P68, DOI 10.3138/cjhs.2018-0022; Trompeter SE, 2012, AM J MED, V125, P37, DOI 10.1016/j.amjmed.2011.07.036; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Wampold CH, 2014, AM J SEX EDUC, V9, P219, DOI 10.1080/15546128.2014.903814; Whipple B, 2015, G SPOT INT ENCY HUMA, P427; Wood J, 2017, CAN J HUM SEX, V26, P196, DOI 10.3138/cjhs.2017-0016; World Association for Sexual Health, 2008, MILLENIUM DECLARATIO; Yoo H, 2014, J SEX MARITAL THER, V40, P275, DOI 10.1080/0092623X.2012.751072; Ziherl S, 2010, PSYCHIAT DANUB, V22, P425	66	7	7	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249242	10.1371/journal.pone.0249242	http://dx.doi.org/10.1371/journal.pone.0249242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852604	gold, Green Published			2022-12-26	WOS:000640604500014
J	Taboada, B; Moran, P; Serrano-Vazquez, A; Isa, P; Rojas-Velazquez, L; Perez-Juarez, H; Lopez, S; Torres, J; Ximenez, C; Arias, CF				Taboada, Blanca; Moran, Patricia; Serrano-Vazquez, Angelica; Isa, Pavel; Rojas-Velazquez, Liliana; Perez-Juarez, Horacio; Lopez, Susana; Torres, Javier; Ximenez, Cecilia; Arias, Carlos F.			The gut virome of healthy children during the first year of life is diverse and dynamic	PLOS ONE			English	Article							METAGENOMIC ANALYSES; YOUNG-CHILDREN; VIRUSES; STOOL; MICROBIOTA; BACTERIOPHAGES; ANELLOVIRUSES; EVOLUTION; COMMUNITY; TWINS	In this work, we determined the diversity and dynamics of the gut virome of infants during the first year of life. Fecal samples were collected monthly, from birth to one year of age, from three healthy children living in a semi-rural village in Mexico. Most of the viral reads were classified into six families of bacteriophages including five dsDNA virus families of the order Caudovirales, with Siphoviridae and Podoviridae being the most abundant. Eukaryotic viruses were detected as early as two weeks after birth and remained present all along the first year of life. Thirty-four different eukaryotic virus families were found, where eight of these families accounted for 98% of all eukaryotic viral reads: Anelloviridae, Astroviridae, Caliciviridae, Genomoviridae, Parvoviridae, Picornaviridae, Reoviridae and the plant-infecting viruses of the Virgaviridae family. Some viruses in these families are known human pathogens, and it is surprising that they were found during the first year of life in infants without gastrointestinal symptoms. The eukaryotic virus species richness found in this work was higher than that observed in previous studies; on average between 7 and 24 virus species were identified per sample. The richness and abundance of the eukaryotic virome significantly increased during the second semester of life, probably because of an increased environmental exposure of infants with age. Our findings suggest an early and permanent contact of infants with a diverse array of bacteriophages and eukaryotic viruses, whose composition changes over time. The bacteriophages and eukaryotic viruses found in these children could represent a metastable virome, whose potential influence on the development of the infant's immune system or on the health of the infants later in life, remains to be investigated.	[Taboada, Blanca; Isa, Pavel; Lopez, Susana; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Moran, Patricia; Serrano-Vazquez, Angelica; Rojas-Velazquez, Liliana; Perez-Juarez, Horacio; Ximenez, Cecilia] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico; [Torres, Javier] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XXI, Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Arias, CF (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.; Ximenez, C (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico.; Torres, J (corresponding author), Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XXI, Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Ciudad De Mexico, Mexico.	uimeip@gmail.com; cximenez2005@yahoo.com.mx; arias@ibt.unam.mx	Isa, Pavel/GVU-8303-2022	Arias, Carlos F./0000-0003-3130-4501; XIMENEZ, CECILIA/0000-0003-0574-4538; Taboada, Blanca/0000-0003-1896-5962	National Council for Science and Technology-Mexico (CONACYT) [272601, 257091]; DGAPA-PAPIIT/UNAM [IG200317, IN215018]	National Council for Science and Technology-Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT/UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was partially supported by grants 272601 and 257091 from the National Council for Science and Technology-Mexico (CONACYT), and by grants IG200317 and IN215018 from DGAPA-PAPIIT/UNAM. NO.	Abbas AA, 2017, AM J TRANSPLANT, V17, P1313, DOI 10.1111/ajt.14076; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Aguado-Garcia Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70684-w; Aiemjoy K, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3674-3; Altan E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202054; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clooney AG, 2019, CELL HOST MICROBE, V26, P764, DOI 10.1016/j.chom.2019.10.009; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Escalante AE, 2008, FEMS MICROBIOL ECOL, V65, P50, DOI 10.1111/j.1574-6941.2008.00496.x; Freer G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00686; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Guerin E, 2018, CELL HOST MICROBE, V24, P653, DOI 10.1016/j.chom.2018.10.002; Hill CJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0213-y; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Kolehmainen P, 2012, J CLIN VIROL, V54, P156, DOI 10.1016/j.jcv.2012.02.006; Kramna L, 2015, DIABETES CARE, V38, P930, DOI 10.2337/dc14-2490; Lazar V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01830; Liang GX, 2020, NATURE, V581, P470, DOI 10.1038/s41586-020-2192-1; Lim ES, 2016, TRENDS MICROBIOL, V24, P801, DOI 10.1016/j.tim.2016.06.001; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Loraine AE, 2015, METHODS MOL BIOL, V1284, P481, DOI 10.1007/978-1-4939-2444-8_24; Manrique P, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060141; Maqsood R, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0766-7; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez MA, 2015, J CLIN MICROBIOL, V53, P136, DOI 10.1128/JCM.01317-14; McCann A, 2018, PEERJ, V6, DOI 10.7717/peerj.4694; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mwangi PN., 2020, VIRUSES-BASEL, P1, DOI [10.3390/v12111260, DOI 10.3390/V12111260]; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Oksanen J., **DATA OBJECT**; Ouedraogo N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153652; Pannaraj PS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01162; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pereira MB, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4637-6; Pifferi M, 2006, PEDIATR INFECT DIS J, V25, P804, DOI 10.1097/01.inf.0000232723.58355.f4; Ponstingl H, 2012, SMALT WELLCOME TRUST; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rascovan N, 2016, ANNU REV MICROBIOL, V70, P125, DOI 10.1146/annurev-micro-102215-095431; RCore Team, 2020, R LANG ENV STAT COMP; Reyesa A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/pnas.1514285112; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rivera L, 2011, VACCINE, V29, P9508, DOI 10.1016/j.vaccine.2011.10.015; Santiago-Rodriguez TM, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070656; Shkoporov AN, 2019, CELL HOST MICROBE, V26, P527, DOI 10.1016/j.chom.2019.09.009; Shkoporov AN, 2019, CELL HOST MICROBE, V25, P195, DOI 10.1016/j.chom.2019.01.017; Shkoporov AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07225-7; Siqueira JD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06502-9; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Taboada B, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00465-18, 10.1128/aem.00465-18]; Tamburini FB., 2018, TRASNSMISSION PERSIS; Tan SK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71791-4; Thom K, 2007, J MED VIROL, V79, P1, DOI 10.1002/jmv.20756; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Wang CH, 2018, VIROLOGY, V518, P116, DOI 10.1016/j.virol.2018.02.004; Yinda CK, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00585-18; Young JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/ajt.13031; Zhao GY, 2017, P NATL ACAD SCI USA, V114, pE6166, DOI 10.1073/pnas.1706359114; Zuo T, 2020, CELL HOST MICROBE, V28, P741, DOI 10.1016/j.chom.2020.08.005; zur Hansen H, 2005, INT J CANCER, V115, P1, DOI 10.1002/ijc.20905	69	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0240958	10.1371/journal.pone.0240958	http://dx.doi.org/10.1371/journal.pone.0240958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852569	Green Published, Green Submitted, gold			2022-12-26	WOS:000640604500038
J	Abad, R; Collart, O; Ganesan, P; Rogers, AJ; Alhusseini, MI; Rodrigo, M; Narayan, SM; Rappel, WJ				Abad, Ricardo; Collart, Orvil; Ganesan, Prasanth; Rogers, A. J.; Alhusseini, Mahmood, I; Rodrigo, Miguel; Narayan, Sanjiv M.; Rappel, Wouter-Jan			Three dimensional reconstruction to visualize atrial fibrillation activation patterns on curved atrial geometry	PLOS ONE			English	Article							CATHETER ABLATION; FOCAL IMPULSE; LOCALIZED SOURCES; PHASE; ROTORS; DRIVERS	Background The rotational activation created by spiral waves may be a mechanism for atrial fibrillation (AF), yet it is unclear how activation patterns obtained from endocardial baskets are influenced by the 3D geometric curvature of the atrium or 'unfolding' into 2D maps. We develop algorithms that can visualize spiral waves and their tip locations on curved atrial geometries. We use these algorithms to quantify differences in AF maps and spiral tip locations between 3D basket reconstructions, projection onto 3D anatomical shells and unfolded 2D surfaces. Methods We tested our algorithms in N = 20 patients in whom AF was recorded from 64-pole baskets (Abbott, CA). Phase maps were generated by non-proprietary software to identify the tips of spiral waves, indicated by phase singularities. The number and density of spiral tips were compared in patient-specific 3D shells constructed from the basket, as well as 3D maps from clinical electroanatomic mapping systems and 2D maps. Results Patients (59.4 +/- 12.7 yrs, 60% M) showed 1.7 +/- 0.8 phase singularities/patient, in whom ablation terminated AF in 11/20 patients (55%). There was no difference in the location of phase singularities, between 3D curved surfaces and 2D unfolded surfaces, with a median correlation coefficient between phase singularity density maps of 0.985 (0.978-0.990). No significant impact was noted by phase singularities location in more curved regions or relative to the basket location (p>0.1). Conclusions AF maps and phase singularities mapped by endocardial baskets are qualitatively and quantitatively similar whether calculated by 3D phase maps on patient-specific curved atrial geometries or in 2D. Phase maps on patient-specific geometries may be easier to interpret relative to critical structures for ablation planning.	[Abad, Ricardo; Collart, Orvil; Ganesan, Prasanth; Rogers, A. J.; Alhusseini, Mahmood, I; Rodrigo, Miguel; Narayan, Sanjiv M.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Rodrigo, Miguel] Univ Politecn Valencia, Valencia, Spain; [Rappel, Wouter-Jan] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Stanford University; Universitat Politecnica de Valencia; University of California System; University of California San Diego	Narayan, SM (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Rappel, WJ (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	sanjiv1@stanford.edu; rappel@physics.ucsd.edu		Ganesan, Prasanth/0000-0002-1885-0690; Rogers, Albert/0000-0001-6585-534X; Narayan, Sanjiv/0000-0001-7552-5053	National Institutes of Health [F32HL144101, HL103800, HL83359, HL122384, HL145500]; GVA [APOSTD/2017, APOSTD/2018, GVA/2018/103]; Fellowship of the Belgian American Educational Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GVA; Fellowship of the Belgian American Educational Foundation	AJR acknowledges research funding from National Institutes of Health (www.nih.gov) (F32HL144101). Drs. Narayan and Rappel report research grants from National Institutes of Health (HL103800, HL83359, HL122384, HL145500). Dr Rodrigo reports research grants from GVA (APOSTD/2017, APOSTD/2018, GVA/2018/103). Orvil Collart was supported by a Fellowship of the Belgian American Educational Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhusseini M, 2017, J CARDIOVASC ELECTR, V28, P615, DOI 10.1111/jce.13177; Baykaner T., 2017, HEART RHYTHM, V14; Baykaner T, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.006119; Bellmann B, 2019, INT J CARDIOL, V286, P56, DOI 10.1016/j.ijcard.2019.02.006; Bellmann B, 2018, CLIN RES CARDIOL, V107, P1021, DOI 10.1007/s00392-018-1274-7; Ben Shabat Y, 2015, PROC CIRP, V36, P279, DOI 10.1016/j.procir.2015.01.057; Berenfeld O, 2018, HEART RHYTHM, V15, pE3, DOI 10.1016/j.hrthm.2017.11.006; Brachmann J, 2019, S LBCT01 02 PROSPECT; Bray MA, 2001, J CARDIOVASC ELECTR, V12, P716, DOI 10.1046/j.1540-8167.2001.00716.x; Buch Eric, 2016, Heart Rhythm, V13, P636, DOI 10.1016/j.hrthm.2015.10.031; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Calkins H, 2017, HEART RHYTHM, V14, pE275, DOI 10.1016/j.hrthm.2017.05.012; Child N, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005897; Christoph J, 2018, NATURE, V555, P667, DOI 10.1038/nature26001; Dharmaprani D, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.119.007569; Grace A, 2017, EUR HEART J, V38, P5, DOI 10.1093/eurheartj/ehw585; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Haissaguerre M, 2016, J PHYSIOL-LONDON, V594, P2387, DOI 10.1113/JP270617; Haissaguerre M, 2014, CIRCULATION, V130, P530, DOI 10.1161/CIRCULATIONAHA.113.005421; Hansen BJ, 2018, JACC-CLIN ELECTROPHY, V4, P1501, DOI 10.1016/j.jacep.2018.08.024; Hansen BJ, 2015, EUR HEART J, V36, P2390, DOI 10.1093/eurheartj/ehv233; Heist EK, 2006, J INTERV CARD ELECTR, V17, P21, DOI 10.1007/s10840-006-9060-2; Honarbakhsh S, 2018, HEART RHYTHM, V15, P1296, DOI 10.1016/j.hrthm.2018.04.020; Honarbakhsh S, 2017, J CARDIOVASC ELECTR, V28, P1423, DOI 10.1111/jce.13331; Kowalewski CAB, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005846; Kuklik P, 2017, IEEE T BIO-MED ENG, V64, P310, DOI 10.1109/TBME.2016.2554660; Kuklik P, 2015, INT J CARDIOL, V199, P407, DOI 10.1016/j.ijcard.2015.07.057; Kuklik P, 2015, IEEE T BIO-MED ENG, V62, P296, DOI 10.1109/TBME.2014.2350029; Li N, 2016, CIRCULATION, V134, P486, DOI 10.1161/CIRCULATIONAHA.115.021165; Lin CY, 2019, PACE, V42, P216, DOI 10.1111/pace.13573; Lin Yenn-Jiang, 2016, JACC Clin Electrophysiol, V2, P667, DOI 10.1016/j.jacep.2016.08.005; Miller JM, 2017, J AM COLL CARDIOL, V69, P1247, DOI 10.1016/j.jacc.2016.11.079; Miller JM, 2014, J CARDIOVASC ELECTR, V25, P921, DOI 10.1111/jce.12474; Narayan SM, 2013, CIRC-ARRHYTHMIA ELEC, V6, P58, DOI 10.1161/CIRCEP.111.977264; Narayan SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046034; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Narayan SM, 2018, CARDIAC ELECTROPHYSI, V7th, P426; Natale A., 2016, HEART RHYTHM, V13, P1373; Nattel S, 2017, NAT REV CARDIOL, V14, P509, DOI 10.1038/nrcardio.2017.37; Nattel S, 2017, CIRC RES, V120, P1396, DOI 10.1161/CIRCRESAHA.116.310489; Navara R, 2018, J CARDIOVASC ELECTR, V29, P687, DOI 10.1111/jce.13446; Pathik B, 2018, HEART RHYTHM, V15, P182, DOI 10.1016/j.hrthm.2017.09.010; Ramirez FD, 2017, J CARDIOVASC ELECTR, V28, P1371, DOI 10.1111/jce.13313; Rappel WJ, 2013, CHAOS, V23, DOI 10.1063/1.4807098; Roney CH, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004899; Rusinkiewicz S, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P486, DOI 10.1109/TDPVT.2004.1335277; Schricker AA, 2014, CIRC-ARRHYTHMIA ELEC, V7, P816, DOI 10.1161/CIRCEP.113.001289; Seitz J, 2017, J AM COLL CARDIOL, V69, P303, DOI 10.1016/j.jacc.2016.10.065; Sknouril L, 2017, PHYSIOL RES, V66, P241, DOI 10.33549/physiolres.933314; Steinberg JS, 2017, HEART RHYTHM, V14, P192, DOI 10.1016/j.hrthm.2016.11.008; Umapathy K, 2010, CIRC-ARRHYTHMIA ELEC, V3, P105, DOI 10.1161/CIRCEP.110.853804; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Vidmar D, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.012407; Vidmar D, 2018, HEART RHYTHM, V15, pE3, DOI 10.1016/j.hrthm.2017.11.004; Zaman JAB, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005258	57	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249873	10.1371/journal.pone.0249873	http://dx.doi.org/10.1371/journal.pone.0249873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836026	gold, Green Published			2022-12-26	WOS:000639361000023
J	Maier, AKB; Reichhart, N; Gonnermann, J; Kociok, N; Riechardt, AI; Gundlach, E; Strauss, O; Joussen, AM				Maier, Anna-Karina B.; Reichhart, Nadine; Gonnermann, Johannes; Kociok, Norbert; Riechardt, Aline, I; Gundlach, Enken; Strauss, Olaf; Joussen, Antonia M.			Effects of TNF alpha receptor TNF-Rp55-or TNF-Rp75-deficiency on corneal neovascularization and lymphangiogenesis in the mouse	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALKALI BURN; MICE; HEMANGIOGENESIS; ANGIOGENESIS; INFLAMMATION; INHIBITOR; RESISTANT; ROLES; CELLS	Tumor necrosis factor (TNF)alpha is an inflammatory cytokine likely to be involved in the process of corneal inflammation and neovascularization. In the present study we evaluate the role of the two receptors, TNF-receptor (TNF-R)p55 and TNF-Rp75, in the mouse model of suture-induced corneal neovascularization and lymphangiogenesis. Corneal neovascularization and lymphangiogenesis were induced by three 11-0 intrastromal corneal sutures in wild-type (WT) C57BL/6J mice and TNF-Rp55-deficient (TNF-Rp55d) and TNF-Rp75-deficient (TNF-Rp75d) mice. The mRNA expression of VEGF-A, VEGF-C, Lyve-1 and TNF alpha and its receptors was quantified by qPCR. The area covered with blood- or lymphatic vessels, respectively, was analyzed by immunohistochemistry of corneal flatmounts. Expression and localization of TNF alpha and its receptors was assessed by immunohistochemistry of sagittal sections and Western Blot. Both receptors are expressed in the murine cornea and are not differentially regulated by the genetic alteration. Both TNF-Rp55d and TNF-Rp75d mice showed a decrease in vascularized area compared to wild-type mice 14 days after suture treatment. After 21 days there were no differences detectable between the groups. The number of VEGF-A-expressing macrophages did not differ when comparing WT to TNF-Rp55d and TNF-Rp75d. The mRNA expression of lymphangiogenic markers VEGF-C or LYVE-1 does not increase after suture in all 3 groups and lymphangiogenesis showed a delayed effect only for TNF-Rp75d. TNF alpha mRNA and protein expression increased after suture treatment but showed no difference between the three groups. In the suture-induced mouse model, TNF alpha and its ligands TNF-Rp55 and TNF-Rp75 do not play a significant role in the pathogenesis of neovascularisation and lymphangiogenesis.	[Maier, Anna-Karina B.; Reichhart, Nadine; Gonnermann, Johannes; Kociok, Norbert; Riechardt, Aline, I; Gundlach, Enken; Strauss, Olaf; Joussen, Antonia M.] Charite Univ Med Berlin, Dept Ophthalmol, Berlin, Germany; [Maier, Anna-Karina B.; Reichhart, Nadine; Gonnermann, Johannes; Kociok, Norbert; Riechardt, Aline, I; Gundlach, Enken; Strauss, Olaf; Joussen, Antonia M.] Free Univ Berlin, Berlin, Germany; [Maier, Anna-Karina B.; Reichhart, Nadine; Gonnermann, Johannes; Kociok, Norbert; Riechardt, Aline, I; Gundlach, Enken; Strauss, Olaf; Joussen, Antonia M.] Humboldt Univ, Berlin, Germany; [Maier, Anna-Karina B.; Reichhart, Nadine; Gonnermann, Johannes; Kociok, Norbert; Riechardt, Aline, I; Gundlach, Enken; Strauss, Olaf; Joussen, Antonia M.] Berlin Inst Hlth, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health	Maier, AKB (corresponding author), Charite Univ Med Berlin, Dept Ophthalmol, Berlin, Germany.	anna-karin.maier@charite.de	Joussen, Antonia/AAA-6901-2022	Strauss, Olaf/0000-0002-6272-8596	Volkswagen Foundation; Charite Foundation; Lydia Rabinowitsch-Stipendium; Charite Universitatsmedizin Berlin	Volkswagen Foundation(Volkswagen); Charite Foundation; Lydia Rabinowitsch-Stipendium; Charite Universitatsmedizin Berlin	AKM: Financial support was provided for Anna-Karina B. Maier by the "Friedrich C. Luft" Clinical Scientist Pilot Program funded by Volkswagen Foundation and Charite ' Foundation and by the "Lydia Rabinowitsch-Stipendium" funded by Charite ' Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bock F, 2008, GRAEF ARCH CLIN EXP, V246, P115, DOI 10.1007/s00417-007-0683-5; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Cade F, 2014, CORNEA, V33, P382, DOI 10.1097/ICO.0000000000000071; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2005, AM J PATHOL, V166, P1367, DOI 10.1016/S0002-9440(10)62355-3; Cursiefen C, 2003, OPHTHALMOLOGE, V100, P292, DOI 10.1007/s00347-003-0798-y; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Ferrari G, 2015, EYE CONTACT LENS, V41, P72, DOI 10.1097/ICL.0000000000000071; Ferrari G, 2013, INVEST OPHTH VIS SCI, V54, P1680, DOI 10.1167/iovs.12-10782; Fujita S, 2007, INVEST OPHTH VIS SCI, V48, P3051, DOI 10.1167/iovs.06-1083; Giacomini C, 2014, EXP EYE RES, V121, P1, DOI 10.1016/j.exer.2014.02.005; Hos D, 2008, INVEST OPHTH VIS SCI, V49, P1836, DOI 10.1167/iovs.07-1314; Ji RC, 2007, CURR MED CHEM, V14, P2359, DOI 10.2174/092986707781745541; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jia CK, 2011, MOL VIS, V17, P2386; Kociok N, 2006, INVEST OPHTH VIS SCI, V47, P5057, DOI 10.1167/iovs.06-0407; Lu PR, 2012, INVEST OPHTH VIS SCI, V53, P3516, DOI 10.1167/iovs.10-5548; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Saika S, 2007, CORNEA, V26, pS70, DOI 10.1097/ICO.0b013e31812f6d14; Saika S, 2006, AM J PATHOL, V168, P1848, DOI 10.2353/ajpath.2006.050980; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Yang SJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1266-6; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326	29	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0245143	10.1371/journal.pone.0245143	http://dx.doi.org/10.1371/journal.pone.0245143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33835999	gold, Green Published			2022-12-26	WOS:000639361000008
J	Ashagrie, D; Genet, C; Abera, B				Ashagrie, Degu; Genet, Chalachew; Abera, Bayeh			Vancomycin-resistant enterococci and coagulase-negative staphylococci prevalence among patients attending at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY PATTERN; ANTIBIOTIC SUSCEPTIBILITY; NOSOCOMIAL INFECTIONS; CLINICAL-SAMPLES; ADDIS-ABABA; BURDEN; UNIVERSITY; PROFILE; SENSITIVITY; METHICILLIN	Background Vancomycin resistant enterococci (VRE) and vancomycin resistance coagulase negative staphylococci (VRCoNS) are common pathogens causing difficult to treat health care associated infections (HAI). Hence, the World Health Organization listed VRE as one of the high priority pathogens for new antibiotic discovery and antimicrobial resistance surveillance. Despite this, data on the prevalence of VRE and VRCoNS in Ethiopia is scarce. Thus, the present study determined prevalence of VRE and VRCoNS among patients attending Felege-Hiwot comprehensive specialized hospital, Ethiopia. Methods A hospital based cross-sectional study was conducted on 384 patients selected conveniently from February to March 2020. Data on demographic and clinical variables were collected using a structured questionnaire by face-to-face interview. Simultaneously urine, venous blood and wound swab were collected and processed following standard bacteriological technique. Antimicrobial susceptibility test was performed by minimum inhibitory concentration method using E-test for vancomycin and Kirby-Bauer disc diffusion method for other classes of antibiotics. Data was entered and analyzed using SPSS version 23. Logistic regression was performed to identify factors associated with VRE infection. P. value < 0.05 was considered as statistically significant. Results The prevalence of enterococci and CoNS were 6.8% and 12% respectively. The prevalence of VRE was 34.61% (9/26), while all CoNS (46 isolates) were susceptible to vancomycin. The majority (66.7%) of VRE was isolated from blood samples. Furthermore all VRE (100%), 58.8% of vancomycin susceptible enterococci and 45.7% of CoNS were multidrug resistant (MDR). Having educational level of secondary school and below (AOR = 12.80, CI = 1.149-142.5), previous exposure to catheterization (AOR = 56.0, CI = 4.331-724.0) and previous antibiotic use practice (AOR = 26.25, CI = 3.041-226.2) were a significant associated explanatory factor for VRE infection. Conclusions The prevalence of vancomycin resistance enterococci, which is also multidrug resistant, was significantly high. Though no vancomycin resistance CoNS detected, the MDR level of CoNS was high. Thus to limit enterococci and CoNS infections and MDR development, focused infection prevention measures should be implemented.	[Ashagrie, Degu] Felege Hiwot Comprehens Specialized Hosp, Diagnost Med Lab Unit, Bahir Dar, Ethiopia; [Genet, Chalachew; Abera, Bayeh] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia	Bahir Dar University	Genet, C (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia.	chaliegenet@gmail.com		Genet, Chalachew/0000-0001-8631-5094				Abebaw A, 2018, PATHOL LAB MED INT, V10, P1, DOI 10.2147/PLMI.S153444; Agegne M, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/7510157; Al-Tamimi M, 2020, J INFECT DEV COUNTR, V14, P28, DOI 10.3855/jidc.11025; Alemayehu T, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4210-1; Ayobami O, 2020, EMERG MICROBES INFEC, V9, P1180, DOI 10.1080/22221751.2020.1769500; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Begum E. S., 2011, International Journal of Medicine and Public Health, V1, P59, DOI 10.5530/ijmedph.4.2011.14; Bereket W, 2012, EUR REV MED PHARMACO, V16, P1039; Bouchami O, 2011, AFR J MICROBIOL RES, V5, P1298; Carmeli Y, 2002, ARCH INTERN MED, V162, P2223, DOI 10.1001/archinte.162.19.2223; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Cho SY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-504; Chong J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164136; CLSI, 2019, M100 CLSI; Deyno S, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1188-6; Ehsan MM, 2013, PAK J MED SCI, V29, P1420; Ferede Zelalem Tena, 2018, BMC Res Notes, V11, P793, DOI 10.1186/s13104-018-3898-0; Garcia-Solache M, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00058-18; Ghadiri H, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/890797; Grace JA., 2019, CLIN MICROBIOL, V8, P325, DOI DOI 10.4172/2327-5073.1000325; Karna A, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/7936156; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; Kramer TS, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0419-9; Ma XX, 2011, J MED MICROBIOL, V60, P1661, DOI 10.1099/jmm.0.034066-0; Mama M, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-14; Melese A, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4833-2; Meseret Guta, 2014, African Journal of Microbiology Research, V8, P1118, DOI 10.5897/AJMR2013.6544; Moghimbeigi A, 2018, ADOLESC HEALTH MED T, V9, P177, DOI 10.2147/AHMT.S180489; Morgenstern M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148437; Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y; Ozsoy S, 2017, BRAZ J MICROBIOL, V48, P489, DOI 10.1016/j.bjm.2016.12.012; Martinez EP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221133; Pfaller MA, 2019, OPEN FORUM INFECT DI, V6, pS54, DOI 10.1093/ofid/ofy344; Puchter L, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0291-z; Raza T, 2018, J PAK MED ASSOC, V68, P768; Remschmidt C, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0353-x; Sewunet T, 2013, ETHIOP J HEALTH SCI, V23, P209, DOI 10.4314/ejhs.v23i3.3; Shiferaw B, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0078-z; Siqueira Carla C. M., 2018, J. Bras. Patol. Med. Lab., V54, P76, DOI 10.5935/1676-2444.20180014; Sisay M, 2018, BMC PHARMACOL TOXICO, V19, DOI 10.1186/s40360-018-0274-6; Srinivasan A, 2002, CLIN MICROBIOL REV, V15, P430, DOI 10.1128/CMR.15.3.430-438.2002; Tadesse BT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2713-1; Toner L, 2016, INVESTIG CLIN UROL, V57, P129, DOI 10.4111/icu.2016.57.2.129; Toru Milkiyas, 2018, BMC Res Notes, V11, P281, DOI 10.1186/s13104-018-3382-x; Upreti N, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0408-z; Vandepitte J, 2003, BASIC LAB PROCEDURES; Wasihun AG, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1056-x; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Widerstrom M, 2012, EUR J CLIN MICROBIOL, V31, P7, DOI 10.1007/s10096-011-1270-6; World Health Organization, 2014, ANT RES GLOB REP SUR; Yilema A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2363-3	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249823	10.1371/journal.pone.0249823	http://dx.doi.org/10.1371/journal.pone.0249823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831089	Green Published, gold			2022-12-26	WOS:000639359600101
J	Banerdt, JK; Mateyo, K; Yan, Y; Liu, DD; Zuo, Y; Di Gravio, C; Thome, JC; Riviello, ED; Saylor, D; Ely, EW; Heimburger, DC				Banerdt, Justin K.; Mateyo, Kondwelani; Yan, Yan; Liu, Dandan; Zuo, Yi; Di Gravio, Chiara; Thome, Julia C.; Riviello, Elisabeth D.; Saylor, Deanna; Ely, E. Wesley; Heimburger, Douglas C.			Risk factors for delirium among hospitalized patients in Zambia	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; TERM COGNITIVE IMPAIRMENT; CRITICALLY-ILL; CARE; MORTALITY	Objective To identify risk factors for delirium among hospitalized patients in Zambia. Methods We conducted a prospective cohort study at the University Teaching Hospital in Lusaka, Zambia, from October 2017 to April 2018. We report associations of exposures including sociodemographic and clinical factors with delirium over the first three days of hospital admission, assessed using a modified Brief Confusion Assessment Method (bCAM). Findings 749 patients were included for analysis (mean age, 42.9 years; 64.8% men; 47.3% with HIV). In individual regression analyses of potential delirium risk factors adjusted for age, sex and education, factors significantly associated with delirium included being divorced/widowed (OR 1.64, 95% CI 1.09-2.47), lowest tercile income (OR 1.58, 95% CI 1.04-2.40), informal employment (OR 1.97, 95% CI 1.25-3.15), untreated HIV infection (OR 2.18, 95% CI 1.21-4.06), unknown HIV status (OR 2.90, 95% CI 1.47-6.16), history of stroke (OR 2.70, 95% CI 1.15-7.19), depression/anxiety (OR 1.52, 95% CI 1.08-2.14), alcohol overuse (OR 1.96, 95% CI 1.39-2.79), sedatives ordered on admission (OR 3.77, 95% CI 1.70-9.54), severity of illness (OR 2.00, 95% CI 1.82-2.22), neurological (OR 7.66, 95% CI 4.90-12.24) and pulmonary-system admission diagnoses (OR 1.91, 95% CI 1.29-2.85), and sepsis (OR 2.44, 95% CI 1.51-4.08). After combining significant risk factors into a multivariable regression analysis, severity of illness, history of stroke, and being divorced/widowed remained predictive of delirium (p<0.05). Conclusion Among hospitalized adults at a national referral hospital in Zambia, severity of illness, history of stroke, and being divorced/widowed were independently predictive of delirium. Extension of this work will inform future efforts to prevent, detect, and manage delirium in low- and middle-income countries.	[Banerdt, Justin K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Banerdt, Justin K.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Mateyo, Kondwelani; Saylor, Deanna; Heimburger, Douglas C.] Univ Zambia, Sch Med, Lusaka, Zambia; [Mateyo, Kondwelani; Saylor, Deanna] Univ Teaching Hosp, Lusaka, Zambia; [Yan, Yan; Liu, Dandan; Zuo, Yi; Di Gravio, Chiara; Thome, Julia C.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Riviello, Elisabeth D.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Riviello, Elisabeth D.] Harvard Med Sch, Boston, MA 02115 USA; [Saylor, Deanna] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Ely, E. Wesley] Vanderbilt Univ, Med Ctr, Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN USA; [Ely, E. Wesley; Heimburger, Douglas C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Ely, E. Wesley] Tennessee Valley Vet Affairs Geriatr Res Educ Cli, Nashville, TN USA; [Heimburger, Douglas C.] Vanderbilt Inst Global Hlth, Nashville, TN USA	Yale University; Vanderbilt University; University of Zambia; University of Zambia; Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Johns Hopkins University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; Vanderbilt University	Banerdt, JK (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Banerdt, JK (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	justin.banerdt@yale.edu		Di Gravio, Chiara/0000-0002-0532-267X; Saylor, Deanna/0000-0002-9297-0244	Fogarty International Center of the US National Institutes of Health [D43 TW009337]; Vanderbilt Institute for Clinical and Translational Research [UL1TR002243]; Vanderbilt Medical Scholars Program of the Vanderbilt University School of Medicine	Fogarty International Center of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Vanderbilt Institute for Clinical and Translational Research; Vanderbilt Medical Scholars Program of the Vanderbilt University School of Medicine	This study was supported by Fogarty International Center of the US National Institutes of Health under award D43 TW009337 (https://www.vumc.org/vecd/home) awarded to JKB, Vanderbilt Institute for Clinical and Translational Research (Grant No. UL1TR002243) awarded to JKB, and by the Vanderbilt Medical Scholars Program of the Vanderbilt University School of Medicine (https://medschool.vanderbilt.edu/curriculum/medicalscholars-program) awarded to JKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, COUNTRY FACTSHEETS Z; Baker T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144801; Banerdt JK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246330; Brito NB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160480; Chaiwat O, 2019, BMC ANESTHESIOL, V19, DOI 10.1186/s12871-019-0694-x; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Han JH, 2016, AM J EMERG MED, V34, P1031, DOI 10.1016/j.ajem.2016.02.069; Han JH, 2013, ANN EMERG MED, V62, P457, DOI 10.1016/j.annemergmed.2013.05.003; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hsieh S Jean, 2013, Ann Am Thorac Soc, V10, P648, DOI 10.1513/AnnalsATS.201307-232FR; Kwizera A, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/491780; Leslie DL, 2011, J AM GERIATR SOC, V59, pS241, DOI 10.1111/j.1532-5415.2011.03671.x; Lewis EG, 2017, DEMENT GERIATR COGN, V44, P160, DOI 10.1159/000479058; Marra A, 2017, CRIT CARE CLIN, V33, P225, DOI 10.1016/j.ccc.2016.12.005; McManus J, 2007, AGE AGEING, V36, P613, DOI 10.1093/ageing/afm140; McMorris T, 2017, NEUROSCI BIOBEHAV R, V74, P225, DOI 10.1016/j.neubiorev.2017.01.019; Moore CC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000344; Murthy Srinivas, 2013, Ann Am Thorac Soc, V10, P509, DOI 10.1513/AnnalsATS.201307-246OT; Paddick SM, 2015, J NEUROL SCI, V348, P6, DOI 10.1016/j.jns.2014.10.034; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; Vasilevskis EE, 2012, BEST PRACT RES-CLIN, V26, P277, DOI 10.1016/j.bpa.2012.07.003; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vukoja M, 2018, CURR OPIN CRIT CARE, V24, P421, DOI 10.1097/MCC.0000000000000528	34	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249097	10.1371/journal.pone.0249097	http://dx.doi.org/10.1371/journal.pone.0249097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831010	gold, Green Published			2022-12-26	WOS:000639359600032
J	Bhardwaj, P; Islam, MZ; Kim, C; Nguyen, UT; Palmer, KL				Bhardwaj, Pooja; Islam, Moutusee Z.; Kim, Christi; Uyen Thy Nguyen; Palmer, Kelli L.			ddcP, pstB, and excess D-lactate impact synergism between vancomycin and chlorhexidine against Enterococcus faecium 1,231,410	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; RESISTANT ENTEROCOCCI; PEPTIDOGLYCAN PRECURSORS; ESCHERICHIA-COLI; CELL-WALLS; TRANSPEPTIDATION; MECHANISMS; EXPRESSION; TRANSPORT; MODE	Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens that cause life-threatening infections. To control hospital-associated infections, skin antisepsis and bathing utilizing chlorhexidine is recommended for VRE patients in acute care hospitals. Previously, we reported that exposure to inhibitory chlorhexidine levels induced the expression of vancomycin resistance genes in VanA-type Enterococcus faecium. However, vancomycin susceptibility actually increased for VanA-type E. faecium in the presence of chlorhexidine. Hence, a synergistic effect of the two antimicrobials was observed. In this study, we used multiple approaches to investigate the mechanism of synergism between chlorhexidine and vancomycin in the VanA-type VRE strain E. faecium 1,231,410. We generated clean deletions of 7 of 11 pbp, transpeptidase, and carboxypeptidase genes in this strain (ponA, pbpF, pbpZ, pbpA, ddcP, ldt(fm), and vanY). Deletion of ddcP, encoding a membrane-bound carboxypeptidase, altered the synergism phenotype. Furthermore, using in vitro evolution, we isolated a spontaneous synergy escaper mutant and utilized whole genome sequencing to determine that a mutation in pstB, encoding an ATPase of phosphate-specific transporters, also altered synergism. Finally, addition of excess D-lactate, but not D-alanine, enhanced synergism to reduce vancomycin MIC levels. Overall, our work identified factors that alter chlorhexidine and vancomycin synergism in a model VanA-type VRE strain.	[Bhardwaj, Pooja; Islam, Moutusee Z.; Kim, Christi; Uyen Thy Nguyen; Palmer, Kelli L.] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA; [Bhardwaj, Pooja] BioEclipse Therapeut, Mountain View, CA USA	University of Texas System; University of Texas Dallas	Palmer, KL (corresponding author), Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA.	kelli.palmer@utdallas.edu		Palmer, Kelli/0000-0002-7343-9271	University of Texas at Dallas; Cecil H. and Ida Green Chair in Systems Biology Science	University of Texas at Dallas; Cecil H. and Ida Green Chair in Systems Biology Science	This work was supported by start-up funds from the University of Texas at Dallas and the Cecil H. and Ida Green Chair in Systems Biology Science to K.L.P.	Adams HM, 2015, ANTIMICROB AGENTS CH, V59, P4139, DOI 10.1128/AAC.00526-15; Agudelo Higuita NI., 2014, ENTEROCOCCI COMMENSA; ALLEN NE, 1992, FEMS MICROBIOL LETT, V98, P109; ANDERSON JS, 1965, P NATL ACAD SCI USA, V53, P881, DOI 10.1073/pnas.53.4.881; ANDERSON JS, 1965, BIOCHEM BIOPH RES CO, V21, P516, DOI 10.1016/0006-291X(65)90414-6; Bhardwaj P, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01235-17; Bhardwaj P, 2016, ANTIMICROB AGENTS CH, V60, P2209, DOI 10.1128/AAC.02595-15; Chan FY, 1996, J BACTERIOL, V178, P3974, DOI 10.1128/jb.178.13.3974-3977.1996; CLSI, 2011, METH ANT SUSC TEST H; Cole MR, 2015, MOLECULES, V20, P6466, DOI 10.3390/molecules20046466; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Coyette J, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P177; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Goffin P, 2005, J BACTERIOL, V187, P6750, DOI 10.1128/JB.187.19.6750-6761.2005; Gold HS, 2001, CLIN INFECT DIS, V33, P210, DOI 10.1086/321815; HAMMES W, 1973, J BACTERIOL, V116, P1029, DOI 10.1128/JB.116.2.1029-1053.1973; Hancock L.E., 2014, ENTEROCOCCI COMMENSA; HANDWERGER S, 1992, J BACTERIOL, V174, P5982, DOI 10.1128/jb.174.18.5982-5984.1992; HUGO WB, 1966, J PHARM PHARMACOL, V18, P569, DOI 10.1111/j.2042-7158.1966.tb07935.x; HUGO WB, 1964, J PHARM PHARMACOL, V16, P655, DOI 10.1111/j.2042-7158.1964.tb07384.x; HUGO WB, 1965, J PHARM PHARMACOL, V17, P28, DOI 10.1111/j.2042-7158.1965.tb07562.x; Komljenovic I, 2010, CHEM PHYS LIPIDS, V163, P480, DOI 10.1016/j.chemphyslip.2010.03.007; KOONTONGKAEW S, 1995, CARIES RES, V29, P413, DOI 10.1159/000262101; Kristich CJ, 2014, ANTIMICROB AGENTS CH, V58, P1556, DOI 10.1128/AAC.02001-13; Lebreton F, 2017, CELL, V169, P849, DOI 10.1016/j.cell.2017.04.027; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; LeDell Kathleen, 2003, Infection Control and Hospital Epidemiology, V24, P639, DOI 10.1086/502924; LIU JP, 1994, ANAL CHEM, V66, P2412, DOI 10.1021/ac00086a031; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; Mechler L, 2015, ANTIMICROB AGENTS CH, V59, P5366, DOI 10.1128/AAC.00643-15; MESSER J, 1992, FEMS MICROBIOL LETT, V94, P195; Munoz-Price LS, 2009, INFECT CONT HOSP EP, V30, P1031, DOI 10.1086/644751; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; NICAS TI, 1989, ANTIMICROB AGENTS CH, V33, P1121, DOI 10.1128/AAC.33.7.1121; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Rice LB, 2009, J BACTERIOL, V191, P3649, DOI 10.1128/JB.01834-08; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Smith JK, 2013, CLIN ORTHOP RELAT R, V471, P3158, DOI 10.1007/s11999-013-2988-5; The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKPOINT TABLES IN; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; van Dam V, 2007, MOL MICROBIOL, V64, P1105, DOI 10.1111/j.1365-2958.2007.05722.x; van der Aart LT, 2016, ANTIMICROB AGENTS CH, V60, P4930, DOI 10.1128/AAC.00276-16; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; van Heijenoort J, 1998, CELL MOL LIFE SCI, V54, P300, DOI 10.1007/s000180050155; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WILLIAMSON R, 1989, J INFECT DIS, V159, P1095, DOI 10.1093/infdis/159.6.1095; Woodford N, 1998, J MED MICROBIOL, V47, P849, DOI 10.1099/00222615-47-10-849; ZARLENGA LJ, 1992, ANTIMICROB AGENTS CH, V36, P902, DOI 10.1128/AAC.36.4.902	56	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249631	10.1371/journal.pone.0249631	http://dx.doi.org/10.1371/journal.pone.0249631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831063	Green Submitted, Green Published, gold			2022-12-26	WOS:000639359600062
J	Bonnet, M; Guedon, G; Pondaven, M; Bertolino, S; Padiolleau, D; Penisson, V; Gastinel, F; Angot, F; Renaud, PC; Fremy, A; Pays, O				Bonnet, Manon; Guedon, Gerald; Pondaven, Marc; Bertolino, Sandro; Padiolleau, Damien; Penisson, Vanessa; Gastinel, Francine; Angot, Fabien; Renaud, Pierre-Cyril; Fremy, Antonin; Pays, Olivier			Aquatic invasive alien rodents in Western France: Where do we stand today after decades of control?	PLOS ONE			English	Article							COYPU MYOCASTOR-COYPUS; ECOSYSTEM SERVICES; ERADICATION; MUSKRATS; BIODIVERSITY; WETLAND; EUROPE; IMPACT; UK	Two aquatic invasive alien rodents, the coypu (Myocastor coypus) and muskrat (Ondatra zibethicus), have taken over a significant amount of wetlands in France. Pays de la Loire is an administrative region of about 32 000 km(2) in the Western France with 6.3% of its area in wetlands (excluding the Loire River). Populations of coypus and muskrats are established and a permanent control programme has been set to reduce their impacts. The control plan is based on few professional trappers and many volunteers which makes this programme unique compared to other programme relying on professionals only. The aim of this study is to analyse the temporal and spatial dynamics of coypu and muskrat captures during the last 10 years to evaluate their effectiveness. The number of rodents removed per year increased by 50% in 10 years and reached about 288 000 individuals in 2016 with about 80% of them being coypus. During the same time length, the number of trappers involved in the programme also increased by 50% to reach 3 000 people in 2016. Although the raise of coypus and muskrats trapped can possibly be explained by an increase of the number of trappers, the number of coypus removed per trapper per year increased by 22%. Despite the outstanding number of individuals removed per year, our results suggest that the programme does not limit the population dynamics of coypus. Finally, since 2017, the number of data gathered from municipalities decreased, as did the total number of individuals trapped. Indeed, although rewards are crucial to recruit new volunteers, subsidies from local and regional authorities are declining. Decision makers and financers should be encouraged to fund this programme from the perspectives of the direct or indirect costs related to the presence of aquatic invasive alien rodents in wetlands.	[Bonnet, Manon; Renaud, Pierre-Cyril; Pays, Olivier] Univ Angers, LETG Angers, UMR 6554, CNRS, Angers, France; [Bonnet, Manon; Pays, Olivier] Nelson Mandela Univ, Univ Lyon 1, CNRS, REHABS Int Res Lab, George, South Africa; [Guedon, Gerald; Pondaven, Marc] Polleniz, Beaucouze, France; [Bertolino, Sandro] Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy; [Padiolleau, Damien] Polleniz 44, Grandchamp Des Fontaines, France; [Penisson, Vanessa] Polleniz 85, BP 141, La Roche Sur Yon, France; [Gastinel, Francine] Polleniz 53, Change, France; [Angot, Fabien] Polleniz 72, ZA Belle Croix, Requeil, France; [Fremy, Antonin] FDGDON 49, Beaucouze, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite d'Angers; Nelson Mandela University; University of Turin	Pays, O (corresponding author), Univ Angers, LETG Angers, UMR 6554, CNRS, Angers, France.; Pays, O (corresponding author), Nelson Mandela Univ, Univ Lyon 1, CNRS, REHABS Int Res Lab, George, South Africa.; Guedon, G (corresponding author), Polleniz, Beaucouze, France.	Gerald.GUEDON@polleniz.fr; olivier.pays@univ-angers.fr		Renaud, Pierre-Cyril/0000-0003-1776-4923	Polleniz	Polleniz	"Polleniz" provided support in the form of salaries for GG, MP, DP, VP, FG, FA and FDGDON49"for AF. Each departmental federation for pest control ("Polleniz 44", "Polleniz 85", "Polleniz 72", "Polleniz 53", and "FDGDON49") has communicated all captures from trappers from 2008 to 2019. "Polleniz" and "FDGDON49" did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ABBAS A, 1991, J ZOOL, V224, P385, DOI 10.1111/j.1469-7998.1991.tb06033.x; [Anonymous], 2017, IMPACT BIOL INVASION; Aubry P., 2016, GIBIER FAUNE SAUVAGE, V310, P1; Ayral F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228577; Bertolino S, 2005, WILDLIFE SOC B, V33, P714, DOI 10.2193/0091-7648(2005)33[714:EOCCIS]2.0.CO;2; Bertolino S, 2011, HYSTRIX, V22, P333, DOI 10.4404/Hystrix-22.2-4595; Bertolino S, 2010, BIOL INVASIONS, V12, P2549, DOI 10.1007/s10530-009-9664-4; Binimelis Rosa, 2007, V193, P331; Born W, 2005, ECOL ECON, V55, P321, DOI 10.1016/j.ecolecon.2005.08.014; Bos D, 2019, EUR J WILDLIFE RES, V65, DOI 10.1007/s10344-019-1279-1; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Bradshaw CJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12986; Braysher M., 1993, MANAGING VERTEBRATE, DOI [10.1038/bjc.1993.157, DOI 10.1038/BJC.1993.157]; Carter J, 2002, WILDLIFE SOC B, V30, P162; Charles Heather, 2007, V193, P217; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Curtet L., 2008, ONCFS FAUNE SAUVAGE, V280, P16; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Diggins TP, 2000, INT REV HYDROBIOL, V85, P505, DOI 10.1002/1522-2632(200008)85:4<505::AID-IROH505>3.3.CO;2-N; Doherty TS, 2016, P NATL ACAD SCI USA, V113, P11261, DOI 10.1073/pnas.1602480113; DONCASTER CP, 1990, HOLARCTIC ECOL, V13, P98; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Evans J., 1970, NUTR THEIR CONTROL; Gethoffee F, 2020, J WILDLIFE BIODIVERS, V4, P1, DOI 10.22120/jwb.2019.109875.1074; GOSLING LM, 1989, BIOL J LINN SOC, V38, P39, DOI 10.1111/j.1095-8312.1989.tb01561.x; Guillois Y, 2018, EUROSURVEILLANCE, V23, P12, DOI 10.2807/1560-7917.ES.2018.23.48.1700848; HOLMES RG, 1977, VET REC, V101, P74, DOI 10.1136/vr.101.4.74; Jones HP, 2016, P NATL ACAD SCI USA, V113, P4033, DOI 10.1073/pnas.1521179113; Jouventin P., 1996, BIOL METHODES LIMITA, DOI [10.1006/hbeh.1996.0031, DOI 10.1006/HBEH.1996.0031]; Kim YC, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11154169; Marini F, 2013, VIE MILIEU, V63, P97; Nummi P, 2006, BIOL INVASIONS, V8, P993, DOI 10.1007/s10530-005-1197-x; Panzacchi M, 2007, WILDLIFE BIOL, V13, P159, DOI 10.2981/0909-6396(2007)13[159:PCOCMC]2.0.CO;2; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pichon C, 2017, MALACO, V13, P3; Pinheiro J, R PACKAGE VERSION; Prigioni C, 2005, FOLIA ZOOL, V54, P269; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; R Core Team, 2020, R LANG ENV STAT COMP; REGGIANI G, 1995, ECOGRAPHY, V18, P138, DOI 10.1111/j.1600-0587.1995.tb00334.x; Robertson P.A., 2019, Occasional Papers of the IUCN Species Survival Commission, V62, P687; Ruys T, 2011, EUR J WILDLIFE RES, V57, P851, DOI 10.1007/s10344-011-0497-y; Schertler A, 2020, NEOBIOTA, P129, DOI 10.3897/neobiota.58.33118; Sheail J, 1999, J ENVIRON MANAGE, V55, P145, DOI 10.1006/jema.1998.0246; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sofia G, 2017, EARTH SURF PROC LAND, V42, P365, DOI 10.1002/esp.4081; Tourneur J, 2019, RONGEURS AQUATIQUES, P17; Turchi L, 2018, J APPL ENTOMOL, V142, P553, DOI 10.1111/jen.12515; Umhang G, 2013, VET PARASITOL, V197, P283, DOI 10.1016/j.vetpar.2013.05.003; Vander Zanden MJ, 2010, J GREAT LAKES RES, V36, P199, DOI 10.1016/j.jglr.2009.11.002; Vein J, 2014, EUR J WILDLIFE RES, V60, P125, DOI 10.1007/s10344-013-0758-z; Walsh JR, 2016, P NATL ACAD SCI USA, V113, P4081, DOI 10.1073/pnas.1600366113; Zuur Alain F., 2009, P1	55	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249904	10.1371/journal.pone.0249904	http://dx.doi.org/10.1371/journal.pone.0249904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831091	Green Published, gold			2022-12-26	WOS:000639359600038
J	Eythorsson, E; Asgeirsdottir, TL; Erlendsdottir, H; Hrafnkelsson, B; Kristinsson, KG; Haraldsson, A				Eythorsson, Elias; Asgeirsdottir, Tinna L.; Erlendsdottir, Helga; Hrafnkelsson, Birgir; Kristinsson, Karl G.; Haraldsson, Asgeir			The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis	PLOS ONE			English	Article							OTITIS-MEDIA; PNEUMONIA HOSPITALIZATIONS; CHILDHOOD IMMUNIZATION; ADMISSIONS; EFFICACY; CHILDREN; DISEASE; USA	Introduction Streptococcus pneumoniae is a cause of infections that range in severity from acute otitis media (AOM) to pneumonia and invasive pneumococcal disease (IPD). The 10-valent pneumococcal conjugate vaccine (PHiD-CV10) was introduced into the Icelandic paediatric immunisation programme in 2011. The aim was to estimate the population impact and cost-effectiveness of PHiD-CV10 introduction. Methods Data on primary care visits from 2005-2015 and hospitalisations from 2005-2017 were obtained from population-based registries. A Bayesian time series analysis with synthetic controls was employed to estimate the number of cases of AOM, pneumonia and IPD that would have occurred between 2013-2017, had PHiD-CV10 not been introduced. Prevented cases were calculated by subtracting the observed number of cases from this estimate. The cost of the programme was calculated accounting for cost-savings due to prevented cases. Results The introduction of PHiD-CV10 prevented 13,767 (95% credible interval [CI] 2,511-29,410) visits for AOM from 2013-2015, and prevented 1,814 (95%CI -523-4,512) hospitalisations for pneumonia and 53 (95%CI -17-177) admissions for IPD from 2013-2017. Visits for AOM decreased both among young children and among children 4-19 years of age, with rate ratios between 0.72-0.89. Decreases were observed in both pneumonia hospitalisations (rate ratios between 0.67-0.92) and IPD (rate ratios between 0.27-0.94). The total cost of implementing PHiD-CV10 in Iceland was -7,463,176 United States Dollars (USD) (95%CI -16,159,551-582,135) with 2.1 USD (95%CI 0.2-4.7) saved for every 1 USD spent. Conclusions The introduction of PHiD-CV10 was associated with large decreases in visits and hospitalisations for infections commonly caused by pneumococcus and was cost-saving during the first five years of the immunisation programme.	[Eythorsson, Elias; Erlendsdottir, Helga; Kristinsson, Karl G.; Haraldsson, Asgeir] Univ Iceland, Fac Med, Reykjavik, Iceland; [Asgeirsdottir, Tinna L.] Univ Iceland, Fac Econ, Reykjavik, Iceland; [Erlendsdottir, Helga; Kristinsson, Karl G.] Landspitali Natl Univ Hosp Iceland, Dept Clin Microbiol, Reykjavik, Iceland; [Hrafnkelsson, Birgir] Univ Iceland, Dept Math, Reykjavik, Iceland; [Haraldsson, Asgeir] Landspitali Natl Univ Hosp Iceland, Childrens Hosp Iceland, Reykjavik, Iceland	University of Iceland; University of Iceland; University of Iceland	Haraldsson, A (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.; Haraldsson, A (corresponding author), Landspitali Natl Univ Hosp Iceland, Childrens Hosp Iceland, Reykjavik, Iceland.	asgeir@landspitali.is		Haraldsson, Asgeir/0000-0001-5364-7877	GlaxoSmithKline Biologicals SA; Landspitali University Hospital Research Fund	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); Landspitali University Hospital Research Fund	An investigator-initiated study funded by GlaxoSmithKline Biologicals SA. The protocol was written and the study planned before any funding was requested. Additionally, a grant was received from the Landspitali University Hospital Research Fund. GlaxoSmithKline Biologicals SA was provided the opportunity to review a draft version of this manuscript, but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript.	Alicino C, 2017, VACCINE, V35, P5776, DOI 10.1016/j.vaccine.2017.09.005; Andrade AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184204; Ben-Shimol S, 2014, CLIN INFECT DIS, V59, P1724, DOI 10.1093/cid/ciu683; Berglund A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112211; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Bruhn CAW, 2017, P NATL ACAD SCI USA, V114, P1524, DOI 10.1073/pnas.1612833114; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; de Oliveira LH, 2021, CLIN INFECT DIS, V73, P306, DOI 10.1093/cid/ciaa614; Eythorsson E., 2017, PEDIAT INFECT DIS J, V1; Gray A., 2011, APPL METHODS COST EF; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Holubar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172414; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Lau WCY, 2015, VACCINE, V33, P5072, DOI 10.1016/j.vaccine.2015.08.022; Marom T, 2014, JAMA PEDIATR, V168, P68, DOI 10.1001/jamapediatrics.2013.3924; Nair H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1693-x; Newall AT, 2016, VACCINE, V34, P320, DOI 10.1016/j.vaccine.2015.11.053; Prymula R, 2011, VACCINE, V29, P1959, DOI 10.1016/j.vaccine.2010.12.086; Ray GT, 2009, VACCINE, V27, P6483, DOI 10.1016/j.vaccine.2009.08.045; Reyburn R, 2021, LANCET GLOB HEALTH, V9, pE91, DOI 10.1016/S2214-109X(20)30421-6; Saokaew S, 2016, PHARMACOECONOMICS, V34, P1211, DOI 10.1007/s40273-016-0439-3; Saxena S, 2015, J INFECTION, V71, P428, DOI 10.1016/j.jinf.2015.06.011; Shioda K., 2018, EPIDEMIOLOGY INTERNE, V4, P1; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Sigurdsson S, 2020, VACCINE, V38, P2707, DOI 10.1016/j.vaccine.2020.01.094; Sigurdsson S, 2018, CLIN INFECT DIS, V67, P1213, DOI 10.1093/cid/ciy233; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Taylor S, 2012, CLIN INFECT DIS, V54, P1765, DOI 10.1093/cid/cis292; Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657; Tsaban G, 2017, VACCINE, V35, P2882, DOI 10.1016/j.vaccine.2017.04.032; van de Vooren K, 2014, PHARMACOECONOMICS, V32, P29, DOI 10.1007/s40273-013-0113-y; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vojtek I, 2017, INT J PEDIATR OTORHI, V100, P174, DOI 10.1016/j.ijporl.2017.07.009; Warren JL, 2017, CLIN INFECT DIS, V65, P1813, DOI 10.1093/cid/cix638; Wu DBC, 2015, VACCINE, V33, P1633, DOI 10.1016/j.vaccine.2015.01.081	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249497	10.1371/journal.pone.0249497	http://dx.doi.org/10.1371/journal.pone.0249497			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831049	gold, Green Published			2022-12-26	WOS:000639359600025
J	Khan, ZA; Khan, L; Ahmad, S; Mumtaz, S; Jafar, M; Khan, Q				Khan, Zain Ahmad; Khan, Laiq; Ahmad, Saghir; Mumtaz, Sidra; Jafar, Muhammad; Khan, Qudrat			RBF neural network based backstepping terminal sliding mode MPPT control technique for PV system	PLOS ONE			English	Article							POWER POINT TRACKING; PHOTOVOLTAIC SYSTEM	The energy demand in the world has increased rapidly in the last few decades. This demand is arising the need for alternative energy resources. Solar energy is the most eminent energy resource which is completely free from pollution and fuel. However, the problem occurs when it comes to efficiency under different atmospheric conditions such as varying temperature and solar irradiance. To achieve its maximum efficiency, an algorithm of maximum power point tracking (MPPT) is needed to fetch maximum power from the photovoltaic (PV) system. In this article, a nonlinear backstepping terminal sliding mode control (BTSMC) is proposed for maximum power extraction. The system is finite-time stable and its stability is validated through the Lyapunov function. A DC-DC buck-boost converter is used to deliver PV power to the load. For the proposed controller, reference voltages are generated by a radial basis function neural network (RBF NN). The proposed controller performance is tested using the MATLAB/Simulink tool. Furthermore, the controller performance is compared with the perturb and observe (P&O) MPPT algorithm, Proportional Integral Derivative (PID) controller and backstepping MPPT nonlinear controller. The results validate that the proposed controller offers better tracking and fast convergence in finite time under rapidly varying conditions of the environment.	[Khan, Zain Ahmad; Ahmad, Saghir; Mumtaz, Sidra] COMSATS Univ Islamabad, Dept Elect & Comp Engn, Abbottabad Campus, Abbottabad, Pakistan; [Khan, Laiq] COMSATS Univ Islamabad, Dept Elect & Comp Engn, Islamabad, Pakistan; [Jafar, Muhammad] Natl Univ Comp & Emerging Sci Islamabad, Sch Elect Engn, Islamabad, Pakistan; [Khan, Qudrat] COMSATS Univ Islamabad, Ctr Adv Studies Telecommun, Islamabad, Pakistan	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Khan, L (corresponding author), COMSATS Univ Islamabad, Dept Elect & Comp Engn, Islamabad, Pakistan.	laiqkhan@comsats.edu.pk		khan, laiq/0000-0003-3659-3824				Ahmad El Khateb, 2011, 2011 IEEE INT EL MAC; Al-Gizi A, 2017, 2017 INTERNATIONAL CONFERENCE ON OPTIMIZATION OF ELECTRICAL AND ELECTRONIC EQUIPMENT (OPTIM) & 2017 INTL AEGEAN CONFERENCE ON ELECTRICAL MACHINES AND POWER ELECTRONICS (ACEMP), P642, DOI 10.1109/OPTIM.2017.7975041; Al-Gizi AG, 2017, INT SYMP ADV TOP, P703, DOI 10.1109/ATEE.2017.7905128; Belhachat F, 2018, RENEW SUST ENERG REV, V92, P513, DOI 10.1016/j.rser.2018.04.094; Besheer AH, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P693, DOI 10.1109/ICIT.2012.6210019; Bounechba H, 2014, ENRGY PROCED, V50, P677, DOI 10.1016/j.egypro.2014.06.083; Dahech K, 2017, ELECTR POW SYST RES, V143, P182, DOI 10.1016/j.epsr.2016.10.043; Ebrahimi Mostafa Jalalian, 2015, 2015 30 INT POW SYST; El-Helw HM, 2017, IEEE ACCESS, V5, P11900, DOI 10.1109/ACCESS.2017.2717540; El-Khozondar Hala J., 2016, Renewables: Wind, Water, and Solar, V3, DOI 10.1186/s40807-016-0022-8; Elgendy M. A., 2012, EVALUATION PERTURB O, P110; Guenounou O, 2014, ENERG CONVERS MANAGE, V78, P843, DOI 10.1016/j.enconman.2013.07.093; Kamarzaman NA, 2014, RENEW SUST ENERG REV, V37, P585, DOI 10.1016/j.rser.2014.05.045; Kharb RK, 2014, RENEW SUST ENERG REV, V33, P602, DOI 10.1016/j.rser.2014.02.014; Lyden S, 2015, RENEW SUST ENERG REV, V52, P1504, DOI 10.1016/j.rser.2015.07.172; Mamarelis E, 2014, IEEE T IND ELECTRON, V61, P3387, DOI 10.1109/TIE.2013.2279361; Martin AD, 2015, IEEE T ENERGY CONVER, V30, P1496, DOI 10.1109/TEC.2015.2431613; Mohamed Saad, 2016, 2016 WORLD S COMP AP; Naghmash, 2018, SOL ENERGY, V159, P134, DOI 10.1016/j.solener.2017.10.062; Ozdemir MT, 2017, ENERGIES, V10, DOI 10.3390/en10122134; Reisi AR, 2013, RENEW SUST ENERG REV, V19, P433, DOI 10.1016/j.rser.2012.11.052; REN21 Renewables, 2016, GLOBAL STATUS REPORT; Renaudineau H, 2015, IEEE T IND ELECTRON, V62, P1047, DOI 10.1109/TIE.2014.2336600; Saad W, 2018, INT J MODEL IDENTIF, V29, P118, DOI 10.1504/IJMIC.2018.090478; Sera D, 2013, IEEE J PHOTOVOLT, V3, P1070, DOI 10.1109/JPHOTOV.2013.2261118; Seyedmahmoudian M, 2016, RENEW SUST ENERG REV, V64, P435, DOI 10.1016/j.rser.2016.06.053; Smida Mouna Ben, 2015, 2015 7 INT C MOD ID; Sundareswaran K, 2016, IEEE T IND INFORM, V12, P187, DOI 10.1109/TII.2015.2502428; Tarek B, 2013, 2013 8TH INTERNATIONAL CONFERENCE AND EXHIBITION ON ECOLOGICAL VEHICLES AND RENEWABLE ENERGIES (EVER), DOI 10.1109/EVER.2013.6521559; Yang ZR, 2017, CHIN CONT DECIS CONF, P549, DOI 10.1109/CCDC.2017.7978154	30	6	6	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249705	10.1371/journal.pone.0249705	http://dx.doi.org/10.1371/journal.pone.0249705			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831094	gold, Green Published			2022-12-26	WOS:000639359600099
J	Kim, ES; Nam, SM; Song, HK; Lee, S; Kim, K; Lim, HK; Lee, H; Kang, KT; Kwon, YJ; Chun, YJ; Park, SY; Jung, J; Moon, A				Kim, Eun-Sook; Nam, Su-Min; Song, Hye Kyung; Lee, Seungeun; Kim, Kyoungmee; Lim, Hyun Kyung; Lee, Hyunsook; Kang, Kyu-Tae; Kwon, Yeo-Jung; Chun, Young-Jin; Park, So Yeon; Jung, Joohee; Moon, Aree			CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity	ONCOGENE			English	Article							NF-KAPPA-B; PROGENITOR CELLS; IN-VIVO; GENE-EXPRESSION; TUBE FORMATION; ANGIOGENESIS; METASTASIS; GROWTH; CD34; PROLIFERATION	Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with a poor prognosis for which no effective therapeutic measures are currently available. The present study aimed to investigate whether interactions with endothelial colony-forming cells (ECFCs) promote aggressive progression of TNBC cells. Herein, using an indirect co-culture system, we showed that co-culture increased the invasive and migratory phenotypes of both MDA-MB-231 TNBC cells and ECFCs. Through a cytokine antibody array and RT-PCR analysis, we revealed that co-culture markedly induced secretion of the chemokine C-C motif ligand (CCL)8 from ECFCs and that of interleukin (IL)-8 from MDA-MB-231 cells. CCL8 was crucial for ECFC-induced IL-8 secretion and invasion of MDA-MB-231 cells as well as for MDA-MB-231-enhanced MMP-2 secretion and angiogenesis of ECFCs. We suggest c-Jun as a transcription factor for CCL8-induced IL-8 expression in MDA-MB-231 cells. IL-8 was important for co-culture-induced CCL8 and MMP-2 upregulation and invasion of ECFCs. Notably, our findings reveal a positive feedback loop between CCL8 and IL-8, which contributes to the aggressive phenotypes of both ECFC and TNBC cells. Using an MDA-MB-231 cell-based xenograft model, we show that tumor growth and metastasis are increased by co-injected ECFCs in vivo. Increased expression of IL-8 was observed in tissues with bone metastases in mice injected with conditioned media from co-cultured cells. High IL-8 levels are correlated with poor recurrence-free survival in TNBC patients. Together, these results suggest that CCL8 and IL-8 mediate the crosstalk between ECFCs and TNBC, leading to aggravation of tumorigenicity in TNBC.	[Kim, Eun-Sook; Nam, Su-Min; Lee, Seungeun; Kim, Kyoungmee; Lim, Hyun Kyung; Lee, Hyunsook; Kang, Kyu-Tae; Jung, Joohee; Moon, Aree] Duksung Womens Univ, Coll Pharm, Duksung Innovat Drug Ctr, Seoul, South Korea; [Song, Hye Kyung] Duksung Womens Univ, Coll Chem, Seoul, South Korea; [Kwon, Yeo-Jung; Chun, Young-Jin] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Park, So Yeon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Coll Med, Seongnam, South Korea	Duksung Women's University; Duksung Women's University; Chung Ang University; Seoul National University (SNU)	Jung, J; Moon, A (corresponding author), Duksung Womens Univ, Coll Pharm, Duksung Innovat Drug Ctr, Seoul, South Korea.	joohee@duksung.ac.kr; armoon@duksung.ac.kr		Park, So Yeon/0000-0002-0299-7268	National Research Foundation of Korea [2016R1A6A1A03007648, 2019R1A2C1009773]	National Research Foundation of Korea(National Research Foundation of Korea)	The present study was supported by the National Research Foundation of Korea (no. 2016R1A6A1A03007648 and no. 2019R1A2C1009773).	Afshar Moghaddam Noushin, 2015, Iran J Pathol, V10, P89; An GL, 2019, ONCOL REP, V42, P2499, DOI 10.3892/or.2019.7344; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bianconi D, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920928635; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; CONNOLLY KM, 1993, J HISTOCHEM CYTOCHEM, V41, P1, DOI 10.1177/41.1.7678022; DELIA D, 1993, BLOOD, V81, P1001; Engels K, 1997, J PATHOL, V181, P207; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Farmaki E, 2016, ONCOGENE, V35, P6309, DOI 10.1038/onc.2016.161; Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fong YC, 2008, J BONE MINER RES, V23, P961, DOI 10.1359/JBMR.080206; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; Gomez-Cuadrado L, 2017, DIS MODEL MECH, V10, P1061, DOI 10.1242/dmm.030403; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Halama N, 2016, CANCER CELL, V29, P587, DOI 10.1016/j.ccell.2016.03.005; Halvorsen EC, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1150398; Hoffmann OI, 2015, J BIOTECHNOL, V205, P14, DOI 10.1016/j.jbiotec.2015.02.029; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Kivisto KT, 1995, BRIT J CLIN PHARMACO, V40, P523, DOI 10.1111/j.1365-2125.1995.tb05796.x; Kwon YH, 2012, BIOMOL THER, V20, P158, DOI 10.4062/biomolther.2012.20.2.158; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Le Bourhis X, 2010, BREAST CANCER RES TR, V120, P17, DOI 10.1007/s10549-009-0686-5; Lee HM, 2016, BIOMOL THER, V24, P62, DOI 10.4062/biomolther.2015.172; Lee H, 2018, KOREAN J PHYSIOL PHA, V22, P705, DOI 10.4196/kjpp.2018.22.6.705; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liu L, 2012, CARDIOVASC RES, V94, P3, DOI 10.1093/cvr/cvs108; MATTHEWS JR, 1995, INT J BIOCHEM CELL B, V27, P865, DOI 10.1016/1357-2725(95)00071-V; McKenney JK, 2001, AM J SURG PATHOL, V25, P1167, DOI 10.1097/00000478-200109000-00007; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Mencarelli A, 2013, TRANSL ONCOL, V6, P784, DOI 10.1593/tlo.13499; MIETTINEN M, 1994, MODERN PATHOL, V7, P82; Miller LJ, 1998, ANTICANCER RES, V18, P77; Neophytou C, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00031; Paschalaki KE, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00295; Riedlinger T, 2019, FASEB J, V33, P4188, DOI 10.1096/fj.201801638R; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Sato T, 2017, J CANCER, V8, P704, DOI 10.7150/jca.18027; Sicoli D, 2014, CANCER RES, V74, P7103, DOI 10.1158/0008-5472.CAN-14-0612; Singh JK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3436; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Snoussi K, 2006, HUM IMMUNOL, V67, P13, DOI 10.1016/j.humimm.2006.03.018; Snoussi K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-283; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Sunaga N, 2014, BRIT J CANCER, V110, P2047, DOI 10.1038/bjc.2014.110; Tsutsui Shinichi, 2003, Breast Cancer, V10, P312, DOI 10.1007/BF02967651; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Velasco-Velazquez M, 2012, CANCER RES, V72, P3839, DOI 10.1158/0008-5472.CAN-11-3917; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Yuan A, 2002, J CLIN ONCOL, V20, P900, DOI 10.1200/JCO.20.4.900; Zhang WW, 2018, FASEB J, V32, P276, DOI 10.1096/fj.201700237RR; Zhang X, 2020, LAB INVEST, V100, P619, DOI 10.1038/s41374-019-0345-3; Zhao K, 2018, CARCINOGENESIS, V39, P588, DOI 10.1093/carcin/bgy007; Zheng HC, 2006, ANTICANCER RES, V26, P3579; Zhou J, 2018, CELL BIOL INT, V42, P365, DOI 10.1002/cbin.10909	67	5	5	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3245	3259		10.1038/s41388-021-01758-w	http://dx.doi.org/10.1038/s41388-021-01758-w		APR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33833397				2022-12-26	WOS:000638023600001
J	Mahmud, R; Rassel, MA; Monayem, FB; Sayeed, SKJB; Islam, MS; Islam, MM; Yusuf, MA; Rahman, S; Islam, KMN; Mahmud, I; Hossain, MZ; Chowdhury, AH; Kabir, AKMH; Ahmed, KGU; Rahman, MM				Mahmud, Reaz; Rassel, Mohammad Aftab; Monayem, Farhana Binte; Sayeed, S. K. Jakaria Been; Islam, Md Shahidul; Islam, Mohammed Monirul; Yusuf, Mohammad Abdullah; Rahman, Sabrina; Islam, K. M. Nazmul; Mahmud, Imran; Hossain, Mohammad Zaid; Chowdhury, Ahmed Hossain; Kabir, A. K. M. Humayon; Ahmed, Kazi Gias Uddin; Rahman, Md Mujibur			Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh	PLOS ONE			English	Article								Background Globally, studies have shown conflicting results regarding the association of blood groups with SARS CoV-2 infection. Objective To observe the association between ABO blood groups and the presentation and outcomes of confirmed COVID-19 cases. Design, setting, and participants This was a prospective cohort study of patients with mild-to-moderately severe COVID-19 infections who presented in the COVID-19 unit of Dhaka Medical College Hospital and were enrolled between 01 June and 25 August, 2020. Patients were followed up for at least 30 days after disease onset. We grouped participants with A-positive and A-negative blood groups into group I and participants with other blood groups into group II. Results The cohort included 438 patients; 52 patients were lost to follow-up, five died, and 381 completed the study. The prevalence of blood group A [144 (32.9%)] was significantly higher among COVID-19 patients than in the general population (p < 0.001). The presenting age [mean (SD)] of group I [42.1 (14.5)] was higher than that of group II [38.8 (12.4), p = 0.014]. Sex (p = 0.23) and co-morbidity (hypertension, p = 0.34; diabetes, p = 0.13) did not differ between the patients in groups I and II. No differences were observed regarding important presenting symptoms, including fever (p = 0.72), cough (p = 0.69), and respiratory distress (p = 0.09). There was no significant difference in the median duration of symptoms in the two group (12 days), and conversion to the next level of severity was observed in 26 (20.6%) and 36 patients (13.8%) in group I and II, respectively. However, persistent positivity of RT-PCR at 14 days of initial positivity was more frequent among the patients in group I [24 (19%)] than among those in group II [29 (11.1%)]. Conclusions The prevalence of blood group A was higher among COVID-19 patients. Although ABO blood groups were not associated with the presentation or recovery period of COVID-19, patients with blood group A had delayed seroconversion.	[Mahmud, Reaz; Rassel, Mohammad Aftab; Chowdhury, Ahmed Hossain; Ahmed, Kazi Gias Uddin] Dhaka Med Coll, Dept Neurol, Dhaka, Bangladesh; [Monayem, Farhana Binte; Islam, Md Shahidul] Sarkari Karmachari Hosp, Dhaka, Bangladesh; [Sayeed, S. K. Jakaria Been; Rahman, Sabrina; Mahmud, Imran; Hossain, Mohammad Zaid; Kabir, A. K. M. Humayon; Rahman, Md Mujibur] Dhaka Med Coll, Dept Med, Dhaka, Bangladesh; [Islam, Mohammed Monirul] Minist Hlth & Family Planning Welf, Dhaka, Bangladesh; [Yusuf, Mohammad Abdullah] Natl Inst Neurosci & Hosp, Dept Microbiol, Dhaka, Bangladesh; [Islam, K. M. Nazmul] Shaheed Suhrawardy Med Coll, Dept Neurol, Dhaka, Bangladesh; [Sayeed, S. K. Jakaria Been] Natl Inst Neurosci & Hosp, Stroke Unit, Dhaka, Bangladesh; [Rahman, Md Mujibur] Bangabandhu Sheikh Mujib Med Univ, Dept Med, Shahbag, Bangladesh	Dhaka Medical College; Dhaka Medical College; Bangabandhu Sheikh Mujib Medical University (BSMMU)	Mahmud, R (corresponding author), Dhaka Med Coll, Dept Neurol, Dhaka, Bangladesh.	reazdmc22@yahoo.com	Mahmud, Reaz/AAO-8592-2021; Yusuf, Dr. Md. Abdullah/I-7968-2015	Been Sayeed, S K Jakaria/0000-0003-1173-4248; Islam, Md Shahidul/0000-0003-4712-4046; Yusuf, Dr. Md. Abdullah/0000-0002-8551-7185; Mahmud, Reaz/0000-0002-9427-1746				[Anonymous], 2020, PEDIATR MED RODZ; [Anonymous], 2020, NATL GUIDELINES CLIN; Dentali F, 2012, SEMIN THROMB HEMOST, V38, P535, DOI 10.1055/s-0032-1315758; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Goker H, 2020, TURK J MED SCI, V50, P679, DOI 10.3906/sag-2005-395; Guillon P, 2008, GLYCOBIOLOGY, V18, P1085, DOI 10.1093/glycob/cwn093; Jing WZ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034114; Karim S., 2015, J DHAKA MED COLL, V24, P53; Latz CA, 2020, ANN HEMATOL, V99, P2113, DOI 10.1007/s00277-020-04169-1; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Varughese S, 2015, EUR J EMERG MED, V22, P316, DOI 10.1097/MEJ.0000000000000285; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; World Health Organization, 2020, GCM TEL NOT REC; Zeng X., 2020, ASS ABO BLOOD GROUPS; Zhao J, 2020, CLIN INFECT DIS, DOI 10.1101/2020.03.11.20031096; Zietz M, 2020, TESTING ASS BLOOD TY	17	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249252	10.1371/journal.pone.0249252	http://dx.doi.org/10.1371/journal.pone.0249252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826648	Green Submitted, Green Published, gold			2022-12-26	WOS:000638119900023
J	Fukui, N; Yamamoto, H; Miyabe, M; Aoyama, Y; Hongo, K; Mizobata, T; Kawahata, I; Yabuki, Y; Shinoda, Y; Fukunaga, K; Kawata, Y				Fukui, Naoya; Yamamoto, Hanae; Miyabe, Moe; Aoyama, Yuki; Hongo, Kunihiro; Mizobata, Tomohiro; Kawahata, Ichiro; Yabuki, Yasushi; Shinoda, Yasuharu; Fukunaga, Kohji; Kawata, Yasushi			An alpha-synuclein decoy peptide prevents cytotoxic alpha-synuclein aggregation caused by fatty acid binding protein 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; LEWY BODIES; DEMENTIA; OLIGOMERS; INCLUSIONS; TOXICITY; MUTANTS	alpha-synuclein (alpha Syn) is a protein known to form intracellular aggregates during the manifestation of Parkinson's disease. Previously, it was shown that aSyn aggregation was strongly suppressed in the midbrain region of mice that did not possess the gene encoding the lipid transport protein fatty acid binding protein 3 (FABP3). An interaction between these two proteins was detected in vitro, suggesting that FABP3 may play a role in the aggregation and deposition of aSyn in neurons. To characterize the molecular mechanisms that underlie the interactions between FABP3 and aSyn that modulate the cellular accumulation of the latter, in this report, we used in vitro fluorescence assays combined with fluorescence microscopy, transmission electron microscopy, and quartz crystal microbalance assays to characterize in detail the process and consequences of FABP3-alpha Syn interaction. We demonstrated that binding of FABP3 to aSyn results in changes in the aggregation mechanism of the latter; specifically, a suppression of fibrillar forms of alpha Syn and also the production of aggregates with an enhanced cytotoxicity toward mice neuro2A cells. Because this interaction involved the C-terminal sequence region of alpha Syn, we tested a peptide derived from this region of alpha Syn (alpha SynP130-140) as a decoy to prevent the FABP3-alpha Syn interaction. We observed that the peptide competitively inhibited binding of alpha Syn to FABP3 in vitro and in cultured cells. We propose that administration of alpha SynP130-140 might be used to prevent the accumulation of toxic FABP3-alpha Syn oligomers in cells, thereby preventing the progression of Parkinson's disease.	[Fukui, Naoya; Yamamoto, Hanae; Miyabe, Moe; Aoyama, Yuki; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Dept Chem & Biotechnol, Fac Engn, Grad Sch Engn, Tottori, Japan; [Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori, Japan; [Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori, Japan; [Kawahata, Ichiro; Yabuki, Yasushi; Shinoda, Yasuharu; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan	Tottori University; Tottori University; Tottori University; Tohoku University	Kawata, Y (corresponding author), Tottori Univ, Dept Chem & Biotechnol, Fac Engn, Grad Sch Engn, Tottori, Japan.; Kawata, Y (corresponding author), Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori, Japan.; Kawata, Y (corresponding author), Tottori Univ, Ctr Res Green Sustainable Chem, Tottori, Japan.	kawata@tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Kawahata, Ichiro/N-4414-2019; Shinoda, Yasuharu/AAE-6135-2019; Fukunaga, Kohji/AAI-8811-2021	Kawahata, Ichiro/0000-0002-5916-7847; Shinoda, Yasuharu/0000-0001-9910-048X; Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Agency for Medical Research and Development, AMED [JP20dm0107073, JP20dm0107071]; Joint Usage/Research Center for Developmental Medicine, IMEG, Kumamoto University	Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Joint Usage/Research Center for Developmental Medicine, IMEG, Kumamoto University	This study was supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED (Grant No. JP20dm0107073 to Y. K. and JP20dm0107071 to K. F.) and partially supported by funding from the Joint Usage/Research Center for Developmental Medicine, IMEG, Kumamoto University.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Baba M, 1998, AM J PATHOL, V152, P879; Basmaciyan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187756; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Cheng A, 2019, BRAIN RES, V1707, P190, DOI 10.1016/j.brainres.2018.11.036; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Dasari AKR, 2019, BIOCHEMISTRY-US, V58, P2814, DOI 10.1021/acs.biochem.9b00215; GLATZ JFC, 1993, PROSTAG LEUKOTR ESS, V48, P33, DOI 10.1016/0952-3278(93)90007-J; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hirose M, 2013, J SYNCHROTRON RADIAT, V20, P923, DOI 10.1107/S0909049513021298; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Izawa Y, 2012, BRAIN BEHAV, V2, P595, DOI 10.1002/brb3.86; Kameda H, 2017, J BIOCHEM, V161, P55, DOI 10.1093/jb/mvw052; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Kawahata I, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010049; Kawahata I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215358; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Matsuo K, 2021, BRAIN RES, V1760, DOI 10.1016/j.brainres.2021.147383; Matsuo K, 2019, NEUROPHARMACOLOGY, V150, P164, DOI 10.1016/j.neuropharm.2019.03.029; Matsuoka S, 2015, ANGEW CHEM INT EDIT, V54, P1508, DOI 10.1002/anie.201409830; Menke T, 2003, BIOFACTORS, V18, P65, DOI 10.1002/biof.5520180208; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Nishiwaki H, 2020, MOVEMENT DISORD, V35, P1626, DOI 10.1002/mds.28119; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Prinsen CFM, 1996, BIOCHEM J, V314, P253, DOI 10.1042/bj3140253; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Remple Krissy, 2011, J Vis Exp, DOI 10.3791/3659; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shioda N, 2014, J BIOL CHEM, V289, P18957, DOI 10.1074/jbc.M113.527341; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Sorrentino ZA, 2020, J BIOL CHEM, V295, P10224, DOI 10.1074/jbc.REV120.011743; Sorrentino ZA, 2018, J BIOL CHEM, V293, P18914, DOI 10.1074/jbc.RA118.005603; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tan MC, 2014, BIOORGAN MED CHEM, V22, P1804, DOI 10.1016/j.bmc.2014.02.001; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van der Wateren IM, 2018, CHEM SCI, V9, P5506, DOI 10.1039/c8sc01109e; Wada-Isoe K, 2008, J NEUROL SCI, V266, P20, DOI 10.1016/j.jns.2007.08.018; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xin W, 2015, BIOMOLECULES, V5, P1634, DOI 10.3390/biom5031634; Yabuki Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062230; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yamamoto H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010047; Yamamoto T, 2009, BIOTECHNOL LETT, V31, P1695, DOI 10.1007/s10529-009-0065-7; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541; Zimmerman AW, 1999, BIOCHEM J, V344, P495, DOI 10.1042/0264-6021:3440495	60	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100663	10.1016/j.jbc.2021.100663	http://dx.doi.org/10.1016/j.jbc.2021.100663			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862084	Green Published, gold			2022-12-26	WOS:000672866400634
J	Nguyen, RH; Vater, LB; Timsina, LR; Durm, GA; Rupp, K; Wright, K; Spitznagle, MH; Paul, B; Jalal, SI; Carter-Harris, L; Hudmon, KS; Hanna, NH; Loehrer, PJ; Ceppa, DP				Nguyen, Ryan H.; Vater, Laura B.; Timsina, Lava R.; Durm, Gregory A.; Rupp, Katelin; Wright, Keylee; Spitznagle, Miranda H.; Paul, Brandy; Jalal, Shadia, I; Carter-Harris, Lisa; Hudmon, Karen S.; Hanna, Nasser H.; Loehrer, Patrick J.; Ceppa, DuyKhanh P.			Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence	PLOS ONE			English	Article							CIGARETTE-SMOKING	Background Smoke-free ordinances (SFO) have been shown to be effective public health interventions, but there is limited data on the impact SFO on lung cancer outcomes. We explored the effect of county-level SFO strength with smoking prevalence and lung cancer incidence in Indiana. Methods We obtained county-level lung cancer incidence from the Indiana State Cancer Registry and county-level characteristics from the Indiana Tobacco Prevention and Cessation Commission's policy database between 1995 and 2016. Using generalized estimating equations, we performed multivariable analyses of smoking prevalence and age-adjusted lung cancer rates with respect to the strength of smoke-free ordinances at the county level over time. Results Of Indiana's 92 counties, 24 had a SFO by 2011. In 2012, Indiana enacted a state-wide SFO enforcing at least moderate level SFO protection. Mean age-adjusted lung cancer incidence per year was 76.8 per 100,000 population and mean smoking prevalence per year was 25% during the study period. Counties with comprehensive or moderate SFO had a smoking prevalence 1.2% (95% CI [-1.88, -0.52]) lower compared with counties with weak or no SFO. Counties that had comprehensive or moderate SFO also had an 8.4 (95% CI [-11.5, -5.3]) decrease in new lung cancer diagnosis per 100,000 population per year compared with counties that had weak or no SFO. Conclusion Counties with stronger smoke-free air ordinances were associated with decreased smoking prevalence and fewer new lung cancer cases per year. Strengthening SFO is paramount to decreasing lung cancer incidence.	[Nguyen, Ryan H.; Vater, Laura B.; Durm, Gregory A.; Jalal, Shadia, I; Hanna, Nasser H.; Loehrer, Patrick J.] Indiana Univ Sch Med, Dept Internal Med, Indianapolis, IN 46202 USA; [Timsina, Lava R.; Ceppa, DuyKhanh P.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Durm, Gregory A.; Jalal, Shadia, I; Hudmon, Karen S.; Hanna, Nasser H.; Loehrer, Patrick J.; Ceppa, DuyKhanh P.] Indiana Univ Hlth Simon Canc Ctr, Indianapolis, IN USA; [Rupp, Katelin; Wright, Keylee; Spitznagle, Miranda H.; Paul, Brandy] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Carter-Harris, Lisa] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Hudmon, Karen S.] Purdue Univ, Coll Pharm, Dept Pharm Practice, W Lafayette, IN 47907 USA; [Nguyen, Ryan H.] Univ Illinois, Dept Med, Chicago, IL 60607 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Memorial Sloan Kettering Cancer Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nguyen, RH (corresponding author), Indiana Univ Sch Med, Dept Internal Med, Indianapolis, IN 46202 USA.; Nguyen, RH (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	rnguye8@uic.edu	Timsina, Lava/AFR-2241-2022	Vater, Laura/0000-0002-5920-9576; Timsina, Lava/0000-0001-7493-5843; Nguyen, Ruby/0000-0002-6598-8457; Nguyen, Ryan/0000-0002-8863-6649				Azagba S, 2020, AM J PREV MED, V58, P97, DOI 10.1016/j.amepre.2019.08.025; Centers for Disease Control and Prevention NCfCDPaHP Division of Population Health, 2015, STAT SCH IMM REQ VAC; Commission TPaC, 2018, STATE FISCAL YEAR 20; Group USCSW. U.S, 2017, CANC STAT DATA VISUA; Hahn EJ, 2008, PREV MED, V47, P206, DOI 10.1016/j.ypmed.2008.04.009; Hahn EJ, 2018, CANCER-AM CANCER SOC, V124, P374, DOI 10.1002/cncr.31142; Hahn EJ, 2014, AM J PUBLIC HEALTH, V104, P1059, DOI 10.2105/AJPH.2014.301887; IARC, 2009, MONOGRAPHS EVALUATIO; Jamal A, 2018, MMWR-MORBID MORTAL W, V67, P53, DOI 10.15585/mmwr.mm6702a1; Lortet-Tieulent J, 2016, JAMA INTERN MED, V176, P1792, DOI 10.1001/jamainternmed.2016.6530; Mackay DF, 2011, POSTGRAD MED J, V87, P311, DOI 10.1136/pgmj.2010.199026rep; McGhee S M, 2014, Hong Kong Med J, V20, P36; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONS SMOK 50 YE; Pierannunzi C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-49; Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Xu X, 2015, AM J PREV MED, V48, P326, DOI 10.1016/j.amepre.2014.10.012	17	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250285	10.1371/journal.pone.0250285	http://dx.doi.org/10.1371/journal.pone.0250285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RP1DH	33861796	Green Published, gold			2022-12-26	WOS:000641475400012
J	Sullenberger, C; Hoffman, B; Wiedeman, J; Kumar, G; Mensa-Wilmot, K				Sullenberger, Catherine; Hoffman, Benjamin; Wiedeman, Justin; Kumar, Gaurav; Mensa-Wilmot, Kojo			Casein kinase TbCK1.2 regulates division of kinetoplast DNA, and movement of basal bodies in the African trypanosome	PLOS ONE			English	Article							MITOCHONDRIAL GENOME SEGREGATION; GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN IMPORT; CELL-CYCLE; CARTWHEEL PROTEIN; BRUCEI REVEALS; BODY MOVEMENTS; REPLICATION; CENTRIOLE; FLAGELLUM	The single mitochondrial nucleoid (kinetoplast) of Trypanosoma brucei is found proximal to a basal body (mature (mBB)/probasal body (pBB) pair). Kinetoplast inheritance requires synthesis of, and scission of kinetoplast DNA (kDNA) generating two kinetoplasts that segregate with basal bodies into daughter cells. Molecular details of kinetoplast scission and the extent to which basal body separation influences the process are unavailable. To address this topic, we followed basal body movements in bloodstream trypanosomes following depletion of protein kinase TbCK1.2 which promotes kinetoplast division. In control cells we found that pBBs are positioned 0.4 um from mBBs in G1, and they mature after separating from mBBs by at least 0.8 um: mBB separation reaches similar to 2.2 um. These data indicate that current models of basal body biogenesis in which pBBs mature in close proximity to mBBs may need to be revisited. Knockdown of TbCK1.2 produced trypanosomes containing one kinetoplast and two nuclei (1K2N), increased the percentage of cells with uncleaved kDNA 400%, decreased mBB spacing by 15%, and inhibited cytokinesis 300%. We conclude that (a) separation of mBBs beyond a threshold of 1.8 um correlates with division of kDNA, and (b) TbCK1.2 regulates kDNA scission. We propose a Kinetoplast Division Factor hypothesis that integrates these data into a pathway for biogenesis of two daughter mitochondrial nucleoids.	[Sullenberger, Catherine; Hoffman, Benjamin; Wiedeman, Justin; Kumar, Gaurav; Mensa-Wilmot, Kojo] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Mensa-Wilmot, Kojo] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30061 USA; [Mensa-Wilmot, Kojo] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; Kennesaw State University; University System of Georgia; University of Georgia	Mensa-Wilmot, K (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.; Mensa-Wilmot, K (corresponding author), Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30061 USA.; Mensa-Wilmot, K (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	kojo.mensawilmot@kennesaw.edu			NIH [R01 AI126311]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grant #R01 AI126311 to KM-W and M.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Andre J, 2014, J BIOL CHEM, V289, P464, DOI 10.1074/jbc.M113.509521; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Banterle N, 2017, ANNU REV CELL DEV BI, V33, P23, DOI 10.1146/annurev-cellbio-100616-060454; Bauer S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005333; Benz C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17779-z; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; Cheng TS, 2008, J BIOL CHEM, V283, P2454, DOI 10.1074/jbc.M706794200; Cho YS, 2020, GENE DEV, V34, P53, DOI 10.1101/gad.333146.119; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; Dang HQ, 2017, MBIO, V8, DOI [10.1128/mBio.02120-16, 10.1128/mbio.02120-16]; Dayde D, 2016, ONCOGENE, V35, P3986, DOI 10.1038/onc.2015.480; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2016, P NATL ACAD SCI USA, V113, pE5135, DOI 10.1073/pnas.1604258113; Dewar CE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007195; Dionyssiou MG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.58; Dittmann K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189087; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Fujita H, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1075643; Gerbeth C, 2013, CELL METAB, V18, P578, DOI 10.1016/j.cmet.2013.09.006; Gilda JE, 2015, METHODS MOL BIOL, V1295, P381, DOI 10.1007/978-1-4939-2550-6_27; Gluenz E, 2011, MOL CELL BIOL, V31, P1012, DOI 10.1128/MCB.01176-10; Goos C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181884; Greer YE, 2014, MOL BIOL CELL, V25, P1629, DOI 10.1091/mbc.E13-10-0598; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Guo GL, 2019, J BIOL RHYTHM, V34, P482, DOI 10.1177/0748730419865406; Gupta A, 2018, J BIOCHEM, V164, P1, DOI 10.1093/jb/mvy031; Guyett PJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01865-16; Guyett PJ, 2016, ACS INFECT DIS, V2, P518, DOI 10.1021/acsinfecdis.6b00077; Harbauer AB, 2014, SCIENCE, V346, P1109, DOI 10.1126/science.1261253; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; HOEIJMAKERS JHJ, 1980, PLASMID, V4, P97, DOI 10.1016/0147-619X(80)90086-4; Hoffmann A, 2018, P NATL ACAD SCI USA, V115, pE1809, DOI 10.1073/pnas.1716582115; Hu HQ, 2015, EUKARYOT CELL, V14, P898, DOI 10.1128/EC.00083-15; Jay J, 2015, MOL CELL BIOL, V35, P111, DOI 10.1128/MCB.01138-14; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; LaBella ML, 2020, DEV CELL, V52, P88, DOI [10.1016/j.devcel.2019.12.005, 10.1016/j.devcel.2020.03.007]; Lacomble S, 2010, J CELL SCI, V123, P2884, DOI 10.1242/jcs.074161; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Mensa-Wilmot K, 2019, TRENDS PARASITOL, V35, P119, DOI 10.1016/j.pt.2018.11.002; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Neumann M, 2011, ONCOGENE, V30, P2485, DOI 10.1038/onc.2010.580; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Novak ZA, 2016, DEV CELL, V37, P545, DOI 10.1016/j.devcel.2016.05.022; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Park ES, 2000, MOL ENDOCRINOL, V14, P662, DOI 10.1210/mend.14.5.0458; Povelones ML, 2014, MOL BIOCHEM PARASIT, V196, P53, DOI 10.1016/j.molbiopara.2014.03.008; Rao S, 2012, MOL BIOL CELL, V23, P1618, DOI 10.1091/mbc.E11-11-0933; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Sanderson Michael J, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.top071795; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Schnarwiler F, 2014, P NATL ACAD SCI USA, V111, P7624, DOI 10.1073/pnas.1404854111; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Schneider A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221820; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shukla A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9077; Straub SP, 2016, BIOL CHEM, V397, P1097, DOI 10.1515/hsz-2016-0145; Sullenberger C, 2017, MOL PHARMACOL, V91, P482, DOI 10.1124/mol.116.106906; Sundaram S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50197-x; Thomis DC, 1999, J IMMUNOL, V163, P5411; Timms MW, 2002, MOL BIOL CELL, V13, P3747, DOI 10.1091/mbc.E02-05-0266; Traxler P, 2004, CANCER RES, V64, P4931, DOI 10.1158/0008-5472.CAN-03-3681; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Urbaniak MD, 2009, MOL BIOCHEM PARASIT, V166, P183, DOI 10.1016/j.molbiopara.2009.03.001; Vaughan Sue, 2015, Cilia, V5, P5, DOI 10.1186/s13630-016-0023-7; Vertii Anastassiia, 2016, Cilia, V5, P13, DOI 10.1186/s13630-016-0030-8; Wang JY, 2012, MOL MICROBIOL, V83, P471, DOI 10.1111/j.1365-2958.2011.07938.x; Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; Yadav SP, 2016, DEVELOPMENT, V143, P1491, DOI 10.1242/dev.130120; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388; Zhao Z, 2008, EMBO J, V27, P143, DOI 10.1038/sj.emboj.7601956; Zhou Q, 2015, MOL MICROBIOL, V98, P667, DOI 10.1111/mmi.13149; Zitouni S, 2016, CURR BIOL, V26, P1127, DOI 10.1016/j.cub.2016.03.055	90	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249908	10.1371/journal.pone.0249908	http://dx.doi.org/10.1371/journal.pone.0249908			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861760	gold, Green Published			2022-12-26	WOS:000641475400060
J	Rezende, MSD; de Almeida, AJPO; Goncalves, TAF; de Azevedo, FDAA; Dantas, SH; Silva, SD; Soares, EMC; Alves, HF; Lima, TT; de Souza, JF; Guerra, RR; Araujo, IGA; de Medeiros, IA				de Almeida Rezende, Mathania Silva; Pontes Oliveira de Almeida, Arthur Jose; Felisberto Goncalves, Tays Amanda; Assuncao Araujo de Azevedo, Fatima de Lourdes; Dantas, Sabine Helena; Silva, Sonaly de Lima; Cardoso Soares, Evyllen Myllena; Alves, Hayaly Felinto; Lima, Thais Trajano; Frederico de Souza Junior, Javanyr; Guerra, Ricardo Romao; Albuquerque Araujo, Islania Giselia; de Medeiros, Isac Almeida			D-(+)-Galactose-induced aging: A novel experimental model of erectile dysfunction	PLOS ONE			English	Article							D-GALACTOSE; VITAMIN-E; SMOOTH-MUSCLE; RATS; OXIDASE; LIVER; HEART	Erectile dysfunction (ED) is defined as the inability to achieve and/or maintain penile erection sufficient for satisfactory sexual relations, and aging is one of the main risk factors involved. The D-(+)-Galactose aging model is a consolidated methodology for studies of cardiovascular aging; however, its potential for use with ED remain unexplored. The present study proposed to characterize a new experimental model for ED, using the D-(+)-Galactose aging model. For the experiments, the animals were randomly divided into three groups receiving: vehicle (CTL), D-galactose 150 mg/kg (DGAL), and D-(+)-galactose 150 mg/Kg + sildenafil 1.5 mg/Kg (DGAL+SD1.5) being administered daily for a period of eight weeks. All of the experimental protocols were previously approved by the Ethics Committee on the Use of Animals at the Federal University of Paraiba n degrees 9706070319. During the treatment, we analyzed physical, molecular, and physiological aspects related to the aging process and implicated in the development of ED. Our findings demonstrate for the first time that D-(+)-Galactose-induced aging represents a suitable experimental model for ED assessment. This was evidenced by an observed hyper-contractility in corpora cavernosa, significant endothelial dysfunction, increased ROS levels, an increase in cavernous tissue senescence, and the loss of essential penile erectile components.	[de Almeida Rezende, Mathania Silva; Felisberto Goncalves, Tays Amanda; Assuncao Araujo de Azevedo, Fatima de Lourdes; de Medeiros, Isac Almeida] Univ Fed Paraiba, Ctr Ciencias Saude, Programa Posgrad Prod Nat & Sintet Bioativos, Joao Pessoa, Paraiba, Brazil; [Pontes Oliveira de Almeida, Arthur Jose; Silva, Sonaly de Lima] Univ Fed Paraiba, Ctr Ciencias Saude, Programa Posgrad Desenvolvimento & Inovacao Tecno, Joao Pessoa, Paraiba, Brazil; [Dantas, Sabine Helena; Albuquerque Araujo, Islania Giselia] Univ Fed Paraiba, Ctr Ciencias Saude, Programa Mestrado Profiss Gerontol, Joao Pessoa, Paraiba, Brazil; [Cardoso Soares, Evyllen Myllena; Alves, Hayaly Felinto; Lima, Thais Trajano; Frederico de Souza Junior, Javanyr] Univ Fed Paraiba, Ctr Ciencias Saude, Joao Pessoa, Paraiba, Brazil; [Guerra, Ricardo Romao] Univ Fed Paraiba, Ctr Ciencias Agr, Dept Ciencias Veterinarias, Areia, Paraiba, Brazil	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba	de Medeiros, IA (corresponding author), Univ Fed Paraiba, Ctr Ciencias Saude, Programa Posgrad Prod Nat & Sintet Bioativos, Joao Pessoa, Paraiba, Brazil.	isac.ufpb@gmail.com	de Souza Júnior, Javanyr Frederico/AAQ-9213-2021; de Medeiros, Isac Almeida/C-5784-2013	de Souza Júnior, Javanyr Frederico/0000-0003-0029-3352; de Medeiros, Isac Almeida/0000-0001-8783-4806; Dantas, Sabine Helena/0000-0001-8724-3029; Jose Pontes Oliveira de Almeida, Arthur/0000-0003-2501-3249	CAPES [88887507825/202000]; CNPQ [427783/2016-0]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Mathania Silva de Almeida Rezende received a scholarship from CAPES (process number 88887507825/202000) Isac Almeida de Medeiros received grant from CNPQ (process number 427783/2016-0).	Akhvlediani ND., UROLOGIIA MOSCOW RUS, V2018, P142; Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Angulo J, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101271; Aversa A, 2010, INT J UROL, V17, P38, DOI 10.1111/j.1442-2042.2009.02426.x; Aydin K, 2018, ANDROLOGIA, V50, DOI 10.1111/and.13062; Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y; Bakircioglu ME, 2001, J UROLOGY, V166, P734, DOI 10.1016/S0022-5347(05)66052-1; Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472; Calabro A, 1996, EUR UROL, V29, P240; Cardoso A, 2015, REJUV RES, V18, P497, DOI 10.1089/rej.2015.1684; Chang YM, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/2624384; Chen WK, 2018, AGING-US, V10, P4166, DOI 10.18632/aging.101714; Cho MC, 2018, SEX MED REV, V6, P572, DOI 10.1016/j.sxmr.2018.02.007; Claudino MA, 2010, UROLOGY, V75, P961, DOI 10.1016/j.urology.2009.05.098; Correa LBNS, 2017, INT J MORPHOL, V35, P1043; Dehghani A, 2019, AGING CLIN EXP RES, V31, P1195, DOI 10.1007/s40520-018-1075-x; Diaz-Diaz E, 2012, ERECTILE DYSFUNCTION, P69; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Echeverri Tirado Laura C, 2016, Sex Med Rev, V4, P63, DOI 10.1016/j.sxmr.2015.10.011; Foldvari M, 1998, UROLOGY, V52, P838, DOI 10.1016/S0090-4295(98)00299-4; Gokce MI, 2017, TURK J UROL, V43, P247, DOI 10.5152/tud.2017.70482; Guo B, 2020, BIOGERONTOLOGY, V21, P311, DOI 10.1007/s10522-020-09859-x; Gur S, 2008, EXPERT OPIN INV DRUG, V17, P855, DOI 10.1517/13543784.17.6.855 ; Helmy MM, 2012, LIFE SCI, V90, P489, DOI 10.1016/j.lfs.2011.12.019; Jing L, 2019, MOLECULES, V24, DOI 10.3390/molecules24183364; Kessler A, 2019, BJU INT, V124, P587, DOI 10.1111/bju.14813; Kim SW, 2019, UROLOGY, V131, P136, DOI 10.1016/j.urology.2019.06.005; Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181; Lafuente-Sanchis A, 2014, ANDROLOGY-US, V2, P537, DOI 10.1111/j.2047-2927.2014.00213.x; Leal MAS, 2020, VASC PHARMACOL, V124, DOI 10.1016/j.vph.2019.106601; Li WJ, 2011, J SEX MED, V8, P400, DOI 10.1111/j.1743-6109.2010.01724.x; Li X, 2016, BIOL TRACE ELEM RES, V173, P433, DOI 10.1007/s12011-016-0681-8; Ma YJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8938207; McMurray G, 2006, BRIT J PHARMACOL, V147, pS62, DOI 10.1038/sj.bjp.0706630; Ni YH, 2018, ENDOCR J, V65, P569, DOI [10.1507/endocrj.ej17-0500, 10.1507/endocrj.EJ17-0500]; Omidi M, 2019, INT J REPROD BIOMED, V17, P789, DOI 10.18502/ijrm.v17i10.5486; de Almeida AJPO, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7941563; Sadigh-Eteghad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184122; Sheweita S, 2015, TOXICOL REP, V2, P933, DOI 10.1016/j.toxrep.2015.06.002; Silva FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166291; Silva GC, 2017, EXP GERONTOL, V93, P7, DOI 10.1016/j.exger.2017.04.006; Tao MF, 2017, INT BRAZ J UROL, V43, P753, DOI [10.1590/S1677-5538.IBJU.2016.0454, 10.1590/s1677-5538.ibju.2016.0454]; WESPES E, 1991, J UROLOGY, V146, P1015, DOI 10.1016/S0022-5347(17)37990-9; Wespes E, 1997, J UROLOGY, V157, P1678, DOI 10.1016/S0022-5347(01)64833-X; Wu C, 2016, EXPERT OPIN DRUG DIS, V11, P185, DOI 10.1517/17460441.2016.1126243; Wu W, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5707830; Yafi FA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.3; Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371; Zheng SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59055-7	49	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249487	10.1371/journal.pone.0249487	http://dx.doi.org/10.1371/journal.pone.0249487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857158	Green Published, gold			2022-12-26	WOS:000641474900005
J	Khan, A; Kumam, W; Khan, I; Saeed, A; Gul, T; Kumam, P; Ali, I				Khan, Arshad; Kumam, Wiyada; Khan, Imran; Saeed, Anwar; Gul, Taza; Kumam, Poom; Ali, Ishtiaq			Chemically reactive nanofluid flow past a thin moving needle with viscous dissipation, magnetic effects and hall current	PLOS ONE			English	Article							BOUNDARY-LAYER; HEAT-TRANSFER; THERMAL-RADIATION; POROUS-MEDIUM; BLASIUS; FLUIDS; WATER; FLUX	This work addresses the ability to manage the distribution of heat transmission for fluid flow occurs upon a paraboloid thin shaped hot needle by using hybrid nanoparticles containing Copper Oxide (CuO) and Silver (Ag) with water as pure fluid. The needle is placed horizontally in nanofluid with an application of Hall current and viscous dissipation. The popular Buongiorno model has employed in the current investigation in order to explore the impact of Brownian and thermophoretic forces exerted by the fluid. The modeled equations with boundary conditions are transformed to non-dimensional form by incorporating a suitable group of similarity variables. This set of ordinary differential equations is then solved by employing homotopy analysis method (HAM). After detail study of the current work, it has established that the flow of fluid reduces with growth in magnetic effects and volume fractions of nanoparticles. Thermal characteristics increase with augmentation of Eckert number, magnetic field, volume fractions of nanoparticles, Brownian motion parameter and decline with increase in Prandtl number. Moreover, concentration of nanoparticles reduces with corresponding growth in Lewis number and thermophoresis, chemical reaction parameters while increases with growth in Brownian motion parameter.	[Khan, Arshad] Natl Univ Sci & Technol NUST, Coll Aeronaut Engn, Islamabad, Pakistan; [Kumam, Wiyada] Rajamangala Univ Technol Thanyaburi, Fac Sci & Technol, Dept Math & Comp Sci, Program Appl Stat, Pathum Thani, Thailand; [Khan, Imran] Bacha Khan Univ, Dept Math & Stat, Khyber, Pakhtunkhwa, Pakistan; [Saeed, Anwar] Abdul Wali Khan Univ, Dept Math, Khyber, Pakhtunkhwa, Pakistan; [Gul, Taza] City Univ Sci & Informat Technol, Dept Math, Peshawar, KP, Pakistan; [Kumam, Poom] King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Ctr Excellence Theoret & Computat Sci TaCS CoE, Bangkok, Thailand; [Kumam, Poom] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Ali, Ishtiaq] King Faisal Univ, Coll Sci, Dept Math & Stat, Hafouf, Al Ahsa, Saudi Arabia	National University of Sciences & Technology - Pakistan; Rajamangala University of Technology Thanyaburi; King Mongkuts University of Technology Thonburi; China Medical University Taiwan; China Medical University Hospital - Taiwan; King Faisal University	Kumam, P (corresponding author), King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Ctr Excellence Theoret & Computat Sci TaCS CoE, Bangkok, Thailand.; Kumam, P (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	poom.kum@kmutt.ac.th	Saeed, Anwar/ABB-5007-2021; Kumam, Poom/E-7122-2011	Saeed, Anwar/0000-0003-1566-6457; Kumam, Poom/0000-0002-5463-4581	Center of Excellence in Theoretical and Computational Science(TaCS-CoE), KMUTT; Thailand Science Research and Innovation (TSRI) Basic Research Fund [64A306000005]	Center of Excellence in Theoretical and Computational Science(TaCS-CoE), KMUTT; Thailand Science Research and Innovation (TSRI) Basic Research Fund	The authors acknowledge the financial support provided by the Center of Excellence in Theoretical and Computational Science (TaCS-CoE), KMUTT. Moreover, this research project is supported by Thailand Science Research and Innovation (TSRI) Basic Research Fund: Fiscal year 2021 under project number 64A306000005.	Ahmad R, 2017, CHINESE J PHYS, V55, P1264, DOI 10.1016/j.cjph.2017.07.004; Al-Hossainy AF, 2021, SURF INTERFACES, V23, DOI 10.1016/j.surfin.2021.100971; Al-Hossainy AF, 2020, J MATER SCI-MATER EL, V31, P15243, DOI 10.1007/s10854-020-04089-w; Alaidrous AA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71543-4; Alotaibi H, 2021, CMC-COMPUT MATER CON, V66, P229, DOI 10.32604/cmc.2020.012234; Choi SUS., 1995, DEV APPL NONNEWTONIA, V6, P99; Eid MR, 2021, WAVE RANDOM COMPLEX, DOI 10.1080/17455030.2021.1873455; Eid MR, 2022, WAVE RANDOM COMPLEX, V32, P1103, DOI 10.1080/17455030.2020.1810365; Eid MR, 2020, PHYSICA A, V540, DOI 10.1016/j.physa.2019.123063; Eid MR., 2020, P I MECH ENG PART C; Farooq U, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20090668; Ghiasi E.K., 2019, CFD LETT, V11, P40; Hamid A, 2020, J MATER RES TECHNOL, V9, P11220, DOI 10.1016/j.jmrt.2020.07.070; Hayat T, 2016, J MOL LIQ, V224, P786, DOI 10.1016/j.molliq.2016.10.069; Hayat T, 2017, RESULTS PHYS, V7, P2317, DOI 10.1016/j.rinp.2017.06.034; Khan M, 2016, INT J HEAT MASS TRAN, V101, P570, DOI 10.1016/j.ijheatmasstransfer.2016.05.056; Khan MI, 2017, J COLLOID INTERF SCI, V498, P85, DOI 10.1016/j.jcis.2017.03.024; Khan WA, 2020, APPL NANOSCI, V10, P3161, DOI 10.1007/s13204-019-01067-5; Khan WA, 2019, APPL PHYS A-MATER, V125, DOI 10.1007/s00339-019-2686-6; Khan WA, 2019, PRAMANA-J PHYS, V92, DOI 10.1007/s12043-018-1678-y; Khan WA, 2019, J BRAZ SOC MECH SCI, V41, DOI 10.1007/s40430-018-1482-0; Khan WA, 2017, J MOL LIQ, V234, P201, DOI 10.1016/j.molliq.2017.03.078; Khan WA, 2019, INT J NUMER METHOD H, V29, P4624, DOI 10.1108/HFF-01-2019-0066; Khan WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105107; Krishna PM, 2017, NUCL ENG TECHNOL, V49, P1654, DOI 10.1016/j.net.2017.07.023; LEE LL, 1967, PHYS FLUIDS, V10, P820, DOI 10.1063/1.1762194; Liao SJ, 2003, J FLUID MECH, V488, P189, DOI 10.1017/S0022112003004865; Liao SJ, 1999, INT J NONLINEAR MECH, V34, P759, DOI 10.1016/S0020-7462(98)00056-0; Mabood F, 2016, ADV POWDER TECHNOL, V27, P742, DOI 10.1016/j.apt.2016.02.033; Mabood F, 2019, EUR PHYS J PLUS, V134, DOI 10.1140/epjp/i2019-12716-9; Makinde OD, 2016, J MOL LIQ, V221, P733, DOI 10.1016/j.molliq.2016.06.047; Mishra A, 2019, SPEC TOP REV POROUS, V10, P171, DOI 10.1615/SpecialTopicsRevPorousMedia.2018026706; NARAIN JP, 1972, J HEAT TRANSF, V94, P240, DOI 10.1115/1.3449910; Narain JP., 1972, PHYS FLUIDS, V15, P928, DOI [10.1063/1.1694001, DOI 10.1063/1.1694001]; Raju SS, 2019, MICROSYST TECHNOL, V25, P3399, DOI 10.1007/s00542-019-04340-3; Ramzan M, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10020432; Soid SK, 2017, APPL THERM ENG, V114, P58, DOI 10.1016/j.applthermaleng.2016.11.165; Sulochana C, 2018, ALEX ENG J, V57, P2559, DOI 10.1016/j.aej.2017.08.020; Upreti H., 2019, MULTIDISCIP MODEL MA; Waini I, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8040612; Waini I, 2019, INT J NUMER METHOD H, V29, P4875, DOI 10.1108/HFF-04-2019-0277	41	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249264	10.1371/journal.pone.0249264	http://dx.doi.org/10.1371/journal.pone.0249264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857175	Green Published, gold			2022-12-26	WOS:000641474900106
J	Kumar, S; Deshpande, PA				Kumar, Shashi; Deshpande, Parag A.			Structural and thermodynamic analysis of factors governing the stability and thermal folding/unfolding of SazCA	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; ALPHA-CARBONIC ANHYDRASE; CRYSTAL-STRUCTURE; HYDRATION WATER; PH-DEPENDENCE; PROTEINS; THERMOSTABILITY; TEMPERATURE; MECHANISM; PATHWAY	Molecular basis of protein stability at different temperatures is a fundamental problem in protein science that is substantially far from being accurately and quantitatively solved as it requires an explicit knowledge of the temperature dependence of folding free energy of amino acid residues. In the present study, we attempted to gain insights into the thermodynamic stability of SazCA and its implications on protein folding/unfolding. We report molecular dynamics simulations of water solvated SazCA in a temperature range of 293-393 K to study the relationship between the thermostability and flexibility. Our structural analysis shows that the protein maintains the highest structural stability at 353 K and the protein conformations are highly flexible at temperatures above 353 K. Larger exposure of hydrophobic surface residues to the solvent medium for conformations beyond 353 K were identified from H-bond analysis. Higher number of secondary structure contents exhibited by SazCA at 353 K corroborated the conformations at 353 K to exhibit the highest thermal stability. The analysis of thermodynamics of protein stability revealed that the conformations that denature at higher melting temperatures tend to have greater maximum thermal stability. Our analysis shows that 353 K conformations have the highest melting temperature, which was found to be close to the experimental optimum temperature. The enhanced protein stability at 353 K due the least value of heat capacity at unfolding suggested an increase in folding. Comparative Gibbs free energy analysis and funnel shaped energy landscape confirmed a transition in folding/unfolding pathway of SazCA at 353 K.	[Kumar, Shashi; Deshpande, Parag A.] Indian Inst Technol Kharagpur, Dept Chem Engn, Quantum & Mol Engn Lab, Kharagpur, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Deshpande, PA (corresponding author), Indian Inst Technol Kharagpur, Dept Chem Engn, Quantum & Mol Engn Lab, Kharagpur, W Bengal, India.	parag@che.iitkgp.ac.in		Deshpande, Parag Arvind/0000-0002-2445-5873	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR7054/BID/7422/2012]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/PR7054/BID/7422/2012) awarded to PAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Akdemir A, 2013, BIOORG MED CHEM LETT, V23, P1087, DOI 10.1016/j.bmcl.2012.12.009; Ali SA, 2014, CURR PROTEIN PEPT SC, V15, P456, DOI 10.2174/1389203715666140327114232; Alterio V, 2014, SUBCELL BIOCHEM, V75, P387, DOI 10.1007/978-94-007-7359-2_19; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bharatiy SK, 2016, ACS OMEGA, V1, P1081, DOI 10.1021/acsomega.6b00041; Boone CD, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030553; Capasso C, 2015, J ENZYM INHIB MED CH, V30, P325, DOI 10.3109/14756366.2014.910202; Capasso C, 2012, J ENZYM INHIB MED CH, V27, P892, DOI 10.3109/14756366.2012.703185; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen XF, 2008, J PHYS CHEM B, V112, P12073, DOI 10.1021/jp802795a; Daniel RM, 2010, BIOCHEM J, V425, P353, DOI 10.1042/BJ20091254; De Luca V, 2013, BIOORGAN MED CHEM, V21, P1465, DOI 10.1016/j.bmc.2012.09.047; De Simone G, 2015, BIOORG MED CHEM LETT, V25, P2002, DOI 10.1016/j.bmcl.2015.02.068; Di Fiore A, 2015, INT J MOL SCI, V16, P15456, DOI 10.3390/ijms160715456; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fisher Z, 2012, PROTEIN ENG DES SEL, V25, P347, DOI 10.1093/protein/gzs027; Folch B, 2008, J CHEM INF MODEL, V48, P119, DOI 10.1021/ci700237g; Folch B, 2010, BIOPHYS J, V98, P667, DOI 10.1016/j.bpj.2009.10.050; Gromiha MM, 2001, BIOPHYS CHEM, V91, P71, DOI 10.1016/S0301-4622(01)00154-5; HAWLEY SA, 1971, BIOCHEMISTRY-US, V10, P2436, DOI 10.1021/bi00789a002; Higo J, 2002, J COMPUT CHEM, V23, P1323, DOI 10.1002/jcc.10100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAGANNADHAM MV, 1985, FEBS LETT, V188, P326, DOI 10.1016/0014-5793(85)80396-3; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; KARARLI T, 1984, ANN NY ACAD SCI, V429, P129, DOI 10.1111/j.1749-6632.1984.tb12323.x; Kean KM, 2018, PROTEIN SCI, V27, P573, DOI 10.1002/pro.3347; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kumar S, 2021, PROTEINS, V89, P375, DOI 10.1002/prot.26022; Lee KJ, 2012, J CHEM INF MODEL, V52, P7, DOI 10.1021/ci200184y; Liljas A, 2000, EMBO REP, V1, P16, DOI 10.1093/embo-reports/kvd016; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; LOUNNAS V, 1994, BIOPHYS J, V66, P601, DOI 10.1016/S0006-3495(94)80835-5; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Matthes D, 2009, BIOPHYS J, V97, P599, DOI 10.1016/j.bpj.2009.04.061; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Nakasako M, 1999, J MOL BIOL, V289, P547, DOI 10.1006/jmbi.1999.2795; Nishimori I, 2008, CURR PHARM DESIGN, V14, P622, DOI 10.2174/138161208783877875; Paquet E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183918; Peterson ME, 2007, BIOCHEM J, V402, P331, DOI 10.1042/BJ20061143; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pokhrel R, 2019, PHYS CHEM CHEM PHYS, V21, P12530, DOI 10.1039/c9cp01558b; Prabhu N, 2006, CHEM REV, V106, P1616, DOI 10.1021/cr040437f; Prakash A, 2018, J BIOMOL STRUCT DYN, V36, P2391, DOI 10.1080/07391102.2017.1355847; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Pucci F, 2017, BIOINFORMATICS, V33, P3415, DOI 10.1093/bioinformatics/btx417; Pucci F, 2016, J BIOMOL STRUCT DYN, V34, P1132, DOI 10.1080/07391102.2015.1073631; Pucci F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003689; Purkiss A, 2001, PHILOS T R SOC A, V359, P1515, DOI 10.1098/rsta.2001.0863; Raschke TM, 2006, CURR OPIN STRUC BIOL, V16, P152, DOI 10.1016/j.sbi.2006.03.002; Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101; Roberts BC, 2008, J CHEM INF MODEL, V48, P397, DOI 10.1021/ci700285e; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Smith KS, 1999, P NATL ACAD SCI USA, V96, P15184, DOI 10.1073/pnas.96.26.15184; Smith MD, 2015, J CHEM INF MODEL, V55, P2587, DOI 10.1021/acs.jcim.5b00308; Supuran CT, 2016, BIOCHEM J, V473, P2023, DOI 10.1042/BCJ20160115; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Villafuerte FC, 2009, BIOPHYS J, V96, p625A, DOI 10.1016/j.bpj.2008.12.3305; WELLS JW, 1979, BIOCHEMISTRY-US, V18, P1989, DOI 10.1021/bi00577a022; ZHENG YJ, 1992, J AM CHEM SOC, V114, P10498, DOI 10.1021/ja00052a054	65	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249866	10.1371/journal.pone.0249866	http://dx.doi.org/10.1371/journal.pone.0249866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857217	Green Published, gold			2022-12-26	WOS:000641474900046
J	Ma, ZL; Zhang, FM; Ma, HX; Chen, XH; Yang, JQ; Yang, YY; Yang, XY; Tian, XJ; Yu, QL; Ma, ZR; Zhou, XY				Ma, Zuolin; Zhang, Fumei; Ma, Hongxin; Chen, Xinghao; Yang, Jiaqing; Yang, Yiyan; Yang, Xueying; Tian, Xiaojing; Yu, Qunli; Ma, Zhongren; Zhou, Xueyan			Effects of different types and doses of whey protein on the physiological and intestinal flora in D-galactose induced aging mice	PLOS ONE			English	Article							RISK-FACTORS; FAT; AGE; POLYSACCHARIDE; BACTERIA; DISEASES; ISOLATE; DIET	The elderly usually suffer from many diseases. Improving the quality of life of the elderly is an urgent social issue. In this present study, D-galactose treated aging mice models were used to reveal the effects of different animal sources and different doses of whey protein (WP) on the immune indexes organs and intestinal flora. A total of 9 groups were set up, including normal control (NC), negative control (NS), positive control (Vc), low-, medium- and high-doses of cow WP intervention groups (CL, CM and CH for short, correspondingly) and low-, medium- and high-doses of goat WP intervention groups (GL, GM and GH for short, correspondingly). The body weight gain, thymus/body weight ratio, superoxide dismutase (SOD) activity, malondialdehyde (MDA) content, spleen immunoglobulins G (IgG), spleen interleukin-2 (IL-2) and spleen interleukin-2 (IL-6) were measured. Then, the intestinal contents were collected, and 16s genes of intestinal bacteria were sequenced to reveal the changes in bacterial flora structure. WP intervention significantly increased the weight gain, thymus/body ratio and SOD activity, but decrease the content of MDA. WP intervention increased some immune indicators. All the WP treated aging mice showed similar values of physiological indexes to that of the Vc group, even better. The relative abundance of Lactobacillus and Stenotrophomonas was increased and decreased, respectively, by both cow and goat WP. Lactobacillus may be involved in regulating the functional repair of organisms. In contrast, Stenotrophomonas might play a negative role in the immune and antioxidant capacity of the body. Combining physiological indicators and intestinal flora structure, low-concentration WP for cow and goat might be optimal for aging models.	[Ma, Zuolin; Yu, Qunli] Gansu Agr Univ, Coll Food Sci & Engn, Lanzhou, Gansu, Peoples R China; [Zhang, Fumei; Ma, Hongxin; Chen, Xinghao; Yang, Jiaqing; Yang, Yiyan; Yang, Xueying; Tian, Xiaojing; Ma, Zhongren; Zhou, Xueyan] Northwest Minzu Univ, Biomed Res Ctr, China Malaysia Natl Joint Lab, Lanzhou, Gansu, Peoples R China; [Zhang, Fumei; Tian, Xiaojing; Ma, Zhongren; Zhou, Xueyan] Gannan Res Inst Yak Milk, Hezuo, Gansu, Peoples R China; [Zhang, Fumei] Northwest Minzu Univ, Dept Med, Lanzhou, Gansu, Peoples R China; [Ma, Hongxin; Chen, Xinghao; Yang, Jiaqing; Yang, Yiyan; Yang, Xueying; Tian, Xiaojing; Ma, Zhongren; Zhou, Xueyan] Northwest Minzu Univ, Coll Life Sci & Engn, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University; Northwest Minzu University; Northwest Minzu University; Northwest Minzu University	Yu, QL (corresponding author), Gansu Agr Univ, Coll Food Sci & Engn, Lanzhou, Gansu, Peoples R China.; Ma, ZR (corresponding author), Northwest Minzu Univ, Biomed Res Ctr, China Malaysia Natl Joint Lab, Lanzhou, Gansu, Peoples R China.; Ma, ZR (corresponding author), Gannan Res Inst Yak Milk, Hezuo, Gansu, Peoples R China.	yuqunlisci@163.com; mzr@xbmu.edu.cn			Fundamental Research Funds for the Central Universities [31920190022]; Gansu province Science and Technology funding plan [17YF1WA166]; Ministry of Science and Technology Assistance Project [KY201501005]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Gansu province Science and Technology funding plan; Ministry of Science and Technology Assistance Project	This research was funded by the Fundamental Research Funds for the Central Universities through Project 31920190022, Gansu province Science and Technology funding plan through Project 17YF1WA166, and Ministry of Science and Technology Assistance Project through Project KY201501005. The funder had no role in study design, data collection and analysis, decision to publish.	Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3760; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P2913, DOI 10.1210/jc.2006-0609; Brimelow RE, 2017, CRIT REV FOOD SCI, V57, P1593, DOI 10.1080/10408398.2014.995264; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Chen YJ, 2020, FOOD FUNCT, V11, P153, DOI [10.1039/C9FO01740B, 10.1039/c9fo01740b]; Chowdhury MI, 2017, J TRACE ELEM MED BIO, V39, P162, DOI 10.1016/j.jtemb.2016.09.012; Cronin O, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00044-18; Cui HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19185; Dore J, 2013, UNITED EUR GASTROENT, V1, P311, DOI 10.1177/2050640613502477; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Evans JM, 2013, J ENDOCRINOL, V218, pR37, DOI 10.1530/JOE-13-0131; Fooks LJ, 2002, FEMS MICROBIOL ECOL, V39, P67, DOI 10.1111/j.1574-6941.2002.tb00907.x; FOX JG, 1995, J CLIN MICROBIOL, V33, P445, DOI 10.1128/JCM.33.2.445-454.1995; Gunnarsson PT, 2006, ENDOCRINOLOGY, V147, P3173, DOI 10.1210/en.2005-1442; Guo W, 2010, APPL BIOCHEM BIOTECH, V161, P124, DOI 10.1007/s12010-009-8857-8; Hackney KJ, 2010, MED SCI SPORT EXER, V42, P998, DOI 10.1249/MSS.0b013e3181c12976; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8; Jaul E, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00335; Kwa ALH, 2008, ANN ACAD MED SINGAP, V37, P826; Lan-Pidhainy X, 2010, AM J CLIN NUTR, V91, P98, DOI 10.3945/ajcn.2009.28125; Lancha AH, 2017, AMINO ACIDS, V49, P33, DOI 10.1007/s00726-016-2355-4; Liu LQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020506; McAllan L, 2013, BRIT J NUTR, V110, P2114, DOI 10.1017/S0007114513001396; Mortensen LS, 2009, AM J CLIN NUTR, V90, P41, DOI 10.3945/ajcn.2008.27281; Morton RW, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00245; Nacher-Vazquez M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02281; NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638; Pacheco Bertoldo MT., 2005, CIENCIA TECNOLOGIA A, DOI [10.1590/s0101-20612005000200026, DOI 10.1590/S0101-20612005000200026]; Pal S, 2010, ATHEROSCLEROSIS, V212, P339, DOI 10.1016/j.atherosclerosis.2010.05.032; Petersen BL, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-47; Pilvi TK, 2007, BRIT J NUTR, V98, P900, DOI 10.1017/S0007114507764760; Reimer RA, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700484; Sanchez-Moya T, 2017, FOOD FUNCT, V8, P3053, DOI [10.1039/c7fO00197e, 10.1039/C7FO00197E, 10.1039/c7fo00197e]; Sousa GTD, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-67; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Takasaki K, 2004, J PHARMACOL SCI, V95, P291, DOI 10.1254/jphs.SC0040043; Theilmann MC, 2017, MBIO, V8, DOI [10.1128/mBio.01421-17, 10.1128/mbio.01421-17]; Wang HY, 2016, INT J IMMUNOPATH PH, V29, P376, DOI 10.1177/0394632016634348; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Yamni N., 2017, NURS TIMES; Zannini E, 2016, APPL MICROBIOL BIOT, V100, P1121, DOI 10.1007/s00253-015-7172-2; ZHENG Zhichang CY., 2018, FOOD SCI, V39, P297, DOI [10.7506/spkx1002-6630-201801045, DOI 10.7506/SPKX1002-6630-201801045]	46	6	6	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248329	10.1371/journal.pone.0248329	http://dx.doi.org/10.1371/journal.pone.0248329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857162	Green Published, gold			2022-12-26	WOS:000641474900017
J	Sadamoto, H; Takahashi, H; Kobayashi, S; Kondoh, H; Tokumaru, H				Sadamoto, Hisayo; Takahashi, Hironobu; Kobayashi, Suguru; Kondoh, Hirooki; Tokumaru, Hiroshi			Identification and classification of innexin gene transcripts in the central nervous system of the terrestrial slug Limax valentianus	PLOS ONE			English	Article							GAP-JUNCTION CHANNEL; CIRCULAR RNAS; LYMNAEA-STAGNALIS; PROLINE RESIDUE; NITRIC-OXIDE; CONNEXIN; PROTEIN; PHOSPHORYLATION; MECHANISM; REVEALS	Intercellular gap junction channels and single-membrane channels have been reported to regulate electrical synapse and the brain function. Innexin is known as a gap junction-related protein in invertebrates and is involved in the formation of intercellular gap junction channels and single-cell membrane channels. Multiple isoforms of innexin protein in each species enable the precise regulation of channel function. In molluscan species, sequence information of innexins is still limited and the sequences of multiple innexin isoforms have not been classified. This study examined the innexin transcripts expressed in the central nervous system of the terrestrial slug Limax valentianus and identified 16 transcripts of 12 innexin isoforms, including the splicing variants. We performed phylogenetic analysis and classified the isoforms with other molluscan innexin sequences. Next, the phosphorylation, N-glycosylation, and S-nitrosylation sites were predicted to characterize the innexin isoforms. Further, we identified 16 circular RNA sequences of nine innexin isoforms in the central nervous system of Limax. The identification and classification of molluscan innexin isoforms provided novel insights for understanding the regulatory mechanism of innexin in this phylum.	[Sadamoto, Hisayo; Kobayashi, Suguru; Kondoh, Hirooki; Tokumaru, Hiroshi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus, Sanuki City, Kagawa, Japan; [Takahashi, Hironobu] Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro Cho, Tokushima, Japan	Tokushima Bunri University; Tokushima Bunri University	Sadamoto, H (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus, Sanuki City, Kagawa, Japan.	sadamotoh@kph.bunri-u.ac.jp		Takahashi, Hironobu/0000-0003-0045-7716; Sadamoto, Hisayo/0000-0003-1838-0649	Tokushima Bunri University; Japan Society for the Promotion of Science [JP20K06750]	Tokushima Bunri University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	HS, HT1, SK and HT2 were supported by Tokushima Bunri University. SK was supported by Grants-in-Aid for KAKENHI from the Japan Society for the Promotion of Science (No. JP20K06750).	Al Deen NN, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00192; Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Bai DL, 2018, BBA-BIOMEMBRANES, V1860, P9, DOI 10.1016/j.bbamem.2017.07.003; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Beyer EC, 2018, BBA-BIOMEMBRANES, V1860, P5, DOI 10.1016/j.bbamem.2017.05.016; Bhattacharya A, 2019, CELL, V176, P1174, DOI 10.1016/j.cell.2018.12.024; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boyce AKJ, 2018, BBA-BIOMEMBRANES, V1860, P72, DOI 10.1016/j.bbamem.2017.03.004; Cai HM, 2019, SCI DATA, V6, DOI 10.1038/sdata.2019.22; Calkins TL, 2015, COMP BIOCHEM PHYS B, V183, P11, DOI 10.1016/j.cbpb.2014.11.013; D'hondt C, 2013, BIOL CELL, V105, P373, DOI 10.1111/boc.201200096; Dudekulay DB, 2016, RNA BIOL, V13, P34, DOI 10.1080/15476286.2015.1128065; Dyakonova VE, 2015, J EXP BIOL, V218, P1151, DOI 10.1242/jeb.111930; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; Ermentrout B, 2004, J COMPUT NEUROSCI, V17, P365, DOI 10.1023/B:JCNS.0000044877.21949.44; Esseltine JL, 2016, TRENDS CELL BIOL, V26, P944, DOI 10.1016/j.tcb.2016.06.003; FERGUSON GP, 1991, J EXP BIOL, V158, P63; Fujie S, 2002, ZOOL SCI, V19, P15, DOI 10.2108/zsj.19.15; Fujisaki Y, 2017, ZOOL SCI, V34, P532, DOI 10.2108/zs170071; Gelperin A, 1996, J NEUROBIOL, V30, P110, DOI 10.1002/(SICI)1097-4695(199605)30:1<110::AID-NEU10>3.0.CO;2-Q; Gong XQ, 2013, J CELL SCI, V126, P3113, DOI 10.1242/jcs.123430; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Kaji H, 2007, MOL CELL PROTEOMICS, V6, P2100, DOI 10.1074/mcp.M600392-MCP200; Kanemitsu MY, 1998, CELL GROWTH DIFFER, V9, P13; Kasai Y, 2006, LEARN MEMORY, V13, P482, DOI 10.1101/lm.257606; Katz PS, 2019, CURR OPIN NEUROBIOL, V56, P1, DOI 10.1016/j.conb.2018.10.009; Kelmanson IV, 2002, EUR J NEUROSCI, V16, P2475, DOI 10.1046/j.1460-9568.2002.02423.x; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402, DOI 10.1152/jn.1994.72.3.1402; Kobayashi S, 2000, NEUROSCI RES, V38, P27, DOI 10.1016/S0168-0102(00)00136-X; Kotini M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06368-x; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Liu CH, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy101; Lohman AW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397976; Lowenthal MS, 2016, J PROTEOME RES, V15, P2087, DOI 10.1021/acs.jproteome.5b00733; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mersman BA, 2020, FRONT SYNAPTIC NEURO, V12, DOI 10.3389/fnsyn.2020.00001; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Oshima A, 2017, MICROSCOPY-JPN, V66, P371, DOI 10.1093/jmicro/dfx035; Oshima A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13681; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Panchin YV, 2005, J EXP BIOL, V208, P1415, DOI 10.1242/jeb.01547; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Pirger Z, 2014, CURR BIOL, V24, P2018, DOI [10.1016/j.cub.2014.07.044, 10.1016/j.cub.2014.09.024]; Pogoda K, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0099-3; Ragan C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37037-0; Retamal MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1356, DOI 10.1152/ajpcell.00054.2009; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; ROSE RM, 1979, J EXP BIOL, V80, P137; Rothwell CM, 2017, J NEUROPHYSIOL, V117, P692, DOI 10.1152/jn.00737.2016; Sadamoto H, 1998, NEUROSCI RES, V32, P57, DOI 10.1016/S0168-0102(98)00066-2; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Sakura M, 2004, NEUROSCI LETT, V370, P257, DOI 10.1016/j.neulet.2004.08.025; Sanchez-Pupo RE, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071837; Smyth JW, 2013, CELL REP, V5, P611, DOI 10.1016/j.celrep.2013.10.009; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Staras K, 1998, J NEUROSCI, V18, P3669; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Turnbull MW., 2014, AUTHOR S PERSONAL CO; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; Welzel G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30966-w; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Yabumoto T, 2008, LEARN MEMORY, V15, P229, DOI 10.1101/lm.936508; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	75	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0244902	10.1371/journal.pone.0244902	http://dx.doi.org/10.1371/journal.pone.0244902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857131	Green Submitted, Green Published			2022-12-26	WOS:000641474900061
J	Fassy, J; Lacoux, C; Leroy, S; Noussair, L; Hubac, S; Degoutte, A; Vassaux, G; Leclercq, V; Rouquie, D; Marquette, CH; Rottman, M; Touron, P; Lemoine, A; Herrmann, JL; Barbry, P; Nahon, JL; Zaragosi, LE; Mari, B				Fassy, Julien; Lacoux, Caroline; Leroy, Sylvie; Noussair, Latifa; Hubac, Sylvain; Degoutte, Aurelien; Vassaux, Georges; Leclercq, Vianney; Rouquie, David; Marquette, Charles-Hugo; Rottman, Martin; Touron, Patrick; Lemoine, Antoinette; Herrmann, Jean-Louis; Barbry, Pascal; Nahon, Jean-Louis; Zaragosi, Laure-Emmanuelle; Mari, Bernard			Versatile and flexible microfluidic qPCR test for high-throughput SARS-CoV-2 and cellular response detection in nasopharyngeal swab samples	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; EXTRACTION; MICRORNAS; COVID-19; ASSAY	The emergence and quick spread of SARS-CoV-2 has pointed at a low capacity response for testing large populations in many countries, in line of material, technical and staff limitations. The traditional RT-qPCR diagnostic test remains the reference method and is by far the most widely used test. These assays are limited to a few probe sets, require large sample PCR reaction volumes, along with an expensive and time-consuming RNA extraction step. Here we describe a quantitative nanofluidic assay that overcomes some of these shortcomings, based on the Biomark(TM) instrument from Fluidigm. This system offers the possibility of performing 4608 qPCR end-points in a single run, equivalent to 192 clinical samples combined with 12 pairs of primers/probe sets in duplicate, thus allowing the monitoring of SARS-CoV-2 including the detection of specific SARS-CoV-2 variants, as well as the detection other pathogens and/or host cellular responses (virus receptors, response markers, microRNAs). The 10 nL-range volume of Biomark(TM) reactions is compatible with sensitive and reproducible reactions that can be easily and cost-effectively adapted to various RT-qPCR configurations and sets of primers/probe. Finally, we also evaluated the use of inactivating lysis buffers composed of various detergents in the presence or absence of proteinase K to assess the compatibility of these buffers with a direct reverse transcription enzymatic step and we propose several protocols, bypassing the need for RNA purification. We advocate that the combined utilization of an optimized processing buffer and a high-throughput real-time PCR device would contribute to improve the turn-around-time to deliver the test results to patients and increase the SARS-CoV-2 testing capacities.	[Fassy, Julien; Lacoux, Caroline; Leroy, Sylvie; Barbry, Pascal; Nahon, Jean-Louis; Mari, Bernard] Univ Cote Azur, Inst Pharmacol Mol & Cellulaire, FHU OncoAge, CNRS, Valbonne, France; [Leroy, Sylvie; Degoutte, Aurelien; Marquette, Charles-Hugo] Univ Cote Azur, Dept Pneumol, FHU OncoAge, CHU Nice, Nice, France; [Noussair, Latifa; Rottman, Martin; Lemoine, Antoinette; Herrmann, Jean-Louis] GHU Paris Saclay, AP HP, Garches, France; [Hubac, Sylvain; Touron, Patrick] Inst Rech Criminelle Gendarmerie Natl IRCGN, Cergy, France; [Vassaux, Georges; Zaragosi, Laure-Emmanuelle] Univ Cote Azur, Inst Pharmacol Mol & Cellulaire, CNRS, INSERM, Valbonne, France; [Leclercq, Vianney] LBM BIOESTEREL, Mouans Sartoux, France; [Rouquie, David] Bayer SAS, Valbonne, France; [Rottman, Martin; Herrmann, Jean-Louis] Univ Paris Saclay, INSERM, Infect & Inflammat, UVSQ, Montigny Le Bretonneux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Bayer AG; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Mari, B (corresponding author), Univ Cote Azur, Inst Pharmacol Mol & Cellulaire, FHU OncoAge, CNRS, Valbonne, France.	mari@unice.fr	Vassaux, Georges/N-9724-2016; Rottman, Martin/I-3005-2012; Zaragosi, Laure-Emmanuelle/P-9887-2016; Mari, Bernard P/GVS-3100-2022; Rottman, Martin/AAD-9075-2021; Mari, Bernard/Q-5832-2019; Barbry, Pascal/O-5021-2016	Vassaux, Georges/0000-0002-1149-7716; Rottman, Martin/0000-0001-5953-3344; Zaragosi, Laure-Emmanuelle/0000-0001-6747-7928; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; Barbry, Pascal/0000-0001-9632-6483	Delegation CNRS Cote d'Azur; UCA GenomiX platform and MICA imaging facility of the University Cote d'Azur; Propagate" consortium; "Centre National de la Recherche Scientifique" (CNRS); Universite Cote d'Azur; French "French Defence Innovation Agency - Agence de l'Innovation de Defense"; Departement des Alpes Maritimes; Canceropole PACA; Plan Cancer 2018 "ARN noncodants en cancerologie: du fondamental au translationnel" [18CN045]; Cote d'Azur-Nice-Interdisciplinary Institute for Artificial Intelligence [ANR-19-P3IA-0002-3IA]; France Genomique [ANR-10-INBS-6 09-03, ANR-10-INBS-09-02]	Delegation CNRS Cote d'Azur; UCA GenomiX platform and MICA imaging facility of the University Cote d'Azur; Propagate" consortium; "Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Cote d'Azur; French "French Defence Innovation Agency - Agence de l'Innovation de Defense"; Departement des Alpes Maritimes; Canceropole PACA(Region Grand-Est); Plan Cancer 2018 "ARN noncodants en cancerologie: du fondamental au translationnel"; Cote d'Azur-Nice-Interdisciplinary Institute for Artificial Intelligence; France Genomique	Supported by funds from the "Centre National de la Recherche Scientifique" (CNRS), the "Universite Cote d'Azur", the French "French Defence Innovation Agency - Agence de l'Innovation de Defense ("project "Safe and direct COV-2 qPCR Test") and the Departement des Alpes Maritimes (COVID-19 Health program). JF is supported by the Canceropole PACA and CL is supported by Plan Cancer 2018 "ARN noncodants en cancerologie: du fondamental au translationnel" (number 18CN045). P.B. is recipient of a chair from ANR-19-P3IA-0002-3IA Cote d'Azur-Nice-Interdisciplinary Institute for Artificial Intelligence. The Biomark equipment was funded by Canceropole PACA and France Genomique (Commissariat aux Grands Investissements: ANR-10-INBS-6 09-03, ANR-10-INBS-09-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bayer and LBM Bioesterel provided support in the form of salaries for authors [DR and VL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Bayer SAS also loaned equipment and reagents for the study.	Beltran-Pavez C, 2021, J VIROL METHODS, V287, DOI 10.1016/j.jviromet.2020.113969; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bruce EA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000896; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colavita F, 2017, J CLIN VIROL, V86, P27, DOI 10.1016/j.jcv.2016.11.009; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Darnell MER, 2006, TRANSFUSION, V46, P1770, DOI 10.1111/j.1537-2995.2006.00976.x; Fomsgaard AS, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.14.2000398; Fukumoto T, 2020, INT J INFECT DIS, V98, P16, DOI 10.1016/j.ijid.2020.06.074; Ghaffari A, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10070453; Goecke NB, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00165; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hasan MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236564; La Marca A, 2020, REPROD BIOMED ONLINE, V41, P483, DOI 10.1016/j.rbmo.2020.06.001; Lalli MA, 2021, CLIN CHEM, V67, P415, DOI 10.1093/clinchem/hvaa267; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Levett LJ., 2020, EXTRACTION FREE COVI, P1, DOI 10.1101/2020.04.06.028316; Lieberman JA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00821-20; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mirzaei R, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107204; Nersisyan S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235987; Olwagen CP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42846-y; Perchetti GA, 2020, J CLIN VIROL, V131, DOI 10.1016/j.jcv.2020.104570; Pettit SD, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012634; Ranoa DRE, 2020, SALIVA BASED MOL TES, DOI [10.1101/2020.06.18.159434, DOI 10.1101/2020.06.18.159434]; Rodino KG, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00590-20; Sentmanat M., 2020, BIORXIV2020112101101, P1, DOI [10.1101/2020.04.02.022384, DOI 10.1101/2020.04.02.022384, 10.1101/2020.04 .02.022384.]; Smyrlaki I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18611-5; Srivatsan Sanjay, 2021, bioRxiv, DOI 10.1101/2020.04.22.056283; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Touron P, 2021, EUR J CLIN MICROBIOL, V40, P197, DOI 10.1007/s10096-020-03989-3; Wei Shan, 2020, medRxiv, DOI 10.1101/2020.05.28.20115220; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Woods PS, 2020, VIROLOGY, V545, P40, DOI 10.1016/j.virol.2020.03.005; Wyler E, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102151; Zhen W, 2020, J MOL DIAGN, V22, P1367, DOI 10.1016/j.jmoldx.2020.09.004; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0243333	10.1371/journal.pone.0243333	http://dx.doi.org/10.1371/journal.pone.0243333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852580	Green Published, Green Submitted, gold			2022-12-26	WOS:000640604500061
J	Nabeshima, Y; Kitano, T; Takeuchi, M				Nabeshima, Yosuke; Kitano, Tetsuji; Takeuchi, Masaaki			Reliability of left atrial strain reference values: A 3D echocardiographic study	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; CLINICAL-RELEVANCE; DEFORMATION; VOLUME	Background Standard apical four-chamber and two-chamber views often maximize the long-axis of the left ventricle, resulting in artifactitious foreshortening of the left atrium (LA), which may overestimate LA longitudinal reservoir strain (LALS). We compared LALS values between 2D echocardiography (2DE) and 3D echocardiography (3DE) in healthy subjects to determine whether 2DE speckle tracking analysis overestimates the reference value of LALS. Methods and results In this study, 4 types of cohorts were included: 1. 105 normal subjects (retrospectively), 2. 53 patients with cardiovascular diseases (retrospectively), 3. 15 patients who received cardiac magnetic resonance (prospectively), and 4. 20 normal subjects (prospectively). LALS and LA length were measured using both 2DE and 3DE in 105 healthy subjects (median age: 42 years). Biplane LALS was measured in apical four- and two-chamber views using 2DE speckle tracking software, and 3DE LALS was measured using new 3DE LA strain software. To determine sensitivity, we also performed the same analysis in 53 patients with cardiovascular disease. The mean value of biplane LALS was 39.6%. LA length at both end-diastole (r = -0.43) and end-systole (r = -0.54) was negatively correlated with biplane LALS. Multivariate regression analysis revealed that both end-diastolic and end-systolic LA length had significant negative relationships with biplane LALS after adjusting for anthropometric and echocardiographic image quality parameters. 3DE LALS (23.7 +/- 7.6%) gave significantly lower values than 2DE LALS (39.5 +/- 12.0%, p<0.001) with a weak correlation (r = 0.33). LA length measured by 2DE was significantly shorter than that measured by 3DE. The same trend was observed in diseased patients. Conclusions Our results revealed that in 2DE, the LA cavity consistently appears longitudinally foreshortened in apical views, potentially overestimating LALS. 3DE may overcome this limitation.	[Nabeshima, Yosuke] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan; [Kitano, Tetsuji] Univ Occupat & Environm Hlth, Dept Cardiol & Nephrol, Wakamatsu Hosp, Kitakyushu, Fukuoka, Japan; [Takeuchi, Masaaki] Univ Occupat & Environm Hlth Hosp, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Nabeshima, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan.	y.nabeshima1016@gmail.com	Kitano, Tetsuji/AAR-7390-2021	Kitano, Tetsuji/0000-0002-8539-5907				Badano LP, 2018, EUR HEART J-CARD IMG, V19, P591, DOI 10.1093/ehjci/jey042; Badano LP, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004229; Freed BH, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003754; Iwataki M, 2012, J AM SOC ECHOCARDIOG, V25, P1319, DOI 10.1016/j.echo.2012.08.017; Kebed K, 2017, INT J CARDIOVAS IMAG, V33, P209, DOI 10.1007/s10554-016-0988-8; Kuwaki H, 2014, JACC-CARDIOVASC IMAG, V7, P749, DOI 10.1016/j.jcmg.2014.05.002; Mochizuki A, 2013, J AM SOC ECHOCARDIOG, V26, P165, DOI 10.1016/j.echo.2012.10.003; Morris DA, 2018, JACC-CARDIOVASC IMAG, V11, P1405, DOI 10.1016/j.jcmg.2017.07.029; Morris DA, 2015, EUR HEART J-CARD IMG, V16, P364, DOI 10.1093/ehjci/jeu219; Muraru D, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003866; Nagata Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180584; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nemes A, 2019, INT J CARDIOVAS IMAG, V35, P991, DOI 10.1007/s10554-019-01559-z; Pathan F, 2017, J AM SOC ECHOCARDIOG, V30, P59, DOI 10.1016/j.echo.2016.09.007; Singh A, 2019, INT J CARDIOVAS IMAG, V35, P23, DOI 10.1007/s10554-018-1425-y; Singh A, 2017, JACC-CARDIOVASC IMAG, V10, P735, DOI 10.1016/j.jcmg.2016.08.014; Sugimoto T, 2018, EUR HEART J-CARD IMG, V19, P630, DOI 10.1093/ehjci/jey018; Sugimoto T, 2017, EUR HEART J-CARD IMG, V18, P833, DOI 10.1093/ehjci/jex140; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Thomas L, 2019, J AM COLL CARDIOL, V73, P1961, DOI 10.1016/j.jacc.2019.01.059; Unlu S, 2020, EUR HEART J-CARD IMG, V21, P337, DOI 10.1093/ehjci/jez189; Voigt JU, 2020, EUR HEART J-CARD IMG, V21, P715, DOI 10.1093/ehjci/jeaa091	22	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250089	10.1371/journal.pone.0250089	http://dx.doi.org/10.1371/journal.pone.0250089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852637	gold, Green Published			2022-12-26	WOS:000640604500019
J	Dey, P; Sharma, SK; Sarkar, I; Ray, SD; Pramod, P; Kochiganti, VHS; Quadros, G; Rathore, SS; Singh, V; Singh, RP				Dey, Prateek; Sharma, Sanjeev Kumar; Sarkar, Indrani; Ray, Swapna Devi; Pramod, Padmanabhan; Kochiganti, Venkata Hanumat Sastry; Quadros, Goldin; Rathore, Saurabh Singh; Singh, Vikram; Singh, Ram Pratap			Complete mitogenome of endemic plum-headed parakeet Psittacula cyanocephala - characterization and phylogenetic analysis	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; PARROTS PSITTACIFORMES; MOLECULAR PHYLOGENY; GENE ORDER; EVOLUTION; PATTERNS; SEQUENCE; INTROGRESSION; EXTINCTION; SPECIATION	Psittacula cyanocephala is an endemic parakeet from the Indian sub-continent that is widespread in the illegal bird trade. Previous studies on Psittacula parakeets have highlighted taxonomic ambiguities, warranting studies to resolve the issues. Since the mitochondrial genome provides useful information concerning the species evolution and phylogenetics, we sequenced the complete mitogenome of P. cyanocephala using NGS, validated 38.86% of the mitogenome using Sanger Sequencing and compared it with other available whole mitogenomes of Psittacula. The complete mitogenome of the species was 16814 bp in length with 54.08% AT composition. P. cyanocephala mitogenome comprises of 13 protein-coding genes, 2 rRNAs and 22 tRNAs. P. cyanocephala mitogenome organization was consistent with other Psittacula mitogenomes. Comparative codon usage analysis indicated the role of natural selection on Psittacula mitogenomes. Strong purifying selection pressure was observed maximum on nad1 and nad4l genes. The mitochondrial control region of all Psittacula species displayed the ancestral avian CR gene order. Phylogenetic analyses revealed the Psittacula genus as paraphyletic nature, containing at least 4 groups of species within the same genus, suggesting its taxonomic reconsideration. Our results provide useful information for developing forensic tests to control the illegal trade of the species and scientific basis for phylogenetic revision of the genus Psittacula.	[Dey, Prateek; Sharma, Sanjeev Kumar; Sarkar, Indrani; Ray, Swapna Devi; Pramod, Padmanabhan; Singh, Ram Pratap] Salim Ali Ctr Ornithol & Nat Hist, Natl Avian Forens Lab, Coimbatore, Tamil Nadu, India; [Kochiganti, Venkata Hanumat Sastry] Natl Inst Anim Nutr & Physiol, Bengaluru, India; [Quadros, Goldin] Salim Ali Ctr Ornithol & Nat Hist, Wetland Ecol Div, Coimbatore, Tamil Nadu, India; [Rathore, Saurabh Singh] Mahatma Gandhi Cent Univ, Motihari, India; [Singh, Vikram] Cent Univ Himachal Pradesh, Dharamshala, India; [Singh, Ram Pratap] Cent Univ South Bihar, Dept Life Sci, Gaya, India	Salim Ali Center for Ornithology & Natural History (SACON); Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Salim Ali Center for Ornithology & Natural History (SACON); Central University of Himachal Pradesh; Central University of South Bihar	Singh, RP (corresponding author), Salim Ali Ctr Ornithol & Nat Hist, Natl Avian Forens Lab, Coimbatore, Tamil Nadu, India.; Singh, RP (corresponding author), Cent Univ South Bihar, Dept Life Sci, Gaya, India.	rampratap@cusb.ac.in	RAY, SWAPNA DEVI/GXF-4891-2022; Quadros, Goldin/AAP-2940-2021	Quadros, Goldin/0000-0002-4813-6762; Dey, Prateek/0000-0001-6486-958X; SHARMA, SANJEEV/0000-0001-9052-5035; Devi Ray, Swapna/0000-0002-8593-689X; Singh, Dr. Vikram/0000-0002-7644-4084	Ministry of Environment, Forest and Climate Change, Govt.	Ministry of Environment, Forest and Climate Change, Govt.	We thank the Ministry of Environment, Forest and Climate Change, Govt. of India for financial support. RPS and PP acquired the funding.	Ahmed A., 1997, LIVE BIRD TRADE NO I; [Anonymous], 2021, LANG ENV STAT COMP; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; BirdLife International, 2020, SPEC FACTSH PSITT CY; Bonn A, 2002, ECOL LETT, V5, P733, DOI 10.1046/j.1461-0248.2002.00376.x; Braun MP, 2019, ZOOTAXA, V4563, P547, DOI 10.11646/zootaxa.4563.3.8; Brauth SE, 1997, ANN NY ACAD SCI, V807, P368, DOI 10.1111/j.1749-6632.1997.tb51933.x; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Campbell V, 2011, MOL PHYLOGENET EVOL, V58, P149, DOI 10.1016/j.ympev.2010.11.017; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Eberhard JR, 2016, MOL PHYLOGENET EVOL, V94, P34, DOI 10.1016/j.ympev.2015.08.011; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Forshaw Joseph, 2010, P15; Fuchs J, 2013, MOL PHYLOGENET EVOL, V67, P578, DOI 10.1016/j.ympev.2013.02.014; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grant RA, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7060047; Groombridge JJ, 2004, MOL PHYLOGENET EVOL, V31, P96, DOI 10.1016/j.ympev.2003.07.008; Harlid A, 1997, MOL BIOL EVOL, V14, P754, DOI 10.1093/oxfordjournals.molbev.a025815; Harrison S, 2017, ANN BOT-LONDON, V119, P207, DOI 10.1093/aob/mcw248; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Jackson H, 2015, IBIS, V157, P496, DOI 10.1111/ibi.12275; Jathar GA., 2006, BUCEROS, P1; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kundu S, 2012, MOL PHYLOGENET EVOL, V62, P296, DOI 10.1016/j.ympev.2011.09.025; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lamichhaney S, 2018, SCIENCE, V359, P224, DOI 10.1126/science.aao4593; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Y, 2019, MITOCHONDRIAL DNA B, V4, P3614, DOI 10.1080/23802359.2019.1678417; Liu HY, 2020, MOL BIOL REP, V47, P3567, DOI 10.1007/s11033-020-05448-w; Liu HY, 2019, MITOCHONDRIAL DNA B, V4, P692, DOI 10.1080/23802359.2019.1573124; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Mindell DP, 1998, P NATL ACAD SCI USA, V95, P10693, DOI 10.1073/pnas.95.18.10693; Nachappa MP, 2020, MITOCHONDRIAL DNA B, V5, P1232, DOI 10.1080/23802359.2020.1731342; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Ottenburghs J, 2017, AVIAN RES, V8, DOI 10.1186/s40657-017-0088-z; Ottenburghs J, 2015, IBIS, V157, P892, DOI 10.1111/ibi.12285; Peden JF., THESIS U NOTTINGHAM; Peng ZG, 2006, GENE, V376, P290, DOI 10.1016/j.gene.2006.04.014; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pires SF, 2012, GLOB CRIME, V13, P176, DOI 10.1080/17440572.2012.700180; Rambaut A., 2014, FIGTREE V1 4 3 SOFTW; Ren QQ, 2014, J GENET, V93, P699, DOI 10.1007/s12041-014-0428-2; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy A, 2015, WORLD J MICROB BIOT, V31, P959, DOI 10.1007/s11274-015-1850-1; Sambrook J., 2002, MOL CLONING LAB MANU; Sarkar I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72674-4; Sarker S, 2019, MITOCHONDRIAL DNA B, V4, P3579, DOI 10.1080/23802359.2019.1676676; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SMITH GA, 1975, IBIS, V117, P18, DOI 10.1111/j.1474-919X.1975.tb04187.x; Smith R., 2019, BIORXIV, V1, DOI DOI 10.1101/644609; Stiller J, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11070115; Sun CH, 2020, INT J BIOL MACROMOL, V151, P924, DOI 10.1016/j.ijbiomac.2020.02.238; Sun CH, 2020, INT J BIOL MACROMOL, V146, P638, DOI 10.1016/j.ijbiomac.2019.12.253; Tatusov T, 2011, NCBI ORF FINDER; Urantowka AD, 2018, MOL BIOL EVOL, V35, P2989, DOI 10.1093/molbev/msy189; van Tuinen M, 2000, MOL BIOL EVOL, V17, P451, DOI 10.1093/oxfordjournals.molbev.a026324; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	62	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0241098	10.1371/journal.pone.0241098	http://dx.doi.org/10.1371/journal.pone.0241098			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836001	Green Submitted, gold, Green Published			2022-12-26	WOS:000639361000018
J	Acacio, S; Nhampossa, T; Quinto, L; Vubil, D; Garrine, M; Bassat, Q; Farag, T; Panchalingam, S; Nataro, JP; Kotloff, KL; Levine, MM; Tennant, SM; Alonso, PL; Mandomando, I				Acacio, Sozinho; Nhampossa, Tacilta; Quinto, Llorenc; Vubil, Delfino; Garrine, Marcelino; Bassat, Quique; Farag, Tamer; Panchalingam, Sandra; Nataro, James P.; Kotloff, Karen L.; Levine, Myron M.; Tennant, Sharon M.; Alonso, Pedro L.; Mandomando, Inacio			Rotavirus disease burden pre-vaccine introduction in young children in Rural Southern Mozambique, an area of high HIV prevalence	PLOS ONE			English	Article							GLOBAL ENTERIC MULTICENTER; DIARRHEAL DISEASE; DEVELOPING-COUNTRIES; MANHICA; GEMS; INFANTS; AGE	Background Rotavirus vaccines have been adopted in African countries since 2009, including Mozambique (2015). Disease burden data are needed to evaluate the impact of rotavirus vaccine. We report the burden of rotavirus-associated diarrhea in Mozambique from the Global Enteric Multicenter Study (GEMS) before vaccine introduction. Methods A case-control study (GEMS), was conducted in Manhica district, recruiting children aged 0-59 months with moderate-to-severe diarrhea (MSD) and less-severe-diarrhea (LSD) between December 2007 and November 2012; including 1-3 matched (age, sex and neighborhood) healthy community controls. Clinical and epidemiological data and stool samples (for laboratory investigation) were collected. Association of rotavirus with MSD or LSD was determined by conditional logistic regression and adjusted attributable fractions (AF) calculated, and risk factors for rotavirus diarrhea assessed. Results Overall 915 cases and 1,977 controls for MSD, and 431 cases and 430 controls for LSD were enrolled. Rotavirus positivity was 44% (217/495) for cases and 15% (160/1046) of controls, with AF = 34.9% (95% CI: 32.85-37.06) and adjusted Odds Ratio (aOR) of 6.4 p< 0.0001 in infants with MSD compared to 30% (46/155) in cases and 14% (22/154) in controls yielding AF = 18.7%, (95% CI: 12.02-25.39) and aOR = 2.8, p = 0.0011 in infants with LSD. The proportion of children with rotavirus was 32% (21/66) among HIV-positive children and 23% (128/566) among HIV-negative ones for MSD. Presence of animals in the compound (OR = 1.9; p = 0.0151) and giving stored water to the child (OR = 2.0, p = 0.0483) were risk factors for MSD; while animals in the compound (OR = 2.37, p = 0.007); not having routine access to water on a daily basis (OR = 1.53, p = 0.015) and washing hands before cooking (OR = 1.76, p = 0.0197) were risk factors for LSD. Conclusion The implementation of vaccination against rotavirus may likely result in a significant reduction of rotavirus-associated diarrhea, suggesting the need for monitoring of vaccine impact.	[Acacio, Sozinho; Nhampossa, Tacilta; Quinto, Llorenc; Vubil, Delfino; Garrine, Marcelino; Bassat, Quique; Alonso, Pedro L.; Mandomando, Inacio] Ctr Invest Saude Manh CISM, Maputo, Mozambique; [Acacio, Sozinho; Nhampossa, Tacilta; Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Quinto, Llorenc; Bassat, Quique; Alonso, Pedro L.] Univ Barcelona, ISGlobal, Hosp Clin, Barcelona, Spain; [Garrine, Marcelino] Univ Nova Lisboa IHMT, Inst Higiene & Med Trop, UNL, Global Hlth & Trop Med, Lisbon, Portugal; [Bassat, Quique] ICREA, Barcelona, Spain; [Bassat, Quique] Univ Barcelona, Hosp St Joan Deu, Pediat Dept, Barcelona, Spain; [Bassat, Quique] Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain; [Farag, Tamer; Panchalingam, Sandra; Nataro, James P.; Kotloff, Karen L.; Levine, Myron M.; Tennant, Sharon M.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth CVD, Baltimore, MD USA; [Alonso, Pedro L.] World Hlth Org, Geneva, Switzerland; [Farag, Tamer] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA	Centro de Investigacao em Saude de Manhica; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; ICREA; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University System of Maryland; University of Maryland Baltimore; World Health Organization; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Virginia	Mandomando, I (corresponding author), Ctr Invest Saude Manh CISM, Maputo, Mozambique.; Mandomando, I (corresponding author), Minist Saude, Inst Nacl Saude, Maputo, Mozambique.	inacio.mandomando@manhica.net	; Bassat, Quique/P-2341-2016	Farag, Tamer/0000-0003-1826-6600; Bassat, Quique/0000-0003-0875-7596; Garrine, Marcelino/0000-0002-8619-8761; Quinto, Llorenc/0000-0001-9992-6951	Bill & Melinda Gates Foundation [OPP 38874, OPP1033572]; Government of Mozambique; Spanish Agency for International Development Cooperation (AECID); Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program [CEX2018-000806-S]; Generalitat de Catalunya through the CERCA Program	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Government of Mozambique; Spanish Agency for International Development Cooperation (AECID)(Spanish Government); Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program(Spanish Government); Generalitat de Catalunya through the CERCA Program	This study is based on the GEMS project, which was supported by the Bill & Melinda Gates Foundation (Project OPP 38874 and OPP1033572) awarded to Myron Mike Levine. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development Cooperation (AECID). ISGlobal receives support from Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acacio S, 2018, INT J INFECT DIS, V73, P10, DOI 10.1016/j.ijid.2018.05.012; [Anonymous], 2013, VACCINE, V31, P6170, DOI 10.1016/j.vaccine.2013.05.037; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Armitage P., STAT METHODS MED RES, P65, DOI [10.1177/0962280215620696, DOI 10.1177/0962280215620696]; Beserra LAR, 2014, AVIAN DIS, V58, P153, DOI 10.1637/10626-080513-ResNote.1; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Bwogi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178855; de Deus Nilsa, 2018, Vaccine, V36, P7205, DOI 10.1016/j.vaccine.2017.10.060; de Deus N, 2018, J TROP PEDIATRICS, V64, P141, DOI 10.1093/tropej/fmx032; de Villiers FPR, 2009, SAMJ S AFR MED J, V99, P249; Dgedge M, 2001, B WORLD HEALTH ORGAN, V79, P546; Feiveson A.H., 1999, WHAT IS DELTA METHOD; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Heylen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100953; Kotloff KL, 2019, LANCET GLOB HEALTH, V7, pE568, DOI 10.1016/S2214-109X(19)30076-2; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Mandomando I, 2017, VACCINE, V35, P1663, DOI 10.1016/j.vaccine.2017.01.072; Martinez M, 2014, INFECT GENET EVOL, V27, P156, DOI 10.1016/j.meegid.2014.07.020; MING ZF, 1991, T ROY SOC TROP MED H, V85, P667, DOI 10.1016/0035-9203(91)90389-G; Mwenda Jason M, 2018, Vaccine, V36, P7119, DOI 10.1016/j.vaccine.2018.06.026; Nhampossa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119824; Nhampossa T, 2013, AM J TROP MED HYG, V89, P41, DOI 10.4269/ajtmh.12-0754; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; RIDER PR, 1960, J AM STAT ASSOC, V55, P148, DOI 10.2307/2282186; Sacarlal J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-67; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Stata, STATACORP LLC; StataCorp, 2013, STAT 12 BAS REF MAN, P255; Strydom A, 2019, J GEN VIROL, V100, P932, DOI 10.1099/jgv.0.001270; Strydom A, 2019, INFECT GENET EVOL, V69, P68, DOI 10.1016/j.meegid.2019.01.011; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249714	10.1371/journal.pone.0249714	http://dx.doi.org/10.1371/journal.pone.0249714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831068	Green Published, gold			2022-12-26	WOS:000639359600123
J	Wang, H; Xu, M; Engelhart, CA; Zhang, X; Yan, BH; Pan, MM; Xu, YY; Fan, SL; Liu, RH; Xu, L; Hua, L; Schnappinger, D; Chen, S				Wang, Heng; Xu, Min; Engelhart, Curtis A.; Zhang, Xi; Yan, Baohua; Pan, Miaomiao; Xu, Yuanyuan; Fan, Shilong; Liu, Renhe; Xu, Lan; Hua, Lan; Schnappinger, Dirk; Chen, Shawn			Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTROPHOTOMETRIC ASSAY; CRYSTAL-STRUCTURES; FAAH INHIBITOR; BACTERIAL; DISCOVERY; ACTIVATION; TRNA(PHE); POCKET	Mycobacterium tuberculosis (Mtb) remains the deadliest pathogenic bacteria worldwide. The search for new antibiotics to treat drug-sensitive as well as drug-resistant tuberculosis has become a priority. The essential enzyme phenylalanyl-tRNA synthetase (PheRS) is an antibacterial drug target because of the large differences between bacterial and human PheRS counterparts. In a high-throughput screening of 2148 bioactive compounds, PF-3845, which is a known inhibitor of human fatty acid amide hydrolase, was identified inhibiting Mtb PheRS at K-i similar to 0.73 +/- 0.06 mu M. The inhibition mechanism was studied with enzyme kinetics, protein structural modeling, and crystallography, in comparison to a PheRS inhibitor of the noted phenyl-thiazolylurea-sulfonamide class. The 2.3-angstrom crystal structure of Mtb PheRS in complex with PF-3845 revealed its novel binding mode, in which a trifluoromethyl-pyridinylphenyl group occupies the phenylalanine pocket, whereas a piperidine-piperazine urea group binds into the ATP pocket through an interaction network enforced by a sulfate ion. It represents the first non-nucleoside bisubstrate competitive inhibitor of bacterial PheRS. PF-3845 inhibits the in vitro growth of Mtb H37Rv at similar to 24 mu M, and the potency of PF-3845 increased against an engineered strain Mtb pheS-FDAS, suggesting on target activity in mycobacterial whole cells. PF-3845 does not inhibit human cytoplasmic or mitochondrial PheRS in biochemical assay, which can be explained from the crystal structures. Further medicinal chemistry efforts focused on the piperidine-piperazine urea moiety may result in the identification of a selective antibacterial lead compound.	[Wang, Heng; Xu, Min; Zhang, Xi; Pan, Miaomiao; Xu, Yuanyuan; Liu, Renhe; Xu, Lan; Hua, Lan; Chen, Shawn] Global Hlth Drug Discovery Inst, Beijing, Peoples R China; [Engelhart, Curtis A.; Schnappinger, Dirk] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Yan, Baohua; Fan, Shilong] Tsinghua Univ, Ctr Prot Sci Facil, Beijing, Peoples R China	Cornell University; Tsinghua University	Chen, S (corresponding author), Global Hlth Drug Discovery Inst, Beijing, Peoples R China.	shuo.chen@ghddi.org		Chen, Shawn/0000-0002-6678-3293; Fan, Shilong/0000-0001-9272-2438	Bill & Melinda Gates Foundation in China; Global Health Drug Discovery Institute in China	Bill & Melinda Gates Foundation in China; Global Health Drug Discovery Institute in China	This work is supported by Bill & Melinda Gates Foundation and Global Health Drug Discovery Institute sponsors in China.	Abibi A, 2014, J BIOL CHEM, V289, P21651, DOI 10.1074/jbc.M114.574061; Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Baragana B, 2019, P NATL ACAD SCI USA, V116, P7015, DOI 10.1073/pnas.1814685116; Beyer D, 2004, ANTIMICROB AGENTS CH, V48, P525, DOI 10.1128/AAC.48.2.525-532.2004; Bhuniya D, 2019, BIOORG MED CHEM LETT, V29, P238, DOI 10.1016/j.bmcl.2018.11.048; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Cowell AN, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0673-3; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Du X, 2002, BIOCHEMISTRY-US, V41, P10623, DOI 10.1021/bi026000o; Finarov I, 2010, STRUCTURE, V18, P343, DOI 10.1016/j.str.2010.01.002; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Francklyn CS, 2019, J BIOL CHEM, V294, P5365, DOI 10.1074/jbc.REV118.002956; Gallant P, 2000, EMERG THER TARGETS, V4(, P1; Grube CD, 2018, RNA BIOL, V15, P659, DOI 10.1080/15476286.2017.1397262; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Hewitt SN, 2017, ACS INFECT DIS, V3, P34, DOI 10.1021/acsinfecdis.6b00078; Hu YM, 2016, ANTIMICROB AGENTS CH, V60, P4820, DOI 10.1128/AAC.00800-16; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Itoh Y, 2008, RNA BIOL, V5, P169, DOI 10.4161/rna.5.3.6876; Janes J, 2018, P NATL ACAD SCI USA, V115, P10750, DOI 10.1073/pnas.1810137115; Johnson DS, 2011, ACS MED CHEM LETT, V2, P91, DOI 10.1021/ml100190t; Kato N, 2016, NATURE, V538, P344, DOI 10.1038/nature19804; Keith JM, 2008, BIOORG MED CHEM LETT, V18, P4838, DOI 10.1016/j.bmcl.2008.07.081; Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020; Kwon NH, 2019, NAT REV DRUG DISCOV, V18, P629, DOI 10.1038/s41573-019-0026-3; Lechler A, 1998, J MOL BIOL, V278, P897, DOI 10.1006/jmbi.1998.1744; LLOYD AJ, 1995, NUCLEIC ACIDS RES, V23, P2886, DOI 10.1093/nar/23.15.2886; MARTIN F, 1993, J MOL BIOL, V234, P965, DOI 10.1006/jmbi.1993.1651; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Montgomery JI, 2009, BIOORG MED CHEM LETT, V19, P665, DOI 10.1016/j.bmcl.2008.12.054; Moor N, 2006, BIOCHEMISTRY-US, V45, P10572, DOI 10.1021/bi060491l; Moor N, 2011, CHEM BIOL, V18, P1221, DOI 10.1016/j.chembiol.2011.08.008; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Reshetnikova L, 1999, J MOL BIOL, V287, P555, DOI 10.1006/jmbi.1999.2617; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Safro M., 2005, AMINOACYL TRNA SYNTH, P265; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Tenero D, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00240-19; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; Wang LN, 2016, COGENT CHEM, V2, DOI 10.1080/23312009.2016.1181536; Wasilewski A, 2017, ACTA BIOCHIM POL, V64, P519, DOI 10.18388/abp.2017_1520; [张志明 Zhang Zhiming], 2012, [微生物学通报, Microbiology], V39, P1437; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	45	5	5	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100257	10.1016/j.jbc.2021.100257	http://dx.doi.org/10.1016/j.jbc.2021.100257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837735	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400233
J	Cho, SB; Kim, JY				Cho, Sung-Bae; Kim, Jin-Young			Clustered embedding using deep learning to analyze urban mobility based on complex transportation data	PLOS ONE			English	Article							NETWORK	Urban mobility is a vital aspect of any city and often influences its physical shape as well as its level of economic and social development. A thorough analysis of mobility patterns in urban areas can provide various benefits, such as the prediction of traffic flow and public transportation usage. In particular, based on its exceptional ability to extract patterns from complex large-scale data, embedding based on deep learning is a promising method for analyzing the mobility patterns of urban residents. However, as urban mobility becomes increasingly complex, it becomes difficult to embed patterns into a single vector because of its limited capacity. In this paper, we propose a novel method for analyzing urban mobility based on deep learning. The proposed method involves clustering mobility patterns and embedding them to capture their implicit meaning. Clustering groups mobility patterns based on their spatiotemporal characteristics, and embedding provides meaningful information regarding both individual residents (i.e., personalized mobility) and all residents as a whole, enabling a more effective analysis of mobility patterns. Experiments were performed to predict the successive points of interest (POIs) based on transportation data collected from 1.5 million citizens in a large metropolitan city; the results demonstrate that the proposed method achieves top-1, 3, and 5 accuracies of 73.64%, 88.65%, and 91.54%, respectively, which are much higher than those of the conventional method (59.48%, 75.85%, and 80.1%, respectively). We also demonstrate that the proposed method facilitates the analysis of urban mobility through arithmetic operations between POI vectors.	[Cho, Sung-Bae] Yonsei Univ, Grad Sch Artificial Intelligence, Seoul, South Korea; [Cho, Sung-Bae; Kim, Jin-Young] Yonsei Univ, Dept Comp Sci, Seoul, South Korea	Yonsei University; Yonsei University	Cho, SB (corresponding author), Yonsei Univ, Grad Sch Artificial Intelligence, Seoul, South Korea.; Cho, SB (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul, South Korea.	sbcho@yonsei.ac.kr		Cho, Sung-Bae/0000-0002-7027-2429	Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korean government (MSIT) [2020-0-01361]; Electronics and Telecommunications Research Institute (ETRI) - Korean government [21ZS1100]	Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korean government (MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Electronics and Telecommunications Research Institute (ETRI) - Korean government	This work was partially supported by an Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korean government (MSIT) (No. 2020-0-01361, Artificial Intelligence Graduate School Program (Yonsei University)) and Electronics and Telecommunications Research Institute (ETRI) grant funded by the Korean government (21ZS1100, Core Technology Research for Self-Improving Integrated Artificial Intelligence System).	Adriansen HK, 2005, GEOJOURNAL, V64, P177, DOI 10.1007/s10708-005-5646-y; Ahas R, 2010, TRANSPORT RES C-EMER, V18, P45, DOI 10.1016/j.trc.2009.04.011; Baral R, 2018, ARXIV PREPRINT ARXIV; Baral R, 2016, PROCEEDINGS OF THE 10TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'16), P281, DOI 10.1145/2959100.2959187; Bulkeley H, 2005, ENVIRON POLIT, V14, P42, DOI 10.1080/0964401042000310178; Cascetta E., 2007, ADV COMPLEX SYST, V10, P339; Chang BR, 2018, PROCEEDINGS OF THE TWENTY-SEVENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P3301; Chen C, 2009, J TRANSP GEOGR, V17, P176, DOI 10.1016/j.jtrangeo.2008.09.002; Cheng X, 2013, IEEE IJCNN, DOI 10.1109/IJCNN.2013.6706853; Craswell N., 2009, ENCY DATABASE SYSTEM, DOI DOI 10.1007/978-0-387-39940-9_488; El Mahrsi MK, 2017, IEEE T INTELL TRANSP, V18, P712, DOI 10.1109/TITS.2016.2600515; Elomre-Yalch R, 1988, TRANSPORTATION RES B, P36; Feng SS, 2017, AAAI CONF ARTIF INTE, P102; Feng SS, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P2069; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Jiang RH, 2018, AAAI CONF ARTIF INTE, P784; Kieu LM, 2015, IEEE T INTELL TRANSP, V16, P1537, DOI 10.1109/TITS.2014.2368998; Kim JY, 2019, IEEE INT CONF BIG DA, P3583, DOI 10.1109/BigData47090.2019.9006301; Kieu LM, 2018, TRANSPORT RES C-EMER, V90, P97, DOI 10.1016/j.trc.2018.03.003; Li RZ, 2018, IEEE DATA MINING, P1110, DOI 10.1109/ICDM.2018.00144; Lipton Z.C., 2015, COMPUT SCI, DOI DOI 10.1093/eurheartj/ehw128; Liu L, 2009, PROCEEDINGS OF THE 12TH IEEE INTERNATIONAL SYMPOSIUM ON OBJECT/COMPONENT/SERVICE-ORIENTED REAL-TIME DISTRIBUTED COMPUTING, P12, DOI 10.1109/ISORC.2009.9; Liu Q, 2016, AAAI CONF ARTIF INTE, P194; Liu X., 2016, P 25 INT JOINT C ART, P1188; Liu Y, 2012, LANDSCAPE URBAN PLAN, V106, P73, DOI 10.1016/j.landurbplan.2012.02.012; Liu ZD, 2018, IEEE NETWORK, V32, P40, DOI 10.1109/MNET.2018.1700411; Lv QJ, 2017, IEEE T VEH TECHNOL, V66, P5204, DOI 10.1109/TVT.2016.2611654; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Maggi E, 2016, RES TRANSP ECON, V55, P50, DOI 10.1016/j.retrec.2016.04.010; Mikolov T., 2013, P ICLR WORKSH POST S; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Le Q, 2014, PR MACH LEARN RES, V32, P1188; Rahmani HA, 2019, PROCEEDINGS OF THE 2019 ACM SIGIR INTERNATIONAL CONFERENCE ON THEORY OF INFORMATION RETRIEVAL (ICTIR'19), P172, DOI 10.1145/3341981.3344240; Salim FD., PAC AS C KNOWL DISC, V2020, P53; Wang MF, 2019, INT CONF BIG DATA, P131; Yao ZJ, 2016, IEEE DATA MINING, P549, DOI [10.1109/ICDM.2016.0066, 10.1109/ICDM.2016.137]; Zhang Y., 2020, IEEE INTELL SYST; Zhao PP, 2017, IEEE DATA MINING, P655, DOI 10.1109/ICDM.2017.75; Zhao SL, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P153; Zhao SL, 2016, AAAI CONF ARTIF INTE, P315; Zhong C, 2014, INT J GEOGR INF SCI, V28, P2178, DOI 10.1080/13658816.2014.914521	42	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2021	16	4							e0249318	10.1371/journal.pone.0249318	http://dx.doi.org/10.1371/journal.pone.0249318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RQ1EM	33878114	gold, Green Published			2022-12-26	WOS:000642162200020
J	Alevronta, E; Skokic, V; Dunberger, G; Bull, C; Bergmark, K; Jornsten, R; Steineck, G				Alevronta, Eleftheria; Skokic, Viktor; Dunberger, Gail; Bull, Cecilia; Bergmark, Karin; Jornsten, Rebecka; Steineck, Gunnar			Dose-response relationships of intestinal organs and excessive mucus discharge after gynaecological radiotherapy	PLOS ONE			English	Article								Background The study aims to determine possible dose-volume response relationships between the rectum, sigmoid colon and small intestine and the 'excessive mucus discharge' syndrome after pelvic radiotherapy for gynaecological cancer. Methods and materials From a larger cohort, 98 gynaecological cancer survivors were included in this study. These survivors, who were followed for 2 to 14 years, received external beam radiation therapy but not brachytherapy and not did not have stoma. Thirteen of the 98 developed excessive mucus discharge syndrome. Three self-assessed symptoms were weighted together to produce a score interpreted as 'excessive mucus discharge' syndrome based on the factor loadings from factor analysis. The dose-volume histograms (DVHs) for rectum, sigmoid colon, small intestine for each survivor were exported from the treatment planning systems. The dose-volume response relationships for excessive mucus discharge and each organ at risk were estimated by fitting the data to the Probit, RS, LKB and gEUD models. Results The small intestine was found to have steep dose-response curves, having estimated dose-response parameters: gamma(50): 1.28, 1.23, 1.32, D-50: 61.6, 63.1, 60.2 for Probit, RS and LKB respectively. The sigmoid colon (AUC: 0.68) and the small intestine (AUC: 0.65) had the highest AUC values. For the small intestine, the DVHs for survivors with and without excessive mucus discharge were well separated for low to intermediate doses; this was not true for the sigmoid colon. Based on all results, we interpret the results for the small intestine to reflect a relevant link. Conclusion An association was found between the mean dose to the small intestine and the occurrence of 'excessive mucus discharge'. When trying to reduce and even eliminate the incidence of 'excessive mucus discharge', it would be useful and important to separately delineate the small intestine and implement the dose-response estimations reported in the study.	[Alevronta, Eleftheria; Skokic, Viktor; Bull, Cecilia; Bergmark, Karin; Steineck, Gunnar] Univ Gothenburg, Inst Clin Sci, Dept Oncol, Div Clin Canc Epidemiol,Sahlgrenska Acad, Gothenburg, Sweden; [Dunberger, Gail] Ersta Skondal Bracke Univ Coll, Dept Hlth Care Sci, Stockholm, Sweden; [Jornsten, Rebecka] Chalmers Univ Technol, Gothenburg, Sweden; [Steineck, Gunnar] Karolinska Inst, Dept Oncol & Pathol, Div Clin Canc Epidemiol, Stockholm, Sweden; [Alevronta, Eleftheria] Charite, Berlin, Germany	University of Gothenburg; Chalmers University of Technology; Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Alevronta, E (corresponding author), Univ Gothenburg, Inst Clin Sci, Dept Oncol, Div Clin Canc Epidemiol,Sahlgrenska Acad, Gothenburg, Sweden.; Alevronta, E (corresponding author), Charite, Berlin, Germany.	el.alevronta@gmail.com		Alevronta, Eleftheria/0000-0003-3432-4866	Swedish Cancer Society [CAN 2006/1321, CAN 2009/1099]; King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden [2018-194]; Swedish state under the ALF agreement in Goteborg and Stockholm [ALFGBG-943266]	Swedish Cancer Society(Swedish Cancer Society); King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden; Swedish state under the ALF agreement in Goteborg and Stockholm	This work was supported by the Swedish Cancer Society (CAN 2006/1321 and CAN 2009/1099), the King Gustav V Jubilee Clinic Cancer Foundation in Goteborg (2018-194), Sweden, the Swedish state under the ALF agreement in Goteborg and Stockholm (ALFGBG-943266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; BURMAN C, 1991, INT J RADIAT ONCOL, V21, P123, DOI 10.1016/0360-3016(91)90172-Z; Dunberger G, 2010, EUR J CANCER, V46, P606, DOI 10.1016/j.ejca.2009.10.023; International Commission on Radiation Units and Measurement, 1993, 50 ICRU; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Jones B, 2001, CLIN ONCOL-UK, V13, P71, DOI 10.1053/clon.2001.9221; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; Lind H, 2011, BRIT J CANCER, V105, P737, DOI 10.1038/bjc.2011.315; Lind H, 2016, ACTA ONCOL, V55, P1285, DOI 10.1080/0284186X.2016.1176247; LYMAN JT, 1985, RADIAT RES, V104, pS13, DOI 10.2307/3576626; Niemierko A, 1997, MED PHYS, V24, P103, DOI 10.1118/1.598063; Niemierko A, 1999, MED PHYS, V26, P1100, DOI DOI 10.1118/1.598063; Philip E, 2001, TECHNICAL REPORT SOL; Steineck G, 2002, ACTA ONCOL, V41, P244, DOI 10.1080/02841860260088782; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Steineck G, 2006, ACTA ONCOL, V45, P421, DOI 10.1080/02841860600649293; Steineck G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171461; Thor M, 2015, ACTA ONCOL, V54, P1326, DOI 10.3109/0284186X.2015.1063779; Zientek LR, 2007, BEHAV RES METHODS, V39, P318, DOI 10.3758/BF03193163	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250004	10.1371/journal.pone.0250004	http://dx.doi.org/10.1371/journal.pone.0250004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861779	Green Published, gold			2022-12-26	WOS:000641475400010
J	Azizi, N; Toma, J; Martin, M; Khalid, MF; Mousavi, F; Win, PW; Borrello, MT; Steele, N; Shi, JQ; di Magliano, MP; Pin, CL				Azizi, Nawab; Toma, Jelena; Martin, Mickenzie; Khalid, Muhammad Faran; Mousavi, Fatemeh; Win, Phyo Wei; Borrello, Maria Teresa; Steele, Nina; Shi, Jiaqi; di Magliano, Marina Pasca; Pin, Christopher L.			Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer	ONCOGENE			English	Article								The unfolded protein response (UPR) is activated in pancreatic pathologies and suggested as a target for therapeutic intervention. In this study, we examined activating transcription factor 3 (ATF3), a mediator of the UPR that promotes acinar-to-ductal metaplasia (ADM) in response to pancreatic injury. Since ADM is an initial step in the progression to pancreatic ductal adenocarcinoma (PDAC), we hypothesized that ATF3 is required for initiation and progression of PDAC. We generated mice carrying a germline mutation of Atf3 (Atf3(-/-)) combined with acinar-specific induction of oncogenic KRAS (Ptf1a(creERT/+)Kras(G12D/+)). Atf3(-/-) mice with (termed APK) and without KRAS(G12D) were exposed to cerulein-induced pancreatitis. In response to recurrent pancreatitis, Atf3(-/-) mice showed decreased ADM and enhanced regeneration based on morphological and biochemical analysis. Similarly, an absence of ATF3 reduced spontaneous pancreatic intraepithelial neoplasia (PanIN) formation and PDAC in Ptf1a(creERT/+)Kras(G12D/+) mice. In response to injury, KRAS(G12D) bypassed the requirement for ATF3 with a dramatic loss in acinar tissue and PanIN formation observed regardless of ATF3 status. Compared to Ptf1a(creERT/+)Kras(G12D/+) mice, APK mice exhibited a significant decrease in pancreatic and total body weight, did not progress through to PDAC, and showed altered pancreatic fibrosis and immune cell infiltration. These findings suggest a complex, multifaceted role for ATF3 in pancreatic cancer pathology.	[Azizi, Nawab; Toma, Jelena; Martin, Mickenzie; Khalid, Muhammad Faran; Mousavi, Fatemeh; Win, Phyo Wei; Pin, Christopher L.] Childrens Hlth Res Inst, London, ON, Canada; [Azizi, Nawab; Toma, Jelena; Martin, Mickenzie; Mousavi, Fatemeh; Pin, Christopher L.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Toma, Jelena; Pin, Christopher L.] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Martin, Mickenzie] Univ Western Ontario, Dept Biol, London, ON, Canada; [Khalid, Muhammad Faran; Win, Phyo Wei; Pin, Christopher L.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Borrello, Maria Teresa] Aix Marseille Univ, Ctr Canc Res Marseille, INSERM, CNRS,UMR 7258,U1068, Marseille, France; [Borrello, Maria Teresa] Inst Paoli Calmettes, Marseille, France; [Steele, Nina; Shi, Jiaqi] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [di Magliano, Marina Pasca] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pin, CL (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.; Pin, CL (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.; Pin, CL (corresponding author), Univ Western Ontario, Dept Oncol, London, ON, Canada.; Pin, CL (corresponding author), Univ Western Ontario, Dept Paediat, London, ON, Canada.	cpin@uwo.ca		Shi, Jiaqi/0000-0003-4893-1587; Azizi, Nawab/0000-0003-1474-6543	Canadian Institutes of Health Research (MOP) [PJT166029]; Cancer Research Society of Canada; Rob Lutterman Foundation for Pancreatic Cancer Research; University of Western Ontario; Ontario Graduate Scholarships; Cancer Research and Technology Training (CaRTT) program; NSERC summer studentship; National Cancer Institute of the National Institutes of Health [K08CA234222]; London Regional Cancer Centre Catalyst Grant	Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society of Canada; Rob Lutterman Foundation for Pancreatic Cancer Research; University of Western Ontario; Ontario Graduate Scholarships(Ontario Graduate Scholarship); Cancer Research and Technology Training (CaRTT) program; NSERC summer studentship(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); London Regional Cancer Centre Catalyst Grant	The authors wish to acknowledge the ongoing support of several national research funding agencies for this work including the Canadian Institutes of Health Research (MOP#PJT166029), the Cancer Research Society of Canada, and the Rob Lutterman Foundation for Pancreatic Cancer Research. This work would not be possible without specific support from a London Regional Cancer Centre Catalyst Grant, co-supported by Keith Sammit and an internal bridge grant from the University of Western Ontario. NA and JT were funded by studentships from the Ontario Graduate Scholarships and Cancer Research and Technology Training (CaRTT) program. MFK was supported by an NSERC summer studentship. JS was supported by National Cancer Institute of the National Institutes of Health under award number K08CA234222.	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Chang YS, 2017, P NATL ACAD SCI USA, V114, pE7159, DOI 10.1073/pnas.1700455114; Chien WW, 2014, ONCOTARGET, V5, P4881, DOI 10.18632/oncotarget.2051; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Dawn B, 2004, CARDIOVASC RES, V64, P61, DOI 10.1016/j.cardiores.2004.05.011; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Fazio EN, 2017, MOL BIOL CELL, V28, P2347, DOI 10.1091/mbc.E17-04-0254; Garcia-Carbonero N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092468; Gardian K, 2012, J CANCER, V3, P285, DOI 10.7150/jca.4537; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Hess DA, 2011, GASTROENTEROLOGY, V141, P1463, DOI 10.1053/j.gastro.2011.06.045; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Je YJ, 2014, BIOCHEM BIOPH RES CO, V444, P81, DOI 10.1016/j.bbrc.2014.01.010; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Kadowaki H, 2013, GENES-BASEL, V4, P306, DOI 10.3390/genes4030306; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim DE, 2017, J EXP MED, V214, P2349, DOI 10.1084/jem.20170724; Kim KJ, 2015, BIOMOL THER, V23, P134, DOI 10.4062/biomolther.2014.107; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kowalik AS, 2007, AM J PHYSIOL-GASTR L, V292, pG1123, DOI 10.1152/ajpgi.00512.2006; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Mallano T, 2016, ANN RHEUM DIS, V75, P586, DOI 10.1136/annrheumdis-2014-206214; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pinho AV, 2011, GUT, V60, P958, DOI 10.1136/gut.2010.225920; Prevot PP, 2012, GUT, V61, P1723, DOI 10.1136/gutjnl-2011-300266; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy N, 2016, GENE DEV, V30, P2669, DOI 10.1101/gad.291021.116; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Song HM, 2016, BIOMOL THER, V24, P140, DOI 10.4062/biomolther.2015.109; Song XX, 2012, THORAC CANCER, V3, P217, DOI 10.1111/j.1759-7714.2011.00110.x; Steele NG, 2021, CLIN CANCER RES, V27, P2023, DOI 10.1158/1078-0432.CCR-20-3715; Thakur PC, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1562-z; Tsuda M, 2018, J CLIN INVEST, V128, P3475, DOI 10.1172/JCI94287; Wang A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-268; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yan F, 2017, ONCOTARGET, V8, P47020, DOI 10.18632/oncotarget.16638; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Young CC, 2019, CELL MOL GASTROENTER, V7, P93, DOI 10.1016/j.jcmgh.2018.09.004	55	6	6	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3118	3135		10.1038/s41388-021-01771-z	http://dx.doi.org/10.1038/s41388-021-01771-z		APR 2021	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33864001	Green Submitted, Green Accepted			2022-12-26	WOS:000640748600003
J	Kosinska, MK; Eichner, G; Schmitz, G; Liebisch, G; Steinmeyer, J				Kosinska, Marta K.; Eichner, Gerrit; Schmitz, Gerd; Liebisch, Gerhard; Steinmeyer, Juergen			A comparative study on the lipidome of normal knee synovial fluid from humans and horses	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; FATTY-ACID-COMPOSITION; PHOSPHOLIPID BIOSYNTHESIS; ERYTHROCYTE-MEMBRANES; ARTICULAR-CARTILAGE; PLASMA; PHOSPHATIDYLCHOLINE; LUBRICATION; SERUM; QUANTIFICATION	The current limitations in evaluating synovial fluid (SF) components in health and disease and between species are due in part to the lack of data on normal SF, because of low availability of SF from healthy articular joints. Our study aimed to quantify species-dependent differences in phospholipid (PL) profiles of normal knee SF obtained from equine and human donors. Knee SF was obtained during autopsy by arthrocentesis from 15 and 13 joint-healthy human and equine donors, respectively. PL species extracted from SF were quantitated by mass spectrometry whereas ELISA determined apolipoprotein (Apo) B-100. Wilcoxon's rank sum test with adjustment of scores for tied values was applied followed by Holm ' s method to account for multiple testing. Six lipid classes with 89 PL species were quantified, namely phosphatidylcholine, lysophosphatidylcholine, sphingomyelin, phosphatidylethanolamine, plasmalogen, and ceramide. Importantly, equine SF contains about half of the PL content determined in human SF with some characteristic changes in PL composition. Nutritional habits, decreased apolipoprotein levels and altered enzymatic activities may have caused the observed different PL profiles. Our study provides comprehensive quantitative data on PL species levels in normal human and equine knee SF so that research in joint diseases and articular lubrication can be facilitated.	[Kosinska, Marta K.; Steinmeyer, Juergen] Justus Liebig Univ Giessen, Dept Orthopaed, Lab Expt Orthopaed, Giessen, Germany; [Eichner, Gerrit] Justus Liebig Univ Giessen, Math Inst, Giessen, Germany; [Schmitz, Gerd; Liebisch, Gerhard] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Regensburg	Steinmeyer, J (corresponding author), Justus Liebig Univ Giessen, Dept Orthopaed, Lab Expt Orthopaed, Giessen, Germany.	juergen.steinmeyer@ortho.med.uni-giessen.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Steinmeyer, Juergen/0000-0002-4053-503X				Chen Yi, 2007, J Orthop Surg Res, V2, P14, DOI 10.1186/1749-799X-2-14; Dedinaite A, 2019, ADV COLLOID INTERFAC, V274, DOI 10.1016/j.cis.2019.102050; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Ditz T, 2019, DIFFERENTIATION, V105, P27, DOI 10.1016/j.diff.2018.12.002; Ferlazzo AM, 2011, VET RES COMMUN, V35, P521, DOI 10.1007/s11259-011-9496-4; Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142, DOI 10.1055/s-0038-1632990; Fuchs B, 2009, J ANIM PHYSIOL AN N, V93, P410, DOI 10.1111/j.1439-0396.2008.00822.x; Gibson DS, 2007, PROTEOM CLIN APPL, V1, P889, DOI 10.1002/prca.200700044; Huang T, 2013, BRIT J NUTR, V109, P1688, DOI 10.1017/S000711451200356X; Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025; Hui AY, 2012, WIRES SYST BIOL MED, V4, P15, DOI 10.1002/wsbm.157; Hunziker EB, 1999, CLIN ORTHOP RELAT R, pS135; Jahn S, 2016, ANNU REV BIOMED ENG, V18, P235, DOI 10.1146/annurev-bioeng-081514-123305; Kahleova H, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.12; KNIGHT AD, 1984, Q J EXP PHYSIOL CMS, V69, P271, DOI 10.1113/expphysiol.1984.sp002805; KNIGHT AD, 1988, Q J EXP PHYSIOL CMS, V73, P47, DOI 10.1113/expphysiol.1988.sp003122; Kosinska MK, 2016, OSTEOARTHR CARTILAGE, V24, P1470, DOI 10.1016/j.joca.2016.03.017; Kosinska MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125192; Kosinska MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091769; Kosinska MK, 2013, ARTHRITIS RHEUM-US, V65, P2323, DOI 10.1002/art.38053; Lee HY, 2000, EUR J CLIN NUTR, V54, P768, DOI 10.1038/sj.ejcn.1601089; Leslie DS, 2008, IMMUNOLOGY, V125, P289, DOI 10.1111/j.1365-2567.2008.02842.x; Levick JR., 1987, JOINT LOADING BIOL H, P149; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Maldjian A, 1996, COMP BIOCHEM PHYS B, V115, P153, DOI 10.1016/0305-0491(96)00086-7; Mann N, 2006, LIPIDS, V41, P637, DOI 10.1007/s11745-006-5014-9; Matei CI, 2014, MICROSC MICROANAL, V20, P903, DOI 10.1017/S1431927614000415; Moesgaard B, 2002, COMP BIOCHEM PHYS B, V131, P475, DOI 10.1016/S1096-4959(02)00003-9; NouriSorkhabi MH, 1996, COMP BIOCHEM PHYS B, V113, P221, DOI 10.1016/0305-0491(95)02011-X; Ogedegbe HO, 2001, LAB MED, V32, P384; Oliviero F, 2012, CLIN CHIM ACTA, V413, P303, DOI 10.1016/j.cca.2011.10.019; Pamplona R, 2000, MECH AGEING DEV, V112, P169, DOI 10.1016/S0047-6374(99)00045-7; Panz T, 2011, FOLIA HISTOCHEM CYTO, V49, P425, DOI 10.5603/FHC.2011.0060; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; R Core Team, 2019, LANGUAGE ENVIRONEMNT; Rosell MS, 2005, AM J CLIN NUTR, V82, P327, DOI 10.1093/ajcn/82.2.327; Ross-Jones TN, 2016, J ANIM PHYSIOL AN N, V100, P565, DOI 10.1111/jpn.12359; Sarkar D., **DATA OBJECT**; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; SIMKIN PA, 1990, ARTHRITIS RHEUM, V33, P73, DOI 10.1002/art.1780330109; Sluzalska KD, 2017, OSTEOARTHR CARTILAGE, V25, P1890, DOI 10.1016/j.joca.2017.07.011; Sluzalska KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14004-9; Sorkin R, 2013, BIOMATERIALS, V34, P5465, DOI 10.1016/j.biomaterials.2013.03.098; Souto PC, 2019, J EQUINE VET SCI, V80, P1, DOI 10.1016/j.jevs.2019.06.002; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; Subbaiah PV, 1996, J LIPID RES, V37, P113; Trunfio-Sfarghiu AM, 2008, LANGMUIR, V24, P8765, DOI 10.1021/la8005234; Tsezou A, 2010, J ORTHOP RES, V28, P1033, DOI 10.1002/jor.21084; van der Kraan PM, 2017, OSTEOARTHR CARTILAGE, V25, P369, DOI 10.1016/j.joca.2016.09.005; WATSON TDG, 1992, EQUINE VET J, V24, P341, DOI 10.1111/j.2042-3306.1992.tb02852.x; WATSON TDG, 1991, EQUINE VET J, V23, P353, DOI 10.1111/j.2042-3306.1991.tb03737.x; WEGMAN EJ, 1990, J AM STAT ASSOC, V85, P664, DOI 10.2307/2290001; Yokoyama Y, 2017, NUTR REV, V75, P683, DOI 10.1093/nutrit/nux030; Zeileis A., 2019, **DATA OBJECT**	55	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0250146	10.1371/journal.pone.0250146	http://dx.doi.org/10.1371/journal.pone.0250146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861772	Green Published, gold			2022-12-26	WOS:000641475400036
J	Wang, RF; Hu, XB; Liu, XR; Bai, L; Gu, JS; Li, QG				Wang, Ruifang; Hu, Xiaobo; Liu, Xiaorui; Bai, Lu; Gu, Junsheng; Li, Qinggang			Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis	PLOS ONE			English	Article							LONG NONCODING RNAS; CANCER STEM-CELLS; COMPLEX DISEASES; TUMOR-SUPPRESSOR; PATHWAY; CERNA; ACHIEVEMENTS; MIR-589-5P; MUTATIONS; MICRORNAS	Liver hepatocellular carcinoma (LIHC) is one of the major causes of cancer-related death worldwide with increasing incidences, however there are very few studies about the underlying mechanisms and pathways in the development of LIHC. We obtained LIHC samples from The Cancer Genome Atlas (TCGA) to screen differentially expressed mRNAs, lncRNAs, miRNAs and driver mutations. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, Gene ontology enrichment analyses and protein-protein interaction (PPI) network were performed. Moreover, we constructed a competing endogenous lncRNAs-miRNAs-mRNAs network. Finally, cox proportional hazards regression analysis was used to identify important prognostic differentially expressed genes. Total of 1284 mRNAs, 123 lncRNAs, 47 miRNAs were identified within different tissues of LIHC patients. GO analysis indicated that upregulated and downregulated differentially expressed mRNAs (DEmRNAs) were mainly associated with cell division, DNA replication, mitotic sister chromatid segregation and complement activation respectively. Meanwhile, KEGG terms revealed that upregulated and downregulated DEmRNAs were primarily involved in DNA replication, Metabolic pathways, cell cycle and Metabolic pathways, chemical carcinogenesis, retinol metabolism pathway respectively. Among the DERNAs, 542 lncRNAs-miRNAs-mRNAs pairs were predicted to construct a ceRNA regulatory network including 35 DElncRNAs, 26 DEmiRNAs and 112 DEmRNAs. In the Kaplan-Meier analysis, total of 43 mRNAs, 14 lncRNAs and 3 miRNAs were screened out to be significantly correlated with overall survival of LIHC. The mutation signatures were analyzed and its correlation with immune infiltrates were evaluated using the TIMER in LIHC. Among the mutation genes, TTN mutation is often associated with poor immune infiltration and a worse prognosis in LIHC. This work conducted a novel lncRNAs-miRNAs-mRNAs network and mutation signatures for finding potential molecular mechanisms underlying the development of LIHC. The biomarkers also can be used for predicting prognosis of LIHC.	[Wang, Ruifang] Zhengzhou Univ, Dept Nucl Med, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Hu, Xiaobo; Liu, Xiaorui; Bai, Lu; Gu, Junsheng; Li, Qinggang] Zhengzhou Univ, Dept Infect Dis, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Li, QG (corresponding author), Zhengzhou Univ, Dept Infect Dis, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	fccliqg@zzu.edu.cn						Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Byam Jerome, 2013, Hepatobiliary Surg Nutr, V2, P22, DOI 10.3978/j.issn.2304-3881.2012.11.03; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060; Chen X, 2020, BRIEF BIOINFORM, V21, P47, DOI 10.1093/bib/bby098; Chen X, 2019, BRIEF FUNCT GENOMICS, V18, P58, DOI 10.1093/bfgp/ely031; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; de Galarreta MR, 2019, CANCER DISCOV, V9, P1124, DOI 10.1158/2159-8290.CD-19-0074; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Frenette C, 2012, WORLD J GASTROENTERO, V18, P498, DOI 10.3748/wjg.v18.i6.498; Giray BG, 2014, MOL BIOL REP, V41, P4513, DOI 10.1007/s11033-014-3322-3; Golubnitschaja O, 2007, SURV OPHTHALMOL, V52, pS155, DOI 10.1016/j.survophthal.2007.08.011; Han B., 2019, NOVEL MICRORNA SIGNA, DOI [10.1002/jcp.28690, DOI 10.1002/JCP.28690]; Huang XL, 2018, AM J PHYSIOL-GASTR L, V314, pG559, DOI 10.1152/ajpgi.00242.2017; Jia QZ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127901; Jiang CL, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0568-3; Karreth FA, 2013, CANCER DISCOV, V3, P1113, DOI 10.1158/2159-8290.CD-13-0202; Li H, 2017, ONCOTARGET, V8, P39859, DOI 10.18632/oncotarget.16339; Li L, 2020, DNA REPAIR, V88, DOI 10.1016/j.dnarep.2020.102785; Li ZL, 2018, ADV MATER, V30, DOI 10.1002/adma.201706981; Liu JX, 2017, BIOMED PHARMACOTHER, V89, P857, DOI 10.1016/j.biopha.2017.01.011; Long JT, 2018, CANCER LETT, V423, P113, DOI 10.1016/j.canlet.2017.11.031; Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942; MacConaill LE, 2013, J CLIN ONCOL, V31, P1815, DOI 10.1200/JCO.2012.46.5948; Matsui M, 2017, NAT REV DRUG DISCOV, V16, P167, DOI 10.1038/nrd.2016.117; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Oliver GR, 2015, CLIN CHEM, V61, P124, DOI 10.1373/clinchem.2014.224360; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Quan J, 2018, ONCOTARGETS THER, V11, P6415, DOI 10.2147/OTT.S167853; Raza A, 2014, WORLD J GASTROENTERO, V20, P4115, DOI 10.3748/wjg.v20.i15.4115; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Su M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0663-8; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wu L, 2015, CHEM SOC REV, V44, P2963, DOI 10.1039/c4cs00370e; Xiong H, 2017, ONCOGENE, V36, P3528, DOI 10.1038/onc.2016.521; Xiong XD, 2016, DRUG RESIST UPDATE, V26, P28, DOI 10.1016/j.drup.2016.04.001; Zhang J, 2020, BRIEF BIOINFORM, V21, P1080, DOI 10.1093/bib/bbz040; Zhang X, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0452-6; Zheng YJ, 2018, CANCER MANAG RES, V10, P6079, DOI 10.2147/CMAR.S181396; Zhou CX, 2018, EUR REV MED PHARMACO, V22, P6002, DOI 10.26355/eurrev_201809_15935	46	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2021	16	4							e0249881	10.1371/journal.pone.0249881	http://dx.doi.org/10.1371/journal.pone.0249881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DH	33861762	gold, Green Published			2022-12-26	WOS:000641475400003
J	DeVries, L; Horstman, C; Fossell, M; Carlson, C				DeVries, Laura; Horstman, Cara; Fossell, Marie; Carlson, Clayton			Ingestion of Bifidobacterium longum changes miRNA levels in the brains of mice	PLOS ONE			English	Article							MICROBIOTA	The purpose of this research is to investigate the relationship between the microbiota of the gastrointestinal (GI) system and relative gene expression of miRNAs and mRNAs in the brain. C57BL/6 mice and Balb/c mice are fed Bifidobacterium longum, a well-characterized probiotic bacterial species shown to change behavior and improve sociability of Balb/c mice. After feeding, RNA was extracted from whole brains and PCR arrays were utilized to determine changes in the gene expression of brain-specific miRNAs. The results of these PCR arrays reveal that the relative gene expression of mmu-mir-652-3p is sensitive to B. longum probiotic treatment in C57BL/6 mice. qPCR was performed to measure expression of Dab1, an mRNA target of this miRNA. Dab1 expression is also dependent on B. longum. The goal of this study is to further understand the relationship between the gut microbiota and its impacts on neurological gene expression and brain function.	[DeVries, Laura; Horstman, Cara; Fossell, Marie; Carlson, Clayton] Trinity Christian Coll, Dept Biol, Palos Hts, IL 60463 USA; [Horstman, Cara] Crown Coll, Student Life Dept, St Bonifacius, MN USA; [Fossell, Marie] Marquette Univ, Dept Nursing, Milwaukee, WI 53233 USA	Marquette University	Carlson, C (corresponding author), Trinity Christian Coll, Dept Biol, Palos Hts, IL 60463 USA.	clayton.carlson@trnty.edu			Trinity Christian College	Trinity Christian College	The study was supported by the Trinity Christian College with Honors awarded to Laura DeVries and Cara Horstman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Ait-Belgnaoui A, 2014, NEUROGASTROENT MOTIL, V26, P510, DOI 10.1111/nmo.12295; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Cryan JF, 2015, NEUROPSYCHOPHARMACOL, V40, P241, DOI 10.1038/npp.2014.224; Heinla I, 2018, PHYSIOL BEHAV, V188, P32, DOI 10.1016/j.physbeh.2018.01.024; Hoban AE, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0321-3; Hugon P, 2015, LANCET INFECT DIS, V15, P1211, DOI 10.1016/S1473-3099(15)00293-5; Mishima E, 2020, TOXINS, V12, DOI 10.3390/toxins12090547; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Rao M, 2016, NAT REV GASTRO HEPAT, V13, DOI 10.1038/nrgastro.2016.107; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Rojas OL, 2019, CELL, V176, P610, DOI 10.1016/j.cell.2018.11.035; Romijn AR, 2015, NUTR REV, V73, P675, DOI 10.1093/nutrit/nuv025; Savignac HM, 2014, NEUROGASTROENT MOTIL, V26, P1615, DOI 10.1111/nmo.12427; Smith CJ, 2014, AM J PHYSIOL-GASTR L, V307, pG793, DOI 10.1152/ajpgi.00238.2014; Teixeira CM, 2014, NEUROPSYCHOPHARMACOL, V39, P556, DOI 10.1038/npp.2013.226; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447	21	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249817	10.1371/journal.pone.0249817	http://dx.doi.org/10.1371/journal.pone.0249817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857178	Green Published, gold			2022-12-26	WOS:000641474900019
J	Guedj, K; Uzzan, M; Soudan, D; Trichet, C; Nicoletti, A; Weiss, E; Manceau, H; Nuzzo, A; Corcos, O; Treton, X; Peoc'h, K				Guedj, Kevin; Uzzan, Mathieu; Soudan, Damien; Trichet, Catherine; Nicoletti, Antonino; Weiss, Emmanuel; Manceau, Hana; Nuzzo, Alexandre; Corcos, Olivier; Treton, Xavier; Peoc'h, Katell			I-FABP is decreased in COVID-19 patients, independently of the prognosis	PLOS ONE			English	Article							ACID-BINDING PROTEIN; MARKER	Background Severe acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) is frequently associated with gastrointestinal manifestations. Herein we evaluated the interest in measuring the intestinal fatty acid-binding protein (I-FABP), a biomarker of intestinal injury, in COVID-19 patients. Methods Serum I-FABP was analyzed in 28 consecutive patients hospitalized for a PCR-confirmed COVID-19, in 24 hospitalized patients with non-COVID-19 pulmonary diseases, and 79 patients admitted to the emergency room for abdominal pain. Results I-FABP serum concentrations were significantly lower in patients with COVID-19, as compared to patients with non-COVID-19 pulmonary diseases [70.3 pg/mL (47-167.9) vs. 161.1 pg/mL (88.98-305.2), respectively, p = 0.008]. I-FABP concentrations in these two populations were significantly lower than in patients with abdominal pain without COVID-19 [344.8 pg/mL (268.9-579.6)]. I-FABP was neither associated with severity nor the duration of symptoms. I-FABP was correlated with polymorphonuclear cell counts. Conclusions In this pilot study, we observed a low I-FABP concentration in COVID-19 patients either with or without gastrointestinal symptoms, of which the pathophysiological mechanisms and clinical impact remain to be established. Further explorations on a larger cohort of patients will be needed to unravel the molecular mechanism of such observation, including the effects of malabsorption and/or abnormal lipid metabolism.	[Guedj, Kevin; Nicoletti, Antonino] INSERM UMRS 1148 LVTS, Paris, France; [Guedj, Kevin; Nicoletti, Antonino; Manceau, Hana; Treton, Xavier; Peoc'h, Katell] Univ Paris, Paris, France; [Uzzan, Mathieu; Soudan, Damien; Nuzzo, Alexandre; Corcos, Olivier; Treton, Xavier] Beaujon Hosp, AP HP, Gastroenterol Dept, Clichy, France; [Trichet, Catherine] Beaujon Hosp, AP HP, Haematol Dept, Clichy, France; [Weiss, Emmanuel] Beaujon Hosp, AP HP, Intens Care Unit, Clichy, France; [Manceau, Hana; Treton, Xavier; Peoc'h, Katell] INSERM UMRs 1149, CRI, Paris, France; [Manceau, Hana; Peoc'h, Katell] Beaujon Hosp, AP HP, Biochem Dept, Clichy, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Guedj, K (corresponding author), INSERM UMRS 1148 LVTS, Paris, France.; Guedj, K (corresponding author), Univ Paris, Paris, France.	Kevin.guedj@gmail.com	Peoc'h, Katell/V-1604-2017; Manceau, Hana/P-2970-2017	Peoc'h, Katell/0000-0002-8203-1243; Manceau, Hana/0000-0003-4158-0964; Nuzzo, Alexandre/0000-0002-8952-7620				Adriaanse MPM, 2013, ALIMENT PHARM THER, V37, P482, DOI 10.1111/apt.12194; Bingold TM, 2015, SURG INFECT, V16, P247, DOI 10.1089/sur.2014.073; El Moheb M, 2020, JAMA-J AM MED ASSOC, V324, P1899, DOI 10.1001/jama.2020.19400; Hoel H, 2021, J INTERN MED, V289, P523, DOI 10.1111/joim.13178; Isnard S, 2020, J INFECT DIS, V221, P110, DOI 10.1093/infdis/jiz423; Lackey AI, 2020, AM J PHYSIOL-GASTR L, V318, pG518, DOI 10.1152/ajpgi.00120.2019; Ma CX, 2020, AM J GASTROENTEROL, V115, P1003, DOI 10.14309/ajg.0000000000000691; Myhre PL, 2020, CIRCULATION, V142, P2128, DOI 10.1161/CIRCULATIONAHA.120.050360; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Oliva A, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofz507; Peoc'h K, 2018, CLIN CHEM LAB MED, V56, P373, DOI 10.1515/cclm-2017-0291; Sekino M, 2017, J CRIT CARE, V42, P92, DOI 10.1016/j.jcrc.2017.07.012; Takano T, 2021, INT IMMUNOL, V33, P241, DOI 10.1093/intimm/dxab005; Tanaka S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239573; Uzzan M, 2020, DIGEST LIVER DIS, V52, P1104, DOI 10.1016/j.dld.2020.06.042; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Webb BJ, 2020, LANCET RHEUMATOL, V2, pE754, DOI 10.1016/S2665-9913(20)30343-X; Wei XQ, 2020, J CLIN LIPIDOL, V14, P297, DOI 10.1016/j.jacl.2020.04.008; Zhang H, 2020, DIGEST LIVER DIS, V52, P1076, DOI 10.1016/j.dld.2020.04.034; Zou L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011782; Zuo T, 2020, GASTROENTEROLOGY, V159, P944, DOI 10.1053/j.gastro.2020.05.048	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249799	10.1371/journal.pone.0249799	http://dx.doi.org/10.1371/journal.pone.0249799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857216	gold, Green Published			2022-12-26	WOS:000641474900115
J	Phadnis, R; Wickramasinghe, C; Zevallos, JC; Davlin, S; Kumarapeli, V; Lea, V; Lee, J; Perera, U; Solorzano, FX; Vasconez, JF				Phadnis, Rachael; Wickramasinghe, Champika; Zevallos, Juan Carlos; Davlin, Stacy; Kumarapeli, Vindya; Lea, Veronica; Lee, Juliette; Perera, Udara; Solorzano, Francisco Xavier; Vasconez, Juan Francisco			Leveraging mobile phone surveys during the COVID-19 pandemic in Ecuador and Sri Lanka: Methods, timeline and findings	PLOS ONE			English	Article								Effective and rapid decision making during a pandemic requires data not only about infections, but also about human behavior. Mobile phone surveys (MPS) offer the opportunity to collect real-time data on behavior, exposure, knowledge, and perception, as well as care and treatment to inform decision making. The surveys aimed to collect coronavirus disease 2019 (COVID-19) related information in Ecuador and Sri Lanka using mobile phones. In Ecuador, a Knowledge, Attitudes and Practices (KAP) survey was conducted. In Sri Lanka, an evaluation of a novel medicine delivery system was conducted. Using the established mobile network operator channels and technical assistance provided through The Bloomberg Philanthropies Data for Health Initiative (D4H), Ministries of Health fielded a population-based COVID-19-specific MPS using Surveda, the open source data collection tool developed as part of the initiative. A total of 1,185 adults in Ecuador completed the MPS in 14 days. A total of 5,001 adults over the age of 35 in Sri Lanka completed the MPS in 44 days. Both samples were adjusted to the 2019 United Nations Population Estimates to produce population-based estimates by age and sex. The Ecuador COVID-19 MPS found that there was compliance with the mitigation strategies implemented in that country. Overall, 96.5% of Ecuadorians reported wearing a face mask or face covering when leaving home. Overall, 3.8% of Sri Lankans used the service to receive medicines from a government clinic. Among those who used the medicine delivery service in Sri Lanka, 95.8% of those who used a private pharmacy received their medications within one week, and 69.9% of those using a government clinic reported the same. These studies demonstrate that MPS can be conducted quickly and gather essential data. MPS can help monitor the impact of interventions and programs, and rapidly identify what works in mitigating the impact of COVID-19.	[Phadnis, Rachael; Davlin, Stacy; Lea, Veronica; Lee, Juliette] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA 30333 USA; [Phadnis, Rachael; Davlin, Stacy; Lee, Juliette] CDC Fdn, Atlanta, GA 30308 USA; [Wickramasinghe, Champika; Kumarapeli, Vindya; Perera, Udara] Minist Hlth, Noncommunicable Dis Bur, Colombo, Sri Lanka; [Zevallos, Juan Carlos; Solorzano, Francisco Xavier] Minist Hlth, Quito, Ecuador; [Vasconez, Juan Francisco] Minist Hlth Ecuador, CDC Fdn, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Phadnis, R (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA 30333 USA.; Phadnis, R (corresponding author), CDC Fdn, Atlanta, GA 30308 USA.	oto4@cdc.gov		Wickramasinghe, Shiranee/0000-0001-7949-6077; Phadnis, Rachael/0000-0002-0150-7749	Bloomberg Philanthropies; Australian Government, Department of Foreign Affairs and Trade	Bloomberg Philanthropies; Australian Government, Department of Foreign Affairs and Trade(Australian Government)	Funding for the Data for Health Initiative and NCD Mobile Phone Survey is provided by Bloomberg Philanthropies and the Australian Government, Department of Foreign Affairs and Trade.	AAPOR, 2016, ENCY SURVEY RES METH; Adjiwanou V., MEASURING EXCESS MOR; [Anonymous], 2020, ABC NEWSIPSOS POLL; [Anonymous], 2020, C MO FUNCIONAN RESTR; [Anonymous], 2020, TOQUE QUEDA ENTRE 19, P0; [Anonymous], 2020, EL COMERCIO; Ballivian A, 2013, MOBILE RES METHODS O, DOI [10.5334/bar.c, DOI 10.5334/BAR.C]; Burki T, 2020, LANCET INFECT DIS, V20, P547, DOI 10.1016/S1473-3099(20)30303-0; Centers for Disease Control and Prevention, 2015, DATA HLTH INITIATIVE; Dabalen A, 2016, MOBILE PHONE PANEL S; Dillon B, 2012, J INT DEV, V24, P518, DOI 10.1002/jid.1771; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; ESCAP U UPU UP  World Health Organization (WHO), **DROPPED REF**; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Gibson DG, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001604; Gibson DG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7428; International Telecommunication Union, 2020, STAT MOBILE CELLULAR; Leo B, 2015, CTR GLOBAL DEV WORKI; Mukhopadhyay A., SRI LANKA SUCCESSFUL; Oliver N., MOBILE PHONE DATA IN; Thasleem Ashkar., 2020, AL JAZEERA; UNHCR, 2020, DATA COLLECTION TIME; UNICEF, 2020, COLLECTING DATA AGE; Wickramaarachchi WPTM, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/4045064; World Health Organization, 2020, DIR GEN OP REM MED B; Yayboke E., 2020, 5 WAYS COVID 19 IS C; Zegarra-Valdivia J., 2020, KNOWLEDGE ATTITUDES, DOI [10.31234/osf.io/w9y6z, DOI 10.31234/OSF.IO/W9Y6Z]	27	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0250171	10.1371/journal.pone.0250171	http://dx.doi.org/10.1371/journal.pone.0250171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857226	gold, Green Published			2022-12-26	WOS:000641474900073
J	Essler, JL; Kane, SA; Nolan, P; Akaho, EH; Berna, AZ; DeAngelo, A; Berk, RA; Kaynaroglu, P; Plymouth, VL; Frank, ID; Weiss, SR; John, ARO; Otto, CM				Essler, Jennifer L.; Kane, Sarah A.; Nolan, Pat; Akaho, Elikplim H.; Berna, Amalia Z.; DeAngelo, Annemarie; Berk, Richard A.; Kaynaroglu, Patricia; Plymouth, Victoria L.; Frank, Ian D.; Weiss, Susan R.; John, Audrey R. Odom; Otto, Cynthia M.			Discrimination of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study	PLOS ONE			English	Article								While the world awaits a widely available COVID-19 vaccine, availability of testing is limited in many regions and can be further compounded by shortages of reagents, prolonged processing time and delayed results. One approach to rapid testing is to leverage the volatile organic compound (VOC) signature of SARS-CoV-2 infection. Detection dogs, a biological sensor of VOCs, were utilized to investigate whether SARS-CoV-2 positive urine and saliva patient samples had a unique odor signature. The virus was inactivated in all training samples with either detergent or heat treatment. Using detergent-inactivated urine samples, dogs were initially trained to find samples collected from hospitalized patients confirmed with SARS-CoV-2 infection, while ignoring samples collected from controls. Dogs were then tested on their ability to spontaneously recognize heat-treated urine samples as well as heat-treated saliva from hospitalized SARS-CoV-2 positive patients. Dogs successfully discriminated between infected and uninfected urine samples, regardless of the inactivation protocol, as well as heat-treated saliva samples. Generalization to novel samples was limited, particularly after intensive training with a restricted sample set. A unique odor associated with SARS-CoV-2 infection present in human urine as well as saliva, provides impetus for the development of odor-based screening, either by electronic, chemical, or biological sensing methods. The use of dogs for screening in an operational setting will require training with a large number of novel SARS-CoV-2 positive and confirmed negative samples.	[Essler, Jennifer L.; Kane, Sarah A.; DeAngelo, Annemarie; Kaynaroglu, Patricia; Plymouth, Victoria L.; Otto, Cynthia M.] Univ Penn, Sch Vet Med, Penn Vet Working Dog Ctr, Philadelphia, PA 19104 USA; [Nolan, Pat] Tact Direct Canine, Smithsburg, MD USA; [Akaho, Elikplim H.; Berna, Amalia Z.; John, Audrey R. Odom] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Berk, Richard A.] Univ Penn, Dept Criminol, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Berk, Richard A.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Frank, Ian D.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Weiss, Susan R.] Univ Penn, Sch Med, Dept Microbiol, Penn Ctr Res Coronaviruses & Other Emerging Patho, Philadelphia, PA 19104 USA; [Otto, Cynthia M.] Univ Penn, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Otto, CM (corresponding author), Univ Penn, Sch Vet Med, Penn Vet Working Dog Ctr, Philadelphia, PA 19104 USA.; Otto, CM (corresponding author), Univ Penn, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA.	cmotto@vet.upenn.edu	Perez, Amalia Berna/C-2139-2008	Perez, Amalia Berna/0000-0003-4932-5415	NIH/NIAID [R21AI144472, R21AI154370, R61DH105594]; NIH [R01-140442]; Ovarian Cancer Symptom Awareness (OCSA) fund	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Symptom Awareness (OCSA) fund	A.O.J. is supported by NIH/NIAID R21AI144472, R21AI154370, R61DH105594, and A.O.J. is an Investigator in the Pathogenesis of Infectious Diseases (PATH) of the Burroughs Wellcome Fund, and SRW is supported by NIH R01-140442 but these agencies did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The gift from Vernon and Shirley Hill provided support in the form of salaries for authors [JLE, SAK, PN, AD, PK and CMO], VLP was supported by the Ovarian Cancer Symptom Awareness (OCSA) fund, these funding agencies did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abd El Qader A, 2015, BIOMED CHROMATOGR, V29, P1783, DOI 10.1002/bmc.3494; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Aksenov AA, 2014, CHEMBIOCHEM, V15, P1040, DOI 10.1002/cbic.201300695; Angle TC, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2015.00079; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006; Edwards TL, 2017, J VET BEHAV, V20, P59, DOI 10.1016/j.jveb.2017.05.002; Furton KG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0262; Furton KG, 2012, UNIVERSAL DETECTOR C; Gadbois S, 2014, DOMESTIC DOG COGNITI, P3, DOI DOI 10.1007/978-3-642-53994-7_1; Grandjean D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243122; Jendrny P, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05281-3; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Kybert N, 2020, AIP ADV, V10, DOI 10.1063/1.5144532; Maughan MN., 2017, METHODS USING TRAINI; Maurer M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw051; Patterson EI, 2020, J INFECT DIS, V222, P1462, DOI 10.1093/infdis/jiaa507; Peng L, 2020, J MED VIROL, V92, P1676, DOI 10.1002/jmv.25936; Perez-Saez J, 2020, LANCET INFECT DIS, DOI [10.1016/S1473-3099%2820%2930584-3, DOI 10.1016/S1473-3099%2820%2930584-3]; Reeve C, 2020, CAN J DIABETES, V44, P37, DOI 10.1016/j.jcjd.2019.04.020; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Skirka H., 2020, THE NATIONAL; Stout AE, 2020, VET MICROBIOL, V247, DOI 10.1016/j.vetmic.2020.108777; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; Trivedi DK, 2019, ACS CENTRAL SCI, V5, P599, DOI 10.1021/acscentsci.8b00879	26	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250158	10.1371/journal.pone.0250158	http://dx.doi.org/10.1371/journal.pone.0250158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852639	gold, Green Published			2022-12-26	WOS:000640604500041
J	Kiguchi, T; Yamamoto-Hanada, K; Saito-Abe, M; Sato, M; Irahara, M; Ogita, H; Miyagi, Y; Inuzuka, Y; Toyokuni, K; Nishimura, K; Ishikawa, F; Miyaji, Y; Kabashima, S; Fukuie, T; Narita, M; Ohya, Y				Kiguchi, Tomoyuki; Yamamoto-Hanada, Kiwako; Saito-Abe, Mayako; Sato, Miori; Irahara, Makoto; Ogita, Hiroya; Miyagi, Yoshitsune; Inuzuka, Yusuke; Toyokuni, Kenji; Nishimura, Koji; Ishikawa, Fumi; Miyaji, Yumiko; Kabashima, Shigenori; Fukuie, Tatsuki; Narita, Masami; Ohya, Yukihiro			Pollen-food allergy syndrome and component sensitization in adolescents: A Japanese population-based study	PLOS ONE			English	Article							CHILDHOOD ISAAC; ASTHMA; SYMPTOMS; IGE; EPIDEMIOLOGY; PREVALENCE; RATIONALE; DIAGNOSIS; POLLINOSIS; CHILDREN	Allergic rhino-conjunctivitis with pollen allergy has been prevalent worldwide and Pollen-food allergy syndrome (PFAS) refers to individuals with pollen allergy who develop oral allergy syndrome (OAS) on consuming fruits and vegetables. The prevalence of PFAS varies by region and that in Japanese adolescents remains to be elucidated. In this cross-sectional study, we examined the epidemiological characteristics of PFAS in a general population of Japanese adolescents according to pollen allergy, OAS, and IgE component sensitization. Participants comprised adolescents, at age 13 years, from a prospective birth cohort study in Japan. We administered questionnaires to collect information from parents regarding pollen allergy, PFAS and OAS at each child's age 13 years. ImmunoCAP ISAC was used to assess IgE component sensitization. Among 506 participants with a complete questionnaire and ISAC measurement results, 56.5% had a history of hay fever, 16.0% had a history of OAS, 51.0% had pollen allergy, and 11.7% had a history of PFAS; additionally, 72.7% were sensitized to one or more tree, grass, and/or weed allergens. The most common sensitization (95.7%) among adolescents with pollen allergy was to Japanese cedar (Cry j 1). The most common causal foods were kiwi and pineapple (both 39.0%). Knowledge levels about PFAS were poor among affected adolescents. We found a high prevalence of PFAS among adolescents in Japan. Although it affects approximately 1/10 adolescents in the general population, public awareness regarding PFAS is poor. Interventional strategies are needed to increase knowledge and to prevent PFAS in the general population.	[Kiguchi, Tomoyuki; Yamamoto-Hanada, Kiwako; Saito-Abe, Mayako; Sato, Miori; Irahara, Makoto; Ogita, Hiroya; Miyagi, Yoshitsune; Inuzuka, Yusuke; Toyokuni, Kenji; Nishimura, Koji; Ishikawa, Fumi; Miyaji, Yumiko; Kabashima, Shigenori; Fukuie, Tatsuki; Narita, Masami; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan	National Center for Child Health & Development - Japan	Yamamoto-Hanada, K (corresponding author), Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan.	yamamoto-k@ncchd.go.jp	Yamamoto-Hanada, Kiwako/AAR-3094-2020; Yamamoto-Hanada, Kiwako/GQH-6445-2022	Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620	National Center for Child Health and Development [26-18]	National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded and supported by the Grant of National Center for Child Health and Development [grant number 26-18].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMLOT PL, 1987, CLIN ALLERGY, V17, P33, DOI 10.1111/j.1365-2222.1987.tb02317.x; Arai Y, 1998, Arerugi, V47, P715; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Biedermann T, 2019, ALLERGY, V74, P1237, DOI 10.1111/all.13758; BIRCHER AJ, 1994, CLIN EXP ALLERGY, V24, P367, DOI 10.1111/j.1365-2222.1994.tb00248.x; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; Brown CEB, 2014, J PAEDIATR CHILD H, V50, P795, DOI 10.1111/jpc.12658; Carlson G, 2019, ANN ALLERG ASTHMA IM, V123, P359, DOI 10.1016/j.anai.2019.07.022; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Hamilton RG, 2020, J ALLER CL IMM-PRACT, V8, P2495, DOI 10.1016/j.jaip.2020.07.021; Irahara M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234161; Jakob Thilo, 2015, Allergo J Int, V24, P320; Kim MA, 2018, ALLERGY ASTHMA IMMUN, V10, P648, DOI 10.4168/aair.2018.10.6.648; Kondo Y, 2002, CLIN EXP ALLERGY, V32, P590, DOI 10.1046/j.0954-7894.2002.01337.x; Koseki R, 2019, J HUM GENET, V64, P911, DOI 10.1038/s10038-019-0628-y; Lessof MH, 1996, J ALLERGY CLIN IMMUN, V98, P239, DOI 10.1016/S0091-6749(96)70252-X; Maeda N, 2010, ANN ALLERG ASTHMA IM, V104, P205, DOI 10.1016/j.anai.2009.11.049; Martinez-Aranguren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088394; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; Nakamura S., 2007, KENBIKYO, V42, P50, DOI [10.11410/kenbikyo2004.42.50, DOI 10.11410/KENBIKYO2004.42.50]; Namba H., 2004, JAPANESE J PALYNOLOG, V50, P73, DOI [10.24524/jjpal.50.2%5F73, DOI 10.24524/JJPAL.50.2%5F73]; Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288, DOI 10.1016/S1081-1206(10)63532-6; Osawa Y, 2020, ALLERGOL INT, V69, P246, DOI 10.1016/j.alit.2019.09.008; Sasaki M, 2020, ALLERGOL INT, V69, P610, DOI 10.1016/j.alit.2020.03.011; Shirasaki H, 2017, AURIS NASUS LARYNX, V44, P442, DOI 10.1016/j.anl.2016.10.004; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Turner PJ, 2020, J ALLER CL IMM-PRACT, V8, P1169, DOI 10.1016/j.jaip.2019.11.027; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Yamamoto-Hanada K, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100105; Yamamoto-Hanada K, 2017, ANN ALLERG ASTHMA IM, V119, P54, DOI 10.1016/j.anai.2017.05.013; Yang LM, 2018, PEDIAT ALLERG IMM-UK, V29, P606, DOI 10.1111/pai.12917	32	9	9	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249649	10.1371/journal.pone.0249649	http://dx.doi.org/10.1371/journal.pone.0249649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852622	Green Published, gold			2022-12-26	WOS:000640604500001
J	Milnerowicz, AI; Milnerowicz, A; Bankowski, T; Protasiewicz, M				Milnerowicz, Artur Igor; Milnerowicz, Aleksandra; Bankowski, Tomasz; Protasiewicz, Marcin			Pressure gradient measurement to verify hemodynamic results of the chimney endovascular aortic repair (chEVAR) technique	PLOS ONE			English	Article							RENAL-ARTERY STENOSIS; ANEURYSM REPAIR; FOLLOW-UP; STENT-GRAFT; PATHOLOGIES; OUTCOMES; RISK	Purpose The use of the pressure gradient measurements to assess the renal artery flow hemodynamics after chimney endovascular aortic repair (chEVAR). Methods The study was a prospective analysis of 37 chEVAR procedures performend in 24 patients with perirenal aortic aneurysm. In all patients the measurement of: distal renal artery pressure (Pd), aortic pressure (Pa), Pd/Pa ratio (Pd/Pa) and mean gradient (MG) between the aorta and the distal renal artery were performed. Measurements were taken with 0.014 inch pressure wire catheter before and after the chEVAR procedure. MG greater than 9 mmHg and Pd/Pa ratio below 0.90 were considered as the measures of a significant decrease in distal pressure that limited flow in renal arteries. The 6 month follow-up computed tomographic angiography (CTA) was performed in all patients to diagnose potential endoleak presence and to verify the patency of the chimney stent-grafts. Results All procedures were successful, and no periprocedural complications were observed in any of the patients. The mean gradient values before and after the chimney implantation did not change significantly (6,2 +/- 2,0 mmHg and 6,8 +/- 2,2 mmHg, respectively). Similarly, no significant change in Pd/Pa values was noted with the value of 0.9 observed both before and after the procedure. All chimney stents were patent on the control CTA. Type Ia endoleak was found in 4 (10.8%) patients. Conclusions The application of the described technique seems to be a safe method which allows a direct measurement of renal artery flow hemodynamics before and after chimney implantation during the chEVAR technique. The use of covered balloon expandable stents, ensures the proper blood flow in the renal arteries during the chEVAR technique.	[Milnerowicz, Artur Igor; Milnerowicz, Aleksandra] 4th Mil Clin Hosp, Dept Vasc Surg, Wroclaw, Poland; [Bankowski, Tomasz] Lower Silesia Specialist Hosp, Dept Cardiol, Tadeusz Marciniak Emergency Med Ctr, Wroclaw, Poland; [Protasiewicz, Marcin] Med Univ Wroclaw, Dept Cardiol, Wroclaw, Poland	Wroclaw Medical University	Protasiewicz, M (corresponding author), Med Univ Wroclaw, Dept Cardiol, Wroclaw, Poland.	mprot@poczta.onet.pl		Protasiewicz, Marcin/0000-0003-0253-0585	Wroclaw Medical University	Wroclaw Medical University	The study was supported by the Wroclaw Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2018, ANN VASC DIS, V11, P458, DOI 10.3400/avd.ra.18-00126; Bruen KJ, 2011, J VASC SURG, V53, P895, DOI 10.1016/j.jvs.2010.10.068; Canavati R, 2013, J VASC SURG, V57, P362, DOI 10.1016/j.jvs.2012.08.040; Caps MT, 1998, KIDNEY INT, V53, P735, DOI 10.1046/j.1523-1755.1998.00805.x; Chabova V, 2000, MAYO CLIN PROC, V75, P437; Chaikof EL, 2002, J VASC SURG, V35, P1048, DOI 10.1067/mva.2002.123763; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; De Bruyne B, 2006, J AM COLL CARDIOL, V48, P1851, DOI 10.1016/j.jacc.2006.05.074; Donas KP, 2016, J VASC SURG, V63, P1, DOI 10.1016/j.jvs.2015.07.080; Donas KP, 2015, ANN SURG, V262, P546, DOI 10.1097/SLA.0000000000001405; Donas KP, 2012, J VASC SURG, V56, P285, DOI 10.1016/j.jvs.2012.01.043; Donas KP, 2012, J VASC SURG, V55, P659, DOI 10.1016/j.jvs.2011.09.052; Greenberg RK, 2003, J VASC SURG, V38, P990, DOI 10.1016/S0741-5214(03)00896-6; Hiramoto JS, 2009, J VASC SURG, V49, P1100, DOI 10.1016/j.jvs.2008.11.060; Hiramoto JS, 2006, J ENDOVASC THER, V13, P72, DOI 10.1583/04-1711R.1; Kansagra K, 2018, CARDIOVASC DIAGN THE, V8, pS175, DOI 10.21037/cdt.2017.08.17; Katsargyris A, 2013, J ENDOVASC THER, V20, P159, DOI 10.1583/1545-1550-20.2.159; Konstantinou N., 2020, J VASC SURG, V19; Linsen MAM, 2012, J VASC SURG, V56, P238, DOI 10.1016/j.jvs.2011.10.092; Mangiacapra F, 2010, CIRC-CARDIOVASC INTE, V3, P537, DOI 10.1161/CIRCINTERVENTIONS.110.957704; Moulakakis KG, 2019, VASC ENDOVASC SURG, V53, P572, DOI 10.1177/1538574419867531; Moulakakis KG, 2012, J VASC SURG, V55, P1497, DOI 10.1016/j.jvs.2011.10.009; Patel R, 2016, LANCET, V388, P2366, DOI 10.1016/S0140-6736(16)31135-7; Patel RP, 2013, CARDIOVASC INTER RAD, V36, P1443, DOI 10.1007/s00270-013-0648-5; Pecoraro F, 2016, EUR J VASC ENDOVASC, V51, P664, DOI 10.1016/j.ejvs.2016.01.010; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pratesi G, 2013, J ENDOVASC THER, V20, P249, DOI 10.1583/1545-1550-20.2.249; Protasiewicz M, 2013, ADV CLIN EXP MED, V22, P875; Protasiewicz M, 2013, AM J CARDIOL, V112, P1417, DOI 10.1016/j.amjcard.2013.06.030; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Ullery BW, 2017, DIFFIC DECIS SURG, P49, DOI 10.1007/978-3-319-33293-2_5; Usai MV, 2015, J ENDOVASC THER, V22, P396, DOI 10.1177/1526602815581161; van Marrewijk C, 2002, J VASC SURG, V35, P461, DOI 10.1067/mva.2002.118823	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249549	10.1371/journal.pone.0249549	http://dx.doi.org/10.1371/journal.pone.0249549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852618	Green Published, gold			2022-12-26	WOS:000640604500047
J	Seong, MJ; Choi, SJ; Joo, EY; Shon, YM; Seo, DW; Hong, SB; Hong, SC				Seong, Min Jae; Choi, Su Jung; Joo, Eun Yeon; Shon, Young-Min; Seo, Dae-Won; Hong, Seung Bong; Hong, Seung Chyul			Surgical outcome and prognostic factors in epilepsy patients with MR-negative focal cortical dysplasia	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; LONG-TERM OUTCOMES; PREDICTIVE FACTORS; SURGERY; SEIZURE; SUBTYPES; CLASSIFICATION; CORTEX; SPECT; EEG	Objective Focal cortical dysplasia (FCD) represents a heterogeneous group of disorders of the cortical formation and is one of the most common causes of epilepsy. Magnetic resonance imaging (MRI) is the modality of choice for detecting structural lesions, and the surgical prognosis in patients with MR lesions is favorable. However, the surgical prognosis of patients with MR-negative FCD is unknown. We aimed to evaluate the long-term surgical outcomes and prognostic factors in MR-negative FCD patients through comprehensive presurgical data. Methods We retrospectively reviewed data from 719 drug-resistant epilepsy patients who underwent resective surgery and selected cases in which surgical specimens were pathologically confirmed as FCD Type I or II. If the epileptogenic focus and surgical specimens were obtained from brain areas with a normal MRI appearance, they were classified as MR-negative FCD. Surgical outcomes were evaluated at 2 and 5 years, and clinical, neurophysiological, and neuroimaging data of MR-negative FCD were compared to those of MR-positive FCD. Results Finally, 47 MR-negative and 34 MR-positive FCD patients were enrolled in the study. The seizure-free rate after surgery (Engel classification I) at postoperative 2 year was 59.5% and 64.7% in the MR-negative and positive FCD groups, respectively (p = 0.81). This rate decreased to 57.5% and 44.4% in the MR-negative and positive FCD groups (p = 0.43) at postoperative 5 years. MR-negative FCD showed a higher proportion of FCD type I (87.2% vs. 50.0%, p = 0.001) than MR-positive FCD. Unilobar cerebral perfusion distribution (odds ratio, OR 5.41) and concordance of interictal epileptiform discharges (OR 5.10) were significantly associated with good surgical outcomes in MR-negative FCD. Conclusion In this study, MR-negative and positive FCD patients had a comparable surgical prognosis, suggesting that comprehensive presurgical evaluations, including multimodal neuroimaging studies, are crucial for obtaining excellent surgical outcomes even in epilepsy patients with MR-negative FCD.	[Seong, Min Jae] Hanyang Univ, Myongji Hosp, Dept Neurol, Coll Med, Goyang, South Korea; [Choi, Su Jung] Sungkyunkwan Univ, Grad Sch Clin Nursing Sci, Dept Clin Nursing Sci, Seoul, South Korea; [Joo, Eun Yeon] Sungkyunkwan Univ, Neurosci Ctr, Samsung Med Ctr, Dept Neurol,Sch Med, Seoul, South Korea; [Shon, Young-Min; Seo, Dae-Won; Hong, Seung Bong] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea; [Hong, Seung Chyul] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea	Hanyang University; Myongji Hospital; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Joo, EY (corresponding author), Sungkyunkwan Univ, Neurosci Ctr, Samsung Med Ctr, Dept Neurol,Sch Med, Seoul, South Korea.	ejoo@skku.edu	Shon, Young-Min/GMX-1704-2022	Shon, Young-Min/0000-0001-5171-1695; JOO, EUN YEON/0000-0003-1233-959X; Choi, Su Jung/0000-0003-2171-7441	Samsung Biomedical Research Institute [OTC1190671]	Samsung Biomedical Research Institute(Samsung)	This research was supported by Samsung Biomedical Research Institute grant (OTC1190671).	Ahmed B, 2015, EPILEPSY BEHAV, V48, P21, DOI 10.1016/j.yebeh.2015.04.055; Bell ML, 2009, EPILEPSIA, V50, P2053, DOI 10.1111/j.1528-1167.2009.02079.x; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Chandra PS, 2014, EPILEPSY RES, V108, P1782, DOI 10.1016/j.eplepsyres.2014.09.024; Chapman K, 2005, J NEUROL NEUROSUR PS, V76, P710, DOI 10.1136/jnnp.2003.026757; Chassoux F, 2000, BRAIN, V123, P1733, DOI 10.1093/brain/123.8.1733; Chassoux F, 2010, NEUROLOGY, V75, P2168, DOI 10.1212/WNL.0b013e31820203a9; Chassoux F, 2012, EPILEPSIA, V53, P349, DOI 10.1111/j.1528-1167.2011.03363.x; Cho JW, 2010, EPILEPSY RES, V88, P247, DOI 10.1016/j.eplepsyres.2009.12.002; Choi SA, 2018, EPILEPSY RES, V139, P54, DOI 10.1016/j.eplepsyres.2017.11.012; Cohen-Gadol AA, 2004, J NEUROSURG, V101, P55, DOI 10.3171/jns.2004.101.1.0055; Fauser S, 2008, J NEUROL NEUROSUR PS, V79, P103, DOI 10.1136/jnnp.2007.116038; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Fauser S, 2015, EPILEPSIA, V56, P66, DOI 10.1111/epi.12876; Guerrini R, 2003, EPILEPTIC DISORD, V5, pS9; Hamiwka L, 2005, EPILEPSIA, V46, P556, DOI 10.1111/j.0013-9580.2005.52504.x; Isler C, 2017, EPILEPSY RES, V136, P130, DOI 10.1016/j.eplepsyres.2017.08.008; Jeha LE, 2007, BRAIN, V130, P574, DOI 10.1093/brain/awl364; Joo EY, 2005, SEIZURE-EUR J EPILEP, V14, P541, DOI 10.1016/j.seizure.2005.08.011; Joo EY, 2005, BRAIN, V128, P1802, DOI 10.1093/brain/awh534; Joo EY, 2004, EPILEPSIA, V45, P686, DOI 10.1111/j.0013-9580.2004.35003.x; Joo EY, 2004, ARCH NEUROL-CHICAGO, V61, P1074, DOI 10.1001/archneur.61.7.1074; Kim DW, 2009, NEUROLOGY, V72, P211, DOI 10.1212/01.wnl.0000327825.48731.c3; KUZNIECKY RI, 1994, EPILEPSIA, V35, pS44, DOI 10.1111/j.1528-1157.1994.tb05988.x; Lawson JA, 2005, NEUROLOGY, V64, P55, DOI 10.1212/01.WNL.0000148647.55705.A3; Noe K, 2013, JAMA NEUROL, V70, P1003, DOI 10.1001/jamaneurol.2013.209; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; PALMINI A, 1995, ANN NEUROL, V37, P476, DOI 10.1002/ana.410370410; Shi JG, 2017, EPILEPSY RES, V133, P103, DOI 10.1016/j.eplepsyres.2017.04.010; Siegel AM, 2006, ACTA NEUROL SCAND, V113, P65, DOI 10.1111/j.1600-0404.2005.00548.x; Smith JR, 1997, STEREOT FUNCT NEUROS, V69, P202, DOI 10.1159/000099875; Tae WS, 2005, NEUROIMAGE, V24, P101, DOI 10.1016/j.neuroimage.2004.08.005; Tassi L, 2002, BRAIN, V125, P1719, DOI 10.1093/brain/awf175; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Veersema TJ, 2019, EPILEPSIA OPEN, V4, P170, DOI 10.1002/epi4.12289; Vossler DG, 2004, EPILEPSIA, V45, P497, DOI 10.1111/j.0013-9580.2004.47103.x; Wang ZI, 2012, EPILEPSY RES, V100, P188, DOI 10.1016/j.eplepsyres.2012.02.011; Widdess-Walsh P, 2007, NEUROLOGY, V69, P660, DOI 10.1212/01.wnl.0000267427.91987.21; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249929	10.1371/journal.pone.0249929	http://dx.doi.org/10.1371/journal.pone.0249929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852634	Green Published, gold			2022-12-26	WOS:000640604500003
J	Singh, A; Vivek, AT; Kumar, S				Singh, Ajeet; Vivek, A. T.; Kumar, Shailesh			AlnC: An extensive database of long non-coding RNAs in angiosperms	PLOS ONE			English	Article							NUMBER	Long non-coding RNAs (lncRNAs) are defined as transcripts of greater than 200 nucleotides that play a crucial role in various cellular processes such as the development, differentiation and gene regulation across all eukaryotes, including plant cells. Since the last decade, there has been a significant rise in our understanding of lncRNA molecular functions in plants, resulting in an exponential increase in lncRNA transcripts, while these went unannounced from the major Angiosperm plant species despite the availability of large-scale high throughput sequencing data in public repositories. We, therefore, developed a user-friendly, open-access web interface, AlnC (Angiosperm lncRNA Catalogue) for the exploration of lncRNAs in diverse Angiosperm plant species using recent 1000 plant (1KP) trancriptomes data. The current version of AlnC offers 10,855,598 annotated lncRNA transcripts across 682 Angiosperm plant species encompassing 809 tissues. To improve the user interface, we added features for browsing, searching, and downloading lncRNA data, interactive graphs, and an online BLAST service. Additionally, each lncRNA record is annotated with possible small open reading frames (sORFs) to facilitate the study of peptides encoded within lncRNAs. With this user-friendly interface, we anticipate that AlnC will provide a rich source of lncRNAs for small-and large-scale studies in a variety of flowering plants, as well as aid in the improvement of key characteristics in relevance to their economic importance. Database URL:	[Singh, Ajeet; Vivek, A. T.; Kumar, Shailesh] Natl Inst Plant Genome Res NIPGR, Bioinformat Lab, Aruna Asaf Ali Marg, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Kumar, S (corresponding author), Natl Inst Plant Genome Res NIPGR, Bioinformat Lab, Aruna Asaf Ali Marg, New Delhi, India.	shailesh@nipgr.ac.in		Kumar, Shailesh/0000-0002-1872-9903	Council of Scientific and Industrial Research; DBT	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India)	The authors are thankful to the Department of Biotechnology (DBT)-eLibrary Consortium, India, for providing access to e-resources. A.S and A.T.V are thankful to the Council of Scientific and Industrial Research and the DBT for research fellowships, respectively. Also, the authors acknowledge the Bioinformatics Center at the National Institute of Plant Genome Research (NIPGR).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayachit G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51355-x; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Budak H, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00276; Cao HF, 2018, TRENDS GENET, V34, P704, DOI 10.1016/j.tig.2018.06.002; Carpenter EJ, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz126; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chekanova JA, 2015, CURR OPIN PLANT BIOL, V27, P207, DOI 10.1016/j.pbi.2015.08.003; Chen L, 2020, PLANTA, V252, DOI 10.1007/s00425-020-03480-5; Christenhusz MJM, 2016, PHYTOTAXA, V261, P201, DOI 10.11646/phytotaxa.261.3.1; Das D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59165-2; Jin JJ, 2021, NUCLEIC ACIDS RES, V49, pD1489, DOI 10.1093/nar/gkaa910; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Gallart AP, 2016, NUCLEIC ACIDS RES, V44, pD1161, DOI 10.1093/nar/gkv1215; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Singh U, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx866; Szczesniak MW, 2019, METHODS MOL BIOL, V1933, P415, DOI 10.1007/978-1-4939-9045-0_26; Thorne RF, 2002, TAXON, V51, P511, DOI 10.2307/1554864; Vivek AT, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa322; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Xuan HD, 2015, GENE, V573, P328, DOI 10.1016/j.gene.2015.07.069; Yotsukura S, 2017, BRIEF BIOINFORM, V18, P9, DOI 10.1093/bib/bbv114; Yu Y, 2019, ANNU REV CELL DEV BI, V35, P407, DOI 10.1146/annurev-cellbio-100818-125218; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098958; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	32	3	3	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0247215	10.1371/journal.pone.0247215	http://dx.doi.org/10.1371/journal.pone.0247215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852582	Green Published, Green Submitted, gold			2022-12-26	WOS:000640604500068
J	Habtemariam, H; Kifle, D; Leta, S; Mucci, M; Lurling, M				Habtemariam, Hanna; Kifle, Demeke; Leta, Seyoum; Mucci, Maira; Lurling, Miquel			Removal of cyanobacteria from a water supply reservoir by sedimentation using flocculants and suspended solids as ballast: Case of Legedadi Reservoir (Ethiopia)	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; MORINGA-OLEIFERA; MICROCYSTIS-AERUGINOSA; CLIMATE-CHANGE; LAKE; CHITOSAN; COAGULATION; EUTROPHICATION; MANAGEMENT; QUALITY	The massive growth of potentially toxic cyanobacteria in water supply reservoirs, such as Legedadi Reservoir (Ethiopia), poses a huge burden to water purification units and represents a serious threat to public health. In this study, we evaluated the efficiency of the flocculants/coagulants chitosan, Moringa oleifera seed (MOS), and poly-aluminium chloride (PAC) in settling cyanobacterial species present in the Legedadi Reservoir. We also tested whether coagulant-treated reservoir water promotes cyanobacteria growth. Our data showed that suspended solids in the turbid reservoir acted as ballast, thereby enhancing settling and hence the removal of cyanobacterial species coagulated with chitosan, Moringa oleifera seed, or their combination. Compared to other coagulants, MOS of 30 mg/L concentration, with the removal efficiency of 93.6%, was the most effective in removing cyanobacterial species without causing cell lysis. Contrary to our expectation, PAC was the least effective coagulant. Moreover, reservoir water treated with MOS alone or MOS combined with chitosan did not support any growth of cyanobacteria during the first two weeks of the experiment. Our data indicate that the efficacy of a flocculant/coagulant in the removal of cyanobacteria is influenced by the uniqueness of individual lakes/reservoirs, implying that mitigation methods should consider the unique characteristic of the lake/reservoir.	[Habtemariam, Hanna; Leta, Seyoum] Addis Ababa Univ, Ctr Environm Sci, Addis Ababa, Ethiopia; [Kifle, Demeke] Addis Ababa Univ, Dept Zool Sci, Addis Ababa, Ethiopia; [Mucci, Maira; Lurling, Miquel] Wageningen Univ, Dept Environm Sci, Aquat Ecol Water Qual Management Grp, Wageningen, Netherlands; [Lurling, Miquel] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Addis Ababa University; Addis Ababa University; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Habtemariam, H (corresponding author), Addis Ababa Univ, Ctr Environm Sci, Addis Ababa, Ethiopia.	hanhabtemariam@gmail.com		Mucci, Maira/0000-0002-3896-2294; Leta, Seyoum/0000-0003-3774-4663; Robel, Hanna/0000-0002-6469-4406				Ali A. S., 2018, J POLLUTION EFFECT C, V6, P208, DOI [10.4172/2375-4397.1000208, DOI 10.4176/2375-4397.1000208]; [Anonymous], 2010, BACKGROUND DOCUMENT; Bamishaiye E. I., 2011, Advance Journal of Food Science & Technology, V3, P233; Barrado-Moreno MM, 2016, TOXICON, V110, P68, DOI 10.1016/j.toxicon.2015.12.001; Camacho FP, 2013, CHEM ENGINEER TRANS, V32, P421, DOI 10.3303/CET1332071; Camacho FP, 2017, CHEM ENG J, V313, P226, DOI 10.1016/j.cej.2016.12.031; Couture RM, 2018, SCI TOTAL ENVIRON, V621, P713, DOI 10.1016/j.scitotenv.2017.11.303; DARAL-OMRAN, 2011, FEDERAL DEMOCRATIC R; Demeke K., 1994, FINAL REPORT, VII; Eyassu Seifu, 2012, Journal of Biological Sciences, V12, P197; Gouvea-Barros S, 2019, CLEAN-SOIL AIR WATER, V47, DOI 10.1002/clen.201800465; Habtemariam H, 2021, SN APPL SCI, V3, DOI 10.1007/s42452-021-04313-0; Hamid SHA, 2016, INT BIODETER BIODEGR, V113, P310, DOI 10.1016/j.ibiod.2016.03.027; He XX, 2016, HARMFUL ALGAE, V54, P174, DOI 10.1016/j.hal.2016.01.001; Huet AA, 2008, MICROBIOL-SGM, V154, P3144, DOI 10.1099/mic.0.2008/021188-0; Huisman J, 2018, NAT REV MICROBIOL, V16, P471, DOI 10.1038/s41579-018-0040-1; Huser BJ, 2016, WATER RES, V97, P142, DOI 10.1016/j.watres.2015.07.036; Jacoby JM, 2000, CAN J FISH AQUAT SCI, V57, P231, DOI 10.1139/cjfas-57-1-231; Li H, 2015, ENVIRON SCI TECHNOL, V49, P6249, DOI 10.1021/acs.est.5b00840; Li L, 2013, ENVIRON SCI TECHNOL, V47, P4555, DOI 10.1021/es305234d; Lurling M, 2014, WATER-SUI, V6, P1807, DOI 10.3390/w6061807; Lurling M, 2006, ANN LIMNOL-INT J LIM, V42, P65, DOI 10.1051/limn/2006010; Lurling M, 2020, ECOL ENG, V158, DOI 10.1016/j.ecoleng.2020.106032; Lurling M, 2017, HARMFUL ALGAE, V66, P1, DOI 10.1016/j.hal.2017.04.011; Lurling M, 2016, WATER RES, V97, P1, DOI 10.1016/j.watres.2016.03.035; Lurling M, 2013, WATER RES, V47, P6527, DOI 10.1016/j.watres.2013.08.019; Lurling M, 2010, J APPL PHYCOL, V22, P503, DOI 10.1007/s10811-009-9485-y; MADSEN M, 1987, J TROP MED HYG, V90, P101; Merel S, 2013, ENVIRON INT, V59, P303, DOI 10.1016/j.envint.2013.06.013; Miranda M, 2017, HARMFUL ALGAE, V65, P27, DOI 10.1016/j.hal.2017.04.007; Mohamed MN, 2019, FRESHW SCI, V38, P675, DOI 10.1086/705915; Mowe MAD, 2015, J LIMNOL, V74, P205, DOI 10.4081/jlimnol.2014.1005; Mucci M, 2017, WATER RES, V118, P121, DOI 10.1016/j.watres.2017.04.020; Naceradska J, 2019, J WATER SUPPLY RES T, V68, P222, DOI 10.2166/aqua.2019.155; Ndabigengesere A, 1998, WATER RES, V32, P781, DOI 10.1016/S0043-1354(97)00295-9; NDABIGENGESERE A, 1995, WATER RES, V29, P703, DOI 10.1016/0043-1354(94)00161-Y; Nishi L, 2011, CYANOBACTERIA REMOVA; Noyma NP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178976; Noyma NP, 2016, WATER RES, V97, P26, DOI 10.1016/j.watres.2015.11.057; Oladoja NA, 2015, SUSTAIN CHEM PHARM, V2, P37, DOI 10.1016/j.scp.2015.08.003; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Pan G, 2011, ECOL ENG, V37, P302, DOI 10.1016/j.ecoleng.2010.11.019; Parkinson D, 1971, METHODS STUDY QUANTI, P34; Pei HY, 2014, BIORESOURCE TECHNOL, V151, P314, DOI 10.1016/j.biortech.2013.10.077; Qun G, 2006, CARBOHYD POLYM, V64, P29, DOI 10.1016/j.carbpol.2005.10.026; Renault F, 2009, EUR POLYM J, V45, P1337, DOI 10.1016/j.eurpolymj.2008.12.027; Vieira AMS, 2010, WATER AIR SOIL POLL, V206, P273, DOI 10.1007/s11270-009-0104-y; Shao JH, 2012, ECOTOXICOLOGY, V21, P698, DOI 10.1007/s10646-011-0828-5; Shen QH, 2011, DESALINATION, V271, P236, DOI 10.1016/j.desal.2010.12.039; Spears BM, 2013, WATER RES, V47, P5930, DOI 10.1016/j.watres.2013.07.016; Strand SP, 2003, COLLOID SURFACE B, V27, P71, DOI 10.1016/S0927-7765(02)00043-7; Sun F, 2013, SEP PURIF TECHNOL, V115, P123, DOI 10.1016/j.seppur.2013.05.004; van Loosdrecht MCM, 2014, SCIENCE, V344, P1452, DOI 10.1126/science.1255183; Van Oosterhout F, 2011, J PLANKTON RES, V33, P255, DOI 10.1093/plankt/fbq092; Waajen G, 2016, WATER RES, V97, P83, DOI 10.1016/j.watres.2015.11.034; WWAP 2017 WWAP (United Nations World Water Assessment Programme), 2017, UN WORLD WATER DEV R; Yang ZL, 2010, CHEM ENG J, V165, P122, DOI 10.1016/j.cej.2010.08.076	57	0	0	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2021	16	4							e0249720	10.1371/journal.pone.0249720	http://dx.doi.org/10.1371/journal.pone.0249720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM7RW	33844703	gold, Green Published			2022-12-26	WOS:000639857200009
J	Kurosawa, S; Shibata, A; Ishii, K; Koohsari, MJ; Oka, K				Kurosawa, Sayaka; Shibata, Ai; Ishii, Kaori; Koohsari, Mohammad Javad; Oka, Koichiro			Identifying typologies of diurnal patterns in desk-based workers' sedentary time	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ADULTS; OFFICE; BEHAVIOR; HEALTH; ASSOCIATION; TOO	The purpose of this study was to identify typologies of diurnal sedentary behavior patterns and sociodemographic characteristics of desk-based workers. The sedentary time of 229 desk-based workers was measured using accelerometer devices. The within individual diurnal variations in sedentary time was calculated for both workdays and non-workdays. Diurnal variations in sedentary time during each time period (morning, afternoon, and evening) was calculated as the percentage of sedentary time during each time period divided by the percentage of the total sedentary time. A hierarchical cluster analysis (Ward's method) was used to identify the optimal number of clusters. To refine the initial clusters, a non-hierarchical cluster analysis (k-means method) was performed. Four clusters were identified: stable sedentary cluster (46.7%), off-morning break cluster (26.6%), off-afternoon break cluster (8.3%), and evening sedentary cluster (18.3%). The stable sedentary cluster had the lowest variations in sedentary time throughout the day and the highest amount of total sedentary time. Participants in the off-morning and off-afternoon break clusters had nearly the same sedentary patterns but took short-term breaks during non-workday mornings or afternoons. The evening sedentary cluster had a completely different pattern, with a longer sedentary time during the evening both on workdays and non-workdays. Sociodemographic attributes such as sex, household income, educational attainment, employment status, sleep duration, and residential area, differed significantly between groups. Initiatives to address desk-based workers' sedentary behavior need to focus not only on the workplace but also on the appropriate timing for reducing excessive sedentary time in non-work contexts depending on the characteristics and diurnal patterns of target subgroups.	[Kurosawa, Sayaka] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Shibata, Ai] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Ishii, Kaori; Koohsari, Mohammad Javad; Oka, Koichiro] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Koohsari, Mohammad Javad] Baker Heart & Diabet Inst, Behav Epidemiol Lab, Melbourne, Vic, Australia; [Koohsari, Mohammad Javad] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	Waseda University; University of Tsukuba; Waseda University; University of Melbourne	Kurosawa, S (corresponding author), Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan.	sayakakurosawa@akane.waseda.jp	Koohsari, Javad/A-4613-2009	Koohsari, Javad/0000-0001-9384-5456	Meiji Yasuda Life Foundation of Health and Welfare; Japan Society for the Promotion of Science [18K10986, 20H04113]; MEXTSupported Program for the Strategic Research Foundation at Private Universities [S1511017]	Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXTSupported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	SK was supported by 34th (2017) Research-Aid from Meiji Yasuda Life Foundation of Health and Welfare (https://www.my-zaidan.or.jp/josei/about/).AS was supported by a Grant-in-Aid for Scientific Research (No. 18K10986) from the Japan Society for the Promotion of Science (https://kaken.nii.ac.jp/ja/grant/KAKENHIPROJECT-18K10986/).KO was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 20H04113) (https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-20H04113/), and a MEXTSupported Program for the Strategic Research Foundation at Private Universities (No. S1511017) (http://www.mext.go.jp/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Buckley JP, 2015, BRIT J SPORT MED, V49, P1357, DOI 10.1136/bjsports-2015-094618; Clemes SA, 2014, J OCCUP ENVIRON MED, V56, P298, DOI 10.1097/JOM.0000000000000101; da Costa BGG, 2020, J SCI MED SPORT, V23, P487, DOI 10.1016/j.jsams.2019.11.007; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Ishii K, 2018, J EPIDEMIOL, V28, P149, DOI 10.2188/jea.JE20170002; Kurita S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-021690; Kurosawa S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113814; Mitsutake S, 2020, J PHYS ACT HEALTH, V17, P709, DOI 10.1123/jpah.2019-0219; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Ohkawara K, 2011, BRIT J NUTR, V105, P1681, DOI 10.1017/S0007114510005441; Oshima Y, 2010, GAIT POSTURE, V31, P370, DOI 10.1016/j.gaitpost.2010.01.005; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Parker KE, 2019, J SCI MED SPORT, V22, P319, DOI 10.1016/j.jsams.2018.08.015; Parry S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-296; Patnode CD, 2011, J PHYS ACT HEALTH, V8, P457, DOI 10.1123/jpah.8.4.457; Slater M D, 1996, J Health Commun, V1, P267, DOI 10.1080/108107396128059; Smith L, 2015, BMC PUBLIC HEALTH, V15, DOI [10.1186/s12889-014-1338-1, 10.1186/s12889-015-1459-1]; Smith LP, 2014, SOC SCI MED, V120, P126, DOI 10.1016/j.socscimed.2014.09.010; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Vagni G, 2018, P NATL ACAD SCI USA, V115, P6183, DOI 10.1073/pnas.1718020115; van Dommelen P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149951; van Weering MGH, 2009, EUR J PAIN, V13, P649, DOI 10.1016/j.ejpain.2008.07.005	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0248304	10.1371/journal.pone.0248304	http://dx.doi.org/10.1371/journal.pone.0248304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836010	Green Published, gold			2022-12-26	WOS:000639361000029
J	Kieran, SRC; Hull, JM; Finger, AJ				Kieran, Shannon Rose C.; Hull, Joshua M.; Finger, Amanda J.			Environmental DNA sampling provides new management strategies for vernal pool branchiopods in California	PLOS ONE			English	Article								California's vernal pools are declining ecosystems that support valuable native plant and animal diversity. Vernal pool branchiopods are particularly at risk from vernal pool habitat loss and conservation efforts have targeted their long-term protection through the establishment of preserves and conservation banks. These conservation strategies require repeated, perpetual monitoring of preserved habitat, which is currently carried out through dip-net surveys and visual identification of specimens. Dip-netting may be destructive and frequently requires some sacrifice of protected species. Environmental DNA offers a new, modern method to monitor many protected freshwater organisms. We designed qPCR-based species-specific assays for four of California's vernal pool branchiopods: The Vernal Pool Fairy Shrimp Branchinecta lynchi (BRLY), the Midvalley Fairy Shrimp Branchinecta mesovallensis (BRME), and the Conservancy Fairy Shrimp Branchinecta conservatio (BRCO), and the Vernal Pool Tadpole Shrimp Lepidurus packardi (LEPA). We tested these assays using eDNA sampling protocols alongside traditional dip-net surveys to assess their viability as an alternative method to monitor vernal pool branchiopods. Based on occupancy modeling, each of our assays achieved a 95% or higher detection rate when using optimized sampling protocols.	[Kieran, Shannon Rose C.; Finger, Amanda J.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Hull, Joshua M.] US Fish & Wildlife Serv, Sacramento Fish & Wildlife Off, Sacramento, CA USA	University of California System; University of California Davis; United States Department of the Interior; US Fish & Wildlife Service	Kieran, SRC (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	sckieran@ucdavis.edu		Kieran, Shannon Rose/0000-0002-2855-6487	U.S. Bureau of Reclamation [CESUR15AC0040]; University of California Natural Reserve System (UCNRS)	U.S. Bureau of Reclamation; University of California Natural Reserve System (UCNRS)	AJF received CESUR15AC0040 from the U.S. Bureau of Reclamation (https://www.usbr.gov/).SRK received additional funding from The University of California Natural Reserve System (UCNRS) (https://ucnrs.org/), with no grant numbers provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Deiner K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176266; Duffy WG, 2011, ECOL APPL, V21, pS18, DOI 10.1890/09-1338.1; Fiske I., 2015, OVERVIEW UNMARKED R, P1, DOI DOI 10.1002/WICS.10; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gold Z, 2020, CONSERV GENET RESOUR, V12, P685, DOI 10.1007/s12686-020-01161-9; Kieran SR, 2020, J FISH WILDL MANAG, V11, P609, DOI 10.3996/052019-JFWM-041; King Jamie L., 1998, P119; King JL, 1996, HYDROBIOLOGIA, V328, P85, DOI 10.1007/BF00018707; Klymus K.E., 2020, ENV DNA, V2, P271, DOI [10.1002/edn3.29, DOI 10.1002/EDN3.29]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035887; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Rogers DC, 2001, J CRUSTACEAN BIOL, V21, P991, DOI 10.1651/0278-0372(2001)021[0991:ROTNLN]2.0.CO;2; Song J., 2017, CARNEGIE MELLON U; U.S. Fish and Wildlife Service, 2005, REC PLAN VERN POOL E; United States Fish and Wildlife Service, 2015, SURV GUID LIST LARG; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams MA, 2019, MOL ECOL RESOUR, V19, P1106, DOI 10.1111/1755-0998.13045	21	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0243338	10.1371/journal.pone.0243338	http://dx.doi.org/10.1371/journal.pone.0243338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33830990	Green Submitted, gold, Green Published			2022-12-26	WOS:000639359600124
J	Wang, ML; Liu, J; Tu, YZ; Zhao, ZH; Qu, JJ; Chen, K; Chen, YL; Sun, Y; Zhao, H; Deng, Y; Wu, CY				Wang, Meiling; Liu, Jie; Tu, Yizeng; Zhao, Zihan; Qu, Jingjing; Chen, Ka; Chen, Yonglong; Sun, Ying; Zhao, Hui; Deng, Yi; Wu, Chuanyue			RSU-1 interaction with prohibitin-2 links cell-extracellular matrix detachment to downregulation of ERK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS SUPPRESSOR RSU-1; ONLY PROTEIN PINCH; LIPID RAFTS; INTEGRIN ADHESOME; ADAPTER PROTEIN; KINASE; GROWTH; ACTIVATION; ADHESION; TRANSDUCTION	Cell-extracellular matrix (ECM) detachment is known to decrease extracellular signal-regulated kinase (ERK) signaling, an intracellular pathway that is central for control of cell behavior. How cell-ECM detachment is linked to down-regulation of ERK signaling, however, is incompletely understood. We show here that focal adhesion protein Ras Suppressor 1 (RSU1) plays a critical role in cell-ECM detachment induced suppression of ERK signaling. We have identified prohibitin 2 (PHB2), a component of membrane lipid rafts, as a novel binding protein of RSU1, and mapped a major RSU1-binding site to PHB2 amino acids 150 to 206 in the C-terminal region of the PHB/SPFH (stomatin/prohibitin/flotillin/HflKC) domain. The PHB2 binding is mediated by multiple sites located in the N-terminal leucine-rich repeat region of RSU1. Depletion of PHB2 suppressed cell-ECM adhesion-induced ERK activation. Furthermore, cell-ECM detachment increased RSU1 association with membrane lipid rafts and interaction with PHB2. Finally, knockout of RSU1 or inhibition of RSU1 interaction with PHB2 by overexpression of the major RSU1-binding PHB2 fragment (amino acids 150-206) effectively suppressed the cell-ECM detachment induced downregulation of ERK signaling. Additionally, expression of venus-tagged wild-type RSU1 restored ERK signaling, while expression of venus-tagged PHB2-binding defective RSU1 mutant in which the N-terminal leucine-rich repeat region is deleted did not. Taken together, Our findings identify a novel RSU1-PHB2 signaling axis that senses cell-ECM detachment and links it to decreased ERK signaling.	[Wang, Meiling] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China; [Wang, Meiling; Liu, Jie; Zhao, Zihan; Qu, Jingjing; Chen, Yonglong; Sun, Ying; Deng, Yi] Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen, Peoples R China; [Wang, Meiling; Liu, Jie; Zhao, Zihan; Qu, Jingjing; Chen, Yonglong; Sun, Ying; Deng, Yi] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China; [Tu, Yizeng; Chen, Ka; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15213 USA; [Zhao, Zihan] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Zhao, Hui] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Peoples R China	Harbin Institute of Technology; Southern University of Science & Technology; Southern University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Macau; Chinese University of Hong Kong	Deng, Y (corresponding author), Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen, Peoples R China.; Deng, Y (corresponding author), Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China.; Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15213 USA.	dengy@sustech.edu.cn; carywu@pitt.edu	; Zhao, Hui/B-8429-2016	, Yonglong/0000-0002-4933-113X; Zhao, Hui/0000-0001-8160-6415	Guangdong Natural Science of Foundation [2017A030313209, 2020A1515011305]; Chinese Ministry of Science and Technology [2016YFC1302100]; Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research [2017B030301018]; Shenzhen Key Laboratory of Cell Microenvironment [ZDSYS20140509142721429]; Shenzhen Innovation Committee of Science and Technology [JCYJ20170412152835439]; Shenzhen Health Family Planning System Research Project [SZBC2018012]; Research Grants Council, University Grants Committee [14167017, 14112618]; National Key R&D Program of China, Synthetic Biology Research [2019YFA0904500]	Guangdong Natural Science of Foundation; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research; Shenzhen Key Laboratory of Cell Microenvironment; Shenzhen Innovation Committee of Science and Technology; Shenzhen Health Family Planning System Research Project; Research Grants Council, University Grants Committee; National Key R&D Program of China, Synthetic Biology Research	This work was supported by grants from Guangdong Natural Science of Foundation (2017A030313209, 2020A1515011305), the Chinese Ministry of Science and Technology (2016YFC1302100), Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research (2017B030301018), Shenzhen Key Laboratory of Cell Microenvironment (ZDSYS20140509142721429), Shenzhen Innovation Committee of Science and Technology grants (JCYJ20170412152835439), and Shenzhen Health Family Planning System Research Project (SZBC2018012). H. Z. is supported by grants from the Research Grants Council, University Grants Committee (14167017, and 14112618) and National Key R&D Program of China, Synthetic Biology Research (2019YFA0904500).	Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Chiu CF, 2013, ONCOGENE, V32, P777, DOI 10.1038/onc.2012.86; Chunduru S, 2002, J NEURO-ONCOL, V60, P201, DOI 10.1023/A:1021130620178; CUTLER ML, 1992, MOL CELL BIOL, V12, P3750, DOI 10.1128/MCB.12.9.3750; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Del Pozo MA, 2004, CELL CYCLE, V3, P725; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Donthamsetty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074625; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Dougherty GW, 2005, EXP CELL RES, V306, P168, DOI 10.1016/j.yexcr.2005.01.025; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Edin ML, 2005, MOL CELL BIOL, V25, P4466, DOI 10.1128/MCB.25.11.4466-4475.2005; Eke I, 2010, J CLIN INVEST, V120, P2516, DOI 10.1172/JCI41078; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gkretsi V, 2017, ONCOTARGET, V8, P27364, DOI 10.18632/oncotarget.16062; Gonzalez-Nieves R, 2013, J CELL COMMUN SIGNAL, V7, P279, DOI 10.1007/s12079-013-0207-5; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kadrmas JL, 2004, J CELL BIOL, V167, P1019, DOI 10.1083/jcb.200408090; Kim YC, 2015, CELL ADHES MIGR, V9, P227, DOI 10.4161/19336918.2014.972775; Lee JW, 2004, MOL CELLS, V17, P188; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li HD, 2017, P NATL ACAD SCI USA, V114, P9349, DOI 10.1073/pnas.1703064114; Lin TH, 1997, J BIOL CHEM, V272, P8849; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Masuelli L, 1996, MOL CELL BIOL, V16, P5466; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nalesnik MA, 2012, AM J PATHOL, V180, P1495, DOI 10.1016/j.ajpath.2011.12.021; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rajalingam K, 2012, CHEM BIOL, V19, P1077, DOI 10.1016/j.chembiol.2012.09.004; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Tatsuta T, 2017, CURR BIOL, V27, pR629, DOI 10.1016/j.cub.2017.04.030; Theisen U, 2012, DEV CELL, V23, P1153, DOI 10.1016/j.devcel.2012.11.005; TSUDA T, 1993, GENOMICS, V18, P461, DOI 10.1006/geno.1993.1503; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vasaturo F, 2000, BREAST CANCER RES TR, V61, P69, DOI 10.1023/A:1006462323260; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006	66	2	2	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100109	10.1074/jbc.RA120.014413RSU-1	http://dx.doi.org/10.1074/jbc.RA120.014413RSU-1			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33853759				2022-12-26	WOS:000672866400089
J	Kibret, AA; Oumer, M; Moges, AM				Kibret, Anteneh Ayelign; Oumer, Mohammed; Moges, Abebe Muche			Prevalence and associated factors of hemorrhoids among adult patients visiting the surgical outpatient department in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia	PLOS ONE			English	Article							CONSTIPATION; GUIDELINES; MANAGEMENT; HEALTH	Introduction Hemorrhoidal disease is a very common benign anorectal disease. It affects millions of people around the world, and represent a major medical and socioeconomic problem. However, studies that determine the magnitude and risk factors are limited. Therefore, the aim this study is to assess the prevalence and associated factors of hemorrhoid among adult patients visiting the surgical outpatient department at the University of Gondar Comprehensive Specialized Hospital (UoGCSH) Northwest Ethiopia. Methods An institution-based cross-sectional study was conducted from February to May 2020. A systematic random sampling technique was used to select a total of 403 participants. The data were collected then entered using EPI DATA version 3.1 and exported to the STATA 14 for analysis. Bivariable and multivariable logistic regression analysis were performed. Adjusted odds ratio (AOR) with 95% confidence interval was used as a measure of association. Variables having P-value < 0.05 from the multivariable analysis were considered to have a significant association with the outcome. Result Out of the 403 study participants, 13.1% (95%CI; 10.1, 16.8) had hemorrhoids. Constipation (AOR = 4.32, 95% CI; 2.20, 8.48) and BMI <greater than or equal to>25kg/m(2) (AOR = 2.6, 95% CI; 1.08, 6.23) had a statistically significant association with hemorrhoid. Conclusion The overall prevalence of hemorrhoid was high and its prevalence was higher in male subjects. Constipation and being overweight were found to increase the odds of having hemorrhoids. Screening for early identification and intervention of hemorrhoids, especially for risk groups is better to be practiced by health professionals.	[Kibret, Anteneh Ayelign; Oumer, Mohammed; Moges, Abebe Muche] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia	University of Gondar	Kibret, AA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia.	antesha04@gmail.com	Oumer, Mohammed/AAE-2467-2019	Oumer, Mohammed/0000-0002-9358-9242; Kibret, Anteneh Ayelign/0000-0002-4487-5015				BLEDAY R, 1992, DIS COLON RECTUM, V35, P477, DOI 10.1007/BF02049406; Carey RM, 2018, ANN INTERN MED, V168, P351, DOI 10.7326/M17-3203; Carter D., 2013, WORLD J COLORECTAL S, V3, P10; Delco F, 1998, DIS COLON RECTUM, V41, P1534, DOI 10.1007/BF02237302; ElBatea H, 2011, DIGEST DIS SCI, V56, P2120, DOI 10.1007/s10620-010-1538-1; Gray JR, 2011, CAN J GASTROENTEROL, P25; Guttenplan Mitchel, 2017, Curr Gastroenterol Rep, V19, P30, DOI 10.1007/s11894-017-0574-9; Halverson Amy, 2007, Clin Colon Rectal Surg, V20, P77, DOI 10.1055/s-2007-977485; Jacobs DO, 2018, CURR OPIN GASTROEN, V34, P46, DOI 10.1097/MOG.0000000000000408; JOHANSON JF, 1994, AM J GASTROENTEROL, V89, P1981; JOHANSON JF, 1990, GASTROENTEROLOGY, V98, P380, DOI 10.1016/0016-5085(90)90828-O; Khan RM., 2015, J BIOL SCI OPIN, V3, P36, DOI DOI 10.7897/2321-6328.0318; Lee JH, 2014, KOREAN J FAM MED, V35, P227, DOI 10.4082/kjfm.2014.35.5.227; Lohsiriwat V, 2012, WORLD J GASTROENTERO, V18, P2009, DOI 10.3748/wjg.v18.i17.2009; Mitra D, 2007, AM J GASTROENTEROL, V102, pS432, DOI 10.14309/00000434-200709002-00852; Peery AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139100; Pigot F, 2005, GASTROEN CLIN BIOL, V29, P1270, DOI 10.1016/S0399-8320(05)82220-1; Riss S, 2012, INT J COLORECTAL DIS, V27, P215, DOI 10.1007/s00384-011-1316-3; Rubbini M, 2019, WORLD J GASTRO SURG, V11, P117, DOI 10.4240/wjgs.v11.i3.117; Rubbini M, 2018, INT J COLORECTAL DIS, V33, P831, DOI 10.1007/s00384-018-3060-4; Sanchez Caroline, 2011, Clin Colon Rectal Surg, V24, P5, DOI 10.1055/s-0031-1272818; Segre D., 1995, Annali Italiani di Chirurgia, V66, P747; Slauf P, 2014, Rozhl Chir, V93, P223; Sun ZF, 2016, CLIN COLON RECT SURG, V29, P22, DOI 10.1055/s-0035-1568144; THOMSON WHF, 1975, BRIT J SURG, V62, P542, DOI 10.1002/bjs.1800620710; Trompetto M, 2015, TECH COLOPROCTOL, V19, P567, DOI 10.1007/s10151-015-1371-9; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Yamana T, 2017, J ANUS RECTUM COLON, V1, P89, DOI 10.23922/jarc.2017-018	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2021	16	4							e0249736	10.1371/journal.pone.0249736	http://dx.doi.org/10.1371/journal.pone.0249736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RQ1EM	33878128	gold, Green Published			2022-12-26	WOS:000642162200021
J	Boschetti, F; Conti, D; Soriano, EM; Mazzotta, C; Pandolfi, A				Boschetti, Federica; Conti, Debora; Soriano, Elvira M.; Mazzotta, Cosimo; Pandolfi, Anna			Experimental in-vitro investigation on Epi-Off-Crosslinking on porcine corneas	PLOS ONE			English	Article							BIOMECHANICAL PROPERTIES; UV-A; RIBOFLAVIN; CXL	Aim To evaluate quantitatively the effects of the Epi-Off-CXL irradiance dose on the stromal stiffening of pig corneas. Setting Laboratory of Biological structures (LaBS), Politecnico di Milano, Milano, Italy. Methods Inflation tests have been carried on 90 excised and de-epithelized pig corneas, monitoring the change of configuration of the corneal dome at specific pressures. Test have been carried out twice on each cornea, once before and once after Epi-Off-CXL performed at a constant irradiance of 9 mW/cm(2) and variable UV-A exposure times. Corneas were grouped according to the exposure time (2.5, 5, 10, 15 and 20 min), proportional to the irradiation dose (1.35, 2.7, 5.4, 8.1, and 10.8 J/cm(2)). A theoretical model based on linearized shell theory has been used to estimate the increment of the corneal stiffness. Results The linearized shell theory allowed to establish a quantitative relation between the increment of the stiffness parameters and the irradiation dose. Relative to the pre-treatment values, in all experiments the post-treatment corneal stiffness revealed a pronounced increase. In general, the stiffness gain increased with the exposure time. No significant differences in stiffening was observed between tests conducted at 2.5, 5, and 10 min exposure. Conclusions Qualitatively, the effectiveness of accelerated CXL treatments observed in pig corneas complies very well with in-vivo clinical results in humans, suggesting that experimental data in pigs can be very useful for the design of the procedure in humans. A larger irradiation dose provides a larger increment of the corneal stiffness. Due to the biological variability of the tissues, however, it is difficult to distinguish quantitatively the level of the reinforcement induced by accelerated protocols (low doses with < = 10 min exposure), less prone to induce damage in the corneal tissue. Therefore, the definition of personalized treatments must be related to the actual biomechanics of the cornea.	[Boschetti, Federica; Conti, Debora; Soriano, Elvira M.] Politecn Milan, Chem Mat & Chem Engn Dept, Milan, Italy; [Mazzotta, Cosimo] Univ Siena, Post Grad Ophthalmol Sch, Dept Med Surg & Neurosci, Siena, Italy; [Mazzotta, Cosimo] Siena Crosslinking Ctr, Siena, Italy; [Pandolfi, Anna] Politecn Milan, Civil & Environm Engn Dept, Milan, Italy	Polytechnic University of Milan; University of Siena; Polytechnic University of Milan	Pandolfi, A (corresponding author), Politecn Milan, Civil & Environm Engn Dept, Milan, Italy.	anna.pandolfi@polimi.it	Pandolfi, Anna/E-1481-2013	Pandolfi, Anna/0000-0002-7084-7456; Mazzotta, Cosimo/0000-0002-1829-9288				Bao FJ, 2018, J REFRACT SURG, V34, P51, DOI 10.3928/1081597X-20171025-01; Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Boschetti F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006089; Bryant MR, 1996, J BIOMECH ENG-T ASME, V118, P473, DOI 10.1115/1.2796033; Caporossi A, 2013, J CATARACT REFR SURG, V39, P1157, DOI 10.1016/j.jcrs.2013.03.026; Caporossi A, 2012, EUR J OPHTHALMOL, V22, pS81, DOI 10.5301/ejo.5000125; Cornaggia A., 2020, MECH SOFT MAT, V2, DOI [10.1007/s42558-020-00030-7, DOI 10.1007/S42558-020-00030-7]; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Du RQ, 2017, SOFT MATER, V15, P27, DOI 10.1080/1539445X.2016.1242497; Elsheikh A, 2008, EXP EYE RES, V86, P783, DOI 10.1016/j.exer.2008.02.006; Hammer A, 2014, INVEST OPHTH VIS SCI, V55, P2881, DOI 10.1167/iovs.13-13748; Hayashi S, 2002, J MORPHOL, V254, P247, DOI 10.1002/jmor.10030; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; Kobashi H, 2020, CORNEA, V39, P172, DOI 10.1097/ICO.0000000000002092; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Konstantopoulos A, 2015, EYE CONTACT LENS, V41, P65, DOI 10.1097/ICL.0000000000000093; Liu TW, 2020, ACTA BIOMATER, V113, P438, DOI 10.1016/j.actbio.2020.06.005; Mazzotta C., 2019, INT J KERATOCONUS EC, V7, P137, DOI DOI 10.5005/JP-JOURNALS-10025-1171; Mazzotta C, 2019, EXPERT REV OPHTHALMO, V14, P115, DOI 10.1080/17469899.2019.1611425; Mazzotta C, 2015, OCUL SURF, V13, P298, DOI 10.1016/j.jtos.2015.04.007; Mencucci R, 2015, CORNEA, V34, P323, DOI 10.1097/ICO.0000000000000324; Pandolfi A, 2019, PHILOS T R SOC A, V377, DOI 10.1098/rsta.2018.0079; Pandolfi A, 2015, COMPUT METHOD BIOMEC, V18, P64, DOI 10.1080/10255842.2013.778983; Pandolfi A, 2010, COMPUTATIONAL MODELING IN BIOMECHANICS, P435, DOI 10.1007/978-90-481-3575-2_15; Pandolfi A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2982251; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raiskup F, 2013, OCUL SURF, V11, P65, DOI 10.1016/j.jtos.2013.01.002; Richoz O, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.7.6; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Turhan SA, 2020, J REFRACT SURG, V36, P265, DOI 10.3928/1081597X-20200302-01; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Zhou YH, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.10.105001; Zhu YR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179580	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249949	10.1371/journal.pone.0249949	http://dx.doi.org/10.1371/journal.pone.0249949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857213	Green Published, gold			2022-12-26	WOS:000641474900102
J	Chalk, M; Tkacik, G; Marre, O				Chalk, Matthew; Tkacik, Gasper; Marre, Olivier			Inferring the function performed by a recurrent neural network	PLOS ONE			English	Article							DYNAMICS; ORIENTATION; ALGORITHMS	A central goal in systems neuroscience is to understand the functions performed by neural circuits. Previous top-down models addressed this question by comparing the behaviour of an ideal model circuit, optimised to perform a given function, with neural recordings. However, this requires guessing in advance what function is being performed, which may not be possible for many neural systems. To address this, we propose an inverse reinforcement learning (RL) framework for inferring the function performed by a neural network from data. We assume that the responses of each neuron in a network are optimised so as to drive the network towards 'rewarded' states, that are desirable for performing a given function. We then show how one can use inverse RL to infer the reward function optimised by the network from observing its responses. This inferred reward function can be used to predict how the neural network should adapt its dynamics to perform the same function when the external environment or network structure changes. This could lead to theoretical predictions about how neural network dynamics adapt to deal with cell death and/or varying sensory stimulus statistics.	[Chalk, Matthew; Marre, Olivier] Sorbonne Univ, Inst Vis, INSERM, CNRS, Paris, France; [Tkacik, Gasper] IST Austria, Klosterneuburg, Austria	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institute of Science & Technology - Austria	Chalk, M (corresponding author), Sorbonne Univ, Inst Vis, INSERM, CNRS, Paris, France.	matthew.chalk@inserm.fr		Marre, Olivier/0000-0002-0090-6190; Tkacik, Gasper/0000-0002-6699-1455; Chalk, Matthew/0000-0001-7782-4436	ANR JCJC grant [ANR-17-CE37-0013]; ANR Trajectory [ANR-15-CE37-0011]; ANR DECORE [ANR-18-CE37-0011]; French State program Investissements d'Avenir [ANR-10-LABX-65]; EC from the Human Brain Project (SGA2) [H2020-785907]; AVIESAN-UNADEV grant	ANR JCJC grant(French National Research Agency (ANR)); ANR Trajectory(French National Research Agency (ANR)); ANR DECORE(French National Research Agency (ANR)); French State program Investissements d'Avenir(French National Research Agency (ANR)); EC from the Human Brain Project (SGA2); AVIESAN-UNADEV grant	This work was supported by ANR JCJC grant (ANR-17-CE37-0013) to M.C, ANR Trajectory (ANR-15-CE37-0011), ANR DECORE (ANR-18-CE37-0011), the French State program Investissements d'Avenir managed by the Agence Nationale de la Recherche (LIFESENSES; ANR-10-LABX-65), EC Grant No. H2020-785907 from the Human Brain Project (SGA2), and an AVIESAN-UNADEV grant to O.M. The authors would like to thank Ulisse Ferrari for useful discussions and feedback.	Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bartlett P. L, 2000, P 17 INT C MACH LEAR, P41; Baxter J, 2019, ARXIV191107247 MLA; Benucci A, 2013, NAT NEUROSCI, V16, P724, DOI 10.1038/nn.3382; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Berger T, 1971, RATE DISTORTION THEO; Bialek W, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, VOLS 1-6, PROCEEDINGS, P659, DOI 10.1109/ISIT.2006.261867; Boerlin M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003258; Chalk M, 2018, P NATL ACAD SCI USA, V115, P186, DOI 10.1073/pnas.1711114115; Chaudhuri R, 2019, 516021 BIORXIV; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Fu C., 2019, ARXIV PREPRINT ARXIV; Geva N, 2019, 540195 BIORXIV; Gjorgjieva J, 2014, J NEUROSCI, V34, P12127, DOI 10.1523/JNEUROSCI.1032-14.2014; Goddard E, 2018, NEUROIMAGE, V180, P41, DOI 10.1016/j.neuroimage.2017.06.068; Gutig R, 2016, SCIENCE, V351, DOI 10.1126/science.aab4113; Haarnoja T, 2017, PR MACH LEARN RES, V70; Heeger DJ, 2017, P NATL ACAD SCI USA, V114, P1773, DOI 10.1073/pnas.1619788114; Herman M, 2016, JMLR WORKSH CONF PRO, V51, P102; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kim SS, 2017, SCIENCE, V356, P849, DOI 10.1126/science.aal4835; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kozma R, 2019, ARXIV 191006489; Laurent GJ, 2011, INT J KNOWL-BASED IN, V15, P55, DOI 10.3233/KES-2010-0206; Levine S, 2018, ROBOTICS SCI SYSTEMS; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Mahadevan S, 1996, MACH LEARN, V22, P159, DOI 10.1007/BF00114727; McIntosh LT, 2016, ADV NEUR IN, V29; Ng A.Y., 2000, MACHINE LEARNING, V1, P2; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Rothkopf CA, 2011, LECT NOTES ARTIF INT, V6913, P34, DOI 10.1007/978-3-642-23808-6_3; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schulman J., 2017, PROXIMAL POLICY OPTI, DOI 10.48550/arXiv.1707.06347; Sharpee T., 2003, ADV NEUR INF PROC SY, P277; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Tishby N, 2017, ARXIV 170301585; Tkacik G, 2019, 848374 BIORXIV; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Todorov E, 2008, IEEE DECIS CONTR P, P4286, DOI 10.1109/CDC.2008.4739438; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Wu Z., 2018, ARXIV181108599; Yang GR, 2019, NAT NEUROSCI, V22, P297, DOI 10.1038/s41593-018-0310-2; Zhang K, 1996, J NEUROSCI, V16, P2112	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248940	10.1371/journal.pone.0248940	http://dx.doi.org/10.1371/journal.pone.0248940			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857170	Green Published, Green Submitted, gold			2022-12-26	WOS:000641474900072
J	Chitrakar, I; Ahmed, SF; Torelli, AT; French, JB				Chitrakar, Iva; Ahmed, Syed Fardin; Torelli, Andrew T.; French, Jarrod B.			Structure of the E. coli agmatinase, SPEB	PLOS ONE			English	Article							CLONIDINE-DISPLACING SUBSTANCE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; NITRIC-OXIDE; ARGININE METABOLITE; CATALYTIC-ACTIVITY; INHIBITION; MANGANESE; POLYAMINES; SUBSTRATE	Agmatine amidinohydrolase, or agmatinase, catalyzes the conversion of agmatine to putrescine and urea. This enzyme is found broadly across kingdoms of life and plays a critical role in polyamine biosynthesis and the regulation of agmatine concentrations. Here we describe the high-resolution X-ray crystal structure of the E. coli agmatinase, SPEB. The data showed a relatively high degree of pseudomerohedral twinning, was ultimately indexed in the P3(1) space group and led to a final model with eighteen chains, corresponding to three full hexamers in the asymmetric unit. There was a solvent content of 38.5% and refined R/R-free values of 0.166/0.216. The protein has the conserved fold characteristic of the agmatine ureohydrolase family and displayed a high degree of structural similarity among individual protomers. Two distinct peaks of electron density were observed in the active site of most of the eighteen chains of SPEB. As the activity of this protein is known to be dependent upon manganese and the fold is similar to other dinuclear metallohydrolases, these peaks were modeled as manganese ions. The orientation of the conserved active site residues, in particular those amino acids that participate in binding the metal ions and a pair of acidic residues (D153 and E274 in SPEB) that play a role in catalysis, are similar to other agmatinase and arginase enzymes and is consistent with a hydrolytic mechanism that proceeds via a metal-activated hydroxide ion.	[Chitrakar, Iva; French, Jarrod B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Chitrakar, Iva] SUNY Stony Brook, Biochem & Struct Biol Grad Program, Stony Brook, NY 11794 USA; [Ahmed, Syed Fardin; Torelli, Andrew T.] Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA; [French, Jarrod B.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [French, Jarrod B.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Minnesota System	French, JB (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.; Torelli, AT (corresponding author), Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA.; French, JB (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.; French, JB (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	atorelli@ithaca.edu; jfrench@umn.edu	French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309; Torelli, Andrew/0000-0003-4130-9867	National Science Foundation [MCB-1750637]; Cottrell Scholar Award from the Research Corporation for Science Advancement [24413]; National Institute of General Medical [GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); Cottrell Scholar Award from the Research Corporation for Science Advancement; National Institute of General Medical; NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE))	This work was supported by the National Science Foundation through award number MCB-1750637 (JBF) and by a Cottrell Scholar Award to JBF from the Research Corporation for Science Advancement (24413). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2004, J BIOL CHEM, V279, P50505, DOI 10.1074/jbc.M409246200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arndt MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1411, DOI 10.1152/ajpcell.00529.2008; ATLAS D, 1984, EUR J BIOCHEM, V144, P287, DOI 10.1111/j.1432-1033.1984.tb08462.x; ATLAS D, 1984, FEBS LETT, V170, P387, DOI 10.1016/0014-5793(84)81350-2; AUGUET M, 1995, JPN J PHARMACOL, V69, P285, DOI 10.1254/jjp.69.285; Barua S, 2019, NEUROCHEM RES, V44, P735, DOI 10.1007/s11064-018-02712-1; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Benitez J, 2018, METABOLISM, V81, P35, DOI 10.1016/j.metabol.2017.11.005; Berkels R, 2004, CARDIOVASC DRUG REV, V22, P7; Bernstein HG, 2011, AMINO ACIDS, V40, P453, DOI 10.1007/s00726-010-0657-5; BRITTON D, 1972, ACTA CRYSTALL A-CRYS, V28, P296, DOI 10.1107/S0567739472000786; BUCH JK, 1985, J BACTERIOL, V163, P522, DOI 10.1128/JB.163.2.522-527.1985; Carvajal N, 2004, ARCH BIOCHEM BIOPHYS, V430, P185, DOI 10.1016/j.abb.2004.07.005; Carvajal N, 1999, BIOCHEM BIOPH RES CO, V264, P196, DOI 10.1006/bbrc.1999.1505; Carvajal N, 1999, BIOCHEM BIOPH RES CO, V258, P808, DOI 10.1006/bbrc.1999.0709; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Colleluori DM, 2005, ARCH BIOCHEM BIOPHYS, V444, P15, DOI 10.1016/j.abb.2005.09.009; Cox JD, 2001, BIOCHEMISTRY-US, V40, P2689, DOI 10.1021/bi002318+; Dowling DP, 2008, CELL MOL LIFE SCI, V65, P2039, DOI 10.1007/s00018-008-7554-z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Galea E, 1996, BIOCHEM J, V316, P247, DOI 10.1042/bj3160247; GILAD GM, 1995, LIFE SCI, V58, pPL41, DOI 10.1016/0024-3205(95)02274-0; Gilad GM, 1996, NEUROREPORT, V7, P1730, DOI 10.1097/00001756-199607290-00007; Gilad GM, 1996, J NEUROCHEM, V67, P1992; Grillo MA, 2004, AMINO ACIDS, V26, P3, DOI 10.1007/s00726-003-0030-z; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Iyer RK, 2002, MOL GENET METAB, V75, P209, DOI 10.1006/mgme.2001.3277; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1623, DOI 10.1128/AAC.50.5.1623-1627.2006; Laube G, 2017, BIOCHEM J, V474, P2619, DOI 10.1042/BCJ20170007; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Mistry SK, 2002, AM J PHYSIOL-GASTR L, V282, pG375, DOI 10.1152/ajpgi.00386.2001; Mitic N, 2014, ADV PROTEIN CHEM STR, V97, P49, DOI 10.1016/bs.apcsb.2014.07.002; MORRIS DR, 1966, J BIOL CHEM, V241, P3129; Morris SM, 2003, ANN NY ACAD SCI, V1009, P30, DOI 10.1196/annals.1304.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Salas M, 2004, J INORG BIOCHEM, V98, P1032, DOI 10.1016/j.jinorgbio.2004.02.022; Salas M, 2002, EUR J BIOCHEM, V269, P5522, DOI 10.1046/j.1432-1033.2002.03255.x; Satriano J, 1999, KIDNEY INT, V56, P1252, DOI 10.1046/j.1523-1755.1999.00697.x; Satriano J, 2008, AM J PHYSIOL-RENAL, V294, pF795, DOI 10.1152/ajprenal.00392.2007; Shek R, 2017, BIOCHEMISTRY-US, V56, P6734, DOI 10.1021/acs.biochem.7b00982; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Uribe E, 2020, J INORG BIOCHEM, V202, DOI 10.1016/j.jinorgbio.2019.110812; Uzbay TI, 2012, NEUROSCI BIOBEHAV R, V36, P502, DOI 10.1016/j.neubiorev.2011.08.006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YEATES TO, 1988, ACTA CRYSTALLOGR A, V44, P142, DOI 10.1107/S0108767387009632	59	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0248991	10.1371/journal.pone.0248991	http://dx.doi.org/10.1371/journal.pone.0248991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857156	Green Published			2022-12-26	WOS:000641474900080
J	Fischer, J; Ardakani, FB; Kattler, K; Walter, J; Schulz, MH				Fischer, Jonas; Ardakani, Fatemeh Behjati; Kattler, Kathrin; Walter, Joern; Schulz, Marcel H.			CpG content-dependent associations between transcription factors and histone modifications	PLOS ONE			English	Article							FACTOR-BINDING; CHIP-SEQ; EPIGENETIC MODIFICATIONS; GENE-EXPRESSION; IN-VIVO; CHROMATIN; ACETYLATION; PROTEIN; TRIMETHYLATION; METHYLATION	Understanding the factors that underlie the epigenetic regulation of genes is crucial to understand the gene regulatory machinery as a whole. Several experimental and computational studies examined the relationship between different factors involved. Here we investigate the relationship between transcription factors (TFs) and histone modifications (HMs), based on ChIP-seq data in cell lines. As it was shown that gene regulation by TFs differs depending on the CpG class of a promoter, we study the impact of the CpG content in promoters on the associations between TFs and HMs. We suggest an approach based on sparse linear regression models to infer associations between TFs and HMs with respect to CpG content. A study of the partial correlation of HMs for the two classes of high and low CpG content reveals possible CpG dependence and potential candidates for confounding factors in our models. We show that the models are accurate, inferred associations reflect known biological relationships, and we give new insight into associations with respect to CpG content. Moreover, analysis of a ChIP-seq dataset in HepG2 cells of the HM H3K122ac, an HM about little is known, reveals novel TF associations and supports a previously established link to active transcription.	[Fischer, Jonas] Max Planck Inst Informat Databases & Informat Sys, Saarbrucken, Germany; [Ardakani, Fatemeh Behjati; Schulz, Marcel H.] Max Planck Inst Informat Computat Biol & Appl Alg, Saarbrucken, Germany; [Fischer, Jonas; Ardakani, Fatemeh Behjati; Schulz, Marcel H.] Cluster Excellence Multimodal Comp & Interact, High Throughput Genom & Syst Biol, Saarbrucken, Germany; [Kattler, Kathrin; Walter, Joern] Univ Saarland, Dept Genet, Saarbrucken, Germany; [Ardakani, Fatemeh Behjati; Schulz, Marcel H.] Goethe Univ, Inst Cardiovasc Regenerat, Frankfurt, Germany	Max Planck Society; Saarland University; Goethe University Frankfurt	Fischer, J (corresponding author), Max Planck Inst Informat Databases & Informat Sys, Saarbrucken, Germany.; Fischer, J (corresponding author), Cluster Excellence Multimodal Comp & Interact, High Throughput Genom & Syst Biol, Saarbrucken, Germany.	fischer@mpi-inf.mpg.de	Walter, Jörn/AFN-6428-2022	Walter, Jörn/0000-0003-0563-7417; Schulz, Marcel H./0000-0002-1252-3656				Abe T, 2011, J BIOL CHEM, V286, P30504, DOI 10.1074/jbc.M111.264721; Arnold TB, 2016, J COMPUT GRAPH STAT, V25, P1, DOI 10.1080/10618600.2015.1008638; Ay E, 2013, AIDS REV, V15, P181; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Benveniste D, 2014, P NATL ACAD SCI USA, V111, P13367, DOI 10.1073/pnas.1412081111; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Budden DM, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-36; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEEP, 2015, MAN EP PROGR DEEP; Derwish R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169338; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; HASTIE T, 2009, SPRINGER SERIES STAT; Huang Q, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00370; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; King AD, 2016, CELL REP, V17, P289, DOI 10.1016/j.celrep.2016.08.083; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lasserre J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003168; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu L, 2015, NUCLEIC ACIDS RES, V43, P3873, DOI 10.1093/nar/gkv255; Lundberg SM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0925-0; Mazzone R, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0632-2; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moniaux N, 2006, ONCOGENE, V25, P3247, DOI 10.1038/sj.onc.1209353; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Park SJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S50; Perner J, 2014, NUCLEIC ACIDS RES, V42, P13689, DOI 10.1093/nar/gku1234; Roider HG, 2009, NUCLEIC ACIDS RES, V37, P6305, DOI 10.1093/nar/gkp682; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt F, 2019, BIOINFORMATICS, V35, P711, DOI 10.1093/bioinformatics/bty674; Sewack GF, 2001, MOL CELL BIOL, V21, P1404, DOI 10.1128/MCB.21.4.1404-1415.2001; Shin Hyunjin, 2013, Quant Biol, V1, P54; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Speranzini V, 2016, EMBO J, V35, P376, DOI 10.15252/embj.201593377; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tzika E, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00361; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walavalkar NM, 2013, J BIOL CHEM, V288, P3419, DOI 10.1074/jbc.M112.431346; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Wilson S, 2018, NPJ SYST BIOL APPL, V4, DOI 10.1038/s41540-018-0061-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xin BB, 2018, GENOME RES, V28, P321, DOI 10.1101/gr.220079.116; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhao ZB, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1870-5; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	69	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249985	10.1371/journal.pone.0249985	http://dx.doi.org/10.1371/journal.pone.0249985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857234	Green Published, gold			2022-12-26	WOS:000641474900047
J	Lohiniva, AL; Dub, T; Hagberg, L; Nohynek, H				Lohiniva, Anna-Leena; Dub, Timothee; Hagberg, Lotta; Nohynek, Hanna			Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland	PLOS ONE			English	Article							HEALTH; DISCRIMINATION; DIAGNOSIS; FRAMEWORK; EPIDEMIC	Background The COVID-19 pandemic has intensely changed the everyday lives of people worldwide. This study explores the forms and outcomes of coronavirus and COVID-19-related social stigma and the experiences of people who were home quarantined or isolated in Finland during the spring 2020. The findings of this study can be used to improve support for those quarantined or isolated and to develop strategies to reduce the stigma associated with coronavirus and COVID-19. Methods The study is based on qualitative one-to-one interviews with households with at least two members and at least one PCR confirmed COVID-19 case. Recruitment took place via website or SMS messages sent to PCR confirmed cases in the capital area of Helsinki. Sampling was based on maximum variation to acquire different types of respondents. The framework of health stigma was used to develop question guides and analyze stigma. Quarantine and isolation experiences were explored through open-ended questions. The analysis was based on thematic analysis. Results The study included 64 participants from 24 households. Perceived stigma among respondents was driven by fear and blame for infection, and it manifested in various ways leading to a reluctance to disclose their coronavirus status to others. Self-stigma developed from conflicting information and advice about coronavirus and COVID-19 led to difficulties interacting with others outside of the house and reluctance to meet people after quarantine and isolation. Quarantine and isolation experiences included uncertainty, health concerns, and boredom. Communication with others in similar situations was perceived vital, whereas discussions with family members about worries and fears related to coronavirus and COVID-19 was not preferred. Conclusions This study shed light on the lives of those quarantined or isolated at home and provided a set of operational recommendations to minimize coronavirus and COVID-19-associated stigma and to reduce challenges faced by those in quarantine or isolation.	[Lohiniva, Anna-Leena; Dub, Timothee; Hagberg, Lotta; Nohynek, Hanna] Finnish Inst Hlth & Welf, Helsinki, Finland		Lohiniva, AL (corresponding author), Finnish Inst Hlth & Welf, Helsinki, Finland.	anna-leena.lohiniva@thl.fi		Lohiniva, Anna-Leena/0000-0003-3169-5872				Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, TIMES JAPAN; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Blake H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092997; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Bruns DP, 2020, J TRANSCULT NURS, V31, P326, DOI 10.1177/1043659620917724; Budhwani H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19301; Bukuluki Paul, 2020, Soc Sci Humanit Open, V2, P100045, DOI 10.1016/j.ssaho.2020.100045; Business Insider, 2020, WHATSAPP IS TOUT STE; Cava MA, 2005, J NURS SCHOLARSHIP, V37, P343, DOI 10.1111/j.1547-5069.2005.00059.x; Centers for Disease Control and Prevention (CDC) , 2017, QUAR IS; Centers for Disease Control and Prevention (CDC), 2018, CERC CRIS EM COMM; Chen DD, 2020, GEN HOSP PSYCHIAT, V66, P81, DOI 10.1016/j.genhosppsych.2020.07.006; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Daoust JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235590; de Vlas SJ, 2009, TROP MED INT HEALTH, V14, P101, DOI 10.1111/j.1365-3156.2009.02348.x; DiIorio C, 2003, EPILEPSY BEHAV, V4, P259, DOI 10.1016/S1525-5050(03)00103-3; Finnish Institute for Health and Welfare (internet), 2020, KAR JA ER; Fisher D, 2020, LANCET, V395, P1109, DOI 10.1016/S0140-6736(20)30679-6; Goh KT, 2006, ANN ACAD MED SINGAP, V35, P301; Gutrie J Kunkel A., 2016, INT ENCY INTERPERSON, VFirs, DOI [10.1002/9781118540190.wbeic0034, DOI 10.1002/9781118540190.WBEIC0034]; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Laura Brady, 2012, MEASURING HIV STIGMA; Lee VJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa039; Lin ECL, 2010, AM J INFECT CONTROL, V38, P302, DOI 10.1016/j.ajic.2009.09.008; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maiorano A, 2017, CAN J PSYCHIAT, V62, P702, DOI 10.1177/0706743717711172; Malecki KMC, 2021, CLIN INFECT DIS, V72, P697, DOI 10.1093/cid/ciaa758; Mason M., 2010, FORUM QUAL SOC RES, V11; Morgan D., 2008, SAGE ENCY QUALITATIV, P816, DOI 10.4135/9781412963909; Naeem S., 2020, UBIN INT PERSPECTIVE, DOI [10.1111/hir.12311, DOI 10.1111/HIR.12311]; Omole FS, 2011, AM FAM PHYSICIAN, V84, P780; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Pearl RL, 2020, OBESITY, V28, P1180, DOI 10.1002/oby.22850; Perry Phil, 2010, Virtual Mentor, V12, P225, DOI 10.1001/virtualmentor.2010.12.3.mhst1-1003; Rong XM, 2020, MATH BIOSCI ENG, V17, P2725, DOI 10.3934/mbe.2020149; Scott N, 2015, PRIM HEALTH CARE RES, V16, P618, DOI 10.1017/S1463423615000043; Sjodin H, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.13.2000280; Sotgiu G, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02461-2020; Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3; Svoboda T, 2004, NEW ENGL J MED, V350, P2352, DOI 10.1056/NEJMoa032111; Taipale S, 2018, LECT NOTES COMPUT SC, V10926, P532, DOI 10.1007/978-3-319-92034-4_40; Thibodeau PH, 2019, LANG LINGUIST COMPAS, V13, DOI 10.1111/lnc3.12327; Tracy CS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-470; Try L., 2006, ASIA PAC DISABIL REH, V17, P55; Turner-Musa J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020168; UNICEF, SOC STIGM ASS COVID; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874; Vatne TM, 2017, PATIENT EDUC COUNS, V100, P2106, DOI 10.1016/j.pec.2017.05.021; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; World Health Organization (WHO), 2020, SOC STIGM PEOPL COVI; Zhang Q, 2019, P NATL ACAD SCI USA, V116, P24463, DOI 10.1073/pnas.1907956116	60	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0247962	10.1371/journal.pone.0247962	http://dx.doi.org/10.1371/journal.pone.0247962			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852581	Green Published, gold			2022-12-26	WOS:000640604500053
J	Bantie, GM; Aynie, AA; Akenew, KH; Belete, MT; Tena, ET; Gebretsadik, GG; Tsegaw, AN; Woldemariam, TB; Woya, AA; Melese, AA; Ayalew, AF; Dessie, G				Bantie, Getasew Mulat; Aynie, Amare Alamirew; Akenew, Kidist Hailu; Belete, Mahlet Tilahun; Tena, Eyerusalem Teshome; Gebretsadik, Genet Gebreselasie; Tsegaw, Aynalem Nebebe; Woldemariam, Tigist Birru; Woya, Ashenafi Abate; Melese, Amare Alemu; Ayalew, Agumas Fentahun; Dessie, Getenet			Prevalence of stunting and associated factors among public primary school pupils of Bahir Dar city, Ethiopia: School-based cross-sectional study	PLOS ONE			English	Article							RISK-FACTORS; AGED CHILDREN; RURAL-AREAS; UNDERNUTRITION; DETERMINANTS; OVERWEIGHT; THINNESS; OBESITY	Background Stunting is a well-established child-health indicator of chronic malnutrition, which reliably gives a picture of the past nutritional history and the prevailing environmental and socioeconomic circumstances. Objective To investigate the prevalence of stunting and associated factors among public primary school children of the Bahir Dar city. Method A cross-sectional study was carried out from March to June 2019. Data were coded and entered into the Epi-Data and exported to SPSS version 23 software. The pupil was stunted if the height- for-age was <= -2 SDs from the median growth standards according to the WHO. A descriptive summary was computed using frequency, percent, mean, median and standard deviation. A simple logistic regression model was fitted to identify associated factors between the independent variables and the dependent variable at a 95% confidence interval (CI) and p-value Results 370 primary school pupils were included in the study with the mean age of 10.15 (+/- 2.23 SD) years. 51.6% of the pupils were females. The total prevalence of stunting was 15.13% (95%CI; 11%, 19%). The burden of stunting was higher in the age group of 11 years and older. Pupil's age older than 11 years (AOR = 15. 6; 95%CI; 3.31, 73.45; p-value < 0. 001) and male sex (AOR = 7. 07; 95%CI: 2.51, 19.89; p-value < 0. 0002) were significantly associated with stunting. Conclusion The prevalence of stunting was relatively lower than the regional estimated stunting level. Older age and male sex were significantly associated with stunting.	[Bantie, Getasew Mulat; Aynie, Amare Alamirew] Alkan Hlth Sci Business & Technol Coll, Fac Community Hlth, Bahir Dar, Ethiopia; [Akenew, Kidist Hailu; Belete, Mahlet Tilahun; Tena, Eyerusalem Teshome; Gebretsadik, Genet Gebreselasie; Tsegaw, Aynalem Nebebe; Woldemariam, Tigist Birru] GAMBY Coll Med Sci, Dept Nursing, Bahir Dar, Ethiopia; [Woya, Ashenafi Abate] Bahir Dar Univ, Dept Stat, Bahir Dar, Ethiopia; [Melese, Amare Alemu] Univ Gondar, Dept Lab Med, Gondar, Ethiopia; [Ayalew, Agumas Fentahun] Woldia Univ, Coll Hlth Sci, Sch Publ Hlth, Woldia, Ethiopia; [Dessie, Getenet] Bahir Dar Univ, Dept Nursing, Bahir Dar, Ethiopia	Bahir Dar University; University of Gondar; Bahir Dar University	Bantie, GM (corresponding author), Alkan Hlth Sci Business & Technol Coll, Fac Community Hlth, Bahir Dar, Ethiopia.	getasewmulat@gmail.com	Dessie, Getenet/AHC-4372-2022; Fentahun, Agumas/AGP-7357-2022; Bantie, Getasew/ABZ-4323-2022; Dessie, Getenet/Y-7728-2018	Bantie, Getasew/0000-0002-5073-6767; Woya, Ashenafi/0000-0003-2612-4370; Fentahun, Agumas/0000-0003-2847-5211				Abate Kalkidan Hassen, 2017, Nutrition and Health (Bicester), V23, P193, DOI 10.1177/0260106017706253; Adedeji IA, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.170.15763; Adenuga W U, 2017, Ann Ib Postgrad Med, V15, P7; Akseer N, 2017, ANN NY ACAD SCI, V1393, P3, DOI 10.1111/nyas.13336; Al-Saffa A J, 2009, East Mediterr Health J, V15, P322; Altare C, 2016, J TROP PEDIATRICS, V62, P390, DOI 10.1093/tropej/fmw024; Bahir Dar city administration, 2017, POPULATION HOUSEHOLD; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bogale TY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5561-z; Brown KH, 2004, INT ZINC NUTR CONSUL; Bukania ZN, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/907153; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Demographic E. Health Survey (EDHS), 2016, KEY INDICATORS REPOR; Dong YH, 2019, PUBLIC HEALTH NUTR, V22, P2043, DOI 10.1017/S1368980019000235; EDHS E., 2016, DHS PROGRAM ICF, V363, P364; Esfarjani F, 2013, INT J PREVENTIVE MED, V4, P173; Ethiopian statistical agency, ETHIOPIAN DEMOGRAPHI; Getaneh Z, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1572-x; Girum Tadesse, 2005, Ethiopian Journal of Health Development, V19, P140; Global Detention Project, 2018, ANN REPORT; Grimes JET, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005948; Hailegebriel T, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3306-3; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; Hussein Mohamed D, 2018, Sudan J Paediatr, V18, P15, DOI 10.24911/SJP.106-1544799078; Khuwaja S, 2005, J TROP PEDIATRICS, V51, P72, DOI 10.1093/tropej/fmh067; Mazengia AL, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/7521751; McDonald CM, 2009, J NUTR, V139, P370, DOI 10.3945/jn.108.098111; Mekonnen A, 2005, CHILD NUTR STATUS PO; Mohamed S, 2015, J TROP PEDIATRICS, V61, P260, DOI 10.1093/tropej/fmv028; Mushtaq MU, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-790; Nutrition Sco, 2014, NUTR POST2015 SUSTAI; Oliveira D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137327; Perignon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112605; Qin Y., 2009, ASIA PAC J CLIN NUTR; Qin Y, 2009, ASIA PAC J CLIN NUTR, V18, P15; Senbanjo IO, 2011, J HEALTH POPUL NUTR, V29, P364, DOI 10.3329/jhpn.v29i4.8452; Tariku EZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206659; Webb P, 2005, NUTR SERV WFP ROME, P17; Wikipedia F, 2016, LIST CITIES TOWNS ET; World Health Organization, 2018, MALN KEY FACTS, P1; Wu HH, 2016, ANN HUM BIOL, V43, P505, DOI 10.3109/03014460.2015.1107129; Yasmin G., 2014, Pakistan Journal of Nutrition, V13, P557; Yeasmin S., 2016, J NUTR HLTH SCI, V3, P1, DOI [10.15744/2393-9060.3.201, DOI 10.15744/2393-9060.3.201]; Yeasmin S., 2016, ASIAN J MED SCI, V7, P59, DOI [DOI 10.3126/AJMS.V7I4.14558, 10.3126/ajms.v7i4.14558]	44	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2021	16	4							e0248108	10.1371/journal.pone.0248108	http://dx.doi.org/10.1371/journal.pone.0248108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM7RW	33844683	Green Published, Green Submitted, gold			2022-12-26	WOS:000639857200001
J	Bjorkqvist, O; Rangel, I; Serrander, L; Magnusson, C; Halfvarson, J; Noren, T; Bergman-Jungestrom, M				Bjorkqvist, Olle; Rangel, Ignacio; Serrander, Lena; Magnusson, Cecilia; Halfvarson, Jonas; Noren, Torbjorn; Bergman-Jungestrom, Malin			Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection	PLOS ONE			English	Article								Objective Fecal microbiota transplantation (FMT) is a highly effective treatment for Clostridioides difficile infection (CDI). However, the fecal transplant's causal components translating into clearance of the CDI are yet to be identified. The commensal bacteria Faecalibacterium prausnitzii may be of great interest in this context, since it is one of the most common species of the healthy gut microbiota and produces metabolites with anti-inflammatory properties. Although there is mounting evidence that F. prausnitzii is an important regulator of intestinal homeostasis, data about its role in CDI and FMT are relatively scarce. Methods Stool samples from patients with recurrent CDI were collected to investigate the relative abundance of F. prausnitzii before and after FMT. Twenty-one patients provided fecal samples before the FMT procedure, at 2 weeks post-FMT, and at 2-4 months post-FMT. The relative abundance of F. prausnitzii was determined using quantitative polymerase chain reaction. Results The abundance of F. prausnitzii was elevated in samples (N = 9) from donors compared to pre-FMT samples (N = 15) from patients (adjusted P<0.001). No significant difference in the abundance of F. prausnitzii between responders (N = 11) and non-responders (N = 4) was found before FMT (P = 0.85). In patients with CDI, the abundance of F. prausnitzii significantly increased in the 2 weeks post-FMT samples (N = 14) compared to the pre-FMT samples (N = 15, adjusted P<0.001). The increase persisted 2-4 months post-FMT (N = 15) compared to pre-FMT samples (N = 15) (adjusted P<0.001). Conclusions FMT increases the relative abundance of F. prausnitzii in patients with recurrent CDI, and this microbial shift remains several months later. The baseline abundance of F. prausnitzii in donors or recipients was not associated with future treatment response, although a true predictive capacity cannot be excluded because of the limited sample size. Further studies are needed to discern whether F. prausnitzii plays an active role in the resolution of CDI.	[Bjorkqvist, Olle; Halfvarson, Jonas] Orebro Univ, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden; [Rangel, Ignacio; Halfvarson, Jonas] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Serrander, Lena; Bergman-Jungestrom, Malin] Linkoping Univ, Dept Clin & Expt Med, Div Clin Microbiol, Linkoping, Sweden; [Magnusson, Cecilia] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Magnusson, Cecilia] Reg Jonkoping Cty, Dept Infect Dis, Jonkoping, Sweden; [Noren, Torbjorn] Orebro Univ, Fac Med & Hlth, Dept Lab Med, Natl Reference Lab Clostridioides Difficile, Orebro, Sweden	Orebro University; Orebro University; Linkoping University; Linkoping University; Orebro University	Bjorkqvist, O (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden.	olle.bjorkqvist@regionorebrolan.se		Magnusson, Cecilia/0000-0002-5540-8930; Bjorkqvist, Olle/0000-0002-4329-1659	Futurum Akademin for Hsaoch Vard, Region Jopings lans	Futurum Akademin for Hsaoch Vard, Region Jopings lans	"Futurum Akademin for Hsaoch Vard, Region Jopings lans" (https://plus.rjl.se/futurum) provided funding for CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barnes D, 2018, J PEDIATR GASTR NUTR, V67, P185, DOI 10.1097/MPG.0000000000001940; Bjrkqvist O, 2019, SCAND J GASTROENTERO, V54, P577, DOI 10.1080/00365521.2019.1599417; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Chu ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170922; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Eppinga H, 2016, J CROHNS COLITIS, V10, P1067, DOI 10.1093/ecco-jcc/jjw070; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Hourigan SK, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz379; Hvas CL, 2019, GASTROENTEROLOGY, V156, P1324, DOI 10.1053/j.gastro.2018.12.019; Jefferson KK, 1999, J IMMUNOL, V163, P5183; Kellingray L, 2018, J INFECTION, V77, P107, DOI 10.1016/j.jinf.2018.04.012; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Martin R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01226; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Mintz M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190997; Moelling Karin, 2016, Bacteriophage, V6, pe1251380, DOI 10.1080/21597081.2016.1251380; Mullish BH, 2019, GUT, V68, P1791, DOI 10.1136/gutjnl-2018-317842; Navab-Moghadam F, 2017, MICROB PATHOGENESIS, V110, P630, DOI 10.1016/j.micpath.2017.07.034; Olsen MA, 2015, CLIN MICROBIOL INFEC, V21, P164, DOI 10.1016/j.cmi.2014.08.017; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Quraishi MN, 2017, ALIMENT PHARM THER, V46, P479, DOI 10.1111/apt.14201; Rizzardi K, 2018, EMERG INFECT DIS, V24, P1617, DOI 10.3201/eid2409.171658; Seekatz AM, 2018, ANAEROBE, V53, P64, DOI 10.1016/j.anaerobe.2018.04.001; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Tvede M, 2015, CLIN MICROBIOL INFEC, V21, P48, DOI 10.1016/j.cmi.2014.07.003; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61	43	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0249861	10.1371/journal.pone.0249861	http://dx.doi.org/10.1371/journal.pone.0249861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836037	Green Published, gold			2022-12-26	WOS:000639361000007
J	DeAngelis, HE; Grillet, AM; Nemer, MB; Wasiolek, MA; Hanson, DJ; Omana, MA; Sanchez, AL; Vehar, DW; Thelen, PM				DeAngelis, Haedi E.; Grillet, Anne M.; Nemer, Martin B.; Wasiolek, Maryla A.; Hanson, Don J.; Omana, Michael A.; Sanchez, Andres L.; Vehar, David W.; Thelen, Paul M.			Gamma radiation sterilization of N95 respirators leads to decreased respirator performance	PLOS ONE			English	Article							MASK	In response to personal protective equipment (PPE) shortages in the United States due to the Coronavirus Disease 2019, two models of N95 respirators were evaluated for reuse after gamma radiation sterilization. Gamma sterilization is attractive for PPE reuse because it can sterilize large quantities of material through hermetically sealed packaging, providing safety and logistic benefits. The Gamma Irradiation Facility at Sandia National Laboratories was used to irradiate N95 filtering facepiece respirators to a sterilization dose of 25 kGy(tissue). Aerosol particle filtration performance testing and electrostatic field measurements were used to determine the efficacy of the respirators after irradiation. Both respirator models exhibited statistically significant decreases in particle filtering efficiencies and electrostatic potential after irradiation. The largest decrease in capture efficiency was 40-50% and peaked near the 200 nm particle size. The key contribution of this effort is correlating the electrostatic potential change of individual filtration layer of the respirator with the decrease filtration efficiency after irradiation. This observation occurred in both variations of N95 respirator that we tested. Electrostatic potential measurement of the filtration layer is a key indicator for predicting filtration efficiency loss.	[DeAngelis, Haedi E.; Grillet, Anne M.; Nemer, Martin B.; Wasiolek, Maryla A.; Hanson, Don J.; Omana, Michael A.; Sanchez, Andres L.; Vehar, David W.; Thelen, Paul M.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Thelen, PM (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	pmthele@sandia.gov			U.S. Department of Energy under Sandia National Laboratories' Laboratory Directed Research and Development Program; U.S. Department of Energy's National Nuclear Security Administration [DENA0003525]; DOE Office of Science through the National Virtual Biotechnology Laboratory; Coronavirus CARES Act	U.S. Department of Energy under Sandia National Laboratories' Laboratory Directed Research and Development Program(United States Department of Energy (DOE)); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration); DOE Office of Science through the National Virtual Biotechnology Laboratory(United States Department of Energy (DOE)); Coronavirus CARES Act	This effort was funded by the U.S. Department of Energy under Sandia National Laboratories' Laboratory Directed Research and Development Program (http://www.sandia.gov/).Sandia National Laboratories is a multimission laboratory managed and operated by National Technology & Engineering Solutions of Sandia, LLC, for the U.S. Department of Energy's National Nuclear Security Administration under contract DENA0003525. This paper describes objective technical results and analysis. Any subjective views or opinions that might be expressed in the paper do not necessarily represent the views of the U.S. Department of Energy or the United States Government. The authors also acknowledge funding by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act. The funders provided internal peer review for this manuscript and recommended it for publication, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	3M, 2020, TECHN B DEC FFRS FRE; American National Standards Institute Inc, 2019, 1111372 ANSIAAMIISO; Anderegg L, 2021, APPL BIOSAF, V26, P80, DOI 10.1089/apb.20.0053; Anderegg L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234851; [Anonymous], 2020, IAEA TECHNICAL REPOR; [Anonymous], CFR SECT, V42; [Anonymous], 2020, GAMMA IRRADIATION FA; Centers for Disease Control and Prevention, 2020, DEC REUS FILT FAC RE; Cramer A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9961; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Feldmann F, 2019, AM J TROP MED HYG, V100, P1275, DOI 10.4269/ajtmh.18-0937; Food and Drug Administration, 2020, FAQS 3D PRINT MED DE; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; Grist SM, 2021, APPL BIOSAF, V26, P90, DOI 10.1089/apb.20.0051; Harrell CR, 2018, INT J MED SCI, V15, P274, DOI 10.7150/ijms.22644; He XJ, 2013, AEROSOL SCI TECH, V47, P1180, DOI 10.1080/02786826.2013.829209; International Atomic Energy Agency, 2004, DIR GAMM PROC FAC ME; Kumar A, 2021, AEROSOL AIR QUAL RES, V21, DOI 10.4209/aaqr.2020.06.0349; Liao L, 2020, ACS NANO, V14, P6348, DOI 10.1021/acsnano.0c03597; Lin TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186217; Liu JX, 2019, ACS APPL MATER INTER, V11, P40592, DOI 10.1021/acsami.9b13162; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; N95Decon, 2020, N95 DEC REUS METH DE; National Institute for Occupational Safety and Health : National Personal Protective Technology Laboratory, 2019, DET PART FILT EFF LE; Noras M.A., 2002, TREK APPL NOTE, pn3002; Omana M., 2020, PARAMETERIZATION STU, DOI [10.2172/1646968, DOI 10.2172/1646968]; Omana M., 2020, FILTRATION PERFORMAN, DOI [10.2172/1617115, DOI 10.2172/1617115]; Ou QS, 2020, J AEROSOL SCI, V150, DOI 10.1016/j.jaerosci.2020.105609; Peltier RE, 2020, INFECT CONT HOSP EP, V41, P1446, DOI 10.1017/ice.2020.332; Pirker L, 2021, J MEMBRANE SCI, V619, DOI 10.1016/j.memsci.2020.118756; Rempel D, 2021, APPL BIOSAF, V26, P71, DOI 10.1089/apb.20.0042; Rodriguez-Martinez CE, 2020, AM J INFECT CONTROL, V48, P1520, DOI 10.1016/j.ajic.2020.07.004; The National Personal Protective Technology Laboratory, 2020, RESP ASS SUPP COVID; Viscusi DJ, 2009, AM J INFECT CONTROL, V37, P381, DOI 10.1016/j.ajic.2008.09.021; Walsh DC, 1998, AEROSOL SCI TECH, V29, P419, DOI 10.1080/02786829808965580; Zhang XC, 1999, J APPL POLYM SCI, V74, P2234, DOI 10.1002/(SICI)1097-4628(19991128)74:9<2234::AID-APP12>3.3.CO;2-J	36	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0248859	10.1371/journal.pone.0248859	http://dx.doi.org/10.1371/journal.pone.0248859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831014	gold, Green Published			2022-12-26	WOS:000639359600104
J	Bui, DHT; Nguyen, BX; Truong, DC; Meyrowitsch, DW; Sondergaard, J; Gammeltoft, T; Bygbjerg, IC; Jannie, N				Dieu Huyen Thi Bui; Bai Xuan Nguyen; Dat Cong Truong; Meyrowitsch, Dan Wolf; Sondergaard, Jens; Gammeltoft, Tine; Bygbjerg, Ib Christian; Jannie, Nielsen			Polypharmacy among people living with type 2 diabetes mellitus in rural communes in Vietnam	PLOS ONE			English	Article							PREVALENCE; DISEASE	Objectives People with diabetes are at high risk of polypharmacy owing to complex treatment of diabetes and comorbidities. Polypharmacy is associated with increased risk of adverse reactions and decreased compliance. Therefore, the objectives of this study were to assess polypharmacy in people with type 2 diabetes (T2D) and associated diabetes-related factors in rural areas in Vietnam. Method People with T2D (n = 806) who had received treatment for diabetes at a district hospital were invited to participate in a questionnaire-based cross-sectional survey. Polypharmacy was defined as >= 5 types of medicine and assessed as a) prescription medicine and non-prescription/over the counter (OTC) medicine and b) prescription medicine and non-prescription/OTC, herbal and traditional medicine, and dietary supplement. Multiple logistic regression was used to investigate the association between polypharmacy and diabetes specific factors: duration, comorbidities and diabetes-related distress. Results Of the people with T2D, 7.8% had a medicine use corresponding to polypharmacy (prescription medicine and non-prescription/OTC), and 40.8% when herbal and traditional medicine, and dietary supplement were included. Mean number of medicine intake (all types of medicines and supplements) were 3.8 +/- 1.5. The odd ratios (ORs) of polypharmacy (medicine and supplements) increased with diabetes duration (5 years OR = 1.74; 95%CI: 1.14-2.64 as compared to <= 1-year duration of diabetes), number of comorbidities (1-2 comorbidities: OR = 2.0; 95%CI: 1.18-3.42; >= 3 comorbidities: OR = 2.63;95%CI: 1.50-4.61 as compared to no comorbidities), and suffering from diabetes-related distress (OR = 1.49; 95%CI: 1.11-2.01) as compared to those without distress. Conclusions In rural northern Vietnam, persons with longer duration of T2D, higher number of comorbidities and diabetes-related stress have higher odds of having a medicine use corresponding to polypharmacy. A high proportion of people with T2D supplement their prescription, non-prescription/OTC medicine with herbal and traditional medicine and dietary supplements.	[Dieu Huyen Thi Bui; Dat Cong Truong] Thai Binh Univ Med & Pharm, Fac Publ Hlth, Thai Binh, Vietnam; [Bai Xuan Nguyen] Thai Binh Univ Med & Pharm, Dept Embryol, Thai Binh, Vietnam; [Meyrowitsch, Dan Wolf; Bygbjerg, Ib Christian; Jannie, Nielsen] Univ Copenhagen, Dept Publ Hlth, Global Hlth Sect, Copenhagen K, Denmark; [Sondergaard, Jens] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense C, Denmark; [Gammeltoft, Tine] Univ Copenhagen, Dept Anthropol, Copenhagen K, Denmark; [Jannie, Nielsen] Emory Univ, Emory Global Diabet Res Ctr, Rollins Sch Global Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Thai Binh University of Medicine & Pharmacy; Thai Binh University of Medicine & Pharmacy; University of Copenhagen; University of Southern Denmark; University of Copenhagen; Emory University	Bui, DHT (corresponding author), Thai Binh Univ Med & Pharm, Fac Publ Hlth, Thai Binh, Vietnam.	huyendieu1410@gmail.com		Gammeltoft, Tine Mette/0000-0002-6723-2370; Bygbjerg, Ib/0000-0001-9100-2754; Nielsen, Jannie/0000-0003-4897-8705	Ministry of Foreign Affairs of Denmark (DANIDA)	Ministry of Foreign Affairs of Denmark (DANIDA)	Study was funded by the Ministry of Foreign Affairs of Denmark (DANIDA)	Alwhaibi M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020852; Anh Tuan Nguyen, 2009, Southern Med Review, V2, P2; [Anonymous], 2018, INVESTMENT PROMOTION; [Anonymous], 2017, VIETNAM MONTHLY INCO; Assari S, 2019, PHARMACY, V7, DOI 10.3390/pharmacy7010014; Austin RP., 2006, DIABETES SPECTR, V19, P13; Bazargan M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091574; Byles JE, 2003, INTERN MED J, V33, P388, DOI 10.1046/j.1445-5994.2003.00399.x; da Silva Córralo Vanessa, 2018, Rev. salud pública, V20, P366, DOI [10.15446/rsap.v20n3.50304, 10.15446/rsap.V20n3.50304]; Dieu BTH, 2019, VIETNAM MED J, P483; Dobrica EC, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080436; Gadsby R, 2012, DIABETIC MED, V29, P136, DOI 10.1111/j.1464-5491.2011.03494.x; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geitona M, 2018, CONSULT PHARM, V33, P562, DOI [10.4140/TCP.n.2018.562, 10.4140/TCP.n.2018.562.]; Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611; Haider SI, 2008, CLIN THER, V30, P419, DOI 10.1016/j.clinthera.2008.02.010; Haider SI, 2009, J AM GERIATR SOC, V57, P62, DOI 10.1111/j.1532-5415.2008.02040.x; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Horii T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49424-2; Indu Rania, 2018, Perspect Clin Res, V9, P139, DOI 10.4103/picr.PICR_81_17; International Diabetes Federation, 2017, DIABETES ATLAS; Josephine Valsa Jose PD, 2019, MEDICINE; Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x; Kasole R, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/2835691; Kasteleyn MJ, 2015, DIABETIC MED, V32, P1617, DOI 10.1111/dme.12743; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; KNUIMAN MW, 1986, DIABETES, V35, P1332, DOI 10.2337/diabetes.35.12.1332; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; Le Q-U., 2019, J APPL BIOPHARMACEUT, V7, P1; Li JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220047; LOI DT, 1991, J ETHNOPHARMACOL, V32, P51, DOI 10.1016/0378-8741(91)90103-K; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5; Mull DS, 2001, WESTERN J MED, V175, P307, DOI 10.1136/ewjm.175.5.307; Nguyen CT, 2015, ASIA-PAC J PUBLIC HE, V27, P588, DOI 10.1177/1010539515595860; Khue NT, 2015, ANN GLOB HEALTH, V81, P870, DOI 10.1016/j.aogh.2016.01.003; Noale M, 2016, ACTA DIABETOL, V53, P323, DOI 10.1007/s00592-015-0790-4; da Silva MRR, 2018, CIENC SAUDE COLETIVA, V23, P2565, DOI 10.1590/1413-81232018238.10222016; Rutters F, 2018, CHARACTERISATION PEO; Security VS, 2019, DIR PAYM EXP MED EX; Teljeur C, 2013, EUR J GEN PRACT, V19, P17, DOI 10.3109/13814788.2012.714768; Nguyen TX, 2020, AUSTRALAS J AGEING, V39, P230, DOI 10.1111/ajag.12722; Thommanduru Priyanka AL, 2015, INDIAN J PHARM PRACT, V8; Wawruch M, 2008, PHARM WORLD SCI, V30, P235, DOI 10.1007/s11096-007-9166-3; WHO, 2016, GLOB REP PSOR; Wimmer BC, 2016, J GERONTOL A-BIOL, V71, P831, DOI 10.1093/gerona/glv219; World Health Organisation, 2019, MED SAF POL	48	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249849	10.1371/journal.pone.0249849	http://dx.doi.org/10.1371/journal.pone.0249849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831073	Green Published, gold			2022-12-26	WOS:000639359600070
J	Huh, DA; Kang, MS; Lee, J; Choi, JY; Moon, KW; Lee, YJ				Huh, Da-An; Kang, Min-Sung; Lee, Jiyun; Choi, Ji Yoon; Moon, Kyong Whan; Lee, Yong-Jin			Occupational and environmental asbestos exposure and the risk of lung cancer in Korea: A case-control study in South Chungcheong Province of Korea	PLOS ONE			English	Article								Despite the use of large amounts of asbestos in the 1990s, few studies have been conducted in Korea on occupational and environmental asbestos exposure and lung cancer risk. The main aim of this study was to estimate the risk of lung cancer development caused by occupational and environmental asbestos exposures in residents of South Chungcheong Province, where about half of the asbestos mines in Korea operated. We conducted a case-control study, for which the information on asbestos exposure history and demographic characteristics was provided by the Environmental Health Center for asbestos of Soonchunhyang University Cheonan Hospital. After adjusting for all covariates, the odds ratios for lung cancer tended to increase with higher exposure probability for both occupational as well as environmental asbestos. The relative risk of occupational asbestos exposure was higher than that of environmental exposure; the interaction of co-exposure was not statistically significant. The estimated means of the latency period were significantly shorter in participants who were engaged in the production of asbestos-containing products and in those who lived near asbestos industries as compared to other groups.	[Huh, Da-An; Kang, Min-Sung] Korea Univ, Dept Hlth Sci, Grad Sch, Seoul, South Korea; [Kang, Min-Sung; Lee, Yong-Jin] Soonchunhyang Univ, Asbestos Environm Hlth Ctr, Cheonan Hosp, Cheonan Si, Chungcheongnam, South Korea; [Lee, Jiyun; Choi, Ji Yoon; Moon, Kyong Whan] Korea Univ, Dept Hlth & Safety Convergence Sci, Grad Sch, Seoul, South Korea; [Moon, Kyong Whan] Korea Univ, BK21 FOUR R&E Ctr Learning Hlth Syst, Grad Sch, Seoul, South Korea; [Moon, Kyong Whan] Korea Univ, Dept Hlth & Environm Sci, Grad Sch, Seoul, South Korea; [Lee, Yong-Jin] Soonchunhyang Univ, Dept Occupat & Environm Med, Cheonan Si, Chungcheongnam, South Korea	Korea University; Soonchunhyang University; Korea University; Korea University; Korea University; Soonchunhyang University	Lee, YJ (corresponding author), Soonchunhyang Univ, Asbestos Environm Hlth Ctr, Cheonan Hosp, Cheonan Si, Chungcheongnam, South Korea.; Lee, YJ (corresponding author), Soonchunhyang Univ, Dept Occupat & Environm Med, Cheonan Si, Chungcheongnam, South Korea.	schcard34274@naver.com		Moon, Kyong Whan/0000-0002-5794-0883; Choi, Ji Yoon/0000-0002-5648-2307; Huh, Da-An/0000-0001-7633-0805	Ministry of Environment (Environmental Health Center for Asbestos); Soonchunhyang University Research Fund	Ministry of Environment (Environmental Health Center for Asbestos)(Ministry of Environment (ME), Republic of Korea); Soonchunhyang University Research Fund	This research was supported by the Ministry of Environment (Environmental Health Center for Asbestos) and the Soonchunhyang University Research Fund.	Breslow NE., 1980, STAT METHODS CANC, P14; Choi J.K., 1998, J KOREAN SOC OCCUP E, V8, P242; Choi JK., 1998, J KOREAN SOC OCCUP E, V8, P254; Dong-uk Park, 2009, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V19, P307; Gustavsson P, 2002, AM J EPIDEMIOL, V155, P1016, DOI 10.1093/aje/155.11.1016; 최호춘, 2011, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V21, P201; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Jung KW, 2020, CANCER RES TREAT, V52, P351, DOI 10.4143/crt.2020.203; Kang DM, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0154-8; Kang Dongmug, 2009, [JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES, 한국환경보건학회지], V35, P71; Kim JW., 2014, J KOREAN SOC MINER E, V51, P1; Kim SH, 2019, THESIS; Kim SY, 2016, SCI TOTAL ENVIRON, V542, P1, DOI 10.1016/j.scitotenv.2015.10.115; Kwak KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183404; Lacourt A, 2012, EUR RESPIR J, V39, P1304, DOI 10.1183/09031936.00005111; Leem JH, 2010, SAF HEALTH WORK, V1, P134, DOI 10.5491/SHAW.2010.1.2.134; Magnani C, 2000, BRIT J CANCER, V83, P104; Metintas S, 2012, INT J ENVIRON HEAL R, V22, P468, DOI 10.1080/09603123.2011.654330; Mine Reclamation Corporation (MIERCO), 2019, YB MIRECO STAT, P12; Ministry of Employment and Labor (MOEL), 1984, INVESTIGATION ACTUAL; Ministry of Environment (MOE), 2010, HLTH IMPACT SURVEY A, P3; Ministry of Environment (MOE), 2009, OFF MEM POL EXP EX P, P3; Ministry of Environment (MOE), 2010, INVESTIGATION ASBEST, P3; Nielsen LS, 2014, ARCH ENVIRON OCCUP H, V69, P191, DOI 10.1080/19338244.2013.863752; Oh SM, 1992, RES REPORT IND HYGIE; Olsson AC, 2017, EPIDEMIOLOGY, V28, P288, DOI 10.1097/EDE.0000000000000604; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Pohlabeln H, 2002, OCCUP ENVIRON MED, V59, P410, DOI 10.1136/oem.59.6.410; Rigby AS, 2000, DISABIL REHABIL, V22, P259, DOI 10.1080/096382800296719; Suraya A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020591; 김지영, 2009, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V19, P8	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249790	10.1371/journal.pone.0249790	http://dx.doi.org/10.1371/journal.pone.0249790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831090	gold, Green Published			2022-12-26	WOS:000639359600132
J	Oechslin, F; Menzi, C; Moreillon, P; Resch, G				Oechslin, Frank; Menzi, Carmen; Moreillon, Philippe; Resch, Gregory			The multidomain architecture of a bacteriophage endolysin enables intramolecular synergism and regulation of bacterial lysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS; STAPHYLOCOCCUS-AUREUS; N-ACETYLGLUCOSAMINIDASE; PEPTIDOGLYCAN; DOMAINS; BINDING; ENDOPEPTIDASE; AUTOLYSIS; AMIDASE; MOTIF	Endolysins are peptidoglycan hydrolases produced at the end of the bacteriophage (phage) replication cycle to lyse the host cell. Endolysins in Gram-positive phages come in a variety of multimodular forms that combine different catalytic and cell wall binding domains. However, the reason why phages adopt endolysins with such complex multidomain architecture is not well understood. In this study, we used the Streptococcus dysgalactiae phage endolysin PlySK1249 as a model to investigate the role of multidomain architecture in phage-induced bacterial lysis and lysis regulation. PlySK1249 consists of an amidase (Ami) domain that lyses bacterial cells, a nonbacteriolytic endopeptidase (CHAP) domain that acts as a dechaining enzyme, and a central LysM cell wall binding domain. We observed that the Ami and CHAP domains synergized for peptidoglycan digestion and bacteriolysis in the native enzyme or when expressed individually and reunified. The CHAP endopeptidase resolved complex polymers of stem-peptides to dimers and helped the Ami domain to digest peptidoglycan to completion. We also found that PlySK1249 was subject to proteolytic cleavage by host cell wall proteases both in vitro and after phage induction. Cleavage disconnected the different domains by hydrolyzing their linker regions, thus hindering their bacteriolytic cooperation and possibly modulating the lytic activity of the enzyme. PlySK1249 cleavage by cell-wall-associated proteases may represent another example of phage adaptation toward the use of existing bacterial regulation mechanism for their own advantage. In addition, understanding more thoroughly the multidomain interplay of PlySK1249 broadens our knowledge on the ideal architecture of therapeutic antibacterial endolysins.	[Oechslin, Frank; Menzi, Carmen; Moreillon, Philippe; Resch, Gregory] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Oechslin, Frank] Univ Laval, Dept Biochem Microbiol & Bioinformat, Quebec City, PQ, Canada; [Resch, Gregory] Lausanne Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Lausanne, Switzerland	University of Lausanne; Laval University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Oechslin, F (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.; Oechslin, F (corresponding author), Univ Laval, Dept Biochem Microbiol & Bioinformat, Quebec City, PQ, Canada.	Frank.Oechslin@gmail.com		Menzi, Carmen/0000-0002-8656-3183; moreillon, philippe/0000-0001-7745-5538; resch, gregory/0000-0003-2341-4591	Foundation for Advancement in Medical Microbiology and Infectious Diseases (FAMMID); Swiss National Science Foundation (SNSF) [P400PB_191059]	Foundation for Advancement in Medical Microbiology and Infectious Diseases (FAMMID); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by a nonrestricted grant from the Foundation for Advancement in Medical Microbiology and Infectious Diseases (FAMMID) (P. M.). This work was also supported by the Swiss National Science Foundation (SNSF) under grant P400PB_191059 (F.O).	Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Broskey NT, 2013, J APPL PHYSIOL, V115, P765, DOI 10.1152/japplphysiol.00063.2013; Buist G, 1998, J BACTERIOL, V180, P5947, DOI 10.1128/JB.180.22.5947-5953.1998; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Christensen JE, 1999, ANTON LEEUW INT J G, V76, P217, DOI 10.1023/A:1002001919720; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; FAN DP, 1970, J BACTERIOL, V103, P494, DOI 10.1128/JB.103.2.494-499.1970; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Gu JM, 2011, J CLIN MICROBIOL, V49, P111, DOI 10.1128/JCM.01144-10; HERBOLD DR, 1975, J BIOL CHEM, V250, P7231; Horgan M, 2009, APPL ENVIRON MICROB, V75, P872, DOI 10.1128/AEM.01831-08; Hyman P, 2012, ADV M C M, P1, DOI 10.1079/9781845939847.0000; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; O'Flaherty S, 2005, J BACTERIOL, V187, P7161, DOI 10.1128/JB.187.20.7161-7164.2005; Oechslin F, 2013, ANTIMICROB AGENTS CH, V57, P6276, DOI 10.1128/AAC.01701-13; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; Pritchard DG, 2004, MICROBIOL-SGM, V150, P2079, DOI 10.1099/mic.0.27063-0; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmelcher M, 2015, J ANTIMICROB CHEMOTH, V70, P1453, DOI 10.1093/jac/dku552; Sheychenko A, 2006, NAT PROTOC, V1, p2856 2860; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Visweswaran GRR, 2014, APPL MICROBIOL BIOT, V98, P4331, DOI 10.1007/s00253-014-5633-7; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WANG X, 1991, GENE, V102, P105; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wong JEMM, 2015, ACTA CRYSTALLOGR D, V71, P592, DOI 10.1107/S139900471402793X; Young R, 2014, J MICROBIOL, V52, P243, DOI 10.1007/s12275-014-4087-z	41	6	6	6	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100639	10.1016/j.jbc.2021.100639	http://dx.doi.org/10.1016/j.jbc.2021.100639			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33838182	gold, Green Published			2022-12-26	WOS:000672866400610
J	Chatterjee, A; Wu, GY; Primakov, S; Oberije, C; Woodruff, H; Kubben, P; Henry, R; Aries, MJH; Beudel, M; Noordzij, PG; Dormans, T; van den Oever, NCG; van den Bergh, JP; Wyers, CE; Simsek, S; Douma, R; Reidinga, AC; de Kruif, MD; Guiot, J; Frix, AN; Louis, R; Moutschen, M; Lovinfosse, P; Lambin, P				Chatterjee, Avishek; Wu, Guangyao; Primakov, Sergey; Oberije, Cary; Woodruff, Henry; Kubben, Pieter; Henry, Ronald; Aries, Marcel J. H.; Beudel, Martijn; Noordzij, Peter G.; Dormans, Tom; van den Oever, Niels C. Gritters; van den Bergh, Joop P.; Wyers, Caroline E.; Simsek, Suat; Douma, Renee; Reidinga, Auke C.; de Kruif, Martijn D.; Guiot, Julien; Frix, Anne-Noelle; Louis, Renaud; Moutschen, Michel; Lovinfosse, Pierre; Lambin, Philippe			Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study	PLOS ONE			English	Article							RISK; OBESITY	Objective To establish whether one can build a mortality prediction model for COVID-19 patients based solely on demographics and comorbidity data that outperforms age alone. Such a model could be a precursor to implementing smart lockdowns and vaccine distribution strategies. Methods The training cohort comprised 2337 COVID-19 inpatients from nine hospitals in The Netherlands. The clinical outcome was death within 21 days of being discharged. The features were derived from electronic health records collected during admission. Three feature selection methods were used: LASSO, univariate using a novel metric, and pairwise (age being half of each pair). 478 patients from Belgium were used to test the model. All modeling attempts were compared against an age-only model. Results In the training cohort, the mortality group's median age was 77 years (interquartile range = 70-83), higher than the non-mortality group (median = 65, IQR = 55-75). The incidence of former/active smokers, male gender, hypertension, diabetes, dementia, cancer, chronic obstructive pulmonary disease, chronic cardiac disease, chronic neurological disease, and chronic kidney disease was higher in the mortality group. All stated differences were statistically significant after Bonferroni correction. LASSO selected eight features, novel univariate chose five, and pairwise chose none. No model was able to surpass an age-only model in the external validation set, where age had an AUC of 0.85 and a balanced accuracy of 0.77. Conclusion When applied to an external validation set, we found that an age-only mortality model outperformed all modeling attempts (curated on ) using three feature selection methods on 22 demographic and comorbid features.	[Chatterjee, Avishek; Wu, Guangyao; Primakov, Sergey; Oberije, Cary; Woodruff, Henry; Lambin, Philippe] Maastricht Univ, GROW Sch Oncol, Dept Precis Med, D Lab, Maastricht, Netherlands; [Kubben, Pieter] Maastricht Univ, Dept Neurosurg, Med Ctr, Maastricht, Netherlands; [Henry, Ronald] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands; [Aries, Marcel J. H.] Maastricht Univ, Dept Neurol, Med Ctr, Maastricht, Netherlands; [Beudel, Martijn] Univ Amsterdam, Dept Neurol, Med Ctr, Amsterdam, Netherlands; [Noordzij, Peter G.] St Antonius Hosp, Dept Anesthesiol & Intens Care, Nieuwegein, Netherlands; [Dormans, Tom] Zuyderland Med Ctr, Dept Intens Care, Heerlen, Netherlands; [van den Oever, Niels C. Gritters] Treant Zorggrp, Dept Intens Care, Emmen, Netherlands; [van den Bergh, Joop P.; Wyers, Caroline E.] VieCuri Med Ctr, Dept Internal Med, Venlo, Netherlands; [Simsek, Suat] Northwest Clin, Dept Internal Med, Alkmaar, Netherlands; [Douma, Renee] Flevoziekenhuis, Dept Internal Med, Almere, Netherlands; [Reidinga, Auke C.] Martiniziekenhuis, Dept Intens Care, Groningen, Netherlands; [de Kruif, Martijn D.] Zuyderland Med Ctr, Dept Pulm Med, Heerlen, Netherlands; [Guiot, Julien; Frix, Anne-Noelle; Louis, Renaud] CHU Liege, Dept Resp Med, Liege, Belgium; [Moutschen, Michel] CHU Liege, Dept Infectiol, Liege, Belgium; [Lovinfosse, Pierre] CHU Liege, Dept Med Phys, Nucl Med & Oncol Imaging, Liege, Belgium	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; St. Antonius Hospital Utrecht; VieCuri Medical Center; Martini Hospital; University of Liege; University of Liege; University of Liege	Chatterjee, A (corresponding author), Maastricht Univ, GROW Sch Oncol, Dept Precis Med, D Lab, Maastricht, Netherlands.	a.chatterjee@maastrichtuniversity.nl	Aries, Marcel/HFF-8727-2022; Oberije, Cary/ABA-6178-2020; Woodruff, Henry/AAS-5573-2021; Wyers, Caroline/F-6221-2013	Oberije, Cary/0000-0003-0749-5117; Guiot, Julien/0000-0001-7800-1730; Lambin, Philippe/0000-0001-7961-0191; Beudel, Martijn/0000-0002-2488-7051; van den Bergh, Joop/0000-0003-3984-2232; Wyers, Caroline/0000-0001-7662-3990; Kubben, Pieter/0000-0002-8059-523X	European Commission's Horizon 2020 Research and Innovation programme [101016131]; Innovative Medicines Initiative 2 Joint Undertaking [101005122]	European Commission's Horizon 2020 Research and Innovation programme; Innovative Medicines Initiative 2 Joint Undertaking	Authors acknowledge financial support from the European Commission's Horizon 2020 Research and Innovation programme under grant agreement 101016131 (ICOVID) and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005122 (DRAGON).	A. C.Reidinga, 2020, medRxiv, DOI 10.1101/2020.10.10.20210591; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Atkins JL, 2020, J GERONTOL A-BIOL, V75, P2224, DOI 10.1093/gerona/glaa183; Bianchetti A, 2020, J NUTR HEALTH AGING, V24, P560, DOI 10.1007/s12603-020-1389-1; Cai H, 2020, LANCET RESP MED, V8, pE20, DOI 10.1016/S2213-2600(20)30117-X; Derosa L, 2020, NAT CANCER, V1, P946, DOI 10.1038/s43018-020-00122-3; Filatov A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7352; Gansevoort RT, 2020, NAT REV NEPHROL, V16, P705, DOI 10.1038/s41581-020-00349-4; Gao Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18684-2; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guiot J, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010041; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Hu L, 2020, CLIN INFECT DIS, V71, P2089, DOI 10.1093/cid/ciaa539; Huang JF, 2020, J MED VIROL, V92, P2152, DOI 10.1002/jmv.26003; Jia X., 2020, 2 THINGS COVID 19 MI, P2020020315, DOI [10.20944/preprints202002.0315.v1, DOI 10.20944/PREPRINTS202002.0315.V1]; Johnston SL, 2020, ALLERGY, V75, P1543, DOI 10.1111/all.14348; Kassir R, 2020, OBES REV, V21, DOI 10.1111/obr.13034; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Liu Y, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01112-2020; Ma RCW, 2020, DIABETIC MED, V37, P723, DOI 10.1111/dme.14300; Magro B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245281; Marques C, 2022, ANN RHEUM DIS, V81, DOI 10.1136/annrheumdis-2020-218388; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Palaiodimos L, 2021, HORM-INT J ENDOCRINO, V20, P305, DOI 10.1007/s42000-020-00246-2; Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262; Schultze A, 2020, LANCET RESP MED, V8, P1106, DOI 10.1016/S2213-2600(20)30415-X; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wu GY, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01104-2020; Xu JX, 2022, CELL MOL NEUROBIOL, V42, P305, DOI 10.1007/s10571-020-00915-1; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Zheng KI, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154244; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zuin M, 2020, J INFECTION, V81, pE84, DOI 10.1016/j.jinf.2020.03.059	37	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249920	10.1371/journal.pone.0249920	http://dx.doi.org/10.1371/journal.pone.0249920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857224	gold, Green Published			2022-12-26	WOS:000641474900008
J	Nishii, K; Moller, M; Iida, H				Nishii, Kanae; Moller, Michael; Iida, Hidetoshi			Mix and match: Patchwork domain evolution of the land plant-specific Ca2+-permeable mechanosensitive channel MCA	PLOS ONE			English	Article							ARABIDOPSIS MCA1; CA2+ INFLUX; R PACKAGE; PROTEIN; REGIONS; ARCHITECTURE; ANNOTATION; EXPRESSION; SELECTION; DYNAMICS	Multidomain proteins can have a complex evolutionary history that may involve de novo domain evolution, recruitment and / or recombination of existing domains and domain losses. Here, the domain evolution of the plant-specific Ca2+-permeable mechanosensitive channel protein, MID1-COMPLEMENTING ACTIVITY (MCA), was investigated. MCA, a multidomain protein, possesses a Ca2+-influx-MCA(func) domain and a PLAC8 domain. Profile Hidden Markov Models (HMMs) of domains were assessed in 25 viridiplantae proteomes. While PLAC8 was detected in plants, animals, and fungi, MCA(func) was found in streptophytes but not in chlorophytes. Full MCA proteins were only found in embryophytes. We identified the MCA(func) domain in all streptophytes including charophytes where it appeared in E3 ubiquitin ligase-like proteins. Our Maximum Likelihood (ML) analyses suggested that the MCA(func) domain evolved early in the history of streptophytes. The PLAC8 domain showed similarity to Plant Cadmium Resistance (PCR) genes, and the coupling of MCA(func) and PLAC8 seemed to represent a single evolutionary event. This combination is unique in MCA, and does not exist in other plant mechanosensitive channels. Within angiosperms, gene duplications increased the number of MCAs. Considering their role in mechanosensing in roots, MCA might be instrumental for the rise of land plants. This study provides a textbook example of de novo domain emergence, recombination, duplication, and losses, leading to the convergence of function of proteins in plants.	[Nishii, Kanae; Moller, Michael] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Nishii, Kanae] Kanagawa Univ, Yokohama, Kanagawa, Japan; [Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan	Kanagawa University; Tokyo Gakugei University	Nishii, K (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.; Nishii, K (corresponding author), Kanagawa Univ, Yokohama, Kanagawa, Japan.; Iida, H (corresponding author), Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan.	kanaenishii@gmail.com; iida@u-gakugei.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKENHI], Ministry of Education, Culture, Sports, Science & Technology of Japan [25120708]; Edinburgh Botanic Garden Sibbald Trust [18]; JSPS [JSPS KAKENHI] [18K06375]; Sumitomo Foundation [170204]	Japan Society for the Promotion of Science (JSPS) [KAKENHI], Ministry of Education, Culture, Sports, Science & Technology of Japan; Edinburgh Botanic Garden Sibbald Trust; JSPS [JSPS KAKENHI]; Sumitomo Foundation	This work was supported by the Japan Society for the Promotion of Science (JSPS) [KAKENHI Grant Number 25120708], Ministry of Education, Culture, Sports, Science & Technology of Japan, to HI. KN's stay at RBGE is financially supported by the Edinburgh Botanic Garden Sibbald Trust [2018#18], JSPS [JSPS KAKENHI Grant Number 18K06375], and the Sumitomo Foundation [170204].	Bagowski CP, 2010, CURR GENOMICS, V11, P368, DOI 10.2174/138920210791616725; Basu D, 2017, CURR OPIN PLANT BIOL, V40, P43, DOI 10.1016/j.pbi.2017.07.002; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Choi IS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061959; Cox CD, 2015, PFLUG ARCH EUR J PHY, V467, P3, DOI 10.1007/s00424-014-1522-2; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Edger PP, 2018, AM J BOT, V105, P463, DOI 10.1002/ajb2.1040; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Furuichi T, 2012, PLANT SIGNAL BEHAV, V7, P1022, DOI 10.4161/psb.20783; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kersting AR, 2012, GENOME BIOL EVOL, V4, P316, DOI 10.1093/gbe/evs004; Kurusu T, 2013, TRENDS PLANT SCI, V18, P227, DOI 10.1016/j.tplants.2012.12.002; Kurusu T, 2012, J PLANT RES, V125, P555, DOI 10.1007/s10265-011-0462-6; Kurusu T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-11; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Liang JY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031097; Liao DH, 2017, NEW PHYTOL, V214, P1646, DOI 10.1111/nph.14472; Liu ZW, 2015, PLANT MOL BIOL, V87, P17, DOI 10.1007/s11103-014-0257-y; Medina R, 2019, J SYST EVOL, V57, P404, DOI 10.1111/jse.12516; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Nakano M, 2011, PLANT CELL PHYSIOL, V52, P1915, DOI 10.1093/pcp/pcr131; Nikolov LA, 2019, NEW PHYTOL, V222, P1638, DOI 10.1111/nph.15732; Nishii K, 2015, TAXON, V64, P1243, DOI 10.12705/646.8; Ohnishi M, 2015, PLANT CELL PHYSIOL, V56, P1297, DOI 10.1093/pcp/pcv048; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Pradhan M., 2019, THESIS FRIEDRICH SCH; Puttick MN, 2018, CURR BIOL, V28, P733, DOI 10.1016/j.cub.2018.01.063; R Core Team, 2018, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rosa M, 2017, PLANT CELL, V29, P474, DOI 10.1105/tpc.16.00878; Saarela JM, 2018, PEERJ, V6, DOI 10.7717/peerj.4299; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Song WY, 2010, PLANT CELL, V22, P2237, DOI 10.1105/tpc.109.070185; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stevens P.F, 2001 ONWARDS ANGIOSP; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamanaka T, 2010, PLANT PHYSIOL, V152, P1284, DOI 10.1104/pp.109.147371; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhang XC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-6	47	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2021	16	4							e0249735	10.1371/journal.pone.0249735	http://dx.doi.org/10.1371/journal.pone.0249735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP1DC	33857196	Green Published			2022-12-26	WOS:000641474900087
J	Nersisyan, S; Galatenko, A; Galatenko, V; Shkurnikov, M; Tonevitsky, A				Nersisyan, Stepan; Galatenko, Alexei; Galatenko, Vladimir; Shkurnikov, Maxim; Tonevitsky, Alexander			miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; FOXM1 PROMOTES; POOR SURVIVAL; FEEDBACK LOOP; EXPRESSION; TRANSCRIPTION; FAMILY; 17-BETA-ESTRADIOL; DYSREGULATION; PROLIFERATION	Analysis of regulatory networks is a powerful framework for identification and quantification of intracellular interactions. We introduce miRGTF-net, a novel tool for construction of miRNA-gene-TF networks. We consider multiple transcriptional and post-transcriptional interaction types, including regulation of gene and miRNA expression by transcription factors, gene silencing by miRNAs, and co-expression of host genes with their intronic miRNAs. The underlying algorithm uses information on experimentally validated interactions as well as integrative miRNA/mRNA expression profiles in a given set of samples. The latter ensures simultaneous tissue-specificity and biological validity of interactions. We applied miRGTF-net to paired miRNA/mRNA-sequencing data of breast cancer samples from The Cancer Genome Atlas (TCGA). Together with topological analysis of the constructed network we showed that considered players can form reliable prognostic gene signatures for ER-positive breast cancer. A number of signatures demonstrated remarkably high accuracy on transcriptomic data obtained by both microarrays and RNA sequencing from several independent patient cohorts. Furthermore, an essential part of prognostic genes were identified as direct targets of transcription factor E2F1. The putative interplay between estrogen receptor alpha and E2F1 was suggested as a potential recurrence factor in patients treated with tamoxifen. Source codes of miRGTF-net are available at GitHub ().	[Nersisyan, Stepan; Tonevitsky, Alexander] HSE Univ, Fac Biol & Biotechnol, Moscow, Russia; [Galatenko, Alexei; Galatenko, Vladimir] Lomonosov Moscow State Univ, Fac Mech & Math, Moscow, Russia; [Galatenko, Alexei] Moscow Ctr Fundamental & Appl Math, Moscow, Russia; [Shkurnikov, Maxim] Minist Hlth Russian Federat, Branch Natl Med Res Radiol Ctr, PA Hertsen Moscow Oncol Res Ctr, Moscow, Russia; [Galatenko, Vladimir] Evotec Int GmbH, Gottingen, Germany	HSE University (National Research University Higher School of Economics); Lomonosov Moscow State University; Ministry of Health of the Russian Federation; Evotec	Nersisyan, S (corresponding author), HSE Univ, Fac Biol & Biotechnol, Moscow, Russia.	snersisyan@hse.ru	Tonevitsky, Alexander/R-5596-2019; Galatenko, Alexei/ABA-6197-2020; Nersisyan, Stepan/AAG-6242-2019	Galatenko, Alexei/0000-0002-7987-2738; Nersisyan, Stepan/0000-0002-8830-4679				Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Berg AO, 2009, GENET MED, V11, P66, DOI 10.1097/GIM.0b013e3181928f56; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Bosia C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-131; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carlomosti F, 2017, ANTIOXID REDOX SIGN, V27, P328, DOI 10.1089/ars.2016.6643; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Colpaert RMW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070737; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Do DN, 2019, GENOMICS, V111, P849, DOI 10.1016/j.ygeno.2018.05.009; Fan YN, 2016, NUCLEIC ACIDS RES, V44, pW135, DOI 10.1093/nar/gkw288; Galatenko VV, 2015, SCI REP-UK, V5, DOI 10.1038/srep14967; Galatenko VV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20215-5; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hall P, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-16; Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013; Hao SH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015158; Hecker N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064543; Hedman H, 2010, ACTA ONCOL, V49, P812, DOI 10.3109/0284186X.2010.492789; Hollern DP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47218-0; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kim HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039482; Kim SJ, 2008, ANN ONCOL, V19, P68, DOI 10.1093/annonc/mdm358; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Leshkowitz D, 2013, RNA, V19, P527, DOI 10.1261/rna.036475.112; Li AM, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0458-3; Liu C, 2019, ONCOTARGETS THER, V12, P3817, DOI 10.2147/OTT.S179870; Liu FL, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00177; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; Lundberg A, 2017, CLIN CANCER RES, V23, P7512, DOI 10.1158/1078-0432.CCR-17-1535; MAHAJAN V, 1977, J MARKETING RES, V14, P586, DOI 10.2307/3151206; Mallik S, 2015, J BIOMED INFORM, V57, P308, DOI 10.1016/j.jbi.2015.08.014; Maltseva Diana V, 2014, BMC Res Notes, V7, P871, DOI 10.1186/1756-0500-7-871; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Milde-Langosch K, 2013, BREAST CANCER RES TR, V137, P57, DOI 10.1007/s10549-012-2296-x; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Moore, 2021, BASIC PRACTICE STAT; Mulrane L, 2013, CANCER RES, V73, P6554, DOI 10.1158/0008-5472.CAN-13-1841; Nersisya S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041228; Nersisyan S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235987; Ngwenya S, 2003, ENDOCRINOLOGY, V144, P1675, DOI 10.1210/en.2002-0009; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Putluri N, 2014, NEOPLASIA, V16, P390, DOI 10.1016/j.neo.2014.05.007; Ramalingam P, 2014, RNA, V20, P76, DOI 10.1261/rna.041814.113; Rao MS, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00636; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Reddy KB, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0185-1; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shah KN, 2014, MOL CANCER RES, V12, P394, DOI 10.1158/1541-7786.MCR-13-0219; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shkurnikov M, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00122; Simon N, 2013, J COMPUT GRAPH STAT, V22, P231, DOI 10.1080/10618600.2012.681250; Sinn BV, 2019, NPJ BREAST CANCER, V5, DOI 10.1038/s41523-019-0111-0; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Steiman-Shimony A, 2018, RNA, V24, P991, DOI 10.1261/rna.064386.117; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong Z, 2019, NUCLEIC ACIDS RES, V47, pD253, DOI 10.1093/nar/gky1023; Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869; Turchinovich A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00011; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vuaroqueaux V, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1681; Wang HH, 2019, BIOINFORMATICS, V35, P1181, DOI 10.1093/bioinformatics/bty750; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Xu H, 2012, IEEE T PATTERN ANAL, V34, P187, DOI 10.1109/TPAMI.2011.177; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang C, 2013, CANCER LETT, V340, P104, DOI 10.1016/j.canlet.2013.07.004; Yao HL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54188-w; Zeidler M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010232; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhang SH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S10; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhang YF, 2017, ONCOTARGET, V8, P57723, DOI 10.18632/oncotarget.17301	102	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249424	10.1371/journal.pone.0249424	http://dx.doi.org/10.1371/journal.pone.0249424			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852600	gold, Green Published			2022-12-26	WOS:000640604500056
J	Tamura, K; Matsumoto, S; Tseng, YH; Kobayashi, T; Miwa, J; Miyazawa, K; Hirao, T; Matsumoto, S; Hiramatsu, S; Otake, H; Okamoto, T				Tamura, Kaori; Matsumoto, Sayaka; Tseng, Yu Hsuan; Kobayashi, Takayuki; Miwa, Jun'ichi; Miyazawa, Ken'ichi; Hirao, Toyotaka; Matsumoto, Soichiro; Hiramatsu, Seiji; Otake, Hiroyuki; Okamoto, Tsuyoshi			Physiological and subjective comfort evaluation under different airflow directions in a cooling environment	PLOS ONE			English	Article							THERMAL COMFORT; MODEL; PERCEPTION; MOVEMENT; DRAFT; PMV	Indoor comfort is influenced by airflow direction, but subjective evaluations can differ. This study evaluates the airflow comfort with subjective assessments and physiological measurements, including skin temperature, electroencephalograms, and electrocardiograms. Nineteen participants entered a test room at 20 degrees C after staying in a room at 32 degrees C for acclimation. They were exposed to indirect and direct airflow conditions to their faces and performed four tasks under each condition: resting, counting to 10 s following time alerts, counting to 10 s in mind, and mental calculation. Subjective assessments showed relatively higher thermal sensation and pleasantness under indirect airflow. The psychological time calculated from counting behaviors was longer under indirect airflow, indicating suppression of negative emotions. The face temperatures significantly declined during experiments under direct airflow. The beta and gamma bands of electroencephalograms were inhibited under the indirect condition, and these amplitudes were negatively correlated with pleasant feelings. Electrocardiogram parameters indicated that sympathetic nervous activity was predominant during counting, following alerts and mental calculation in indirect airflow. This study supports the comfort of indirect airflow based on reliable evidence.	[Tamura, Kaori; Matsumoto, Sayaka; Okamoto, Tsuyoshi] Kyushu Univ, Fac Arts & Sci, Nishi Ku, Fukuoka, Japan; [Tseng, Yu Hsuan; Okamoto, Tsuyoshi] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka, Japan; [Kobayashi, Takayuki; Miwa, Jun'ichi] Mitsubishi Heavy Ind Co Ltd, Res & Innovat Ctr, Nagoya, Aichi, Japan; [Miyazawa, Ken'ichi; Hirao, Toyotaka; Matsumoto, Soichiro; Hiramatsu, Seiji; Otake, Hiroyuki] Mitsubishi Heavy Ind Thermal Syst LTD, Kiyosu, Aichi, Japan	Kyushu University; Kyushu University; Mitsubishi Heavy Industries; Mitsubishi Heavy Industries	Okamoto, T (corresponding author), Kyushu Univ, Fac Arts & Sci, Nishi Ku, Fukuoka, Japan.; Okamoto, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka, Japan.	okamoto@artsci.kyushu-u.ac.jp		Tamura, Kaori/0000-0001-6458-2247				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Camm AJ, 1996, EUR HEART J, V17, P354; Cheung T, 2019, BUILD ENVIRON, V153, P205, DOI 10.1016/j.buildenv.2019.01.055; Choi Y, 2015, BUILD ENVIRON, V88, P65, DOI 10.1016/j.buildenv.2014.10.003; de Dear RJ, 2013, INDOOR AIR, V23, P442, DOI 10.1111/ina.12046; FANGER P. O., 1970, Thermal comfort. Analysis and applications in environmental engineering.; FANGER PO, 1988, ENERG BUILDINGS, V12, P21, DOI 10.1016/0378-7788(88)90053-9; FANGER PO, 1986, ERGONOMICS, V29, P215, DOI 10.1080/00140138608968261; Fardo F, 2017, J NEUROPHYSIOL, V117, P1959, DOI 10.1152/jn.00843.2016; Hoyt T, 2009, P HLTH BUILD 2009 SY; Humphreys MA, 2002, ENERG BUILDINGS, V34, P667, DOI 10.1016/S0378-7788(02)00018-X; JAFFE RS, 1994, J AUTONOM NERV SYST, V46, P37, DOI 10.1016/0165-1838(94)90142-2; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Miller J, 2013, PSYCHON B REV, V20, P819, DOI 10.3758/s13423-013-0404-5; Okamoto T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11755-3; Rieder MK, 2011, INT J PSYCHOPHYSIOL, V79, P39, DOI 10.1016/j.ijpsycho.2010.08.010; Son YJ, 2018, INDOOR AIR, V28, P916, DOI 10.1111/ina.12491; Steinborn MB, 2018, PSYCHOL ASSESSMENT, V30, P339, DOI 10.1037/pas0000482; Toftum J, 1996, INT J IND ERGONOM, V18, P295, DOI 10.1016/0169-8141(95)00070-4; Toftum J, 2004, INDOOR AIR, V14, P40, DOI 10.1111/j.1600-0668.2004.00271.x; Toftum J, 2002, ENERG BUILDINGS, V34, P601, DOI 10.1016/S0378-7788(02)00010-5; Tran Y, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13554; van Hoof J, 2008, INDOOR AIR, V18, P182, DOI 10.1111/j.1600-0668.2007.00516.x; Zakay D, 2015, CONSCIOUS COGN, V38, P182, DOI 10.1016/j.concog.2015.10.006; Zakay D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00917; Zhang GQ, 2007, INDOOR BUILT ENVIRON, V16, P148, DOI 10.1177/1420326X06076792; Zhang H, 2007, INT J BIOMETEOROL, V51, P349, DOI 10.1007/s00484-006-0079-y; Zhang Y, 2016, INDOOR AIR, V26, P820, DOI 10.1111/ina.12256	29	2	2	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0249235	10.1371/journal.pone.0249235	http://dx.doi.org/10.1371/journal.pone.0249235			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RN8MG	33852598	gold, Green Published			2022-12-26	WOS:000640604500064
J	Zhao, HW; Merchant, NN; McNulty, A; Radcliff, TA; Cote, MJ; Fischer, RSB; Sang, HY; Ory, MG				Zhao, Hongwei; Merchant, Naveed N.; McNulty, Alyssa; Radcliff, Tiffany A.; Cote, Murray J.; Fischer, Rebecca S. B.; Sang, Huiyan; Ory, Marcia G.			COVID-19: Short term prediction model using daily incidence data	PLOS ONE			English	Article								Background Prediction of the dynamics of new SARS-CoV-2 infections during the current COVID-19 pandemic is critical for public health planning of efficient health care allocation and monitoring the effects of policy interventions. We describe a new approach that forecasts the number of incident cases in the near future given past occurrences using only a small number of assumptions. Methods Our approach to forecasting future COVID-19 cases involves 1) modeling the observed incidence cases using a Poisson distribution for the daily incidence number, and a gamma distribution for the series interval; 2) estimating the effective reproduction number assuming its value stays constant during a short time interval; and 3) drawing future incidence cases from their posterior distributions, assuming that the current transmission rate will stay the same, or change by a certain degree. Results We apply our method to predicting the number of new COVID-19 cases in a single state in the U.S. and for a subset of counties within the state to demonstrate the utility of this method at varying scales of prediction. Our method produces reasonably accurate results when the effective reproduction number is distributed similarly in the future as in the past. Large deviations from the predicted results can imply that a change in policy or some other factors have occurred that have dramatically altered the disease transmission over time. Conclusion We presented a modelling approach that we believe can be easily adopted by others, and immediately useful for local or state planning.	[Zhao, Hongwei; McNulty, Alyssa; Radcliff, Tiffany A.; Cote, Murray J.; Fischer, Rebecca S. B.; Ory, Marcia G.] Texas A&M Univ, Sch Publ Hlth, College Stn, TX 77843 USA; [Merchant, Naveed N.; Sang, Huiyan] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Zhao, HW (corresponding author), Texas A&M Univ, Sch Publ Hlth, College Stn, TX 77843 USA.	hongweizhao@tamu.edu		Zhao, Hongwei/0000-0001-8604-8694; McNulty-Nebel, Alyssa/0000-0002-4281-8236; Fischer, Rebecca/0000-0002-5048-2955; Ory, Marcia/0000-0001-8036-2383				Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; [Anonymous], 2020, COVID 19 FOR CAS; [Anonymous], 2020, WHO SURG CALC; [Anonymous], 2020, COR DIS COVID 19 DAS; Begley S, 2020, INFLUENTIAL COVID 19; Best R, 2020, 538 1002; Bjornstad ON, 2020, NAT METHODS, V17, P557, DOI 10.1038/s41592-020-0856-2; Bui Q., 2020, WHAT 5 CORONAVIRUS M; Carey B., 2020, NEW YORK; Chen Y, 2020, J INVERSE ILL-POSE P, V28, P243, DOI 10.1515/jiip-2020-0010; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Crary D., 2020, EUROPE US REEL VIRUS; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Friston Karl J, 2020, Wellcome Open Res, V5, P89, DOI [10.12688/wellcomeopenres.15881.2, 10.12688/wellcomeopenres.15881.1]; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Godio A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103535; Joseph A., 2020, BREAKING POINT NEW S; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Leeuwenberg AM, 2020, LANCET DIGIT HEALTH, V2, pE496, DOI 10.1016/S2589-7500(20)30226-0; Marfak A, 2020, DATA BRIEF, V32, DOI 10.1016/j.dib.2020.106067; Pan HS, 2020, QUANT BIOL, V8, P325, DOI 10.1007/s40484-020-0224-3; Roth M., 2020, HEALTHLEADERS E 1012; Sahai AK, 2020, DIABETES METAB SYND, V14, P1419, DOI 10.1016/j.dsx.2020.07.042; Salzberg S., 2020, CORONAVIRUS THERE AR; Scudellari M, 2020, NATURE, V584, P22, DOI 10.1038/d41586-020-02278-5; Shao N, 2020, MATH METHOD APPL SCI, V43, P4943, DOI 10.1002/mma.6345; Sperrin M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3777; Sun HX., 2020, TRACKING PREDICTING, DOI [10.1101/2020.02.17.20024257, DOI 10.1101/2020.02.17.20024257]; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhao YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124582; Zhu YF, 2021, STAT BIOSCI, V13, P1, DOI 10.1007/s12561-020-09277-0	31	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2021	16	4							e0250110	10.1371/journal.pone.0250110	http://dx.doi.org/10.1371/journal.pone.0250110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8MG	33852642	gold, Green Published, Green Submitted			2022-12-26	WOS:000640604500044
J	D'Agata, F; Caroppo, P; Spalatro, A; Lavagnino, L; Daga, GA; Boghi, A; Bergui, M; Cicerale, A; Vitiello, B; Fassino, S; Derntl, B; Amianto, F				D'Agata, Federico; Caroppo, Paola; Spalatro, Angela; Lavagnino, Luca; Daga, Giovanni Abbate; Boghi, Andrea; Bergui, Mauro; Cicerale, Alessandro; Vitiello, Benedetto; Fassino, Secondo; Derntl, Birgit; Amianto, Federico			Emotional imagination of negative situations: Functional neuroimaging in anorexia and bulimia	PLOS ONE			English	Article							EATING-DISORDERS; PREFRONTAL CORTEX; EMPATHY; NERVOSA; AMYGDALA; ALEXITHYMIA; SELF; FEAR; VALIDATION; THERAPY	Aim The present study aims to extend the knowledge of the neural correlates of emotion processing in first episode subjects affected by anorexia nervosa (AN) or bulimia nervosa (BN). We applied an emotional distress paradigm targeting negative emotions thought to be relevant for interpersonal difficulties and therapeutic resistance mechanisms. Methods The current study applied to 44 female participants with newly diagnosed AN or BN and 20 matched controls a neuroimaging paradigm eliciting affective responses. The measurements also included an extensive assessment comprising clinical scales, neuropsychological tests, measures of emotion processing and empathy. Results AN and BN did not differ from controls in terms of emotional response, emotion matching, self-reported empathy and cognitive performance. However, eating disorder and psychopathological clinical scores, as well as alexithymia levels, were increased in AN and BN. On a neural level, no significant group differences emerged, even when focusing on a region of interest selected a priori: the amygdala. Some interesting findings put in relation the hippocampal activity with the level of Body Dissatisfaction of the participants, the relative importance of the key nodes for the common network in the decoding of different emotions (BN = right amygdala, AN = anterior cingulate area), and the qualitative profile of the deactivations. Conclusions Our data do not support the hypothesis that participants with AN or BN display reduced emotional responsiveness. However, peculiar characteristics in emotion processing could be associated to the three different groups. Therefore, relational difficulties in eating disorders, as well as therapeutic resistance, could be not secondary to a simple difficulty in feeling and identifying basic negative emotions in AN and BN participants.	[D'Agata, Federico; Spalatro, Angela; Daga, Giovanni Abbate; Bergui, Mauro; Cicerale, Alessandro; Fassino, Secondo; Amianto, Federico] Univ Torino, Dept Neurosci, Turin, Italy; [D'Agata, Federico] Univ Med Ctr Utrecht, Ctr Image Sci, Computat Imaging Grp MR Diagnost & Therapy, Utrecht, Netherlands; [Caroppo, Paola] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy; [Lavagnino, Luca] UT Houston Med Sch, Dept Psychiat & Behav Sci, UT Ctr Excellence Mood Disorders, Houston, TX USA; [Boghi, Andrea] ASL TO2 San Giovanni Bosco Hosp, Turin, Italy; [Vitiello, Benedetto] Univ Torino, Dept Publ Hlth & Pediat Sci, Turin, Italy; [Derntl, Birgit] Univ Hosp Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany	University of Turin; Utrecht University; Utrecht University Medical Center; IRCCS Istituto Neurologico Besta; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Turin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	D'Agata, F (corresponding author), Univ Torino, Dept Neurosci, Turin, Italy.; D'Agata, F (corresponding author), Univ Med Ctr Utrecht, Ctr Image Sci, Computat Imaging Grp MR Diagnost & Therapy, Utrecht, Netherlands.	federico.dagata@unito.it	bergui, mauro/AAY-2430-2021; D'Agata, Federico/ABG-8839-2021; Abbate Daga, Giovanni/AAE-3155-2022; Vitiello, Benedetto/AAC-1758-2022	bergui, mauro/0000-0002-5336-695X; D'Agata, Federico/0000-0001-9432-0248; Boghi, Andrea/0000-0003-1729-4036				Abbate-Daga G, 2012, EUR EAT DISORD REV, V20, P496, DOI 10.1002/erv.2199; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; Alia-Klein N, 2020, NEUROSCI BIOBEHAV R, V108, P480, DOI 10.1016/j.neubiorev.2019.12.002; Amianto F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00849; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bang L, 2016, PSYCHIAT RES-NEUROIM, V248, P126, DOI 10.1016/j.pscychresns.2015.12.008; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Beadle JN, 2013, ANN CLIN PSYCHIATRY, V25, P107; Bisby JA, 2017, CURR OPIN BEHAV SCI, V17, P124, DOI 10.1016/j.cobeha.2017.07.012; Bisby JA, 2016, SOC COGN AFFECT NEUR, V11, P981, DOI 10.1093/scan/nsw028; Boghi A, 2011, PSYCHIAT RES-NEUROIM, V192, P154, DOI 10.1016/j.pscychresns.2010.12.008; BRUCH H, 1982, AM J PSYCHIAT, V139, P1531; Cardi V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133827; Cicerale A, 2013, CLIN NEUROPSYCHIATR, V10, P217; Cowdrey FA, 2012, PSYCHIAT RES-NEUROIM, V201, P190, DOI 10.1016/j.pscychresns.2011.08.009; D'Agata F, 2015, PSYCHIAT CLIN NEUROS, V69, P708, DOI 10.1111/pcn.12318; de Sampaio FTP, 2015, PSYCHIAT RES, V229, P887, DOI 10.1016/j.psychres.2015.07.049; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Derntl B, 2012, SCHIZOPHR RES, V136, P70, DOI 10.1016/j.schres.2011.12.018; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; Derntl B, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-91; Derntl B, 2009, SCHIZOPHR RES, V108, P197, DOI 10.1016/j.schres.2008.11.009; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Donnelly B, 2018, J EAT DISORD, V6, DOI 10.1186/s40337-018-0187-1; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Fassino S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-282; Fichter MM, 2016, INT J EAT DISORDER, V49, P391, DOI 10.1002/eat.22501; First M. B., 1997, STRUCTURED CLIN INTE; Fonville L, 2014, NEUROIMAGE-CLIN, V4, P266, DOI 10.1016/j.nicl.2013.12.002; Frank GKW, 2019, CHILD ADOL PSYCH CL, V28, P629, DOI 10.1016/j.chc.2019.05.007; Frank GKW, 2012, INT J EAT DISORDER, V45, P227, DOI 10.1002/eat.20929; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hambrook D, 2008, BRIT J CLIN PSYCHOL, V47, P335, DOI 10.1348/014466507X272475; Hambrook D, 2011, BRIT J CLIN PSYCHOL, V50, P310, DOI 10.1348/014466510X519215; Harrison A, 2011, CLIN PSYCHOL PSYCHOT, V18, P445, DOI 10.1002/cpp.726; Hebart MN, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00088; Horster I, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00777; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lavender JM, 2015, CLIN PSYCHOL REV, V40, P111, DOI 10.1016/j.cpr.2015.05.010; Leppanen J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00780; Lloyd EC, 2018, J EAT DISORD, V6, DOI 10.1186/s40337-018-0217-z; Maier S, 2019, EUR EAT DISORD REV, V27, P315, DOI 10.1002/erv.2663; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Morris R, 2014, COGN NEUROPSYCHIATRY, V19, P47, DOI 10.1080/13546805.2013.794723; Olivo G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081907; Pauli WM, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.63; Pedersen SH, 2015, J AM PSYCHOANAL ASS, V63, P671, DOI 10.1177/0003065115602440; Pedersen SH, 2012, EUR EAT DISORD REV, V20, P303, DOI 10.1002/erv.2158; Phillipou A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01181; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Poulsen S, 2014, AM J PSYCHIAT, V171, P109, DOI 10.1176/appi.ajp.2013.12121511; PRUITT JA, 1992, J CLIN PSYCHOL, V48, P472; Roberts ME, 2013, WORLD J BIOL PSYCHIA, V14, P452, DOI 10.3109/15622975.2011.639804; Rodriguez-Cano T, 2014, COMPR PSYCHIAT, V55, P1130, DOI 10.1016/j.comppsych.2014.02.009; Scalabrini A, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00346; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Seidel M, 2018, NEUROIMAGE-CLIN, V18, P1, DOI 10.1016/j.nicl.2017.12.035; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Silva JR, 2011, EAT WEIGHT DISORD-ST, V16, pE73, DOI 10.3275/7310; Tabibnia G, 2005, PSYCHOTHER PSYCHOSOM, V74, P81, DOI 10.1159/000083166; Tasca Giorgio A, 2014, Psychodyn Psychiatry, V42, P257, DOI 10.1521/pdps.2014.42.2.257; Tchanturia K, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0537-x; Tian Y, 2020, NAT NEUROSCI, V23, P1421, DOI 10.1038/s41593-020-00711-6; Treasure J, 2012, EUR EAT DISORD REV, V20, P431, DOI 10.1002/erv.2181; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; van Zutphen L, 2019, EAT WEIGHT DISORD-ST, V24, P1155, DOI 10.1007/s40519-017-0474-x; Vizueta N, 2012, NEUROIMAGE, V59, P761, DOI 10.1016/j.neuroimage.2011.07.015; Wilson S, 2017, INT J EAT DISORDER, V50, P1437, DOI 10.1002/eat.22789; Yuan BK, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00243; Zhou L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21657; Zipfel S, 2014, LANCET, V383, P127, DOI 10.1016/S0140-6736(13)61746-8	81	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0231684	10.1371/journal.pone.0231684	http://dx.doi.org/10.1371/journal.pone.0231684			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0OE	33836002	gold, Green Published			2022-12-26	WOS:000639361000015
J	Kafita, D; Daka, V; Nkhoma, P; Zulu, M; Zulu, E; Tembo, R; Ngwira, Z; Mwaba, F; Sinkala, M; Munsaka, S				Kafita, Doris; Daka, Victor; Nkhoma, Panji; Zulu, Mildred; Zulu, Ephraim; Tembo, Rabecca; Ngwira, Zifa; Mwaba, Florence; Sinkala, Musalula; Munsaka, Sody			High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF/ELF4; PROMOTE	The malignant phenotype of tumour cells is fuelled by changes in the expression of various transcription factors, including some of the well-studied proteins such as p53 and Myc. Despite significant progress made, little is known about several other transcription factors, including ELF4, and how they help shape the oncogenic processes in cancer cells. To this end, we performed a bioinformatics analysis to facilitate a detailed understanding of how the expression variations of ELF4 in human cancers are related to disease outcomes and the cancer cell drug responses. Here, using ELF4 mRNA expression data of 9,350 samples from the Cancer Genome Atlas pan-cancer project, we identify two groups of patient's tumours: those that expressed high ELF4 transcripts and those that expressed low ELF4 transcripts across 32 different human cancers. We uncover that patients segregated into these two groups are associated with different clinical outcomes. Further, we find that tumours that express high ELF4 mRNA levels tend to be of a higher-grade, afflict a significantly older patient population and have a significantly higher mutation burden. By analysing dose-response profiles to 397 anti-cancer drugs of 612 well-characterised human cancer cell lines, we discover that cell lines that expressed high ELF4 mRNA transcript are significantly less responsive to 129 anti-cancer drugs, and only significantly more response to three drugs: dasatinib, WH-4-023, and Ponatinib, all of which remarkably target the proto-oncogene tyrosine-protein kinase SRC and tyrosine-protein kinase ABL1. Collectively our analyses have shown that, across the 32 different human cancers, the patients afflicted with tumours that overexpress ELF4 tended to have a more aggressive disease that is also is more likely more refractory to most anti-cancer drugs, a finding upon which we could devise novel categorisation of patient tumours, treatment, and prognostic strategies.	[Kafita, Doris; Nkhoma, Panji; Zulu, Ephraim; Sinkala, Musalula; Munsaka, Sody] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Daka, Victor] Univ Zambia, Sch Med, Dept Pathol & Microbiol, Lusaka, Zambia; [Zulu, Mildred; Tembo, Rabecca; Ngwira, Zifa; Mwaba, Florence] Copperbelt Univ, Sch Med, Dept Clin Sci, Ndola, Zambia	University of Zambia; University of Zambia; Copperbelt University	Kafita, D (corresponding author), Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.	kafitadorisk@gmail.com	Munsaka, Sody/AAD-9186-2022	Munsaka, Sody/0000-0002-6917-3888; Zulu, Mildred/0000-0002-3250-4196				Aier I, 2018, 2018 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB), P207, DOI 10.1109/BSB.2018.8770545; Ando K, 2013, J BIOL CHEM, V288, P9457, DOI 10.1074/jbc.M112.415703; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bauer DC, 2014, TRENDS MOL MED, V20, P479, DOI 10.1016/j.molmed.2014.04.001; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Budka Justin A, 2018, Genes Cancer, V9, P198, DOI 10.18632/genesandcancer.182; D.Kafita, 2020, medRxiv, DOI 10.1101/2020.05.12.20099424; Nguyen DT, 2017, NUCLEIC ACIDS RES, V45, pD995, DOI 10.1093/nar/gkw1072; Diaz-Moralli S, 2013, PHARMACOL THERAPEUT, V138, P255, DOI 10.1016/j.pharmthera.2013.01.011; Epstein JB, 2012, CA-CANCER J CLIN, V62, P401, DOI 10.3322/caac.21157; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Hagenbuchner J, 2016, BIOCHEM PHARMACOL, V107, P1, DOI 10.1016/j.bcp.2015.12.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helgadottir HT., 2019, SOMATIC MUTATIONS HL; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Hsing M, 2020, MED RES REV, V40, P413, DOI 10.1002/med.21575; Hung JS, 2014, ONCOTARGET, V5, P2096, DOI 10.18632/oncotarget.1815; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Kafita D., 2020, PROTEOGENOMIC ANAL P, DOI [10.1101/2020.04.13.039834, DOI 10.1101/2020.04.13.039834]; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Kim JY, 2017, ONCOTARGET, V8, P27997, DOI 10.18632/oncotarget.15881; Kosti A, 2020, MOL CANCER RES, V18, P68, DOI 10.1158/1541-7786.MCR-19-0187; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Ma'ayan A, 2014, TRENDS PHARMACOL SCI, V35, P450, DOI 10.1016/j.tips.2014.07.001; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Masamoto Yosuke, 2018, Stem Cell Investig, V5, P10, DOI 10.21037/sci.2018.03.05; Mason CC, 2016, LEUKEMIA, V30, P906, DOI 10.1038/leu.2015.337; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sashida G, 2010, CELL CYCLE, V9, P3457, DOI 10.4161/cc.9.17.13000; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Silver JK, 2013, AM J PHYS MED REHAB, V92, P715, DOI 10.1097/PHM.0b013e31829b4afe; Sinkala M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58290-2; Sinkala M, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0666-1; Suico MA, 2004, J BIOL CHEM, V279, P19091, DOI 10.1074/jbc.M312439200; Suico MA, 2017, J MOL CELL BIOL, V9, P168, DOI 10.1093/jmcb/mjw051; Suico MA, 2014, J BIOL CHEM, V289, P26143, DOI 10.1074/jbc.M114.580209; Sze KMF, 2021, HEPATOLOGY, V73, P23, DOI 10.1002/hep.31231; Very N, 2018, ONCOTARGET, V9, P1380, DOI 10.18632/oncotarget.22377; Wang L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3500-5; Wang YM, 2018, CELL REP, V25, P1304, DOI 10.1016/j.celrep.2018.10.001; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yamaguchi Shigeo, 2018, Oncotarget, V9, P14193, DOI 10.18632/oncotarget.24447; Yang J, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0954-x; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]; Zhang XY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009795	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2021	16	4							e0248984	10.1371/journal.pone.0248984	http://dx.doi.org/10.1371/journal.pone.0248984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0OE	33836003	gold, Green Published, Green Submitted			2022-12-26	WOS:000639361000032
J	Baheti, A; Hanson, CA; McArdle, M; Lall, SK; Beller, GA; Bourque, JM				Baheti, Aparna; Hanson, Christopher A.; McArdle, Michael; Lall, Sumeet K.; Beller, George A.; Bourque, Jamieson M.			Lead aVR predicts early revascularization but not long-term events in patients referred for stress electrocardiography	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; CORONARY-ARTERY-DISEASE; PROGNOSTIC VALUE; DECISION-MAKING; TREADMILL SCORE; LEFT MAIN; EXERCISE	Background Exercise stress electrocardiography (ExECG) is recommended as a first-line tool to assess ischemia, but standard ST-analysis has limited diagnostic accuracy. ST elevation in lead aVR has been associated with left main and LAD disease in the population undergoing coronary angiography but has not been studied in the general population undergoing stress testing for the initial evaluation of CAD without coronary angiography. We sought to determine the predictive value of lead aVR elevation for ischemia, early revascularization, and subsequent cardiac events in consecutive patients undergoing ExECG. Methods and results The study cohort included 641 subjects referred for ExECG who were dichotomized by presence or absence of aVR elevation >= 1mm and compared for prevalence and predictors of ischemia and a composite of cardiac death, nonfatal myocardial infarction, and late revascularization. The cohort had a median age of 57 and 57% were male. The prevalence of aVR elevation was 11.5%. The prevalence of significant ischemia on patients who received imaging was significantly higher with aVR elevation (14.3% vs 2.3%, p<0.001). Early revascularization occurred in 10.9% with vs 0.2% without aVR elevation, p<0.001. No subjects without aVR elevation or ST-depression underwent early revascularization. However, cardiac event rates were similar over a median 4.0 years of follow-up with and without aVR elevation (2.8% vs. 2.6%, p = 0.80). aVR elevation did not predict long-term cardiac events by Kaplan-Meier survival analysis (p = 0.94) or Cox proportional hazards modeling (p = 0.35). Conclusions aVR elevation during ExECG predicts ischemia on imaging and early revascularization but not long-term outcomes and could serve as a useful adjunct to standard ST-analysis and potentially reduce the need for concurrent imaging.	[Baheti, Aparna; McArdle, Michael; Lall, Sumeet K.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Hanson, Christopher A.; Beller, George A.; Bourque, Jamieson M.] Univ Virginia Hlth Syst, Cardiovasc Imaging Ctr, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Bourque, JM (corresponding author), Univ Virginia Hlth Syst, Cardiovasc Imaging Ctr, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22903 USA.	jbourque@virginia.edu		Hanson, Christopher/0000-0002-8002-6213				Aygul N, 2008, J ELECTROCARDIOL, V41, P335, DOI 10.1016/j.jelectrocard.2008.02.025; Barrabes JA, 2003, CIRCULATION, V108, P814, DOI 10.1161/01.CIR.0000084553.92734.83; Bourque JM, 2009, J AM COLL CARDIOL, V54, P538, DOI 10.1016/j.jacc.2009.04.042; D'Ascenzo F, 2012, HEART, V98, P914, DOI 10.1136/heartjnl-2011-301596; Des Prez RD, 2005, J NUCL CARDIOL, V12, P750, DOI 10.1016/j.nuclcard.2005.10.001; Dilsizian V, 2011, JACC-CARDIOVASC IMAG, V4, P209, DOI 10.1016/j.jcmg.2011.01.001; Dorbala S, 2018, J NUCL CARDIOL, V25, P1784, DOI 10.1007/s12350-018-1283-y; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Einstein AJ, 2014, J AM COLL CARDIOL, V63, P1480, DOI 10.1016/j.jacc.2013.10.092; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kligfield P, 2006, CIRCULATION, V114, P2070, DOI 10.1161/CIRCULATIONAHA.105.561944; Kosuge M, 2006, AM J CARDIOL, V97, P334, DOI 10.1016/j.amjcard.2005.08.049; Ladapo JA, 2014, ANN INTERN MED, V161, P482, DOI 10.7326/M14-0296; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; Maron DJ, 2020, NEW ENGL J MED, V382, P1395, DOI 10.1056/NEJMoa1915922; Michaelides AP, 2003, CLIN CARDIOL, V26, P226, DOI 10.1002/clc.4960260506; Michaelides AP, 1999, INT J CARDIOL, V71, P49, DOI 10.1016/S0167-5273(99)00115-1; Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520; Neill J, 2007, EUR J NUCL MED MOL I, V34, P338, DOI 10.1007/s00259-006-0188-1; Pellikka PA, 2020, J AM SOC ECHOCARDIOG, V33, P1, DOI 10.1016/j.echo.2019.07.001; Shaw LJ, 2010, JACC-CARDIOVASC IMAG, V3, P789, DOI 10.1016/j.jcmg.2010.05.004; Shaw LJ, 1998, CIRCULATION, V98, P1622, DOI 10.1161/01.CIR.98.16.1622; Uthamalingam S, 2011, JACC-CARDIOVASC IMAG, V4, P176, DOI 10.1016/j.jcmg.2010.11.014; Vorobiof G, 2011, JACC-CARDIOVASC IMAG, V4, P187, DOI 10.1016/j.jcmg.2010.11.011; Wagener M, 2017, AM J CARDIOL, V119, P959, DOI 10.1016/j.amjcard.2016.11.056; Watson DD, 2007, J NUCL CARDIOL, V14, P466, DOI 10.1016/j.nuclcard.2007.06.007	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249779	10.1371/journal.pone.0249779	http://dx.doi.org/10.1371/journal.pone.0249779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM0NQ	33831085	Green Published, gold			2022-12-26	WOS:000639359600019
J	Galido, A; Ecleo, JJ; Husnayain, A; Su, ECY				Galido, Adrian; Ecleo, Jerina Jean; Husnayain, Atina; Su, Emily Chia-Yu			Exploring online search behavior for COVID-19 preventive measures: The Philippine case	PLOS ONE			English	Article							INFORMATION; TRENDS	Public health agencies have suggested nonpharmaceutical interventions to curb the spread of the COVID-19 infections. The study intended to explore the information-seeking behavior and information needs on preventive measures for COVID-19 in the Philippine context. The search interests and related queries for COVID-19 terms and each of the preventive measures for the period from December 31, 2019 to April 6, 2020 were generated from Google Trends. The search terms employed for COVID-19 were coronavirus, ncov, covid-19, covid19 and "covid 19." The search terms of the preventive measures considered for this study included "community quarantine", "cough etiquette", "face mask" or facemask, "hand sanitizer", handwashing or "hand washing" and "social distancing." Spearman's correlation was employed between the new daily COVID-19 cases, COVID-19 terms and the different preventive measures. The relative search volume for the coronavirus disease showed an increase up to the pronouncement of the country's first case of COVID-19. An uptrend was also evident after the country's first local transmission was confirmed. A strong positive correlation (r(s) = .788, p < .001) was observed between the new daily cases and search interests for COVID-19. The search interests for the different measures and the new daily cases were also positively correlated. Similarly, the search interests for the different measures and the COVID-19 terms were all positively correlated. The search interests for "face mask" or facemask, "hand sanitizer" and handwashing or "hand washing" were more correlated with the search interest for COVID-19 than with the number of new daily COVID-19 cases. The search interests for "cough etiquette", "social distancing" and "community quarantine" were more correlated with the number of new daily COVID-19 cases than with the search interest for COVID-19. The public sought for additional details such as type, directions for proper use, and where to purchase as well as do-it-yourself alternatives for personal protective items. Personal protective or community measures were expected to be accompanied with definitions and guidelines as well as be available in translated versions. Google Trends could be a viable option to monitor and address the information needs of the public during a disease outbreak. Capturing and analyzing the search interests of the public could support the design and timely delivery of appropriate information essential to drive preventive measures during a disease outbreak.	[Galido, Adrian; Ecleo, Jerina Jean] MSU Iligan Inst Technol, Coll Comp Studies, Dept Informat Technol, Iligan, Philippines; [Husnayain, Atina; Su, Emily Chia-Yu] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Husnayain, Atina] Univ Gadjah Mada, Dept Biostat Epidemiol & Populat Hlth, Fac Med, Publ Hlth & Nursing, Yogyakarta, Indonesia; [Su, Emily Chia-Yu] Taipei Med Univ Hosp, Clin Big Data Res Ctr, Taipei, Taiwan	Mindanao State University System; Mindanao State University-IIT; Taipei Medical University; Gadjah Mada University; Taipei Medical University; Taipei Medical University Hospital	Galido, A (corresponding author), MSU Iligan Inst Technol, Coll Comp Studies, Dept Informat Technol, Iligan, Philippines.	adrian.galido@g.msuiit.edu.ph	Galido, Adrian/GLV-0420-2022; Galido, Adrian/ABC-2899-2021	Galido, Adrian/0000-0002-9344-2945; Husnayain, Atina/0000-0003-3002-8728				Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9; [Anonymous], 2020, COVID 19 DATA REPOSI; Arora VS, 2019, HEALTH POLICY, V123, P338, DOI 10.1016/j.healthpol.2019.01.001; Bento AI, 2020, P NATL ACAD SCI USA, V117, P11220, DOI 10.1073/pnas.2005335117; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; CNN Philippines Staff, 2020, CNN PHILIPPINES; DOH, 2020, DOH INV PNEUM CAS HI; DOH, 2020, WHAT CAN I DO PREV S; DOST-PHIVOLCS, 2020, ER UPD TAAL VOLC 13; Galvez D, 2020, MERCURY DRUG RUNS OU, DOI [1212381/mercury-drug-runs-out-of-face-masks-as-taal-volcano-eruption-wreaks-ashfall, DOI 1212381/MERCURY-DRUG-RUNS-OUT-OF-FACE-MASKS-AS-TAAL-VOLCANO-ERUPTION-WREAKS-ASHFALL]; Gan N, 2020, NEW VIRUS RELATED SA; Hawkins RP, 2008, HEALTH EDUC RES, V23, P454, DOI 10.1093/her/cyn004; Husnayain A, 2020, INT J INFECT DIS, V95, P221, DOI 10.1016/j.ijid.2020.03.021; Keller AM, 2020, COGN RES, V5, DOI 10.1186/s41235-020-00245-2; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Kreuter MW, 2003, AM J HEALTH BEHAV, V27, pS227; KUHLTHAU CC, 1993, J DOC, V49, P339, DOI 10.1108/eb026918; Legaspi A, 2020, DEMAND N95 MASKS ASH; Mahroum N, 2019, HEALTH INFORM J, V25, P1383, DOI 10.1177/1460458218766573; Malig K, 2020, HERES PREVENT COVID; Milinovich GJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0690-1; Paunan JCR, 2020, MONTH LONG COMMUNITY; Pineda LT., 2020, DOH UNDERSCORES SOCI; Radin M, 2017, LUPUS, V26, P886, DOI 10.1177/0961203317691372; Ripberger JT, 2011, POLICY STUD J, V39, P239, DOI 10.1111/j.1541-0072.2011.00406.x; Sanchez MJ, 2019, MARKET SHARE SEARCH; Santos E, 2020, PHILIPPINES COVID 19; Southwell BG., HLTH ISSUES, V6, P7; Stocking Galen, 2017, USING GOOGLE TRENDS; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; WHO, 2020, 67 WHO; World Health Organization, 2020, DIR GEN OP REM MED B	33	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2021	16	4							e0249810	10.1371/journal.pone.0249810	http://dx.doi.org/10.1371/journal.pone.0249810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RM0NQ	33831076	gold, Green Published			2022-12-26	WOS:000639359600029
J	Monestime, S; Beech, B; Kermah, D; Norris, K				Monestime, Shanada; Beech, Bettina; Kermah, Dulcie; Norris, Keith			Prevalence and predictors of obesity-related cancers among racial/ethnic groups with metabolic syndrome	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; RISK; POPULATION; METAANALYSIS; EPIGENETICS; WEIGHT; IMPACT	Background Obesity-related cancer (ORC) is associated with higher amounts of body fat, which could increase the risk of developing cardiovascular disease (CVD). A significant factor associated with CVD is metabolic syndrome (MetS), and MetS prevalence differs by race/ethnicity. The purpose of this study was to compare the prevalence and predictors of ORCs by race/ethnicity among adults (>18) with MetS. Methods This was a retrospective, cross-sectional study using data from the 1999-2014 National Health and Nutrition Examination Survey (NHANES). A chi-square test was performed to determine differences in ORC prevalence between non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic participants with MetS. A multivariate logistic regression was used to evaluate predictors (race, sex, income, insurance, education, marital status, and smoking status) of ORC among adults with MetS. Results Of the 1,554 adults, the prevalence of ORC was 30.6% among NHWs, 51.3% in NHBs, and 54.1% in Hispanics (p = <0.001). Females were 6.27 times more likely to have an ORC compared to males (95% CI = 4.95-14.11). Compared to NHWs, NHBs were 2.1 times more likely to have an ORC (95% CI = 1.40-3.38); and Hispanics were 2.5 times more likely (95% CI = 1.39-4.77). For every 1-year unit increase in age, the odds of ORC increased by 3% (95% CI = 1.00-1.05). Conclusions Among NHANES participants with MetS, the prevalence of ORCs was significantly higher in NHBs and Hispanics, females, and older adults with MetS. Future studies, by race/ethnicity, are warranted on mortality risk of persons with MetS and ORC.	[Monestime, Shanada] Univ North Texas Syst, Dept Pharmacotherapy, Coll Pharm, Ft Worth, TX 76107 USA; [Beech, Bettina] Univ Houston, Coll Med, Houston, TX USA; [Kermah, Dulcie] Charles R Drew Univ Med & Sci, 1621 E 120th St, Los Angeles, CA 90059 USA; [Norris, Keith] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA	University of Houston System; University of Houston; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles	Monestime, S (corresponding author), Univ North Texas Syst, Dept Pharmacotherapy, Coll Pharm, Ft Worth, TX 76107 USA.	Shanada.monestime@gmail.com		Monestime, Shanada/0000-0002-5994-065X	National Heart, Lung, and Blood Institute [2R25HL126145]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SM, BB, DK, NK-This research was supported by a grant from the National Heart, Lung, and Blood Institute to the University of Mississippi Medical Center (Grant #2R25HL126145 -MPIs Beech and Norris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Chadid S, 2020, INT J OBESITY, V44, P601, DOI 10.1038/s41366-020-0519-5; Chebet JJ, 2020, CANCER EPIDEM BIOMAR, V29, P591, DOI 10.1158/1055-9965.EPI-19-1063; Chen Y, 2013, CANCER EPIDEM BIOMAR, V22, P1395, DOI 10.1158/1055-9965.EPI-13-0042; Chen Y, 2012, EUR J CANCER, V48, P2137, DOI 10.1016/j.ejca.2012.02.063; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Faldoni FLC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051164; de Haas EC, 2010, LANCET ONCOL, V11, P193, DOI 10.1016/S1470-2045(09)70287-6; Friedenreich CM, 2008, BRIT J SPORT MED, V42, P636, DOI 10.1136/bjsm.2006.029132; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Greenlee H, 2016, J CLIN ONCOL, V34, P3133, DOI 10.1200/JCO.2016.66.4391; Hodge AM, 2018, PUBLIC HEALTH NUTR, V21, P1618, DOI 10.1017/S1368980017002555; Hong YR, 2019, VALUE HEALTH, V22, P1378, DOI 10.1016/j.jval.2019.07.004; Hoyo C, 2012, INT J EPIDEMIOL, V41, P1706, DOI 10.1093/ije/dys176; Jacobs EJ, 2020, AM J EPIDEMIOL, V189, P108, DOI 10.1093/aje/kwz230; Kazanjian A, 2012, EUR J ONCOL NURS, V16, P399, DOI 10.1016/j.ejon.2011.09.002; Kwon H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38203-0; Mehta P, 2008, J CANCER EDUC, V23, P201, DOI 10.1080/08858190802470778; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Notterman DA, 2015, PEDIATR CLIN N AM, V62, P1227, DOI 10.1016/j.pcl.2015.05.012; Plan and operation of the Third National Health and Nutrition Examination Survey, 1994, PROGR COLL PROC V 1, V32, P1; Steele CB, 2017, MMWR-MORBID MORTAL W, V66, P1052, DOI 10.15585/mmwr.mm6639e1; Sturgeon KM, 2019, EUR HEART J, V40, P3889, DOI 10.1093/eurheartj/ehz766; Sun JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119313; Wang FR, 2014, INT J CANCER, V135, P1673, DOI 10.1002/ijc.28813; Westerink MDNL, 2016, CRIT REV ONCOL HEMAT, V108, P128, DOI 10.1016/j.critrevonc.2016.10.011; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664	27	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249188	10.1371/journal.pone.0249188	http://dx.doi.org/10.1371/journal.pone.0249188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826671	gold, Green Published			2022-12-26	WOS:000638119900030
J	Woodman, N; Ikram, S; Rowland, J				Woodman, Neal; Ikram, Salima; Rowland, Joanne			A new addition to the embalmed fauna of ancient Egypt: Guldenstaedt's White-toothed Shrew, Crocidura gueldenstaedtii (Pallas, 1811) (Mammalia: Eulipotyphla: Soricidae)	PLOS ONE			English	Article								The Falcon Necropolis at Quesna in the Nile Delta of Egypt is considered to have been founded by the priest Djedhor, the Saviour, of Athribis (Tell Atrib in modern Benha) at the beginning of the Ptolemaic Period. Recent excavations here have revealed abundant avian remains from mummies dedicated to the ancient Egyptian god Horus Khenty-Khety. Among the few mammal remains from the site are five species of shrews (Eulipotyphla: Soricidae), including some that we identified as Guldenstaedt's White-toothed Shrew, Crocidura gueldenstaedtii (Pallas, 1811). Discovery of this species at Quesna increases the number of shrews recovered from ancient Egyptian archaeological sites to eight species. Crocidura gueldenstaedtii no longer occurs in the Nile Delta, and its presence in a diverse shrew fauna at Quesna that includes one other extirpated species, Crocidura fulvastra (Sundevall, 1843), supports the hypothesis of a moister regional environment 2000-3000 years ago. Inadvertently preserved local faunas, such as that from Quesna, can provide valuable information about ancient environments and subsequent turnover in faunal communities.	[Woodman, Neal] US Geol Survey, Leetown Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Woodman, Neal] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20002 USA; [Ikram, Salima] Amer Univ Cairo, Dept Sociol Egyptol & Anthropol, New Cairo, Egypt; [Ikram, Salima] Stellenbosch Univ, Dept Ancient Studies, Stellenbosch, South Africa; [Rowland, Joanne] Univ Edinburgh, Sch Hist Class & Archaeol, Dept Archaeol, Edinburgh, Midlothian, Scotland	United States Department of the Interior; United States Geological Survey; Smithsonian Institution; Smithsonian National Museum of Natural History; Egyptian Knowledge Bank (EKB); American University Cairo; Stellenbosch University; University of Edinburgh	Woodman, N (corresponding author), US Geol Survey, Leetown Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA.; Woodman, N (corresponding author), Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20002 USA.	woodmann@si.edu		Woodman, Neal/0000-0003-2689-7373				Bannikova AA, 2006, MAMMALIA, V70, P106, DOI 10.1515/MAMM.2006.011; Bernhardt CE, 2012, GEOLOGY, V40, P615, DOI 10.1130/G33012.1; Brunner-Traut E., 1965, PHILOLOGISCH HIST KL, V7, P123; Burgin C.J., 2018, P332; BUTZER KW, 1980, SAHARA NILE, P253, DOI DOI 10.1126/SCIENCE.208.4445.736-A; Butzer KW., 1976, EARLY HYDRAULIC CIVI, DOI [10.1001/archneur.1976.00500030062014, DOI 10.1001/ARCHNEUR.1976.00500030062014]; Carraway Leslie N., 1995, Occasional Papers of the Museum of Natural History University of Kansas, V175, P1; Charron A., 2012, EGYPTE AFRIQUE ORIEN, V66, P3; Churchfield S., 2013, HEDGEHOGS SHREWS BAT, V4, P79; Dubey S, 2007, MOL ECOL, V16, P3438, DOI 10.1111/j.1365-294X.2007.03396.x; Dubey S, 2006, MOL PHYLOGENET EVOL, V38, P635, DOI 10.1016/j.ympev.2005.11.005; Flores DV., 2003, FUNERARY SACRIFICE A; Fouda MM., 2014, EGYPTS 5 NATL REPORT; Galan JM, 2014, CONSERVATION OF SUBTERRANEAN CULTURAL HERITAGE, P3; Goodman Steven M., 1992, Palaeoecology of Africa and the Surrounding Islands, V23, P73; Heim de Balsac H, 1971, Mammalia, V35, P220, DOI 10.1515/mamm.1971.35.2.220; Hekkala ER, 2020, J ARCHAEOL SCI-REP, V33, DOI 10.1016/j.jasrep.2020.102483; Hoogstraal H., 1962, Journal of the Egyptian Public Health Association, V37, P143; Hutterer R., 1983, SENCKENBERGIANA BIOL, V63, P17; Hutterer Rainer, 2002, Bonner Zoologische Beitraege, V50, P249; Hutterer Rainer, 1994, Carnegie Museum of Natural History Special Publication, V18, P407; Ikram S., 2008, KMT, V19, P34; Ikram S., 2005, DIVINE CREATURES ANI; Ikram S., 2005, STRUCTURE SIGNIFICAN, V33 25, P336; Ikram S., 2012, HEAVEN EARTH BIRDS A; Ikram S., 2015, APPRIVOISER SAUVAGET; Ikram S, 2015, J ARCHAEOL SCI, V63, P72, DOI 10.1016/j.jas.2015.08.015; Jelinkova-Reymond E, 1956, BDE, V23, pXI; Jenkins PD., 2013, HEDGEHOGS SHREWS BAT, P78; Kessler D., 2005, DIVINE CREATURES ANI; Kessler D, 1989, AGYPTEN ALTES TESTAM, V16, P1; KOWALSKI K, 1989, QUATERNARY RES, V32, P335, DOI 10.1016/0033-5894(89)90099-9; McKnight L., 2015, ANCIENT EGYPTIAN ANI; Nicholson PT, 2015, ANTIQUITY, V89, P645, DOI 10.15184/aqy.2014.53; Osborn DJ, 1980, ZOOLOGY, V5, P1; Passalacqua J, 1826, CATALOGUE RAISONN HI; Richardin P, 2017, RADIOCARBON, V59, P595, DOI 10.1017/RDC.2016.102; Rowland J., 2014, POPULAR ARCHAEOLOGY; Rowland J, 2013, J EGYPT ARCHAEOL, V99, P53; Setzer H. W., 1957, Journal of the Egyptian Public Health Association, V32, P1; Sherman Elizabeth J., 1981, J EGYPT ARCHAEOL, V67, P82; Shpirer E, 2021, MAMMALIA, V85, P79, DOI 10.1515/mammalia-2019-0143; Vernus P, 1978, BDE, V74, P193; von den Driesch A., 2005, AGYPTEN LEVANTE EGYP, V15, P203, DOI DOI 10.1553/AEUNDL15S203; Westendorf W., 1986, LEXIKON GYPTOLOGIE, P571; Williams MAJ, 2015, QUATERNARY SCI REV, V130, P72, DOI 10.1016/j.quascirev.2015.03.007; Williams MAJ, 2009, GLOBAL PLANET CHANGE, V69, P1, DOI 10.1016/j.gloplacha.2009.07.005; Woodman N., QUAT RES FORTHCOMING, DOI [10.1016/j.yqres.2010.11.003, DOI 10.1016/J.YQRES.2010.11.003]; Woodman N, 2017, ZOOTAXA, V4341, P1, DOI 10.11646/zootaxa.4341.1.1; Yeakel JD, 2014, P NATL ACAD SCI USA, V111, P14472, DOI 10.1073/pnas.1408471111	50	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2021	16	4							e0249377	10.1371/journal.pone.0249377	http://dx.doi.org/10.1371/journal.pone.0249377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RK2GO	33826664	Green Published, gold			2022-12-26	WOS:000638119900012
J	Robinson, KP; Jochem, A; Johnson, SE; Reddy, TR; Russell, JD; Coon, JJ; Pagliarini, DJ				Robinson, Kyle P.; Jochem, Adam; Johnson, Sheila E.; Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.; Pagliarini, David J.			Defining intermediates and redundancies in coenzyme Q precursor biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC ROBUSTNESS; ACID; METABOLISM; PATHWAY; MUTANTS	Coenzyme Q (CoQ), a redox-active lipid essential for oxidative phosphorylation, is synthesized by virtually all cells, but how eukaryotes make the universal CoQ head group precursor 4-hydroxybenzoate (4-HB) from tyrosine is unknown. The first and last steps of this pathway have been defined in Saccharomyces cerevisiae, but the intermediates and enzymes involved in converting 4-hydroxyphenylpyruvate (4-HPP) to 4-hydroxybenzaldehyde (4-HBz) have not been described. Here, we interrogate this pathway with genetic screens, targeted LC-MS, and chemical genetics. We identify three redundant aminotransferases (Bna3, Bat2, and Aat2) that support CoQ biosynthesis in the absence of the established pathway tyrosine aminotransferases, Aro8 and Aro9. We use isotope labeling to identify bona fide tyrosine catabolites, including 4-hydroxyphenylacetate (4-HPA) and 4-hydroxyphenyllactate (4-HPL). Additionally, we find multiple compounds that rescue this pathway when exogenously supplemented, most notably 4-hydroxyphenylacetaldehyde (4-HPAA) and 4-hydroxymandelate (4-HMA). Finally, we show that the Ehrlich pathway decarboxylase Aro10 is dispensable for 4-HB production. These results define new features of 4-HB synthesis in yeast, demonstrate the redundant nature of this pathway, and provide a foundation for further study.	[Robinson, Kyle P.; Johnson, Sheila E.; Pagliarini, David J.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Robinson, Kyle P.; Jochem, Adam; Johnson, Sheila E.; Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.; Pagliarini, David J.] Morgridge Inst Res, Madison, WI 53715 USA; [Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.; Pagliarini, David J.] Natl Ctr Quantitat Biol Complex Syst, Madison, WI 53706 USA; [Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Coon, Joshua J.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Pagliarini, David J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Pagliarini, David J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Pagliarini, David J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pagliarini, DJ (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.; Pagliarini, DJ (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.; Pagliarini, DJ (corresponding author), Natl Ctr Quantitat Biol Complex Syst, Madison, WI 53706 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	pagliarini@wustl.edu			National Institutes of Health [R01 ES026955, R01 ES010546, P01 CA160032]; Vanderbilt-Ingram Cancer Center [P30 CA-068485]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES026955 (to F. P. G. and M. E.), R01 ES010546 (to F. P. G.), P01 CA160032 (to M. E. and C. J. R.), and Vanderbilt-Ingram Cancer Center (P30 CA-068485). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Block A, 2014, PLANT CELL, V26, P1938, DOI 10.1105/tpc.114.125807; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Cheng W, 2014, SCIENCE, V343, P878, DOI 10.1126/science.1246774; COX GB, 1964, BIOCHIM BIOPHYS ACTA, V93, P204, DOI 10.1016/0304-4165(64)90285-5; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; EDMAN JC, 1993, YEAST, V9, P669, DOI 10.1002/yea.320090613; Generoso WC, 2016, J MICROBIOL METH, V127, P203, DOI 10.1016/j.mimet.2016.06.020; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Valera MJ, 2020, YEAST, V37, P427, DOI 10.1002/yea.3508; Valera MJ, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00701-20; Kemmerer Z.A., 2020, BIORXIV, DOI [10.1101/2020.12.09.418202, DOI 10.1101/2020.12.09.418202]; KISHORE G, 1976, J BACTERIOL, V128, P182, DOI 10.1128/JB.128.1.182-191.1976; Kneen MM, 2011, FEBS J, V278, P1842, DOI 10.1111/j.1742-4658.2011.08103.x; LESTER RL, 1959, J BIOL CHEM, V234, P2169; Loke WM, 2009, J NUTR, V139, P2309, DOI 10.3945/jn.109.113613; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munier-Lehmann H, 2013, J MED CHEM, V56, P3148, DOI 10.1021/jm301848w; OLSON RE, 1963, J BIOL CHEM, V238, P3146; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Payet LA, 2016, CELL CHEM BIOL, V23, P1241, DOI 10.1016/j.chembiol.2016.08.008; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; RAO DNR, 1977, CAN J MICROBIOL, V23, P1496, DOI 10.1139/m77-222; Romagnoli G, 2012, APPL ENVIRON MICROB, V78, P7538, DOI 10.1128/AEM.01675-12; Salviati L, 2017, GENEREVIEWS R; Soubeyrand E, 2018, PLANT CELL, V30, P2910, DOI 10.1105/tpc.18.00688; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; uo X., 2010, NAT BIOTECHNOL; Urrestarazu A, 1998, MOL GEN GENET, V257, P230, DOI 10.1007/s004380050643; Xie LTX, 2015, J LIPID RES, V56, P909, DOI 10.1194/jlr.M057919; Zhang Y, 2020, BIORESOUR TECHNOL RE, V11, DOI DOI 10.1016/J.BITEB.2020.100517; Ziosi M, 2017, EMBO MOL MED, V9, P96, DOI 10.15252/emmm.201606356	41	6	6	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100643	10.1016/j.jbc.2021.100643	http://dx.doi.org/10.1016/j.jbc.2021.100643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862086	Green Published, gold			2022-12-26	WOS:000672866400614
